PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Brown, G; Daniels, IR; Heald, RJ; Quirke, P; Blomqvist, L; Sebag-Montefiore, D; Moran, BJ; Holm, T; Strassbourg, J; Peppercorn, PD; Fisher, SE; Mason, B				Brown, G.; Daniels, I. R.; Heald, R. J.; Quirke, P.; Blomqvist, L.; Sebag-Montefiore, D.; Moran, B. J.; Holm, T.; Strassbourg, J.; Peppercorn, P. D.; Fisher, S. E.; Mason, B.		MERCURY Study Grp	Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study	BRITISH MEDICAL JOURNAL			English	Article							TOTAL MESORECTAL EXCISION; PROGNOSTIC-SIGNIFICANCE; CIRCUMFERENTIAL MARGIN; CARCINOMA; INVOLVEMENT; MRI; CHEMORADIOTHERAPY; RADIOTHERAPY; SPECIMEN; SURVIVAL	Objective To assess the accuracy of preoperative staging of rectal cancer with magnetic resonance imaging to predict surgical circumferential resection margins. Design Prospective observational study of rectal cancers treated by colorectal multidisciplinary teams between January 2002 and October 2003. Setting 11 colorectal units in four European countries. Participants 408 consecutive patients presenting with all stages of rectal cancer and undergoing magnetic resonance imaging before total mesorectal excision surgery and histopathological assessment of the surgical specimen. Main outcome measures Accuracy of magnetic resonance imaging in predicting a curative resection based on the histological yardstick of presence or absence of tumour at the margins of the specimen. Results 354 of the 408 patients had a clear circumferential resection margin (87%, 95% confidence interval 83% to 90%). Specificity for prediction of a clear margin by magnetic resonance imaging was 92% (327/354, 90% to 95%). High resolution scans were technically satisfactory in 93% (379/408). Surgical specimens were histopathologically graded as complete or moderate in 80% (328/408), and the median lymph node harvest was 12 (range 0-49). Magnetic resonance imaging predicted clear margins in 349 patients. At surgery 327 had clear margins (94%, 91% to 96%). Conclusion High resolution magnetic resonance imaging accurately predicts whether the surgical resection margins will be clear or affected by tumour. This technique can be reproduced accurately in multiple centres to predict curative resection and warns the multidisciplinary team of potential failure of surgery, thus enabling selection of patients for preoperative treatment.	Royal Marsden Hosp, Surrey SM2 5PT, England	Royal Marsden NHS Foundation Trust	Brown, G (corresponding author), Royal Marsden Hosp, Surrey SM2 5PT, England.	gina.brown@rmh.nhs.uk	BROWN, GINA/F-8081-2012; Quirke, Philip/AAI-1362-2019	Brown, Gina/0000-0002-2336-622X; Burke, Dermot/0000-0002-4342-7464				A'Hern RP, 2001, STAT MED, V20, P859, DOI 10.1002/sim.721; ADAM IJ, 1994, LANCET, V344, P707, DOI 10.1016/S0140-6736(94)92206-3; *ASS COL GREAT BRI, 1996, GUID MAN COL CANC, P65; Bipat S, 2004, RADIOLOGY, V232, P773, DOI 10.1148/radiol.2323031368; Birbeck KF, 2002, ANN SURG, V235, P449, DOI 10.1097/00000658-200204000-00001; Blomqvist L, 1999, BRIT J RADIOL, V72, P18, DOI 10.1259/bjr.72.853.10341684; Brown G, 2005, BRIT J RADIOL, V78, P245, DOI 10.1259/bjr/33540239; Brown G, 2003, RADIOLOGY, V227, P371, DOI 10.1148/radiol.2272011747; Brown G, 2004, AM J ROENTGENOL, V182, P431, DOI 10.2214/ajr.182.2.1820431; Brown G, 2003, BRIT J SURG, V90, P355, DOI 10.1002/bjs.4034; Brown G, 1999, RADIOLOGY, V211, P215, DOI 10.1148/radiology.211.1.r99ap35215; Burton S, 2006, BRIT J CANCER, V94, P351, DOI 10.1038/sj.bjc.6602947; FRYKHOLM GJ, 1995, RADIOTHER ONCOL, V34, P185, DOI 10.1016/0167-8140(95)01519-M; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; MACFARLANE JK, 1993, LANCET, V341, P457, DOI 10.1016/0140-6736(93)90207-W; Mackay SG, 2003, BRIT J SURG, V90, P346, DOI 10.1002/bjs.4042; Marr R, 2005, ANN SURG, V242, P74, DOI 10.1097/01.sla.0000167926.60908.15; Martling AL, 2000, LANCET, V356, P93, DOI 10.1016/S0140-6736(00)02469-7; MASON AY, 1976, AUST NZ J SURG, V46, P322; Maughan N J, 2003, Scand J Surg, V92, P11; Mawdsley S, 2005, INT J RADIAT ONCOL, V63, P745, DOI 10.1016/j.ijrobp.2005.03.003; Mohiuddin M, 2000, INT J RADIAT ONCOL, V46, P883, DOI 10.1016/S0360-3016(99)00486-1; Mohiuddin M, 1996, CANCER, V78, P717; Nagtegaal ID, 2002, J CLIN ONCOL, V20, P1729, DOI 10.1200/JCO.2002.07.010; NICHOLLS RJ, 1985, BRIT J SURG, V72, pS51, DOI 10.1002/bjs.1800721329; NICHOLLS RJ, 1982, BRIT J SURG, V69, P404, DOI 10.1002/bjs.1800690716; NICHOLLS RJ, 1985, BR J SURG S, V72, P51; Pahlman L, 1997, NEW ENGL J MED, V336, P980; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; van Lingen Christiaan P, 2003, Int J Gastrointest Cancer, V34, P129, DOI 10.1385/IJGC:34:2-3:129; Wibe A, 2002, BRIT J SURG, V89, P327, DOI 10.1046/j.0007-1323.2001.02024.x; Wibe A, 2002, DIS COLON RECTUM, V45, P857, DOI 10.1007/s10350-004-6317-7; WILLIAMS GT, 1998, MINIMUM DATA SET COL; Zerhouni EA, 1996, RADIOLOGY, V200, P443, DOI 10.1148/radiology.200.2.8685340; 2004, COLORECTAL DIS, V6, P521	35	604	616	0	16	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 14	2006	333	7572					779	782		10.1136/bmj.38937.646400.55	http://dx.doi.org/10.1136/bmj.38937.646400.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099AX	16984925	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000241566000013
J	Crino, PB; Nathanson, KL; Henske, EP				Crino, Peter B.; Nathanson, Katherine L.; Henske, Elizabeth Petri			The tuberous sclerosis complex	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							POLYCYSTIC KIDNEY-DISEASE; TUMOR-SUPPRESSOR GENE; RENAL-CELL CARCINOMA; B-RAF KINASE; PULMONARY LYMPHANGIOLEIOMYOMATOSIS; TSC1 GENE; MUTATIONAL ANALYSIS; INFANTILE SPASMS; 3-KINASE/AKT PATHWAY; CONSENSUS CONFERENCE		Univ Penn, Med Ctr, Dept Neurol, Philadelphia, PA 19104 USA; Univ Penn, Med Ctr, Div Med Genet, Philadelphia, PA 19104 USA; Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA	University of Pennsylvania; University of Pennsylvania; Fox Chase Cancer Center	Crino, PB (corresponding author), Univ Penn, Med Ctr, Dept Neurol, 3 W Gates Bldg,3400 Spruce St, Philadelphia, PA 19104 USA.	peter.crino@uphs.upenn.edu	Warfield, Simon/B-3352-2009	Warfield, Simon/0000-0002-7659-3880; Lipsker, Dan/0000-0003-4675-0336; Nathanson, Katherine/0000-0002-6740-0901	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051052, R29DK051052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045021] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL60746] Funding Source: Medline; NIDDK NIH HHS [DK51052] Funding Source: Medline; NINDS NIH HHS [NS045021] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Astrinidis A, 2006, HUM MOL GENET, V15, P287, DOI 10.1093/hmg/ddi444; Astrinidis A, 2003, J BIOL CHEM, V278, P51372, DOI 10.1074/jbc.M303956200; Astrinidis A, 2002, ONCOGENE, V21, P8470, DOI 10.1038/sj.onc.1205962; Bader RS, 2003, J PEDIATR-US, V143, P620, DOI 10.1067/S0022-3476(03)00494-3; Baybis M, 2004, ANN NEUROL, V56, P478, DOI 10.1002/ana.20211; Birchenall-Roberts MC, 2004, J BIOL CHEM, V279, P25605, DOI 10.1074/jbc.M402790200; Bjornsson J, 1996, AM J PATHOL, V149, P1201; Bourneville D., 1880, ARCH NEUROL-CHICAGO, V1, P81; BROOKCARTER PT, 1994, NAT GENET, V8, P328, DOI 10.1038/ng1294-328; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Catania MG, 2001, J NEUROPATH EXP NEUR, V60, P711, DOI 10.1093/jnen/60.7.711; Chan JA, 2004, J NEUROPATH EXP NEUR, V63, P1236, DOI 10.1093/jnen/63.12.1236; Costello LC, 2000, MAYO CLIN PROC, V75, P591, DOI 10.4065/75.6.591; Curatolo P, 2001, BRAIN DEV-JPN, V23, P502, DOI 10.1016/S0387-7604(01)00300-X; Dabora SL, 2001, AM J HUM GENET, V68, P64, DOI 10.1086/316951; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; El-Hashemite N, 2003, LANCET, V361, P1348, DOI 10.1016/S0140-6736(03)13044-9; Ewalt DH, 2005, J UROLOGY, V174, P1764, DOI 10.1097/01.ju.0000177497.31986.64; Ewalt DH, 1998, J UROLOGY, V160, P141, DOI 10.1016/S0022-5347(01)63072-6; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Finlay GA, 2004, J BIOL CHEM, V279, P23114, DOI 10.1074/jbc.M401912200; Franz DN, 2001, AM J RESP CRIT CARE, V164, P661, DOI 10.1164/ajrccm.164.4.2011025; Franz DN, 2006, ANN NEUROL, V59, P490, DOI 10.1002/ana.20784; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Goh S, 2005, NEUROLOGY, V65, P235, DOI 10.1212/01.wnl.0000168908.78118.99; Goh S, 2004, NEUROLOGY, V63, P1457, DOI 10.1212/01.wnl.0000142039.14522.1a; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Goodman M, 1997, J CHILD NEUROL, V12, P85, DOI 10.1177/088307389701200203; Haddad LA, 2002, J BIOL CHEM, V277, P44180, DOI 10.1074/jbc.M207211200; Henske EP, 1996, AM J HUM GENET, V59, P400; Hyman MH, 2000, ARCH NEUROL-CHICAGO, V57, P662, DOI 10.1001/archneur.57.5.662; Im E, 2002, ONCOGENE, V21, P6356, DOI 10.1038/sj.onc.1205792; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Johnson MW, 2001, MODERN PATHOL, V14, P202, DOI 10.1038/modpathol.3880286; Joinson C, 2003, PSYCHOL MED, V33, P335, DOI 10.1017/S0033291702007092; Jones AC, 1997, HUM MOL GENET, V6, P2155, DOI 10.1093/hmg/6.12.2155; Jones AC, 1999, AM J HUM GENET, V64, P1305, DOI 10.1086/302381; KANDT RS, 1992, NAT GENET, V2, P37, DOI 10.1038/ng0992-37; Karbowniczek M, 2004, J BIOL CHEM, V279, P29930, DOI 10.1074/jbc.M402591200; Karbowniczek M, 2003, AM J RESP CRIT CARE, V167, P976, DOI 10.1164/rccm.200208-969OC; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Koh S, 2000, EPILEPSIA, V41, P1206, DOI 10.1111/j.1528-1157.2000.tb00327.x; Kothary N, 2005, J VASC INTERV RADIOL, V16, P45, DOI 10.1079/01.RVI.0000143769.79774.70; Kwiatkowska J, 1998, ANN HUM GENET, V62, P277, DOI 10.1046/j.1469-1809.1998.6240277.x; Kwiatkowska J, 1999, NEW ENGL J MED, V340, P703, DOI 10.1056/NEJM199903043400905; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Lee L, 2005, GENE CHROMOSOME CANC, V42, P213, DOI 10.1002/gcc.20118; Li Y, 2003, J BIOL CHEM, V278, P13663, DOI 10.1074/jbc.M300862200; Liu MY, 2002, CANCER RES, V62, P6475; Lou Dingyuan, 2001, Molecular Cell Biology Research Communications, V4, P374, DOI 10.1006/mcbr.2001.0307; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Maheshwar MM, 1997, HUM MOL GENET, V6, P1991, DOI 10.1093/hmg/6.11.1991; Mak BC, 2005, AM J PATHOL, V167, P107, DOI 10.1016/S0002-9440(10)62958-6; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Miyata H, 2004, ANN NEUROL, V56, P510, DOI 10.1002/ana.20234; Mizuguchi M, 2001, BRAIN DEV-JPN, V23, P508, DOI 10.1016/S0387-7604(01)00304-7; Murthy V, 2004, J BIOL CHEM, V279, P1351, DOI 10.1074/jbc.M310208200; Nellist M, 2005, EUR J HUM GENET, V13, P59, DOI 10.1038/sj.ejhg.5201276; NELLIST M, 1993, CELL, V75, P1305; Niida Y, 1999, HUM MUTAT, V14, P412, DOI 10.1002/(SICI)1098-1004(199911)14:5<412::AID-HUMU7>3.0.CO;2-K; Niida Y, 2001, AM J HUM GENET, V69, P493, DOI 10.1086/321972; Noonan DJ, 2002, ARCH BIOCHEM BIOPHYS, V398, P132, DOI 10.1006/abbi.2001.2682; O'Callaghan FJ, 2004, BJU INT, V94, P853, DOI 10.1111/j.1464-410X.2004.05046.x; O'Callaghan FJK, 2004, ARCH DIS CHILD, V89, P530, DOI 10.1136/adc.2003.026815; Park SH, 1997, ACTA NEUROPATHOL, V94, P180, DOI 10.1007/s004010050691; Plank TL, 1999, MODERN PATHOL, V12, P539; Plank TL, 1998, CANCER RES, V58, P4766; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; POVEY S, 1994, ANN HUM GENET, V58, P107, DOI 10.1111/j.1469-1809.1994.tb01881.x; Prather P, 2004, J CHILD NEUROL, V19, P666, DOI 10.1177/08830738040190090601; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; Robertson FM, 1996, J PEDIATR SURG, V31, P729, DOI 10.1016/S0022-3468(96)90689-2; Rosner M, 2004, J BIOL CHEM, V279, P48707, DOI 10.1074/jbc.M405528200; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Ryu JH, 2006, AM J RESP CRIT CARE, V173, P105, DOI 10.1164/rccm.200409-1298OC; Sampson JR, 1997, AM J HUM GENET, V61, P843, DOI 10.1086/514888; Sancak O, 2005, EUR J HUM GENET, V13, P731, DOI 10.1038/sj.ejhg.5201402; Sato T, 2002, J HUM GENET, V47, P20, DOI 10.1007/s10038-002-8651-8; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Saucedo LJ, 2003, NAT CELL BIOL, V5, P680, DOI 10.1038/ncb0703-680c; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; SHEPHERD CW, 1991, MAYO CLIN PROC, V66, P792, DOI 10.1016/S0025-6196(12)61196-3; Smalley SL, 1998, J AUTISM DEV DISORD, V28, P407, DOI 10.1023/A:1026052421693; SMYTHE JF, 1990, AM J CARDIOL, V66, P1247, DOI 10.1016/0002-9149(90)91109-J; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Thiele EA, 2004, J CHILD NEUROL, V19, P680, DOI 10.1177/08830738040190090801; van Slegtenhorst M, 1999, J MED GENET, V36, P285; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; WASHECKA R, 1991, UROLOGY, V37, P340, DOI 10.1016/0090-4295(91)80261-5; Weiner HL, 2004, EPILEPSIA, V45, P41, DOI 10.1111/j.0013-9580.2004.04009.x; Wienecke R, 1996, ONCOGENE, V13, P913; Xiao GH, 1997, J BIOL CHEM, V272, P6097, DOI 10.1074/jbc.272.10.6097; XU L, 1995, GENOMICS, V27, P475, DOI 10.1006/geno.1995.1079; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	98	1191	1239	1	85	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2006	355	13					1345	1356		10.1056/NEJMra055323	http://dx.doi.org/10.1056/NEJMra055323			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088EF	17005952				2022-12-28	WOS:000240793600008
J	Saleh, M				Saleh, Maya			Caspase-1 builds a new barrier to infection	CELL			English	Editorial Material							FLAGELLIN; INTERLEUKIN-1-BETA; INFLAMMASOME; MACROPHAGES; ACTIVATE; IPAF	Caspase-1 promotes both the maturation of proinflammatory cytokines and apoptosis in cells infected by certain pathogens. Work by Gurcel et al. (2006) now reveals a surprising new function for caspase-1: the stimulation of membrane biogenesis to repair damage caused by bacterial pore-forming toxins. Thus, caspase-1 may promote host cell survival as a means of resistance to pathogenic bacteria.	McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada	McGill University	Saleh, M (corresponding author), McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada.	maya.saleh@mcgill.ca		Saleh, Maya/0000-0003-1538-9146				Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kuranaga E, 2006, CELL, V126, P583, DOI 10.1016/j.cell.2006.05.048; Launay S, 2005, ONCOGENE, V24, P5137, DOI 10.1038/sj.onc.1208524; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018	9	17	19	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 22	2006	126	6					1028	1030		10.1016/j.cell.2006.09.006	http://dx.doi.org/10.1016/j.cell.2006.09.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990128	Bronze			2022-12-28	WOS:000240897600009
J	Coca, SG; Krumholz, HM; Garg, AX; Parikh, CR				Coca, Steven G.; Krumholz, Harlan M.; Garg, Amit X.; Parikh, Chirag R.			Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CHRONIC KIDNEY-DISEASE; ACUTE MYOCARDIAL-INFARCTION; ACUTE CORONARY SYNDROMES; CHRONIC HEART-FAILURE; ENDOTHELIAL DYSFUNCTION; REVISED RECOMMENDATIONS; CREATININE CLEARANCE; FUNCTIONAL-CAPACITY; CONSORT STATEMENT; OXIDATIVE STRESS	Context Patients with renal disease are at high risk for cardiovascular mortality. Determining which interventions best offset this risk remains a health priority. Objective To quantify the representation of patients with renal disease in randomized controlled trials for interventions proven efficacious for cardiovascular disease. Data Sources We searched MEDLINE for trials published from 1985 through 2005 in 11 major medical and subspecialty journals. Study Selection Randomized controlled trials for chronic congestive heart failure and acute myocardial infarction of treatments that are currently listed as class I or II recommendations in the current American College of Cardiology/American Heart Association guidelines were included. Data Extraction Two reviewers independently abstracted data on study and patient characteristics, renal measurements, outcomes, and prognostic features. Data Synthesis A total of 153 trials were reviewed. Patients with renal disease were reported as excluded in 86 (56%) trials. Patients with renal disease were more likely to be excluded from trials that were multicenter; of moderate enrollment size; North American; that tested renin-angiotensin-aldosterone system antagonists and anticoagulants; and that tested chronic congestive heart failure. Only 8 (5%) original articles reported the proportion of enrolled patients with renal disease, and only 15 (10%) reported mean baseline renal function. While 81 (53%) trials performed subgroup analyses of some baseline characteristic in the original article, only 4 (3%) subgroup analyses of treatment stratified by renal disease were performed. Conclusion Major cardiovascular disease trials frequently exclude patients with renal disease and do not provide adequate information on the renal function of enrollees or the effect of interventions on patients with renal disease.	Vet Affairs Med Ctr, Clin Epidemiol Res Ctr, Nephrol Sect, West Haven, CT 06516 USA; Yale Univ, Sch Med, Dept Med, Clin Epidemiol Res Ctr, West Haven, CT 06516 USA; Univ Western Ontario, Dept Med, London, ON, Canada; Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Western University (University of Western Ontario); Western University (University of Western Ontario)	Parikh, CR (corresponding author), Vet Affairs Med Ctr, Clin Epidemiol Res Ctr, Nephrol Sect, 950 Campbell Ave,Mail Code 151B,Bldg 35A,Room 219, West Haven, CT 06516 USA.	chirag.parikh@yale.edu	, Harlan/AAI-2875-2020; Coca, Steven/L-7801-2019; Garg, Amit X/G-3295-2011	Coca, Steven/0000-0002-0928-9168; Parikh, Chirag/0000-0001-9051-7385	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK064689] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; [Anonymous], 1993, Lancet, V342, P767; Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002; BALL SG, 1993, LANCET, V342, P821; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Best PJM, 2002, J AM COLL CARDIOL, V39, P1113, DOI 10.1016/S0735-1097(02)01745-X; Boccardo P, 2004, SEMIN THROMB HEMOST, V30, P579, DOI 10.1055/s-2004-835678; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Caimi G, 2004, CLIN NEPHROL, V62, P331; Chertow GM, 2004, J AM SOC NEPHROL, V15, P2462, DOI 10.1097/01.ASN.0000135969.33773.0B; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; DEVITA C, 1994, LANCET, V343, P1115; DIBIANCO R, 1989, NEW ENGL J MED, V320, P677, DOI 10.1056/NEJM198903163201101; Dumaine R, 2004, AM J CARDIOL, V94, P1543, DOI 10.1016/j.amjcard.2004.08.035; Ezekowitz J, 2004, J AM COLL CARDIOL, V44, P1587, DOI 10.1016/j.jacc.2004.06.072; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Freedman BI, 2005, J AM SOC NEPHROL, V16, P2156, DOI 10.1681/ASN.2004100884; Freeman RV, 2003, J AM COLL CARDIOL, V41, P718, DOI 10.1016/S0735-1097(02)02956-X; Frilling B, 2002, AM J CARDIOL, V89, P450, DOI 10.1016/S0002-9149(01)02267-6; Gerlach AT, 2000, PHARMACOTHERAPY, V20, P771, DOI 10.1592/phco.20.9.771.35210; Ghiadoni L, 2004, J NEPHROL, V17, P512; Gibney EM, 2005, KIDNEY INT, V68, P826, DOI 10.1111/j.1523-1755.2005.00463.x; Gibson CM, 2003, J AM COLL CARDIOL, V42, P1535, DOI 10.1016/j.jacc.2003.06.001; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; Grines CL, 1999, NEW ENGL J MED, V341, P1949, DOI 10.1056/NEJM199912233412601; Hillege HL, 2000, CIRCULATION, V102, P203, DOI 10.1161/01.CIR.102.2.203; Horwich TB, 2002, J AM COLL CARDIOL, V39, P1780, DOI 10.1016/S0735-1097(02)01854-5; Hunt SA, 2005, CIRCULATION, V112, P1825, DOI 10.1016/j.jacc.2005.08.023; Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706; Januzzi JL, 2002, AM J CARDIOL, V90, P1246, DOI 10.1016/S0002-9149(02)02844-8; Januzzi JL, 2002, CIRCULATION, V105, P2361, DOI 10.1161/01.CIR.0000016359.94919.16; Kearney MT, 2002, J AM COLL CARDIOL, V40, P1801, DOI 10.1016/S0735-1097(02)02490-7; Keeley EC, 2003, AM J CARDIOL, V92, P509, DOI 10.1016/S0002-9149(03)00716-1; Kielstein JT, 2002, J AM SOC NEPHROL, V13, P170, DOI 10.1681/ASN.V131170; Lechat P, 1999, LANCET, V353, P9; Mahon NG, 2002, J AM COLL CARDIOL, V40, P1106, DOI 10.1016/S0735-1097(02)02125-3; Masoudi FA, 2003, AM HEART J, V146, P250, DOI 10.1016/S0002-8703(03)00189-3; McAlister FA, 2004, CIRCULATION, V109, P1004, DOI 10.1161/01.CIR.0000116764.53225.A9; Mcclellan WM, 2004, J AM SOC NEPHROL, V15, P1912, DOI 10.1097/01.asn.0000129982.10611.4c; McClellan WM, 2002, J AM SOC NEPHROL, V13, P1928, DOI 10.1097/01.ASN.0000018409.45834.FA; McCullough PA, 2002, AM HEART J, V144, P226, DOI 10.1067/mhj.2002.125513; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Muntner P, 2004, ANN INTERN MED, V140, P9, DOI 10.7326/0003-4819-140-1-200401060-00006; Murthy VH, 2004, JAMA-J AM MED ASSOC, V291, P2720, DOI 10.1001/jama.291.22.2720; PACKER M, 1993, NEW ENGL J MED, V329, P1, DOI 10.1056/NEJM199307013290101; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rasty S, 2002, J CLIN PHARMACOL, V42, P1366, DOI 10.1177/0091270002239367; Rathore SS, 2003, AM J MED, V114, P307, DOI 10.1016/S0002-9343(02)01531-0; Reddan DN, 2003, J AM SOC NEPHROL, V14, P2373, DOI 10.1097/01.ASN.0000083900.92829.F5; Sadeghi HM, 2003, CIRCULATION, V108, P2769, DOI 10.1161/01.CIR.0000103623.63687.21; Schwarz U, 2000, NEPHROL DIAL TRANSPL, V15, P218, DOI 10.1093/ndt/15.2.218; Shlipak MG, 2002, ANN INTERN MED, V137, P555, DOI 10.7326/0003-4819-137-7-200210010-00006; Shlipak MG, 2004, J AM SOC NEPHROL, V15, P2195, DOI 10.1097/01.ASN.0000135121.81744.75; Shlipak MG, 2003, CIRCULATION, V107, P87, DOI 10.1161/01.CIR.0000042700.48769.59; Shlipak MG, 2003, ANN INTERN MED, V138, P917, DOI 10.7326/0003-4819-138-11-200306030-00013; Silverberg DS, 2003, CLIN NEPHROL, V60, pS93; Stone GW, 2002, NEW ENGL J MED, V346, P957, DOI 10.1056/NEJMoa013404; SWEDBERG K, 1992, NEW ENGL J MED, V327, P678, DOI 10.1056/NEJM199209033271002; Szczech LA, 2002, CIRCULATION, V105, P2253, DOI 10.1161/01.CIR.0000016051.33225.33; Tokmakova MP, 2004, CIRCULATION, V110, P3667, DOI 10.1161/01.CIR.0000149806.01354.BF; Tonelli M, 2005, J AM SOC NEPHROL, V16, P3748, DOI 10.1681/ASN.2005070779; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Topol E, 1998, NEW ENGL J MED, V339, P436; Vaccarino V, 2005, NEW ENGL J MED, V353, P671, DOI 10.1056/NEJMsa032214; VALLANCE P, 1992, LANCET, V339, P572; Vaziri ND, 2002, HYPERTENSION, V39, P135, DOI 10.1161/hy0102.100540; Wallentin L, 1999, LANCET, V354, P708; Wang MC, 2005, AM J KIDNEY DIS, V45, P494, DOI 10.1053/j.ajkd.2004.11.011; WEAVER WD, 1993, JAMA-J AM MED ASSOC, V270, P1211, DOI 10.1001/jama.270.10.1211; Weiner DE, 2004, AM J KIDNEY DIS, V44, P198, DOI 10.1053/j.ajkd.2004.04.024; Willenheimer R, 2005, CIRCULATION, V112, P2426, DOI 10.1161/CIRCULATIONAHA.105.582320; Wright RS, 2002, ANN INTERN MED, V137, P563, DOI 10.7326/0003-4819-137-7-200210010-00007; Yusuf S, 2005, JAMA-J AM MED ASSOC, V293, P427	77	311	315	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2006	296	11					1377	1384		10.1001/jama.296.11.1377	http://dx.doi.org/10.1001/jama.296.11.1377			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085HS	16985230				2022-12-28	WOS:000240595800025
J	Buttiker, M				Buettiker, Markus			Detecting and controlling electron correlations	SCIENCE			English	Editorial Material							HANBURY-BROWN; NOISE		Univ Geneva, Dept Phys Theor, CH-1211 Geneva 4, Switzerland	University of Geneva	Buttiker, M (corresponding author), Univ Geneva, Dept Phys Theor, CH-1211 Geneva 4, Switzerland.	markus.buttiker@physics.unige.ch						Anantram MP, 1996, PHYS REV B, V53, P16390, DOI 10.1103/PhysRevB.53.16390; BEENAKKER CWJ, PREPRINT; Blanter YM, 2000, PHYS REP, V336, P1, DOI 10.1016/S0370-1573(99)00123-4; Chen YZ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.066604; Cottet A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.206801; Henny M, 1999, SCIENCE, V284, P296, DOI 10.1126/science.284.5412.296; Martin AM, 2000, PHYS REV LETT, V84, P3386, DOI 10.1103/PhysRevLett.84.3386; Martin T, 1996, PHYS LETT A, V220, P137, DOI 10.1016/0375-9601(96)00484-7; MCCLURE D, PREPRINT; Oberholzer S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.046804; Oberholzer S, 2000, PHYSICA E, V6, P314, DOI 10.1016/S1386-9477(99)00162-9; Oliver WD, 1999, SCIENCE, V284, P299, DOI 10.1126/science.284.5412.299; Rychkov V, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.166806; Samuelsson P, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.026805; Sauret O, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.106601; Texier C, 2000, PHYS REV B, V62, P7454, DOI 10.1103/PhysRevB.62.7454; Wu ST, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.153101	17	4	4	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2006	313	5793					1587	1588		10.1126/science.1127386	http://dx.doi.org/10.1126/science.1127386			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973869				2022-12-28	WOS:000240498900032
J	Naik, A; Buu, O; LaHaye, MD; Armour, AD; Clerk, AA; Blencowe, MP; Schwab, KC				Naik, A.; Buu, O.; LaHaye, M. D.; Armour, A. D.; Clerk, A. A.; Blencowe, M. P.; Schwab, K. C.			Cooling a nanomechanical resonator with quantum back-action	NATURE			English	Article							SINGLE-ELECTRON TRANSISTOR; NOISE; JOSEPHSON	Quantum mechanics demands that the act of measurement must affect the measured object. When a linear amplifier is used to continuously monitor the position of an object, the Heisenberg uncertainty relationship requires that the object be driven by force impulses, called back-action(1-3). Here we measure the back-action of a superconducting single-electron transistor (SSET) on a radiofrequency nanomechanical resonator. The conductance of the SSET, which is capacitively coupled to the resonator, provides a sensitive probe of the latter's position; back-action effects manifest themselves as an effective thermal bath, the properties of which depend sensitively on SSET bias conditions. Surprisingly, when the SSET is biased near a transport resonance, we observe cooling of the nanomechanical mode from 550 mK to 300 mK - an effect that is analogous to laser cooling in atomic physics. Our measurements have implications for nanomechanical readout of quantum information devices and the limits of ultrasensitive force microscopy ( such as single-nuclear-spin magnetic resonance force microscopy). Furthermore, we anticipate the use of these back-action effects to prepare ultracold and quantum states of mechanical structures, which would not be accessible with existing technology.	Univ Maryland, Lab Phys Sci, College Pk, MD 20740 USA; Univ Maryland, Dept Elect & Comp Engn, College Pk, MD 20740 USA; Univ Maryland, Dept Phys, College Pk, MD 20740 USA; Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England; McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Nottingham; McGill University; Dartmouth College	Schwab, KC (corresponding author), Univ Maryland, Lab Phys Sci, College Pk, MD 20740 USA.	schwab@ccmr.cornell.edu	Clerk, Aashish/A-4008-2008; Naik, Akshay K/C-4108-2009	Clerk, Aashish/0000-0001-7297-9068; Naik, Akshay K/0000-0001-6325-7231; LaHaye, Matthew/0000-0003-1911-0704; Blencowe, Miles/0000-0003-0051-0492; Armour, Andrew/0000-0002-7190-8601	Engineering and Physical Sciences Research Council [EP/C540182/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Abbott B, 2005, PHYS REV D, V72, DOI [10.1103/PhysRevD.72.062001, 10.1103/PhysRevD.72.082001]; Armour AD, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.125313; Armour AD, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.148301; Blencowe MP, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/236; Braginsky V. B., 1995, QUANTUM MEASUREMENT; Braginsky VB, 2002, PHYS LETT A, V293, P228, DOI 10.1016/S0375-9601(02)00020-8; CAVES CM, 1982, PHYS REV D, V26, P1817, DOI 10.1103/PhysRevD.26.1817; Choi MS, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.045105; Clerk AA, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/238; Clerk AA, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.245306; Clerk AA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.176804; Deblock R, 2003, SCIENCE, V301, P203, DOI 10.1126/science.1084175; FULTON TA, 1989, PHYS REV LETT, V63, P1307, DOI 10.1103/PhysRevLett.63.1307; Gavish U, 2000, PHYS REV B, V62, pR10637, DOI 10.1103/PhysRevB.62.R10637; Irish EK, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.155311; LaHaye MD, 2004, SCIENCE, V304, P74, DOI 10.1126/science.1094419; LETT PD, 1989, J OPT SOC AM B, V6, P2084, DOI 10.1364/JOSAB.6.002084; Lundin U, 2004, PHYS LETT A, V332, P127, DOI 10.1016/j.physleta.2004.09.058; Martin I, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.125339; Mozyrsky D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.018303; Mozyrsky D, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.018301; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; Ojha RP, 2004, NATURE, V427, P521, DOI 10.1038/nature02294; Pohlen SL, 2000, PHYSICA B, V284, P1812, DOI 10.1016/S0921-4526(99)03027-6; Rugar D, 2004, NATURE, V430, P329, DOI 10.1038/nature02658; Ruskov R, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.235407; Schoelkopf RJ, 1998, SCIENCE, V280, P1238, DOI 10.1126/science.280.5367.1238; SCHOELKOPF RJ, 2003, QUANTUM NOISE MESOSC; Tittonen I, 1999, PHYS REV A, V59, P1038, DOI 10.1103/PhysRevA.59.1038; Wilson-Rae I, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.075507	30	452	453	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2006	443	7108					193	196		10.1038/nature05027	http://dx.doi.org/10.1038/nature05027			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16971944	Green Accepted, Green Submitted			2022-12-28	WOS:000240467000042
J	Spiro, DM; Tay, KY; Arnold, DH; Dziura, JD; Baker, MD; Shapiro, ED				Spiro, David M.; Tay, Khoon-Yen; Arnold, Donald H.; Dziura, James D.; Baker, Mark D.; Shapiro, Eugene D.			Wait-and-see prescription for the treatment of acute otitis media - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESISTANT STREPTOCOCCUS-PNEUMONIAE; DOUBLE-BLIND; PRESCRIBING STRATEGIES; ANTIBIOTIC-TREATMENT; JUDICIOUS USE; CHILDREN; PLACEBO; AMOXICILLIN; PRINCIPLES; PHYSICIANS	Context Acute otitis media (AOM) is the most common diagnosis for which antibiotics are prescribed for children. Previous trials that have evaluated a "wait-and-see prescription" (WASP) for antibiotics, with which parents are asked not to fill the prescription unless the child either is not better or is worse in 48 hours, have excluded children with severe AOM. None of these trials were conducted in an emergency department. Objectives To determine whether treatment of AOM using a WASP significantly reduces use of antibiotics compared with a "standard prescription" (SP) and to evaluate the effects of this intervention on clinical symptoms and adverse outcomes related to antibiotic use. Design, Setting, and Patients A randomized controlled trial conducted between July 12, 2004, and July 11, 2005. Children with AOM aged 6 months to 12 years seen in an emergency department were randomly assigned to receive either a WASP or an SP. All patients received ibuprofen and otic analgesic drops for use at home. A research assistant, blinded to group assignment, conducted structured phone interviews 4 to 6, 11 to 14, and 30 to 40 days after enrollment to determine outcomes. Main Outcome Measures Filling of the antibiotic prescription and clinical course. Results Overall, 283 patients were randomized either to the WASP group (n = 138) or the SP group (n = 145). Substantially more parents in the WASP group did not fill the antibiotic prescription (62% vs 13%; P < .001). There was no statistically significant difference between the groups in the frequency of subsequent fever, otalgia, or unscheduled visits for medical care. Within the WASP group, both fever (relative risk [RR], 2.95; 95% confidence interval [CI], 1.75 - 4.99; P < .001) and otalgia (RR, 1.62; 95% CI, 1.26 - 2.03; P < .001) were associated with filling the prescription. Conclusion The WASP approach substantially reduced unnecessary use of antibiotics in children with AOM seen in an emergency department and may be an alternative to routine use of antimicrobials for treatment of such children.	Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; Vanderbilt Univ, Sch Med, Dept Emergency Med, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA	Yale University; Yale University; Yale University; Vanderbilt University; Vanderbilt University	Spiro, DM (corresponding author), Oregon Hlth & Sci Univ, Dept Emergency Med, Mail Code CDW-EM,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	spirod@ohsu.edu	Baker, Mark/N-7720-2019	Arnold, Donald/0000-0001-8694-4288	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI001703] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000142] Funding Source: Medline; NCRR NIH HHS [M01-RR00125] Funding Source: Medline; NIAID NIH HHS [AI01703] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bertin L, 1996, FUNDAM CLIN PHARM, V10, P387, DOI 10.1111/j.1472-8206.1996.tb00590.x; BURKE P, 1991, BRIT MED J, V303, P558, DOI 10.1136/bmj.303.6802.558; Dagan R, 2000, VACCINE, V19, pS9, DOI 10.1016/S0264-410X(00)00272-3; Dagan R, 2001, J INFECT DIS, V183, P880, DOI 10.1086/319250; Damoiseaux RAMJ, 2000, BRIT MED J, V320, P350, DOI 10.1136/bmj.320.7231.350; DelMar C, 1997, BRIT MED J, V314, P1526, DOI 10.1136/bmj.314.7093.1526; Dowell SF, 1998, PEDIATRICS, V101, P163; Dowell SF, 1998, PEDIATRICS, V101, P165; Finkelstein JA, 2005, PEDIATRICS, V115, P1466, DOI 10.1542/peds.2004-1473; Finkelstein JA, 2001, PEDIATRICS, V108, pU113; GLASZIOU PP, 2000, COCHRANE DB SYST REV, V4; Heikkinen T, 2000, ACTA PAEDIATR, V89, P1316, DOI 10.1080/080352500300002499; Hoberman A, 1997, ARCH PEDIAT ADOL MED, V151, P675, DOI 10.1001/archpedi.1997.02170440037006; Hoberman A, 1997, PEDIATR INFECT DIS J, V16, P463, DOI 10.1097/00006454-199705000-00002; Kozyrskyj AL, 1998, JAMA-J AM MED ASSOC, V279, P1736, DOI 10.1001/jama.279.21.1736; Le Saux N, 2005, CAN MED ASSOC J, V172, P335, DOI 10.1503/cmaj.1040771; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; Little P, 2001, BMJ-BRIT MED J, V322, P336, DOI 10.1136/bmj.322.7282.336; Little P, 1997, BRIT MED J, V315, P350; Louie JP, 2002, EMERG MED CLIN N AM, V20, P69, DOI 10.1016/S0733-8627(03)00052-X; Marchetti F, 2005, ARCH PEDIAT ADOL MED, V159, P679, DOI 10.1001/archpedi.159.7.679; McCaig LF, 2002, JAMA-J AM MED ASSOC, V287, P3096, DOI 10.1001/jama.287.23.3096; MCCAIG LF, 1995, JAMA-J AM MED ASSOC, V273, P214, DOI 10.1001/jama.273.3.214; McCormick DP, 2005, PEDIATRICS, V115, P1455, DOI 10.1542/peds.2004-1665; Rosenfeld RM, 2003, LARYNGOSCOPE, V113, P1645, DOI 10.1097/00005537-200310000-00004; Siegel RM, 2003, PEDIATRICS, V112, P527, DOI 10.1542/peds.112.3.527; Van Zuijlen DA, 2001, PEDIATR INFECT DIS J, V20, P140, DOI 10.1097/00006454-200102000-00004; Whitney CG, 2000, NEW ENGL J MED, V343, P1917, DOI 10.1056/NEJM200012283432603; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	29	125	130	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2006	296	10					1235	1241		10.1001/jama.296.10.1235	http://dx.doi.org/10.1001/jama.296.10.1235			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083EA	16968847	Bronze			2022-12-28	WOS:000240437500025
J	Inoki, K; Ouyang, H; Zhu, TQ; Lindvall, C; Wang, Y; Zhang, XJ; Yang, Q; Bennett, C; Harada, Y; Stankunas, K; Wang, CY; He, X; MacDougald, OA; You, M; Williams, BO; Guan, KL				Inoki, Ken; Ouyang, Hongjiao; Zhu, Tianqing; Lindvall, Charlotta; Wang, Yian; Zhang, Xiaojie; Yang, Qian; Bennett, Christina; Harada, Yuko; Stankunas, Kryn; Wang, Cun-yu; He, Xi; MacDougald, Ormond A.; You, Ming; Williams, Bart O.; Guan, Kun-Liang			TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth	CELL			English	Article							ACTIVATED PROTEIN-KINASE; GLYCOGEN-SYNTHASE KINASE-3; BETA-CATENIN; TUBEROUS-SCLEROSIS; TUMOR-SUPPRESSOR; CYCLIN D1; COMPLEX; EXPRESSION; TOR; INHIBITION	Mutation in the TSC2 tumor suppressor causes tuberous sclerosis complex, a disease characterized by hamartoma formation in multiple tissues. TSC2 inhibits cell growth by acting as a GTPase-activating protein toward Rheb, thereby inhibiting mTOR, a central controller of cell growth. Here, we show that Wnt activates mTOR via inhibiting GSK3 without involving beta-catenin-dependent transcription. GSK3 inhibits the mTOR pathway by phosphorylating TSC2 in a manner dependent on AMPK-priming phosphorylation. Inhibition of mTOR by rapamycin blocks Wnt-induced cell growth and tumor development, suggesting a potential therapeutic value of rapamycin for cancers with activated Wnt signaling. Our results show that, in addition to transcriptional activation, Wnt stimulates translation and cell growth by activating the TSC-mTOR pathway. Furthermore, the sequential phosphorylation of TSC2 by AMPK and GSK3 reveals a molecular mechanism of signal integration in cell growth regulation.	Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Cariol Restorat Sci & Endodontol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol & Integerat Physiol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA; Van Andel Res Inst, Lab Cell Signaling & Carcinogenesis, Grand Rapids, MI 49503 USA; Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO 63110 USA; Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Van Andel Institute; Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Harvard University; Boston Children's Hospital; Harvard Medical School; Stanford University; University of Michigan System; University of Michigan	Guan, KL (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	kunliang@umich.edu	Guan, Kun-Liang/ADK-7088-2022; Williams, Bart/A-3539-2013; INOKI, KEN/A-1202-2007	Williams, Bart/0000-0002-5261-5301; MacDougald, Ormond/0000-0001-6907-7960	NCI NIH HHS [R21 CA161150] Funding Source: Medline; NIDCR NIH HHS [R01 DE017439, R01 DE017439-02] Funding Source: Medline; NIDDK NIH HHS [R01 DK124709] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA161150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017439] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Astrinidis A, 2003, J BIOL CHEM, V278, P51372, DOI 10.1074/jbc.M303956200; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Barker N, 2000, BIOESSAYS, V22, P961; Barry FA, 2003, FEBS LETT, V553, P173, DOI 10.1016/S0014-5793(03)01015-9; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Brugarolas J, 2004, CANCER CELL, V6, P7, DOI 10.1016/j.ccr.2004.06.020; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Cook D, 1996, EMBO J, V15, P4526, DOI 10.1002/j.1460-2075.1996.tb00830.x; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Dominguez I, 2001, DEV BIOL, V235, P303, DOI 10.1006/dbio.2001.0317; Easwaran V, 2003, CANCER RES, V63, P3145; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Hashemolhosseini S, 1998, J BIOL CHEM, V273, P14424, DOI 10.1074/jbc.273.23.14424; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Horman S, 2002, CURR BIOL, V12, P1419, DOI 10.1016/S0960-9822(02)01077-1; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kolligs FT, 2000, GENE DEV, V14, P1319; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; Li Y, 2000, ONCOGENE, V19, P1002, DOI 10.1038/sj.onc.1203273; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Mak BC, 2005, AM J PATHOL, V167, P107, DOI 10.1016/S0002-9440(10)62958-6; Mak BC, 2003, J BIOL CHEM, V278, P5947, DOI 10.1074/jbc.C200473200; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Ouyang HJ, 2000, ENDOCRINOLOGY, V141, P4671, DOI 10.1210/en.141.12.4671; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Polakis P, 2000, GENE DEV, V14, P1837; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sansom OJ, 2005, J BIOL CHEM, V280, P28463, DOI 10.1074/jbc.M500191200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhang XB, 2001, CANCER RES, V61, P6050; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	53	991	1032	0	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2006	126	5					955	968		10.1016/j.cell.2006.06.055	http://dx.doi.org/10.1016/j.cell.2006.06.055			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959574	Bronze			2022-12-28	WOS:000240675000022
J	Masly, JP; Jones, CD; Noor, MAF; Locke, J; Orr, HA				Masly, John P.; Jones, Corbin D.; Noor, Mohamed A. F.; Locke, John; Orr, H. Allen			Gene transposition as a cause of hybrid sterility in Drosophila	SCIENCE			English	Article							EVOLUTION; MELANOGASTER; ORIGIN; DIVERGENCE; ISOFORM; COMPLEX; RESCUE	We describe reproductive isolation caused by a gene transposition. In certain Drosophila melanogaster - D. simulans hybrids, hybrid male sterility is caused by the lack of a single-copy gene essential for male fertility, JYAlpha. This gene is located on the fourth chromosome of D. melanogaster but on the third chromosome of D. simulans. Genomic and molecular analyses show that JYAlpha transposed to the third chromosome during the evolutionary history of the D. simulans lineage. Because of this transposition, a fraction of hybrids completely lack JYAlpha and are sterile, representing reproductive isolation without sequence evolution.	Univ Rochester, Dept Biol, Rochester, NY 14627 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; Duke Univ, Dept Biol, Dev Cell & Mol Biol Grp, Durham, NC 27708 USA; Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada	University of Rochester; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; University of Alberta	Masly, JP (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	msly@mail.rochester.edu	Locke, John/A-2661-2014	Locke, John/0000-0003-4998-3127; Noor, Mohamed/0000-0002-5400-4408				Barbash DA, 2003, P NATL ACAD SCI USA, V100, P5302, DOI 10.1073/pnas.0836927100; Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; BRIDGES C. B., 1935, Biol. Z., V4, P401; Coyne J.A., 2004, SPECIATION; Davis AW, 1996, NATURE, V380, P157, DOI 10.1038/380157a0; Dobzhansky T., 1937; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Jones CD, 2005, GENETICS, V170, P207, DOI 10.1534/genetics.104.037283; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kliman RM, 2000, GENETICS, V156, P1913; Lingrel J, 2003, ANN NY ACAD SCI, V986, P354, DOI 10.1111/j.1749-6632.2003.tb07214.x; Long M, 2001, CURR OPIN GENET DEV, V11, P673, DOI 10.1016/S0959-437X(00)00252-5; Lynch M, 2000, AM NAT, V156, P590, DOI 10.1086/316992; MULLER H. J., 1942, GENETICS, V27, P157; Muller HJ, 1940, NATURE, V146, P199, DOI 10.1038/146199b0; Orr HA, 2004, CURR OPIN GENET DEV, V14, P675, DOI 10.1016/j.gde.2004.08.009; ORR HA, 1992, GENET RES, V59, P73, DOI 10.1017/S0016672300030275; Podemski L, 2004, CHROMOSOMA, V112, P381, DOI 10.1007/s00412-002-0286-4; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Przeworski M, 2002, GENETICS, V160, P1179; SAWAMURA K, 1993, GENETICS, V133, P307; Stempfl T, 2002, GENETICS, V160, P571; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; Woo AL, 2000, J BIOL CHEM, V275, P20693, DOI 10.1074/jbc.M002323200; Woo AL, 1999, J MEMBRANE BIOL, V169, P39, DOI 10.1007/PL00005899	27	141	143	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2006	313	5792					1448	1450		10.1126/science.1128721	http://dx.doi.org/10.1126/science.1128721			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16960009				2022-12-28	WOS:000240348700046
J	Ledford, H				Ledford, Heidi			The farmyard drug store	NATURE			English	News Item								Pharmaceuticals made in genetically modified animals was hailed as a way to drive down production costs while maintaining production. Despite a disappointing beginning, hopes have been renewed by a transgenic goat named Sweetheart. In August 2006, the anti-clotting agent in Sweetheart's milk, ATryn, was approved by the European Medicines Agency. Other companies have also created pharmaceuticals in a similar way.											0	8	8	7	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2006	443	7107					16	17		10.1038/443016a	http://dx.doi.org/10.1038/443016a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16957702				2022-12-28	WOS:000240313900013
J	Campana, S; Mangano, V; Blustin, AJ; Brown, P; Burrows, DN; Chincarini, G; Cummings, JR; Cusumano, G; Della Valle, M; Malesani, D; Meszaros, P; Nousek, JA; Page, M; Sakamoto, T; Waxman, E; Zhang, B; Dai, ZG; Gehrels, N; Immler, S; Marshall, FE; Mason, KO; Moretti, A; O'Brien, PT; Osborne, JP; Page, KL; Romano, P; Roming, PWA; Tagliaferri, G; Cominsky, LR; Giommi, P; Godet, O; Kennea, JA; Krimm, H; Angelini, L; Barthelmy, SD; Boyd, PT; Palmer, DM; Wells, AA; White, NE				Campana, S.; Mangano, V.; Blustin, A. J.; Brown, P.; Burrows, D. N.; Chincarini, G.; Cummings, J. R.; Cusumano, G.; Della Valle, M.; Malesani, D.; Meszaros, P.; Nousek, J. A.; Page, M.; Sakamoto, T.; Waxman, E.; Zhang, B.; Dai, Z. G.; Gehrels, N.; Immler, S.; Marshall, F. E.; Mason, K. O.; Moretti, A.; O'Brien, P. T.; Osborne, J. P.; Page, K. L.; Romano, P.; Roming, P. W. A.; Tagliaferri, G.; Cominsky, L. R.; Giommi, P.; Godet, O.; Kennea, J. A.; Krimm, H.; Angelini, L.; Barthelmy, S. D.; Boyd, P. T.; Palmer, D. M.; Wells, A. A.; White, N. E.			The association of GRB 060218 with a supernova and the evolution of the shock wave	NATURE			English	Article							GAMMA-RAY BURST; RADIO-EMISSION; 1998BW	Although the link between long gamma-ray bursts (GRBs) and supernovae has been established(1-4), hitherto there have been no observations of the beginning of a supernova explosion and its intimate link to a GRB. In particular, we do not know how the jet that defines a gamma-ray burst emerges from the star's surface, nor how a GRB progenitor explodes. Here we report observations of the relatively nearby GRB 060218 (ref. 5) and its connection to supernova SN 2006aj ( ref. 6). In addition to the classical non-thermal emission, GRB 060218 shows a thermal component in its X-ray spectrum, which cools and shifts into the optical/ ultraviolet band as time passes. We interpret these features as arising from the break-out of a shock wave driven by a mildly relativistic shell into the dense wind surrounding the progenitor(7). We have caught a supernova in the act of exploding, directly observing the shock break-out, which indicates that the GRB progenitor was a Wolf Rayet star.	Osserv Astron Brera, INAF, I-23807 Merate, LC, Italy; Ist Astrofis Spaziale & Fis Cosm Palermo, INAF, I-90146 Palermo, Italy; UCL, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; Univ Milano Bicocca, I-20126 Milan, Italy; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; CNR, Washington, DC 20418 USA; Osserv Astrofis Arcetri, INAF, I-50125 Florence, Italy; Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; SISSA, ISAS, I-34014 Trieste, Italy; Penn State Univ, Dept Phys, University Pk, PA 16802 USA; Weizmann Inst Sci, Fac Phys, IL-76100 Rehovot, Israel; Univ Nevada, Dept Phys, Las Vegas, NV 89154 USA; Nanjing Univ, Dept Astron, Nanjing 210093, Peoples R China; PPARC, Swindon SN2 1SZ, Wilts, England; Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; Sonoma State Univ, Dept Phys & Astron, Rohnert Pk, CA 94928 USA; ASI Sci Data Ctr, I-00044 Frascati, Roma, Italy; Univ Space Res Assoc, Columbia, MD 21044 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA	Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Milano-Bicocca; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Istituto Nazionale Astrofisica (INAF); University of California System; University of California Santa Barbara; International School for Advanced Studies (SISSA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Weizmann Institute of Science; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Nanjing University; University of Leicester; California State University System; Sonoma State University; Agenzia Spaziale Italiana (ASI); Universities Space Research Association (USRA); United States Department of Energy (DOE); Los Alamos National Laboratory	Campana, S (corresponding author), Osserv Astron Brera, INAF, Via E Bianchi 46, I-23807 Merate, LC, Italy.	sergio.campana@brera.inaf.it	Barthelmy, Scott D/D-2943-2012; Boyd, Patricia/D-3274-2012; Della Valle, Massimo/AAE-8884-2021; Tagliaferri, Gianpiero/ABD-7556-2021; WAXMAN, ELI/K-1557-2012; Gehrels, Neil/D-2971-2012; Kennea, Jamie/AAF-2090-2019; Campana, Sergio/AAL-6012-2020; Zhang, Bing/AAG-2824-2019; White, Nicholas/B-6428-2012; giommi, paolo/L-1006-2018	Della Valle, Massimo/0000-0003-3142-5020; Tagliaferri, Gianpiero/0000-0003-0121-0723; Kennea, Jamie/0000-0002-6745-4790; Campana, Sergio/0000-0001-6278-1576; White, Nicholas/0000-0003-3853-3462; giommi, paolo/0000-0002-2265-5003; Romano, Patrizia/0000-0003-0258-7469; moretti, alberto/0000-0002-9770-0315; Mangano, Vanessa/0000-0003-4262-8616; Zhang, Bing/0000-0002-9725-2524; O'Brien, Paul/0000-0002-5128-1899; Page, Kim/0000-0001-5624-2613; Meszaros, Peter/0000-0002-4132-1746; Cusumano, Giancarlo/0000-0002-8151-1990				AMATI L, 2006, 4846 GCN; ARNETT WD, 1989, ANNU REV ASTRON ASTR, V27, P629, DOI 10.1146/annurev.aa.27.090189.003213; Barthelmy SD, 2005, SPACE SCI REV, V120, P143, DOI 10.1007/s11214-005-5096-3; Burrows DN, 2005, SPACE SCI REV, V120, P165, DOI 10.1007/s11214-005-5097-2; COLGATE SA, 1968, CAN J PHYS, V46, pS476, DOI 10.1139/p68-274; CUSUMANO G, 2006, 4775 GCN; ENSMAN L, 1992, ASTROPHYS J, V393, P742, DOI 10.1086/171542; Galama TJ, 1998, NATURE, V395, P670, DOI 10.1038/27150; Heise J, 2001, ESO ASTROPHY SYMP, P16, DOI 10.1007/10853853_4; Kulkarni SR, 1998, NATURE, V395, P663, DOI 10.1038/27139; Leonard DC, 2006, NATURE, V440, P505, DOI 10.1038/nature04558; Li ZY, 1999, ASTROPHYS J, V526, P716, DOI 10.1086/308031; MacFadyen AI, 1999, ASTROPHYS J, V524, P262, DOI 10.1086/307790; Mazzali PA, 2005, SCIENCE, V308, P1284, DOI 10.1126/science.1111384; MIRABAL N, 2006, 4792 GCN; Norris JP, 2004, AIP CONF PROC, V727, P412, DOI 10.1063/1.1810876; OBRIEN PT, UNPUB ASTROPHYS J; Paczynski B, 1998, ASTROPHYS J, V494, pL45, DOI 10.1086/311148; PEI YCC, 1992, ASTROPHYS J, V395, P130, DOI 10.1086/171637; Pian E, 2006, NATURE, V442, P1011, DOI 10.1038/nature05082; Roming PWA, 2005, SPACE SCI REV, V120, P95, DOI 10.1007/s11214-005-5095-4; Tagliaferri G, 2005, NATURE, V436, P985, DOI 10.1038/nature03934; Tan JC, 2001, ASTROPHYS J, V551, P946, DOI 10.1086/320245; Waxman E, 2004, ASTROPHYS J, V605, pL97, DOI 10.1086/420846; Waxman E, 1999, ASTROPHYS J, V515, P721, DOI 10.1086/307066; WOOSLEY SE, 1993, ASTROPHYS J, V405, P273, DOI 10.1086/172359; [No title captured]	28	631	640	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2006	442	7106					1008	1010		10.1038/nature04892	http://dx.doi.org/10.1038/nature04892			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	078YF	16943830	Green Submitted			2022-12-28	WOS:000240142000041
J	Cooke, M; Irby, DM; Sullivan, W; Ludmerer, KM				Cooke, Molly; Irby, David M.; Sullivan, William; Ludmerer, Kenneth M.			American medical education 100 years after the Flexner report	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PROGRAM; MODELS; IMPACT		Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Carnegie Fdn Advancement Teaching, Stanford, CA USA; Washington Univ, Dept Med, St Louis, MO 63130 USA	University of California System; University of California San Francisco; Washington University (WUSTL)	Cooke, M (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.			Irby, David/0000-0001-5753-8918				Association of American Medical Colleges, 2004, ED DOCT PROV HIGH QU; Berger TJ, 2004, ACAD EMERG MED, V11, P1364, DOI 10.1197/j.aem.2004.07.015; BERWICK D, 2004, ESCAPE FIRE DESIGNS; *BLUE RIDG AC HLTH, 2003, REF MED ED URG PRIOR; Bonner T., 2002, ICONOCLAST A FLEXNER; BRANSFORD J, 1999, PEOPLE LEARN BRAIN C; Collins A, 1989, KNOWING LEARNING INS, P453, DOI DOI 10.5840/THINKING19888129; *COMM FUND, 2002, TRAIN TOM DOCT MED E; Cruess RL, 1997, ACAD MED, V72, P941, DOI 10.1097/00001888-199711000-00009; DaRosa DA, 2003, SURGERY, V133, P13, DOI 10.1067/msy.2003.67; Dewey CM, 2005, ACAD MED, V80, P358, DOI 10.1097/00001888-200504000-00012; Epstein RM, 2002, JAMA-J AM MED ASSOC, V287, P226, DOI 10.1001/jama.287.2.226; Flexner A., 1910, MEDICAL ED US CANADA; Flexner A, 1925, MED ED COMP STUDY; Flexner A, 1940, I REMEMBER AUTOBIOGR; Goldman L, 2004, AM J MED, V117, P133, DOI 10.1016/j.amjmed.2004.05.001; Harden RM, 2000, MED EDUC, V34, P391; Kahn N, 2001, ACAD MED, V76, pS9, DOI 10.1097/00001888-200104001-00004; Knapp R, 2002, AM J SURG, V184, P187, DOI 10.1016/S0002-9610(02)00928-5; Knapp RM, 2002, ACAD MED, V77, P1076, DOI 10.1097/00001888-200211000-00003; Krackov SK, 1998, ACAD MED, V73, pS1; Lagemann E.C., 1983, PRIVATE POWER PUBLIC; Leach DC, 2004, MED EDUC, V38, P12, DOI 10.1111/j.1365-2923.2004.01732.x; Ludmerer Kenneth M, 2003, Trans Am Clin Climatol Assoc, V114, P241; Ludmerer Kenneth M., 1985, LEARNING HEAL DEV AM; Ludmerer KM, 2004, NEW ENGL J MED, V351, P1163, DOI 10.1056/NEJMp048112; Miller J, 1998, BRIT J GEN PRACT, V48, P1429; Norman G, 2005, MED EDUC, V39, P418, DOI 10.1111/j.1365-2929.2005.02127.x; PASCOE JM, 2004, FAM MED, V36, pS2; Pellegrini CA, 2004, SURGERY, V136, P953, DOI 10.1016/j.surg.2004.09.001; Reinhardt UE, 2000, JAMA-J AM MED ASSOC, V284, P1136, DOI 10.1001/jama.284.9.1136; SINCLAIR S., 1997, MAKING DOCTORS I APP; SPEER AJ, 1995, AM J MED, V99, P451, DOI 10.1016/S0002-9343(99)80217-4; Sullivan WM, 2005, WORK INTEGRITY CRISI; Tarquinio GT, 2003, ACAD MED, V78, P690, DOI 10.1097/00001888-200307000-00008; Van Eaton EG, 2005, ARCH SURG-CHICAGO, V140, P230, DOI 10.1001/archsurg.140.3.230; Whitcomb ME, 2005, ACAD MED, V80, P615, DOI 10.1097/00001888-200507000-00001; Williams RG, 2003, ACAD MED, V78, P156, DOI 10.1097/00001888-200302000-00010; 2004, QUAL LETT HEALTHC LE, V16, P1	39	537	575	1	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2006	355	13					1339	1344		10.1056/NEJMra055445	http://dx.doi.org/10.1056/NEJMra055445			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088EF	17005951				2022-12-28	WOS:000240793600007
J	Lu, CL; Michaud, CM; Gakidou, E; Khan, K; Murray, CJL				Lu, Chunling; Michaud, Catherine M.; Gakidou, Emmanuela; Khan, Kashif; Murray, Christopher J. L.			Effect of the Global Alliance for Vaccines and Immunisation on diphtheria, tetanus, and pertussis vaccine coverage: an independent assessment	LANCET			English	Article							DEVELOPING-COUNTRIES; GAVI; STRATEGIES; PROGRAMS; COSTS; FUND	Background The Global Alliance for Vaccines and Immunisation (GAVI) was created in 1999 to enable even the poorest countries to provide vaccines to all children. We aimed to assess the effect of GAVI on combined diphtheria, tetanus, and pertussis vaccine (DTP3) coverage. Methods We examined the relation between DTP3 coverage for GAVI recipient countries from 1995 to 2004 and immunisation services support (ISS) and non-ISS expenditure per surviving child, controlling for income per head and local political governance variables. We analysed DTP3 coverage reported by governments and estimated by WHO/UNICEF. We also investigated the effect of GAVI on country reporting behaviour. Results In countries with DTP3 coverage of 65% or less at baseline, IS S spending per surviving child had a significant positive effect on DTP3 coverage (p=0.0005). This effect was not present in countries with DTP3 coverage of 65-80% or 80% or more at baseline. If IS S expenditure only is assessed, the estimated cost per additional child immunised in countries with baseline coverage of 65% or less is US$14 and if ISS and non-ISS expenditures are included the cost per child is almost $20. Interpretation The success of ISS funding in countries with baseline DTP3 coverage of 65% or less provides evidence that a public-private partnership can work to reverse a negative trend in global health and that performance-related disbursement can work in some settings. Because ISS funding seems to have no effect in countries with baseline coverage greater than 65%, GAVI should consider redistributing its resources to countries with the lowest coverage.	Harvard Univ, Initiat Global Hlth, Cambridge, MA 02138 USA; Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Murray, CJL (corresponding author), Harvard Univ, Initiat Global Hlth, 104 Mt Auburn St, Cambridge, MA 02138 USA.	christopher_murray@harvard.edu						BECK N, 1995, AM POLIT SCI REV, V89, P634, DOI 10.2307/2082979; Beck N, 2001, INT ORGAN, V55, P487, DOI 10.1162/00208180151140658; BHAWALKAR M, 2004, COMP METHODOLOGIES N; Bishai D, 2006, HEALTH AFFAIR, V25, P348, DOI 10.1377/hlthaff.25.2.348; BRENZEL L, 1994, SOC SCI MED, V39, P527, DOI 10.1016/0277-9536(94)90095-7; Brugha R, 2002, LANCET, V359, P435, DOI 10.1016/S0140-6736(02)07607-9; Burnside C, 2000, AM ECON REV, V90, P847, DOI 10.1257/aer.90.4.847; Chee G, 2004, EVALUATION GAVI IMMU; Cutts FT, 2000, TROP MED INT HEALTH, V5, P157, DOI 10.1046/j.1365-3156.2000.00536.x; FLECK F, 2002, BRIT MED J, V324, P974; FOXRUSHBY JA, 2004, B WORLD HEALTH ORGAN, V82, P9; *GAVI, 11 GAVI BOARD M ANN; *GAVI, 7 GAVI BOARD M ANN 1; *GAVI, INT FIN FAC IMM IFFI; *GAVI, 17 GAVI BOARD M SUMM; Godal T, 2000, TROP MED INT HEALTH, V5, P160, DOI 10.1046/j.1365-3156.2000.00534.x; GREEN DP, 2003, INT ORGAN, V55, P441; Hardon A, 2005, SOC SCI MED, V60, P345, DOI 10.1016/j.socscimed.2004.05.008; Kaddar M, 2004, B WORLD HEALTH ORGAN, V82, P697; Katz JonathanN., 1996, POLIT ANAL, V6, DOI [10.1093/pan/6.1.1, DOI 10.1093/PAN/6.1.1]; Kaufmann Daniel, 2005, GOVERNANCE MATTERS, VIV; KRISTENSEN IP, LAGGING DOG ROBUSTNE; Lu C, 2006, LANCET, V368, P483, DOI 10.1016/S0140-6736(06)69156-3; Mahoney RT, 2000, VACCINE, V18, P2625, DOI 10.1016/S0264-410X(00)00073-6; Martin JF, 2003, VACCINE, V21, P587, DOI 10.1016/S0264-410X(02)00564-9; Muraskin W, 2004, AM J PUBLIC HEALTH, V94, P1922, DOI 10.2105/AJPH.94.11.1922; Murray CJL, 2003, LANCET, V362, P1022, DOI 10.1016/S0140-6736(03)14411-X; Peny JM, 2005, VACCINE, V23, P4610, DOI 10.1016/j.vaccine.2005.04.044; Ronveaux O, 2005, B WORLD HEALTH ORGAN, V83, P503; Starling M., 2002, NEW PRODUCTS OLD SYS; Waters HR, 2004, B WORLD HEALTH ORGAN, V82, P668; *WHO, IMM FIN; *WHO UNICEF, WHO UNICEF EST COV T; *WHO UNICEF, WHO UNICEF REP EST I; Wittet S, 2000, VACCINE, V19, P385, DOI 10.1016/S0264-410X(00)00196-1	35	55	55	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2006	368	9541					1088	1095		10.1016/S0140-6736(06)69337-9	http://dx.doi.org/10.1016/S0140-6736(06)69337-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	089IC	16997663				2022-12-28	WOS:000240873000024
J	Marone, C; Richardson, E				Marone, Chris; Richardson, Eliza			Do earthquakes rupture piece by piece or all together?	SCIENCE			English	Editorial Material									Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Marone, C (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	cjm38@psu.edu						AKI K, 1967, J GEOPHYS RES, V72, P1217, DOI 10.1029/JZ072i004p01217; Lykotrafitis G, 2006, SCIENCE, V313, P1765, DOI 10.1126/science.1128359	2	5	5	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2006	313	5794					1748	1749		10.1126/science.1131296	http://dx.doi.org/10.1126/science.1131296			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990540				2022-12-28	WOS:000240655700035
J	Roos, CF; Chwalla, M; Kim, K; Riebe, M; Blatt, R				Roos, C. F.; Chwalla, M.; Kim, K.; Riebe, M.; Blatt, R.			'Designer atoms' for quantum metrology	NATURE			English	Article							DECOHERENCE; FREQUENCY; SPECTROSCOPY	Entanglement is recognized as a key resource for quantum computation(1) and quantum cryptography(2). For quantum metrology, the use of entangled states has been discussed(3-5) and demonstrated(6) as a means of improving the signal-to-noise ratio. In addition, entangled states have been used in experiments for efficient quantum state detection(7) and for the measurement of scattering lengths(8). In quantum information processing, manipulation of individual quantum bits allows for the tailored design of specific states that are insensitive to the detrimental influences of an environment(9). Such 'decoherence-free subspaces' ( ref. 10) protect quantum information and yield significantly enhanced coherence times(11). Here we use a decoherence-free subspace with specifically designed entangled states(12) to demonstrate precision spectroscopy of a pair of trapped Ca+ ions; we obtain the electric quadrupole moment, which is of use for frequency standard applications. We find that entangled states are not only useful for enhancing the signal-to-noise ratio in frequency measurements - a suitably designed pair of atoms also allows clock measurements in the presence of strong technical noise. Our technique makes explicit use of non-locality as an entanglement property and provides an approach for 'designed' quantum metrology.	Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria; Austrian Acad Sci, Inst Quantenopt & Quanteninformat, A-6020 Innsbruck, Austria	University of Innsbruck; Austrian Academy of Sciences	Roos, CF (corresponding author), Univ Innsbruck, Inst Expt Phys, Technikerstr 25, A-6020 Innsbruck, Austria.	christian.roos@uibk.ac.at	Blatt, Rainer/H-9527-2014; Roos, Christian F/D-8475-2011	Roos, Christian F/0000-0001-7121-8259				Barwood GP, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.133001; Bollinger JJ, 1996, PHYS REV A, V54, pR4649, DOI 10.1103/PhysRevA.54.R4649; Diddams SA, 2004, SCIENCE, V306, P1318, DOI 10.1126/science.1102330; Dube P, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.033001; Giovannetti V, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.010401; Giovannetti V, 2004, SCIENCE, V306, P1330, DOI 10.1126/science.1104149; Gisin N, 2002, REV MOD PHYS, V74, P145, DOI 10.1103/RevModPhys.74.145; Haffner H, 2005, APPL PHYS B-LASERS O, V81, P151, DOI 10.1007/s00340-005-1917-z; Itano WM, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.022510; Itano WM, 2000, J RES NATL INST STAN, V105, P829, DOI 10.6028/jres.105.065; Kielpinski D, 2001, SCIENCE, V291, P1013, DOI 10.1126/science.1057357; Langer C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060502; Leibfried D, 2004, SCIENCE, V304, P1476, DOI 10.1126/science.1097576; Lidar DA, 1998, PHYS REV LETT, V81, P2594, DOI 10.1103/PhysRevLett.81.2594; Madej AA, 2000, TOP APPL PHYS, V79, P153; Margolis HS, 2004, SCIENCE, V306, P1355, DOI 10.1126/science.1105497; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Oskay WH, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.163001; Roos C, 1999, PHYS REV LETT, V83, P4713, DOI 10.1103/PhysRevLett.83.4713; Roos CF, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.220402; ROOS CF, 2005, PRECISION FREQUENCY; Schmidt PO, 2005, SCIENCE, V309, P749, DOI 10.1126/science.1114375; Schmidt-Kaler F, 2003, APPL PHYS B-LASERS O, V77, P789, DOI 10.1007/s00340-003-1346-9; Schneider T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.230801; Sur C, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.193001; Widera A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.160406	27	246	249	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2006	443	7109					316	319		10.1038/nature05101	http://dx.doi.org/10.1038/nature05101			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085RL	16988707	Green Submitted			2022-12-28	WOS:000240622000041
J	Basso, O; Rasmussen, S; Weinberg, CR; Wilcox, AJ; Irgens, LM; Skjaerven, R				Basso, Olga; Rasmussen, Svein; Weinberg, Clarice R.; Wilcox, Allen J.; Irgens, Lorentz M.; Skjaerven, Rolv			Trends in fetal and infant survival following preeclampsia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRETERM BIRTH; MANAGEMENT; SMOKING; PATHOGENESIS	Context Management of preeclampsia often culminates in induced delivery of a very preterm infant. While early termination protects the fetus from an intrauterine death, the newborn then faces increased risks associated with preterm delivery. This practice has increased in recent decades, but its net effect on fetal and infant survival has not been assessed. Objective To assess the effect on fetal and infant survival of increased rates of early delivery of preeclamptic pregnancies. Design, Setting, and Participants Population-based observational longitudinal study using registry data from 804 448 singleton first-born infants with Norwegian-born mothers and registered in the Medical Birth Registry of Norway between 1967 and 2003. Main Outcome Measures Odds ratio ( OR) of fetal and early childhood death in relation to preeclampsia. Results Among preeclamptic pregnancies, inductions before 37 weeks increased from 8% in 1967- 1978 to nearly 20% in 1991- 2003. During this period, the adjusted OR for stillbirth decreased from 4.2 (95% confidence interval [CI], 3.8-4.7) to 1.3 ( 95% CI, 1.1-1.7) for preeclamptic compared with nonpreeclamptic pregnancies. During the same period, the OR for neonatal death after preeclamptic pregnancy remained relatively stable (1.7 in 1967- 1978 vs 2.0 in 1991- 2003). Later infant and childhood mortality also showed little change. Conclusions Fetal survival in preeclamptic pregnancies has vastly improved over the past 35 years in Norway, presumably because of more aggressive clinical management. However, the relative risk of neonatal death following a preeclamptic pregnancy has not changed over time.	NIEHS, Epidemiol Branch, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; NIEHS, Biostat Branch, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; Univ Bergen, Locus Registry Based Epidemiol, Med Birth Registry Norway, Bergen, Norway; Norwegian Inst Publ Hlth, Bergen, Norway; Univ Bergen, Dept Obstet & Gynaecol, Inst Clin Med, N-5020 Bergen, Norway	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Bergen; Norwegian Institute of Public Health (NIPH); University of Bergen	Basso, O (corresponding author), NIEHS, Epidemiol Branch, NIH, Dept Hlth & Human Serv, MD A3-05,POB 12233,111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	bassoo2@niehs.nih.gov	Basso, Olga/E-5384-2010; Wilcox, Allen J/C-7723-2019	Basso, Olga/0000-0001-9298-4921; Wilcox, Allen J/0000-0002-3376-1311; Weinberg, Clarice/0000-0002-7713-8556	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES044003, ZIAES045005, Z01ES045005, Z01ES044003] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ananth CV, 2005, OBSTET GYNECOL, V105, P1084, DOI 10.1097/01.AOG.0000158124.96300.c7; [Anonymous], 1990, AM J OBSTET GYNECOL, V163, P1691; Conde-Agudelo A, 1999, AM J OBSTET GYNECOL, V181, P1026, DOI 10.1016/S0002-9378(99)70341-8; Eriksson KM, 1996, ACTA OBSTET GYN SCAN, V75, P355, DOI 10.3109/00016349609033331; Friedman SA, 1999, CLIN OBSTET GYNECOL, V42, P470, DOI 10.1097/00003081-199909000-00005; Goldenberg RL, 1998, NEW ENGL J MED, V339, P313, DOI 10.1056/NEJM199807303390506; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Haug K, 2000, ACTA OBSTET GYN SCAN, V79, P485, DOI 10.1034/j.1600-0412.2000.079006485.x; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Kramer MS, 2000, JAMA-J AM MED ASSOC, V284, P843, DOI 10.1001/jama.284.7.843; Lain KY, 2002, JAMA-J AM MED ASSOC, V287, P3183, DOI 10.1001/jama.287.24.3183; Midthjell K, 1999, DIABETES CARE, V22, P1813, DOI 10.2337/diacare.22.11.1813; OIAN P, 1999, NORWEGIAN SOC OBSTET, P101; Roberts JM, 2002, PLACENTA, V23, P359, DOI 10.1053/plac.2002.0819; Sibai BM, 2000, AM J OBSTET GYNECOL, V182, P938, DOI 10.1016/S0002-9378(00)70350-4; Sibai BM, 2003, OBSTET GYNECOL, V102, P181, DOI 10.1016/S0029-7844(03)00475-7; WEINBERG CR, 1993, AM J EPIDEMIOL, V137, P1; *WORLD BANK GROUP, 2005 WORLD DEV IND P	18	112	115	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2006	296	11					1357	1362		10.1001/jama.296.11.1357	http://dx.doi.org/10.1001/jama.296.11.1357			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085HS	16985227	Bronze			2022-12-28	WOS:000240595800022
J	White, MY; Gundry, RL; Cordwell, SJ				White, Melanie Y.; Gundry, Rebekah L.; Cordwell, Stuart J.			When does a fingerprint constitute a diagnostic?	LANCET			English	Editorial Material							PLASMA-PROTEOME-PROJECT; CANCER-DETECTION; SERUM; TECHNOLOGY		Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; Johns Hopkins Univ, Dept Med, Baltimore, MD 21224 USA	University of Sydney; Johns Hopkins University	Cordwell, SJ (corresponding author), Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia.	s.cordwell@mmb.usyd.edu.au	Gundry, Rebekah/K-6080-2019	White, Melanie/0000-0003-2571-2816; Gundry, Rebekah L./0000-0002-9263-833X; Cordwell, Stuart/0000-0002-0995-0171				AGRANOFF D, 2006, LANCET          0914, DOI DOI 10.1016/S0140-6736(06)69342-2; Barker PE, 2006, CLIN CHEM, V52, P1669, DOI 10.1373/clinchem.2006.067249; Haab BB, 2005, PROTEOMICS, V5, P3278, DOI 10.1002/pmic.200401276; Hortin GL, 2006, CLIN CHEM, V52, P1223, DOI 10.1373/clinchem.2006.069252; Koomen JM, 2005, J PROTEOME RES, V4, P972, DOI 10.1021/pr050046x; Liotta LA, 2006, J CLIN INVEST, V116, P26, DOI 10.1172/JCI27467; Omenn GS, 2005, PROTEOMICS, V5, P3226, DOI 10.1002/pmic.200500358; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Plebani M, 2005, CLIN CHIM ACTA, V357, P113, DOI 10.1016/j.cccn.2005.03.017; Rai AJ, 2005, PROTEOMICS, V5, P3262, DOI 10.1002/pmic.200401245; Seibert V, 2004, PATHOL RES PRACT, V200, P83, DOI 10.1016/j.prp.2004.01.010	11	7	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 16	2006	368	9540					971	973		10.1016/S0140-6736(06)69379-3	http://dx.doi.org/10.1016/S0140-6736(06)69379-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	086UO	16980095				2022-12-28	WOS:000240698700007
J	Kappos, L; Antel, J; Comi, G; Montalban, X; O'Connor, P; Polman, CH; Haas, T; Korn, AA; Karlsson, G; Radue, EW				Kappos, Ludwig; Antel, Jack; Comi, Giancarlo; Montalban, Xavier; O'Connor, Paul; Polman, Chris H.; Haas, Tomas; Korn, Alexander A.; Karlsson, Goeril; Radue, Ernst W.		FTY720 D2201 Study Grp	Oral fingolimod (FTY720) for relapsing multiple sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SIGNAL-TRANSDUCTION; LYMPHOCYTE EGRESS; DISABILITY; ACID	BACKGROUND: Fingolimod (FTY720) is a new oral immunomodulating agent under evaluation for the treatment of relapsing multiple sclerosis. METHODS: We randomly assigned 281 patients to receive oral fingolimod, at a dose of 1.25 mg or 5.0 mg, or a placebo once daily, and we followed these patients for 6 months with magnetic resonance imaging (MRI) and clinical evaluations (core study, months 0 to 6). The primary end point was the total number of gadolinium-enhanced lesions recorded on T(sub 1)-weighted MRI at monthly intervals for 6 months. In an extension study in which the investigators and patients remained unaware of the dose assignments (months 7 to 12), patients who received placebo underwent randomization again to one of the fingolimod doses. RESULTS: A total of 255 patients completed the core study. The median total number of gadolinium-enhanced lesions on MRI was lower with 1.25 mg of fingolimod (1 lesion, P<0.001) and 5.0 mg of fingolimod (3 lesions, P=0.006) than with placebo (5 lesions). The annualized relapse rate was 0.77 in the placebo group, as compared with 0.35 in the group given 1.25 mg of fingolimod (P=0.009) and 0.36 in the group given 5.0 mg of fingolimod (P=0.01). For the 227 patients who completed the extension study, the number of gadolinium-enhanced lesions and relapse rates remained low in the groups that received continuous fingolimod, and both measures decreased in patients who switched from placebo to fingolimod. Adverse events included nasopharyngitis, dyspnea, headache, diarrhea, and nausea. Clinically asymptomatic elevations of alanine aminotransferase levels were more frequent with fingolimod (10 to 12%, vs. 1% in the placebo group). One case of the posterior reversible encephalopathy syndrome occurred in the 5.0-mg group. Fingolimod was also associated with an initial reduction in the heart rate and a modest decrease in the forced expiratory volume in 1 second. CONCLUSIONS: In this proof-of-concept study, fingolimod reduced the number of lesions detected on MRI and clinical disease activity in patients with multiple sclerosis. Evaluation in larger, longer-term studies is warranted.	Univ Hosp, Dept Neurol, CH-4031 Basel, Switzerland; Univ Hosp, Dept Res, CH-4031 Basel, Switzerland; McGill Univ, Montreal Neurol Inst, Ctr Univ Sante McGill, Montreal, PQ, Canada; Univ Vita & Salute, Hosp San Raffaele, Neurol Clin, I-20132 Milan, Italy; Hosp Valle De Hebron, Neuroimmunol Unit, Barcelona, Spain; St Michaels Hosp, Div Neurol, Toronto, ON M5B 1W8, Canada; Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands; Novartis Pharmaceut, Biostat & Stat Reporting, Basel, Switzerland; Novartis Pharmaceut, Clin Dev & Med Affairs, Basel, Switzerland; Novartis Pharmaceut, Clin Dev & Med Affairs, E Hanover, NJ USA; Univ Hosp, Neuroradiol & MS MRI Evaluat Ctr, Basel, Switzerland	McGill University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Hospital Universitari Vall d'Hebron; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Vrije Universiteit Amsterdam; Novartis; Novartis; Novartis	Kappos, L (corresponding author), Univ Hosp, Dept Neurol, Petersgraben 4, CH-4031 Basel, Switzerland.	lkappos@uhbs.ch	Montalban, Xavier/J-5938-2016; Macedo, Ana/L-9912-2018	Montalban, Xavier/0000-0002-0098-9918; Macedo, Ana/0000-0002-6978-8989; antel, jack/0000-0002-5148-0636				Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; Calabresi PA, 2002, NEUROLOGY, V58, pS10, DOI 10.1212/WNL.58.8_suppl_4.S10; Compston A, 2002, LANCET, V360, P648; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; DUQUETTE P, 1995, NEUROLOGY, V45, P1277; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Ebers GC, 1999, LANCET, V353, P678; *EV CTR BAS, INT SEGM PROGR DEV A; Frohman EM, 2002, NEUROLOGY, V59, P480; Fujino M, 2003, J PHARMACOL EXP THER, V305, P70, DOI 10.1124/jpet.102.045658; Galetta SL, 2005, CNS DRUGS, V19, P239, DOI 10.2165/00023210-200519030-00005; Goodin DS, 2002, NEUROLOGY, V58, P169, DOI 10.1212/WNL.58.2.169; Hardin JW, 2012, GEN ESTIMATING EQUAT; ICH, 1996, ICH HARM TRIP GUID G; Jacobs LD, 1996, ANN NEUROL, V40, P480; Jardine A, 2004, AM J TRANSPLANT, V4, P443; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; KAPPOS L, 2003, NEUROSTATUS TRAINING; Koyrakh L, 2005, AM J TRANSPLANT, V5, P529, DOI 10.1111/j.1600-6143.2005.00754.x; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lamy C, 2004, J NEUROIMAGING, V14, P89, DOI 10.1177/1051228403258161; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McFarland HF, 2002, MULT SCLER J, V8, P40, DOI 10.1191/1352458502ms767xx; MILLER DH, 1991, J NEUROL NEUROSUR PS, V54, P683, DOI 10.1136/jnnp.54.8.683; NAUTA JJP, 1994, J NEUROL SCI, V122, P6, DOI 10.1016/0022-510X(94)90045-0; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Pinschewer DD, 2000, J IMMUNOL, V164, P5761, DOI 10.4049/jimmunol.164.11.5761; Rao TS, 2003, BRAIN RES, V990, P182, DOI 10.1016/S0006-8993(03)03527-3; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Stott VL, 2005, INTERN MED J, V35, P83, DOI 10.1111/j.1445-5994.2004.00750.x; Tedesco-Silva H, 2005, TRANSPLANTATION, V79, P1553, DOI 10.1097/01.TP.0000121761.02129.A6; Tham CS, 2003, INT J DEV NEUROSCI, V21, P431, DOI 10.1016/j.ijdevneu.2003.09.003; Toman RE, 2004, J CELL BIOL, V166, P381, DOI 10.1083/jcb.200402016; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Webb M, 2004, J NEUROIMMUNOL, V153, P108, DOI 10.1016/j.jneuroim.2004.04.015; *WHO, DECL HELS ETH PRINC; Yu NC, 2004, GLIA, V45, P17, DOI 10.1002/glia.10297	41	844	930	0	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 14	2006	355	11					1124	1140		10.1056/NEJMoa052643	http://dx.doi.org/10.1056/NEJMoa052643			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083NJ	16971719				2022-12-28	WOS:000240462800007
J	Patel, AK; Chapple, CR				Patel, Anand K.; Chapple, Christopher R.			BMJ Learning - Benign prostatic hyperplasia: treatment in primary care	BRITISH MEDICAL JOURNAL			English	Article							URINARY-TRACT SYMPTOMS; TAMSULOSIN; THERAPY; MEN; SAFETY; TOLERABILITY; DUTASTERIDE; FINASTERIDE; MANAGEMENT; DOXAZOSIN		Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Chapple, CR (corresponding author), Royal Hallamshire Hosp, J Floor, Sheffield S10 2JF, S Yorkshire, England.	c.r.chapple@sheffield.ac.uk		Patel, Anand/0000-0001-9543-9267; Chapple, Christopher/0000-0002-2960-9931				Andriole GL, 2003, EUR UROL, V44, P82, DOI 10.1016/S0302-2838(03)00198-2; Barendrecht MM, 2005, BJU INT, V95, P19, DOI 10.1111/j.1464-410X.2005.05487.x; Chang DF, 2005, J CATARACT REFR SURG, V31, P664, DOI 10.1016/j.jcrs.2005.02.027; CHAPPLE C, 2006, MALE LOWER URINARY T, P143; Chapple CR, 2005, EUR UROL SUPPL, V4, P20, DOI 10.1016/j.eursup.2005.07.006; Chapple CR, 2004, BJU INT, V94, P738, DOI 10.1111/j.1464-410X.2004.05022.x; Chapple CR, 1997, EUR UROL, V32, P462, DOI 10.1159/000480808; Crawford ED, 2005, BJU INT, V95, P1, DOI 10.1111/j.1464-410X.2005.05484.x; Edwards Jayne E, 2002, BMC Urol, V2, P14, DOI 10.1186/1471-2490-2-14; GlaxoSmithKline, ARI40001 GLAXOSMITHK; Kaplan S, 2000, UROLOGY, V56, P610, DOI 10.1016/S0090-4295(00)00724-X; Kloner RA, 2004, J UROLOGY, V172, P1935, DOI 10.1097/01.ju.0000142687.75577.e4; Lowe FC, 2005, BJU INT, V95, P12, DOI 10.1111/j.1464-410X.2005.05486.x; Lowe FC, 1999, UROLOGY, V54, P81, DOI 10.1016/S0090-4295(99)00057-6; Lowe FC, 1997, CLIN THER, V19, P730, DOI 10.1016/S0149-2918(97)80097-5; Madersbacher S, 2004, EUR UROL, V46, P547, DOI 10.1016/j.eururo.2004.07.016; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; Milani S, 2005, BJU INT, V95, P29, DOI 10.1111/j.1464-410X.2005.05485.x; *NAT I CLIN EXC, 2000, CLIN GUID REF PROT R; Roehrborn CG, 2004, UROLOGY, V63, P709, DOI 10.1016/j.urology.2004.01.001; Speakman MJ, 2004, BJU INT, V93, P985, DOI 10.1111/j.1464-410X.2004.04765.x; van Kerrebroeck P, 2002, EUR UROL, V41, P54, DOI 10.1016/S0302-2838(01)00016-1	22	19	22	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 9	2006	333	7567					535	539		10.1136/bmj.38946.616551.BE1	http://dx.doi.org/10.1136/bmj.38946.616551.BE1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	084LD	16960209	Green Published			2022-12-28	WOS:000240533500019
J	Yoshida, Y; Kuroiwa, H; Misumi, O; Nishida, K; Yagisawa, F; Fujiwara, T; Nanamiya, H; Kawamura, F; Kuroiwa, T				Yoshida, Yamato; Kuroiwa, Haruko; Misumi, Osami; Nishida, Keiji; Yagisawa, Fumi; Fujiwara, Takayuki; Nanamiya, Hideaki; Kawamura, Fujio; Kuroiwa, Tsuneyoshi			Isolated chloroplast division machinery can actively constrict after stretching	SCIENCE			English	Article							PLASTID DIVISION; RED ALGA; DYNAMIN; ORGANELLES; APPARATUS; PROTEIN; RING	Chloroplast division involves plastid-dividing, dynamin, and FtsZ (PDF) rings. We isolated intact supertwisted ( or spiral) and circular PDF machineries from chloroplasts of the red alga Cyanidioschyzon merolae. After individual intact PDF machineries were stretched to four times their original lengths with optical tweezers, they spontaneously returned to their original sizes. Dynamin-released PDF machineries did not retain the spiral structure and could not be stretched. Thus, dynamin may generate the motive force for contraction by filament sliding in dividing chloroplasts, in addition to pinching-off the membranes.	Rikkyo St Pauls Univ, Coll Sci, Dept Life Sci, Cell Biol Lab, Tokyo 1718501, Japan; Rikkyo St Pauls Univ, Res Informat Ctr Extremophile, Tokyo 1718501, Japan	Rikkyo University; Rikkyo University	Kuroiwa, T (corresponding author), Rikkyo St Pauls Univ, Coll Sci, Dept Life Sci, Cell Biol Lab, Tokyo 1718501, Japan.	tsune@rikkyo.ne.jp						Gao HB, 2003, P NATL ACAD SCI USA, V100, P4328, DOI 10.1073/pnas.0530206100; GILLHUM NW, 1994, ORGANELLE GENES GENO; Kuroiwa T, 1998, INT REV CYTOL, V181, P1, DOI 10.1016/S0074-7696(08)60415-5; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Miyagishima S, 2003, PLANT CELL, V15, P655, DOI 10.1105/tpc.009373; Miyagishima SY, 2001, PLANT CELL, V13, P2257, DOI 10.1105/tpc.010185; Miyagishima SY, 2001, PLANT CELL, V13, P707; Nishida K, 2003, P NATL ACAD SCI USA, V100, P2146, DOI 10.1073/pnas.0436886100; Osteryoung KW, 2003, SCIENCE, V302, P1698, DOI 10.1126/science.1082192; OSTERYOUNG KW, 1995, NATURE, V376, P473, DOI 10.1038/376473b0; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6	14	72	83	3	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2006	313	5792					1435	1438		10.1126/science.1129689	http://dx.doi.org/10.1126/science.1129689			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16960006				2022-12-28	WOS:000240348700042
J	Iezzoni, LI				Iezzoni, Lisa I.			Going beyond Disease to Address Disability	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Iezzoni, LI (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							*DEP HHS, 2000, HLTH PEOPL 2010; *DEP HHS, 2005, SURG GEN CALL ACT IM; Iezzoni Lisa I., 2006, MORE RAMPS GUIDE IMP; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSS QUAL CHASM NEW	4	27	27	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 7	2006	355	10					976	979		10.1056/NEJMp068093	http://dx.doi.org/10.1056/NEJMp068093			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080UF	16957143				2022-12-28	WOS:000240273300002
J	Madan, P; Vardhan, P				Madan, Pankaj; Vardhan, Prern			Congenital erythropoietic porphyria	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									All India Inst Med Sci, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Madan, P (corresponding author), All India Inst Med Sci, New Delhi 110029, India.	pankajmadaan@rediffmail.com							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 7	2006	355	10					1047	1047		10.1056/NEJMicm041174	http://dx.doi.org/10.1056/NEJMicm041174			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080UF	16957150				2022-12-28	WOS:000240273300010
J	Davis, DA; Mazmanian, PE; Fordis, M; Van Harrison, R; Thorpe, KE; Perrier, L				Davis, David A.; Mazmanian, Paul E.; Fordis, Michael; Van Harrison, R.; Thorpe, Kevin E.; Perrier, Laure			Accuracy of physician self-assessment compared with observed measures of competence - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CONTINUING MEDICAL-EDUCATION; HEALTH-PROFESSIONS; OWN INCOMPETENCE; CLINICAL SKILLS; PRIMARY-CARE; PERFORMANCE; DIFFICULTIES; CONFIDENCE; PARADIGM; OFFICERS	Context Core physician activities of lifelong learning, continuing medical education credit, relicensure, specialty recertification, and clinical competence are linked to the abilities of physicians to assess their own learning needs and choose educational activities that meet these needs. Objective To determine how accurately physicians self-assess compared with external observations of their competence. Data Sources The electronic databases MEDLINE (1966-July 2006), EMBASE (1980-July 2006), CINAHL (1982-July 2006), PsycINFO (1967-July 2006), the Research and Development Resource Base in CME (1978-July 2006), and proprietary search engines were searched using terms related to self-directed learning, self-assessment, and self-reflection. Study Selection Studies were included if they compared physicians' self-rated assessments with external observations, used quantifiable and replicable measures, included a study population of at least 50% practicing physicians, residents, or similar health professionals, and were conducted in the United Kingdom, Canada, United States, Australia, or New Zealand. Studies were excluded if they were comparisons of self-reports, studies of medical students, assessed physician beliefs about patient status, described the development of self-assessment measures, or were self-assessment programs of specialty societies. Studies conducted in the context of an educational or quality improvement intervention were included only if comparative data were obtained before the intervention. Data Extraction Study population, content area and self-assessment domain of the study, methods used to measure the self-assessment of study participants and those used to measure their competence or performance, existence and use of statistical tests, study outcomes, and explanatory comparative data were extracted. Data Synthesis The search yielded 725 articles, of which 17 met all inclusion criteria. The studies included a wide range of domains, comparisons, measures, and methodological rigor. Of the 20 comparisons between self- and external assessment, 13 demonstrated little, no, or an inverse relationship and 7 demonstrated positive associations. A number of studies found the worst accuracy in self-assessment among physicians who were the least skilled and those who were the most confident. These results are consistent with those found in other professions. Conclusions While suboptimal in quality, the preponderance of evidence suggests that physicians have a limited ability to accurately self-assess. The processes currently used to undertake professional development and evaluate competence may need to focus more on external assessment.	Univ Toronto, Off Continuing Educ & Profess Dev, Toronto, ON M5G 1V7, Canada; Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Knowledge Translat Program, Toronto, ON M5G 1V7, Canada; Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5G 1V7, Canada; Univ Toronto, Dept Family & Community Med, Toronto, ON M5G 1V7, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON M5G 1V7, Canada; Virginia Commonwealth Univ, Sch Med, Dept Family Med, Richmond, VA USA; Virginia Commonwealth Univ, Sch Med, Dept Epidemiol & Community Hlth, Richmond, VA USA; Baylor Coll Med, Ctr Collaborat Interact Technol, Houston, TX 77030 USA; Univ Michigan, Dept Med Educ, Ann Arbor, MI 48109 USA	University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; Virginia Commonwealth University; Virginia Commonwealth University; Baylor College of Medicine; University of Michigan System; University of Michigan	Perrier, L (corresponding author), Univ Toronto, Off Continuing Educ & Profess Dev, 500 Univ Ave,6th Floor, Toronto, ON M5G 1V7, Canada.	l.perrier@utoronto.ca	Perrier, Laure/D-4638-2011	Perrier, Laure/0000-0001-9941-7129; Thorpe, Kevin/0000-0002-7586-3893				*ACCR COUNC GRAD M, GEN COMP; *AM BOARD MED SPEC, APPR IN MAINT CERT A; American Medical Association, PHYS RES CME; Amery J, 2004, PALLIATIVE MED, V18, P727, DOI 10.1191/0269216304pm902oa; [Anonymous], 2000, MED TEACH, V22, P549; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; Barnsley L, 2004, MED EDUC, V38, P358, DOI 10.1046/j.1365-2923.2004.01773.x; BASOOK PG, CREDENTIALING PHYS S; Biernat K, 2003, ADV HEALTH SCI EDUC, V8, P105, DOI 10.1023/A:1024961618669; Claridge JA, 2003, AM J SURG, V185, P323, DOI 10.1016/S0002-9610(02)01421-6; Colliver JA, 2005, TEACH LEARN MED, V17, P200, DOI 10.1207/s15328015tlm1703_1; Conlon M, 2003, BMJ-BRIT MED J, V327, P3890; Davis Nancy L, 2004, J Contin Educ Health Prof, V24, P139, DOI 10.1002/chp.1340240304; Dunning David, 2004, Psychol Sci Public Interest, V5, P69, DOI 10.1111/j.1529-1006.2004.00018.x; Epstein RM, 2002, JAMA-J AM MED ASSOC, V287, P226, DOI 10.1001/jama.287.2.226; Eva KW, 2005, ACAD MED, V80, pS46, DOI 10.1097/00001888-200510001-00015; Eva KW, 2004, ADV HEALTH SCI EDUC, V9, P211, DOI 10.1023/B:AHSE.0000038209.65714.d4; FALCHIKOV N, 1989, REV EDUC RES, V59, P395, DOI 10.3102/00346543059004395; Fernandez A, 2004, J GEN INTERN MED, V19, P167, DOI 10.1111/j.1525-1497.2004.30266.x; Fox RA, 2000, MED EDUC, V34, P1007, DOI 10.1046/j.1365-2923.2000.00729.x; GORDON MJ, 1991, ACAD MED, V66, P762, DOI 10.1097/00001888-199112000-00012; Hays RB, 2002, MED EDUC, V36, P965, DOI 10.1046/j.1365-2923.2002.01317.x; Hodges B, 2001, ACAD MED, V76, pS87, DOI 10.1097/00001888-200110001-00029; HOPPE RB, 1990, J GEN INTERN MED, V5, P415, DOI 10.1007/BF02599430; Institute of Medicine, 2003, HLTH PROFESSIONS ED; Ireton H R, 1988, Fam Pract Res J, V7, P236; Johnson D, 1998, CRIT CARE MED, V26, P1811, DOI 10.1097/00003246-199811000-00020; Johnson DA, 2005, J CONTIN EDUC HEALTH, V25, P183, DOI 10.1002/chp.27; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; Leopold SS, 2005, J BONE JOINT SURG AM, V87A, P1031, DOI 10.2106/JBJS.D.02434; Lockyer Jocelyn, 2003, J Contin Educ Health Prof, V23, P4, DOI 10.1002/chp.1340230103; Mamede S, 2004, MED EDUC, V38, P1302, DOI 10.1111/j.1365-2929.2004.01917.x; Moret L, 2004, AM J INFECT CONTROL, V32, P384, DOI 10.1016/j.ajic.2004.02.004; Paradise JE, 1997, ARCH PEDIAT ADOL MED, V151, P883, DOI 10.1001/archpedi.1997.02170460021004; Parker RW, 2004, FAM MED, V36, P705; ROBBINS JM, 1994, MED CARE, V32, P795, DOI 10.1097/00005650-199408000-00004; Sachdeva AK, 2005, ARCH SURG-CHICAGO, V140, P264, DOI 10.1001/archsurg.140.3.264; Sherman C D Jr, 1995, J Cancer Educ, V10, P131; SIBLEY JC, 1982, NEW ENGL J MED, V306, P511, DOI 10.1056/NEJM198203043060904; Simon FA, 2005, J CONTIN EDUC HEALTH, V25, P157, DOI 10.1002/chp.23; STERN DT, 1995, ACAD MED, V70, P152, DOI 10.1097/00001888-199502000-00021; Tracey JM, 1997, BRIT MED J, V315, P1426, DOI 10.1136/bmj.315.7120.1426; Ward M, 2002, ADV HEALTH SCI EDUC, V7, P63, DOI 10.1023/A:1014585522084; Wasserman SI, 2000, ANN INTERN MED, V133, P202, DOI 10.7326/0003-4819-133-3-200008010-00012; Westberg J, 1994, Fam Med, V26, P278; Woods R, 2004, BIOSECUR BIOTERROR, V2, P157, DOI 10.1089/15387130460759209; Young JM, 2002, BRIT MED J, V324, P950, DOI 10.1136/bmj.324.7343.950	47	1476	1481	2	145	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2006	296	9					1094	1102		10.1001/jama.296.9.1094	http://dx.doi.org/10.1001/jama.296.9.1094			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	081DW	16954489				2022-12-28	WOS:000240298400011
J	Bartlett, S				Bartlett, Stephanie			Pluto left out in the cold	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Bartlett, S (corresponding author), Lancet, London NW1 7BY, England.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 2	2006	368	9538					828	828		10.1016/S0140-6736(06)69306-9	http://dx.doi.org/10.1016/S0140-6736(06)69306-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	082FD	16950345				2022-12-28	WOS:000240371200011
J	Corfe, IJ; Butler, RJ				Corfe, Ian J.; Butler, Richard J.			Comment on "A well-preserved Archaeopteryx specimen with theropod features"	SCIENCE			English	Editorial Material							LIMITS		Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; Nat Hist Museum, Dept Zool, London SW7 5BD, England; Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England	University of Bristol; Natural History Museum London; Natural History Museum London	Corfe, IJ (corresponding author), Univ Bristol, Dept Earth Sci, Wills Mem Bldg,Queens Rd, Bristol BS8 1RJ, Avon, England.	ian.corfe@bristol.ac.uk	Butler, Richard J./A-5239-2011; Corfe, Ian/GSN-6109-2022	Butler, Richard J./0000-0003-2136-7541; Corfe, Ian/0000-0002-1824-755X				BREMER K, 1988, EVOLUTION, V42, P795, DOI 10.1111/j.1558-5646.1988.tb02497.x; CHIAPPE LM, 2002, MESOZOIC BIRDS HEADS, pCH20; CLARK JM, 2002, MESOZOIC BIRDS HEADS, pCH3; ELZANOWSKI A, 2002, MESOZOIC BIRDS HEADS, pCH6; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Goloboff P., 1999, NONA NO NAME VER 2; Hwang SH, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)381<0001:NSOMZT>2.0.CO;2; Hwang Sunny H., 2004, Journal of Systematic Palaeontology, V2, P13, DOI 10.1017/S1477201903001081; Maddison D. R., 2003, MACCLADE 4 ANAL PHYL; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Mayr G, 2005, SCIENCE, V310, P1483, DOI 10.1126/science.1120331; PADIAN K, 2004, DINOSAURIA, pCH11; SWOFFORD DL, 2002, PAUP VERSION 4 0B10; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x	15	4	5	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 1	2006	313	5791								10.1126/science.1130800	http://dx.doi.org/10.1126/science.1130800			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16946054				2022-12-28	WOS:000240313500020
J	Piro, NA; Figueroa, JS; McKellar, JT; Cummins, CC				Piro, Nicholas A.; Figueroa, Joshua S.; McKellar, Jessica T.; Cummins, Christopher C.			Triple-bond reactivity of diphosphorus molecules	SCIENCE			English	Article							TRANSITION-METAL-COMPLEXES; WHITE PHOSPHORUS; IMIDOMETAL COMPLEXES; MATRIX REACTIONS; ORGANIC AZIDES; O-3 MOLECULES; P-2; PHOSPHIDE; ACTIVATION; LIGANDS	We report a mild method for generating the diphosphorus molecule or its synthetic equivalent in homogeneous solution; the P-2 allotrope of the element phosphorus is normally obtained only under extreme conditions (for example, from P-4 at 1100 kelvin). Diphosphorus is extruded from a niobium complex designed for this purpose and can be trapped efficiently by two equivalents of an organic diene to produce an organodiph'osphorus compound. Diphosphorus stabilized by coordination to tungsten pentacarbonyl can be generated similarly at 25 degrees C, and in this stabilized form it still efficiently consumes two organic diene molecules for every diphosphorus unit.	MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Cummins, CC (corresponding author), MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ccummins@mit.edu	Cummins, Christopher/J-2961-2014; Piro, Nicholas/L-1925-2018; Figueroa, Joshua/GSO-0962-2022	Cummins, Christopher/0000-0003-2568-3269; Piro, Nicholas/0000-0003-4219-0909; 				ANDREWS L, 1990, J MOL STRUCT, V222, P95, DOI 10.1016/0022-2860(90)80008-8; BOCK H, 1984, INORG CHEM, V23, P4365, DOI 10.1021/ic00193a051; BORM J, 1985, J ORGANOMET CHEM, V282, P53, DOI 10.1016/0022-328X(85)87141-2; Charrier C, 1996, ANGEW CHEM INT EDIT, V35, P2133, DOI 10.1002/anie.199621331; Cummins CC, 2006, ANGEW CHEM INT EDIT, V45, P862, DOI 10.1002/anie.200503327; Dillon K. B., 1998, PHOSPHORUS CARBON CO; Ehses M, 2002, TOP CURR CHEM, V220, P107; Esterhuysen C, 2003, CHEM-EUR J, V9, P3518, DOI 10.1002/chem.200304723; FICKES MG, 1995, J AM CHEM SOC, V117, P6384, DOI 10.1021/ja00128a039; Figueroa JS, 2006, DALTON T, P2161, DOI 10.1039/b602530g; Figueroa JS, 2004, J AM CHEM SOC, V126, P13916, DOI 10.1021/ja0461522; Figueroa JS, 2004, ANGEW CHEM INT EDIT, V43, P984, DOI 10.1002/anie.200352779; Greenwood N.N., 1997, CHEM ELEMENTS; Grimme W, 1998, J CHEM SOC PERK T 2, P1893, DOI 10.1039/a803481h; HOFFMANN R, 1965, J AM CHEM SOC, V87, P4388, DOI 10.1021/ja00947a033; Huber K.P., 1979, MOL SPECTRA MOL STRU; HUY NHT, 1999, J ORGANOMET CHEM, V582, P53; KOBAYASHI N, 1991, JPN J APPL PHYS 2, V30, pL1699, DOI 10.1143/JJAP.30.L1699; Kornath A, 2002, J CHEM PHYS, V116, P3323, DOI 10.1063/1.1436112; MARTIN JG, 1961, CHEM REV, V61, P537, DOI 10.1021/cr60214a001; MCCLUSKEY M, 1991, J PHYS CHEM-US, V95, P2988, DOI 10.1021/j100161a011; Melville HW, 1936, T FARADAY SOC, V32, P0271, DOI 10.1039/tf9363200271; MIELKE Z, 1990, CHEM PHYS LETT, V165, P146, DOI 10.1016/0009-2614(90)85420-H; NIECKE E, 1996, SYNTHETIC METHODS OR, V3, P28; PETTERSSON LGM, 1993, CHEM PHYS, V170, P149, DOI 10.1016/0301-0104(93)80059-I; PROULX G, 1995, J AM CHEM SOC, V117, P6382, DOI 10.1021/ja00128a038; Proulx G, 1996, ORGANOMETALLICS, V15, P684, DOI 10.1021/om950796o; REGITZ M, 1990, MULTIPLE BONDS LOW C; SAUER J, 1980, ANGEW CHEM INT EDIT, V19, P779, DOI 10.1002/anie.198007791; SAUVAL AJ, 1984, ASTROPHYS J SUPPL S, V56, P193, DOI 10.1086/190980; Scherer OJ, 1998, ANGEW CHEM INT EDIT, V37, P507, DOI 10.1002/(SICI)1521-3773(19980302)37:4<507::AID-ANIE507>3.0.CO;2-M; Scherer OJ, 2000, ANGEW CHEM INT EDIT, V39, P1029, DOI 10.1002/(SICI)1521-3773(20000317)39:6<1029::AID-ANIE1029>3.0.CO;2-6; Stevenson DP, 1941, J CHEM PHYS, V9, P403, DOI 10.1063/1.1750923; Wilson JE, 2006, ANGEW CHEM INT EDIT, V45, P1426, DOI 10.1002/anie.200503312; Zhu XF, 2003, J AM CHEM SOC, V125, P4716, DOI 10.1021/ja0344009	35	134	134	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 1	2006	313	5791					1276	1279		10.1126/science.1129630	http://dx.doi.org/10.1126/science.1129630			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	081JI	16946068				2022-12-28	WOS:000240313500037
J	Winzenberg, T; Shaw, K; Fryer, J; Jones, G				Winzenberg, Tania; Shaw, Kelly; Fryer, Jayne; Jones, Graeme			Effects of calcium supplementation on bone density in healthy children: meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SYMPTOMATIC FRACTURE INCIDENCE; MINERAL DENSITY; DOUBLE-BLIND; PHYSICAL-ACTIVITY; PREPUBERTAL GIRLS; BODY-COMPOSITION; MENARCHEAL AGE; DAIRY-PRODUCTS; MASS GROWTH; ACQUISITION	Objectives To assess the effectiveness of calcium supplementation for improving bone mineral density in healthy children and to determine if any effect is modified by other factors and persists after supplementation stops. Design Meta-analysis. Data sources Electronic bibliographic databases, hand searching of conference proceedings, and contacting authors for unpublished data. Review methods We included. randomised placebo controlled trials of calcium supplementation in healthy children that lasted at least three months and had bone outcomes measured after at least six months of follow-up. Two reviewers independently extracted data and assessed quality. Meta-analyses predominantly used fixed effects models with outcomes given as standardised mean differences. Results We included 19 studies involving 2859 children. Calcium supplementation had no effect on bone mineral density at the femoral neck or lumbar. spine. There was a small effect on total body bone mineral content (standardised mean difference 0.14, 95% confidence interval 0.01 to 0.27) and upper limb bone mineral density (0.14, 0.04 to 0.24). This effect persisted after the end of supplementation only at the upper limb (0.14, 0.01 to 0.28). There was no evidence that sex, baseline calcium intake, pubertal stage, ethnicity, or level of physical activity modified the effect. Conclusions The small effect of calcium supplementation on bone mineral density in the upper limb is unlikely to reduce the risk of fracture, either in childhood or later life, to a degree of major public health importance.	Menzies Res Inst, Hobart, Tas 7001, Australia; Dept Hlth & Human Serv, Hobart, Tas 7000, Australia	University of Tasmania; Menzies Institute for Medical Research	Winzenberg, T (corresponding author), Menzies Res Inst, Private Bag 23, Hobart, Tas 7001, Australia.	tania.winzenberg@utas.edu.au	Winzenberg, Tania/J-7522-2014	Winzenberg, Tania/0000-0002-4112-3491				Abrams SA, 1996, J CLIN ENDOCR METAB, V81, P2017, DOI 10.1210/jc.81.6.2017; ALDERSON P, 2002, COCHRANE COLLABORATI; Bailey DA, 1999, J BONE MINER RES, V14, P1672, DOI 10.1359/jbmr.1999.14.10.1672; BONJOUR JP, 1995, J BONE MINER RES, V10, pS152; BONJOUR JP, 1991, J CLIN ENDOCR METAB, V73, P555, DOI 10.1210/jcem-73-3-555; Bonjour JP, 1997, J CLIN INVEST, V99, P1287, DOI 10.1172/JCI119287; Bonjour JP, 2001, LANCET, V358, P1208, DOI 10.1016/S0140-6736(01)06342-5; Cameron MA, 2004, J CLIN ENDOCR METAB, V89, P4916, DOI 10.1210/jc.2003-031985; CHAN GM, 1995, J PEDIATR-US, V126, P551, DOI 10.1016/S0022-3476(95)70348-9; Chevalley T, 2005, J CLIN ENDOCR METAB, V90, P44, DOI 10.1210/jc.2004-1043; Chevalley T, 2003, J BONE MINER RES, V18, pS33; CHEVALLEY T, 2005, J CLIN ENDOCRINOL ME; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cooley H, 2001, OSTEOPOROSIS INT, V12, P124, DOI 10.1007/s001980170144; Courteix D, 2005, INT J SPORTS MED, V26, P332, DOI 10.1055/s-2004-821040; Dibba B, 2002, AM J CLIN NUTR, V76, P681, DOI 10.1093/ajcn/76.3.681; Dibba B, 2000, AM J CLIN NUTR, V71, P544; Dodiuk-Gad RP, 2005, AM J CLIN NUTR, V81, P168; French SA, 2000, PREV MED, V31, P722, DOI 10.1006/pmed.2000.0758; Goulding A, 1998, J BONE MINER RES, V13, P143, DOI 10.1359/jbmr.1998.13.1.143; Goulding A, 2001, J PEDIATR-US, V139, P509, DOI 10.1067/mpd.2001.116297; HANSEN MA, 1991, BMJ-BRIT MED J, V303, P961, DOI 10.1136/bmj.303.6808.961; Heaney RP, 2001, NUTR REV, V59, P327, DOI 10.1111/j.1753-4887.2001.tb06957.x; Iuliano-Burns S, 2003, J BONE MINER RES, V18, P156, DOI 10.1359/jbmr.2003.18.1.156; Jackman LA, 1997, AM J CLIN NUTR, V66, P327, DOI 10.1093/ajcn/66.2.327; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Javaid MK, 2002, BEST PRACT RES CL EN, V16, P349, DOI 10.1053/beem.2002.0199; JOHNSTON CC, 1992, NEW ENGL J MED, V327, P82, DOI 10.1056/NEJM199207093270204; JONES G, 1994, OSTEOPOROSIS INT, V4, P277, DOI 10.1007/BF01623352; Jones G, 2001, AM J CLIN NUTR, V73, P839; Jones G, 2002, J PAEDIATR CHILD H, V38, P278, DOI 10.1046/j.1440-1754.2002.00811.x; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Landoll JD, 2003, J BONE MINER RES, V18, pS182; Lanou AJ, 2005, PEDIATRICS, V115, P736, DOI 10.1542/peds.2004-0548; LEE WTK, 1995, BRIT J NUTR, V74, P125, DOI 10.1079/BJN19950112; Lee WTK, 1996, AM J CLIN NUTR, V64, P71, DOI 10.1093/ajcn/64.1.71; LEE WTK, 1994, AM J CLIN NUTR, V60, P744, DOI 10.1093/ajcn/60.5.744; Lee WTK, 1997, ACTA PAEDIATR, V86, P570, DOI 10.1111/j.1651-2227.1997.tb08936.x; LLOYD T, 1995, J BONE MINER RES, V10, pS152; LLOYD T, 1993, JAMA-J AM MED ASSOC, V270, P841, DOI 10.1001/jama.270.7.841; Lloyd T, 1996, OSTEOPOROSIS INT, V6, P276, DOI 10.1007/BF01623385; LLOYD T, 1996, J BONE MINER RES, pS154; Ma DQ, 2003, J CLIN ENDOCR METAB, V88, P1486, DOI 10.1210/jc.2002-021682; Markovic V, 2005, AM J CLIN NUTR, V81, P175; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Matkovic V, 2004, J NUTR, V134, p701S, DOI 10.1093/jn/134.3.701S; Matkovic V, 2002, J BONE MINER RES, V17, pS172; MATKOVIC V, 1992, AM J CLIN NUTR, V55, P992, DOI 10.1093/ajcn/55.5.992; Molgaard C, 2004, AM J CLIN NUTR, V80, P1422, DOI 10.1093/ajcn/80.5.1422; Moyer-Mileur L. J., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P63; Nowson CA, 1997, OSTEOPOROSIS INT, V7, P219, DOI 10.1007/BF01622292; PRENTICE A, 1994, AM J CLIN NUTR, V60, P837; PRENTICE A, 2005, J CLIN ENDOCRINOL ME; Riis BJ, 1996, BONE, V19, P9, DOI 10.1016/8756-3282(96)00102-0; RODDA C, 2004, AUSTR NZ BONE MINERL, P50; Rozen GS, 2003, AM J CLIN NUTR, V78, P993, DOI 10.1093/ajcn/78.5.993; SHEA B, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004526.PUB2; Slemenda CW, 1997, J BONE MINER RES, V12, P676, DOI 10.1359/jbmr.1997.12.4.676; SLEMENDA CW, 1993, J BONE MINER RES, V8, pS154; Specker B, 2003, J BONE MINER RES, V18, P885, DOI 10.1359/jbmr.2003.18.5.885; Stear SJ, 2003, AM J CLIN NUTR, V77, P985, DOI 10.1093/ajcn/77.4.985; WANG S, 1996, ACTA NUTR SINICA, V18, P97; Winzenberg TM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005119.pub2; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; Wosje KS, 2000, NUTR REV, V58, P253, DOI 10.1111/j.1753-4887.2000.tb01879.x; ZHU K, 2004, ASIA PAC J CLIN NUTR, V13, pS83	67	137	148	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 14	2006	333	7572					775	778F		10.1136/bmj.38950.561400.55	http://dx.doi.org/10.1136/bmj.38950.561400.55			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099AX	16980314	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000241566000012
J	Zahradka, K; Slade, D; Bailone, A; Sommer, S; Averbeck, D; Petranovic, M; Lindner, AB; Radman, M				Zahradka, Ksenija; Slade, Dea; Bailone, Adriana; Sommer, Suzanne; Averbeck, Dietrich; Petranovic, Mirjana; Lindner, Ariel B.; Radman, Miroslav			Reassembly of shattered chromosomes in Deinococcus radiodurans	NATURE			English	Article							RADIATION-RESISTANT BACTERIA; IONIZING-RADIATION; DEOXYRIBONUCLEIC ACID; ESCHERICHIA-COLI; STRAND BREAKS; DNA-REPAIR; GENOME; RADIORESISTANCE; RECOMBINATION; RECA	Dehydration or desiccation is one of the most frequent and severe challenges to living cells(1). The bacterium Deinococcus radiodurans is the best known extremophile among the few organisms that can survive extremely high exposures to desiccation and ionizing radiation, which shatter its genome into hundreds of short DNA fragments(2-5). Remarkably, these fragments are readily reassembled into a functional 3.28-megabase genome. Here we describe the relevant two-stage DNA repair process, which involves a previously unknown molecular mechanism for fragment reassembly called 'extended synthesis-dependent strand annealing' (ESDSA), followed and completed by crossovers. At least two genome copies and random DNA breakage are requirements for effective ESDSA. In ESDSA, chromosomal fragments with overlapping homologies are used both as primers and as templates for massive synthesis of complementary single strands, as occurs in a single-round multiplex polymerase chain reaction. This synthesis depends on DNA polymerase I and incorporates more nucleotides than does normal replication in intact cells. Newly synthesized complementary single-stranded extensions become 'sticky ends' that anneal with high precision, joining together contiguous DNA fragments into long, linear, double-stranded intermediates. These intermediates require RecA-dependent crossovers to mature into circular chromosomes that comprise double-stranded patchworks of numerous DNA blocks synthesized before radiation, connected by DNA blocks synthesized after radiation.	Univ Paris 05, Fac Med, INSERM, F-75015 Paris, France; Rudjer Boskovic Inst, Div Mol Biol, Zagreb 10002, Croatia; Univ Paris 11, Inst Genet & Microbiol, CNRS, CEA,UMR8621, F-91405 Orsay, France; Ctr Univ Paris Sud, Inst Curie, Sect Rech, CNRS,UMR 2027, F-91405 Orsay, France; Mediterranean Inst Life Sci, Split 21000, Croatia	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Rudjer Boskovic Institute; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay	Radman, M (corresponding author), Univ Paris 05, Fac Med, INSERM, Site Necker,U571,156 Rue Vaugirard, F-75015 Paris, France.	radman@necker.fr	Lindner, Ariel/K-9247-2019; Lindner, Ariel B/I-8503-2016; Radman, Miroslav/HDM-5955-2022	Lindner, Ariel/0000-0001-5015-6511; Lindner, Ariel B/0000-0001-5015-6511; Slade, Dea/0000-0002-0052-5910; Radman, Miroslav/0000-0003-0216-3148; Radman, Miroslav/0000-0002-7034-4365				ANDERSON AW, 1956, FOOD TECHNOL-CHICAGO, V10, P575; Battista JR, 1999, TRENDS MICROBIOL, V7, P362, DOI 10.1016/S0966-842X(99)01566-8; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Daly MJ, 1996, J BACTERIOL, V178, P4461, DOI 10.1128/jb.178.15.4461-4471.1996; de Almeida CB, 2002, MOL GENET GENOMICS, V268, P28, DOI 10.1007/s00438-002-0718-x; DEAN CJ, 1966, NATURE, V209, P49, DOI 10.1038/209049a0; Ferreira AC, 1999, EXTREMOPHILES, V3, P235, DOI 10.1007/s007920050121; Fujimori A, 2001, EMBO J, V20, P5513, DOI 10.1093/emboj/20.19.5513; Harris DR, 2004, PLOS BIOL, V2, P1629, DOI 10.1371/journal.pbio.0020304; HARSOJO, 1981, J BIOCHEM-TOKYO, V90, P877, DOI 10.1093/oxfordjournals.jbchem.a133544; KRASIN F, 1977, J MOL BIOL, V116, P81, DOI 10.1016/0022-2836(77)90120-6; Levin-Zaidman S, 2003, SCIENCE, V299, P254, DOI 10.1126/science.1077865; Lin JY, 1999, SCIENCE, V285, P1558, DOI 10.1126/science.285.5433.1558; LINDAHL T, 1982, ANNU REV BIOCHEM, V51, P61, DOI 10.1146/annurev.bi.51.070182.000425; LION MB, 1970, BIOCHIM BIOPHYS ACTA, V209, P24, DOI 10.1016/0005-2787(70)90657-X; LOHMAN PHM, 1972, RADIAT RES, V52, P627, DOI 10.2307/3573520; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Mattimore V, 1996, J BACTERIOL, V178, P633, DOI 10.1128/jb.178.3.633-637.1996; Mennecier S, 2004, MOL GENET GENOMICS, V272, P460, DOI 10.1007/s00438-004-1077-6; MESELSON M, 1958, COLD SPRING HARB SYM, V23, P9, DOI 10.1101/SQB.1958.023.01.004; Milligan JR, 2000, INT J RADIAT BIOL, V76, P1475; MINTON KW, 1994, MOL MICROBIOL, V13, P9, DOI 10.1111/j.1365-2958.1994.tb00397.x; Narumi I, 2003, TRENDS MICROBIOL, V11, P422, DOI 10.1016/S0966-842X(03)00204-X; Potts M, 2001, TRENDS MICROBIOL, V9, P553, DOI 10.1016/S0966-842X(01)02231-4; Rainey FA, 2005, APPL ENVIRON MICROB, V71, P5225, DOI 10.1128/AEM.71.9.5225-5235.2005; RAYSSIGUIER C, 1989, NATURE, V342, P396, DOI 10.1038/342396a0; SANDERS SW, 1979, APPL ENVIRON MICROB, V38, P436, DOI 10.1128/AEM.38.3.436-439.1979; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Zimmerman JM, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-17	29	306	332	5	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2006	443	7111					569	573		10.1038/nature05160	http://dx.doi.org/10.1038/nature05160			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	17006450				2022-12-28	WOS:000240988200042
J	Demokritov, SO; Demidov, VE; Dzyapko, O; Melkov, GA; Serga, AA; Hillebrands, B; Slavin, AN				Demokritov, S. O.; Demidov, V. E.; Dzyapko, O.; Melkov, G. A.; Serga, A. A.; Hillebrands, B.; Slavin, A. N.			Bose-Einstein condensation of quasi-equilibrium magnons at room temperature under pumping	NATURE			English	Article							COUPLED QUANTUM-WELLS; PHASE-TRANSITION; RESONANCE; TLCUCL3; ATOMS; MODES; FILMS; GAS	Bose-Einstein condensation(1,2) is one of the most fascinating phenomena predicted by quantum mechanics. It involves the formation of a collective quantum state composed of identical particles with integer angular momentum (bosons), if the particle density exceeds a critical value. To achieve Bose - Einstein condensation, one can either decrease the temperature or increase the density of bosons. It has been predicted(3,4) that a quasi-equilibrium system of bosons could undergo Bose - Einstein condensation even at relatively high temperatures, if the flow rate of energy pumped into the system exceeds a critical value. Here we report the observation of Bose - Einstein condensation in a gas of magnons at room temperature. Magnons are the quanta of magnetic excitations in a magnetically ordered ensemble of magnetic moments. In thermal equilibrium, they can be described by Bose - Einstein statistics with zero chemical potential and a temperature-dependent density. In the experiments presented here, we show that by using a technique of microwave pumping it is possible to excite additional magnons and to create a gas of quasi-equilibrium magnons with a non-zero chemical potential. With increasing pumping intensity, the chemical potential reaches the energy of the lowest magnon state, and a Bose condensate of magnons is formed.	Univ Munster, Inst Appl Phys, D-48149 Munster, Germany; Natl Taras Schevchenko Univ Kiev, Dept Radiophys, UA-01033 Kiev, Ukraine; Tech Univ Kaiserslautern, Fachbereich Phys, D-67663 Kaiserslautern, Germany; Oakland Univ, Dept Phys, Rochester, MI 48309 USA	University of Munster; Ministry of Education & Science of Ukraine; Taras Shevchenko National University Kiev; University of Kaiserslautern; Oakland University	Demokritov, SO (corresponding author), Univ Munster, Inst Appl Phys, D-48149 Munster, Germany.	demokrit@uni-muenster.de	Melkov, Gennadiy A/ABC-5951-2021; Serga, Alexander A/J-4646-2017; Hillebrands, Burkard/C-6242-2008; Demokritov, Sergej O/C-4347-2013	Serga, Alexander A/0000-0003-2634-8569; Hillebrands, Burkard/0000-0001-8910-0355; Demokritov, Sergej O/0000-0003-4422-4201; Melkov, Gennadiy/0000-0003-0387-1488				ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; Bloch I, 2000, NATURE, V403, P166, DOI 10.1038/35003132; Butov LV, 2004, J PHYS-CONDENS MAT, V16, pR1577, DOI 10.1088/0953-8984/16/50/R02; Cottam M.G., 1986, LIGHT SCATTERING MAG; DAVIS KB, 1995, PHYS REV LETT, V75, P3969, DOI 10.1103/PhysRevLett.75.3969; Della Torre E, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.147210; Demokritov SO, 2001, PHYS REP, V348, P441, DOI 10.1016/S0370-1573(00)00116-2; Einstein A, 1925, SITZBER PREUSS AKAD, P3; Einstein A, 1924, SITZBER PREUSS AKAD, P261; Eisenstein JP, 2004, NATURE, V432, P691, DOI 10.1038/nature03081; FROHLICH H, 1968, PHYS LETT A, VA 26, P402, DOI 10.1016/0375-9601(68)90242-9; FUKUZAWA T, 1990, PHYS REV LETT, V64, P3066, DOI 10.1103/PhysRevLett.64.3066; Hancox CI, 2004, NATURE, V431, P281, DOI 10.1038/nature02938; Kaganov M. I., 1997, Physics-Uspekhi, V40, P181, DOI 10.1070/PU1997v040n02ABEH000194; Kalafati Yu. D., 1989, Soviet Physics - JETP, V68, P1162; KELDYSH LV, 1986, CONTEMP PHYS, V27, P395, DOI 10.1080/00107518608211022; L'vov V. S., 1994, WAVE TURBULENCE PARA; Mesquita MV, 1998, INT J QUANTUM CHEM, V66, P177, DOI 10.1002/(SICI)1097-461X(1998)66:2<177::AID-QUA8>3.0.CO;2-S; Misochko OV, 2004, PHYS LETT A, V321, P381, DOI 10.1016/j.physleta.2003.11.063; Nikuni T, 2000, PHYS REV LETT, V84, P5868, DOI 10.1103/PhysRevLett.84.5868; Ruegg C, 2003, NATURE, V423, P62, DOI 10.1038/nature01617; SPARKS M, 1970, PHYS REV B-SOLID ST, V1, P3831, DOI 10.1103/PhysRevB.1.3831; WOLFRAM T, 1971, PHYS REV B, V4, P3125, DOI 10.1103/PhysRevB.4.3125; Yamamoto Y, 2000, NATURE, V405, P629, DOI 10.1038/35015196	27	647	652	5	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2006	443	7110					430	433		10.1038/nature05117	http://dx.doi.org/10.1038/nature05117			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	17006509				2022-12-28	WOS:000240798800040
J	de Lange, T				de Lange, Titia			Lasker laurels for telomerase	CELL			English	Editorial Material							TERMINAL TRANSFERASE; TETRAHYMENA; YEAST; CHROMOSOME; SENESCENCE; SEQUENCES; RNA; DNA	This year the Lasker Foundation pays tribute to telomerase, a medically important enzyme required for chromosome stability and long-term cell proliferation.	Rockefeller Univ, Cell Biol & Genet Lab, New York, NY 10021 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, Cell Biol & Genet Lab, 1230 York Ave, New York, NY 10021 USA.	delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X				BERNARDS A, 1983, NATURE, V303, P592, DOI 10.1038/303592a0; BLACKBURN EH, 1978, J MOL BIOL, V120, P33, DOI 10.1016/0022-2836(78)90294-2; Cech TR, 2004, CELL, V116, P273, DOI 10.1016/S0092-8674(04)00038-8; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Lundblad V, 2003, CURR BIOL, V13, pR439, DOI 10.1016/S0960-9822(03)00365-8; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; ORRWEAVER TL, 1981, P NATL ACAD SCI-BIOL, V78, P6354, DOI 10.1073/pnas.78.10.6354; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; SZOSTAK JW, 1982, CELL, V29, P245, DOI 10.1016/0092-8674(82)90109-X; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; YU GL, 1990, NATURE, V344, P126, DOI 10.1038/344126a0	15	5	6	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 22	2006	126	6					1017	1020		10.1016/j.cell.2006.09.004	http://dx.doi.org/10.1016/j.cell.2006.09.004			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990125	Bronze			2022-12-28	WOS:000240897600006
J	Srivastava, D				Srivastava, Deepak			Making or breaking the heart: From lineage determination to morphogenesis	CELL			English	Review							BHLH TRANSCRIPTION FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; SERUM RESPONSE FACTOR; CARDIAC DEVELOPMENT; NEURAL-CREST; PHARYNGEAL ARCH; SONIC HEDGEHOG; HOMEOBOX GENE; CARDIOVASCULAR DEVELOPMENT; MYOCARDIAL-CELLS	The cues governing cardiac cell-fate decisions, cardiac differentiation, and three-dimensional morphogenesis are rapidly being elucidated. Several themes are emerging that are relevant for childhood and adult heart disease and the growing field of stem cell biology. This review will consider our current understanding of cardiac cell-fate determination and cardiogenesis - largely derived from developmental studies in model organisms and human genetic approaches - and examine future implications for diagnosis, prevention, and treatment of heart disease in the young and old.	Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Srivastava, D (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, 1650 Owens St, San Francisco, CA 94158 USA.	dsrivastava@gladstone.ucsf.edu						Abu-Issa R, 2002, DEVELOPMENT, V129, P4613; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Baldini A, 2005, CURR OPIN GENET DEV, V15, P279, DOI 10.1016/j.gde.2005.03.001; Bao ZZ, 1999, SCIENCE, V283, P1161, DOI 10.1126/science.283.5405.1161; Biben C, 1997, GENE DEV, V11, P1357, DOI 10.1101/gad.11.11.1357; Biben C, 2000, CIRC RES, V87, P888, DOI 10.1161/01.RES.87.10.888; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; BODMER R, 1993, DEVELOPMENT, V118, P719; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Cai CL, 2005, DEVELOPMENT, V132, P2475, DOI 10.1242/dev.01832; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chen BB, 2000, NAT GENET, V24, P296, DOI 10.1038/73528; Chen F, 2002, CELL, V110, P713, DOI 10.1016/S0092-8674(02)00932-7; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Ching YH, 2005, NAT GENET, V37, P423, DOI 10.1038/ng1526; Christoffels VM, 2004, TRENDS CARDIOVAS MED, V14, P301, DOI 10.1016/j.tcm.2004.09.002; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; Cripe L, 2004, J AM COLL CARDIOL, V44, P138, DOI 10.1016/j.jacc.2004.03.050; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Epstein JA, 2005, CIRCULATION, V112, P592, DOI 10.1161/CIRCULATIONAHA.104.479857; Firulli AB, 1997, TRENDS GENET, V13, P364, DOI 10.1016/S0168-9525(97)01171-2; Frank B, 2003, TAPPI J, V2, P13; Frank DU, 2002, DEVELOPMENT, V129, P4591; Galvin KM, 2000, NAT GENET, V24, P171, DOI 10.1038/72835; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Garg V, 2001, DEV BIOL, V235, P62, DOI 10.1006/dbio.2001.0283; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Grant D S, 1999, Angiogenesis, V3, P125, DOI 10.1023/A:1009041911493; Han Z, 2006, DEVELOPMENT, V133, P1175, DOI 10.1242/dev.02285; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hu TH, 2004, DEVELOPMENT, V131, P5491, DOI 10.1242/dev.01399; Hutson Mary Redmond, 2003, Birth Defects Research, V69, P2, DOI 10.1002/bdrc.10002; Jay PY, 2004, J CLIN INVEST, V113, P1130, DOI 10.1172/JCI200419846; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kokubo H, 2005, TRENDS CARDIOVAS MED, V15, P190, DOI 10.1016/j.tcm.2005.05.005; Krantz Ian D., 1999, Current Opinion in Pediatrics, V11, P558, DOI 10.1097/00008480-199912000-00015; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Kusano KF, 2005, NAT MED, V11, P1197, DOI 10.1038/nm1313; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Le Douarin NM, 2004, DEVELOPMENT, V131, P4637, DOI 10.1242/dev.01350; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Leri A, 2005, PHYSIOL REV, V85, P1373, DOI 10.1152/physrev.00013.2005; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lin Q, 1997, COLD SPRING HARB SYM, V62, P405; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Meilhac SM, 2004, DEV CELL, V6, P685, DOI 10.1016/S1534-5807(04)00133-9; Mikawa T., 2003, NOVART FDN SYMP, V250, P276; Mikawa T., 2003, NOVART FDN SYMP, V250, P153; Mikawa Takashi, 2003, Novartis Found Symp, V250, P142; Mitchell LE, 2004, LANCET, V364, P1885, DOI 10.1016/S0140-6736(04)17445-X; Mori AD, 2004, CURR OPIN CARDIOL, V19, P211, DOI 10.1097/00001573-200405000-00004; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nowotschin S, 2006, DEVELOPMENT, V133, P1565, DOI 10.1242/dev.02309; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Palmer AR, 2004, SCIENCE, V306, P828, DOI 10.1126/science.1103707; Parmacek MS, 2005, CELL, V120, P295, DOI 10.1016/j.cell.2005.01.025; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Phan D, 2005, DEVELOPMENT, V132, P2669, DOI 10.1242/dev.01849; Rajamannan NM, 2003, HEART, V89, P801, DOI 10.1136/heart.89.7.801; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Satoda M, 2000, NAT GENET, V25, P42, DOI 10.1038/75578; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; Singh MK, 2005, DEVELOPMENT, V132, P2697, DOI 10.1242/dev.01854; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; Srivastava D, 2006, NATURE, V441, P1097, DOI 10.1038/nature04961; Srivastava D, 2004, NATURE, V429, P819, DOI 10.1038/429819a; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Stennard FA, 2005, DEVELOPMENT, V132, P2451, DOI 10.1242/dev.01799; Stoller JZ, 2005, SEMIN CELL DEV BIOL, V16, P704, DOI 10.1016/j.semcdb.2005.06.004; Takeuchi JK, 2005, DEVELOPMENT, V132, P2463, DOI 10.1242/dev.01827; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Thomas T, 1998, DEVELOPMENT, V125, P3005; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Uhlen P, 2006, P NATL ACAD SCI USA, V103, P2160, DOI 10.1073/pnas.0510876103; von Both I, 2004, DEV CELL, V7, P331, DOI 10.1016/j.devcel.2004.07.023; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Xu HS, 2004, DEVELOPMENT, V131, P3217, DOI 10.1242/dev.01174; Yamagishi H, 2003, GENE DEV, V17, P269, DOI 10.1101/gad.1048903; Yamagishi H, 2001, DEV BIOL, V239, P190, DOI 10.1006/dbio.2001.0417; Yelon D, 2000, DEVELOPMENT, V127, P2573; Zaffran S, 2002, CIRC RES, V91, P457, DOI 10.1161/01.RES.0000034152.74523.A8; Zeisberg EM, 2005, J CLIN INVEST, V115, P1522, DOI 10.1172/JCI23769; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	105	453	479	0	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 22	2006	126	6					1037	1048		10.1016/j.cell.2006.09.003	http://dx.doi.org/10.1016/j.cell.2006.09.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990131	Bronze			2022-12-28	WOS:000240897600012
J	Arzy, S; Seeck, M; Ortigue, S; Spinelli, L; Blanke, O				Arzy, Shahar; Seeck, Margitta; Ortigue, Stephanie; Spinelli, Laurent; Blanke, Olaf			Induction of an illusory shadow person	NATURE			English	Article									Ecole Polytech Fed Lausanne, Cognit Neurosci Lab, CH-1015 Lausanne, Switzerland; Univ Hosp, Presurg Epilepsy Evaluat Unit, CH-1211 Geneva, Switzerland; Univ Hosp, Dept Neurol, CH-1211 Geneva, Switzerland; Dartmouth Coll, Ctr Cognit Neurosci, Hanover, NH 03755 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; University of Geneva; Dartmouth College	Arzy, S (corresponding author), Ecole Polytech Fed Lausanne, Cognit Neurosci Lab, CH-1015 Lausanne, Switzerland.	olaf.blanke@epfl.ch		Arzy, Shahar/0000-0001-6500-8095				Blakemore SJ, 2002, TRENDS COGN SCI, V6, P237, DOI 10.1016/S1364-6613(02)01907-1; Blanke O, 2000, J NEUROL NEUROSUR PS, V69, P553, DOI 10.1136/jnnp.69.4.553; Blanke O, 2004, BRAIN, V127, P243, DOI 10.1093/brain/awh040; Blanke O, 2003, NEUROCASE, V9, P329, DOI 10.1076/neur.9.4.329.15552; Brugger P, 1996, NEUROPSY NEUROPSY BE, V9, P114; Critchley M, 1955, ACTA PSYCH NEUROL, V30, P155, DOI 10.1111/j.1600-0447.1955.tb06055.x; Farrer C, 2004, PSYCHIAT RES-NEUROIM, V131, P31, DOI 10.1016/j.pscychresns.2004.02.004; Jaspers K., 1972, GEN PSYCHOPATHOLOGY; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; THOMPSON C, 1982, BRIT J PSYCHIAT, V141, P628, DOI 10.1192/bjp.141.6.628	10	138	138	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2006	443	7109					287	287		10.1038/443287a	http://dx.doi.org/10.1038/443287a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085RL	16988702	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000240622000032
J	Murray, F; Spar, D				Murray, Fiona; Spar, Debora			Bit players or powerhouse? China and stemm-cell research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Cody Edward, 2006, WASH POST, pA16; DEP'T OF DEF. TECH. AND PRIVACY ADVISORY COMM, 2004, STAND US CHALL HOM S, P4; Fishman T.C., 2005, RISE NEXT SUPERPOWER	3	17	18	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 21	2006	355	12					1191	1194		10.1056/NEJMp068151	http://dx.doi.org/10.1056/NEJMp068151			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	085IT	16990381				2022-12-28	WOS:000240598500002
J	Schulze, MR; Strasser, RH				Schulze, Matthias R.; Strasser, Ruth H.			Uni-, bi-, tri-, and quadricuspid aortic valves	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Dresden Univ Technol, D-01307 Dresden, Germany	Technische Universitat Dresden	Schulze, MR (corresponding author), Dresden Univ Technol, D-01307 Dresden, Germany.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 21	2006	355	12					E11	E11		10.1056/NEJMicm050385	http://dx.doi.org/10.1056/NEJMicm050385			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085IT	16990379				2022-12-28	WOS:000240598500011
J	Roig, M				Roig, Miguel			Commentary: Ethical writing should be taught	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PLAGIARISM; COLLEGE		St Johns Univ, Staten Isl, NY 10301 USA	Saint John's University	Roig, M (corresponding author), St Johns Univ, 300 Howard Ave, Staten Isl, NY 10301 USA.	roigrn@stjohns.edu						BIROS MH, 2000, ADVICE AUTHORS GETTI; Chalmers L, 2006, BRIT MED J, V333, P594, DOI 10.1136/bmj.38968.611296.F7; Hammond Kenric W, 2003, AMIA Annu Symp Proc, P269; Julliard K, 1994, Fam Med, V26, P356; KOLIN FC, 2002, SUCCESSFUL WRITING W; LEVIN JR, 1993, J EDUC PSYCHOL, V85, P3, DOI 10.1037/0022-0663.85.1.3; Price JH, 2001, HEALTH EDUC BEHAV, V28, P51, DOI 10.1177/109019810102800106; Roig M, 1999, PSYCHOL REP, V84, P973, DOI 10.2466/PR0.84.3.973-982; Roig M, 2001, ETHICS BEHAV, V11, P307, DOI 10.1207/S15327019EB1103_8; *US DEP HHS OFF RE, ORI POL PLAG; Zigmond MJ, 2002, SCI ENG ETHICS, V8, P229, DOI 10.1007/s11948-002-0024-3	11	10	10	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2006	333	7568					596	597		10.1136/bmj.38946.501215.68	http://dx.doi.org/10.1136/bmj.38946.501215.68			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	089KB	16974017	Green Published			2022-12-28	WOS:000240878200020
J	Flasar, FM				Flasar, F. M.			Titan's polar weather	SCIENCE			English	Editorial Material							CLOUDS; VORTEX; STRATOSPHERE; TEMPERATURE; ATMOSPHERE; DYNAMICS		NASA, Goddard Space Flight Ctr, Planetary Syst Lab, Greenbelt, MD 20771 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Flasar, FM (corresponding author), NASA, Goddard Space Flight Ctr, Planetary Syst Lab, Greenbelt, MD 20771 USA.	f.m.flasar@nasa.gov	Flasar, F Michael/C-8509-2012					Abrams MC, 1996, GEOPHYS RES LETT, V23, P2345, DOI 10.1029/96GL00704; Abrams MC, 1996, GEOPHYS RES LETT, V23, P2341, DOI 10.1029/96GL00705; Brown ME, 2002, NATURE, V420, P795, DOI 10.1038/nature01302; COUSTENIS A, 1995, ICARUS, V115, P126, DOI 10.1006/icar.1995.1084; Flasar FM, 2005, SCIENCE, V308, P975, DOI 10.1126/science.1111150; Griffith CA, 2006, SCIENCE, V313, P1620, DOI 10.1126/science.1128245; Griffith CA, 2005, SCIENCE, V310, P474, DOI 10.1126/science.1117702; Hourdin F, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002282; Khanna RK, 2005, ICARUS, V178, P165, DOI 10.1016/j.icarus.2005.03.011; Khanna RK, 2005, ICARUS, V177, P116, DOI 10.1016/j.icarus.2005.02.014; Lebonnois S, 2001, ICARUS, V152, P384, DOI 10.1006/icar.2001.6632; LEOVY CB, 1973, ICARUS, V19, P195, DOI 10.1016/0019-1035(73)90122-X; Roe HG, 2002, ASTROPHYS J, V581, P1399, DOI 10.1086/344403; Samuelson RE, 1997, PLANET SPACE SCI, V45, P941, DOI 10.1016/S0032-0633(97)00088-3; SCHOEBERL MR, 1991, SCIENCE, V251, P46, DOI 10.1126/science.251.4989.46	15	5	6	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2006	313	5793					1582	1583		10.1126/science.1130698	http://dx.doi.org/10.1126/science.1130698			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973865				2022-12-28	WOS:000240498900028
J	Frenk, J				Frenk, Julio			Bridging the divide: global lessons from evidence-based health policy in Mexico	LANCET			English	Article; Proceedings Paper	Conference on Disease Control Priorities in Developing Countries	APR   03, 2006	Beijing, PEOPLES R CHINA				CHILD HEALTH; CHALLENGES; TRANSITION; SYSTEMS; REFORM; CARE	During the past 6 years, Mexico has undergone a large-scale transformation of its health system. This paper provides an overview of the main features of the Mexican reform experience. Because of its high degree of social inequality, Mexico is a microcosm of the range of problems that affect countries at all levels of development. Its health system had not kept up with the pressures of the double burden of disease, whereby malnutrition, common infections, and reproductive health problems coexist with non-communicable disease and injury. With half of its population uninsured, Mexico was facing an unacceptable paradox: whereas health is a key factor in the fight against poverty; a large number of families became impoverished by expenditures in health care and drugs. The reform was designed to correct this paradox by introducing a new scheme called Popular Health Insurance (Seguro Popular). This innovative initiative is gradually protecting the 50 million Mexicans, most of them poor, who had until now been excluded from formal social insurance. This paper reports encouraging results in the achievement of the ultimate objective of the reform: universal access to high-quality services with social protection for all.	Minist Hlth Mexico, Secretaria Salud, Mexico City 06696, DF, Mexico		Frenk, J (corresponding author), Minist Hlth Mexico, Secretaria Salud, Lieja 7, Mexico City 06696, DF, Mexico.	jfrenk@salud.gob.mx						[Anonymous], 2004, LANCET, V364, P1911; [Anonymous], 2001, MACR HLTH INV HLTH E; [Anonymous], 2005, MILLENNIUM DEV GOALS; Baltussen R, 2004, B WORLD HEALTH ORGAN, V82, P338; Chen MQ, 2001, CHINESE J ORG CHEM, V21, P294; de Salud Secretaria, 2001, HOG CON GAST CAT MOT; *DIR GEN INF SAL, 2005, SALUD PUBLICA MEXICO, V47, P171; Donabedian A, 1986, J Health Adm Educ, V4, P611; Frenk J, 2003, LANCET, V362, P1667, DOI 10.1016/S0140-6736(03)14803-9; Frenk J, 2002, HEALTH AFFAIR, V21, P160, DOI 10.1377/hlthaff.21.3.160; Frenk J., 1989, Health Policy and Planning, V4, P29, DOI 10.1093/heapol/4.1.29; Frenk J, 2004, GLOBAL FORUM UPDATE, P48; Frenk J, 1994, EC SALUD PROPUESTAS; Gertler P, 2004, AM ECON REV, V94, P336, DOI 10.1257/0002828041302109; HERNANDEZ P, 1997, OBSERVATORIO SALUD N, P119; Horton R, 2006, LANCET, V367, P3, DOI 10.1016/S0140-6736(06)67899-9; *I NAC EST, 2005, GEOGR INF SECR SAL B; Instituto Nacional de Salud Publica, 2006, ENC NAC SAL NUTR 200; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P3, DOI 10.1596/978-0-8213-6179-5/Chpt-1; Jamison DT, 1998, LANCET, V351, P514, DOI 10.1016/S0140-6736(97)11451-9; Kaul I, 2003, PROVIDING GLOBAL PUB; Knaul FM, 2005, SALUD PUBLICA MEXICO, V47, P430; Knaul FM, 2005, HEALTH AFFAIR, V24, P1467, DOI 10.1377/hlthaff.24.6.1467; KNAUL FM, 2005, PREVENTING IMPOVERIS; Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P717; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Rivera JA, 2004, JAMA-J AM MED ASSOC, V291, P2563, DOI 10.1001/jama.291.21.2563; *SECR SAL, 2006, SAL MEX 2001 2005; *SECR SAL, 2000, B INF EST, V2025; Sepulveda J, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, pXIII; VANDOORSLAER E, IN PRESS LANCET; Walton DA, 2004, J PUBLIC HEALTH POL, V25, P137, DOI 10.1057/palgrave.jphp.3190013; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, 2004, WORLD HLTH REP 2004; Xu K., 2005, DESIGNING HLTH FINAN	35	145	152	1	36	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 9	2006	368	9539					954	961		10.1016/S0140-6736(06)69376-8	http://dx.doi.org/10.1016/S0140-6736(06)69376-8			8	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	083ZX	16962886				2022-12-28	WOS:000240502300034
J	Melotto, M; Underwood, W; Koczan, J; Nomura, K; He, SY				Melotto, Maeli; Underwood, William; Koczan, Jessica; Nomura, Kinya; He, Sheng Yang			Plant stomata function in innate immunity against bacterial invasion	CELL			English	Article							SALICYLIC-ACID; GUARD-CELLS; PHYTOTOXIN CORONATINE; ARABIDOPSIS-THALIANA; SECRETION SYSTEM; ABSCISIC-ACID; III EFFECTORS; SIGNALING PATHWAYS; DISEASE RESISTANCE; DEFENSE	Microbial entry into host tissue is a critical first step in causing infection in animals and plants. In plants, it has been assumed that microscopic surface openings, such as stomata, serve as passive ports of bacterial entry during infection. Surprisingly, we found that stomatal closure is part of a plant innate immune response to restrict bacterial invasion. Stomatal guard cells of Arabidopsis perceive bacterial surface molecules, which requires the FLS2 receptor, production of nitric oxide, and the guard-cell-specific OST1 kinase. To circumvent this innate immune response, plant pathogenic bacteria have evolved specific virulence factors to effectively cause stomatal reopening as an important pathogenesis strategy. We provide evidence that supports a model in which stomata, as part of an integral innate immune system, act as a barrier against bacterial infection.	Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; Michigan State Univ, Grad Program Genet, E Lansing, MI 48824 USA; Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	He, SY (corresponding author), Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA.	hes@msu.edu	poinssot, benoit/B-2569-2009	poinssot, benoit/0000-0001-5890-4318; Melotto, Maeli/0000-0001-6021-9803; Underwood, William/0000-0002-9920-8228; He, Sheng Yang/0000-0003-1308-498X				Abramovitch RB, 2004, CURR OPIN PLANT BIOL, V7, P356, DOI 10.1016/j.pbi.2004.05.002; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; Beuchat LR, 2002, MICROBES INFECT, V4, P413, DOI 10.1016/S1286-4579(02)01555-1; Blatt MR, 1999, PLANT J, V19, P453, DOI 10.1046/j.1365-313x.1999.00534.x; Brooks DM, 2005, MOL PLANT PATHOL, V6, P629, DOI [10.1111/j.1364-3703.2005.00311.x, 10.1111/J.1364-3703.2005.00311.X]; Brooks DM, 2004, MOL PLANT MICROBE IN, V17, P162, DOI 10.1094/MPMI.2004.17.2.162; Buttner D, 2002, EMBO J, V21, P5313, DOI 10.1093/emboj/cdf536; Chang JH, 2005, P NATL ACAD SCI USA, V102, P2549, DOI 10.1073/pnas.0409660102; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Collmer A, 2002, TRENDS MICROBIOL, V10, P462, DOI 10.1016/S0966-842X(02)02451-4; Coursol S, 2003, NATURE, V423, P651, DOI 10.1038/nature01643; Cui J, 2005, P NATL ACAD SCI USA, V102, P1791, DOI 10.1073/pnas.0409450102; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Fan LM, 2004, CURR OPIN PLANT BIOL, V7, P537, DOI 10.1016/j.pbi.2004.07.009; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Greenberg JT, 2003, CURR OPIN MICROBIOL, V6, P20, DOI 10.1016/S1369-5274(02)00004-8; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011; Hirano SS, 2000, MICROBIOL MOL BIOL R, V64, P624, DOI 10.1128/MMBR.64.3.624-653.2000; Katagiri F., 2002, ARABIDOPSIS BOOK; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Kinkel LL, 2000, MICROBIAL ECOL, V39, P1, DOI 10.1007/s002489900182; Kloek AP, 2001, PLANT J, V26, P509, DOI 10.1046/j.1365-313x.2001.01050.x; Lee S, 1999, PLANT PHYSIOL, V121, P147, DOI 10.1104/pp.121.1.147; LeonKloosterziel KM, 1996, PLANT J, V10, P655, DOI 10.1046/j.1365-313X.1996.10040655.x; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; MA SW, 1991, MOL PLANT MICROBE IN, V4, P69, DOI 10.1094/MPMI-4-069; MITTAL S, 1995, MOL PLANT MICROBE IN, V8, P165, DOI 10.1094/MPMI-8-0165; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Naimi TS, 2003, J FOOD PROTECT, V66, P535, DOI 10.4315/0362-028X-66.4.535; Nomura K, 2005, CURR OPIN PLANT BIOL, V8, P361, DOI 10.1016/j.pbi.2005.05.005; Nomura K, 2005, P NATL ACAD SCI USA, V102, P3527, DOI 10.1073/pnas.0500724102; Park SS, 2001, CRIT REV BIOTECHNOL, V21, P27, DOI 10.1080/20013891081674; Peiter E, 2005, NATURE, V434, P404, DOI 10.1038/nature03381; Penaloza-Vazquez A, 2000, MICROBIOL-SGM, V146, P2447, DOI 10.1099/00221287-146-10-2447; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Suhita D, 2004, PLANT PHYSIOL, V134, P1536, DOI 10.1104/pp.103.032250; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zhao YF, 2003, PLANT J, V36, P485, DOI 10.1046/j.1365-313X.2003.01895.x; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	54	1193	1273	13	361	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2006	126	5					969	980		10.1016/j.cell.2006.06.054	http://dx.doi.org/10.1016/j.cell.2006.06.054			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959575	Bronze			2022-12-28	WOS:000240675000023
J	Grundmann, H; Aires-De-Sousa, M; Boyce, J; Tiemersma, E				Grundmann, Hajo; Aires-de-Sousa, Marta; Boyce, John; Tiemersma, Edine			Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat	LANCET			English	Review							CASSETTE CHROMOSOME MEC; PANTON-VALENTINE LEUKOCIDIN; INFECTION-CONTROL MEASURES; SEQUENCE-LIKE ELEMENT; INTENSIVE-CARE UNITS; METHICILLIN-RESISTANT; ANTIMICROBIAL RESISTANCE; HOSPITAL OUTBREAK; NOSOCOMIAL TRANSMISSION; MOLECULAR EPIDEMIOLOGY	Staphylococcus aureus is a gram-positive bacterium that colonises the skin and is present in the anterior nares in about 25-30% of healthy people.(1) Dependent on its intrinsic virulence or the ability of the host to contain its opportunistic behaviour, S aureus can cause a range of diseases in man. The bacterium readily acquires resistance against all classes of antibiotics by one of two distinct mechanisms: mutation of an existing bacterial gene or horizontal transfer of a resistance gene from another bacterium. Several mobile genetic elements carrying exogenous antibiotic resistance genes might mediate resistance acquisition.(2) Of all the resistance traits S aureus has acquired since the introduction of antimicrobial chemotherapy in the 1930s, meticillin resistance is clinically the most important, since a single genetic element confers resistance to the most commonly prescribed class of antimicrobials-the beta-lactam antibiotics, which include penicillins, cephalosporins, and carbapenems.	Natl Inst Publ Hlth & Environm, Ctr Infect Dis Epidemiol, NL-3720 BA Bilthoven, Netherlands; Univ Groningen, Med Ctr, Dept Med Microbiol, NL-9700 AB Groningen, Netherlands; Univ Nova Lisboa, Inst Tecnol Quim & Biol, Genet Mol Lab, P-2780 Oeiras, Portugal; Hosp St Raphael, Infect Dis Sect, New Haven, CT USA; Yale Univ, Sch Med, New Haven, CT USA	Netherlands National Institute for Public Health & the Environment; University of Groningen; Universidade Nova de Lisboa; Hospital Saint Raphael; Yale University	Grundmann, H (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Epidemiol, NL-3720 BA Bilthoven, Netherlands.			Aires-de-Sousa, Marta/0000-0001-5036-2446				ALTEMEIER WA, 1962, RES BURNS, V9, P203; Amaral MM, 2005, J INFECT DIS, V192, P801, DOI 10.1086/432515; [Anonymous], 1961, BMJ-BRIT MED J, V1, P113; ARCHER GL, 1994, ANTIMICROB AGENTS CH, V38, P447, DOI 10.1128/AAC.38.3.447; Archer GL, 1996, ANTIMICROB AGENTS CH, V40, P924, DOI 10.1128/AAC.40.4.924; Arias CA, 2003, J ANTIMICROB CHEMOTH, V51, P59, DOI 10.1093/jac/dkg002; *ARMED EARSS, ANT RES SURV CONTR M; Ayliffe GAJ, 1998, J HOSP INFECT, V39, P253, DOI 10.1016/S0195-6701(98)90293-6; BARBER M, 1948, LANCET, V252, P641; BARTZOKAS CA, 1984, NEW ENGL J MED, V311, P1422, DOI 10.1056/NEJM198411293112207; BENNER EJ, 1968, LANCET, V2, P741; Beretta ALRZ, 2004, BRAZ J MED BIOL RES, V37, P1345, DOI 10.1590/S0100-879X2004000900009; Bisognano C, 2000, ANTIMICROB AGENTS CH, V44, P1428, DOI 10.1128/AAC.44.6.1428-1437.2000; Bjorholt I, 2004, EUR J CLIN MICROBIOL, V23, P688, DOI 10.1007/s10096-004-1198-1; Blok HEM, 2003, INFECT CONT HOSP EP, V24, P679, DOI 10.1086/502275; BORG M, IN PRESS EURO SURVEI; BOYCE JM, 1993, CLIN INFECT DIS, V17, P496, DOI 10.1093/clinids/17.3.496; Boyce JM, 2004, INFECT CONT HOSP EP, V25, P395, DOI 10.1086/502412; Boyce JM, 1997, INFECT CONT HOSP EP, V18, P622; BOYCE JM, 1983, J INFECT DIS, V148, P763, DOI 10.1093/infdis/148.4.763; Bratu S, 2005, EMERG INFECT DIS, V11, P808, DOI 10.3201/eid1106.040885; Brun-Buisson C, 2005, LANCET, V365, P1303, DOI 10.1016/S0140-6736(05)61018-5; Calderon-Jaimes E, 2002, SALUD PUBLICA MEXICO, V44, P108, DOI 10.1590/S0036-36342002000200004; Carleton HA, 2004, J INFECT DIS, V190, P1730, DOI 10.1086/425019; CARLTON H, 43 ANN INT C ANT AG; CARTER A, 2002, MINISTRY HLTH GUIDEL; CASEWELL MW, 1986, J ANTIMICROB CHEMOTH, V18, P1; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P902; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P992; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P707; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P88; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P793; Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P565; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P322; Cepeda JA, 2005, LANCET, V365, P295, DOI 10.1016/S0140-6736(05)17783-6; Chaix C, 1999, JAMA-J AM MED ASSOC, V282, P1745, DOI 10.1001/jama.282.18.1745; Charles PGP, 2004, CLIN INFECT DIS, V38, P448, DOI 10.1086/381093; Coia JE, 2006, J HOSP INFECT, V63, pS1, DOI 10.1016/j.jhin.2006.01.001; COOK J, 1957, BMJ-BRIT MED J, V1, P542, DOI 10.1136/bmj.1.5018.542; COOKSON B, 1989, J CLIN MICROBIOL, V27, P1471, DOI 10.1128/JCM.27.7.1471-1476.1989; COOKSON BD, 1988, J ANTIMICROB CHEMOTH, V21, P57, DOI 10.1093/jac/21.suppl_C.57; Cookson BD, 1998, J ANTIMICROB CHEMOTH, V41, P11, DOI 10.1093/jac/41.1.11; Cooper BS, 2004, P NATL ACAD SCI USA, V101, P10223, DOI 10.1073/pnas.0401324101; Cooper BS, 2004, BMJ-BRIT MED J, V329, P533, DOI 10.1136/bmj.329.7465.533; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; Couto I, 1996, MICROB DRUG RESIST, V2, P377, DOI 10.1089/mdr.1996.2.377; CRAVEN DE, 1981, AM J MED, V71, P53, DOI 10.1016/0002-9343(81)90258-8; CROSSLEY K, 1979, J INFECT DIS, V139, P280, DOI 10.1093/infdis/139.3.280; De Sousa MA, 2000, MICROB DRUG RESIST, V6, P253, DOI 10.1089/mdr.2000.6.253; De Sousa MA, 2000, MICROB DRUG RESIST, V6, P133, DOI 10.1089/107662900419447; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2004, J CLIN MICROBIOL, V42, P2080, DOI 10.1128/JCM.42.5.2080-2084.2004; DUCKWORTH GJ, 1988, J HOSP INFECT, V11, P1, DOI 10.1016/0195-6701(88)90034-5; Dufour P, 2002, CLIN INFECT DIS, V35, P819, DOI 10.1086/342576; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; Enright MC, 2003, CURR OPIN PHARMACOL, V3, P474, DOI 10.1016/S1471-4892(03)00109-7; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Eveillard M, 2005, J HOSP INFECT, V59, P254, DOI 10.1016/j.jhin.2004.09.028; Faibis F, 2005, INFECT CONT HOSP EP, V26, P213, DOI 10.1086/502529; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Fishbain JT, 2003, INFECT CONT HOSP EP, V24, P415, DOI 10.1086/502224; French GL, 2004, J HOSP INFECT, V57, P31, DOI 10.1016/j.jhin.2004.03.006; Fridkin SK, 2001, CLIN INFECT DIS, V33, P324, DOI 10.1086/321893; Fridkin SK, 2002, EMERG INFECT DIS, V8, P697, DOI 10.3201/eid0807.010427; Garner Julia S., 1996, Infection Control and Hospital Epidemiology, V17, P53; Garrouste-Orgeas M, 2001, INFECT CONT HOSP EP, V22, P687, DOI 10.1086/501846; GAYNES R, 1991, J INFECT DIS, V163, P117, DOI 10.1093/infdis/163.1.117; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Girou E, 1998, CLIN INFECT DIS, V27, P543, DOI 10.1086/514695; GREEN K, 2002, P 42 INT C ANT AG CH, pK661; Groom AV, 2001, JAMA-J AM MED ASSOC, V286, P1201, DOI 10.1001/jama.286.10.1201; Grundmann H, 2002, J INFECT DIS, V185, P481, DOI 10.1086/338568; Harbarth S, 1999, ANTIMICROB AGENTS CH, V43, P1412, DOI 10.1128/AAC.43.6.1412; Harbarth S, 2005, EMERG INFECT DIS, V11, P962, DOI 10.3201/eid1106.041308; Harbarth S, 2000, J HOSP INFECT, V46, P43, DOI 10.1053/jhin.2000.0798; HARTMAN B, 1981, ANTIMICROB AGENTS CH, V19, P726, DOI 10.1128/AAC.19.5.726; Health Protection Agency, 2005, CDR WEEKLY, V15; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; HERWALDT LA, 1999, AM J MED, V106, pS48; Herwaldt Loreen A., 1999, American Journal of Medicine, V106, p11S, DOI 10.1016/S0002-9343(98)00350-7; Hiramatsu K, 2001, TRENDS MICROBIOL, V9, P486, DOI 10.1016/S0966-842X(01)02175-8; Howden BP, 2004, CLIN INFECT DIS, V38, P521, DOI 10.1086/381202; Huskins WC, 2005, LANCET, V365, P273; ISBISTER C, 1954, Med J Aust, V2, P897; Ito T, 2003, DRUG RESIST UPDATE, V6, P41, DOI 10.1016/S1368-7646(03)00003-7; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Ito T, 1999, ANTIMICROB AGENTS CH, V43, P1449, DOI 10.1128/AAC.43.6.1449; Jernigan JA, 1995, INFECT CONT HOSP EP, V16, P686; Jernigan JA, 1996, AM J EPIDEMIOL, V143, P496, DOI 10.1093/oxfordjournals.aje.a008770; JESSEN O, 1969, NEW ENGL J MED, V281, P627, DOI 10.1056/NEJM196909182811201; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; Karchmer TB, 2002, J HOSP INFECT, V51, P126, DOI 10.1053/jhin.2002.1200; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; KAYSER FH, 1975, LANCET, V2, P650; KEANE CT, 1984, J INFECTION, V9, P6, DOI 10.1016/S0163-4453(84)94368-8; KERR S, 1990, J HOSP INFECT, V16, P35, DOI 10.1016/0195-6701(90)90047-R; Kim HB, 2003, J CLIN MICROBIOL, V41, P2279, DOI [10.1128/JCM.41.6.2279-2281.2003, 10.1128/JCM.41.6.2779-2281.2003]; Kobayashi N, 1999, ANTIMICROB AGENTS CH, V43, P2780, DOI 10.1128/AAC.43.11.2780; Kotilainen P, 2003, EMERG INFECT DIS, V9, P169; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Lacey S, 2001, J HOSP INFECT, V48, P308, DOI 10.1053/jhin.2001.1024; Lessing MPA, 1996, J HOSP INFECT, V34, P205, DOI 10.1016/S0195-6701(96)90067-5; LEVINE DP, 1982, ANN INTERN MED, V97, P330, DOI 10.7326/0003-4819-97-3-330; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; LOCKSLEY RM, 1982, ANN INTERN MED, V97, P317, DOI 10.7326/0003-4819-97-3-317; Lucet JC, 2005, INFECT CONT HOSP EP, V26, P121, DOI 10.1086/502514; Lucet JC, 2003, ARCH INTERN MED, V163, P181, DOI 10.1001/archinte.163.2.181; Lucet JC, 2005, INTENS CARE MED, V31, P1051, DOI 10.1007/s00134-005-2679-0; Ma XX, 2002, ANTIMICROB AGENTS CH, V46, P1147, DOI 10.1128/AAC.46.4.1147-1152.2002; MacDougall C, 2005, CLIN INFECT DIS, V41, P435, DOI 10.1086/432056; Manian FA, 2002, INFECT CONT HOSP EP, V23, P516, DOI 10.1086/502099; Marshall C, 2004, J HOSP INFECT, V56, P253, DOI 10.1016/j.jhin.2004.02.001; Meyer E, 2003, INFECTION, V31, P208, DOI 10.1007/s15010-003-3201-7; Miklasevics E, 2004, Euro Surveill, V9, P29, DOI 10.2807/esm.09.11.00485-en; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Mishal J, 2001, SCAND J INFECT DIS, V33, P498, DOI 10.1080/00365540110026575; MUSSER JM, 1992, J CLIN MICROBIOL, V30, P2058, DOI 10.1128/JCM.30.8.2058-2063.1992; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; NAAS T, IN PRESS J HOSP INFE; Nicolle LE, 1999, INFECT CONT HOSP EP, V20, P202, DOI 10.1086/501613; Nijssen S, 2005, CLIN INFECT DIS, V40, P405, DOI 10.1086/427281; Nimmo GR, 2003, MICROB DRUG RESIST, V9, P155, DOI 10.1089/107662903765826741; NOBLE WC, 1992, FEMS MICROBIOL LETT, V93, P195; O'Brien FG, 1999, J CLIN MICROBIOL, V37, P2858; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Okesola AO, 1999, J HOSP INFECT, V41, P74, DOI 10.1016/S0195-6701(99)90041-5; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Oliveira DC, 2001, MICROB DRUG RESIST, V7, P349, DOI 10.1089/10766290152773365; Orrett FA, 1999, JPN J INFECT DIS, V52, P238; PAL S C, 1964, J Indian Med Assoc, V42, P512; Papia G, 1999, INFECT CONT HOSP EP, V20, P473, DOI 10.1086/501655; Parker M T, 1966, Sci Basis Med Annu Rev, P157; PARKER MT, 1970, LANCET, V1, P800; PARKER MT, 1962, J APPL BACTERIOL, V25, P389, DOI 10.1111/j.1365-2672.1962.tb04752.x; PAVILLARD R, 1982, MED J AUSTRALIA, V1, P451, DOI 10.5694/j.1326-5377.1982.tb132413.x; Pinho MG, 2001, P NATL ACAD SCI USA, V98, P10886, DOI 10.1073/pnas.191260798; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 1999, ARCH INTERN MED, V159, P821, DOI 10.1001/archinte.159.8.821; Porter R, 2003, INTENS CARE MED, V29, P655, DOI 10.1007/s00134-003-1679-1; Rammelkamp CH, 1942, P SOC EXP BIOL MED, V51, P386, DOI 10.3181/00379727-51-13986; Robinson DA, 2004, J BACTERIOL, V186, P1060, DOI 10.1128/JB.186.4.1060-1064.2004; Robinson DA, 2003, ANTIMICROB AGENTS CH, V47, P3926, DOI 10.1128/AAC.47.12.3926-3934.2003; Robinson DA, 2005, LANCET, V365, P1256, DOI 10.1016/S0140-6736(05)74814-5; ROSDAHL VT, 1991, INFECT CONT HOSP EP, V12, P83; ROSENDAL K, 1976, ACTA PATH MICRO IM B, V84, P359; Rountree P M, 1968, Med J Aust, V2, P1163; Sader HS, 2002, DIAGN MICR INFEC DIS, V44, P273, DOI 10.1016/S0732-8893(02)00469-8; Saiman L, 2003, CLIN INFECT DIS, V37, P1313, DOI 10.1086/379022; Salmenlinna S, 2000, EUR J CLIN MICROBIOL, V19, P101, DOI 10.1007/s100960050438; Samad A, 2002, J HOSP INFECT, V51, P43, DOI 10.1053/jhin.2002.1182; SANFORD MD, 1994, CLIN INFECT DIS, V19, P1123, DOI 10.1093/clinids/19.6.1123; SARAVOLATZ LD, 1982, ANN INTERN MED, V97, P325, DOI 10.7326/0003-4819-97-3-325; SCOTT RD, 2005, ANTIBIOTIC OPTIMIZAT, P141; Shahin R, 1999, ARCH PEDIAT ADOL MED, V153, P864, DOI 10.1001/archpedi.153.8.864; Sherertz RJ, 1996, ANN INTERN MED, V124, P539, DOI 10.7326/0003-4819-124-6-199603150-00001; SHIBL AM, 1994, J ANTIMICROB CHEMOTH, V33, P1255, DOI 10.1093/jac/33.6.1255; Shore A, 2005, ANTIMICROB AGENTS CH, V49, P2070, DOI 10.1128/AAC.49.5.2070-2083.2005; Sieradzki K, 1997, J BACTERIOL, V179, P2557, DOI 10.1128/jb.179.8.2557-2566.1997; Smith DL, 2004, P NATL ACAD SCI USA, V101, P3709, DOI 10.1073/pnas.0400456101; *SOC HEALTHC EP AM, 1998, 8 ANN SCI M SOC HEAL; *SOC REAN LANG FRA, 2002, REC EXP SOC REAN LAN; *SSAC NORD WORK PA, 2004, 1 SSAC NORD WORK PAR; SUNENSHINE RH, 2005, INFECT CONT HOSP EP, V26, P183; SUZUKI E, 1993, ANTIMICROB AGENTS CH, V37, P1219, DOI 10.1128/AAC.37.6.1219; Tahnkiwale Supriya S, 2002, Indian J Med Sci, V56, P330; Takizawa Y, 2005, J CLIN MICROBIOL, V43, P3356, DOI 10.1128/JCM.43.7.3356-3363.2005; Tarzi S, 2001, J HOSP INFECT, V49, P250, DOI 10.1053/jhin.2001.1098; Tenorio AR, 2001, CLIN INFECT DIS, V32, P826, DOI 10.1086/319214; THOMPSON RL, 1982, ANN INTERN MED, V97, P309, DOI 10.7326/0003-4819-97-3-309; Tiemersma EW, 2004, EMERG INFECT DIS, V10, P1627, DOI 10.3201/eid1009.040069; Tomic V, 2004, ARCH INTERN MED, V164, P2038, DOI 10.1001/archinte.164.18.2038; Troillet N, 1998, INFECT CONT HOSP EP, V19, P181, DOI 10.1086/647791; Turnidge JD, 2000, MICROB DRUG RESIST, V6, P223; UDO EE, 1993, J HOSP INFECT, V25, P97, DOI 10.1016/0195-6701(93)90100-E; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Verhoef J, 1999, EUR J CLIN MICROBIOL, V18, P461, DOI 10.1007/s100960050324; Vriens M, 2002, EUR J CLIN MICROBIOL, V21, P782, DOI 10.1007/s10096-002-0811-4; Wannet WJB, 2005, J CLIN MICROBIOL, V43, P3341, DOI 10.1128/JCM.43.7.3341-3345.2005; WARD TT, 1981, INFECT CONT HOSP EP, V2, P453, DOI 10.1017/S0195941700055715; Weber SG, 2003, EMERG INFECT DIS, V9, P1415, DOI 10.3201/eid0911.030284; Wielders CLC, 2001, LANCET, V357, P1674, DOI 10.1016/S0140-6736(00)04832-7; WILLIAMS RE, 1959, BMJ-BRIT MED J, V5153, P658; WILLIAMS REO, 1959, LANCET, V1, P190; WILSON GS, 1945, LANCET, V248, P647; Wisplinghoff H, 2003, ANTIMICROB AGENTS CH, V47, P3574, DOI 10.1128/AAC.47.11.3574-3579.2003; Witte Wolfgang, 1997, Clin Microbiol Infect, V3, P414, DOI 10.1111/j.1469-0691.1997.tb00277.x; *WORK GROUP INF PR, 2004, MAN POL METH RES STA; Wu SW, 1996, MICROB DRUG RESIST, V2, P435, DOI 10.1089/mdr.1996.2.435; Wu SW, 2001, J BACTERIOL, V183, P2417, DOI 10.1128/JB.183.8.2417-2424.2001; ZECHOVSKY N, 1974, NOUV PRESSE MED, V3, P433; Zinderman CE, 2004, EMERG INFECT DIS, V10, P941, DOI 10.3201/eid1005.030604; 2000, DANMAP 99 CONSUMPTIO; SPOTLIGHT COMMUNITY; 1958, BMJ, V29, P207	199	755	837	4	192	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2006	368	9538					874	885		10.1016/S0140-6736(06)68853-3	http://dx.doi.org/10.1016/S0140-6736(06)68853-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	082FD	16950365	Green Submitted			2022-12-28	WOS:000240371200035
J	Rudebeck, PH; Buckley, MJ; Walton, ME; Rushworth, MFS				Rudebeck, P. H.; Buckley, M. J.; Walton, M. E.; Rushworth, M. F. S.			A role for the macaque anterior cingulate gyrus in social valuation	SCIENCE			English	Article							ORBITAL PREFRONTAL CORTEX; RHESUS-MONKEYS; ORBITOFRONTAL CORTEX; DECISION-MAKING; LESIONS; AMYGDALA; BEHAVIOR; EMOTION; HUMANS; AUTISM	Complex human social interaction is disrupted when the frontal lobe is damaged in disease, and in extreme cases patients are described as having acquired sociopathy. We compared, in macaques, the effects of lesions in subdivisions of the anterior cingulate and the orbitofrontal cortices believed to be anatomically homologous to those damaged in such patients. We show that the anterior cingulate gyrus in male macaques is critical for normal patterns of social interest in other individual male or female macaques. Conversely, the orbitofrontal cortex lesion had a marked effect only on responses to mildly fear-inducing stimuli. These results suggest that damage to the anterior cingulate gyrus may be the cause of changes in social interaction seen after frontal lobe damage.	Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford	Rudebeck, PH (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	peter.rudebeck@psy.ox.ac.uk	Rudebeck, Peter/G-7931-2012; Tudusciuc, Oana/C-1339-2011	Rushworth, Matthew/0000-0002-5578-9884; Rudebeck, Peter/0000-0002-1411-7555	MRC [G0300665] Funding Source: UKRI; Medical Research Council [G0300665] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bachevalier J, 2006, NEUROSCI BIOBEHAV R, V30, P97, DOI 10.1016/j.neubiorev.2005.07.002; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bussey TJ, 2001, BEHAV NEUROSCI, V115, P971, DOI 10.1037//0735-7044.115.5.971; Croxson PL, 2005, J NEUROSCI, V25, P8854, DOI 10.1523/JNEUROSCI.1311-05.2005; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; Fellows LK, 2003, BRAIN, V126, P1830, DOI 10.1093/brain/awg180; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Hadland KA, 2003, NEUROPSYCHOLOGIA, V41, P919, DOI 10.1016/S0028-3932(02)00325-1; Izquierdo A, 2005, J NEUROSCI, V25, P8534, DOI 10.1523/JNEUROSCI.1232-05.2005; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Izquierdo A, 2004, J NEUROPHYSIOL, V91, P2023, DOI 10.1152/jn.00968.2003; Kalin NH, 2004, J NEUROSCI, V24, P5506, DOI 10.1523/JNEUROSCI.0292-04.2004; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mineka S., 1987, THEORETICAL FDN BEHA; Ohnishi T, 2000, BRAIN, V123, P1838, DOI 10.1093/brain/123.9.1838; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Paxinos G., 2000, RHESUS MONKEY BRAIN; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rilling JK, 2004, NEUROIMAGE, V22, P1694, DOI 10.1016/j.neuroimage.2004.04.015; Rolls E. T., 1999, BRAIN EMOTION, P367; Saunders RC, 1998, NATURE, V393, P169, DOI 10.1038/30245; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; Schoenbaum G, 2005, NEURON, V47, P633, DOI 10.1016/j.neuron.2005.07.018; Shepherd SV, 2006, CURR BIOL, V16, pR119, DOI 10.1016/j.cub.2006.02.013; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Sprague DS, 1998, AM J PHYS ANTHROPOL, V105, P511, DOI 10.1002/(SICI)1096-8644(199804)105:4<511::AID-AJPA8>3.3.CO;2-Z; Van Hoesen G. W. M., 1993, NEUROBIOLOGY CINGULA, P249, DOI DOI 10.1007/978-1-4899-6704-6_9	29	228	229	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 1	2006	313	5791					1310	1312		10.1126/science.1128197	http://dx.doi.org/10.1126/science.1128197			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16946075				2022-12-28	WOS:000240313500048
J	Ranney, L; Melvin, C; Lux, L; McClain, E; Lohr, KN				Ranney, Leah; Melvin, Cathy; Lux, Linda; McClain, Erin; Lohr, Kathleen N.			Systematic review: Smoking cessation intervention strategies for adults and adults in special populations	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; NICOTINE REPLACEMENT THERAPY; PLACEBO-CONTROLLED-TRIAL; SELF-HELP MATERIALS; SUSTAINED-RELEASE; DOUBLE-BLIND; PREVENTIVE-SERVICES; HOSPITAL PATIENTS; PRIMARY-CARE; BUPROPION	Background: While smoking cessation interventions have been shown to work, questions remain about how to increase their efficacy. Purpose: To examine strategies for effective tobacco treatment in adults and special populations. Data Sources: MEDLINE, Cumulative Index to Nursing and Applied Health (CINAHL), Cochrane Library, Cochrane Clinical Trials Register, Psychological Abstracts, and Sociological Abstracts (1 January 1980 to 10 June 2005). Study Selection: Systematic reviews; randomized, controlled trials; and observational studies. Data Extraction: Two reviewers independently abstracted data on study design, population, sample size, treatment, outcomes, and quality. Data Synthesis: Findings from systematic reviews were summarized and compared with findings from original research published beyond date ranges included in the reviews. Strength of evidence was used to assess the body of evidence. Our review included studies evaluating the efficacy of cessation strategies, such as self-help, counseling, single pharmaceutical agents, combined pharmacotherapies, and pharmacotherapies combined with psychological counseling. Research findings consistent with previous reviews show that self-help strategies alone are ineffective, but counseling and pharmacotherapy used either alone or in combination can improve rates of success with quit attempts. Two studies of self-help materials reported discrepancies across effects. Five studies provided mixed results for counseling interventions. Fourteen studies provided sufficient evidence of the efficacy of single pharmacotherapy, combined pharmacotherapy, and psychological interventions either with or without pharmacotherapy. Few studies focused on ways to reach or treat special populations. Three studies with hospitalized patients had findings consistent with a previous review showing no strong evidence that clinical diagnosis affected the likelihood of quitting. New evidence was insufficient to address the effectiveness of interventions for persons with coexisting psychiatric conditions and substance abuse problems. Limitations: Previous systematic reviews variably cover the range of issues we addressed. More recent studies do not fill all gaps, especially those for persons with coexisting disease. Conclusions: Although self-help strategies alone marginally affect quit rates, individual and combined pharmacotherapies and counseling either alone or in combination can significantly increase cessation. Using effective smoking treatments is strongly encouraged for all populations, especially those with high and heavy rates of smoking, such as psychiatric and substance abuse populations.	Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27599 USA; RTI Int, Res Triangle Pk, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Research Triangle Institute	Ranney, L (corresponding author), Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, 725 Martin Luther King Blvd, Chapel Hill, NC 27599 USA.		Lux, Linda/GPX-3639-2022	Lohr, Kathleen/0000-0002-3825-0713	PHS HHS [290-02-0016] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aveyard P, 2003, ADDICTION, V98, P345, DOI 10.1046/j.1360-0443.2003.00302.x; Bier ID, 2002, AM J PUBLIC HEALTH, V92, P1642, DOI 10.2105/AJPH.92.10.1642; Bohadana A, 2000, ARCH INTERN MED, V160, P3128, DOI 10.1001/archinte.160.20.3128; Briss PA, 2000, AM J PREV MED, V18, P35, DOI 10.1016/S0749-3797(99)00119-1; Brown RA, 2001, J CONSULT CLIN PSYCH, V69, P471, DOI 10.1037/0022-006X.69.3.471; Canga N, 2000, DIABETES CARE, V23, P1455, DOI 10.2337/diacare.23.10.1455; Carpenter MJ, 2004, J CONSULT CLIN PSYCH, V72, P371, DOI 10.1037/0022-006X.72.3.371; Chalmers K, 2001, J Community Health Nurs, V18, P115, DOI 10.1207/153276501300118539; Clark MM, 2004, LUNG CANCER-J IASLC, V44, P13, DOI 10.1016/j.lungcan.2003.10.001; Covey LS, 2002, AM J PSYCHIAT, V159, P1731, DOI 10.1176/appi.ajp.159.10.1731; Croghan GA, 2003, NICOTINE TOB RES, V5, P181, DOI 10.1080/1462220031000073252; Dalsgaro OJ, 2004, NICOTINE TOB RES, V6, P55, DOI 10.1080/14622200310001656867; Davies SL, 2005, AM J HEALTH BEHAV, V29, P228, DOI 10.5993/AJHB.29.3.4; el-Guebaly N, 2002, PSYCHIATR SERV, V53, P1166, DOI 10.1176/appi.ps.53.9.1166; FIORE MC, 2000, TREATING TOBACCO USE; Garvey A J, 2000, Nicotine Tob Res, V2, P53; Hahn EJ, 2004, PREV MED, V39, P543, DOI 10.1016/j.ypmed.2004.02.012; Hall SM, 2004, AM J PSYCHIAT, V161, P2100, DOI 10.1176/appi.ajp.161.11.2100; Hand S, 2002, THORAX, V57, P715, DOI 10.1136/thorax.57.8.715; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Helgason AR, 2004, EUR J PUBLIC HEALTH, V14, P306, DOI 10.1093/eurpub/14.3.306; Hennrikus DJ, 2005, PREV MED, V40, P249, DOI 10.1016/j.ypmed.2004.05.030; Hitsman B, 1999, J CONSULT CLIN PSYCH, V67, P547, DOI 10.1037/0022-006X.67.4.547; Holt S, 2005, THORAX, V60, P120, DOI 10.1136/thx.2004.030239; Jones C, 2001, INTENS CARE MED, V27, P1547, DOI 10.1007/s001340101051; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; JOSEPH AM, 1993, J SUBST ABUSE TREAT, V10, P147, DOI 10.1016/0740-5472(93)90039-5; Joseph AM, 2004, J STUD ALCOHOL, V65, P681, DOI 10.15288/jsa.2004.65.681; Killen JD, 2000, J CONSULT CLIN PSYCH, V68, P883, DOI 10.1037//0022-006X.68.5.883; Lancaster T, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001292.pub2, 10.1002/14651858.CD001292.pub3]; Lancaster T, 1999, BRIT J GEN PRACT, V49, P191; Lawrence T, 2005, ADDICTION, V100, P107, DOI 10.1111/j.1360-0443.2005.00936.x; Lerman C, 2004, ANN INTERN MED, V140, P426, DOI 10.7326/0003-4819-140-6-200403160-00009; LUMLEY J, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001055.PUB2; Macleod ZR, 2003, MED J AUSTRALIA, V179, P349, DOI 10.5694/j.1326-5377.2003.tb05590.x; McBride CM, 2004, AM J PREV MED, V27, P232, DOI 10.1016/j.amepre.2004.06.005; Melvin CL, 2004, NICOTINE TOB RES, V6, pS107, DOI 10.1080/14622200410001669231; Mermelstein R, 2003, J CONSULT CLIN PSYCH, V71, P565, DOI 10.1037/0022-006X.71.3.565; Murray R P, 2001, Nicotine Tob Res, V3, P375, DOI 10.1080/14622200110081435; MURRAY RP, 1995, J STUD ALCOHOL, V56, P74, DOI 10.15288/jsa.1995.56.74; *NAT HLTH SERV CTR, 2001, 4 CRD NAT HLTH SERV; Peterson Wendy, 2004, Evid Based Nurs, V7, P83, DOI 10.1136/ebn.7.3.83; Prochaska JJ, 2004, J CONSULT CLIN PSYCH, V72, P1144, DOI 10.1037/0022-006X.72.6.1144; Quist-Paulsen P, 2003, BMJ-BRIT MED J, V327, P1254, DOI 10.1136/bmj.327.7426.1254; Ranney L, 2006, AHRQ PUBLICATION; Ratner PA, 2004, RES NURS HEALTH, V27, P148, DOI 10.1002/nur.20017; Reid Robert, 2003, J Cardiopulm Rehabil, V23, P176, DOI 10.1097/00008483-200305000-00003; Rigotti N.A., 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001837.PUB2; Rosen-Chase C, 1999, J SUBST ABUSE TREAT, V16, P315, DOI 10.1016/S0740-5472(98)00077-4; Rowe K, 1999, INT J NURS STUD, V36, P301, DOI 10.1016/S0020-7489(99)00024-3; Saules KK, 2004, AM J ADDICTION, V13, P438, DOI 10.1080/10550490490512762; Simon JA, 2004, ARCH INTERN MED, V164, P1797, DOI 10.1001/archinte.164.16.1797; Swan GE, 2003, NICOTINE TOB RES, V5, P911, DOI 10.1080/14622200310001646903; Swan GE, 2003, ARCH INTERN MED, V163, P2337, DOI 10.1001/archinte.163.19.2337; *US DEP HHS CDCP O, 2000, RED TOB US REP SURG; US Task Force on Community Preventive Services, 2005, GUIDE COMMUNITY PREV; Wakefield M, 2004, NURS RES, V53, P396, DOI 10.1097/00006199-200411000-00008	57	154	160	1	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 5	2006	145	11					845	856		10.7326/0003-4819-145-11-200612050-00142	http://dx.doi.org/10.7326/0003-4819-145-11-200612050-00142			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	114PE	16954352				2022-12-28	WOS:000242677300007
J	Childress, L; Dutt, MVG; Taylor, JM; Zibrov, AS; Jelezko, F; Wrachtrup, J; Hemmer, PR; Lukin, MD				Childress, L.; Dutt, M. V. Gurudev; Taylor, J. M.; Zibrov, A. S.; Jelezko, F.; Wrachtrup, J.; Hemmer, P. R.; Lukin, M. D.			Coherent dynamics of coupled electron and nuclear spin qubits in diamond	SCIENCE			English	Article							SINGLE SPINS; QUANTUM	Understanding and controlling the complex environment of solid-state quantum bits is a central challenge in spintronics and quantum information science. Coherent manipulation of an individual electron spin associated with a nitrogen-vacancy center in diamond was used to gain insight into its local environment. We show that this environment is effectively separated into a set of individual proximal C-13 nuclear spins, which are coupled coherently to the electron spin, and the remainder of the C-13 nuclear spins, which cause the loss of coherence. The proximal nuclear spins can be addressed and coupled individually because of quantum back-action from the electron, which modifies their energy levels and magnetic moments, effectively distinguishing them from the rest of the nuclei. These results open the door to coherent manipulation of individual isolated nuclear spins in a solid-state environment even at room temperature.	Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Harvard Univ, Inst Quantum Sci & Engn, Cambridge, MA 02138 USA; Univ Stuttgart, Inst Phys, D-70550 Stuttgart, Germany; Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA	Harvard University; Harvard University; University of Stuttgart; Texas A&M University System; Texas A&M University College Station	Lukin, MD (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	lukin@fas.harvard.edu	Zibrov, Alexander S/G-7419-2014; Childress, Lilian/H-1359-2012; Taylor, Jacob M/B-7826-2011; Taylor, Jacob/O-1670-2019; Dutt, Gurudev/B-2889-2009	Childress, Lilian/0000-0002-0507-6392; Taylor, Jacob M/0000-0003-0493-5594; Taylor, Jacob/0000-0003-0493-5594; Dutt, Gurudev/0000-0001-7426-9246				Atature M, 2006, SCIENCE, V312, P551, DOI 10.1126/science.1126074; Childress L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.070504; Cirac JI, 2004, PHYS TODAY, V57, P38, DOI 10.1063/1.1712500; Clark RG, 2003, PHILOS T R SOC A, V361, P1451, DOI 10.1098/rsta.2003.1221; de Sousa R, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.115322; DIVINCENZO DP, 1995, SCIENCE, V270, P255, DOI 10.1126/science.270.5234.255; Epstein RJ, 2005, NAT PHYS, V1, P94, DOI 10.1038/nphys141; Gaebel T, 2006, NAT PHYS, V2, P408, DOI 10.1038/nphys318; HAHN EL, 1950, PHYS REV, V80, P580, DOI 10.1103/PhysRev.80.580; Hanson R, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.087601; Jelezko F, 2004, J PHYS-CONDENS MAT, V16, pR1089, DOI 10.1088/0953-8984/16/30/R03; Jelezko F, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.076401; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Khaetskii AV, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.186802; Koppens FHL, 2005, SCIENCE, V309, P1346, DOI 10.1126/science.1113719; Ladd TD, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.014401; Li XQ, 2003, SCIENCE, V301, P809, DOI 10.1126/science.1083800; Makhlin Y, 2001, REV MOD PHYS, V73, P357, DOI 10.1103/RevModPhys.73.357; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Schliemann J, 2003, J PHYS-CONDENS MAT, V15, pR1809, DOI 10.1088/0953-8984/15/50/R01; Shenvi N, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.144419; SZABO A, 1990, PHYS REV B, V42, P7769, DOI 10.1103/PhysRevB.42.7769; van Loock P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.240501; VANOORT E, 1990, CHEM PHYS, V143, P131, DOI 10.1016/0301-0104(90)85013-M; [No title captured]; [No title captured]	26	922	966	13	275	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2006	314	5797					281	285		10.1126/science.1131871	http://dx.doi.org/10.1126/science.1131871			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093TV	16973839				2022-12-28	WOS:000241194100036
J	Heit, JJ; Apelqvist, AA; Gu, XY; Winslow, MM; Neilson, JR; Crabtree, GR; Kim, SK				Heit, Jeremy J.; Apelqvist, Asa A.; Gu, Xueying; Winslow, Monte M.; Neilson, Joel R.; Crabtree, Gerald R.; Kim, Seung K.			Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function	NATURE			English	Article							INSULIN GENE-EXPRESSION; DIABETES-MELLITUS; GLUCOSE; SECRETION; MICE; PROLIFERATION; TRANSCRIPTION; HYPERPLASIA; PROGRESSION; ACTIVATION	The growth and function of organs such as pancreatic islets adapt to meet physiological challenges and maintain metabolic balance, but the mechanisms controlling these facultative responses are unclear(1,2). Diabetes in patients treated with calcineurin inhibitors such as cyclosporin A indicates that calcineurin/nuclear factor of activated T-cells ( NFAT) signalling might control adaptive islet responses(3), but the roles of this pathway in beta-cells in vivo are not understood. Here we show that mice with a beta-cell-specific deletion of the calcineurin phosphatase regulatory subunit, calcineurin b1 (Cnb1), develop age-dependent diabetes characterized by decreased beta-cell proliferation and mass, reduced pancreatic insulin content and hypoinsulinaemia. Moreover, beta-cells lacking Cnb1 have a reduced expression of established regulators of beta-cell proliferation(1,4,5). Conditional expression of active NFATc1 in Cnb1-deficient beta-cells rescues these defects and prevents diabetes. In normal adult beta-cells, conditional NFAT activation promotes the expression of cell-cycle regulators and increases beta-cell proliferation and mass, resulting in hyperinsulinaemia. Conditional NFAT activation also induces the expression of genes critical for beta-cell endocrine function, including all six genes mutated in hereditary forms of monogenic type 2 diabetes. Thus, calcineurin/ NFAT signalling regulates multiple factors that control growth and hallmark beta-cell functions, revealing unique models for the pathogenesis and therapy of diabetes.	Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Program Immunol, Stanford, CA 94305 USA; Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Med, Div Oncol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Kim, SK (corresponding author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.	seungkim@stanford.edu		Neilson, Joel R./0000-0002-3408-608X; Kim, Seung/0000-0001-6135-7810; Heit, Jeremy/0000-0003-1055-8000				Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; Cozar-Castellano I, 2006, ENDOCR REV, V27, P356, DOI 10.1210/er.2006-0004; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Lawrence MC, 2005, J BIOL CHEM, V280, P26751, DOI 10.1074/jbc.M503158200; Lawrence MC, 2002, DIABETES, V51, P691, DOI 10.2337/diabetes.51.3.691; Lawrence MC, 2001, MOL ENDOCRINOL, V15, P1758, DOI 10.1210/me.15.10.1758; Laybutt DR, 2002, DIABETES, V51, P1793, DOI 10.2337/diabetes.51.6.1793; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; O'Rahilly S, 2005, SCIENCE, V307, P370, DOI 10.1126/science.1104346; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Redmon JB, 1996, J CLIN INVEST, V98, P2786, DOI 10.1172/JCI119105; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Smart NG, 2006, PLOS BIOL, V4, P200, DOI 10.1371/journal.pbio.0040039; Thorens B, 2000, J BIOL CHEM, V275, P23751, DOI 10.1074/jbc.M002908200; Weir MR, 1999, AM J KIDNEY DIS, V34, P1, DOI 10.1016/S0272-6386(99)70101-0; Winslow MM, 2006, IMMUNITY, V24, P141, DOI 10.1016/j.immuni.2005.12.013; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006	29	335	353	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2006	443	7109					345	349		10.1038/nature05097	http://dx.doi.org/10.1038/nature05097			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085RL	16988714				2022-12-28	WOS:000240622000048
J	Hillmen, P; Young, NS; Schubert, J; Brodsky, RA; Socie, G; Muus, P; Roth, A; Szer, J; Elebute, MO; Nakamura, R; Browne, P; Risitano, AM; Hill, A; Schrezenmeier, H; Fu, C; Maciejewski, J; Rollins, SA; Mojcik, CF; Rother, RP; Luzzatto, L				Hillmen, Peter; Young, Neal S.; Schubert, Joerg; Brodsky, Robert A.; Socie, Gerard; Muus, Petra; Roeth, Alexander; Szer, Jeffrey; Elebute, Modupe O.; Nakamura, Ryotaro; Browne, Paul; Risitano, Antonio M.; Hill, Anita; Schrezenmeier, Hubert; Fu, Chieh-Lin; Maciejewski, Jaroslaw; Rollins, Scott A.; Mojcik, Christopher F.; Rother, Russell P.; Luzzatto, Lucio			The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PIG-A GENE; DEFICIENCY; MECHANISM; PLATELETS; HEMOLYSIS; FATIGUE; ANCHOR; C5B-9	BACKGROUND: We tested the safety and efficacy of eculizumab, a humanized monoclonal antibody against terminal complement protein C5 that inhibits terminal complement activation, in patients with paroxysmal nocturnal hemoglobinuria (PNH). METHODS: We conducted a double-blind, randomized, placebo-controlled, multicenter, phase 3 trial. Patients received either placebo or eculizumab intravenously; eculizumab was given at a dose of 600 mg weekly for 4 weeks, followed 1 week later by a 900-mg dose and then 900 mg every other week through week 26. The two primary end points were the stabilization of hemoglobin levels and the number of units of packed red cells transfused. Biochemical indicators of intravascular hemolysis and the patients' quality of life were also assessed. RESULTS: Eighty-seven patients underwent randomization. Stabilization of hemoglobin levels in the absence of transfusions was achieved in 49% (21 of 43) of the patients assigned to eculizumab and none (0 of 44) of those assigned to placebo (P<0.001). During the study, a median of 0 units of packed red cells was administered in the eculizumab group, as compared with 10 units in the placebo group (P<0.001). Eculizumab reduced intravascular hemolysis, as shown by the 85.8% lower median area under the curve for lactate dehydrogenase plotted against time (in days) in the eculizumab group, as compared with the placebo group (58,587 vs. 411,822 U per liter; P<0.001). Clinically significant improvements were also found in the quality of life, as measured by scores on the Functional Assessment of Chronic Illness Therapy-Fatigue instrument (P<0.001) and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire. Of the 87 patients, 4 in the eculizumab group and 9 in the placebo group had serious adverse events, none of which were considered to be treatment-related; all these patients recovered without sequelae. CONCLUSIONS: Eculizumab is an effective therapy for PNH.	Gen Infirm, Dept Haematol, Leeds LS1 3EX, W Yorkshire, England; NHLBI, Bethesda, MD 20892 USA; Univ Saarland, Sch Med, D-6650 Homburg, Germany; Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; Hop St Louis, Paris, France; INSERM, Paris, France; Radboud Univ Med Ctr, Nijmegen, Netherlands; Univ Hosp Essen, Essen, Germany; Royal Melbourne Hosp, Melbourne, Vic, Australia; Univ London St Georges Hosp, London, England; City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA; Univ Dublin Trinity Coll, St James Hosp, Dublin 2, Ireland; Univ Naples Federico II, Naples, Italy; Univ Hosp, Inst Transfus Med, Ulm, Germany; Cleveland Clin Florida, Weston, FL USA; Cleveland Clin Fdn, Taussig Canc Ctr, Cleveland, OH 44195 USA; Alex Pharmaceut, Cheshire, CT USA; Ist Toscano Tumori, Florence, Italy	Leeds General Infirmary; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Saarland University; Johns Hopkins University; Johns Hopkins Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Radboud University Nijmegen; University of Duisburg Essen; Royal Melbourne Hospital; St Georges University London; City of Hope; Beckman Research Institute of City of Hope; Trinity College Dublin; University of Naples Federico II; Ulm University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Hillmen, P (corresponding author), Gen Infirm, Dept Haematol, Great George St, Leeds LS1 3EX, W Yorkshire, England.	peter.hillmen@nhs.net	Muus, P./L-4539-2015	Szer, Jeff/0000-0001-6783-2301; Browne, Paul/0000-0001-5310-1487				AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; BESSLER M, 1994, EMBO J, V13, P110, DOI 10.1002/j.1460-2075.1994.tb06240.x; Cella D, 2002, J PAIN SYMPTOM MANAG, V24, P547, DOI 10.1016/S0885-3924(02)00529-8; Cella D, 2002, CANCER-AM CANCER SOC, V94, P528, DOI 10.1002/cncr.10245; Cella D, 1997, MANUAL FUNCTIONAL AS; Fayers P, 2001, EORTC QLQ C30 SCORIN; HILL A, 2005, BLOOD, V106, pA1046; HILL A, 2005, HAEMATOLOGICA S12, V90; Hillmen P, 2004, NEW ENGL J MED, V350, P552, DOI 10.1056/NEJMoa031688; HOLGUIN MH, 1989, J CLIN INVEST, V84, P7, DOI 10.1172/JCI114172; Jasinski M, 2004, BLOOD, V103, P2827, DOI 10.1182/blood-2003-09-3057; MOTOYAMA N, 1992, EUR J IMMUNOL, V22, P2669, DOI 10.1002/eji.1830221029; Parker C, 2005, BLOOD, V106, P3699, DOI 10.1182/blood-2005-04-1717; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; ROSSE WF, 2000, HEMATOLOGY BASIC PRI, P331; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; SIMS PJ, 1989, J BIOL CHEM, V264, P19228; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; Thomas TC, 1996, MOL IMMUNOL, V33, P1389, DOI 10.1016/S0161-5890(96)00078-8; WIEDMER T, 1993, BLOOD, V82, P1192, DOI 10.1182/blood.V82.4.1192.bloodjournal8241192; YAMASHINA M, 1990, NEW ENGL J MED, V323, P1184, DOI 10.1056/NEJM199010253231707	21	793	864	0	549	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 21	2006	355	12					1233	1243		10.1056/NEJMoa061648	http://dx.doi.org/10.1056/NEJMoa061648			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085IT	16990386				2022-12-28	WOS:000240598500007
J	Shanafelt, TD; Byrd, JC; Call, TG; Zent, CS; Kay, NE				Shanafelt, Tait D.; Byrd, John C.; Call, Timothy G.; Zent, Clive S.; Kay, Neil E.			Narrative review: Initial management of newly diagnosed, early-stage chronic lymphocytic leukemia	ANNALS OF INTERNAL MEDICINE			English	Review							AUTOIMMUNE HEMOLYTIC-ANEMIA; VARIABLE-REGION MUTATIONS; IN-SITU HYBRIDIZATION; CD38 EXPRESSION; ZAP-70 EXPRESSION; GENE MUTATION; P53 GENE; GENOMIC ABERRATIONS; DISEASE PROGRESSION; PROGNOSTIC FACTORS	Chronic lymphocytic leukemia is one of the most common malignant lymphoid diseases in the western world and is frequently diagnosed by internists. There have been clinically significant changes in method of diagnosis, prognostic tools, supportive care, and treatment over the past 2 decades. Most patients with chronic lymphocytic leukemia now have Rai stage 0 or I disease at diagnosis. Patients with early-stage disease are a heterogeneous group: Approximately 30% to 50% will have accelerated disease progression, and the remainder may live for decades and possibly never require therapy. Recent insights into the biological characteristics of leukemic B cells have led to the discovery of new prognostic tools (immunoglobulin variable-region heavy chain gene mutation status, cytogenetic abnormalities assessed by fluorescent in situ hybridization, and Z-chain-associated protein kinase-70 protein expression) that can identify patients with early-stage disease who are at high risk for early disease progression. These tools allow physicians to individualize counseling, follow-up, and management on the basis of disease risk. In addition, new treatments developed over the past 2 decades (purine nucleoside analogues, monoclonal antibodies, and combination chemoimmunotherapy regimens) have dramatically improved response rates and appear to prolong survival. In this review, the authors discuss the current work-up of lymphocytosis and highlight how to use recently identified prognostic tools to stratify risk in patients with newly diagnosed, early-stage chronic lymphocytic leukemia. Recommendations for patient counseling, follow-up, supportive care, and initial treatment are presented for each risk category.	Mayo Clin, Coll Med, Dept Internal Med, Div Hematol, Rochester, MN 55902 USA; Ohio State Univ, Columbus, OH 43210 USA	Mayo Clinic; University System of Ohio; Ohio State University	Shanafelt, TD (corresponding author), Mayo Clin, Coll Med, Dept Internal Med, Div Hematol, 200 1st St, Rochester, MN 55902 USA.				NCI NIH HHS [K12 CA90628, CA97274] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA097274, K12CA090628] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 1999, J Natl Cancer Inst, V91, P861; BERGMANN M, 2004, BLOOD, V102, P2464; BINET JL, 1977, CANCER-AM CANCER SOC, V40, P855, DOI 10.1002/1097-0142(197708)40:2<855::AID-CNCR2820400239>3.0.CO;2-1; Binet JL, 2006, BLOOD, V107, P859, DOI 10.1182/blood-2005-04-1677; BINET JL, 1981, CANCER-AM CANCER SOC, V48, P198, DOI 10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V; BLATTNER WA, 1976, ANN INTERN MED, V84, P554, DOI 10.7326/0003-4819-84-5-554; BUNCH C, 1988, NEW ENGL J MED, V319, P902; Byrd JC, 1999, BRIT J HAEMATOL, V105, P445, DOI 10.1046/j.1365-2141.1999.01364.x; Byrd JC, 2004, BLOOD, V104, p101A, DOI 10.1182/blood.V104.11.341.341; Byrd JC, 2003, BLOOD, V101, P6, DOI 10.1182/blood-2002-04-1258; Byrd JC, 2005, BLOOD, V105, P49, DOI 10.1182/blood-2004-03-0796; Byrd JC, 2006, J CLIN ONCOL, V24, P437, DOI 10.1200/JCO.2005.03.1021; CALL TG, 1994, MAYO CLIN PROC, V69, P323, DOI 10.1016/S0025-6196(12)62215-0; Castro JE, 2005, BLOOD, V106, P2506, DOI 10.1182/blood-2005-03-1099; CATOVSKY D, 1989, BRIT J HAEMATOL, V72, P141, DOI 10.1111/j.1365-2141.1989.tb07674.x; Chen LG, 2002, BLOOD, V100, P4609, DOI 10.1182/blood-2002-06-1683; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; Chevallier P, 2002, BRIT J HAEMATOL, V116, P142, DOI 10.1046/j.0007-1048.2001.3205.x; Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Deaglio S, 2005, BLOOD, V105, P3042, DOI 10.1182/blood-2004-10-3873; Dewald GW, 2003, BRIT J HAEMATOL, V121, P287, DOI 10.1046/j.1365-2141.2003.04265.x; Diehl LF, 1999, CANCER-AM CANCER SOC, V86, P2684; Diehl LF, 1998, SEMIN ONCOL, V25, P80; Dighiero G, 1998, NEW ENGL J MED, V338, P1506, DOI 10.1056/NEJM199805213382104; DIRAIMONDO F, 1993, LEUKEMIA LYMPHOMA, V11, P63; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; DOHNER H, 1995, BLOOD, V85, P1580, DOI 10.1182/blood.V85.6.1580.bloodjournal8561580; Durig J, 2003, LEUKEMIA, V17, P2426, DOI 10.1038/sj.leu.2403147; Eichhorst BF, 2006, BLOOD, V107, P885, DOI 10.1182/blood-2005-06-2395; ELROUBY S, 1993, BLOOD, V82, P3452; Flinn IW, 2004, BLOOD, V104, p139A; FRAUMENI JF, 1969, ANN INTERN MED, V71, P279, DOI 10.7326/0003-4819-71-2-279; Ghia P, 2003, BLOOD, V101, P1262, DOI 10.1182/blood-2002-06-1801; Goldin LR, 1999, AM J HUM GENET, V65, P265, DOI 10.1086/302458; GREVER MR, 1988, NOUV REV FR HEMATOL, V30, P457; Hamblin TJ, 2002, BLOOD, V99, P1023, DOI 10.1182/blood.V99.3.1023; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Harris NL, 1999, J CLIN ONCOL, V17, P3835, DOI 10.1200/JCO.1999.17.12.3835; Ishibe N, 2001, LEUKEMIA LYMPHOMA, V42, P99, DOI 10.3109/10428190109097681; Jelinek DF, 2001, BRIT J HAEMATOL, V115, P854, DOI 10.1046/j.1365-2141.2001.03149.x; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Johnson S, 1996, Lancet, V347, P1432; JURLANDER J, 1995, LEUKEMIA, V9, P1902; Kay NE, 2004, BLOOD, V104, p100A, DOI 10.1182/blood.V104.11.339.339; Keating MJ, 2005, J CLIN ONCOL, V23, P4079, DOI 10.1200/JCO.2005.12.051; KEATING MJ, 1991, J CLIN ONCOL, V9, P44, DOI 10.1200/JCO.1991.9.1.44; KEATING MJ, 1989, BLOOD, V74, P19; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Krober A, 2002, BLOOD, V100, P1410, DOI 10.1182/blood.V100.4.1410.h81602001410_1410_1416; Kyasa MJ, 2004, LEUKEMIA LYMPHOMA, V45, P507, DOI 10.1080/10428190310001612939; Kyasa MJ, 2003, AM J HEMATOL, V74, P1, DOI 10.1002/ajh.10369; Leporrier M, 2001, BLOOD, V98, P2319, DOI 10.1182/blood.V98.8.2319; Levy V, 2001, J CLIN EPIDEMIOL, V54, P747, DOI 10.1016/S0895-4356(00)00359-0; Lozanski G, 2004, BLOOD, V103, P3278, DOI 10.1182/blood-2003-10-3729; Marti GE, 2005, BRIT J HAEMATOL, V130, P325, DOI 10.1111/j.1365-2141.2005.05550.x; MARTI GE, 1997, P USPHS WORKSH LAB A, P37; Mauro FR, 2000, BLOOD, V95, P2786, DOI 10.1182/blood.V95.9.2786.009k30_2786_2792; Mehrany K, 2005, DERMATOL SURG, V31, P38, DOI 10.1097/00042728-200501000-00008; MOLICA S, 1987, CANCER, V60, P2712, DOI 10.1002/1097-0142(19871201)60:11<2712::AID-CNCR2820601122>3.0.CO;2-1; Molica S, 2001, HAEMATOLOGICA, V86, P8; Molica S, 1999, HAEMATOLOGICA, V84, P1094; MONTSERRAT E, 1986, BRIT J HAEMATOL, V62, P567, DOI 10.1111/j.1365-2141.1986.tb02969.x; Morrison V A, 2001, Expert Rev Anticancer Ther, V1, P84, DOI 10.1586/14737140.1.1.84; Morton LM, 2006, BLOOD, V107, P265, DOI 10.1182/blood-2005-06-2508; MYINT H, 1995, BRIT J HAEMATOL, V91, P341, DOI 10.1111/j.1365-2141.1995.tb05300.x; Nolz JC, 2005, LEUKEMIA, V19, P1018, DOI 10.1038/sj.leu.2403726; Nowakowski GS, 2005, BRIT J HAEMATOL, V130, P36, DOI 10.1111/j.1365-2141.2005.05548.x; Orchard JA, 2004, LANCET, V363, P105, DOI 10.1016/S0140-6736(03)15260-9; Oscier DG, 2002, BLOOD, V100, P1177, DOI 10.1182/blood.V100.4.1177.h81602001177_1177_1184; Oscier DG, 2005, BLOOD, V106, p594A, DOI 10.1182/blood.V106.11.2099.2099; Pittner BT, 2005, LEUKEMIA, V19, P2264, DOI 10.1038/sj.leu.2403975; Rai KR, 2000, NEW ENGL J MED, V343, P1750, DOI 10.1056/NEJM200012143432402; RAI KR, 1975, BLOOD, V46, P219, DOI 10.1182/blood.V46.2.219.219; Rassenti LZ, 2004, NEW ENGL J MED, V351, P893, DOI 10.1056/NEJMoa040857; ROBERTSON LE, 1993, J CLIN ONCOL, V11, P1985, DOI 10.1200/JCO.1993.11.10.1985; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Rozman C, 1997, LEUKEMIA, V11, P775, DOI 10.1038/sj.leu.2400679; SARASUA SM, 1997, P USPHS WORKSH LAB A, P7; Shanafelt TD, 2004, MAYO CLIN PROC, V79, P388, DOI 10.4065/79.3.388; Shanafelt TD, 2004, BLOOD, V103, P1202, DOI 10.1182/blood-2003-07-2281; SHANAFELT TD, 2006, IN PRESS J CLIN ONCO; Sinisalo M, 2003, LEUKEMIA LYMPHOMA, V44, P649, DOI 10.1080/1042819031000063408; Tsimberidou AM, 2005, CANCER-AM CANCER SOC, V103, P216, DOI 10.1002/cncr.20773; VOGT RF, 1997, P USPHS WORKSH LAB A, P19; Weiss RB, 1998, J CLIN ONCOL, V16, P1885, DOI 10.1200/JCO.1998.16.5.1885; Yamauchi T, 2001, CLIN CANCER RES, V7, P3580; Zent CS, 2001, CANCER-AM CANCER SOC, V92, P1325, DOI 10.1002/1097-0142(20010901)92:5<1325::AID-CNCR1454>3.0.CO;2-E	88	41	43	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2006	145	6					435	447		10.7326/0003-4819-145-6-200609190-00007	http://dx.doi.org/10.7326/0003-4819-145-6-200609190-00007			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087OU	16983131				2022-12-28	WOS:000240752500005
J	Bach, RG				Bach, Richard G.			The early invasive strategy revisited: FRISC II at 5 years	LANCET			English	Editorial Material							CORONARY-ARTERY-DISEASE; ELEVATION MYOCARDIAL-INFARCTION; RITA-3 RANDOMIZED-TRIAL; UNSTABLE ANGINA; CONSERVATIVE STRATEGIES; ELUTING STENT; MANAGEMENT; ROUTINE		Washington Univ, Sch Med, Div Cardiovasc, St Louis, MO 63110 USA	Washington University (WUSTL)	Bach, RG (corresponding author), Washington Univ, Sch Med, Div Cardiovasc, St Louis, MO 63110 USA.	rbach@im.wustl.edu	Bach, Richard G/G-9764-2011; Bach, Richard/AAI-2515-2021					ANDERSON HV, 1995, J AM COLL CARDIOL, V26, P1643, DOI 10.1016/0735-1097(95)00404-1; Bach RG, 2004, ANN INTERN MED, V141, P186, DOI 10.7326/0003-4819-141-3-200408030-00007; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Boden WE, 1998, NEW ENGL J MED, V338, P1785, DOI 10.1056/NEJM199806183382501; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; de Winter RJ, 2005, NEW ENGL J MED, V353, P1095, DOI 10.1056/NEJMoa044259; Fox KAA, 2005, LANCET, V366, P914, DOI 10.1016/S0140-6736(05)67222-4; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Janzon M, 2004, AM HEART J, V148, P114, DOI 10.1016/j.ahj.2003.11.026; Lagerqvist B, 2002, J AM COLL CARDIOL, V40, P1902, DOI 10.1016/S0735-1097(02)02572-X; Lagerqvist B, 2006, LANCET, V368, P998, DOI 10.1016/S0140-6736(06)69416-6; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Wallentin L, 1999, LANCET, V354, P708; Wallentin L, 2000, LANCET, V356, P9, DOI 10.1016/S0140-6736(00)02427-2	17	1	1	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 16	2006	368	9540					966	969		10.1016/S0140-6736(06)69393-8	http://dx.doi.org/10.1016/S0140-6736(06)69393-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	086UO	16980093				2022-12-28	WOS:000240698700005
J	Ize, B; Palmer, T				Ize, Berengere; Palmer, Tracy			Mycobacteria's export strategy	SCIENCE			English	Editorial Material							SECRETION SYSTEM; BOVIS BCG; TUBERCULOSIS; VIRULENCE; ESAT-6; COMPLEX; IMMUNOGENICITY; ATTENUATION; CFP-10		Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; John Innes Ctr Plant Sci Res, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England	University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Palmer, T (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	tracy.palmer@bbsrc.ac.uk	IZE, Bérengère/GLQ-7207-2022	IZE, Bérengère/0000-0001-9106-9254; Palmer, Tracy/0000-0001-9043-2592	Medical Research Council [G117/519] Funding Source: Medline; MRC [G117/519] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Brodin P, 2005, J BIOL CHEM, V280, P33953, DOI 10.1074/jbc.M503515200; Champion PAD, 2006, SCIENCE, V313, P1632, DOI 10.1126/science.1131167; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100	14	11	13	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2006	313	5793					1583	1584		10.1126/science.1132537	http://dx.doi.org/10.1126/science.1132537			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973866				2022-12-28	WOS:000240498900029
J	McKern, NM; Lawrence, MC; Streltsov, VA; Lou, MZ; Adams, TE; Lovrecz, GO; Elleman, TC; Richards, KM; Bentley, JD; Pilling, PA; Hoyne, PA; Cartledge, KA; Pham, TM; Lewis, JL; Sankovich, SE; Stoichevska, V; Da Silva, E; Robinson, CP; Frenkel, MJ; Sparrow, LG; Fernley, RT; Epa, VC; Ward, CW				McKern, Neil M.; Lawrence, Michael C.; Streltsov, Victor A.; Lou, Mei-Zhen; Adams, Timothy E.; Lovrecz, George O.; Elleman, Thomas C.; Richards, Kim M.; Bentley, John D.; Pilling, Patricia A.; Hoyne, Peter A.; Cartledge, Kellie A.; Pham, Tam M.; Lewis, Jennifer L.; Sankovich, Sonia E.; Stoichevska, Violet; Da Silva, Elizabeth; Robinson, Christine P.; Frenkel, Maurice J.; Sparrow, Lindsay G.; Fernley, Ross T.; Epa, V. Chandana; Ward, Colin W.			Structure of the insulin receptor ectodomain reveals a folded-over conformation	NATURE			English	Article							GROWTH-FACTOR RECEPTOR; 1ST 3 DOMAINS; ALPHA-SUBUNIT; MONOCLONAL-ANTIBODIES; BINDING DOMAIN; SPECIFICITY; ACTIVATION; REGION	The insulin receptor is a phylogenetically ancient tyrosine kinase receptor found in organisms as primitive as cnidarians and insects. In higher organisms it is essential for glucose homeostasis(1), whereas the closely related insulin-like growth factor receptor (IGF-1R) is involved in normal growth and development(2). The insulin receptor is expressed in two isoforms, IR-A and IR-B; the former also functions as a high-affinity receptor for IGF-II and is implicated, along with IGF-1R, in malignant transformation(3). Here we present the crystal structure at 3.8 angstrom resolution of the IR-A ectodomain dimer, complexed with four Fabs from the monoclonal antibodies 83-7 and 83-14 ( ref. 4), grown in the presence of a fragment of an insulin mimetic peptide(5). The structure reveals the domain arrangement in the disulphide-linked ectodomain dimer, showing that the insulin receptor adopts a folded-over conformation that places the ligand-binding regions in juxtaposition. This arrangement is very different from previous models(6). It shows that the two L1 domains are on opposite sides of the dimer, too far apart to allow insulin to bind both L1 domains simultaneously as previously proposed(7). Instead, the structure implicates the carboxy-terminal surface of the first fibronectin type III domain as the second binding site involved in high-affinity binding.	CSIRO Mol & Hlth Technol, Parkville, Vic 3052, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Lawrence, MC (corresponding author), CSIRO Mol & Hlth Technol, 343 Royal Parade, Parkville, Vic 3052, Australia.	Mike.Lawrence@csiro.au; Colin.Ward@csiro.au	Lovrecz, George/H-8602-2013; Streltsov, Victor/M-9446-2019; Adams, Timothy E/I-6231-2012; Lawrence, Michael C/A-5357-2009; Epa, Vidana C./D-2320-2013; Pilling, Patricia/AAT-7845-2021	Streltsov, Victor/0000-0002-7846-4396; Adams, Timothy E/0000-0003-3436-0066; Lawrence, Michael/0000-0003-1999-0801				Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; CHEATHAM B, 1992, J BIOL CHEM, V267, P7108; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; Denley A, 2003, HORM METAB RES, V35, P778; FABRY M, 1992, J BIOL CHEM, V267, P8950; Florke RR, 2001, BIOCHEM J, V360, P189, DOI 10.1042/0264-6021:3600189; Garrett TPJ, 1998, NATURE, V394, P395, DOI 10.1038/28668; Hoyne PA, 2000, FEBS LETT, V479, P15, DOI 10.1016/S0014-5793(00)01872-X; KADOWAKI H, 1990, J BIOL CHEM, V265, P21285; Kitamura T, 2003, ANNU REV PHYSIOL, V65, P313, DOI 10.1146/annurev.physiol.65.092101.142540; Kristensen C, 1999, J BIOL CHEM, V274, P37351, DOI 10.1074/jbc.274.52.37351; KUROSE T, 1994, J BIOL CHEM, V269, P29190; Lee J, 1997, BIOCHEMISTRY-US, V36, P2701, DOI 10.1021/bi961815g; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; Marino-Buslje C, 1999, BIOCHEM SOC T, V27, P715, DOI 10.1042/bst0270715; Ottensmeyer FP, 2000, BIOCHEMISTRY-US, V39, P12103, DOI 10.1021/bi0015921; Ottensmeyer FP, 2001, BIOCHEMISTRY-US, V40, P6988, DOI 10.1021/bi015135b; Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886; SCHAEFER EM, 1992, J BIOL CHEM, V267, P23393; Schaffer L, 2003, P NATL ACAD SCI USA, V100, P4435, DOI 10.1073/pnas.0830026100; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; SCHUMACHER R, 1993, J BIOL CHEM, V268, P1087; SOOS MA, 1986, BIOCHEM J, V235, P199, DOI 10.1042/bj2350199; Sparrow LG, 1997, J BIOL CHEM, V272, P29460, DOI 10.1074/jbc.272.47.29460; Surinya HH, 2002, J BIOL CHEM, V277, P16718, DOI 10.1074/bjc.M112014200; Tulloch PA, 1999, J STRUCT BIOL, V125, P11, DOI 10.1006/jsbi.1998.4066; Yip CC, 2003, J BIOL CHEM, V278, P27329, DOI 10.1074/jbc.R300021200; ZHANG B, 1991, P NATL ACAD SCI USA, V88, P9858, DOI 10.1073/pnas.88.21.9858	31	226	266	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2006	443	7108					218	221		10.1038/nature05106	http://dx.doi.org/10.1038/nature05106			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16957736				2022-12-28	WOS:000240467000048
J	Frank, C				Frank, Christopher			Medical education - Evidence based checklists for objective structured clinical examinations	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSING PNEUMONIA; PHYSICAL-EXAMINATION; PATIENT; SIGNS; CHEST		Providence Continuing Care Ctr, Kingston, ON K7L 5A2, Canada		Frank, C (corresponding author), Providence Continuing Care Ctr, 340 Union St,POB 3600, Kingston, ON K7L 5A2, Canada.	frankc@pccchealth.org						Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Dauphinee WD, 1997, ADV HEALTH SCI EDUC, V2, P201, DOI 10.1023/A:1009768127620; Gennis P, 1989, J Emerg Med, V7, P263, DOI 10.1016/0736-4679(89)90358-2; Gorter S, 2000, ACAD MED, V75, P1130, DOI 10.1097/00001888-200011000-00022; HARDEN RM, 1975, BRIT MED J, V1, P447, DOI 10.1136/bmj.1.5955.447; Hodges B, 1999, ACAD MED, V74, P1129, DOI 10.1097/00001888-199910000-00017; Joshua AM, 2005, INTERN MED J, V35, P178, DOI 10.1111/j.1445-5994.2004.00795.x; Mangione S, 2003, CHEST, V124, P1430, DOI 10.1016/S0012-3692(16)48689-7; MCGEE S, 2001, EVIDENCE BASED PHYS; MCGEE SR, 2003, JAMA-J AM MED ASSOC, V281, P1022; Metlay JP, 1997, JAMA-J AM MED ASSOC, V278, P1440, DOI 10.1001/jama.278.17.1440; MILLER M, 1992, J GEN INTERN MED, V7, P646, DOI 10.1007/BF02599208; RETEGUIZ J, 1999, MASTERING OSCE CSA; SCHNEIDERMAN H, 2006, BEDSIDE DIAGNOSIS AN; SCHRIGER DL, 2003, ARCH INTERN MED, V20, P601; *SOC GEN INT MED, CLIN EX RES INT GROU; SPITERI MA, 1988, LANCET, V1, P873; Wipf JE, 1999, ARCH INTERN MED, V159, P1082, DOI 10.1001/archinte.159.10.1082	18	8	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2006	333	7567					546	548		10.1136/bmj.38943.463565.68	http://dx.doi.org/10.1136/bmj.38943.463565.68			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	084LD	16960213	Green Published			2022-12-28	WOS:000240533500023
J	Hamilton, SR; Davidson, RC; Sethuraman, N; Nett, JH; Jiang, YW; Rios, S; Bobrowicz, P; Stadheim, TA; Li, HJ; Choi, BK; Hopkins, D; Wischnewski, H; Roser, J; Mitchell, T; Strawbridge, RR; Hoopes, J; Wildt, S; Gerngross, TU				Hamilton, Stephen R.; Davidson, Robert C.; Sethuraman, Natarajan; Nett, Juergen H.; Jiang, Youwei; Rios, Sandra; Bobrowicz, Piotr; Stadheim, Terrance A.; Li, Huijuan; Choi, Byung-Kwon; Hopkins, Daniel; Wischnewski, Harry; Roser, Jessica; Mitchell, Teresa; Strawbridge, Rendall R.; Hoopes, Jack; Wildt, Stefan; Gerngross, Tillman U.			Humanization of yeast to produce complex terminally sialylated glycoproteins	SCIENCE			English	Article							PICHIA-PASTORIS; HUMAN-ERYTHROPOIETIN; GLYCOSYLATION	Yeast is a widely used recombinant protein expression system. We expanded its utility by engineering the yeast Pichia pastoris to secrete human glycoproteins with fully complex terminally sialylated N-glycans. After the knockout of four genes to eliminate yeast-specific glycosylation, we introduced 14 heterologous genes, allowing us to replicate the sequential steps of human glycosylation. The reported cell lines produce complex glycoproteins with greater than 90% terminal sialylation. Finally, to demonstrate the utility of these yeast strains, functional recombinant erythropoietin was produced.	GlycoFi Inc, Lebanon, NH 03766 USA; Dartmouth Hitchcock Med Ctr, Dept Surg, Lebanon, NH 03766 USA; Dartmouth Coll, Thayer Sch Engn, Dept Biol Sci, Hanover, NH 03755 USA; Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College; Dartmouth College	Gerngross, TU (corresponding author), GlycoFi Inc, 21 Lafayette St,Suite 200, Lebanon, NH 03766 USA.	tillman.gerngross@dartmouth.edu						ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; Bobrowicz P, 2004, GLYCOBIOLOGY, V14, P757, DOI 10.1093/glycob/cwh104; Choi BK, 2003, P NATL ACAD SCI USA, V100, P5022, DOI 10.1073/pnas.0931263100; DAVIS JM, 1987, BIOCHEMISTRY-US, V26, P2633, DOI 10.1021/bi00383a034; FUKUDA MN, 1989, BLOOD, V73, P84; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Hamilton SR, 2003, SCIENCE, V301, P1244, DOI 10.1126/science.1088166; LAI PH, 1986, J BIOL CHEM, V261, P3116; Li HJ, 2006, NAT BIOTECHNOL, V24, P210, DOI 10.1038/nbt1178; SPIVAK JL, 1989, BLOOD REV, V3, P130, DOI 10.1016/0268-960X(89)90008-8; STOCKERT RJ, 1995, PHYSIOL REV, V75, P591, DOI 10.1152/physrev.1995.75.3.591	11	360	446	3	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2006	313	5792					1441	1443		10.1126/science.1130256	http://dx.doi.org/10.1126/science.1130256			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16960007				2022-12-28	WOS:000240348700044
J	Lamers, MH; Georgescu, RE; Lee, SG; O'Donnell, M; Kuriyan, J				Lamers, Meindert H.; Georgescu, Roxana E.; Lee, Sang-Gyu; O'Donnell, Mike; Kuriyan, John			Crystal structure of the catalytic alpha subunit of E. coli replicative DNA polymerase III	CELL			English	Article							ESCHERICHIA-COLI; NUCLEOTIDYLTRANSFERASE SUPERFAMILY; PROCESSIVE REPLICATION; MAXIMUM-LIKELIHOOD; TERNARY COMPLEXES; ACTIVE-SITE; ERROR-PRONE; BETA; PROTEIN; HOLOENZYME	Bacterial replicative DNA polymerases such as Polymerase III (Pol III) share no sequence similarity with other polymerases. The crystal structure, determined at 2.3 angstrom resolution, of a large fragment of Pol III (residues 1-917), reveals a unique chain fold with localized similarity in the catalytic domain to DNA polymerase beta and related nucleotidyltransferases. The structure of Pol III is strikingly different from those of members of the canonical DNA polymerase families, which include eukaryotic replicative polymerases, suggesting that the DNA replication machinery in bacteria arose independently. A structural element near the active site in Pol III that is not present in nucleotidyltransferases but which resembles an element at the active sites of some canonical DNA polymerases suggests that, at a more distant level, all DNA polymerases may share a common ancestor. The structure also suggests a model for interaction of Pol III with the sliding clamp and DNA.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Rockefeller Univ, Howard Hughes Med Inst, Lab DNA Replicat, New York, NY 10021 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; Rockefeller University	Kuriyan, J (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu	Georgescu, Roxana/B-9943-2011; Lamers, Meindert/AGG-8911-2022	Lamers, Meindert/0000-0002-4205-1338	NIGMS NIH HHS [GM38839, GM45547] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038839, R37GM038839] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P17, DOI 10.1016/S0968-0004(97)01162-6; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P3746, DOI 10.1093/nar/26.16.3746; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bloom LB, 1997, J BIOL CHEM, V272, P27919, DOI 10.1074/jbc.272.44.27919; BONNER CA, 1990, P NATL ACAD SCI USA, V87, P7663, DOI 10.1073/pnas.87.19.7663; Bowman GD, 2005, FEBS LETT, V579, P863, DOI 10.1016/j.febslet.2004.11.038; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bruck I, 2003, J BIOL CHEM, V278, P44361, DOI 10.1074/jbc.M308307200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DAVIES JF, 1994, CELL, V76, P1123, DOI 10.1016/0092-8674(94)90388-3; De Saro FJL, 2003, P NATL ACAD SCI USA, V100, P14689, DOI 10.1073/pnas.2435454100; Dohrmann PR, 2005, J MOL BIOL, V350, P228, DOI 10.1016/j.jmb.2005.04.065; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EORN SH, 1996, NATURE, V382, P278; Forterre P, 2006, P NATL ACAD SCI USA, V103, P3669, DOI 10.1073/pnas.0510333103; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Garcia-Diaz M, 2004, MOL CELL, V13, P561, DOI 10.1016/S1097-2765(04)00061-9; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hopfner KP, 1999, P NATL ACAD SCI USA, V96, P3600, DOI 10.1073/pnas.96.7.3600; Huang YP, 1997, FEBS LETT, V400, P94, DOI 10.1016/S0014-5793(96)01361-0; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Leipe DD, 1999, NUCLEIC ACIDS RES, V27, P3389, DOI 10.1093/nar/27.17.3389; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; MAKI H, 1985, J BIOL CHEM, V260, P2987; Merckel MC, 2001, STRUCTURE, V9, P289, DOI 10.1016/S0969-2126(01)00587-1; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Pritchard AE, 1999, J MOL BIOL, V285, P1067, DOI 10.1006/jmbi.1998.2352; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Rodriguez AC, 2000, J MOL BIOL, V299, P447, DOI 10.1006/jmbi.2000.3728; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Stano NM, 2006, NAT STRUCT MOL BIOL, V13, P458, DOI 10.1038/nsmb1078; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; STUDWELL PS, 1990, J BIOL CHEM, V265, P1171; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Takagi H, 2004, BIOCHEM BIOPH RES CO, V319, P787, DOI 10.1016/j.bbrc.2004.05.055; Teplyakov A, 2003, PROTEINS, V51, P315, DOI 10.1002/prot.10352; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Wieczorek A, 2006, J BIOL CHEM, V281, P12561, DOI 10.1074/jbc.M513844200; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yamagata A, 2002, P NATL ACAD SCI USA, V99, P5908, DOI 10.1073/pnas.092547099; Yao N, 2000, J BIOL CHEM, V275, P11440, DOI 10.1074/jbc.275.15.11440; Zhao YX, 1999, STRUCTURE, V7, P1189, DOI 10.1016/S0969-2126(00)80053-2	62	124	124	4	30	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 8	2006	126	5					881	892		10.1016/j.cell.2006.07.028	http://dx.doi.org/10.1016/j.cell.2006.07.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959568	Bronze			2022-12-28	WOS:000240675000016
J	Warren, EH; Vigneron, NJ; Gavin, MA; Coulie, PG; Stroobant, V; Dalet, A; Tykodi, SS; Xuereb, SM; Mito, JK; Riddell, SR; Van den Eynde, BJ				Warren, Edus H.; Vigneron, Nathalie J.; Gavin, Marc A.; Coulie, Pierre G.; Stroobant, Vincent; Dalet, Alexandre; Tykodi, Scott S.; Xuereb, Suzanne M.; Mito, Jeffrey K.; Riddell, Stanley R.; Van den Eynde, Benoit J.			An antigen produced by splicing of noncontiguous peptides in the reverse order	SCIENCE			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR; PROTEASOME; ACTIVATION; PROTEIN	CD8-positive T lymphocytes recognize peptides that are usually derived from the degradation of cellular proteins and are presented by class I molecules of the major histocompatibility complex. Here we describe a human minor histocompatibility antigen created by a polymorphism in the SP110 nuclear phosphoprotein gene. The antigenic peptide comprises two noncontiguous SP110 peptide segments spliced together in reverse order to that in which they occur in the predicted SP110 protein. The antigenic peptide could be produced in vitro by incubation of precursor peptides with highly purified 20S proteasomes. Cutting and splicing probably occur within the proteasome by transpeptidation.	Ludwig Inst Canc Res, Brussels Ranch, B-1200 Brussels, Belgium; Fred Hutchinson Canc Res Ctr, Div Clin Res, Program Immunol, Seattle, WA 98109 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Catholique Louvain, Cellular Genet Unit, Inst Cellular Pathol, B-1200 Brussels, Belgium	Ludwig Institute for Cancer Research; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Universite Catholique Louvain	Van den Eynde, BJ (corresponding author), Ludwig Inst Canc Res, Brussels Ranch, B-1200 Brussels, Belgium.	benoit.vandeneynde@bru.licr.org		Warren, Edus/0000-0002-9570-2755	NCI NIH HHS [CA18029, CA106512] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA106512, P01CA018029] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bleakley M, 2004, NAT REV CANCER, V4, P371, DOI 10.1038/nrc1365; Bloch DB, 2000, MOL CELL BIOL, V20, P6138, DOI 10.1128/MCB.20.16.6138-6146.2000; Bonnett D, 1999, P NATL ACAD SCI USA, V96, P8639, DOI 10.1073/pnas.96.15.8639; DIBRINO M, 1993, P NATL ACAD SCI USA, V90, P1508, DOI 10.1073/pnas.90.4.1508; Hanada K, 2004, NATURE, V427, P252, DOI 10.1038/nature02240; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; KADEREIT S, 1993, J BIOL CHEM, V268, P24432; KUBO RT, 1994, J IMMUNOL, V152, P3913; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Vigneron N, 2004, SCIENCE, V304, P587, DOI 10.1126/science.1095522; Warren EH, 1998, BLOOD, V91, P2197, DOI 10.1182/blood.V91.6.2197; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250	16	153	161	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2006	313	5792					1444	1447		10.1126/science.1130660	http://dx.doi.org/10.1126/science.1130660			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16960008				2022-12-28	WOS:000240348700045
J	Chu, DS; Liu, HB; Nix, P; Wu, TF; Ralston, EJ; Yates, JR; Meyer, BJ				Chu, Diana S.; Liu, Hongbin; Nix, Paola; Wu, Tammy F.; Ralston, Edward J.; Yates, John R., III; Meyer, Barbara J.			Sperm chromatin proteomics identifies evolutionarily conserved fertility factors	NATURE			English	Article							DNA TOPOISOMERASE-I; CAENORHABDITIS-ELEGANS; FUNCTIONAL-ANALYSIS; SHOTGUN PROTEOMICS; SR PROTEINS; GERM-CELLS; HISTONE H1; SPERMIOGENESIS; EMBRYOGENESIS; LOCALIZATION	Male infertility is a long-standing enigma of significant medical concern. The integrity of sperm chromatin is a clinical indicator of male fertility and in vitro fertilization potential(1): chromosome aneuploidy and DNA decondensation or damage are correlated with reproductive failure. Identifying conserved proteins important for sperm chromatin structure and packaging can reveal universal causes of infertility. Here we combine proteomics, cytology and functional analysis in Caenorhabditis elegans to identify spermatogenic chromatin-associated proteins that are important for fertility. Our strategy employed multiple steps: purification of chromatin from comparable meiotic cell types, namely those undergoing spermatogenesis or oogenesis; proteomic analysis by multidimensional protein identification technology (MudPIT) of factors that co-purify with chromatin; prioritization of sperm proteins based on abundance; and subtraction of common proteins to eliminate general chromatin and meiotic factors. Our approach reduced 1,099 proteins co-purified with spermatogenic chromatin, currently the most extensive catalogue, to 132 proteins for functional analysis. Reduction of gene function through RNA interference coupled with protein localization studies revealed conserved spermatogenesis-specific proteins vital for DNA compaction, chromosome segregation, and fertility. Unexpected roles in spermatogenesis were also detected for factors involved in other processes. Our strategy to find fertility factors conserved from C. elegans to mammals achieved its goal: of mouse gene knockouts corresponding to nematode proteins, 37% (7/19) cause male sterility. Our list therefore provides significant opportunity to identify causes of male infertility and targets for male contraceptives.	San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Agilent Technol, Wilmington, DE 19808 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	California State University System; San Francisco State University; Scripps Research Institute; Agilent Technologies; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Chu, DS (corresponding author), San Francisco State Univ, Dept Biol, 1600 Holloway Ave, San Francisco, CA 94132 USA.	chud@sfsu.edu		Meyer, Barbara/0000-0002-6530-4588	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM030702-28, R01 GM030702] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030702] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal A, 2003, HUM REPROD UPDATE, V9, P331, DOI 10.1093/humupd/dmg027; Boag PR, 2003, INT J PARASITOL, V33, P313, DOI 10.1016/S0020-7519(02)00263-1; Browning H, 1996, DEVELOPMENT, V122, P391; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gruidl ME, 1996, P NATL ACAD SCI USA, V93, P13837, DOI 10.1073/pnas.93.24.13837; Hanazawa M, 2001, P NATL ACAD SCI USA, V98, P8686, DOI 10.1073/pnas.141004698; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kawano T, 2000, MECH DEVELOP, V95, P67, DOI 10.1016/S0925-4773(00)00339-7; Kimmins S, 2005, NATURE, V434, P583, DOI 10.1038/nature03368; Lee MH, 2001, GENES CELLS, V6, P303, DOI 10.1046/j.1365-2443.2001.00423.x; Lewis JD, 2004, BIOCHEMISTRY-US, V43, P7766, DOI 10.1021/bi0360455; Lewis JD, 2003, CHROMOSOMA, V111, P473, DOI 10.1007/s00412-002-0226-0; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Martianov I, 2005, P NATL ACAD SCI USA, V102, P2808, DOI 10.1073/pnas.0406060102; Moore LL, 2001, J CELL BIOL, V153, P1199, DOI 10.1083/jcb.153.6.1199; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Rogers E, 2002, J CELL BIOL, V157, P219, DOI 10.1083/jcb.200110045; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tanaka SS, 2000, GENE DEV, V14, P841; Varmuza S, 1999, DEV BIOL, V205, P98, DOI 10.1006/dbio.1998.9100; Vogt PH, 2005, REPROD BIOMED ONLINE, V10, P81, DOI 10.1016/S1472-6483(10)60807-3; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WARD S, 1982, DEV BIOL, V92, P203, DOI 10.1016/0012-1606(82)90164-6; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686	30	136	177	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2006	443	7107					101	105		10.1038/nature05050	http://dx.doi.org/10.1038/nature05050			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16943775	Green Accepted			2022-12-28	WOS:000240313900048
J	Montalescot, G; White, HD; Gallo, R; Cohen, M; Steg, PG; Aylward, PEG; Bode, C; Chiariello, M; King, SB; Harrington, RA; Desmet, WJ; Macaya, C; Steinhubl, SR				Montalescot, Gilles; White, Harvey D.; Gallo, Richard; Cohen, Marc; Steg, P. Gabriel; Aylward, Philip E. G.; Bode, Christoph; Chiariello, Massimo; King, Spencer B., III; Harrington, Robert A.; Desmet, Walter J.; Macaya, Carlos; Steinhubl, Steven R.		STEEPLE Investigators	Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MOLECULAR-WEIGHT HEPARIN; INTRAVENOUS ENOXAPARIN; MYOCARDIAL-INFARCTION; ELUTING STENTS; TASK-FORCE; EPTIFIBATIDE; ACTIVATION; GUIDELINES	Background: Despite its limitations, unfractionated heparin has been the standard anticoagulant used during percutaneous coronary intervention (PCI). Several small studies have suggested that intravenous enoxaparin may be a safe and effective alternative. Our primary aim was to assess the safety of enoxaparin as compared with that of unfractionated heparin in elective PCI. Methods: In this prospective, open-label, multicenter, randomized trial, we randomly assigned 3528 patients with PCI to receive enoxaparin (0.5 or 0.75 mg per kilogram of body weight) or unfractionated heparin adjusted for activated clotting time, stratified according to the use or nonuse of glycoprotein IIb/IIIa inhibitors. The primary end point was the incidence of major or minor bleeding that was not related to coronary-artery bypass grafting. The main secondary end point was the percentage of patients in whom the target anticoagulation levels were reached. Results: Enoxaparin at a dose of 0.5 mg per kilogram was associated with a significant reduction in the rate of non-CABG-related bleeding in the first 48 hours, as compared with unfractionated heparin (5.9% vs. 8.5%; absolute difference, -2.6; 95% confidence interval [CI], -4.7 to -0.6; P=0.01), but the higher enoxaparin dose was not (6.5% vs. 8.5%; absolute difference, -2.0; 95% CI, -4.0 to 0.0; P=0.051). The incidence of major bleeding was significantly reduced in both enoxaparin groups, as compared with the unfractionated heparin group. Target anticoagulation levels were reached in significantly more patients who received enoxaparin (0.5-mg-per-kilogram dose, 79%; 0.75-mg-per-kilogram dose, 92%) than who received unfractionated heparin (20%, P<0.001). Conclusions: In elective PCI, a single intravenous bolus of 0.5 mg of enoxaparin per kilogram is associated with reduced rates of bleeding, and a dose of 0.75 mg per kilogram yields rates similar to those for unfractionated heparin, with more predictable anticoagulation levels. The trial was not large enough to provide a definitive comparison of efficacy in the prevention of ischemic events.	Ctr Hosp Univ Pitie Salpetriere, Inst Cardiol, Bur 2 236, F-75013 Paris, France; Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland, New Zealand; Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; Newark Beth Israel Med Ctr, Div Cardiol, Newark, NJ USA; Hop Bichat Claude Bernard, Serv Cardiol, F-75877 Paris, France; Flinders Med Ctr, Dept Cardiol, Adelaide, SA, Australia; Univ Freiburg Klinikum, Abt Innere Med 3, Freiburg, Germany; Federico 2nd Univ, Div Cardiol, Naples, Italy; Piedmont Hosp, Fuqua Heart Ctr Atlanta, Atlanta, GA USA; Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA; Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium; Univ Hosp, Serv Cardiol, Madrid, Spain; Univ Kentucky, Div Cardiol, Lexington, KY USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Auckland City Hospital; Universite de Montreal; Newark Beth Israel Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Flinders Medical Centre; University of Freiburg; University of Naples Federico II; Duke University; KU Leuven; University Hospital Leuven; University of Kentucky	Montalescot, G (corresponding author), Ctr Hosp Univ Pitie Salpetriere, Inst Cardiol, Bur 2 236, 47 Blvd Hop, F-75013 Paris, France.	gilles.montalescot@psl.aphp.fr	Gallo, Richard L/A-8931-2009; STEG, Philippe Gabriel/Z-1567-2019	Gallo, Richard L/0000-0002-1401-7861; Aylward, Philip/0000-0002-5358-8552; STEG, Philippe Gabriel/0000-0001-6896-2941				Bhatt DL, 2003, J AM COLL CARDIOL, V41, P20, DOI 10.1016/S0735-1097(02)02631-1; Bijsterveld NR, 2003, J AM COLL CARDIOL, V42, P424, DOI 10.1016/S0735-1097(03)00653-3; Borentain M, 2005, CATHETER CARDIO INTE, V65, P212, DOI 10.1002/ccd.20352; Braunwald E, 1997, J AM COLL CARDIOL, V29, P1474; Chen Wai-Hong, 2002, J Invasive Cardiol, V14, P439; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; Choussat R, 2002, J AM COLL CARDIOL, V40, P1943, DOI 10.1016/S0735-1097(02)02531-7; Cohen M, 2003, J AM COLL CARDIOL, V41, p55S, DOI 10.1016/S0735-1097(02)02901-7; Collet JP, 2001, CIRCULATION, V103, P658; Dibra A, 2005, NEW ENGL J MED, V353, P663, DOI 10.1056/NEJMoa044372; DROZD J, 2001, KARDIOL POL, V55, P520; Dudek D, 2000, AM J CARDIOL, V86, p15I; Ferguson JJ, 2003, AM HEART J, V146, P628, DOI 10.1016/S0002-8703(03)00165-0; Ferguson JJ, 2004, JAMA-J AM MED ASSOC, V292, P45; Galeote G, 2001, EUR HEART J, V22, P663; Kereiakes D J, 2001, J Invasive Cardiol, V13, P272; Lincoff AM, 2003, JAMA-J AM MED ASSOC, V289, P853, DOI 10.1001/jama.289.7.853; LINCOFF AM, 2003, JAMA-J AM MED ASSOC, V289, P1638; Madan M, 2005, AM J CARDIOL, V95, P1295, DOI 10.1016/j.amjcard.2005.01.071; Miller C, 2002, J DEV PHYS DISABIL, V14, P247, DOI 10.1023/A:1016072321661; Montalescot G, 1998, CIRCULATION, V98, P294, DOI 10.1161/01.CIR.98.4.294; Montalescot G, 2004, CIRCULATION, V110, P392, DOI 10.1161/01.CIR.0000136830.65073.C7; Montalescot G, 2003, AM J CARDIOL, V91, P925, DOI 10.1016/S0002-9149(03)00105-X; Montalescot G, 2000, J AM COLL CARDIOL, V36, P110, DOI 10.1016/S0735-1097(00)00695-1; POPMA JJ, 2004, CHEST, V126, pS567; Rabah MM, 1999, AM J CARDIOL, V84, P1391, DOI 10.1016/S0002-9149(99)00582-2; Samama MM, 2000, SEMIN THROMB HEMOST, V26, P31, DOI 10.1055/s-2000-9497; Sanchez-Pena P, 2005, BRIT J CLIN PHARMACO, V60, P364, DOI 10.1111/j.1365-2125.2005.02452.x; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Smith SC, 2001, J AM COLL CARDIOL, V37, P2215, DOI 10.1016/S0735-1097(01)01344-4; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Windecker S, 2005, NEW ENGL J MED, V353, P653, DOI 10.1056/NEJMoa051175; Xiao ZH, 1998, CIRCULATION, V97, P251, DOI 10.1161/01.CIR.97.3.251	34	272	295	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 7	2006	355	10					1006	1017		10.1056/NEJMoa052711	http://dx.doi.org/10.1056/NEJMoa052711			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080UF	16957147	Bronze			2022-12-28	WOS:000240273300006
J	Endo, M				Endo, Makoto			Setsuro Ebashi (1922-2006) - Obituary	NATURE			English	Biographical-Item									Univ Tokyo, Dept Pharmacol, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Endo, M (corresponding author), Univ Tokyo, Dept Pharmacol, Bunkyo Ku, 7-3-1, Tokyo 1130033, Japan.	makoendo@gakushikai.jp							0	2	2	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 31	2006	442	7106					996	996		10.1038/442996a	http://dx.doi.org/10.1038/442996a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	078YF	16943829	Bronze			2022-12-28	WOS:000240142000038
J	Mazzali, PA; Deng, JS; Nomoto, K; Sauer, DN; Pian, E; Tominaga, N; Tanaka, M; Maeda, K; Filippenko, AV				Mazzali, Paolo A.; Deng, Jinsong; Nomoto, Ken'ichi; Sauer, Daniel N.; Pian, Elena; Tominaga, Nozomu; Tanaka, Masaomi; Maeda, Keiichi; Filippenko, Alexei V.			A neutron-star-driven X-ray flash associated with supernova SN 2006aj	NATURE			English	Article							25 APRIL 1998; LIGHT-CURVE; OFF-AXIS; BURSTS; SPECTRA; MODEL; EXPLOSIONS; GRB-030329; AFTERGLOW	Supernovae connected with long-duration gamma-ray bursts(1-3) (GRBs) are hyper-energetic explosions resulting from the collapse of very massive stars (similar to 40M(.), where M-. is the mass of the Sun) stripped of their outer hydrogen and helium envelopes(4-7). A very massive progenitor, collapsing to a black hole, was thought to be a requirement for the launch of a GRB(8). Here we report the results of modelling the spectra and light curve of SN 2006aj ( ref. 9), which demonstrate that the supernova had a much smaller explosion energy and ejected much less mass than the other GRB - supernovae, suggesting that it was produced by a star whose initial mass was only similar to 20 M-.. A star of this mass is expected to form a neutron star rather than a black hole when its core collapses. The smaller explosion energy of SN 2006aj is matched by the weakness and softness(10) of GRB 060218 ( an X-ray flash), and the weakness of the radio flux of the supernova(11). Our results indicate that the supernova - GRB connection extends to a much broader range of stellar masses than previously thought, possibly involving different physical mechanisms: a 'collapsar' ( ref. 8) for the more massive stars collapsing to a black hole, and magnetic activity of the nascent neutron star(12) for the less massive stars.	Max Planck Inst Astrophys, D-85748 Garching, Germany; CAS, Natl Astron Observ, Beijing 100012, Peoples R China; Univ Tokyo, Sch Sci, Res Ctr Early Universe, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; Osserv Astron Trieste, Ist Nazl Astrofis, I-34131 Trieste, Italy; Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; Univ Tokyo, Coll Arts & Sci, Dept Earth Sci & Astron, Meguro Ku, Tokyo 1538902, Japan; Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA	Max Planck Society; Chinese Academy of Sciences; National Astronomical Observatory, CAS; University of Tokyo; University of Tokyo; Istituto Nazionale Astrofisica (INAF); University of California System; University of California Santa Barbara; University of Tokyo; University of California System; University of California Berkeley	Mazzali, PA (corresponding author), Max Planck Inst Astrophys, Karl Schwarzschild Str 1, D-85748 Garching, Germany.	mazzali@mpa-garching.mpg.de; jsdeng@bao.ac.cn	Sauer, Daniel N/A-3033-2012	Sauer, Daniel N/0000-0002-0317-5063; Mazzali, Paolo/0000-0001-6876-8284; Tominaga, Nozomu/0000-0001-8537-3153; Pian, Elena/0000-0001-8646-4858; Maeda, Keiichi/0000-0003-2611-7269				ARNETT WD, 1982, ASTROPHYS J, V253, P785, DOI 10.1086/159681; CAMPANA S, NATURE; Deng J, 2005, ASTROPHYS J, V624, P898, DOI 10.1086/429284; Foley RJ, 2003, PUBL ASTRON SOC PAC, V115, P1220, DOI 10.1086/378242; Fryer CL, 1999, ASTROPHYS J, V526, P152, DOI 10.1086/307992; Fynbo JPU, 2004, ASTROPHYS J, V609, P962, DOI 10.1086/421260; Galama TJ, 1998, NATURE, V395, P670, DOI 10.1038/27150; Hamuy M, 2003, ASTROPHYS J, V582, P905, DOI 10.1086/344689; Hurley K, 2005, NATURE, V434, P1098, DOI 10.1038/nature03519; Iwamoto K, 1998, NATURE, V395, P672, DOI 10.1038/27155; MacFadyen AI, 1999, ASTROPHYS J, V524, P262, DOI 10.1086/307790; Maeda K, 2002, ASTROPHYS J, V565, P405, DOI 10.1086/324487; MALESANI D, 2004, APJ, V609, P5; Mazzali P. A., 2002, APJ, V572, P61; Mazzali PA, 2005, SCIENCE, V308, P1284, DOI 10.1126/science.1111384; Mazzali PA, 2003, ASTROPHYS J, V599, pL95, DOI 10.1086/381259; Mazzali PA, 2000, ASTRON ASTROPHYS, V363, P705; Mazzali PA, 2006, ASTROPHYS J, V645, P1323, DOI 10.1086/504415; Nakamura T, 1998, PROG THEOR PHYS, V100, P921, DOI 10.1143/PTP.100.921; NARAYAN R, 1992, APJ, V395, P83; Nomoto K, 2005, ASTROPHYS SPACE SCI, V298, P81, DOI 10.1007/s10509-005-3915-3; NOMOTO K, 1995, PHYS REP, V256, P173, DOI 10.1016/0370-1573(94)00107-E; NOMOTO K, 1994, NATURE, V371, P227, DOI 10.1038/371227a0; PIAN E, NATURE; SODERBERG AM, NATURE; Stanek KZ, 2003, ASTROPHYS J, V591, pL17, DOI 10.1086/376976; THOMPSON C, 1995, MON NOT R ASTRON SOC, V275, P255, DOI 10.1093/mnras/275.2.255; Thompson TA, 2004, ASTROPHYS J, V611, P380, DOI 10.1086/421969; Tominaga N, 2005, ASTROPHYS J, V633, pL97, DOI 10.1086/498570; Tominaga N, 2004, ASTROPHYS J, V612, pL105, DOI 10.1086/424841	30	257	259	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 31	2006	442	7106					1018	1020		10.1038/nature05081	http://dx.doi.org/10.1038/nature05081			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	078YF	16943833				2022-12-28	WOS:000240142000044
J	Sjoblom, T; Jones, S; Wood, LD; Parsons, DW; Lin, J; Barber, TD; Mandelker, D; Leary, RJ; Ptak, J; Silliman, N; Szabo, S; Buckhaults, P; Farrell, C; Meeh, P; Markowitz, SD; Willis, J; Dawson, D; Willson, JKV; Gazdar, AF; Hartigan, J; Wu, L; Liu, CS; Parmigiani, G; Park, BH; Bachman, KE; Papadopoulos, N; Vogelstein, B; Kinzler, KW; Velculescu, VE				Sjoeblom, Tobias; Jones, Sian; Wood, Laura D.; Parsons, D. Williams; Lin, Jimmy; Barber, Thomas D.; Mandelker, Diana; Leary, Rebecca J.; Ptak, Janine; Silliman, Natalie; Szabo, Steve; Buckhaults, Phillip; Farrell, Christopher; Meeh, Paul; Markowitz, Sanford D.; Willis, Joseph; Dawson, Dawn; Willson, James K. V.; Gazdar, Adi F.; Hartigan, James; Wu, Leo; Liu, Changsheng; Parmigiani, Giovanni; Park, Ben Ho; Bachman, Kurtis E.; Papadopoulos, Nickolas; Vogelstein, Bert; Kinzler, Kenneth W.; Velculescu, Victor E.			The consensus coding sequences of human breast and colorectal cancers	SCIENCE			English	Article							MUTATIONAL ANALYSIS; SOMATIC MUTATIONS; GENE FAMILY; PROTEIN; RECEPTOR; IDENTIFICATION; TRANSLOCATION; INACTIVATION; TRANSCRIPTS; PREVALENCE	The elucidation of the human genome sequence has made it possible to identify genetic alterations in cancers in unprecedented detail. To begin a systematic analysis of such alterations, we determined the sequence of well-annotated human protein-coding genes in two common tumor types. Analysis of 13,023 genes in 11 breast and 11 colorectal cancers revealed that individual tumors accumulate an average of similar to 90 mutant genes but that only a subset of these contribute to the neoplastic process. Using stringent criteria to delineate this subset, we identified 189 genes ( average of 11 per tumor) that were mutated at significant frequency. The vast majority of these genes were not known to be genetically altered in tumors and are predicted to affect a wide range of cellular functions, including transcription, adhesion, and invasion. These data define the genetic landscape of two human cancer types, provide new targets for diagnostic and therapeutic intervention, and open fertile avenues for basic research in tumor biology.	Johns Hopkins, Ludwig Ctr, Baltimore, MD 21231 USA; Johns Hopkins, Howard Hughes Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; Univ S Carolina, Sch Med, S Carolina Canc Ctr, Div Basic Res, Columbia, SC 29229 USA; Univ S Carolina, Sch Med, Ctr Colon Canc Res, Dept Pathol & Microbiol, Columbia, SC 29229 USA; Case Western Reserve Univ, Ireland Canc Ctr, Dept Med, Cleveland, OH 44106 USA; Case Western Reserve Univ, Howard Hughes Med Inst, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; Univ Texas, SW Med Ctr, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol & Res, Dallas, TX 75390 USA; Agencourt Biosci Corp, Beverly, MA 01915 USA; SoftGenet LLC, State Coll, PA 16803 USA; Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Biostat, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; Univ Maryland, Sch Med, Dept Radiat Oncol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Case Western Reserve University; Case Western Reserve University; Howard Hughes Medical Institute; University Hospitals of Cleveland; Case Western Reserve University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Vogelstein, B (corresponding author), Johns Hopkins, Ludwig Ctr, Baltimore, MD 21231 USA.	vogelbe@jhmi.edu; kinzlke@jhmi.edu; velculescu@jhmi.edu	Velculescu, Victor/ABF-4846-2020; Jones, Sian/A-5050-2012; Papadopoulos, Nickolas/K-7272-2012; Wood, Laura/ABF-1531-2020	Velculescu, Victor/0000-0003-1195-438X; Parsons, Donald/0000-0002-8775-3501; Edsall, Lee Elizabeth/0000-0002-0326-2829	NATIONAL CANCER INSTITUTE [R01CA121113, R01CA057345, R01CA043460, R37CA043460, P50CA062924, R37CA057345, R01CA109274, P30CA043703, R55CA109274] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017698] Funding Source: NIH RePORTER; NCI NIH HHS [CA109274, CA 62924, CA 121113, P30-CA43703, CA 57345, CA 43460] Funding Source: Medline; NCRR NIH HHS [RR 017698] Funding Source: Medline; NIGMS NIH HHS [GM 07309] Funding Source: Medline; PHS HHS [HHSN261200433002C] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Arai Y, 1997, BLOOD, V89, P3936, DOI 10.1182/blood.V89.11.3936; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Bardelli A, 2005, CURR OPIN GENET DEV, V15, P5, DOI 10.1016/j.gde.2004.12.009; Bluteau O, 2002, NAT GENET, V32, P312, DOI 10.1038/ng1001; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Brent R, 2000, CELL, V100, P169, DOI 10.1016/S0092-8674(00)81693-1; *CCDS, CCDS DAT; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Duval A, 1999, CANCER RES, V59, P4213; Eppert K, 1996, CELL, V86, P543, DOI 10.1016/S0092-8674(00)80128-2; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Greenman C, 2006, GENETICS, V173, P2187, DOI 10.1534/genetics.105.044677; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Kern SE, 2006, CANCER BIOL THER, V5, P349, DOI 10.4161/cbt.5.4.2551; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Ku JL, 2007, CANCER LETT, V247, P283, DOI 10.1016/j.canlet.2006.05.008; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Loeb LA, 2001, CANCER RES, V61, P3230; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Olivier Magali, 2004, IARC Sci Publ, P247; Onishi Y, 2003, CLIN EXP METASTAS, V20, P51, DOI 10.1023/A:1022594503657; Ooi SL, 2006, TRENDS GENET, V22, P56, DOI 10.1016/j.tig.2005.11.003; OWENS AH, 1982, TUMOR CELL HETEROGEN, P441; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Riggins GJ, 1996, NAT GENET, V13, P347, DOI 10.1038/ng0796-347; Rogers YH, 2005, NATURE, V437, P326, DOI 10.1038/437326a; Ruault M, 2002, GENE, V284, P73, DOI 10.1016/S0378-1119(02)00392-X; Salassidis K, 2000, CANCER RES, V60, P2786; Sasaki A, 2001, J BIOL CHEM, V276, P17871, DOI 10.1074/jbc.M008422200; Sato M, 2005, GENE CHROMOSOME CANC, V44, P405, DOI 10.1002/gcc.20253; SHEN DW, UNPUB; Soussi T, 2005, BIOCHEM BIOPH RES CO, V331, P834, DOI 10.1016/j.bbrc.2005.03.190; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; TANAKA M, 1995, CANCER RES, V55, P3228; Tang XX, 1999, CLIN CANCER RES, V5, P455; The Cancer Genome Atlas, CANC GENOME ATLAS; Varmus H, 2006, SCIENCE, V312, P1162, DOI 10.1126/science.1126758; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Vogelstein B., 2002, GENETIC BASIS HUMAN; Wang TL, 2002, P NATL ACAD SCI USA, V99, P3076, DOI 10.1073/pnas.261714699; Wang ZH, 2004, CANCER RES, V64, P2998, DOI 10.1158/0008-5472.CAN-04-0587	47	2648	3720	4	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2006	314	5797					268	274		10.1126/science.1133427	http://dx.doi.org/10.1126/science.1133427			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093TV	16959974				2022-12-28	WOS:000241194100033
J	Bardia, A; Rao, RD				Bardia, Aditya; Rao, Ravi D.			Intratracheal melanoma metastases	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Bardia, A (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	rao.ravi@mayo.edu							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2006	355	13					1357	1357		10.1056/NEJMicm053976	http://dx.doi.org/10.1056/NEJMicm053976			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088EF	17005953				2022-12-28	WOS:000240793600010
J	Balmana, J; Stockwell, DH; Steyerberg, EW; Stoffel, EM; Deffenbaugh, AM; Reid, JE; Ward, B; Scholl, T; Hendrickson, B; Tazelaar, J; Burbidge, LA; Syngal, S				Balmana, Judith; Stockwell, David H.; Steyerberg, Ewout W.; Stoffel, Elena M.; Deffenbaugh, Amie M.; Reid, Julia E.; Ward, Brian; Scholl, Thomas; Hendrickson, Brant; Tazelaar, John; Burbidge, Lynn Anne; Syngal, Sapna			Prediction of MLH1 and MSH2 mutations in Lynch syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; DNA MISMATCH-REPAIR; REVISED BETHESDA GUIDELINES; FAMILY-HISTORY; MICROSATELLITE INSTABILITY; CARRIER PROBABILITIES; AMSTERDAM CRITERIA; GENE-MUTATIONS; BREAST-CANCER; IMMUNOHISTOCHEMISTRY	Context Lynch syndrome is caused primarily by mutations in the mismatch repair genes MLH1 and MSH2. Objectives To analyze MLH1/MSH2 mutation prevalence in a large cohort of patients undergoing genetic testing and to develop a clinical model to predict the likelihood of finding a mutation in at-risk patients. Design, Setting, and Participants Personal and family history were obtained for 1914 unrelated probands who submitted blood samples starting in the year 2000 for full gene sequencing of MLH1/MSH2. Genetic analysis was performed using a combination of sequence analysis and Southern blotting. A multivariable model was developed using logistic regression in an initial cohort of 898 individuals and subsequently prospectively validated in 1016 patients. The complex model that we have named PREMM1,2 (Prediction of Mutations in MLH1 and MSH2) was developed into a Web-based tool that incorporates personal and family history of cancer and adenomas. Main Outcome Measure Deleterious mutations in MLH1/MSH2 genes. Results Overall, 14.5% of the probands (130/898) carried a pathogenic mutation (MLH1, 6.5%; MSH2, 8.0%) in the development cohort and 15.3% (155/1016) in the validation cohort, with 42 (27%) of the latter being large rearrangements. Strong predictors of mutations included proband characteristics (presence of colorectal cancer, especially >= 2 separate diagnoses, or endometrial cancer) and family history (especially the number of first-degree relatives with colorectal or endometrial cancer). Age at diagnosis was particularly important for colorectal cancer. The multivariable model discriminated well at external validation, with an area under the receiver operating characteristic curve of 0.80 (95% confidence interval, 0.76-0.84). Conclusions Personal and family history characteristics can accurately predict the outcome of genetic testing in a large population at risk of Lynch syndrome. The PREMM1,2 model provides clinicians with an objective, easy-to-use tool to estimate the likelihood of finding mutations in the MLH1/MSH2 genes and may guide the strategy for molecular evaluation.	Dana Farber Canc Inst, Div Populat Sci, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Erasmus MC, Dept Publ Hlth, Ctr Med Decis Making, Rotterdam, Netherlands; Myriad Genet Labs Inc, Salt Lake City, UT USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Erasmus University Rotterdam; Erasmus MC; Myriad Genetics, Inc	Syngal, S (corresponding author), Dana Farber Canc Inst, Div Populat Sci, 44 Binney St, Boston, MA 02115 USA.	ssyngal@partners.org	Califano, Andrea/F-7239-2012; Steyerberg, Ewout/C-1509-2018	Steyerberg, Ewout/0000-0002-7787-0122; Balmana, Judith/0000-0002-0762-6415	NATIONAL CANCER INSTITUTE [K24CA113433] Funding Source: NIH RePORTER; NCI NIH HHS [K24 CA 113433] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; AITKEN J, 1995, AM J EPIDEMIOL, V141, P863, DOI 10.1093/oxfordjournals.aje.a117522; Barnetson RA, 2006, NEW ENGL J MED, V354, P2751, DOI 10.1056/NEJMoa053493; Bellacosa A, 1996, AM J MED GENET, V62, P353, DOI 10.1002/(SICI)1096-8628(19960424)62:4<353::AID-AJMG7>3.0.CO;2-S; Chung DC, 2003, ANN INTERN MED, V138, P560, DOI 10.7326/0003-4819-138-7-200304010-00012; Couch FJ, 1997, NEW ENGL J MED, V336, P1409, DOI 10.1056/NEJM199705153362002; Giardiello FM, 2001, GASTROENTEROLOGY, V121, P198, DOI 10.1053/gast.2001.25581; Hampel H, 2005, NEW ENGL J MED, V352, P1851, DOI 10.1056/NEJMoa043146; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; Kerber RA, 1997, AM J EPIDEMIOL, V146, P244; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Lipton LR, 2004, J CLIN ONCOL, V22, P4934, DOI 10.1200/JCO.2004.11.084; Lynch HT, 1999, J MED GENET, V36, P801; Marroni F, 2006, CLIN GENET, V69, P254, DOI 10.1111/j.1399-0004.2006.00577.x; Mitchell RJ, 2004, GUT, V53, P291, DOI 10.1136/gut.2003.027896; Miyaki M, 1997, NAT GENET, V17, P271, DOI 10.1038/ng1197-271; Murff HJ, 2004, JAMA-J AM MED ASSOC, V292, P1480, DOI 10.1001/jama.292.12.1480; NystromLahti M, 1996, HUM MOL GENET, V5, P763, DOI 10.1093/hmg/5.6.763; Parmigiani G, 1998, AM J HUM GENET, V62, P145, DOI 10.1086/301670; Pinol V, 2005, JAMA-J AM MED ASSOC, V293, P1986, DOI 10.1001/jama.293.16.1986; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; Southey MC, 2005, J CLIN ONCOL, V23, P6524, DOI 10.1200/JCO.2005.04.671; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Stormorken AT, 2005, J CLIN ONCOL, V23, P4705, DOI 10.1200/JCO.2005.05.180; Terdiman JP, 2005, GASTROENTEROLOGY, V129, P741, DOI 10.1016/j.gastro.2005.06.033; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Wagner A, 2003, AM J HUM GENET, V72, P1088, DOI 10.1086/373963; Wang Q, 1999, HUM GENET, V105, P79, DOI 10.1007/s004390051067; Wijnen J, 1997, AM J HUM GENET, V61, P329, DOI 10.1086/514847; WLJNEN JT, 1998, NEW ENGL J MED, V339, P511	32	131	133	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2006	296	12					1469	1478		10.1001/jama.296.12.1469	http://dx.doi.org/10.1001/jama.296.12.1469			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087VD	17003395				2022-12-28	WOS:000240770000023
J	Albright, RA; Ibar, JLV; Kim, CU; Gruner, SM; Morais-Cabral, JH				Albright, Ronald A.; Ibar, Jose-Luis Vaquez; Kim, Chae Un; Gruner, Soi M.; Morais-Cabral, Joao Henrique			The RCK domain of the KtrAB K+ transporter: Multiple conformations of an octameric ring	CELL			English	Article							ESCHERICHIA-COLI; VIBRIO-ALGINOLYTICUS; POTASSIUM CHANNEL; UPTAKE SYSTEM; SELECTIVITY; SEQUENCE; BINDING; NA+	The KtrAB ion transporter is a complex of the KtrB membrane protein and KtrA, an RCK domain. RCK domains regulate eukaryotic and prokaryotic membrane proteins involved in K+ transport. Conflicting functional models have proposed two different oligomeric arrangements for RCK domains, tetramer versus octamer. Our results for the KtrAB RCK domain clearly show an octamer in solution and in the crystal. We determined the structure of this protein in three different octameric ring conformations that resemble the RCK-domain octamer observed in the MthK potassium channel but show striking differences in size and symmetry. We present experimental evidence for the association between one RCK octameric ring and two KtrB membrane proteins. These results provide insights into the quaternary organization of the KtrAB transporter and its mechanism of activation and show that the RCK-domain octameric ring model is generally applicable to other ion-transport systems.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Cornell Univ, Cornell High Energy Synchrotron Source, Ithaca, NY 14853 USA; Cornell Univ, Dept Phys, Ithaca, NY 14853 USA	Yale University; Cornell University; Cornell University	Morais-Cabral, JH (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA.	joao.cabral@yale.edu	Morais-Cabral, Joao H/J-4914-2013; Gruner, Sol/G-2924-2010; Vazquez-Ibar, Jose-Luis/AAD-8827-2021; Kim, Chae Un/D-2956-2014	Morais-Cabral, Joao H/0000-0002-4461-9716; Gruner, Sol/0000-0002-1171-4426; Vazquez-Ibar, Jose-Luis/0000-0002-8314-3378; 	NIGMS NIH HHS [GM 068585] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068585] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARAKAWA T, 1992, ANAL BIOCHEM, V203, P53, DOI 10.1016/0003-2697(92)90042-6; Bellamacina CR, 1996, FASEB J, V10, P1257, DOI 10.1096/fasebj.10.11.8836039; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Canonaco F, 2003, BIOTECHNOL LETT, V25, P1013, DOI 10.1023/A:1024172518062; Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030; Dong JB, 2005, J BIOL CHEM, V280, P41716, DOI 10.1074/jbc.M508144200; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 1999, BIOPHYS J, V77, P775, DOI 10.1016/S0006-3495(99)76931-6; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Folta-Stogniew Ewa, 2006, V328, P97; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; HAYASHI Y, 1989, METHOD ENZYMOL, V172, P514; Jensen PR, 1999, EUR J BIOCHEM, V266, P865; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim CU, 2005, ACTA CRYSTALLOGR D, V61, P881, DOI 10.1107/S090744490500836X; Kuo MMC, 2005, FEMS MICROBIOL REV, V29, P961, DOI 10.1016/j.femsre.2005.03.003; Loukin SH, 2005, J GEN PHYSIOL, V125, P521, DOI 10.1085/jgp.200509261; Matsuda N, 2004, J BIOL CHEM, V279, P54952, DOI 10.1074/jbc.M407268200; MUNRO AW, 1991, MOL MICROBIOL, V5, P607, DOI 10.1111/j.1365-2958.1991.tb00731.x; Nakamura T, 1998, J BACTERIOL, V180, P3491, DOI 10.1128/JB.180.13.3491-3494.1998; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SCHLOSSER A, 1993, MOL MICROBIOL, V9, P533, DOI 10.1111/j.1365-2958.1993.tb01714.x; Tholema N, 2005, J BIOL CHEM, V280, P41146, DOI 10.1074/jbc.M507647200; Tholema N, 1999, FEBS LETT, V450, P217, DOI 10.1016/S0014-5793(99)00504-9; Ye S, 2006, CELL, V126, P1161, DOI 10.1016/j.cell.2006.08.029; Yernool D, 2003, BIOCHEMISTRY-US, V42, P12981, DOI 10.1021/bi030161q	30	70	72	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 22	2006	126	6					1147	1159		10.1016/j.cell.2006.08.028	http://dx.doi.org/10.1016/j.cell.2006.08.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990138	Bronze			2022-12-28	WOS:000240897600020
J	Balanya, J; Oller, JM; Huey, RB; Gilchrist, GW; Serra, L				Balanya, Joan; Oller, Josep M.; Huey, Raymond B.; Gilchrist, George W.; Serra, Luis			Global genetic change tracks global climate warming in Drosophila subobscura	SCIENCE			English	Article							CHROMOSOMAL-INVERSION POLYMORPHISM; LONG-TERM CHANGES; RAPID EVOLUTION; POPULATIONS; COLONIZATION; CLINES; PSEUDOOBSCURA; FREQUENCIES; AMERICA; PATTERN	Comparisons of recent with historical samples of chromosome inversion frequencies provide opportunities to determine whether genetic change is tracking climate change in natural populations. We determined the magnitude and direction of shifts over time (24 years between samples on average) in chromosome inversion frequencies and in ambient temperature for populations of the fly Drosophila subobscura on three continents. In 22 of 26 populations, climates warmed over the intervals, and genotypes characteristic of low latitudes (warm climates) increased in frequency in 21 of those 22 populations. Thus, genetic change in this fly is tracking climate warming and is doing so globally.	Univ Barcelona, Fac Biol, Dept Genet, E-08071 Barcelona, Spain; Univ Barcelona, Fac Biol, Dept Stat, E-08071 Barcelona, Spain; Univ Washington, Dept Biol, Seattle, WA 98195 USA; Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA	University of Barcelona; University of Barcelona; University of Washington; University of Washington Seattle; William & Mary	Balanya, J (corresponding author), Univ Barcelona, Fac Biol, Dept Genet, Diagonal 645, E-08071 Barcelona, Spain.	jbalanya@ub.edu	Oller, JM/G-4284-2015; /A-8683-2008; Huey, Raymond/F-1597-2010	Oller, JM/0000-0002-9643-4406; /0000-0002-8236-4101; Huey, Raymond/0000-0002-4962-8670				ANDERSON WW, 1991, P NATL ACAD SCI USA, V88, P10367, DOI 10.1073/pnas.88.22.10367; AYALA FJ, 1989, GENOME, V31, P246, DOI 10.1139/g89-042; Balanya J, 2004, J ZOOL SYST EVOL RES, V42, P191, DOI 10.1111/j.1439-0469.2004.00274.x; Balanya J, 2003, EVOLUTION, V57, P1837; BECKENBACH AT, 1986, AM MIDL NAT, V115, P10, DOI 10.2307/2425832; Bradshaw WE, 2001, P NATL ACAD SCI USA, V98, P14509, DOI 10.1073/pnas.241391498; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; BRNCIC D, 1981, GENETICA, V56, P3; Brncic D, 1980, DROSOPHILA INF SERV, V55, P20; COYNE JA, 1992, EVOLUTION, V46, P1558, DOI 10.1111/j.1558-5646.1992.tb01146.x; de Jong PW, 1998, P ROY SOC B-BIOL SCI, V265, P39, DOI 10.1098/rspb.1998.0261; DOBZHANSKY T, 1944, CARNEGIE I WASH PUBL, V554; Gilchrist GW, 2001, GENETICA, V112, P273, DOI 10.1023/A:1013358931816; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Kinnison MT, 2001, GENETICA, V112, P145, DOI 10.1023/A:1013375419520; Krimbas CB., 1993, DROSOPHILA SUBOBSCUR; Levitan M, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-4; Lovejoy TE, 2006, CLIMATE CHANGE BIODI; MENOZZI P, 1992, J EVOLUTION BIOL, V5, P625, DOI 10.1046/j.1420-9101.1992.5040625.x; Orengo DJ, 1996, EVOLUTION, V50, P1346, DOI 10.1111/j.1558-5646.1996.tb02376.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pascual M, 2001, MOL BIOL EVOL, V18, P731, DOI 10.1093/oxfordjournals.molbev.a003855; PREVOSTI A, 1985, EVOLUTION, V39, P838, DOI 10.1111/j.1558-5646.1985.tb00425.x; PREVOSTI A, 1964, GENET RES, V5, P27, DOI 10.1017/S0016672300001002; PREVOSTI A, 1988, P NATL ACAD SCI USA, V85, P5597, DOI 10.1073/pnas.85.15.5597; RODRIGUEZTRELLES F, 1998, CONSERV ECOL, V2; Santos M, 2005, AM NAT, V165, P258, DOI 10.1086/427093; Sole E, 2002, EVOLUTION, V56, P830, DOI 10.1111/j.0014-3820.2002.tb01393.x; Umina PA, 2005, SCIENCE, V308, P691, DOI 10.1126/science.1109523	29	252	263	1	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2006	313	5794					1773	1775		10.1126/science.1131002	http://dx.doi.org/10.1126/science.1131002			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16946033				2022-12-28	WOS:000240655700045
J	Gurcel, L; Abrami, L; Girardin, S; Tschopp, J; van der Goot, FG				Gurcel, Laure; Abrami, Laurence; Girardin, Stephen; Tschopp, Jurg; van der Goot, F. Gisou			Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival	CELL			English	Article							ELEMENT-BINDING PROTEINS; AEROMONAS-HYDROPHILA; CYTOTOXIC ENTEROTOXIN; ALPHA-TOXIN; GENE-EXPRESSION; INTERLEUKIN-1-BETA; RECEPTOR; CHOLESTEROL; SECRETION; AEROLYSIN	Many pathogenic organisms produce pore-forming toxins as virulence factors. Target cells however mount a response to such membrane damage. Here we show that toxin-induced membrane permeabilization leads to a decrease in cytoplasmic potassium, which promotes the formation of a multiprotein oligomeric innate immune complex, called the inflammasome, and the activation of caspase-1. Further, we find that when rendered proteolytic in this context caspase-1 induces the activation of the central regulators of membrane biogenesis, the Sterol Regulatory Element Binding Proteins (SREBPs), which in turn promote cell survival upon toxin challenge possibly by facilitating membrane repair. This study highlights that, in addition to its well-established role in triggering inflammation via the processing of the precursor forms of interleukins, caspase-1 has a broader role, in particular linking the intracellular ion composition to lipid metabolic pathways, membrane biogenesis, and survival.	Univ Geneva, Dept Microbiol & Mol Med, CH-1211 Geneva 4, Switzerland; Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland; Inst Pasteur, F-75724 Paris, France; Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; Ecole Polytech Fed Lausanne, Inst Global Hlth, CH-1015 Lausanne, Switzerland	University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	van der Goot, FG (corresponding author), Univ Geneva, Dept Microbiol & Mol Med, 1 Rue Servet, CH-1211 Geneva 4, Switzerland.	gisou.vandergoot@epfl.ch	van der Goot, Gisou G/B-2279-2012	van der Goot, Gisou G/0000-0002-8522-274X; ABRAMI, laurence/0000-0002-1774-0481				Abrami L, 2000, TRENDS MICROBIOL, V8, P168, DOI 10.1016/S0966-842X(00)01722-4; Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; Abrami L, 1999, J CELL BIOL, V147, P175, DOI 10.1083/jcb.147.1.175; Bantel H, 2001, J CELL BIOL, V155, P637, DOI 10.1083/jcb.200105081; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; BUCKLEY JT, 1990, BIOCHEM CELL BIOL, V68, P221, DOI 10.1139/o90-029; Castoreno AB, 2005, P NATL ACAD SCI USA, V102, P13129, DOI 10.1073/pnas.0506716102; CHAKRABORTY T, 1987, INFECT IMMUN, V55, P2274, DOI 10.1128/IAI.55.9.2274-2280.1987; Chamaillard M, 2003, CELL MICROBIOL, V5, P581, DOI 10.1046/j.1462-5822.2003.00304.x; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; Demoulin JB, 2004, J BIOL CHEM, V279, P35392, DOI 10.1074/jbc.M405924200; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Fantuzzi G, 1999, J CLIN IMMUNOL, V19, P1, DOI 10.1023/A:1020506300324; Fickl H, 2005, CLIN EXP IMMUNOL, V140, P274, DOI 10.1111/j.1365-2249.2005.02757.x; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Galindo CL, 2004, J BIOL CHEM, V279, P37597, DOI 10.1074/jbc.M404641200; Galindo CL, 2004, INFECT IMMUN, V72, P5439, DOI 10.1128/IAI.72.9.5439-5445.2004; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Horton JD, 1999, CURR OPIN LIPIDOL, V10, P143, DOI 10.1097/00041433-199904000-00008; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Kornmann B, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.11.e51; Krause KH, 1998, J BIOL CHEM, V273, P18122, DOI 10.1074/jbc.273.29.18122; Lee JN, 2004, J BIOL CHEM, V279, P45257, DOI 10.1074/jbc.M408235200; Logette E, 2005, BBA-MOL CELL BIOL L, V1738, P1, DOI 10.1016/j.bbalip.2005.11.006; Logette E, 2005, MOL CELL BIOL, V25, P9621, DOI 10.1128/MCB.25.21.9621-9631.2005; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Mota LJ, 2005, FEMS MICROBIOL LETT, V252, P1, DOI 10.1016/j.femsle.2005.08.036; Nadeau KJ, 2004, J BIOL CHEM, V279, P34380, DOI 10.1074/jbc.M403596200; Nelson KL, 1999, CELL MICROBIOL, V1, P69, DOI 10.1046/j.1462-5822.1999.00009.x; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Ratner AJ, 2006, J BIOL CHEM, V281, P12994, DOI 10.1074/jbc.M511431200; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Rawson RB, 1998, J BIOL CHEM, V273, P28261, DOI 10.1074/jbc.273.43.28261; Ribardo DA, 2002, MICROB PATHOGENESIS, V32, P149, DOI 10.1006/mpat.2001.0490; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tsitrin Y, 2002, NAT STRUCT BIOL, V9, P729, DOI 10.1038/nsb839; VecseySemjen B, 1996, J BIOL CHEM, V271, P8655, DOI 10.1074/jbc.271.15.8655; WALEV I, 1995, EMBO J, V14, P1607, DOI 10.1002/j.1460-2075.1995.tb07149.x; WALEV I, 1994, MICROB PATHOGENESIS, V17, P187, DOI 10.1006/mpat.1994.1065; Walev I, 2001, P NATL ACAD SCI USA, V98, P3185, DOI 10.1073/pnas.051429498; Walev I, 2000, J IMMUNOL, V164, P5120, DOI 10.4049/jimmunol.164.10.5120; Wang H, 2001, J NEUROCHEM, V77, P53; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; [No title captured]; [No title captured]; [No title captured]	56	410	421	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 22	2006	126	6					1135	1145		10.1016/j.cell.2006.07.033	http://dx.doi.org/10.1016/j.cell.2006.07.033			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990137	Bronze			2022-12-28	WOS:000240897600019
J	Salehi-Ashtiani, K; Luptak, A; Litovchick, A; Szostak, JW				Salehi-Ashtiani, Kourosh; Luptak, Andrej; Litovchick, Alexander; Szostak, Jack W.			A genomewide search for ribozymes reveals an HDV-like sequence in the human CPEB3 gene	SCIENCE			English	Article							HEPATITIS-DELTA-VIRUS; IN-VITRO SELECTION; SELF-CLEAVAGE; MESSENGER-RNA; NEURONAL ISOFORM; TRANSCRIPTION; CATALYSIS; SITE; HAMMERHEAD; EXPRESSION	Ribozymes are thought to have played a pivotal role in the early evolution of life, but relatively few have been identified in modern organisms. We performed an in vitro selection aimed at isolating self-cleaving RNAs from the human genome. The selection yielded several ribozymes, one of which is a conserved mammalian sequence that resides in an intron of the CPEB3 gene, which belongs to a family of genes regulating messenger RNA polyadenylation. The CPEB3 ribozyme is structurally and biochemically related to the human hepatitis delta virus (HDV) ribozymes. The occurrence of this ribozyme exclusively in mammals suggests that it may have evolved as recently as 200 million years ago. We postulate that HDV arose from the human transcriptome.	Massachusetts Gen Hosp, Dept Mol Biol, Howard Hughes Med Inst, Boston, MA 02114 USA; Massachusetts Gen Hosp, CCIB, Simches Res Ctr 7215, Boston, MA 02114 USA; Dana Farber Canc Inst, CCSB, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Szostak, JW (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Howard Hughes Med Inst, 185 Cambridge St, Boston, MA 02114 USA.	szostak@molbio.mgh.harvard.edu		Salehi-Ashtiani, Kourosh/0000-0002-6521-5243	NHLBI NIH HHS [HL66678] Funding Source: Medline; NIGMS NIH HHS [GM53936] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053936] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Brazas R, 1996, SCIENCE, V274, P90, DOI 10.1126/science.274.5284.90; CHRISTIAN EL, 1992, J MOL BIOL, V228, P743, DOI 10.1016/0022-2836(92)90861-D; Das SR, 2005, NAT CHEM BIOL, V1, P45, DOI 10.1038/nchembio703; Daubendiek SL, 1997, NAT BIOTECHNOL, V15, P273, DOI 10.1038/nbt0397-273; Fedor MJ, 2005, NAT REV MOL CELL BIO, V6, P399, DOI 10.1038/nrm1647; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; FORSTER AC, 1987, CELL, V50, P9, DOI 10.1016/0092-8674(87)90657-X; Gesteland R.F., 2006, RNA WORLD NATURE MOD, V3rd; HAMPEL A, 1989, BIOCHEMISTRY-US, V28, P4929, DOI 10.1021/bi00438a002; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Huang YS, 2004, CURR OPIN CELL BIOL, V16, P308, DOI 10.1016/j.ceb.2004.03.002; Ke AL, 2004, NATURE, V429, P201, DOI 10.1038/nature02522; KUO MYP, 1988, J VIROL, V62, P4439, DOI 10.1128/JVI.62.12.4439-4444.1988; Legiewicz M, 2006, NUCLEIC ACIDS RES, V34, P1270, DOI 10.1093/nar/gkl018; Murray JB, 1998, CHEM BIOL, V5, P587, DOI 10.1016/S1074-5521(98)90116-8; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; Nakano S, 2000, SCIENCE, V287, P1493, DOI 10.1126/science.287.5457.1493; Nehdi A, 2006, NUCLEIC ACIDS RES, V34, P584, DOI 10.1093/nar/gkj463; Nielsen H, 2005, SCIENCE, V309, P1584, DOI 10.1126/science.1113645; Perrotta AT, 1999, SCIENCE, V286, P123, DOI 10.1126/science.286.5437.123; Prabhu NS, 1997, NUCLEIC ACIDS RES, V25, P5119, DOI 10.1093/nar/25.24.5119; Rosenstein SP, 1996, BIOCHEMISTRY-US, V35, P11403, DOI 10.1021/bi9609984; Salehi-Ashtiani K, 2001, NATURE, V414, P82, DOI 10.1038/35102081; SAVILLE BJ, 1990, CELL, V61, P685, DOI 10.1016/0092-8674(90)90480-3; SHARMEEN L, 1988, J VIROL, V62, P2674, DOI 10.1128/JVI.62.8.2674-2679.1988; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Teixeira A, 2004, NATURE, V432, P526, DOI 10.1038/nature03032; Theis M, 2003, P NATL ACAD SCI USA, V100, P9602, DOI 10.1073/pnas.1133424100; UCKER DS, 1984, J BIOL CHEM, V259, P7416; Wadkins TS, 1999, RNA, V5, P720, DOI 10.1017/S1355838299990209; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362	34	198	210	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2006	313	5794					1788	1792		10.1126/science.1129308	http://dx.doi.org/10.1126/science.1129308			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990549				2022-12-28	WOS:000240655700049
J	Nakamura, N; Fujita, T; Nakamura, M; Shimada, M; Kurnasaka, R; Murakami, R; Osawa, H; Yamabe, H; Okumura, K				Nakamura, Norio; Fujita, Takeshi; Nakamura, Masayuki; Shimada, Michiko; Kurnasaka, Ryuichiro; Murakami, Reiichi; Osawa, Hiroshi; Yamabe, Hideaki; Okumura, Ken			Systemic lupus erythematosus and blood type	LANCET			English	Editorial Material									Hirosaki Univ, Sch Med, Dept Nephrol, Hirosaki, Aomori 0368562, Japan	Hirosaki University	Nakamura, N (corresponding author), Hirosaki Univ, Sch Med, Dept Nephrol, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	nnakamur@r2.dion.ne.jp							0	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 16	2006	368	9540					1022	1022		10.1016/S0140-6736(06)69417-8	http://dx.doi.org/10.1016/S0140-6736(06)69417-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	086UO	16980118	Bronze			2022-12-28	WOS:000240698700031
J	Gilijamse, JJ; Hoekstra, S; van de Meerakker, SYT; Groenenboom, GC; Meijer, G				Gilijamse, Joop J.; Hoekstra, Steven; van de Meerakker, Sebastiaan Y. T.; Groenenboom, Gerrit C.; Meijer, Gerard			Near-threshold inelastic collisions using molecular beams with a tunable velocity	SCIENCE			English	Article							INTEGRAL CROSS-SECTIONS; OH(X (2)PI)+AR; STATE; SCATTERING; CO	Molecular scattering behavior has generally proven difficult to study at low collision energies. We formed a molecular beam of OH radicals with a narrow velocity distribution and a tunable absolute velocity by passing the beam through a Stark decelerator. The transition probabilities for inelastic scattering of the OH radicals with Xe atoms were measured as a function of the collision energy in the range of 50 to 400 wavenumbers, with an overall energy resolution of about 13 wavenumbers. The behavior of the cross-sections for inelastic scattering near the energetic thresholds was accurately measured, and excellent agreement was obtained with cross-sections derived from coupled-channel calculations on ab initio computed potential energy surfaces.	Max Planck Gesell, Fritz Haber Inst, D-14195 Berlin, Germany; Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 ED Nijmegen, Netherlands	Max Planck Society; Fritz Haber Institute of the Max Planck Society; Radboud University Nijmegen	van de Meerakker, SYT (corresponding author), Max Planck Gesell, Fritz Haber Inst, Faradayweg 4-6, D-14195 Berlin, Germany.	gerritg@theochem.ru.nl	van de Meerakker, Sebastiaan Y.T./D-4581-2012; Groenenboom, Gerrit C/F-9692-2015; Groenenboom, Gerrit/S-8138-2019; Meijer, Gerard/D-2141-2009; Hoekstra, Steven/D-4073-2009	Groenenboom, Gerrit/0000-0002-0920-3707; Meijer, Gerard/0000-0001-9669-8340; Hoekstra, Steven/0000-0002-9571-4510				ALEXANDER MH, 1982, J CHEM PHYS, V76, P5974, DOI 10.1063/1.442951; Balakrishnan N, 2000, J CHEM PHYS, V113, P621, DOI 10.1063/1.481838; Ball CD, 1998, PHYS REV LETT, V81, P305, DOI 10.1103/PhysRevLett.81.305; Bethlem HL, 2003, INT REV PHYS CHEM, V22, P73, DOI 10.1080/0144235021000046422; Bethlem HL, 1999, PHYS REV LETT, V83, P1558, DOI 10.1103/PhysRevLett.83.1558; COWLEY LT, 1970, REV SCI INSTRUM, V41, P666, DOI 10.1063/1.1684613; Dhont G, 2004, J CHEM PHYS, V120, P103, DOI 10.1063/1.1629672; Forrey RC, 1998, PHYS REV A, V58, pR2645, DOI 10.1103/PhysRevA.58.R2645; Groenenboom GC, 2003, J CHEM PHYS, V118, P7380, DOI 10.1063/1.1562946; HALL G, 1983, J CHEM PHYS, V78, P5260, DOI 10.1063/1.445393; Harich SA, 2002, NATURE, V419, P281, DOI 10.1038/nature01068; Heiner CE, 2006, PHYS CHEM CHEM PHYS, V8, P2666, DOI 10.1039/b602260j; Ho TS, 1996, J CHEM PHYS, V104, P2584, DOI 10.1063/1.470984; KNOWLES PJ, 1993, J CHEM PHYS, V99, P5219, DOI 10.1063/1.465990; LEVINE RD, 1987, MOL REACTION DYNAMIC; Lin JJ, 2003, SCIENCE, V300, P966, DOI 10.1126/science.1083672; Liu XH, 2000, SCIENCE, V289, P1536, DOI 10.1126/science.289.5484.1536; MACDONALD RG, 1989, J CHEM PHYS, V91, P821, DOI 10.1063/1.457134; Peterson KA, 2003, J CHEM PHYS, V119, P11113, DOI 10.1063/1.1622924; Rakitzis TP, 2004, SCIENCE, V303, P1852, DOI 10.1126/science.1094186; Scoles G., 1992, ATOMIC MOL BEAM METH, V2; Scoles G., 1988, ATOMIC MOL BEAM METH, V1; Shiu W, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.103201; SIMS IR, 1992, J CHEM PHYS, V97, P8798, DOI 10.1063/1.463349; Skodje RT, 2000, PHYS REV LETT, V85, P1206, DOI 10.1103/PhysRevLett.85.1206; Skouteris D, 1999, SCIENCE, V286, P1713, DOI 10.1126/science.286.5445.1713; SONNENFROH DM, 1991, J CHEM PHYS, V94, P6508, DOI 10.1063/1.460279; Staanum P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.023201; van Beek MC, 2000, J CHEM PHYS, V113, P637, DOI 10.1063/1.481840; van Beek MC, 2000, J CHEM PHYS, V113, P628, DOI 10.1063/1.481839; van Beek MC, 2001, PHYS REV LETT, V86, P4001, DOI 10.1103/PhysRevLett.86.4001; van de Meerakker SYT, 2006, ANNU REV PHYS CHEM, V57, P159, DOI 10.1146/annurev.physchem.55.091602.094337; vanLeuken JJ, 1996, CHEM PHYS LETT, V260, P595, DOI 10.1016/0009-2614(96)00926-8; WIGNER EP, 1948, PHYS REV, V73, P1002, DOI 10.1103/PhysRev.73.1002; Zahzam N, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.023202; Zare RN, 1998, SCIENCE, V279, P1875, DOI 10.1126/science.279.5358.1875	36	201	209	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2006	313	5793					1617	1620		10.1126/science.1131867	http://dx.doi.org/10.1126/science.1131867			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973875	Green Submitted			2022-12-28	WOS:000240498900039
J	Kuriyama, S; Shimazu, T; Ohmori, K; Kikuchi, N; Nakaya, N; Nishino, Y; Tsubono, Y; Tsuji, I				Kuriyama, Shinichi; Shimazu, Taichi; Ohmori, Kaori; Kikuchi, Nobutaka; Nakaya, Naoki; Nishino, Yoshikazu; Tsubono, Yoshitaka; Tsuji, Ichiro			Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan - The Ohsaki Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH INSURANCE BENEFICIARIES; MEDICINAL BENEFITS; PREVENTION; CATECHINS	Context Green tea polyphenols have been extensively studied as cardiovascular disease and cancer chemopreventive agents in vitro and in animal studies. However, the effects of green tea consumption in humans remain unclear. Objective To investigate the associations between green tea consumption and all-cause and cause-specific mortality. Design, Setting, and Participants The Ohsaki National Health Insurance Cohort Study, a population-based, prospective cohort study initiated in 1994 among 40 530 Japanese adults aged 40 to 79 years without history of stroke, coronary heart disease, or cancer at baseline. Participants were followed up for up to 11 years (1995-2005) for all-cause mortality and for up to 7 years (1995-2001) for cause-specific mortality. Main Outcome Measures Mortality due to cardiovascular disease, cancer, and all causes. Results Over 11 years of follow-up (follow-up rate, 86.1%), 4209 participants died, and over 7 years of follow-up (follow-up rate, 89.6%), 892 participants died of cardiovascular disease and 1134 participants died of cancer. Green tea consumption was inversely associated with mortality due to all causes and due to cardiovascular disease. The inverse association with all-cause mortality was stronger in women (P = .03 for interaction with sex). In men, the multivariate hazard ratios of mortality due to all causes associated with different green tea consumption frequencies were 1.00 (reference) for less than 1 cup/d, 0.93 (95% confidence interval [CI], 0.83-1.05) for 1 to 2 cups/d, 0.95 (95% CI, 0.85-1.06) for 3 to 4 cups/d, and 0.88 (95% CI, 0.79-0.98) for 5 or more cups/d, respectively (P = .03 for trend). The corresponding data for women were 1.00, 0.98 (95% CI, 0.84-1.15), 0.82 (95% CI, 0.70-0.95), and 0.77 (95% CI, 0.67-0.89), respectively (P < .001 for trend). The inverse association with cardiovascular disease mortality was stronger than that with all-cause mortality. This inverse association was also stronger in women (P = .08 for interaction with sex). In women, the multivariate hazard ratios of cardiovascular disease mortality across increasing green tea consumption categories were 1.00, 0.84 (95% CI, 0.63-1.12), 0.69 (95% CI, 0.52-0.93), and 0.69 ( 95% CI, 0.53-0.90), respectively (P = .004 for trend). Among the types of cardiovascular disease mortality, the strongest inverse association was observed for stroke mortality. In contrast, the hazard ratios of cancer mortality were not significantly different from 1.00 in all green tea categories compared with the lowest-consumption category. Conclusion Green tea consumption is associated with reduced mortality due to all causes and due to cardiovascular disease but not with reduced mortality due to cancer.	Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol,Aoba Ku, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Sch Publ Policy, Div Hlth Policy, Sendai, Miyagi 980, Japan; Miyagi Canc Ctr Res Inst, Div Epidemiol, Natori, Miyagi, Japan	Tohoku University; Tohoku University; Miyagi Cancer Center	Kuriyama, S (corresponding author), Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol,Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	kuriyama-thk@umin.ac.jp	Shimazu, Taichi/A-4470-2015	Shimazu, Taichi/0000-0001-6000-9830				Arts ICW, 2001, AM J CLIN NUTR, V74, P227; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Cooper R, 2005, J ALTERN COMPLEM MED, V11, P639, DOI 10.1089/acm.2005.11.639; Cooper R, 2005, J ALTERN COMPLEM MED, V11, P521, DOI 10.1089/acm.2005.11.521; Frei B, 2003, J NUTR, V133, p3275S, DOI 10.1093/jn/133.10.3275S; Iwai Nobuo, 2002, J Epidemiol, V12, P191; Kris-Etherton PM, 2002, CURR OPIN LIPIDOL, V13, P41, DOI 10.1097/00041433-200202000-00007; Kuriyama S, 2004, PREV MED, V39, P1194, DOI 10.1016/j.ypmed.2004.04.033; Nagao T, 2005, AM J CLIN NUTR, V81, P122; Nakachi K, 2000, BIOFACTORS, V13, P49, DOI 10.1002/biof.5520130109; Nakachi K, 2003, AGEING RES REV, V2, P1, DOI 10.1016/S1568-1637(02)00047-8; Ogawa K, 2003, PUBLIC HEALTH NUTR, V6, P147, DOI 10.1079/PHN2002411; Rahman RMA, 2005, NEUROSCI LETT, V382, P227, DOI 10.1016/j.neulet.2005.03.018; Rimm EB, 2004, JAMA-J AM MED ASSOC, V292, P1490, DOI 10.1001/jama.292.12.1490; SATO Y, 1989, TOHOKU J EXP MED, V157, P337, DOI 10.1620/tjem.157.337; Tsubono Y, 2001, NEW ENGL J MED, V344, P632, DOI 10.1056/NEJM200103013440903; Tsubono Yoshitaka, 2002, J Epidemiol, V12, P305; Tsuji I, 1999, J AM GERIATR SOC, V47, P470, DOI 10.1111/j.1532-5415.1999.tb07241.x; Tsuji I, 1998, J Epidemiol, V8, P258; WHO, 2004, LANCET, V363, P902; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616; Yang YC, 2004, ARCH INTERN MED, V164, P1534, DOI 10.1001/archinte.164.14.1534; Zaveri NT, 2006, LIFE SCI, V78, P2073, DOI 10.1016/j.lfs.2005.12.006; 1995, WHO TECH REP SER, V854, P312	25	568	592	3	145	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2006	296	10					1255	1265		10.1001/jama.296.10.1255	http://dx.doi.org/10.1001/jama.296.10.1255			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083EA	16968850	Bronze			2022-12-28	WOS:000240437500028
J	Deedwania, P; Barter, P; Carmena, R; Fruchart, JC; Grundy, SM; Haffner, S; Kastelein, JJP; LaRosa, JC; Schachner, H; Shepherd, J; Waters, DD				Deedwania, Prakash; Barter, Philip; Carmena, Rafael; Fruchart, Jean-Charles; Grundy, Scott M.; Haffner, Steven; Kastelein, John J. P.; LaRosa, John C.; Schachner, Holly; Shepherd, James; Waters, David D.		Treating New Targets Investigators	Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study	LANCET			English	Article							SCANDINAVIAN SIMVASTATIN SURVIVAL; AMERICAN-DIABETES-ASSOCIATION; RISK-FACTORS; CARDIOVASCULAR MORTALITY; EDUCATION-PROGRAM; VASCULAR-DISEASE; ALL-CAUSE; PREVENTION; GUIDELINES; EVENTS	Background Despite the prognostic value of metabolic syndrome for predicting cardiovascular events, few trials have investigated the effects of statin therapy on cardiovascular morbidity and mortality in patients with the metabolic syndrome. Our post hoc analysis of the Treating to New Targets (TNT) study assessed whether intensive lowering of low-density lipoprotein cholesterol with high-dose atorvastatin therapy results in cardiovascular benefits for patients with both coronary heart disease and the metabolic syndrome. Methods The TNT study was a prospective, double blind, parallel-group trial done at 256 sites in 14 countries between April, 1998, and August, 2004, with a median follow-up of 4.9 years. 10001 patients were enrolled aged 35-75 years with clinically evident coronary heart disease. Our analysis includes 5584 patients with metabolic syndrome based on the 2005 NCEP ATP III criteria. Patients were randomly assigned to receive either atorvastatin 10 mg per day (n=2820) or 80 mg per day (n=2764). The primary outcome measure was time to first major cardiovascular event, defined as death from coronary heart disease, non-fatal non-procedure-related myocardial infarction, resuscitated cardiac arrest, or fatal or non-fatal stroke. Findings In patients with coronary heart disease and metabolic syndrome, mean on-treatment low-density lipoprotein cholesterol concentrations at 3 months were 2.6 mmol/L (99.3 mg/dL) with atorvastatin 10 mg, and 1.9 mmol/L (72.6 mg/dL) with atorvastatin 80 mg. At a median follow-up of 4.9 years, major cardiovascular events occurred in 367 (13%) patients receiving atorvastatin 10 mg, compared with 262 (9.5%) receiving atorvastatin 80 mg (hazard ratio 0.71; 95% CI 0.61-0.84; p<0.0001). Irrespective of treatment assignment, significantly more patients with metabolic syndrome (11.3%) had a major cardiovascular event at a median of 4.9 years than those without metabolic syndrome (8.0%; hazard ratio 1.44; 95% CI 1.26-1.64; p<0.0001). This increased risk was significantly reduced by intensive therapy with atorvastatin 80 mg beyond that achieved with atorvastatin 10 mg. Interpretation These data indicate that patients with coronary heart disease and metabolic syndrome derive incremental benefit from high-dose atorvastatin therapy, irrespective of the presence of diabetes.	Vet Affairs Cent Calif Healthcare Syst, Fresno, CA 93703 USA; Univ Calif San Francisco, Sch Med, San Francisco, CA USA; Heart Res Inst, Sydney, NSW, Australia; Univ Valencia, Valencia, Spain; Inst Pasteur, F-59019 Lille, France; Univ Texas, SW Med Ctr, Dallas, TX USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; SUNY Hlth Sci Ctr, Brooklyn, NY 11203 USA; Pfizer Inc, New York, NY USA; Univ Glasgow, Glasgow, Lanark, Scotland; San Francisco Gen Hosp, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; University of Sydney; Heart Research Institute; University of Valencia; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Health San Antonio; University of Amsterdam; Academic Medical Center Amsterdam; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Pfizer; University of Glasgow; San Francisco General Hospital Medical Center	Deedwania, P (corresponding author), Vet Affairs Cent Calif Healthcare Syst, 2615 E Clinton Ave, Fresno, CA 93703 USA.	pdeedwania@fresno.ucsf.edu	Kastelein, John/AAF-7950-2020; Adiels, Martin/C-9278-2011					Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Deedwania PC, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000110642.73995.BF; Eberly LE, 2006, DIABETES CARE, V29, P123, DOI 10.2337/diacare.29.01.06.dc05-1320; Eckel RH, 2006, CIRCULATION, V113, P2943, DOI 10.1161/CIRCULATIONAHA.106.176583; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Geluk CA, 2005, EUR HEART J, V26, P1314, DOI 10.1093/eurheartj/ehi253; Girman CJ, 2004, AM J CARDIOL, V93, P136, DOI 10.1016/j.amjcard.2003.09.028; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hu G, 2004, ARCH INTERN MED, V164, P1066, DOI 10.1001/archinte.164.10.1066; Hunt KJ, 2004, CIRCULATION, V110, P1251, DOI 10.1161/01.CIR.0000140762.04598.F9; JEPPESEN J, 2006, ATHEROSCLEROSIS, DOI DOI 10.1016/J.AT.HEROSCLEROSIS.2005.12.010; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; PEDERSEN TR, 1994, LANCET, V344, P1383; Pyorala K, 2004, DIABETES CARE, V27, P1735, DOI 10.2337/diacare.27.7.1735; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Sattar N, 2003, CIRCULATION, V108, P414, DOI 10.1161/01.CIR.0000080897.52664.94; Schwartz GG, 2005, DIABETES CARE, V28, P2508, DOI 10.2337/diacare.28.10.2508; Shepherd J, 2006, DIABETES CARE, V29, P1220, DOI 10.2337/dc05-2465; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; STERN MP, 1986, ARTERIOSCLEROSIS, V6, P123, DOI 10.1161/01.ATV.6.2.123; Waters DD, 2004, AM J CARDIOL, V93, P154, DOI 10.1016/j.amjcard.2003.09.031; WINGARD DL, 1983, AM J EPIDEMIOL, V117, P19, DOI 10.1093/oxfordjournals.aje.a113510; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988; Zhu SK, 2002, AM J CLIN NUTR, V76, P743, DOI 10.1093/ajcn/76.4.743	28	278	290	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2006	368	9539					919	928		10.1016/S0140-6736(06)69292-1	http://dx.doi.org/10.1016/S0140-6736(06)69292-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083ZX	16962881				2022-12-28	WOS:000240502300029
J	Macdougall, IC; Eckardt, KU				Macdougall, Iain C.; Eckardt, Kai-Uwe			Novel strategies for stimulating erythropoiesis and potential new treatments for anaemia	LANCET			English	Review							RED-CELL APLASIA; RECOMBINANT-HUMAN-ERYTHROPOIETIN; HUMAN PRIMARY FIBROBLASTS; CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; DARBEPOETIN-ALPHA; DIALYSIS PATIENTS; THERAPEUTIC PROTEINS; HEMOGLOBIN LEVELS; CONTROLLED TRIAL	As with many other therapeutic areas in modern-day medicine, scientific advances in drug development (using such techniques as recombinant DNA technology, site-directed mutagenesis, pegylation of molecules, peptide library screening, and gene transfer) have resulted in the development of potential new agents and strategies for stimulating erythropoiesis. These advances are of possible benefit in treating anaemia due to various causes, including chronic renal failure. Several new treatments will soon become clinically available, while others are at present at an early stage of development but are nevertheless of scientific interest. We review these new therapeutic strategies, and discuss at what stage some of the newer products are in relation to their clinical development programme.	Kings Coll Hosp London, Dept Renal Med, London SE5 9RS, England; Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, Erlangen, Germany	King's College Hospital NHS Foundation Trust; King's College Hospital; University of Erlangen Nuremberg	Macdougall, IC (corresponding author), Kings Coll Hosp London, Dept Renal Med, Denmark Hill, London SE5 9RS, England.	iain.macdougall@kingsch.nhs.uk						Akagi S, 2004, J AM SOC NEPHROL, V15, P3215, DOI 10.1097/01.ASN.0000145457.73744.24; ALEXANIAN R, 1967, J LAB CLIN MED, V70, P777; Bennett CL, 2004, NEW ENGL J MED, V351, P1403, DOI 10.1056/NEJMoa040528; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Binley K, 2002, BLOOD, V100, P2406, DOI 10.1182/blood-2002-02-0605; Boven K, 2005, KIDNEY INT, V67, P2346, DOI 10.1111/j.1523-1755.2005.00340.x; CARO J, 1979, J LAB CLIN MED, V93, P449; Casadevall N, 2002, NEW ENGL J MED, V346, P469, DOI 10.1056/NEJMoa011931; Chatterjee PK, 2005, LANCET, V365, P1890, DOI 10.1016/S0140-6736(05)66622-6; *COMM PROPR MED PR, 2003, GUID COMP MED PROD C; DMOSZYNSKA A, 2004, J CLIN ONCOL S15, V22, pS14; Egrie JC, 2001, BRIT J CANCER, V84, P3, DOI 10.1054/bjoc.2001.1746; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; ESCHBACH JW, 1987, NEW ENGL J MED, V316, P73, DOI 10.1056/NEJM198701083160203; Fattori E, 2005, J GENE MED, V7, P228, DOI 10.1002/jgm.652; Gordeuk VR, 2004, BLOOD, V103, P3924, DOI 10.1182/blood-2003-07-2535; Haselbeck A, 2002, BLOOD, V100, p228A; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Jadoul M, 2004, NEPHROL DIAL TRANSPL, V19, P898, DOI 10.1093/ndt/gfh021; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; Johnson DL, 2000, NEPHROL DIAL TRANSPL, V15, P1274, DOI 10.1093/ndt/15.9.1274; Kakeda M, 2005, GENE THER, V12, P852, DOI 10.1038/sj.gt.3302483; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; Kochendoerfer GG, 2003, SCIENCE, V299, P884, DOI 10.1126/science.1079085; KOURY MJ, 1990, SCIENCE, V248, P378, DOI 10.1126/science.2326648; Lacombe C, 1999, NEPHROL DIAL TRANSPL, V14, P22, DOI 10.1093/ndt/14.suppl_2.22; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Leyland-Jones B, 2005, J CLIN ONCOL, V23, P5960, DOI 10.1200/JCO.2005.06.150; LIN FK, 1985, P NATL ACAD SCI USA, V82, P7580, DOI 10.1073/pnas.82.22.7580; Lippin Y, 2005, BLOOD, V106, P2280, DOI 10.1182/blood-2004-11-4174; Lipton SA, 2004, NEW ENGL J MED, V350, P2516, DOI 10.1056/NEJMcibr041121; Locatelli F, 2004, J AM SOC NEPHROL, V15, pS25, DOI 10.1097/01.ASN.0000093239.32602.04; Macdougall Iain C, 2005, Curr Hematol Rep, V4, P436; Macdougall IC, 1999, J AM SOC NEPHROL, V10, P2392; Maxwell P, 2003, J AM SOC NEPHROL, V14, P2712, DOI 10.1097/01.ASN.0000092792.97122.E0; Mix TCH, 2005, AM HEART J, V149, P408, DOI 10.1016/j.ahj.2004.09.047; MIYAKE T, 1977, J BIOL CHEM, V252, P5558; Nissenson AR, 2002, AM J KIDNEY DIS, V40, P110, DOI 10.1053/ajkd.2002.33919; Parfrey PS, 2005, J AM SOC NEPHROL, V16, P2180, DOI 10.1681/ASN.2004121039; Parsa CJ, 2003, J CLIN INVEST, V112, P999, DOI 10.1172/JCI200318200; PROVENZANO R, 2004, J AM SOC NEPHROL, V15, pA544; Qureshi SA, 1999, P NATL ACAD SCI USA, V96, P12156, DOI 10.1073/pnas.96.21.12156; Rivera VM, 2005, BLOOD, V105, P1424, DOI 10.1182/blood-2004-06-2501; Rossert J, 2005, NEPHROL DIAL TRANSPL, V20, P1025, DOI 10.1093/ndt/gfh800; Sarnak MJ, 2002, J AM COLL CARDIOL, V40, P27, DOI 10.1016/S0735-1097(02)01938-1; Schellekens H, 2005, NEPHROL DIAL TRANSPL, V20, P3, DOI 10.1093/ndt/gfh1092; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Schwenter F, 2004, HUM GENE THER, V15, P669, DOI 10.1089/1043034041361172; Sharma B, 2004, EUR J HOSP PHARM, V5, P86, DOI DOI 10.1002/JPS.21985; Sharples EJ, 2004, J AM SOC NEPHROL, V15, P2115, DOI 10.1097/01.ASN.0000135059.67385.5D; STEAD R, IN PRESS BLOOD; Sytkowski AJ, 1999, J BIOL CHEM, V274, P24773, DOI 10.1074/jbc.274.35.24773; Takacs K, 2004, P NATL ACAD SCI USA, V101, P16298, DOI 10.1073/pnas.0405271101; TAN CC, 1992, AM J PHYSIOL, V263, pF474, DOI 10.1152/ajprenal.1992.263.3.F474; Urquilla P., 2004, J AM SOC NEPHROL, V15, p546A; Vanrenterghem Y, 2002, KIDNEY INT, V62, P2167, DOI 10.1046/j.1523-1755.2002.00657.x; Wiecek A, 2005, NEPHROL DIAL TRANSPL, V20, pV195; WINEARLS CG, 1986, LANCET, V2, P1175, DOI 10.1016/S0140-6736(86)92192-6; Woodburn KW, 2004, BLOOD, V104, p794A, DOI 10.1182/blood.V104.11.2904.2904; WOODBURN KW, 2005, EUR HAEM ASS M; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458	61	108	119	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2006	368	9539					947	953		10.1016/S0140-6736(06)69120-4	http://dx.doi.org/10.1016/S0140-6736(06)69120-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083ZX	16962885				2022-12-28	WOS:000240502300033
J	Araujo, MB; Rahbek, C				Araujo, Miguel B.; Rahbek, Carsten			How does climate change affect biodiversity?	SCIENCE			English	Editorial Material							EXTINCTION RISK; MODELS; PROJECTIONS; UNCERTAINTY; PREDICTION; EUROPE		Natl Museum Nat Sci, Dept Biodivers & Evolutionary Biol, Madrid 28006, Spain; Inst Biol, Ctr Macroecol, DK-2100 Copenhagen, Denmark		Araujo, MB (corresponding author), Natl Museum Nat Sci, Dept Biodivers & Evolutionary Biol, Madrid 28006, Spain.	maraujo@mncn.csic.es; crahbek@bi.ku.dk	Rahbek, Carsten/L-1129-2013; Rahbek, Carsten/D-9372-2013; Araújo, Miguel B/B-6117-2008	Rahbek, Carsten/0000-0003-4585-0300; Araújo, Miguel B/0000-0002-5107-7265				Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2004, NATURE, V430, DOI 10.1038/nature02716; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102	16	377	393	17	215	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2006	313	5792					1396	1397		10.1126/science.1131758	http://dx.doi.org/10.1126/science.1131758			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	081WQ	16959994				2022-12-28	WOS:000240348700028
J	Sambunjak, D; Straus, SE; Marusic, A				Sambunjak, Dario; Straus, Sharon E.; Marusic, Ana			Mentoring in academic medicine - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ADOLESCENT-PSYCHIATRY; PRIMARY-CARE; ROLE MODELS; PROFESSIONAL-DEVELOPMENT; FAMILY MEDICINE; NATIONAL-SURVEY; AMERICAN CHILD; FACULTY; WOMEN; SATISFACTION	Context Mentoring, as a partnership in personal and professional growth and development, is central to academic medicine, but it is challenged by increased clinical, administrative, research, and other educational demands on medical faculty. Therefore, evidence for the value of mentoring needs to be evaluated. Objective To systematically review the evidence about the prevalence of mentorship and its relationship to career development. Data Sources MEDLINE, Current Contents, Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects, Cochrane Central Register of Controlled Trials, PsycINFO, and Scopus databases from the earliest available date to May 2006. Study Selection and Data Extraction We identified all studies evaluating the effect of mentoring on career choices and academic advancement among medical students and physicians. Minimum inclusion criteria were a description of the study population and availability of extractable data. No restrictions were placed on study methods or language. Data Synthesis The literature search identified 3640 citations. Review of abstracts led to retrieval of 142 full-text articles for assessment; 42 articles describing 39 studies were selected for review. Of these, 34 (87%) were cross-sectional self-report surveys with small sample size and response rates ranging from 5% to 99%. One case-control study nested in a survey used a comparison group that had not received mentoring, and 1 cohort study had a small sample size and a large loss to follow-up. Less than 50% of medical students and in some fields less than 20% of faculty members had a mentor. Women perceived that they had more difficulty finding mentors than their colleagues who are men. Mentorship was reported to have an important influence on personal development, career guidance, career choice, and research productivity, including publication and grant success. Conclusions Mentoring is perceived as an important part of academic medicine, but the evidence to support this perception is not strong. Practical recommendations on mentoring in medicine that are evidence-based will require studies using more rigorous methods, addressing contextual issues, and using cross-disciplinary approaches.	Univ Zagreb, Sch Med, HR-10000 Zagreb, Croatia; Univ Calgary, Dept Med, Calgary, AB, Canada	University of Zagreb; University of Calgary	Marusic, A (corresponding author), Univ Zagreb, Sch Med, Salata 3, HR-10000 Zagreb, Croatia.	marusica@mef.hr	Mikhailova, Elena/G-8352-2014; Marusic, Ana/E-7683-2013	Mikhailova, Elena/0000-0002-5280-6327; Marusic, Ana/0000-0001-6272-0917; Sambunjak, Dario/0000-0002-9016-2198				Aagaard EM, 2003, J GEN INTERN MED, V18, P298, DOI 10.1046/j.1525-1497.2003.20334.x; Benson CA, 2002, MED TEACH, V24, P550, DOI 10.1080/0142159021000002612; *BEST EV MED ED CO, 2003, GUID TOP REV GROUPS; Caiola E, 2000, J GEN INTERN MED, V15, P656, DOI 10.1046/j.1525-1497.2000.06389.x; Caniano DA, 2004, J PEDIATR SURG, V39, P984, DOI 10.1016/j.jpedsurg.2004.02.039; Coleman VH, 2005, J CONTIN EDUC HEALTH, V25, P268, DOI 10.1002/chp.40; Curtis P, 2003, FAM MED, V35, P124; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1060, DOI 10.1001/jama.292.9.1060; Donaldson LJ, 1996, PUBLIC HEALTH, V110, P61, DOI 10.1016/S0033-3506(96)80037-0; Dorsey Laurie E, 2004, Nurse Educ, V29, P260, DOI 10.1097/00006223-200411000-00013; elGuebaly N, 1996, CAN J PSYCHIAT, V41, P144, DOI 10.1177/070674379604100303; Fried LP, 1996, JAMA-J AM MED ASSOC, V276, P898, DOI 10.1001/jama.276.11.898; Genuardi FJ, 2001, J ADOLESCENT HEALTH, V29, P46, DOI 10.1016/S1054-139X(01)00213-0; Gray J, 2003, CLIN INVEST MED, V26, P315; Healy C. C., 1990, EDUC RESEARCHER, V19, P17, DOI [DOI 10.3102/0013189X019009017, 10.3102/0013189X019009017]; Hueston WJ, 1996, J FAM PRACTICE, V43, P171; Illes J, 2000, ACAD RADIOL, V7, P959; Ko CY, 1998, ARCH SURG-CHICAGO, V133, P900, DOI 10.1001/archsurg.133.8.900; Leppert PC, 2002, J SOC GYNECOL INVEST, V9, P372, DOI 10.1016/S1071-5576(02)00178-8; LEVINSON W, 1991, WESTERN J MED, V154, P423; Lukish J, 2005, AM SURGEON, V71, P971; McGuire LK, 2004, ACAD MED, V79, P319, DOI 10.1097/00001888-200404000-00007; Medina-Walpole A, 2002, J AM GERIATR SOC, V50, P949, DOI 10.1046/j.1532-5415.2002.50225.x; Miller CJ, 2006, DERMATOL SURG, V32, P70, DOI 10.1097/00042728-200601000-00012; Mills O F, 1995, Fam Med, V27, P188; MRAZEK DA, 1991, J AM ACAD CHILD PSY, V30, P1003, DOI 10.1097/00004583-199111000-00021; OSBORN EHS, 1992, ACAD MED, V67, P59, DOI 10.1097/00001888-199201000-00012; OSBORN EHS, 1993, ACAD MED, V68, P572, DOI 10.1097/00001888-199307000-00018; Paice E, 2002, BMJ-BRIT MED J, V325, P707, DOI 10.1136/bmj.325.7366.707; Palepu A, 1998, ACAD MED, V73, P318, DOI 10.1097/00001888-199803000-00021; Paukert JL, 2001, JAMA-J AM MED ASSOC, V285, P2781, DOI 10.1001/jama.285.21.2781; Pearlman SA, 2004, AM J PERINAT, V21, P371, DOI 10.1055/s-2004-835308; PINCUS HA, 1995, AM J PSYCHIAT, V152, P596; Polsky D, 2004, J CHILD NEUROL, V19, P6, DOI 10.1177/088307380401900102011; Ragins BR, 1997, ACAD MANAGE REV, V22, P482, DOI 10.2307/259331; Ramondetta LM, 2003, J CANCER EDUC, V18, P15, DOI 10.1207/S15430154JCE1801_9; Rivera JA, 2005, J GEN INTERN MED, V20, P366, DOI 10.1111/j.1525-1497.2005.04157.x; Rose GL, 2005, ACAD MED, V80, P344, DOI 10.1097/00001888-200504000-00007; RUBECK RF, 1995, ACAD MED, V70, P318, DOI 10.1097/00001888-199504000-00016; Sciscione AC, 1998, OBSTET GYNECOL, V91, P1023, DOI 10.1016/S0029-7844(98)00076-3; Scribner DR, 2005, J REPROD MED, V50, P29; SHAPIRO T, 1991, J AM ACAD CHILD PSY, V30, P443, DOI 10.1097/00004583-199105000-00015; Sosik JJ, 2000, J ORGAN BEHAV, V21, P365, DOI 10.1002/(SICI)1099-1379(200006)21:4<365::AID-JOB14>3.0.CO;2-H; Steiner JF, 2004, ACAD MED, V79, P865, DOI 10.1097/00001888-200409000-00012; Steiner JF, 2002, J GEN INTERN MED, V17, P854, DOI 10.1046/j.1525-1497.2002.10515.x; Stubbe DE, 2002, J AM ACAD CHILD PSY, V41, P131, DOI 10.1097/00004583-200202000-00006; Thakur A, 2001, J PEDIATR SURG, V36, P1802, DOI 10.1053/jpsu.2001.28842; TURBAN DB, 1994, ACAD MANAGE J, V37, P688, DOI 10.2307/256706; Underhill CM, 2006, J VOCAT BEHAV, V68, P292, DOI 10.1016/j.jvb.2005.05.003; WAKEFORD R, 1985, LANCET, V2, P262; Weber T, 2005, CHIRURG, V76, P703, DOI 10.1007/s00104-005-1017-y; Wingard DL, 2004, ACAD MED, V79, pS9, DOI 10.1097/00001888-200410001-00003; Wise Michelle R, 2004, J Obstet Gynaecol Can, V26, P127; Young AM, 2000, J MANAGE, V26, P611, DOI 10.1016/S0149-2063(00)00049-0; Yu EHC, 2003, CAN J CARDIOL, V19, P553; 2002, AM HERITAGE STEDMANS	56	949	957	5	130	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2006	296	9					1103	1115		10.1001/jama.296.9.1103	http://dx.doi.org/10.1001/jama.296.9.1103			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	081DW	16954490				2022-12-28	WOS:000240298400012
J	Lindor, NM; Petersen, GM; Hadley, DW; Kinney, AY; Miesfeldt, S; Lu, KH; Lynch, P; Burke, W; Press, N				Lindor, Noralane M.; Petersen, Gloria M.; Hadley, Donald W.; Kinney, Anita Y.; Miesfeldt, Susan; Lu, Karen H.; Lynch, Patrick; Burke, Wylie; Press, Nancy			Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							NONPOLYPOSIS COLORECTAL-CANCER; DNA-MISMATCH-REPAIR; MICROSATELLITE INSTABILITY; COLON-CANCER; GERMLINE MUTATIONS; ENDOMETRIAL CARCINOMA; FOLLOW-UP; EXTRACOLONIC CANCER; SCREENING PRACTICES; FAMILY-HISTORY	Context About 2% of all colorectal cancer occurs in the context of the autosomal dominantly inherited Lynch syndrome, which is due to mutations in mismatch repair genes. Potential risk-reducing interventions are recommended for individuals known to have these mutations. Objectives To review cancer risks and data on screening efficacy in the context of Lynch syndrome (hereditary nonpolyposis colorectal cancer) and to provide recommendations for clinical management for affected families, based on available evidence and expert opinion. Data Sources and Study Selection A systematic literature search using PubMed and the Cochrane Database of Systematic Reviews, reference list review of retrieved articles, manual searches of relevant articles, and direct communication with other researchers in the field. Search terms included hereditary non-polyposis colon cancer, Lynch syndrome, microsatellite instability, mismatch repair genes, and terms related to the biology of Lynch syndrome. Only peer-reviewed, full-text, English-language articles concerning human subjects published between January 1, 1996, and February 2006 were included. The US Preventive Services Task Force's 2-tier system was adapted to describe the quality of evidence and to assign strength to the recommendations for each guideline. Evidence Synthesis The evidence supports colonoscopic surveillance for individuals with Lynch syndrome, although the optimal age at initiation and frequency of examinations is unresolved. Colonoscopy is recommended every 1 to 2 years starting at ages 20 to 25 years (age 30 years for those with MSH6 mutations), or 10 years younger than the youngest age of the person diagnosed in the family. While fully acknowledging absence of demonstrated efficacy, the following are also recommended annually: endometrial sampling and transvaginal ultrasound of the uterus and ovaries (ages 30-35 years); urinalysis with cytology (ages 25-35 years); history, examination, review of systems, education and genetic counseling regarding Lynch syndrome (age 21 years). Regular colonoscopy was favored for at-risk persons without colorectal neoplasia. For individuals who will undergo surgical resection of a colon cancer, subtotal colectomy is favored. Evidence supports the efficacy of prophylactic hysterectomy and oophorectomy. Conclusions The past 10 years have seen major advances in the understanding of Lynch syndrome. Current recommendations regarding cancer screening and prevention require careful consultation between clinicians, clinical cancer genetic services, and well-informed patients.	Oregon Hlth & Sci Univ, Sch Nursing, Portland, OR 97239 USA; Mayo Clin, Coll Med, Dept Med Genet, Rochester, MN USA; Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN USA; NHGRI, Social & Behav Res Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA; Maine Ctr Canc Med & Blood Disorders, Portland, ME USA; Maine Med Ctr, Portland, ME 04102 USA; Univ Texas, MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Gastrointestinal Med & Nutr, Houston, TX 77030 USA; Univ Washington, Dept Med Hist & Eth, Seattle, WA 98195 USA; Oregon Hlth & Sci Univ, Sch Med, Portland, OR 97239 USA	Oregon Health & Science University; Mayo Clinic; Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA); Maine Medical Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Washington; University of Washington Seattle; Oregon Health & Science University	Press, N (corresponding author), Oregon Hlth & Sci Univ, Sch Nursing, 3455 SW US Vet Hosp Rd, Portland, OR 97239 USA.	pressn@ohsu.edu			NATIONAL CANCER INSTITUTE [U01CA074800] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001885] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [U01 CA074800] Funding Source: Medline; NHGRI NIH HHS [3R01HG001885-03S2] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.3.CO;2-C; Aarnio M, 1997, INT J CANCER, V74, P551, DOI 10.1002/(SICI)1097-0215(19971021)74:5<551::AID-IJC13>3.0.CO;2-9; Aarnio M, 1995, INT J CANCER, V64, P430, DOI 10.1002/ijc.2910640613; *AG HEALTHC RES QU, US PREV HLTH SERV TA; [Anonymous], 1983, JAMA, V249, P1600; Apessos A, 2005, BRIT J CANCER, V92, P396, DOI 10.1038/sj.bjc.6602260; Arana VM, 2002, ANN ONCOL, V13, P807, DOI 10.1093/annonc/mdf163; Bai YQ, 1999, INT J CANCER, V82, P512, DOI 10.1002/(SICI)1097-0215(19990812)82:4<512::AID-IJC7>3.0.CO;2-8; Bapat BV, 1999, HUM GENET, V104, P167, DOI 10.1007/s004390050931; Baudhuin LM, 2005, FAM CANCER, V4, P255, DOI 10.1007/s10689-004-1447-6; BERGTHORSSON JT, 1995, CLIN GENET, V47, P305; Bisgaard ML, 2002, HUM MUTAT, V20, P20, DOI 10.1002/humu.10083; Boks DES, 2002, INT J CANCER, V102, P198, DOI 10.1002/ijc.10667; Broaddus RR, 2006, CANCER, V106, P87, DOI 10.1002/cncr.21560; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P915, DOI 10.1001/jama.277.11.915; Caldes T, 2004, ONCOL REP, V12, P621; Caldes T, 2002, INT J CANCER, V98, P774, DOI 10.1002/ijc.10240; Cappel WHDTN, 2003, GUT, V52, P1752; Cappel WHDTN, 2002, DIS COLON RECTUM, V45, P1588, DOI 10.1097/01.DCR.0000034502.64985.3F; CATS A, 1995, JNCI-J NATL CANCER I, V87, P598, DOI 10.1093/jnci/87.8.598; Cederquist K, 2005, CLIN GENET, V68, P533, DOI 10.1111/j.1399-0004.2005.00537.x; *COCHR COLL, COCHR DAT SYST REV; Colditz GA, 2006, NAT REV CANCER, V6, P75, DOI 10.1038/nrc1784; Cunningham JM, 1998, CANCER RES, V58, P3455; Cunningham JM, 2001, AM J HUM GENET, V69, P780, DOI 10.1086/323658; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; den Bakker MA, 2003, HISTOPATHOLOGY, V43, P297, DOI 10.1046/j.1365-2559.2003.01681.x; Deng GR, 2004, CLIN CANCER RES, V10, P191, DOI 10.1158/1078-0432.CCR-1118-3; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Domingo E, 2005, ONCOGENE, V24, P3995, DOI 10.1038/sj.onc.1208569; Dove-Edwin I, 2005, BMJ-BRIT MED J, V331, P1047, DOI 10.1136/bmj.38606.794560.EB; Dove-Edwin I, 2002, CANCER, V94, P1708, DOI 10.1002/cncr.10380; Dunlop MG, 1997, HUM MOL GENET, V6, P105, DOI 10.1093/hmg/6.1.105; Engel C, 2006, INT J CANCER, V118, P115, DOI 10.1002/ijc.21313; Gruber SB, 2006, GASTROENTEROLOGY, V130, P577, DOI 10.1053/j.gastro.2006.01.031; Hadley DW, 2004, J CLIN ONCOL, V22, P39, DOI 10.1200/JCO.2004.06.128; Halbert CH, 2004, ARCH INTERN MED, V164, P1881, DOI 10.1001/archinte.164.17.1881; Hampel H, 2005, GASTROENTEROLOGY, V129, P415, DOI 10.1053/j.gastro.2005.05.011; Hendriks YMC, 2004, GASTROENTEROLOGY, V127, P17, DOI 10.1053/j.gastro.2004.03.068; Hendriks YMC, 2006, CA-CANCER J CLIN, V56, P213, DOI 10.3322/canjclin.56.4.213; Huang RL, 2004, CANCER GENET CYTOGEN, V153, P108, DOI 10.1016/j.cancergencyto.2004.01.003; Hurlstone DP, 2005, AM J GASTROENTEROL, V100, P2167, DOI 10.1111/j.1572-0241.2005.41481.x; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; JARVINEN HJ, 1995, GASTROENTEROLOGY, V108, P1405, DOI 10.1016/0016-5085(95)90688-6; JASS JR, 1995, LANCET, V346, P1200, DOI 10.1016/S0140-6736(95)92902-9; Jass JR, 2005, ARCH PATHOL LAB MED, V129, P1380; JENKINS M, IN PRESS CLIN GASTRO; Kakar S, 2003, CANCER-AM CANCER SOC, V97, P1421, DOI 10.1002/cncr.11206; Katballe N, 2002, GUT, V50, P43, DOI 10.1136/gut.50.1.43; Kurzawski G, 2006, CLIN GENET, V69, P40, DOI 10.1111/j.1399-0004.2006.00550.x; LEE NC, 1987, JAMA-J AM MED ASSOC, V257, P796; Lin K M, 1998, J Gastrointest Surg, V2, P67, DOI 10.1016/S1091-255X(98)80105-4; Lin KM, 1998, DIS COLON RECTUM, V41, P428, DOI 10.1007/BF02235755; Lindor NM, 2005, JAMA-J AM MED ASSOC, V293, P1979, DOI 10.1001/jama.293.16.1979; Lindor NM, 2002, J CLIN ONCOL, V20, P1043, DOI 10.1200/JCO.20.4.1043; Liu SR, 2004, WORLD J GASTROENTERO, V10, P2647, DOI 10.3748/wjg.v10.i18.2647; Lubomierski N, 2005, CANCER-AM CANCER SOC, V104, P952, DOI 10.1002/cncr.21266; Lynch HT, 2006, EUR J HUM GENET, V14, P390, DOI 10.1038/sj.ejhg.5201584; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; MARRA G, 1995, J NATL CANCER I, V87, P1114, DOI 10.1093/jnci/87.15.1114; McGivern A, 2004, Fam Cancer, V3, P101; Menigatti M, 2001, GENE CHROMOSOME CANC, V31, P357, DOI 10.1002/gcc.1154; Merg A, 2005, CURR PROB SURG, V42, P262, DOI 10.1067/j.cpsurg.2005.04.004; Miquel C, 2004, HUM PATHOL, V35, P1564, DOI 10.1016/j.humpath.2004.09.017; Moslein G, 2003, LANGENBECK ARCH SURG, V388, P9, DOI 10.1007/s00423-003-0364-8; Mueller-Koch Y, 2005, GUT, V54, P1733, DOI 10.1136/gut.2004.060905; Nakagawa H, 2004, CANCER RES, V64, P4721, DOI 10.1158/0008-5472.CAN-03-2879; *NAT CANC I, CANC GEN SERV DIR; *NAT LIB MED, ENTR PUBMED; National Comprehensive Cancer Network, NCCN PRACT GUID ONC; Park YJ, 2000, CLIN CANCER RES, V6, P2994; Peltomaki P, 2004, DIS MARKERS, V20, P269, DOI 10.1155/2004/305058; Plaschke J, 2004, J CLIN ONCOL, V22, P4486, DOI 10.1200/JCO.2004.02.033; Platz EA, 2000, CANCER CAUSE CONTROL, V11, P579, DOI 10.1023/A:1008999232442; Rijcken FEM, 2003, GYNECOL ONCOL, V91, P74, DOI 10.1016/S0090-8258(03)00371-8; Risinger JI, 1996, CANCER, V77, P1836, DOI 10.1002/(SICI)1097-0142(19960501)77:9<1836::AID-CNCR12>3.0.CO;2-0; Rodriguez-Bigas MA, 2006, SURG ONCOL CLIN N AM, V15, P51, DOI 10.1016/j.soc.2005.08.002; RodriguezBigas MA, 1997, ANN SURG, V225, P202, DOI 10.1097/00000658-199702000-00008; Salovaara R, 2000, J CLIN ONCOL, V18, P2193, DOI 10.1200/JCO.2000.18.11.2193; Schmeler KM, 2006, NEW ENGL J MED, V354, P261, DOI 10.1056/NEJMoa052627; Sheng Jianqiu, 2002, Zhonghua Yi Xue Za Zhi, V82, P1371; Sijmons R, 2000, GENE CHROMOSOME CANC, V29, P353, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1042>3.0.CO;2-T; Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38; Soravia C, 2003, AM J MED GENET A, V121A, P159, DOI 10.1002/ajmg.a.20106; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; *US DEP HHS, US SURG GEN FAM HIST; Vasen HFA, 2005, GUT, V54, P1501, DOI 10.1136/gut.2005.075820; Vasen HFA, 1996, GASTROENTEROLOGY, V110, P1020, DOI 10.1053/gast.1996.v110.pm8612988; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Vasen HFA, 2001, J CLIN ONCOL, V19, P4074, DOI 10.1200/JCO.2001.19.20.4074; Wagner A, 2005, FAM CANCER, V4, P295, DOI 10.1007/s10689-005-0658-9; Walsh JME, 2005, J GEN INTERN MED, V20, P1097, DOI 10.1111/j.1525-1497.2005.0245.x; Wang L, 2003, CANCER RES, V63, P5209; Wang L, 2004, GASTROENTEROLOGY, V127, P9, DOI 10.1053/j.gastro.2004.03.070; Wang Q, 1999, HUM GENET, V105, P79, DOI 10.1007/s004390051067; Wang YP, 2003, INT J CANCER, V103, P636, DOI 10.1002/ijc.10869; Watson P, 2004, ARCH INTERN MED, V164, P2429, DOI 10.1001/archinte.164.22.2429; WATSON P, 1993, CANCER, V71, P677, DOI 10.1002/1097-0142(19930201)71:3<677::AID-CNCR2820710305>3.0.CO;2-#; Wheeler JMD, 2005, ANN ROY COLL SURG, V87, P15, DOI 10.1308/1478708051423; Wijnen JT, 1998, NEW ENGL J MED, V339, P511, DOI 10.1056/NEJM199808203390804; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Zapka JG, 2002, AM J PREV MED, V23, P28, DOI 10.1016/S0749-3797(02)00444-0; Zhang YZ, 2005, WORLD J GASTROENTERO, V11, P1481, DOI 10.3748/wjg.v11.i10.1481	105	463	476	0	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2006	296	12					1507	1517		10.1001/jama.296.12.1507	http://dx.doi.org/10.1001/jama.296.12.1507			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087VD	17003399	Bronze			2022-12-28	WOS:000240770000027
J	Horton, R				Horton, Richard			A new global commitment to child survival	LANCET			English	Editorial Material							HEALTH		The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							AusAID, 2006, HELP HLTH SYST DEL P; BRYCE J, 2006, LANCET          0918, DOI [10.1016/S0140-6736(06)68477-8, DOI 10.1016/S0140-6736(06)68477-8, DOI 10.1016/S0140-6736(06)69339-2]; Bryce J, 2006, LANCET, V368, P817, DOI 10.1016/S0140-6736(06)69299-4; DALMIYA N, 2006, LANCET          0918; HOEKSTRA E, 2006, LANCET          0918; Horton R, 2006, LANCET, V367, P554, DOI 10.1016/S0140-6736(06)68201-9; Horton R, 2006, LANCET, V367, P3, DOI 10.1016/S0140-6736(06)67899-9; Horton R, 2006, LANCET, V368, P716, DOI 10.1016/S0140-6736(06)69266-0; LU C, 2006, LANCET          0918; POWELLJACKSON T, 2006, LANCET          0918, DOI DOI 10.1016/S0140-6736(06)69338-0; Sall M, 2005, LANCET, V366, P1988, DOI 10.1016/S0140-6736(05)67796-3; STOLTENBERG J, 2006, LANCET          0918; VENEMAN A, 2006, LANCET          0918; WARDLAW T, 2006, LANCET          0918, DOI DOI 10.1016/S0140-6736(06)69334-3; World Health Organization, 2005, WORLD HLTH REP 2005	15	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 23	2006	368	9541					1041	1042		10.1016/S0140-6736(06)69331-8	http://dx.doi.org/10.1016/S0140-6736(06)69331-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	089IC	16997646				2022-12-28	WOS:000240873000004
J	Powell-Jackson, T; Borghi, J; Mueller, DH; Patouillard, E; Mills, A				Powell-Jackson, Timothy; Borghi, Josephine; Mueller, Dirk H.; Patouillard, Edith; Mills, Anne			Countdown to 2015: tracking donor assistance to maternal, newborn, and child health	LANCET			English	Article							MALARIA CONTROL	Background Timely reliable data on aid flows to maternal, newborn, and child health are essential for assessing the adequacy of current levels of funding, and to promote accountability among donors for attainment of the Millennium Development Goals (MDGs) for child and maternal health. We provide global estimates of official development assistance (ODA) to maternal, newborn, and child health in 2003 and 2004, drawing on data reported by high-income donor countries and aid agencies to the Organisation for Economic Development and Cooperation. Methods ODA was tracked on a project-by-project basis to 150 developing countries. We applied a standard definition of maternal, newborn, and child health across donors, and included not only funds specific to these areas, but also integrated health funds and disease-specific funds allocated on a proportional distribution basis, using appropriate factors. Findings Donor spending on activities related to maternal, newborn, and child health was estimated to be US$1990 million in 2004, representing just 2% of gross aid disbursements to developing countries. The 60 priority low-income countries that account for most child and newborn deaths received $1363 million, or $3.1 per child. Across recipient countries, there is a positive association between mortality and ODA per head, although at any given rate of mortality for children aged younger than 5 years or maternal mortality, there is significant variation in the amount of ODA per person received by developing countries. Interpretation The current level of ODA to maternal, newborn, and child health is inadequate to provide more than a small portion of the total resources needed to reach the MDGs for child and maternal health. If commitments are to be honoured, global aid flows will need to increase sharply during the next 5 years. The challenge will be to ensure a sufficient share of these new funds is channelled effectively towards the scaling up of key maternal, newborn, and child health interventions in high priority countries.	London Sch Hyg & Trop Med, Hlth Econ & Financing Programme, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Powell-Jackson, T (corresponding author), London Sch Hyg & Trop Med, Hlth Econ & Financing Programme, London WC1, England.	timothy.powell-jackson@lshtm.ac.uk		Mills, Anne/0000-0001-9863-9950; Patouillard, Edith/0000-0001-7347-2824; Borghi, Josephine/0000-0002-0482-5451				Abel-Smith B, 1963, WHO PUBLIC HLTH PAPE; [Anonymous], 2005, WORLD POP PROSP 2004; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bryce J, 2005, LANCET, V365, P2193, DOI 10.1016/S0140-6736(05)66777-3; BRYCE J, 2006, LANCET          0918, DOI [10.1016/S0140-6736(06)68477-8, DOI 10.1016/S0140-6736(06)68477-8, DOI 10.1016/S0140-6736(06)69339-2]; Caiden N., 1980, PLANNING BUDGETING P; Costello A, 2005, LANCET, V366, P603, DOI 10.1016/S0140-6736(05)66703-7; Eiseman E, 2005, CHALLENGES CREATING; *EXP GROUP CHILD H, 2005, C CALL BOUND CHILD H; Foster M., 2001, 158 OV DEV I; *GLOB HLTH COUNC, 2006, GLOB HLTH OPP 2006 U; *GLOB HLTH RES TRA, 2005, FOLL MON GLOB HLTH R; HANSON K, 1992, BAMAKO INITIATIVE TE; *HM TREAS, 2003, INT FIN FAC; Kirkwood BR, 2003, ESSENTIAL MED STAT; Korenromp EL, 2003, TROP MED INT HEALTH, V8, P693, DOI 10.1046/j.1365-3156.2003.01084.x; KORENROMP EL, 2004, MALARIA INCIDENCE ES; LAWRENCE S, 2005, FDN FUNDING CHILDREN; MICHAUD C, 1994, B WORLD HEALTH ORGAN, V72, P639; Mills A., 1990, Health Policy and Planning, V5, P107, DOI 10.1093/heapol/5.2.107; MILLS AJ, 1993, B WORLD HEALTH ORGAN, V71, P329; *MIN FOR AFF GOV F, 2005, AIRL TICK SOL TAX; Narasimhan V, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-8; OECD, 2002, REP DIR CRED REP SYS; *OECD, 2005, REP DIR CRED REP SYS; *OECD, 2005, STAT ANN 2005 DEV CO; *OECD, 2005, DAC LIST ODA REC; *OECD, 2005, OECD DAC SECR SIM DA; Poullier JP., 2003, HLTH SYSTEMS PERFORM, P195; POWELLJACKSON T, 2006, TRACKING OFFICIAL DE; *SPA BUDG SUPP WOR, 2005, SURV AL BUDG SUPP BA; UNAIDS, 2004, 4 UNAIDS; *UNAIDS, 2005, RES NEEDS EXP RESP H; UNICEF, 2005, ANN REP 2004; *UNICEF, 1995, COST RES US FIN DIST; United Nations Children's Fund (UNICEF), 2005, TRACK PROGR CHILD SU; Waddington C, 2005, TRENDS INT FUNDING M; WALKER N, 2005, PRICE TAG NEWBORN CH; *WHO, 2004, PROGR BUDG 2002 2003; *WHO, 2005, GLOB TUB CONTR SURV; WHO, 2005, EST COST SCAL UP MAT; World Bank, 2006, GLOB EC PROSP 2006 E; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization (WHO), 2005, METH ASS US EST COST; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; World Health Organization World Bank USAID, 2003, GUID PROD NAT HLTH A	46	73	73	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 23	2006	368	9541					1077	1087		10.1016/S0140-6736(06)69338-0	http://dx.doi.org/10.1016/S0140-6736(06)69338-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089IC	16997662				2022-12-28	WOS:000240873000023
J	Ganguly-Fitzgerald, I; Donlea, J; Shaw, PJ				Ganguly-Fitzgerald, Indrani; Donlea, Jeff; Shaw, Paul J.			Waking experience affects sleep need in Drosophila	SCIENCE			English	Article							LONG-TERM-MEMORY; MUSHROOM BODIES; GENE-EXPRESSION; REM-SLEEP; MELANOGASTER; BRAIN	Sleep is a vital, evolutionarily conserved phenomenon, whose function is unclear. Although mounting evidence supports a role for sleep in the consolidation of memories, until now, a molecular connection between sleep, plasticity, and memory formation has been difficult to demonstrate. We establish Drosophila as a model to investigate this relation and demonstrate that the intensity and/or complexity of prior social experience stably modifies sleep need and architecture. Furthermore, this experience-dependent plasticity in sleep need is subserved by the dopaminergic and adenosine 3', 5'-monophosphate signaling pathways and a particular subset of 17 long-term memory genes.	Inst Neurosci, San Diego, CA 92101 USA; Washington Univ, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Ganguly-Fitzgerald, I (corresponding author), Inst Neurosci, 10640 John Jay Hopkins Dr, San Diego, CA 92101 USA.	transposase@gmail.com			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051305] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS051305-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALLING A, 1987, J NEUROGENET, V4, P65, DOI 10.3109/01677068709102334; Brodbeck D, 1998, DNA CELL BIOL, V17, P621, DOI 10.1089/dna.1998.17.621; CAMPBELL SS, 1984, NEUROSCI BIOBEHAV R, V8, P269, DOI 10.1016/0149-7634(84)90054-X; DAUWALDER B, 1995, J NEUROSCI, V15, P3490; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Goldman-Rakic P S, 1998, Adv Pharmacol, V42, P707; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Ho KS, 2005, METHOD ENZYMOL, V393, P772, DOI 10.1016/S0076-6879(05)93041-3; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Levine JD, 2002, SCIENCE, V298, P2010, DOI 10.1126/science.1076008; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; Miyamoto H, 2003, NAT NEUROSCI, V6, P553, DOI 10.1038/nn1064; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Ribeiro S, 1999, LEARN MEMORY, V6, P500, DOI 10.1101/lm.6.5.500; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; SIWICKI K, COMMUNICATION; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Yin JCP, 1996, CURR OPIN NEUROBIOL, V6, P264, DOI 10.1016/S0959-4388(96)80082-1	26	208	214	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2006	313	5794					1775	1781		10.1126/science.1130408	http://dx.doi.org/10.1126/science.1130408			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990546				2022-12-28	WOS:000240655700046
J	Korostelev, A; Trakhanov, S; Laurberg, M; Noller, HF				Korostelev, Andrei; Trakhanov, Sergei; Laurberg, Martin; Noller, Harry F.			Crystal structure of a 70S ribosome-tRNA complex reveals functional interactions and rearrangements	CELL			English	Article							PEPTIDE-BOND FORMATION; TRANSFER RIBONUCLEIC-ACID; THERMUS-THERMOPHILUS HB8; REAL-SPACE REFINEMENT; SITE TRANSFER-RNA; P-SITE; ANGSTROM RESOLUTION; MESSENGER-RNA; DATA QUALITY; A-SITES	Our understanding of the mechanism of protein synthesis has undergone rapid progress in recent years as a result of low-resolution X-ray and cryo-EM structures of ribosome functional complexes and high-resolution structures of ribosomal subunits and vacant ribosomes. Here, we present the crystal structure of the Thermus thermophilus 70S ribosome containing a model mRNA and two tRNAs at 3.7 angstrom resolution. Many structural details of the interactions between the ribosome, tRNA, and mRNA in the P and E sites and the ways in which tRNA structure is distorted by its interactions with the ribosome are seen. Differences between the conformations of vacant and tRNA-bound 70S ribosomes suggest an induced fit of the ribosome structure in response to tRNA binding, including significant changes in the peptidyl-transferase catalytic site.	Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Noller, HF (corresponding author), Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA.	harry@nuvolari.ucsc.edu		Korostelev, Andrei/0000-0003-1588-717X				Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Auffinger P, 1999, BIOPHYS J, V76, P50, DOI 10.1016/S0006-3495(99)77177-8; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bieling P, 2006, NAT STRUCT MOL BIOL, V13, P423, DOI 10.1038/nsmb1091; Bocchetta M, 2001, RNA, V7, P54, DOI 10.1017/S1355838201001650; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Brunelle JL, 2006, RNA, V12, P33, DOI 10.1261/rna.2256706; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cai ZP, 1996, BIOCHEMISTRY-US, V35, P6026, DOI 10.1021/bi952985g; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Chang KY, 1999, P NATL ACAD SCI USA, V96, P11764, DOI 10.1073/pnas.96.21.11764; Culver GM, 1999, SCIENCE, V285, P2133, DOI 10.1126/science.285.5436.2133; Dallas A, 2001, MOL CELL, V8, P855, DOI 10.1016/S1097-2765(01)00356-2; DeLaBarre B, 2006, ACTA CRYSTALLOGR D, V62, P923, DOI 10.1107/S0907444906012650; Dorner S, 2003, NUCLEIC ACIDS RES, V31, P6536, DOI 10.1093/nar/gkg842; EHRENBERG M, 1979, BIOCHEMISTRY-US, V18, P4588, DOI 10.1021/bi00588a020; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FAHNESTOCK S, 1970, BIOCHEMISTRY-US, V9, P2477, DOI 10.1021/bi00814a013; Feinberg JS, 2001, P NATL ACAD SCI USA, V98, P11120, DOI 10.1073/pnas.211184098; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Friederich MW, 1998, P NATL ACAD SCI USA, V95, P3572, DOI 10.1073/pnas.95.7.3572; Gao HX, 2003, CELL, V113, P789, DOI 10.1016/S0092-8674(03)00427-6; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; Guymon R, 2006, BIOCHEMISTRY-US, V45, P4888, DOI 10.1021/bi052579p; GUYMON R, 2006, ANNU REV BIOCHEM, V45, P4888; Hansen JL, 2002, MOL CELL, V10, P117, DOI 10.1016/S1097-2765(02)00570-1; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Hesslein AE, 2004, NUCLEIC ACIDS RES, V32, P3760, DOI 10.1093/nar/gkh672; HODEL A, 1992, ACTA CRYSTALLOGR A, V48, P851, DOI 10.1107/S0108767392006044; Jenner L, 2005, SCIENCE, V308, P120, DOI 10.1126/science.1105639; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jovine L, 2000, J MOL BIOL, V301, P401, DOI 10.1006/jmbi.2000.3950; Katunin VI, 2002, MOL CELL, V10, P339, DOI 10.1016/S1097-2765(02)00566-X; Kirillov SV, 2002, FEBS LETT, V514, P60, DOI 10.1016/S0014-5793(02)02302-5; Korostelev A, 2002, ACTA CRYSTALLOGR D, V58, P761, DOI 10.1107/S0907444902003402; Lancaster L, 2005, MOL CELL, V20, P623, DOI 10.1016/j.molcel.2005.10.006; LILL R, 1988, J MOL BIOL, V203, P699, DOI 10.1016/0022-2836(88)90203-3; LILLO C, 1989, Norwegian Journal of Agricultural Sciences, V3, P23; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n; McGarry KG, 2005, MOL CELL, V20, P613, DOI 10.1016/j.molcel.2005.10.007; MOAZED D, 1991, P NATL ACAD SCI USA, V88, P3725, DOI 10.1073/pnas.88.9.3725; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; MOAZED D, 1990, J MOL BIOL, V211, P135, DOI 10.1016/0022-2836(90)90016-F; MOAZED D, 1986, CELL, V47, P985, DOI 10.1016/0092-8674(86)90813-5; NIERHAUS KH, 1990, BIOCHEMISTRY-US, V29, P4997, DOI 10.1021/bi00473a001; Nishimura M, 2004, J MOL BIOL, V344, P1369, DOI 10.1016/j.jmb.2004.10.011; NOLLER HF, 1992, SCIENCE, V256, P1416, DOI 10.1126/science.1604315; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Ohman A, 2003, J BIOMOL NMR, V26, P131, DOI 10.1023/A:1023502307069; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Pioletti M, 2001, EMBO J, V20, P1829, DOI 10.1093/emboj/20.8.1829; PRINCE JB, 1982, P NATL ACAD SCI-BIOL, V79, P5450, DOI 10.1073/pnas.79.18.5450; QUIGGLE K, 1981, BIOCHEMISTRY-US, V20, P3480, DOI 10.1021/bi00515a027; Ramos A, 1997, NUCLEIC ACIDS RES, V25, P2083, DOI 10.1093/nar/25.11.2083; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; Schmeing TM, 2005, MOL CELL, V20, P437, DOI 10.1016/j.molcel.2005.09.006; Schmeing TM, 2003, RNA, V9, P1345, DOI 10.1261/rna.5120503; Schmeing TM, 2002, NAT STRUCT BIOL, V9, P225, DOI 10.1038/nsb758; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Sergiev PV, 2005, NUCLEIC ACIDS RES, V33, P6048, DOI 10.1093/nar/gki910; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; Tung CS, 2004, BIOPHYS J, V87, P2714, DOI 10.1529/biophysj.104.040162; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; VONAHSEN U, 1995, SCIENCE, V267, P234, DOI 10.1126/science.7528943; Wang HF, 2004, PROTEIN SCI, V13, P2806, DOI 10.1110/ps.04864904; Weinger JS, 2004, NAT STRUCT MOL BIOL, V11, P1101, DOI 10.1038/nsmb841; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wilson DN, 2005, EMBO J, V24, P251, DOI 10.1038/sj.emboj.7600525; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Woestenenk EA, 2002, BIOCHEM J, V363, P553, DOI 10.1042/0264-6021:3630553; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	80	399	416	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 22	2006	126	6					1065	1077		10.1016/j.cell.2006.08.032	http://dx.doi.org/10.1016/j.cell.2006.08.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16962654	Bronze			2022-12-28	WOS:000240897600014
J	Meyer-Luehmann, M; Coomaraswamy, J; Bolmont, T; Kaeser, S; Schaefer, C; Kilger, E; Neuenschwander, A; Abramowski, D; Frey, P; Jaton, AL; Vigouret, JM; Paganetti, P; Walsh, DM; Mathews, PM; Ghiso, J; Staufenbiel, M; Walker, LC; Jucker, M				Meyer-Luehmann, Melanie; Coomaraswamy, Janaky; Bolmont, Tristan; Kaeser, Stephan; Schaefer, Claudia; Kilger, Ellen; Neuenschwander, Anton; Abramowski, Dorothee; Frey, Peter; Jaton, Anneliese L.; Vigouret, Jean-Marie; Paganetti, Paolo; Walsh, Dominic M.; Mathews, Paul M.; Ghiso, Jorge; Staufenbiel, Matthias; Walker, Lary C.; Jucker, Mathias			Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host	SCIENCE			English	Article							DISEASE-LIKE PATHOLOGY; ALZHEIMERS-DISEASE; TRANSGENIC MICE; LONG-TERM; IN-VIVO; PROTEIN; DEPOSITION; OLIGOMERS; MOUSE; CONFORMATION	Protein aggregation is an established pathogenic mechanism in Alzheimer's disease, but little is known about the initiation of this process in vivo. Intracerebral injection of dilute, amyloid-beta (A beta)-containing brain extracts from humans with Alzheimer's disease or beta-amyloid precursor protein (APP) transgenic mice induced cerebral beta-amyloidosis and associated pathology in APP transgenic mice in a time- and concentration-dependent manner. The seeding activity of brain extracts was reduced or abolished by A beta immunodepletion, protein denaturation, or by A beta immunization of the host. The phenotype of the exogenously induced amyloidosis depended on both the host and the source of the agent, suggesting the existence of polymorphic A beta strains with varying biological activities reminiscent of prion strains.	Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, D-72076 Tubingen, Germany; Univ Basel, Inst Pathol, CH-4003 Basel, Switzerland; Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; NYU, Sch Med, Nathan Kline Inst, Orangeburg, NY 10962 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA; Emory Univ, Dept Neurol, Atlanta, GA 30322 USA	Emory University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Basel; Novartis; University College Dublin; Nathan Kline Institute for Psychiatric Research; New York University; New York University; New York University; Emory University	Walker, LC (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.	lary.walker@emory.edu; mathias.jucker@uni-tuebingen.de	Walker, L C/J-6541-2015; Paganetti, Paolo/AAF-8039-2020	Walker, L C/0000-0001-9166-3261; Meyer-Luehmann, Melanie/0000-0003-3661-2220; Mathews, Paul/0000-0003-1742-7687; Jucker, Mathias/0000-0001-9045-1072; Paganetti, Paolo/0000-0003-1896-6324	NCRR NIH HHS [RR-00165] Funding Source: Medline; NINDS NIH HHS [NS45357] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS045357] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aguzzi A, 2003, SCIENCE, V302, P814, DOI 10.1126/science.1087348; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Calhoun ME, 1999, P NATL ACAD SCI USA, V96, P14088, DOI 10.1073/pnas.96.24.14088; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Demattos RB, 2004, J MOL NEUROSCI, V23, P255, DOI 10.1385/JMN:23:3:255; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mohajeri MH, 2002, J BIOL CHEM, V277, P35460, DOI 10.1074/jbc.M202899200; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200; Prinz M, 2003, NATURE, V425, P957, DOI 10.1038/nature02072; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Ridley RM, 2006, J NEURAL TRANSM, V113, P1243, DOI 10.1007/s00702-005-0385-2; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schmechel A, 2003, J BIOL CHEM, V278, P35317, DOI 10.1074/jbc.M303547200; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Stephan A, 2001, J NEUROSCI, V21, P5703, DOI 10.1523/JNEUROSCI.21-15-05703.2001; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a	31	730	747	0	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2006	313	5794					1781	1784		10.1126/science.1131864	http://dx.doi.org/10.1126/science.1131864			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990547				2022-12-28	WOS:000240655700047
J	Schob, H; Grossniklaus, U				Schob, Hanspeter; Grossniklaus, Ueli			The first high-resolution DNA "methylome"	CELL			English	Editorial Material							METHYLATION; GENES	Cytosine methylation plays a crucial role in the regulation of gene expression and the control of genome stability in higher eukaryotes. Despite its importance for normal development, the degree and genome-wide distribution of DNA methylation has remained largely unknown. In this issue of Cell, Zhang et al. (2006) fill this gap by presenting a high-resolution map of DNA methylation in the genome of the flowering plant Arabidopsis.	Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland	University of Zurich; University of Zurich	Schob, H (corresponding author), Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	hampe@botinst.unizh.ch; grossnik@botinst.unizh.ch	Grossniklaus, Ueli/E-9995-2016; Grossniklaus, Ueli/A-2736-2012	Grossniklaus, Ueli/0000-0002-0522-8974; 				Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Chan SWL, 2006, PLOS GENET, V2, P791, DOI 10.1371/journal.pgen.0020083; Day RC, 2005, TRENDS PLANT SCI, V10, P397, DOI 10.1016/j.tplants.2005.06.006; Gutierrez-Marcos JF, 2006, NAT GENET, V38, P876, DOI 10.1038/ng1828; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Tompa R, 2002, CURR BIOL, V12, P65, DOI 10.1016/S0960-9822(01)00622-4; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101	11	19	21	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 22	2006	126	6					1025	1028		10.1016/j.cell.2006.09.002	http://dx.doi.org/10.1016/j.cell.2006.09.002			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990127	Bronze			2022-12-28	WOS:000240897600008
J	Sadler, LE; Higbie, JM; Leslie, SR; Vengalattore, M; Stamper-Kurn, DM				Sadler, L. E.; Higbie, J. M.; Leslie, S. R.; Vengalattore, M.; Stamper-Kurn, D. M.			Spontaneous symmetry breaking in a quenched ferromagnetic spinor Bose-Einstein condensate	NATURE			English	Article							DYNAMICS; DOMAINS; VORTEX; ANALOG; PHASE	A central goal in condensed matter and modern atomic physics is the exploration of quantum phases of matter - in particular, how the universal characteristics of zero-temperature quantum phase transitions differ from those established for thermal phase transitions at non-zero temperature. Compared to conventional condensed matter systems, atomic gases provide a unique opportunity to explore quantum dynamics far from equilibrium. For example, gaseous spinor Bose - Einstein condensates(1-3) ( whose atoms have non-zero internal angular momentum) are quantum fluids that simultaneously realize superfluidity and magnetism, both of which are associated with symmetry breaking. Here we explore spontaneous symmetry breaking in Rb-87 spinor condensates, rapidly quenched across a quantum phase transition to a ferromagnetic state. We observe the formation of spin textures, ferromagnetic domains and domain walls, and demonstrate phase-sensitive in situ detection of spin vortices. The latter are topological defects resulting from the symmetry breaking, containing non-zero spin current but no net mass current(4).	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Stamper-Kurn, DM (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	dmsk@berkeley.edu	Leslie, Sabrina/M-3626-2016; Vengalattore, Mukund/B-2781-2015; Stamper-Kurn, Dan/B-5442-2015	Stamper-Kurn, Dan/0000-0002-4845-5835				Bauerle C, 1996, NATURE, V382, P332, DOI 10.1038/382332a0; Chang MS, 2005, NAT PHYS, V1, P111, DOI 10.1038/nphys153; Chang MS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.140403; CHUANG I, 1991, SCIENCE, V251, P1336, DOI 10.1126/science.251.4999.1336; Goldstein EV, 1997, PHYS REV A, V55, P2935, DOI 10.1103/PhysRevA.55.2935; Hall DS, 1998, PHYS REV LETT, V81, P1539, DOI 10.1103/PhysRevLett.81.1539; HENDRY PC, 1994, NATURE, V368, P315, DOI 10.1038/368315a0; Higbie JM, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.050401; Ho TL, 1998, PHYS REV LETT, V81, P742, DOI 10.1103/PhysRevLett.81.742; Isoshima T, 2001, J PHYS SOC JPN, V70, P1604, DOI 10.1143/JPSJ.70.1604; KIBBLE TWB, 1976, J PHYS A-MATH GEN, V9, P1387, DOI 10.1088/0305-4470/9/8/029; Klausen NN, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.053602; MERMIN ND, 1976, PHYS REV LETT, V36, P594, DOI 10.1103/PhysRevLett.36.594; Miesner HJ, 1999, PHYS REV LETT, V82, P2228, DOI 10.1103/PhysRevLett.82.2228; Ohmi T, 1998, J PHYS SOC JPN, V67, P1822, DOI 10.1143/JPSJ.67.1822; Pu H, 1999, PHYS REV A, V60, P1463, DOI 10.1103/PhysRevA.60.1463; Robins NP, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.021601; Ruutu VMH, 1996, NATURE, V382, P334, DOI 10.1038/382334a0; Saito H, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.065302; Saito H, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.023610; Schmaljohann H, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040402; Stamper-Kurn DM, 2001, LES HOUCH S, V72, P139; Stenger J, 1998, NATURE, V396, P345, DOI 10.1038/24567; Timmermans E, 1998, PHYS REV LETT, V81, P5718, DOI 10.1103/PhysRevLett.81.5718; Widera A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.190405; Zhang WX, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.180403; Zurek WH, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.105701; ZUREK WH, 1985, NATURE, V317, P505, DOI 10.1038/317505a0	28	748	750	4	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2006	443	7109					312	315		10.1038/nature05094	http://dx.doi.org/10.1038/nature05094			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085RL	16988706	Green Submitted			2022-12-28	WOS:000240622000040
J	Chalmers, L				Chalmers, Lain			Research and publication ethics - Role of systematic reviews in detecting plagiarism: case of Asim Kujak	BRITISH MEDICAL JOURNAL			English	Editorial Material									James Lind Lib, Oxford OX2 7LG, England		Chalmers, L (corresponding author), James Lind Lib, Oxford OX2 7LG, England.	ichalmers@jameslindlibrary.org						[Anonymous], 2004, NATURE, V427, P1; BLAAS HGK, 2002, GYNEKOLOGEN, V15, P37; BLAAS HGK, 1999, THESIS NORWEGIAN U S; Howell C J, 1992, Int J Obstet Anesth, V1, P93, DOI 10.1016/0959-289X(92)90008-R; Jefferson T, 2003, NATURE, V421, P209, DOI 10.1038/421209b; Jefferson T, 1999, PEER REV HLTH SCI, P224; Katavic V, 2006, CROAT MED J, V47, P220; Kurjak A, 1974, Acta Med Iugosl, V28, P15; KURJAK A, 2001, FETAL NEONATAL NEURO, P39; NOBLE AD, 1971, J OBSTET GYN BR COMM, V78, P559	10	58	61	1	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 16	2006	333	7568					594	596		10.1136/bmj.38968.611296.F7	http://dx.doi.org/10.1136/bmj.38968.611296.F7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089KB	16974016	Green Published, Bronze			2022-12-28	WOS:000240878200019
J	Bosset, JF; Collette, L; Calais, G; Mineur, L; Maingon, P; Radosevic-Jelic, L; Daban, A; Bardet, E; Beny, A; Ollier, J				Bosset, Jean-Francois; Collette, Laurence; Calais, Gilles; Mineur, Laurent; Maingon, Philippe; Radosevic-Jelic, Ljiljana; Daban, Alain; Bardet, Etienne; Beny, Alexander; Ollier, Jean-Claude		EORTC Radiotherapy Grp Trial 22921	Chemotherapy with preoperative radiotherapy in rectal cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TOTAL MESORECTAL EXCISION; RANDOMIZED-TRIAL; CARCINOMA; CHEMORADIOTHERAPY; FRACTIONATION; IRRADIATION; RECURRENCE; TOXICITY; PATTERNS; SURGERY	BACKGROUND: Preoperative radiotherapy is recommended for selected patients with rectal cancer. We evaluated the addition of chemotherapy to preoperative radiotherapy and the use of postoperative chemotherapy in the treatment of rectal cancer. METHODS: We randomly assigned patients with clinical stage T3 or T4 resectable rectal cancer to receive preoperative radiotherapy, preoperative chemoradiotherapy, preoperative radiotherapy and postoperative chemotherapy, or preoperative chemoradiotherapy and postoperative chemotherapy. Radiotherapy consisted of 45 Gy delivered over a period of 5 weeks. One course of chemotherapy consisted of 350 mg of fluorouracil per square meter of body-surface area per day and 20 mg of leucovorin per square meter per day, both given for 5 days. Two courses were combined with preoperative radiotherapy in the group receiving preoperative chemoradiotherapy and the group receiving preoperative chemoradiotherapy and postoperative chemotherapy; four courses were planned postoperatively in the group receiving preoperative radiotherapy and postoperative chemotherapy and the group receiving preoperative chemoradiotherapy and postoperative chemotherapy. The primary end point was overall survival. RESULTS: We enrolled 1011 patients in the trial. There was no significant difference in overall survival between the groups that received chemotherapy preoperatively (P=0.84) and those that received it postoperatively (P=0.12). The combined 5-year overall survival rate for all four groups was 65.2%. The 5-year cumulative incidence rates for local recurrences were 8.7%, 9.6%, and 7.6% in the groups that received chemotherapy preoperatively, postoperatively, or both, respectively, and 17.1% in the group that did not receive chemotherapy (P=0.002). The rate of adherence to preoperative chemotherapy was 82.0%, and to postoperative chemotherapy was 42.9%. CONCLUSIONS: In patients with rectal cancer who receive preoperative radiotherapy, adding fluorouracil-based chemotherapy preoperatively or postoperatively has no significant effect on survival. Chemotherapy, regardless of whether it is administered before or after surgery, confers a significant benefit with respect to local control.	Univ Franche Comte, Dept Radiat Therapy, F-25030 Besancon, France; European Org Res Treatment Canc, Ctr Data, Brussels, Belgium; Univ Tours, Dept Radiat Therapy, Tours, France; Clin Ste Catherine, Dept Radiat Therapy, Avignon, France; Canc Ctr Dijon, Dept Radiat Therapy, Dijon, France; Inst Oncol & Radiol, Belgrade, Serbia; Univ Poitiers, Dept Radiat Therapy, Poitiers, France; Canc Ctr Nantes, Dept Radiat Therapy, Nantes, France; Rambam Med Ctr, Dept Radiat Therapy, Haifa, Israel; Canc Ctr Strasbourg, Dept Surg, Strasbourg, France	Universite de Franche-Comte; European Organisation for Research & Treatment of Cancer; Universite de Tours; Institute for Oncology & Radiology of Serbia (IORS); Universite de Poitiers; Rambam Health Care Campus; Technion Israel Institute of Technology	Bosset, JF (corresponding author), Besancon Univ Hosp, Dept Radiotherapy, Blvd Fleming, F-25030 Besancon, France.	jean-francois.bosset@ufc-chu.univ-fcomte.fr		Collette, Laurence/0000-0003-2518-7281	NATIONAL CANCER INSTITUTE [U10CA011488] Funding Source: NIH RePORTER; NCI NIH HHS [2U10-CA11488-21, 2U10-CA11488-34, 2U10-CA11488-30, 2U10-CA11488-27, 2U10-CA11488-22, 2U10-CA11488-25, 2U10-CA11488-24, 2U10-CA11488-28, 2U10-CA11488-31, 2U10-CA11488-29, 2U10-CA11488-26, 2U10-CA11488-23, 2U10-CA11488-32, 2U10-CA11488-35, 2U10-CA11488-33] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARENDSEN GW, 1982, INT J RADIAT ONCOL, V8, P1981, DOI 10.1016/0360-3016(82)90459-X; Bosset JF, 2005, J CLIN ONCOL, V23, P5620, DOI 10.1200/JCO.2005.02.113; Bosset JF, 2004, EUR J CANCER, V40, P219, DOI 10.1016/j.ejca.2003.09.032; BOSSET JF, 1993, EUR J CANCER, V29A, P1406, DOI 10.1016/0959-8049(93)90012-5; CEDERMARK B, 1995, CANCER-AM CANCER SOC, V75, P2269, DOI 10.1002/1097-0142(19950501)75:9<2269::AID-CNCR2820750913>3.0.CO;2-I; CEDERMARK B, 1994, P AN M AM SOC CLIN, V13, P198; Chan I, 2006, J CLIN ONCOL, V24, P668, DOI 10.1200/JCO.2005.04.4875; DAHL O, 1990, CANCER-AM CANCER SOC, V66, P2286, DOI 10.1002/1097-0142(19901201)66:11<2286::AID-CNCR2820661106>3.0.CO;2-T; Dahlberg M, 1998, DIS COLON RECTUM, V41, P543, DOI 10.1007/BF02235256; GALANDIUK S, 1992, SURG GYNECOL OBSTET, V174, P27; GERARD A, 1988, ANN SURG, V208, P606, DOI 10.1097/00000658-198811000-00011; GOLDBERG PA, 1994, EUR J CANCER, V30A, P1602, DOI 10.1016/0959-8049(94)00312-S; Gray R, 2001, LANCET, V358, P1291; HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P1444; Kalbfleisch JD, 1980, STAT ANAL FAILURE TI, P163; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kouloulias VE, 2002, EUR J CANCER, V38, P1849, DOI 10.1016/S0959-8049(02)00174-0; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Marijnen CAM, 2004, RADIOTHER ONCOL, V73, pS127; MARSH PJ, 1994, DIS COLON RECTUM, V37, P1205, DOI 10.1007/BF02257783; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; MINSKY BD, 1988, CANCER-AM CANCER SOC, V61, P1408, DOI 10.1002/1097-0142(19880401)61:7<1408::AID-CNCR2820610722>3.0.CO;2-A; MUSAT E, 2005, EJC SUPPL, V2, P171; NETO JAR, 1989, DIS COLON RECTUM, V32, P702, DOI 10.1007/BF02555778; Oates GD, 1996, LANCET, V348, P1605; Pahlman L, 1997, NEW ENGL J MED, V336, P1539; Pahlman L, 1997, NEW ENGL J MED, V336, P980; Peeters KCMJ, 2005, J CLIN ONCOL, V23, P6199, DOI 10.1200/JCO.2005.14.779; PHILLIPS RKS, 1984, BRIT J SURG, V71, P12, DOI 10.1002/bjs.1800710104; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Sobin LH, 1987, TNM CLASSIFICATION M; TURESSON I, 1984, INT J RADIAT ONCOL, V10, P593, DOI 10.1016/0360-3016(84)90289-X	33	1969	2101	2	71	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 14	2006	355	11					1114	1123		10.1056/NEJMoa060829	http://dx.doi.org/10.1056/NEJMoa060829			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083NJ	16971718				2022-12-28	WOS:000240462800006
J	Nieder, A; Diester, I; Tudusciuc, O				Nieder, Andreas; Diester, Ilka; Tudusciuc, Oana			Temporal and spatial enumeration processes in the primate parietal cortex	SCIENCE			English	Article							PREFRONTAL CORTEX; NUMBER REPRESENTATION; NUMERICAL INFORMATION; MONKEY; DISSOCIATION; COGNITION; CHILDREN; ADULTS; MODEL	Humans and animals can nonverbally enumerate visual items across time in a sequence or rapidly estimate the set size of spatial dot patterns at a single glance. We found that temporal and spatial enumeration processes engaged different populations of neurons in the intraparietal sulcus of behaving monkeys. Once the enumeration process was completed, however, another neuronal population represented the cardinality of a set irrespective of whether it had been cued in a spatial layout or across time. These data suggest distinct neural processing stages for different numerical formats, but also a final convergence of the segregated information to form most abstract quantity representations.	Univ Tubingen, Dept Cognit Neurosci, Hertie Inst Clin Brain Res, Primate NeuroCognit Lab, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Nieder, A (corresponding author), Univ Tubingen, Dept Cognit Neurosci, Hertie Inst Clin Brain Res, Primate NeuroCognit Lab, Otfried Muller Str 27, D-72076 Tubingen, Germany.	andreas.nieder@uni-tuebingen.de	Tudusciuc, Oana/C-1339-2011					ANSARI D, IN PRESS BRAIN RES; Barth H, 2003, COGNITION, V86, P201, DOI 10.1016/S0010-0277(02)00178-6; Cantlon JF, 2006, PLOS BIOL, V4, P844, DOI 10.1371/journal.pbio.0040125; CIPOLOTTI L, 1991, BRAIN, V114, P2619, DOI 10.1093/brain/114.6.2619; Cordes S, 2001, PSYCHON B REV, V8, P698, DOI 10.3758/BF03196206; Dehaene S, 1997, CORTEX, V33, P219, DOI 10.1016/S0010-9452(08)70002-9; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DEHAENE S, 1993, J COGNITIVE NEUROSCI, V5, P390, DOI 10.1162/jocn.1993.5.4.390; Delazer M, 1997, COGN NEUROPSYCHOL, V14, P613; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; Gordon P, 2004, SCIENCE, V306, P496, DOI 10.1126/science.1094492; HAUSER MD, 2004, COGNITIVE NEUROSCIEN, V3; Isaacs EB, 2001, BRAIN, V124, P1701, DOI 10.1093/brain/124.9.1701; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; Nieder A, 2005, NAT REV NEUROSCI, V6, P177, DOI 10.1038/nrn1626; Nieder A, 2004, J COGNITIVE NEUROSCI, V16, P889, DOI 10.1162/089892904970807; Nieder A, 2004, P NATL ACAD SCI USA, V101, P7457, DOI 10.1073/pnas.0402239101; Nieder A, 2003, NEURON, V37, P149, DOI 10.1016/S0896-6273(02)01144-3; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; Ninokura Y, 2004, J NEUROPHYSIOL, V91, P555, DOI 10.1152/jn.00694.2003; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Sawamura H, 2002, NATURE, V415, P918, DOI 10.1038/415918a; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; Turconi E, 2004, COGNITIVE BRAIN RES, V21, P22, DOI 10.1016/j.cogbrainres.2004.05.003; Whalen J, 1999, PSYCHOL SCI, V10, P130, DOI 10.1111/1467-9280.00120; Wood JN, 2005, COGNITION, V97, P23, DOI 10.1016/j.cognition.2004.06.007	28	221	223	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2006	313	5792					1431	1435		10.1126/science.1130308	http://dx.doi.org/10.1126/science.1130308			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	081WQ	16960005				2022-12-28	WOS:000240348700041
J	Owen, AM; Coleman, MR; Boly, M; Davis, MH; Laureys, S; Pickard, JD				Owen, Adrian M.; Coleman, Martin R.; Boly, Melanie; Davis, Matthew H.; Laureys, Steven; Pickard, John D.			Detecting awareness in the vegetative state	SCIENCE			English	Article									MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England; Addenbrookes Hosp, Div Acad Neurosurg, Cambridge CB2 2QQ, England; Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge CB2 2QQ, England; Univ Liege, Cyclotron Res Ctr, B-4000 Liege, Belgium; Univ Liege, Dept Neurol, B-4000 Liege, Belgium	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Liege; University of Liege	Owen, AM (corresponding author), MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England.	adrian.owen@mrc-cbu.cam.ac.uk	Owen, Adrian M/B-4997-2015; Laureys, Steven/A-3349-2011; Davis, Matthew/F-6039-2010; Laureys, Steven/AAN-2097-2021	Laureys, Steven/0000-0002-3096-3807; Davis, Matt/0000-0003-2239-0778; Boly, Melanie/0000-0001-9584-0907	Medical Research Council [G0001237, MC_U105580446, G9439390, MC_U105559847] Funding Source: Medline; MRC [MC_U105580446, G0001237, G9439390, MC_U105559847] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		*ROYAL COLL PHYS, 2003, VEG STAT GUID DIAGN; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131	2	999	1025	5	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2006	313	5792					1402	1402		10.1126/science.1130197	http://dx.doi.org/10.1126/science.1130197			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16959998	Green Submitted			2022-12-28	WOS:000240348700032
J	Chanana, C				Chanana, Charu			Where next for China? Birth ratio in India is also dwindling	BRITISH MEDICAL JOURNAL			English	Letter									All India Inst Med Sci, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Chanana, C (corresponding author), All India Inst Med Sci, New Delhi 110029, India.	charuchanana@rediffmail.com						Ding QJ, 2006, BMJ-BRIT MED J, V333, P371, DOI 10.1136/bmj.38775.672662.80	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 2	2006	333	7566					500	500		10.1136/bmj.333.7566.500	http://dx.doi.org/10.1136/bmj.333.7566.500			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085QP	16946349	Green Published			2022-12-28	WOS:000240618900030
J	Woyke, T; Teeling, H; Ivanova, NN; Huntemann, M; Richter, M; Gloeckner, FO; Boffelli, D; Anderson, IJ; Barry, KW; Shapiro, HJ; Szeto, E; Kyrpides, NC; Mussmann, M; Amann, R; Bergin, C; Ruehland, C; Rubin, EM; Dubilier, N				Woyke, Tanja; Teeling, Hanno; Ivanova, Natalia N.; Huntemann, Marcel; Richter, Michael; Gloeckner, Frank Oliver; Boffelli, Dario; Anderson, Iain J.; Barry, Kerrie W.; Shapiro, Harris J.; Szeto, Ernest; Kyrpides, Nikos C.; Mussmann, Marc; Amann, Rudolf; Bergin, Claudia; Ruehland, Caroline; Rubin, Edward M.; Dubilier, Nicole			Symbiosis insights through metagenomic analysis of a microbial consortium	NATURE			English	Article							BACTERIA; GENOME; GENE; OLIGOCHAETA; COMMUNITIES; SYSTEM; WORM; SEA	Symbioses between bacteria and eukaryotes are ubiquitous, yet our understanding of the interactions driving these associations is hampered by our inability to cultivate most host-associated microbes. Here we use a metagenomic approach to describe four co-occurring symbionts from the marine oligochaete Olavius algarvensis, a worm lacking a mouth, gut and nephridia. Shotgun sequencing and metabolic pathway reconstruction revealed that the symbionts are sulphur-oxidizing and sulphate-reducing bacteria, all of which are capable of carbon fixation, thus providing the host with multiple sources of nutrition. Molecular evidence for the uptake and recycling of wormwaste products by the symbionts suggests how the worm could eliminate its excretory system, an adaptation unique among annelid worms. We propose a model that describes how the versatile metabolism within this symbiotic consortium provides the host with an optimal energy supply as it shuttles between the upper oxic and lower anoxic coastal sediments that it inhabits.	Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; Int Jacobs Univ Bremen, D-28759 Bremen, Germany	Max Planck Society; United States Department of Energy (DOE); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Rubin, EM (corresponding author), Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany.	EMRubin@lbl.gov; ndubilie@mpi-bremen.de	Amann, Rudolf I/C-6534-2014; Barry, Kerrie Whitelaw/AAA-5500-2020; Dubilier, Nicole/I-8203-2018; Kyrpides, Nikos C./A-6305-2014; Huntemann, Marcel/HCH-8928-2022; Mussmann, Marc/AAA-6108-2021; Mussmann, Marc/A-8649-2017	Amann, Rudolf I/0000-0002-0846-7372; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Dubilier, Nicole/0000-0002-9394-825X; Kyrpides, Nikos C./0000-0002-6131-0462; Huntemann, Marcel/0000-0002-1284-3748; Mussmann, Marc/0000-0003-3102-8703; , Marc/0000-0003-2785-2521; Ivanova, Natalia/0000-0002-5802-9485				[Anonymous], 2002, HIST PHIL LIFE SCI; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Blazejak A, 2005, APPL ENVIRON MICROB, V71, P1553, DOI 10.1128/AEM.71.3.1553-1561.2005; Cavanaugh CM, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 1, THIRD EDITION, P475, DOI 10.1007/0-387-30741-9_18; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; De Cian MC, 2000, J EXP BIOL, V203, P2907; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; DeLong EF, 2002, CURR OPIN MICROBIOL, V5, P520, DOI 10.1016/S1369-5274(02)00353-3; Denger K, 2004, MICROBIOL-SGM, V150, P1859, DOI 10.1099/mic.0.27077-0; Dubilier N, 2001, NATURE, V411, P298, DOI 10.1038/35077067; Dubilier Nicole, 2006, V41, P251; Giere O, 2002, ORG DIVERS EVOL, V2, P289, DOI 10.1078/1439-6092-00044; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; HUNTEMANN M, 2006, THESIS U BREMEN; Kelly DJ, 2001, FEMS MICROBIOL REV, V25, P405, DOI 10.1111/j.1574-6976.2001.tb00584.x; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Kletzin A, 1996, J BACTERIOL, V178, P248, DOI 10.1128/jb.178.1.248-257.1996; Liu JY, 1999, MOL MICROBIOL, V31, P1845, DOI 10.1046/j.1365-2958.1999.01321.x; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Matias PM, 2005, PROG BIOPHYS MOL BIO, V89, P292, DOI 10.1016/j.pbiomolbio.2004.11.003; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Moran NA, 2003, CURR OPIN MICROBIOL, V6, P512, DOI 10.1016/j.mib.2003.08.001; Moran NA, 2004, CURR OPIN GENET DEV, V14, P627, DOI 10.1016/j.gde.2004.09.003; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Mowat CG, 2004, NAT STRUCT MOL BIOL, V11, P1023, DOI 10.1038/nsmb827; Paul L, 2000, J BACTERIOL, V182, P2520, DOI 10.1128/JB.182.9.2520-2529.2000; Quast C, 2006, THESIS U BREMEN; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Ruby E, 2004, SCIENCE, V303, P1305, DOI 10.1126/science.1094662; Teeling H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-163; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; vandenEnde FP, 1997, FEMS MICROBIOL ECOL, V23, P65, DOI 10.1016/S0168-6496(97)00014-7; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188; Yancey PH, 2002, COMP BIOCHEM PHYS A, V133, P667, DOI 10.1016/S1095-6433(02)00182-4; YANG CC, 1995, EUR J BIOCHEM, V232, P264, DOI 10.1111/j.1432-1033.1995.tb20808.x	39	311	327	2	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	2006	443	7114					950	955		10.1038/nature05192	http://dx.doi.org/10.1038/nature05192			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	16980956	Green Submitted			2022-12-28	WOS:000241523400045
J	Bosch, J; Yusuf, S; Gerstein, HC; Pogue, J; Sheridan, P; Dagenais, G; Chiasson, JL; Diaz, R; Avezum, A; Lanas, F; Probstfield, J; Fodor, G; Holman, RR				Bosch, Jackie; Yusuf, Salim; Gerstein, Hertzel C.; Pogue, Janice; Sheridan, Patrick; Dagenais, Gilles; Chiasson, Jean Louis; Diaz, Rafael; Avezum, Alvaro; Lanas, Fernando; Probstfield, Jeffrey; Fodor, George; Holman, Rury R.		DREAM Trial Investigators	Effect of ramipril on the incidence of diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONVERTING-ENZYME INHIBITORS; CARDIOVASCULAR-DISEASE; HEART-FAILURE; MELLITUS; RISK; PREVENTION; GLUCOSE; HYPERTENSION; DYSFUNCTION; MORTALITY	BACKGROUND Previous studies have suggested that blockade of the renin-angiotensin system may prevent diabetes in people with cardiovascular disease or hypertension. METHODS In a double-blind, randomized clinical trial with a 2-by-2 factorial design, we randomly assigned 5269 participants without cardiovascular disease but with impaired fasting glucose levels (after an 8-hour fast) or impaired glucose tolerance to receive ramipril (up to 15 mg per day) or placebo (and rosiglitazone or placebo) and followed them for a median of 3 years. We studied the effects of ramipril on the development of diabetes or death, whichever came first (the primary outcome), and on secondary outcomes, including regression to normoglycemia. RESULTS The incidence of the primary outcome did not differ significantly between the ramipril group (18.1%) and the placebo group (19.5%; hazard ratio for the ramipril group, 0.91; 95% confidence interval [CI], 0.81 to 1.03; P=0.15). Participants receiving ramipril were more likely to have regression to normoglycemia than those receiving placebo (hazard ratio, 1.16; 95% CI, 1.07 to 1.27; P=0.001). At the end of the study, the median fasting plasma glucose level was not significantly lower in the ramipril group (102.7 mg per deciliter [5.70 mmol per liter]) than in the placebo group (103.4 mg per deciliter [5.74 mmol per liter], P=0.07), though plasma glucose levels 2 hours after an oral glucose load were significantly lower in the ramipril group (135.1 mg per deciliter [7.50 mmol per liter] vs. 140.5 mg per deciliter [7.80 mmol per liter], P=0.01). CONCLUSIONS Among persons with impaired fasting glucose levels or impaired glucose tolerance, the use of ramipril for 3 years does not significantly reduce the incidence of diabetes or death but does significantly increase regression to normoglycemia.	McMaster Univ, Hamilton, ON, Canada; Univ Laval, Heart & Lung Inst, Quebec City, PQ, Canada; Ctr Hosp Univ Montreal, Hotel Dieu, Res Ctr, Montreal, PQ, Canada; Inst Cardiovasc Res, Rosario, Santa Fe, Argentina; Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; Univ La Frontera, Temuco, Chile; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Univ Ottawa, Inst Heart, Ottawa, ON, Canada; Oxford Ctr Diabet Endocrinol & Metab, Oxford, England	McMaster University; Laval University; Quebec Heart & Lung Institute; Laval University; Universite de Montreal; Instituto Dante Pazzanese de Cardiologia; Universidad de La Frontera; Fred Hutchinson Cancer Center; University of Ottawa; University of Ottawa Heart Institute; University of Oxford	Bosch, J (corresponding author), Populat Hlth Res Inst, DREAM Project Off, 2nd Fl,McMaster Clin,237 Barton St E, Hamilton, ON L8L 2X2, Canada.	dream@cardio.on.ca	Gerstein, Hertzel C/B-1235-2013; Lanas, Fernando/AAE-8842-2022; Gerstein, Hertzel/ABB-8781-2020; Avezum, Alvaro/AAP-7687-2020; Bosch, Jacqueline/AAP-6910-2021; Bernardino, Jose Ignacio/H-7898-2017; Cohen, Neale/B-7595-2015; Piskorz, Daniel/AAJ-8751-2020; Gray, Stuart/L-2489-2017; TUTUNCU, YILDIZ/D-3955-2015; Fuste, Pere/P-7244-2015	Gerstein, Hertzel C/0000-0001-8072-2836; Gerstein, Hertzel/0000-0001-8072-2836; Bosch, Jacqueline/0000-0001-6292-4207; Bernardino, Jose Ignacio/0000-0003-3501-8529; Cohen, Neale/0000-0002-4441-9511; Davies, Melanie/0000-0002-9987-9371; Piskorz, Daniel/0000-0002-8615-5446; Gray, Stuart/0000-0001-8969-9636; Bryan, Laura/0000-0002-9422-2338; Kashyap, Sangeeta/0000-0002-7489-6650; Segura, Julian/0000-0003-4677-9526; , Chippada Appa Rao/0000-0002-4817-8946; TUTUNCU, YILDIZ/0000-0002-3905-6429; Chippada, Apparao/0000-0002-9683-2738; Fernandez, Angel L./0000-0003-1307-8221; Fuste, Pere/0000-0002-8129-9897; Colman, Peter/0000-0001-8718-6175; Gonzalez-Gonzalez, Jose Gerardo/0000-0002-6609-9483; Yusuf, Salim/0000-0003-4776-5601; Lochnan, Heather/0000-0002-3820-7897; Pirags, Valdis/0000-0002-3650-7394; Andreotti Turatti, Luiz Alberto/0000-0002-0089-5794; Lanas, Fernando/0000-0003-3595-9759				Booth GL, 2006, LANCET, V368, P29, DOI 10.1016/S0140-6736(06)68967-8; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Dagenais GR, 2006, LANCET, V368, P581, DOI 10.1016/S0140-6736(06)69201-5; Diabetes Prevention Program Research Group, 2002, NEW ENGL J MED, V346, P393, DOI [10.1056/NEJMoa012512, DOI 10.1056/NEJMOA012512]; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gerstein HC, 2004, DIABETOLOGIA, V47, P1519, DOI 10.1007/s00125-004-1485-5; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Lachin JM, 1999, CONTROL CLIN TRIALS, V20, P408, DOI 10.1016/S0197-2456(99)00022-7; Lindholm LH, 2002, J HYPERTENS, V20, P1879, DOI 10.1097/00004872-200209000-00035; Lindholm LH, 2003, J HYPERTENS, V21, P1563, DOI 10.1097/00004872-200308000-00022; Norhammar A, 2002, LANCET, V359, P2140, DOI 10.1016/S0140-6736(02)09089-X; Padwal R, 2005, DIABETES CARE, V28, P736, DOI 10.2337/diacare.28.3.736; Razak F, 2005, CIRCULATION, V111, pE254; Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130; Taylor EN, 2006, DIABETES CARE, V29, P1065, DOI 10.2337/dc05-2366; Teo KK, 2004, AM HEART J, V148, P52, DOI 10.1016/j.ahj.2004.03.020; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vermes E, 2003, CIRCULATION, V107, P1291, DOI 10.1161/01.CIR.0000054611.89228.92; Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716; Yusuf S, 2005, CIRCULATION, V112, P48, DOI 10.1161/CIRCULATIONAHA.104.528166; Yusuf S, 2001, JAMA-J AM MED ASSOC, V286, P1882, DOI 10.1001/jama.286.15.1882	25	515	546	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 12	2006	355	15					1551	1562						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	093HW	16980380				2022-12-28	WOS:000241160400006
J	Janzen, V; Forkert, R; Fleming, HE; Saito, Y; Waring, MT; Dombkowski, DM; Cheng, T; DePinho, RA; Sharpless, NE; Scadden, DT				Janzen, Viktor; Forkert, Randolf; Fleming, Heather E.; Saito, Yoriko; Waring, Michael T.; Dombkowski, David M.; Cheng, Tao; DePinho, Ronald A.; Sharpless, Norman E.; Scadden, David T.			Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16(INK4a)	NATURE			English	Article							HEMATOPOIETIC STEM; SELF-RENEWAL; IN-VIVO; EXPRESSION; ENGRAFTMENT; SENESCENCE; INCREASES; P19(ARF); YOUNG; MICE	Stem-cell ageing is thought to contribute to altered tissue maintenance and repair. Older humans experience increased bone marrow failure and poorer haematologic tolerance of cytotoxic injury. Haematopoietic stem cells (HSCs) in older mice have decreased per-cell repopulating activity, self-renewal and homing abilities, myeloid skewing of differentiation, and increased apoptosis with stress. Here we report that the cyclin-dependent kinase inhibitor p16(INK4a), the level of which was previously noted to increase in other cell types with age, accumulates and modulates specific age-associated HSC functions. Notably, in the absence of p16(INK4a), HSC repopulating defects and apoptosis were mitigated, improving the stress tolerance of cells and the survival of animals in successive transplants, a stem- cell-autonomous tissue regeneration model. Inhibition of p16(INK4a) may ameliorate the physiological impact of ageing on stem cells and thereby improve injury repair in aged tissue.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Canc Ctr,Ctr Regenerat Med, Boston, MA 02114 USA; Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Ctr Appl Canc Sci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Scadden, DT (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Canc Ctr,Ctr Regenerat Med, 185 Cambridge St, Boston, MA 02114 USA.	scadden.david@mgh.harvard.edu		Sharpless, Norman/0000-0001-7078-9455; Cheng, Tao/0000-0002-5925-2769; DePinho, Ronald/0000-0002-5625-577X				Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Chen JC, 1999, EXP HEMATOL, V27, P928, DOI 10.1016/S0301-472X(99)00018-1; Chen JC, 2000, EXP HEMATOL, V28, P442, DOI 10.1016/S0301-472X(99)00157-5; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Chimenti C, 2003, CIRC RES, V93, P604, DOI 10.1161/01.RES.0000093985.76901.AF; Chkhotua AB, 2003, AM J KIDNEY DIS, V41, P1303, DOI 10.1016/S0272-6386(03)00363-9; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; HARRISON DE, 1972, NATURE-NEW BIOL, V237, P220, DOI 10.1038/newbio237220a0; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; KRISHNAMURTHY J, 2006, NATURE          0906, DOI DOI 10.1038/NATURE05092; Kunisato A, 2003, BLOOD, V101, P1777, DOI 10.1182/blood-2002-07-2051; Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282; MOLOFSKY AV, 2006, NATURE          0906, DOI DOI 10.1038/NATURE05091; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; OGDEN DA, 1976, TRANSPLANTATION, V22, P287, DOI 10.1097/00007890-197609000-00010; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; PHELPS WC, 1992, J VIROL, V66, P2418, DOI 10.1128/JVI.66.4.2418-2427.1992; Rocco JW, 2001, EXP CELL RES, V264, P42, DOI 10.1006/excr.2000.5149; Sharpless NE, 2004, EXP GERONTOL, V39, P1751, DOI 10.1016/j.exger.2004.06.025; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; SIMINOVITCH L, 1964, J CELL COMPAR PHYSL, V64, P23, DOI 10.1002/jcp.1030640104; Stepanova L, 2005, BLOOD, V106, P827, DOI 10.1182/blood-2004-06-2242; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Walkley CR, 2005, NAT CELL BIOL, V7, P172, DOI 10.1038/ncb1214; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	33	838	900	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2006	443	7110					421	426		10.1038/nature05159	http://dx.doi.org/10.1038/nature05159			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	16957735				2022-12-28	WOS:000240798800038
J	Atik, B; Thanh, TTK; Luong, VQ; Lagree, S; Dean, D				Atik, Berna; Thanh, Ton Ton Kim; Luong, Vu Quoc; Lagree, Stephane; Dean, Deborah			Impact of annual targeted treatment on infectious trachoma and susceptibility to reinfection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SINGLE-DOSE AZITHROMYCIN; OCULAR CHLAMYDIA-TRACHOMATIS; ORAL AZITHROMYCIN; MASS TREATMENT; TOPICAL OXYTETRACYCLINE/POLYMYXIN; PREVALENCE; TETRACYCLINE	Context The World Health Organization developed the SAFE strategy ( Surgery for trichiasis; Antibiotics for Chlamydia trachomatis infection; Facial cleanliness; and Environmental improvement) to eliminate blinding trachoma globally by the year 2020. Despite a number of studies using various intervals of treatment for different prevalence rates, there has been a lack of sufficient follow-up beyond the final treatment point to determine rates of recurrence of disease and infection and the risk factors that may contribute to each. Objective To evaluate the impact of 2 annual targeted azithromycin treatments on active trachoma and C trachomatis infection rates over 3 years in Vietnam. Design, Setting, and Participants Three communes were randomly selected for a longitudinal study in Vietnam from November 2000 through November 2003. Individuals (n = 3186) were graded for trachoma followed by conjunctival sampling to detect chlamydiae by commercial polymerase chain reaction. Grading and chlamydial detection were repeated every 6 months for 3 years. Intervention Azithromycin was given to children aged 5 through 15 years with active trachoma and their household members in SAFE and SA communes at baseline and 12 months; these communes were compared with the S-only control commune that did not receive azithromycin targeted treatment. Main Outcome Measures Prevalence and incidence of active trachoma and C trachomatis infection in all communes at baseline, 6, 12, 18, 24, and 36 months. Subgroup analysis evaluated new infection, continuing infection, and reinfection at 6, 12, 18, 24, and 36 months and risk factors for each. Results Reinfection rates increased significantly between 12 and 36 months for SAFE ( from 1.6 to 29.3 per 1000; P < .001) and SA (5.1 to 25.3 per 1000; P = . 002) communes but not for the S-only commune (13.4 to 6.7 per 1000; P = .55) after 24 months. Compared with the S-only commune, mixed-effects and generalized estimating equations ( GEE) logistic models showed that reinfection risk was significantly higher for SAFE ( odds ratio [OR], 4.1; 95% confidence interval [CI], 1.5- 9.8; P = .005) and SA ( OR, 4.2; 95% CI, 1.1-17.3; P = .04) communes at 36 months. Conclusions Increasing reinfection rates suggest that treatment may interrupt the duration of infection required for developing immunity, increasing the number of individuals susceptible to reinfection and adversely affecting disease prevalence over time. Additional research is needed to determine optimal trachoma control strategies, including evaluation of the "F" and "E" components.	Childrens Hosp Oakland, Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA; Natl Inst Ophthalmol, Hanoi, Vietnam; Int Trachoma Initiat, Hanoi, Vietnam; Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California San Francisco	Dean, D (corresponding author), Childrens Hosp Oakland, Res Inst, Ctr Immunobiol & Vaccine Dev, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	ddean@chori.org			NIAID NIH HHS [EY/AI12219] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASSAAD FA, 1971, B WORLD HEALTH ORGAN, V44, P605; Bailey R, 1999, EPIDEMIOL INFECT, V123, P479, DOI 10.1017/S0950268899003076; BAILEY R, 1989, INT J EPIDEMIOL, V18, P944, DOI 10.1093/ije/18.4.944; BAILEY RL, 1993, LANCET, V342, P453, DOI 10.1016/0140-6736(93)91591-9; Baral K, 1999, B WORLD HEALTH ORGAN, V77, P461; BARSOUM IS, 1988, MED MICROBIOL IMMUN, V177, P349, DOI 10.1007/BF02389907; Bowman RJC, 2000, INVEST OPHTH VIS SCI, V41, P4074; BRAFF E, 1952, PUBLIC HEALTH REP, V67, P1233, DOI 10.2307/4588340; Brunham RC, 2005, J INFECT DIS, V192, P1836, DOI 10.1086/497341; Burton MJ, 2003, INVEST OPHTH VIS SCI, V44, P4215, DOI 10.1167/iovs.03-0107; Chidambaram JD, 2006, JAMA-J AM MED ASSOC, V295, P1142, DOI 10.1001/jama.295.10.1142; Chidambaram JD, 2004, EMERG INFECT DIS, V10, P1895; Dawson CR, 1997, CLIN INFECT DIS, V24, P363, DOI 10.1093/clinids/24.3.363; Dean D, 2001, INFECT IMMUN, V69, P2442, DOI 10.1128/IAI.69.4.2442-2447.2001; Dean D, 1997, PATHOLOGY INFECT DIS, P498; Fraser-Hurt N, 2001, B WORLD HEALTH ORGAN, V79, P632; Frick KD, 2001, B WORLD HEALTH ORGAN, V79, P201; Gaynor BD, 2003, EMERG INFECT DIS, V9, P596, DOI 10.3201/eid0905.020577; Guzey M, 2000, JPN J OPHTHALMOL, V44, P387, DOI 10.1016/S0021-5155(00)00167-2; HALLORAN ME, 1998, MODERN EPIDEMIOLOGY, P529; Holm SO, 2001, B WORLD HEALTH ORGAN, V79, P194; Jha H, 2002, CLIN INFECT DIS, V35, P765, DOI 10.1086/342298; Laming AC, 2000, MED J AUSTRALIA, V172, P163, DOI 10.5694/j.1326-5377.2000.tb125541.x; Lietman T, 1999, NAT MED, V5, P572, DOI 10.1038/8451; LUNA EJA, 1992, INT J EPIDEMIOL, V21, P169, DOI 10.1093/ije/21.1.169; Melese M, 2004, JAMA-J AM MED ASSOC, V292, P721, DOI 10.1001/jama.292.6.721; Nguyen D H, 1991, Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique, V68, P171; Schachter J, 1999, LANCET, V354, P630, DOI 10.1016/S0140-6736(98)12387-5; Sheffield JS, 2005, OBSTET GYNECOL, V105, P557, DOI 10.1097/01.AOG.0000153533.13658.c2; Solomon AW, 2004, NEW ENGL J MED, V351, P1962, DOI 10.1056/NEJMoa040979; Standard I, 2000, 4049 ISO, V1, P27; Tabbara KF, 1996, OPHTHALMOLOGY, V103, P842; TAYLOR HR, 1987, INVEST OPHTH VIS SCI, V28, P249; TAYLOR HR, 1990, AM J TROP MED HYG, V42, P358, DOI 10.4269/ajtmh.1990.42.358; TAYLOR HR, 1992, AM J TROP MED HYG, V46, P552, DOI 10.4269/ajtmh.1992.46.552; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; *UNICEF, STAT GLANC VIET NAM; United Nations, POP VIT STAT REP; VERIN P, 1997, INT TRACH PATHOL OCU, V74, P57; WANG SP, 1967, AM J OPHTHALMOL, V63, P1615, DOI 10.1016/0002-9394(67)94155-4; *WHO, 1999, 4 M WHO ALL GLOB EL; *WHO, 1996, REP PLANN GLOB EL TR; *WHO, 1998, 2 M WHO ALL GLOB EL; World Health Organization, 1997, 1 M WHO ALL GLOB EL; Zhang H, 2004, ARCH OPHTHALMOL-CHIC, V122, P511, DOI 10.1001/archopht.122.4.511	46	56	56	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2006	296	12					1488	1497		10.1001/jama.296.12.1488	http://dx.doi.org/10.1001/jama.296.12.1488			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087VD	17003397	Bronze			2022-12-28	WOS:000240770000025
J	Baker-Brown, S				Baker-Brown, Stuart			A patient's journey: living with paranoid schizophrenia	BRITISH MEDICAL JOURNAL			English	Article											Baker-Brown, S (corresponding author), 15 Acreman St, Cerne Abbas DT2 7JX, Dorset, England.	s.bakerbrown@btopenworld.com							0	4	4	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 23	2006	333	7569					636	638		10.1136/bmj.38968.608275.AE	http://dx.doi.org/10.1136/bmj.38968.608275.AE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089KD	16990323	Green Published			2022-12-28	WOS:000240878500018
J	Chakvetadze, C; Bani-Sadr, F; Develoux, M; Le Breton, C; Pialoux, G				Chakvetadze, Catherine; Bani-Sadr, Firouze; Develoux, Michel; Le Breton, Caroline; Pialoux, Gilles			Limb swelling with hypereosinophilia	LANCET			English	Editorial Material							ONCHOCERCIASIS; TRAVELER		Hop Tenon, Serv Malad Infect & Trop, F-75970 Paris 20, France; Hop Tenon, Parasitol Lab, F-75970 Paris 20, France; Hop Tenon, Serv Radiol, F-75970 Paris 20, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Bani-Sadr, F (corresponding author), Hop Tenon, Serv Malad Infect & Trop, F-75970 Paris 20, France.	firouze.bani-sadr@tnn.aphp.fr						Ezzedine K, 2006, J TRAVEL MED, V13, P50, DOI 10.1111/j.1708-8305.2006.00008.x; Hoerauf A, 2001, LANCET, V357, P1415, DOI 10.1016/S0140-6736(00)04581-5; Moulton SJ, 2005, AM J ROENTGENOL, V184, P975, DOI 10.2214/ajr.184.3.01840975; Nguyen JC, 2005, INT J DERMATOL, V44, P125, DOI 10.1111/j.1365-4632.2004.02203.x; Nozais JP, 1997, B SOC PATHOL EXOT, V90, P335	5	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 23	2006	368	9541					1126	1126		10.1016/S0140-6736(06)69441-5	http://dx.doi.org/10.1016/S0140-6736(06)69441-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089IC	16997667				2022-12-28	WOS:000240873000028
J	Alemseged, Z; Spoor, F; Kimbel, WH; Bobe, R; Geraads, D; Reed, D; Wynn, JG				Alemseged, Zeresenay; Spoor, Fred; Kimbel, William H.; Bobe, Rene; Geraads, Denis; Reed, Denne; Wynn, Jonathan G.			A juvenile early hominin skeleton from Dikika, Ethiopia	NATURE			English	Article							HADAR FORMATION; AUSTRALOPITHECUS-ANAMENSIS; 1974-1977 COLLECTIONS; EVOLUTION; MORPHOLOGY; AFARENSIS; PRIMATES; REMAINS; CONTEXT; WALKING	Understanding changes in ontogenetic development is central to the study of human evolution. With the exception of Neanderthals, the growth patterns of fossil hominins have not been studied comprehensively because the fossil record currently lacks specimens that document both cranial and postcranial development at young ontogenetic stages. Here we describe a well-preserved 3.3-million-year-old juvenile partial skeleton of Australopithecus afarensis discovered in the Dikika research area of Ethiopia. The skull of the approximately three-year-old presumed female shows that most features diagnostic of the species are evident even at this early stage of development. The find includes many previously unknown skeletal elements from the Pliocene hominin record, including a hyoid bone that has a typical African ape morphology. The foot and other evidence from the lower limb provide clear evidence for bipedal locomotion, but the gorilla-like scapula and long and curved manual phalanges raise new questions about the importance of arboreal behaviour in the A. afarensis locomotor repertoire.	Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Arizona State Univ, Sch Human Evolut & Social Change, Inst Human Origins, Tempe, AZ 85287 USA; Univ Georgia, Dept Anthropol, Athens, GA 30602 USA; CNRS, UPR 2147, F-75014 Paris, France; Univ Texas, Dept Anthropol, Austin, TX 78712 USA; Univ St Andrews, Sch Geog & Geosci, St Andrews KY16 9AL, Fife, Scotland	Max Planck Society; University of London; University College London; Arizona State University; Arizona State University-Tempe; University System of Georgia; University of Georgia; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); University of Texas System; University of Texas Austin; University of St Andrews	Alemseged, Z (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Deutsch Pl 6, D-04103 Leipzig, Germany.	zeray@eva.mpg.de	Wynn, Jonathan/C-1646-2010; GERAADS, Denis/AAC-7241-2021; Spoor, Fred/C-1718-2008; Geraads, Denis/AAY-6051-2020	GERAADS, Denis/0000-0003-2475-8011; Bobe, Rene/0000-0001-9059-2203				AIELLO A, 1990, INTRO HUMAN EVOLUTIO; Alemseged Z, 2005, J HUM EVOL, V49, P499, DOI 10.1016/j.jhevol.2005.06.001; ARENSBURG B, 1989, NATURE, V338, P758, DOI 10.1038/338758a0; Avril C., 1963, PAN TROGLOD MORPHOL, V105, P74; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; BROOM R, 1964, TRANSVAAL MUSEUM MEM, V2; CLEGG M, 2001, THESIS U COLL LONDON; Dart RA, 1925, NATURE, V115, P195, DOI 10.1038/115195a0; DEAN C, 2003, DIGITAL ARCH HUMAN P, V3; Hewitt G, 2002, FOLIA PRIMATOL, V73, P70, DOI 10.1159/000064786; Holloway R. L., 2004, HUMAN FOSSIL RECORD, V3; Johanson D.C., 1985, P203; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P545, DOI 10.1002/ajpa.1330570406; Kimbel W.H., 2004, HUMAN EVOLUTION SERI; KIMBEL WH, 1982, AM J PHYS ANTHROPOL, V57, P453, DOI 10.1002/ajpa.1330570404; Kimbel WH, 2006, J HUM EVOL, V51, P134, DOI 10.1016/j.jhevol.2006.02.003; Latimer B., 1991, P169; Leakey MG, 1998, NATURE, V393, P62, DOI 10.1038/29972; Leigh SR, 2004, AM J PRIMATOL, V62, P139, DOI 10.1002/ajp.20012; LOVEJOY CO, 1988, SCI AM, V259, P118, DOI 10.1038/scientificamerican1188-118; LOVEJOY CO, 1982, AM J PHYS ANTHROPOL, V57, P679, DOI 10.1002/ajpa.1330570411; LOVEJOY CO, 1981, SCIENCE, V211, P341, DOI 10.1126/science.211.4480.341; LUBOGA SA, 1990, AM J PHYS ANTHROPOL, V81, P67, DOI 10.1002/ajpa.1330810108; Rak Y., 1983, AUSTRALOPITHECINE FA, DOI [10.1016/B978-0-12-576280-9.50006-7, DOI 10.1016/B978-0-12-576280-9.50006-7]; Richmond BG, 2000, NATURE, V404, P382, DOI 10.1038/35006045; Schultz AH, 1955, AM J PHYS ANTHROP-NE, V13, P97, DOI 10.1002/ajpa.1330130108; SENUT B, 1979, ANCESTORS HARD EVIDE, P193; SPOOR F, 1994, NATURE, V369, P645, DOI 10.1038/369645a0; Stern J.T. Jr, 1991, P99; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; SUSMAN RL, 1984, FOLIA PRIMATOL, V43, P113, DOI 10.1159/000156176; Ward CV, 2001, J HUM EVOL, V41, P255, DOI 10.1006/jhev.2001.0507; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; WHITE TD, 1977, AM J PHYS ANTHROPOL, V46, P197, DOI 10.1002/ajpa.1330460203; WHITE TD, 1982, AM J PHYS ANTHROPOL, V57, P501, DOI 10.1002/ajpa.1330570405; Wood B., 1991, HOMINID CRANIAL REMA, V4; Wynn JG, 2006, NATURE, V443, P332, DOI 10.1038/nature05048	37	227	242	0	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2006	443	7109					296	301		10.1038/nature05047	http://dx.doi.org/10.1038/nature05047			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085RL	16988704				2022-12-28	WOS:000240622000037
J	Danik, JS; Rifai, N; Buring, JE; Ridker, PM				Danik, Jacqueline Suk; Rifai, Nader; Buring, Julie E.; Ridker, Paul M.			Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; RANDOMIZED CONTROLLED-TRIAL; LOW-DOSE ASPIRIN; MIDDLE-AGED MEN; PLASMA LIPOPROTEIN(A); MYOCARDIAL-INFARCTION; PRIMARY PREVENTION; ELEVATED LIPOPROTEIN(A); LP(A) LIPOPROTEIN; ARTERY-DISEASE	Context Controversy exists as to whether lipoprotein( a), a lipoprotein with homology to plasminogen, is a clinically meaningful cardiovascular risk marker in women. There is also poor agreement among lipoprotein( a) levels obtained by different assays. Objective To determine the association of lipoprotein( a) levels, measured with an assay independent of apolipoprotein( a) isoform size, with the incidence of future cardiovascular events. Design, Setting, and Participants Prospective study of 27 791 initially healthy women in the Women's Health Study, enrolled between November 1992 and July 1995 and followed up for 10 years. Lipoprotein( a) level was measured in blood samples obtained at baseline with an assay independent of apolipoprotein( a) isoform size. Main Outcome Measure Hazard ratios (HRs) for first-ever major cardiovascular events (nonfatal myocardial infarction, nonfatal cerebrovascular event, coronary revascularization, or cardiovascular deaths). Results During follow-up, there were 899 incident cardiovascular events. After adjusting for age, smoking, blood pressure, body mass index, total cholesterol, high-density lipoprotein cholesterol, diabetes, hormone use, C-reactive protein, and randomization treatment groups, women in the highest quintile of lipoprotein( a) ( >= 44.0 mg/dL) were 1.47 times more likely (95% CI, 1.21- 1.79; P for trend <. 001) to develop cardiovascular events than women in the lowest quintile ( <= 3.4 mg/dL). This association, however, was due almost entirely to a threshold effect among those with the highest lipoprotein ( a) levels. After adjusting for all of the variables listed above, the HR associated with lipoprotein( a) levels exceeding the 90th percentile ( >= 65.5 mg/dL) was 1.66 ( 95% CI, 1.38-1.99); 95th percentile ( >= 83 mg/dL), 1.87 ( 95% CI, 1.50-2.34); and 99th percentile ( >= 130.7 mg/dL), 1.99 ( 95% CI, 1.32-3.00), with almost no risk gradient at lower levels. Associations were strongest among women with low-density lipoprotein cholesterol (LDL-C) above the median level. In this subgroup, the adjusted HR associated with lipoprotein( a) levels exceeding the 90th percentile was 1.81 ( 95% CI, 1.48-2.23); 95th percentile, 1.93 ( 95% CI, 1.51-2.48); and 99th percentile, 1.93 ( 95% CI, 1.21-3.05) ( P value for interaction with LDL-C=. 001). Conclusions In this cohort of initially healthy women, extremely high levels of lipoprotein( a) (>= 90th percentile), measured with an assay independent of apolipoprotein( a) isoform size, were associated with increased cardiovascular risk, particularly in women with high levels of LDL-C. However, the threshold and interaction effects observed do not support routine measurement of lipoprotein( a) for cardiovascular stratification in women.	Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA; Donald W Reynolds Ctr Cardiovasc Res, Boston, MA USA; Leducq Fdn Ctr Vasc Res, Boston, MA USA; Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Div Cardiol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Childrens Hosp, Dept Lab Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School	Danik, JS (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave, Boston, MA 02215 USA.	jdanik@partners.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL076443, R01HL043851] Funding Source: NIH RePORTER; NCI NIH HHS [CA-47988] Funding Source: Medline; NHLBI NIH HHS [HL-43851, HL-076443] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALFTHAN G, 1994, ATHEROSCLEROSIS, V106, P9, DOI 10.1016/0021-9150(94)90078-7; Ariyo AA, 2003, NEW ENGL J MED, V349, P2108, DOI 10.1056/NEJMoa001066; ARMSTRONG VW, 1986, ATHEROSCLEROSIS, V62, P249, DOI 10.1016/0021-9150(86)90099-7; Assmann G, 1996, AM J CARDIOL, V77, P1179, DOI 10.1016/S0002-9149(96)00159-2; Baldassarre D, 1996, STROKE, V27, P1044, DOI 10.1161/01.STR.27.6.1044; BERG K, 1963, ACTA PATHOL MIC SC, V59, P369; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; Bostom AG, 1996, JAMA-J AM MED ASSOC, V276, P544, DOI 10.1001/jama.276.7.544; BOSTOM AG, 1994, CIRCULATION, V90, P1688, DOI 10.1161/01.CIR.90.4.1688; Cantin B, 2002, AM J CARDIOL, V89, P662, DOI 10.1016/S0002-9149(01)02336-0; Cantin B, 1998, J AM COLL CARDIOL, V31, P519, DOI 10.1016/S0735-1097(97)00528-7; Caplice NM, 2001, BLOOD, V98, P2980, DOI 10.1182/blood.V98.10.2980; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Craig WY, 1998, CLIN CHEM, V44, P2301; DAHLEN GH, 1986, CIRCULATION, V74, P758, DOI 10.1161/01.CIR.74.4.758; Danesh J, 2000, CIRCULATION, V102, P1082, DOI 10.1161/01.CIR.102.10.1082; EZRATTY A, 1993, BIOCHEMISTRY-US, V32, P4628, DOI 10.1021/bi00068a021; Guerra R, 2005, CIRCULATION, V111, P1471, DOI 10.1161/01.CIR.0000159263.50305.BD; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hobbs HH, 1999, CURR OPIN LIPIDOL, V10, P225, DOI 10.1097/00041433-199906000-00005; JAUHIAINEN M, 1991, ATHEROSCLEROSIS, V89, P59, DOI 10.1016/0021-9150(91)90007-P; KOSTNER GM, 1981, ATHEROSCLEROSIS, V38, P51, DOI 10.1016/0021-9150(81)90103-9; Kronenberg F, 1999, CIRCULATION, V100, P1154, DOI 10.1161/01.CIR.100.11.1154; Kronenberg F, 1996, ARTERIOSCL THROM VAS, V16, P1568, DOI 10.1161/01.ATV.16.12.1568; LACKNER C, 1993, HUM MOL GENET, V2, P933, DOI 10.1093/hmg/2.7.933; LaRosa J C, 1992, Womens Health Issues, V2, P102, DOI 10.1016/S1049-3867(05)80278-6; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; LOSCALZO J, 1990, ARTERIOSCLEROSIS, V10, P240, DOI 10.1161/01.ATV.10.2.240; Luc G, 2002, ATHEROSCLEROSIS, V163, P377, DOI 10.1016/S0021-9150(02)00026-6; MAHER VMG, 1995, JAMA-J AM MED ASSOC, V274, P1771, DOI 10.1001/jama.274.22.1771; Marcovina SM, 2003, CLIN CHEM, V49, P1785, DOI 10.1373/clinchem.2003.023689; Marcovina SM, 2000, CLIN CHEM, V46, P1956; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; Poon M, 1997, CIRCULATION, V96, P2514, DOI 10.1161/01.CIR.96.8.2514; RADER DJ, 1992, JAMA-J AM MED ASSOC, V267, P1109, DOI 10.1001/jama.267.8.1109; RHOADS GG, 1986, JAMA-J AM MED ASSOC, V256, P2540, DOI 10.1001/jama.256.18.2540; RIDKER PM, 1993, JAMA-J AM MED ASSOC, V270, P2195, DOI 10.1001/jama.270.18.2195; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; RIDKER PM, 1995, JAMA-J AM MED ASSOC, V273, P1269, DOI 10.1001/jama.273.16.1269; Rifai N, 2004, CLIN CHEM, V50, P1364, DOI 10.1373/clinchem.2003.030031; Roberts WL, 2001, CLIN CHEM, V47, P418; ROSENGREN A, 1990, BRIT MED J, V301, P1248, DOI 10.1136/bmj.301.6763.1248; SCHAEFER EJ, 1994, JAMA-J AM MED ASSOC, V271, P999, DOI 10.1001/jama.271.13.999; SCHWARTZKOPFF W, 1990, ATHEROSCLEROSIS, V82, P253, DOI 10.1016/0021-9150(90)90047-M; Seman LJ, 1999, CLIN CHEM, V45, P1039; SGOUTAS DS, 1992, CLIN CHEM, V38, P1873; Shai I, 2005, EUR HEART J, V26, P1633, DOI 10.1093/eurheartj/ehi222; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; SIGURDSSON G, 1992, AM J CARDIOL, V69, P1251, DOI 10.1016/0002-9149(92)91215-P; Sunayama S, 1996, CIRCULATION, V94, P1263, DOI 10.1161/01.CIR.94.6.1263; Tsimikas S, 2005, NEW ENGL J MED, V353, P46, DOI 10.1056/NEJMoa043175; von Eckardstein A, 2001, J AM COLL CARDIOL, V37, P434, DOI 10.1016/S0735-1097(00)01126-8; WALD NJ, 1994, LANCET, V343, P75, DOI 10.1016/S0140-6736(94)90814-1	53	155	168	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2006	296	11					1363	1370						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085HS	16985228	Bronze			2022-12-28	WOS:000240595800023
J	Hasper, HE; Kramer, NE; Smith, JL; Hillman, JD; Zachariah, C; Kuipers, OP; de Kruijff, B; Breukink, E				Hasper, Hester E.; Kramer, Naomi E.; Smith, James L.; Hillman, J. D.; Zachariah, Cherian; Kuipers, Oscar P.; de Kruijff, Ben; Breukink, Eefjan			An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II	SCIENCE			English	Article							NISIN; BIOSYNTHESIS; ANTIBIOTICS; MODE; WALL; CELL; MORPHOGENESIS; PURIFICATION; GALLIDERMIN; EPIDERMIN	Lantibiotics are polycyclic peptides containing unusual amino acids, which have binding specificity for bacterial cells, targeting the bacterial cell wall component lipid II to form pores and thereby lyse the cells. Yet several members of these lipid II - targeted lantibiotics are too short to be able to span the lipid bilayer and cannot form pores, but somehow they maintain their antibacterial efficacy. We describe an alternative mechanism by which members of the lantibiotic family kill Gram-positive bacteria by removing lipid II from the cell division site ( or septum) and thus block cell wall synthesis.	Univ Utrecht, Dept Membrane Biochem, Bijvoet Ctr Biomol Res, Biomembrane Inst, NL-3584 CH Utrecht, Netherlands; Univ Groningen, Dept Genet, Groningne Biomol Sci & Biotechnol Inst, NL-9750 AA Haren, Netherlands; Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA; Oragen Inc, Alachua, FL 32615 USA; Banyon Biomarkers, Alachua, FL 32615 USA	Utrecht University; University of Groningen; Mississippi State University	Breukink, E (corresponding author), Univ Utrecht, Dept Membrane Biochem, Bijvoet Ctr Biomol Res, Biomembrane Inst, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	e.j.breukink@chem.uu.nl	Breukink, Eefjan/I-3039-2016; Kuipers, Oscar/B-6752-2009	Breukink, Eefjan/0000-0002-7311-0660; Kuipers, Oscar/0000-0001-5596-7735; Smith, James/0000-0002-0876-7260				Bonelli RR, 2006, ANTIMICROB AGENTS CH, V50, P1449, DOI 10.1128/AAC.50.4.1449-1457.2006; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Furmanek B, 1999, J APPL MICROBIOL, V87, P856, DOI 10.1046/j.1365-2672.1999.00937.x; Hasper HE, 2004, BIOCHEMISTRY-US, V43, P11567, DOI 10.1021/bi049476b; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; Koch AL, 2003, CLIN MICROBIOL REV, V16, P673, DOI 10.1128/CMR.16.4.673-687.2003; Li B, 2006, SCIENCE, V311, P1464, DOI 10.1126/science.1121422; McAuliffe O, 2001, FEMS MICROBIOL REV, V25, P285, DOI 10.1016/S0168-6445(00)00065-6; Morency H, 2001, CAN J MICROBIOL, V47, P322, DOI 10.1139/w01-013; Stein T, 2002, J BACTERIOL, V184, P1703, DOI 10.1128/JB.184.6.1703-1711.2002; VANHEIJENOORT Y, 1992, J BACTERIOL, V174, P3549, DOI 10.1128/JB.174.11.3549-3557.1992; Vollmer W, 2001, CURR OPIN MICROBIOL, V4, P625, DOI 10.1016/S1369-5274(01)00261-2; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Wescombe PA, 2003, APPL ENVIRON MICROB, V69, P2737, DOI 10.1128/AEM.69.5.2737-2747.2003; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Xie LL, 2004, SCIENCE, V303, P679, DOI 10.1126/science.1092600	20	371	380	3	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2006	313	5793					1636	1637		10.1126/science.1129818	http://dx.doi.org/10.1126/science.1129818			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973881	Green Submitted			2022-12-28	WOS:000240498900045
J	List, B; Yang, JW				List, Benjamin; Yang, Jung Woon			The organic approach to asymmetric catalysis	SCIENCE			English	Editorial Material							CHIRAL BRONSTED ACID; ALDOL REACTIONS		Max Planck Inst Kohlenforsch, D-45470 Mulheim, Germany	Max Planck Society	List, B (corresponding author), Max Planck Inst Kohlenforsch, D-45470 Mulheim, Germany.	list@mpi-muelheim.mpg.de	List, Benjamin/A-2121-2014; Yang, Jung Woon/N-6725-2019; Yang, Jung Woon/A-5072-2013	Yang, Jung Woon/0000-0001-8636-0901; Yang, Jung Woon/0000-0001-8636-0901				Berkessel A, 2005, ASYMMETRIC ORGANOCATALYSIS: FROM BIOMIMETIC CONCEPTS TO APPLICATIONS IN ASYMMETRIC SYNTHESIS, P1, DOI 10.1002/3527604677; Bredig G, 1912, BIOCHEM Z, V46, P7; Enders D, 2006, NATURE, V441, P861, DOI 10.1038/nature04820; Itoh J, 2006, ANGEW CHEM INT EDIT, V45, P4796, DOI 10.1002/anie.200601345; Kano T, 2005, J AM CHEM SOC, V127, P16408, DOI 10.1021/ja056008w; Knowles WS, 2003, ADV SYNTH CATAL, V345, P3, DOI 10.1002/adsc.200390028; List B, 2000, J AM CHEM SOC, V122, P2395, DOI 10.1021/ja994280y; Movassaghi M, 2002, SCIENCE, V298, P1904, DOI 10.1126/science.1076547; NICOLAOU KC, 1996, CLASICS TOTAL SYNTHE, P344; Northrup AB, 2004, SCIENCE, V305, P1752, DOI 10.1126/science.1101710; Taylor MS, 2006, ANGEW CHEM INT EDIT, V45, P1520, DOI 10.1002/anie.200503132; Terada M, 2006, ANGEW CHEM INT EDIT, V45, P2254, DOI 10.1002/anie.200503477; Vachal P, 2002, J AM CHEM SOC, V124, P10012, DOI 10.1021/ja027246j	13	283	286	12	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2006	313	5793					1584	1586		10.1126/science.1131945	http://dx.doi.org/10.1126/science.1131945			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973867				2022-12-28	WOS:000240498900030
J	Montorsi, F; Salonia, A				Montorsi, Francesco; Salonia, Andrea			Medical therapy for premature ejaculation	LANCET			English	Editorial Material							MANAGEMENT		Univ Vita Salute San Raffaele, Dept Urol, I-20132 Milan, Italy	Vita-Salute San Raffaele University	Montorsi, F (corresponding author), Univ Vita Salute San Raffaele, Dept Urol, I-20132 Milan, Italy.	montorsi.francesco@hsr.it	Montorsi, Francesco/AAN-2473-2020; Salonia, Andrea/H-1025-2016	Salonia, Andrea/0000-0002-0595-7165				Giuliano F, 2006, EUR UROL, V50, P454, DOI 10.1016/j.eururo.2006.05.055; McMahon CG, 2005, NAT CLIN PRACT UROL, V2, P426, DOI 10.1038/ncpuro0293; Pryor JL, 2006, LANCET, V368, P929, DOI 10.1016/S0140-6736(06)69373-2; Waldinger MD, 2003, INT J IMPOT RES, V15, P309, DOI 10.1038/sj.ijir.3901023; Wylie KR, 2005, CURR OPIN UROL, V15, P393, DOI 10.1097/01.mou.0000186844.40506.98	5	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 9	2006	368	9539					894	896		10.1016/S0140-6736(06)69346-X	http://dx.doi.org/10.1016/S0140-6736(06)69346-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	083ZX	16962861				2022-12-28	WOS:000240502300005
J	Bailey, S; Wing, RA; Steitz, TA				Bailey, Scott; Wing, Richard A.; Steitz, Thomas A.			The structure of T-aquaticus DNA polymerase III is distinct from eukaryotic replicative DNA polymerases	CELL			English	Article							CRYSTAL-STRUCTURE; LESION-BYPASS; ALPHA-SUBUNIT; BETA-SUBUNIT; ACTIVE-SITE; HOLOENZYME; MECHANISM; IDENTIFICATION; FRAGMENT; PRIMER	The crystal structure of Thermus aquaticus DNA polymerase III alpha subunit reveals that the structure of the catalytic domain of the eubacterial replicative polymerase is unrelated to that of the eukaryotic replicative polymerase but rather belongs to the Pol beta-like nucleotidyltransferase superfamily. A model of the polymerase complexed with both DNA and beta-sliding clamp interacting with a reoriented binding domain and internal beta binding site was constructed that is consistent with existing biochemical data. Within the crystal, two C-terminal domains are interacting through a surface that is larger than many dimer interfaces. Since replicative polymerases; of eubacteria and eukaryotes/archaea are not homologous, the nature of the replicative polymerase in the last common ancestor is unknown. Although other possibilities have been proposed, the plausibility of a ribozyme DNA polymerase should be considered.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	eatherton@csb.yale.edu	Steitz, Thomas A./C-6559-2009	Wing, Richard/0000-0001-5642-9349	NIGMS NIH HHS [GM57510] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057510] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravind L, 1998, NUCLEIC ACIDS RES, V26, P3746, DOI 10.1093/nar/26.16.3746; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEESE LS, 1993, BIOCHEMISTRY-US, V32, P14095, DOI 10.1021/bi00214a004; Bloom LB, 1997, J BIOL CHEM, V272, P27919, DOI 10.1074/jbc.272.44.27919; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bullard JM, 2002, J BIOL CHEM, V277, P13401, DOI 10.1074/jbc.M110833200; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; DAVIES JF, 1994, CELL, V76, P1123, DOI 10.1016/0092-8674(94)90388-3; De Saro FJL, 2003, P NATL ACAD SCI USA, V100, P14689, DOI 10.1073/pnas.2435454100; Doherty AJ, 1996, NUCLEIC ACIDS RES, V24, P2488, DOI 10.1093/nar/24.13.2488; Dohrmann PR, 2005, J MOL BIOL, V350, P228, DOI 10.1016/j.jmb.2005.04.065; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Filee J, 2002, J MOL EVOL, V54, P763, DOI 10.1007/s00239-001-0078-x; GRIEP MA, 1992, J BIOL CHEM, V267, P3052; JOHNSON J, 2005, ANNU REV BIOCHEM, P283; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kerins SM, 2003, J BIOL CHEM, V278, P3048, DOI 10.1074/jbc.M210750200; Kim DR, 1997, J BACTERIOL, V179, P6721, DOI 10.1128/jb.179.21.6721-6728.1997; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Kornberg A., 1992, DNA REPLICATION; KUNKEL TA, 1985, J BIOL CHEM, V260, P2866; Leipe DD, 1999, NUCLEIC ACIDS RES, V27, P3389, DOI 10.1093/nar/27.17.3389; Leu FP, 2003, MOL CELL, V11, P315, DOI 10.1016/S1097-2765(03)00042-X; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Pritchard AE, 1999, J MOL BIOL, V285, P1067, DOI 10.1006/jmbi.1998.2352; REEMS JA, 1995, J BIOL CHEM, V270, P5606, DOI 10.1074/jbc.270.10.5606; REEMS JA, 1994, J BIOL CHEM, V269, P33091; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; SOUSA R, 1993, NATURE, V364, P593, DOI 10.1038/364593a0; STANO NM, 2006, IN PRESS NAT STRUCT; STEITZ TA, 1994, SCIENCE, V266, P2022, DOI 10.1126/science.7528445; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Steitz TA, 2004, PHILOS T R SOC B, V359, P17, DOI 10.1098/rstb.2003.1374; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Teplyakov A, 2003, PROTEINS, V51, P315, DOI 10.1002/prot.10352; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Wieczorek A, 2006, J BIOL CHEM, V281, P12561, DOI 10.1074/jbc.M513844200; Xiong Y, 2004, NATURE, V430, P640, DOI 10.1038/nature02711; Zhou BL, 2001, MOL CELL, V8, P427, DOI 10.1016/S1097-2765(01)00310-0	48	102	104	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2006	126	5					893	904		10.1016/j.cell.2006.07.027	http://dx.doi.org/10.1016/j.cell.2006.07.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959569	Bronze			2022-12-28	WOS:000240675000017
J	Mooi, WJ; Peeper, DS				Mooi, W. J.; Peeper, D. S.			Oncogene-induced cell senescence - Halting on the road to cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HUMAN TUMOR-CELLS; DNA-DAMAGE; HUMAN FIBROBLASTS; IN-VIVO; TELOMERASE ACTIVITY; MALIGNANT-MELANOMA; MELANOCYTIC TUMORS; GERMLINE MUTATION; BRAF MUTATIONS; CYCLE REENTRY		Vrije Univ Amsterdam, Med Ctr, Dept Pathol, NL-1081 HV Amsterdam, Netherlands; Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Netherlands Cancer Institute	Mooi, WJ (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	wj.mooi@vumc.nl	Peeper, Daniel/AAA-2430-2020					Alrawi SJ, 2006, ANTICANCER RES, V26, P107; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bastian BC, 2000, AM J PATHOL, V157, P967, DOI 10.1016/S0002-9440(10)64609-3; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Bennett DC, 2003, ONCOGENE, V22, P3063, DOI 10.1038/sj.onc.1206446; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chin L, 1998, GENE DEV, V12, P3467, DOI 10.1101/gad.12.22.3467; Chin L, 1997, GENE DEV, V11, P2822, DOI 10.1101/gad.11.21.2822; Chudnovsky Y, 2005, NAT GENET, V37, P745, DOI 10.1038/ng1586; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; COUNTER CM, 1994, P NATL ACAD SCI USA, V91, P2900, DOI 10.1073/pnas.91.8.2900; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Denchi EL, 2005, MOL CELL BIOL, V25, P2660, DOI 10.1128/MCB.25.7.2660-2672.2005; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; FRANZA BR, 1986, CELL, V44, P409, DOI 10.1016/0092-8674(86)90462-9; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; GRAYSCHOPFER VC, IN PRESS BR J CANC; GRUIS NA, 1995, NAT GENET, V10, P351, DOI 10.1038/ng0795-351; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Gwosdz C, 2006, INT J CANCER, V118, P577, DOI 10.1002/ijc.21366; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Hingorani SR, 2003, CANCER RES, V63, P5198; Jonason AS, 1996, P NATL ACAD SCI USA, V93, P14025, DOI 10.1073/pnas.93.24.14025; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; KUWATA T, 1993, VIRCHOWS ARCH A, V423, P359, DOI 10.1007/BF01607148; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Maitra A, 2001, AM J PATHOL, V159, P119, DOI 10.1016/S0002-9440(10)61679-3; Maldonado JL, 2004, AM J PATHOL, V164, P1783, DOI 10.1016/S0002-9440(10)63736-4; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Miracco C, 2002, BRIT J DERMATOL, V146, P399, DOI 10.1046/j.1365-2133.2002.04600.x; MOOI WJ, 2002, HISTOPATHOLOGY S2, V41, P139; Muntoni A, 2005, HUM MOL GENET, V14, pR191, DOI 10.1093/hmg/ddi266; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Peeper DS, 2002, NAT CELL BIOL, V4, P148, DOI 10.1038/ncb742; Peeper DS, 2001, NAT CELL BIOL, V3, P198, DOI 10.1038/35055110; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Randerson-Moor JA, 2001, HUM MOL GENET, V10, P55, DOI 10.1093/hmg/10.1.55; Rizos H, 2001, ONCOGENE, V20, P5543, DOI 10.1038/sj.onc.1204728; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Saldanha G, 2004, INT J CANCER, V111, P705, DOI 10.1002/ijc.20325; Satyanarayana A, 2003, EMBO J, V22, P4003, DOI 10.1093/emboj/cdg367; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Shay JW, 2000, NAT REV MOL CELL BIO, V1, P72, DOI 10.1038/35036093; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Sparrow LE, 1998, AM J DERMATOPATH, V20, P255, DOI 10.1097/00000372-199806000-00006; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; te Poele RH, 2002, CANCER RES, V62, P1876; Tuveson DA, 2003, CANCER CELL, V4, P95, DOI 10.1016/S1535-6108(03)00189-2; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; van Heemst D, 2005, EXP GERONTOL, V40, P11, DOI 10.1016/j.exger.2004.10.001; Vanni R, 2000, HISTOPATHOLOGY, V37, P212, DOI 10.1046/j.1365-2559.2000.00947.x; WANG E, 1995, CANCER RES, V55, P2284; Wang YL, 1996, BRIT J DERMATOL, V134, P269; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029	84	269	278	0	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 7	2006	355	10					1037	1046		10.1056/NEJMra062285	http://dx.doi.org/10.1056/NEJMra062285			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080UF	16957149				2022-12-28	WOS:000240273300009
J	Blank, A				Blank, Arnold			Swan's way	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PULMONARY-ARTERY CATHETER; TRIALS					arnold.blank@verizon.net						Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Dalen JE, 1996, JAMA-J AM MED ASSOC, V276, P916, DOI 10.1001/jama.276.11.916; Friedberg M, 1999, JAMA-J AM MED ASSOC, V282, P1453, DOI 10.1001/jama.282.15.1453; ROBIN ED, 1985, ANN INTERN MED, V103, P445, DOI 10.7326/0003-4819-103-3-445; Shah MR, 2005, JAMA-J AM MED ASSOC, V294, P1664, DOI 10.1001/jama.294.13.1664; Shure D, 2006, NEW ENGL J MED, V354, P2273, DOI 10.1056/NEJMe068099; Wheeler AP, 2006, NEW ENGL J MED, V354, P2213	7	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2006	296	9					1041	1042		10.1001/jama.296.9.1041	http://dx.doi.org/10.1001/jama.296.9.1041			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	081DW	16954480				2022-12-28	WOS:000240298400001
J	Figueiras, A; Herdeiro, MT; Polonia, J; Gestal-Otero, JJ				Figueiras, Adolfo; Herdeiro, Maria T.; Polonia, Jorge; Jesus Gestal-Otero, Juan			An educational intervention to improve physician reporting of adverse drug reactions - A cluster-randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONTINUING MEDICAL-EDUCATION; CONFLICT-OF-INTEREST; ATTITUDES; SAFETY; SURVEILLANCE; INTENTION; RISK	Context Data on the adverse effects of newly marketed drugs are limited. Voluntary reporting is an important part of postmarketing surveillance but is underused by physicians. Objective To evaluate the effectiveness of educational outreach visits for improving adverse drug reaction (ADR) reporting by physicians. Design, Setting, and Participants A cluster-randomized controlled trial covering all National Health System physicians in the north of Portugal, with intervention in March 2004 through July 2004, and 13 to 16 months of follow-up. A total of 1388 physicians were assigned in 4 spatial clusters to the intervention group, and 5063 were assigned in 11 clusters to the control group. Intervention One-hour educational outreach visits tailored to training needs identified in a previous study. Main Outcome Measures Change in total number of reported ADRs and number of serious, high-causality, unexpected, and new-drug-related ADRs, using generalized linear mixed models adjusted for baseline ADR reporting, age, specialty, and work setting. Results At baseline, ADR reporting rates (per 1000 physician-years) did not differ significantly between the intervention groups and the control groups in reporting ADRs overall (7.6 vs 11.3), nor did they differ significantly by category: serious, 4.3 vs 6.0; high-causality, 5.4 vs 7.6; unexpected, 1.6 vs 3.5; and new-drug-related ADRs, 3.7 vs 3.8. (P>.05 for all comparisons). The control group had no significant increase in ADR reports during follow-up. The adjusted increase in ADR reporting rates attributable to intervention was 90.19 for total ADRs (95% confidence interval [CI], 54.51-125.87; relative risk [RR], 10.23; 95% CI, 3.81-27.51), 30.16 for serious ADRs (95% CI, 18.84-41.47; RR, 6.32; 95% CI, 2.09-19.16), 64.90 for high-causality ADRs (95% CI, 38.38-91.42; RR, 8.75; 95% CI, 3.05-25.07), 28.04 for unexpected ADRs (95% CI, 16.25-39.83; RR, 30.21; 95% CI, 4.54-200.84), and 42.17 for new-drug-related ADRs (95% CI, 21.58-62.76; RR, 8.05; 95% CI, 2.10-30.83). The greatest difference occurred during the first 4 months after intervention, but differences remained statistically significant for 12 months. Conclusion A targeted outreach program may improve high-quality reporting of ADRs among physicians.	Univ Santiago de Compostela, Fac Med, Dept Prevent Med & Publ Hlth, Santiago De Compostela 15783, Spain; CESPU, No Polytech Hlth Inst, Oporto, Portugal; Univ Porto, Fac Med, No Pharmacosurveillance Unit, Oporto, Portugal; Univ Hosp Santiago de Compostela, Prevent Med Serv, Compostela, Spain	Universidade de Santiago de Compostela; Universidade do Porto; Complexo Hospitalario Universitario de Santiago de Compostela	Figueiras, A (corresponding author), Univ Santiago de Compostela, Fac Med, Dept Prevent Med & Publ Hlth, Calle San Francisco S-N, Santiago De Compostela 15783, Spain.	adolfo.figueiras@usc.es	POLONIA, JORGE/J-8288-2013; Figueiras, Adolfo/K-8563-2015; Herdeiro, Maria/H-8195-2013	Figueiras, Adolfo/0000-0002-5766-8672; Herdeiro, Maria/0000-0002-0500-4049; Polonia, Jorge/0000-0002-0133-7217; Juan, Gestal-Otero/0000-0002-4235-1808				Ahmad SR, 2003, J GEN INTERN MED, V18, P57, DOI 10.1046/j.1525-1497.2003.20130.x; [Anonymous], USE WHO UMC SYSTEM S; Backstrom M, 2004, PHARMACOEPIDEM DR S, V13, P483, DOI 10.1002/pds.962; BELTON KJ, 1995, BRIT J CLIN PHARMACO, V39, P223, DOI 10.1111/j.1365-2125.1995.tb04440.x; Brown H., 1999, APPL MIXED MODELS ME; Castel JM, 2003, DRUG SAFETY, V26, P1049, DOI 10.2165/00002018-200326140-00005; *COMM SAF MED, ANN REP 2004; Couzin J, 2005, SCIENCE, V307, P196, DOI 10.1126/science.307.5707.196; Davis D, 1999, JAMA-J AM MED ASSOC, V282, P867, DOI 10.1001/jama.282.9.867; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; EDWARDS IR, 1994, DRUG SAFETY, V10, P93, DOI 10.2165/00002018-199410020-00001; European Medicines Agency, GUID GOOD CLIN PRACT; FEELY J, 1990, BRIT MED J, V300, P22, DOI 10.1136/bmj.300.6716.22; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Figueiras A, 1999, MED CARE, V37, P809, DOI 10.1097/00005650-199908000-00010; Fincham J, 1989, J PHARM PRACT, V2, P239; FLETCHER AP, 1991, J ROY SOC MED, V84, P341, DOI 10.1177/014107689108400612; Fontanarosa PB, 2004, JAMA-J AM MED ASSOC, V292, P2647, DOI 10.1001/jama.292.21.2647; GRIMSHAW JM, 2001, MED CARE S2, V39, P2, DOI DOI 10.1097/00005650-200108002-00002; GUYATT GH, 1993, JAMA-J AM MED ASSOC, V270, P2598, DOI 10.1001/jama.270.21.2598; Hasford J, 2002, J CLIN EPIDEMIOL, V55, P945, DOI 10.1016/S0895-4356(02)00450-X; Hazell L, 2006, DRUG SAFETY, V29, P385, DOI 10.2165/00002018-200629050-00003; Heeley E, 2001, LANCET, V358, P1872, DOI 10.1016/S0140-6736(01)06898-2; Heo M, 2005, STAT MED, V24, P911, DOI 10.1002/sim.1958; Herdeiro MT, 2005, DRUG SAFETY, V28, P825, DOI 10.2165/00002018-200528090-00007; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; *I NAC FARM MED PO, 2003, FARM PORT; Inman W., 1976, EPIDEMIOLOGICAL ISSU, P17; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V285, P437, DOI 10.1001/jama.285.4.437; Klar N, 2004, STAT MED, V23, P2341, DOI 10.1002/sim.1858; Lexchin J, 2006, CAN MED ASSOC J, V174, P191, DOI 10.1503/cmaj.050971; McGettigan P, 1997, BRIT J CLIN PHARMACO, V44, P98, DOI 10.1046/j.1365-2125.1997.00616.x; Moride Y, 1997, BRIT J CLIN PHARMACO, V43, P177, DOI 10.1046/j.1365-2125.1997.05417.x; NAZARIO M, 1994, HOSP PHARM, V244, P249; O'Brien MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000409.pub2; OBRIEN MAT, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003030; Perlik F, 2002, EUR J CLIN PHARMACOL, V58, P367, DOI 10.1007/s00228-002-0476-z; Pocock SJ., 2013, CLIN TRIALS PRACTICA; Psaty BM, 2004, JAMA-J AM MED ASSOC, V292, P2622, DOI 10.1001/jama.292.21.2622; Richards D, 2003, FAM PRACT, V20, P199, DOI 10.1093/fampra/20.2.199; SCOTT HD, 1990, JAMA-J AM MED ASSOC, V263, P1785, DOI 10.1001/jama.263.13.1785; SOUMERAI SB, 1990, JAMA-J AM MED ASSOC, V263, P549, DOI 10.1001/jama.263.4.549; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Strom BL, 2004, JAMA-J AM MED ASSOC, V292, P2643, DOI 10.1001/jama.292.21.2643; Torgerson DJ, 2000, BMJ-BRIT MED J, V321, P759, DOI 10.1136/bmj.321.7263.759; Ukoumunne OC, 1999, HLTH TECHNOLOGY ASSE, V3, piii, DOI [DOI 10.3310/HTA3050, DOI 10.3310/hta3050]; *UPPS MON CTR, 2000, SAF MON MED PROD; van Grootheest K, 2004, PHARMACOEPIDEM DR S, V13, P457, DOI 10.1002/pds.897; VANGROOTHEEST K, 2003, THESIS U GRONINGEN G; Whitley E, 2002, CRIT CARE, V6, P335; Williams D, 1999, IRISH J MED SCI, V168, P257, DOI 10.1007/BF02944353; Wysowski DK, 2005, ARCH INTERN MED, V165, P1363, DOI 10.1001/archinte.165.12.1363	52	119	123	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2006	296	9					1086	1093		10.1001/jama.296.9.1086	http://dx.doi.org/10.1001/jama.296.9.1086			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	081DW	16954488	Bronze			2022-12-28	WOS:000240298400010
J	Cronberg, N; Natcheva, R; Hedlund, K				Cronberg, Nils; Natcheva, Rayna; Hedlund, Katarina			Microarthropods mediate sperm transfer in mosses	SCIENCE			English	Article									Lund Univ, Dept Ecol, S-22362 Lund, Sweden; Bulgarian Acad Sci, BU-1113 Sofia, Bulgaria	Lund University; Bulgarian Academy of Sciences	Cronberg, N (corresponding author), Lund Univ, Dept Ecol, S-22362 Lund, Sweden.	Nils.Cronberg@ekol.lu.se	Hedlund, Katarina/AAC-3333-2022; Cronberg, Nils/D-3275-2013	Cronberg, Nils/0000-0002-3369-8420; Natcheva, Rayna/0000-0001-7873-5523				Harvey-Gibson RJ, 1927, ANN BOT-LONDON, V41, P190; Labandeira CC, 1998, SCIENCE, V280, P57, DOI 10.1126/science.280.5360.57; PAOLILLO DJ, 1979, BRYOLOGIST, V82, P93, DOI 10.2307/3241977; Pfeffer W., 1884, UNTERS BOT I T BINGE, V1, P363; Renzaglia KS, 2001, CRIT REV PLANT SCI, V20, P107, DOI 10.1016/S0735-2689(01)80034-4; Willis K. J., 2002, EVOLUTION PLANTS	6	62	65	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 1	2006	313	5791					1255	1255		10.1126/science.1128707	http://dx.doi.org/10.1126/science.1128707			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16946062				2022-12-28	WOS:000240313500031
J	Pian, E; Mazzali, PA; Masetti, N; Ferrero, P; Klose, S; Palazzi, E; Ramirez-Ruiz, E; Woosley, SE; Kouveliotou, C; Deng, J; Filippenko, AV; Foley, RJ; Fynbo, JPU; Kann, DA; Li, W; Hjorth, J; Nomoto, K; Patat, F; Sauer, DN; Sollerman, J; Vreeswijk, PM; Guenther, EW; Levan, A; O'Brien, P; Tanvir, NR; Wijers, RAMJ; Dumas, C; Hainaut, O; Wong, DS; Baade, D; Wang, L; Amati, L; Cappellaro, E; Castro-Tirado, AJ; Ellison, S; Frontera, F; Fruchter, AS; Greiner, J; Kawabata, K; Ledoux, C; Maeda, K; Moller, P; Nicastro, L; Rol, E; Starling, R				Pian, E.; Mazzali, P. A.; Masetti, N.; Ferrero, P.; Klose, S.; Palazzi, E.; Ramirez-Ruiz, E.; Woosley, S. E.; Kouveliotou, C.; Deng, J.; Filippenko, A. V.; Foley, R. J.; Fynbo, J. P. U.; Kann, D. A.; Li, W.; Hjorth, J.; Nomoto, K.; Patat, F.; Sauer, D. N.; Sollerman, J.; Vreeswijk, P. M.; Guenther, E. W.; Levan, A.; O'Brien, P.; Tanvir, N. R.; Wijers, R. A. M. J.; Dumas, C.; Hainaut, O.; Wong, D. S.; Baade, D.; Wang, L.; Amati, L.; Cappellaro, E.; Castro-Tirado, A. J.; Ellison, S.; Frontera, F.; Fruchter, A. S.; Greiner, J.; Kawabata, K.; Ledoux, C.; Maeda, K.; Moller, P.; Nicastro, L.; Rol, E.; Starling, R.			An optical supernova associated with the X-ray flash XRF 060218	NATURE			English	Article							LOW-LUMINOSITY; LIGHT-CURVE; BURST; AFTERGLOW; MODELS; GRB-030329; GRB-031203; DISCOVERY; SN-2006AJ; EMISSION	Long-duration gamma-ray bursts (GRBs) are associated with type Ic supernovae(1) that are more luminous than average(2-5) and that eject material at very high velocities. Less-luminous supernovae were not hitherto known to be associated with GRBs, and therefore GRB - supernovae were thought to be rare events(6). Whether X-ray flashes - analogues of GRBs, but with lower luminosities and fewer gamma-rays - can also be associated with supernovae, and whether they are intrinsically 'weak' events or typical GRBs viewed off the axis of the burst(7), is unclear. Here we report the optical discovery and follow-up observations of the type Ic supernova SN 2006aj associated with X-ray flash XRF 060218. Supernova 2006aj is intrinsically less luminous than the GRB - supernovae, but more luminous than many supernovae not accompanied by a GRB. The ejecta velocities derived from our spectra are intermediate between these two groups, which is consistent with the weakness of both the GRB output(8) and the supernova radio flux(9). Our data, combined with radio and X-ray observations(8-10), suggest that XRF 060218 is an intrinsically weak and soft event, rather than a classical GRB observed off-axis. This extends the GRB - supernova connection to X-ray flashes and fainter supernovae, implying a common origin. Events such as XRF 060218 are probably more numerous than GRB - supernovae.	Trieste Astron Observ, Ist Nazl Astrofis, I-34131 Trieste, Italy; Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; Max Planck Inst Astrophys, D-85748 Garching, Germany; Univ Tokyo, Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Sch Sci, Res Ctr Early Universe, Bunkyo Ku, Tokyo 1130033, Japan; IASF, Ist Nazl Astrofis, I-40129 Bologna, Italy; Thuringer Landessternwarte Tautenburg, D-07778 Tautenburg, Germany; Inst Adv Study, Princeton, NJ 08540 USA; Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; NASA, MSFC, NSSTC, Huntsville, AL 35805 USA; Chinese Acad Sci, Natl Astron Observ, Beijing 100012, Peoples R China; Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; Univ Copenhagen, Niels Bohr Inst, Dark Cosmol Ctr, DK-2100 Copenhagen O, Denmark; European So Observ, D-85748 Garching, Germany; Stockholm Univ, Dept Astron, S-10691 Stockholm, Sweden; Univ Chile, Dept Astron, Santiago, Chile; European So Observ, Santiago 19, Chile; Univ Hertfordshire, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England; Univ Leicester, Dept Phys & Astron, Xray & Observat Astron Grp, Leicester LE1 7RH, Leics, England; Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 SJ Amsterdam, Netherlands; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; Chinese Acad Sci, Purple Mt Observ, Nanjing 210008, Jiangsu, Peoples R China; Padova Astron Observ, Ist Nazl Astrofis, I-35122 Padua, Italy; CSIC, IAA, E-18080 Granada, Spain; Univ Victoria, Dept Phys & Astron, Victoria, BC V8P 1A1, Canada; Univ Ferrara, Dept Phys, I-44100 Ferrara, Italy; Space Telescope Sci Inst, Baltimore, MD 21218 USA; Max Planck Inst Extraterr Phys, D-85741 Garching, Germany; Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Hiroshima 7398526, Japan; Univ Tokyo, Coll Arts & Sci, Dept Earth Sci & Astron, Meguro Ku, Tokyo 1538902, Japan	Istituto Nazionale Astrofisica (INAF); University of California System; University of California Santa Barbara; Max Planck Society; University of Tokyo; University of Tokyo; Istituto Nazionale Astrofisica (INAF); Institute for Advanced Study - USA; University of California System; University of California Santa Cruz; National Aeronautics & Space Administration (NASA); Chinese Academy of Sciences; National Astronomical Observatory, CAS; University of California System; University of California Berkeley; University of Copenhagen; Niels Bohr Institute; European Southern Observatory; Stockholm University; Universidad de Chile; European Southern Observatory; University of Hertfordshire; University of Leicester; University of Amsterdam; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Chinese Academy of Sciences; Nanjing Institute of Astronomical Optics & Technology, NAOC, CAS; Purple Mountain Observatory, CAS; University of Padua; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); University of Victoria; University of Ferrara; Space Telescope Science Institute; Max Planck Society; Hiroshima University; University of Tokyo	Pian, E (corresponding author), Trieste Astron Observ, Ist Nazl Astrofis, Via GB Tiepolo 11, I-34131 Trieste, Italy.	pian@oats.inaf.it	Hainaut, Olivier R./AAY-7006-2021; Sauer, Daniel N/A-3033-2012; Fynbo, Johan P. U./L-8496-2014; Palazzi, Eliana/N-4746-2015; Kawabata, Koji S/G-1957-2017; Nicastro, Luciano/F-5866-2015; Hjorth, Jens/M-5787-2014; Nicastro, Luciano/AAU-5914-2021; Frontera, Filippo/B-4410-2014; Amati, Lorenzo/N-5586-2015	Sauer, Daniel N/0000-0002-0317-5063; Fynbo, Johan P. U./0000-0002-8149-8298; Kawabata, Koji S/0000-0001-6099-9539; Nicastro, Luciano/0000-0001-8534-6788; Hjorth, Jens/0000-0002-4571-2306; Nicastro, Luciano/0000-0001-8534-6788; Ledoux, Cedric/0000-0002-7864-3327; Pian, Elena/0000-0001-8646-4858; Kann, David Alexander/0000-0003-2902-3583; Mazzali, Paolo/0000-0001-6876-8284; Ellison, Sara/0000-0002-1768-1899; Fruchter, Andrew/0000-0002-6652-9279; Foley, Ryan/0000-0002-2445-5275; Patat, Ferdinando/0000-0002-0537-3573; Sollerman, Jesper/0000-0003-1546-6615; Palazzi, Eliana/0000-0002-8691-7666; Frontera, Filippo/0000-0003-2284-571X; Amati, Lorenzo/0000-0001-5355-7388; Baade, Dietrich/0000-0003-1637-9679; Cappellaro, Enrico/0000-0001-5008-8619; Masetti, Nicola/0000-0001-9487-7740; O'Brien, Paul/0000-0002-5128-1899; Castro-Tirado, A. J./0000-0003-2999-3563; Wijers, Ralph/0000-0002-3101-1808; Maeda, Keiichi/0000-0003-2611-7269	STFC [PP/D000920/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/D000920/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		AMATI L, 2006, 4846 GCN; Campana S, 2006, NATURE, V442, P1008, DOI 10.1038/natureO4892; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; Cobb BE, 2006, ASTROPHYS J, V645, pL113, DOI 10.1086/506271; Deng J, 2005, ASTROPHYS J, V624, P898, DOI 10.1086/429284; Filippenko AV, 1997, ANNU REV ASTRON ASTR, V35, P309, DOI 10.1146/annurev.astro.35.1.309; Fynbo JPU, 2004, ASTROPHYS J, V609, P962, DOI 10.1086/421260; Galama TJ, 1998, NATURE, V395, P670, DOI 10.1038/27150; Granot J, 2005, ASTROPHYS J, V630, P1003, DOI 10.1086/431477; GUENTHER EW, 2006, 4863 GCN; Hjorth J, 2003, NATURE, V423, P847, DOI 10.1038/nature01750; Maeda K, 2006, ASTROPHYS J, V645, P1331, DOI 10.1086/504581; MALESANI D, 2004, APJ, V609, P5; Mazzali PA, 2004, ASTROPHYS J, V614, P858, DOI 10.1086/423888; MAZZALI PA, NATURE, DOI DOI 10.1038/NATURE05081; Mazzali PA, 2006, ASTROPHYS J, V645, P1323, DOI 10.1086/504415; Mirabal N, 2006, ASTROPHYS J, V643, pL99, DOI 10.1086/505177; Modjaz M, 2006, ASTROPHYS J, V645, pL21, DOI 10.1086/505906; Sauer DN, 2006, MON NOT R ASTRON SOC, V369, P1939, DOI 10.1111/j.1365-2966.2006.10438.x; Sazonov SY, 2004, NATURE, V430, P646, DOI 10.1038/nature02748; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Soderberg AM, 2005, ASTROPHYS J, V627, P877, DOI 10.1086/430405; Soderberg AM, 2004, NATURE, V430, P648, DOI 10.1038/nature02757; SODERBERG AM, NATURE; Stanek KZ, 2003, ASTROPHYS J, V591, pL17, DOI 10.1086/376976; Tominaga N, 2004, ASTROPHYS J, V612, pL105, DOI 10.1086/424841; Tomita H, 2006, ASTROPHYS J, V644, P400, DOI 10.1086/503554; Woosley SE, 2006, ANNU REV ASTRON ASTR, V44, P507, DOI 10.1146/annurev.astro.43.072103.150558; Woosley SE, 2006, ASTROPHYS J, V637, P914, DOI 10.1086/498500; [No title captured]	30	415	418	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 31	2006	442	7106					1011	1013		10.1038/nature05082	http://dx.doi.org/10.1038/nature05082			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	078YF	16943831	Green Submitted			2022-12-28	WOS:000240142000042
J	Luke, TC; Kilbane, EM; Jackson, JL; Hoffman, SL				Luke, Thomas C.; Kilbane, Edward M.; Jackson, Jeffrey L.; Hoffman, Stephen L.			Meta-analysis: Convalescent blood products for Spanish influenza pneumonia: A future H5N1 treatment?	ANNALS OF INTERNAL MEDICINE			English	Review							COMPLICATING INFLUENZA; MATERNAL IMMUNIZATION; NEONATAL FERRETS; VIRUS-INFECTION; HUMAN SERUM; PROTECTION; ANTIBODY; PLASMA; TRANSFUSION; GUIDELINES	Background: Studies from the Spanish influenza era reported that transfusion of influenza-convalescent human blood products reduced mortality in patients with influenza complicated by pneumonia. Treatments for H5N1 influenza are unsatisfactory, and convalescent human plasma containing H5N1 antibodies could be an effective therapy during outbreaks and pandemics. Purpose: To determine whether transfusion with influenza-convalescent human blood products reduced the risk for death in patients with Spanish influenza pneumonia. Data Sources: Manual search of English-language journals from 1918 to 1925. Citations from retrieved studies were also searched. Study Selection: Published English-language studies that had at least 10 patients in the treatment group, used convalescent blood products to treat Spanish influenza pneumonia in a hospital setting, and reported on a control or comparison group. Data Extraction: Two investigators independently extracted data on study characteristics, outcomes, adverse events, and quality. Data Synthesis: Eight relevant studies involving 1703 patients were found. Treated patients, who were often selected because of more severe illness, were compared with untreated controls with influenza pneumonia in the same hospital or ward. The overall crude case-fatality rate was 16% (54 of 336) among treated patients and 37% (452 of 1219) among controls. The range of absolute risk differences in mortality between the treatment and control groups was 8% to 26% (pooled risk difference, 21% [95% Cl, 15% to 27%]). The overall crude case-fatality rate was 19% (28 of 148) among patients who received early treatment (after < 4 days of pneumonia complications) and 59% (49 of 83) among patients who received late treatment (after 4 days of pneumonia complications). The range of absolute risk differences in mortality between the early treatment group and the late treatment group was 26% to 50% (pooled risk difference, 41% [Cl, 29% to 54%]). Adverse effects included chill reactions and possible exacerbations of symptoms in a few patients. Limitations: Studies were few and had many methodologic limitations. No study was a blinded, randomized, or placebo-controlled trial. Some pertinent studies may have been missed. Conclusions: Patients with Spanish influenza pneumonia who received influenza-convalescent human blood products may have experienced a clinically important reduction in the risk for death. Convalescent human H5N1 plasma could be an effective, timely, and widely available treatment that should be studied in clinical trials.	Prot Potential LLC, Rockville, MD 20852 USA; Bur Med & Surg, USN, Washington, DC USA; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	United States Department of Defense; United States Navy; Uniformed Services University of the Health Sciences - USA	Hoffman, SL (corresponding author), Prot Potential LLC, 12111 Parklawn Dr, Rockville, MD 20852 USA.	slhoffman@protpot.com	Jackson, Jeffrey/AAA-3519-2019	Jackson, Jeffrey/0000-0002-9820-5834				[Anonymous], 1919, NY MED J, V109, P765; Bang O., 1920, NOR MAG LAEGEVIDENSK, V81, P255; Bass J, 1919, NAVAL MED B DIVISION, P71; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; BEREZINA A I, 1956, Sov Med, V20, P67; Brown WL, 1918, J AMER MED ASSOC, V71, P1602, DOI 10.1001/jama.1918.02600450078022; Carlyle PM, 1919, BR MED J, V1, P698; Cheng Y, 2005, EUR J CLIN MICROBIOL, V24, P44, DOI 10.1007/s10096-004-1271-9; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ehrenberg L, 1919, HYGIEA, V81, P113; ENGLUND JA, 1993, J INFECT DIS, V168, P647, DOI 10.1093/infdis/168.3.647; Fedson DS, 2005, J PUBLIC HEALTH POL, V26, P4, DOI 10.1057/palgrave.jphp.3200008; Firsov S L, 1985, Tr Inst Im Pastera, V63, P52; Francis FD, 1920, MIL SURG, V47, P177; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Gould EW, 1919, N Y MED J, V109, P666, DOI [10.1146/annurev.immu-nol.15.1.235, DOI 10.1146/ANNUREV.IMMU-NOL.15.1.235.]; Hellstern P, 2002, THROMB RES, V107, pS53, DOI 10.1016/S0049-3848(02)00153-6; Hemming VG, 2001, CLIN DIAGN LAB IMMUN, V8, P859, DOI 10.1128/CDLI.8.5.859-863.2001; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holst J., 1919, NORSK MAGAZINE LAEGE, V80, P531; Hsieh YC, 2006, J FORMOS MED ASSOC, V105, P1, DOI 10.1016/S0929-6646(09)60102-9; Huff-Hewitt W., 1919, BMJ-BRIT MED J, V1, P575; Jacobaeus, 1920, SVEN LAKARTIDN, V18, P385; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kahn MH, 1919, J AMER MED ASSOC, V72, P102, DOI 10.1001/jama.1919.02610020020007; Lesne EBP, 1919, PRESSE MED, V27, P181; LIEBMANN, 1918, BLATT SCHWEIZER 1012; LOCKE EA, 1919, BOSTON MED SURG J, V161, P691; LORD FT, 1919, BOSTON MED SURG J, V161, P691; Lu JH, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-43; Maclachlan WWG, 1918, JAMA-J AM MED ASSOC, V71, P2053; Madore F, 2002, CRIT CARE CLIN, V18, P375, DOI 10.1016/S0749-0704(01)00010-0; McClure JT, 2001, EQUINE VET J, V33, P681, DOI 10.2746/042516401776249273; McGuire LW, 1918, J AMER MED ASSOC, V71, P1311, DOI 10.1001/jama.1918.26020420013013e; McGuire LW, 1919, J AMER MED ASSOC, V72, P709, DOI 10.1001/jama.1919.02610100017007; Miller O, 1919, KYMED, V17, P218; Mozdzanowska K, 1997, J VIROL, V71, P4347, DOI 10.1128/JVI.71.6.4347-4355.1997; O'Malley JJ, 1919, JAMA, V72, P3437; O'Shaughnessy DF, 2004, BRIT J HAEMATOL, V126, P11, DOI 10.1111/j.1365-2141.2004.04972.x; REDEN WR, 1919, BOSTON MED SURG J, V161, P688; REUMAN PD, 1987, PEDIATR INFECT DIS J, V6, P398, DOI 10.1097/00006454-198704000-00011; Ross CW, 1918, J AMER MED ASSOC, V71, P1992, DOI 10.1001/jama.1918.26020500018006e; Ross CW, 1919, J AMER MED ASSOC, V72, P640, DOI 10.1001/jama.1919.02610090024007; Sanborn G, 1920, BOSTON MED SURG J, V183, P171, DOI DOI 10.1056/NEJM192008051830609; SELIVANOV A. A., 1967, VRACH DELO, V1, P104; Siami GA, 2002, INT J ARTIF ORGANS, V25, P499, DOI 10.1177/039139880202500603; Simici D., 1922, PARIS MED, V43, P474; STAVSKAYA V. V., 1963, KLIN MED, V41, P69; Stoll HF, 1919, J AMER MED ASSOC, V73, P478, DOI 10.1001/jama.1919.02610330016006; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; SWEET C, 1987, J GEN VIROL, V68, P2681, DOI 10.1099/0022-1317-68-10-2681; SWEET C, 1987, IMMUNOLOGY, V60, P83; TAKIGUCHI K, 1992, ARCH VIROL, V122, P1, DOI 10.1007/BF01321113; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; *US FDA, 2003, COD FED REG TIT 21 6; VIRELIZIER JL, 1975, J IMMUNOL, V115, P434; Yeh KM, 2005, J ANTIMICROB CHEMOTH, V56, P919, DOI 10.1093/jac/dki346; Zhang FH, 2005, DNA CELL BIOL, V24, P758, DOI 10.1089/dna.2005.24.758; Zhukova E A, 1985, Tr Inst Im Pastera, V63, P47	63	414	460	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2006	145	8					599	609		10.7326/0003-4819-145-8-200610170-00139	http://dx.doi.org/10.7326/0003-4819-145-8-200610170-00139			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095NX	16940336				2022-12-28	WOS:000241315700006
J	Molofsky, AV; Slutsky, SG; Joseph, NM; He, SH; Pardal, R; Krishnamurthy, J; Sharpless, NE; Morrison, SJ				Molofsky, Anna V.; Slutsky, Shalom G.; Joseph, Nancy M.; He, Shenghui; Pardal, Ricardo; Krishnamurthy, Janakiraman; Sharpless, Norman E.; Morrison, Sean J.			Increasing p16(INK4a) expression decreases forebrain progenitors and neurogenesis during ageing	NATURE			English	Article							NEURAL STEM-CELL; SELF-RENEWAL; SUBVENTRICULAR ZONE; TUMOR SUPPRESSION; ADULT; PROLIFERATION; SENESCENCE; GROWTH; MICE; TUMORIGENESIS	Mammalian ageing is associated with reduced regenerative capacity in tissues that contain stem cells(1,2). It has been proposed that this is at least partially caused by the senescence of progenitors with age(3,4); however, it has not yet been tested whether genes associated with senescence functionally contribute to physiological declines in progenitor activity. Here we show that progenitor proliferation in the subventricular zone and neurogenesis in the olfactory bulb, as well as multipotent progenitor frequency and self-renewal potential, all decline with age in the mouse forebrain. These declines in progenitor frequency and function correlate with increased expression of p16(INK4a), which encodes a cyclin-dependent kinase inhibitor linked to senescence(5). Ageing p16(INK4a)-deficient mice showed a significantly smaller decline in subventricular zone proliferation, olfactory bulb neurogenesis, and the frequency and self-renewal potential of multipotent progenitors. p16(INK4a) deficiency did not detectably affect progenitor function in the dentate gyrus or enteric nervous system, indicating regional differences in the response of neural progenitors to increased p16(INK4a) expression during ageing. Declining subventricular zone progenitor function and olfactory bulb neurogenesis during ageing are thus caused partly by increasing p16(INK4a) expression.	Univ Michigan, Dept Internal Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Morrison, SJ (corresponding author), Univ Michigan, Dept Internal Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.	seanjm@umich.edu	IBIS, FISIOPATOLOGIA/O-9510-2015; Molofsky, Anna Victoria/P-2506-2018; He, Shenghui/L-4833-2018; Morrison, Sean/ABD-5326-2021; Pardal, Ricardo/C-4370-2015	Molofsky, Anna Victoria/0000-0002-4709-2411; He, Shenghui/0000-0001-8842-7137; Pardal, Ricardo/0000-0003-1085-0714; Slutsky, Guy/0000-0001-5135-5694; Sharpless, Norman/0000-0001-7078-9455; Morrison, Sean/0000-0003-1587-8329	NATIONAL INSTITUTE ON AGING [R01AG024945] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG024945-01, R01 AG024945-03S1, R01 AG024945, R01 AG024945-05, R01 AG024945-03, R01 AG024945-04, R01 AG024945-02] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Chen JC, 2000, EXP HEMATOL, V28, P442, DOI 10.1016/S0301-472X(99)00157-5; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Chien KR, 2005, CELL, V120, P533, DOI 10.1016/j.cell.2005.02.006; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; deHaan G, 1997, BLOOD, V89, P1543, DOI 10.1182/blood.V89.5.1543.1543_1543_1550; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Geiger H, 2002, NAT IMMUNOL, V3, P329, DOI 10.1038/ni0402-329; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Matheu A, 2004, GENE DEV, V18, P2736, DOI 10.1101/gad.310304; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Nielsen GP, 1999, LAB INVEST, V79, P1137; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sharpless NE, 2004, ONCOGENE, V23, P379, DOI 10.1038/sj.onc.1207074; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	30	733	779	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2006	443	7110					448	452		10.1038/nature05091	http://dx.doi.org/10.1038/nature05091			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	16957738	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000240798800044
J	Alkuraya, FS; Saadi, I; Lund, JJ; Turbe-Doan, A; Morton, CC; Maas, RL				Alkuraya, Fowzan S.; Saadi, Irfan; Lund, Jennifer J.; Turbe-Doan, Annick; Morton, Cynthia C.; Maas, Richard L.			SUMO1 haploinsufficiency leads to cleft lip and palate	SCIENCE			English	Article							SATB2; GENE		Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Obstet & Gynecol & Reprod Biol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Maas, RL (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, NRB-458,77 Louis Pasteur, Boston, MA 02115 USA.	maas@genetics.med.harvard.edu	Alkuraya, Fowzan S./A-1542-2009; Saadi, Irfan/I-5989-2019	Alkuraya, Fowzan S./0000-0003-4158-341X; Saadi, Irfan/0000-0002-6250-6651	NICHD NIH HHS [HD043430] Funding Source: Medline; NIDCR NIH HHS [DE015246, DE11697] Funding Source: Medline; NIGMS NIH HHS [GM061365, P01 GM061354] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD043430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE011697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015246, R37DE011697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; FitzPatrick DR, 2003, HUM MOL GENET, V12, P2491, DOI 10.1093/hmg/ddg248; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Lee H, 2006, GENE DEV, V20, P784, DOI 10.1101/gad.1392006; Lin X, 2003, J BIOL CHEM, V278, P18714, DOI 10.1074/jbc.M302243200; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722	7	145	159	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2006	313	5794					1751	1751		10.1126/science.1128406	http://dx.doi.org/10.1126/science.1128406			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990542				2022-12-28	WOS:000240655700037
J	Fukata, Y; Adesnik, H; Iwanaga, T; Bredt, DS; Nicoll, RA; Fukata, M				Fukata, Yuko; Adesnik, Hillel; Iwanaga, Tsuyoshi; Bredt, David S.; Nicoll, Roger A.; Fukata, Masaki			Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission	SCIENCE			English	Article							PROTEINS; GENE; MUTATIONS; RECEPTORS; MICE; MECHANISMS; SYNAPSES; PSD-95; 10Q24; BRAIN	Abnormally synchronized synaptic transmission in the brain causes epilepsy. Most inherited forms of epilepsy result from mutations in ion channels. However, one form of epilepsy, autosomal dominant partial epilepsy with auditory features (ADPEAF), is characterized by mutations in a secreted neuronal protein, LGI1. We show that ADAM22, a transmembrane protein that when mutated itself causes seizure, serves as a receptor for LGI1. LGI1 enhances AMPA receptor-mediated synaptic transmission in hippocampal slices. The mutated form of LGI1 fails to bind to ADAM22. ADAM22 is anchored to the postsynaptic density by cytoskeletal scaffolds containing stargazin. These studies in rat brain indicate possible avenues for understanding human epilepsy.	Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Lab Genom & Proteom, Aichi 4748522, Japan; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Eli Lilly & Co, Dept Integrat Biol, Indianapolis, IN 46285 USA; Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	National Center for Geriatrics & Gerontology; University of California System; University of California San Francisco; Eli Lilly; Japan Science & Technology Agency (JST)	Fukata, M (corresponding author), Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Lab Genom & Proteom, Aichi 4748522, Japan.	fmasaki@nils.go.jp	Fukata, Masaki/AAZ-2476-2021	Fukata, Masaki/0000-0001-5200-9806; Fukata, Yuko/0000-0001-7724-8643				Bermingham JR, 2006, NAT NEUROSCI, V9, P76, DOI 10.1038/nn1598; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chernova OB, 1998, ONCOGENE, V17, P2873, DOI 10.1038/sj.onc.1202481; El-Hussein AE, 2000, SCIENCE, V290, P1364; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Kalachikov S, 2002, NAT GENET, V30, P335, DOI 10.1038/ng832; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Morante-Redolat JM, 2002, HUM MOL GENET, V11, P1119, DOI 10.1093/hmg/11.9.1119; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Novak U, 2004, J CLIN NEUROSCI, V11, P227, DOI 10.1016/j.jocn.2003.10.006; Sagane K, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-33; Scheel H, 2002, HUM MOL GENET, V11, P1757, DOI 10.1093/hmg/11.15.1757; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Schulte U, 2006, NEURON, V49, P697, DOI 10.1016/j.neuron.2006.01.033; Senechal KR, 2005, HUM MOL GENET, V14, P1613, DOI 10.1093/hmg/ddi169; Skradski SL, 2001, NEURON, V31, P537, DOI 10.1016/S0896-6273(01)00397-X; Staub E, 2002, TRENDS BIOCHEM SCI, V27, P441, DOI 10.1016/S0968-0004(02)02163-1; Steinlein OK, 2004, NAT REV NEUROSCI, V5, P400, DOI 10.1038/nrn1388; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Yagi H, 2005, J NEUROCHEM, V92, P191, DOI 10.1111/j.1471-4159.2004.02875.x	25	265	278	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2006	313	5794					1792	1795		10.1126/science.1129947	http://dx.doi.org/10.1126/science.1129947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990550				2022-12-28	WOS:000240655700050
J	Shaked, Y; Ciarrocchi, A; Franco, M; Lee, CR; Man, S; Cheung, AM; Hicklin, DJ; Chaplin, D; Foster, FS; Benezra, R; Kerbel, RS				Shaked, Yuval; Ciarrocchi, Alessia; Franco, Marcela; Lee, Christina R.; Man, Shan; Cheung, Alison M.; Hicklin, Daniel J.; Chaplin, David; Foster, F. Stuart; Benezra, Robert; Kerbel, Robert S.			Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors	SCIENCE			English	Article							STEM-CELLS; ANGIOGENESIS; GROWTH; CHEMOTHERAPY; TERM	The contribution of bone marrow-derived circulating endothelial progenitor cells (CEPs) to tumor angiogenesis has been controversial, primarily because of their low numbers in blood vessels of untreated tumors. We show that treatment of tumor-bearing mice with vascular disrupting agents (VDAs) leads to an acute mobilization of CEPs, which home to the viable tumor rim that characteristically remains after such therapy. Disruption of this CEP spike by antiangiogenic drugs or by genetic manipulation resulted in marked reductions in tumor rim size and blood flow as well as enhanced VDA antitumor activity. These findings also provide a mechanistic rationale for the enhanced efficacy of VDAs when combined with antiangiogenic drugs.	Sunnybrook Hlth Sci Ctr, Dept Mol & Cellular Biol Res, Toronto, ON M4N 3M5, Canada; Mem Sloan Kettering Canc Ctr, Program Canc Biol & Genet, New York, NY 10021 USA; Sunnybrook Hlth Sci Ctr, Dept Imaging Res, Toronto, ON M4N 3M5, Canada; ImClone Syst, New York, NY 10014 USA; OXiGENE Inc, Waltham, MA 02451 USA	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Memorial Sloan Kettering Cancer Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Eli Lilly	Kerbel, RS (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Mol & Cellular Biol Res, Toronto, ON M4N 3M5, Canada.	robert.kerbel@sri.utoronto.ca	Ciarrocchi, Alessia/AAA-1130-2019	Ciarrocchi, Alessia/0000-0002-5541-2075; Foster, F. Stuart/0000-0003-3972-8296	NATIONAL CANCER INSTITUTE [R01CA107429, R01CA041233] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA-107429, CA-41233] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bertolini F, 2003, CANCER RES, V63, P4342; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Foster FS, 2002, ULTRASOUND MED BIOL, V28, P1165, DOI 10.1016/S0301-5629(02)00567-7; Franco M, 2006, CANCER RES, V66, P3639, DOI 10.1158/0008-5472.CAN-05-3295; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Heil M, 2004, CIRC RES, V94, P573, DOI 10.1161/01.RES.0000124603.46777.EB; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Prewett M, 1999, CANCER RES, V59, P5209; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Ruzinova MB, 2003, CANCER CELL, V4, P277, DOI 10.1016/S1535-6108(03)00240-X; Shaked Y, 2005, CANCER CELL, V7, P101, DOI 10.1016/j.ccr.2004.11.023; Shaked Y, 2005, CANCER RES, V65, P7045, DOI 10.1158/0008-5472.CAN-05-0765; Siemann DW, 2004, CANCER-AM CANCER SOC, V100, P2491, DOI 10.1002/cncr.20299; Siemann DW, 2005, INT J RADIAT ONCOL, V62, P846, DOI 10.1016/j.ijrobp.2005.02.048; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78	19	470	493	3	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2006	313	5794					1785	1787		10.1126/science.1127592	http://dx.doi.org/10.1126/science.1127592			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990548				2022-12-28	WOS:000240655700048
J	Howell, DA; Sullivan, M; Nugent, PE; Ellis, RS; Conley, AJ; Le Borgne, D; Carlberg, RG; Guy, J; Balam, D; Basa, S; Fouchez, D; Hook, IM; Hsiao, EY; Neill, JD; Pain, R; Perrett, KM; Pritchet, CJ				Howell, D. Andrew; Sullivan, Mark; Nugent, Peter E.; Ellis, Richard S.; Conley, Alexander J.; Le Borgne, Damien; Carlberg, Raymond G.; Guy, Julien; Balam, David; Basa, Stephane; Fouchez, Dominique; Hook, Isobel M.; Hsiao, Eric Y.; Neill, James D.; Pain, Reynald; Perrett, Kathryn M.; Pritchet, Christopher J.			The type Ia supernova SNLS-03D3bb from a super-Chandrasekhar-mass white dwarf star	NATURE			English	Article							HUBBLE CONSTANT; MODELS; PHYSICS	The accelerating expansion of the Universe, and the need for dark energy, were inferred from observations(1,2) of type Ia supernovae. There is a consensus that type Ia supernovae are thermonuclear explosions that destroy carbon - oxygen white dwarf stars that have accreted matter from a companion star(3), although the nature of this companion remains uncertain. These supernovae are thought to be reliable distance indicators because they have a standard amount of fuel and a uniform trigger: they are predicted to explode when the mass of the white dwarf nears the Chandrase-khar mass(4) of 1.4 solar masses (M-.). Here we show that the high-redshift supernova SNLS-03D3bb has an exceptionally high luminosity and low kinetic energy that both imply a super-Chandrasekhar-mass progenitor. Super-Chandrasekhar-mass supernovae should occur preferentially in a young stellar population, so this may provide an explanation for the observed trend that overluminous type Ia supernovae occur only in 'young' environments(5,6). As this supernova does not obey the relations that allow type Ia supernovae to be calibrated as standard candles, and as no counterparts have been found at low redshift, future cosmology studies will have to consider possible contamination from such events.	Univ Toronto, Dept Astron & Astrophys, Toronto, ON M5S 3H8, Canada; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; CALTECH, Pasadena, CA 91125 USA; CEA Saclay, Serv Astrophys, DAPNIA, F-91191 Gif Sur Yvette, France; CNRS, IN2P3, LPNHE, F-75005 Paris, France; Univ Paris 06, F-75005 Paris, France; Univ Paris 07, F-75005 Paris, France; Univ Victoria, Dept Phys & Astron, Victoria, BC V8W 3P6, Canada; CNRS, LAM, F-13376 Marseille 12, France; CNRS, IN2P3, CPPM, F-13288 Marseille 9, France; Univ Aix Marseille 2, F-13288 Marseille 9, France; Univ Oxford, Oxford OX1 3RH, England	University of Toronto; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; California Institute of Technology; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; University of Victoria; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of Oxford	Howell, DA (corresponding author), Univ Toronto, Dept Astron & Astrophys, 60 St George St, Toronto, ON M5S 3H8, Canada.	howell@astro.utoronto.ca	Howell, Andy/ABE-6446-2020; Hook, Isobel M/S-8590-2017; Nugent, Peter Edward/AGG-8472-2022; Carlberg, Raymond G/I-6947-2012	Hook, Isobel M/0000-0002-2960-978X; Carlberg, Raymond G/0000-0002-7667-0081; Hsiao, Eric Y./0000-0003-1039-2928; Le Borgne, Damien/0000-0002-3145-6268; Nugent, Peter/0000-0002-3389-0586; Sullivan, Mark/0000-0001-9053-4820				ARNETT WD, 1982, ASTROPHYS J, V253, P785, DOI 10.1086/159681; ARNETT WD, 1985, NATURE, V314, P337, DOI 10.1038/314337a0; Astier P, 2006, ASTRON ASTROPHYS, V447, P31, DOI 10.1051/0004-6361:20054185; Benetti S, 2005, ASTROPHYS J, V623, P1011, DOI 10.1086/428608; BESSELL MS, 1990, PUBL ASTRON SOC PAC, V102, P1181, DOI 10.1086/132749; BRANCH D, 1992, ASTROPHYS J, V392, P35, DOI 10.1086/171401; Chandrasekhar S, 1931, ASTROPHYS J, V74, P81, DOI 10.1086/143324; COLGATE SA, 1969, ASTROPHYS J, V157, P623, DOI 10.1086/150102; CONLEY A, IN PRESS ASTRON J; Fisher A, 1999, MON NOT R ASTRON SOC, V304, P67, DOI 10.1046/j.1365-8711.1999.02299.x; Fisher A, 1997, ASTROPHYS J, V481, pL89, DOI 10.1086/310660; Hamuy M, 1996, ASTRON J, V112, P2438, DOI 10.1086/118193; HOFLICH P, 1995, ASTROPHYS J, V443, P89, DOI 10.1086/175505; Howell DA, 2001, ASTROPHYS J, V556, P302, DOI 10.1086/321584; Howell DA, 2001, ASTROPHYS J, V554, pL193, DOI 10.1086/321702; HOYLE F, 1960, ASTROPHYS J, V132, P565, DOI 10.1086/146963; Kasen D, 2004, ASTROPHYS J, V610, P876, DOI 10.1086/421699; KHOKHLOV A, 1993, ASTRON ASTROPHYS, V270, P223; Marion GH, 2006, ASTROPHYS J, V645, P1392, DOI 10.1086/502712; NOMOTO K, 1984, ASTROPHYS J, V286, P644, DOI 10.1086/162639; Nugent P, 2002, PUBL ASTRON SOC PAC, V114, P803, DOI 10.1086/341707; NUGENT P, 1995, PHYS REV LETT, V75, P394, DOI 10.1103/PhysRevLett.75.394; NUGENT PE, 1997, THESIS U OKLAHOMA; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; SULLIVAN M, 2006, IN PRESS ASTROPHYS J; TUTUKOV AV, 1994, MON NOT R ASTRON SOC, V268, P871, DOI 10.1093/mnras/268.4.871; WOOSLEY SE, 1986, ANNU REV ASTRON ASTR, V24, P205, DOI 10.1146/annurev.aa.24.090186.001225; Yoon SC, 2005, ASTRON ASTROPHYS, V435, P967, DOI 10.1051/0004-6361:20042542	30	396	397	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2006	443	7109					308	311		10.1038/nature05103	http://dx.doi.org/10.1038/nature05103			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085RL	16988705	Green Submitted			2022-12-28	WOS:000240622000039
J	Sharp, D				Sharp, David			Shocked, shot, and pardoned	LANCET			English	Editorial Material							SHELL-SHOCK; ACCOUNT		The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							Arthur M., 2002, FORGOTTEN VOICES GRE; BABINGTON A, 1994, SAKE EXAMPLE CAPITAL; Jones E, 2005, SHELL SHOCK PTSD MIL; May C, 1998, J ROY SOC MED, V91, P95, DOI 10.1177/014107689809100218; *MIN DEF, 2006, GOV SEEK PARD EX WWI; Myers CS, 1916, LANCET, V1, P65; Myers CS, 1915, LANCET, V1, P316; PARRIS M, 2006, TIMES LOND      0826; PUTKOWSKI J, 1992, SHOT DAWN; Wessely S, 2006, J ROY SOC MED, V99, P440, DOI 10.1258/jrsm.99.9.440; Zimmermann P, 2005, FORTSCHR NEUROL PSYC, V73, P91, DOI 10.1055/s-2004-830026	11	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 16	2006	368	9540					975	976		10.1016/S0140-6736(06)69395-1	http://dx.doi.org/10.1016/S0140-6736(06)69395-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	086UO	16980097				2022-12-28	WOS:000240698700009
J	Tenne, DA; Bruchhausen, A; Lanzillotti-Kimura, ND; Fainstein, A; Katiyar, RS; Cantarero, A; Soukiassian, A; Vaithyanathan, V; Haeni, JH; Tian, W; Schlom, DG; Choi, KJ; Kim, DM; Eom, CB; Sun, HP; Pan, XQ; Li, YL; Chen, LQ; Jia, QX; Nakhmanson, SM; Rabe, KM; Xi, XX				Tenne, D. A.; Bruchhausen, A.; Lanzillotti-Kimura, N. D.; Fainstein, A.; Katiyar, R. S.; Cantarero, A.; Soukiassian, A.; Vaithyanathan, V.; Haeni, J. H.; Tian, W.; Schlom, D. G.; Choi, K. J.; Kim, D. M.; Eom, C. B.; Sun, H. P.; Pan, X. Q.; Li, Y. L.; Chen, L. Q.; Jia, Q. X.; Nakhmanson, S. M.; Rabe, K. M.; Xi, X. X.			Probing nanoscale ferroelectricity by ultraviolet Raman spectroscopy	SCIENCE			English	Article							THIN-FILMS; PEROVSKITE FILMS; ULTRATHIN FILMS; SRTIO3; SUPERLATTICES; PHONONS; POLARIZATION; ENHANCEMENT; BATIO3	We demonstrated that ultraviolet Raman spectroscopy is an effective technique to measure the transition temperature (T-c) in ferroelectric ultrathin films and superlattices. We showed that one-unit-cell-thick BaTiO3 layers in BaTiO3/ SrTiO3 superlattices are not only ferroelectric (with T-c as high as 250 kelvin) but also polarize the quantum paraelectric SrTiO3 layers adjacent to them. T-c was tuned by similar to 500 kelvin by varying the thicknesses of the BaTiO3 and SrTiO3 layers, revealing the essential roles of electrical and mechanical boundary conditions for nanoscale ferroelectricity.	Penn State Univ, Dept Phys, University Pk, PA 16802 USA; Comis Nacl Energia Atom, Ctr Atom Bariloche, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; Comis Nacl Energia Atom, Inst Balseiro, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; Univ Puerto Rico, Dept Phys, Rio Piedras, PR 00931 USA; Univ Valencia, Inst Sci Mat, E-46071 Valencia, Spain; Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA; Univ Wisconsin, Dept Mat Sci & Engn, Madison, WI 53706 USA; Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA; Los Alamos Natl Lab, Div Mat Sci & Technol, Los Alamos, NM 87545 USA; Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; Comision Nacional de Energia Atomica (CNEA); University Nacional Cuyo Mendoza; Instituto Balseiro; University of Puerto Rico; University of Puerto Rico Rio Piedras; University of Valencia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan; United States Department of Energy (DOE); Los Alamos National Laboratory; Rutgers State University New Brunswick	Tenne, DA (corresponding author), Boise State Univ, Dept Phys, 1910 Univ Dr, Boise, ID 83725 USA.	dmitritenne@boisestate.edu	Schlom, Darrell G/J-2412-2013; Choi, Kyoung Jin/N-4662-2013; Chen, LongQing/I-7536-2012; Choi, Kyoung Jin/D-6941-2013; Xi, Xiaoxing/D-8498-2011; Jia, Q. X./C-5194-2008; Tenne, Dmitri/C-3294-2009; Nakhmanson, Serge M/A-6329-2014; Pan, Xiaoqing/ABF-4088-2020; Li, Yulan/F-8929-2018; Eom, Chang-Beom/I-5567-2014; Kimura, Norberto Daniel Lanzillotti/C-2452-2008; Cantarero, Andres/F-6349-2013	Schlom, Darrell G/0000-0003-2493-6113; Chen, LongQing/0000-0003-3359-3781; Tenne, Dmitri/0000-0003-2697-8958; Pan, Xiaoqing/0000-0002-0965-8568; Li, Yulan/0000-0002-2431-5408; Kimura, Norberto Daniel Lanzillotti/0000-0002-6056-5551; Cantarero, Andres/0000-0003-1999-4933; Xi, Xiaoxing/0000-0002-3808-1358; Nakhmanson, Serge/0000-0002-0539-5828; Jia, Quanxi/0000-0002-7683-5202; Fainstein, Alejandro/0000-0001-7875-3609				Ahn CH, 2004, SCIENCE, V303, P488, DOI 10.1126/science.1092508; Bartels A, 1999, PHYS REV LETT, V82, P1044, DOI 10.1103/PhysRevLett.82.1044; Chen LQ, 2002, ANNU REV MATER RES, V32, P113, DOI 10.1146/annurev.matsci.32.112001.132041; Chen LQ, 1998, COMPUT PHYS COMMUN, V108, P147, DOI 10.1016/S0010-4655(97)00115-X; Choi KJ, 2004, SCIENCE, V306, P1005, DOI 10.1126/science.1103218; COLVARD C, 1985, PHYS REV B, V31, P2080, DOI 10.1103/PhysRevB.31.2080; Cross L.E., 1993, FERROELECTRIC CERAMI, P1; FLEURY PA, 1968, PHYS REV, V174, P613, DOI 10.1103/PhysRev.174.613; Haeni JH, 2004, NATURE, V430, P758, DOI 10.1038/nature02773; Junquera J, 2003, NATURE, V422, P506, DOI 10.1038/nature01501; Jusserand B., 1989, LIGHT SCATTERING SOL, P49; Katiyar RS, 2005, FERROELECTRICS, V329, P907, DOI 10.1080/00150190500314833; Lee HN, 2005, NATURE, V433, P395, DOI 10.1038/nature03261; Lines M.E., 2001, PRINCIPLES APPL FERR; MULLER KA, 1979, PHYS REV B, V19, P3593, DOI 10.1103/PhysRevB.19.3593; NILSEN WG, 1968, J CHEM PHYS, V48, P2240, DOI 10.1063/1.1669418; Ostapchuk T, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.235406; SCALABRIN A, 1977, PHYS STATUS SOLIDI B, V79, P731, DOI 10.1002/pssb.2220790240; Schlom DG, 2001, MAT SCI ENG B-SOLID, V87, P282, DOI 10.1016/S0921-5107(01)00726-7; Sirenko AA, 2000, NATURE, V404, P373, DOI 10.1038/35006023; Stephanovich VA, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047601; Tenne DA, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.174101; Tisinger LH, 2003, J VAC SCI TECHNOL B, V21, P53, DOI 10.1116/1.1531645; Trigo M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.227402; Tybell T, 1999, APPL PHYS LETT, V75, P856, DOI 10.1063/1.124536; van Benthem K, 2001, J APPL PHYS, V90, P6156, DOI 10.1063/1.1415766	27	274	276	9	270	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2006	313	5793					1614	1616		10.1126/science.1130306	http://dx.doi.org/10.1126/science.1130306			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973874	Green Submitted			2022-12-28	WOS:000240498900038
J	Schiff, ER				Schiff, Eugene R.			Prevention of mortality from hepatitis B and hepatitis C	LANCET			English	Editorial Material							VIRUS INFECTION		Univ Miami, Sch Med, Ctr Liver Dis, Div Hepatol, Miami, FL 33136 USA	University of Miami	Schiff, ER (corresponding author), Univ Miami, Sch Med, Ctr Liver Dis, Div Hepatol, Miami, FL 33136 USA.	eschiff@med.miami.edu						Amin J, 2006, LANCET, V368, P938, DOI 10.1016/S0140-6736(06)69374-4; Chang KC, 2006, EUR J CLIN INVEST, V36, P1, DOI 10.1111/j.1365-2362.2006.01588.x; Edwards Karen, 2006, Pediatr Nurs, V32, P257; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Keeffe EB, 2006, CLIN GASTROENTEROL H, V4, P936, DOI 10.1016/j.cgh.2006.05.016; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; McMahon BJ, 2005, ANN INTERN MED, V142, P333, DOI 10.7326/0003-4819-142-5-200503010-00008; Schreibman Ian R, 2006, Ann Clin Microbiol Antimicrob, V5, P8, DOI 10.1186/1476-0711-5-8; Terrault NA, 2006, LIVER TRANSPLANT, V12, P1192, DOI 10.1002/lt.20865; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Yim HJ, 2006, HEPATOLOGY, V43, pS173, DOI 10.1002/hep.20956; Yim HJ, 2006, HEPATOLOGY, V44, P703, DOI 10.1002/hep.21290	13	24	24	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 9	2006	368	9539					896	897		10.1016/S0140-6736(06)69347-1	http://dx.doi.org/10.1016/S0140-6736(06)69347-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	083ZX	16962862				2022-12-28	WOS:000240502300006
J	Hulko, M; Berndt, F; Gruber, M; Linder, JU; Truffault, V; Schultz, A; Martin, J; Schultz, JE; Lupas, AN; Coles, M				Hulko, Michael; Berndt, Franziska; Gruber, Markus; Linder, Juergen U.; Truffault, Vincent; Schultz, Anita; Martin, Joerg; Schultz, Joachim E.; Lupas, Andrei N.; Coles, Murray			The HAMP domain structure implies helix rotation in transmembrane signaling	CELL			English	Article							LINKER REGION; COILED-COIL; ESCHERICHIA-COLI; HISTIDINE KINASE; MUTATIONAL ANALYSIS; ASPARTATE RECEPTOR; ADENYLYL CYCLASES; SENSORY-RHODOPSIN; EXCHANGE-RATES; LAC REPRESSOR	HAMP domains connect extracellular sensory with intracellular signaling domains in over 7500 proteins, including histidine kinases, adenylyl cyclases, chemotaxis receptors, and phosphatases. The solution structure of an archaeal HAMP domain shows a homodimeric, four-helical, parallel coiled coil with unusual interhelical packing, related to the canonical packing by rotation of the helices. This suggests a model for the mechanism of signal transduction, in which HAMP alternates between the observed conformation and a canonical coiled coil. We explored this mechanism in vitro and in vivo using HAMP domain fusions with a mycobacterial adenylyl cyclase and an E coli chemotaxis receptor. Structural and functional studies show that the equilibrium between the two forms is dependent on the sidechain size of residue 291, which is alanine in the wild-type protein.	Univ Tubingen, Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany; Univ Tubingen, Sch Pharm, Dept Pharmaceut Biol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Max Planck Society; Eberhard Karls University of Tubingen	Lupas, AN (corresponding author), Univ Tubingen, Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany.	andrei.lupas@tuebingen.mpg.de						ALBERTI S, 1993, EMBO J, V12, P3227, DOI 10.1002/j.1460-2075.1993.tb05992.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Appleman JA, 2003, J BACTERIOL, V185, P4872, DOI 10.1128/JB.185.16.4872-4882.2003; Appleman JA, 2003, J BACTERIOL, V185, P89, DOI 10.1128/JB.185.1.89-97.2003; Aravind L, 1999, FEMS MICROBIOL LETT, V176, P111, DOI 10.1016/S0378-1097(99)00197-4; Berg, 2018, RANDOM WALKS BIOL; Bordignon E, 2005, J BIOL CHEM, V280, P38767, DOI 10.1074/jbc.M509391200; Butler SL, 1998, BIOCHEMISTRY-US, V37, P10746, DOI 10.1021/bi980607g; Chervitz SA, 1996, P NATL ACAD SCI USA, V93, P2545, DOI 10.1073/pnas.93.6.2545; Cochran AG, 1996, SCIENCE, V271, P1113, DOI 10.1126/science.271.5252.1113; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Deng YQ, 2006, STRUCTURE, V14, P247, DOI 10.1016/j.str.2005.10.010; Diercks T, 1999, J BIOMOL NMR, V15, P177, DOI 10.1023/A:1008367912535; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; GEMMECKER G, 1993, J AM CHEM SOC, V115, P11620, DOI 10.1021/ja00077a080; GERNERT KM, 1995, PROTEIN SCI, V4, P2252, DOI 10.1002/pro.5560041102; Gruber M, 2003, TRENDS BIOCHEM SCI, V28, P679, DOI 10.1016/j.tibs.2003.10.008; JIN T, 1994, J MOL BIOL, V244, P477, DOI 10.1006/jmbi.1994.1746; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; KOIDE S, 1995, J BIOMOL NMR, V6, P306; Koretke KK, 2000, MOL BIOL EVOL, V17, P1956, DOI 10.1093/oxfordjournals.molbev.a026297; KORETKE KK, 2003, HISTIDINE KINASES SI, P483; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Linder JU, 2004, EUR J BIOCHEM, V271, P2446, DOI 10.1111/j.1432-1033.2004.04172.x; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Miller AS, 2004, BIOCHEMISTRY-US, V43, P1763, DOI 10.1021/bi0360206; Moukhametzianov R, 2006, NATURE, V440, P115, DOI 10.1038/nature04520; Ottemann KM, 1999, SCIENCE, V285, P1751, DOI 10.1126/science.285.5434.1751; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SCOTT WG, 1994, STRUCTURE, V2, P877, DOI 10.1016/S0969-2126(94)00088-3; Singh M, 1998, P NATL ACAD SCI USA, V95, P2738, DOI 10.1073/pnas.95.6.2738; Sinha SC, 2005, EMBO J, V24, P663, DOI 10.1038/sj.emboj.7600573; Solan A, 2002, J MOL BIOL, V317, P601, DOI 10.1006/jmbi.2002.5427; Tao W, 2002, MOL MICROBIOL, V43, P459, DOI 10.1046/j.1365-2958.2002.02757.x; Tews I, 2005, SCIENCE, V308, P1020, DOI 10.1126/science.1107642; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOKISHITA S, 1992, J BIOCHEM-TOKYO, V111, P707, DOI 10.1093/oxfordjournals.jbchem.a123823; Truffault V, 2001, J MOL BIOL, V309, P949, DOI 10.1006/jmbi.2001.4683; UTSUMI R, 1989, SCIENCE, V245, P1246, DOI 10.1126/science.2476847; WANG AC, 1995, J AM CHEM SOC, V117, P1810, DOI 10.1021/ja00111a021; Williams SB, 1999, MOL MICROBIOL, V33, P1093, DOI 10.1046/j.1365-2958.1999.01562.x; Yadav MK, 2005, BIOCHEMISTRY-US, V44, P9723, DOI 10.1021/bi050742a; Yadav MK, 2006, BIOCHEMISTRY-US, V45, P4463, DOI 10.1021/bi060092q; Zhu Y, 2003, J BIOL CHEM, V278, P22812, DOI 10.1074/jbc.M300916200	46	318	322	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2006	126	5					929	940		10.1016/j.cell.2006.06.058	http://dx.doi.org/10.1016/j.cell.2006.06.058			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959572	Bronze			2022-12-28	WOS:000240675000020
J	McCauley, DJ				McCauley, Douglas J.			Selling out on nature	NATURE			English	Editorial Material									Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	McCauley, DJ (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.							[Anonymous], 1997, NATURES SERVICES; DEPALMA A, 2006, NY TIMES        0720; Gibbard S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024550; HAYWARD B, 2005, MOUNTAIN TAP LAND US; MEA (Millenium Ecosystem Assessment), 2003, ECOSYSTEMS HUMAN WEL; Ricketts TH, 2004, P NATL ACAD SCI USA, V101, P12579, DOI 10.1073/pnas.0405147101; TERBORGH J, 1999, REQUIEM NATURE; Willott E, 2004, RESTOR ECOL, V12, P147, DOI 10.1111/j.1061-2971.2004.00392.x; WILSON E O, 1992; Woodroffe R., 2005, CONSERV BIOL	10	444	459	10	257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 7	2006	443	7107					27	28		10.1038/443027a	http://dx.doi.org/10.1038/443027a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16957711				2022-12-28	WOS:000240313900020
J	Pelosi, AJ; McNulty, SV; Jackson, GA				Pelosi, Anthony J.; McNulty, Seamus V.; Jackson, Graham A.			Controversy - Role of cholinesterase inhibitors in dementia care needs rethinking	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NURSING-HOME PLACEMENT; ALZHEIMERS-DISEASE		Hairmyres Hosp, Dept Psychiat, E Kilbride G75 8RG, Lanark, Scotland; Ayrshire Cent Hosp, Dept Old Age Psychiat, Irvine KA12 8SS, Scotland; Leverndale Hosp, Dept Old Age Psychiat, Glasgow G52 7TU, Lanark, Scotland	University Hospital Hairmyres	Pelosi, AJ (corresponding author), Hairmyres Hosp, Dept Psychiat, E Kilbride G75 8RG, Lanark, Scotland.	a.pelosi@dinmed.gla.ac.uk		jackson, graham/0000-0002-0526-7084; Pelosi, Anthony/0000-0002-5501-2661				*AD2000 COLL GROUP, 2000, LANCET, V363, P2105; Akintade L, 2004, LANCET, V364, P1214, DOI 10.1016/S0140-6736(04)17128-6; Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub2, 10.1002/14651858.CD001190.pub3]; Birks J., 2000, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD001191; BOSELEY S, 2002, GUARDIAN        1125; BURNS A, 2005, GERIATR MED, V35, P30; BYRNE A, 2006, GERIATR MED, V36, P13; Clegg A, 2001, Health Technol Assess, V5, P1; COREYBLOOM J, 2005, DEMENTIA, P376; DENING T, 1992, INT J GERIATR PSYCH, V7, P757, DOI 10.1002/gps.930071012; Finucane TE, 2004, J AM GERIATR SOC, V52, P843, DOI 10.1111/j.1532-5415.2004.52230_1.x; Geldmacher DS, 2003, J AM GERIATR SOC, V51, P937, DOI 10.1046/j.1365-2389.2003.51306.x; GRADY D, 2004, NY TIMES        0407; HOPE J, 2005, DAILY MAIL      0310; LEVY R, 1982, PSYCHIAT LATE LIFE; Loy C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001747.pub3; *NAT I HLTH CLIN E, APPR COMM M 20 DEC 2; Neumann PJ, 1999, MED CARE, V37, P27, DOI 10.1097/00005650-199901000-00005; *NICE, 2005, 2 NICE; NICE, 2006, FIN APPR DET DON GAL; NICE, 2006, DEM SUPP PEOPL DEM T; *NICE, 2001, 19 NICE; *NICE, 2006, ALZH DIS MAIN ISS AC; *NICE, 2005, APPR CONS DOC DON GA; O'Brien JT, 2001, BRIT MED J, V323, P123, DOI 10.1136/bmj.323.7305.123; O'Loughlin C, 2006, PSYCHIATR BULL, V30, P131, DOI 10.1192/pb.30.4.131; Royall DR, 2004, J AM GERIATR SOC, V52, P843, DOI 10.1111/j.1532-5415.2004.52230_2.x; Sheehan B, 2006, PSYCHIATR BULL, V30, P146, DOI 10.1192/pb.30.4.146; Takeda AL, 2007, HEALTH TECHNOL ASSES, V11, P1; Thompson P, 1997, AGING MENT HEALTH, V1, P181, DOI 10.1080/13607869757281; WALKER Z, 2001, MEMORY CLIN GUIDE; WILCOCK GK, 1999, DIAGNOSIS MANAGEMENT; Yaffe K, 2002, JAMA-J AM MED ASSOC, V287, P2090, DOI 10.1001/jama.287.16.2090; YEO G, 1996, ETHNICITY DEMENTIAS	34	30	30	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2006	333	7566					491	493		10.1136/bmj.38945.478160.94	http://dx.doi.org/10.1136/bmj.38945.478160.94			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	085QP	16946340	Green Published			2022-12-28	WOS:000240618900025
J	Spratt, A; Ogunbowale, L; Wormald, R; Franks, W				Spratt, A.; Ogunbowale, L.; Wormald, R.; Franks, W.			What's in a name? New glaucoma drugs	LANCET			English	Editorial Material							TIMOLOL		Moorfields Eye Hosp, London EC1V 2PD, England	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Spratt, A (corresponding author), Moorfields Eye Hosp, City Rd, London EC1V 2PD, England.	alex.spratt@moorfields.nhs.uk						GLYNN RJ, 1991, ARCH OPHTHALMOL-CHIC, V109, P205, DOI 10.1001/archopht.1991.01080020051041; Kirwan JF, 2002, BRIT MED J, V325, P1396, DOI 10.1136/bmj.325.7377.1396; Lee AJ, 2006, OPHTHALMOLOGY, V113, P1069, DOI 10.1016/j.ophtha.2006.02.062; Miller JA, 2000, RESPIRATION, V67, P216, DOI 10.1159/000029491; NELSON WL, 1986, AM J OPHTHALMOL, V102, P606, DOI 10.1016/0002-9394(86)90532-5; Nieminen T, 2005, EUR J CLIN PHARMACOL, V61, P369, DOI 10.1007/s00228-005-0945-2; PATEL SC, 1995, OPHTHALMIC SURG LAS, V26, P233; UUSALITO H, 2005, ACTA OPHTHALMOL SCAN, V83, P723; VUORI M, 1995, GRAEFES ARCH CLIN EX, V223, P131	9	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 2	2006	368	9538					826	827		10.1016/S0140-6736(06)69304-5	http://dx.doi.org/10.1016/S0140-6736(06)69304-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	082FD	16950343				2022-12-28	WOS:000240371200009
J	Conte, M; Budroni, G; Bartley, JK; Taylor, SH; Carley, AF; Schmidt, A; Murphy, DM; Girgsdies, F; Ressler, T; Schlogl, R; Hutchings, GJ				Conte, Marco; Budroni, Gerolamo; Bartley, Jonathan K.; Taylor, Stuart H.; Carley, Albert F.; Schmidt, Andi; Murphy, Damien M.; Girgsdies, Frank; Ressler, Thorsten; Schloegl, Robert; Hutchings, Graham J.			Chemically induced fast solid-state transitions of omega-VOPO4 in vanadium phosphate catalysts	SCIENCE			English	Article							MALEIC-ANHYDRIDE; N-BUTANE; SELECTIVE OXIDATION; SYSTEM	Vanadium phosphates are important catalysts for the oxidation of alkanes, and commercial catalysts comprise a complex range of V4+ and V5+ phosphates. We used three complementary in situ characterization methodologies-powder x-ray diffraction and laser Raman and electron paramagnetic resonance spectroscopies-to show that the metastable phase omega-VOPO4 is very sensitive to many of the reactants and products of butane oxidation. A rapid transformation from omega-VOPO4 to delta-VOPO4 occurs on exposure to butane at the reaction temperature, and hence the metastable omega-VOPO4 may play a role in the formation of commercial catalysts.	Cardiff Univ, Sch Chem, Cardiff CF10 3AT, Wales; Max Planck Gesell, Fritz Haber Inst, Dept Inorgan Chem, D-14195 Berlin, Germany	Cardiff University; Max Planck Society; Fritz Haber Institute of the Max Planck Society	Hutchings, GJ (corresponding author), Cardiff Univ, Sch Chem, Main Bldg,Pk Pl, Cardiff CF10 3AT, Wales.	hutch@cf.ac.uk	Murphy, Damien Martin/A-4024-2011; Girgsdies, Frank/A-6240-2009; Taylor, Stuart/A-3125-2011; Carley, Albert/A-7372-2010; Bartley, Jonathan Keith/AAE-3706-2022; Conte, Marco/C-1439-2008	Murphy, Damien Martin/0000-0002-5941-4879; Girgsdies, Frank/0000-0002-0994-0686; Taylor, Stuart/0000-0002-1933-4874; Bartley, Jonathan Keith/0000-0003-4640-541X; Conte, Marco/0000-0002-1399-0344				Amoros P, 1999, CURR OPIN SOLID ST M, V4, P123, DOI 10.1016/S1359-0286(99)00016-9; Amoros P, 2001, J PHYS CHEM SOLIDS, V62, P1393, DOI 10.1016/S0022-3697(01)00054-3; Bordes E., 1987, CATAL TODAY, V1, P499, DOI DOI 10.1016/0920-5861(87)85003-4; Burnett JC, 1987, CATAL TODAY, V1, P537, DOI DOI 10.1016/0920-5861(87)85005-8; CENTI G, 1993, CATALYSIS TODAY 1, V16; Contractor RM, 1999, CHEM ENG SCI, V54, P5627, DOI 10.1016/S0009-2509(99)00295-X; Coulston GW, 1997, SCIENCE, V275, P191, DOI 10.1126/science.275.5297.191; Dente M, 2003, CHEM ENG SCI, V58, P643, DOI 10.1016/S0009-2509(02)00590-0; GIRGSDIES F, 2006, 39 JAHR DTSCH KAT M; GLEAVES JT, 1988, CATAL REV, V30, P49, DOI 10.1080/01614948808078616; Hutchings GJ, 2004, J MATER CHEM, V14, P3385, DOI 10.1039/b404610m; HUTCHINGS GJ, 1994, NATURE, V368, P41, DOI 10.1038/368041a0; HUTCHINGS GJ, 1991, APPL CATAL, V72, P1, DOI 10.1016/0166-9834(91)85024-P; Hutchings GJ, 2002, J CATAL, V208, P197, DOI 10.1006/jcat.2002.3555; Ressler T, 2000, J CATAL, V191, P75, DOI 10.1006/jcat.1999.2772; VILLENEUVE G, 1992, CHEM MATER, V4, P108, DOI 10.1021/cm00019a023; WIBBEKE H, 1996, 37809 INT CTR DIFFR	17	71	72	2	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 1	2006	313	5791					1270	1273		10.1126/science.1130493	http://dx.doi.org/10.1126/science.1130493			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16946066				2022-12-28	WOS:000240313500035
J	Behrenfeld, MJ; Worthington, K; Sherrell, RM; Chavez, FP; Strutton, P; McPhaden, M; Shea, DM				Behrenfeld, Michael J.; Worthington, Kirby; Sherrell, Robert M.; Chavez, Francisco P.; Strutton, Peter; McPhaden, Michael; Shea, Donald M.			Controls on tropical Pacific Ocean productivity revealed through nutrient stress diagnostics	NATURE			English	Article							IRON-DEFICIENCY; ELECTRON-TRANSPORT; SYNECHOCOCCUS SP; PHOTOSYSTEM-II; PHYTOPLANKTON BLOOM; SOUTHERN-OCEAN; CHLOROPHYLL; LIGHT; CYANOBACTERIA; FLUORESCENCE	In situ enrichment experiments have shown that the growth of bloom-forming diatoms in the major high-nitrate low-chlorophyll (HNLC) regions of the world's oceans is limited by the availability of iron(1-3). Yet even the largest of these manipulative experiments represents only a small fraction of an ocean basin, and the responses observed are strongly influenced by the proliferation of rare species rather than the growth of naturally dominant populations(4,5). Here we link unique fluorescence attributes of phytoplankton to specific physiological responses to nutrient stress, and use these relationships to evaluate the factors that constrain phytoplankton growth in the tropical Pacific Ocean on an unprecedented spatial scale. On the basis of fluorescence measurements taken over 12 years, we delineate three major ecophysiological regimes in this region. We find that iron has a key function in regulating phytoplankton growth in both HNLC and oligotrophic waters near the Equator and further south, whereas nitrogen and zooplankton grazing are the primary factors that regulate biomass production in the north. Application of our findings to the interpretation of satellite chlorophyll fields shows that productivity in the tropical Pacific basin may be 1.2 - 2.5 Pg C yr(-1) lower than previous estimates have suggested, a difference that is comparable to the global change in ocean production that accompanied the largest El Nino to La Nina transition on record(6).	Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; NASA, Sci Applicat Int Corp, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Dept Geol Sci, New Brunswick, NJ 08901 USA; Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA	Oregon State University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Science Applications International Corporation (SAIC); Rutgers State University New Brunswick; Rutgers State University New Brunswick; Monterey Bay Aquarium Research Institute; Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA	Behrenfeld, MJ (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Cordley Hall 2082, Corvallis, OR 97331 USA.	mjb@science.oregonstate.edu	McPhaden, Michael J/D-9799-2016; Strutton, Peter G/C-4466-2011	McPhaden, Michael J/0000-0002-8423-5805; Strutton, Peter G/0000-0002-2395-9471				Behrenfeld MJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002299; Behrenfeld MJ, 1999, SCIENCE, V283, P840, DOI 10.1126/science.283.5403.840; Behrenfeld MJ, 2001, SCIENCE, V291, P2594, DOI 10.1126/science.1055071; Belkhodja R, 1998, PHOTOSYNTH RES, V56, P265, DOI 10.1023/A:1006039917599; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Boyd PW, 2001, DEEP-SEA RES PT II, V48, P2529, DOI 10.1016/S0967-0645(01)00007-8; Cavender-Bares KK, 1999, LIMNOL OCEANOGR, V44, P237, DOI 10.4319/lo.1999.44.2.0237; Chavez FP, 1999, SCIENCE, V286, P2126, DOI 10.1126/science.286.5447.2126; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; DITULLIO GR, 1993, LIMNOL OCEANOGR, V38, P495, DOI 10.4319/lo.1993.38.3.0495; Feely RA, 1999, NATURE, V398, P597, DOI 10.1038/19273; GREENE RM, 1992, PLANT PHYSIOL, V100, P565, DOI 10.1104/pp.100.2.565; GUIKEMA JA, 1983, PLANT PHYSIOL, V73, P250, DOI 10.1104/pp.73.2.250; Ivanov AG, 2000, FEBS LETT, V485, P173, DOI 10.1016/S0014-5793(00)02211-0; Larbi A, 2004, PHOTOSYNTH RES, V79, P59, DOI 10.1023/B:PRES.0000011919.35309.5e; LaRoche J, 1996, NATURE, V382, P802; Michel KP, 2004, PHYSIOL PLANTARUM, V120, P36, DOI 10.1111/j.0031-9317.2004.0229.x; Morales F, 2001, PHOTOSYNTH RES, V70, P207, DOI 10.1023/A:1017965229788; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Olson RJ, 2000, DEEP-SEA RES PT II, V47, P3181, DOI 10.1016/S0967-0645(00)00064-3; Park YI, 1999, MOL MICROBIOL, V32, P123, DOI 10.1046/j.1365-2958.1999.01332.x; RIETHMAN HC, 1988, BIOCHIM BIOPHYS ACTA, V935, P141, DOI 10.1016/0005-2728(88)90211-3; SANDMANN G, 1985, PHOTOSYNTH RES, V6, P261, DOI 10.1007/BF00049282; Sandstrom S, 2002, PHYSIOL PLANTARUM, V116, P255, DOI 10.1034/j.1399-3054.2002.1160216.x; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; Troyan T., 1989, TECHNIQUES NEW DEV P, P601; Tsuda A, 2003, SCIENCE, V300, P958, DOI 10.1126/science.1082000; Varsano T, 2003, J PLANT NUTR, V26, P2197, DOI 10.1081/PLN-120024275; VASSILIEV IR, 1995, PLANT PHYSIOL, V109, P963, DOI 10.1104/pp.109.3.963	29	203	217	0	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2006	442	7106					1025	1028		10.1038/nature05083	http://dx.doi.org/10.1038/nature05083			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	078YF	16943835				2022-12-28	WOS:000240142000046
J	Cutler, DM; Rosen, AB; Vijan, S				Cutler, David M.; Rosen, Allison B.; Vijan, Sandeep			TGhe value of medical spending in the United States, 1960-2000	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; MORTALITY-RATES; SECULAR TRENDS; RECENT DECLINE; CARE COSTS; HEALTH; TECHNOLOGY; LIFE	Background: The increased use of medical therapies has led to increased medical costs. To provide insight into the value of this increased spending, we compared gains in life expectancy with the increased costs of care from 1960 through 2000. Methods: We estimated life expectancy in 1960, 1970, 1980, 1990, and 2000 for four age groups. To control for the influence of nonmedical factors on survival, we assumed in our base-case analysis that 50 percent of the gains were due to medical care. We compared the adjusted increases in life expectancy with the lifetime cost of medical care in the same years. Results: From 1960 through 2000, the life expectancy for newborns increased by 6.97 years, lifetime medical spending adjusted for inflation increased by approximately $69,000, and the cost per year of life gained was $19,900. The cost increased from $7,400 per year of life gained in the 1970s to $36,300 in the 1990s. The average cost per year of life gained in 1960-2000 was approximately $31,600 at 15 years of age, $53,700 at 45 years of age, and $84,700 at 65 years of age. At 65 years of age, costs rose more rapidly than did life expectancy: the cost per year of life gained was $121,000 between 1980 and 1990 and $145,000 between 1990 and 2000. Conclusions: On average, the increases in medical spending since 1960 have provided reasonable value. However, the spending increases in medical care for the elderly since 1980 are associated with a high cost per year of life gained. The national focus on the rise in medical spending should be balanced by attention to the health benefits of this increased spending.	Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; Natl Bur Econ Res, Cambridge, MA 02138 USA; Ann Arbor Vet Affairs Med Ctr, Ctr Practice Management & Outcomes Res, Ann Arbor, MI USA; Univ Michigan Hlth Syst, Div Gen Med, Ann Arbor, MI USA	Harvard University; National Bureau of Economic Research; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Cutler, DM (corresponding author), Harvard Univ, Dept Econ, 1875 Cambridge St, Cambridge, MA 02138 USA.	dcutler@harvard.edu		Cutler, David/0000-0002-4949-8917	NIA NIH HHS [R01 AG015911] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG015911] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANDERSON CM, 2001, MONOGRAPH NCI, V14; Anderson GF, 2006, HEALTH AFFAIR, V25, P819, DOI 10.1377/hlthaff.25.3.819; [Anonymous], 1994, VALUING HLTH POLICY; Bodenheimer T, 2005, ANN INTERN MED, V142, P847, DOI 10.7326/0003-4819-142-10-200505170-00010; BUNKER JP, 1995, J ROY COLL PHYS LOND, V29, P105; Bunker JP, 2001, INT J EPIDEMIOL, V30, P1260, DOI 10.1093/ije/30.6.1260; BUNKER JP, 1994, MILBANK Q, V72, P225, DOI 10.2307/3350295; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; *CDCP, 2005, NAT VIT STAT REP; *CTR MED MED SERV, 2005, NAT HLTH EXP ACC; Cutler DM, 2000, NBER FR HLTH POL RES, V3, P33, DOI 10.1162/109623100300091069; Cutler DM, 2004, YOUR MONEY YOUR LIFE; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Freedman VA, 2003, JAMA-J AM MED ASSOC, V289, P3242; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Giovino Gary A., 1994, Morbidity and Mortality Weekly Report, V43, P1; GOLDMAN L, 1984, ANN INTERN MED, V101, P825, DOI 10.7326/0003-4819-101-6-825; *HARV SCH PUBL HLT, 2003, COMPR TABL COST UT R; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; KLIEGMAN RM, 1995, AM J PUBLIC HEALTH, V85, P909, DOI 10.2105/AJPH.85.7.909; LEE KS, 1980, AM J PUBLIC HEALTH, V70, P15, DOI 10.2105/AJPH.70.1.15; Li GH, 2001, ACCIDENT ANAL PREV, V33, P423, DOI 10.1016/S0001-4575(00)00056-7; Lichtenberg FR, 2001, HEALTH AFFAIR, V20, P241, DOI 10.1377/hlthaff.20.5.241; Meara E, 2004, HEALTH AFFAIR, V23, P176, DOI 10.1377/hlthaff.23.4.176; Murphy KM, 2003, MEASURING THE GAINS FROM MEDICAL RESEARCH, P41; NEWHOUSE JP, 1992, J ECON PERSPECT, V6, P3, DOI 10.1257/jep.6.3.3; Nordhaus WD, 2003, MEASURING THE GAINS FROM MEDICAL RESEARCH, P9; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; Richardson DK, 1998, PEDIATRICS, V102, P893, DOI 10.1542/peds.102.4.893; THUN MJ, 1997, MONOGRAPH NCI, V8; *TIPS, 2005, NAT HLTH INT SURV SE; TSAI SP, 1978, AM J PUBLIC HEALTH, V68, P966, DOI 10.2105/AJPH.68.10.966; Unal B, 2005, BMJ-BRIT MED J, V331, P614, DOI 10.1136/bmj.38561.633345.8F; Viscusi WK, 2003, J RISK UNCERTAINTY, V27, P5, DOI 10.1023/A:1025598106257; WILLIAMS RL, 1982, NEW ENGL J MED, V306, P207, DOI 10.1056/NEJM198201283060404	35	283	286	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2006	355	9					920	927		10.1056/NEJMsa054744	http://dx.doi.org/10.1056/NEJMsa054744			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	078OM	16943404				2022-12-28	WOS:000240113100009
J	Marris, E				Marris, Emma			Mothers of invention?	NATURE			English	Article																		Ding WW, 2006, SCIENCE, V313, P665, DOI 10.1126/science.1124832; Thursby J G, 2005, J TECHNOLOGY TRANSFE, V30, P343, DOI DOI 10.1007/S10961-005-2580-6; Whittington K., 2005, J TECHNOL TRANSFER, V30, P355, DOI DOI 10.1007/S10961-005-2581-5>	3	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 31	2006	442	7106					973	973		10.1038/442973a	http://dx.doi.org/10.1038/442973a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	078YF	16943814	Bronze			2022-12-28	WOS:000240142000021
J	Qi, YJ; He, XY; Wang, XJ; Kohany, O; Jurka, J; Hannon, GJ				Qi, Yijun; He, Xingyue; Wang, Xiu-Jie; Kohany, Oleksiy; Jurka, Jerzy; Hannon, Gregory J.			Distinct catalytic and non-catalytic roles of ARGONAUTE4 in RNA-directed DNA methylation	NATURE			English	Article							SIRNA; HETEROCHROMATIN	DNA methylation has important functions in stable, transcriptional gene silencing, immobilization of transposable elements and genome organization(1). In Arabidopsis, DNA methylation can be induced by double-stranded RNA through the RNA interference (RNAi) pathway, a response known as RNA-directed DNA methylation(2). This requires a specialized set of RNAi components, including ARGONAUTE4 (AGO4)(3-6). Here we show that AGO4 binds to small RNAs including small interfering RNAs (siRNAs) originating from transposable and repetitive elements, and cleaves target RNA transcripts. Single mutations in the Asp-Asp-His catalytic motif of AGO4 do not affect siRNA-binding activity but abolish its catalytic potential. siRNA accumulation and non-CpG DNA methylation at some loci require the catalytic activity of AGO4, whereas others are less dependent on this activity. Our results are consistent with a model in which AGO4 can function at target loci through two distinct and separable mechanisms. First, AGO4 can recruit components that signal DNA methylation in a manner independent of its catalytic activity. Second, AGO4 catalytic activity can be crucial for the generation of secondary siRNAs that reinforce its repressive effects.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Genet Program, Stony Brook, NY 11794 USA; Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China; Genet Informat Res Inst, Mountain View, CA 94043 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Wang, Xiu-Jie/L-1312-2019; Hannon, Gregory/AAB-3568-2019; Qi, Yijun/AAE-8797-2019; Hu, Ruogu/B-2203-2008					Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Bao N, 2004, DEV CELL, V7, P653, DOI 10.1016/j.devcel.2004.10.003; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Qi YJ, 2005, FEBS LETT, V579, P5899, DOI 10.1016/j.febslet.2005.08.035; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Rohila JS, 2004, PLANT J, V38, P172, DOI 10.1111/j.1365-313X.2004.02031.x; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	27	330	359	2	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	2006	443	7114					1008	1012		10.1038/nature05198	http://dx.doi.org/10.1038/nature05198			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	16998468				2022-12-28	WOS:000241523400058
J	Kash, JC; Tumpey, TM; Proll, SC; Carter, V; Perwitasari, O; Thomas, MJ; Basler, CF; Palese, P; Taubenberger, JK; Garcia-Sastre, A; Swayne, DE; Katze, MG				Kash, John C.; Tumpey, Terrence M.; Proll, Sean C.; Carter, Victoria; Perwitasari, Olivia; Thomas, Matthew J.; Basler, Christopher F.; Palese, Peter; Taubenberger, Jeffery K.; Garcia-Sastre, Adolfo; Swayne, David E.; Katze, Michael G.			Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus	NATURE			English	Article							PANDEMIC VIRUS; A VIRUSES; ENHANCED VIRULENCE; GENES; MACROPHAGES; HEMAGGLUTININ; MICE; PATHOGENESIS; MORTALITY; SEGMENT	The influenza pandemic of 1918 - 19 was responsible for about 50 million deaths worldwide(1). Modern histopathological analysis of autopsy samples from human influenza cases from 1918 revealed significant damage to the lungs with acute, focal bronchitis and alveolitis associated with massive pulmonary oedema, haemorrhage and rapid destruction of the respiratory epithelium(2). The contribution of the host immune response leading to this severe pathology remains largely unknown. Here we show, in a comprehensive analysis of the global host response induced by the 1918 influenza virus, that mice infected with the reconstructed 1918 influenza virus displayed an increased and accelerated activation of host immune response genes associated with severe pulmonary pathology. We found that mice infected with a virus containing all eight genes from the pandemic virus showed marked activation of pro-inflammatory and cell-death pathways by 24 h after infection that remained unabated until death on day 5. This was in contrast with smaller host immune responses as measured at the genomic level, accompanied by less severe disease pathology and delays in death in mice infected with influenza viruses containing only subsets of 1918 genes. The results indicate a cooperative interaction between the 1918 influenza genes and show that study of the virulence of the 1918 influenza virus requires the use of the fully reconstructed virus. With recent concerns about the introduction of highly pathogenic avian influenza viruses into humans and their potential to cause a worldwide pandemic with disastrous health and economic consequences, a comprehensive understanding of the global host response to the 1918 virus is crucial. Moreover, understanding the contribution of host immune responses to virulent influenza virus infections is an important starting point for the identification of prognostic indicators and the development of novel antiviral therapies.	Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; NCID, Influenza Branch, DVRD, Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; CUNY Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; Armed Forces Inst Pathol, Dept Mol Pathol, Dept Cellular Pathol & Genet, Rockville, MD 20850 USA; USDA, SE Poultry Res Lab, Agr Res Lab, Athens, GA 30606 USA	University of Washington; University of Washington Seattle; Centers for Disease Control & Prevention - USA; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; United States Department of Defense; United States Department of Agriculture (USDA)	Kash, JC (corresponding author), Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA.	jkash@u.washington.edu	Kash, John/ABE-8280-2021; Taubenberger, Jeffery/AAQ-1407-2021; Swayne, David/AAP-7166-2020; Basler, Christopher/AAG-8346-2019	Basler, Christopher/0000-0003-4195-425X; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Palese, Peter/0000-0002-0337-5823; Swayne, David/0000-0001-7472-1992	Intramural NIH HHS [Z01 AI000986-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000986] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kash JC, 2006, J VIROL, V80, P3009, DOI 10.1128/JVI.80.6.3009-3020.2006; Kash JC, 2004, J VIROL, V78, P9499, DOI 10.1128/JVI.78.17.9499-9511.2004; Katz JM, 2000, J VIROL, V74, P10807, DOI 10.1128/JVI.74.22.10807-10810.2000; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Reid AH, 2000, P NATL ACAD SCI USA, V97, P6785, DOI 10.1073/pnas.100140097; Reid AH, 2004, J VIROL, V78, P12462, DOI 10.1128/JVI.78.22.12462-12470.2004; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Reid AH, 2002, J VIROL, V76, P10717, DOI 10.1128/JVI.76.21.10717-10723.2002; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40; Zhou JF, 2006, J INFECT DIS, V193, P945, DOI 10.1086/500954; Zhou JF, 2006, J INFECT DIS, V194, P61, DOI 10.1086/504690	26	436	456	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2006	443	7111					578	581		10.1038/nature05181	http://dx.doi.org/10.1038/nature05181			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	17006449	Green Accepted, Bronze			2022-12-28	WOS:000240988200044
J	Annas, GJ				Annas, George J.			Hunger strikes at Guantanamo - Medical ethics and human rights in a "legal black hole''	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				Annas GJ, 2005, NEW ENGL J MED, V352, P2127, DOI 10.1056/NEJMlim044131; ANNAS GJ, 1982, HASTINGS CENT REP, V12, P21, DOI 10.2307/3561359; ANNAS GJ, 1995, BRIT MED J, V311, P1114, DOI 10.1136/bmj.311.7013.1114; Beam TE, 2003, MILITARY MED ETHICS; BUKOVSKY V, 2003, BEING HUMAN READINGS, P218; Center for Constitutional Rights, 2005, GUANT PRIS HUNG STRI; *DEP DEF, 2006, 231008E DOD; *DEP DEF ASS SECR, 2006, MED ROUNDT; Golden Tim, 2006, N Y Times Web, pA20; Gordan England Memorandum for Secretaries of the Military Departments, 2006, COMMUNICATION   0707; *J WIER FDN HLTH H, 1995, ASS HUNG STRIK MAN P; Nicholl DJ, 2006, LANCET, V367, P811, DOI 10.1016/S0140-6736(06)68326-8; Oguz NY, 2005, J MED ETHICS, V31, P169, DOI 10.1136/jme.2004.006973; Okie S, 2005, NEW ENGL J MED, V353, P2529, DOI 10.1056/NEJMp058296; Reyes Hernan, 1998, MED ETHICAL ASPECTS, P291; SCHMITT E, 2006, NY TIMES        0222, pA5; Silove D, 1996, JAMA-J AM MED ASSOC, V276, P410; Silver M, 2005, STANFORD LAW REV, V58, P631; Situation of Detainees at Guant anamo Bay, 2006, SIT DET GUANT BAY; Wilks M, 2006, BRIT MED J, V332, P560, DOI 10.1136/bmj.332.7541.560; *WORLD MED ASS, 1991, DECL HUNG STRIK	21	40	41	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2006	355	13					1377	1382		10.1056/NEJMhle062316	http://dx.doi.org/10.1056/NEJMhle062316			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088EF	17005959	Green Published			2022-12-28	WOS:000240793600017
J	Shuchman, M				Shuchman, Miriam			Delaying generic competition - Corporate payoffs and the future of plavix	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Buffalo Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Shuchman, M (corresponding author), Univ Buffalo Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY 14260 USA.								0	14	14	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2006	355	13					1297	1300		10.1056/NEJMp068193	http://dx.doi.org/10.1056/NEJMp068193			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088EF	17005945				2022-12-28	WOS:000240793600001
J	Thomas, KJ; MacPherson, H; Thorpe, L; Brazier, J; Fitter, M; Campbell, MJ; Roman, M; Walters, SJ; Nicholl, J				Thomas, K. J.; MacPherson, H.; Thorpe, L.; Brazier, J.; Fitter, M.; Campbell, M. J.; Roman, M.; Walters, S. J.; Nicholl, J.			Randomised controlled trial of a short course of traditional acupuncture compared with usual care for persistent non-specific low back pain	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH; COMPLEMENTARY; FRAMEWORK; SF-36	Objective To determine whether a short course of traditional acupuncture improves longer term outcomes for patients with persistent non-specific low back pain in primary care. Design Pragmatic, open, randomised controlled trial. Setting Three private acupuncture clinics and 18 general practices in York, England. Participants 241 adults aged 18-65 with non-specific low back pain of 4-52 weeks' duration. Interventions 10 individualised acupuncture treatments from one of six qualified acupuncturists (160 patients) or usual care only (81 patients). Main outcome measures The primary outcome was SF-36 bodily pain, measured at 12 and 24 months. Other outcomes included reported use of analgesics, scores on the Oswestry pain disability index, safety, and patient satisfaction. Results 39 general practitioners referred 289 patients of whom 241 were randomised. At 12 months average SF-36 pain scores increased by 33.2 to 64.0 in the acupuncture group and by 27.9 to 58.3 in the control group. Adjusting for baseline score and for any clustering by acupuncturist, the estimated intervention effect was 5.6 points (95% confidence interval - 0.2 to 11.4) at 12 months (n = 213) and 8.0 points (2.8 to 13.2) at 24 months (n = 182). The magnitude of the difference between the groups was about 10%-15% of the final pain score in the control group. Functional disability was not improved. No serious or life threatening events were reported. Conclusions Weak evidence was found of an effect of acupuncture on persistent non-specific low back pain at 12 months, but stronger evidence of a small benefit at 24 months. Referral to a qualified traditional acupuncturist for a short course of treatment seems safe and acceptable to patients with low back pain.	Fdn Tradit Chinese Med, York YO24 1ET, N Yorkshire, England; Univ Sheffield, Sch Hlth & Related Res, Sheffield S10 2TN, S Yorkshire, England; Selby & York Primary Care Trust, York, N Yorkshire, England	University of Sheffield	MacPherson, H (corresponding author), Fdn Tradit Chinese Med, York YO24 1ET, N Yorkshire, England.	hm18@york.ac.uk	Nicholl, Jon/B-8257-2008; Campbell, Michael J/I-4253-2014; brazier, john e/B-1936-2008	Campbell, Michael J/0000-0003-3529-2739; Brazier, John/0000-0001-8645-4780; Walters, Stephen/0000-0001-9000-8126; MacPherson, Hugh/0000-0003-4255-4768				Angst F, 2001, ARTHRIT RHEUM-ARTHR, V45, P384, DOI 10.1002/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0; *BMJ PUBL GROUP, 2003, CLIN EV LOW BACK PAI; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Bronfort G, 1999, PAIN, V83, P201, DOI 10.1016/S0304-3959(99)00103-7; *CLIN STAND ADV GR, 1994, BACK PAIN EP COSTS; CROFT P, 1997, HLTH CARE NEEDS ASSE; *DEP HLTH, 1999, PREV BACK PAIN GREAT; DEYO R, 1992, USERS MANUAL LOW BAC; Dincer F, 2003, COMPLEMENT THER MED, V11, P235, DOI 10.1016/S0965-2299(03)00124-9; Fairbank J C, 1980, Physiotherapy, V66, P271; Furlan AD, 2005, SPINE, V30, P944, DOI 10.1097/01.brs.0000158941.21571.01; Kalauokalani D, 2001, SPINE, V26, P1418, DOI 10.1097/00007632-200107010-00005; Kaptchuk TJ, 1998, LANCET, V351, P1722, DOI 10.1016/S0140-6736(97)10111-8; Lee KJ, 2005, BRIT MED J, V330, P142, DOI 10.1136/bmj.330.7483.142; Lewith GT, 2002, AM J PUBLIC HEALTH, V92, P1604, DOI 10.2105/AJPH.92.10.1604; MacAuley D, 2004, BRIT MED J, V329, P694, DOI 10.1136/bmj.329.7468.694; MacPherson H, 2004, COMPLEMENT THER MED, V12, P38, DOI 10.1016/S0965-2299(03)00125-0; MacPherson H, 2003, J ALTERN COMPLEM MED, V9, P869, DOI 10.1089/107555303771952226; MacPherson H, 1999, Complement Ther Med, V7, P83; MacPherson H, 2001, BMJ-BRIT MED J, V323, P486, DOI 10.1136/bmj.323.7311.486; Meenan R, 2001, J Health Serv Res Policy, V6, P38, DOI 10.1258/1355819011927189; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Ratcliffe J, 2006, BRIT MED J, V333, P626, DOI 10.1136/bmj.38932.806134.7C; Thomas K J, 1999, Complement Ther Med, V7, P91, DOI 10.1016/S0965-2299(99)80087-9; Thomas KJ, 2003, FAM PRACT, V20, P575, DOI 10.1093/fampra/cmg514; THOMAS KJ, 1997, COMPLEMENTARY THERAP, V5, P94; Thomaseth K, 2001, SIMULAT PRACT THEORY, V9, P1, DOI 10.1016/S0928-4869(01)00038-6; Thompson I, 2005, LANG LEARN TECHNOL, V9, P1; Ware J. E., 1993, SF36 HLTH SURVEY MAN; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	30	136	145	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2006	333	7569					623	626		10.1136/bmj.38878.907361.7C	http://dx.doi.org/10.1136/bmj.38878.907361.7C			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089KD	16980316	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000240878500014
J	Ruth, A; Newman, NJ				Ruth, Adrienne; Newman, Nancy J.			Regression of optociliary shunt vessels	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Emory Univ, Sch Med, Atlanta, GA 30322 USA	Emory University	Ruth, A (corresponding author), Emory Univ, Sch Med, Atlanta, GA 30322 USA.		Newman, Nancy/AAB-2532-2021						0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 21	2006	355	12					1262	1262		10.1056/NEJMicm050639	http://dx.doi.org/10.1056/NEJMicm050639			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085IT	16990389				2022-12-28	WOS:000240598500010
J	Iye, M; Ota, K; Kashikawa, N; Furusawa, H; Hashimoto, T; Hattori, T; Matsuda, Y; Morokuma, T; Ouchi, M; Shimasaku, K				Iye, Masanori; Ota, Kazuaki; Kashikawa, Nobunari; Furusawa, Hisanori; Hashimoto, Tetsuya; Hattori, Takashi; Matsuda, Yuichi; Morokuma, Tomoki; Ouchi, Masami; Shimasaku, Kazuhiro			A galaxy at a redshift z=6.96	NATURE			English	Article							LY-ALPHA EMITTERS; SUBARU DEEP FIELD; REIONIZATION; CONSTRAINTS; EMISSION; SEARCH; CAMERA	When galaxy formation started in the history of the Universe remains unclear. Studies of the cosmic microwave background indicate that the Universe, after initial cooling ( following the Big Bang), was reheated and reionized by hot stars in newborn galaxies at a redshift in the range 6 < z < 14 ( ref. 1). Though several candidate galaxies at redshift z > 7 have been identified photometrically(2,3), galaxies with spectroscopically confirmed redshifts have been confined to z < 6.6 ( refs 4 - 8). Here we report a spectroscopic redshift of z = 6.96 ( corresponding to just 750 Myr after the Big Bang) for a galaxy whose spectrum clearly shows Lyman-alpha emission at 9,682 angstrom, indicating active star formation at a rate of similar to 10M(.) yr(-1), where M-. is the mass of the Sun. This demonstrates that galaxy formation was under way when the Universe was only similar to 6 per cent of its present age. The number density of galaxies at z approximate to 7 seems to be only 18 - 36 per cent of the density at z = 6.6.	Natl Astron Observ, Tokyo 1818588, Japan; Univ Tokyo, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; Grad Univ Adv Studies, Tokyo 1818588, Japan; Subaru Telescope, Hilo, HI 96720 USA; Kyoto Univ, Grad Sch Sci, Dept Astron, Kyoto 6068502, Japan; Univ Tokyo, Inst Astron, Tokyo 1810015, Japan; Space Telescope Sci Inst, Baltimore, MD 21218 USA	National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); University of Tokyo; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Kyoto University; University of Tokyo; Space Telescope Science Institute	Iye, M (corresponding author), Natl Astron Observ, 2-21-1 Osawa, Tokyo 1818588, Japan.	iye@optik.mtk.nao.ac.jp	SHIMASAKU, KAZUHIRO/G-5056-2014; Ouchi, Masami/AAA-9826-2019; Hashimoto, Tetsuya/ABG-3643-2021	Ouchi, Masami/0000-0002-1049-6658; Kashikawa, Nobunari/0000-0003-3954-4219; Hashimoto, Tetsuya/0000-0001-7228-1428; Shimasaku, Kazuhiro/0000-0002-2597-2231; Furusawa, Hisanori/0000-0002-6174-8165				Ajiki M, 2003, ASTRON J, V126, P2091, DOI 10.1086/378481; Barton EJ, 2006, NEW ASTRON REV, V50, P1, DOI 10.1016/j.newar.2005.11.024; Bouwens RJ, 2005, ASTROPHYS J, V624, pL5, DOI 10.1086/430302; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Egami E, 2005, ASTROPHYS J, V618, pL5, DOI 10.1086/427550; Fan XH, 2002, ASTRON J, V123, P1247, DOI 10.1086/339030; GEHRELS N, 1986, ASTROPHYS J, V303, P336, DOI 10.1086/164079; GUNN JE, 1965, ASTROPHYS J, V142, P1633, DOI 10.1086/148444; Horton A, 2004, P SOC PHOTO-OPT INS, V5492, P1022, DOI 10.1117/12.551591; Hu EM, 1999, ASTROPHYS J, V522, pL9, DOI 10.1086/312205; Hu EM, 2004, ASTRON J, V127, P563, DOI 10.1086/381302; Hu EM, 2002, ASTROPHYS J, V568, pL75, DOI 10.1086/340424; Iye M, 2004, PUBL ASTRON SOC JPN, V56, P381, DOI 10.1093/pasj/56.2.381; Kashikawa N, 2002, PUBL ASTRON SOC JPN, V54, P819, DOI 10.1093/pasj/54.6.819; Kashikawa N, 2004, PUBL ASTRON SOC JPN, V56, P1011, DOI 10.1093/pasj/56.6.1011; KASHIKAWA N, 2006, IN PRESS ASTROPHYS J, V648; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; MADAU P, 1995, ASTROPHYS J, V441, P18, DOI 10.1086/175332; Malhotra S, 2004, ASTROPHYS J, V617, pL5, DOI 10.1086/427182; Miyazaki S, 2002, PUBL ASTRON SOC JPN, V54, P833, DOI 10.1093/pasj/54.6.833; Ouchi M, 2005, ASTROPHYS J, V620, pL1, DOI 10.1086/428499; PAGE L, 2006, UNPUB ASTROPHYS J; Santos MR, 2004, MON NOT R ASTRON SOC, V349, P1137, DOI 10.1111/j.1365-2966.2004.07594.x; Sheth RK, 1999, MON NOT R ASTRON SOC, V308, P119, DOI 10.1046/j.1365-8711.1999.02692.x; Stark DP, 2006, NEW ASTRON REV, V50, P46, DOI 10.1016/j.newar.2005.11.012; Taniguchi Y, 2005, PUBL ASTRON SOC JPN, V57, P165, DOI 10.1093/pasj/57.1.165; Willis JP, 2005, MON NOT R ASTRON SOC, V357, P1348, DOI 10.1111/j.1365-2966.2005.08755.x	27	302	303	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2006	443	7108					186	188		10.1038/nature05104	http://dx.doi.org/10.1038/nature05104			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16971942				2022-12-28	WOS:000240467000040
J	Kronauer, CM				Kronauer, Christoph M.			Catamenial pneumothorax	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									City Hosp Waid, CH-8037 Zurich, Switzerland		Kronauer, CM (corresponding author), City Hosp Waid, CH-8037 Zurich, Switzerland.								0	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 7	2006	355	10					E9	E9		10.1056/NEJMicm050598	http://dx.doi.org/10.1056/NEJMicm050598			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080UF	16957142				2022-12-28	WOS:000240273300011
J	Grumbach, K; Chen, E				Grumbach, Kevin; Chen, Eric			Effectiveness of University of California postbaccalaureate premedical programs in increasing medical school matriculation for minority and disadvantaged students	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNDERREPRESENTED MINORITY; HEALTH-CARE; ACCEPTANCE	Context Many medical schools administer postbaccalaureate premedical programs targeting underrepresented minority and disadvantaged students, with the goal of increasing the number of these students matriculating into medical school. Objective To determine whether University of California (UC) postbaccalaureate programs are effective in increasing medical school matriculation rates for program participants. Design, Setting, and Participants Retrospective cohort study assessing 5 UC medical school postbaccalaureate programs. The cohort comprised 265 participants in the postbaccalaureate programs in the 1999 through 2002 academic years and a control group of 396 college graduates who applied to the programs but did not participate. Of the participants, 66% were underrepresented minorities, and for 50% neither parent had attended college. Main Outcome Measure Matriculation by 2005 into a US medical school accredited by the Liaison Committee on Medical Education. Results By 2005, 67.6% of participants and 22.5% of controls had matriculated into medical school (P<.001). After adjusting for baseline student characteristics, students who participated in postbaccalaureate programs had a higher probability of matriculating into medical school in a regression model controlling for grade point average and demographic characteristics (odds ratio, 6.30; 95% confidence interval, 4.08-9.72) and in a model further controlling for preparticipation Medical College Admissions Test score (odds ratio, 8.06; 95% confidence interval, 4.65-13.97). Conclusion Postbaccalaureate premedical programs appear to be an effective intervention to increase the number of medical school matriculants from disadvantaged and underrepresented groups.	Univ Calif San Francisco, Dept Family & Community Med, Ctr Calif Hlth Workforce Studies, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Grumbach, K (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, 1001 Potrero Ave, San Francisco, CA 94110 USA.	kgrumbach@fcm.ucsf.edu	Grumbach, Kevin/L-9222-2016		PHS HHS [U79HP00004] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Association of American Medical Colleges, FACTS APPL MATR GRAD; Association of American Medical Colleges, POSTB PREM PROGR; Blakely AW, 2003, ACAD MED, V78, P437, DOI 10.1097/00001888-200305000-00004; Brody H A, 2000, J Dent Educ, V64, P775; Cantor JC, 1998, JAMA-J AM MED ASSOC, V280, P772, DOI 10.1001/jama.280.9.772; Carline JD, 2003, ACAD MED, V78, P467, DOI 10.1097/00001888-200305000-00008; Cohen JJ, 2002, HEALTH AFFAIR, V21, P90, DOI 10.1377/hlthaff.21.5.90; Giordani B, 2001, ACAD MED, V76, P844, DOI 10.1097/00001888-200108000-00020; Grumbach KCJ., 2003, STRATEGIES IMPROVING; *HLTH RES SERV ADM, FISC YEAR 2007 JUST; Jackson EW, 2003, ACAD MED, V78, P448, DOI 10.1097/00001888-200305000-00005; JOLLY P, 2004, MED SCH TUITION YOUN; Komaromy M, 1996, NEW ENGL J MED, V334, P1305, DOI 10.1056/NEJM199605163342006; Mertz EA, 2001, J PUBLIC HEALTH DENT, V61, P172, DOI 10.1111/j.1752-7325.2001.tb03386.x; Smedley BD, 2004, NATIONS COMPELLING I; Strayhorn G, 2000, ACAD MED, V75, P355, DOI 10.1097/00001888-200004000-00015; Whitten CF, 1999, ACAD MED, V74, P393, DOI 10.1097/00001888-199904000-00034	17	57	57	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2006	296	9					1079	1085		10.1001/jama.296.9.1079	http://dx.doi.org/10.1001/jama.296.9.1079			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	081DW	16954487	Bronze			2022-12-28	WOS:000240298400009
J	Vanags, D; Williams, B; Johnson, B; Hall, S; Nash, P; Taylor, A; Weiss, J; Feeney, D				Vanags, Daina; Williams, Bronwyn; Johnson, Barbara; Hall, Stephen; Nash, Peter; Taylor, Andrew; Weiss, Julissa; Feeney, Dennis			Therapeutic efficacy and safety of chaperonin 10 in patients with rheumatoid arthritis: a double-blind randomised trial	LANCET			English	Article							ALPHA MONOCLONAL-ANTIBODY; METHOTREXATE; CYTOKINES; TOLL-LIKE-RECEPTOR-4; ETANERCEPT; EXPRESSION; ADALIMUMAB	Background Chaperonin 10 (heat shock protein 10, XToll(TM)) has anti-inflammatory properties related to the inhibition of Toll-like receptor signalling pathways. Our aim was to establish whether chaperonin 10 is safe and effective in the treatment of rheumatoid arthritis. Methods in this randomised, double-blind, multicentre study, 23 patients with moderate to severe active rheumatoid arthritis receiving disease-modifying antirheumatic drugs were randomly allocated to three treatment groups receiving intravenous chaperonin 10 twice weekly for 12 weeks at doses of 5 mg (n=8), 7.5 mg (8), or 10 mg (7). The primary outcomes were change in disease activity score (DAS28) and improvement of core disease measures (American College of Rheumatology response score) from baseline to week 12. All analyses were done by intention to treat. This study is registered with the Australian Clinical Trials Registry, number ACTRNO12606000041550. Findings Primary endpoint measures improved from day 14 in all groups and continued to improve to day 84. By end of study, a 20% improvement of core disease measures was seen in six (86%, 95% Cl 43-100), a 50% improvement in four (57%, 14-86), and a 70% improvement in two (29%, 0-57) patients given the highest dose of chaperonin 10. Clinical remission (as defined by a DAS28 <2.6) was achieved in three (13%) of 23 patients. Three individuals dropped out during the study: one in the 5 mg group (rheumatoid arthritis not controlled), one in the 7.5 mg group (adverse event), and one in the 10 mg group (lost to follow-up). The most common adverse events were exacerbation of rheumatoid arthritis (both during and after the study) and upper respiratory tract infection. Only one adverse event was judged to be of severe intensity. Interpretation Chaperonin 10 seems to be well tolerated and efficacious in treatment of the symptoms of rheumatoid arthritis, at least in the short term.	Cbio Ltd, Eight Mile Plains, Qld 4113, Australia; Cabrini Med Ctr, Melbourne, Vic, Australia; Monash Univ, Melbourne, Vic 3004, Australia; Univ Queensland, Dept Med, Rheumatol Res Unit, Brisbane, Qld, Australia; Royal Perth Hosp, Goatcher Clin Res Unit, Perth, WA, Australia	Cabrini Health; Monash University; University of Queensland; Royal Perth Hospital; University of Western Australia	Feeney, D (corresponding author), Cbio Ltd, 85 Brandl St, Eight Mile Plains, Qld 4113, Australia.	dennis.feeney@cbio.com.au	Nash, Peter/D-7392-2013	Nash, Peter/0000-0002-2571-788X				Andreakos E, 2004, IMMUNOL REV, V202, P250, DOI 10.1111/j.0105-2896.2004.00202.x; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bathon JM, 2000, NEW ENGL J MED, V343, P1586, DOI 10.1056/NEJM200011303432201; Broadley SA, 2005, J NEUROL SCI, V238, pS223; Christodoulou C, 2006, CLIN EXP MED, V6, P13, DOI 10.1007/s10238-006-0088-5; Feige U, 2000, CELL MOL LIFE SCI, V57, P1457, DOI 10.1007/PL00000629; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Furst DE, 2003, J RHEUMATOL, V30, P2563; Han JH, 2005, NAT IMMUNOL, V6, P1198, DOI 10.1038/ni1274; Harlow E., 1988, ANTIBODIES LAB MANUA; HOCHBERG MC, 1992, ARTHRITIS RHEUM, V35, P498, DOI 10.1002/art.1780350502; Johnson BJ, 2005, J BIOL CHEM, V280, P4037, DOI 10.1074/jbc.M411569200; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Madhok R, 1999, LANCET, V353, P257, DOI 10.1016/S0140-6736(05)74938-2; Radstake TRDJ, 2004, ARTHRITIS RHEUM-US, V50, P3856, DOI 10.1002/art.20678; Roelofs MF, 2005, ARTHRITIS RHEUM, V52, P2313, DOI 10.1002/art.21278; Slavotinek AM, 2001, TRENDS GENET, V17, P528, DOI 10.1016/S0168-9525(01)02413-1; Smolen JS, 2005, CLIN REV ALLERG IMMU, V28, P239, DOI 10.1385/CRIAI:28:3:239; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; van de Putte BA, 2004, ANN RHEUM DIS, V63, P508, DOI 10.1136/ard.2003.013052; VANRIEL PCL, WELCOME HOME DAS; Weisman MH, 2003, CLIN THER, V25, P1700, DOI 10.1016/S0149-2918(03)80164-9; Westhovens R, 2006, ARTHRITIS RHEUM-US, V54, P1075, DOI 10.1002/art.21734	26	106	113	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2006	368	9538					855	863		10.1016/S0140-6736(06)69210-6	http://dx.doi.org/10.1016/S0140-6736(06)69210-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	082FD	16950363				2022-12-28	WOS:000240371200033
J	Hannon, JB; Shenoy, VB; Schwarz, KW				Hannon, J. B.; Shenoy, V. B.; Schwarz, K. W.			Anomalous spiral motion of steps near dislocations on silicon surfaces	SCIENCE			English	Article							ENERGY-ELECTRON MICROSCOPY; SI(001); GROWTH; STRESS; STRAIN	We have used low-energy electron microscopy to measure step motion on Si(111) and Si(001) near dislocations during growth and sublimation. Steps on Si(111) exhibit the classic rotating Archimedean spiral motion, as predicted by Burton, Cabrera, and Frank. Steps on Si(001), however, move in a strikingly different manner. The anomalous behavior can be understood in detail by considering how the local step velocity is affected by the nonuniform strain field arising from the dislocation. We show how the dynamic step-flow pattern is related to the dislocation slip system.	IBM Corp, Div Res, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA; Brown Univ, Div Engn, Providence, RI 02912 USA	International Business Machines (IBM); Brown University	Hannon, JB (corresponding author), IBM Corp, Div Res, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA.	jbhannon@us.ibm.com	Shenoy, Vivek/ABD-5075-2021					ALERHAND OL, 1988, PHYS REV LETT, V61, P1973, DOI 10.1103/PhysRevLett.61.1973; Bartelt NC, 1996, PHYS REV B, V54, P11731, DOI 10.1103/PhysRevB.54.11731; BARTELT NC, 1994, PHYS REV LETT, V73, P1656, DOI 10.1103/PhysRevLett.73.1656; BARTELT NC, 1992, SURF SCI, V273, P252, DOI 10.1016/0039-6028(92)90290-M; Bartelt NC, 1996, PHYS REV B, V54, P11741, DOI 10.1103/PhysRevB.54.11741; BAUER E, 1994, REP PROG PHYS, V57, P895, DOI 10.1088/0034-4885/57/9/002; BURTON WK, 1951, PHILOS T R SOC S-A, V243, P299, DOI 10.1098/rsta.1951.0006; FRANK FC, 1949, DISCUSS FARADAY SOC, P48, DOI 10.1039/df9490500048; HSU CC, 1994, APPL PHYS LETT, V64, P1959, DOI 10.1116/1.587719; Kim Y, 1997, APPL PHYS LETT, V71, P3489, DOI 10.1063/1.120368; Kodambaka S, 2004, NATURE, V429, P49, DOI 10.1038/nature02495; Leroy F, 2002, APPL PHYS LETT, V80, P3078, DOI 10.1063/1.1474601; Liu XH, 2005, MODEL SIMUL MATER SC, V13, P1233, DOI 10.1088/0965-0393/13/8/003; Lothe J., 1970, SPEC PUB NAT BUR STA, V317, P11; MEN FK, 1988, PHYS REV LETT, V61, P2469, DOI 10.1103/PhysRevLett.61.2469; Shiryaev SY, 1997, PHYS REV LETT, V78, P503, DOI 10.1103/PhysRevLett.78.503; Sutter P, 1999, PHYS REV LETT, V82, P1490, DOI 10.1103/PhysRevLett.82.1490; TANAKA S, 1997, PHYS REV LETT, V78, P334; Teng HH, 1998, SCIENCE, V282, P724, DOI 10.1126/science.282.5389.724; WEBB MB, 1991, SURF SCI, V242, P23, DOI 10.1016/0039-6028(91)90236-L	20	16	16	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 1	2006	313	5791					1266	1269		10.1126/science.1129342	http://dx.doi.org/10.1126/science.1129342			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16946065				2022-12-28	WOS:000240313500034
J	Eisenstein, M				Eisenstein, Michael			Standards and practices	NATURE			English	Article																			0	30	31	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 31	2006	442	7106					1067	1067		10.1038/4421067b	http://dx.doi.org/10.1038/4421067b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	078YF	16943838	Bronze			2022-12-28	WOS:000240142000057
J	Wann, S; Schuchard, G				Wann, Samuel; Schuchard, Gregory			Anomalous origin of the right coronary artery	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Wisconsin Heart Hosp, Milwaukee, WI 53226 USA		Wann, S (corresponding author), Wisconsin Heart Hosp, Milwaukee, WI 53226 USA.								0	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2006	355	9					E8	E8		10.1056/NEJMicm050051	http://dx.doi.org/10.1056/NEJMicm050051			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	078OM	16943395				2022-12-28	WOS:000240113100012
J							NIH State-of-the-Science Panel	National Institutes of Health state-of-the-science conference statement: Tobacco use: Prevention, cessation, and control	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								National Institutes of Health (NIH) consensus and state-of-the-science statements are prepared by independent panels of health professionals and public representatives on the basis of 1) the results of a systematic literature review prepared under contract with the Agency for Healthcare Research and Quality (AHRQ), 2) presentations by investigators working in areas relevant to the conference questions during a 2-day public session, 3) questions and statements from conference attendees during open discussion periods that are part of the public session, and 4) closed deliberations by the panel during the remainder of the second day and the morning of the third. This statement is an independent report of the panel and is not a policy statement of the NIH or the federal government The statement reflects the panel's assessment of medical knowledge available at the time the statement was written. Thus, it provides a "snapshot in time" of the state of knowledge on the conference topic. When reading the statement, keep in mind that new knowledge is inevitably accumulating through medical research.											0	56	58	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 5	2006	145	11					839	844		10.7326/0003-4819-145-11-200612050-00141	http://dx.doi.org/10.7326/0003-4819-145-11-200612050-00141			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	114PE	16954353				2022-12-28	WOS:000242677300006
J	Krishnamurthy, J; Ramsey, MR; Ligon, KL; Torrice, C; Koh, A; Bonner-Weir, S; Sharpless, NE				Krishnamurthy, Janakiraman; Ramsey, Matthew R.; Ligon, Keith L.; Torrice, Chad; Koh, Angela; Bonner-Weir, Susan; Sharpless, Norman E.			p16(INK4a) induces an age-dependent decline in islet regenerative potential	NATURE			English	Article							PANCREATIC BETA-CELLS; PREMATURE SENESCENCE; TRANSGENIC MICE; DIABETIC MICE; EXPRESSION; CDK4; STREPTOZOTOCIN; GROWTH; ADULT; DIFFERENTIATION	The p16(INK4a) tumour suppressor accumulates in many tissues as a function of advancing age(1-3). p16(INK4a) is an effector of senescence(4,5) and a potent inhibitor of the proliferative kinase Cdk4 (ref. 6), which is essential for pancreatic beta-cell proliferation in adult mammals(7,8). Here we show that p16(INK4a) constrains islet proliferation and regeneration in an age-dependent manner. Expression of the p16(INK4a) transcript is enriched in purified islets compared with the exocrine pancreas, and islet-specific expression of p16(INK4a), but not other cyclin-dependent kinase inhibitors, increases markedly with ageing. To determine the physiological significance of p16(INK4a) accumulation on islet function, we assessed the impact of p16(INK4a) deficiency and overexpression with increasing age and in the regenerative response after exposure to a specific beta-cell toxin. Transgenic mice that overexpress p16(INK4a) to a degree seen with ageing demonstrated decreased islet proliferation. Similarly, islet proliferation was unaffected by p16(INK4a) deficiency in young mice, but was relatively increased in p16(INK4a)-deficient old mice. Survival after toxin-mediated ablation of beta-cells, which requires islet proliferation, declined with advancing age; however, mice lacking p16(INK4a) demonstrated enhanced islet proliferation and survival after beta-cell ablation. These genetic data support the view that an age-induced increase of p16(INK4a) expression limits the regenerative capacity of beta-cells with ageing.	Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Sharpless, NE (corresponding author), Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Med, Chapel Hill, NC 27599 USA.	NES@med.unc.edu		Sharpless, Norman/0000-0001-7078-9455; Bonner-Weir, Susan/0000-0003-4682-0656; Ramsey, Matthew/0000-0003-2402-8502; Ligon, Keith/0000-0002-7733-600X				Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; BONNERWEIR S, 1981, DIABETES, V30, P64, DOI 10.2337/diabetes.30.1.64; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Campisi J, 2003, NAT REV CANCER, V3, P339, DOI 10.1038/nrc1073; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Fernandes A, 1997, ENDOCRINOLOGY, V138, P1750, DOI 10.1210/en.138.4.1750; Gu DL, 1997, PANCREAS, V15, P246, DOI 10.1097/00006676-199710000-00005; Halvorsen TL, 2000, J ENDOCRINOL, V166, P103, DOI 10.1677/joe.0.1660103; Hino S, 2004, DIABETOLOGIA, V47, P1819, DOI 10.1007/s00125-004-1522-4; Jacobs JJL, 2004, CURR BIOL, V14, P2302, DOI 10.1016/j.cub.2004.12.025; JANZEN V, 2006, NATURE          0906, DOI DOI 10.1038/NATURE05159; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Marzo N, 2004, DIABETOLOGIA, V47, P686, DOI 10.1007/s00125-004-1372-0; Meng AM, 2003, CANCER RES, V63, P5414; MOLOFSKY AV, 2006, NATURE          0906, DOI DOI 10.1038/NATURE05091; MONTANA E, 1993, J CLIN INVEST, V91, P780, DOI 10.1172/JCI116297; Nielsen GP, 1999, LAB INVEST, V79, P1137; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Pei XH, 2004, MOL CELL BIOL, V24, P6653, DOI 10.1128/mcb.24.15.6653-6664.2004; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; RILEY WJ, 1981, DIABETES, V30, P718, DOI 10.2337/diabetes.30.9.718; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sharpless NE, 2004, ONCOGENE, V23, P379, DOI 10.1038/sj.onc.1207074; Sone H, 2005, DIABETOLOGIA, V48, P58, DOI 10.1007/s00125-004-1605-2; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; Uchida T, 2005, NAT MED, V11, P175, DOI 10.1038/nm1187; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	32	717	755	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2006	443	7110					453	457		10.1038/nature05092	http://dx.doi.org/10.1038/nature05092			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	16957737				2022-12-28	WOS:000240798800045
J	Chen, SN; Wang, WY; Lee, S; Nafa, K; Lee, J; Romans, K; Watson, P; Gruber, SB; Euhus, D; Kinzler, KW; Jass, J; Gallinger, S; Lindor, NM; Casey, G; Ellis, N; Giardiello, FM; Offit, K; Parmigiani, G				Chen, Sining; Wang, Wenyi; Lee, Shing; Nafa, Khedoudja; Lee, Johanna; Romans, Kathy; Watson, Patrice; Gruber, Stephen B.; Euhus, David; Kinzler, Kenneth W.; Jass, Jeremy; Gallinger, Steven; Lindor, Noralane M.; Casey, Graham; Ellis, Nathan; Giardiello, Francis M.; Offit, Kenneth; Parmigiani, Giovanni		Colon Canc Family Registry	Prediction of germline mutations and cancer risk in the Lynch syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; MISMATCH REPAIR GENE; TUMOR MICROSATELLITE INSTABILITY; FAMILY-HISTORY; COLON-CANCER; BETHESDA GUIDELINES; ENDOMETRIAL CANCER; PROTEIN EXPRESSION; CLINICAL-CRITERIA; BREAST-CANCER	Context Identifying families at high risk for the Lynch syndrome (ie, hereditary non-polyposis colorectal cancer) is critical for both genetic counseling and cancer prevention. Current clinical guidelines are effective but limited by applicability and cost. Objective To develop and validate a genetic counseling and risk prediction tool that estimates the probability of carrying a deleterious mutation in mismatch repair genes MLH1, MSH2, or MSH6 and the probability of developing colorectal or endometrial cancer. Design, Setting, and Patients External validation of the MMRpro model was conducted on 279 individuals from 226 clinic-based families in the United States, Canada, and Australia (referred between 1993-2005) by comparing model predictions with results of highly sensitive germline mutation detection techniques. MMRpro models the autosomal dominant inheritance of mismatch repair mutations, with parameters based on meta-analyses of the penetrance and prevalence of mutations and of the predictive values of tumor characteristics. The model's prediction is tailored to each individual's detailed family history information on colorectal and endometrial cancer and to tumor characteristics including microsatellite instability. Main Outcome Measure Ability of MMRpro to correctly predict mutation carrier status, as measured by operating characteristics, calibration, and overall accuracy. Results In the independent validation, MMRpro provided a concordance index of 0.83 (95% confidence interval, 0.78-0.88) and a ratio of observed to predicted cases of 0.94 (95% confidence interval, 0.84-1.05). This results in higher accuracy than existing alternatives and current clinical guidelines. Conclusions MMRpro is a broadly applicable, accurate prediction model that can contribute to current screening and genetic counseling practices in a high-risk population. It is more sensitive and more specific than existing clinical guidelines for identifying individuals who may benefit from MMR germline testing. It is applicable to individuals for whom tumor samples are not available and to individuals in whom germline testing finds no mutation.	Johns Hopkins, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; Johns Hopkins, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Creighton Univ, Sch Med, Omaha, NE USA; Univ Michigan, Sch Med, Ann Arbor, MI USA; Univ Texas, SW Med Ctr, Dallas, TX USA; McGill Univ, Dept Pathol, Montreal, PQ, Canada; Univ Toronto, Toronto, ON, Canada; Mayo Clin, Coll Med, Rochester, MN USA; Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Columbia University; Memorial Sloan Kettering Cancer Center; Creighton University; University of Michigan System; University of Michigan; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; McGill University; University of Toronto; Mayo Clinic; Case Western Reserve University; Cleveland Clinic Foundation; University of Chicago	Chen, SN (corresponding author), Johns Hopkins, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, 615 N Wolfe St,Room W7033A, Baltimore, MD 21205 USA.	sichen@jhsph.edu	Gallinger, Steven/E-4575-2013	Wang, Wenyi/0000-0003-0617-9438	NATIONAL CANCER INSTITUTE [R03CA103500, P50CA062924, R01CA105090] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA105090, R03 CA103500, R03 CA103500-02, P50CA62924, R01 CA105090-03, R01 CA105090-01A1, R01 CA105090, P50 CA062924, R01 CA105090-04, P50 CA062924-090014, CA-96-001, R01 CA105090-02] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*AM SOC CLIN ONC, 1997, NAT ACT PLAN BREAST; Antoniou AC, 2000, GENET EPIDEMIOL, V18, P173; Bapat BV, 1999, HUM GENET, V104, P167, DOI 10.1007/s004390050931; Berry DA, 1997, J NATL CANCER I, V89, P227, DOI 10.1093/jnci/89.3.227; Boland CR, 1998, CANCER RES, V58, P5248; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Bruinooge SS, 2003, J CLIN ONCOL, V21, P2397, DOI 10.1200/JCO.2003.03.189; Buttin BM, 2004, AM J HUM GENET, V74, P1262, DOI 10.1086/421332; Caldes T, 2004, ONCOL REP, V12, P621; Calistri D, 2000, INT J CANCER, V89, P87, DOI 10.1002/(SICI)1097-0215(20000120)89:1<87::AID-IJC14>3.0.CO;2-9; Casey G, 2005, JAMA-J AM MED ASSOC, V293, P799, DOI 10.1001/jama.293.7.799; Cederquist K, 2001, INT J CANCER, V91, P486, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1093>3.0.CO;2-P; Charbonnier F, 2000, CANCER RES, V60, P2760; Chen S., 2004, STAT APPL GENET MOL, V3, P1; Chen SN, 2005, BIOSTATISTICS, V6, P450, DOI 10.1093/biostatistics/kxi021; de Leon MP, 2004, BRIT J CANCER, V90, P882, DOI 10.1038/sj.bjc.6601529; Debniak T, 2000, EUR J CANCER, V36, P49, DOI 10.1016/S0959-8049(99)00208-7; deGroot M.H., 1982, STATISTICIAN, V32, P12; Dietmaier W, 1997, CANCER RES, V57, P4749; Dieumegard B, 2000, BRIT J CANCER, V82, P871, DOI 10.1054/bjoc.1999.1014; Dunlop MG, 1997, HUM MOL GENET, V6, P105, DOI 10.1093/hmg/6.1.105; Efron B, 2000, J AM STAT ASSOC, V95, P1293, DOI 10.2307/2669773; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Engel C, 2006, INT J CANCER, V118, P115, DOI 10.1002/ijc.21313; Euhus D M, 2001, Breast J, V7, P224, DOI 10.1046/j.1524-4741.2001.20012.x; Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; Fredricks DN, 1999, BIOTECHNIQUES, V26, P198, DOI 10.2144/99262bm04; Hampel H, 2005, GASTROENTEROLOGY, V129, P415, DOI 10.1053/j.gastro.2005.05.011; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Jenkins MA, 2006, CLIN GASTROENTEROL H, V4, P489, DOI 10.1016/j.cgh.2006.01.002; Kakar S, 2003, CANCER-AM CANCER SOC, V97, P1421, DOI 10.1002/cncr.11206; Lamberti C, 1999, GUT, V44, P839, DOI 10.1136/gut.44.6.839; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Li FR, 1995, ENVIRON HEALTH PERSP, V103, P297, DOI 10.2307/3432329; Lindor NM, 2002, J CLIN ONCOL, V20, P1043, DOI 10.1200/JCO.20.4.1043; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; Liu T, 2000, GENE CHROMOSOME CANC, V27, P17, DOI 10.1002/(SICI)1098-2264(200001)27:1<17::AID-GCC3>3.0.CO;2-Y; Loukola A, 1999, AM J PATHOL, V155, P1849, DOI 10.1016/S0002-9440(10)65503-4; Lynch HT, 1999, J MED GENET, V36, P801; Marcus VA, 1999, AM J SURG PATHOL, V23, P1248, DOI 10.1097/00000478-199910000-00010; Miyaki M, 1997, NAT GENET, V17, P271, DOI 10.1038/ng1197-271; MURPHY EA, 1969, HUM HERED, V19, P126, DOI 10.1159/000152210; Nakagawa H, 2001, CANCER RES, V61, P6991; Nanda R, 2005, JAMA-J AM MED ASSOC, V294, P1925, DOI 10.1001/jama.294.15.1925; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; OFFIT K, 1994, J CLIN ONCOL, V12, P1724, DOI 10.1200/JCO.1994.12.8.1724; PAPADOPOULOS N, 1995, NAT GENET, V11, P99, DOI 10.1038/ng0995-99; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; Parmigiani G, 1998, AM J HUM GENET, V62, P145, DOI 10.1086/301670; Percesepe A, 2001, J CLIN ONCOL, V19, P3944, DOI 10.1200/JCO.2001.19.19.3944; Peterlongo P, 2003, INT J CANCER, V107, P571, DOI 10.1002/ijc.11415; Quehenberger F, 2005, J MED GENET, V42, P491, DOI 10.1136/jmg.2004.024299; Ransohoff DF, 2002, NEW ENGL J MED, V346, P40, DOI 10.1056/NEJMcp010886; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; Salahshor S, 1999, BRIT J CANCER, V81, P190, DOI 10.1038/sj.bjc.6690676; Salovaara R, 2000, J CLIN ONCOL, V18, P2193, DOI 10.1200/JCO.2000.18.11.2193; Scartozzi M, 2002, J CLIN ONCOL, V20, P1203, DOI 10.1200/JCO.20.5.1203; Schmeler KM, 2006, NEW ENGL J MED, V354, P261, DOI 10.1056/NEJMoa052627; Shia J, 2005, AM J SURG PATHOL, V29, P96, DOI 10.1097/01.pas.0000146009.85309.3b; Syngal S, 2000, J MED GENET, V37, P641, DOI 10.1136/jmg.37.9.641; Szolovits P., 1992, MEDINFO 92. Proceedings of the Seventh World Congress on Medical Informatics, P679; Terdiman JP, 2001, GASTROENTEROLOGY, V120, P21, DOI 10.1053/gast.2001.20874; Trepanier Angela, 2004, J Genet Couns, V13, P83, DOI 10.1023/B:JOGC.0000018821.48330.77; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Wang YP, 2003, INT J CANCER, V103, P636, DOI 10.1002/ijc.10869; WATSON P, 1993, CANCER, V71, P677, DOI 10.1002/1097-0142(19930201)71:3<677::AID-CNCR2820710305>3.0.CO;2-#; Wijnen JT, 1998, NEW ENGL J MED, V339, P511, DOI 10.1056/NEJM199808203390804; Yan H, 2000, NATURE, V403, P723, DOI 10.1038/35001659	70	264	269	1	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2006	296	12					1479	1487		10.1001/jama.296.12.1479	http://dx.doi.org/10.1001/jama.296.12.1479			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087VD	17003396	Green Accepted, Bronze			2022-12-28	WOS:000240770000024
J	Hawkes, N				Hawkes, Nigel			NHS reorganisation - Who's kicking who?	BRITISH MEDICAL JOURNAL			English	Editorial Material									The Times, London E98 1TT, England		Hawkes, N (corresponding author), The Times, London E98 1TT, England.	nigel.hawkes@thetimes.co.uk						*AUD COMM, 2003, WHIT LIST ACC ASS AC; COMERFORD C, 2006, DOCTOR          0711, P2; CRUMP H, 2006, PULSE           0706, P1; *DEP HLTH, 2006, PRACT BAS COMM IMPL; *DEP HLTH, 2006, HLTH REF ENGL; *DEP HLTH, 2006, GOOD DOCT SAF PAT; *DEP HLTH, 2006, REORG PRIM CAR AMB T; HAWKES N, 2006, TIMES           0309; *HC HLTH SEL COMM, 2006, IND SECT TREATM CTR; *ICM RES, 2005, OP POLL NEWS WORLD; *NHS, 2006, CHIEF EX REP NHS; *NHS APP COMM, 2006, ANN REP ACC 2005 06, P39; Salisbury C, 2005, BMJ-BRIT MED J, V331, P1441, DOI 10.1136/bmj.38670.494734.7C; Vayssiere C, 2006, GP              0602, P1; WILSON HR, 1972, BIOPHYS J, V12, P2	15	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 23	2006	333	7569					645	648		10.1136/bmj.38967.410428.68	http://dx.doi.org/10.1136/bmj.38967.410428.68			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089KD	16990326	Green Published			2022-12-28	WOS:000240878500021
J	Leather, A; Ismail, EA; Ali, R; Abdi, YA; Abby, MH; Gulaid, SA; Walhad, SA; Guleid, S; Ervine, IM; Lowe-Lauri, M; Parker, M; Adams, S; Datema, M; Parry, E				Leather, Andrew; Ismail, Edna Adan; Ali, Roda; Abdi, Yasin Arab; Abby, Mohamed Hussein; Gulaid, Suleiman Ahmed; Walhad, Said Ahmed; Guleid, Suleiman; Ervine, Ian Maxwell; Lowe-Lauri, Malcolm; Parker, Michael; Adams, Sarah; Datema, Marieke; Parry, Eldryd			Working together to rebuild health care in post-conflict Somaliland	LANCET			English	Article								In 1991, the Somali National Movement fighters recaptured the Somaliland capital city of Hargeisa after a 3-year civil war. The government troops of the dictator General Mohamed Siad Barre fled south, plunging most of Somalia into a state of anarchy that persists to this day. In the north of the region, the redeclaration of independence of Somaliland took place on May 18, 1991. Despite some sporadic civil unrest between 1994 and 1996, and a few tragic killings of members of the international community, the country has enjoyed peace and stability and has an impressive development record. However, Somaliland continues to await international recognition. The civil war resulted in the destruction of most of Somaliland's health-care facilities, compounded by mass migration or death of trained health personnel. Access to good, affordable health care for the average Somali remains greatly compromised. A former medical director of the general hospital of Hargeisa, Abdirahman Ahmed Mohamed, suggested the idea of a link between King's College Hospital in London, UK, and Somaliland. With support from two British colleagues, a fact-finding trip sponsored by the Tropical Health and Education Trust (THET) took place in July, 2000, followed by a needs assessment by a THET programme coordinator. Here, we describe the challenges of health-care reconstruction in Somaliland and the evolving role of the partnership between Kings College Hospital, THET, and Somaliland within the context of the growing movement to link UK NHS trusts and teaching institutions with counterparts in developing countries.	Kings Coll Hosp London, London SE5 9RS, England; Edna Adan Hosp, Hargeisa, Somalia; Somaliland Govt, Hargeisa, Somalia; Hargeisa Grp Hosp, Hargeisa, Somalia; Reg Hlth Board, Hargeisa, Somalia; Amoud Univ, Borama, Somalia; Somaliland Med Assoc, Hargeisa, Somalia; Somaliland Nursing Assoc, Hargeisa, Somalia; Trop Hlth & Educ Trust, London NW1 2BE, England; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; London School of Hygiene & Tropical Medicine	Leather, A (corresponding author), Kings Coll Hosp London, Denmark Hill, London SE5 9RS, England.	Andy.Leather@kingsch.nhs.uk		Leather, Andy/0000-0003-0500-5962				Ahmed II, 2000, DISASTERS, V24, P380, DOI 10.1111/1467-7717.00154; Commission for Africa, 2005, OUR COMMON INTEREST; HANSEN P, 2004, MIGR DEV WORKSH 3; JHAZBAY I, 2003, UMRABULO, V18, P53; Mensah K, 2005, SKILLS DRAIN HLTH PR; *THET INT, 2005, TROP HLTH ED TRUST L; Vaux T, 2005, SERVICE DELIVERY COU; WSP International, 2005, REB SOM ISS POSS	8	48	48	0	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 23	2006	368	9541					1119	1125		10.1016/S0140-6736(06)69047-8	http://dx.doi.org/10.1016/S0140-6736(06)69047-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	089IC	16997666				2022-12-28	WOS:000240873000027
J	Alonso, D; Pascual, M				Alonso, David; Pascual, Mercedes			Comment on "A keystone mutualism drives pattern in a power function"	SCIENCE			English	Editorial Material							SAMPLING THEORY; CRITICALITY		Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Alonso, D (corresponding author), Univ Michigan, N Univ Ave, Ann Arbor, MI 48109 USA.	dalonso@umich.edu	Alonso, David/A-5406-2008	Alonso, David/0000-0002-8888-1644				Alonso D, 2004, ECOL LETT, V7, P901, DOI 10.1111/j.1461-0248.2004.00640.x; Chave J, 2002, AM NAT, V159, P1, DOI 10.1086/324112; Etienne RS, 2007, J STAT PHYS, V128, P485, DOI 10.1007/s10955-006-9163-2; Etienne RS, 2005, ECOL LETT, V8, P1147, DOI 10.1111/j.1461-0248.2005.00817.x; Hilborn Ray, 1997, V28; Hubbell Stephen P., 2001, V32, pi; KENDALL DG, 1948, BIOMETRIKA, V35, P6, DOI 10.2307/2332624; Pascual M, 2005, TRENDS ECOL EVOL, V20, P88, DOI 10.1016/j.tree.2004.11.012; Pueyo S, 2006, OIKOS, V112, P392, DOI 10.1111/j.0030-1299.2006.14188.x; Pueyo S, 2003, THESIS U BARCELONA; Purves Drew W., 2005, P107, DOI 10.1017/CBO9780511541971.006; Rannala B, 1996, THEOR POPUL BIOL, V50, P91, DOI 10.1006/tpbi.1996.0024; Sole RV, 1999, TRENDS ECOL EVOL, V14, P156, DOI 10.1016/S0169-5347(98)01518-3; Sole RV, 2002, PHILOS T R SOC B, V357, P667, DOI 10.1098/rstb.2001.0992; Vandermeer J, 2006, SCIENCE, V311, P1000, DOI 10.1126/science.1121432	15	5	5	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2006	313	5794								10.1126/science.1129115	http://dx.doi.org/10.1126/science.1129115			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990534				2022-12-28	WOS:000240655700025
J	Petronczki, M; Matos, J; Mori, S; Gregan, J; Bogdanova, A; Schwickart, M; Mechtler, K; Shirahige, K; Zachariae, W; Nasmyth, K				Petronczki, Mark; Matos, Joao; Mori, Saori; Gregan, Juraj; Bogdanova, Aliona; Schwickart, Martin; Mechtler, Karl; Shirahige, Katsuhiko; Zachariae, Wolfgang; Nasmyth, Kim			Monopolar attachment of sister kinetochores at meiosis I requires casein kinase 1	CELL			English	Article							REDUCTIONAL CHROMOSOME SEGREGATION; PROTEIN PHOSPHATASE 2A; CHROMATID COHESION; S-PHASE; CLEAVAGE; YEAST; REC8; ORIENTATION; HOMOLOGS	In meiosis, a single round of DNA replication is followed by two consecutive rounds of chromosome segregation, called meiosis I and II. Disjunction of maternal from paternal centromeres during meiosis I depends on the attachment of sister kinetochores to microtubules emanating from the same pole. In budding yeast, monopolar attachment requires recruitment to kinetochores of the monopolin complex. How monopolin promotes monopolar attachment was unclear, as its subunits are poorly conserved and lack similarities to proteins with known functions. We show here that the monopolin subunit Mam1 binds tightly to Hrr25, a highly conserved casein kinase 1 delta/epsilon (CK1 delta/epsilon), and recruits it to meiosis I centromeres. Hrr25 kinase activity and Mam1 binding are both essential for monopolar attachment. Since CK1 delta/epsilon activity is important for accurate chromosome segregation during meiosis I also in fission yeast, phosphorylation of kinetochore proteins by CK1 delta/epsilon might be an evolutionary conserved process required for monopolar attachment.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Tokyo Inst Technol, Ctr Biol Resources & Informat, Lab Genome Struct & Funct, Div Gene Res,Midori Ku, Yokohama, Kanagawa 2268501, Japan; Genentech Inc, San Francisco, CA 94080 USA; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Max Planck Society; Tokyo Institute of Technology; Roche Holding; Genentech; University of Oxford	Zachariae, W (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	zachariae@mpi-cbg.de; kim.nasmyth@bioch.ox.ac.uk	Mechtler, Karl/AAF-2717-2019; Matos, Joao/C-1488-2014; Gregan, Juraj/I-4161-2014	Mechtler, Karl/0000-0002-3392-9946; Matos, Joao/0000-0002-3754-3709; Gregan, Juraj/0000-0002-2989-8374; Nasmyth, Kim/0000-0001-7030-4403; Shirahige, Katsuhiko/0000-0002-7862-1144; Petronczki, Mark/0000-0003-0139-5692				Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Chelysheva L, 2005, J CELL SCI, V118, P4621, DOI 10.1242/jcs.02583; Dewar H, 2004, NATURE, V428, P93, DOI 10.1038/nature02328; DHILLON N, 1994, EMBO J, V13, P2777, DOI 10.1002/j.1460-2075.1994.tb06571.x; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hauf S, 2004, CELL, V119, P317, DOI 10.1016/j.cell.2004.10.014; HOEKSTRA MF, 1991, SCIENCE, V253, P1031, DOI 10.1126/science.1887218; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2003, EMBO J, V22, P5643, DOI 10.1093/emboj/cdg527; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Knop M, 2000, EMBO J, V19, P3657, DOI 10.1093/emboj/19.14.3657; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Nasmyth K, 2005, PHILOS T R SOC B, V360, P483, DOI 10.1098/rstb.2004.1604; Oelschlaegel T, 2005, CELL, V120, P773, DOI 10.1016/j.cell.2005.01.032; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Rabitsch KP, 2004, CURR BIOL, V14, P287, DOI 10.1016/j.cub.2004.01.051; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Visintin R, 2000, CURR OPIN CELL BIOL, V12, P752, DOI 10.1016/S0955-0674(00)00165-4; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Watanabe Y, 2001, NATURE, V409, P359, DOI 10.1038/35053103; Watanabe Y, 2005, TRENDS GENET, V21, P405, DOI 10.1016/j.tig.2005.05.009; XU RM, 1995, EMBO J, V14, P1015, DOI 10.1002/j.1460-2075.1995.tb07082.x; Yamamoto A, 2003, EMBO J, V22, P2284, DOI 10.1093/emboj/cdg222; Yokobayashi S, 2003, MOL CELL BIOL, V23, P3965, DOI 10.1128/MCB.23.11.3965-3973.2003; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013; Yu HG, 2000, J CELL BIOL, V151, P131, DOI 10.1083/jcb.151.1.131	32	134	138	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 22	2006	126	6					1049	1064		10.1016/j.cell.2006.07.029	http://dx.doi.org/10.1016/j.cell.2006.07.029			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990132	Bronze			2022-12-28	WOS:000240897600013
J	Jordan, CT; Guzman, ML; Noble, M				Jordan, Craig T.; Guzman, Monica L.; Noble, Mark			Mechanisms of disease - Cancer stem cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM; PROGENITOR CELLS; GEMTUZUMAB OZOGAMICIN; MAMMARY-GLAND; SELF-RENEWAL; QUIESCENT; SURVIVAL; IDENTIFICATION; THERAPY		Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY 14642 USA; Univ Rochester, Sch Med, Dept Biomed Genet, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Jordan, CT (corresponding author), Univ Rochester, Sch Med, James P Wilmot Canc Ctr, 601 Elmwood Ave,Box 703, Rochester, NY 14642 USA.	craig_jordan@urmc.rochester.edu	jordan, craig/D-7666-2014	jordan, craig/0000-0003-0869-3465	NATIONAL CANCER INSTITUTE [R01CA090446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044701] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA90446] Funding Source: Medline; NINDS NIH HHS [R0-1NS44701] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Al-Hajj M, 2004, CURR OPIN GENET DEV, V14, P43, DOI 10.1016/j.gde.2003.11.007; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P6890, DOI 10.1073/pnas.1131491100; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Barnett SC, 1998, CARCINOGENESIS, V19, P1529, DOI 10.1093/carcin/19.9.1529; Behbod F, 2005, CARCINOGENESIS, V26, P703, DOI 10.1093/carcin/bgh293; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bonnett D, 1999, P NATL ACAD SCI USA, V96, P8639, DOI 10.1073/pnas.96.15.8639; Cairns J, 2002, P NATL ACAD SCI USA, V99, P10567, DOI 10.1073/pnas.162369899; Castor A, 2005, NAT MED, V11, P630, DOI 10.1038/nm1253; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Clarke RB, 2005, CELL PROLIFERAT, V38, P375, DOI 10.1111/j.1365-2184.2005.00357.x; Cobaleda C, 2000, BLOOD, V95, P1007, DOI 10.1182/blood.V95.3.1007.003k35_1007_1013; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Cortes, 2005, J CLIN ONCOL, V23, P9034, DOI 10.1200/JCO.2005.11.001; Cortes J, 2005, J CLIN ONCOL, V23, P6316, DOI 10.1200/JCO.2005.05.009; Cortes J, 2004, BLOOD, V104, P2204, DOI 10.1182/blood-2004-04-1335; Cox CV, 2004, BLOOD, V104, P2919, DOI 10.1182/blood-2004-03-0901; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Dick JE, 2005, ANN NY ACAD SCI, V1044, P1, DOI 10.1196/annals.1349.001; Donnenberg VS, 2005, J CLIN PHARMACOL, V45, P872, DOI 10.1177/0091270005276905; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Feller N, 2004, LEUKEMIA, V18, P1380, DOI 10.1038/sj.leu.2403405; Feuring-Buske M, 2002, CANCER RES, V62, P1730; FIALKOW PJ, 1967, P NATL ACAD SCI USA, V58, P1468, DOI 10.1073/pnas.58.4.1468; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; GROVES AK, 1993, NATURE, V362, P453, DOI 10.1038/362453a0; Guan YH, 2003, BLOOD, V101, P3142, DOI 10.1182/blood-2002-10-3062; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Guzman ML, 2002, P NATL ACAD SCI USA, V99, P16220, DOI 10.1073/pnas.252462599; Guzman Monica L, 2004, Cancer Control, V11, P97; Hamann PR, 2002, BIOCONJUGATE CHEM, V13, P47, DOI 10.1021/bc010021y; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Holyoake T, 1999, BLOOD, V94, P2056, DOI 10.1182/blood.V94.6.2056; Holyoake TL, 2002, LEUKEMIA, V16, P549, DOI 10.1038/sj.leu.2402444; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; Jordan CT, 2005, NAT CLIN PRACT ONCOL, V2, P224, DOI 10.1038/ncponc0164; Jordan CT, 2004, ONCOGENE, V23, P7178, DOI 10.1038/sj.onc.1207935; Jordan CT, 2002, LEUKEMIA, V16, P559, DOI 10.1038/sj.leu.2402446; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Larson RA, 2005, CANCER, V104, P1442, DOI 10.1002/cncr.21326; Li Y, 2005, J MAMMARY GLAND BIOL, V10, P17, DOI 10.1007/s10911-005-2537-2; Liu SL, 2005, BREAST CANCER RES, V7, P86, DOI 10.1186/bcr1021; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lowenberg Bob, 1998, Current Opinion in Oncology, V10, P31; Meng AM, 2003, CANCER RES, V63, P5414; Narita M, 2005, NAT MED, V11, P920, DOI 10.1038/nm0905-920; NOBLE M, 1984, EMBO J, V3, P2243, DOI 10.1002/j.1460-2075.1984.tb02122.x; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Rao MS, 1998, P NATL ACAD SCI USA, V95, P3996, DOI 10.1073/pnas.95.7.3996; Rao MS, 1997, DEV BIOL, V188, P48, DOI 10.1006/dbio.1997.8597; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Seaberg RM, 2003, TRENDS NEUROSCI, V26, P125, DOI 10.1016/S0166-2236(03)00031-6; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shizuru JA, 2005, ANNU REV MED, V56, P509, DOI 10.1146/annurev.med.54.101601.152334; Shmelkov SV, 2005, INT J BIOCHEM CELL B, V37, P715, DOI 10.1016/j.biocel.2004.08.010; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Tallman, 2005, BLOOD, V106, P2243; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Taussig DC, 2005, BLOOD, V106, P4086, DOI 10.1182/blood-2005-03-1072; Terpstra W, 1996, BLOOD, V88, P1944, DOI 10.1182/blood.V88.6.1944.bloodjournal8861944; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; van Rhenen A, 2005, CLIN CANCER RES, V11, P6520, DOI 10.1158/1078-0432.CCR-05-0468; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Woodward WA, 2005, J CELL SCI, V118, P3585, DOI 10.1242/jcs.02532; Xu Q, 2005, BLOOD, V106, P4261, DOI 10.1182/blood-2004-11-4468; Xu Q, 2003, BLOOD, V102, P972, DOI 10.1182/blood-2002-11-3429; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703	84	1228	1322	3	112	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 21	2006	355	12					1253	1261		10.1056/NEJMra061808	http://dx.doi.org/10.1056/NEJMra061808			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085IT	16990388				2022-12-28	WOS:000240598500009
J	Wolk, A; Larsson, SC; Johansson, JE; Ekman, P				Wolk, Alicja; Larsson, Susanna C.; Johansson, Jan-Erik; Ekman, Peter			Long-term fatty fish consumption and renal cell carcinoma incidence in women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VITAMIN-D-RECEPTOR; RISK-FACTORS; CANCER; PREVENTION; ACTIVATION; ACIDS; DIET	Context The epidemiological evidence that fatty fish consumption may be associated with the lower risk of several cancers is not consistent and no studies of renal cell carcinoma (RCC) exist. Objective To examine the association between fatty and lean fish consumption and risk of RCC in women. Design, Setting, and Participants The Swedish Mammography Cohort, a population-based prospective cohort study of 61 433 women aged 40 to 76 years without previous diagnosis of cancer at baseline ( March 1, 1987-December 14, 1990). Participants filled in a food frequency questionnaire at baseline and in September 1997. Main Outcome Measure Incident renal cell carcinoma. Results During a mean of 15.3 years ( 940 357 person-years) of follow-up between 1987 and 2004, 150 incident RCC cases were diagnosed. After adjustment for potential confounders, an inverse association of fatty fish consumption with the risk of RCC was found ( P for trend=.02), but no association was found with lean fish consumption. Compared with no consumption, the multivariate rate ratio (RR) was 0.56 ( 95% confidence interval [CI], 0.35-0.91) for women eating fatty fish once a week or more. Compared with women consistently reporting no fish consumption, the multivariate RR was 0.26 ( 95% CI, 0.10-0.67) for those women reporting consistent consumption of fatty fish at baseline and 1997 ( based on a subset of 36 664 women who filled in the baseline and 1997 questionnaires, with 40 incident RCC cases during the 1998-2004 follow-up period). Conclusion Our study suggests that consumption of fatty fish may reduce the occurrence of RCC in women.	Karolinska Inst, Natl Inst Environm Med, Div Nutr Epidemiol, SE-17177 Stockholm, Sweden; Univ Hosp, Dept Urol, Orebro, Sweden; Univ Hosp, Ctr Assessment Med Technol, Orebro, Sweden; Karolinska Univ Hosp, Dept Mol Med & Surg, Stockholm, Sweden	Karolinska Institutet; Orebro University; Orebro University; Karolinska Institutet; Karolinska University Hospital	Wolk, A (corresponding author), Karolinska Inst, Natl Inst Environm Med, Div Nutr Epidemiol, POB 210, SE-17177 Stockholm, Sweden.	alicja.wolk@ki.se	Larsson, Susanna C./F-6065-2015	Larsson, Susanna C./0000-0003-0118-0341				Bergstrom L., 1991, Var Foda, V43, P439; Chow WH, 1999, JAMA-J AM MED ASSOC, V281, P1628, DOI 10.1001/jama.281.17.1628; Cox D. R., 1984, ANAL SURVIVAL DATA; Ekstrom AM, 1999, JNCI-J NATL CANCER I, V91, P786, DOI 10.1093/jnci/91.9.786; Fujioka T, 2000, WORLD J SURG, V24, P1205, DOI 10.1007/s002680010206; Healy KD, 2005, ARCH BIOCHEM BIOPHYS, V433, P466, DOI 10.1016/j.abb.2004.10.001; Holick MF, 2005, J NUTR, V135, p2739S, DOI 10.1093/jn/135.11.2739S; Hu JF, 2003, CANCER CAUSE CONTROL, V14, P705, DOI 10.1023/A:1026310323882; Ikuyama T, 2002, ENDOCR J, V49, P433, DOI 10.1507/endocrj.49.433; Inoue K, 2001, BIOCHEM BIOPH RES CO, V287, P727, DOI 10.1006/bbrc.2001.5640; *INT AG RES CANC, 2000, INT ANN REP, V15; KREIGER N, 1993, CANCER CAUSE CONTROL, V4, P101, DOI 10.1007/BF00053150; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; LYNCH CF, 1995, CANCER, V75, P316, DOI 10.1002/1097-0142(19950101)75:1+<316::AID-CNCR2820751314>3.0.CO;2-T; MacLean CH, 2006, JAMA-J AM MED ASSOC, V295, P403, DOI 10.1001/jama.295.4.403; MATTSSON B, 1984, ACTA RADIOL ONCOL, V23, P305, DOI 10.3109/02841868409136026; McCabe AJ, 2005, J NUTR BIOCHEM, V16, P17, DOI 10.1016/j.jnutbio.2004.07.006; MCLAUGHLIN JK, 1992, INT J CANCER, V52, P562, DOI 10.1002/ijc.2910520411; *NAT CANC I CANC S, 2001, SEER 9 REG PUBL US F; *NAT CANC I CANC S, 2001, SEER 11 REG PUBL US; Skopinska-Rozewska E, 1999, ONCOL REP, V6, P1341; *SWED CANC REG CTR, 2006, STAT HLTH DIS 2005, V9; Terry PD, 2003, AM J CLIN NUTR, V77, P532, DOI 10.1093/ajcn/77.3.532; Wolk A, 1996, INT J CANCER, V65, P67, DOI 10.1002/(SICI)1097-0215(19960103)65:1&lt;67::AID-IJC12&gt;3.0.CO;2-F; YU K, 1995, J BIOL CHEM, V270, P23975, DOI 10.1074/jbc.270.41.23975	25	87	88	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2006	296	11					1371	1376		10.1001/jama.296.11.1371	http://dx.doi.org/10.1001/jama.296.11.1371			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085HS	16985229	Bronze			2022-12-28	WOS:000240595800024
J	Huston, DP				Huston, David P.			Update in allergy and immunology	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							THYMIC STROMAL LYMPHOPOIETIN; COMMON VARIABLE IMMUNODEFICIENCY; ASTHMA; RECEPTOR; INFLAMMATION; DISORDER; MICE		Baylor Coll Med, Biol Inflammat Ctr, Houston, TX 77030 USA	Baylor College of Medicine	Huston, DP (corresponding author), Baylor Coll Med, Biol Inflammat Ctr, 1 Baylor Plaza,BCM 285, Houston, TX 77030 USA.	dhuston@bcm.edu		Huston, David/0000-0002-2332-0010				Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Hull KM, 2002, MEDICINE, V81, P349, DOI 10.1097/00005792-200209000-00002; Kinet JP, 2005, NEW ENGL J MED, V353, P310, DOI 10.1056/NEJMcibr051440; Lee WI, 2005, BLOOD, V105, P1881, DOI 10.1182/blood-2003-12-4420; Liu YJ, 2006, J EXP MED, V203, P269, DOI 10.1084/jem.20051745; National Asthma Education and Prevention, 1997, NIH PUBL, V97; *NIH, 2002, NIH PUBL, V2; Pauwels RA, 2003, LANCET, V361, P1071, DOI 10.1016/S0140-6736(03)12891-7; Schneider P, 2005, CURR OPIN IMMUNOL, V17, P282, DOI 10.1016/j.coi.2005.04.005; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Siraganian RP, 2003, CURR OPIN IMMUNOL, V15, P639, DOI 10.1016/j.coi.2003.09.010; Straus SE, 1999, ANN INTERN MED, V130, P591, DOI 10.7326/0003-4819-130-7-199904060-00020; Taylor PE, 2002, J ALLERGY CLIN IMMUN, V109, P51, DOI 10.1067/mai.2002.120759; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Zhang K, 2004, J ALLERGY CLIN IMMUN, V114, P321, DOI 10.1016/j.jaci.2004.03.058; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	20	0	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2006	145	6					454	458		10.7326/0003-4819-145-6-200609190-00009	http://dx.doi.org/10.7326/0003-4819-145-6-200609190-00009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087OU	16983133				2022-12-28	WOS:000240752500007
J	Canolty, RT; Edwards, E; Dalal, SS; Soltani, M; Nagarajan, SS; Kirsch, HE; Berger, MS; Barbaro, NM; Knight, RT				Canolty, R. T.; Edwards, E.; Dalal, S. S.; Soltani, M.; Nagarajan, S. S.; Kirsch, H. E.; Berger, M. S.; Barbaro, N. M.; Knight, R. T.			High gamma power is phase-locked to theta oscillations in human neocortex	SCIENCE			English	Article							NEURONAL OSCILLATIONS; CORTEX; SYNCHRONIZATION; MECHANISM; DYNAMICS; LOCKING; MEMORY	We observed robust coupling between the high- and low-frequency bands of ongoing electrical activity in the human brain. In particular, the phase of the low-frequency theta ( 4 to 8 hertz) rhythm modulates power in the high gamma ( 80 to 150 hertz) band of the electrocorticogram, with stronger modulation occurring at higher theta amplitudes. Furthermore, different behavioral tasks evoke distinct patterns of theta/high gamma coupling across the cortex. The results indicate that transient coupling between low- and high-frequency brain rhythms coordinates activity in distributed cortical areas, providing a mechanism for effective communication during cognitive processing in humans.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Canolty, RT (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	rcanolty@berkeley.edu		Kirsch, Heidi/0000-0002-3144-2085; Dalal, Sarang/0000-0002-1699-7218	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS021135, R01NS021135, R56NS021135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004855, F31DC006762] Funding Source: NIH RePORTER; NIDCD NIH HHS [F31DC006762, R01 DC004855-01A1, R01 DC004855] Funding Source: Medline; NINDS NIH HHS [R01 NS021135-20, NS21135, R01 NS021135] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BRAGIN A, 1995, J NEUROSCI, V15, P47; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; Chrobak JJ, 1998, J NEUROSCI, V18, P388; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Edwards E, 2005, J NEUROPHYSIOL, V94, P4269, DOI 10.1152/jn.00324.2005; Ekstrom AD, 2005, HIPPOCAMPUS, V15, P881, DOI 10.1002/hipo.20109; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Izhikevich EM, 2001, NEURAL NETWORKS, V14, P883, DOI 10.1016/S0893-6080(01)00078-8; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Lachaux JP, 2005, NEUROIMAGE, V25, P491, DOI 10.1016/j.neuroimage.2004.11.052; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Lin SC, 2006, J NEUROPHYSIOL, V96, P3209, DOI 10.1152/jn.00524.2006; Linkenkaer-Hansen K, 2004, J NEUROSCI, V24, P10186, DOI 10.1523/JNEUROSCI.2584-04.2004; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Miller R., 1991, CORTICO HIPPOCAMPAL; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Nunez P.L., 2005, ELECT FIELDS BRAIN N; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Schack B, 2002, INT J PSYCHOPHYSIOL, V44, P143, DOI 10.1016/S0167-8760(01)00199-4; Schoffelen JM, 2005, SCIENCE, V308, P111, DOI 10.1126/science.1107027; Sederberg PB, 2003, J NEUROSCI, V23, P10809; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258	27	1664	1735	22	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2006	313	5793					1626	1628		10.1126/science.1128115	http://dx.doi.org/10.1126/science.1128115			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973878	Green Accepted			2022-12-28	WOS:000240498900042
J	Dawson, RJP; Locher, KP				Dawson, Roger J. P.; Locher, Kaspar P.			Structure of a bacterial multidrug ABC transporter	NATURE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMAN P-GLYCOPROTEIN; BINDING CASSETTE TRANSPORTER; CATALYTIC TRANSITION-STATE; ATP-BINDING; CLOSED CONFORMATION; MALTOSE TRANSPORT; ESCHERICHIA-COLI; DRUG TRANSPORT; MECHANISM	Multidrug transporters of the ABC family facilitate the export of diverse cytotoxic drugs across cell membranes. This is clinically relevant, as tumour cells may become resistant to agents used in chemotherapy. To understand the molecular basis of this process, we have determined the 3.0 angstrom crystal structure of a bacterial ABC transporter (Sav1866) from Staphylococcus aureus. The homodimeric protein consists of 12 transmembrane helices in an arrangement that is consistent with cross-linking studies and electron microscopic imaging of the human multidrug resistance protein MDR1, but critically different from that reported for the bacterial lipid flippase MsbA. The observed, outward-facing conformation reflects the ATP-bound state, with the two nucleotide-binding domains in close contact and the two transmembrane domains forming a central cavity - presumably the drug translocation pathway - that is shielded from the inner leaflet of the lipid bilayer and from the cytoplasm, but exposed to the outer leaflet and the extracellular space.	ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Locher, KP (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	kaspar.locher@mol.biol.ethz.ch		Dawson, Roger/0000-0003-2161-5883				Abramson J, 2004, CURR OPIN STRUC BIOL, V14, P413, DOI 10.1016/j.sbi.2004.07.005; Awayn NH, 2005, BIOCHEM SOC T, V33, P996, DOI 10.1042/BST0330996; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; Chang G, 2003, J MOL BIOL, V330, P419, DOI 10.1016/S0022-2836(03)00587-4; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Cotten JF, 1996, J BIOL CHEM, V271, P21279, DOI 10.1074/jbc.271.35.21279; CURRIER SJ, 1992, J BIOL CHEM, V267, P25153; Gaudet R, 2001, EMBO J, V20, P4964, DOI 10.1093/emboj/20.17.4964; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Holland I. B., 2003, ABC PROTEINS BACTERI; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hrycyna CA, 1998, J BIOL CHEM, V273, P16631, DOI 10.1074/jbc.273.27.16631; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; Lankat-Buttgereit B, 2002, PHYSIOL REV, V82, P187, DOI 10.1152/physrev.00025.2001; Lee JY, 2002, J BIOL CHEM, V277, P40125, DOI 10.1074/jbc.M206871200; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loo TW, 2005, J MEMBRANE BIOL, V206, P173, DOI 10.1007/s00232-005-0792-1; Mannering DE, 2001, J BIOL CHEM, V276, P12362, DOI 10.1074/jbc.M011686200; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Nijenhuis M, 1996, J IMMUNOL, V157, P5467; Patzlaff JS, 2003, J BIOL CHEM, V278, P29546, DOI 10.1074/jbc.M304796200; Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u; Reyes CL, 2005, SCIENCE, V308, P1028, DOI 10.1126/science.1107733; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Sauna ZE, 2000, P NATL ACAD SCI USA, V97, P2515, DOI 10.1073/pnas.97.6.2515; Schneider E, 1998, FEMS MICROBIOL REV, V22, P1; Senior AE, 1998, BIOCHEMISTRY-US, V37, P831, DOI 10.1021/bi9719962; Shapiro AB, 1997, EUR J BIOCHEM, V250, P130, DOI 10.1111/j.1432-1033.1997.00130.x; SHAPIRO AB, 1995, J BIOL CHEM, V270, P16167, DOI 10.1074/jbc.270.27.16167; Sheppard DN, 1999, PHYSIOL REV, V79, P23; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Stenham DR, 2003, FASEB J, V17, P2287, DOI 10.1096/fj.03-0107fje; Stroud RM, 2003, CURR OPIN STRUC BIOL, V13, P424, DOI 10.1016/S0959-440X(03)00114-3; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; van Veen HW, 2000, EMBO J, V19, P2503, DOI 10.1093/emboj/19.11.2503; van Veen HW, 1998, NATURE, V391, P291, DOI 10.1038/34669; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Zelcer N, 2003, J BIOL CHEM, V278, P23538, DOI 10.1074/jbc.M303504200	45	1027	1062	4	218	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2006	443	7108					180	185		10.1038/nature05155	http://dx.doi.org/10.1038/nature05155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16943773				2022-12-28	WOS:000240467000039
J	Spaulding, C; Henry, P; Teiger, E; Beatt, K; Bramucci, E; Carrie, D; Slama, MS; Merkely, B; Erglis, A; Margheri, M; Varenne, O; Cebrian, A; Stoll, H; Snead, DB; Bode, C				Spaulding, Christian; Henry, Patrick; Teiger, Emmanuel; Beatt, Kevin; Bramucci, Ezio; Carrie, Didier; Slama, Michel S.; Merkely, Bela; Erglis, Andrejs; Margheri, Massimo; Varenne, Olivier; Cebrian, Ana; Stoll, Hans-Peter; Snead, David B.; Bode, Christoph		TYPHOON Investigators	Sirolimus-eluting versus uncoated stents in acute myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONVENTIONAL BALLOON ANGIOPLASTY; RANDOMIZED CONTROLLED-TRIAL; CORONARY REVASCULARIZATION; IMPLANTATION; ARTERY; ABCIXIMAB; REGISTRY; LESIONS	BACKGROUND: Sirolimus-eluting stents reduce rates of restenosis and reintervention, as compared with uncoated stents. Data are limited regarding the safety and efficacy of such stents in primary percutaneous coronary intervention (PCI) for acute myocardial infarction with ST-segment elevation. METHODS: We performed a single-blind, multicenter, prospectively randomized trial to compare sirolimus-eluting stents with uncoated stents in primary PCI for acute myocardial infarction with ST-segment elevation. The trial included 712 patients at 48 medical centers. The primary end point was target-vessel failure at 1 year after the procedure, defined as target-vessel-related death, recurrent myocardial infarction, or target-vessel revascularization. A follow-up angiographic substudy was performed at 8 months among 174 patients from selected centers. RESULTS: The rate of the primary end point was significantly lower in the sirolimus-stent group than in the uncoated-stent group (7.3% vs. 14.3%, P=0.004). This reduction was driven by a decrease in the rate of target-vessel revascularization (5.6% and 13.4%, respectively; P<0.001). There was no significant difference between the two groups in the rate of death (2.3% and 2.2%, respectively; P=1.00), reinfarction (1.1% and 1.4%, respectively; P=1.00), or stent thrombosis (3.4% and 3.6%, respectively; P=1.00). The degree of neointimal proliferation, as assessed by the mean (+/-SD) in-stent late luminal loss, was significantly lower in the sirolimus-stent group (0.14+/-0.49 mm, vs. 0.83+/-0.52 mm in the uncoated stent group; P<0.001). CONCLUSIONS: Among selected patients with acute myocardial infarction, the use of sirolimus-eluting stents significantly reduced the rate of target-vessel revascularization at 1 year.	Univ Paris 05, Paris Sch Med 5, Cochin Hosp, Assistance Publ Hop Paris, Paris, France; INSERM, U780, Paris, France; Univ Denis Diderot, Paris Sch Med 7, Lariboisiere Hosp, AP HP, Paris, France; Hop Henri Mondor, AP HP, Paris Med Sch 12, F-94010 Creteil, France; Hosp Rangueil, Toulouse, France; Univ Paris Sud, Paris Med Sch 12, Hop Antoine Beclere, AP HP, Clamart, France; Mayday Univ Hosp, London, England; Policlin San Matteo, Ist Ricovero & Cura Carattere Sci, I-27100 Pavia, Italy; Azienda Univ Osped Careggi, Florence, Italy; Semmelweis Univ, Budapest, Hungary; Pauls Stradins Univ Hosp, Riga, Latvia; Cordis, Waterloo, ON, Canada; Univ Freiburg, Freiburg, Germany	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; Universite Paris Saclay; Croydon University Hospital; IRCCS Fondazione San Matteo; University of Florence; Azienda Ospedaliero Universitaria Careggi; Semmelweis University; Pauls Stradins Clinical University Hospital; Johnson & Johnson; University of Freiburg	Spaulding, C (corresponding author), Cochin Hosp, 27 Rue Faubourg St Jacques, F-75014 Paris, France.	christian.spaulding@cch.ap-hop-paris.fr		Merkely, Bela/0000-0001-6514-0723; CARRIE, didier/0000-0003-2479-8144; TEIGER, emmanuel/0000-0001-7515-4344; Erglis, Andrejs/0000-0002-3999-0182				Antoniucci D, 1998, J AM COLL CARDIOL, V31, P1234, DOI 10.1016/S0735-1097(98)00097-7; Grines CL, 1999, NEW ENGL J MED, V341, P1949, DOI 10.1056/NEJM199912233412601; Laarman GJ, 2006, NEW ENGL J MED, V355, P1105, DOI 10.1056/NEJMoa062598; Lemos PA, 2003, J AM COLL CARDIOL, V41, P2093, DOI 10.1016/S0735-1097(03)00429-7; Maillard L, 2000, J AM COLL CARDIOL, V35, P1729, DOI 10.1016/S0735-1097(00)00612-4; Monassier JP, 1997, CATHETER CARDIO DIAG, V42, P243, DOI 10.1002/(SICI)1097-0304(199711)42:3<243::AID-CCD1>3.0.CO;2-C; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Morice MC, 2006, JAMA-J AM MED ASSOC, V295, P895, DOI 10.1001/jama.295.8.895; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Rodriguez A, 1998, AM J CARDIOL, V81, P1286, DOI 10.1016/S0002-9149(98)00154-4; Saia F, 2003, CIRCULATION, V108, P1927, DOI 10.1161/01.CIR.0000096053.87580.CD; Saito S, 1999, CATHETER CARDIO INTE, V48, P262, DOI 10.1002/(SICI)1522-726X(199911)48:3<262::AID-CCD5>3.0.CO;2-4; Schofer J, 2003, LANCET, V362, P1093, DOI 10.1016/S0140-6736(03)14462-5; Serruys P.W., 1994, QUANTITATIVE CORONAR; SMITH SC, 2001, ACC AHA SCAI 2005 GU; Spaulding C, 1997, AM J CARDIOL, V79, P1592, DOI 10.1016/S0002-9149(97)00204-X; Stone GW, 2002, NEW ENGL J MED, V346, P957, DOI 10.1056/NEJMoa013404; *TIMS STUD GROUP, 1985, NEW ENGL J MED, V312, P932; Valgimigli M, 2005, JAMA-J AM MED ASSOC, V293, P2109, DOI 10.1001/jama.293.17.2109; Windecker S, 2005, NEW ENGL J MED, V353, P653, DOI 10.1056/NEJMoa051175	20	455	505	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 14	2006	355	11					1093	1104		10.1056/NEJMoa062006	http://dx.doi.org/10.1056/NEJMoa062006			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083NJ	16971716	Green Accepted, Bronze			2022-12-28	WOS:000240462800004
J	Pryor, JL; Althof, SE; Steidle, C; Rosen, RC; Hellstrom, WJG; Shabsigh, R; Miloslavsky, M; Kell, S				Pryor, Jon L.; Althof, Stanley E.; Steidle, Christopher; Rosen, Raymond C.; Hellstrom, Wayne J. G.; Shabsigh, Ridwan; Miloslavsky, Maja; Kell, Sherron		Dapoxetine Study Grp	Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials	LANCET			English	Article							SEROTONIN REUPTAKE INHIBITORS; INDUCED SEXUAL DYSFUNCTION; QUALITY-OF-LIFE; RAPID EJACULATION; MEN; HYDROCHLORIDE; PREVALENCE; PAROXETINE; PHARMACOKINETICS; SERTRALINE	Background No drugs are approved for treatment of premature ejaculation. Our aim was to determine the efficacy and tolerability of on-demand dapoxetine in patients with severe premature ejaculation. Methods We determined the efficacy of dapoxetine in a prospectively predefined integrated analysis of two 12-week randomised, double-blind, placebo-controlled, phase III trials of identical design done independently, in parallel, at 121 sites in the USA. Men with moderate-to-severe premature ejaculation in stable, heterosexual relationships took placebo (n=870), 30 mg dapoxetine (874), or 60 mg dapoxetine (870) on-demand (as needed, 1-3 h before anticipated sexual activity). The primary endpoint was intravaginal ejaculatory latency time (IELT) measured by stopwatch. Safety and tolerability were assessed. All analyses were done on an intention-to-treat basis. The trials are registered at ClinicalTrials.gov, numbers NCT00211107 and NCT00211094. Findings 672, 676, and 610 patients completed in the placebo, 30 mg dapoxetine, and 60 mg dapoxetine groups, respectively. Dapoxetine significantly prolonged IELT (p<0.0001, all doses vs placebo). Mean IELT at baseline was 0.90 (SD 0.47) minute, 0.92 (0.50) minute, and 0.91 (0.48) minute, and at study endpoint (week 12 or final visit) was 1.75 (2.21) minutes for placebo, 2.78 (3.48) minutes for 30 mg dapoxetine, and 3.32 (3.68) minutes for 60 mg dapoxetine. Both dapoxetine doses were effective on the first dose. Common adverse events (30 mg and 60 mg dapoxetine, respectively) were nausea (8.7%, 20.1%), diarrhoea (3.9%, 6.8%), headache (5.9%, 6.8%), and dizziness (3.0%, 6.2%). Interpretation On-demand dapoxetine is an effective and generally well tolerated treatment for men with moderate-to-severe premature ejaculation.	Univ Minnesota, Dept Urol Surg, Minneapolis, MN 55455 USA; Case Med Sch, Cleveland, OH USA; NE Indiana Res LLC, Ft Wayne, IN USA; Robert Wood Johnson Med Sch, Piscataway, NJ USA; Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70118 USA; Columbia Univ, New York Ctr Human Sexual, New York, NY USA; ALZA Corp, Mountain View, CA USA	University of Minnesota System; University of Minnesota Twin Cities; Case Western Reserve University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Tulane University; Columbia University; Johnson & Johnson; Johnson & Johnson USA	Pryor, JL (corresponding author), Univ Minnesota, Dept Urol Surg, 420 Delaware St SE,MMC 394, Minneapolis, MN 55455 USA.	pryor001@umn.edu		Hellstrom, Wayne/0000-0003-1284-959X				*AM UR ASS, PHARM TREATM PREM EJ; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Byers ES, 2003, ARCH SEX BEHAV, V32, P261, DOI 10.1023/A:1023417718557; Gengo PJ, 2005, J UROLOGY, V173, P239; Goldstein BJ, 1998, J PSYCHOPHARMACOL, V12, pS55, DOI 10.1177/0269881198012003041; GRENIER G, 1995, ARCH SEX BEHAV, V24, P447, DOI 10.1007/BF01541858; Guyatt GH, 2002, MAYO CLIN PROC, V77, P371, DOI 10.4065/77.4.371; Hellstrom WJG, 2005, J UROLOGY, V173, P238, DOI 10.1016/S0022-5347(18)35046-8; Hiemke C, 2000, PHARMACOL THERAPEUT, V85, P11, DOI 10.1016/S0163-7258(99)00048-0; Hu XH, 2004, J CLIN PSYCHIAT, V65, P959; Kara H, 1996, J UROLOGY, V156, P1631, DOI 10.1016/S0022-5347(01)65467-3; Lane R, 1997, J CLIN PSYCHOPHARM, V17, P208, DOI 10.1097/00004714-199706000-00012; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; McCabe MP, 1997, J SEX MARITAL THER, V23, P276, DOI 10.1080/00926239708403932; McMahon CG, 1999, J UROLOGY, V161, P1826, DOI 10.1016/S0022-5347(05)68816-7; McMahon CG, 1998, J UROLOGY, V159, P1935, DOI 10.1016/S0022-5347(01)63201-4; McMahon CG, 1999, INT J IMPOT RES, V11, P241, DOI 10.1038/sj.ijir.3900415; Modi NB, 2006, J CLIN PHARMACOL, V46, P301, DOI 10.1177/0091270005284850; Montague DK, 2004, J UROLOGY, V172, P290, DOI 10.1097/01.ju.0000132159.61156.ea; MontejoGonzalez AL, 1997, J SEX MARITAL THER, V23, P176; Patrick DL, 2005, J SEX MED, V2, P358, DOI 10.1111/j.1743-6109.2005.20353.x; Patrick DL, 1999, UROLOGY, V53, P71, DOI 10.1016/S0090-4295(98)00454-3; Rosen RC, 2004, J SEX MED, V1, P57; Rosen RC, 1999, J CLIN PSYCHOPHARM, V19, P67, DOI 10.1097/00004714-199902000-00013; Rowland D, 2004, J SEX MED, V1, P225, DOI 10.1111/j.1743-6109.2004.04033.x; Rowland DL, 2000, J PSYCHOSOM RES, V48, P69, DOI 10.1016/S0022-3999(99)00078-1; Spigset O, 1999, DRUG SAFETY, V20, P277, DOI 10.2165/00002018-199920030-00007; Symonds T, 2003, J SEX MARITAL THER, V29, P361, DOI 10.1080/00926230390224738; Waldinger MD, 2004, INT J IMPOT RES, V16, P369, DOI 10.1038/sj.ijir.3901172; Waldinger MD, 2005, WORLD J UROL, V23, P102, DOI 10.1007/s00345-004-0491-z; Waldinger MD, 1998, J CLIN PSYCHOPHARM, V18, P274, DOI 10.1097/00004714-199808000-00004; Waldinger MD, 2002, J UROLOGY, V168, P2359, DOI 10.1016/S0022-5347(05)64146-8; Waldinger MD, 1998, BEHAV BRAIN RES, V92, P111, DOI 10.1016/S0166-4328(97)00183-6; Williams VSL, 2006, J CLIN PSYCHIAT, V67, P204, DOI 10.4088/JCP.v67n0205; 2005, PAXIL PAROXETINE HYD; 2005, VIAGRA SILDENAFIL CI; 2004, PHYS DESK REFERENCE; 2005, LEVITRA VARDENAFIL H	38	233	257	1	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2006	368	9539					929	937		10.1016/S0140-6736(06)69373-2	http://dx.doi.org/10.1016/S0140-6736(06)69373-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	083ZX	16962882				2022-12-28	WOS:000240502300030
J	Argmann, C; Auwerx, J				Argmann, Carmen; Auwerx, Johan			Insulin secretion: SIRT4 gets in on the act	CELL			English	Editorial Material								Despite their initial characterization as histone deacetylases controlling transcription, sirtuins also turn out to be critical regulators of metabolism. In this issue of Cell, Haigis et al. (2006) demonstrate that the mammalian Sir2 homolog SIRT4 acts in the mitochondria of pancreatic beta cells to repress the activity of glutamate dehydrogenase through ADP-ribosylation. In this way, SIRT4 downregulates insulin secretion by beta cells in response to amino acids.	Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol Cellulaire, F-67404 Iilkirch, France; Inst Clin Souris, F-67404 Iilkirch, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Auwerx, J (corresponding author), Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol Cellulaire, F-67404 Iilkirch, France.	auwerx@igbmc.u-strasbg.fr	Auwerx, Johan/ABE-9307-2021	Auwerx, Johan/0000-0002-5065-5393				Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Herrero-Yraola A, 2001, EMBO J, V20, P2404, DOI 10.1093/emboj/20.10.2404; Maechler P, 2006, INT J BIOCHEM CELL B, V38, P696, DOI 10.1016/j.biocel.2005.12.006; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Smith BC, 2006, BIOCHEMISTRY-US, V45, P272, DOI 10.1021/bi052014t	10	56	58	2	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2006	126	5					837	839		10.1016/j.cell.2006.08.031	http://dx.doi.org/10.1016/j.cell.2006.08.031			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959562	Bronze			2022-12-28	WOS:000240675000010
J	Nelson, CJ; Santos-Rosa, H; Kouzarides, T				Nelson, Christopher J.; Santos-Rosa, Helena; Kouzarides, Tony			Proline isomerization of histone H3 regulates lysine methylation and gene expression	CELL			English	Article							NUCLEOSOME CORE PARTICLE; CIS PEPTIDE-BONDS; SACCHAROMYCES-CEREVISIAE; FK506-BINDING PROTEIN; PROLYL ISOMERIZATION; JMJD2 FAMILY; SET2; ISOMERASES; METHYLTRANSFERASE; ASSOCIATION	The cis-trans isomerization of proline serves as a regulatory switch in signaling pathways. We identify the proline isomerase Fpr4, a member of the FK506 binding protein family in Saccharomyces cerevisiae, as an enzyme which binds the amino-terminal tail of histones H3 and H4 and catalyses the isomerization of H3 proline P30 and P38 in vitro. We show that P38 is necessary for methylation of K36 and that isomerization by Fpr4 inhibits the ability of Set2 to methylate H3 K36 in vitro. These results suggest that the conformational state of P38, controlled by Fpr4, is important for methylation of H3K36 by Set2. Consistent with such an antagonistic role, abrogation of Fpr4 catalytic activity in vivo results in increased levels of H3K36 methylation and delayed transcriptional induction kinetics of specific genes in yeast. These results identify proline isomerization as a novel noncovalent histone modification that regulates transcription and provides evidence for crosstalk between histone lysine methylation and proline isomerization.	Gurdon Inst, Cambridge CB2 1QR, England; Dept Pathol, Cambridge CB2 1QR, England		Kouzarides, T (corresponding author), Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	t.kouzarides@gurdon.cam.ac.uk		Kouzarides, Tony/0000-0002-8918-4162				Arevalo-Rodriguez M, 2004, FRONT BIOSCI-LANDMRK, V9, P2420, DOI 10.2741/1405; Arevalo-Rodriguez M, 2005, EUKARYOT CELL, V4, P17, DOI 10.1128/EC.4.1.17-29.2005; BENTON BM, 1994, J CELL BIOL, V127, P623, DOI 10.1083/jcb.127.3.623; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Davey M, 2000, MOL GEN GENET, V263, P520, DOI 10.1007/s004380051197; Dolinski K, 1997, P NATL ACAD SCI USA, V94, P13093, DOI 10.1073/pnas.94.24.13093; Duina AA, 1996, YEAST, V12, P943, DOI 10.1002/(SICI)1097-0061(199608)12:10<943::AID-YEA997>3.0.CO;2-3; Duina AA, 1996, SCIENCE, V274, P1713, DOI 10.1126/science.274.5293.1713; FISCHER G, 1984, BIOCHIM BIOPHYS ACTA, V791, P87, DOI 10.1016/0167-4838(84)90285-1; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; HEITMAN J, 1992, NEW BIOL, V4, P448; Hochwagen A, 2005, CELL, V122, P861, DOI 10.1016/j.cell.2005.07.010; Jabs A, 1999, J MOL BIOL, V286, P291, DOI 10.1006/jmbi.1998.2459; JIN YJ, 1993, P NATL ACAD SCI USA, V90, P7769, DOI 10.1073/pnas.90.16.7769; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; JUSTICE RM, 1990, BIOCHEM BIOPH RES CO, V171, P445, DOI 10.1016/0006-291X(90)91413-M; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Kuzuhara T, 2004, NAT STRUCT MOL BIOL, V11, P275, DOI 10.1038/nsmb733; Landry J, 2003, MOL CELL BIOL, V23, P5972, DOI 10.1128/MCB.23.17.5972-5978.2003; Leverson JD, 1998, MOL CELL, V1, P203, DOI 10.1016/S1097-2765(00)80021-0; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MANNINGKRIEG UC, 1994, FEBS LETT, V352, P98, DOI 10.1016/0014-5793(94)00927-9; Pahlke D, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-8; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; RAMACHANDRAN GN, 1976, J MOL BIOL, V107, P85, DOI 10.1016/S0022-2836(76)80019-8; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Santos-Rosa H, 2004, J BIOL CHEM, V279, P47506, DOI 10.1074/jbc.M407949200; Schaft D, 2003, NUCLEIC ACIDS RES, V31, P2475, DOI 10.1093/nar/gkg372; SCHMID FX, 1995, CURR BIOL, V5, P993, DOI 10.1016/S0960-9822(95)00197-7; SHAN XY, 1994, J CELL BIOL, V126, P853, DOI 10.1083/jcb.126.4.853; STEWART DE, 1990, J MOL BIOL, V214, P253, DOI 10.1016/0022-2836(90)90159-J; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Weiss MS, 1998, NAT STRUCT BIOL, V5, P676, DOI 10.1038/1368; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yang WM, 2001, EMBO J, V20, P4814, DOI 10.1093/emboj/20.17.4814; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X; Zhou XZ, 1999, CELL MOL LIFE SCI, V56, P788, DOI 10.1007/s000180050026	51	227	233	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2006	126	5					905	916		10.1016/j.cell.2006.07.026	http://dx.doi.org/10.1016/j.cell.2006.07.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959570	Bronze			2022-12-28	WOS:000240675000018
J	Gilboa, L; Lehmann, R				Gilboa, Lilach; Lehmann, Ruth			Soma-germline interactions coordinate homeostasis and growth in the Drosophila gonad	NATURE			English	Article							STEM-CELLS; SUPPORT CELLS; OVARY; DIFFERENTIATION; MORPHOGENESIS; OOGENESIS; SURVIVAL; LINEAGE; NUMBER	The ability of organs such as the liver or the lymphoid system to maintain their original size or regain it after injury is well documented(1,2). However, little is known about how these organs sense that equilibrium is breached, and how they cease changing when homeostasis is reached. Similarly, it remains unclear how, during normal development, different cell types within an organ coordinate their growth. Here we show that during gonad development in the fruitfly Drosophila melanogaster the proliferation of primordial germ cells (PGCs) and survival of the somatic intermingled cells (ICs) that contact them are coordinated by means of a feedback mechanism composed of a positive signal and a negative signal. PGCs express the EGF receptor (EGFR) ligand Spitz, which is required for IC survival. In turn, ICs inhibit PGC proliferation. Thus, homeostasis and coordination of growth between soma and germ line in the larval ovary is achieved by using a sensor of PGC numbers (EGFR-mediated survival of ICs) coupled to a correction mechanism inhibiting PGC proliferation. This feedback loop ensures that sufficient numbers of PGCs exist to fill all the stem-cell niches that form at the end of larval development. We propose that similar feedback mechanisms might be generally used for coordinated growth, regeneration and homeostasis.	NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst, Dev Genet Program, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University; New York University; New York University	Lehmann, R (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, 540 1st Ave, New York, NY 10016 USA.	lehmann@saturn.med.nyu.edu		Lehmann, Ruth/0000-0002-8454-5651				Bergmann A, 2002, DEV CELL, V2, P159, DOI 10.1016/S1534-5807(02)00116-8; Datar SA, 2000, EMBO J, V19, P4543, DOI 10.1093/emboj/19.17.4543; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Gilboa L, 2004, DEVELOPMENT, V131, P4895, DOI 10.1242/dev.01373; Gilboa L, 2004, CURR BIOL, V14, P981, DOI 10.1016/j.cub.2004.05.049; GODT D, 1995, DEVELOPMENT, V121, P173; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Nilson LA, 1999, CURR TOP DEV BIOL, V44, P203; POIRIE M, 1995, DEVELOPMENT, V121, P1867; Robertson SE, 1999, DEV BIOL, V215, P288, DOI 10.1006/dbio.1999.9453; Rodrigues AB, 2005, DEVELOPMENT, V132, P4697, DOI 10.1242/dev.02058; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Schulz C, 2002, DEVELOPMENT, V129, P4523; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Van Buskirk C, 1999, TRENDS CELL BIOL, V9, P1, DOI 10.1016/S0962-8924(98)01413-5; Van Doren M, 1998, CURR BIOL, V8, P243; Yohn CB, 2003, GENETICS, V165, P1889; Zhu CH, 2003, DEVELOPMENT, V130, P2579, DOI 10.1242/dev.00499	24	100	102	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2006	443	7107					97	100		10.1038/nature05068	http://dx.doi.org/10.1038/nature05068			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16936717				2022-12-28	WOS:000240313900047
J	Risgaard-Petersen, N; Langezaal, AM; Ingvardsen, S; Schmid, MC; Jetten, MSM; Op den Camp, HJM; Derksen, JWM; Pina-Ochoa, E; Eriksson, SP; Nielsen, LP; Revsbech, NP; Cedhagen, T; van der Zwaan, GJ				Risgaard-Petersen, Nils; Langezaal, Alexandra M.; Ingvardsen, Signe; Schmid, Markus C.; Jetten, Mike S. M.; Op den Camp, Huub J. M.; Derksen, Jan W. M.; Pina-Ochoa, Elisa; Eriksson, Susanne P.; Nielsen, Lars Peter; Revsbech, Niels Peter; Cedhagen, Tomas; van der Zwaan, Gijsbert J.			Evidence for complete denitrification in a benthic foraminifer	NATURE			English	Article							ANAEROBIC AMMONIUM OXIDATION; OXYGEN MINIMUM ZONE; SULFUR BACTERIA; N-2 PRODUCTION; NITRATE; ANAMMOX; THIOPLOCA; NITRITE	Benthic foraminifera are unicellular eukaryotes found abundantly in many types of marine sediments. Many species survive and possibly reproduce in anoxic habitats(1), but sustainable anaerobic metabolism has not been previously described. Here we demonstrate that the foraminifer Globobulimina pseudospinescens accumulates intracellular nitrate stores and that these can be respired to dinitrogen gas. The amounts of nitrate detected are estimated to be sufficient to support respiration for over a month. In a Swedish fjord sediment where G. pseudospinescens is the dominant foraminifer, the intracellular nitrate pool in this species accounted for 20% of the large, cell-bound, nitrate pool present in an oxygen-free zone. Similarly high nitrate concentrations were also detected in foraminifera Nonionella cf. stella and a Stainforthia species, the two dominant benthic taxa occurring within the oxygen minimum zone of the continental shelf off Chile. Given the high abundance of foraminifera in anoxic marine environments(1-3), these new findings suggest that foraminifera may play an important role in global nitrogen cycling and indicate that our understanding of the complexity of the marine nitrogen cycle is far from complete.	Natl Environm Res Inst, Dept Marine Ecol, DK-8600 Silkeborg, Denmark; Univ Utrecht, Fac Geosci, Dept Earth Sci, NL-3584 CD Utrecht, Netherlands; Aarhus Univ, Dept Biol Sci, DK-8000 Aarhus C, Denmark; Radboud Univ Nijmegen, IWWR, Dept Plant Cell Biol, NL-6525 ED Nijmegen, Netherlands; CSIC, Ctr Environm Sci, Dept Aquat Ecol, E-28006 Madrid, Spain; Univ Gothenburg, Kristineberg Marine Res Stn, Dept Marine Ecol, S-45034 Fiskebackskil, Sweden; Radboud Univ Nijmegen, IWWR, Dept Microbiol, NL-6525 ED Nijmegen, Netherlands	Aarhus University; Utrecht University; Aarhus University; Radboud University Nijmegen; Consejo Superior de Investigaciones Cientificas (CSIC); University of Gothenburg; Radboud University Nijmegen	Risgaard-Petersen, N (corresponding author), Natl Environm Res Inst, Dept Marine Ecol, Vejlsovej 25, DK-8600 Silkeborg, Denmark.	nri@dmu.dk	Revsbech, Niels P/I-8040-2013; Risgaard-Petersen, Nils/AAX-6747-2021; Nielsen, Lars Peter/AAL-6274-2021; Jetten, Mike/B-8834-2011; Cedhagen, Tomas/J-6426-2013; Nielsen, Lars Peter/J-7401-2013; Camp, Huub J.M. Op den/F-5114-2011; Risgaard-Petersen, Nils/J-2479-2013; Schmid, Markus C/D-2669-2012	Risgaard-Petersen, Nils/0000-0002-2767-2080; Nielsen, Lars Peter/0000-0002-7269-4860; Jetten, Mike/0000-0002-4691-7039; Cedhagen, Tomas/0000-0003-4550-8177; Nielsen, Lars Peter/0000-0002-7269-4860; Camp, Huub J.M. Op den/0000-0003-1990-9030; Risgaard-Petersen, Nils/0000-0002-2767-2080; Hogslund, Signe/0000-0001-5926-8464; Revsbech, Niels Peter/0000-0002-2193-262X				Alberts B., 2008, MOL BIOL CEL, V5th ed.; BERNHARD JM, 1991, BIOGEOCHEMISTRY, V15, P127; Bernhard JM, 2000, MICROPALEONTOLOGY, V46, P38; Bernhard Joan M., 1996, Revue de Paleobiologie, V15, P261; BRAMAN RS, 1989, ANAL CHEM, V61, P2715, DOI 10.1021/ac00199a007; Chen F, 2003, APPL ENVIRON MICROB, V69, P6715, DOI 10.1128/AEM.69.11.6715-6722.2003; Dalsgaard T, 2003, NATURE, V422, P606, DOI 10.1038/nature01526; Engstrom P, 2005, GEOCHIM COSMOCHIM AC, V69, P2057, DOI 10.1016/j.gca.2004.09.032; FINLAY BJ, 1983, NATURE, V303, P333, DOI 10.1038/303333a0; Fontanier C, 2003, DEEP-SEA RES PT I, V50, P457, DOI 10.1016/S0967-0637(02)00167-X; Geslin E, 2004, MAR MICROPALEONTOL, V53, P227, DOI 10.1016/j.marmicro.2004.05.010; Gooday AJ, 2000, DEEP-SEA RES PT II, V47, P25, DOI 10.1016/S0967-0645(99)00099-5; Huettel M, 1996, APPL ENVIRON MICROB, V62, P1863, DOI 10.1128/AEM.62.6.1863-1872.1996; Kuypers MMM, 2003, NATURE, V422, P608, DOI 10.1038/nature01472; Larsen LH, 1997, ANAL CHEM, V69, P3527, DOI 10.1021/ac9700890; Levin L, 2002, PROG OCEANOGR, V53, P1, DOI 10.1016/S0079-6611(02)00022-8; Meyer RL, 2001, AQUAT MICROB ECOL, V26, P181, DOI 10.3354/ame026181; NIELSEN LP, 1992, FEMS MICROBIOL ECOL, V86, P357, DOI 10.1016/0378-1097(92)90800-4; Raghoebarsing AA, 2005, NATURE, V436, P1153, DOI 10.1038/nature03802; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Risgaard-Petersen N., 1995, ANAEROB MICROB ACT S, P287; RISGAARDPETERSEN N, 1993, J MICROBIOL METH, V17, P155, DOI 10.1016/0167-7012(93)90009-7; Sayama M, 2001, APPL ENVIRON MICROB, V67, P3481, DOI 10.1128/AEM.67.8.3481-3487.2001; Tielens AGM, 2002, TRENDS BIOCHEM SCI, V27, P564, DOI 10.1016/S0968-0004(02)02193-X; Vester F, 1998, APPL ENVIRON MICROB, V64, P1700; Zopfi J, 2001, APPL ENVIRON MICROB, V67, P5530, DOI 10.1128/AEM.67.12.5530-5537.2001	26	306	325	5	169	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2006	443	7107					93	96		10.1038/nature05070	http://dx.doi.org/10.1038/nature05070			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16957731				2022-12-28	WOS:000240313900046
J	Yamamoto-Kawai, M; Carmack, E; McLaughlin, F				Yamamoto-Kawai, Michiyo; Carmack, Eddy; McLaughlin, Fiona			Nitrogen balance and Arctic throughflow	NATURE			English	Article							WORLDS OCEANS; DENITRIFICATION; WATER; SEDIMENTS; FIXATION; SHELF		Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC V8L 4B2, Canada	Fisheries & Oceans Canada	Yamamoto-Kawai, M (corresponding author), Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC V8L 4B2, Canada.	kawaim@pac.dfo-mpo.gc.ca	Yamamoto-Kawai, Michiyo/F-7611-2013	Yamamoto-Kawai, Michiyo/0000-0002-1035-2179				Devol AH, 1997, CONT SHELF RES, V17, P1029, DOI 10.1016/S0278-4343(97)00003-4; Ganeshram RS, 2000, PALEOCEANOGRAPHY, V15, P361, DOI 10.1029/1999PA000422; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Jones EP, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001141; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Loeng Harald, 2005, P453; Middelburg JJ, 1996, GLOBAL BIOGEOCHEM CY, V10, P661, DOI 10.1029/96GB02562; Moore JK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002220; Tanaka T, 2004, CONT SHELF RES, V24, P1271, DOI 10.1016/j.csr.2004.04.004; Taylor JR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001635; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; Woodgate RA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021747	12	100	102	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 7	2006	443	7107					43	43		10.1038/443043a	http://dx.doi.org/10.1038/443043a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16957723	Bronze			2022-12-28	WOS:000240313900032
J	Gladysz, JA				Gladysz, John A.			Fluorous to the core	SCIENCE			English	Editorial Material									Univ Erlangen Nurnberg, Inst Organ Chem, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Gladysz, JA (corresponding author), Univ Erlangen Nurnberg, Inst Organ Chem, D-91054 Erlangen, Germany.	gladysz@chemie.uni-erlangen.de	Gladysz, John A/B-4347-2015	Gladysz, John A/0000-0002-7012-4872				CURRAN DP, 2004, HDB FLUOROUS CHEM, P101; Dinh LV, 2005, ANGEW CHEM INT EDIT, V44, P4095, DOI 10.1002/anie.200500237; Garcia-Bernabe A, 2004, CHEM-EUR J, V10, P2822, DOI 10.1002/chem.200305305; Hogue C, 2005, CHEM ENG NEWS, V83, P5, DOI 10.1021/cen-v083n027.p005; Horvath I. T., 2004, HDB FLUOROUS CHEM, P5; Horvath I. T., 2004, HDB FLUOROUS CHEM, P1; Krafft M. P., 2004, HDB FLUOROUS CHEM, P478; MORENOMANAS M, 2004, HDB FLUOROUS CHEM, P491; Percec V, 2005, ANGEW CHEM INT EDIT, V44, P4739, DOI 10.1002/anie.200501254; Ritter SK, 2006, CHEM ENG NEWS, V84, P37, DOI 10.1021/cen-v084n016.p037; Sato S, 2006, SCIENCE, V313, P1273, DOI 10.1126/science.1129830; Tominaga M, 2005, J AM CHEM SOC, V127, P11950, DOI 10.1021/ja054069o	12	14	14	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2006	313	5791					1249	1250		10.1126/science.1131944	http://dx.doi.org/10.1126/science.1131944			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16946059				2022-12-28	WOS:000240313500028
J	Ghossain, A				Ghossain, Antoine			Anthrax of the cecum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Rizk Hosp, Beirut 11072130, Lebanon	Lebanese American University	Ghossain, A (corresponding author), Rizk Hosp, Beirut 11072130, Lebanon.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2006	355	9					940	940		10.1056/NEJMicm010886	http://dx.doi.org/10.1056/NEJMicm010886			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	078OM	16943406				2022-12-28	WOS:000240113100011
J	Imai, T; Suzuki, M; Sakano, H				Imai, Takeshi; Suzuki, Misao; Sakano, Hitoshi			Odorant receptor-derived cAMP signals direct axonal targeting	SCIENCE			English	Article							MICE DEFICIENT; OLFACTORY-BULB; EXPRESSION; GUIDANCE; ORGANIZATION; PROJECTIONS; SUBUNIT; NEURONS	In mammals, odorant receptors (ORs) direct the axons of olfactory sensory neurons (OSNs) toward targets in the olfactory bulb. We show that cyclic adenosine monophosphate ( cAMP) signals that regulate the expression of axon guidance molecules are essential for the OR-instructed axonal projection. Genetic manipulations of ORs, stimulatory G protein, cAMP-dependent protein kinase, and cAMP response element - binding protein shifted the axonal projection sites along the anterior-posterior axis in the olfactory bulb. Thus, it is the OR-derived cAMP signals, rather than direct action of OR molecules, that determine the target destinations of OSNs.	Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1030027, Japan; Kumamoto Univ, Ctr Anim Resources, Div Transgen Technol, Kumamoto 8600811, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Kumamoto University	Sakano, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan.	sakano@mail.ecc.u-tokyo.ac.jp	Imai, Takeshi/L-2201-2013	Imai, Takeshi/0000-0002-8449-0080				Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Berghard A, 1996, J NEUROSCI, V16, P909; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Luo AH, 2002, BRAIN RES, V941, P62, DOI 10.1016/S0006-8993(02)02566-0; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Scheer A, 1996, EMBO J, V15, P3566, DOI 10.1002/j.1460-2075.1996.tb00726.x; Schwarting GA, 2000, J NEUROSCI, V20, P7691; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Strotmann J, 2004, J NEUROSCI, V24, P7754, DOI 10.1523/JNEUROSCI.2588-04.2004; Taniguchi M, 2003, J NEUROSCI, V23, P1390, DOI 10.1523/JNEUROSCI.23-04-01390.2003; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	27	232	235	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					657	661		10.1126/science.1131794	http://dx.doi.org/10.1126/science.1131794			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	16990513				2022-12-28	WOS:000241557800051
J	Beltran, MT; Cesaroni, R; Codella, C; Testi, L; Furuya, RS; Olmi, L				Beltran, Maria T.; Cesaroni, Riccardo; Codella, Claudio; Testi, Leonardo; Furuya, Ray S.; Olmi, Luca			Infall of gas as the formation mechanism of stars up to 20 times more massive than the Sun	NATURE			English	Article							ULTRACOMPACT HII-REGIONS; MOLECULAR CLOUDS; AMMONIA OBSERVATIONS; DISK; G24.78+0.08; G10.6-0.4; PROTOSTAR; ACCRETION; OUTFLOW; CORES	Theory predicts and observations confirm that low-mass stars ( like the Sun) in their early life grow by accreting gas from the surrounding material. But for stars similar to 10 times more massive than the Sun (similar to 10M(.)), the powerful stellar radiation is expected to inhibit accretion1 and thus limit the growth of their mass. Clearly, stars with masses > 10M(.) exist, so there must be a way for them to form. The problem may be solved by non-spherical accretion(2,3), which allows some of the stellar photons to escape along the symmetry axis where the density is lower. The recent detection of rotating disks(4-6) and toroids(7) around very young massive stars has lent support to the idea that high- mass (greater than or similar to 8M(.)) stars could formin this way. Here we report observations of an ammonia line towards a high- mass star forming region. We conclude that the gas is falling inwards towards a very young star of similar to 20M(.), in line with theoretical predictions of non-spherical accretion.	Univ Barcelona, Dept Astron & Meteorol, E-08028 Barcelona, Catalunya, Spain; Osserv Astrofis Arcetri, I-50125 Florence, Italy; Ist Nazl Fis Nucl, Ist Radioastron, Sez Firenze, I-50125 Florence, Italy; Natl Astron Observ Japan, Subaru Telescope, Hilo, HI 96720 USA	University of Barcelona; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale di Fisica Nucleare (INFN); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ)	Beltran, MT (corresponding author), Univ Barcelona, Dept Astron & Meteorol, Av Diagonal 647, E-08028 Barcelona, Catalunya, Spain.	mbeltran@am.ub.es	Testi, Leonardo/L-7038-2013; Codella, Claudio/AAB-2539-2021	Olmi, Luca/0000-0002-1162-7947; Cesaroni, Riccardo/0000-0002-2430-5103; Beltran Sorolla, Maria Teresa/0000-0003-3315-5626; Codella, Claudio/0000-0003-1514-3074				Beltran MT, 2005, ASTRON ASTROPHYS, V435, P901, DOI 10.1051/0004-6361:20042381; Beltran MT, 2004, ASTROPHYS J, V601, pL187, DOI 10.1086/382150; Bonnell IA, 2005, MON NOT R ASTRON SOC, V362, P915, DOI 10.1111/j.1365-2966.2005.09360.x; Bonnell IA, 2004, MON NOT R ASTRON SOC, V349, P735, DOI 10.1111/j.1365-2966.2004.07543.x; Cesaroni R, 1997, ASTRON ASTROPHYS, V325, P725; Cesaroni R, 2005, ASTROPHYS SPACE SCI, V295, P5, DOI 10.1007/s10509-005-3651-8; Cesaroni R, 2005, ASTRON ASTROPHYS, V434, P1039, DOI 10.1051/0004-6361:20041639; CESARONI R, 1994, ASTRON ASTROPHYS, V288, P903; Cesaroni R, 2003, ASTRON ASTROPHYS, V401, P227, DOI 10.1051/0004-6361:20030116; Cesaroni R., 2005, P IAU S, V227, P59; Chini R, 2004, NATURE, V429, P155, DOI 10.1038/nature02507; Codella C, 1997, ASTRON ASTROPHYS, V325, P282; Furuya RS, 2002, ASTRON ASTROPHYS, V390, pL1, DOI 10.1051/0004-6361:20020850; HO PTP, 1986, ASTROPHYS J, V304, P501, DOI 10.1086/164184; Hofner P, 1999, ASTROPHYS J, V514, P899, DOI 10.1086/306968; Jiang ZB, 2005, NATURE, V437, P112, DOI 10.1038/nature04012; KAHN FD, 1974, ASTRON ASTROPHYS, V37, P149; Keto E, 2002, ASTROPHYS J, V580, P980, DOI 10.1086/343794; KETO ER, 1987, ASTROPHYS J, V318, P712, DOI 10.1086/165405; Krumholz MR, 2005, ASTROPHYS J, V618, pL33, DOI 10.1086/427555; McKee CF, 2003, ASTROPHYS J, V585, P850, DOI 10.1086/346149; McKee CF, 2002, NATURE, V416, P59, DOI 10.1038/416059a; Patel NA, 2005, NATURE, V437, P109, DOI 10.1038/nature04011; Sollins PK, 2005, ASTROPHYS J, V630, P987, DOI 10.1086/432254; UNGERECHTS H, 1986, ASTRON ASTROPHYS, V157, P207; WALMSLEY M, 1995, REV MEX AST ASTR, V1, P137; WOLFIRE MG, 1987, ASTROPHYS J, V319, P850, DOI 10.1086/165503; Yorke HW, 2002, ASTROPHYS J, V569, P846, DOI 10.1086/339264; Zhang Q., 2005, P IAU S, V227, P135; Zhang QZ, 1997, ASTROPHYS J, V488, P241, DOI 10.1086/304667	30	92	93	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2006	443	7110					427	429		10.1038/nature05074	http://dx.doi.org/10.1038/nature05074			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	17006508				2022-12-28	WOS:000240798800039
J	Gorb, SN; Niederegger, S; Hayashi, CY; Summers, AP; Voetsch, W; Walther, P				Gorb, Stanislav N.; Niederegger, Senta; Hayashi, Cheryl Y.; Summers, Adam P.; Voetsch, Walter; Walther, Paul			Silk-like secretion from tarantula feet	NATURE			English	Article							SPIDER SILK; ORIGIN; EVOLUTION; ARANEAE		Max Planck Inst Met Res, Evolutionary Biomat Grp, D-70569 Stuttgart, Germany; Max Planck Inst Dev Biol, D-71076 Tubingen, Germany; Univ Jena, Inst Forens Med, D-07743 Jena, Germany; Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; Univ Ulm, Dept Electron Microscopy, D-89069 Ulm, Germany	Max Planck Society; Max Planck Society; Friedrich Schiller University of Jena; University of California System; University of California Riverside; Ulm University	Gorb, SN (corresponding author), Max Planck Inst Met Res, Evolutionary Biomat Grp, D-70569 Stuttgart, Germany.	s.gorb@mf.mpg.de	Summers, Adam/A-9060-2013	Summers, Adam/0000-0003-1930-9748; Niederegger, Senta/0000-0001-8784-8570				Arzt E, 2003, P NATL ACAD SCI USA, V100, P10603, DOI 10.1073/pnas.1534701100; Bristowe W.S., 1932, P ZOOL SOC LOND, V103, P1015; CODDINGTON JA, 1991, ANNU REV ECOL SYST, V22, P565, DOI 10.1146/annurev.es.22.110191.003025; Craig CL, 1997, ANNU REV ENTOMOL, V42, P231, DOI 10.1146/annurev.ento.42.1.231; Damen WGM, 2002, CURR BIOL, V12, P1711, DOI 10.1016/S0960-9822(02)01126-0; Garb JE, 2006, SCIENCE, V312, P1762, DOI 10.1126/science.1127946; Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561; Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112; PALMER JM, 1982, J MORPHOL, V174, P269, DOI 10.1002/jmor.1051740303; SHULTZ JW, 1987, BIOL REV, V62, P89, DOI 10.1111/j.1469-185X.1987.tb01263.x; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000	11	45	47	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2006	443	7110					407	407		10.1038/443407a	http://dx.doi.org/10.1038/443407a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	17006505	Bronze			2022-12-28	WOS:000240798800033
J	Been, MD				Been, Michael D.			Versatility of self-cleaving ribozymes	SCIENCE			English	Editorial Material							DELTA VIRUS RIBOZYME; GENE-EXPRESSION; RIBOSWITCHES		Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA	Duke University	Been, MD (corresponding author), Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA.	mdbeen@duke.edu						Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; DIENER TO, 1989, P NATL ACAD SCI USA, V86, P9370, DOI 10.1073/pnas.86.23.9370; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; Klein DJ, 2006, SCIENCE, V313, P1752, DOI 10.1126/science.1129666; McCarthy TJ, 2005, CHEM BIOL, V12, P1221, DOI 10.1016/j.chembiol.2005.09.006; Nakano S, 2000, SCIENCE, V287, P1493, DOI 10.1126/science.287.5457.1493; Salehi-Ashtiani K, 2006, SCIENCE, V313, P1788, DOI 10.1126/science.1129308; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362	9	7	8	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2006	313	5794					1745	1747		10.1126/science.1133259	http://dx.doi.org/10.1126/science.1133259			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990539				2022-12-28	WOS:000240655700033
J	Lykotrafitis, G; Rosakis, AJ; Ravichandran, G				Lykotrafitis, George; Rosakis, Ares J.; Ravichandran, Guruswami			Self-healing pulse-like shear ruptures in the laboratory	SCIENCE			English	Article							STATE-DEPENDENT FRICTION; EARTHQUAKE RUPTURE; FAULT RUPTURE; GROUND MOTION; SLIP-PULSE; VELOCITY; DYNAMICS; CALIFORNIA; VIBRATIONS; CRACKS	Models predict that dynamic shear ruptures during earthquake faulting occur as either sliding cracks, where a large section of the interface slides behind a fast-moving rupture front, or self-healing slip pulses, where the fault relocks shortly behind the rupture front. We report experimental visualizations of crack-like, pulse-like, and mixed rupture modes propagating along frictionally held, "incoherent'' interfaces separating identical solids, and we describe the conditions under which those modes develop. A combination of simultaneously performed measurements via dynamic photoelasticity and laser interferometry reveals the rupture mode type, the exact point of rupture initiation, the sliding velocity history, and the rupture propagation speed.	CALTECH, Grad Aeronaut Labs, Pasadena, CA 91125 USA	California Institute of Technology	Rosakis, AJ (corresponding author), CALTECH, Grad Aeronaut Labs, Pasadena, CA 91125 USA.	Rosakis@aero.caltech.edu		Rosakis, Ares/0000-0003-0559-0794				AKI K, 1979, J GEOPHYS RES, V84, P140; ANDREWS DJ, 1985, B SEISMOL SOC AM, V75, P1; Beeler NM, 1996, B SEISMOL SOC AM, V86, P1130; Bodin P, 1998, J GEOPHYS RES-SOL EA, V103, P29931, DOI 10.1029/98JB02733; BRUNE JN, 1976, SEISMIC RISK ENG DEC, P141; Cochard A, 2000, J GEOPHYS RES-SOL EA, V105, P25891, DOI 10.1029/2000JB900230; Cochard A, 1996, J GEOPHYS RES-SOL EA, V101, P25321, DOI 10.1029/96JB02095; Coker D, 2005, J MECH PHYS SOLIDS, V53, P884, DOI 10.1016/j.jmps.2004.11.003; DAS S, 1977, GEOPHYS J ROY ASTR S, V50, P643, DOI 10.1111/j.1365-246X.1977.tb01339.x; DAY SM, 1982, B SEISMOL SOC AM, V72, P705; Di Toro G, 2004, NATURE, V427, P436, DOI 10.1038/nature02249; HARRIS RA, 1993, J GEOPHYS RES-SOL EA, V98, P4461, DOI 10.1029/92JB02272; HARTZELL SH, 1983, B SEISMOL SOC AM, V73, P1553; HEATON TH, 1990, PHYS EARTH PLANET IN, V64, P1, DOI 10.1016/0031-9201(90)90002-F; JOHNSON E, 1990, GEOPHYS J INT, V101, P125, DOI 10.1111/j.1365-246X.1990.tb00762.x; Lapusta N, 2000, J GEOPHYS RES-SOL EA, V105, P23765, DOI 10.1029/2000JB900250; LIU HL, 1983, B SEISMOL SOC AM, V73, P201; Lykotrafitis G, 2006, EXP MECH, V46, P205, DOI 10.1007/s11340-006-6418-4; MADARIAGA R, 1976, B SEISMOL SOC AM, V66, P639; Needleman A, 1999, J APPL MECH-T ASME, V66, P847, DOI 10.1115/1.2791788; Nielsen S, 2003, B SEISMOL SOC AM, V93, P2375, DOI 10.1785/0120020090; Nielsen SB, 2000, J GEOPHYS RES-SOL EA, V105, P6069, DOI 10.1029/1999JB900350; PERRIN G, 1995, J MECH PHYS SOLIDS, V43, P1461, DOI 10.1016/0022-5096(95)00036-I; Rice J. R., 2001, P 20 INT C THEOR APP, P1; Rice JR, 2001, J MECH PHYS SOLIDS, V49, P1865, DOI 10.1016/S0022-5096(01)00042-4; Richardson E, 1999, J GEOPHYS RES-SOL EA, V104, P28859, DOI 10.1029/1999JB900320; Rosakis AJ, 1999, SCIENCE, V284, P1337, DOI 10.1126/science.284.5418.1337; Rosakis AJ, 2002, ADV PHYS, V51, P1189, DOI 10.1080/00018730210122328; SAMUDRALA O, 2002, J GEOPHYS RES, V107; Zheng G, 1998, B SEISMOL SOC AM, V88, P1466	30	55	57	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2006	313	5794					1765	1768		10.1126/science.1128359	http://dx.doi.org/10.1126/science.1128359			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990544				2022-12-28	WOS:000240655700042
J	Neiditch, MB; Federle, MJ; Pompeani, AJ; Kelly, RC; Swem, DL; Jeffrey, PD; Bassler, BL; Hughson, FM				Neiditch, Matthew B.; Federle, Michael J.; Pompeani, Audra J.; Kelly, Robert C.; Swem, Danielle L.; Jeffrey, Philip D.; Bassler, Bonnie L.; Hughson, Frederick M.			Ligand-induced asymmetry in histidine sensor kinase complex regulates quorum sensing	CELL			English	Article							VIBRIO-HARVEYI; ESCHERICHIA-COLI; STRUCTURAL IDENTIFICATION; GENETIC-ANALYSIS; BINDING DOMAIN; SIGNAL; PROTEIN; EXPRESSION; RECEPTORS; SEQUENCE	Bacteria sense their environment using receptors of the histidine sensor kinase family, but how kinase activity is regulated by ligand binding is not well understood. Autoinducer-2 (Al-2), a secreted signaling molecule originally identified in studies of the marine bacterium Vibrio harveyi, regulates quorum-sensing responses and allows communication between different bacterial species. Al-2 signal transduction in V. harveyi requires the integral membrane receptor LuxPQ, comprised of periplasmic binding protein (LuxP) and histidine sensor kinase (LuxQ) subunits. Combined X-ray crystallographic and functional studies show that Al-2 binding causes a major conformational change within LuxP, which in turn stabilizes a quaternary arrangement in which two LuxPQ monomers are asymmetrically associated. We propose that formation of this asymmetric quaternary structure is responsible for repressing the kinase activity of both LuxQ subunits and triggering the transition of V. harveyi into quorum-sensing mode.	Princeton Univ, Howard Hughes Med Inst, Dept Mol Biol, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Princeton University	Hughson, FM (corresponding author), Princeton Univ, Howard Hughes Med Inst, Dept Mol Biol, Princeton, NJ 08544 USA.	hughson@princeton.edu	Federle, Michael J./E-5522-2017	Neiditch, Matthew/0000-0002-7039-4469; Jeffrey, Philip/0000-0002-4351-5341; Bassler, Bonnie/0000-0002-0043-746X	NIAID NIH HHS [R01 AI054442, AI-054442] Funding Source: Medline; NIGMS NIH HHS [GM-065859, F32 GM068371, R37 GM065859, R01 GM065859] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM068371, R01GM065859] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Bjorkman AJ, 1998, J MOL BIOL, V279, P651, DOI 10.1006/jmbi.1998.1785; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAO JG, 1989, J BIOL CHEM, V264, P21670; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DeLano W.L, PYMOL MOL GRAPHICS S; Dunn AK, 2006, APPL ENVIRON MICROB, V72, P802, DOI 10.1128/AEM.72.1.802-810.2006; Falke JJ, 2001, TRENDS BIOCHEM SCI, V26, P257, DOI 10.1016/S0968-0004(00)01770-9; FELLAY R, 1987, GENE, V52, P147, DOI 10.1016/0378-1119(87)90041-2; Freeman JA, 1999, J BACTERIOL, V181, P899, DOI 10.1128/JB.181.3.899-906.1999; Freeman JA, 1999, MOL MICROBIOL, V31, P665, DOI 10.1046/j.1365-2958.1999.01208.x; Freeman JA, 2000, MOL MICROBIOL, V35, P139, DOI 10.1046/j.1365-2958.2000.01684.x; GREENBERG EP, 1979, ARCH MICROBIOL, V120, P87, DOI 10.1007/BF00409093; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Heermann R, 1998, BBA-BIOMEMBRANES, V1415, P114, DOI 10.1016/S0005-2736(98)00181-3; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Henke JM, 2004, J BACTERIOL, V186, P3794, DOI 10.1128/JB.186.12.3794-3805.2004; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keymer JE, 2006, P NATL ACAD SCI USA, V103, P1786, DOI 10.1073/pnas.0507438103; Khorchid A, 2006, INT J BIOCHEM CELL B, V38, P307, DOI 10.1016/j.biocel.2005.08.018; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee RA, 2003, BIOINFORMATICS, V19, P1290, DOI 10.1093/bioinformatics/btg137; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; MADDOCK JR, 1993, SCIENCE, V259, P1717; Marina A, 2005, EMBO J, V24, P4247, DOI 10.1038/sj.emboj.7600886; MILBURN MV, 1991, SCIENCE, V254, P1342, DOI 10.1126/science.1660187; Miller ST, 2004, MOL CELL, V15, P677, DOI 10.1016/j.molcel.2004.07.020; Moukhametzianov R, 2006, NATURE, V440, P115, DOI 10.1038/nature04520; MULLERDIECKMANN HJ, 2003, HISTIDINE KINASES SI, P123; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neiditch MB, 2005, MOL CELL, V18, P507, DOI 10.1016/j.molcel.2005.04.020; NINFA EG, 1993, J BACTERIOL, V175, P7024, DOI 10.1128/jb.175.21.7024-7032.1993; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pappas KM, 2004, MOL MICROBIOL, V53, P755, DOI 10.1111/j.1365-2958.2004.04212.x; Parkinson JS, 2005, CURR OPIN MICROBIOL, V8, P116, DOI 10.1016/j.mib.2005.02.008; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Semmelhack MF, 2005, ORG LETT, V7, P569, DOI 10.1021/ol047695j; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Surette MG, 1996, J BIOL CHEM, V271, P939, DOI 10.1074/jbc.271.2.939; Tomomori C., 2003, HISTIDINE KINASES SI, P11, DOI [10.1016/B978-012372484-7/50003-5, DOI 10.1016/B978-012372484-7/50003-5]; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang L, 2001, J BACTERIOL, V183, P2795, DOI 10.1128/JB.183.9.2795-2802.2001; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; WOLANIN PM, 2003, HISTIDINE KINASES SI, P73; Xavier KB, 2005, NATURE, V437, P750, DOI 10.1038/nature03960; Xavier KB, 2003, CURR OPIN MICROBIOL, V6, P191, DOI 10.1016/S1369-5274(03)00028-6; YANG Y, 1991, P NATL ACAD SCI USA, V88, P11057, DOI 10.1073/pnas.88.24.11057; Yeh JI, 1996, J MOL BIOL, V262, P186, DOI 10.1006/jmbi.1996.0507; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	58	207	213	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 22	2006	126	6					1095	1108		10.1016/j.cell.2006.07.032	http://dx.doi.org/10.1016/j.cell.2006.07.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990134	Bronze, Green Accepted			2022-12-28	WOS:000240897600016
J	Thrasher, AJ; Gaspar, HB; Baum, C; Modlich, U; Schambach, A; Candotti, F; Otsu, M; Sorrentino, B; Scobie, L; Cameron, E; Blyth, K; Neil, J; Abina, SHB; Cavazzana-Calvo, M; Fischer, A				Thrasher, Adrian J.; Gaspar, H. Bobby; Baum, Christopher; Modlich, Ute; Schambach, Axel; Candotti, Fabio; Otsu, Makoto; Sorrentino, Brian; Scobie, Linda; Cameron, Ewan; Blyth, Karen; Neil, Jim; Abina, Salima Hacein-Bey; Cavazzana-Calvo, Marina; Fischer, Alain			Gene therapy - X-SCID transgene leukaemogenicity	NATURE			English	Letter							SEVERE COMBINED IMMUNODEFICIENCY; INSERTIONAL MUTAGENESIS; MICE		UCL, Inst Child Hlth, Mol Immunol Unit, London WC1N 1EH, England; Great Ormond St Hosp Sick Children, London WC1N 3JH, England; Hannover Med Sch, Dept Expt Hematol, D-30625 Hannover, Germany; Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol, Cincinnati, OH 45229 USA; NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; Univ Tokyo, Ctr Med Expt, Tokyo 1088639, Japan; St Jude Childrens Hosp, Dept Hematol Oncol, Div Expt Hematol, Memphis, TN 38105 USA; Univ Glasgow, Fac Vet Med, Inst Comparat Med, Div Pathol Sci, Glasgow G61 1QH, Lanark, Scotland; Assistance Publ Hop Paris, Hop Necker, INSERM, U768, F-75743 Paris, France; Assistance Publ Hop Paris, Dept Biotherapies, F-75743 Paris, France; Assistance Publ Hop Paris, Unite Immunohematol, F-75743 Paris, France; Univ Paris 05, Fac Med, F-75270 Paris, France	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Hannover Medical School; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Tokyo; St Jude Children's Research Hospital; University of Glasgow; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Universite Paris Cite	Thrasher, AJ (corresponding author), UCL, Inst Child Hlth, Mol Immunol Unit, London WC1N 1EH, England.	a.thrasher@ich.ucl.ac.uk	Schambach, Axel/C-5491-2011	Candotti, Fabio/0000-0001-6399-6042; Blyth, Karen/0000-0002-9304-439X; Thrasher, Adrian/0000-0002-6097-6115; Modlich, Ute/0000-0001-8018-4118; Otsu, Makoto/0000-0002-9769-0217	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000121, ZIAHG000121] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Dave UP, 2004, SCIENCE, V303, P333, DOI 10.1126/science.1091667; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Modlich U, 2005, BLOOD, V105, P4235, DOI 10.1182/blood-2004-11-4535; Otsu M, 2000, MOL THER, V1, P145, DOI 10.1006/mthe.1999.0020; Soudais C, 2000, BLOOD, V95, P3071, DOI 10.1182/blood.V95.10.3071.010k06_3071_3077; Woods NB, 2006, NATURE, V440, P1123, DOI 10.1038/4401123a	10	115	119	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2006	443	7109					E5	E6		10.1038/nature05219	http://dx.doi.org/10.1038/nature05219			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085RL	16988659				2022-12-28	WOS:000240622000034
J	Walensky, RP; Paltiel, AD				Walensky, Rochelle P.; Paltiel, A. David			Rapid HIV testing at home: Does it solve a problem or create one?	ANNALS OF INTERNAL MEDICINE			English	Article							COLLECTION; INFECTION	The U.S. Food and Drug Administration (FDA) is considering approval of an over-the-counter, rapid HIV test for home use. To date, testimony presented before the FDA has been overwhelmingly supportive. Advocates have argued enthusiastically that there is value in empowering individuals to manage their HIV risks and have suggested that the availability of a rapid home HIV test will dramatically increase rates of disease detection in communities that have proven difficult to reach and to link to appropriate care. The authors offer a more cautious perspective. According to what is already known about the market demand for over-the-counter HIV testing kits, their costs, and the performance of rapid HIV tests in that market, the authors do not anticipate that the rapid home test will have a profound impact either on the HIV public health crisis or on the populations in greatest need. Home HIV testing will attract a predominantly affluent clientele, composed disproportionately of HIV-uninfected new couples and "worried well" persons, as well as very recently infected persons with undetectable disease. The authors illustrate how testing in these populations may have the perverse effect of increasing both false-positive and false-negative results. A poorly functioning home HIV test may thereby undermine confidence in the reliability of HIV testing more generally and weaken critical efforts to expand HIV detection and linkage to lifesaving care for the estimated 300 000 U.S. citizens with unidentified HIV infection.	Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr AIDS Res, Boston, MA 02115 USA; Yale Univ, Sch Med, New Haven, CT USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Yale University	Walensky, RP (corresponding author), Massachusetts Gen Hosp, Div Gen Med, 50 Staniford St,9th Floor, Boston, MA 02114 USA.	rwalensky@partners.org		Walensky, Rochelle P./0000-0002-8795-379X; Paltiel, A. David/0000-0002-4861-3290	NIAID NIH HHS [R01 AI042006, K23 AI01794, K23 AI001794, P30 AI060354, R01 AI42006] Funding Source: Medline; NIDA NIH HHS [R01 DA015612] Funding Source: Medline; NIMH NIH HHS [R01 MH65869, R01 MH065869] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R01AI042006, K23AI001794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015612, R01DA015612] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BARTLETT JG, 2005, 2005 2006 MED MANAGE; Branson BM, 1998, JAMA-J AM MED ASSOC, V280, P1699, DOI 10.1001/jama.280.19.1699; Bush G. W., 2006, STATE UNION ADDRESS; CAMPSMITH M, 2001, 2001 NAT HIV PREV C; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P329; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P538; Chippindale S, 2001, BRIT MED J, V322, P1533, DOI 10.1136/bmj.322.7301.1533; Colfax G. N., 1997, JGIM, V12, P106; Doyle NM, 2005, AM J OBSTET GYNECOL, V193, P1280, DOI 10.1016/j.ajog.2005.07.001; Ekwueme DU, 2003, AM J PREV MED, V25, P112, DOI 10.1016/S0749-3797(03)00115-6; *FDA BLOOD PROD AD, 2005, APPR OV COUNT HOM US; GLYNN MK, 2005, 2005 NAT HIV PREV C; HARRIS G, 2005, NY TIMES        1127, P16; McQuitty M, 1999, J ACQ IMMUN DEF SYND, V21, P417; MEYER KB, 1987, NEW ENGL J MED, V317, P238, DOI 10.1056/NEJM198707233170410; Mylonakis E, 2000, AM J MED, V109, P568, DOI 10.1016/S0002-9343(00)00583-0; NASH T, 2005, C MAY STRIP 12 MILLI; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; PHILLIPS KA, 1995, NEW ENGL J MED, V332, P1308, DOI 10.1056/NEJM199505113321918; Rothman RE, 2004, ANN EMERG MED, V44, P31, DOI 10.1016/j.annemergmed.2004.01.016; Smith Dawn K., 2005, Morbidity and Mortality Weekly Report, V54, P1; SPEILBERG F, 2005, FDA BLOOD PROD ADV C; *US FDA, TEST YOURS HIV 1 VIR; Walensky RP, 2005, MED DECIS MAKING, V25, P321, DOI 10.1177/0272989X05276955; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411	25	60	60	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2006	145	6					459	462		10.7326/0003-4819-145-6-200609190-00010	http://dx.doi.org/10.7326/0003-4819-145-6-200609190-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087OU	16983134				2022-12-28	WOS:000240752500008
J	Boehr, DD; McElheny, D; Dyson, HJ; Wright, PE				Boehr, David D.; McElheny, Dan; Dyson, H. Jane; Wright, Peter E.			The dynamic energy landscape of dihydrofolate reductase catalysis	SCIENCE			English	Article							ESCHERICHIA-COLI; NMR-SPECTROSCOPY; ENZYME CATALYSIS; BINDING; STATES; LOOP; FLUCTUATIONS; MECHANISM; SUBSTRATE; PROTEINS	We used nuclear magnetic resonance relaxation dispersion to characterize higher energy conformational substates of Escherichia coli dihydrofolate reductase. Each intermediate in the catalytic cycle samples low-lying excited states whose conformations resemble the ground-state structures of preceding and following intermediates. Substrate and cofactor exchange occurs through these excited substates. The maximum hydride transfer and steady-state turnover rates are governed by the dynamics of transitions between ground and excited states of the intermediates. Thus, the modulation of the energy landscape by the bound ligands funnels the enzyme through its reaction cycle along a preferred kinetic path.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Wright, PE (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wright@scripps.edu	Dyson, Jane/D-4160-2011; Boehr, David/A-2068-2010	Dyson, Jane/0000-0001-6855-3398; 	NIGMS NIH HHS [GM56879, GM75995] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM056879, R01GM075995] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beach H, 2005, J AM CHEM SOC, V127, P9167, DOI 10.1021/ja0514949; Bosshard HR, 2001, NEWS PHYSIOL SCI, V16, P171; Cannon WR, 1996, NAT STRUCT BIOL, V3, P821, DOI 10.1038/nsb1096-821; CARERI G, 1979, ANNU REV BIOPHYS BIO, V8, P69, DOI 10.1146/annurev.bb.08.060179.000441; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Evenas J, 2001, STRUCTURE, V9, P185, DOI 10.1016/S0969-2126(01)00575-5; FIERKE CA, 1987, BIOCHEMISTRY-US, V26, P4085, DOI 10.1021/bi00387a052; FRAUENFELDER H, 1988, ANNU REV BIOPHYS BIO, V17, P451; GAVISH B, 1979, BIOCHEMISTRY-US, V18, P1269, DOI 10.1021/bi00574a023; HAMMES GG, 1964, NATURE, V204, P342, DOI 10.1038/204342a0; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Kumar S, 2000, PROTEIN SCI, V9, P10; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; McElheny D, 2005, P NATL ACAD SCI USA, V102, P5032, DOI 10.1073/pnas.0500699102; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Osborne MJ, 2003, PROTEIN SCI, V12, P2230, DOI 10.1110/ps.03219603; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P586, DOI 10.1021/bi962337c; Schnell JR, 2004, ANNU REV BIOPH BIOM, V33, P119, DOI 10.1146/annurev.biophys.33.110502.133613; Skrynnikov NR, 2002, J AM CHEM SOC, V124, P12352, DOI 10.1021/ja0207089; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Venkitakrishnan RP, 2004, BIOCHEMISTRY-US, V43, P16046, DOI 10.1021/bi048119y; Wang CY, 2004, J MOL BIOL, V342, P525, DOI 10.1016/j.jmb.2004.07.001; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821	28	738	751	1	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2006	313	5793					1638	1642		10.1126/science.1130258	http://dx.doi.org/10.1126/science.1130258			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973882				2022-12-28	WOS:000240498900046
J	Fernandez, MA; Albor, C; Ingelmo-Torres, M; Nixon, SJ; Ferguson, C; Kurzchalia, T; Tebar, F; Enrich, C; Parton, RG; Pol, A				Fernandez, Manuel A.; Albor, Cecilia; Ingelmo-Torres, Mercedes; Nixon, Susan J.; Ferguson, Charles; Kurzchalia, Teymuras; Tebar, Francesc; Enrich, Carlos; Parton, Robert G.; Pol, Albert			Caveolin-1 is essential for liver regeneration	SCIENCE			English	Article							DOMINANT-NEGATIVE MUTANT; PARTIAL-HEPATECTOMY; LIPID BODIES; GLUCOSE; RATS; FAT	Liver regeneration is an orchestrated cellular response that coordinates cell activation, lipid metabolism, and cell division. We found that caveolin-1 gene - disrupted mice (cav1(-/-) mice) exhibited impaired liver regeneration and low survival after a partial hepatectomy. Hepatocytes showed dramatically reduced lipid droplet accumulation and did not advance through the cell division cycle. Treatment of cav1(-/-) mice with glucose ( which is a predominant energy substrate when compared to lipids) drastically increased survival and reestablished progression of the cell cycle. Thus, caveolin-1 plays a crucial role in the mechanisms that coordinate lipid metabolism with the proliferative response occurring in the liver after cellular injury.	Univ Queensland, Inst Mol Biosci, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia; Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Fac Med, Dept Cellular Biol, E-08036 Barcelona, Spain; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	University of Queensland; University of Queensland; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Max Planck Society	Parton, RG (corresponding author), Univ Queensland, Inst Mol Biosci, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia.	R.Parton@imb.uq.edu.au; apols@ub.edu	Tebar, Francesc/H-1498-2015; Parton, Robert G/C-5673-2009; Pol, Albert/M-1865-2014; Fernandez-Rojo, Manuel Alejandro/P-2981-2014; Nixon, Susan/D-4588-2017	Tebar, Francesc/0000-0002-9522-9726; Parton, Robert G/0000-0002-7494-5248; Pol, Albert/0000-0002-1750-1085; Fernandez-Rojo, Manuel Alejandro/0000-0002-2240-1951; Nixon, Susan/0000-0003-0346-9683; Ingelmo, Mercedes/0000-0002-7116-2045; Enrich, Carlos/0000-0003-0382-2993				Albrecht JH, 1998, ONCOGENE, V16, P2141, DOI 10.1038/sj.onc.1201728; Bucher N.L.R., 1971, REGENERATION LIVER K; CARUANA JA, 1986, ENDOCR RES, V12, P147, DOI 10.1080/07435808609035434; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Farrell GC, 2004, HEPATOLOGY, V40, P1252, DOI 10.1002/hep.20522; Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214; GLENDE EA, 1968, EXP MOL PATHOL, V8, P190, DOI 10.1016/0014-4800(68)90015-4; HOLECEK M, 1988, EXP PATHOL-JENA, V33, P257; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; LAI HS, 1992, JPEN-PARENTER ENTER, V16, P152, DOI 10.1177/0148607192016002152; Le Lay S, 2005, BBA-MOL CELL RES, V1746, P322, DOI 10.1016/j.bbamcr.2005.06.001; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Pol A, 2001, J CELL BIOL, V152, P1057, DOI 10.1083/jcb.152.5.1057; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; SIMEK J, 1967, NATURE, V213, P910, DOI 10.1038/213910a0; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489	16	203	213	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2006	313	5793					1628	1632		10.1126/science.1130773	http://dx.doi.org/10.1126/science.1130773			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973879				2022-12-28	WOS:000240498900043
J	McDougal, WS; Tolkoff-Rubin, NE; Michaelson, MD; Mueller, PR; Braaten, K				McDougal, W. Scott; Tolkoff-Rubin, Nina E.; Michaelson, M. Dror; Mueller, Peter R.; Braaten, Kristina			Case 28-2006: A 59-year-old man with masses in both kidneys - Renal-cell carcinoma, clear-cell type, involving both kidneys, with solitary metastasis to the right lung	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GUIDED RADIOFREQUENCY ABLATION; RADIO-FREQUENCY ABLATION; TUMORS		Massachusetts Gen Hosp, Dept Urol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Div Nephrol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Urol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University	McDougal, WS (corresponding author), Massachusetts Gen Hosp, Dept Urol, Boston, MA 02114 USA.			Michaelson, Dror/0000-0001-9249-6338				Dupuy DE, 2001, J VASC INTERV RADIOL, V12, P1135, DOI 10.1016/S1051-0443(07)61670-4; Farrell MA, 2003, AM J ROENTGENOL, V180, P1509, DOI 10.2214/ajr.180.6.1801509; Ficarra V, 2001, UROL INT, V67, P130, DOI 10.1159/000050968; Gervais DA, 2005, AM J ROENTGENOL, V185, P64, DOI 10.2214/ajr.185.1.01850064; Hofmann HS, 2005, EUR UROL, V48, P77, DOI 10.1016/j.eururo.2005.03.004; Mayo-Smith WW, 2003, AM J ROENTGENOL, V180, P1503, DOI 10.2214/ajr.180.6.1801503; McDougal WS, 2005, J UROLOGY, V174, P61, DOI 10.1097/01.ju.0000162046.45024.2b; McGovern FJ, 1999, J UROLOGY, V161, P599, DOI 10.1016/S0022-5347(01)61961-X; STEWART JR, 1991, ANN THORAC SURG, V51, P717, DOI 10.1016/0003-4975(91)90111-3; Zagoria RJ, 2004, AM J ROENTGENOL, V183, P201, DOI 10.2214/ajr.183.1.1830201	10	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 14	2006	355	11					1161	1167		10.1056/NEJMcpc069019	http://dx.doi.org/10.1056/NEJMcpc069019			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083NJ	16971723				2022-12-28	WOS:000240462800012
J	Taylor, KM; Sisson, G; Harris, AW				Taylor, Kirstin M.; Sisson, Guy; Harris, Adam W.			Thyroxine in goiter, H-pylori infection, and gastritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									Kent & Sussex Hosp, Tunbridge Wells TN4 8AT, Kent, England		Taylor, KM (corresponding author), Kent & Sussex Hosp, Tunbridge Wells TN4 8AT, Kent, England.	kirstin.taylor@nhs.net							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 14	2006	355	11					1177	1177						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083NJ	16977705				2022-12-28	WOS:000240462800024
J	Olsson, S; Pal, S				Olsson, Sten; Pal, Shanthi			Drug bulletins: independent information for global use	LANCET			English	Editorial Material							PRESCRIBING BEHAVIOR		WHO, Collaborating Ctr Int Drug Monitoring, SE-75320 Uppsala, Sweden; World Hlth Org, Dept Med Policy & Stand, Geneva, Switzerland	World Health Organization; World Health Organization	Olsson, S (corresponding author), WHO, Collaborating Ctr Int Drug Monitoring, SE-75320 Uppsala, Sweden.	sten.olsson@who-umc.org						BOSELEY S, 2006, GUARDIAN        0613; DENIG P, 1990, DICP ANN PHARMAC, V24, P87, DOI 10.1177/106002809002400116; Dormuth CR, 2004, CAN MED ASSOC J, V171, P1057, DOI 10.1503/cmaj.1031621; Gibson L, 2004, BRIT MED J, V328, P307, DOI 10.1136/bmj.328.7435.307-b; *INT SOC, 2006, INT SOC DRUG B; *WHO, 2005, INT SOC DRUG B	6	7	7	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 9	2006	368	9539					903	904		10.1016/S0140-6736(06)69351-3	http://dx.doi.org/10.1016/S0140-6736(06)69351-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	083ZX	16962866				2022-12-28	WOS:000240502300010
J	Haigis, MC; Mostoslavsky, R; Haigis, KM; Fahie, K; Christodoulou, DC; Murphy, AJ; Valenzuela, DM; Yancopoulos, GD; Karow, M; Blander, G; Wolberger, C; Prolla, TA; Weindruch, R; Alt, FW; Guarente, L				Haigis, Marcia C.; Mostoslavsky, Raul; Haigis, Kevin M.; Fahie, Kamau; Christodoulou, Danos C.; Murphy, Andrew J.; Valenzuela, David M.; Yancopoulos, George D.; Karow, Margaret; Blander, Gil; Wolberger, Cynthia; Prolla, Tomas A.; Weindruch, Richard; Alt, Frederick W.; Guarente, Leonard			SIRT4 inhibits glutamate dehydrogehase and opposes the effects of calorie restriction in pancreatic beta cells	CELL			English	Article							STIMULATED INSULIN-SECRETION; LIFE-SPAN EXTENSION; ADP-RIBOSYLATION; SACCHAROMYCES-CEREVISIAE; DEPENDENT DEACETYLASE; TRANSCRIPTION FACTORS; PROTEIN DEACETYLASES; ENZYME-ACTIVITIES; MAMMALIAN SIR2; MOUSE-LIVER	Sir2 is an NAD-dependent deacetylase that connects metabolism with longevity in yeast, flies, and worms. Mammals have seven Sir2 homologs (SIRT1-7). We show that SIRT4 is a mitochondrial enzyme that uses NAD to ADP-ribosylate and downregulate glutamate dehydrogenase (GDH) activity. GDH is known to promote the metabolism of glutamate and glutamine, generating ATP, which promotes insulin secretion. Loss of SIRT4 in insulinoma cells activates GDH, thereby upregulating amino acid-stimulated insulin secretion. A similar effect is observed in pancreatic beta cells from mice deficient in SIRT4 or on the dietary regimen of calorie restriction (CR). Furthermore, GDH from SIRT4-deficient or CR mice is insensitive to phosphodiesterase, an enzyme that cleaves ADP-ribose, suggesting the absence of ADP-ribosylation. These results indicate that SIRT4 functions in beta cell mitochondria to repress the activity of GDH by ADP-ribosylation, thereby downregulating insulin secretion in response to amino acids, effects that are alleviated during CR.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Canc Res Ctr, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Childrens Hosp, CBR Inst Biomed Res, Howard Hughes Med Inst, Boston, MA 02115 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; Univ Wisconsin, Dept Med, Madison, WI 53705 USA; Univ Wisconsin, Vet Adm Hosp, Madison, WI 53705 USA; Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Howard Hughes Medical Institute; Howard Hughes Medical Institute; Johns Hopkins University; Regeneron; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University; University of Wisconsin System; University of Wisconsin Madison	Guarente, L (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu		Murphy, Andrew/0000-0003-4152-4081; Wolberger, Cynthia/0000-0001-8578-2969				Armstrong CM, 2002, MOL BIOL CELL, V13, P1427, DOI 10.1091/mbc.01-10-0482; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; CERVANTESLAUREAN D, 1993, BIOCHEMISTRY-US, V32, P1528, DOI 10.1021/bi00057a017; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Cline GW, 2004, J BIOL CHEM, V279, P44370, DOI 10.1074/jbc.M311842200; Dhahbi JM, 2001, MECH AGEING DEV, V122, P1033, DOI 10.1016/S0047-6374(01)00230-5; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Hagopian K, 2005, FEBS LETT, V579, P2009, DOI 10.1016/j.febslet.2005.02.062; Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4; Hagopian K, 2003, EXP GERONTOL, V38, P253, DOI 10.1016/S0531-5565(02)00203-6; Herrero-Yraola A, 2001, EMBO J, V20, P2404, DOI 10.1093/emboj/20.10.2404; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jorcke D, 1998, BIOCHEM J, V332, P189, DOI 10.1042/bj3320189; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kelly A, 2001, MENT RETARD DEV D R, V7, P287, DOI 10.1002/mrdd.1040; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Li CH, 2003, J BIOL CHEM, V278, P2853, DOI 10.1074/jbc.M210577200; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MEYER T, 1986, EUR J BIOCHEM, V155, P157, DOI 10.1111/j.1432-1033.1986.tb09471.x; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Pugh TD, 1999, NEUROBIOL AGING, V20, P157, DOI 10.1016/S0197-4580(99)00043-3; REAVEN E, 1983, DIABETES, V32, P175, DOI 10.2337/diabetes.32.2.175; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Schwab CJ, 2000, P SOC EXP BIOL MED, V223, P389, DOI 10.1046/j.1525-1373.2000.22355.x; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; SENER A, 1980, NATURE, V288, P187, DOI 10.1038/288187a0; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Tsuchiya T, 2004, PHYSIOL GENOMICS, V17, P307, DOI 10.1152/physiolgenomics.00039.2004; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; WITTERS LA, 1986, BIOCHEMISTRY-US, V25, P7216, DOI 10.1021/bi00370a067; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789	55	883	932	3	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2006	126	5					941	954		10.1016/j.cell.2006.06.057	http://dx.doi.org/10.1016/j.cell.2006.06.057			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959573	Bronze			2022-12-28	WOS:000240675000021
J	Inouye, M				Inouye, Masayori			Signaling by transmembrane proteins shifts gears	CELL			English	Editorial Material							HISTIDINE KINASE; ESCHERICHIA-COLI; LINKER REGION; ENVZ; TRANSDUCTION; DOMAIN; OSMOSENSOR	The HAMP domain is present in a large number of transmembrane proteins in prokaryotes including histidine kinases, adenylyl cyclases, chemotaxis receptors, and phosphatases. In this issue of Cell, Hulko et al. (2006) report the NMR structure of a HAMP domain and present data suggesting that it transduces signals through a simple rotation of its four-helix parallel coiled coil.	Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Inouye, M (corresponding author), Robert Wood Johnson Med Sch, Dept Biochem, 675 Hoes Lane, Piscataway, NJ 08854 USA.	inouye@umdnj.edu						Aravind L, 1999, FEMS MICROBIOL LETT, V176, P111, DOI 10.1016/S0378-1097(99)00197-4; KORETKE KK, 2003, HISTIDINE KINASES SI, P483; Park H, 1997, J BACTERIOL, V179, P4382, DOI 10.1128/jb.179.13.4382-4390.1997; Tanaka T, 1998, NATURE, V396, P88, DOI 10.1038/23968; Tomomori C, 1999, NAT STRUCT BIOL, V6, P729; UTSUMI R, 1989, SCIENCE, V245, P1246, DOI 10.1126/science.2476847; Williams SB, 1999, MOL MICROBIOL, V33, P1093, DOI 10.1046/j.1365-2958.1999.01562.x; Zhu Y, 2004, J BIOL CHEM, V279, P48152, DOI 10.1074/jbc.M401024200; Zhu Y, 2003, J BIOL CHEM, V278, P22812, DOI 10.1074/jbc.M300916200	9	11	12	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 8	2006	126	5					829	831		10.1016/j.cell.2006.08.024	http://dx.doi.org/10.1016/j.cell.2006.08.024			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959559	Bronze			2022-12-28	WOS:000240675000007
J	Ohtsubo, K; Marth, JD				Ohtsubo, Kazuaki; Marth, Jamey D.			Glycosylation in cellular mechanisms of health and disease	CELL			English	Review							SELECTIN LIGAND EXPRESSION; PROTEIN GLYCOSYLATION; CONGENITAL DISORDERS; HEPARAN-SULFATE; MICE LACKING; RECEPTOR; MUTATION; COMPLEX; CELLS; CD22	Glycosylation produces an abundant, diverse, and highly regulated repertoire of cellular glycans that are frequently attached to proteins and lipids. The past decade of research on glycan function has revealed that the enzymes responsible for glycosylation-the glycosyl-transferases and glycosidases-are essential in the development and physiology of living organisms. Glycans participate in many key biological processes including cell adhesion, molecular trafficking and clearance, receptor activation, signal transduction, and endocytosis. This review discusses the increasingly sophisticated molecular mechanisms being discovered by which mammalian glycosylation governs physiology and contributes to disease.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Marth, JD (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, 9500 Gilman Dr MC0625, La Jolla, CA 92093 USA.	jmarth@ucsd.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL57345] Funding Source: Medline; NIDDK NIH HHS [DK4247] Funding Source: Medline; NIGMS NIH HHS [GM62116] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aebi M, 2001, TRENDS CELL BIOL, V11, P136, DOI 10.1016/S0962-8924(01)01925-0; Akama TO, 2002, SCIENCE, V295, P124, DOI 10.1126/science.1065570; AL X, 2003, J CELL BIOL, V162, P341; Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; BESSLER M, 1994, EMBO J, V13, P110, DOI 10.1002/j.1460-2075.1994.tb06240.x; Bochner BS, 2005, J BIOL CHEM, V280, P4307, DOI 10.1074/jbc.M412378200; Butters TD, 2005, GLYCOBIOLOGY, V15, pR43, DOI 10.1093/glycob/cwi076; Carbone FR, 1997, GLYCOBIOLOGY, V7, P725, DOI 10.1093/glycob/7.6.725-d; Chen L, 1998, ONCOGENE, V17, P2087, DOI 10.1038/sj.onc.1202124; Chen SH, 2005, J EXP MED, V202, P1679, DOI 10.1084/jem.20051473; Chui D, 2001, P NATL ACAD SCI USA, V98, P1142, DOI 10.1073/pnas.98.3.1142; Cobb BA, 2005, EUR J IMMUNOL, V35, P352, DOI 10.1002/eji.200425889; Collins BE, 2004, P NATL ACAD SCI USA, V101, P6104, DOI 10.1073/pnas.0400851101; Collins BE, 2006, NAT IMMUNOL, V7, P199, DOI 10.1038/ni1283; Comelli EM, 2006, GLYCOBIOLOGY, V16, P117, DOI 10.1093/glycob/cwj048; Crocker PR, 2001, IMMUNOLOGY, V103, P137, DOI 10.1046/j.0019-2805.2001.01241.x; Dell A, 2001, SCIENCE, V291, P2351, DOI 10.1126/science.1058890; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Drickamer K, 2003, METHOD ENZYMOL, V362, P560; Duncan G, 2001, J CLIN INVEST, V108, P511, DOI 10.1172/JCI200113737; Ellies LG, 2002, P NATL ACAD SCI USA, V99, P10042, DOI 10.1073/pnas.142005099; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Foulquier F, 2006, P NATL ACAD SCI USA, V103, P3764, DOI 10.1073/pnas.0507685103; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Fukuda M, 2001, J BIOL CHEM, V276, P47747, DOI 10.1074/jbc.R100049200; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Goldstein IJ, 2002, J AGR FOOD CHEM, V50, P6583, DOI 10.1021/jf0201879; Grewal PK, 2006, MOL CELL BIOL, V26, P4970, DOI 10.1128/MCB.00308-06; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Han S, 2005, NAT CHEM BIOL, V1, P93, DOI 10.1038/nchembio713; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HOFFMAN S, 1983, P NATL ACAD SCI-BIOL, V80, P5762, DOI 10.1073/pnas.80.18.5762; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; ISHIBASHI S, 1994, J BIOL CHEM, V269, P27803; Jaeken J, 2004, CURR OPIN PEDIATR, V16, P434, DOI 10.1097/01.mop.0000133636.56790.4a; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kikuchi N, 2006, BBA-GEN SUBJECTS, V1760, P578, DOI 10.1016/j.bbagen.2005.12.024; Kinoshita T, 1997, J BIOCHEM-TOKYO, V122, P251; Klein A, 1998, BIOCHIMIE, V80, P49, DOI 10.1016/S0300-9084(98)80056-4; Kobata A, 2005, IMMUNOL CELL BIOL, V83, P429, DOI 10.1111/j.1440-1711.2005.01351.x; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KORNFELD S, 1985, HOSP PRACT, V20, P71; Kudo M, 2006, AM J HUM GENET, V78, P451, DOI 10.1086/500849; Landsteiner K, 1931, SCIENCE, V73, P403, DOI 10.1126/science.73.1894.403; Lau K, 2005, GLYCOBIOLOGY, V15, P1196; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Li SR, 2004, SCIENCE, V305, P1619, DOI 10.1126/science.1098674; LINHARDT RJ, 1991, CHEM IND-LONDON, P45; Lowe JB, 2003, CURR OPIN CELL BIOL, V15, P531, DOI 10.1016/j.ceb.2003.08.002; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/88299; Maccioni HJF, 2002, NEUROCHEM RES, V27, P629, DOI 10.1023/A:1020271932760; MCCAFFREY G, 1993, COMP BIOCHEM PHYS B, V104, P91, DOI 10.1016/0305-0491(93)90342-3; McGowan KA, 2000, MICROSC RES TECHNIQ, V51, P262, DOI 10.1002/1097-0029(20001101)51:3<262::AID-JEMT6>3.0.CO;2-V; METZLER M, 1994, EMBO J, V13, P2056, DOI 10.1002/j.1460-2075.1994.tb06480.x; Mi YL, 2002, J CLIN INVEST, V109, P269, DOI 10.1172/JCI13997; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; MILJAN EA, 2002, SCI STKE, pRE15; Morris S, 2004, GLYCOBIOLOGY, V14, P293, DOI 10.1093/glycob/cwh029; Niehues R, 1998, J CLIN INVEST, V101, P1414, DOI 10.1172/JCI2350; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Park EI, 2005, P NATL ACAD SCI USA, V102, P17125, DOI 10.1073/pnas.0508537102; Parodi AJ, 2000, BIOCHEM J, V348, P1, DOI 10.1042/0264-6021:3480001; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Paulson JC, 2006, NAT CHEM BIOL, V2, P238, DOI 10.1038/nchembio785; Prescher JA, 2004, NATURE, V430, P873, DOI 10.1038/nature02791; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Schachter H, 2000, GLYCOCONJUGATE J, V17, P465; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Schweizer F, 1999, CURR OPIN CHEM BIOL, V3, P291, DOI 10.1016/S1367-5931(99)80045-3; Seeberger PH, 2005, NAT REV DRUG DISCOV, V4, P751, DOI 10.1038/nrd1823; Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122; Shriver Z, 2004, NAT REV DRUG DISCOV, V3, P863, DOI 10.1038/nrd1521; Shur BD, 2004, CURR BIOL, V14, pR691, DOI 10.1016/j.cub.2004.08.037; Simpson MA, 2004, NAT GENET, V36, P1225, DOI 10.1038/ng1460; Smith PL, 2002, J CELL BIOL, V158, P801, DOI 10.1083/jcb.200203125; Sparrow DB, 2006, AM J HUM GENET, V78, P28, DOI 10.1086/498879; Suji G, 2004, BIOGERONTOLOGY, V5, P365, DOI 10.1007/s10522-004-3189-0; SURANI MAH, 1979, CELL, V18, P217; TABAK LA, 1995, ANNU REV PHYSIOL, V57, P547, DOI 10.1146/annurev.ph.57.030195.002555; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Tedder TF, 1997, ANNU REV IMMUNOL, V15, P481, DOI 10.1146/annurev.immunol.15.1.481; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Underhill GH, 2005, BLOOD, V106, P3867, DOI 10.1182/blood-2005-03-0984; Varki A, 2001, BRAZ J MED BIOL RES, V34, P711, DOI 10.1590/S0100-879X2001000600003; Vogt G, 2005, NAT GENET, V37, P692, DOI 10.1038/ng1581; Wakeland EK, 2001, IMMUNITY, V15, P397, DOI 10.1016/S1074-7613(01)00201-1; Wang P, 2004, BIOCHEM J, V380, P425, DOI 10.1042/BJ20031896; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang Y, 2001, GLYCOBIOLOGY, V11, P1051, DOI 10.1093/glycob/11.12.1051; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Wu XH, 2004, NAT MED, V10, P518, DOI 10.1038/nm1041; Yan AX, 2005, J BIOL CHEM, V280, P3121, DOI 10.1074/jbc.R400036200; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7	108	1996	2072	23	659	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2006	126	5					855	867		10.1016/j.cell.2006.08.019	http://dx.doi.org/10.1016/j.cell.2006.08.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959566	Bronze			2022-12-28	WOS:000240675000014
J	Frazao, C; Mcvey, CE; Amblar, M; Barbas, A; Vonrhein, C; Arraiano, CM; Carrondo, MA				Frazao, Carlos; McVey, Colin E.; Amblar, Monica; Barbas, Ana; Vonrhein, Clemens; Arraiano, Cecilia M.; Carrondo, Maria A.			Unravelling the dynamics of RNA degradation by ribonuclease II and its RNA-bound complex	NATURE			English	Article							MESSENGER-RNAS; EXOSOME; SUPERFAMILY; MECHANISM; RECOGNITION; PROTEINS; PROGRAM; DENSITY; BINDING; DOMAIN	RNA degradation is a determining factor in the control of gene expression. The maturation, turnover and quality control of RNA is performed by many different classes of ribonucleases(1). Ribonuclease II (RNase II) is a major exoribonuclease that intervenes in all of these fundamental processes(1); it can act independently or as a component of the exosome, an essential RNA-degrading multiprotein complex(2). RNase II-like enzymes are found in all three kingdoms of life, but there are no structural data for any of the proteins of this family(1-5). Here we report the X-ray crystallographic structures of both the ligand-free (at 2.44 angstrom resolution) and RNA-bound (at 2.74 angstrom resolution) forms of Escherichia coli RNase II. In contrast to sequence predictions, the structures show that RNase II is organized into four domains: two cold-shock domains, one RNB catalytic domain, which has an unprecedented alpha beta-fold, and one S1 domain. The enzyme establishes contacts with RNA in two distinct regions, the 'anchor' and the 'catalytic' regions, which act synergistically to provide catalysis(6). The active site is buried within the RNB catalytic domain, in a pocket formed by four conserved sequence motifs. The structure shows that the catalytic pocket is only accessible to single-stranded RNA, and explains the specificity for RNA versus DNA cleavage. It also explains the dynamic mechanism of RNA degradation by providing the structural basis for RNA translocation and enzyme processivity. We propose a reaction mechanism for exonucleolytic RNA degradation involving key conserved residues. Our three-dimensional model corroborates all existing biochemical data for RNase II, and elucidates the general basis for RNA degradation. Moreover, it reveals important structural features that can be extrapolated to other members of this family.	Univ Nova Lisboa, Inst Tecnol Quim & Biol, Div Biol Chem, P-2781901 Oeiras, Portugal; Univ Nova Lisboa, Inst Tecnol Quim & Biol, Div Biol, P-2781901 Oeiras, Portugal; Global Phasing Ltd, Cambridge CB3 0AX, England	Universidade Nova de Lisboa; Universidade Nova de Lisboa; Global Phasing Limited	Carrondo, MA (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Div Biol Chem, Apt 127, P-2781901 Oeiras, Portugal.	cecilia@itqb.unl.pt; carrondo@itqb.unl.pt	McVey, Colin E/C-2110-2008; Amblar, Monica/E-2366-2016; Amblar, 2405/C-3941-2011; Frazao, Carlos/C-1965-2008	McVey, Colin E/0000-0001-7457-2130; Amblar, Monica/0000-0003-3530-615X; Frazao, Carlos/0000-0002-7725-1671; Carrondo, Maria Armenia/0000-0002-1261-1162; Barbas, Ana/0000-0002-6245-8549; Arraiano, Cecilia/0000-0003-1934-9301				Amblar M, 2005, FEBS J, V272, P363, DOI 10.1111/j.1742-4658.2004.04477.x; Amblar M, 2006, J MOL BIOL, V360, P921, DOI 10.1016/j.jmb.2006.05.043; Bollenbach TJ, 2005, NUCLEIC ACIDS RES, V33, P2751, DOI 10.1093/nar/gki576; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bycroft M, 1997, CELL, V88, P235, DOI 10.1016/S0092-8674(00)81844-9; Cairrao F, 2005, DEV DYNAM, V232, P733, DOI 10.1002/dvdy.20269; Cairrao F, 2003, MOL MICROBIOL, V50, P1349, DOI 10.1046/j.1365-2958.2003.03766.x; CANNISTRARO VJ, 1994, J MOL BIOL, V243, P930, DOI 10.1006/jmbi.1994.1693; Cassano AG, 2004, BIOPOLYMERS, V73, P110, DOI 10.1002/bip.10517; Cheng ZF, 1998, J BIOL CHEM, V273, P14077, DOI 10.1074/jbc.273.23.14077; Dreyfus M, 2002, CELL, V111, P611, DOI 10.1016/S0092-8674(02)01137-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gan JH, 2006, CELL, V124, P355, DOI 10.1016/j.cell.2005.11.034; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lejeune F, 2003, MOL CELL, V12, P675, DOI 10.1016/S1097-2765(03)00349-6; Lim JT, 1997, CANCER RES, V57, P921; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; McVey CE, 2006, ACTA CRYSTALLOGR F, V62, P684, DOI 10.1107/S1744309106021506; Mian IS, 1997, NUCLEIC ACIDS RES, V25, P3187, DOI 10.1093/nar/25.16.3187; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Symmons MF, 2002, TRENDS BIOCHEM SCI, V27, P11, DOI 10.1016/S0968-0004(01)01999-5; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272	30	180	185	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 7	2006	443	7107					110	114		10.1038/nature05080	http://dx.doi.org/10.1038/nature05080			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16957732				2022-12-28	WOS:000240313900050
J	Jaillais, Y; Fobis-Loisy, I; Miege, C; Rollin, C; Gaude, T				Jaillais, Yvon; Fobis-Loisy, Isabelle; Miege, Christine; Rollin, Claire; Gaude, Thierry			AtSNX1 defines an endosome for auxin-carrier trafficking in Arabidopsis	NATURE			English	Article							GNOM ARF-GEF; PERMEASE AUX1; PIN PROTEINS; EFFLUX; TRANSPORT; LOCALIZATION; ENDOCYTOSIS; EXPRESSION; GRADIENTS; GOLGI	Polarized cellular distribution of the phytohormone auxin and its carriers is essential for normal plant growth and development. Polar auxin transport(1,2) is maintained by a network of auxin influx (AUX)(3) and efflux (PIN)(1,2,4-6) carriers. Both auxin transport and PIN protein cycling between the plasma membrane and endosomes require the activity of the endosomal GNOM(1,2,7,8); however, intracellular routes taken by these carriers remain largely unknown. Here we show that Arabidopsis thaliana SORTING NEXIN 1 (AtSNX1) is involved in the auxin pathway and that PIN2, but not PIN1 or AUX1, is transported through AtSNX1-containing endosomes. We demonstrate that the snx1-null mutant exhibits multiple auxin-related defects and that loss of function of AtSNX1 severely enhances the phenotype of a weak gnom mutant. In root cells, we further show that AtSNX1 localizes to an endosomal compartment distinct from GNOM-containing endosomes, and that PIN2 accumulates in this compartment after treatment with the phosphatidylinositol-3-OH kinase inhibitor wortmannin or after a gravity stimulus. Our data reveal the existence of a novel endosomal compartment involved in PIN2 endocytic sorting and plant development.	Univ Lyon 1, Ecole Normale Super Lyon, Inst Natl Rech Agron, CNRS,IFR Biosci Lyon Gerland 128, F-69364 Lyon 07, France	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Gaude, T (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, Inst Natl Rech Agron, CNRS,IFR Biosci Lyon Gerland 128, 46 Allee Italie, F-69364 Lyon 07, France.	thierry.gaude@ens-lyon.fr	JAILLAIS, Yvon/U-3223-2018	JAILLAIS, Yvon/0000-0003-4923-883X; GAUDE, Thierry/0000-0002-0804-9445				Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bassham DC, 2000, MOL BIOL CELL, V11, P2251, DOI 10.1091/mbc.11.7.2251; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Brandizzi F, 2002, PLANT CELL, V14, P1293, DOI 10.1105/tpc.001586; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Geldner N, 2004, DEVELOPMENT, V131, P389, DOI 10.1242/dev.00926; Grebe M, 2003, CURR BIOL, V13, P1378, DOI 10.1016/S0960-9822(03)00538-4; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Perret E, 2005, CURR OPIN CELL BIOL, V17, P423, DOI 10.1016/j.ceb.2005.06.008; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Swarup R, 2004, PLANT CELL, V16, P3069, DOI 10.1105/tpc.104.024737; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Ueda T, 2004, PLANT J, V40, P783, DOI 10.1111/j.1365-313X.2004.02249.x; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vanoosthuyse V, 2003, PLANT PHYSIOL, V133, P919, DOI 10.1104/pp.103.023846; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Xu J, 2006, SCIENCE, V311, P385, DOI 10.1126/science.1121790; Xu Y, 2001, NAT CELL BIOL, V3, P658, DOI 10.1038/35083051; Zhong Q, 2002, P NATL ACAD SCI USA, V99, P6767, DOI 10.1073/pnas.092142699	27	273	285	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2006	443	7107					106	109		10.1038/nature05046	http://dx.doi.org/10.1038/nature05046			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16936718				2022-12-28	WOS:000240313900049
J	Zheng, HY; Patel, M; Hryniewicz, K; Katz, SD				Zheng, Haoyi; Patel, Milan; Hryniewicz, Katarzyna; Katz, Stuart D.			Association of extended work shifts, vascular function, and inflammatory markers in internal medicine residents: A randomized crossover trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							SLEEP LOSS; PERFORMANCE		Yale Univ, Sch Med, New Haven, CT 06510 USA	Yale University	Zheng, HY (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06510 USA.	stuart.katz@yale.edu		Stuart, Katz/0000-0003-2340-2021	NCRR NIH HHS [MO1 RR00645] Funding Source: Medline; NHLBI NIH HHS [K24 HL0404, R01 HL51433] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000645] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051433] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Amir O, 2004, AM J CARDIOL, V93, P947, DOI 10.1016/j.amjcard.2003.12.032; Arnedt JT, 2005, JAMA-J AM MED ASSOC, V294, P1025, DOI 10.1001/jama.294.9.1025; Katz SD, 2000, J AM COLL CARDIOL, V36, P845, DOI 10.1016/S0735-1097(00)00790-7; Libby Peter, 2004, Am J Med, V116 Suppl 6A, p9S; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; Mancini GBJ, 2004, J AM COLL CARDIOL, V43, P624, DOI 10.1016/j.jacc.2003.11.017; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Philibert I, 2005, SLEEP, V28, P1392, DOI 10.1093/sleep/28.11.1392; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562	9	23	25	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2006	296	9					1049	1050		10.1001/jama.296.9.1049	http://dx.doi.org/10.1001/jama.296.9.1049			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	081DW	16954481				2022-12-28	WOS:000240298400002
J	Marshall, SM; Flyvbjerg, A				Marshall, Sally M.; Flyvbjerg, Allan			Prevention and early detection of vascular complications of diabetes	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RENIN-ANGIOTENSIN SYSTEM; SIGHT-THREATENING RETINOPATHY; CARDIOVASCULAR-DISEASE; MICROVASCULAR COMPLICATIONS; ETHNIC-DIFFERENCES; BLOOD-PRESSURE; DUAL BLOCKADE; TYPE-2; CARE; MICROALBUMINURIA		Newcastle Univ, Sch Med, Diabet Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Aarhus Univ, DK-8000 Aarhus, Denmark	Newcastle University - UK; Aarhus University	Marshall, SM (corresponding author), Newcastle Univ, Sch Med, Diabet Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	s.m.marshall@ncl.ac.uk	Northe, Hilda/I-1916-2012	Northe, Hilda/0000-0002-8873-5014				Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; AGINS E, 2006, DIABETIC MED, V23, P331; Alberti H, 2005, DIABETES RES CLIN PR, V68, P237, DOI 10.1016/j.diabres.2004.09.016; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Casas JP, 2005, LANCET, V366, P2026, DOI 10.1016/S0140-6736(05)67814-2; Chaturvedi N, 2001, ANN INTERN MED, V134, P370, DOI 10.7326/0003-4819-134-5-200103060-00009; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Costa J, 2006, BMJ-BRIT MED J, V332, P1115, DOI 10.1136/bmj.38793.468449.AE; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; DeCosmo S, 1997, DIABETOLOGIA, V40, P1191, DOI 10.1007/s001250050806; ELIASSON B, 1996, GAP GUIDELINES RELIT; FORSBLOM CM, 1995, DIABETOLOGIA, V38, P363, DOI 10.1007/s001250050294; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Glasgow RE, 2001, MILBANK Q, V79, P579, DOI 10.1111/1468-0009.00222; Godley PJ, 2005, AM J MANAG CARE, V11, P206; Jonsson B, 2002, DIABETOLOGIA, V45, pS5, DOI 10.1007/s00125-002-0858-x; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Laing SP, 2003, DIABETOLOGIA, V46, P760, DOI 10.1007/s00125-003-1116-6; Laing SP, 1999, DIABETIC MED, V16, P466, DOI 10.1046/j.1464-5491.1999.00076.x; Lanting LC, 2005, DIABETES CARE, V28, P2280, DOI 10.2337/diacare.28.9.2280; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LITZELMAN DK, 1993, ANN INTERN MED, V119, P36, DOI 10.7326/0003-4819-119-1-199307010-00006; Martin CL, 2006, DIABETES CARE, V29, P340, DOI 10.2337/diacare.29.02.06.dc05-1549; Mogensen CE, 2000, BRIT MED J, V321, P1440, DOI 10.1136/bmj.321.7274.1440; *NAT I CLIN EXC, 2004, CLIN GUID 10 TYP 2 D; *NAT SCREEN COMM, DIAB RET SCREEN WORK; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Parris ES, 2005, DIABETES CARE, V28, P595, DOI 10.2337/diacare.28.3.595; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Perkins BA, 2003, NEW ENGL J MED, V348, P2285, DOI 10.1056/NEJMoa021835; Pladevall M, 2004, DIABETES CARE, V27, P2800, DOI 10.2337/diacare.27.12.2800; Puent Brian D, 2004, Optometry, V75, P709, DOI 10.1016/S1529-1839(04)70223-7; Quattrini C, 2003, DIABETES-METAB RES, V19, pS2, DOI 10.1002/dmrr.360; Reiber GE, 2005, LANCET, V366, P1676, DOI 10.1016/S0140-6736(05)67674-X; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rith-Najarian S, 1998, J FAM PRACTICE, V47, P127; Roper NA, 2001, BRIT MED J, V322, P1389, DOI 10.1136/bmj.322.7299.1389; Rossing K, 2002, DIABETES CARE, V25, P95, DOI 10.2337/diacare.25.1.95; Rossing P, 2005, DIABETOLOGIA, V48, P1439, DOI 10.1007/s00125-005-1836-x; Rubin RR, 2005, AM J MED, V118, P27, DOI 10.1016/j.amjmed.2005.04.012; SCHAP MK, 2003, DIABETOLOGIA, V45, P302; Schjoedt KJ, 2005, KIDNEY INT, V68, P2829, DOI 10.1111/j.1523-1755.2005.00756.x; Schrijvers BF, 2004, ENDOCR REV, V25, P971, DOI 10.1210/er.2003-0018; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shannon H, 2000, NEW ENGL J MED, V342, P381; Shaw JE, 1999, DIABETES REV, V7, P245; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; STIPPOLI GF, 2005, COCHRANE DB SYST REV, V4; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Strippoli GFM, 2005, COCHRANE DB SYST REV, V4; Tesfaye S, 2005, DIABETOLOGIA, V48, P805, DOI 10.1007/s00125-005-1721-7; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; US Renal Data System, 2005, USRDS 2005 ANN DAT R; Van Dijk PCW, 2005, KIDNEY INT, V67, P1489, DOI 10.1111/j.1523-1755.2005.00227.x; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Williams R, 2002, DIABETOLOGIA, V45, pS13, DOI 10.1007/s00125-002-0859-9; Young BA, 2005, J AM SOC NEPHROL, V16, P219, DOI 10.1681/ASN.2004030162; Younis N, 2003, DIABETIC MED, V20, P758, DOI 10.1046/j.1464-5491.2003.01035.x; Younis N, 2003, LANCET, V361, P195, DOI 10.1016/S0140-6736(03)12267-2; Younis N, 2002, DIABETIC MED, V19, P44, DOI 10.1046/j.1464-5491.19.s4.9.x	65	141	153	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2006	333	7566					475	480		10.1136/bmj.38922.650521.80	http://dx.doi.org/10.1136/bmj.38922.650521.80			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085QP	16946335	Green Published			2022-12-28	WOS:000240618900020
J	Popesco, MC; MacLaren, EJ; Hopkins, J; Dumas, L; Cox, M; Meltesen, L; McGavran, L; Wyckoff, GJ; Sikela, JM				Popesco, Magdalena C.; MacLaren, Erik J.; Hopkins, Janet; Dumas, Laura; Cox, Michael; Meltesen, Lynne; McGavran, Loris; Wyckoff, Gerald J.; Sikela, James M.			Human lineage-specific amplification, selection, and neuronal expression of DUF1220 domains	SCIENCE			English	Article							PROTEIN; IDENTIFICATION; DUPLICATION; GENOME; PFAM	Extreme gene duplication is a major source of evolutionary novelty. A genome-wide survey of gene copy number variation among human and great ape lineages revealed that the most striking human lineage-specific amplification was due to an unknown gene, MGC8902, which is predicted to encode multiple copies of a protein domain of unknown function (DUF1220). Sequences encoding these domains are virtually all primate-specific, show signs of positive selection, and are increasingly amplified generally as a function of a species' evolutionary proximity to humans, where the greatest number of copies (212) is found. DUF1220 domains are highly expressed in brain regions associated with higher cognitive function, and in brain show neuron-specific expression preferentially in cell bodies and dendrites.	Univ Colorado Denver, Human Med Genet Program, Aurora, CO 80045 USA; Univ Colorado Denver, Neurosci Program, Aurora, CO 80045 USA; Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; Univ Colorado Denver, Dept Pathol, Aurora, CO 80045 USA; Hlth Sci Ctr, Aurora, CO 80045 USA; Univ Missouri, Div Mol Biol & Biochem, Kansas City, MO 64110 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Missouri System; University of Missouri Kansas City	Sikela, JM (corresponding author), Univ Colorado Denver, Human Med Genet Program, Aurora, CO 80045 USA.	james.sikela@uchsc.edu		Wyckoff, Gerald/0000-0003-2604-2666	NIAAA NIH HHS [AA11853] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011853] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; *BAYL COLL MED HUM, RHES MONK GEN PROJ; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; Goidts V, 2006, HUM GENET, V119, P185, DOI 10.1007/s00439-005-0130-9; Goodman M, 1999, AM J HUM GENET, V64, P31, DOI 10.1086/302218; Gregory SG, 2006, NATURE, V441, P315, DOI 10.1038/nature04727; Horvath JE, 2005, GENOME RES, V15, P914, DOI 10.1101/gr.3916405; Kreitman M, 2000, ANNU REV GENOM HUM G, V1, P539, DOI 10.1146/annurev.genom.1.1.539; Malcom CM, 2003, MOL BIOL EVOL, V20, P1633, DOI 10.1093/molbev/msg178; Ohno S, 1970, EVOLUTION GENE GENOM; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Sikela JM, 2006, PLOS GENET, V2, P646, DOI 10.1371/journal.pgen.0020080; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; SWOFFORD DL, 1998, PAUP VERSION 4; Vandepoele K, 2005, MOL BIOL EVOL, V22, P2265, DOI 10.1093/molbev/msi222; Verde I, 2001, J BIOL CHEM, V276, P11189, DOI 10.1074/jbc.M006546200; Wilson GM, 2006, GENOME RES, V16, P173, DOI 10.1101/gr.4456006	20	142	147	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2006	313	5791					1304	1307		10.1126/science.1127980	http://dx.doi.org/10.1126/science.1127980			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16946073				2022-12-28	WOS:000240313500046
J	Hladik, W; Dollard, SC; Mermin, J; Fowlkes, AL; Downing, R; Amin, MM; Banage, F; Nzaro, E; Kataaha, P; Dondero, TJ; Pellett, PE; Lackritz, EM				Hladik, Wolfgang; Dollard, Sheila C.; Mermin, Jonathan; Fowlkes, Ashley L.; Downing, Robert; Amin, Minal M.; Banage, Flora; Nzaro, Esau; Kataaha, Peter; Dondero, Timothy J.; Pellett, Philip E.; Lackritz, Eve M.			Transmission of human herpesvirus 8 by blood transfusion	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; KAPOSIS-SARCOMA; SEROLOGIC ASSAYS; DNA-SEQUENCES; INFECTION; RISK; DONORS; AIDS; SEROPREVALENCE; PREVALENCE	Background: Whether human herpesvirus 8 (HHV-8) is transmissible by blood transfusion remains undetermined. We evaluated the risk of HHV-8 transmission by blood transfusion in Uganda, where HHV-8 is endemic. Methods: We enrolled patients in Kampala, Uganda, who had received blood transfusions between December 2000 and October 2001. Pretransfusion and multiple post-transfusion blood specimens from up to nine visits over a 6-month period were tested for HHV-8 antibody. We calculated the excess risk of seroconversion over time among recipients of HHV-8-seropositive blood as compared with recipients of seronegative blood. Results: Of the 1811 transfusion recipients enrolled, 991 were HHV-8-seronegative before transfusion and completed the requisite follow-up, 43% of whom received HHV-8-seropositive blood and 57% of whom received seronegative blood. HHV-8 seroconversion occurred in 41 of the 991 recipients. The risk of seroconversion was significantly higher among recipients of HHV-8-seropositive blood than among recipients of seronegative blood (excess risk, 2.8%; P < 0.05), and the increase in risk was seen mainly among patients in whom seroconversion occurred 3 to 10 weeks after transfusion (excess risk, 2.7%; P=0.005), a result consistent with the transmission of the virus by transfusion. Blood units stored for up to 4 days were more often associated with seroconversion than those stored for more than 4 days (excess risk, 4.2%; P < 0.05). Conclusions: This study provides strong evidence that HHV-8 is transmitted by blood transfusion. The risk may be diminished as the period of blood storage increases.	Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Global Acquired Immunodeficiency Syndrome Program, Natl Ctr Human Immunodeficiency Virus Sexually Tr, Entebbe, Uganda; Ctr Dis Control & Prevent, Global Acquired Immunodeficiency Syndrome Program, Natl Ctr Human Immunodeficiency Virus Sexually Tr, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA; Mulago Hosp, Kampala, Uganda; Nakasero Blood Bank, Kampala, Uganda; Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA	Centers for Disease Control & Prevention - USA; Uganda Virus Research Institute; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Mulago National Referral Hospital; Cleveland Clinic Foundation	Dollard, SC (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Infect Dis, Mailstop G-18,1600 Clifton Rd, Atlanta, GA 30333 USA.	sgd5@cdc.gov	Moore, Patrick S./F-3960-2011; Moore, Patrick/GVR-8294-2022; Parisi, Saverio G/C-6088-2009; cruciani, mario/A-3181-2012; Chang, Yuan/F-4146-2011	Moore, Patrick S./0000-0002-8132-858X; Chang, Yuan/0000-0003-1125-4041; Lackritz, Eve/0000-0002-5397-7291; Pellett, Philip/0000-0002-8536-8343				ADLER SP, 1989, TRANSFUSION, V29, P667, DOI 10.1046/j.1537-2995.1989.29890020436.x; Atkinson J, 2003, J INFECT DIS, V187, P974, DOI 10.1086/368332; Belec L, 1998, TRANSFUSION, V38, P771, DOI 10.1046/j.1537-2995.1998.38898375517.x; Bigoni B, 1996, J INFECT DIS, V173, P542, DOI 10.1093/infdis/173.3.542; Blackbourn DJ, 1997, LANCET, V349, P609, DOI 10.1016/S0140-6736(96)10004-0; Cannon MJ, 2001, NEW ENGL J MED, V344, P637, DOI 10.1056/NEJM200103013440904; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; COCKERILL FR, 1986, AM J MED, V80, P1237, DOI 10.1016/0002-9343(86)90695-9; DAVIS KC, 1983, ANN INTERN MED, V98, P284, DOI 10.7326/0003-4819-98-3-284; Dedicoat M, 2003, BRIT J CANCER, V88, P1, DOI 10.1038/sj.bjc.6600745; Dodd RY, 2005, TRANSFUSION, V45, P463, DOI 10.1111/j.0041-1132.2005.05008.x; Dollard SC, 2005, TRANSFUSION, V45, P500, DOI 10.1111/j.0041-1132.2005.04334.x; Engels EA, 1999, J NATL CANCER I, V91, P1773, DOI 10.1093/jnci/91.20.1773; Henke-Gendo C, 2004, CURR OPIN INFECT DIS, V17, P53, DOI 10.1097/00001432-200402000-00011; Hladik W, 2003, JAIDS-J ACQ IMM DEF, V33, P206, DOI 10.1097/00126334-200306010-00015; Lefrere JJ, 1997, LANCET, V350, P217, DOI 10.1016/S0140-6736(05)62382-3; Lennette ET, 1996, LANCET, V348, P858, DOI 10.1016/S0140-6736(96)03240-0; Marcelin AG, 1998, AIDS, V12, P2351; Marchioli CC, 1996, J CLIN MICROBIOL, V34, P2635, DOI 10.1128/JCM.34.10.2635-2638.1996; Mbulaiteye SM, 2003, J NATL CANCER I, V95, P1330, DOI 10.1093/jnci/djg039; Offner PJ, 2004, CRIT CARE, V8, pS24, DOI 10.1186/cc2405; Operskalski EA, 1997, LANCET, V349, P1327, DOI 10.1016/S0140-6736(05)62544-5; Parravicini C, 1997, BLOOD, V90, P2826; Pau CP, 1998, J CLIN MICROBIOL, V36, P1574, DOI 10.1128/JCM.36.6.1574-1577.1998; Pellett PE, 2003, TRANSFUSION, V43, P1260, DOI 10.1046/j.1537-2995.2003.00490.x; Pfeiffer RM, 2004, BIOMETRICS, V60, P249, DOI 10.1111/j.0006-341X.2004.00168.x; Pierrotti LC, 2000, J CLIN VIROL, V16, P247, DOI 10.1016/S1386-6532(99)00078-5; Regamey N, 1998, NEW ENGL J MED, V339, P1358, DOI 10.1056/NEJM199811053391903; Spira TJ, 2000, J CLIN MICROBIOL, V38, P2174; Velez-Garcia E, 1984, AIDS Res, V1, P401; VELEZGARCIA E, 1985, NEW ENGL J MED, V312, P648; WHITBY D, 1995, LANCET, V346, P799, DOI 10.1016/S0140-6736(95)91619-9	32	125	140	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2006	355	13					1331	1338		10.1056/NEJMoa055009	http://dx.doi.org/10.1056/NEJMoa055009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088EF	17005950				2022-12-28	WOS:000240793600006
J	Bryce, J; Terreri, N; Victora, CG; Mason, E; Daelmans, B; Bhutta, ZA; Bustreo, F; Songane, F; Salama, P; Wardlaw, T				Bryce, Jennifer; Terreri, Nancy; Victora, Cesar G.; Mason, Elizabeth; Daelmans, Bernadette; Bhutta, Zulfiqar A.; Bustreo, Flavia; Songane, Francisco; Salama, Peter; Wardlaw, Tessa			Countdown to 2015: tracking intervention coverage for child survival	LANCET			English	Article							DEATHS; HEALTH; COUNTRIES; MORTALITY	Background The fourth Millennium Development Goal (MDG) calls for a two-thirds' reduction between 1990 and 2015 in deaths of children younger than five years; achieving this will require widespread use of effective interventions, especially in poor countries. We present the first report of the Child Survival Countdown, a worldwide effort to monitor coverage of key child-survival interventions in 60 countries with the worlds highest numbers or rates of child mortality. Methods In 2005, we developed a profile for each of the 60 countries to summarise information on coverage with essential child survival interventions. The profiles also present information on demographics, nutritional status, major causes of death in children under 5 years of age, and the status of selected health policies. Progress toward the fourth MDG is summarised by comparing the average annual rate of reduction in under-5 mortality in each country with that needed to achieve the goal. The profiles also include a comparison of the proportions of children in the poorest and richest quintiles of the population who received six or more essential prevention interventions. Each country's progress (as measured by defined indicators of intervention coverage) was put into one of three groups created on the basis of international targets: "on track"; "watch and act"; and "high alert". For indicators without targets, arbitrary thresholds for high, middle, and low performance across the 60 countries were used as a basis for categorisation. Findings Only seven countries are on track to met MDG-4, 39 countries are making some progress, although they need to accelerate the speed, and 14 countries are cause for serious concern. Coverage of the key child survival interventions remains critically low, although some countries have made substantial improvements in increasing the proportion of mothers and children with access to life saving interventions by as much as ten percentage points in 2 years. Children from the poorest families were less likely than those from wealthier families to have received at least six essential prevention interventions. Interpretation Our results show that tremendous efforts are urgently needed to achieve the MDG for child survival. Profiles for each country show where efforts need to be intensified, and highlight the extent to which prevention interventions are being delivered equitably and reaching poor families. This first report also shows country-specific improvements in coverage and highlights missed opportunities. The "Countdown to 2015" will report on progress every 2 years as a strategy for increasing accountability worldwide for progress in child survival.	UNICEF, Programme Div, Hlth Sect, New York, NY 10017 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; Univ Fed Pelotas, Pelotas, Brazil; WHO, Dept Child & Adolescent Hlth & Dev, CH-1211 Geneva, Switzerland; Aga Khan Univ, Karachi, Pakistan; World Bank, Washington, DC 20433 USA; Partnership Maternal Newborn & Child Hlth, Geneva, Switzerland; UNICEF, Div Policy & Planning, New York, NY USA	UNICEF; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidade Federal de Pelotas; University of Geneva; World Health Organization; Aga Khan University; The World Bank; UNICEF	Terreri, N (corresponding author), UNICEF, Programme Div, Hlth Sect, United Nations Plaza, New York, NY 10017 USA.	nterreri@unicef.org	Victora, Cesar G/D-4476-2013; Victora, Cesar Gomes/Y-2455-2019	Victora, Cesar G/0000-0002-2465-2180; Victora, Cesar Gomes/0000-0002-2465-2180				[Anonymous], 2005, STAT WORLDS CHILDR 2; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Hill K, 2006, B WORLD HEALTH ORGAN, V84, P225, DOI 10.2471/BLT.05.029744; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Morris SS, 2003, INT J EPIDEMIOL, V32, P1041, DOI 10.1093/ije/dyg241; POWELLJACKSON T, 2006, LANCET          0918, DOI DOI 10.1016/S0140-6736(06)69334-3; *ROLL BACK MAL PAR, GLOB STRAT PLAN ROLL; Starfield B, 2001, J EPIDEMIOL COMMUN H, V55, P452, DOI 10.1136/jech.55.7.452; UN, MILL DEV GOALS; *UNICEF, 2005, PMTCT REP CARD 2005; *UNICEF, 2004, UNICEF WHO M CHILD S; *UNICEF, WORLD FIT CHILDR; UNICEF, 2006, VIT MIN DEF GLOB PRO; United Nations, UN MILL DECL; Victora CG, 2000, B WORLD HEALTH ORGAN, V78, P1246; Victora CG, 2005, LANCET, V366, P1460, DOI 10.1016/S0140-6736(05)67599-X; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; WARDLAW T, 2006, LANCET          0918, DOI DOI 10.1016/S0140-6736(06)69334-3; *WHO, WORLD HLTH STAT 2006; WHO, 2002, WHOFCHCAH0223; *WHO UNICEF, CONS M ASS MON VACC; *WHO UNICEF, WHO UNICEF JOINT STA; *WHO UNICEF, 2005, GLOB IMM VIS STRAT; WHO UNICEF, 2005, WORLD MAL REP 2005; World Health Organization, 2000, INTR HAEM INFL TYP B; World Health Organization, 2005, WORLD HLTH REP 2005; TRACKING PROGR CHILD; WORLD SUMM CHILDR 20	32	153	156	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2006	368	9541					1067	1076		10.1016/S0140-6736(06)69339-2	http://dx.doi.org/10.1016/S0140-6736(06)69339-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089IC	16997661				2022-12-28	WOS:000240873000022
J	Gelfand, AA				Gelfand, Amy A.			Triggers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												GelfandA@peds.ucsf.edu	Gelfand, Amy/P-9386-2019	Gelfand, Amy/0000-0002-0911-7905				Frederiks J A, 1997, J Hist Neurosci, V6, P147	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2006	296	10					1211	1212		10.1001/jama.296.10.1211	http://dx.doi.org/10.1001/jama.296.10.1211			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083EA	16968834				2022-12-28	WOS:000240437500001
J	Kraemer, HC; Frank, E; Kupfer, DJ				Kraemer, Helena C.; Frank, Ellen; Kupfer, David J.			Moderators of treatment outcomes - Clinical, research, and policy importance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS; ESTROGEN PLUS PROGESTIN; CONSORT STATEMENT; POSTMENOPAUSAL WOMEN		Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Dept Psychiat, Pittsburgh, PA USA	Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC	Kraemer, HC (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, 401 Quarry Rd, Stanford, CA 94305 USA.	hck@stanford.edu			NIA NIH HHS [AG 17824] Funding Source: Medline; NIMH NIH HHS [MH 29618, MH 65376, MH 39015] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065376, R01MH029618, R37MH029618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG017824] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; ESSEX MJ, IN PRESS ARCH GEN PS; Humphreys K, 2005, ADDICTION, V100, P1249, DOI 10.1111/j.1360-0443.2005.01175.x; KRAEMER HC, 1979, BEHAV THER, V10, P615, DOI 10.1016/S0005-7894(79)80065-9; Kraemer HC, 2005, CONTEMP CLIN TRIALS, V26, P518, DOI 10.1016/j.cct.2005.05.002; Kraemer HC, 2001, AM J PSYCHIAT, V158, P848, DOI 10.1176/appi.ajp.158.6.848; Kraemer HC, 2006, BIOL PSYCHIAT, V59, P990, DOI 10.1016/j.biopsych.2005.09.014; Kravitz RL, 2004, MILBANK Q, V82, P661, DOI 10.1111/j.0887-378X.2004.00327.x; Maki PM, 2006, NEUROSCIENCE, V138, P1027, DOI 10.1016/j.neuroscience.2006.01.001; MCKINLAY SM, 1977, BIOMETRICS, V33, P725, DOI 10.2307/2529471; Meinert CL., 1986, CLIN TRIALS DESIGN C; Moffitt TE, 2005, ARCH GEN PSYCHIAT, V62, P473, DOI 10.1001/archpsyc.62.5.473; Owens EB, 2003, J CONSULT CLIN PSYCH, V71, P540, DOI 10.1037/0022-006X.71.3.540; Rennie D, 1996, JAMA-J AM MED ASSOC, V276, P649, DOI 10.1001/jama.276.8.649; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Smeraldi E, 1998, MOL PSYCHIATR, V3, P508, DOI 10.1038/sj.mp.4000425	20	207	207	2	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2006	296	10					1286	1289		10.1001/jama.296.10.1286	http://dx.doi.org/10.1001/jama.296.10.1286			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083EA	16968853				2022-12-28	WOS:000240437500032
J	Schulze-Lefert, P; Robatzek, S				Schulze-Lefert, Paul; Robatzek, Silke			Plant pathogens trick guard cells into opening the gates	CELL			English	Editorial Material							DISEASE RESISTANCE; ARABIDOPSIS; EVOLUTION; TOMATO; ACID	The stomata of plants regulate gas exchange and water transpiration in response to changing environmental conditions. New work reveals that stomata also have an important role in host defense. In this issue of Cell, Melotto et al. (2006) show that stomata close upon detection of potential microbial pathogens to prevent the infection of the leaf interior. Moreover, pathogenic bacteria have evolved strategies to suppress the closure of stomata.	Max Planck Inst Zuchtungsforsch, D-50829 Cologne, Germany	Max Planck Society	Schulze-Lefert, P (corresponding author), Max Planck Inst Zuchtungsforsch, Carl von Linne Weg 10, D-50829 Cologne, Germany.	schlef@mpiz-koeln.mpg.de	Robatzek, Silke/B-6844-2013; Schulze-Lefert, Paul/A-7746-2008; Schulze-Lefert, Paul/B-6707-2011					Assmann SM, 2003, TRENDS PLANT SCI, V8, P151, DOI 10.1016/S1360-1385(03)00052-9; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Dong XN, 2004, CURR OPIN PLANT BIOL, V7, P547, DOI 10.1016/j.pbi.2004.07.005; Ellis J, 2006, PLANT CELL, V18, P523, DOI 10.1105/tpc.105.040584; Lee S, 1999, PLANT PHYSIOL, V121, P147, DOI 10.1104/pp.121.1.147; MITTAL S, 1995, MOL PLANT MICROBE IN, V8, P165, DOI 10.1094/MPMI-8-0165; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Suhita D, 2004, PLANT PHYSIOL, V134, P1536, DOI 10.1104/pp.103.032250; Yao J, 2006, J BACTERIOL, V188, P3697, DOI 10.1128/JB.188.10.3697-3708.2006; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	10	33	34	3	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2006	126	5					831	834		10.1016/j.cell.2006.08.020	http://dx.doi.org/10.1016/j.cell.2006.08.020			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959560	Bronze, Green Published			2022-12-28	WOS:000240675000008
J	Nguyen, JS; Marinopoulos, SS; Ashar, BH; Flynn, JA				Nguyen, John S.; Marinopoulos, Spyridon S.; Ashar, Bimal H.; Flynn, John A.			More than meets the eye	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; ACUTE-RENAL-FAILURE; INTRAVASCULAR HEMOLYSIS		Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University	Marinopoulos, SS (corresponding author), 601 N Caroline St,Suite 7143, Baltimore, MD 21287 USA.	smarino1@jhmi.edu						Brodsky RA, 2000, AM J CLIN PATHOL, V114, P459, DOI 10.1093/ajcp/114.3.459; Chow KM, 2001, AM J KIDNEY DIS, V37, DOI 10.1053/ajkd.2001.21361; CLARK DA, 1981, BLOOD, V57, P83; DACIE J V, 1972, Series Haematologica, V5, P3; De Vriese AS, 1998, AM J KIDNEY DIS, V31, P108, DOI 10.1053/ajkd.1998.v31.pm9428460; Hillmen P, 2004, NEW ENGL J MED, V350, P552, DOI 10.1056/NEJMoa031688; MALHOTRA KK, 1978, AM J TROP MED HYG, V27, P623, DOI 10.4269/ajtmh.1978.27.623; Moyo VM, 2004, BRIT J HAEMATOL, V126, P133, DOI 10.1111/j.1365-2141.2004.04992.x; ONWUBALILI JK, 1988, T ROY SOC TROP MED H, V82, P482, DOI 10.1016/0035-9203(88)90171-X; Parab R B, 1990, J Postgrad Med, V36, P23; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; RUBIN H, 1971, J AMER MED ASSOC, V215, P433, DOI 10.1001/jama.215.3.433; TAKAHASHI H, 1979, SCAND J HAEMATOL, V23, P169; TRANG TTM, 1992, CLIN INFECT DIS, V15, P874, DOI 10.1093/clind/15.5.874; WOOLF DCS, 1990, S AFR MED J, V77, P213	15	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 7	2006	355	10					1048	1052		10.1056/NEJMcps044359	http://dx.doi.org/10.1056/NEJMcps044359			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080UF	16957151				2022-12-28	WOS:000240273300012
J	Squyres, SW; Aharonson, O; Arvidson, RE; Bell, JF; Christensen, PR; Clark, BC; Crisp, JA; Farrand, W; Glotch, T; Golombek, MP; Grant, J; Grotzinger, J; Herkenhoff, KE; Johnson, JR; Jolliff, BL; Knoll, AH; McLennan, SM; McSween, HY; Moore, JM; Rice, JW; Tosca, N				Squyres, S. W.; Aharonson, O.; Arvidson, R. E.; Bell, J. F., III; Christensen, P. R.; Clark, B. C.; Crisp, J. A.; Farrand, W.; Glotch, T.; Golombek, M. P.; Grant, J.; Grotzinger, J.; Herkenhoff, K. E.; Johnson, J. R.; Jolliff, B. L.; Knoll, A. H.; McLennan, S. M.; McSween, H. Y.; Moore, J. M.; Rice, J. W., Jr.; Tosca, N.			Bedrock formation at Meridiani Planum	NATURE			English	Letter							BURNS FORMATION; MARS; ENVIRONMENT; DIAGENESIS		Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Lockheed Martin Corp, Littleton, CO 80127 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Space Sci Inst, Boulder, CO 80301 USA; Smithsonian Inst, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Harvard Univ, Bot Museum, Cambridge, MA 02138 USA; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	Cornell University; California Institute of Technology; Washington University (WUSTL); Arizona State University; Arizona State University-Tempe; Lockheed Martin; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Smithsonian Institution; United States Department of the Interior; United States Geological Survey; Harvard University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Squyres, SW (corresponding author), Cornell Univ, Dept Astron, Ithaca, NY 14853 USA.	squyres@astro.cornell.edu	Crisp, Joy/H-8287-2016; Johnson, Jeffrey R/F-3972-2015	Crisp, Joy/0000-0002-3202-4416; Johnson, Jeffrey R/0000-0002-5586-4901; McLennan, Scott/0000-0003-4259-7178; Tosca, Nicholas/0000-0003-4415-4231; Aharonson, Oded/0000-0001-9930-2495				Clark BC, 2005, EARTH PLANET SC LETT, V240, P73, DOI 10.1016/j.epsl.2005.09.040; Edgett K.S., 2005, MARS, V1, P5, DOI DOI 10.1555/MARS.2005.0002; Grotzinger JP, 2005, EARTH PLANET SC LETT, V240, P11, DOI 10.1016/j.epsl.2005.09.039; McCollom TM, 2005, NATURE, V438, P1129, DOI 10.1038/nature04390; McLennan SM, 2005, EARTH PLANET SC LETT, V240, P95, DOI 10.1016/j.epsl.2005.09.041; NESBITT HW, 1992, AM J SCI, V292, P740, DOI 10.2475/ajs.292.10.740; Squyres SW, 2005, EARTH PLANET SC LETT, V240, P1, DOI 10.1016/j.epsl.2005.09.038; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; Tosca NJ, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002218; Tosca NJ, 2005, EARTH PLANET SC LETT, V240, P122, DOI 10.1016/j.epsl.2005.09.042	11	17	17	2	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2006	443	7107					E1	E2		10.1038/nature05212	http://dx.doi.org/10.1038/nature05212			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16957684				2022-12-28	WOS:000240313900033
J	Smellie, WSA; Ryder, SD				Smellie, W. Stuart A.; Ryder, Stephen			Cases in primary care laboratory medicine - Biochemical "liver function tests"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHEMISTRY TESTS		Gen Hosp, Clin Lab, Bishop Auckland DL14 6AD, England; Queens Med Ctr, Dept Gastroenterol, Nottingham NG7 2UH, England	University of Nottingham	Smellie, WSA (corresponding author), Gen Hosp, Clin Lab, Bishop Auckland DL14 6AD, England.	info@smellie.com		Ryder, Stephen David/0000-0001-9649-4444				Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Dubois-Laforgue D, 2000, DIABETES METAB, V26, P318; Green RM, 2002, GASTROENTEROLOGY, V123, P1367, DOI 10.1053/gast.2002.36061; Hoagland R J, 1975, Prim Care, V2, P295; HULTCRANTZ R, 1986, SCAND J GASTROENTERO, V21, P109, DOI 10.3109/00365528609034632; Lichtenstein GR, 2002, GASTROENTEROLOGY, V123, P1364, DOI 10.1053/gast.2002.36060; Skelly MM, 2001, J HEPATOL, V35, P195, DOI 10.1016/S0168-8278(01)00094-0; SMELLIE WSA, 2006, J CLIN PATHOL   0705; TOMSEN HF, 1981, SCAND J GASTROENTERO, V16, P699	9	2	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2006	333	7566					481	483		10.1136/bmj.333.7566.481	http://dx.doi.org/10.1136/bmj.333.7566.481			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085QP	16946336	Green Published			2022-12-28	WOS:000240618900021
J	Stock, JM				Stock, Joann M.			The Hawaiian-Emperor Bend: Older than expected	SCIENCE			English	Editorial Material							HOTSPOT PLUME; PLATE MOTION; PACIFIC; AGE		CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology	Stock, JM (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	jstock@gps.caltech.edu	Stock, Joann Miriam/AAN-1526-2021	Stock, Joann Miriam/0000-0003-4816-7865				ATWATER T, 1989, E PACIFIC OCEAN HAWA, P21, DOI DOI 10.1130/DNAG-GNA-N.21; Bianco TA, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000945; Clague DA, 1987, VOLCANISM HAWAII, V1350, P5; Cosca MA, 1998, ISL ARC, V7, P579, DOI 10.1046/j.1440-1738.1998.00211.x; DALRYMPLE GB, 1976, EARTH PLANET SC LETT, V31, P313, DOI 10.1016/0012-821X(76)90113-8; Duncan RA, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000704; Gurnis M, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000681; Kerr BC, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000705; NORTON IO, 1995, TECTONICS, V14, P1080, DOI 10.1029/95TC01256; Pares JM, 2005, EARTH PLANET SC LETT, V237, P951, DOI 10.1016/j.epsl.2005.06.012; Raymond C. A., 2000, GEOPHYS MONOGR SER, V121, P359; Richards MA, 1996, EARTH PLANET SC LETT, V137, P19, DOI 10.1016/0012-821X(95)00209-U; Sharp WD, 2006, SCIENCE, V313, P1281, DOI 10.1126/science.1128489; Steinberger B, 2004, NATURE, V430, P167, DOI 10.1038/nature02660; Tarduno JA, 2003, SCIENCE, V301, P1064, DOI 10.1126/science.1086442	15	2	3	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2006	313	5791					1250	1251		10.1126/science.1131789	http://dx.doi.org/10.1126/science.1131789			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16946060				2022-12-28	WOS:000240313500029
J	Soderberg, AM; Kulkarni, SR; Nakar, E; Berger, E; Cameron, PB; Fox, DB; Frail, D; Gal-Yam, A; Sari, R; Cenko, SB; Kasliwal, M; Chevalier, RA; Piran, T; Price, PA; Schmidt, BP; Pooley, G; Moon, DS; Penprase, BE; Ofek, E; Rau, A; Gehrels, N; Nousek, JA; Burrows, DN; Persson, SE; McCarthy, PJ				Soderberg, A. M.; Kulkarni, S. R.; Nakar, E.; Berger, E.; Cameron, P. B.; Fox, D. B.; Frail, D.; Gal-Yam, A.; Sari, R.; Cenko, S. B.; Kasliwal, M.; Chevalier, R. A.; Piran, T.; Price, P. A.; Schmidt, B. P.; Pooley, G.; Moon, D. -S.; Penprase, B. E.; Ofek, E.; Rau, A.; Gehrels, N.; Nousek, J. A.; Burrows, D. N.; Persson, S. E.; McCarthy, P. J.			Relativistic ejecta from X-ray flash XRF 060218 and the rate of cosmic explosions	NATURE			English	Article							25 APRIL 1998; UNUSUAL SUPERNOVA; BURST; PROGENITORS; GRB-980425; LUMINOSITY; EMISSION; PULSAR	Over the past decade, long-duration gamma-ray bursts (GRBs) - including the subclass of X-ray flashes (XRFs) - have been revealed(1-3) to be a rare variety of type Ibc supernova. Although all these events result from the death of massive stars, the electromagnetic luminosities of GRBs and XRFs exceed those of ordinary type Ibc supernovae by many orders of magnitude. The essential physical process that causes a dying star to produce a GRB or XRF, and not just a supernova, is still unknown. Here we report radio and X-ray observations of XRF 060218 ( associated(4) with supernova SN 2006aj), the second-nearest(5,6) GRB identified until now. We show that this event is a hundred times less energetic but ten times more common than cosmological GRBs. Moreover, it is distinguished from ordinary type Ibc supernovae by the presence of 10(48) erg coupled to mildly relativistic ejecta, along with a central engine ( an accretion-fed, rapidly rotating compact source) that produces X-rays for weeks after the explosion. This suggests that the production of relativistic ejecta is the key physical distinction between GRBs or XRFs and ordinary supernovae, while the nature of the central engine ( black hole or magnetar) may distinguish typical bursts from low-luminosity, spherical events like XRF 060218.	CALTECH, Caltech Opt Observ 105 24, Pasadena, CA 91125 USA; CALTECH, Space Radiat Lab 220 47, Pasadena, CA 91125 USA; Carnegie Observ, Pasadena, CA 91101 USA; Penn State Univ, Dept Astron, University Pk, PA 16802 USA; Natl Radio Astron Observ, Socorro, NM 87801 USA; Univ Virginia, Dept Astron, Charlottesville, VA 22903 USA; Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; ANU, Mt Stromlo Observ, RSAA, Weston, ACT 2611, Australia; Univ Cambridge, Cavendish Lab, Mullard Radio Astron Observ, Cambridge CB3 0HE, England; Pomona Coll, Dept Phys & Astron, Claremont, CA 91711 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	California Institute of Technology; California Institute of Technology; Carnegie Institution for Science; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Radio Astronomy Observatory (NRAO); University of Virginia; Hebrew University of Jerusalem; University of Hawaii System; Australian National University; University of Cambridge; Claremont Colleges; Pomona College; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Soderberg, AM (corresponding author), CALTECH, Caltech Opt Observ 105 24, Pasadena, CA 91125 USA.	ams@astro.caltech.edu	Gehrels, Neil/D-2971-2012	Fox, Derek/0000-0002-3714-672X; Nakar, Ehud/0000-0002-4534-7089; Schmidt, Brian/0000-0002-8538-9195; Schmidt, Brian/0000-0001-6589-1287				Baron E, 1999, ASTROPHYS J, V527, P739, DOI 10.1086/308107; Berger E, 2003, ASTROPHYS J, V599, P408, DOI 10.1086/379214; Berger E, 2003, NATURE, V426, P154, DOI 10.1038/nature01998; Campana S, 2006, NATURE, V442, P1008, DOI 10.1038/natureO4892; Cappellaro E, 1999, ASTRON ASTROPHYS, V351, P459; Chevalier RA, 1998, ASTROPHYS J, V499, P810, DOI 10.1086/305676; Dahlen T, 2004, ASTROPHYS J, V613, P189, DOI 10.1086/422899; DELUCA A, 2006, 4853 GRB; Gaensler BM, 2005, ASTROPHYS J, V620, pL95, DOI 10.1086/428725; Galama TJ, 1998, NATURE, V395, P670, DOI 10.1038/27150; Granot J, 2002, ASTROPHYS J, V568, P820, DOI 10.1086/338966; Heise J, 2001, ESO ASTROPHY SYMP, P16, DOI 10.1007/10853853_4; Hurley K, 2005, NATURE, V434, P1098, DOI 10.1038/nature03519; Kulkarni SR, 1998, NATURE, V395, P663, DOI 10.1038/27139; Lyne AG, 1996, NATURE, V381, P497, DOI 10.1038/381497a0; MALESANI D, 2004, APJ, V609, P5; Matheson T, 2003, ASTROPHYS J, V599, P394, DOI 10.1086/379228; MAZZALI PA, NATURE, DOI DOI 10.1038/NATURE05081; MIRABAL N, 2006, UNPUB ASTROPHYS J; Pian E, 2006, NATURE, V442, P1011, DOI 10.1038/nature05082; Sari R, 1999, ASTROPHYS J, V519, pL17, DOI 10.1086/312109; Sazonov SY, 2004, NATURE, V430, P646, DOI 10.1038/nature02748; Schmidt M, 2001, ASTROPHYS J, V552, P36, DOI 10.1086/320450; Soderberg AM, 2006, ASTROPHYS J, V638, P930, DOI 10.1086/499121; Soderberg AM, 2004, NATURE, V430, P648, DOI 10.1038/nature02757; Soderberg AM, 2004, ASTROPHYS J, V606, P994, DOI 10.1086/383082; Tan JC, 2001, ASTROPHYS J, V551, P946, DOI 10.1086/320245; USOV VV, 1992, NATURE, V357, P472, DOI 10.1038/357472a0; Waxman E, 2004, ASTROPHYS J, V602, P886, DOI 10.1086/381230	30	407	411	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2006	442	7106					1014	1017		10.1038/nature05087	http://dx.doi.org/10.1038/nature05087			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	078YF	16943832	Green Submitted			2022-12-28	WOS:000240142000043
J	Woo, B				Woo, Beverly			Becoming a physician: Primary care - The best job in medicine?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Woo, B (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.							Dorsey ER, 2005, ACAD MED, V80, P791, DOI 10.1097/00001888-200509000-00002; Garibaldi RA, 2005, ACAD MED, V80, P507, DOI 10.1097/00001888-200505000-00021; Safran DG, 2003, ANN INTERN MED, V138, P248, DOI 10.7326/0003-4819-138-3-200302040-00033; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x	4	32	35	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2006	355	9					864	866		10.1056/NEJMp068154	http://dx.doi.org/10.1056/NEJMp068154			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	078OM	16943397				2022-12-28	WOS:000240113100002
J	Bousquet, P; Ciais, P; Miller, JB; Dlugokencky, EJ; Hauglustaine, DA; Prigent, C; Van der Werf, GR; Peylin, P; Brunke, EG; Carouge, C; Langenfelds, RL; Lathiere, J; Papa, F; Ramonet, M; Schmidt, M; Steele, LP; Tyler, SC; White, J				Bousquet, P.; Ciais, P.; Miller, J. B.; Dlugokencky, E. J.; Hauglustaine, D. A.; Prigent, C.; Van der Werf, G. R.; Peylin, P.; Brunke, E. -G.; Carouge, C.; Langenfelds, R. L.; Lathiere, J.; Papa, F.; Ramonet, M.; Schmidt, M.; Steele, L. P.; Tyler, S. C.; White, J.			Contribution of anthropogenic and natural sources to atmospheric methane variability	NATURE			English	Article							INTERANNUAL GROWTH-RATE; ISOTOPIC COMPOSITION; CH4; EMISSIONS; TRANSPORT; AIR; CO2; INVERSION; PINATUBO; PERIOD	Methane is an important greenhouse gas, and its atmospheric concentration has nearly tripled since pre-industrial times(1). The growth rate of atmospheric methane is determined by the balance between surface emissions and photochemical destruction by the hydroxyl radical, the major atmospheric oxidant. Remarkably, this growth rate has decreased(2) markedly since the early 1990s, and the level of methane has remained relatively constant since 1999, leading to a downward revision of its projected influence on global temperatures. Large fluctuations in the growth rate of atmospheric methane are also observed from one year to the next(2), but their causes remain uncertain(2-13). Here we quantify the processes that controlled variations in methane emissions between 1984 and 2003 using an inversion model of atmospheric transport and chemistry. Our results indicate that wetland emissions dominated the inter-annual variability of methane sources, whereas fire emissions played a smaller role, except during the 1997 - 1998 El Nino event. These top-down estimates of changes in wetland and fire emissions are in good agreement with independent estimates based on remote sensing information and biogeochemical models. On longer timescales, our results show that the decrease in atmospheric methane growth during the 1990s was caused by a decline in anthropogenic emissions. Since 1999, however, they indicate that anthropogenic emissions of methane have risen again. The effect of this increase on the growth rate of atmospheric methane has been masked by a coincident decrease in wetland emissions, but atmospheric methane levels may increase in the near future if wetland emissions return to their mean 1990s levels.	UVSQ, CNRS, CEA, IPSL,LSCE, F-91191 Gif Sur Yvette, France; Univ Versailles, F-78035 Versailles, France; NOAA, Earth Syst Res Lab, Global Monitoring Div, Boulder, CO 80305 USA; Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; Observ Paris, LERMA, F-75014 Paris, France; Vrije Univ Amsterdam, Fac Earth & Life Sci, Amsterdam, Netherlands; LBI, F-78026 Versailles, France; S African Weather Serv, ZA-7599 Stellenbosch, South Africa; CSIRO, Mordialloc, Vic 3195, Australia; Columbia Univ, NASA, GISS, New York, NY 10025 USA; Univ Calif Irvine, Earth Syst Sci Dept, Irvine, CA 92697 USA; Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA	UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Vrije Universiteit Amsterdam; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Columbia University; National Aeronautics & Space Administration (NASA); University of California System; University of California Irvine; University of Colorado System; University of Colorado Boulder	Bousquet, P (corresponding author), UVSQ, CNRS, CEA, IPSL,LSCE, F-91191 Gif Sur Yvette, France.	philippe.bousquet@cea.fr	Hauglustaine, Didier/A-4154-2012; Papa, Fabrice/D-3695-2009; van der Werf, Guido/M-8260-2016; LATHIERE, Juliette/GPG-3400-2022; Miller, John B./AAE-7714-2019; Schmidt, Martina/Q-6627-2017; Langenfelds, Raymond L/B-5381-2012; White, James W.C./A-7845-2009; Steele, Paul/B-3185-2009; Ciais, Philippe/A-6840-2011; Dlugokencky, Edward/AAN-8746-2020; Prigent, Catherine/ABF-7175-2020; Carouge, Claire/A-4755-2012	Hauglustaine, Didier/0000-0002-4826-5118; Papa, Fabrice/0000-0001-6305-6253; van der Werf, Guido/0000-0001-9042-8630; Miller, John B./0000-0001-8630-1610; Schmidt, Martina/0000-0002-4648-769X; Langenfelds, Raymond L/0000-0003-4890-2049; White, James W.C./0000-0001-6041-4684; Steele, Paul/0000-0002-8234-3730; Ciais, Philippe/0000-0001-8560-4943; Dlugokencky, Edward/0000-0003-0612-6985; Carouge, Claire/0000-0002-0313-8385; Peylin, Philippe/0000-0001-9335-6994; Bousquet, Philippe/0000-0002-4444-2703				Bergamaschi P, 2005, ATMOS CHEM PHYS, V5, P2431, DOI 10.5194/acp-5-2431-2005; Bousquet P, 2000, SCIENCE, V290, P1342, DOI 10.1126/science.290.5495.1342; Bousquet P, 2005, ATMOS CHEM PHYS, V5, P2635, DOI 10.5194/acp-5-2635-2005; Butler TM, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006071; Chen YH, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006058; Dentener F, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002916; DLUGOKENCKY EJ, 1994, GEOPHYS RES LETT, V21, P507, DOI 10.1029/94GL00606; Dlugokencky EJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018126; Dlugokencky EJ, 1996, GEOPHYS RES LETT, V23, P2761, DOI 10.1029/96GL02638; DLUGOKENCKY EJ, 1994, J GEOPHYS RES-ATMOS, V99, P17021, DOI 10.1029/94JD01245; Fletcher SEM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002223; *GLOBALVIEW CH4, 2005, COOP ATM DAT INT PRO; Gurney KR, 2002, NATURE, V415, P626, DOI 10.1038/415626a; Hansen J, 1996, GEOPHYS RES LETT, V23, P1665, DOI 10.1029/96GL01040; Hauglustaine DA, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003957; Hein R, 1997, GLOBAL BIOGEOCHEM CY, V11, P43, DOI 10.1029/96GB03043; Hoerling M, 2003, SCIENCE, V299, P691, DOI 10.1126/science.1079053; Houghton J. T., 2001, CLIMATE CHANGE 2001; Keppler F, 2006, NATURE, V439, P187, DOI 10.1038/nature04420; Langenfelds RL, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001466; Manning MR, 2005, NATURE, V436, P1001, DOI 10.1038/nature03900; Miller JB, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000630; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Prigent C, 2001, GEOPHYS RES LETT, V28, P4631, DOI 10.1029/2001GL013263; Quay P, 1999, GLOBAL BIOGEOCHEM CY, V13, P445, DOI 10.1029/1998GB900006; Rodenbeck C, 2003, ATMOS CHEM PHYS, V3, P1919; Simmonds PG, 2005, ATMOS ENVIRON, V39, P2513, DOI 10.1016/j.atmosenv.2005.02.018; Tyler SC, 1999, J GEOPHYS RES-ATMOS, V104, P13895, DOI 10.1029/1999JD900029; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; van der Werf GR, 2004, SCIENCE, V303, P73, DOI 10.1126/science.1090753; Walter BP, 2001, J GEOPHYS RES-ATMOS, V106, P34207, DOI 10.1029/2001JD900164; Wang JS, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002180; Warwick NJ, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015282	33	643	684	16	365	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2006	443	7110					439	443		10.1038/nature05132	http://dx.doi.org/10.1038/nature05132			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	17006511				2022-12-28	WOS:000240798800042
J	Stafford, N				Stafford, Ned			Turbulent times	NATURE			English	News Item																			0	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2006	443	7110					385	385		10.1038/443385a	http://dx.doi.org/10.1038/443385a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	17006487	Bronze			2022-12-28	WOS:000240798800013
J	Rodriguez, B; Sethi, AK; Cheruvu, VK; Mackay, W; Bosch, RJ; Kitahata, M; Boswell, SL; Mathews, WC; Bangsberg, DR; Martin, J; Whalen, CC; Sieg, S; Yadavalli, S; Deeks, SG; Lederman, MM				Rodriguez, Benigno; Sethi, Ajay K.; Cheruvu, Vinay K.; Mackay, Wilma; Bosch, Ronald J.; Kitahata, Mari; Boswell, Stephen L.; Mathews, W. Christopher; Bangsberg, David R.; Martin, Jeffrey; Whalen, Christopher C.; Sieg, Scott; Yadavalli, Suhrida; Deeks, Steven G.; Lederman, Michael M.			Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; TYPE-1 RNA; VIRAL LOAD; HIV-1-INFECTED PATIENTS; IMMUNE ACTIVATION; PROGNOSTIC VALUE; CONTROLLED-TRIAL; SAN-FRANCISCO; TENOFOVIR DF	Context Plasma human immunodeficiency virus (HIV) RNA level predicts HIV disease progression, but the extent to which it explains the variability in rate of CD4 cell depletion is poorly characterized. Objective To estimate the proportion of variability in rate of CD4 cell loss predicted by presenting plasma HIV RNA levels in untreated HIV-infected persons. Design Repeated-measures analyses of 2 multicenter cohorts, comprising observations beginning on May 12, 1984, and ending on August 26, 2004. Analyses were conducted between August 2004 and March 2006. Setting Two cohorts of HIV-infected persons: patients followed up at 4 US teaching medical institutions or participating in either the Research in Access to Care for the Homeless Cohort (REACH) or the San Francisco Men's Health Study (SFMHS) cohorts and participants in the Multicenter AIDS Cohort Study (MACS) cohort. Participants Antiretroviral treatment-naive, chronically HIV-infected persons (n = 1289 and n = 1512 for each of the 2 cohorts) untreated during the observation period (>= 6 months) and with at least 1 HIV RNA level and 2 CD4 cell counts available. Approximately 35% were nonwhite, and 35% had risk factors other than male-to-male sexual contact. Main Outcome Measures The extent to which presenting plasma HIV RNA level could explain the rate of model-derived yearly CD4 cell loss, as estimated by the coefficient of determination (R-2). Results In both cohorts, higher presenting HIV RNA levels were associated with greater subsequent CD4 cell decline. In the study cohort, median model-estimated CD4 cell decrease among participants with HIV RNA levels of 500 or less, 501 to 2000, 2001 to 10 000, 10 001 to 40 000, and more than 40 000 copies/mL were 20, 39, 48, 56, and 78 cells/mu L, respectively. Despite this trend across broad categories of HIV RNA levels, only a small proportion of CD4 cell loss variability (4%-6%) could be explained by presenting plasma HIV RNA level. Analyses using multiple HIV RNA measurements or restricting to participants with high HIV RNA levels improved this correlation minimally (R-2, 0.09), and measurement error was estimated to attenuate these associations only marginally (deattenuated R-2 in the 2 cohorts, 0.05 and 0.08, respectively). Conclusions Presenting HIV RNA level predicts the rate of CD4 cell decline only minimally in untreated persons. Other factors, as yet undefined, likely drive CD4 cell losses in HIV infection. These findings have implications for treatment decisions in HIV infection and for understanding the pathogenesis of progressive immune deficiency.	Case Western Reserve Univ, Ctr AIDS Res, Cleveland, OH 44106 USA; Case Western Reserve Univ, Ctr Modern Epidemiol Infect Dis, Cleveland, OH 44106 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Univ Washington, Dept Med, Seattle, WA USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; Univ Calif San Francisco, Dept Med & Epidemiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Case Western Reserve University; Case Western Reserve University; Harvard University; Harvard T.H. Chan School of Public Health; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; University of California System; University of California San Diego; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rodriguez, B (corresponding author), 2061 Cornell Rd,Off 401B, Cleveland, OH 44106 USA.	rodriguez.benigno@clevelandactu.org	Rodriguez, Benigno/C-3365-2009; Mathews, William C/E-4451-2010; Sieg, Scott/AAV-2429-2021	Rodriguez, Benigno/0000-0001-9736-7957; Mathews, William C/0000-0002-2352-0725; 	FOGARTY INTERNATIONAL CENTER [D43TW000011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219, R01AI051219, P30AI027757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054907] Funding Source: NIH RePORTER; FIC NIH HHS [D43 TW000011] Funding Source: Medline; NIAID NIH HHS [R01 AI051219, P30 AI027757, AI36219] Funding Source: Medline; NIMH NIH HHS [R01 MH054907, MH54907] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anastos K, 2000, J ACQ IMMUN DEF SYND, V24, P218; Arduino JM, 2001, AIDS RES HUM RETROV, V17, P1099, DOI 10.1089/088922201316912709; *BHIVA EX COMM, 2005, BRIT HIV ASS BHIVA G, P28; Bofill M, 1996, AIDS, V10, P827, DOI 10.1097/00002030-199607000-00005; Brambilla D, 1999, AIDS, V13, P2269, DOI 10.1097/00002030-199911120-00009; Broussard SR, 2001, J VIROL, V75, P2262, DOI 10.1128/JVI.75.5.2262-2275.2001; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; *DHHS PAN ANT GUID, 2006, GUID US ANT AG HIV 1, P4; *DHHS PAN ANT GUID, 2006, GUID US ANT AG HIV 1; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Erice A, 2000, J CLIN MICROBIOL, V38, P2837, DOI 10.1128/JCM.38.8.2837-2845.2000; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Fuller W.A., 2009, MEASUREMENT ERROR MO; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gange SJ, 2001, AIDS RES HUM RETROV, V17, P1223, DOI 10.1089/088922201750461276; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Haase AT, 1996, SCIENCE, V274, P985, DOI 10.1126/science.274.5289.985; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hazenberg MD, 2000, NAT IMMUNOL, V1, P285, DOI 10.1038/79724; Hockett RD, 1999, J EXP MED, V189, P1545, DOI 10.1084/jem.189.10.1545; Holm GH, 2005, J VIROL, V79, P6299, DOI 10.1128/JVI.79.10.6299-6311.2005; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; MASUR H, 1981, NEW ENGL J MED, V305, P1431, DOI 10.1056/NEJM198112103052402; MCCLURE HM, 1989, VET IMMUNOL IMMUNOP, V21, P13, DOI 10.1016/0165-2427(89)90126-8; McCune JM, 2001, NATURE, V410, P974, DOI 10.1038/35073648; McNeil AC, 2001, P NATL ACAD SCI USA, V98, P13878, DOI 10.1073/pnas.251539598; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mohri H, 2001, J EXP MED, V194, P1277, DOI 10.1084/jem.194.9.1277; Moss AR, 2004, CLIN INFECT DIS, V39, P1190, DOI 10.1086/424008; Muchinsky PM, 1996, EDUC PSYCHOL MEAS, V56, P63, DOI 10.1177/0013164496056001004; MUNOZ A, 1989, AM J EPIDEMIOL, V130, P530, DOI 10.1093/oxfordjournals.aje.a115367; OBrien TR, 1996, JAMA-J AM MED ASSOC, V276, P105, DOI 10.1001/jama.276.2.105; PANTALEO G, 1993, NEW ENGL J MED, V328, P327, DOI 10.1056/NEJM199302043280508; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Rey-Cuille MA, 1998, J VIROL, V72, P3872; Robbins GK, 2003, NEW ENGL J MED, V349, P2293, DOI 10.1056/NEJMoa030264; Selliah N, 2003, IMMUNOL RES, V27, P247, DOI 10.1385/IR:27:2-3:247; Sieg SF, 2005, J INFECT DIS, V192, P62, DOI 10.1086/430620; VENET A, 1991, AIDS, V5, P283, DOI 10.1097/00002030-199103000-00006; WINKELSTEIN W, 1987, JAMA-J AM MED ASSOC, V257, P321, DOI 10.1001/jama.257.3.321	48	219	230	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2006	296	12					1498	1506		10.1001/jama.296.12.1498	http://dx.doi.org/10.1001/jama.296.12.1498			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087VD	17003398	Bronze			2022-12-28	WOS:000240770000026
J	Stainton, M				Stainton, Mary			Raising a woman	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												stainton@uic.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2006	296	12					1445	1446		10.1001/jama.296.12.1445	http://dx.doi.org/10.1001/jama.296.12.1445			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087VD	17003384				2022-12-28	WOS:000240770000001
J	Li, L; Ye, KQ				Li, Ling; Ye, Keqiong			Crystal structure of an H/ACA box ribonucleoprotein particle	NATURE			English	Article							SMALL NUCLEOLAR RNAS; RIBOSOMAL-RNA; PSEUDOURIDINE SYNTHASE; DYSKERATOSIS-CONGENITA; SNORNAS; COMPLEX; PROTEIN; TELOMERASE; NHP2P; CBF5P	H/ACA ribonucleoprotein particles (RNPs) are a family of RNA pseudouridine synthases that specify modification sites through guide RNAs. They also participate in eukaryotic ribosomal RNA processing and are a component of vertebrate telomerases. Here we report the crystal structure, at 2.3 angstrom resolution, of an entire archaeal H/ACA RNP consisting of proteins Cbf5, Nop10, Gar1 and L7ae, and a single-hairpin H/ACA RNA, revealing a modular organization of the complex. The RNA upper stem is bound to a composite surface formed by L7ae, Nop10 and Cbf5, and the RNA lower stem and ACA signature motif are bound to the PUA domain of Cbf5, thereby positioning middle guide sequences so that they are primed to pair with substrate RNA. Furthermore, Gar1 may regulate substrate loading and release. The structure rationalizes the consensus structure of H/ACA RNAs, suggests a functional role of each protein, and provides a framework for understanding the mechanism of RNA-guided pseudouridylation, as well as various cellular functions of H/ACA RNP.	Natl Inst Biol Sci, Beijing 102206, Peoples R China	National Institute of Biological Sciences, Beijing	Ye, KQ (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd,Zhongguancun Life Sci Pk, Beijing 102206, Peoples R China.	yekeqiong@nibs.ac.cn						Atzorn V, 2004, MOL CELL BIOL, V24, P1769, DOI 10.1128/MCB.24.4.1769-1778.2004; Balakin AG, 1996, CELL, V86, P823, DOI 10.1016/S0092-8674(00)80156-7; BousquetAntonelli C, 1997, EMBO J, V16, P4770, DOI 10.1093/emboj/16.15.4770; Charpentier B, 2005, NUCLEIC ACIDS RES, V33, P3133, DOI 10.1093/nar/gki630; DeLano WL, 2002, PYMOL USERS MANUAL; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Ganot P, 1997, GENE DEV, V11, P941, DOI 10.1101/gad.11.7.941; GIRARD JP, 1994, J BIOL CHEM, V269, P18499; GIRARD JP, 1992, EMBO J, V11, P673, DOI 10.1002/j.1460-2075.1992.tb05099.x; Hamma T, 2005, NAT STRUCT MOL BIOL, V12, P1101, DOI 10.1038/nsmb1036; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Henras A, 1998, EMBO J, V17, P7078, DOI 10.1093/emboj/17.23.7078; Henras AK, 2004, RNA, V10, P1704, DOI 10.1261/rna.7770604; Hoang C, 2001, CELL, V107, P929, DOI 10.1016/S0092-8674(01)00618-3; Ishitani R, 2003, CELL, V113, P383, DOI 10.1016/S0092-8674(03)00280-0; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Lafontaine DLJ, 1998, GENE DEV, V12, P527, DOI 10.1101/gad.12.4.527; Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002; Liang XH, 2005, RNA, V11, P619, DOI 10.1261/rna.7174805; Manival X, 2006, NUCLEIC ACIDS RES, V34, P826, DOI 10.1093/nar/gkj482; Marrone A, 2005, CURR OPIN GENET DEV, V15, P249, DOI 10.1016/j.gde.2005.04.004; Meier UT, 2005, CHROMOSOMA, V114, P1, DOI 10.1007/s00412-005-0333-9; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; MORRISSEY JP, 1993, MOL CELL BIOL, V13, P2469, DOI 10.1128/MCB.13.4.2469; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Ofengand J, 2002, FEBS LETT, V514, P17, DOI 10.1016/S0014-5793(02)02305-0; Pan H, 2003, P NATL ACAD SCI USA, V100, P12648, DOI 10.1073/pnas.2135585100; Rashid R, 2006, MOL CELL, V21, P249, DOI 10.1016/j.molcel.2005.11.017; Rozhdestvensky TS, 2003, NUCLEIC ACIDS RES, V31, P869, DOI 10.1093/nar/gkg175; Russell AG, 2004, RNA, V10, P1034, DOI 10.1261/rna.7300804; Torchet C, 2005, RNA, V11, P928, DOI 10.1261/rna.2100905; Wang C, 2004, EMBO J, V23, P1857, DOI 10.1038/sj.emboj.7600181; Watkins NJ, 1998, RNA, V4, P1549, DOI 10.1017/S1355838298980761	34	165	172	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2006	443	7109					302	307		10.1038/nature05151	http://dx.doi.org/10.1038/nature05151			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085RL	16943774				2022-12-28	WOS:000240622000038
J	Christophorou, MA; Ringshausen, I; Finch, AJ; Swigart, LB; Evan, GI				Christophorou, M. A.; Ringshausen, I.; Finch, A. J.; Swigart, L. Brown; Evan, G. I.			The pathological response to DNA damage does not contribute to p53-mediated tumour suppression	NATURE			English	Article							CELL-CYCLE ARREST; IN-VIVO; P53; APOPTOSIS; MICE; P19(ARF); TUMORIGENESIS; P16(INK4A); ACTIVATION; TARGET	The p53 protein has a highly evolutionarily conserved role in metazoans as 'guardian of the genome', mediating cell-cycle arrest and apoptosis in response to genotoxic injury(1). In large, long-lived animals with substantial somatic regenerative capacity, such as vertebrates, p53 is an important tumour suppressor - an attribute thought to stem directly from its induction of death or arrest in mutant cells with damaged or unstable genomes. Chemotherapy and radiation exposure both induce widespread p53-dependent DNA damage. This triggers potentially lethal pathologies(2) that are generally deemed an unfortunate but unavoidable consequence of the role p53 has in tumour suppression. Here we show, using a mouse model in which p53 status can be reversibly switched in vivo between functional and inactive states(3), that the p53-mediated pathological response to whole-body irradiation, a prototypical genotoxic carcinogen, is irrelevant for suppression of radiation-induced lymphoma. In contrast, delaying the restoration of p53 function until the acute radiation response has subsided abrogates all of the radiation-induced pathology yet preserves much of the protection from lymphoma. Such protection is absolutely dependent on p19(ARF) - a tumour suppressor induced not by DNA damage, but by oncogenic disruption of the cell cycle.	Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Evan, GI (corresponding author), Univ Calif San Francisco, Canc Res Inst, Box 0128, San Francisco, CA 94143 USA.	gevan@cc.ucsf.edu	Ringshausen, Ingo/AAW-8762-2020	Finch, Andrew/0000-0002-8065-4623; Ringshausen, Ingo/0000-0002-7247-311X; Christophorou, Maria/0000-0001-5455-7283				Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; HERMEKING H, 1994, SCIENCE, V265, P2091, DOI 10.1126/science.8091232; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Komarova EA, 1998, SEMIN CANCER BIOL, V8, P389, DOI 10.1006/scbi.1998.0101; Lain S, 2003, EUR J CANCER, V39, P1053, DOI 10.1016/S0959-8049(03)00063-7; LANE DP, 1992, NATURE, V358, P16; Liao MJ, 1999, MOL CELL BIOL, V19, P3095; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; MAO L, 1995, CANCER RES, V55, P2995; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; QUELLE DE, 1995, CELL, V83, P993; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sluss HK, 2004, MOL CELL BIOL, V24, P976, DOI 10.1128/MCB.24.3.976-984.2004; Soengas MS, 2000, NAT GENET, V26, P391, DOI 10.1038/82497; WAGNER AJ, 1994, GENE DEV, V8, P2817, DOI 10.1101/gad.8.23.2817; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424; Zindy F, 2003, P NATL ACAD SCI USA, V100, P15930, DOI 10.1073/pnas.2536808100	29	324	329	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2006	443	7108					214	217		10.1038/nature05077	http://dx.doi.org/10.1038/nature05077			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16957739				2022-12-28	WOS:000240467000047
J	Seneviratne, SI; Luthi, D; Litschi, M; Schar, C				Seneviratne, Sonia I.; Luethi, Daniel; Litschi, Michael; Schaer, Christoph			Land-atmosphere coupling and climate change in Europe	NATURE			English	Article							SOIL-MOISTURE; TEMPERATURE VARIABILITY; CHANGE SCENARIOS; MODEL; PRECIPITATION; TRENDS; PREDICTABILITY; FEEDBACK	Increasing greenhouse gas concentrations are expected to enhance the interannual variability of summer climate in Europe(1-3) and other mid-latitude regions(4,5), potentially causing more frequent heatwaves(1,3,5,6). Climate models consistently predict an increase in the variability of summer temperatures in these areas, but the underlying mechanisms responsible for this increase remain uncertain. Here we explore these mechanisms using regional simulations of recent and future climatic conditions with and without land - atmosphere interactions. Our results indicate that the increase in summer temperature variability predicted in central and eastern Europe is mainly due to feedbacks between the land surface and the atmosphere. Furthermore, they suggest that land - atmosphere interactions increase climate variability in this region because climatic regimes in Europe shift northwards in response to increasing greenhouse gas concentrations, creating a new transitional climate zone with strong land - atmosphere coupling in central and eastern Europe. These findings emphasize the importance of soil- moisture - temperature feedbacks ( in addition to soil- moisture - precipitation feedbacks(7-10)) in influencing summer climate variability and the potential migration of climate zones with strong land - atmosphere coupling(7,11) as a consequence of global warming. This highlights the crucial role of land atmosphere interactions in future climate change.	ETH, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Seneviratne, SI (corresponding author), ETH, Inst Atmospher & Climate Sci, Univ Str 16, CH-8092 Zurich, Switzerland.	sonia.seneviratne@env.ethz.ch	Schar, Christoph/A-1033-2008; Seneviratne, Sonia I./G-8761-2011	Schar, Christoph/0000-0002-4171-1613; Seneviratne, Sonia I./0000-0001-9528-2917				Betts AK, 2004, B AM METEOROL SOC, V85, P1673, DOI 10.1175/BAMS-85-11-1673; Christensen JH, 2003, NATURE, V421, P805, DOI 10.1038/421805a; Christensen JH, 2002, EOS, V83, P147, DOI DOI 10.1029/2002E0000094; Eltahir EAB, 1998, WATER RESOUR RES, V34, P765, DOI 10.1029/97WR03499; Findell KL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023414; Frei C, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD005965; Giorgi F, 2004, CLIM DYNAM, V23, P839, DOI 10.1007/s00382-004-0467-0; Johns TC, 2003, CLIM DYNAM, V20, P583, DOI 10.1007/s00382-002-0296-y; Koster RD, 2006, J HYDROMETEOROL, V7, P590, DOI 10.1175/JHM510.1; Koster RD, 2004, SCIENCE, V305, P1138, DOI 10.1126/science.1100217; Koster RD, 2000, J HYDROMETEOROL, V1, P26, DOI 10.1175/1525-7541(2000)001<0026:VAPOPA>2.0.CO;2; Lawrence DM, 2005, J HYDROMETEOROL, V6, P670, DOI 10.1175/JHM445.1; LENDERINK G, IN PRESS CLIM CHANGE; Luterbacher J, 2004, SCIENCE, V303, P1499, DOI 10.1126/science.1093877; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Milly PCD, 2005, NATURE, V438, P347, DOI 10.1038/nature04312; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Ogi M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021528; Pal JS, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019836; Pope VD, 2000, CLIM DYNAM, V16, P123, DOI 10.1007/s003820050009; Raisanen J, 2002, J CLIMATE, V15, P2395, DOI 10.1175/1520-0442(2002)015<2395:CICIIT>2.0.CO;2; Robock A, 2000, B AM METEOROL SOC, V81, P1281, DOI [10.1175/1520-0477(2000)081<1281:TGSMDB>2.3.CO;2, 10.1175/1520-0477(2000)081&lt;1281:TGSMDB&gt;2.3.CO;2]; Schar C, 1999, J CLIMATE, V12, P722, DOI 10.1175/1520-0442(1999)012<0722:TSPFAP>2.0.CO;2; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Scherrer SC, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024108; Seneviratne SI, 2002, CLIM DYNAM, V20, P69, DOI 10.1007/s00382-002-0258-4; Stott PA, 2004, NATURE, V432, P610, DOI 10.1038/nature03089; Sutton RT, 2005, SCIENCE, V309, P115, DOI 10.1126/science.1109496; van Ulden AP, 2006, ATMOS CHEM PHYS, V6, P863, DOI 10.5194/acp-6-863-2006; Vidale PL, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002810; VIDALE PL, IN PRESS CLIM CHANGE	31	1069	1101	35	368	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2006	443	7108					205	209		10.1038/nature05095	http://dx.doi.org/10.1038/nature05095			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16971947				2022-12-28	WOS:000240467000045
J	Higginbotham, EJ				Higginbotham, Eve J.			Managing glaucoma during pregnancy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FEMALE REPRODUCTIVE FACTORS; EYE		Morehouse Sch Med, Atlanta, GA 30310 USA	Morehouse School of Medicine	Higginbotham, EJ (corresponding author), Morehouse Sch Med, 720 Westview Dr SW, Atlanta, GA 30310 USA.	ejhigginbotham@msm.edu						Brauner SC, 2006, ARCH OPHTHALMOL-CHIC, V124, P1089, DOI 10.1001/archopht.124.8.1089; Higginbotham E, 2004, ARCH OPHTHALMOL-CHIC, V122, P374, DOI 10.1001/archopht.122.3.374; Lee AJ, 2003, BRIT J OPHTHALMOL, V87, P1324, DOI 10.1136/bjo.87.11.1324; Nirmalan PK, 2004, INVEST OPHTH VIS SCI, V45, P4273, DOI 10.1167/iovs.04-0285; Wizeman T.M., 2001, EXPLORING BIOL CONTR	5	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2006	296	10					1284	1285		10.1001/jama.296.10.1284	http://dx.doi.org/10.1001/jama.296.10.1284			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083EA	16972344				2022-12-28	WOS:000240437500031
J	Hobbs, JB; Peterson, DR; Moss, AJ; McNitt, S; Zareba, W; Goldenberg, I; Qi, M; Robinson, JL; Sauer, AJ; Ackerman, MJ; Benhorin, J; Kaufman, ES; Locati, EH; Napolitano, C; Priori, SG; Towbin, JA; Vincent, GM; Zhang, L				Hobbs, Jenny B.; Peterson, Derick R.; Moss, Arthur J.; McNitt, Scott; Zareba, Wojciech; Goldenberg, Ilan; Qi, Ming; Robinson, Jennifer L.; Sauer, Andrew J.; Ackerman, Michael J.; Benhorin, Jesaia; Kaufman, Elizabeth S.; Locati, Emanuela H.; Napolitano, Carlo; Priori, Silvia G.; Towbin, Jeffrey A.; Vincent, G. Michael; Zhang, Li			Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-COURSE; SEX-DIFFERENCES; INTERVAL; GENDER; AGE; EXPRESSION; FAMILIES; CYCLE	Context Analysis of predictors of cardiac events in hereditary long-QT syndrome (LQTS) has primarily considered syncope as the predominant end point. Risk factors specific for aborted cardiac arrest and sudden cardiac death have not been investigated. Objective To identify risk factors associated with aborted cardiac arrest and sudden cardiac death during adolescence in patients with clinically suspected LQTS. Design, Setting, and Participants The study involved 2772 participants from the International Long QT Syndrome Registry who were alive at age 10 years and were followed up during adolescence until age 20 years. The registry enrollment began in 1979 at 5 cardiology centers in the United States and Europe. Main Outcome Measures Aborted cardiac arrest or LQTS-related sudden cardiac death; follow-up ended on February 15, 2005. Results There were 81 patients who experienced aborted cardiac arrest and 45 who had sudden cardiac death; 9 of the 81 patients who had an aborted cardiac arrest event experienced subsequent sudden cardiac death. Significant independent predictors of aborted cardiac arrest or sudden cardiac death during adolescence included recent syncope, QTc interval, and sex. Compared with those with no syncopal events in the last 10 years, patients with 1 or 2 or more episodes of syncope 2 to 10 years ago (but none in the last 2 years) had an adjusted hazard ratio (HR) of 2.7; (95% confidence interval [CI], 1.3-5.7; P < .01) and an adjusted HR of 5.8 (95% CI, 3.6-9.4; P < .001), respectively, for life-threatening events; those with 1 syncopal episodes in the last 2 years had an adjusted HR of 11.7 (95% CI, 7.0-19.5; P < .001) and those with 2 or more syncopal episodes in the last 2 years had an adjusted HR of 18.1 (95% CI, 10.4-31.2; P < .001). Irrespective of events occurring more than 2 years ago, QTc of 530 ms or longer was associated with increased risk (adjusted HR, 2.3; 95% CI, 1.6-3.3; P < .001) compared with those having a shorter QTc. Males between the ages of 10 and 12 years had higher risk than females (HR, 4.0; 95% CI, 1.8-9.2; P = .001), but there was no significant risk difference between males and females between the ages of 13 and 20 years. Among individuals with syncope in the past 2 years, beta-blocker therapy was associated with a 64% reduced risk (HR, 0.36; 95% CI, 0.18-0.72; P < .01). Conclusions In LQTS, the timing and frequency of syncope, QTc prolongation, and sex were predictive of risk for aborted cardiac arrest and sudden cardiac death during adolescence. Among patients with recent syncope, beta-blocker treatment was associated with reduced risk.	Univ Rochester, Med Ctr, HeartRes Followup Program, Dept Med,Cardiol Unit, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Pathol, Rochester, NY 14642 USA; Mayo Clin Coll Med, Dept Med, Rochester, MN USA; Mayo Clin Coll Med, Dept Pediat, Rochester, MN USA; Mayo Clin Coll Med, Dept Mol Pharmacol, Rochester, MN USA; Bikur Cholim Hosp, Dept Cardiol, Jerusalem, Israel; Case Western Reserve Univ, Heart & Vasc Res Ctr, Cleveland, OH 44106 USA; Osped Niguarda Ca Granda, Cardiovasc Dept De Gasperis, Milan, Italy; Univ Pavia, Fdn S Maugeri, I-27100 Pavia, Italy; Baylor Coll Med, Dept Pediat Cardiol, Houston, TX 77030 USA; Univ Utah, Sch Med, Dept Med, Salt Lake City, UT USA	University of Rochester; University of Rochester; University of Rochester; Mayo Clinic; Mayo Clinic; Mayo Clinic; Case Western Reserve University; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia; Baylor College of Medicine; Utah System of Higher Education; University of Utah	Moss, AJ (corresponding author), Univ Rochester, Med Ctr, HeartRes Followup Program, Dept Med,Cardiol Unit, 601 Elmwood Ave,Box 653, Rochester, NY 14642 USA.	heartajm@heart.rochester.edu	Sauer, Andrew/AAB-5953-2021; Priori, Silvia G/ABH-6894-2020; Peterson, Derick/W-5240-2019; Priori, Silvia G G/A-6116-2014; Towbin, Jeffrey A./J-5595-2019; Sauer, Andrew J./K-6612-2019; napolitano, carlo/ABI-4608-2020; Locati, Emanuela Teresina/AAW-3821-2020; Napolitano, Carlo/K-4760-2016	Priori, Silvia G/0000-0001-6877-0288; Peterson, Derick/0000-0001-8603-660X; Priori, Silvia G G/0000-0001-6877-0288; Towbin, Jeffrey A./0000-0002-6585-714X; napolitano, carlo/0000-0002-7643-4628; Locati, Emanuela Teresina/0000-0002-4488-0455; Napolitano, Carlo/0000-0002-7643-4628; Sauer, Andrew/0000-0002-9268-2795	NHLBI NIH HHS [HL-33843, HL-51618] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033843, R01HL051618] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Benhorin J, 2002, ANN NONINVAS ELECTRO, V7, P40; Bidoggia H, 2000, AM HEART J, V140, P678, DOI 10.1067/mhj.2000.109918; BOYLE MB, 1987, NATURE, V330, P373, DOI 10.1038/330373a0; Drici MD, 1996, CIRCULATION, V94, P1471, DOI 10.1161/01.CIR.94.6.1471; Kimbrough J, 2001, CIRCULATION, V104, P557, DOI 10.1161/hc3001.093501; Lehmann MH, 1997, J AM COLL CARDIOL, V29, P93, DOI 10.1016/S0735-1097(96)00454-8; Liu XK, 1998, J PHARMACOL EXP THER, V285, P672; Locati EH, 1998, CIRCULATION, V97, P2237, DOI 10.1161/01.CIR.97.22.2237; MERRI M, 1989, CIRCULATION, V80, P1301, DOI 10.1161/01.CIR.80.5.1301; Moss AJ, 1999, DRUG SAFETY, V21, P5, DOI 10.2165/00002018-199921001-00002; MOSS AJ, 1991, CIRCULATION, V84, P1136, DOI 10.1161/01.CIR.84.3.1136; Moss AJ, 2000, CIRCULATION, V101, P616, DOI 10.1161/01.CIR.101.6.616; Priori SG, 2004, JAMA-J AM MED ASSOC, V292, P1341, DOI 10.1001/jama.292.11.1341; Priori SG, 2003, NEW ENGL J MED, V348, P1866, DOI 10.1056/NEJMoa022147; Priori SG, 1999, CIRCULATION, V99, P529, DOI 10.1161/01.CIR.99.4.529; RAUTAHARJU PM, 1992, CAN J CARDIOL, V8, P690; Schwartz PJ, 2006, CIRCULATION, V113, P783, DOI 10.1161/CIRCULATIONAHA.105.592899; Schwartz PJ, 2004, CIRCULATION, V109, P1826, DOI 10.1161/01.CIR.0000125523.14403.1E; Schwartz PJ, 1997, CURR PROB CARDIOLOGY, V22, P302, DOI 10.1016/S0146-2806(97)80009-6; Therneau TM, 2000, MODELING SURVIVAL DA; Zareba W, 2003, J AM COLL CARDIOL, V42, P103, DOI 10.1016/S0735-1097(03)00554-0; Zareba W, 1998, NEW ENGL J MED, V339, P960, DOI 10.1056/NEJM199810013391404; Zareba W, 2003, J CARDIOVASC ELECTR, V14, P337, DOI 10.1046/j.1540-8167.2003.02545.x	23	200	201	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2006	296	10					1249	1254		10.1001/jama.296.10.1249	http://dx.doi.org/10.1001/jama.296.10.1249			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083EA	16968849	Bronze			2022-12-28	WOS:000240437500027
J	Raymond, SN; Mandell, AM; Sigurdsson, S				Raymond, Sean N.; Mandell, Avi M.; Sigurdsson, Steinn			Exotic Earths: Forming habitable worlds with giant planet migration	SCIENCE			English	Article							TERRESTRIAL PLANETS; ORBITAL MIGRATION; MASS; ACCRETION; GROWTH; PROTOPLANETS; EVOLUTION; SYSTEMS	Close-in giant planets (e.g., "hot Jupiters'') are thought to form far from their host stars and migrate inward, through the terrestrial planet zone, via torques with a massive gaseous disk. Here we simulate terrestrial planet growth during and after giant planet migration. Several-Earth-mass planets also form interior to the migrating jovian planet, analogous to recently discovered "hot Earths.'' Very-water-rich, Earth-mass planets form from surviving material outside the giant planet's orbit, often in the habitable zone and with low orbital eccentricities. More than a third of the known systems of giant planets may harbor Earth-like planets.	Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA; Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	University of Colorado System; University of Colorado Boulder; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Raymond, SN (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, Campus Box 392, Boulder, CO 80309 USA.	raymond@lasp.colorado.edu; mandell@astro.psu.edu	Mandell, Avi M/F-9361-2012	Mandell, Avi M/0000-0002-8119-3355; Raymond, Sean/0000-0001-8974-0758; Sigurdsson, Steinn/0000-0002-8187-1144				Armitage PJ, 2003, ASTROPHYS J, V582, pL47, DOI 10.1086/346198; Bodenheimer P, 2000, ICARUS, V143, P2, DOI 10.1006/icar.1999.6246; Boss AP, 1997, SCIENCE, V276, P1836, DOI 10.1126/science.276.5320.1836; Butler RP, 2006, ASTROPHYS J, V646, P505, DOI 10.1086/504701; Chambers JE, 1999, MON NOT R ASTRON SOC, V304, P793, DOI 10.1046/j.1365-8711.1999.02379.x; CLAIRE M, IN PRESS GEOBIOLOGY; Edgar R, 2004, MON NOT R ASTRON SOC, V354, P769, DOI 10.1111/j.1365-2966.2004.08238.x; Fischer DA, 2005, ASTROPHYS J, V622, P1102, DOI 10.1086/428383; Haisch KE, 2001, ASTROPHYS J, V553, pL153, DOI 10.1086/320685; Hillenbrand LA, 2004, ASTROPHYS J, V604, P741, DOI 10.1086/382021; Kim JS, 2005, ASTROPHYS J, V632, P659, DOI 10.1086/432863; Kleine T, 2002, NATURE, V418, P952, DOI 10.1038/nature00982; Lin DNC, 1996, NATURE, V380, P606, DOI 10.1038/380606a0; Lodders K., 1998, PLANETARY SCI COMPAN; Mandell AM, 2003, ASTROPHYS J, V599, pL111, DOI 10.1086/381245; McArthur BE, 2004, ASTROPHYS J, V614, pL81, DOI 10.1086/425561; Rasio FA, 1996, SCIENCE, V274, P954, DOI 10.1126/science.274.5289.954; Raymond SN, 2005, ICARUS, V177, P256, DOI 10.1016/j.icarus.2005.03.008; Raymond SN, 2004, ICARUS, V168, P1, DOI 10.1016/j.icarus.2003.11.019; Rivera EJ, 2005, ASTROPHYS J, V634, P625, DOI 10.1086/491669; SCHNEIDER J, EXTRASOLAR PLANETS E; Silverstone MD, 2006, ASTROPHYS J, V639, P1138, DOI 10.1086/499418; Tabachnik S, 2002, MON NOT R ASTRON SOC, V335, P151, DOI 10.1046/j.1365-8711.2002.05610.x; Thommes EW, 2003, ICARUS, V161, P431, DOI 10.1016/S0019-1035(02)00043-X; WETHERILL GW, 1989, ICARUS, V77, P330, DOI 10.1016/0019-1035(89)90093-6; Williams DM, 1997, NATURE, V385, P234, DOI 10.1038/385234a0; Zhou JL, 2005, ASTROPHYS J, V631, pL85, DOI 10.1086/497094	35	149	152	3	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2006	313	5792					1413	1416		10.1126/science.1130461	http://dx.doi.org/10.1126/science.1130461			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16960000	Green Submitted			2022-12-28	WOS:000240348700035
J	Brody, B				Brody, Benjamin			Becoming a physician: The script	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Albert Einstein Coll Med, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Brody, B (corresponding author), Albert Einstein Coll Med, Bronx, NY 10461 USA.								0	5	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 7	2006	355	10					979	981		10.1056/NEJMp068101	http://dx.doi.org/10.1056/NEJMp068101			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080UF	16957144				2022-12-28	WOS:000240273300003
J	Keightley, PD; Otto, SP				Keightley, Peter D.; Otto, Sarah P.			Interference among deleterious mutations favours sex and recombination in finite populations	NATURE			English	Article							EVOLUTIONARY ADVANTAGE; SELECTION; LINKAGE; MODEL	Sex and recombination are widespread, but explaining these phenomena has been one of the most difficult problems in evolutionary biology. Recombination is advantageous when different individuals in a population carry different advantageous alleles(1,2). By bringing together advantageous alleles onto the same chromosome, recombination speeds up the process of adaptation(1,3-5) and opposes the fixation of harmful mutations by means of Muller's ratchet(4,5). Nevertheless, adaptive substitutions favour sex and recombination only if the rate of adaptive mutation is high(1,6), and Muller's ratchet operates only in small or asexual populations(7). Here, by tracking the fate of modifier alleles that alter the frequency of sex and recombination, we show that background selection against deleterious mutant alleles provides a stochastic advantage to sex and recombination that increases with population size. The advantage arises because, with low levels of recombination, selection at other loci severely reduces the effective population size and genetic variance in fitness at a focal locus(8) (the Hill-Robertson effect), making a population less able to respond to selection and to rid itself of deleterious mutations. Sex and recombination reveal the hidden genetic variance in fitness by combining chromosomes of intermediate fitness to create chromosomes that are relatively free of (or are loaded with) deleterious mutations. This increase in genetic variance within finite populations improves the response to selection and generates a substantial advantage to sex and recombination that is fairly insensitive to the form of epistatic interactions between deleterious alleles. The mechanism supported by our results offers a robust and broadly applicable explanation for the evolutionary advantage of recombination and can explain the spread of costly sex.	Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	University of Edinburgh; University of British Columbia	Keightley, PD (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	keightley.nature2006@spambob.net	Otto, Sarah Perin/K-5625-2012	Otto, Sarah Perin/0000-0003-3042-0818				BARTON NH, 1995, GENET RES, V65, P123, DOI 10.1017/S0016672300033140; Barton NH, 2005, GENETICS, V169, P2353, DOI 10.1534/genetics.104.032821; BELL G, 1982, MASTERPIECE NATURE E; Bierne N, 2004, MOL BIOL EVOL, V21, P1350, DOI 10.1093/molbev/msh134; Burger R, 1999, GENETICS, V153, P1055; CABALLERO A, 1994, GENETICS, V138, P883; Charlesworth B, 1998, GENETICA, V102-3, P3, DOI 10.1023/A:1017066304739; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Denver DR, 2004, NATURE, V430, P679, DOI 10.1038/nature02697; FELSENSTEIN J, 1965, GENETICS, V52, P349; FELSENSTEIN J, 1974, GENETICS, V78, P737; FELSENSTEIN J, 1976, GENETICS, V83, P845; Fisher R.A., 1930, GENETICAL THEORY NAT; Halligan DL, 2006, GENOME RES, V16, P875, DOI 10.1101/gr.5022906; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Iles MM, 2003, GENETICS, V165, P2249; Keightley PD, 2000, SCIENCE, V290, P331, DOI 10.1126/science.290.5490.331; KIMURA M., 1964, J. appl. Prob., V1, P177, DOI 10.2307/3211856; KONDRASHOV AS, 1984, GENET RES, V44, P199, DOI 10.1017/S0016672300026392; Lynch M, 1995, EVOLUTION, V49, P1067, DOI [10.1111/j.1558-5646.1995.tb04434.x, 10.2307/2410432]; Martin G, 2006, GENETICS, V172, P593, DOI 10.1534/genetics.104.039982; Morgan T.H., 1913, HEREDITY SEX; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; Otto SP, 2004, SCIENCE, V304, P1018, DOI 10.1126/science.1094072; Otto SP, 1997, THEOR POPUL BIOL, V51, P134, DOI 10.1006/tpbi.1997.1301; Otto SP, 2001, EVOLUTION, V55, P1921, DOI 10.1111/j.0014-3820.2001.tb01310.x; Palsson S, 2002, J HERED, V93, P22, DOI 10.1093/jhered/93.1.22; Rice WR, 2002, NAT REV GENET, V3, P241, DOI 10.1038/nrg760; Santiago E, 1998, GENETICS, V149, P2105	30	260	263	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 7	2006	443	7107					89	92		10.1038/nature05049	http://dx.doi.org/10.1038/nature05049			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16957730				2022-12-28	WOS:000240313900045
J	Anandan, C; Sheikh, A				Anandan, Chantelle; Sheikh, Aziz			10-minute consultation - Preventing development of allergic disorders in children	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PLACEBO-CONTROLLED TRIAL; ATOPIC DISEASE; PROBIOTICS		Univ Edinburgh, Community Hlth Sci GP Sect, Edinburgh EH8 9DX, Midlothian, Scotland	University of Edinburgh	Sheikh, A (corresponding author), Univ Edinburgh, Community Hlth Sci GP Sect, Edinburgh EH8 9DX, Midlothian, Scotland.	Aziz.Sheikh@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056				Committee on Toxicity of Chemicals in Food, 1998, PEAN ALL; Dunstan JA, 2005, CURR OPIN ALLERGY CL, V5, P215, DOI 10.1097/01.all.0000168784.74582.32; Kalliomaki M, 2003, LANCET, V361, P1869, DOI 10.1016/S0140-6736(03)13490-3; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; van Odijk J, 2003, ALLERGY, V58, P833, DOI 10.1034/j.1398-9995.2003.00264.x	5	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2006	333	7566					485	485		10.1136/bmj.333.7566.485	http://dx.doi.org/10.1136/bmj.333.7566.485			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085QP	16946338	Green Published, Green Submitted			2022-12-28	WOS:000240618900023
J	Selmer, M; Dunham, CM; Murphy, FV; Weixlbaumer, A; Petry, S; Kelley, AC; Weir, JR; Ramakrishnan, V				Selmer, Maria; Dunham, Christine M.; Murphy, Frank V.; Weixlbaumer, Albert; Petry, Sabine; Kelley, Ann C.; Weir, John R.; Ramakrishnan, V.			Structure of the 70S ribosome complexed with mRNA and tRNA	SCIENCE			English	Article							PEPTIDE-BOND FORMATION; PHENYLALANINE TRANSFER-RNA; ESCHERICHIA-COLI RIBOSOME; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; P-SITE; BACTERIAL RIBOSOME; ATOMIC-STRUCTURE; 50S SUBUNITS; PROTEIN L27	The crystal structure of the bacterial 70S ribosome refined to 2.8 angstrom resolution reveals atomic details of its interactions with messenger RNA ( mRNA) and transfer RNA ( tRNA). A metal ion stabilizes a kink in the mRNA that demarcates the boundary between A and P sites, which is potentially important to prevent slippage of mRNA. Metal ions also stabilize the intersubunit interface. The interactions of E-site tRNA with the 50S subunit have both similarities and differences compared to those in the archaeal ribosome. The structure also rationalizes much biochemical and genetic data on translation.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ramak@mrc-lmb.cam.ac.uk	Weixlbaumer, Albert/AAI-8474-2021; Weixlbaumer, Albert/P-3587-2016; Weir, John R./AAF-5435-2020	Weixlbaumer, Albert/0000-0001-9635-3844; Weixlbaumer, Albert/0000-0001-9635-3844; Weir, John R./0000-0002-6904-0284; Selmer, Maria/0000-0001-9079-2774; Ramakrishnan, V/0000-0002-4699-2194	Medical Research Council [MC_U105184332] Funding Source: Medline; NIGMS NIH HHS [GM67624] Funding Source: Medline; MRC [MC_U105184332] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067624] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdi NM, 2005, RNA, V11, P1624, DOI 10.1261/rna.2118105; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bashan A, 2003, MOL CELL, V11, P91, DOI 10.1016/S1097-2765(03)00009-1; Battle DJ, 2002, P NATL ACAD SCI USA, V99, P11676, DOI 10.1073/pnas.182221799; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; CHAO FC, 1957, ARCH BIOCHEM BIOPHYS, V70, P426, DOI 10.1016/0003-9861(57)90130-3; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Eistetter AJ, 1999, FEMS MICROBIOL LETT, V180, P345, DOI 10.1111/j.1574-6968.1999.tb08816.x; Erlacher MD, 2005, NUCLEIC ACIDS RES, V33, P1618, DOI 10.1093/nar/gki308; Feinberg JS, 2001, P NATL ACAD SCI USA, V98, P11120, DOI 10.1073/pnas.211184098; Frank J, 1995, BIOCHEM CELL BIOL, V73, P757, DOI 10.1139/o95-084; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; GEIGENMULLER U, 1990, EMBO J, V9, P4527, DOI 10.1002/j.1460-2075.1990.tb07904.x; Ghosh S, 2005, RNA, V11, P657, DOI 10.1261/rna.7224305; Hard T, 2000, J MOL BIOL, V296, P169, DOI 10.1006/jmbi.1999.3433; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Jenner L, 2005, SCIENCE, V308, P120, DOI 10.1126/science.1105639; Jovine L, 2000, J MOL BIOL, V301, P401, DOI 10.1006/jmbi.2000.3950; KENNY JW, 1979, J MOL BIOL, V127, P243, DOI 10.1016/0022-2836(79)90328-0; Kirillov SV, 2002, FEBS LETT, V514, P60, DOI 10.1016/S0014-5793(02)02302-5; Lancaster L, 2005, MOL CELL, V20, P623, DOI 10.1016/j.molcel.2005.10.006; LILL R, 1989, EMBO J, V8, P3933, DOI 10.1002/j.1460-2075.1989.tb08574.x; Maguire BA, 2005, MOL CELL, V20, P427, DOI 10.1016/j.molcel.2005.09.009; Mitra K, 2006, ANNU REV BIOPH BIOM, V35, P299, DOI 10.1146/annurev.biophys.35.040405.101950; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; Nikulin A, 2003, NAT STRUCT BIOL, V10, P104, DOI 10.1038/nsb886; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; OSSWALD M, 1990, NUCLEIC ACIDS RES, V18, P6755; Rajbhandary Uttam L., 1995, P511; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; Schmeing TM, 2003, RNA, V9, P1345, DOI 10.1261/rna.5120503; Schmeing TM, 2002, NAT STRUCT BIOL, V9, P225, DOI 10.1038/nsb758; Schmitt E, 1998, EMBO J, V17, P6819, DOI 10.1093/emboj/17.23.6819; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Semenkov YP, 1996, P NATL ACAD SCI USA, V93, P12183, DOI 10.1073/pnas.93.22.12183; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; VONAHSEN U, 1995, SCIENCE, V267, P234, DOI 10.1126/science.7528943; Wang HF, 2004, PROTEIN SCI, V13, P2806, DOI 10.1110/ps.04864904; Weinger JS, 2004, NAT STRUCT MOL BIOL, V11, P1101, DOI 10.1038/nsmb841; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; YUSUPOVA GZ, 2002, SCIENCE         0329, V292, P883, DOI DOI 10.1126/SCIENCE.1060089	45	1015	1051	2	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2006	313	5795					1935	1942		10.1126/science.1131127	http://dx.doi.org/10.1126/science.1131127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	16959973				2022-12-28	WOS:000240832200044
J	Apkarian, VA				Apkarian, V. A.			A pixellated window on chemistry in solids	SCIENCE			English	Editorial Material									Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Apkarian, VA (corresponding author), Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA.	aapkaria@uci.edu						Apkarian VA, 1999, CHEM REV, V99, P1481, DOI 10.1021/cr9404609; BACON F, 1620, NATURE HEAT; Dlott DD, 2006, MATER SCI TECH-LOND, V22, P463, DOI 10.1179/174328406X83987; Moss WC, 1997, SCIENCE, V276, P1398, DOI 10.1126/science.276.5317.1398; Poulin PR, 2006, SCIENCE, V313, P1756, DOI 10.1126/science.1127826; SHAKHASHIRI BZ, 1983, EXPLOSIVE DECOMPOSIT, V1, P96; SUSLICK KS, 1990, SCIENCE, V247, P1439, DOI 10.1126/science.247.4949.1439; Taleyarkhan RP, 2002, SCIENCE, V295, P1868, DOI 10.1126/science.1067589; Yang YQ, 2003, J PHYS CHEM B, V107, P4485, DOI 10.1021/jp0269322; ZINK JI, 1978, ACCOUNTS CHEM RES, V11, P289, DOI 10.1021/ar50128a001	10	3	3	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2006	313	5794					1747	1748		10.1126/science.1133024	http://dx.doi.org/10.1126/science.1133024			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16946034				2022-12-28	WOS:000240655700034
J	Iung, B; Vahanian, A				Iung, Bernard; Vahanian, Alec			Valvular heart diseases in elderly people	LANCET			English	Editorial Material							AORTIC-STENOSIS		Hop Xavier Bichat, AP HP, Dept Cardiol, F-75018 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Iung, B (corresponding author), Hop Xavier Bichat, AP HP, Dept Cardiol, F-75018 Paris, France.	bernard.iung@bch.aphp.fr	Iung, Bernard/AAQ-9004-2020	Iung, Bernard/0000-0002-9127-348X				Ambler G, 2005, CIRCULATION, V112, P224, DOI 10.1161/CIRCULATIONAHA.104.515049; [Anonymous], 2006, J AM COLL CARDIOL, V48, P598, DOI 10.1016/j.jacc.2006.05.030; Baumgartner H, 2005, HEART, V91, P1483, DOI 10.1136/hrt.2004.056176; Iung B, 2005, EUR HEART J, V26, P2714, DOI 10.1093/eurheartj/ehi471; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Iung B, 2002, EUR HEART J, V23, P1253, DOI 10.1053/euhj.2002.3320; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; NKOMO VT, 2006, LANCET          0818, DOI DOI 10.1016/S0140-6736(06)69208-8; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Rabkin E, 2001, CIRCULATION, V104, P2525, DOI 10.1161/hc4601.099489; Rajamannan NM, 2003, HEART, V89, P801, DOI 10.1136/heart.89.7.801; Vahanian A, 2004, CIRCULATION, V109, P1572, DOI 10.1161/01.CIR.0000124794.16806.E3	12	19	20	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 16	2006	368	9540					969	971		10.1016/S0140-6736(06)69216-7	http://dx.doi.org/10.1016/S0140-6736(06)69216-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	086UO	16980094				2022-12-28	WOS:000240698700006
J	McVeigh, CM; Cairns, AP				McVeigh, Claire M.; Cairns, Andrew P.			Diagnosis and management of ankylosing spondylitis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ANTITUMOR NECROSIS FACTOR; RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; SACROILIAC JOINT; SPINAL INFLAMMATION; CLINICAL-RESPONSE; ALPHA BLOCKERS; THERAPY; INFLIXIMAB; MULTICENTER		Queens Univ Belfast, Musgrave Pk Hosp, Dept Rheumatol, Belfast BT9 7JB, Antrim, North Ireland	Queens University Belfast	Cairns, AP (corresponding author), Queens Univ Belfast, Musgrave Pk Hosp, Dept Rheumatol, Belfast BT9 7JB, Antrim, North Ireland.	andrew.cairns@greenpark.n-i.nhs.uk		Riddell, Claire/0000-0002-3187-7337				Balint PV, 2002, ANN RHEUM DIS, V61, P905, DOI 10.1136/ard.61.10.905; Baraliakos X, 2005, ARTHRIT RHEUM-ARTHR, V53, P856, DOI 10.1002/art.21588; Baraliakos X, 2005, ARTHRITIS RES THER, V7, pR439, DOI 10.1186/ar1693; Bessant R, 2003, J RHEUMATOL, V30, P779; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Braun J, 2002, LANCET, V359, P1187, DOI 10.1016/S0140-6736(02)08215-6; Braun J, 2006, ARTHRITIS RHEUM, V54, P1646, DOI 10.1002/art.21790; Cairns AP, 2005, ANN RHEUM DIS, V64, P338, DOI 10.1136/ard.2004.022871; Cairns AP, 2003, RHEUMATOLOGY, V42, P188, DOI 10.1093/rheumatology/keg046; Cairns AP, 2002, ULSTER MED J, V71, P101; Calin A, 2004, ANN RHEUM DIS, V63, P1594, DOI 10.1136/ard.2004.020875; Chen J, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004800.pub2; CHEN J, 2004, COCHRANE DB SYST REV; COOPER C, 1994, J RHEUMATOL, V21, P1877; DAGFINRUD H, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002822.PUB2; Davis JC, 2003, ARTHRITIS RHEUM, V48, P3230, DOI 10.1002/art.11325; EDMUNDS L, 1991, J RHEUMATOL, V18, P50; GARRETT S, 1994, J RHEUMATOL, V21, P2286; GONDALEZLOPEZ L, 2004, J RHEUMATOL, V31, P1568; Gorman JD, 2002, NEW ENGL J MED, V346, P1349, DOI 10.1056/NEJMoa012664; GRAN JT, 2003, RHEUMATOLOGY, V2, P1153; Grover R, 2006, ANN RHEUM DIS, V65, P688, DOI 10.1136/ard.2005.041392; Haibel H, 2006, ARTHRITIS RHEUM-US, V54, P678, DOI 10.1002/art.21563; Haibel H, 2003, RHEUMATOLOGY, V42, DOI 10.1093/rheumatology/keg256; Heiberg MS, 2005, ARTHRITIS RHEUM-US, V52, P2506, DOI 10.1002/art.21209; Heuft-Dorenbosch L, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1859; Keat A, 2005, RHEUMATOLOGY, V44, P939, DOI 10.1093/rheumatology/keh669; Khan MA, 2002, BEST PRACT RES CL RH, V16, P675, DOI 10.1053/BERH.2002.0243; KHAN MA, 2003, RHEUMATOLOGY, P1161; Kim DH, 2005, CURR OPIN IMMUNOL, V17, P4, DOI 10.1016/j.coi.2004.11.007; Kroesen S, 2003, RHEUMATOLOGY, V42, P617, DOI 10.1093/rheumatology/keg263; Kubiak EN, 2005, J AM ACAD ORTHOP SUR, V13, P267, DOI 10.5435/00124635-200507000-00006; Listing J, 2004, ANN RHEUM DIS, V63, P1670, DOI 10.1136/ard.2003.017327; Luukkainen R, 1999, CLIN EXP RHEUMATOL, V17, P88; Maksymowych WP, 2005, ARTHRIT RHEUM-ARTHR, V53, P703, DOI 10.1002/art.21445; Maksymowych WP, 2002, ARTHRITIS RHEUM, V46, P766, DOI 10.1002/art.10139; Martin TM, 2002, CURR OPIN RHEUMATOL, V14, P337, DOI 10.1097/00002281-200207000-00001; MAUGARS Y, 1992, ARTHRITIS RHEUM, V35, P564, DOI 10.1002/art.1780350512; Mitra D, 2000, RHEUMATOLOGY, V39, P85, DOI 10.1093/rheumatology/39.1.85; MOLL JMH, 1973, ANN RHEUM DIS, V32, P354, DOI 10.1136/ard.32.4.354; *NAT I CLIN EXC, 2002, 36 NICE; Peters MJ, 2004, SEMIN ARTHRITIS RHEU, V34, P585, DOI 10.1016/j.semarthrit.2004.07.010; Quinn MA, 2005, ARTHRITIS RHEUM-US, V52, P27, DOI 10.1002/art.20712; RALSTON SH, 1990, BMJ-BRIT MED J, V300, P563, DOI 10.1136/bmj.300.6724.563; Rudwaleit M, 2004, ANN RHEUM DIS, V63, P665, DOI 10.1136/ard.2003.016386; Rudwaleit M, 2006, ARTHRITIS RHEUM, V54, P569, DOI 10.1002/art.21619; Rudwaleit M, 2005, ARTHRITIS RHEUM, V52, P1000, DOI 10.1002/art.20990; Sieper J, 2005, RHEUMATOLOGY, V44, P1525, DOI 10.1093/rheumatology/kei046; Sweeney S, 2001, J RHEUMATOL, V28, P1862; van Denderen JC, 2006, ANN RHEUM DIS, V65, P695, DOI 10.1136/ard.2005.044503; van Denderen JC, 2005, ANN RHEUM DIS, V64, P1761, DOI 10.1136/ard.2005.036491; van der Heijde D, 2005, ARTHRITIS RHEUM-US, V52, P582, DOI 10.1002/art.20852; Van Tubergen A, 2001, ARTHRIT RHEUM-ARTHR, V45, P430, DOI 10.1002/1529-0131(200110)45:5<430::AID-ART362>3.0.CO;2-F; VANDERHEIJDE D, 2006, RHEUMATOLOGY OXFO S1, V45, pOP15; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Wanders A, 2005, ARTHRITIS RHEUM-US, V52, P1756, DOI 10.1002/art.21054; Yu W, 1998, SKELETAL RADIOL, V27, P311, DOI 10.1007/s002560050388; Zochling J, 2006, ANN RHEUM DIS, V65, P442, DOI 10.1136/ard.2005.041137; Zochling J, 2006, ANN RHEUM DIS, V65, P423, DOI 10.1136/ard.2005.041129	59	53	61	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2006	333	7568					581	585		10.1136/bmj.38954.689583.DE	http://dx.doi.org/10.1136/bmj.38954.689583.DE			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089KB	16974012	Green Published			2022-12-28	WOS:000240878200016
J	Vendruscolo, M; Dobson, CM				Vendruscolo, Michele; Dobson, Christopher M.			Dynamic visions of enzymatic reactions	SCIENCE			English	Editorial Material							PROTEIN; CATALYSIS; NMR		Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Vendruscolo, M (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.		Vendruscolo, Michele/F-5901-2012	Vendruscolo, Michele/0000-0002-3616-1610				Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Feynman R., 1963, FEYNMAN LECT PHYS, V1; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655; Krishna MMG, 2004, METHODS, V34, P51, DOI 10.1016/j.ymeth.2004.03.005; Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447	15	72	73	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2006	313	5793					1586	1587		10.1126/science.1132851	http://dx.doi.org/10.1126/science.1132851			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973868				2022-12-28	WOS:000240498900031
J	Shastri, N				Shastri, Nilabh			Peptides, scrambled and stitched	SCIENCE			English	Editorial Material							ANTIGEN		Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Shastri, N (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	nshastri@berkeley.edu						Gogarten JP, 2002, ANNU REV MICROBIOL, V56, P263, DOI 10.1146/annurev.micro.56.012302.160741; Goldberg AL, 2001, SCI AM, V284, P68, DOI 10.1038/scientificamerican0101-68; Hanada K, 2004, NATURE, V427, P252, DOI 10.1038/nature02240; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Shastri N, 2005, IMMUNOL REV, V207, P31, DOI 10.1111/j.0105-2896.2005.00321.x; Vigneron N, 2004, SCIENCE, V304, P587, DOI 10.1126/science.1095522; Warren EH, 2006, SCIENCE, V313, P1444, DOI 10.1126/science.1130660; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250	9	4	4	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2006	313	5792					1398	1399		10.1126/science.1132882	http://dx.doi.org/10.1126/science.1132882			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16959995				2022-12-28	WOS:000240348700029
J	Marsden, PA				Marsden, Philip A.			RNA interference as potential therapy - Not so fast.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									St Michaels Hosp, Div Nephrol, Toronto, ON M5B 1W8, Canada; Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Marsden, PA (corresponding author), St Michaels Hosp, Div Nephrol, 30 Bond St, Toronto, ON M5B 1W8, Canada.		Marsden, Philip A/B-1441-2012					Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806	4	22	25	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2006	355	9					953	954		10.1056/NEJMcibr063864	http://dx.doi.org/10.1056/NEJMcibr063864			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	078OM	16943409				2022-12-28	WOS:000240113100015
J	Pelton, SI; Kim, JY; Kradin, RL; Lee, MS; Harris, NL; Pasternack, MS; Goldstein, MA				Pelton, Stephen I.; Kim, John Y.; Kradin, Richard L.; Lee, Melissa Sue; Harris, Nancy Lee; Pasternack, Mark S.; Goldstein, Mark A.			A 17-year-old boy with fever and lesions in the liver and spleen - Hepatitis caused by Bartonella henselae.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CAT-SCRATCH DISEASE; YERSINIA-ENTEROCOLITICA; BACILLARY ANGIOMATOSIS; MULTIPLE ABSCESSES; MICROABSCESSES; INFECTION		Boston Med Ctr, Dept Pediat Infect Dis, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Boston Medical Center; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Pelton, SI (corresponding author), Boston Med Ctr, Dept Pediat Infect Dis, Boston, MA 02118 USA.			Pelton, Stephen/0000-0003-4862-5344				Bass JW, 1998, PEDIATR INFECT DIS J, V17, P447, DOI 10.1097/00006454-199806000-00002; Bass JW, 1997, PEDIATR INFECT DIS J, V16, P163, DOI 10.1097/00006454-199702000-00002; BRMBOLIC B, 1995, J CLIN GASTROENTEROL, V20, P307, DOI 10.1097/00004836-199506000-00011; Brook I, 1998, J MED MICROBIOL, V47, P1075, DOI 10.1099/00222615-47-12-1075; Chen CH, 2004, J FORMOS MED ASSOC, V103, P939; EATON M, 1997, PATHOLOGY EMERGING I; FARRER W, 1988, AM J MED SCI, V295, P129, DOI 10.1097/00000441-198802000-00008; GELFAND MS, 1989, REV INFECT DIS, V11, P983; Hopfner M, 2001, SCAND J GASTROENTERO, V36, P220, DOI 10.1080/003655201750066004; JACKSON LA, 1993, AM J PUBLIC HEALTH, V83, P1707, DOI 10.2105/AJPH.83.12.1707; KOEHLER JE, 1993, CLIN INFECT DIS, V17, P612, DOI 10.1093/clinids/17.4.612; Lechiche C, 2001, REV MED INTERNE, V22, P198, DOI 10.1016/S0248-8663(00)00314-3; Lodhi S, 2004, TROP MED INT HEALTH, V9, P718, DOI 10.1111/j.1365-3156.2004.01246.x; MANJUNATHA S, 1992, BRIT J HOSP MED, V47, P375; MARGILETH AM, 1987, J INFECT DIS, V155, P390, DOI 10.1093/infdis/155.3.390; RELMAN DA, 1990, NEW ENGL J MED, V323, P1573, DOI 10.1056/NEJM199012063232301; RIZKALLAH MF, 1988, PEDIATR INFECT DIS J, V7, P191, DOI 10.1097/00006454-198803000-00011; Schwartzman W. A., 2000, Current Treatment Options in Infectious Diseases, V2, P155; Sood A, 2001, Trop Gastroenterol, V22, P144; Strungs I, 1995, PATHOLOGY, V27, P374, DOI 10.1080/00313029500169353; Verbanck J, 1999, J CLIN ULTRASOUND, V27, P478, DOI 10.1002/(SICI)1097-0096(199910)27:8<478::AID-JCU11>3.0.CO;2-2; WEAR DJ, 1994, ADV DIAGNOSTIC PATHO, P29; Zheng RQ, 2004, J GASTROENTEROL, V39, P497, DOI 10.1007/s00535-003-1327-0	23	13	13	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2006	355	9					941	948		10.1056/NEJMcpc069017	http://dx.doi.org/10.1056/NEJMcpc069017			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	078OM	16943407				2022-12-28	WOS:000240113100013
J	Savukov, IM; Lee, SK; Romalis, MV				Savukov, I. M.; Lee, S. -K.; Romalis, M. V.			Optical detection of liquid-state NMR	NATURE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; CIRCULARLY-POLARIZED LIGHT; SPECTROSCOPY; SPECTRA; GASES; HG-199; VAPORS; VACUUM; XE-129; PHASE	Nuclear magnetic resonance (NMR) in liquids and solids is primarily detected by recording the net dipolar magnetic field outside the spin-polarized sample. But the recorded bulk magnetic field itself provides only limited spatial or structural information about the sample. Most NMR applications rely therefore on more elaborate techniques such as magnetic field gradient encoding(1) or spin correlation spectroscopy(2), which enable spatially resolved imaging and molecular structure analysis, respectively. Here we demonstrate a fundamentally different and intrinsically information-richer modality of detecting NMR, based on the rotation of the polarization of a laser beam by the nuclear spins in a liquid sample. Optical NMR detection has in fact a long history in atomic vapours with narrow resonance lines(3,4), but has so far only been applied to highly specialized condensed matter systems such as quantum dots(5). It has been predicted(6) that laser illumination can shift NMR frequencies and thus aid detection, but the effect is very small and has never been observed. In contrast, our measurements on water and liquid Xe-129 show that the complementary effect the rotation of light polarization by nuclear spins - is readily measurable, and that it is enhanced dramatically in samples containing heavy nuclei. This approach to optical NMR detection should allow correlated optical and NMR spectroscopy on complex molecules, and continuous two-dimensional imaging of nuclear magnetization with spatial resolution limited only by light diffraction.	Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	Princeton University	Romalis, MV (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	romalis@princeton.edu	lee, seungkyun/A-3464-2008	lee, seungkyun/0000-0001-7625-3141				AUE WP, 1976, J CHEM PHYS, V64, P2229, DOI 10.1063/1.432450; Barron L. D., 1982, MOL LIGHT SCATTERING; Buckingham, 1967, ADV CHEM PHYS, V12, P107, DOI DOI 10.1002/9780470143582.CH2; Buckingham AD, 1997, MOL PHYS, V91, P805, DOI 10.1080/00268979709482771; BUCKINGHAM AD, 1994, SCIENCE, V264, P1748, DOI 10.1126/science.264.5166.1748; Cox FM, 2006, OPT EXPRESS, V14, P4135, DOI 10.1364/OE.14.004135; Driehuys B, 1996, APPL PHYS LETT, V69, P1668, DOI 10.1063/1.117022; EVANS MW, 1991, J PHYS CHEM-US, V95, P2256, DOI 10.1021/j100159a030; Fini JM, 2004, MEAS SCI TECHNOL, V15, P1120, DOI 10.1088/0957-0233/15/6/011; HAPPER W, 1967, PHYS REV, V163, P12, DOI 10.1103/PhysRev.163.12; HARRIS RA, 1994, J CHEM PHYS, V101, P9289, DOI 10.1063/1.467959; INGERSOLL LR, 1956, J OPT SOC AM, V46, P538, DOI 10.1364/JOSA.46.000538; Jaszunski M, 1999, MOL PHYS, V96, P855, DOI 10.1080/002689799165242; Kikkawa JM, 2000, SCIENCE, V287, P473, DOI 10.1126/science.287.5452.473; LAUTERBUR PC, 1973, NATURE, V242, P190, DOI 10.1038/242190a0; Ledbetter MP, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.287601; Li L, 1998, J PHYS CHEM A, V102, P10385, DOI 10.1021/jp982748y; LUCKOENIG E, 1972, J PHYS-PARIS, V33, P847, DOI 10.1051/jphys:019720033010084700; MANUEL J, 1963, CR HEBD ACAD SCI, V257, P413; MAYSTRE F, 1989, OPT LETT, V14, P587, DOI 10.1364/OL.14.000587; OLSON DL, 1995, SCIENCE, V270, P1967, DOI 10.1126/science.270.5244.1967; Romalis MV, 2001, PHYS REV LETT, V86, P2505, DOI 10.1103/PhysRevLett.86.2505; Romero RH, 2004, CHEM PHYS LETT, V400, P226, DOI 10.1016/j.cplett.2004.10.113; SCHAEFER SR, 1989, PHYS REV A, V39, P5613, DOI 10.1103/PhysRevA.39.5613; VANDERZIEL JP, 1965, PHYS REV LETT, V15, P190, DOI 10.1103/PhysRevLett.15.190; WARREN WS, 1992, SCIENCE, V255, P1683, DOI 10.1126/science.1553555; Warren WS, 1998, MOL PHYS, V93, P371, DOI 10.1080/002689798169041; Xu SC, 2002, REV SCI INSTRUM, V73, P255, DOI 10.1063/1.1430729; YOSHINO K, 1985, J OPT SOC AM B, V2, P1268, DOI 10.1364/JOSAB.2.001268; Zavattini E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.110406	30	74	75	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 31	2006	442	7106					1021	1024		10.1038/nature05088	http://dx.doi.org/10.1038/nature05088			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	078YF	16943834				2022-12-28	WOS:000240142000045
J	Blajchman, MA; Vamvakas, EC				Blajchman, Morris A.; Vamvakas, Eleftherios C.			The continuing risk of transfusion-transmitted infections	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BLOOD; DISEASE		McMaster Univ, Hamilton, ON, Canada; McMaster Hamilton Reg Lab Med Program, Transfus Med Serv, Hamilton, ON, Canada; Hamilton Ctr Canadian Blood Serv, Hamilton, ON, Canada; Univ Ottawa, Fac Med, Ottawa, ON, Canada	McMaster University; McMaster University; Canadian Blood Services; University of Ottawa	Blajchman, MA (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Collinge J, 2006, LANCET, V367, P2068, DOI 10.1016/S0140-6736(06)68930-7; Dodd RY, 2002, TRANSFUSION, V42, P975, DOI 10.1046/j.1537-2995.2002.00174.x; Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Wilson K, 2003, TRANSFUS MED REV, V17, P89, DOI 10.1053/tmrv.2003.50007	5	78	93	2	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2006	355	13					1303	1305		10.1056/NEJMp068178	http://dx.doi.org/10.1056/NEJMp068178			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088EF	17005947				2022-12-28	WOS:000240793600003
J	Stinchcombe, JC; Majorovits, E; Bossi, G; Fuller, S; Griffiths, GM				Stinchcombe, Jane C.; Majorovits, Endre; Bossi, Giovanna; Fuller, Stephen; Griffiths, Gillian M.			Centrosome polarization delivers secretory granules to the immunological synapse	NATURE			English	Article							MICROTUBULE; CYTOSKELETON; LYMPHOCYTES; TRANSPORT	Cytotoxic T lymphocytes (CTLs) destroy virally infected and tumorigenic cells by releasing the contents of specialized secretory lysosomes - termed 'lytic granules' - at the immunological synapse formed between the CTL and the target(1). On contact with the target cell, the microtubule organizing centre of the CTL polarizes towards the target(2,3) and granules move along microtubules in a minus-end direction towards the polarized microtubule organizing centre. However, the final steps of secretion have remained unclear. Here we show that CTLs do not require actin or plus-end microtubule motors for secretion, but instead the centrosome moves to and contacts the plasma membrane at the central supramolecular activation cluster of the immunological synapse. Actin and IQGAP1 are cleared away from the synapse, and granules are delivered directly to the plasma membrane. These data show that CTLs use a previously unreported mechanism for delivering secretory granules to the immunological synapse, with granule secretion controlled by centrosome delivery to the plasma membrane.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics	Griffiths, GM (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	gillian.griffiths@path.ox.ac.uk		stinchcombe, jane/0000-0003-1459-9299; Griffiths, Gillian/0000-0003-0434-5842	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Cannon JL, 2002, IMMUNOL REV, V186, P90, DOI 10.1034/j.1600-065X.2002.18609.x; Cowan CR, 2004, NATURE, V431, P92, DOI 10.1038/nature02825; FRUTH U, 1987, EUR J IMMUNOL, V17, P1625, DOI 10.1002/eji.1830171116; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; GEIGER B, 1982, J CELL BIOL, V95, P137, DOI 10.1083/jcb.95.1.137; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Ishikawa H, 2005, NAT CELL BIOL, V7, P517, DOI 10.1038/ncb1251; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Kuhn JR, 2002, IMMUNITY, V16, P111, DOI 10.1016/S1074-7613(02)00262-5; KUPFER A, 1984, J IMMUNOL, V133, P2762; LANGE BMH, 1995, J CELL BIOL, V130, P919, DOI 10.1083/jcb.130.4.919; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Lin J, 2005, J CELL BIOL, V170, P177, DOI 10.1083/jcb.200503032; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Poenie M, 2004, CURR OPIN IMMUNOL, V16, P428, DOI 10.1016/j.coi.2004.05.016; SOROKIN SP, 1968, J CELL SCI, V3, P207; Stinchcombe J, 2004, SCIENCE, V305, P55, DOI 10.1126/science.1095291; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027	23	451	459	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2006	443	7110					462	465		10.1038/nature05071	http://dx.doi.org/10.1038/nature05071			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	17006514				2022-12-28	WOS:000240798800047
J	Morton, GJ; Cummings, DE; Baskin, DG; Barsh, GS; Schwartz, MW				Morton, G. J.; Cummings, D. E.; Baskin, D. G.; Barsh, G. S.; Schwartz, M. W.			Central nervous system control of food intake and body weight	NATURE			English	Review							PLASMA GHRELIN LEVELS; CAUDAL BRAIN-STEM; INSULIN-RECEPTOR; LEPTIN RECEPTOR; ARCUATE NUCLEUS; RECOMBINANT LEPTIN; PLACE PREFERENCE; MESSENGER-RNA; ADULT MICE; NEURONS	The capacity to adjust food intake in response to changing energy requirements is essential for survival. Recent progress has provided an insight into the molecular, cellular and behavioural mechanisms that link changes of body fat stores to adaptive adjustments of feeding behaviour. The physiological importance of this homeostatic control system is highlighted by the severe obesity that results from dysfunction of any of several of its key components. This new information provides a biological context within which to consider the global obesity epidemic and identifies numerous potential avenues for therapeutic intervention and future research.	Harborview Med Ctr, Dept Med, Seattle, WA 98104 USA; Univ Washington, Dept Med, Seattle, WA 98104 USA; Vet Affairs Puget Sound Hlth Care Syst, Dept Med, Seattle, WA 98108 USA; Univ Washington, Dept Biol Struct, Seattle, WA 98104 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA	Harborview Medical Center; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; Stanford University; Stanford University	Schwartz, MW (corresponding author), Harborview Med Ctr, Dept Med, Seattle, WA 98104 USA.	mschwart@u.washington.edu	Schwartz, Michael W/H-9950-2012					Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Berthoud HR, 2004, PHYSIOL BEHAV, V81, P781, DOI 10.1016/j.physbeh.2004.04.034; Bewick GA, 2005, FASEB J, V19, P1680, DOI 10.1096/fj.04-3434fje; Bjorbaek C, 1997, J BIOL CHEM, V272, P32686, DOI 10.1074/jbc.272.51.32686; Blevins JE, 2004, AM J PHYSIOL-REG I, V287, pR87, DOI 10.1152/ajpregu.00604.2003; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; CARROLL ME, 1979, SCIENCE, V205, P319, DOI 10.1126/science.36665; Choudhury AI, 2005, J CLIN INVEST, V115, P940; Cohen P, 2001, J CLIN INVEST, V108, P1113, DOI 10.1172/JCI200113914; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Cummings DE, 2002, NEW ENGL J MED, V346, P1623, DOI 10.1056/NEJMoa012908; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Doyon C, 2001, GEN COMP ENDOCR, V124, P188, DOI 10.1006/gcen.2001.7701; Elmquist JK, 1998, J COMP NEUROL, V395, P535; EMOND M, 1997, AM J PHYSIOL, V276, pR1545; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Figlewicz DP, 2004, BEHAV NEUROSCI, V118, P479, DOI 10.1037/0735-7044.118.3.479; Figlewicz DP, 2003, AM J PHYSIOL-REG I, V284, pR882, DOI 10.1152/ajpregu.00602.2002; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Fulton S, 2000, SCIENCE, V287, P125, DOI 10.1126/science.287.5450.125; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; GIBBS J, 1973, J COMP PHYSIOL PSYCH, V84, P488, DOI 10.1037/h0034870; Grill HJ, 2002, ENDOCRINOLOGY, V143, P239, DOI 10.1210/en.143.1.239; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; He W, 2006, NAT NEUROSCI, V9, P227, DOI 10.1038/nn1626; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Kelley AE, 2002, J NEUROSCI, V22, P3306; KENNEDY GC, 1953, PROC R SOC SER B-BIO, V140, P578, DOI 10.1098/rspb.1953.0009; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Kringelbach ML, 2003, CEREB CORTEX, V13, P1064, DOI 10.1093/cercor/13.10.1064; Lambert PD, 2001, P NATL ACAD SCI USA, V98, P4652, DOI 10.1073/pnas.061034298; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Leibowitz SF, 1998, BIOL PSYCHIAT, V44, P851, DOI 10.1016/S0006-3223(98)00186-3; LEIBOWITZ SF, 1984, PHARMACOL BIOCHEM BE, V21, P801, DOI 10.1016/S0091-3057(84)80022-2; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Morton GJ, 2005, J CLIN INVEST, V115, P703, DOI 10.1172/JCI200522081; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Niswender KD, 2003, DIABETES, V52, P227, DOI 10.2337/diabetes.52.2.227; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Rolls ET, 2005, PHYSIOL BEHAV, V85, P45, DOI 10.1016/j.physbeh.2005.04.012; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seeley RJ, 1997, NATURE, V390, P349, DOI 10.1038/37016; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; Sims E A, 1973, Recent Prog Horm Res, V29, P457; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; Strubbe JH, 2004, PSYCHOL REV, V111, P128, DOI 10.1037/0033-295X.111.1.128; Stuber GD, 2002, SYNAPSE, V46, P83, DOI 10.1002/syn.10120; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Thornton JE, 1997, ENDOCRINOLOGY, V138, P5063, DOI 10.1210/en.138.11.5063; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; van den Top M, 2004, NAT NEUROSCI, V7, P493, DOI 10.1038/nn1226; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Xu AW, 2005, PLOS BIOL, V3, P2168, DOI 10.1371/journal.pbio.0030415; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	75	1748	1821	11	368	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 21	2006	443	7109					289	295		10.1038/nature05026	http://dx.doi.org/10.1038/nature05026			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085RL	16988703				2022-12-28	WOS:000240622000036
J	Vogeli, KM; Jin, SW; Martin, GR; Stainier, DYR				Vogeli, Kevin M.; Jin, Suk-Won; Martin, Gail R.; Stainier, Didier Y. R.			A common progenitor for haematopoietic and endothelial lineages in the zebrafish gastrula	NATURE			English	Article							CELLS; HEMANGIOBLAST; ORGANIZATION; COMMITMENT; ORIGIN	It has been proposed that haematopoietic and endothelial cells share a common progenitor, termed the haemangioblast. This idea was initially conceived as a result of the observation that these two cell types develop in close proximity to each other within the embryo(1,2). Support for this hypothesis was provided by studies on single-cell-derived colonies that can produce both haematopoietic and endothelial cells in vitro(3-7). Although these data point towards the existence of a common progenitor for these two lineages, the presence of a bipotential progenitor cell has yet to be demonstrated in vivo. Through the construction of single-cell-resolution fate maps of the zebrafish late blastula and gastrula, we demonstrate that individual cells can give rise to both haematopoietic and endothelial cells. These bipotential progenitors arise along the entire extent of the ventral mesoderm and contribute solely to haematopoietic and endothelial cells. We also find that only a subset of haematopoietic and endothelial cells arise from haemangioblasts. The endothelial descendants of the haemangioblasts all clustered in a specific region of the axial vessels regardless of the location of their progenitors. Our results provide in vivo evidence supporting the existence of the haemangioblast and reveal distinct features of this cell population.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stainier, DYR (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 1550 4th St, San Francisco, CA 94158 USA.	didier_stainier@biochem.ucsf.edu		Stainier, Didier/0000-0002-0382-0026				Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Choi K, 1998, DEVELOPMENT, V125, P725; D'Souza SL, 2005, BLOOD, V105, P3862, DOI 10.1182/blood-2004-09-3611; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Horne-Badovinac S, 2003, SCIENCE, V302, P662, DOI 10.1126/science.1085397; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Keegan BR, 2004, DEVELOPMENT, V131, P3081, DOI 10.1242/dev.01185; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; Kinder SJ, 1999, DEVELOPMENT, V126, P4691; Kozlowski DJ, 1997, BIOCHEM CELL BIOL, V75, P551, DOI 10.1139/bcb-75-5-551; Murray PDF, 1932, P R SOC LOND B-CONTA, V111, P497, DOI 10.1098/rspb.1932.0070; Parker LH, 1999, METHOD CELL BIOL, V59, P313; Sabin FR, 1917, ANAT REC, V13, P199, DOI 10.1002/ar.1090130403; Schuh AC, 1999, P NATL ACAD SCI USA, V96, P2159, DOI 10.1073/pnas.96.5.2159; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Warga RM, 1999, DEVELOPMENT, V126, P827; Westerfield M, 1993, ZEBRAFISH BOOK	18	222	227	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2006	443	7109					337	339		10.1038/nature05045	http://dx.doi.org/10.1038/nature05045			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085RL	16988712				2022-12-28	WOS:000240622000046
J	Pathela, P; Hajat, A; Schillinger, J; Blank, S; Sell, R; Mostashari, F				Pathela, Preeti; Hajat, Anjum; Schillinger, Julia; Blank, Susan; Sell, Randall; Mostashari, Farzad			Discordance between sexual behavior and self-reported sexual identity: A population-based survey of New York City men	ANNALS OF INTERNAL MEDICINE			English	Article							RISK BEHAVIORS; HIV EPIDEMIC; GAY; PREVENTION; SAMPLE	Background: Persons reporting sexual identity that is discordant with their sexual behavior may engage in riskier sexual behaviors than those with concordant identity and behavior. The former group could play an important role in the spread of sexually transmitted diseases. Objective: To describe discordance between self-described sexual identity and behavior among men who have sex with men and associations between identity-behavior and risk behaviors. Design: Cross-sectional, random digit-dialed telephone survey of health status and risk behaviors. Setting: New York City. Participants: Population-based sample of 4193 men. Measurements: Concurrent measures of sexual identity and sexual behaviors, including number and sex of sex partners, condom use during last sexual encounter, and recent testing for HIV infection . Sex partner information was ascertained in a separate section from sexual identity; all participants were asked about the number of male sex partners and then were asked about the number of female sex partners in the past year. Results: Of New York City men reporting a sexual identity, 12% reported sex with other men. Men who had sex with men exclusively but self-identified as heterosexual were more likely than their gay-identified counterparts to belong to minority racial or ethnic groups, be foreign-born, have lower education and income levels, and be married. These men were more likely than gay-identified men who have sex with men to report having only 1 sexual partner in the previous year. However, they were less likely to have been tested for HIV infection during that time (adjusted prevalence ratio, 0.6 [95% CI, 0.4 to 0.9]) and less likely to have used condoms during their last sexual encounter (adjusted prevalence ratio, 0.5 [CI, 0.3 to 1.0]). Limitations: The survey did not sample groups that cannot be reached by using residential telephone services. Conclusions: Many New York City men who have sex with men do not identify as gay. Medical providers cannot rely on patients' self-reported identities to appropriately assess risk for HIV infection and sexually transmitted diseases; they must inquire about behavior. Public health prevention messages should target risky sexual activities rather than a person's sexual identity.	New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA; Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10013 USA; Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA; Ctr Dis Control & Prevent, Div Sexually Transmitted Dis Prevent, Atlanta, GA USA	New York City Department of Health & Mental Hygiene; Columbia University; University of North Carolina; University of North Carolina Chapel Hill; Centers for Disease Control & Prevention - USA	Pathela, P (corresponding author), New York City Dept Hlth & Mental Hyg, 125 Worth St,Room 207,CN73, New York, NY 10013 USA.							Agronick G, 2004, AIDS BEHAV, V8, P185, DOI 10.1023/B:AIBE.0000030249.11679.d0; [Anonymous], 1999, MMWR MORB MORTAL WKL, V48, P45; Behavioral Risk Factors Surveillance System, 2005, OP US GUID VERS 3 0; Blumberg SJ, 2003, J SEX RES, V40, P121, DOI 10.1080/00224490309552173; Caceres CF, 2002, AIDS, V16, pS23, DOI 10.1097/00002030-200212003-00005; CARRIER JM, 1985, BISEXUALITIES THEORY, P75; Catania JA, 2001, AM J PUBLIC HEALTH, V91, P907, DOI 10.2105/AJPH.91.6.907; Catania Joseph A., 1995, V6, P77; *CDCP, 2004, HIV AIDS SURV REP 20, P10; DOLL LS, 1992, J SEX RES, V29, P1, DOI 10.1080/00224499209551630; EARL WL, 1990, J SEX MARITAL THER, V16, P251; Elford J, 2003, AIDS EDUC PREV, V15, P294, DOI 10.1521/aeap.15.5.294.23825; FAY RE, 1989, SCIENCE, V243, P338, DOI 10.1126/science.2911744; Garofalo R, 1998, PEDIATRICS, V101, P895, DOI 10.1542/peds.101.5.895; Goldbaum G, 1996, PUBLIC HEALTH REP, V111, P36; Goldbaum G, 1998, AIDS BEHAV, V2, P13, DOI DOI 10.1023/A:1022399021926; *I MED, 2000, NO TIM LOS GETT MOR; Kennamer JD, 2000, AIDS EDUC PREV, V12, P519; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Lau JTF, 2004, SEX TRANSM INFECT, V80, P459, DOI 10.1136/sti.2003.008854; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; *NAT CTR HLTH STAT, DAT DEF REL STAND ER; QUAN VM, 2000, 13 INT C AIDS DURB S; Research Triangle Institute, 2001, SUDAAN US MAN REL 8; Rietmeijer CA, 1998, SEX TRANSM DIS, V25, P353, DOI 10.1097/00007435-199808000-00006; Ross MW, 2003, SEX TRANSM DIS, V30, P110, DOI 10.1097/00007435-200302000-00003; Smith AMA, 2003, AUST NZ J PUBL HEAL, V27, P138, DOI 10.1111/j.1467-842X.2003.tb00801.x; Wolitski RJ, 2001, AM J PUBLIC HEALTH, V91, P883, DOI 10.2105/AJPH.91.6.883; 2004, MMWR MORB MORTAL WKL, V53, P575; 2003, MMWR MORB MORTAL WKL, V52, P81; 2002, MMWR MORTAL WKLY REP, V51, P853; 1993, MMWR MORB MORTAL WKL, V42, P7; 2004, MMWR MORB MORTAL WKL, V53, P985; 2004, MMWR MORB MORTAL WKL, V53, P731; 2003, MMWR MORB MORTAL WKL, V52, P1145; 1993, MMWR MORB MORTAL WKL, V42, P13; 2002, MMWR RECOMM REP, V51, P7	37	196	199	1	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2006	145	6					416	425		10.7326/0003-4819-145-6-200609190-00005	http://dx.doi.org/10.7326/0003-4819-145-6-200609190-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	087OU	16983129				2022-12-28	WOS:000240752500003
J	McNiven, MA; Thompson, HM				McNiven, Mark A.; Thompson, Heather M.			Vesicle formation at the plasma membrane and trans-Golgi network: The same but different	SCIENCE			English	Review							CLATHRIN-MEDIATED ENDOCYTOSIS; ACTIN CYTOSKELETON; SORTING NEXIN-9; BINDING PROTEIN; ENTH DOMAIN; COATED PITS; DYNAMIN; TRAFFICKING; COMPLEX; EPS15	An elaborate vesicle transport system supports the active exchange of membranes and protein cargo between the plasma membrane and the trans-Golgi network. Many observations suggest that highly conserved mechanisms are used in vesicle formation and scission. Such similarity is found both at the level of the receptor-ligand sequestration process that uses clathrin and associated polymeric and monomeric adaptor proteins, and in the machinery used to deform and vesiculate lipid membranes.	Mayo Clin & Mayo Fdn, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Miles & Shirley Fiterman Ctr Digest Dis, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	McNiven, MA (corresponding author), Mayo Clin & Mayo Fdn, Coll Med, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.	mcniven.mark@mayo.edu			NATIONAL CANCER INSTITUTE [R01CA104125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044650, R01DK044650, R29DK044650] Funding Source: NIH RePORTER; NCI NIH HHS [CA104125-02, R01 CA104125-05, R01 CA104125] Funding Source: Medline; NIDDK NIH HHS [R01 DK044650, DK44650-15] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Benmerah A, 1996, J BIOL CHEM, V271, P12111, DOI 10.1074/jbc.271.20.12111; Benmerah A, 2000, J BIOL CHEM, V275, P3288, DOI 10.1074/jbc.275.5.3288; Boehm M, 2002, GENE, V286, P175, DOI 10.1016/S0378-1119(02)00422-5; Bonazzi M, 2005, NAT CELL BIOL, V7, P570, DOI 10.1038/ncb1260; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brett TJ, 2006, CURR OPIN CELL BIOL, V18, P395, DOI 10.1016/j.ceb.2006.06.014; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Cao H, 2005, NAT CELL BIOL, V7, P483, DOI 10.1038/ncb1246; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Carreno S, 2004, J CELL BIOL, V165, P781, DOI 10.1083/jcb.200403120; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; De Camilli P, 2002, FEBS LETT, V513, P11, DOI 10.1016/S0014-5793(01)03306-3; De Matteis MA, 2004, BBA-BIOMEMBRANES, V1666, P264, DOI 10.1016/j.bbamem.2004.07.002; De Matteis MA, 2004, NAT CELL BIOL, V6, P487, DOI 10.1038/ncb0604-487; Di Fiore PP, 2003, NAT REV MOL CELL BIO, V4, P491, DOI 10.1038/nrm1124; Donaldson JG, 2005, BBA-MOL CELL RES, V1744, P364, DOI 10.1016/j.bbamcr.2005.03.001; Downes CP, 2005, TRENDS CELL BIOL, V15, P259, DOI 10.1016/j.tcb.2005.03.008; Duncan MC, 2003, TRENDS CELL BIOL, V13, P211, DOI 10.1016/S0962-8924(03)00076-X; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Ellis S, 2000, TRENDS CELL BIOL, V10, P85, DOI 10.1016/S0962-8924(99)01710-9; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Engqvist-Goldstein AEY, 2004, MOL BIOL CELL, V15, P1666, DOI 10.1091/mbc.E03-09-0639; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; FAZIOLI F, 1993, MOL CELL BIOL, V13, P5814, DOI 10.1128/MCB.13.9.5814; Gkantiragas I, 2001, MOL BIOL CELL, V12, P1819, DOI 10.1091/mbc.12.6.1819; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hinners I, 2003, J CELL SCI, V116, P763, DOI 10.1242/jcs.00270; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; Holthuis JCM, 2003, MOL MEMBR BIOL, V20, P231, DOI 10.1080/0988768031000100768; Iannolo G, 1997, CANCER RES, V57, P240; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kent HM, 2002, STRUCTURE, V10, P1139, DOI 10.1016/S0969-2126(02)00801-8; Kessels MM, 2006, J CELL SCI, V119, P1504, DOI 10.1242/jcs.02877; Kessels MM, 2004, J CELL SCI, V117, P3077, DOI 10.1242/jcs.01290; Kessels MM, 2001, J CELL BIOL, V153, P351, DOI 10.1083/jcb.153.2.351; Legendre-Guillemin V, 2004, J CELL SCI, V117, P9, DOI 10.1242/jcs.00928; Liscum L, 1999, BBA-MOL CELL BIOL L, V1438, P19, DOI 10.1016/S1388-1981(99)00043-8; Lundmark R, 2004, J BIOL CHEM, V279, P42694, DOI 10.1074/jbc.M407430200; Lundmark R, 2003, J BIOL CHEM, V278, P46772, DOI 10.1074/jbc.M307334200; Lundmark R, 2002, BIOCHEM J, V362, P597, DOI 10.1042/0264-6021:3620597; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; Modregger J, 2003, J BIOL CHEM, V278, P4160, DOI 10.1074/jbc.M208568200; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Paleotti O, 2005, J BIOL CHEM, V280, P21661, DOI 10.1074/jbc.m503099200; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Puertollano R, 2004, NAT CELL BIOL, V6, P244, DOI 10.1038/ncb1106; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Sarret P, 2004, J BIOL CHEM, V279, P8029, DOI 10.1074/jbc.M310792200; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; van Meer G, 2000, BBA-MOL CELL BIOL L, V1486, P145, DOI 10.1016/S1388-1981(00)00054-8; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	68	82	86	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2006	313	5793					1591	1594		10.1126/science.1118133	http://dx.doi.org/10.1126/science.1118133			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973870				2022-12-28	WOS:000240498900033
J	Okie, S				Okie, Susan			Global health - The Gates-Buffet effect	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Gottret P. E., 2006, HLTH FINANCING REVIS; SPECTER M, 2005, NEW YORKER      1024	2	23	24	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 14	2006	355	11					1084	1088		10.1056/NEJMp068186	http://dx.doi.org/10.1056/NEJMp068186			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	083NJ	16971714				2022-12-28	WOS:000240462800002
J	Oonk, MHM; van der Ploeg, JM; van Lonkhuijzen, LRCW				Oonk, Maaike H. M.; van der Ploeg, J. Marinus; van Lonkhuijzen, Luc R. C. W.			Vulvar ulceration with an unexpected underlying cause	LANCET			English	Editorial Material							CROHNS-DISEASE		Univ Groningen, Med Ctr, Dept Gynaecol, NL-9700 RB Groningen, Netherlands; Martini Hosp, Dept Obstet & Gynaecol, Groningen, Netherlands	University of Groningen; Martini Hospital	Oonk, MHM (corresponding author), Univ Groningen, Med Ctr, Dept Gynaecol, POB 30-001, NL-9700 RB Groningen, Netherlands.	m.h.m.oonk@og.umcg.nl						Bhaduri S, 2005, INT J STD AIDS, V16, P512, DOI 10.1258/0956462054308468; Fenniche S, 1997, ANN DERMATOL VENER, V124, P629; Kolivras A, 2003, DERMATOLOGY, V206, P381, DOI 10.1159/000069963	3	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 9	2006	368	9539					962	962		10.1016/S0140-6736(06)69377-X	http://dx.doi.org/10.1016/S0140-6736(06)69377-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083ZX	16962887				2022-12-28	WOS:000240502300035
J	Oransky, I				Oransky, Ivan			Joan Wright Goodman - Obituary	LANCET			English	Biographical-Item												ivan-oransky@erols.com						GOODMAN J, PUBLICATION LIST	1	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 9	2006	368	9539					912	912		10.1016/S0140-6736(06)69358-6	http://dx.doi.org/10.1016/S0140-6736(06)69358-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083ZX	16998958	Bronze			2022-12-28	WOS:000240502300014
J	Bryce, J; El Arifeen, S; Bhutta, ZA; Black, RE; Claeson, M; Gillespie, D; Gwatkin, DR; Habicht, JP; Jone, G; Lanata, CF; Morris, SS; Mshinda, H; Pariyo, G; Perkin, G; Schellenberg, JA; Steketee, R; Troedsson, H; Victora, CG				Bryce, Jennifer; El Arifeen, Shams; Bhutta, Zulpqar A.; Black, Robert E.; Claeson, Mariam; Gillespie, Duff; Gwatkin, Davidson R.; Habicht, Jean-Pierre; Jone, Gareth; Lanata, Claudio F.; Morris, Saul S.; Mshinda, Hassan; Pariyo, George; Perkin, Gordon; Schellenberg, Joanna Armstrong; W Steketee, Richard; Troedsson, Hans; Victora, Cesar G.			Getting it right for children: a review of UNICEFjoint health and nutrition strategy for 2006-15	LANCET			English	Editorial Material									Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA; ICDDR B, Ctr Hlth & Populat Res B, Child Hlth Programme, Dhaka, Bangladesh; Aga Khan Univ, Dept Paediat, Karachi, Pakistan; World Bank, Washington, DC 20433 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Bill & Melinda Gates Inst Populat & Reprod Hlth, Baltimore, MD USA; Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; Inst Invest Nutr, Lima, Peru; London Sch Hyg & Trop Med, London WC1, England; Ifakara Ctr Res & Dev, Ifakara, Tanzania; Makerere Univ, Inst Publ Hlth, Kampala, Uganda; Bill & Melinda Gates Fdn, Seattle, WA USA; PATH, Ferney Voltaire, France; WHO, Hanoi, Vietnam; Univ Fed Pelotas, Pelotas, Brazil	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; International Centre for Diarrhoeal Disease Research (ICDDR); Aga Khan University; The World Bank; Bill & Melinda Gates Foundation; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Cornell University; University of London; London School of Hygiene & Tropical Medicine; Ifakara Health Institute; Makerere University; Bill & Melinda Gates Foundation; World Health Organization; Universidade Federal de Pelotas	Bryce, J (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA.	jbrycedanby@aol.com	Victora, Cesar G/D-4476-2013; Victora, Cesar Gomes/Y-2455-2019; Lanata, Claudio F./N-7997-2018; Pariyo, George W/K-2335-2017	Victora, Cesar G/0000-0002-2465-2180; Victora, Cesar Gomes/0000-0002-2465-2180; Lanata, Claudio F./0000-0002-6994-7425; Pariyo, George W/0000-0002-4411-2309; Morris, Saul/0000-0002-9372-7342; Arifeen, Shams/0000-0002-5372-5932; Black, Robert/0000-0001-9926-7984; Schellenberg, Joanna/0000-0002-0708-3676				Bryce J, 2005, LANCET, V365, P2193, DOI 10.1016/S0140-6736(05)66777-3; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; BRYCE J, 2006, IN PRESS LANCET; Claeson M, 2003, LANCET, V362, P323, DOI 10.1016/S0140-6736(03)13977-3; Freedman LP, 2005, WHOS GOT POWER TRANS; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; POWELLJACKSON T, 2006, IN PRESS LANCET; *UN MILL DEV GOALS, 2005, WHAT AR MILL DEV GOA; United Nations Children's Fund (UNICEF), 2005, UNICEF JOINT HLTH NU; *WORLD BANK, 2005, MILL DEV GOALS HLTH	10	12	12	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2006	368	9538					817	819		10.1016/S0140-6736(06)69299-4	http://dx.doi.org/10.1016/S0140-6736(06)69299-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	082FD	16950338				2022-12-28	WOS:000240371200004
J	Quilty, S; Anderson, K; Hewitt, J; Fahy, R; Clothier, T; Roseby, R				Quilty, Simon; Anderson, Kym; Hewitt, Jacky; Fahy, Rose; Clothier, Tors; Roseby, Rob			Deprivation in the desert: a case report from central Australia	LANCET			English	Editorial Material									Alice Springs Hosp, Alice Springs, NT 0871, Australia		Quilty, S (corresponding author), Alice Springs Hosp, POB 2234, Alice Springs, NT 0871, Australia.	squilty@med.usyd.edu.au	Hewitt, Jacqueline/F-6082-2012	Hewitt, Jacqueline/0000-0002-3809-8475				*AUSTR BUR STAT, 2004, YB AUSTR 2004 CAT 13; BERL T, 1977, J CLIN INVEST, V60, P620, DOI 10.1172/JCI108813; Couzos S, 2003, ABORIGINAL PRIMARY H; FREIMAN I, 1987, J PEDIAT GASTROENTER, V1, P547	4	1	1	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 2	2006	368	9538					890	890		10.1016/S0140-6736(06)69330-6	http://dx.doi.org/10.1016/S0140-6736(06)69330-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	082FD	16950367				2022-12-28	WOS:000240371200037
J	Suh, BC; Inoue, T; Meyer, T; Hille, B				Suh, Byung-Chang; Inoue, Takanari; Meyer, Tobias; Hille, Bertil			Rapid chemically induced changes of Ptdlns(4,5)P-2 gate KCNQ ion channels	SCIENCE			English	Article							PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; LIVING CELLS; KINASE; ACTIVATION; 3-KINASE; INHIBITION; PATHWAYS	To resolve the controversy about messengers regulating KCNQ ion channels during phospholipase C - mediated suppression of current, we designed translocatable enzymes that quickly alter the phosphoinositide composition of the plasma membrane after application of a chemical cue. The KCNQ current falls rapidly to zero when phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5) P-2 or PI(4,5) P-2] is depleted without changing Ca2+, diacylglycerol, or inositol 1,4,5-trisphosphate. Current rises by 30% when PI(4,5) P-2 is overproduced and does not change when phosphatidylinositol 3,4,5-trisphosphate is raised. Hence, the depletion of PI(4,5) P-2 suffices to suppress current fully, and other second messengers are not needed. Our approach is ideally suited to study biological signaling networks involving membrane phosphoinositides.	Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA; Stanford Univ, Dept Mol Pharmacol, Clark Ctr, Stanford, CA 94305 USA	University of Washington; University of Washington Seattle; Stanford University	Hille, B (corresponding author), Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA.	hille@u.washington.edu		Meyer, Tobias/0000-0003-4339-3804	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR017803, R37AR017803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030179, R01GM063702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS008174, R01NS008174] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR017803, AR17803] Funding Source: Medline; NIGMS NIH HHS [R01 GM030179-24A1, R01 GM063702, R01 GM030179, GM63702, R01 GM030179-25] Funding Source: Medline; NIMH NIH HHS [R01 MH064801, MH64801] Funding Source: Medline; NINDS NIH HHS [NS08174, R01 NS008174, R37 NS008174] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Kontos CD, 1998, MOL CELL BIOL, V18, P4131, DOI 10.1128/MCB.18.7.4131; Lerche H, 2005, CURR PHARM DESIGN, V11, P2737, DOI 10.2174/1381612054546815; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2004, J GEN PHYSIOL, V123, P663, DOI 10.1085/jgp.200409029; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Tsujishita Y, 2001, CELL, V105, P379, DOI 10.1016/S0092-8674(01)00326-9; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005	25	390	390	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 1	2006	314	5804					1454	1457		10.1126/science.1131163	http://dx.doi.org/10.1126/science.1131163			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	16990515	Green Accepted			2022-12-28	WOS:000242406100042
J	Kellermann, AL				Kellermann, Arthur L.			Crisis in the emergency department	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA	Emory University	Kellermann, AL (corresponding author), Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA.							*AM COLL SURG, 2006, GROW CRIS PAT ACC EM; Burt CW, 2006, ANN EMERG MED, V47, P317, DOI 10.1016/j.annemergmed.2005.12.001; Institute of Medicine, 2003, SHAR DEST COMM EFF U; *LEW GROUP, 2002, EM DEP OV GROW CRIS; National Academy of Sciences (US) and National Research Council (US) Committee on Trauma National Academy of Sciences (US) and National Research Council (US) Committee on Shock, 1966, ACC DEATH DIS NEGL D	5	176	180	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2006	355	13					1300	1303		10.1056/NEJMp068194	http://dx.doi.org/10.1056/NEJMp068194			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088EF	17005946				2022-12-28	WOS:000240793600002
J	Hirsch, J				Hirsch, Jules			An anniversary for cancer chemotherapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Hirsch, J (corresponding author), Rockefeller Univ, 1230 York Ave,Box 181, New York, NY 10021 USA.	hirsch@mail.rockefeller.edu						Alexander SF, 1947, MIL SURG, V101, P2; BERGH GS, 1946, HIST 26 GEN HOSP FEB; BRIDEL B, 2003, AMBULANCES CROIX ROU; COOK T, 1999, NO PLACE TO RUN; CURTIS J, 2005, YALE MED, V39, P16; FRIERICH E, 1984, JAMA-J AM MED ASSOC, V251, P2262; GOODMAN LS, 1946, JAMA-J AM MED ASSOC, V132, P126, DOI 10.1001/jama.1946.02870380008004; GOODMAN LS, 1965, PHARMACOLOGIC BAS ED, P1345; Infield G., 1988, DISASTER BARI; Krumbhaar E.B., 1919, JAMA-J AM MED ASSOC, V72, P39, DOI 10.1001/jama.1919.26110010018009f; Pechura C., 1993, VETERANS RISK HLTH E; Reminick G., 2001, NIGHTMARE BARI WORLD; Rhoads C.P., 1946, J MT SINAI HOSP, V13, P299; ROOSEVELT FD, 1943, CURRENT HIST     AUG, P405; ROSENTHAL E, 2006, NY TIMES        0625, P4; Southern George, 2002, POISONOUS INFERNO WO; United Nations Security Council, 1988, REP MISS DISP SECR G	17	72	78	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2006	296	12					1518	1520		10.1001/jama.296.12.1518	http://dx.doi.org/10.1001/jama.296.12.1518			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087VD	17003400				2022-12-28	WOS:000240770000028
J	Stoltenberg, J				Stoltenberg, Jens			Our children: the key to our common future	LANCET			English	Editorial Material												Tore.Godal@smk.dep.no						Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bloom DE, 2011, ADV EXP MED BIOL, V697, P1, DOI 10.1007/978-1-4419-7185-2_1; Bloom DE, 1998, BROOKINGS PAP ECO AC, P207, DOI 10.2307/2534695; Bloom DE, 1998, WORLD BANK ECON REV, V12, P419, DOI 10.1093/wber/12.3.419; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Freedman LP, 2005, LANCET, V365, P997, DOI 10.1016/S0140-6736(05)71090-4; GANDHI MK, 1972, TO MY COUNTRYMEN; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1	8	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2006	368	9541					1042	1044		10.1016/S0140-6736(06)69332-X	http://dx.doi.org/10.1016/S0140-6736(06)69332-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	089IC	16997647				2022-12-28	WOS:000240873000005
J	Assmus, B; Honold, J; Schachinger, V; Britten, MB; Fischer-Rasokat, U; Lehmann, R; Teupe, C; Pistorius, K; Martin, H; Abolmaali, ND; Tonn, T; Dimmeler, S; Zeiher, AM				Assmus, Birgit; Honold, Joerg; Schaechinger, Volker; Britten, Martina B.; Fischer-Rasokat, Ulrich; Lehmann, Ralf; Teupe, Claudius; Pistorius, Katrin; Martin, Hans; Abolmaali, Nasreddin D.; Tonn, Torsten; Dimmeler, Stefanie; Zeiher, Andreas M.			Transcoronary transplantation of progenitor cells after myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; TOPCARE-AMI; REGENERATION ENHANCEMENT; ISCHEMIC-MYOCARDIUM; STATIN THERAPY; NEOVASCULARIZATION; INCREASE; IMPROVES; TRIAL	BACKGROUND: Pilot studies suggest that intracoronary transplantation of progenitor cells derived from bone marrow (BMC) or circulating blood (CPC) may improve left ventricular function after acute myocardial infarction. The effects of cell transplantation in patients with healed myocardial infarction are unknown. METHODS: After an initial pilot trial involving 17 patients, we randomly assigned, in a controlled crossover study, 75 patients with stable ischemic heart disease who had had a myocardial infarction at least 3 months previously to receive either no cell infusion (23 patients) or infusion of CPC (24 patients) or BMC (28 patients) into the patent coronary artery supplying the most dyskinetic left ventricular area. The patients in the control group were subsequently randomly assigned to receive CPC or BMC, and the patients who initially received BMC or CPC crossed over to receive CPC or BMC, respectively, at 3 months' follow-up. RESULTS: The absolute change in left ventricular ejection fraction was significantly greater among patients receiving BMC (+2.9 percentage points) than among those receiving CPC (-0.4 percentage point, P=0.003) or no infusion (-1.2 percentage points, P<0.001). The increase in global cardiac function was related to significantly enhanced regional contractility in the area targeted by intracoronary infusion of BMC. The crossover phase of the study revealed that intracoronary infusion of BMC was associated with a significant increase in global and regional left ventricular function, regardless of whether patients crossed over from control to BMC or from CPC to BMC. CONCLUSIONS: Intracoronary infusion of progenitor cells is safe and feasible in patients with healed myocardial infarction. Transplantation of BMC is associated with moderate but significant improvement in the left ventricular ejection fraction after 3 months.	Univ Frankfurt, Dept Med 3, Div Cardiol & Mol Cardiol, D-60590 Frankfurt, Germany; Univ Frankfurt, Dept Med 2, Div Hematol, D-6000 Frankfurt, Germany; Univ Frankfurt, Dept Diagnost & Intervent Radiol, D-6000 Frankfurt, Germany; Red Cross Blood Donor Serv Baden Wurttemberg Hess, Inst Transfus Med & Immunohematol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Zeiher, AM (corresponding author), Univ Frankfurt, Dept Med 3, Div Cardiol & Mol Cardiol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	zeiher@em.uni-frankfurt.de	Abolmaali, Nasreddin/AAG-7655-2022; Assmus, Birgit/AAX-3004-2021; Assmus, Birgit/ABF-6853-2021; Abolmaali, Nasreddin/A-1061-2012; Assmus, Birgit/L-3274-2017; Abolmaali, Nasreddin/AFL-7713-2022	Assmus, Birgit/0000-0003-2658-6444; Assmus, Birgit/0000-0003-2658-6444; Dimmeler, Stefanie/0000-0002-1045-2436				American Heart Association, 2000, 2001 HEART STROK STA; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; Britten MB, 2003, CIRCULATION, V108, P2212, DOI 10.1161/01.CIR.0000095788.78169.AF; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kawamoto A, 2001, CIRCULATION, V103, P634; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Lange RA, 2002, NEW ENGL J MED, V346, P954, DOI 10.1056/NEJM200203283461302; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Montalescot G, 2001, NEW ENGL J MED, V344, P1895, DOI 10.1056/NEJM200106213442503; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Rupp S, 2004, BASIC RES CARDIOL, V99, P61, DOI 10.1007/s00395-003-0441-3; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; Stone GW, 2002, NEW ENGL J MED, V346, P957, DOI 10.1056/NEJMoa013404; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Valgimigli M, 2004, CIRCULATION, V110, P1209, DOI 10.1161/01.CIR.0000136813.89036.21; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9	23	822	884	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 21	2006	355	12					1222	1232		10.1056/NEJMoa051779	http://dx.doi.org/10.1056/NEJMoa051779			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085IT	16990385	Bronze			2022-12-28	WOS:000240598500006
J	Eckert, LO				Eckert, Linda O.			Acute vulvovaginitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREVENT PRETERM DELIVERY; ABNORMAL VAGINAL FLORA; BACTERIAL VAGINOSIS; CLINICAL-MANIFESTATIONS; ORAL METRONIDAZOLE; PREGNANT-WOMEN; RISK-FACTORS; FOLLOW-UP; CANDIDIASIS; TRICHOMONIASIS		Univ Washington, Harborview Med Ctr, Dept Obstet & Gynecol, Seattle, WA 98104 USA	Harborview Medical Center; University of Washington; University of Washington Seattle	Eckert, LO (corresponding author), Univ Washington, Harborview Med Ctr, Dept Obstet & Gynecol, 325 9th Ave,Box 359865, Seattle, WA 98104 USA.	eckert@u.washington.edu						ACOG Committee on Practice Bulletins--Gynecology, 2006, Obstet Gynecol, V107, P1195; Anderson MR, 2004, JAMA-J AM MED ASSOC, V291, P1368, DOI 10.1001/jama.291.11.1368; BARBONE F, 1990, AM J OBSTET GYNECOL, V163, P510, DOI 10.1016/0002-9378(90)91186-G; Carey JC, 2000, NEW ENGL J MED, V342, P534, DOI 10.1056/NEJM200002243420802; CARUSO LJ, 1964, AM J OBSTET GYNECOL, V90, P374; COTCH MF, 1991, OBSTET GYNECOL, V78, P1087; Culhane JF, 2002, AM J OBSTET GYNECOL, V187, P1272, DOI 10.1067/mob.2002.127311; Eckert Linda O, 2003, Infect Dis Obstet Gynecol, V11, P11, DOI 10.1155/S1064744903000024; Eckert LO, 1998, OBSTET GYNECOL, V92, P757, DOI 10.1016/S0029-7844(98)00264-6; ESCHENBACH DA, 1988, AM J OBSTET GYNECOL, V158, P819, DOI 10.1016/0002-9378(88)90078-6; Faro Sebastian, 2005, Infect Dis Obstet Gynecol, V13, P155, DOI 10.1080/10647440500148321; Ferris DG, 2002, OBSTET GYNECOL, V99, P419, DOI 10.1016/S0029-7844(01)01759-8; Fidel PL, 2004, INFECT IMMUN, V72, P2939, DOI 10.1128/IAI.72.5.2939-2946.2004; Fidel PL, 1997, J INFECT DIS, V176, P728, DOI 10.1086/514097; FISCHBACH F, 1993, OBSTET GYNECOL, V82, P405; FOXMAN B, 1990, AM J PUBLIC HEALTH, V80, P329, DOI 10.2105/AJPH.80.3.329; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Hauth JC, 1995, NEW ENGL J MED, V333, P1732, DOI 10.1056/NEJM199512283332603; Hawes SE, 1996, J INFECT DIS, V174, P1058, DOI 10.1093/infdis/174.5.1058; Kiss H, 2004, BMJ-BRIT MED J, V329, P371, DOI 10.1136/bmj.38169.519653.EB; Klebanoff MA, 2001, NEW ENGL J MED, V345, P487, DOI 10.1056/NEJMoa003329; KLEBANOFF SJ, 1991, J EXP MED, V174, P289, DOI 10.1084/jem.174.1.289; KRIEGER JN, 1988, JAMA-J AM MED ASSOC, V259, P1223, DOI 10.1001/jama.259.8.1223; Lamont RF, 2003, OBSTET GYNECOL, V101, P516, DOI 10.1016/S0029-7844(02)03054-5; Lipsky M S, 2000, J Am Board Fam Pract, V13, P178; Marrazzo JM, 2002, J INFECT DIS, V185, P1307, DOI 10.1086/339884; McDonald HM, 1997, BRIT J OBSTET GYNAEC, V104, P1391, DOI 10.1111/j.1471-0528.1997.tb11009.x; MORALES WJ, 1994, AM J OBSTET GYNECOL, V171, P345, DOI 10.1016/S0002-9378(94)70033-8; Nanda Neha, 2006, Expert Rev Anti Infect Ther, V4, P125, DOI 10.1586/14787210.4.1.125; Ralph SG, 1999, BRIT MED J, V319, P220, DOI 10.1136/bmj.319.7204.220; Reed B D, 1992, Obstet Gynecol Surv, V47, P551, DOI 10.1097/00006254-199208000-00015; Rodgers CA, 1999, INT J STD AIDS, V10, P435, DOI 10.1258/0956462991914429; Royce RA, 1999, SEX TRANSM DIS, V26, P96, DOI 10.1097/00007435-199902000-00007; Schwebke JR, 2005, J INFECT DIS, V192, P1315, DOI 10.1086/462430; Shurbaji MS, 1999, DIAGN CYTOPATHOL, V21, P14, DOI 10.1002/(SICI)1097-0339(199907)21:1<14::AID-DC5>3.0.CO;2-N; Sobel JD, 2006, AM J OBSTET GYNECOL, V194, P1283, DOI 10.1016/j.ajog.2005.11.041; Sobel JD, 2004, NEW ENGL J MED, V351, P876, DOI 10.1056/NEJMoa033114; Sobel JD, 2003, AM J OBSTET GYNECOL, V189, P1297, DOI 10.1067/S0002-9378(03)00726-9; Sobel JD, 2001, AM J OBSTET GYNECOL, V185, P363, DOI 10.1067/mob.2001.115116; SOBEL JD, 1993, J INFECT DIS, V167, P783, DOI 10.1093/infdis/167.3.783; Sood G, 2000, Infect Dis Obstet Gynecol, V8, P240, DOI 10.1155/S1064744900000351; Soper D, 2004, AM J OBSTET GYNECOL, V190, P281, DOI 10.1016/j.ajog.2003.08.023; SOPER DE, 1990, AM J OBSTET GYNECOL, V163, P1016, DOI 10.1016/0002-9378(90)91115-S; SWEDBERG J, 1985, JAMA-J AM MED ASSOC, V254, P1046, DOI 10.1001/jama.254.8.1046; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Ugwumadu A, 2003, LANCET, V361, P983, DOI 10.1016/S0140-6736(03)12823-1; Van Kessel K, 2003, OBSTET GYNECOL SURV, V58, P351, DOI 10.1097/00006254-200305000-00024; WATTS DH, 1990, OBSTET GYNECOL, V75, P52; WOLNERHANSSEN P, 1989, JAMA-J AM MED ASSOC, V261, P571; 2006, MMWR RECOMM REP, V55, P49	50	63	72	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 21	2006	355	12					1244	1252		10.1056/NEJMcp053720	http://dx.doi.org/10.1056/NEJMcp053720			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085IT	16990387				2022-12-28	WOS:000240598500008
J	Velicogna, I; Wahr, J				Velicogna, Isabella; Wahr, John			Acceleration of Greenland ice mass loss in spring 2004	NATURE			English	Article							SHEET; SURFACE; BALANCE; MODEL	In 2001 the Intergovernmental Panel on Climate Change projected the contribution to sea level rise from the Greenland ice sheet to be between -0.02 and +0.09m from 1990 to 2100 (ref. 1). However, recent work(2-4) has suggested that the ice sheet responds more quickly to climate perturbations than previously thought, particularly near the coast. Here we use a satellite gravity survey by the Gravity Recovery and Climate Experiment ( GRACE) conducted from April 2002 to April 2006 to provide an independent estimate of the contribution of Greenland icemass loss to sea level change. We detect an ice mass loss of 248 +/- 36 km(3) yr(-1), equivalent to a global sea level rise of 0.5 +/- 0.1 mm yr(-1). The rate of ice loss increased by 250 per cent between the periods April 2002 to April 2004 and May 2004 to April 2006, almost entirely due to accelerated rates of ice loss in southern Greenland; the rate of mass loss in north Greenland was almost constant. Continued monitoring will be needed to identify any future changes in the rate of ice loss in Greenland.	Univ Colorado, Dept Phys, Boulder, CO 80309 USA; Univ Colorado, CIRES, Boulder, CO 80309 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Velicogna, I (corresponding author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.	isabella@colorado.edu	Velicogna, Isabella/R-5561-2018	Velicogna, Isabella/0000-0002-9020-1898				Abdalati W, 2001, J GEOPHYS RES-ATMOS, V106, P33729, DOI 10.1029/2001JD900192; Box JE, 2006, J CLIMATE, V19, P2783, DOI 10.1175/JCLI3738.1; Cheng MK, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003028; Church JA, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P639; Dobslaw H, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022990; Fleming K, 2004, QUATERNARY SCI REV, V23, P1053, DOI 10.1016/j.quascirev.2003.11.001; Horwath M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025550; Howat IM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024737; Johannessen OM, 2005, SCIENCE, V310, P1013, DOI 10.1126/science.1115356; Krabill W, 2000, SCIENCE, V289, P428, DOI 10.1126/science.289.5478.428; Krabill W, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021533; Luckman A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025428; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; Rodell M, 2004, B AM METEOROL SOC, V85, P381, DOI 10.1175/BAMS-85-3-381; STEFFEN K, 2005, GREENLAND CLIMATE NE; Swenson S, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001808; Tapley BD, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019920; TUSHINGHAM AM, 1991, J GEOPHYS RES-SOLID, V96, P4497, DOI 10.1029/90JB01583; Velicogna I, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023955; Wahr J, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025305; Zwally HJ, 2005, J GLACIOL, V51, P509, DOI 10.3189/172756505781829007	22	275	288	3	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2006	443	7109					329	331		10.1038/nature05168	http://dx.doi.org/10.1038/nature05168			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085RL	16988710	Green Published			2022-12-28	WOS:000240622000044
J	Markowitz, AJ; McPhee, SJ				Markowitz, Amy J.; McPhee, Stephen J.			Sudden traumatic death in children: "We did everything but your child didn't survive"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material														Markowitz, Amy/0000-0001-9314-2814				Truog RD, 2006, JAMA-J AM MED ASSOC, V295, P2646, DOI 10.1001/jama.295.22.2646	1	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2006	296	11					1393	1393		10.1001/jama.296.11.1393	http://dx.doi.org/10.1001/jama.296.11.1393			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085HS	16985232				2022-12-28	WOS:000240595800027
J	Hagan, J; Palloni, A				Hagan, John; Palloni, Alberto			Death in Darfur	SCIENCE			English	Editorial Material									Northwestern Univ, Dept Sociol, Evanston, IL 60208 USA; Amer Bar Fdn, Chicago, IL 60611 USA; Univ Wisconsin, Dept Sociol, Madison, WI 53706 USA	Northwestern University; University of Wisconsin System; University of Wisconsin Madison	Hagan, J (corresponding author), Northwestern Univ, Dept Sociol, Evanston, IL 60208 USA.	j-hagan@northwestern.edu						ANNAN K, 2005, NY TIMES        0413, pA29; *COAL INT JUST, 2006, CHRON REP EV CONFL D; COEBERGH J, 2005, SUDAN GENOCIDE HAS K, V5, P5; Depoortere E, 2004, LANCET, V364, P1315, DOI 10.1016/S0140-6736(04)17187-0; Hagan J, 2005, CRIMINOLOGY, V43, P525, DOI 10.1111/j.0011-1348.2005.00016.x; REEVES E, 2005, SUDAN TRIBUNE   0701; U.S. Department of State, 2004, US DEP STAT PUBL; *UK HOUS COMM INT, 5 SESS 2004 05, V1, P11; *UN, 2006, 22 UN; *US DEP STAT, 2005, SUD DEATH TOLL DARF; *WHO, 2004, MORT PROJ DARF; *WHO, 2004, RETR MORT SURV INT D; *WHO MED CTR, 2004, MORT PROJ DARF; *WHO SUD FED MIN H, 2005, MORT SURV INT DISPL; ZOELLICK R, 2005, WASHINGTON POST 0427, pA22; 2005, NY TIMES        0316; 2005, WASHINGTON POST 0424, pB6; 2006, NY TIMES        0823, pA12	18	36	36	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2006	313	5793					1578	1579		10.1126/science.1127397	http://dx.doi.org/10.1126/science.1127397			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	083YS	16973863				2022-12-28	WOS:000240498900026
J	Bennett, JE				Bennett, John E.			Echinocandins for candidemia in adults without neutropenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INVASIVE CANDIDIASIS; AMPHOTERICIN-B; FUNGAL-INFECTIONS; CASPOFUNGIN; SUSCEPTIBILITY; GUIDELINES; MICAFUNGIN; RESISTANT; ALBICANS; OUTCOMES		NIAID, Clin Mycol Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Bennett, JE (corresponding author), NIAID, Clin Mycol Sect, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000654, ZIAAI000654] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bohme A, 2003, ANN HEMATOL, V82, pS133, DOI 10.1007/s00277-003-0767-1; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; Chandra J, 2005, CURR DRUG TARGETS, V6, P887, DOI 10.2174/138945005774912762; Chandrasekar PH, 2006, CLIN INFECT DIS, V42, P1171, DOI 10.1086/501020; Colombo AL, 2003, EUR J CLIN MICROBIOL, V22, P470, DOI 10.1007/s10096-003-0973-8; Cuenca-Estrella M, 2000, J ANTIMICROB CHEMOTH, V46, P475, DOI 10.1093/jac/46.3.475; Denning DW, 2003, LANCET, V362, P1142, DOI 10.1016/S0140-6736(03)14472-8; Denning DW, 2003, LANCET INFECT DIS, V3, P230, DOI 10.1016/S1473-3099(03)00580-2; Gavalda J, 2003, ENFERM INFEC MICR CL, V21, P498, DOI 10.1157/13052334; GAVALDA J, 2004, ENFERM INFEC MICR CL, V22, P137; Hernandez S, 2004, ANTIMICROB AGENTS CH, V48, P1382, DOI 10.1128/AAC.48.4.1382-1383.2004; Johnson MD, 2003, EXPERT OPIN PHARMACO, V4, P807, DOI 10.1517/14656566.4.5.807; Kartsonis N, 2005, ANTIMICROB AGENTS CH, V49, P3616, DOI 10.1128/AAC.49.9.3616-3623.2005; Mikamo H, 2000, J ANTIMICROB CHEMOTH, V46, P485, DOI 10.1093/jac/46.3.485; Mora-Duarte J, 2002, NEW ENGL J MED, V347, P2020, DOI 10.1056/NEJMoa021585; Morgan Juliette, 2005, Curr Infect Dis Rep, V7, P429, DOI 10.1007/s11908-005-0044-7; Moudgal V, 2005, ANTIMICROB AGENTS CH, V49, P767, DOI 10.1128/AAC.49.2.767-769.2005; Onishi J, 2000, ANTIMICROB AGENTS CH, V44, P368, DOI 10.1128/AAC.44.2.368-377.2000; Ostrosky-Zeichner L, 2006, CRIT CARE MED, V34, P857, DOI 10.1097/01.CCM.0000201897.78123.44; Ostrosky-Zeichner L, 2006, EUR J CLIN MICROBIOL, V25, P69, DOI 10.1007/s10096-005-0069-8; Ostrosky-Zeichner L, 2005, EUR J CLIN MICROBIOL, V24, P654, DOI 10.1007/s10096-005-0024-8; Pappas PG, 2004, CLIN INFECT DIS, V38, P161, DOI 10.1086/380796; Park S, 2005, ANTIMICROB AGENTS CH, V49, P3264, DOI 10.1128/AAC.49.8.3264-3273.2005; Pfaller MA, 2004, EXPERT OPIN INV DRUG, V13, P1183, DOI 10.1517/13543784.13.9.1183; REBOLI A, 2005, 45 INT C ANT AG CHEM; REX JH, 1995, CLIN INFECT DIS, V21, P994, DOI 10.1093/clinids/21.4.994; RUHNKE M, 2005, 45 INT C ANT AG CHEM; Rybowicz Joseph, 2002, Proc (Bayl Univ Med Cent), V15, P97; SLAVIN MA, 2003, GUIDELINES USE ANTIF; Villareal NC, 2004, 44 INT C ANT AG CHEM; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Zaoutis TE, 2005, CLIN INFECT DIS, V41, P1232, DOI 10.1086/496922; 2006, MED LETT DRUGS THER, V48, P43	33	77	82	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 14	2006	355	11					1154	1159		10.1056/NEJMct060052	http://dx.doi.org/10.1056/NEJMct060052			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083NJ	16971721				2022-12-28	WOS:000240462800009
J	Detsky, ME; McDonald, DR; Baerlocher, MO; Tomlinson, GA; McCrory, DC; Booth, CM				Detsky, Michael E.; McDonald, Devon R.; Baerlocher, Mark O.; Tomlinson, George A.; McCrory, Douglas C.; Booth, Christopher M.			Does this patient with headache have a migraine or need neuroimaging?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPUTED-TOMOGRAPHY; SUBARACHNOID HEMORRHAGE; GENERAL-POPULATION; UNITED-STATES; PRIMARY-CARE; DIAGNOSIS; VALIDATION; BRAIN; EPIDEMIOLOGY; PREVALENCE	Context In assessing the patient with headache, clinicians are often faced with 2 important questions: Is this headache a migraine? Does this patient require neuroimaging? The diagnosis of migraine can direct therapy, and information obtained from the history and physical examination is used by physicians to determine which patients require neuroimaging. Objective To determine the usefulness of the history and physical examination that distinguish patients with migraine from those with other headache types and that identify those patients who should undergo neuroimaging. Data Sources and Study Selection A systematic review was performed using articles from MEDLINE (1966-November 2005) that assessed the performance characteristics of screening questions in diagnosing migraine (with the International Headache Society diagnostic criteria as a gold standard) and addressed the accuracy of the clinical examination in predicting the presence of underlying intracranial pathology (with computed tomography/magnetic resonance imaging as the reference standard). Data Extraction Two authors independently reviewed each study to determine eligibility, abstract data, and classify methodological quality using predetermined criteria. Disagreement was resolved by consensus with a third author. Data Synthesis Four studies of screening questions for migraine (n = 1745 patients) and 11 neuroimaging studies (n = 3725 patients) met inclusion criteria. All 4 of the migraine studies illustrated high sensitivity and specificity if 3 or 4 criteria were met. The best predictors can be summarized by the mnemonic POUNDing (Pulsating, duration of 4-72 hOurs, Unilateral, Nausea, Disabling). If 4 of the 5 criteria are met, the likelihood ratio (LR) for definite or possible migraine is 24 (95% confidence interval [CI], 1.5-388); if 3 are met, the LR is 3.5 (95% CI, 1.3-9.2), and if 2 or fewer are met, the LR is 0.41 (95% CI, 0.32-0.52). For the neuroimaging question, several clinical features were found on pooled analysis to predict the presence of a serious intracranial abnormality: cluster-type headache (LR, 10.7; 95% CI, 2.2-52); abnormal findings on neurologic examination (LR, 5.3; 95% CI, 2.4-12); undefined headache (ie, not cluster-, migraine-, or tension-type) (LR, 3.8; 95% CI, 2.0-7.1); headache with aura (LR, 3.2; 95% CI, 1.6-6.6); headache aggravated by exertion or a valsalva-like maneuver (LR, 2.3; 95% CI, 1.4-3.8); and headache with vomiting (LR, 1.8; 95% CI, 1.2-2.6). No clinical features were useful in ruling out significant pathologic conditions. Conclusions The presence of 4 simple historical features can accurately diagnose migraine. Several individual clinical features were found to be associated with a significant intracranial abnormality, and patients with these features should undergo neuroimaging.	Univ Toronto, Fac Med, Toronto, ON, Canada; Univ Toronto, Dept Med Imaging, Toronto, ON, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	University of Toronto; University of Toronto; University of Toronto; University of Toronto; Duke University	Booth, CM (corresponding author), Mt Sinai Hosp, Suite 427,600 Univ Ave, Toronto, ON M5G 1X5, Canada.	christopher.booth@utoronto.ca	Tomlinson, George A/L-5432-2016	Tomlinson, George A/0000-0002-9328-6399; McCrory, Douglas/0000-0003-2093-0611				Aygun D, 2003, EUR J NEUROL, V10, P437, DOI 10.1046/j.1468-1331.2003.00645.x; BAKER HL, 1983, J NEURORADIOLOGY, V10, P112; BECKER LA, 1993, J FAM PRACTICE, V37, P129; Cady RK, 2004, HEADACHE, V44, P323, DOI 10.1111/j.1526-4610.2004.04075.x; CALA L A, 1976, Proceedings of the Australian Association of Neurologists, V13, P35; CALA LA, 1980, MED J AUSTRALIA, V2, P616, DOI 10.5694/j.1326-5377.1980.tb77065.x; CARRERA GF, 1977, J COMPUT ASSIST TOMO, V1, P200; CASCADE PN, 2000, RADIOLOGY S, V214, pS3; Christiaans MH, 2002, CANCER, V94, P2063, DOI 10.1002/cncr.10379; CULL RE, 1995, SCOT MED J, V40, P50, DOI 10.1177/003693309504000205; DAY JW, 1986, LANCET, V2, P1247; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DHOPESH V, 1979, HEADACHE, V19, P37, DOI 10.1111/j.1526-4610.1979.hed1901037.x; DIEHR P, 1981, J CHRON DIS, V34, P147, DOI 10.1016/0021-9681(81)90025-4; Dodick DW, 2006, NEW ENGL J MED, V354, P158, DOI 10.1056/NEJMcp042897; Duarte J, 1996, ACTA NEUROL SCAND, V94, P67, DOI 10.1111/j.1600-0404.1996.tb00042.x; DUMAS MD, 1994, CAN MED ASSOC J, V151, P1447; Frishberg BM, 2000, EVIDENCE BASED GUIDE; Gervil M, 1998, CEPHALALGIA, V18, P342, DOI 10.1046/j.1468-2982.1998.1806342.x; Gifford AL, 2001, HEADACHE, V41, P441, DOI 10.1046/j.1526-4610.2001.01081.x; GRANELLA F, 1994, CEPHALALGIA, V14, P16, DOI 10.1046/j.1468-2982.1994.1401016.x; GROSSKREUTZ SR, 1991, MIL MED, V156, P137, DOI 10.1093/milmed/156.3.137; Harris JE, 2000, J ACCID EMERG MED, V17, P15; HOLLEMAN DR, 1995, JAMA-J AM MED ASSOC, V273, P313, DOI 10.1001/jama.273.4.313; JOSEPH R, 1985, PRACTITIONER, V229, P477; KAHN CE, 1993, CAN ASSOC RADIOL J, V44, P189; Khorasani R, 1998, AM J ROENTGENOL, V170, P859, DOI 10.2214/ajr.170.4.9530023; Lainez MJA, 2005, HEADACHE, V45, P1328, DOI 10.1111/j.1526-4610.2005.00265.x; Landtblom AM, 2002, CEPHALALGIA, V22, P354, DOI 10.1046/j.1468-2982.2002.00368.x; LARSON EB, 1980, JAMA-J AM MED ASSOC, V243, P359, DOI 10.1001/jama.243.4.359; Lederle FA, 1999, JAMA-J AM MED ASSOC, V281, P77, DOI 10.1001/jama.281.1.77; LEICHT MJ, 1980, ANN EMERG MED, V9, P404, DOI 10.1016/S0196-0644(80)80152-1; Linn FHH, 1998, J NEUROL NEUROSUR PS, V65, P791, DOI 10.1136/jnnp.65.5.791; Lipton RB, 2002, NEUROLOGY, V58, P885, DOI 10.1212/WNL.58.6.885; Lipton RB, 2003, NEUROLOGY, V61, P375, DOI 10.1212/01.WNL.0000078940.53438.83; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; Locker T, 2004, EMERG MED J, V21, P327, DOI 10.1136/emj.2003.012351; Maitino AJ, 2003, RADIOLOGY, V228, P795, DOI 10.1148/radiol.2283021254; Maizels M, 2003, HEADACHE, V43, P441, DOI 10.1046/j.1526-4610.2003.03088.x; McCrory DC, 2000, EVIDENCE BASED GUIDE; MERIKANGAS KR, 1994, NEUROLOGY, V44, P11; MICHEL P, 1993, CEPHALALGIA, V13, P54, DOI 10.1177/0333102493013S1211; MITCHELL CS, 1993, HEADACHE, V33, P82, DOI 10.1111/j.1526-4610.1993.hed3302082.x; Morgenstern LB, 1998, ANN EMERG MED, V32, P297; NIKIFOROW R, 1981, CEPHALALGIA, V1, P99, DOI 10.1111/j.1468-2982.1981.tb00016.x; Pryse-Phillips W, 2002, HEADACHE, V42, P728, DOI 10.1046/j.1526-4610.2002.02174.x; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; RamirezLassepas M, 1997, ARCH NEUROL-CHICAGO, V54, P1506, DOI 10.1001/archneur.1997.00550240058013; RASMUSSEN BK, 1991, HEADACHE, V31, P290, DOI 10.1111/j.1526-4610.1991.hed3105290.x; RASMUSSEN BK, 1991, J CLIN EPIDEMIOL, V44, P1147, DOI 10.1016/0895-4356(91)90147-2; Rosner B., 2011, FUNDAMENTALS BIOSTAT, V7th; RUSSELL MB, 1992, CEPHALALGIA, V12, P369, DOI 10.1111/j.1468-2982.1992.00369.x; SACKETT DL, 1992, JAMA-J AM MED ASSOC, V267, P2638, DOI 10.1001/jama.267.19.2638; SARGENT JD, 1983, HEADACHE, V23, P62, DOI 10.1111/j.1526-4610.1983.hed2302062.x; Schwartz BS, 1998, JAMA-J AM MED ASSOC, V279, P381, DOI 10.1007/s11916-010-0146-2; Sempere AP, 2005, CEPHALALGIA, V25, P30, DOI 10.1111/j.1468-2982.2004.00798.x; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Silberstein SD, 2001, WOLFFS HEADACHE OTHE; SIMEL DL, 1998, PRIMARY CARE INTERNA, V11, P105; Sjaastad O, 2003, CEPHALALGIA, V23, P528, DOI 10.1046/j.1468-2982.2003.00585.x; Smetana GW, 2000, ARCH INTERN MED, V160, P2729, DOI 10.1001/archinte.160.18.2729; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; SOTANIEMI KA, 1991, J NEUROL NEUROSUR PS, V54, P645, DOI 10.1136/jnnp.54.7.645; Spiegelhalter DJ, 2004, WINBUGS VERSION 1 4; STEWART WF, 1994, NEUROLOGY, V44, P17; TOM T, 1994, NEUROLOGY, V44, P925, DOI 10.1212/WNL.44.5.925; WEINGARTEN S, 1992, ARCH INTERN MED, V152, P2457, DOI 10.1001/archinte.152.12.2457	67	91	96	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2006	296	10					1274	1283		10.1001/jama.296.10.1274	http://dx.doi.org/10.1001/jama.296.10.1274			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083EA	16968852				2022-12-28	WOS:000240437500030
J	Tondolo, V; Nanni, G; Citterio, F; Di Stasi, C; Castagneto, M				Tondolo, Vincenzo; Nanni, Giuseppe; Citterio, Franco; Di Stasi, Carmine; Castagneto, Marco			A kidney non-transplantable	LANCET			English	Editorial Material									Univ Sacred Heart, Dept Surg, Div Transplantat, I-00168 Rome, Italy; Univ Sacred Heart, Dept Radiol, I-00168 Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Tondolo, V (corresponding author), Univ Sacred Heart, Dept Surg, Div Transplantat, Largo A Gemelli 8, I-00168 Rome, Italy.	vincenzo.tondolo@rm.unicatt.it		Tondolo, Vincenzo/0000-0003-0256-3766					0	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 9	2006	368	9539					946	946		10.1016/S0140-6736(06)69375-6	http://dx.doi.org/10.1016/S0140-6736(06)69375-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083ZX	16962884	Bronze			2022-12-28	WOS:000240502300032
J	Sepulchre, P; Ramstein, G; Fluteau, F; Schuster, M; Tiercelin, JJ; Brunet, M				Sepulchre, Pierre; Ramstein, Gilles; Fluteau, Frederic; Schuster, Mathieu; Tiercelin, Jean-Jacques; Brunet, Michel			Tectonic uplift and Eastern Africa aridification	SCIENCE			English	Article							CLIMATE-CHANGE; RIFT SYSTEM; LATE MIOCENE; EVOLUTION; VEGETATION; TANGANYIKA; EXPANSION; ETHIOPIA; HISTORY; HOMINID	The history of Eastern African hominids has been linked to a progressive increase of open grassland during the past 8 million years. This trend was explained by global climatic processes, which do not account for the massive uplift of eastern African topography that occurred during this period. Atmosphere and biosphere simulations quantify the role played by these tectonic events. The reduced topographic barrier before 8 million years ago permitted a zonal circulation with associated moisture transport and strong precipitation. Our results suggest that the uplift itself led to a drastic reorganization of atmospheric circulation, engendering the strong aridification and paleoenvironmental changes suggested by the data.	Inst Pierre Simon Laplace, Lab Sci Climat & Environm, UMR 1572, F-91191 Gif Sur Yvette, France; Univ Poitiers, CNRS, UMR 6046,Fac Sci, Lab Geobiol Biochronol & Paleontol Humaine, F-86022 Poitiers, France; Inst Phys Globe, Lab Paleomagnetisme, F-75252 Paris, France; Inst Univ Europeen Mer, CNRS, UMR 6538, F-29280 Plouzane, France; Bur Rech Geol & Minieres, F-45060 Orleans, France	UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Bureau de Recherches Geologiques et Minieres (BRGM)	Sepulchre, P (corresponding author), Inst Pierre Simon Laplace, Lab Sci Climat & Environm, UMR 1572, F-91191 Gif Sur Yvette, France.	Pierre.sepulchre@cea.fr	Lund, Laura/H-7335-2012; Sepulchre, Pierre/Q-2006-2017; Ramstein, Gilles/L-3328-2014; fluteau, frederic/A-7523-2011	Sepulchre, Pierre/0000-0002-4267-4025; Ramstein, Gilles/0000-0002-1522-917X; fluteau, frederic/0000-0002-9952-7325; Schuster, Mathieu/0000-0002-4412-8685				Bobe R, 2004, PALAEOGEOGR PALAEOCL, V207, P399, DOI 10.1016/j.palaeo.2003.09.033; Bonnefille R, 2004, P NATL ACAD SCI USA, V101, P12125, DOI 10.1073/pnas.0401709101; Bonnefille R, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P299; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Cane MA, 2001, NATURE, V411, P157, DOI 10.1038/35075500; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Chorowicz J, 2005, J AFR EARTH SCI, V43, P379, DOI 10.1016/j.jafrearsci.2005.07.019; COHEN AS, 1993, GEOLOGY, V21, P511, DOI 10.1130/0091-7613(1993)021<0511:ETAOFO>2.3.CO;2; Coulie E, 2003, EARTH PLANET SC LETT, V206, P477, DOI 10.1016/S0012-821X(02)01089-0; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; EBINGER CJ, 1993, J GEOPHYS RES-SOL EA, V98, P17821, DOI 10.1029/93JB01392; Feakins SJ, 2005, GEOLOGY, V33, P977, DOI 10.1130/G21814.1; Foster A, 1997, J GEOL SOC LONDON, V154, P689, DOI 10.1144/gsjgs.154.4.0689; Gatebe CK, 1999, J GEOPHYS RES-ATMOS, V104, P14237, DOI 10.1029/1998JD200103; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; Hay WW, 2002, INT J EARTH SCI, V91, P746, DOI 10.1007/s00531-002-0263-1; Hill A, 2002, J HUM EVOL, V42, P75, DOI 10.1006/jhev.2001.0518; Krinner G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002199; Leakey MG, 1996, J VERTEBR PALEONTOL, V16, P556, DOI 10.1080/02724634.1996.10011339; Lezzar KE, 1996, BASIN RES, V8, P1, DOI 10.1111/j.1365-2117.1996.tb00112.x; Li ZX, 2003, J CLIMATE, V16, P3993, DOI 10.1175/1520-0442(2003)016<3993:TROAAG>2.0.CO;2; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Pagani M, 1999, SCIENCE, V285, P876, DOI 10.1126/science.285.5429.876; Partridge T.C, 1997, TECTONIC UPLIFT CLIM, P63, DOI DOI 10.1007/978-1-4615-5935-1; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; Ramstein G, 1997, NATURE, V386, P788, DOI 10.1038/386788a0; Trauth MH, 2005, SCIENCE, V309, P2051, DOI 10.1126/science.1112964; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; Wolfenden E, 2004, EARTH PLANET SC LETT, V224, P213, DOI 10.1016/j.epsl.2004.04.022	29	329	338	6	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2006	313	5792					1419	1423		10.1126/science.1129158	http://dx.doi.org/10.1126/science.1129158			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16960002				2022-12-28	WOS:000240348700037
J	Leach, DC; Philibert, I				Leach, David C.; Philibert, Ingrid			High-quality learning for high-quality health care - Getting it right	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							WORK HOURS; CONTINUITY; SAFETY		Accreditat Council Grad Med Educ, Chicago, IL 60610 USA		Philibert, I (corresponding author), Accreditat Council Grad Med Educ, 515 N State St,Suite 2000, Chicago, IL 60610 USA.	iphilibert@acgme.org	Philibert, Ingrid/V-2656-2019					Accreditation Council for Graduate Medical Education, ACGMES APPR LIM RES; Batalden P, 2002, HEALTH AFFAIR, V21, P103, DOI 10.1377/hlthaff.21.5.103; BURKE R, 2006, 2006 ACCR COUNC GRAD; DaRosa DA, 2004, SURGERY, V136, P966, DOI 10.1016/j.surg.2004.09.003; Fischer JE, 2004, ACAD MED, V79, P381, DOI 10.1097/00001888-200405000-00004; Fletcher KE, 2005, JAMA-J AM MED ASSOC, V294, P1088, DOI 10.1001/jama.294.9.1088; Fletcher KE, 2004, ANN INTERN MED, V141, P851, DOI 10.7326/0003-4819-141-11-200412070-00009; FRIEDMAN W, 2005, 2005 ACCR COUNC GRAD; Gabow PA, 2006, ACAD MED, V81, P766, DOI 10.1097/00001888-200608000-00016; Jagsi R, 2005, ARCH INTERN MED, V165, P2607, DOI 10.1001/archinte.165.22.2607; Kellogg KC, 2006, J AM COLL SURGEONS, V202, P630, DOI 10.1016/j.jamcollsurg.2005.11.024; Lockley SW, 2006, CLIN ORTHOP RELAT R, P116, DOI 10.1097/01.blo.0000224057.32367.84; Lund KJ, 2004, AM J OBSTET GYNECOL, V191, P1805, DOI 10.1016/j.ajog.2004.07.072; Miller D., 2005, GOING LEAN HLTH CARE; Mohr JJ, 2002, QUAL SAF HEALTH CARE, V11, P45, DOI 10.1136/qhc.11.1.45; PHILIBERT I, 2002, JAMA-J AM MED ASSOC, V288, P112; Ratanawongsa N, 2006, J GEN INTERN MED, V21, P758, DOI 10.1111/j.1525-1497.2006.00496.x; Van Eaton EG, 2005, J AM COLL SURGEONS, V200, P538, DOI 10.1016/j.jamcollsurg.2004.11.009; Volpp KGM, 2003, NEW ENGL J MED, V348, P851, DOI 10.1056/NEJMsb021667; Wachter RM, 2006, JAMA-J AM MED ASSOC, V295, P2780, DOI 10.1001/jama.295.23.2780	20	14	14	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2006	296	9					1132	1134		10.1001/jama.296.9.1132	http://dx.doi.org/10.1001/jama.296.9.1132			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	081DW	16954493				2022-12-28	WOS:000240298400015
J	Shaneyfelt, T; Baum, KD; Bell, D; Feldstein, D; Houston, TK; Kaatz, S; Whelan, C; Green, M				Shaneyfelt, Terrence; Baum, Karyn D.; Bell, Douglas; Feldstein, David; Houston, Thomas K.; Kaatz, Scott; Whelan, Chad; Green, Michael			Instruments for evaluating education in evidence-based practice - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							EVIDENCE-BASED MEDICINE; CRITICAL-APPRAISAL SKILLS; TEACHING CRITICAL-APPRAISAL; FAMILY-PRACTICE RESIDENCY; CONTROLLED-TRIAL; JOURNAL CLUB; RANDOMIZED-TRIAL; INFORMATION MANAGEMENT; CLINICAL EPIDEMIOLOGY; STUDENTS SKILLS	Context Evidence-based practice (EBP) is the integration of the best research evidence with patients' values and clinical circumstances in clinical decision making. Teaching of EBP should be evaluated and guided by evidence of its own effectiveness. Objective To appraise, summarize, and describe currently available EBP teaching evaluation instruments. Data Sources and Study Selection We searched the MEDLINE, EMBASE, CINAHL, HAPI, and ERIC databases; reference lists of retrieved articles; EBP Internet sites; and 8 education journals from 1980 through April 2006. For inclusion, studies had to report an instrument evaluating EBP, contain sufficient description to permit analysis, and present quantitative results of administering the instrument. Data Extraction Two raters independently abstracted information on the development, format, learner levels, evaluation domains, feasibility, reliability, and validity of the EBP evaluation instruments from each article. We defined 3 levels of instruments based on the type, extent, methods, and results of psychometric testing and suitability for different evaluation purposes. Data Synthesis Of 347 articles identified, 115 were included, representing 104 unique instruments. The instruments were most commonly administered to medical students and postgraduate trainees and evaluated EBP skills. Among EBP skills, acquiring evidence and appraising evidence were most commonly evaluated, but newer instruments evaluated asking answerable questions and applying evidence to individual patients. Most behavior instruments measured the performance of EBP steps in practice but newer instruments documented the performance of evidence-based clinical maneuvers or patient-level outcomes. At least 1 type of validity evidence was demonstrated for 53% of instruments, but 3 or more types of validity evidence were established for only 10%. High-quality instruments were identified for evaluating the EBP competence of individual trainees, determining the effectiveness of EBP curricula, and assessing EBP behaviors with objective outcome measures. Conclusions Instruments with reasonable validity are available for evaluating some domains of EBP and may be targeted to different evaluation needs. Further development and testing is required to evaluate EBP attitudes, behaviors, and more recently articulated EBP skills.	Univ Alabama Birmingham, Sch Med, Vet Affairs Med Ctr, Dept Med, Birmingham, AL 35233 USA; Dept Vet Affairs Med Ctr, Birmingham, AL USA; Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Gen Internal Med, Los Angeles, CA USA; Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI USA; Henry Ford Hosp, Detroit, MI 48202 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA	University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Wisconsin System; University of Wisconsin Madison; Henry Ford Health System; Henry Ford Hospital; University of Chicago; Yale University	Shaneyfelt, T (corresponding author), Univ Alabama Birmingham, Sch Med, Vet Affairs Med Ctr, Dept Med, 700 S 19th St, Birmingham, AL 35233 USA.	terry.shaneyfelt@med.va.gov	Houston, Thomas/F-2469-2013; Bell, Douglas/HGE-6048-2022; Bell, Douglas S/G-6702-2013	Bell, Douglas S/0000-0002-5063-8294				*ACCR COUNC GRAD M, GEN COMP; Akl EA, 2004, ACAD MED, V79, P897, DOI 10.1097/00001888-200409000-00018; American Educational Research Association American Psychological Association & National Council on Measurement in Education, 1999, STAND ED PSYCH TEST; *ASS AM MED COLL, 1998, CONT ISS MED, V2; Badgett R G, 2001, BMC Med Educ, V1, P3, DOI 10.1186/1472-6920-1-3; Barnett SH, 2000, MT SINAI J MED, V67, P163; Baum KD, 2003, MED ED ONLINE, V8, P4; Bazarian JJ, 1999, ANN EMERG MED, V34, P148, DOI 10.1016/S0196-0644(99)70222-2; Beasley BW, 2002, J GEN INTERN MED, V17, P632, DOI 10.1046/j.1525-1497.2002.11110.x; BENNETT KJ, 1987, JAMA-J AM MED ASSOC, V257, P2451, DOI 10.1001/jama.257.18.2451; Bergus George, 2004, BMC Med Educ, V4, P20, DOI 10.1186/1472-6920-4-20; Bergus GR, 2005, FAM MED, V37, P486; Berner ES, 2002, ACAD MED, V77, P547, DOI 10.1097/00001888-200206000-00014; Bradley DR, 2002, J MED LIBR ASSOC, V90, P194; Bradley P, 2005, MED EDUC, V39, P1027, DOI 10.1111/j.1365-2929.2005.02268.x; Bradley P, 1999, MED EDUC, V33, P815, DOI 10.1046/j.1365-2923.1999.00466.x; Bradley P, 2004, MED ED ONLINE, V9, P15; Burrows SC, 1999, B MED LIBR ASSOC, V87, P471; Cabell CH, 2001, J GEN INTERN MED, V16, P838, DOI 10.1046/j.1525-1497.2001.10239.x; Cartwright CA, 2002, ACAD MED, V77, P385, DOI 10.1097/00001888-200205000-00006; Cayley William E Jr, 2005, WMJ, V104, P34; Cheng Grace Y T, 2003, Health Info Libr J, V20 Suppl 1, P22, DOI 10.1046/j.1365-2532.20.s1.5.x; Connor Elizabeth, 2003, Medical Reference Services Quarterly, V22, P31, DOI 10.1300/J115v22n04_04; Coomarasamy A, 2004, BMJ-BRIT MED J, V329, P1017, DOI 10.1136/bmj.329.7473.1017; Cork RD, 1998, J AM MED INFORM ASSN, V5, P164, DOI 10.1136/jamia.1998.0050164; COVELL DG, 1985, ANN INTERN MED, V103, P596, DOI 10.7326/0003-4819-103-4-596; Cramer J S, 2001, BMC Med Educ, V1, P6, DOI 10.1186/1472-6920-1-6; Crites GE, 2004, MED TEACH, V26, P74, DOI 10.1080/0142159032000150467; Crowley SD, 2003, ACAD MED, V78, P270, DOI 10.1097/00001888-200303000-00007; Cuddy P G, 1984, J Biocommun, V11, P2; Davidson RA, 2004, ACAD MED, V79, P272, DOI 10.1097/00001888-200403000-00016; Dee C, 2005, J MED LIBR ASSOC, V93, P213; DeLisa JA, 1999, AM J PHYS MED REHAB, V78, P228, DOI 10.1097/00002060-199905000-00008; Dorsch JL, 2004, J MED LIBR ASSOC, V92, P397; Downing SM, 2004, MED EDUC, V38, P1006, DOI 10.1111/j.1365-2929.2004.01932.x; Downing SM, 2003, MED EDUC, V37, P830, DOI 10.1046/j.1365-2923.2003.01594.x; Ebbert JO, 2001, MED TEACH, V23, P455; Edwards R, 2001, MED EDUC, V35, P691, DOI 10.1046/j.1365-2923.2001.00972.x; ELLIS J, 1995, LANCET, V346, P407, DOI 10.1016/S0140-6736(95)92781-6; EMERSON JD, 1983, NEW ENGL J MED, V309, P709, DOI 10.1056/NEJM198309223091206; Epling J, 2002, FAM MED, V34, P646; Erickson S, 1998, MED EDUC, V32, P269, DOI 10.1046/j.1365-2923.1998.00229.x; Fliegel Jonathan E, 2002, Acad Med, V77, P1157, DOI 10.1097/00001888-200211000-00022; Forsetlund Louise, 2003, BMC Med Educ, V3, P2, DOI 10.1186/1472-6920-3-2; Fox NJ, 1999, MED EDUC, V33, P365; FRASCA MA, 1992, B MED LIBR ASSOC, V80, P23; Fritsche L, 2002, BMJ-BRIT MED J, V325, P1338, DOI 10.1136/bmj.325.7376.1338; Fung MFK, 2000, MED EDUC, V34, P474, DOI 10.1046/j.1365-2923.2000.00571.x; GEHLBACH SH, 1980, J MED EDUC, V55, P362; Ghali WA, 2000, MED EDUC, V34, P18, DOI 10.1046/j.1365-2923.2000.00402.x; Godwin Marshall, 2003, BMC Med Educ, V3, P10, DOI 10.1186/1472-6920-3-10; Grad R, 2001, FAM MED, V33, P602; Green ML, 1999, ACAD MED, V74, P686, DOI 10.1097/00001888-199906000-00017; Green ML, 1997, J GEN INTERN MED, V12, P742, DOI 10.1046/j.1525-1497.1997.07159.x; Green ML, 2000, J GEN INTERN MED, V15, P129, DOI 10.1046/j.1525-1497.2000.03119.x; Gruppen LD, 2005, ACAD MED, V80, P940, DOI 10.1097/00001888-200510000-00014; Hatala R, 2002, JAMA-J AM MED ASSOC, V288, P1110, DOI 10.1001/jama.288.9.1110; HAYNES RB, 1990, ANN INTERN MED, V112, P78, DOI 10.7326/0003-4819-112-1-78; HAYNES RB, 2001, ACP J CLUB, V134, P11; HAYNES RB, 1993, ONLINE J CURR CLIN T; HAYNES TB, 2002, ACP J CLUB, V136, pA11; Hayward RA, 2005, J GEN INTERN MED, V20, P686, DOI 10.1111/j.1525-1497.2005.0152.x; Hunt DP, 2003, TEACH LEARN MED, V15, P131, DOI 10.1207/S15328015TLM1502_11; Ibbotson T, 1998, MED EDUC, V32, P486; Institute of Medicine, 2003, HLTH PROF ED BRIDG Q; Jerant AF, 2000, FAM MED, V32, P267; Jette DU, 2003, PHYS THER, V83, P786, DOI 10.1093/ptj/83.9.786; Johnston JM, 2003, MED EDUC, V37, P992, DOI 10.1046/j.1365-2923.2003.01678.x; Kellum JA, 2000, CRIT CARE MED, V28, P3067, DOI 10.1097/00003246-200008000-00065; Khan K. S., 1999, Journal of Obstetrics and Gynaecology (Abingdon), V19, P231; Khan KS, 2001, MED TEACH, V23, P92, DOI 10.1080/01421590150214654; KITCHENS JM, 1989, J GEN INTERN MED, V4, P384, DOI 10.1007/BF02599686; Kronick J, 2003, CAN FAM PHYSICIAN, V49, P312; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LANDRY FJ, 1994, J GEN INTERN MED, V9, P436, DOI 10.1007/BF02599058; Langham J, 2002, BRIT J GEN PRACT, V52, P818; Lawrence Janna C, 2004, Med Ref Serv Q, V23, P73, DOI 10.1300/J115v23n01_07; Lieberman SA, 2000, ACAD MED, V75, pS84, DOI 10.1097/00001888-200010001-00027; Linton Anne M, 2004, Med Ref Serv Q, V23, P21; LINZER M, 1987, J MED EDUC, V62, P690; LINZER M, 1988, JAMA-J AM MED ASSOC, V260, P2537, DOI 10.1001/jama.260.17.2537; Lloyd FJ, 2001, J GEN INTERN MED, V16, P94, DOI 10.1111/j.1525-1497.2001.00214.x; Lucas BP, 2004, J GEN INTERN MED, V19, P402, DOI 10.1111/j.1525-1497.2004.30306.x; Lynch DC, 2004, MED TEACH, V26, P366, DOI 10.1080/01421590410001696434; MacRae HM, 2004, SURGERY, V136, P641, DOI 10.1016/j.surg.2004.02.003; MacRae HM, 2004, AM J SURG, V187, P120, DOI 10.1016/j.amjsurg.2002.12.006; Markey P, 2001, FAM PRACT, V18, P364, DOI 10.1093/fampra/18.4.364; McAlister FA, 1999, J GEN INTERN MED, V14, P236, DOI 10.1046/j.1525-1497.1999.00323.x; McColl A, 1998, BRIT MED J, V316, P361, DOI 10.1136/bmj.316.7128.361; McGlade KJ, 2001, MED EDUC, V35, P62, DOI 10.1046/j.1365-2923.2001.00840.x; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; McKenna HP, 2004, J ADV NURS, V45, P178, DOI 10.1046/j.1365-2648.2003.02879.x; MCKIBBON KA, 1990, COMPUT BIOMED RES, V23, P583, DOI 10.1016/0010-4809(90)90042-B; Mukohara K, 2005, MED EDUC, V39, P402, DOI 10.1111/j.1365-2929.2005.02109.x; Naidr JP, 2004, TEACH LEARN MED, V16, P255, DOI 10.1207/s15328015tlm1603_6; Neville AJ, 2000, ACAD MED, V75, pS87, DOI 10.1097/00001888-200010001-00028; Norman GR, 1998, CAN MED ASSOC J, V158, P177; Oliveri RS, 2004, J EVAL CLIN PRACT, V10, P219, DOI 10.1111/j.1365-2753.2003.00477.x; ORSCH JL, 1990, B MED LIB ASS, V78, P38; PARKES J, 2001, COCHRANE DB SYST REV, V3; PIERCE S, 2000, THESIS NW STATE U LO; Poyner Ann, 2004, Health Info Libr J, V21, P57, DOI 10.1111/j.1471-1842.2004.00471.x; Pravikoff DS, 2005, AM J NURS, V105, P40, DOI 10.1097/00000446-200509000-00025; Ramos KD, 2003, BRIT MED J, V326, P319, DOI 10.1136/bmj.326.7384.319; Reiter HI, 2000, ADV HEALTH SCI EDUC, V5, P221, DOI 10.1023/A:1009877514060; Richardson W S, 1995, ACP J Club, V123, pA12; RIEGELMAN RK, 1983, J MED EDUC, V58, P411; RIEGELMAN RK, 1986, J MED EDUC, V61, P454; ROMM FJ, 1989, AM J PREV MED, V5, P50, DOI 10.1016/S0749-3797(18)31129-2; Rosenberg WMC, 1998, J ROY COLL PHYS LOND, V32, P557; Rosenfeld P, 2002, CIN-COMPUT INFORM NU, V20, P236, DOI 10.1097/00024665-200211000-00009; Ross R, 2003, ACAD MED, V78, P412, DOI 10.1097/00001888-200304000-00019; Schoenfeld P, 2000, ACAD MED, V75, P1212, DOI 10.1097/00001888-200012000-00019; Schwartz A, 2005, MED TEACH, V27, P76, DOI 10.1080/01421590400016415; Schwartz A, 2003, BRIT MED J, V326, P536, DOI 10.1136/bmj.326.7388.536; SCHWARTZ DG, 1995, MED EDUC, V29, P133, DOI 10.1111/j.1365-2923.1995.tb02816.x; Schwartz K, 2003, FAM MED, V35, P251; Scott I, 2000, AUST NZ J MED, V30, P319, DOI 10.1111/j.1445-5994.2000.tb00832.x; SEELIG CB, 1991, J GEN INTERN MED, V6, P330; Smith CA, 2000, J GEN INTERN MED, V15, P710, DOI 10.1046/j.1525-1497.2000.91026.x; Srinivasan M, 2002, J GEN INTERN MED, V17, P58, DOI 10.1046/j.1525-1497.2002.10121.x; STARR SS, 1987, B MED LIBR ASSOC, V75, P193; Steele Godfrey, 2002, Health Info Libr J, V19, P206, DOI 10.1046/j.1471-1842.2002.00381.x; STERN DT, 1995, ACAD MED, V70, P152, DOI 10.1097/00001888-199502000-00021; Stevermer JJ, 1999, ACAD MED, V74, P70; Straus SE, 2004, BRIT MED J, V329, P1029, DOI 10.1136/bmj.329.7473.1029; Straus SE, 2005, J GEN INTERN MED, V20, P340, DOI 10.1111/j.1525-1497.2005.04045.x; Taylor R, 2001, MED EDUC, V35, P544, DOI 10.1046/j.1365-2923.2001.00916.x; Taylor R, 2000, MED EDUC, V34, P120, DOI 10.1046/j.1365-2923.2000.00574.x; Taylor Rod S, 2004, BMC Med Educ, V4, P30, DOI 10.1186/1472-6920-4-30; Thom David H, 2004, BMC Med Educ, V4, P19, DOI 10.1186/1472-6920-4-19; Thomas KG, 2004, MED EDUC, V38, P569, DOI 10.1111/j.1365-2929.2004.01880.x; Thomas PA, 2001, J GEN INTERN MED, V16, P244, DOI 10.1046/j.1525-1497.2001.016004244.x; Toedter LJ, 2004, J AM COLL SURGEONS, V199, P293, DOI 10.1016/j.jamcollsurg.2004.04.006; Veloski JJ, 2005, ACAD MED, V80, P366, DOI 10.1097/00001888-200504000-00014; Villanueva E V, 2001, BMC Med Inform Decis Mak, V1, P4, DOI 10.1186/1472-6947-1-4; Vogel EW, 2002, J MED LIBR ASSOC, V90, p327A; Wadland W C, 1999, Fam Med, V31, P703; Wainwright JR, 1999, MED EDUC, V33, P907; Weberschock TB, 2005, MED EDUC, V39, P665, DOI 10.1111/j.1365-2929.2005.02191.x; Whitcomb ME, 2002, ACAD MED, V77, P1067, DOI 10.1097/00001888-200211000-00001; Young JM, 2002, BRIT MED J, V324, P950, DOI 10.1136/bmj.324.7343.950	142	270	276	0	68	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2006	296	9					1116	1127		10.1001/jama.296.9.1116	http://dx.doi.org/10.1001/jama.296.9.1116			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	081DW	16954491				2022-12-28	WOS:000240298400013
J	West, CP; Huschka, MM; Novotny, PJ; Sloan, JA; Kolars, JC; Habermann, TM; Shanafelt, TD				West, Colin P.; Huschka, Mashele M.; Novotny, Paul J.; Sloan, Jeff A.; Kolars, Joseph C.; Habermann, Thomas M.; Shanafelt, Tait D.			Association of perceived medical errors with resident distress and empathy - A prospective longitudinal study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVERSE DRUG EVENTS; VISUAL ANALOG SCALE; QUALITY-OF-LIFE; HOSPITALIZED-PATIENTS; INTENSIVE-CARE; HOUSE OFFICERS; PATIENT-CARE; PERSONAL AWARENESS; EXCESS LENGTH; MISTAKES	Context Medical errors are associated with feelings of distress in physicians, but little is known about the magnitude and direction of these associations. Objective To assess the frequency of self-perceived medical errors among resident physicians and to determine the association of self-perceived medical errors with resident quality of life, burnout, depression, and empathy using validated metrics. Design, Setting, and Participants Prospective longitudinal cohort study of categorical and preliminary internal medicine residents at Mayo Clinic Rochester. Data were provided by 184 (84%) of 219 eligible residents. Participants began training in the 2003-2004, 2004-2005, and 2005-2006 academic years and completed surveys quarterly through May 2006. Surveys included self-assessment of medical errors and linear analog scale assessment of quality of life every 3 months, and the Maslach Burnout Inventory (depersonalization, emotional exhaustion, and personal accomplishment), Interpersonal Reactivity Index, and a validated depression screening tool every 6 months. Main Outcome Measures Frequency of self-perceived medical errors was recorded. Associations of an error with quality of life, burnout, empathy, and symptoms of depression were determined using generalized estimating equations for repeated measures. Results Thirty-four percent of participants reported making at least 1 major medical error during the study period. Making a medical error in the previous 3 months was reported by a mean of 14.7% of participants at each quarter. Self-perceived medical errors were associated with a subsequent decrease in quality of life (P=.02) and worsened measures in all domains of burnout (P=.002 for each). Self-perceived errors were associated with an odds ratio of screening positive for depression at the subsequent time point of 3.29 (95% confidence interval, 1.90-5.64). In addition, increased burnout in all domains and reduced empathy were associated with increased odds of self-perceived error in the following 3 months (P=.001, P<.001, and P=.02 for depersonalization, emotional exhaustion, and lower personal accomplishment, respectively; P=.02 and P=.01 for emotive and cognitive empathy, respectively). Conclusions Self-perceived medical errors are common among internal medicine residents and are associated with substantial subsequent personal distress. Personal distress and decreased empathy are also associated with increased odds of future self-perceived errors, suggesting that perceived errors and distress may be related in a reciprocal cycle.	Mayo Clin Coll Med, Dept Med, Div Gen Internal Med, Rochester, MN 55905 USA; Mayo Clin Coll Med, Dept Hlth Sci Res, Div Biostat, Rochester, MN 55905 USA; Mayo Clin Coll Med, Dept Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; Mayo Clin Coll Med, Dept Med, Div Hematol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	West, CP (corresponding author), Mayo Clin Coll Med, Dept Med, Div Gen Internal Med, 200 1st St SW, Rochester, MN 55905 USA.	west.colin@mayo.edu		Kolars, Joseph/0000-0002-2603-188X				Andrews LB, 1997, LANCET, V349, P309, DOI 10.1016/S0140-6736(96)08268-2; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; Bellini LM, 2005, ACAD MED, V80, P164, DOI 10.1097/00001888-200502000-00013; Bellini LM, 2002, JAMA-J AM MED ASSOC, V287, P3143, DOI 10.1001/jama.287.23.3143; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Chaudhry SI, 2003, J GEN INTERN MED, V18, P595, DOI 10.1046/j.1525-1497.2003.20919.x; CHRISTENSEN JF, 1992, J GEN INTERN MED, V7, P424, DOI 10.1007/BF02599161; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; Collier VU, 2002, ANN INTERN MED, V136, P384, DOI 10.7326/0003-4819-136-5-200203050-00011; Cunningham Wayne, 2004, N Z Med J, V117, pU972; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Diggle PJ, 1994, ANAL LONGITUDINAL DA; Engel KG, 2006, ACAD MED, V81, P86, DOI 10.1097/00001888-200601000-00021; Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833; FirthCozens J, 1997, SOC SCI MED, V44, P1017, DOI 10.1016/S0277-9536(96)00227-4; Gaba DM, 2002, NEW ENGL J MED, V347, P1249, DOI 10.1056/NEJMsa020846; Gawande AA, 1999, SURGERY, V126, P66, DOI 10.1067/msy.1999.98664; Goitein L, 2005, ARCH INTERN MED, V165, P2601, DOI 10.1001/archinte.165.22.2601; Goldberg RM, 2002, ANN EMERG MED, V39, P287, DOI 10.1067/mem.2002.121995; Gopal R, 2005, ARCH INTERN MED, V165, P2595, DOI 10.1001/archinte.165.22.2595; Graf J, 2005, ACTA ANAESTH SCAND, V49, P930, DOI 10.1111/j.1399-6576.2005.00731.x; Grunberg SM, 1996, QUAL LIFE RES, V5, P65, DOI 10.1007/BF00435970; Gudex C, 1996, QUAL LIFE RES, V5, P521, DOI 10.1007/BF00439226; Haas JS, 2000, J GEN INTERN MED, V15, P122, DOI 10.1046/j.1525-1497.2000.02219.x; Halpern J, 2003, J GEN INTERN MED, V18, P670, DOI 10.1046/j.1525-1497.2003.21017.x; Hobgood C, 2005, ACAD MED, V80, P758, DOI 10.1097/00001888-200508000-00012; Hojat M, 2002, AM J PSYCHIAT, V159, P1563, DOI 10.1176/appi.ajp.159.9.1563; Ioannidis JPA, 2001, J GEN INTERN MED, V16, P325, DOI 10.1046/j.1525-1497.2001.00714.x; Jagsi R, 2005, ARCH INTERN MED, V165, P2607, DOI 10.1001/archinte.165.22.2607; Kalish R L, 1995, Am J Med Qual, V10, P48, DOI 10.1177/0885713X9501000108; Kellerman SE, 2001, AM J PREV MED, V20, P61, DOI 10.1016/S0749-3797(00)00258-0; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; Leape LL, 2005, JAMA-J AM MED ASSOC, V293, P2384, DOI 10.1001/jama.293.19.2384; Lester H, 2001, MED EDUC, V35, P855, DOI 10.1046/j.1365-2923.2001.01003.x; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Longo DR, 2005, JAMA-J AM MED ASSOC, V294, P2858, DOI 10.1001/jama.294.22.2858; Luszczak M, 2003, ANN EMERG MED, V41, P155, DOI 10.1067/mem.2003.29; MIZRAHI T, 1984, SOC SCI MED, V19, P135, DOI 10.1016/0277-9536(84)90280-6; Newman MC, 1996, ARCH FAM MED, V5, P71, DOI 10.1001/archfami.5.2.71; Novack DH, 1997, JAMA-J AM MED ASSOC, V278, P502, DOI 10.1001/jama.278.6.502; ONEIL AC, 1993, ANN INTERN MED, V119, P370, DOI 10.7326/0003-4819-119-5-199309010-00004; Penson RT, 2001, ONCOLOGIST, V6, P92, DOI 10.1634/theoncologist.6-1-92; Philibert I, 2002, JAMA-J AM MED ASSOC, V288, P1112, DOI 10.1001/jama.288.9.1112; REUBEN DB, 1985, ARCH INTERN MED, V145, P286, DOI 10.1001/archinte.145.2.286; Rosen IM, 2006, ACAD MED, V81, P82, DOI 10.1097/00001888-200601000-00020; Rothschild JM, 2005, CRIT CARE MED, V33, P1694, DOI 10.1097/01.CCM.0000171609.91035.BD; Rowe M, 2004, CRIT REV ONCOL HEMAT, V52, P147, DOI 10.1016/j.critrevonc.2004.06.003; Rummans TA, 2006, J CLIN ONCOL, V24, P635, DOI 10.1200/JCO.2006.06.209; Schaufeli W.B., 1996, MASLACH BURNOUT INVE, V3rd, P22; Shanafelt TD, 2005, J GEN INTERN MED, V20, P559, DOI 10.1007/s11606-005-0102-8; Shanafelt TD, 2005, ONCOLOGY-BASEL, V68, P23, DOI 10.1159/000084519; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; SHOJANIA K, 2001, AHRQ PUBLICATION; Sloan JA, 2005, J CLIN EPIDEMIOL, V58, P1217, DOI 10.1016/j.jclinepi.2005.07.009; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; SPITZER WO, 1981, J CHRON DIS, V34, P585, DOI 10.1016/0021-9681(81)90058-8; STEEL K, 1981, NEW ENGL J MED, V304, P638, DOI 10.1056/NEJM198103123041104; Thomas EJ, 2003, J GEN INTERN MED, V18, P61, DOI 10.1046/j.1525-1497.2003.20147.x; Thomas NK, 2004, JAMA-J AM MED ASSOC, V292, P2880, DOI 10.1001/jama.292.23.2880; Vincent C, 2003, NEW ENGL J MED, V348, P1051, DOI 10.1056/NEJMhpr020760; Wears RL, 2002, ANN EMERG MED, V39, P344, DOI 10.1067/mem.2002.121996; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Williams JW, 2002, JAMA-J AM MED ASSOC, V287, P1160, DOI 10.1001/jama.287.9.1160; WU AW, 1991, JAMA-J AM MED ASSOC, V265, P2089, DOI 10.1001/jama.265.16.2089; WU AW, 1993, WESTERN J MED, V159, P565; Wu AW, 2000, BRIT MED J, V320, P726, DOI 10.1136/bmj.320.7237.726; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868	73	878	899	3	92	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2006	296	9					1071	1078		10.1001/jama.296.9.1071	http://dx.doi.org/10.1001/jama.296.9.1071			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	081DW	16954486	Bronze			2022-12-28	WOS:000240298400008
J	Wirth, L; Allen, AM; Machtay, M				Wirth, Lori; Allen, Aaron M.; Machtay, Mitchell			Altered fractionation: a fractional benefit?	LANCET			English	Editorial Material							ADVANCED LARYNGEAL-CANCER; SQUAMOUS-CELL CARCINOMA; RADIATION-THERAPY; PHASE-III; NECK-CANCER; ACCELERATED FRACTIONATION; RANDOMIZED-TRIAL; RADIOTHERAPY; HEAD; CHEMOTHERAPY		Dana Farber Canc Inst, Boston, MA 02115 USA; Thomas Jefferson Univ, Philadelphia, PA 19107 USA; Amgen Inc, Thousand Oaks, CA 91320 USA	Harvard University; Dana-Farber Cancer Institute; Jefferson University; Amgen	Wirth, L (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	Lori_Wirth@dfci.harvard.edu						Adelstein DJ, 2003, J CLIN ONCOL, V21, P92, DOI 10.1200/JCO.2003.01.008; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; BOURHIS J, 2004, P AN M AM SOC CLIN, V22, P5505; Bourhis J, 2006, LANCET, V368, P843, DOI 10.1016/S0140-6736(06)69121-6; Butler EB, 1999, INT J RADIAT ONCOL, V45, P21, DOI 10.1016/S0360-3016(99)00101-7; Calais G, 1999, J NATL CANCER I, V91, P2081, DOI 10.1093/jnci/91.24.2081; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Fu KK, 2000, INT J RADIAT ONCOL, V48, P7, DOI 10.1016/S0360-3016(00)00663-5; Hitt R, 2005, J CLIN ONCOL, V23, P8636, DOI 10.1200/JCO.2004.00.1990; HORIOT JC, 1992, RADIOTHER ONCOL, V25, P231, DOI 10.1016/0167-8140(92)90242-M; Khalil AA, 2003, INT J RADIAT ONCOL, V55, P568, DOI 10.1016/S0360-3016(02)03790-2; Lefebvre JL, 1996, J NATL CANCER I, V88, P890, DOI 10.1093/jnci/88.13.890; Overgaard J, 2003, LANCET, V362, P933, DOI 10.1016/S0140-6736(03)14361-9; POSNER M, 2006, AM SOC CLIN ONC ATL; VERMORKEN JB, 2004, P AN M AM SOC CLIN, V23, P5508; WOLF GT, 1991, NEW ENGL J MED, V324, P1685, DOI 10.1056/nejm199106133242402	16	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2006	368	9538					819	821		10.1016/S0140-6736(06)69300-8	http://dx.doi.org/10.1016/S0140-6736(06)69300-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	082FD	16950339				2022-12-28	WOS:000240371200005
J	Singh, SC; Crawford, WC; Carton, H; Seher, T; Combier, V; Cannat, M; Canales, JP; Dusunur, D; Escartin, J; Miranda, JM				Singh, Satish C.; Crawford, Wayne C.; Carton, Helene; Seher, Tim; Combier, Violaine; Cannat, Mathilde; Canales, Juan Pablo; Duesuenuer, Doga; Escartin, Javier; Miranda, J. Miguel			Discovery of a magma chamber and faults beneath a Mid-Atlantic Ridge hydrothermal field	NATURE			English	Article							RIFT-VALLEY; CRUSTAL THICKNESS; OCEANIC-CRUST; MARK AREA; AZORES; MELT; IMAGES	Crust at slow-spreading ridges is formed by a combination of magmatic and tectonic processes, with magmatic accretion possibly involving short-lived crustal magma chambers(1). The reflections of seismic waves from crustal magma chambers have been observed beneath intermediate(2,3) and fast-spreading centres(4,5), but it has been difficult to image such magma chambers beneath slow-spreading centres(6,7), owing to rough seafloor topography and associated seafloor scattering(7,8). In the absence of any images of magma chambers(6) or of subsurface near-axis faults, it has been difficult to characterize the interplay of magmatic and tectonic processes in crustal accretion and hydrothermal circulation at slow-spreading ridges. Here we report the presence of a crustal magma chamber beneath the slow-spreading Lucky Strike segment of the Mid-Atlantic Ridge. The reflection from the top of the magma chamber, centred beneath the Lucky Strike volcano and hydrothermal field, is approximately 3 km beneath the sea floor, 3 - 4 km wide and extends up to 7 km along-axis. We suggest that this magma chamber provides the heat for the active hydrothermal vent field above it. We also observe axial valley bounding faults that seem to penetrate down to the magma chamber depth as well as a set of inward-dipping faults cutting through the volcanic edifice, suggesting continuous interactions between tectonic and magmatic processes.	Inst Phys Globe, Lab Geosci Marines, F-75252 Paris, France; Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; Univ Lisbon, Ctr Geofis, P-1749016 Lisbon, Portugal	UDICE-French Research Universities; Universite Paris Cite; Woods Hole Oceanographic Institution; Universidade de Lisboa	Singh, SC (corresponding author), Inst Phys Globe, Lab Geosci Marines, 4 Pl Jussieu, F-75252 Paris, France.	singh@ipgp.jussieu.fr	de Miranda, Jorge Miguel/B-5287-2008; Crawford, Wayne C/A-5658-2011; pgp, lgm/F-8796-2010; Cannat, Mathilde/F-9304-2010; Carton, Helene D/N-9417-2017; Escartin, Javier/B-3344-2008; doğan, doğa/ABA-8919-2020; ESCARTIN, Javier/A-1043-2010	de Miranda, Jorge Miguel/0000-0002-1321-8709; Crawford, Wayne C/0000-0002-3260-1826; doğan, doğa/0000-0001-5678-1879; ESCARTIN, Javier/0000-0002-3416-6856; Canales, Juan Pablo/0000-0003-3066-7888				CALVERT AJ, 1995, NATURE, V377, P410, DOI 10.1038/377410a0; Calvert AJ, 1997, J GEOPHYS RES-SOL EA, V102, P5119, DOI 10.1029/96JB03798; Canales JP, 2000, J GEOPHYS RES-SOL EA, V105, P28411, DOI 10.1029/2000JB900301; CANALES JP, 2005, J GEOPHYS RES, V110, DOI DOI 10.1029/2005/JB003630; Cannat M, 1999, EARTH PLANET SC LETT, V173, P257, DOI 10.1016/S0012-821X(99)00234-4; CANNAT M, 1993, J GEOPHYS RES-SOL EA, V98, P4163, DOI 10.1029/92JB02221; Cannat M, 1996, J GEOPHYS RES-SOL EA, V101, P2847, DOI 10.1029/95JB03116; CHEN YS, 1990, J GEOPHYS RES-SOLID, V95, P17571, DOI 10.1029/JB095iB11p17571; COLLIER J, 1990, NATURE, V346, P646, DOI 10.1038/346646a0; Desbruyeres D, 2001, DEEP-SEA RES PT I, V48, P1325, DOI 10.1016/S0967-0637(00)00083-2; DETRICK RS, 1995, J GEOPHYS RES-SOL EA, V100, P3767, DOI 10.1029/94JB02649; DETRICK RS, 1987, NATURE, V326, P35, DOI 10.1038/326035a0; DETRICK RS, 1990, NATURE, V347, P61, DOI 10.1038/347061a0; Dosso L, 1999, EARTH PLANET SC LETT, V170, P269, DOI 10.1016/S0012-821X(99)00109-0; Dziak RP, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003141; Dziak RP, 1999, GEOPHYS RES LETT, V26, P3641, DOI 10.1029/1999GL002326; Escartin J, 2001, J GEOPHYS RES-SOL EA, V106, P21719, DOI 10.1029/2001JB000224; Humphris SE, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000284; Kent GM, 2000, NATURE, V406, P614, DOI 10.1038/35020543; Langmuir C, 1997, EARTH PLANET SC LETT, V148, P69, DOI 10.1016/S0012-821X(97)00027-7; Maclennan J, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000605; Meurer WP, 2002, EARTH PLANET SC LETT, V201, P45, DOI 10.1016/S0012-821X(02)00660-X; Navin DA, 1998, GEOPHYS J INT, V135, P746, DOI 10.1046/j.1365-246X.1998.00709.x; SCHILLING JG, 1991, NATURE, V352, P397, DOI 10.1038/352397a0; Singh SC, 1998, NATURE, V394, P874, DOI 10.1038/29740; Smith DK, 1999, J GEOPHYS RES-SOL EA, V104, P25379, DOI 10.1029/1999JB900177; THATCHER W, 1995, J GEOPHYS RES-SOL EA, V100, P561, DOI 10.1029/94JB02593; TOOMEY DR, 1988, J GEOPHYS RES-SOLID, V93, P9093, DOI 10.1029/JB093iB08p09093; Von Damm K. L., 1995, GEOPHYS MONOGR SER, P222, DOI [10.1029/GM091, DOI 10.1029/GM091]; Wilcock WSD, 1996, EARTH PLANET SC LETT, V145, P49, DOI 10.1016/S0012-821X(96)00195-1	30	202	210	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2006	442	7106					1029	1032		10.1038/nature05105	http://dx.doi.org/10.1038/nature05105			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	078YF	16943836				2022-12-28	WOS:000240142000047
J	Willem, M; Garratt, AN; Novak, B; Citron, M; Kaufmann, S; Rittger, A; DeStrooper, B; Saftig, P; Birchmeier, C; Haass, C				Willem, Michael; Garratt, Alistair N.; Novak, Bozidar; Citron, Martin; Kaufmann, Steve; Rittger, Andrea; DeStrooper, Bart; Saftig, Paul; Birchmeier, Carmen; Haass, Christian			Control of peripheral nerve myelination by the beta-secretase BACE1	SCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; NEUREGULIN ISOFORMS; ASPARTYL PROTEASE; CLEAVING ENZYME; SCHWANN-CELL; CLEAVAGE; SITE; GENERATION	Although BACE1 (beta-site amyloid precursor protein - cleaving enzyme 1) is essential for the generation of amyloid-beta peptide in Alzheimer's disease, its physiological function is unclear. We found that very high levels of BACE1 were expressed at time points when peripheral nerves become myelinated. Deficiency of BACE1 resulted in the accumulation of unprocessed neuregulin 1 (NRG1), an axonally expressed factor required for glial cell development and myelination. BACE1(-/-) mice displayed hypomyelination of peripheral nerves and aberrant axonal segregation of small-diameter afferent fibers, very similar to that seen in mice with mutations in type III NRG1 or Schwann cell specific ErbB2 knockouts. Thus, BACE1 is required for myelination and correct bundling of axons by Schwann cells, probably through processing of type III NRG1.	Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; Univ Munich, Adolf Butenandt Inst, Lab Alzheimers & Parkinsons Dis Res, Dept Biochem, D-80336 Munich, Germany; Amgen Inc, Dept Neurosci, Thousand Oaks, CA 93120 USA; Amgen Inc, Dept Pathol, Thousand Oaks, CA 93120 USA; Univ Kiel, Inst Biochem, D-24098 Kiel, Germany; Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; VIB, Dept Human Genet, B-3000 Louvain, Belgium	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Munich; Amgen; Amgen; University of Kiel; KU Leuven; Flanders Institute for Biotechnology (VIB)	Garratt, AN (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13092 Berlin, Germany.	agarratt@mdc-berlin.de; chaass@med.uni-muenchen.de	De Strooper, Bart/F-6507-2012; de+Strooper, Bart/Z-1638-2019; Garratt, Alistair/HGC-0774-2022; Garratt, Alistair N/D-9893-2013; Garratt, Alistair/AAG-2715-2021; Saftig, Paul/A-7966-2010; Messier, Claude/A-2322-2008	De Strooper, Bart/0000-0001-5455-5819; Garratt, Alistair N/0000-0001-9631-3041; Messier, Claude/0000-0002-4791-1763				Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Citron M, 2004, TRENDS PHARMACOL SCI, V25, P92, DOI 10.1016/j.tips.2003.12.004; CITRON M, 2004, 4413 SOC NEUR; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Falls DL, 2003, J NEUROCYTOL, V32, P619, DOI 10.1023/B:NEUR.0000020614.83883.be; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Fluhrer R, 2003, J BIOL CHEM, V278, P5531, DOI 10.1074/jbc.M211485200; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Horiuchi K, 2005, DEV BIOL, V283, P459, DOI 10.1016/j.ydbio.2005.05.004; Hussain I, 2000, MOL CELL NEUROSCI, V16, P609, DOI 10.1006/mcne.2000.0884; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Jones JT, 1999, FEBS LETT, V447, P227, DOI 10.1016/S0014-5793(99)00283-5; Kitazume S, 2003, J BIOL CHEM, V278, P14865, DOI 10.1074/jbc.M206262200; Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; LEMKE G, 2006, SCI STKE, pPE11; Li L, 2002, ONCOGENE, V21, P4900, DOI 10.1038/sj.onc.1205634; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Marjaux E, 2004, NEURON, V42, P189, DOI 10.1016/S0896-6273(04)00218-1; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Montero JC, 2000, MOL CELL NEUROSCI, V16, P631, DOI 10.1006/mcne.2000.0896; Montero JC, 2002, BIOCHEM J, V363, P211, DOI 10.1042/0264-6021:3630211; Oberto M, 2001, EUR J NEUROSCI, V14, P513, DOI 10.1046/j.0953-816x.2001.01667.x; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Schenk D, 2004, CURR OPIN IMMUNOL, V16, P599, DOI 10.1016/j.coi.2004.07.012; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shi XP, 2003, J BIOL CHEM, V278, P21286, DOI 10.1074/jbc.M209859200; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Vandermeeren M, 2001, NEUROSCI LETT, V315, P145, DOI 10.1016/S0304-3940(01)02369-2; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2004, J MOL NEUROSCI, V23, P105, DOI 10.1385/JMN:23:1-2:105; Wang JY, 2001, J BIOL CHEM, V276, P2841, DOI 10.1074/jbc.M005700200; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Yan RQ, 2001, J BIOL CHEM, V276, P34019, DOI 10.1074/jbc.M105583200; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107	43	562	581	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					664	666		10.1126/science.1132341	http://dx.doi.org/10.1126/science.1132341			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	16990514				2022-12-28	WOS:000241557800053
J	Kramer, M; Stairs, IH; Manchester, RN; McLaughlin, MA; Lyne, AG; Ferdman, RD; Burgay, M; Lorimer, DR; Possenti, A; D'Amico, N; Sarkissian, JM; Hobbs, GB; Reynolds, JE; Freire, PCC; Camilo, F				Kramer, M.; Stairs, I. H.; Manchester, R. N.; McLaughlin, M. A.; Lyne, A. G.; Ferdman, R. D.; Burgay, M.; Lorimer, D. R.; Possenti, A.; D'Amico, N.; Sarkissian, J. M.; Hobbs, G. B.; Reynolds, J. E.; Freire, P. C. C.; Camilo, F.			Tests of general relativity from timing the double pulsar	SCIENCE			English	Article							STRONG-FIELD TESTS; CELESTIAL MECHANICS; BINARY-SYSTEMS; GRAVITY; EMISSION; J0737-3039A; EQUATION; INERTIA; MOMENT	The double pulsar system PSR J0737-3039A/B is unique in that both neutron stars are detectable as radio pulsars. They are also known to have much higher mean orbital velocities and accelerations than those of other binary pulsars. The system is therefore a good candidate for testing Einstein's theory of general relativity and alternative theories of gravity in the strong-field regime. We report on precision timing observations taken over the 2.5 years since its discovery and present four independent strong-field tests of general relativity. These tests use the theory-independent mass ratio of the two stars. By measuring relativistic corrections to the Keplerian description of the orbital motion, we find that the "post-Keplerian'' parameter s agrees with the value predicted by general relativity within an uncertainty of 0.05%, the most precise test yet obtained. We also show that the transverse velocity of the system's center of mass is extremely small. Combined with the system's location near the Sun, this result suggests that future tests of gravitational theories with the double pulsar will supersede the best current solar system tests. It also implies that the second-born pulsar may not have formed through the core collapse of a helium star, as is usually assumed.	Univ Manchester, Jodrell Bank Observ, Macclesfield SK11 9DL, Cheshire, England; Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; Australia Telescope Natl Facil, CSIRO, Epping, NSW 1710, Australia; W Virginia Univ, Dept Phys, Morgantown, WV 26505 USA; Osservatorio Astron Cagliari, INAF, I-09012 Capoterra, Italy; Univ Cagliari, Dipartimento Fis, SP Monserrato Sestu, I-09042 Monserrato, CA, Italy; NAIC, Arecibo Observ, Arecibo, PR 00612 USA; Columbia Univ, Columbia Astrophys Lab, New York, NY 10027 USA	University of Manchester; Jodrell Bank Centre for Astrophysics; University of British Columbia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); West Virginia University; Istituto Nazionale Astrofisica (INAF); University of Cagliari; National Aeronautics & Space Administration (NASA); Columbia University	Kramer, M (corresponding author), Univ Manchester, Jodrell Bank Observ, Macclesfield SK11 9DL, Cheshire, England.	mkramer@jb.man.ac.uk	Freire, Paulo/ABE-8926-2021; Lorimer, Duncan/ABH-7909-2020; D'Amico, Nichi/A-5715-2009	Freire, Paulo/0000-0003-1307-9435; Ferdman, Robert/0000-0002-2223-1235; Burgay, Marta/0000-0002-8265-4344; Kramer, Michael/0000-0002-4175-2271; McLaughlin, Maura/0000-0001-7697-7422				BARKER BM, 1975, ASTROPHYS J, V199, pL25, DOI 10.1086/181840; Bertotti B, 2003, NATURE, V425, P374, DOI 10.1038/nature01997; Burgay M, 2005, ASTROPHYS J, V624, pL113, DOI 10.1086/430668; Burgay M, 2003, NATURE, V426, P531, DOI 10.1038/nature02124; Coles WA, 2005, ASTROPHYS J, V623, P392, DOI 10.1086/428342; CORDES JM, 2002, ORGABSASTROPH0207156; DAMOUR T, 1991, ASTROPHYS J, V366, P501, DOI 10.1086/169585; DAMOUR T, 1986, ANN I H POINCARE-PHY, V44, P263; Damour T, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.042001; DAMOUR T, 1992, PHYS REV D, V45, P1840, DOI 10.1103/PhysRevD.45.1840; DAMOUR T, 1985, ANN I H POINCARE-PHY, V43, P107; DAMOUR T, 1974, CR ACAD SCI A MATH, V279, P971; DAMOUR T, 1988, NUOVO CIMENTO B, V101, P127, DOI 10.1007/BF02828697; Damour T, UNPUB; Kramer M, 1999, ASTROPHYS J, V526, P957, DOI 10.1086/308042; Kramer M, 2006, ANN PHYS-BERLIN, V15, P34, DOI 10.1002/andp.200510165; KUIJKEN K, 1989, MON NOT R ASTRON SOC, V239, P571, DOI 10.1093/mnras/239.2.571; Lange C, 2001, MON NOT R ASTRON SOC, V326, P274, DOI 10.1046/j.1365-8711.2001.04606.x; Lattimer JM, 2005, ASTROPHYS J, V629, P979, DOI 10.1086/431543; Lyne AG, 2004, SCIENCE, V303, P1153, DOI 10.1126/science.1094645; Manchester RN, 2005, ASTROPHYS J, V621, pL49, DOI 10.1086/429128; Morrison IA, 2004, ASTROPHYS J, V617, pL135, DOI 10.1086/427235; Pfahl E, 2002, ASTROPHYS J, V574, P364, DOI 10.1086/340794; Piran T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.051102; Rafikov RR, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.063003; RANSOM SM, 2004, APJ, V609, P71; Stairs IH, 2002, ASTROPHYS J, V581, P501, DOI 10.1086/344157; STAIRS IH, 2006, IN PRESS MON NOT R A; Standish EM, 1998, ASTRON ASTROPHYS, V336, P381; TAYLOR JH, 1992, NATURE, V355, P132, DOI 10.1038/355132a0; TAYLOR JH, 1989, ASTROPHYS J, V345, P434, DOI 10.1086/167917; WEX N, 1995, CLASSICAL QUANT GRAV, V12, P983, DOI 10.1088/0264-9381/12/4/009; Will Clifford M, 2001, Living Rev Relativ, V4, P4, DOI 10.12942/lrr-2001-4; Williams JG, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.261101; [No title captured]	36	592	601	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2006	314	5796					97	102		10.1126/science.1132305	http://dx.doi.org/10.1126/science.1132305			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	16973838	Green Submitted			2022-12-28	WOS:000241031200043
J	Hoekstra, EJ; McFarland, JW; Shaw, C; Salama, P				Hoekstra, Edward J.; McFarland, Jeffrey W.; Shaw, Catherine; Salama, Peter			Reducing measles mortality, reducing child mortality	LANCET			English	Editorial Material									UNICEF, Hlth Programme Div, Child Survival & Immunizat Unit, New York, NY 10017 USA	UNICEF	Hoekstra, EJ (corresponding author), UNICEF, Hlth Programme Div, Child Survival & Immunizat Unit, New York, NY 10017 USA.	ehoekstra@unicef.org						[Anonymous], 2006, Wkly Epidemiol Rec, V81, P90; [Anonymous], 2005, MMWR MORB MORTAL WKL, V54, P994; de Quadros CA, 2004, J INFECT DIS, V189, pS227, DOI 10.1086/377741; DEQUADROS CA, 1996, JAMA-J AM MED ASSOC, V275, P1311; Otten M, 2005, LANCET, V366, P832, DOI 10.1016/S0140-6736(05)67216-9; WHO, 2000, AB DECL PLAN ACT EXT; *WHO UNICEF, 2006, WHOIVB0511 UNICEF; *WHO UNICEF, 2001, GLOB MEASL MORT RED; WHO UNICEF, 2005, WORLD MAL REP 2005	9	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 23	2006	368	9541					1050	1052		10.1016/S0140-6736(06)69335-5	http://dx.doi.org/10.1016/S0140-6736(06)69335-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	089IC	16997650				2022-12-28	WOS:000240873000008
J	Williams, N				Williams, Nigel			10-minute consultation - Problem drug use	BRITISH MEDICAL JOURNAL			English	Editorial Material									Sighthill Hlth Ctr, Edinburgh EH11 4AU, Midlothian, Scotland		Williams, N (corresponding author), Sighthill Hlth Ctr, Calder Rd, Edinburgh EH11 4AU, Midlothian, Scotland.	williams.nigel@btinternet.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 23	2006	333	7569					639	639		10.1136/bmj.333.7569.639	http://dx.doi.org/10.1136/bmj.333.7569.639			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089KD	16990324	Green Published			2022-12-28	WOS:000240878500019
J	Ballon, DR; Flanary, PL; Gladue, DP; Konopka, JB; Dohlman, HG; Thorner, J				Ballon, Daniel R.; Flanary, Paul L.; Gladue, Douglas P.; Konopka, James B.; Dohlman, Henrik G.; Thorner, Jeremy			DEP-domain-mediated regulation of GPCR signaling responses	CELL			English	Article							PROTEIN ALPHA-SUBUNIT; GTPASE-ACTIVATING PROTEIN; YEAST SACCHAROMYCES-CEREVISIAE; HETEROTRIMERIC G-PROTEINS; SINGLE-POINT MUTATION; PLASMA-MEMBRANE; FACTOR RECEPTOR; PHEROMONE RECEPTOR; COUPLED RECEPTOR; BINDING DOMAINS	G protein-coupled receptors (GPCRs) mediate cellular responses to a variety of stimuli, but how specific responses are regulated has been elusive, as the types of GPCRs vastly outnumber the classes of G protein heterotrimers available to initiate downstream signaling. In our analysis of signaling proteins containing DEP domains (similar to 90 residue sequence motifs first recognized in fly Dishevelled, worm EGL-10, and mammalian Pleckstrin), we find that DEP domains are responsible for specific recognition of GPCRs. We examined the yeast regulator of G protein signaling (RGS) protein Sst2 and demonstrate that the DEP domains in Sst2 mediate binding to its cognate GPCR (Ste2). DEP-domain-mediated tethering promotes downregulation by placing the RGS protein in proximity to its substrate (receptor-activated G alpha subunit). Sst2 docks to the Ste2 cytosolic tail, but only its unphosphorylated state, allowing for release and recycling of this regulator upon receptor desensitization and internalization. DEP-domain-mediated targeting of effectors and regulators to specific GPCRs provides a means to dictate the nature, duration, and specificity of the response.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem & Mol Biol, Berkeley, CA 94720 USA; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	University of California System; University of California Berkeley; University of North Carolina; University of North Carolina Chapel Hill; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Thorner, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem & Mol Biol, Berkeley, CA 94720 USA.	jthorner@berkeley.edu	Gladue, Douglas/P-6280-2018; THORNER, Jeremy/O-6132-2019	Gladue, Douglas/0000-0002-7894-0233; THORNER, Jeremy/0000-0002-2583-500X; Dohlman, Henrik/0000-0003-2443-0729; Konopka, James/0000-0001-5989-4086	NIGMS NIH HHS [GM65533, GM21841, P01 GM065533, GM55107, GM07232] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM065533, T32GM007232, R37GM021841, R01GM055107, R01GM021841] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Apanovitch DM, 1998, BIOCHEMISTRY-US, V37, P4815, DOI 10.1021/bi9729965; Burchett SA, 2000, J NEUROCHEM, V75, P1335, DOI 10.1046/j.1471-4159.2000.0751335.x; Chen QJ, 1996, MOL CELL BIOL, V16, P247; Civera C, 2005, PROTEINS, V58, P354, DOI 10.1002/prot.20320; David NE, 1997, J BIOL CHEM, V272, P15553, DOI 10.1074/jbc.272.24.15553; DiBello PR, 1998, J BIOL CHEM, V273, P5780, DOI 10.1074/jbc.273.10.5780; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; DOHLMAN HG, 1993, P NATL ACAD SCI USA, V90, P9688, DOI 10.1073/pnas.90.20.9688; Dosil M, 2000, MOL CELL BIOL, V20, P5321, DOI 10.1128/MCB.20.14.5321-5329.2000; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Druey KM, 1996, NATURE, V379, P742, DOI 10.1038/379742a0; Feng Y, 2000, MOL CELL BIOL, V20, P5350, DOI 10.1128/MCB.20.14.5350-5359.2000; Fetchko M, 2004, METHODS, V32, P349, DOI 10.1016/j.ymeth.2003.10.010; Gartner A, 1998, MOL CELL BIOL, V18, P3681, DOI 10.1128/MCB.18.7.3681; Hague C, 2005, J BIOL CHEM, V280, P27289, DOI 10.1074/jbc.M502365200; Heiman MG, 2000, J CELL BIOL, V151, P719, DOI 10.1083/jcb.151.3.719; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Hoffman GA, 2000, J BIOL CHEM, V275, P37533, DOI 10.1074/jbc.M005751200; Hoffman GA, 2002, METHOD ENZYMOL, V344, P617; Horecka J, 2000, METHOD ENZYMOL, V326, P107; Huang HC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-234; Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473; Kharrat A, 1998, BBA-PROTEIN STRUCT M, V1385, P157, DOI 10.1016/S0167-4838(98)00041-7; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; KONOPKA JB, 1988, CELL, V54, P609, DOI 10.1016/S0092-8674(88)80005-9; KONOPKA JB, 2004, ENCY BIOL CHEM, P256; Kovoor A, 2005, J NEUROSCI, V25, P2157, DOI 10.1523/JNEUROSCI.2840-04.2005; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Martemyanov KA, 2003, J NEUROSCI, V23, P10175; Overton MC, 2003, J BIOL CHEM, V278, P49369, DOI 10.1074/jbc.M308654200; Pan WJ, 2004, CELL RES, V14, P324, DOI 10.1038/sj.cr.7290232; Penton A, 2002, GENETICS, V161, P747; Popov S, 1997, P NATL ACAD SCI USA, V94, P7216, DOI 10.1073/pnas.94.14.7216; Rehmann H, 2003, NAT STRUCT BIOL, V10, P26, DOI 10.1038/nsb878; RENEKE JE, 1988, CELL, V55, P221, DOI 10.1016/0092-8674(88)90045-1; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Siekhaus DE, 2003, NAT CELL BIOL, V5, P231, DOI 10.1038/ncb941; Snow BE, 1998, J BIOL CHEM, V273, P17749, DOI 10.1074/jbc.273.28.17749; Srinivasa SP, 1998, P NATL ACAD SCI USA, V95, P5584, DOI 10.1073/pnas.95.10.5584; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Versele M, 1999, EMBO J, V18, P5577, DOI 10.1093/emboj/18.20.5577; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Wong HC, 2000, NAT STRUCT BIOL, V7, P1178; Wu YL, 2004, J BIOL CHEM, V279, P35287, DOI 10.1074/jbc.M404896200	48	140	143	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 22	2006	126	6					1079	1093		10.1016/j.cell.2006.07.030	http://dx.doi.org/10.1016/j.cell.2006.07.030			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990133	Bronze, Green Submitted			2022-12-28	WOS:000240897600015
J	Zhang, XY; Yazaki, J; Sundaresan, A; Cokus, S; Chan, SWL; Chen, HM; Henderson, IR; Shinn, P; Pellegrini, M; Jacobsen, SE; Ecker, JR				Zhang, Xiaoyu; Yazaki, Junshi; Sundaresan, Ambika; Cokus, Shawn; Chan, Simon W. -L.; Chen, Huaming; Henderson, Ian R.; Shinn, Paul; Pellegrini, Matteo; Jacobsen, Steve E.; Ecker, Joseph R.			Genome-wide high-resolution mapping and functional analysis of DNA methylation in Arabidopsis	CELL			English	Article							HISTONE H3 METHYLTRANSFERASE; TRANS-ACTING SIRNAS; TRANSPOSABLE ELEMENTS; PROMOTER METHYLATION; NEUROSPORA-CRASSA; GENE-EXPRESSION; CPG METHYLATION; MESSENGER-RNAS; THALIANA; PATTERNS	Cytosine methylation is important for transposon silencing and epigenetic regulation of endogenous genes, although the extent to which this DNA modification functions to regulate the genome is still unknown. Here we report the first comprehensive DNA methylation map of an entire genome, at 35 base pair resolution, using the flowering plant Arabidopsis thaliana as a model. We find that pericentromeric heterochromatin, repetitive sequences, and regions producing small interfering RNAs are heavily methylated. Unexpectedly, over one-third of expressed genes contain methylation within transcribed regions, whereas only similar to 5% of genes show methylation within promoter regions. Interestingly, genes methylated in transcribed regions are highly expressed and constitutively active, whereas promoter-methylated genes show a greater degree of tissue-specific expression. Whole-genome tiling-array transcriptional profiling of DNA methyltransferase null mutants identified hundreds of genes and intergenic noncoding RNAs with altered expression levels, many of which may be epigenetically controlled by DNA methylation.	Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA	University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Salk Institute; Salk Institute	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	jacobsen@ucla.edu; ecker@salk.edu	Zhang, xiaoyu/GXA-3206-2022; Ecker, Joseph R/B-9144-2008; Yazaki, Junshi/B-1557-2012; Jacobsen, Sten Eirik W/D-3974-2018; Henderson, Ian/A-2174-2012; jia, xu/A-8386-2016	Ecker, Joseph R/0000-0001-5799-5895; Jacobsen, Sten Eirik W/0000-0002-1362-3659; Henderson, Ian/0000-0001-5066-1489; Pellegrini, Matteo/0000-0001-9355-9564; Yazaki, Junshi/0000-0002-0697-8320; Chen, Huaming/0000-0001-5289-7882	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060398, T32GM008666, R37GM060398] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG003523] Funding Source: Medline; NIGMS NIH HHS [GM60398, T32 GM08666] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Bao N, 2004, DEV CELL, V7, P653, DOI 10.1016/j.devcel.2004.10.003; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Chan SWL, 2006, PLOS GENET, V2, P791, DOI 10.1371/journal.pgen.0020083; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Ching TT, 2005, NAT GENET, V37, P645, DOI 10.1038/ng1563; CROSS SH, 1994, NAT GENET, V6, P236, DOI 10.1038/ng0394-236; Dalmay T, 2000, PLANT CELL, V12, P369, DOI 10.1105/tpc.12.3.369; Faghihi MA, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r38; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hatada I, 2006, ONCOGENE, V25, P3059, DOI 10.1038/sj.onc.1209331; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Mockler TC, 2005, GENOMICS, V85, P1, DOI 10.1016/j.ygeno.2004.10.005; NGERNPRASIRTSIRI J, 1988, P NATL ACAD SCI USA, V85, P4750, DOI 10.1073/pnas.85.13.4750; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Selker EU, 2003, NATURE, V422, P893, DOI 10.1038/nature01564; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tariq M, 2003, P NATL ACAD SCI USA, V100, P8823, DOI 10.1073/pnas.1432939100; Tran RK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r90; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305	46	1259	1362	5	222	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 22	2006	126	6					1189	1201		10.1016/j.cell.2006.08.003	http://dx.doi.org/10.1016/j.cell.2006.08.003			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16949657	Bronze			2022-12-28	WOS:000240897600023
J	Dalton, R				Dalton, Rex			Sequencers step up to the speed challenge	NATURE			English	News Item								In the future, hospitals should be able to sequence patient DNA swiftly and cheaply.Connecticut, is marketing a tabletop DNA- sequencing machine that works much faster than today's mainstream techniques.										Dalton R, 2006, NATURE, V441, P260, DOI 10.1038/441260b; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437	6	5	5	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2006	443	7109					258	259		10.1038/443258a	http://dx.doi.org/10.1038/443258a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085RL	16988678				2022-12-28	WOS:000240622000012
J	Woo, YM; Crail, S; Curry, G; Geddes, CC				Woo, Y. Mun; Crail, Susan; Curry, Graham; Geddes, Colin C.			Lesson of the week - A life threatening complication after ingestion of sodium phosphate bowel preparation	BRITISH MEDICAL JOURNAL			English	Review							LAVAGE SOLUTION; SEVERE HYPERPHOSPHATEMIA; RENAL-FAILURE; COLONOSCOPY; ELECTROLYTE		Inverclyde Royal Hosp, Renal Unit, Greenock PA16 0XN, Scotland; Univ Glasgow, Western Infirm, Renal Unit, Glasgow G11 6NT, Lanark, Scotland; Inverclyde Royal Hosp, Med Unit, Greenock PA16 0XN, Scotland	University of Glasgow	Woo, YM (corresponding author), Inverclyde Royal Hosp, Renal Unit, Greenock PA16 0XN, Scotland.	yook.woo@irh.scot.nhs.uk						Ainley EJ, 2005, DIGEST DIS SCI, V50, P1319, DOI 10.1007/s10620-005-2780-9; Bowles CJA, 2004, GUT, V53, P277, DOI 10.1136/gut.2003.016436; *CB FLEET, CLIN STUD; Chan A, 1997, CAN J GASTROENTEROL, V11, P334, DOI 10.1155/1997/797486; Clark LE, 2004, DRUG SAFETY, V27, P1235, DOI 10.2165/00002018-200427150-00006; DiPalma JA, 2003, AM J GASTROENTEROL, V98, P2187, DOI 10.1016/S0002-9270(03)00696-8; DIPALMA JA, 1990, GASTROINTEST ENDOSC, V36, P285, DOI 10.1016/S0016-5107(90)71025-5; Fine A, 1997, AM J KIDNEY DIS, V29, P103, DOI 10.1016/S0272-6386(97)90015-9; GOLDSMITH RS, 1970, NEW ENGL J MED, V282, P927, DOI 10.1056/NEJM197004162821611; HUYNH T, 1995, AM J GASTROENTEROL, V90, P104; Markowitz GS, 2005, J AM SOC NEPHROL, V16, P3389, DOI 10.1681/ASN.2005050496; Tan HL, 2002, ANAESTHESIA, V57, P478, DOI 10.1046/j.0003-2409.2001.02519.x; Toledo TK, 2001, ALIMENT PHARM THERAP, V15, P605, DOI 10.1046/j.1365-2036.2001.00966.x; Ullah N, 2002, J CLIN GASTROENTEROL, V34, P457, DOI 10.1097/00004836-200204000-00017; VANNER SJ, 1990, AM J GASTROENTEROL, V85, P422	15	9	10	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 16	2006	333	7568					589	590		10.1136/bmj.333.7568.589	http://dx.doi.org/10.1136/bmj.333.7568.589			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089KB	16974014	Green Published			2022-12-28	WOS:000240878200018
J	Choo, AY; Roux, PP; Blenis, J				Choo, Andrew Y.; Roux, Philippe P.; Blenis, John			Mind the GAP: Wnt steps onto the mTORC1 train	CELL			English	Editorial Material							TUBEROUS-SCLEROSIS; PHOSPHORYLATION; TSC2	The TSC1/2 tumor-suppressor complex controls protein synthesis through the regulation of mTOR. In this issue of Cell, Inoki et al. (2006) report that the kinases GSK3 and AMPK cooperate in the activation of TSC2 to inhibit mTOR activity. Surprisingly, the phosphorylation of TSC2 by GSK3 is markedly suppressed by Wnt signaling. This suggests that components of the mTOR pathway may be therapeutic targets for diseases linked to hyperactive Wnt signaling.	Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; Harvard Univ, Sch Med, Prog Biol & Biomed Sci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Universite de Montreal; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Blenis, J (corresponding author), Harvard Univ, Sch Med, Prog Biol & Biomed Sci, Boston, MA 02115 USA.	john_blenis@hms.harvard.edu	Roux, Philippe P./J-3996-2012	Roux, Philippe P./0000-0002-5962-0250				Ballif BA, 2005, P NATL ACAD SCI USA, V102, P667, DOI 10.1073/pnas.0409143102; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Mak BC, 2005, AM J PATHOL, V167, P107, DOI 10.1016/S0002-9440(10)62958-6; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Patel S, 2004, BIOCHEM SOC T, V32, P803, DOI 10.1042/BST0320803; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	12	30	30	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2006	126	5					834	836		10.1016/j.cell.2006.08.025	http://dx.doi.org/10.1016/j.cell.2006.08.025			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959561	Bronze			2022-12-28	WOS:000240675000009
J	Sheng, P				Sheng, Ping			Waves on the horizon	SCIENCE			English	Editorial Material									Hong Kong Univ Sci & Technol, Dept Phys, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Sheng, P (corresponding author), Hong Kong Univ Sci & Technol, Dept Phys, Hong Kong, Hong Kong, Peoples R China.	sheng@ust.hk	Sheng, Ping/I-3733-2013	Sheng, Ping/0000-0001-9000-6366				Bertolotti J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.113903; KLAR T, 2006, JSTQE IEEE; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Milton GW, 2005, P ROY SOC A-MATH PHY, V461, P3999, DOI 10.1098/rspa.2005.1570; MILTON GW, 2006, P R SOC A; *OPT SOC AM C PHOT, 2006, RAND PER; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; PENDRY JB, 1987, J PHYS C SOLID STATE, V20, P733, DOI 10.1088/0022-3719/20/5/009; Podolskiy VA, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.201101; Sebbah P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.183902; SHENG P, 2006, INTRO WAVE SCATTERIN, pCH5; Song BS, 2005, NAT MATER, V4, P207, DOI 10.1038/nmat1320; Storzer M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.063904; Svirko Y, 2001, APPL PHYS LETT, V78, P498, DOI 10.1063/1.1342210; WHITE B, 1987, PHYS REV LETT, V59, P1918, DOI 10.1103/PhysRevLett.59.1918	15	13	13	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2006	313	5792					1399	1400		10.1126/science.1131711	http://dx.doi.org/10.1126/science.1131711			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16959996				2022-12-28	WOS:000240348700030
J	Squyres, SW; Knoll, AH; Arvidson, RE; Clark, BC; Grotzinger, JP; Jolliff, BL; McLennan, SM; Tosca, N; Bell, JF; Calvin, WM; Farrand, WH; Glotch, TD; Golombek, MP; Herkenhoff, KE; Johnson, JR; Klingelhofer, G; McSween, HY; Yen, AS				Squyres, S. W.; Knoll, A. H.; Arvidson, R. E.; Clark, B. C.; Grotzinger, J. P.; Jolliff, B. L.; McLennan, S. M.; Tosca, N.; Bell, J. F., III; Calvin, W. M.; Farrand, W. H.; Glotch, T. D.; Golombek, M. P.; Herkenhoff, K. E.; Johnson, J. R.; Klingelhoefer, G.; McSween, H. Y.; Yen, A. S.			Two years at Meridiani Planum: Results from the Opportunity Rover	SCIENCE			English	Article							BURNS FORMATION; ENVIRONMENT; DIAGENESIS; ORIGIN	The Mars Exploration Rover Opportunity has spent more than 2 years exploring Meridiani Planum, traveling similar to 8 kilometers and detecting features that reveal ancient environmental conditions. These include well-developed festoon ( trough) cross-lamination formed in flowing liquid water, strata with smaller and more abundant hematite-rich concretions than those seen previously, possible relict "hopper crystals'' that might reflect the formation of halite, thick weathering rinds on rock surfaces, resistant fracture fills, and networks of polygonal fractures likely caused by dehydration of sulfate salts. Chemical variations with depth show that the siliciclastic fraction of outcrop rock has undergone substantial chemical alteration from a precursor basaltic composition. Observations from microscopic to orbital scales indicate that ancient Meridiani once had abundant acidic groundwater, arid and oxidizing surface conditions, and occasional liquid flow on the surface.	Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Harvard Univ, Bot Museum, Cambridge, MA 02138 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63031 USA; Lockheed Martin Corp, Littleton, CO 80127 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Univ Nevada, Reno, NV 89557 USA; Space Sci Inst, Boulder, CO 80301 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Johannes Gutenberg Univ Mainz, Inst Anorgan & Analyt Chem, D-55099 Mainz, Germany; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA	Cornell University; Harvard University; Washington University (WUSTL); Lockheed Martin; California Institute of Technology; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Nevada System of Higher Education (NSHE); University of Nevada Reno; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of the Interior; United States Geological Survey; Johannes Gutenberg University of Mainz; University of Tennessee System; University of Tennessee Knoxville	Squyres, SW (corresponding author), Cornell Univ, Dept Astron, Space Sci Bldg, Ithaca, NY 14853 USA.		Johnson, Jeffrey R/F-3972-2015; Glotch, Timothy/B-6829-2008	Johnson, Jeffrey R/0000-0002-5586-4901; Tosca, Nicholas/0000-0003-4415-4231; McLennan, Scott/0000-0003-4259-7178				Ahlbrandt T.S., 1979, 1052 US GEOL SURV, P21; Arvidson RE, 2005, SCIENCE, V307, P1591, DOI 10.1126/science.1109509; ARVIDSON RE, 2003, J GEOPHYS RES, V108, DOI DOI 10.1029/2002JE0011982; BANFIELD JF, 2001, NANOPARTICLES ENV, V44; BELL JF, 2003, J GEOPHYS RES-PLANET, V108, DOI DOI 10.1029/2003JE002070; Branney M.J., 2002, MEMOIRS, DOI DOI 10.1144/GSL.MEM.2003.027; Bruckner J, 2003, J GEOPHYS RES-PLANET, V108, DOI [10.1029/2003JE002060, 10.1029/2003JE002150]; Christensen PR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002117; Clark BC, 2005, EARTH PLANET SC LETT, V240, P73, DOI 10.1016/j.epsl.2005.09.040; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Gorevan SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002061; GORNITZ VM, 1981, J SEDIMENT PETROL, V51, P787; Grotzinger JP, 2005, EARTH PLANET SC LETT, V240, P11, DOI 10.1016/j.epsl.2005.09.039; Herkenhoff KE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002076; HUNTER RE, 1977, SEDIMENTOLOGY, V24, P361, DOI 10.1111/j.1365-3091.1977.tb00128.x; HYNEK BM, 2002, J GEOPHYS RES, V107, DOI DOI 10.1029/2002E001891; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; Knauth LP, 2005, NATURE, V438, P1123, DOI 10.1038/nature04383; Knoll AH, 2005, EARTH PLANET SC LETT, V240, P179, DOI 10.1016/j.epsl.2005.09.045; LASAGA AC, 1998, PR S GEOCH, P3; McCollom TM, 2005, NATURE, V438, P1129, DOI 10.1038/nature04390; McLennan SM, 2005, EARTH PLANET SC LETT, V240, P95, DOI 10.1016/j.epsl.2005.09.041; Rubin D. M., 1987, CROSS BEDDING BEDFOR, DOI [10.2110/csp.87.01, DOI 10.2110/CSP.87.01]; RUBIN DM, 1987, J SEDIMENT PETROL, V57, P39; Schreiber BC, 2000, SEDIMENTOLOGY, V47, P215, DOI 10.1046/j.1365-3091.2000.00002.x; SHARP RP, 1963, J GEOL, V71, P617, DOI 10.1086/626936; Shearman DJ., 1978, MARINE EVAPORITES, V4, P6; SOUTHARD JB, 1990, J SEDIMENT PETROL, V60, P658, DOI 10.1306/212F9241-2B24-11D7-8648000102C1865D; SOUTHARD JB, 1971, J SEDIMENT PETROL, V41, P903; SPARKS RSJ, 1976, SEDIMENTOLOGY, V23, P147, DOI 10.1111/j.1365-3091.1976.tb00045.x; Squyres SW, 2005, EARTH PLANET SC LETT, V240, P1, DOI 10.1016/j.epsl.2005.09.038; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; WALKER GPL, 1971, J GEOL, V79, P696, DOI 10.1086/627699	34	150	150	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2006	313	5792					1403	1407		10.1126/science.1130890	http://dx.doi.org/10.1126/science.1130890			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16959999				2022-12-28	WOS:000240348700033
J	Varki, A				Varki, Ajit			Nothing in glycobiology makes sense, except in the light of evolution	CELL			English	Editorial Material							DIVERSITY; SIGLECS	The remarkable structural diversity of glycans in nature, and their roles in cellular processes, host-pathogen interactions, biological diversity and speciation can be explained by evolutionary processes.	Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Varki, A (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	a1varki@ucsd.edu						Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Crocker PR, 2005, CURR OPIN PHARMACOL, V5, P431, DOI 10.1016/j.coph.2005.03.003; Diekman AB, 2003, CELL MOL LIFE SCI, V60, P298, DOI 10.1007/s000180300025; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; Drickamer K, 1998, TRENDS BIOCHEM SCI, V23, P321, DOI 10.1016/S0968-0004(98)01246-8; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; GALILI U, 1987, P NATL ACAD SCI USA, V84, P1369, DOI 10.1073/pnas.84.5.1369; Hakomori S, 1999, BBA-GEN SUBJECTS, V1473, P247, DOI 10.1016/S0304-4165(99)00183-X; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; HART GW, 1989, ANNU REV BIOCHEM, V58, P841; Lapid K, 2006, GLYCOBIOLOGY, V16, p39R, DOI 10.1093/glycob/cwj059; Lederberg J, 1999, GENETICS, V153, P1; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Mengerink KJ, 2001, GLYCOBIOLOGY, V11, p37R, DOI 10.1093/glycob/11.4.37R; Perrier C, 2006, J BIOL CHEM, V281, P14280, DOI 10.1074/jbc.M512958200; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Sharon N, 1996, ADV EXP MED BIOL, V408, P1; Takeuchi Y, 1996, NATURE, V379, P85, DOI 10.1038/379085a0; VANVALEN L, 1974, NATURE, V252, P298; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008	23	179	189	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2006	126	5					841	845		10.1016/j.cell.2006.08.022	http://dx.doi.org/10.1016/j.cell.2006.08.022			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959563	Bronze			2022-12-28	WOS:000240675000011
J	Schneier, FR				Schneier, Franklin R.			Social anxiety disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NATIONAL COMORBIDITY SURVEY; BEHAVIORAL GROUP-THERAPY; DOUBLE-BLIND; PHARMACOLOGICAL TREATMENTS; EXTENDED-RELEASE; CONTROLLED-TRIAL; PRIMARY-CARE; PHOBIA; PLACEBO; METAANALYSIS		New York State Psychiat Inst & Hosp, Anxiety Disorders Clin, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA	New York State Psychiatry Institute; Columbia University	Schneier, FR (corresponding author), New York State Psychiat Inst & Hosp, Anxiety Disorders Clin, 1051 Riverside Dr,Unit 69, New York, NY 10032 USA.	frs1@columbia.edu						American Psychiatric Association, 2000, DIAGN STAT MAN MENT, P456; Argyropoulos SV, 2001, PSYCHIAT CLIN N AM, V24, P707, DOI 10.1016/S0193-953X(05)70259-8; Blanco C, 2003, DEPRESS ANXIETY, V18, P29, DOI 10.1002/da.10096; Blomhoff S, 2001, BRIT J PSYCHIAT, V179, P23, DOI 10.1192/bjp.179.1.23; Chavira DA, 2005, CHILD ADOL PSYCH CL, V14, P797, DOI 10.1016/j.chc.2005.05.003; Clark DM, 2003, J CONSULT CLIN PSYCH, V71, P1058, DOI 10.1037/0022-006X.71.6.1058; Connor KM, 1998, J CLIN PSYCHOPHARM, V18, P373, DOI 10.1097/00004714-199810000-00004; Connor KM, 2001, DEPRESS ANXIETY, V14, P137, DOI 10.1002/da.1055; DAVIDSON JRT, 1993, J CLIN PSYCHOPHARM, V13, P423; Davidson JRT, 2004, ARCH GEN PSYCHIAT, V61, P1005, DOI 10.1001/archpsyc.61.10.1005; Fedoroff IC, 2001, J CLIN PSYCHOPHARM, V21, P311, DOI 10.1097/00004714-200106000-00011; FESKE U, 1995, BEHAV THER, V26, P695, DOI 10.1016/S0005-7894(05)80040-1; GELERNTER CS, 1991, ARCH GEN PSYCHIAT, V48, P938; Gould RA, 1997, CLIN PSYCHOL-SCI PR, V4, P291, DOI 10.1111/j.1468-2850.1997.tb00123.x; Gross R, 2005, GEN HOSP PSYCHIAT, V27, P161, DOI 10.1016/j.genhosppsych.2005.01.006; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; HARTLEY LR, 1983, BRIT J PSYCHIAT, V142, P512, DOI 10.1192/bjp.142.5.512; Heckelman L.R., 1995, SOCIAL PHOBIA DIAGNO, P3; Heimberg RG, 1998, ARCH GEN PSYCHIAT, V55, P1133, DOI 10.1001/archpsyc.55.12.1133; Hofmann SG, 2004, CLIN PSYCHOL REV, V24, P769, DOI 10.1016/j.cpr.2004.07.004; Hope D. A., 2000, MANAGING SOCIAL ANXI; JAMES IM, 1983, J ROY SOC MED, V76, P194, DOI 10.1177/014107688307600308; Juster HR, 1995, PSYCHIAT CLIN N AM, V18, P821, DOI 10.1016/S0193-953X(18)30025-X; Katzelnick DJ, 2001, AM J PSYCHIAT, V158, P1999, DOI 10.1176/appi.ajp.158.12.1999; KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P273; Kessler RC, 1998, AM J PSYCHIAT, V155, P613, DOI 10.1176/ajp.155.5.613; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kobak KA, 2002, J CLIN PSYCHOPHARM, V22, P257, DOI 10.1097/00004714-200206000-00005; Kushner MG, 2005, ALCOHOL CLIN EXP RES, V29, P1432, DOI 10.1097/01.alc.0000175072.17623.f8; Lader M, 2004, DEPRESS ANXIETY, V19, P241, DOI 10.1002/da.20014; Liebowitz MR, 2005, ARCH GEN PSYCHIAT, V62, P190, DOI 10.1001/archpsyc.62.2.190; LIEBOWITZ MR, 1985, ARCH GEN PSYCHIAT, V42, P729; LIEBOWITZ MR, 1992, ARCH GEN PSYCHIAT, V49, P290; Liebowitz MR, 1999, DEPRESS ANXIETY, V10, P89, DOI 10.1002/(SICI)1520-6394(1999)10:3<89::AID-DA1>3.3.CO;2-X; Mancini C, 2005, J CHILD ADOL PSYCHOP, V15, P589, DOI 10.1089/cap.2005.15.589; Muehlbacher M, 2005, J CLIN PSYCHOPHARM, V25, P580, DOI 10.1097/01.jcp.0000186871.04984.8d; Pande AC, 2004, J CLIN PSYCHOPHARM, V24, P141, DOI 10.1097/01.jcp.0000117423.05703.e7; Pande AC, 1999, J CLIN PSYCHOPHARM, V19, P341, DOI 10.1097/00004714-199908000-00010; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; Rapee RM, 2004, CLIN PSYCHOL REV, V24, P737, DOI 10.1016/j.cpr.2004.06.004; Rodebaugh TL, 2004, CLIN PSYCHOL REV, V24, P883, DOI 10.1016/j.cpr.2004.07.007; Sareen J, 2005, ARCH GEN PSYCHIAT, V62, P1249, DOI 10.1001/archpsyc.62.11.1249; SCHNEIER FR, 1992, ARCH GEN PSYCHIAT, V49, P282; Stein DJ, 2002, J CLIN PSYCHIAT, V63, P152, DOI 10.4088/JCP.v63n0211; Stein DJ, 2004, COCHRANE DB SYST REV; Stein MB, 2005, PSYCHOPHARMACOLOGY, V177, P280, DOI 10.1007/s00213-004-1957-9; Stein MB, 2005, MED CARE, V43, P1164, DOI 10.1097/01.mlr.0000185750.18119.fd; Stein MB, 2002, ARCH GEN PSYCHIAT, V59, P1027, DOI 10.1001/archpsyc.59.11.1027; Stein MB, 1996, AM J PSYCHIAT, V153, P278; Taylor S, 1996, J BEHAV THER EXP PSY, V27, P1, DOI 10.1016/0005-7916(95)00058-5; Van Ameringen M, 2003, CNS SPECTR, V8, P40, DOI 10.1017/S1092852900006933	51	73	79	1	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 7	2006	355	10					1029	1036		10.1056/NEJMcp060145	http://dx.doi.org/10.1056/NEJMcp060145			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080UF	16957148				2022-12-28	WOS:000240273300008
J	Angers, S; Li, T; Yi, XH; MacCoss, MJ; Moon, RT; Zheng, N				Angers, Stephane; Li, Ti; Yi, Xianhua; MacCoss, Michael J.; Moon, Randall T.; Zheng, Ning			Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery	NATURE			English	Article							PIGMENTOSUM GROUP-E; DNA-DAMAGE; SCHIZOSACCHAROMYCES-POMBE; V-PROTEIN; DEGRADATION; COMPLEX; UBIQUITYLATION; PROTEOLYSIS; MECHANISMS; CHECKPOINT	Protein ubiquitination is a common form of post-translational modification that regulates a broad spectrum of protein substrates in diverse cellular pathways(1). Through a three-enzyme (E1 - E2 - E3) cascade, the attachment of ubiquitin to proteins is catalysed by the E3 ubiquitin ligase, which is best represented by the superfamily of the cullin-RING complexes(2,3). Conserved from yeast to human, the DDB1 - CUL4 - ROC1 complex is a recently identified cullin-RING ubiquitin ligase, which regulates DNA repair(4-10), DNA replication(11-14) and transcription(15), and can also be subverted by pathogenic viruses to benefit viral infection(16). Lacking a canonical SKP1-like cullin adaptor and a defined substrate recruitment module, how the DDB1 - CUL4 - ROC1 E3 apparatus is assembled for ubiquitinating various substrates remains unclear. Here we present crystallographic analyses of the virally hijacked form of the human DDB1 - CUL4A - ROC1 machinery, which show that DDB1 uses one beta-propeller domain for cullin scaffold binding and a variably attached separate double-beta-propeller fold for substrate presentation. Through tandem-affinity purification of human DDB1 and CUL4A complexes followed by mass spectrometry analysis, we then identify a novel family of WD40-repeat proteins, which directly bind to the double-propeller fold of DDB1 and serve as the substrate-recruiting module of the E3. Together, our structural and proteomic results reveal the structural mechanisms and molecular logic underlying the assembly and versatility of a new family of cullin-RING E3 complexes.	Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Sch Med, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Zheng, N (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Box 357280, Seattle, WA 98195 USA.	rtmoon@u.washington.edu; nzheng@u.washington.edu	Angers, Stephane/E-1432-2014; Moon, Randall/M-5605-2019; Moon, Randall T/B-1743-2014	Angers, Stephane/0000-0001-7241-9044; Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408				Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Bondar T, 2004, J BIOL CHEM, V279, P9937, DOI 10.1074/jbc.M312570200; Chen XA, 2001, J BIOL CHEM, V276, P48175, DOI 10.1074/jbc.M106808200; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Horvath CM, 2004, EUR J BIOCHEM, V271, P4621, DOI 10.1111/j.1432-1033.2004.04425.x; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Leupin O, 2003, J VIROL, V77, P6274, DOI 10.1128/JVI.77.11.6274-6283.2003; Li F, 2005, CURR BIOL, V15, P1448, DOI 10.1016/j.cub.2005.07.021; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Liu C, 2005, EMBO J, V24, P3940, DOI 10.1038/sj.emboj.7600854; Liu C, 2003, GENE DEV, V17, P1130, DOI 10.1101/gad.1090803; Nag A, 2001, MOL CELL BIOL, V21, P6738, DOI 10.1128/MCB.21.20.6738-6747.2001; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Shiyanov P, 1999, MOL CELL BIOL, V19, P4935; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Thon G, 2005, GENETICS, V171, P1583, DOI 10.1534/genetics.105.048298; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	26	497	543	3	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2006	443	7111					590	593		10.1038/nature05175	http://dx.doi.org/10.1038/nature05175			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	16964240				2022-12-28	WOS:000240988200047
J	Kasprzak, J; Richard, M; Kundermann, S; Baas, A; Jeambrun, P; Keeling, JMJ; Marchetti, FM; Szymanska, MH; Andre, R; Staehli, JL; Savona, V; Littlewood, PB; Deveaud, B; Dang, LS				Kasprzak, J.; Richard, M.; Kundermann, S.; Baas, A.; Jeambrun, P.; Keeling, J. M. J.; Marchetti, F. M.; Szymanska, M. H.; Andre, R.; Staehli, J. L.; Savona, V.; Littlewood, P. B.; Deveaud, B.; Dang, Le Si			Bose-Einstein condensation of exciton polaritons	NATURE			English	Article							SEMICONDUCTOR MICROCAVITIES; GAS; COHERENCE; DYNAMICS; PHOTOLUMINESCENCE; RELAXATION; STATES	Phase transitions to quantum condensed phases - such as Bose - Einstein condensation (BEC), superfluidity, and superconductivity - have long fascinated scientists, as they bring pure quantum effects to a macroscopic scale. BEC has, for example, famously been demonstrated in dilute atom gas of rubidium atoms at temperatures below 200 nanokelvin. Much effort has been devoted to finding a solid-state system in which BEC can take place. Promising candidate systems are semiconductor microcavities, in which photons are confined and strongly coupled to electronic excitations, leading to the creation of exciton polaritons. These bosonic quasi-particles are 10 9 times lighter than rubidium atoms, thus theoretically permitting BEC to occur at standard cryogenic temperatures. Here we detail a comprehensive set of experiments giving compelling evidence for BEC of polaritons. Above a critical density, we observe massive occupation of the ground state developing from a polariton gas at thermal equilibrium at 19 K, an increase of temporal coherence, and the build-up of long-range spatial coherence and linear polarization, all of which indicate the spontaneous onset of a macroscopic quantum phase.	Ecole Polytech Fed Lausanne, Stn 3, CH-1015 Lausanne, Switzerland; Univ Grenoble 1, Spectrometrie Phys Lab, CEA CNRS UJF Joint Grp Nanophys & Semicond, CNRS,UMR5588, F-38402 St Martin Dheres, France; MIT, Dept Phys, Cambridge, MA 02139 USA; Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Massachusetts Institute of Technology (MIT); University of Cambridge; University of Oxford	Deveaud, B (corresponding author), Ecole Polytech Fed Lausanne, Stn 3, CH-1015 Lausanne, Switzerland.	jkasprz@spectro.ujf-grenoble.fr; benoit.deveaud-pledran@epfl.ch	Deveaud, Benoit/A-4782-2013; André, Régis/M-4629-2014; Savona, Vincenzo/A-8847-2010; Murakokshi, Kei/I-8701-2014; maxime, richard/Q-3548-2019; Littlewood, Peter B/B-7746-2008; Marchetti, Francesca Maria/F-7695-2012; Littlewood, Peter/M-4960-2019; maxime, richard/S-4963-2016; Deveaud, Benoit/N-1947-2014; Keeling, Jonathan M J/B-7827-2008	Deveaud, Benoit/0000-0002-9776-6314; André, Régis/0000-0003-3035-4291; Savona, Vincenzo/0000-0002-8984-6584; maxime, richard/0000-0001-9596-2891; Marchetti, Francesca Maria/0000-0003-1394-7394; maxime, richard/0000-0001-9596-2891; Deveaud, Benoit/0000-0002-9776-6314; Keeling, Jonathan M J/0000-0002-4283-552X	Engineering and Physical Sciences Research Council [GR/S92892/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; Andre R, 1998, J CRYST GROWTH, V184, P758, DOI 10.1016/S0022-0248(98)80158-9; Andrews MR, 1997, SCIENCE, V275, P637, DOI 10.1126/science.275.5300.637; BLATT JM, 1962, PHYS REV, V126, P1691, DOI 10.1103/PhysRev.126.1691; Bloch I, 2000, NATURE, V403, P166, DOI 10.1038/35003132; Bloch J, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.155311; Boeuf F, 2000, PHYS REV B, V62, pR2279, DOI 10.1103/PhysRevB.62.R2279; Burt EA, 1997, PHYS REV LETT, V79, P337, DOI 10.1103/PhysRevLett.79.337; Butov LV, 2002, NATURE, V417, P47, DOI 10.1038/417047a; Ciuti C, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.041303; DAVIS KB, 1995, PHYS REV LETT, V75, P3969, DOI 10.1103/PhysRevLett.75.3969; Deng H, 2002, SCIENCE, V298, P199, DOI 10.1126/science.1074464; Eisenstein JP, 2004, NATURE, V432, P691, DOI 10.1038/nature03081; Ensher JR, 1996, PHYS REV LETT, V77, P4984, DOI 10.1103/PhysRevLett.77.4984; Imamoglu A, 1996, PHYS LETT A, V214, P193, DOI 10.1016/0375-9601(96)00175-2; Kavokin A., 2003, CAVITY POLARITONS; Keeling J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.226403; KELDYSH LV, 1968, SOV PHYS JETP-USSR, V27, P521; Laussy FP, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.035315; LE SD, 1998, PHYS REV LETT, V81, P3920; Leggett AJ, 2001, REV MOD PHYS, V73, P307, DOI 10.1103/RevModPhys.73.307; Marchetti FM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.066405; Martin MD, 2005, PHYS STATUS SOLIDI C, V2, P3880, DOI 10.1002/pssc.200562036; MERMIN ND, 1966, PHYS REV LETT, V17, P1133, DOI 10.1103/PhysRevLett.17.1133; MOSKALENKO SA, 1962, SOV PHYS-SOL STATE, V4, P199; Muller M, 2000, PHYS REV B, V62, P16886, DOI 10.1103/PhysRevB.62.16886; PITAEVSKII L, 2003, BOSE EINSTEIN CONDEN, pCH1; Porras D, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.161310; Porras D, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.085304; Richard M, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.201301; Richard M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.187401; Ruegg C, 2003, NATURE, V423, P62, DOI 10.1038/nature01617; Savona V, 1996, PHYS REV B, V53, P13051, DOI 10.1103/PhysRevB.53.13051; Savvidis PG, 2000, PHYS REV LETT, V84, P1547, DOI 10.1103/PhysRevLett.84.1547; Snoke D, 2002, SCIENCE, V298, P1368, DOI 10.1126/science.1078082; Snoke D, 2002, NATURE, V418, P754, DOI 10.1038/nature00940; Snoke DW, 2003, PHYS STATUS SOLIDI B, V238, P389, DOI 10.1002/pssb.200303151; Szymanska MH, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.230602; Tassone F, 1997, PHYS REV B, V56, P7554, DOI 10.1103/PhysRevB.56.7554; WEISBUCH C, 1992, PHYS REV LETT, V69, P3314, DOI 10.1103/PhysRevLett.69.3314; [No title captured]	41	2246	2266	23	568	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2006	443	7110					409	414		10.1038/nature05131	http://dx.doi.org/10.1038/nature05131			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	17006506				2022-12-28	WOS:000240798800036
J	Ratcliffe, J; Thomas, KJ; MacPherson, H; Brazier, J				Ratcliffe, J.; Thomas, K. J.; MacPherson, H.; Brazier, J.			A randomised controlled trial of acupuncture care for persistent low back pain: cost effectiveness analysis	BRITISH MEDICAL JOURNAL			English	Article							UK		Univ Sheffield, Sch Hlth & Related Res, Sheffield S10 2TN, S Yorkshire, England; Fdn Tradit Chinese Med, York YO24 1ET, N Yorkshire, England	University of Sheffield	Ratcliffe, J (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Sheffield S10 2TN, S Yorkshire, England.	j.ratcliffe@sheffield.ac.uk	brazier, john e/B-1936-2008; Ratcliffe, Julie/G-3169-2017	Ratcliffe, Julie/0000-0001-7365-1988; Brazier, John/0000-0001-8645-4780; MacPherson, Hugh/0000-0003-4255-4768				Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; *BRIT MED ASS ROYA, 2002, BRIT NAT FORM; *CLIN STAND ADV GR, 1994, BACK PAIN EP COSTS; *DEP HLTH, 1999, PREV BACK PAIN GREAT; Ezzo J, 2000, PAIN, V86, P217, DOI 10.1016/S0304-3959(99)00304-8; Frost H, 2004, BRIT MED J, V329, P708, DOI 10.1136/bmj.38216.868808.7C; Glick H A, 2001, Expert Rev Pharmacoecon Outcomes Res, V1, P25, DOI 10.1586/14737167.1.1.25; HM Treasury, 2003, GREEN BOOK APPR EV C; MacPherson H, 2004, COMPLEMENT THER MED, V12, P136, DOI 10.1016/j.ctim.2004.07.043; Manca A, 2004, BMJ-BRIT MED J, V329, P1381, DOI 10.1136/bmj.38282.607859.AE; Manca A, 2005, APPL HEALTH ECON HEA, V4, P65, DOI 10.2165/00148365-200504020-00001; Maniadakis N, 2000, PAIN, V84, P95, DOI 10.1016/S0304-3959(99)00187-6; MATHEWS JNS, 1990, BRIT MED J, V300, P230; MEADE TW, 1990, BRIT MED J, V300, P1431, DOI 10.1136/bmj.300.6737.1431; National Institute for Clinical Excellence, 2004, GUID METH TECHN APPR; Netten A., 2001, UNIT COSTS HLTH SOCI; *NHS EX, 2004, NHS REF COSTS; *OFF NAT STAT, NEW EARN SURV 2003; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Thomas KJ, 2006, BMJ-BRIT MED J, V333, P623, DOI 10.1136/bmj.38878.907361.7C; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197; Wonderling D, 2004, BMJ-BRIT MED J, V328, P747, DOI 10.1136/bmj.38033.896505.EB	22	84	90	1	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 23	2006	333	7569					626	628A		10.1136/bmj.38932.806134.7C	http://dx.doi.org/10.1136/bmj.38932.806134.7C			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089KD	16980315	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000240878500015
J	Kunze, E; Dower, JF; Beveridge, I; Dewey, R; Bartlett, KP				Kunze, Eric; Dower, John F.; Beveridge, Ian; Dewey, Richard; Bartlett, Kevin P.			Observations of biologically generated turbulence in a coastal inlet	SCIENCE			English	Article							VISUAL PREDATION RISK; EUPHAUSIA-PACIFICA; VERTICAL MIGRATION; ZOOPLANKTON; KRILL; WAKE	Measurements in a coastal inlet revealed turbulence that was three to four orders of magnitude larger during the dusk ascent of a dense acoustic-scattering layer of krill than during the day, elevating daily-averaged mixing in the inlet by a factor of 100. Because vertically migrating layers of swimming organisms are found in much of the ocean, biologically generated turbulence may affect (i) the transport of inorganic nutrients to the often nutrient-depleted surface layer from underlying nutrient-rich stratified waters to affect biological productivity and (ii) the exchange of atmospheric gases such as CO2 with the stratified ocean interior, which has no direct communication with the atmosphere.	Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8W 3P6, Canada; Univ Victoria, Dept Biol, Victoria, BC V8W 3N5, Canada	University of Victoria; University of Victoria	Kunze, E (corresponding author), Univ Victoria, Sch Earth & Ocean Sci, POB 3055,STN CSC, Victoria, BC V8W 3P6, Canada.	kunze@uvic.ca; dower@uvic.ca						Brierley AS, 2006, LIMNOL OCEANOGR-METH, V4, P18, DOI 10.4319/lom.2006.4.18; Cheng JY, 2001, COMP BIOCHEM PHYS A, V131, P51, DOI 10.1016/S1095-6433(01)00464-0; De Robertis A, 2003, ICES J MAR SCI, V60, P885, DOI 10.1016/S1054-3139(03)00070-5; De Robertis A, 2002, LIMNOL OCEANOGR, V47, P925, DOI 10.4319/lo.2002.47.4.0925; De Robertis A, 2000, LIMNOL OCEANOGR, V45, P1838, DOI 10.4319/lo.2000.45.8.1838; Dewar WK, 2006, J MAR RES, V64, P541, DOI 10.1357/002224006778715720; DEWEY RK, 1988, J PHYS OCEANOGR, V18, P1167, DOI 10.1175/1520-0485(1988)018<1167:BSEFVD>2.0.CO;2; Gargett AE, 2003, ESTUAR COAST SHELF S, V56, P1141, DOI 10.1016/S0272-7714(02)00319-0; Gargett AE, 1999, J ATMOS OCEAN TECH, V16, P1973, DOI 10.1175/1520-0426(1999)016<1973:VMOTKE>2.0.CO;2; GREENLAW CF, 1979, LIMNOL OCEANOGR, V24, P226, DOI 10.4319/lo.1979.24.2.0226; GREGG MC, 1987, J GEOPHYS RES-OCEANS, V92, P5249, DOI 10.1029/JC092iC05p05249; Hamme RC, 2006, J MAR RES, V64, P73, DOI 10.1357/002224006776412322; Huntley ME, 2004, MAR ECOL PROG SER, V273, P65, DOI 10.3354/meps273065; Jaffe JS, 1999, CAN J FISH AQUAT SCI, V56, P2000, DOI 10.1139/cjfas-56-11-2000; Jenkins WJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002085; LEDWELL JR, 1993, NATURE, V364, P701, DOI 10.1038/364701a0; MACKIE GO, 1983, CAN J FISH AQUAT SCI, V40, P763, DOI 10.1139/f83-099; Mangel M, 2000, CAN J FISH AQUAT SCI, V57, P1, DOI 10.1139/cjfas-57-S3-1; Muller UK, 1997, J EXP BIOL, V200, P2893; MUNK W., 1966, DEEP SEA RES OCEANOG, V13, P707, DOI [10.1016/0011-7471(66)90602-4, DOI 10.1016/0011-7471(66)90602-4]; Videler JJ, 2002, INTEGR COMP BIOL, V42, P988, DOI 10.1093/icb/42.5.988; Vogel S., 1981, LIFE MOVING FLUIDS P, V2nd; Yamamura O, 1998, MAR BIOL, V132, P195, DOI 10.1007/s002270050386; Yen J, 2003, MAR FRESHW BEHAV PHY, V36, P307, DOI 10.1080/10236240310001614439	24	96	96	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2006	313	5794					1768	1770		10.1126/science.1129378	http://dx.doi.org/10.1126/science.1129378			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990545				2022-12-28	WOS:000240655700043
J	Bernards, DA; Flores-Torres, S; Abruna, HD; Malliaras, GG				Bernards, Daniel A.; Flores-Torres, Samuel; Abruna, Hector D.; Malliaras, George G.			Observation of electroluminescence and photovoltaic response in ionic junctions	SCIENCE			English	Article							LIGHT-EMITTING DEVICES; COMPLEXES; CONTACTS; DIODES	Electronic devices primarily use electronic rather than ionic charge carriers. Using soft-contact lamination, we fabricated ionic junctions between two organic semiconductors with mobile anions and cations, respectively. Mobile ionic charge was successfully deployed to control the direction of electronic current flow in semiconductor devices. As a result, these devices showed electroluminescence under forward bias and a photovoltage upon illumination with visible light. Thus, ionic charge carriers can enhance the performance of existing electronic devices, as well as enable new functionalities.	Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA; Cornell Univ, Dept Chem & Biol Chem, Ithaca, NY 14853 USA	Cornell University; Cornell University	Malliaras, GG (corresponding author), Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA.	ggm1@cornell.edu	Malliaras, George/HDM-2006-2022	Malliaras, George/0000-0002-4582-8501				Bernards DA, 2004, APPL PHYS LETT, V84, P3675, DOI 10.1063/1.1739270; CATALANI LH, 1987, PHOTOCHEM PHOTOBIOL, V45, P273, DOI 10.1111/j.1751-1097.1987.tb05375.x; Cheng CHW, 2004, J AM CHEM SOC, V126, P10536, DOI 10.1021/ja046880p; Cheng CHW, 2004, J AM CHEM SOC, V126, P8666, DOI 10.1021/ja0493695; deMello JC, 1998, PHYS REV B, V57, P12951, DOI 10.1103/PhysRevB.57.12951; Gao FG, 2000, J AM CHEM SOC, V122, P7426, DOI 10.1021/ja000666t; Gorodetsky AA, 2004, APPL PHYS LETT, V84, P807, DOI 10.1063/1.1644918; GREGG BA, 2003, SEMICONDUCTOR PHOTOC; Handy ES, 1999, J AM CHEM SOC, V121, P3525, DOI 10.1021/ja984163n; Kalyanasundaram K., 1992, PHOTOCHEMISTRY POLYP; Kim S, 1998, MACROMOLECULES, V31, P964, DOI 10.1021/ma970781x; Loo YL, 2002, P NATL ACAD SCI USA, V99, P10252, DOI 10.1073/pnas.162128299; LOVRECEK B, 1959, J PHYS CHEM-US, V63, P750, DOI 10.1021/j150575a030; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; PEI QB, 1995, SCIENCE, V269, P1086, DOI 10.1126/science.269.5227.1086; RICHARDS TC, 1995, ANAL CHEM, V67, P3140, DOI 10.1021/ac00114a007; Slinker J, 2003, CHEM COMMUN, P2392, DOI 10.1039/b304265k; Stryer L., 1995, BIOCHEMISTRY-US, V4th ed.; Sze S., 1981, PHYS SEMICONDUCTOR D, V2nd ed., P85	19	74	76	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2006	313	5792					1416	1419		10.1126/science.1128145	http://dx.doi.org/10.1126/science.1128145			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16960001				2022-12-28	WOS:000240348700036
J	Kiel, S; Little, CTS				Kiel, Steffen; Little, Crispin T. S.			Cold-seep mollusks are older than the general marine mollusk fauna	SCIENCE			English	Article							HYDROTHERMAL VENT; SEA; EVOLUTION; PATTERNS; ECOLOGY; ORIGINS	The origin and possible antiquity of faunas at deep- sea hydrothermal vents and seeps have been debated since their discovery. We used the fossil record of seep mollusks to show that the living seep genera have significantly longer geologic ranges than the marine mollusks in general, but have ranges similar to those of deep- sea taxa, suggesting that seep faunas may be shaped by the factors that drive the evolution of life in the deep sea in general. Our data indicate that deep- sea anoxic/dysoxic events did not affect seep faunas, casting doubt on the suggested anoxic nature and/or global extent of these events.	Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; Smithsonian Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA	University of Leeds; Smithsonian Institution; Smithsonian National Museum of Natural History	Kiel, S (corresponding author), Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England.	steffen.kiel@gmx.de	Kiel, Steffen/C-3150-2009	Kiel, Steffen/0000-0001-6281-100X; Little, Crispin/0000-0002-1917-4460				Baco AR, 1999, MAR ECOL PROG SER, V182, P137, DOI 10.3354/meps182137; Chevaldonne P, 2002, CAH BIOL MAR, V43, P367; Crampton JS, 2003, SCIENCE, V301, P358, DOI 10.1126/science.1085075; Foote M, 2001, EVOLUTIONARY PATTERNS: GROWTH, FORM, AND TEMPO IN THE FOSSIL RECORD, P245; Fordyce RE., 2001, SECONDARY ADAPTATION, P169; Geiger Daniel L., 2005, Molluscan Research, V25, P47; Halanych KM, 1998, CAH BIOL MAR, V39, P355; HICKMAN CS, 1984, ZOOL SCR, V13, P19, DOI 10.1111/j.1463-6409.1984.tb00018.x; JABLONSKI D, 1983, SCIENCE, V222, P1123, DOI 10.1126/science.222.4628.1123; JABLONSKI D, 1991, SCIENCE, V252, P1831, DOI 10.1126/science.252.5014.1831; Jacobs DK, 1998, P NATL ACAD SCI USA, V95, P9396, DOI 10.1073/pnas.95.16.9396; Jones WJ, 2006, MAR BIOL, V148, P841, DOI 10.1007/s00227-005-0115-1; Levin LA, 2005, OCEANOGR MAR BIOL, V43, P1, DOI 10.1201/9781420037449.ch1; Little CTS, 2003, TRENDS ECOL EVOL, V18, P582, DOI 10.1016/j.tree.2003.08.009; McArthur AG, 1998, GEOL SOC SPEC PUBL, V148, P271, DOI 10.1144/GSL.SP.1998.148.01.15; NEWMAN WA, 1985, B BIOL SOC WASH, V6, P231; Nunes F, 2006, NATURE, V439, P60, DOI 10.1038/nature04386; Peek AS, 1997, MAR BIOL, V130, P151, DOI 10.1007/s002270050234; Peters SE, 2001, PALEOBIOLOGY, V27, P583, DOI 10.1666/0094-8373(2001)027<0583:BITPAR>2.0.CO;2; Powell EN, 1998, PALAEOGEOGR PALAEOCL, V144, P85, DOI 10.1016/S0031-0182(98)00087-X; Sepkoski J.J., 2002, B AM PALEONTOL, V363, P1; Smith AB, 2005, P ROY SOC B-BIOL SCI, V272, P865, DOI 10.1098/rspb.2004.2996; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; SQUIRES RL, 1991, NATURE, V349, P574, DOI 10.1038/349574a0; TUNNICLIFFE V, 1992, Palaios, V7, P338, DOI 10.2307/3514820; UHEN MD, 2001, ENCY MARINE MAMMALS, P78; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361	27	103	109	2	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2006	313	5792					1429	1431		10.1126/science.1126286	http://dx.doi.org/10.1126/science.1126286			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16960004				2022-12-28	WOS:000240348700040
J	Cohen, GL; Garcia, J; Apfel, N; Master, A				Cohen, Geoffrey L.; Garcia, Julio; Apfel, Nancy; Master, Allison			Reducing the racial achievement gap: A social-psychological intervention	SCIENCE			English	Article							STEREOTYPE THREAT; TEST-PERFORMANCE	Two randomized field experiments tested a social-psychological intervention designed to improve minority student performance and increase our understanding of how psychological threat mediates performance in chronically evaluative real-world environments. We expected that the risk of confirming a negative stereotype aimed at one's group could undermine academic performance in minority students by elevating their level of psychological threat. We tested whether such psychological threat could be lessened by having students reaffirm their sense of personal adequacy or "self-integrity.'' The intervention, a brief in-class writing assignment, significantly improved the grades of African American students and reduced the racial achievement gap by 40%. These results suggest that the racial achievement gap, a major social concern in the United States, could be ameliorated by the use of timely and targeted social-psychological interventions.	Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; Yale Univ, Dept Psychol, New Haven, CT 06520 USA	University of Colorado System; University of Colorado Boulder; Yale University	Cohen, GL (corresponding author), Univ Colorado, Dept Psychol, Muenzinger Psychol Bldg, Boulder, CO 80309 USA.	cohen.geoff@gmail.com; jpmex@gmail.com	Master, Allison/K-9307-2019					ABELSON RP, 1985, PSYCHOL BULL, V97, P129, DOI 10.1037/0033-2909.97.1.129; Aronson J, 2002, J EXP SOC PSYCHOL, V38, P113, DOI 10.1006/jesp.2001.1491; Ceci SJ, 2005, AM PSYCHOL, V60, P149, DOI 10.1037/0003-066X.60.2.149; Cohen GL, 2005, J PERS SOC PSYCHOL, V89, P566, DOI 10.1037/0022-3514.89.4.566; Creswell JD, 2005, PSYCHOL SCI, V16, P846, DOI 10.1111/j.1467-9280.2005.01624.x; Fiske S. T., 1991, SOCIAL COGNITION 2, V2nd; Sherman DK, 2006, ADV EXP SOC PSYCHOL, V38, P183, DOI 10.1016/S0065-2601(06)38004-5; Steele C.M., 1988, ADV EXP SOC PSYCHOL, P261, DOI DOI 10.1016/S0065-2601(08)60229-4; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Steele CM, 2002, ADV EXP SOC PSYCHOL, V34, P379, DOI 10.1016/S0065-2601(02)80009-0; Tajfel H., 1986, DIFFERENTIATION SOCI, V5, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; WILSON TD, 1985, J PERS SOC PSYCHOL, V49, P287, DOI 10.1037/0022-3514.49.1.287; Zajonc R.B, 1980, PSYCHOL GROUP INFLUE, P35; ZIGLER E, 1968, CHILD DEV, V39, P1, DOI 10.2307/1127353	15	604	613	8	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2006	313	5791					1307	1310		10.1126/science.1128317	http://dx.doi.org/10.1126/science.1128317			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	081JI	16946074				2022-12-28	WOS:000240313500047
J	Tyler, BM; Tripathy, S; Zhang, XM; Dehal, P; Jiang, RHY; Aerts, A; Arredondo, FD; Baxter, L; Bensasson, D; Beynon, JL; Chapman, J; Damasceno, CMB; Dorrance, AE; Dou, DL; Dickerman, AW; Dubchak, IL; Garbelotto, M; Gijzen, M; Gordon, SG; Govers, F; Grunwald, NJ; Huang, W; Ivors, KL; Jones, RW; Kamoun, S; Krampis, K; Lamour, KH; Lee, MK; McDonald, WH; Medina, M; Meijer, HJG; Nordberg, EK; Maclean, DJ; Ospina-Giraldo, MD; Morris, PF; Phuntumart, V; Putnam, NH; Rash, S; Rose, JKC; Sakihama, Y; Salamov, AA; Savidor, A; Scheuring, CF; Smith, BM; Sobral, BWS; Terry, A; Torto-Alalibo, TA; Win, J; Xu, ZY; Zhang, HB; Grigoriev, IV; Rokhsar, DS; Boore, JL				Tyler, Brett M.; Tripathy, Sucheta; Zhang, Xuemin; Dehal, Paramvir; Jiang, Rays H. Y.; Aerts, Andrea; Arredondo, Felipe D.; Baxter, Laura; Bensasson, Douda; Beynon, Jim L.; Chapman, Jarrod; Damasceno, Cynthia M. B.; Dorrance, Anne E.; Dou, Daolong; Dickerman, Allan W.; Dubchak, Inna L.; Garbelotto, Matteo; Gijzen, Mark; Gordon, Stuart G.; Govers, Francine; Grunwald, Niklaus J.; Huang, Wayne; Ivors, Kelly L.; Jones, Richard W.; Kamoun, Sophien; Krampis, Konstantinos; Lamour, Kurt H.; Lee, Mi-Kyung; McDonald, W. Hayes; Medina, Monica; Meijer, Harold J. G.; Nordberg, Eric K.; Maclean, Donald J.; Ospina-Giraldo, Manuel D.; Morris, Paul F.; Phuntumart, Vipaporn; Putnam, Nicholas H.; Rash, Sam; Rose, Jocelyn K. C.; Sakihama, Yasuko; Salamov, Asaf A.; Savidor, Alon; Scheuring, Chantel F.; Smith, Brian M.; Sobral, Bruno W. S.; Terry, Astrid; Torto-Alalibo, Trudy A.; Win, Joe; Xu, Zhanyou; Zhang, Hongbin; Grigoriev, Igor V.; Rokhsar, Daniel S.; Boore, Jeffrey L.			Phytophthora genome sequences uncover evolutionary origins and mechanisms of pathogenesis	SCIENCE			English	Article							EFFECTOR PROTEINS; AVIRULENCE; RESISTANCE; GENES; LOCUS; SOJAE; ARABIDOPSIS; EXPRESSION; VIRULENCE; SECRETOME	Draft genome sequences have been determined for the soybean pathogen Phytophthora sojae and the sudden oak death pathogen Phytophthora ramorum. Oomycetes such as these Phytophthora species share the kingdom Stramenopila with photosynthetic algae such as diatoms, and the presence of many Phytophthora genes of probable phototroph origin supports a photosynthetic ancestry for the stramenopiles. Comparison of the two species' genomes reveals a rapid expansion and diversification of many protein families associated with plant infection such as hydrolases, ABC transporters, protein toxins, proteinase inhibitors, and, in particular, a superfamily of 700 proteins with similarity to known oomycete avirulence genes.	Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; Dept Energy, Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; Univ Wageningen & Res Ctr, Phytopathol Lab, NL-6709 PD Wageningen, Netherlands; Hort Res Int, Warwick CV35 9EF, England; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SL5 7PY, England; Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; Cornell Univ, Dept Plant Pathol, Ithaca, NY 14853 USA; Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Plant Pathol, Wooster, OH 44691 USA; Univ Calif Berkeley, Dept Environm Sci Policy & Management, Ecosyst Sci Div, Berkeley, CA 94720 USA; Agr & Agri Food Canada, London, ON N5V 4T3, Canada; ARS, Hort Crops Res Lab, USDA, Corvallis, OR 97330 USA; Lawrence Livermore Natl Lab, Biosci Directorate, Livermore, CA 94550 USA; Lawrence Livermore Natl Lab, Computat Directorate, Livermore, CA 94550 USA; N Carolina State Univ, Mt Hort Crops Res & Extens Ctr, Fletcher, NC 28732 USA; ARS, Vegetable Lab, Henry Wallace Beltsville Agr Res Ctr, USDA, Beltsville, MD 20705 USA; Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37996 USA; Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN 37831 USA; Univ Calif, Sch Nat Sci, Merced, CA 95344 USA; Univ Queensland, Dept Biochem & Mol Biol, St Lucia, Qld 4072, Australia; Wilkes Univ, Dept Biol, Wilkes Barre, PA 18766 USA; Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43402 USA; Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA; Hokkaido Univ, Lab Ecol Chem, Sapporo, Hokkaido 0608589, Japan; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Genome Project Solut, Hercules, CA 94547 USA	Virginia Polytechnic Institute & State University; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Wageningen University & Research; Imperial College London; University of California System; University of California Berkeley; Cornell University; University System of Ohio; Ohio State University; University of California System; University of California Berkeley; Agriculture & Agri Food Canada; United States Department of Agriculture (USDA); United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA); University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Texas A&M University System; Texas A&M University College Station; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of California System; University of California Merced; University of Queensland; Wilkes University; University System of Ohio; Bowling Green State University; Cornell University; Hokkaido University; University of California System; University of California Berkeley	Tyler, BM (corresponding author), Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	bmtyler@vt.edu	Win, Joe/H-2557-2014; Meijer, Harold/S-3891-2019; Govers, Francine/A-5616-2009; McDonald, W. Hayes/B-4109-2016; Sobral, Bruno/GVU-7637-2022; Damasceno, Cynthia/C-3074-2008; Tripathy, Sucheta/N-3097-2019; Grunwald, Niklaus` J/K-6041-2013; Meijer, Harold/G-5703-2012; Meijer, HJG/AFN-5216-2022; Kamoun, Sophien/B-3529-2009; Baxter, laura/GWD-1304-2022; Putnam, Nicholas/B-9968-2008; Gijzen, Mark/C-6284-2011; Sakihama, Yasuko/B-1047-2012; Terry, Astrid Y/A-2538-2011; Grunwald, Niklaus J/B-9535-2008	Win, Joe/0000-0002-9851-2404; Meijer, Harold/0000-0002-0883-219X; Govers, Francine/0000-0001-5311-929X; McDonald, W. Hayes/0000-0002-3510-426X; Sobral, Bruno/0000-0003-3908-577X; Tripathy, Sucheta/0000-0003-0611-8088; Grunwald, Niklaus` J/0000-0003-1656-7602; Meijer, HJG/0000-0002-0883-219X; Kamoun, Sophien/0000-0002-0290-0315; Putnam, Nicholas/0000-0002-1315-782X; Gijzen, Mark/0000-0002-3715-6389; Terry, Astrid Y/0000-0002-5234-1224; Grunwald, Niklaus J/0000-0003-1656-7602; Dou, Daolong/0000-0001-5226-6642; Grigoriev, Igor/0000-0002-3136-8903; Rokhsar, Daniel/0000-0002-8704-2224; Bensasson, Douda/0000-0002-9015-2707; Morris, Paul/0000-0002-2989-041X	Biotechnology and Biological Sciences Research Council [BB/C509123/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Bakthavatsalam D, 2006, TRENDS MICROBIOL, V14, P378, DOI 10.1016/j.tim.2006.07.006; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; CATERINA MJ, 1991, FASEB J, V5, P3078, DOI 10.1096/fasebj.5.15.1743439; Chang JH, 2004, CURR OPIN MICROBIOL, V7, P11, DOI 10.1016/j.mib.2003.12.006; Dvornyk V, 2006, MICROBIOL-SGM, V152, P75, DOI 10.1099/mic.0.28400-0; ERWIN DC, 1996, PHYTOPHTHORAC DIS WO; Fellbrich G, 2002, PLANT J, V32, P375, DOI 10.1046/j.1365-313X.2002.01454.x; Gao HY, 2005, MOL PLANT MICROBE IN, V18, P1035, DOI 10.1094/MPMI-18-1035; Hackett JD, 2004, CURR BIOL, V14, P213, DOI 10.1016/j.cub.2004.01.032; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Kamoun S, 2003, EUKARYOT CELL, V2, P191, DOI 10.1128/EC.2.2.191-199.2003; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Kelly SL, 2001, BIOCHEM SOC T, V29, P122, DOI 10.1042/0300-5127:0290122; Li SL, 2006, MOL BIOL EVOL, V23, P663, DOI 10.1093/molbev/msj075; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; MORRIS PF, 1992, PHYSIOL MOL PLANT P, V40, P17, DOI 10.1016/0885-5765(92)90067-6; Orsomando G, 2001, J BIOL CHEM, V276, P21578, DOI 10.1074/jbc.M101377200; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; Randall TA, 2005, MOL PLANT MICROBE IN, V18, P229, DOI 10.1094/MPMI-18-0229; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Rizzo DM, 2005, ANNU REV PHYTOPATHOL, V43, P309, DOI 10.1146/annurev.phyto.42.040803.140418; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Swofford DL, 2002, PHYLOGENETIC ANAL US; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Tyler BM, 2001, TRENDS GENET, V17, P611, DOI 10.1016/S0168-9525(01)02517-3; Yoon HS, 2002, P NATL ACAD SCI USA, V99, P15507, DOI 10.1073/pnas.242379899	30	793	865	4	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2006	313	5791					1261	1266		10.1126/science.1128796	http://dx.doi.org/10.1126/science.1128796			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16946064	Green Submitted			2022-12-28	WOS:000240313500033
J	Bodenheimer, T				Bodenheimer, Thomas			Primary care - Will it survive?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, Dept Family & Community Med, Ctr Excellence Primary Care, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bodenheimer, T (corresponding author), Univ Calif San Francisco, Dept Family & Community Med, Ctr Excellence Primary Care, San Francisco, CA 94143 USA.							American College of Physicians, 2006, IMP COLL PRIM CAR ME; Garibaldi RA, 2005, ACAD MED, V80, P507, DOI 10.1097/00001888-200505000-00021; Grumbach K, 1999, JAMA-J AM MED ASSOC, V282, P261, DOI 10.1001/jama.282.3.261; Ostbye T, 2005, ANN FAM MED, V3, P209, DOI 10.1370/afm.310; ROTER DL, 1989, ANNU REV PUBL HEALTH, V10, P163, DOI 10.1146/annurev.pu.10.050189.001115; Safran DG, 2003, ANN INTERN MED, V138, P248, DOI 10.7326/0003-4819-138-3-200302040-00033	6	301	305	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2006	355	9					861	864		10.1056/NEJMp068155	http://dx.doi.org/10.1056/NEJMp068155			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	078OM	16943396				2022-12-28	WOS:000240113100001
J	Wigley, TML				Wigley, T. M. L.			A combined mitigation/geoengineering approach to climate stabilization	SCIENCE			English	Article							ANTHROPOGENIC OZONE DEPLETION; VOLCANIC-ERUPTIONS; AEROSOL VARIATIONS; ENERGY; DIOXIDE; CARBON	Projected anthropogenic warming and increases in CO2 concentration present a twofold threat, both from climate changes and from CO2 directly through increasing the acidity of the oceans. Future climate change may be reduced through mitigation ( reductions in greenhouse gas emissions) or through geoengineering. Most geoengineering approaches, however, do not address the problem of increasing ocean acidity. A combined mitigation/ geoengineering strategy could remove this deficiency. Here we consider the deliberate injection of sulfate aerosol precursors into the stratosphere. This action could substantially offset future warming and provide additional time to reduce human dependence on fossil fuels and stabilize CO2 concentrations cost-effectively at an acceptable level.	Natl Ctr Atmospher Res, Boulder, CO 80307 USA	National Center Atmospheric Research (NCAR) - USA	Wigley, TML (corresponding author), Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA.	wigley@ucar.edu						Ammann CM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016875; Andersson AJ, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002506; BLUTH GJS, 1992, GEOPHYS RES LETT, V19, P151, DOI 10.1029/91GL02792; Budyko M. I., 1977, CLIMATE CHANGES; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Cazenave A, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000139; Church JA, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P639; Crutzen PJ, 2006, CLIMATIC CHANGE, V77, P211, DOI 10.1007/s10584-006-9101-y; Cubasch U., 2001, PROJECTIONS FUTURE C, P525; Flannery B. P., 1997, ENG RESPONSE GLOBAL, P379; GOVINDASAMY B, 2000, GEOPHYS RES LETT, V17, P2151; Guo S, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000654; Hoffert MI, 2002, SCIENCE, V298, P981, DOI 10.1126/science.1072357; Hoffert MI, 1998, NATURE, V395, P881, DOI 10.1038/27638; Keith DW, 2000, ANNU REV ENERG ENV, V25, P245, DOI 10.1146/annurev.energy.25.1.245; KHESHGI HS, 1995, ENERGY, V20, P915, DOI 10.1016/0360-5442(95)00035-F; Lackner KS, 2002, ANNU REV ENERG ENV, V27, P193, DOI 10.1146/annurev.energy.27.122001.083433; Nakicenovic N., 2000, SPECIAL REPORT EMISS; *NAT AC SCI, 1992, POL IMPL GREENH WARM, P433; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Portmann RW, 1996, J GEOPHYS RES-ATMOS, V101, P22991, DOI 10.1029/96JD02608; Raper SCB, 2001, CLIM DYNAM, V17, P601, DOI 10.1007/PL00007931; Robock A, 2000, REV GEOPHYS, V38, P191, DOI 10.1029/1998RG000054; Schneider SH, 2001, NATURE, V409, P417, DOI 10.1038/35053203; Smith SJ, 2001, GLOBAL PLANET CHANGE, V29, P99, DOI 10.1016/S0921-8181(00)00057-6; Solomon S, 1996, J GEOPHYS RES-ATMOS, V101, P6713, DOI 10.1029/95JD03353; TIE XX, 1995, GEOPHYS RES LETT, V22, P3035, DOI 10.1029/95GL03057; Wigley TML, 1996, NATURE, V379, P240, DOI 10.1038/379240a0; Wigley TML, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021238; Wigley TML, 2001, SCIENCE, V293, P451, DOI 10.1126/science.1061604; WIGLEY TML, 2005, J GEOPHYS RES, V110, DOI DOI 10.1020/2004JD005557; Wood L., 2002, UCRLJC148012 LAWR LI	33	260	273	1	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2006	314	5798					452	454		10.1126/science.1131728	http://dx.doi.org/10.1126/science.1131728			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	16973840	Green Published			2022-12-28	WOS:000241382500038
J	Casrouge, A; Zhang, SY; Eidenschenk, C; Jouanguy, E; Puel, A; Yang, K; Alcais, A; Picard, C; Mahfoufi, N; Nicolas, N; Lorenzo, L; Plancoulaine, S; Senechal, B; Geissmann, F; Tabeta, K; Hoebe, K; Du, X; Miller, RL; Heron, B; Mignot, C; de Villemeur, TB; Lebon, P; Dulac, O; Rozenberg, F; Beutler, B; Tardieu, M; Abel, L; Casanova, JL				Casrouge, Armanda; Zhang, Shen-Ying; Eidenschenk, Celine; Jouanguy, Emmanuelle; Puel, Anne; Yang, Kun; Alcais, Alexandre; Picard, Capucine; Mahfoufi, Nora; Nicolas, Nathalie; Lorenzo, Lazaro; Plancoulaine, Sabine; Senechal, Brigitte; Geissmann, Frederic; Tabeta, Koichi; Hoebe, Kasper; Du, Xin; Miller, Richard L.; Heron, Benedicte; Mignot, Cyril; de Villemeur, Thierry Billette; Lebon, Pierre; Dulac, Olivier; Rozenberg, Flore; Beutler, Bruce; Tardieu, Marc; Abel, Laurent; Casanova, Jean-Laurent			Herpes simplex virus encephalitis in human UNC-93B deficiency	SCIENCE			English	Article							TOLL-LIKE RECEPTOR-3; PLASMACYTOID DENDRITIC CELLS; GENETIC DISSECTION; HUMAN-MODEL; IMMUNITY; ALPHA/BETA; ACYCLOVIR; INDUCTION; INFECTION; FAMILY	Herpes simplex virus-1 (HSV-1) encephalitis (HSE) is the most common form of sporadic viral encephalitis in western countries. Its pathogenesis remains unclear, as it affects otherwise healthy patients and only a small minority of HSV-1 - infected individuals. Here, we elucidate a genetic etiology for HSE in two children with autosomal recessive deficiency in the intracellular protein UNC-93B, resulting in impaired cellular interferon-alpha/beta and -lambda antiviral responses. HSE can result from a single-gene immunodeficiency that does not compromise immunity to most pathogens, unlike most known primary immunodeficiencies. Other severe infectious diseases may also reflect monogenic disorders of immunity.	Univ Paris 05, Fac Med Necker, INSERM,U550, Lab Genet Humaine MAlad Infect, F-75015 Paris, France; Shanghai Jiao Tong Univ, French Chinese Lab Genom & Life Sci, Rui Jin Hosp, Shanghai 200025, Peoples R China; Hop Necker Enfants Malad, Ctr Etud Deficits Immunitaires, F-75015 Paris, France; Hop Necker Enfants Malad, Lab Etud Cellules Mononucleees, F-75015 Paris, France; Scripps Res Inst, La Jolla, CA 92037 USA; 3M Ctr, St Paul, MN 55144 USA; Hop Trousseau, Serv Neurol Pediat, F-75012 Paris, France; Hop St Vincent de Paul, Serv Virol, F-75014 Paris, France; Hop Necker Enfants Malad, Serv Neurol Pediat, F-75015 Paris, France; Hop Bicetre, INSERM, U802, F-94270 Le Kremlin Bicetre, France; Hop Bicetre, Serv Neurol Pediat, F-94270 Le Kremlin Bicetre, France; Hop Necker Enfants Malad, Unite Immunol & Hematol Pediat, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Shanghai Jiao Tong University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Scripps Research Institute; 3M; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Casanova, JL (corresponding author), Univ Paris 05, Fac Med Necker, INSERM,U550, Lab Genet Humaine MAlad Infect, F-75015 Paris, France.	casanova@necker.fr	Puel, Anne/H-7305-2017; Abel, Laurent/H-8888-2017; Jouanguy, Emmanuelle/H-7901-2017; TABTA, KOICHI/AAG-6481-2020; Picard, Capucine/H-3914-2017; Alcais, Alexandre/J-5882-2017; Casanova, Jean-Laurent/I-3418-2017; Lorenzo, Lazaro/H-7902-2017; Li, Chia Cheng/D-9906-2015; Zhang, Shen-Ying/I-2685-2017; Rozenberg, Flore/O-8854-2017; PLANCOULAINE, Sabine/E-2824-2017	Puel, Anne/0000-0003-2603-0323; Abel, Laurent/0000-0001-7016-6493; Jouanguy, Emmanuelle/0000-0002-7358-9157; TABTA, KOICHI/0000-0002-7019-1872; Picard, Capucine/0000-0001-8788-5056; Alcais, Alexandre/0000-0002-1012-2226; Lorenzo, Lazaro/0000-0001-6648-8684; Zhang, Shen-Ying/0000-0002-9449-3672; PLANCOULAINE, Sabine/0000-0003-0725-8306; Hoebe, Kasper/0000-0002-3626-8098; geissmann, frederic/0000-0001-5029-2468; Casanova, Jean-Laurent/0000-0002-7782-4169	Medical Research Council [G0900867] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alcais A, 2005, J EXP MED, V202, P1617, DOI 10.1084/jem.20052302; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Casanova JL, 2005, J EXP MED, V202, P197, DOI 10.1084/jem.20050854; Casanova JL, 2004, NAT REV IMMUNOL, V4, P55, DOI 10.1038/nri1264; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Gazquez I, 1996, LANCET, V347, P910, DOI 10.1016/S0140-6736(96)91398-7; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Jackson AC, 2002, ANN NEUROL, V51, P406, DOI 10.1002/ana.10110; Kashuba VI, 2002, GENE, V283, P209, DOI 10.1016/S0378-1119(01)00856-3; Kawamura K, 2006, BLOOD, V107, P1031, DOI 10.1182/blood-2005-04-1737; KOSKINIEMI M, 1995, LANCET, V346, P1553, DOI 10.1016/S0140-6736(95)92081-1; LERNER AM, 1983, NEW ENGL J MED, V308, P1481; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; OCHS H, 2006, PRIMARY IMMUNODEFICI; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Pollara G, 2004, J IMMUNOL, V173, P4108, DOI 10.4049/jimmunol.173.6.4108; Puel A, 2006, AM J HUM GENET, V78, P691, DOI 10.1086/501532; Smith MG, 1941, AM J PATHOL, V17, P55; STANBERRY LR, 1997, VIRAL INFECT HUMANS; Sun YP, 2004, J INTERF CYTOK RES, V24, P350, DOI 10.1089/107999004323142213; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Tyler Kenneth L, 2004, Rev Neurol Dis, V1, P169; Whitley Richard J, 2005, Semin Pediatr Infect Dis, V16, P17, DOI 10.1053/j.spid.2004.09.007; WHITLEY RJ, 1986, NEW ENGL J MED, V314, P144, DOI 10.1056/NEJM198601163140303; Wintergerst U, 1999, ANTIVIR RES, V44, P75, DOI 10.1016/S0166-3542(99)00055-8; Yang K, 2005, IMMUNITY, V23, P465, DOI 10.1016/j.immuni.2005.09.016	30	548	566	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2006	314	5797					308	312		10.1126/science.1128346	http://dx.doi.org/10.1126/science.1128346			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093TV	16973841				2022-12-28	WOS:000241194100044
J	McGettigan, P; Henry, D				McGettigan, Patricia; Henry, David			Cardiovascular risk and inhibition of cyclooxygenase - A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ACUTE MYOCARDIAL-INFARCTION; CYCLO-OXYGENASE-2 INHIBITORS; ROFECOXIB; EVENTS; CELECOXIB; NAPROXEN; IBUPROFEN; INCREASE; ASPIRIN	Context Evidence that rofecoxib increases the risk of myocardial infarction has led to scrutiny of other nonsteroidal anti-inflammatory drugs ( NSAIDs). Regulatory agencies have provided variable advice regarding the cardiovascular risks with older nonselective NSAIDs. Objective To undertake a systematic review and meta-analysis of controlled observational studies to compare the risks of serious cardiovascular events with individual NSAIDs and cyclooxygenase 2 inhibitors. Data Sources Searches were conducted of electronic databases (1985-2006), scientific meeting proceedings, epidemiological research Web sites, and bibliographies of eligible studies. Study Selection Eligible studies were of case-control or cohort design, reported on cardiovascular events ( predominantly myocardial infarction) with cyclooxygenase 2 inhibitor, NSAID use, or both with nonuse/remote use of the drugs as the reference exposure. Of 7086 potentially eligible titles, 17 case-control and 6 cohort studies were included. Thirteen studies reported on cyclooxygenase 2 inhibitors, 23 on NSAIDs, and 13 on both groups of drugs. Data Extraction Two people independently extracted data and assessed study quality with disagreements resolved by consensus. Data Synthesis Data were combined using a random-effects model. A dose-related risk was evident with rofecoxib, summary relative risk with 25 mg/d or less, 1.33 (95% confidence interval [CI], 1.00-1.79) and 2.19 ( 95% CI, 1.64-2.91) with more than 25 mg/d. The risk was elevated during the first month of treatment. Celecoxib was not associated with an elevated risk of vascular occlusion, summary relative risk 1.06 ( 95% CI, 0.91-1.23). Among older nonselective drugs, diclofenac had the highest risk with a summary relative risk of 1.40 ( 95% CI, 1.16-1.70). The other drugs had summary relative risks close to 1: naproxen, 0.97 ( 95% CI, 0.87-1.07); piroxicam, 1.06 ( 95% CI, 0.70-1.59); and ibuprofen, 1.07 ( 95% CI, 0.97-1.18). Conclusions This review confirms the findings from randomized trials regarding the risk of cardiovascular events with rofecoxib and suggests that celecoxib in commonly used doses may not increase the risk, contradicts claims of a protective effect of naproxen, and raises serious questions about the safety of diclofenac, an older drug.	Univ Newcastle, Sch Med & Publ Hlth, Div Clin Pharmacol, Newcastle, NSW 2308, Australia	University of Newcastle	Henry, D (corresponding author), Newcastle Mater Hosp, Level 5 Clin Sci Bldg, Waratah, NSW 2298, Australia.	david.henry@newcastle.edu.au	Henry, David/AAJ-4332-2020; Henry, David/AAU-4650-2020	Henry, David/0000-0003-2934-2242; Henry, David/0000-0001-7169-7704				Bak S, 2003, STROKE, V34, P379, DOI 10.1161/01.STR.0000053029.45352.A0; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bresalier RS, 2006, NEW ENGL J MED, V355, P221; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Caldwell B, 2006, J ROY SOC MED, V99, P132, DOI 10.1258/jrsm.99.3.132; Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; Cryer B, 1998, AM J MED, V104, P413, DOI 10.1016/S0002-9343(98)00091-6; Curtis JP, 2003, BRIT MED J, V327, P1322, DOI 10.1136/bmj.327.7427.1322; *EUR MED AG, EUR MED AG CONCL ACT; *EUR MED AG, EUR MED AG UPD NONS; Finckh A, 2005, ANN INTERN MED, V142, P212, DOI 10.7326/0003-4819-142-3-200502010-00013; Fischer LM, 2005, PHARMACOTHERAPY, V25, P503, DOI 10.1592/phco.25.4.503.61021; Fischer LM, 2004, ARCH INTERN MED, V164, P2472, DOI 10.1001/archinte.164.22.2472; Rodriguez LAG, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-17; Gislason GH, 2006, CIRCULATION, V113, P2906, DOI 10.1161/CIRCULATIONAHA.106.616219; Graham DJ, 2005, LANCET, V365, P475, DOI 10.1016/S0140-6736(05)17864-7; Hippisley-Cox J, 2005, BMJ-BRIT MED J, V330, P1366, DOI 10.1136/bmj.330.7504.1366; Johnsen SP, 2005, ARCH INTERN MED, V165, P978, DOI 10.1001/archinte.165.9.978; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Kimmel SE, 2004, J AM COLL CARDIOL, V43, P985, DOI 10.1016/j.jacc.2003.08.064; Kimmel SE, 2005, ANN INTERN MED, V142, P157, DOI 10.7326/0003-4819-142-3-200502010-00005; Kimmel SE, 2002, PHARMACOEPIDEM DR S, V11, P113, DOI 10.1002/pds.670; Ko D, 2002, AM HEART J, V143, P475, DOI 10.1067/mhj.2002.121270; Levesque LE, 2005, ANN INTERN MED, V142, P481, DOI 10.7326/0003-4819-142-7-200504050-00113; Levesque LE, 2006, CAN MED ASSOC J, V174, P1563, DOI 10.1503/cmaj.051679; MacDonald TM, 2003, LANCET, V361, P573, DOI 10.1016/S0140-6736(03)12509-3; Mamdani M, 2003, ARCH INTERN MED, V163, P481, DOI 10.1001/archinte.163.4.481; McGettigan P, 2006, BRIT J CLIN PHARMACO, V62, P358, DOI 10.1111/j.1365-2125.2006.02660.x; Morant SV, 2004, PHARMACOEPIDEM DR S, V13, P345, DOI 10.1002/pds.946; Patrono C, 2001, J CLIN INVEST, V108, P7, DOI 10.1172/JCI13418; Ray WA, 2002, LANCET, V360, P1071, DOI 10.1016/S0140-6736(02)11131-7; Ray WA, 2002, LANCET, V359, P118, DOI 10.1016/S0140-6736(02)07370-1; Rodriguez LAG, 2000, EPIDEMIOLOGY, V11, P382, DOI 10.1097/00001648-200007000-00004; Rodriguez LAG, 2004, CIRCULATION, V109, P3000, DOI 10.1161/01.CIR.0000132491.96623.04; Schlienger RG, 2002, BRIT J CLIN PHARMACO, V54, P327, DOI 10.1046/j.1365-2125.2002.01637.x; Singh G, 2005, ANN RHEUM DIS, V64, P85; Solomon DH, 2004, CIRCULATION, V109, P2068, DOI 10.1161/01.CIR.0000127578.21885.3E; Solomon DH, 2002, ARCH INTERN MED, V162, P1099, DOI 10.1001/archinte.162.10.1099; Sturkenboom MC, 2005, PHARMACOEPIDEM DR S, V14, pS57; Sudbo J, 2005, LANCET, V366, P1359, DOI 10.1016/S0140-6736(05)67488-0; *US FDA, AL HLTH CAR PROF NON; Watson DJ, 2002, ARCH INTERN MED, V162, P1105, DOI 10.1001/archinte.162.10.1105; Wells G., NEWCASTLE OTTAWA SCA	44	786	831	0	107	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2006	296	13					1633	1644		10.1001/jama.296.13.jrv60011	http://dx.doi.org/10.1001/jama.296.13.jrv60011			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	090JS	16968831				2022-12-28	WOS:000240948200023
J	Mouchel, CF; Osmont, KS; Hardtke, CS				Mouchel, Celine F.; Osmont, Karen S.; Hardtke, Christian S.			BRX mediates feedback between brassinosteroid levels and auxin signalling in root growth	NATURE			English	Article							GENE-EXPRESSION; ARABIDOPSIS-THALIANA; CELL-PROLIFERATION; REGULATED GENES; BREVIS-RADIX; ELONGATION; EFFLUX; CYTOCHROME-P450; CYTOKININ; DIVISION	Brassinosteroid and auxin decisively influence plant development, and overlapping transcriptional responses to these phytohormones suggest an interaction between the two pathways(1-3). However, whether this reflects direct feedback or merely parallel inputs on common targets is unclear. Here we show that in Arabidopsis roots, this interaction is mediated by BREVIS RADIX (BRX), which is required for optimal root growth(4). We demonstrate that the brx phenotype results from a root-specific deficiency of brassinosteroid and is due to reduced, BRX-dependent expression of a rate-limiting enzyme in brassinosteroid biosynthesis. Unexpectedly, this deficiency affects the root expression level of similar to 15% of all Arabidopsis genes, but the transcriptome profile can be restored to wild type by brassinosteroid treatment. Thus, proper brassinosteroid levels are required for the correct expression of many more genes than previously suspected. Moreover, embryonic or post-embryonic brassinosteroid application fully or partially, respectively, rescues the brx phenotype. Further, auxin-responsive gene expression is globally impaired in brx, demonstrating that brassinosteroid levels are rate-limiting for auxin-responsive transcription. BRX expression is strongly induced by auxin and mildly repressed by brassinolide, which means that BRX acts at the nexus of a feedback loop that maintains threshold brassinosteroid levels to permit optimal auxin action.	Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland	University of Lausanne	Hardtke, CS (corresponding author), Univ Lausanne, Dept Plant Mol Biol, Biophore Bldg, CH-1015 Lausanne, Switzerland.	christian.hardtke@unil.ch	Hardtke, Christian S/B-5861-2009	Hardtke, Christian S./0000-0003-3203-1058				Bancos S, 2002, PLANT PHYSIOL, V130, P504, DOI 10.1104/pp.005439; Beemster GTS, 2000, PLANT PHYSIOL, V124, P1718, DOI 10.1104/pp.124.4.1718; Beemster GTS, 1998, PLANT PHYSIOL, V116, P1515, DOI 10.1104/pp.116.4.1515; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Briggs GC, 2006, PLANT PHYSIOL, V140, P1306, DOI 10.1104/pp.105.075382; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Goda H, 2002, PLANT PHYSIOL, V130, P1319, DOI 10.1104/pp.011254; Goda H, 2004, PLANT PHYSIOL, V134, P1555, DOI 10.1104/pp.103.034736; Himanen K, 2002, PLANT CELL, V14, P2339, DOI 10.1105/tpc.004960; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Leyser O, 2002, ANNU REV PLANT BIOL, V53, P377, DOI 10.1146/annurev.arplant.53.100301.135227; Mouchel CF, 2004, GENE DEV, V18, P700, DOI 10.1101/gad.1187704; Mussig C, 2002, PLANT PHYSIOL, V129, P1241, DOI 10.1104/pp.011003; Nakamura A, 2003, PLANT PHYSIOL, V133, P1843, DOI 10.1104/pp.103.030031; Nakamura A, 2006, PLANT J, V45, P193, DOI 10.1111/j.1365-313X.2005.02582.x; NERNHAUSER JL, 2004, PLOS BIOL, V2, pE258; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Shimada Y, 2003, PLANT PHYSIOL, V131, P287, DOI 10.1104/pp.013029; Sieberer T, 2003, CURR BIOL, V13, P837, DOI 10.1016/S0960-9822(03)00327-0; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Tanaka K, 2005, PLANT PHYSIOL, V138, P1117, DOI 10.1104/pp.104.058040; Terasaka K, 2005, PLANT CELL, V17, P2922, DOI 10.1105/tpc.105.035816; Tsugeki R, 1999, P NATL ACAD SCI USA, V96, P12941, DOI 10.1073/pnas.96.22.12941; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang SC, 2005, PLANT CELL, V17, P1979, DOI 10.1105/tpc.105.031096; ZUREK DM, 1994, PLANT PHYSIOL, V104, P505, DOI 10.1104/pp.104.2.505	30	196	211	9	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2006	443	7110					458	461		10.1038/nature05130	http://dx.doi.org/10.1038/nature05130			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	17006513				2022-12-28	WOS:000240798800046
J	Haslam, D; Sattar, N; Lean, M				Haslam, David; Sattar, Naveed; Lean, Mike			ABC of obesity - Obesity - time to wake up	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow		nsattar@clinmed.gla.ac.uk						[Anonymous]; [Anonymous], SCOTTISH INTERCOLLEG; De Bacquer D, 2004, EUR HEART J, V25, P121, DOI 10.1016/j.ehj.2003.10.024; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; James WPT, 2000, LANCET, V356, P2119, DOI 10.1016/S0140-6736(00)03491-7; McQuigg M, 2005, EUR J CLIN NUTR, V59, pS93, DOI 10.1038/sj.ejcn.1602180; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155	7	114	114	0	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2006	333	7569					640	642		10.1136/bmj.333.7569.640	http://dx.doi.org/10.1136/bmj.333.7569.640			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089KD	16990325	Green Published			2022-12-28	WOS:000240878500020
J	O'Malley, BW				O'Malley, Bert W.			Little molecules with big goals	SCIENCE			English	Editorial Material							COACTIVATOR		Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	O'Malley, BW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	berto@bcm.edu						Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; ONATE SA, 1995, SCIENCE, V270, P1354; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Wu RC, 2004, MOL CELL, V15, P937, DOI 10.1016/j.molcel.2004.08.019	7	55	56	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2006	313	5794					1749	1750		10.1126/science.1132509	http://dx.doi.org/10.1126/science.1132509			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990541				2022-12-28	WOS:000240655700036
J	Raghu, S; Anderson, RC; Daehler, CC; Davis, AS; Wiedenmann, RN; Simberloff, D; Mack, RN				Raghu, S.; Anderson, R. C.; Daehler, C. C.; Davis, A. S.; Wiedenmann, R. N.; Simberloff, D.; Mack, R. N.			Adding biofuels to the invasive species fire?	SCIENCE			English	Editorial Material							GRASSES		Illinois Nat Hist Survey, Champaign, IL 61820 USA; Illinois State Univ, Normal, IL 61709 USA; Univ Hawaii Manoa, Honolulu, HI 96822 USA; ARS, USDA, Invas Weed Management Unit, Urbana, IL 61801 USA; Univ Arkansas, Fayetteville, AR 72701 USA; Univ Tennessee, Knoxville, TN 37996 USA; Washington State Univ, Pullman, WA 99164 USA	Illinois Natural History Survey; Illinois State University; University of Hawaii System; University of Hawaii Manoa; United States Department of Agriculture (USDA); University of Arkansas System; University of Arkansas Fayetteville; University of Tennessee System; University of Tennessee Knoxville; Washington State University	Raghu, S (corresponding author), Illinois Nat Hist Survey, Champaign, IL 61820 USA.	raghu@uiuc.edu	Raghu, S./A-1281-2010	Raghu, S./0000-0001-5843-5435; Davis, Adam/0000-0002-7196-1197				[Anonymous], JOURNAL, V38, P705, DOI [10.1016/j.ijforecast.2021.11.001, DOI 10.1016/J.IJFORECAST.2021.11.001, DOI 10.1016/B978-012257305-7/50081-3]; Daehler CC, 1998, BIOL CONSERV, V84, P167, DOI 10.1016/S0006-3207(97)00096-7; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Dudley T. L., 2000, INVASIVE PLANTS CALI, P53; Ewel JJ, 1999, BIOSCIENCE, V49, P619, DOI 10.2307/1313438; Forman J, 2003, PLANT INVASIONS: ECOLOGICAL THREATS AND MANAGEMENT SOLUTIONS, P17; GRAY AJ, 1991, ADV ECOL RES, V21, P1, DOI 10.1016/S0065-2504(08)60096-3; Heaton E. A., 2004, Mitigation and Adaptation Strategies for Global Change, V9, P433, DOI 10.1023/B:MITI.0000038848.94134.be; Hilbeck A., 2004, ENV RISK ASSESSMENT; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Lewandowski I, 2000, BIOMASS BIOENERG, V19, P209, DOI 10.1016/S0961-9534(00)00032-5; Lewandowski I, 2003, BIOMASS BIOENERG, V25, P335, DOI 10.1016/S0961-9534(03)00030-8; MCWHORTER CG, 1993, WEED SCI, V41, P669, DOI 10.1017/S0043174500076499; Molofsky J., 1999, Biological Invasions, V1, P181, DOI 10.1023/A:1010091227793; Moody ML, 2002, P NATL ACAD SCI USA, V99, P14867, DOI 10.1073/pnas.172391499; *NAT EN POL DEV GR, REL AFF ENV SOUND EN; *NAT RES COUNC, 2002, PRED INV NON PLANTS, P194; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; Randall JM, 1996, INVASIVE PLANTS WEED; Sheppard A. W., 2003, Biocontrol News and Information, V24, p91N	20	243	250	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2006	313	5794					1742	1742		10.1126/science.1129313	http://dx.doi.org/10.1126/science.1129313			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990536				2022-12-28	WOS:000240655700030
J	Chang, P; Fang, Y; Saravanan, R; Ji, L; Seidel, H				Chang, Ping; Fang, Yue; Saravanan, R.; Ji, Link; Seidel, Howard			The cause of the fragile relationship between the Pacific El Nino and the Atlantic Nino	NATURE			English	Article							TROPICAL ATLANTIC; SOUTHERN-OSCILLATION; ENSO TELECONNECTION; TEMPERATURE; VARIABILITY; REMOTE; RAINFALL; CLIMATE; SCALES; OCEAN	El Nino, the most prominent climate fluctuation at seasonal-to-interannual timescales, has long been known to have a remote impact on climate variability in the tropical Atlantic Ocean, but a robust influence is found only in the northern tropical Atlantic region(1). Fluctuations in the equatorial Atlantic are dominated by the Atlantic Nino(2,3), a phenomenon analogous to El Nino, characterized by irregular episodes of anomalous warming during the boreal summer. The Atlantic Nino strongly affects seasonal climate prediction in African countries bordering the Gulf of Guinea(4,5). The relationship between El Nino and the Atlantic Nino is ambiguous and inconsistent. Here we combine observational and modelling analysis to show that the fragile relationship is a result of destructive interference between atmospheric and oceanic processes in response to El Nino. The net effect of El Nino on the Atlantic Nino depends not only on the atmospheric response that propagates the El Nino signal to the tropical Atlantic, but also on a dynamic ocean - atmosphere interaction in the equatorial Atlantic that works against the atmospheric response. These results emphasize the importance of having an improved ocean-observing system in the tropical Atlantic, because our ability to predict the Atlantic Nino will depend not only on our knowledge of conditions in the tropical Pacific, but also on an accurate estimate of the state of the upper ocean in the equatorial Atlantic.	Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; Texas A&M Univ, Dept Atmospher Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Chang, P (corresponding author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA.	ping@tamu.edu	Saravanan, Ramalingam/G-8879-2012; Chang, Ping/A-1642-2013	Saravanan, Ramalingam/0000-0002-0005-6907; Chang, Ping/0000-0002-9085-0759				Alexander M, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014347; Brown RG, 1997, J ATMOS SCI, V54, P624, DOI 10.1175/1520-0469(1997)054<0624:ATOTSQ>2.0.CO;2; CARTON JA, 1994, J PHYS OCEANOGR, V24, P888, DOI 10.1175/1520-0485(1994)024<0888:WEITTA>2.0.CO;2; Chang P, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016119; Chiang JCH, 2005, J CLIMATE, V18, P4130, DOI 10.1175/JCLI3529.1; Chiang JCH, 2002, J CLIMATE, V15, P2616, DOI 10.1175/1520-0442(2002)015<2616:TTTVCB>2.0.CO;2; DELECLUSE P, 1994, TELLUS A, V46, P448, DOI 10.1034/j.1600-0870.1994.t01-1-00009.x; Enfield DB, 1997, J GEOPHYS RES-OCEANS, V102, P929, DOI 10.1029/96JC03296; Giannini A, 2001, J CLIMATE, V14, P4530, DOI 10.1175/1520-0442(2001)014<4530:TETTTT>2.0.CO;2; Giannini A, 2004, CLIM DYNAM, V22, P839, DOI 10.1007/s00382-004-0420-2; Giannini A, 2003, SCIENCE, V302, P1027, DOI 10.1126/science.1089357; GILL AE, 1980, Q J ROY METEOR SOC, V106, P447, DOI 10.1002/qj.49710644905; Goddard L, 2002, CLIM DYNAM, V19, P619, DOI 10.1007/s00382-002-0251-y; Huang B, 2004, CLIM DYNAM, V23, P133, DOI 10.1007/s00382-004-0443-8; Kiehl JT, 1998, J CLIMATE, V11, P1131, DOI 10.1175/1520-0442(1998)011<1131:TNCFAR>2.0.CO;2; LATIF M, 1995, J CLIMATE, V8, P952, DOI 10.1175/1520-0442(1995)008<0952:IOTTO>2.0.CO;2; MERLE J, 1980, OCEANOL ACTA, V3, P209; REYNOLDS RW, 1994, J CLIMATE, V7, P929, DOI 10.1175/1520-0442(1994)007<0929:IGSSTA>2.0.CO;2; Saravanan R, 2000, J CLIMATE, V13, P2177, DOI 10.1175/1520-0442(2000)013<2177:IBTAVA>2.0.CO;2; YULAEVA E, 1994, J CLIMATE, V7, P1719, DOI 10.1175/1520-0442(1994)007<1719:TSOEIG>2.0.CO;2; ZEBIAK SE, 1987, MON WEATHER REV, V115, P2262, DOI 10.1175/1520-0493(1987)115<2262:AMENO>2.0.CO;2; ZEBIAK SE, 1993, J CLIMATE, V6, P1567, DOI 10.1175/1520-0442(1993)006<1567:AIITEA>2.0.CO;2	22	146	152	4	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2006	443	7109					324	328		10.1038/nature05053	http://dx.doi.org/10.1038/nature05053			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085RL	16988709				2022-12-28	WOS:000240622000043
J	Guloy, AM; Ramlau, R; Tang, ZJ; Schnelle, W; Baitinger, M; Grin, Y				Guloy, Arnold M.; Ramlau, Reiner; Tang, Zhongjia; Schnelle, Walter; Baitinger, Michael; Grin, Yuri			A guest-free germanium clathrate	NATURE			English	Article							SILICON; SEMICONDUCTORS; CLUSTERS; SODIUM; PHASES; FORM; GE; SI	The challenges associated with synthesizing expanded semiconductor frameworks with cage-like crystal structures continue to be of interest(1,2). Filled low-density germanium and silicon framework structures have distinct properties that address important issues in thermoelectric phonon glass - electron crystals(3), superconductivity(4) and the possibility of Kondo insulators(5). Interest in empty framework structures of silicon and germanium is motivated by their predicted wide optical bandgaps of the same magnitude as quantum dots and porous silicon, making them and their alloys promising materials for silicon-based optoelectronic devices(6,7). Although almost-empty Na1-xSi136 has already been reported(8,9), the synthesis of guest-free germanium clathrate has so far been unsuccessful. Here we report the high-yield synthesis and characteristics of germanium with the empty clathrate-II structure through the oxidation of Ge-9(4-) Zintl anions in ionic liquids under ambient conditions. The approach demonstrates the potential of ionic liquids as media for the reactions of polar intermetallic phases.	Max Planck Inst Chem Phys Stoffe, D-01187 Dresden, Germany; Univ Houston, Texas Ctr Superconduct, Houston, TX 77204 USA	Max Planck Society; University of Houston System; University of Houston	Guloy, AM (corresponding author), Max Planck Inst Chem Phys Stoffe, D-01187 Dresden, Germany.	aguloy@uh.edu; grin@cpfs.mpg.de	Baitinger, Michael/D-4360-2009; Baitinger, Michael/F-4940-2013; Guloy, Arnold/P-3945-2014	Baitinger, Michael/0000-0003-1242-2959; Guloy, Arnold/0000-0003-2492-4323				ADAMS GB, 1994, PHYS REV B, V49, P8048, DOI 10.1103/PhysRevB.49.8048; Ammar A, 2004, SOLID STATE SCI, V6, P393, DOI 10.1016/j.solidstatesciences.2004.02.006; Bobev S, 1999, J AM CHEM SOC, V121, P3795, DOI 10.1021/ja9844175; Cohn JL, 1999, PHYS REV LETT, V82, P779, DOI 10.1103/PhysRevLett.82.779; Connetable D, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247001; Cooper ER, 2004, NATURE, V430, P1012, DOI 10.1038/nature02860; Cros C., 1970, J SOLID STATE CHEM, V2, P570, DOI [10.1016/0022-4596(70)90053-8, DOI 10.1016/0022-4596(70)90053-8]; Cundy CS, 2003, CHEM REV, V103, P663, DOI 10.1021/cr020060i; Dong JJ, 1999, J PHYS-CONDENS MAT, V11, P6129, DOI 10.1088/0953-8984/11/32/305; Downie C, 2004, INORG CHEM, V43, P1992, DOI 10.1021/ic034704w; Downie C, 2000, ANGEW CHEM INT EDIT, V39, P338; Feng PY, 2005, ACCOUNTS CHEM RES, V38, P293, DOI 10.1021/ar0401754; Gies H., 1982, ANGEW CHEM, V94, P214; GROVENSTEIN E, 1959, J AM CHEM SOC, V81, P4850, DOI 10.1021/ja01527a024; GRUTTNER A, 1982, ANGEW CHEM INT EDIT, V21, P912, DOI 10.1002/anie.198209122; Gryko J, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.115208; Gryko J, 2000, PHYS REV B, V62, pR7707, DOI 10.1103/PhysRevB.62.R7707; KASPER JS, 1965, SCIENCE, V150, P1713, DOI 10.1126/science.150.3704.1713; MCGRATH KM, 1995, LANGMUIR, V11, P1835, DOI 10.1021/la00005a066; Moriguchi K, 2000, PHYS REV B, V62, P7138, DOI 10.1103/PhysRevB.62.7138; Munetoh S, 2001, PHYS REV LETT, V86, P4879, DOI 10.1103/PhysRevLett.86.4879; Paschen S, 2002, J PHYS CHEM SOLIDS, V63, P1183, DOI 10.1016/S0022-3697(02)00160-9; Queneau V, 1997, ANGEW CHEM INT EDIT, V36, P1754, DOI 10.1002/anie.199717541; Soler-illia GJD, 2002, CHEM REV, V102, P4093, DOI 10.1021/cr0200062; Trikalitis PN, 2001, NATURE, V410, P671, DOI 10.1038/35070533; von Schnering HG, 1998, ANGEW CHEM INT EDIT, V37, P2359, DOI 10.1002/(SICI)1521-3773(19980918)37:17<2359::AID-ANIE2359>3.0.CO;2-G; VONSCHNERING HG, 1988, J LESS-COMMON MET, V137, P297, DOI 10.1016/0022-5088(88)90095-1; VONSCHNERING HG, 1988, BOL SOC CHIL QUIM, V33, P41; VONSTACKELBERG M, 1954, Z ELEKTROCHEM, V58, P25; Wilson M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.135703	30	324	329	5	217	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2006	443	7109					320	323		10.1038/nature05145	http://dx.doi.org/10.1038/nature05145			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085RL	16988708				2022-12-28	WOS:000240622000042
J	Lunde, K; Solheim, S; Aakhus, S; Arnesen, H; Abdelnoor, M; Egeland, T; Endresen, K; Ilebekk, A; Mangschau, A; Fjeld, JG; Smith, HJ; Taraldsrud, E; Grogaard, HK; Bjornerheim, R; Brekke, M; Muller, C; Hopp, E; Ragnarsson, A; Brinchmann, JE; Forfang, K				Lunde, Ketil; Solheim, Svein; Aakhus, Svend; Arnesen, Harald; Abdelnoor, Michael; Egeland, Torstein; Endresen, Knut; Ilebekk, Arnfinn; Mangschau, Arild; Fjeld, Jan G.; Smith, Hans Jorgen; Taraldsrud, Eli; Grogaard, Haakon Kiil; Bjornerheim, Reidar; Brekke, Magne; Mueller, Carl; Hopp, Einar; Ragnarsson, Asgrimur; Brinchmann, Jan E.; Forfang, Kolbjorn			Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; LEFT-VENTRICULAR VOLUMES; STEM-CELLS; PROGENITOR CELLS; REGENERATION ENHANCEMENT; CARDIAC MYOCYTES; TOPCARE-AMI; TRANSPLANTATION; CARDIOMYOCYTES; APOPTOSIS	BACKGROUND Previous studies have shown improvement in left ventricular function after intracoronary injection of autologous cells derived from bone marrow (BMC) in the acute phase of myocardial infarction. We designed a randomized, controlled trial to further investigate the effects of this treatment. METHODS: Patients with acute ST-elevation myocardial infarction of the anterior wall treated with percutaneous coronary intervention were randomly assigned to the group that underwent intracoronary injection of autologous mononuclear BMC or to the control group, in which neither aspiration nor sham injection was performed. Left ventricular function was assessed with the use of electrocardiogram-gated single-photon-emission computed tomography (SPECT) and echocardiography at baseline and magnetic resonance imaging (MRI) 2 to 3 weeks after the infarction. These procedures were repeated 6 months after the infarction. End points were changes in the left ventricular ejection fraction (LVEF), end-diastolic volume, and infarct size. RESULTS: Of the 50 patients assigned to treatment with mononuclear BMC, 47 underwent intracoronary injection of the cells at a median of 6 days after myocardial infarction. There were 50 patients in the control group. The mean (+/-SD) change in LVEF, measured with the use of SPECT, between baseline and 6 months after infarction for all patients was 7.6+/-10.4 percentage points. The effect of BMC treatment on the change in LVEF was an increase of 0.6 percentage point (95% confidence interval [CI], -3.4 to 4.6; P=0.77) on SPECT, an increase of 0.6 percentage point (95% CI, -2.6 to 3.8; P=0.70) on echocardiography, and a decrease of 3.0 percentage points (95% CI, 0.1 to -6.1; P=0.054) on MRI. The two groups did not differ significantly in changes in left ventricular end-diastolic volume or infarct size and had similar rates of adverse events. CONCLUSIONS: With the methods used, we found no effects of intracoronary injection of autologous mononuclear BMC on global left ventricular function.	Rikshosp Univ Hosp, Dept Cardiol, N-0027 Oslo, Norway; Rikshosp Univ Hosp, Dept Nucl Med, Oslo, Norway; Rikshosp Univ Hosp, Dept Radiol, Oslo, Norway; Rikshosp Univ Hosp, Inst Immunol, Oslo, Norway; Ullevaal Univ Hosp, Dept Cardiol, Oslo, Norway; Ullevaal Univ Hosp, Dept Cardiovasc Radiol, Oslo, Norway; Ullevaal Univ Hosp, Dept Nucl Med, Oslo, Norway; Ullevaal Univ Hosp, Clin Res Ctr, Unit Epidemiol & Biostat, Oslo, Norway; Univ Oslo, Expt Med Res Inst, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Lunde, K (corresponding author), Rikshosp Univ Hosp, Dept Cardiol, N-0027 Oslo, Norway.	ketil.lunde@rikshospitalet.no	abdelnoor, michael/K-4248-2019					Alison MR, 2002, J PATHOL, V197, P419, DOI 10.1002/path.1187; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; BELTRAMI CA, 1994, CIRCULATION, V89, P151, DOI 10.1161/01.CIR.89.1.151; Braunwald E, 2000, CIRCULATION, V102, P14; Britten MB, 2003, CIRCULATION, V108, P2212, DOI 10.1161/01.CIR.0000095788.78169.AF; Chien KR, 2004, NATURE, V428, P607, DOI 10.1038/nature02500; Fernandez-Aviles F, 2004, CIRC RES, V95, P742, DOI 10.1161/01.RES.0000144798.54040.ed; Fuchs S, 2001, J AM COLL CARDIOL, V37, P1726, DOI 10.1016/S0735-1097(01)01200-1; Geng YJ, 2003, ANN NY ACAD SCI, V1010, P687, DOI 10.1196/annals.1299.126; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0; KILLIP T, 1967, AM J CARDIOL, V20, P457, DOI 10.1016/0002-9149(67)90023-9; Kloner RA, 2001, CIRCULATION, V104, P2981, DOI 10.1161/hc4801.100038; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361; Lawson MA, 1996, AM J CARDIOL, V77, P1098, DOI 10.1016/S0002-9149(96)00140-3; Limbourg FP, 2005, CIRC RES, V96, P6, DOI 10.1161/01.RES.0000153667.26414.10; Lunde K, 2005, SCAND CARDIOVASC J, V39, P150, DOI 10.1080/14017430510009131; Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nosir YFM, 1997, EUR HEART J, V18, P1175; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; PASSAMANI E, 1985, NEW ENGL J MED, V312, P932; Penicka M, 2005, CIRCULATION, V112, pE63, DOI 10.1161/CIRCULATIONAHA.104.496133; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Pocock SJ., 2013, CLIN TRIALS PRACTICA; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Schulz-Menger J, 2003, J AM COLL CARDIOL, V42, P513, DOI 10.1016/S0735-1097(03)00717-4; Sievers B, 2004, J CARDIOVASC MAGN R, V6, P593, DOI 10.1081/JCMR-120038081; STEEN R, 1994, STEM CELLS, V12, P214, DOI 10.1002/stem.5530120210; STONE PH, 1988, J AM COLL CARDIOL, V11, P453, DOI 10.1016/0735-1097(88)91517-3; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Takeuchi M, 1993, J Am Soc Echocardiogr, V6, P593; Thum T, 2005, J AM COLL CARDIOL, V46, P1799, DOI 10.1016/j.jacc.2005.07.053; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Yeh ETH, 2003, CIRCULATION, V108, P2070, DOI 10.1161/01.CIR.0000099501.52718.70	42	989	1063	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 21	2006	355	12					1199	1209		10.1056/NEJMoa055706	http://dx.doi.org/10.1056/NEJMoa055706			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085IT	16990383				2022-12-28	WOS:000240598500004
J	Schwartz, RS				Schwartz, Robert S.			The politics and promise of stem-cell research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FUSION											Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Jiang SG, 2004, P NATL ACAD SCI USA, V101, P16891, DOI 10.1073/pnas.0404398101; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531	5	34	40	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 21	2006	355	12					1189	1191		10.1056/NEJMp068180	http://dx.doi.org/10.1056/NEJMp068180			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	085IT	16990380				2022-12-28	WOS:000240598500001
J	Martinez, MDR; Ceballos, PO; Coe, MD; Diehl, RA; Houston, SD; Taube, KA; Calderon, AD				Rodriguez Martinez, Ma. del Carmen; Ceballos, Ponciano Ortiz; Coe, Michael D.; Diehl, Richard A.; Houston, Stephen D.; Taube, Karl A.; Delgado Calderon, Alfredo			Oldest writing in the New World	SCIENCE			English	Article									Brown Univ, Dept Anthropol, Providence, RI 02912 USA; Inst Nacl Antropol & Hist Ctr, Xalapa, Veracruz, Mexico; Univ Veracruzana, Inst Anthropol, Xalapa 91000, Veracruz, Mexico; Univ Alabama, Dept Anthropol, Tuscaloosa, AL 35487 USA; Univ Calif Riverside, Dept Anthropol, Riverside, CA 92521 USA	Brown University; Universidad Veracruzana; University of Alabama System; University of Alabama Tuscaloosa; University of California System; University of California Riverside	Houston, SD (corresponding author), Brown Univ, Dept Anthropol, 128 Hope St, Providence, RI 02912 USA.	Stephen_Houston@brown.edu	Calderón, Angie/GXV-9507-2022					BASSO KH, 1975, W APACHE WRITING SYS, P5; CHEETHAM D, 2006, 19 S INV ARQ GUAT 20; COE MD, 1999, BREAKING MAYA CODE, P13; Coe Michael D., 1980, LAND OLMEC; DIEHL RA, 2005, OLMECS AM 1 CIVILIZA; HOLMES H, 1907, AM ANTHROPOL, V9, P691; Houston S, 2003, COMP STUD SOC HIST, V45, P430; HOUSTON S, 2004, 1 WRITING, P284; HOUSTON SD, 2004, MEXICON, V25, P151; Joralemon Peter David, 1971, STUDY OLMEC ICONOGRA; MARSHALL JH, 1924, ILLUSTRATED LONDON N, V20, P528; Ortiz Ceballos P., 2000, OLMEC ART ARCHAEOLOG, P75; ORTIZ P, IN PRESS ARQUEOLOGIA; Pohl MED, 2002, SCIENCE, V298, P1984, DOI 10.1126/science.1078474; Saturno WA, 2006, SCIENCE, V311, P1281, DOI 10.1126/science.1121745; SCHEIL V, 1905, DOCUMENTS ECRITURE P; SULLIVAN TD, 1994, SCATTERING JADES STO, P229; Taube K.A., 1995, OLMEC WORLD RITUAL R; Taube Karl A, 2004, OLMEC ART DUMBARTON	19	34	34	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2006	313	5793					1610	1614		10.1126/science.1131492	http://dx.doi.org/10.1126/science.1131492			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973873				2022-12-28	WOS:000240498900037
J	Foukal, P; Frohlich, C; Spruit, H; Wigley, TML				Foukal, P.; Froehlich, C.; Spruit, H.; Wigley, T. M. L.			Variations in solar luminosity and their effect on the Earth's climate	NATURE			English	Review							NORTHERN-HEMISPHERE TEMPERATURES; ENERGY-BALANCE; HEAT-FLOW; IRRADIANCE; SUN; MODULATION; MODEL; MAGNETOCONVECTION; 20TH-CENTURY; VARIABILITY	Variations in the Sun's total energy output ( luminosity) are caused by changing dark ( sunspot) and bright structures on the solar disk during the 11-year sunspot cycle. The variations measured from spacecraft since 1978 are too small to have contributed appreciably to accelerated global warming over the past 30 years. In this Review, we show that detailed analysis of these small output variations has greatly advanced our understanding of solar luminosity change, and this new understanding indicates that brightening of the Sun is unlikely to have had a significant influence on global warming since the seventeenth century. Additional climate forcing by changes in the Sun's output of ultraviolet light, and of magnetized plasmas, cannot be ruled out. The suggested mechanisms are, however, too complex to evaluate meaningfully at present.	Max Planck Inst Astrophys, D-85741 Garching, Germany; Natl Ctr Atmospher Res, Boulder, CO 80307 USA; Heliophys Inc, Nahant, MA 01908 USA; Phys Meteorol Observ Davos, World Radiat Ctr, CH-7260 Davos, Switzerland	Max Planck Society; National Center Atmospheric Research (NCAR) - USA	Spruit, H (corresponding author), Max Planck Inst Astrophys, D-85741 Garching, Germany.	henk@mpa-garching.mpg.de						Ammann CM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016875; Antia HM, 2003, ASTROPHYS J, V590, P567, DOI 10.1086/374916; Bard E, 1997, EARTH PLANET SC LETT, V150, P453, DOI 10.1016/S0012-821X(97)00082-4; Bond G, 2001, SCIENCE, V294, P2130, DOI 10.1126/science.1065680; Briffa KR, 2001, J GEOPHYS RES-ATMOS, V106, P2929, DOI 10.1029/2000JD900617; Brown TM, 1998, ASTROPHYS J, V500, pL195, DOI 10.1086/311416; Carlsson M, 2004, ASTROPHYS J, V610, pL137, DOI 10.1086/423305; Chapman GA, 1996, J GEOPHYS RES-SPACE, V101, P13541, DOI 10.1029/96JA00683; CHIANG WH, 1985, SOL PHYS, V97, P9, DOI 10.1007/BF00152975; CHIANG WH, 1987, SOL PHYS, V110, P129, DOI 10.1007/BF00148208; Crowley TJ, 2000, SCIENCE, V289, P270, DOI 10.1126/science.289.5477.270; Cubasch U., 2001, PROJECTIONS FUTURE C, P525; Dziembowski WA, 2005, ASTROPHYS J, V625, P548, DOI 10.1086/429712; Esper J, 2002, SCIENCE, V295, P2250, DOI 10.1126/science.1066208; FIELD C, 2006, IN PRESS J GEOPHYS R; Fisk LA, 1998, SPACE SCI REV, V83, P179, DOI 10.1023/A:1005074923940; FOUKAL P, 1983, ASTROPHYS J, V267, P863, DOI 10.1086/160920; FOUKAL P, 1984, ASTROPHYS J, V281, P442, DOI 10.1086/162115; Foukal P, 1998, ASTROPHYS J, V500, P958, DOI 10.1086/305764; Foukal P, 2004, SCIENCE, V306, P68, DOI 10.1126/science.1101694; Foukal P, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015474; FOUKAL P, 1988, ASTROPHYS J, V328, P347, DOI 10.1086/166297; Foukal P, 2001, GEOPHYS RES LETT, V28, P883, DOI 10.1029/2000GL012072; FOUKAL P, IN PRESS ASTROPHYS J; Foukal P.V., 2004, SOLAR ASTROPHYSICS; FOWLER LA, 1983, SOL PHYS, V84, P33, DOI 10.1007/BF00157440; Frohlich C, 2004, ASTRON ASTROPHYS REV, V12, P273, DOI 10.1007/s00159-004-0024-1; FROHLICH C, IN PRESS SPACE SCI R; GEGIDI A, 2006, SOL PHYS, V235, P407; Gilliland R. L., 1988, Advances in Space Research, V8, P151, DOI 10.1016/0273-1177(88)90185-8; GOLDREICH P, 1991, ASTROPHYS J, V370, P752, DOI 10.1086/169858; Haigh JD, 2003, PHILOS T ROY SOC A, V361, P95, DOI 10.1098/rsta.2002.1111; Harrison RG, 2004, SURV GEOPHYS, V25, P441, DOI 10.1007/s10712-004-5439-8; HARVEY PD, 1997, CNS SPECTRUMS, V2, P1; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; HOYT DV, 1993, J GEOPHYS RES-SPACE, V98, P18895, DOI 10.1029/93JA01944; Hu FS, 2003, SCIENCE, V301, P1890, DOI 10.1126/science.1088568; Jones PD, 2001, SCIENCE, V292, P662, DOI 10.1126/science.1059126; Kasting JF, 1997, SCIENCE, V276, P1213, DOI 10.1126/science.276.5316.1213; Kuhn JR, 2004, ASTROPHYS J, V613, P1241, DOI 10.1086/423301; Kuhn JR, 1998, NATURE, V392, P155, DOI 10.1038/32361; LEAN J, 1995, GEOPHYS RES LETT, V22, P3195, DOI 10.1029/95GL03093; Lean J, 2000, GEOPHYS RES LETT, V27, P2425, DOI 10.1029/2000GL000043; Lean JL, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015880; LIBBRECHT KG, 1990, NATURE, V345, P779, DOI 10.1038/345779a0; Lites BW, 2004, SOL PHYS, V221, P65, DOI 10.1023/B:SOLA.0000033355.24845.5a; Livingston W, 2003, SOL PHYS, V212, P227, DOI 10.1023/A:1022994002653; Lockwood M, 1999, NATURE, V399, P437, DOI 10.1038/20867; Mann ME, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017814; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Muscheler R, 2005, NATURE, V436, pE3, DOI 10.1038/nature04045; PARKER EN, 1995, ASTROPHYS J, V440, P415, DOI 10.1086/175283; PETRO LD, 1985, SOL PHYS, V98, P23, DOI 10.1007/BF00177196; Radick RR, 1998, ASTROPHYS J SUPPL S, V118, P239, DOI 10.1086/313135; Raper SCB, 2001, CLIM DYNAM, V17, P601, DOI 10.1007/PL00007931; Rast MP, 1999, NATURE, V401, P678, DOI 10.1038/44343; Rosenthal CS, 1999, ASTRON ASTROPHYS, V351, P689; SCHATTEN KH, 1986, ASTROPHYS J, V311, P460, DOI 10.1086/164786; Schussler M, 2006, ASTROPHYS J, V641, pL73, DOI 10.1086/503772; Shindell DT, 2003, J CLIMATE, V16, P4094, DOI 10.1175/1520-0442(2003)016<4094:VASFOC>2.0.CO;2; Sofia S., 1998, Memorie della Societa Astronomica Italiana, V69, P531; SOFIA S, 2004, EOS, V85, P217; Solanki SK, 1998, GEOPHYS RES LETT, V25, P341, DOI 10.1029/98GL50038; Solanki SK, 2004, NATURE, V431, P1084, DOI 10.1038/nature02995; SPRUIT HC, 1976, SOL PHYS, V50, P269, DOI 10.1007/BF00155292; Spruit HC, 2003, SOL PHYS, V213, P1, DOI 10.1023/A:1023202605379; SPRUIT HC, 1982, ASTRON ASTROPHYS, V108, P356; SPRUIT HC, 1977, SOL PHYS, V55, P3, DOI 10.1007/BF00150871; SPRUIT HC, 1991, SUN TIME, P118; WENZLER T, 2005, THESIS EIDGENOSSISCH; Wigley TML, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005557; Wigley TML, 2001, SCIENCE, V293, P451, DOI 10.1126/science.1061604; WIGLEY TML, 1990, GEOPHYS RES LETT, V17, P2169, DOI 10.1029/GL017i012p02169; WILLSON RC, 1981, SCIENCE, V211, P700, DOI 10.1126/science.211.4483.700; WILSON PR, 1982, PHYS SUNSPOTS, P83; Woodard MF, 2003, SOL PHYS, V212, P51, DOI 10.1023/A:1022952206013; Zahid HJ, 2004, SOL PHYS, V222, P1, DOI 10.1023/B:SOLA.0000036856.85611.1e	78	226	238	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2006	443	7108					161	166		10.1038/nature05072	http://dx.doi.org/10.1038/nature05072			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16971941				2022-12-28	WOS:000240467000036
J	Goldie, SJ; Yazdanpanah, Y; Losina, E; Weinstein, MC; Anglaret, X; Walensky, RP; Hsu, HE; Kimmel, A; Holmes, C; Kaplan, JE; Freedberg, KA				Goldie, Sue J.; Yazdanpanah, Yazdan; Losina, Elena; Weinstein, Milton C.; Anglaret, Xavier; Walensky, Rochelle P.; Hsu, Heather E.; Kimmel, April; Holmes, Charles; Kaplan, Jonathan E.; Freedberg, Kenneth A.			Cost-effectiveness of HIV treatment in resource-poor settings - The case of Cote d'Ivoire	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-1-INFECTED ADULTS; COTRIMOXAZOLE PROPHYLAXIS; TRIMETHOPRIM-SULFAMETHOXAZOLE; DEVELOPING-COUNTRIES; VIROLOGICAL FAILURE; VIRAL LOAD; INTERVENTIONS; ABIDJAN; COMBINATION	BACKGROUND: As antiretroviral therapy is increasingly used in settings with limited resources, key questions about the timing of treatment and use of diagnostic tests to guide clinical decisions must be addressed. METHODS: We assessed the cost-effectiveness of treatment strategies for a cohort of adults in Cote d'Ivoire who were infected with the human immunodeficiency virus (HIV) (mean age, 33 years; CD4 cell count, 331 per cubic millimeter; HIV RNA level, 5.3 log copies per milliliter). Using a computer-based simulation model that incorporates the CD4 cell count and HIV RNA level as predictors of disease progression, we compared the long-term clinical and economic outcomes associated with no treatment, trimethoprim-sulfamethoxazole prophylaxis alone, antiretroviral therapy alone, and prophylaxis with antiretroviral therapy. RESULTS: Undiscounted gains in life expectancy ranged from 10.7 months with antiretroviral therapy and prophylaxis initiated on the basis of clinical criteria to 45.9 months with antiretroviral therapy and prophylaxis initiated on the basis of CD4 testing and clinical criteria, as compared with trimethoprim-sulfamethoxazole prophylaxis alone. The incremental cost per year of life gained was $240 (in 2002 U.S. dollars) for prophylaxis alone, $620 for antiretroviral therapy and prophylaxis without CD4 testing, and $1,180 for antiretroviral therapy and prophylaxis with CD4 testing, each compared with the next least expensive strategy. None of the strategies that used antiretroviral therapy alone were as cost-effective as those that also used trimethoprim-sulfamethoxazole prophylaxis. Life expectancy was increased by 30% with use of a second line of antiretroviral therapy after failure of the first-line regimen. CONCLUSIONS: A strategy of trimethoprim-sulfamethoxazole prophylaxis and antiretroviral therapy, with the use of clinical criteria alone or in combination with CD4 testing to guide the timing of treatment, is an economically attractive health investment in settings with limited resources.	Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Program Hlth Decis Sci, Boston, MA 02115 USA; Fac Med Lille, Ctr Hosp Tourcoing, Serv Univ Malad Infect & Voyageur, F-59045 Lille, France; CNRS, URA 362, Lab Rech Econ & Sociales, Lille, France; Boston Univ, Sch Publ Hlth, Boston, MA USA; INSERM, U593, Bordeaux, France; Programme PAC CI, Abidjan, Cote Ivoire; Massachusetts Gen Hosp, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Pittsburgh, Sch Med, Sect Decis Sci & Clin Syst Modeling, Pittsburgh, PA USA; Ctr Dis Control & Prevent, Atlanta, GA USA	Harvard University; Harvard T.H. Chan School of Public Health; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Boston University; Institut National de la Sante et de la Recherche Medicale (Inserm); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Disease Control & Prevention - USA	Goldie, SJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Program Hlth Decis Sci, 718 Huntington Ave,2nd Fl, Boston, MA 02115 USA.	sue_goldie@harvard.edu	Anglaret, Xavier/T-2757-2019; Anglaret, Xavier/F-7333-2013	Losina, ELENA/0000-0002-3424-0892; Anglaret, Xavier/0000-0003-3319-8423; Hsu, Heather/0000-0002-5863-1804; Walensky, Rochelle P./0000-0002-8795-379X	NIAID NIH HHS [K25 AI050436, K25-AI50436, K23 AI001794, K24-AI062476, K24 AI062476, R01-AI058736, K23-AI01794, R01 AI058736] Funding Source: Medline; PHS HHS [U64/CCU 114927, U64/CCU 119525] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI062476, K23AI001794, K25AI050436, R01AI058736] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AIDS Epidemic Update, 2004, AIDS EP UPD; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; Anglaret X, 2003, AIDS, V17, P575, DOI 10.1097/00002030-200303070-00013; [Anonymous], 2001, MACR HLTH INV HLTH E; [Anonymous], 2002, WORLD MORTALITY 2000; Aseffa A, 1997, E AFR MED J, V74, P708; CLEARY S, 2004, COST EFFECTIVENESS A; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Cole SR, 2003, AM J EPIDEMIOL, V158, P687, DOI 10.1093/aje/kwg206; Deeks SG, 2002, AIDS, V16, P201, DOI 10.1097/00002030-200201250-00009; Deeks SG, 2000, J INFECT DIS, V181, P946, DOI 10.1086/315334; Djomand G, 2003, AIDS, V17, pS5, DOI 10.1097/00002030-200317003-00002; Evans DB, 2005, BMJ-BRIT MED J, V331, P1137, DOI 10.1136/bmj.331.7525.1137; Farmer P, 2001, LANCET, V358, P404, DOI 10.1016/S0140-6736(01)05550-7; Forsythe SS, 1998, AIDS, V12, pS11; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Gold MR, 1996, COST EFFECTIVENESS H; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Goldie SJ, 2003, AM J MED, V115, P632, DOI 10.1016/j.amjmed.2003.07.007; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Johns B, 2005, HEALTH POLICY PLANN, V20, P1, DOI 10.1093/heapol/czi001; Kumarasamy N, 2004, JAIDS-J ACQ IMM DEF, V37, P1574, DOI 10.1097/00126334-200412150-00007; Kuntz KM, 2001, EC EVALUATION HLTH C, P141; Lamptey P, 2005, PLOS MED, V2, P102, DOI 10.1371/journal.pmed.0020039; Landman R, 2003, AIDS, V17, P1017, DOI 10.1097/00002030-200305020-00010; Laurent C, 2004, LANCET, V364, P29, DOI 10.1016/S0140-6736(04)16586-0; Laurent C, 2005, JAIDS-J ACQ IMM DEF, V38, P14, DOI 10.1097/00126334-200501010-00003; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; Levitz SM, 1998, NEW ENGL J MED, V338, P1074, DOI 10.1056/NEJM199804093381517; LOSINA E, 2002, INT AIDS C BARC JUL; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; Marseille E, 1999, LANCET, V354, P803, DOI 10.1016/S0140-6736(99)80009-9; Marseille E, 2002, LANCET, V359, P1851, DOI 10.1016/S0140-6736(02)08705-6; Matheron S, 2006, AIDS, V20, P459, DOI 10.1097/01.aids.0000199829.57112.2f; Matheron S, 2003, AIDS, V17, P2593, DOI 10.1097/00002030-200312050-00006; *MED FRONT, 2005, UNT WEB PRIC RED PRI; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Moatti JP, 2003, NAT MED, V9, P1449, DOI 10.1038/nm1203-1449; *MULT AIDS COH STU, 1995, PUBL US DAT; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; Musgrove P, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P271; *OANDA CORP, NOM INT EXCH RAT YEA; Palella FJ, 2003, ANN INTERN MED, V138, P620, DOI 10.7326/0003-4819-138-8-200304150-00007; Salomon JA, 2005, PLOS MED, V2, P50, DOI 10.1371/journal.pmed.0020016; Schwartlander B, 2001, SCIENCE, V292, P2434, DOI 10.1126/science.1062876; Seyler C, 2003, ANTIVIR THER, V8, P385; Sow A I, 1999, Dakar Med, V44, P20; *UNAIDS SECR, 2003, SOURC PRIC SEL DRUGS; van Oosterhout JJG, 2005, JAIDS-J ACQ IMM DEF, V39, P626; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; *WHO, 2004, IND CSTS PER PAT PER; *WHO, AIDS MED DIAGN SERV; *WHO CHOICE, 2004, PRIC HOSP HLTH CTR; *WHO CHOICE, 2006, PRIC HOSP HLTH CTR; *WORLD BANK, 2002, WORLD BANK DEV IND 2; World Health Organization, 2003, SCAL ANT THER RES LT; Wright JC, 1998, NEW ENGL J MED, V339, P380, DOI 10.1056/NEJM199808063390606; Yazdanpanah Y, 2005, AIDS, V19, P1299, DOI 10.1097/01.aids.0000180101.80888.c6	59	220	225	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 14	2006	355	11					1141	1153		10.1056/NEJMsa060247	http://dx.doi.org/10.1056/NEJMsa060247			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	083NJ	16971720				2022-12-28	WOS:000240462800008
J	Amin, J; Law, MG; Bartlett, M; Kaldor, JM; Dore, GJ				Amin, Janaki; Law, Matthew G.; Bartlett, Mark; Kaldor, John M.; Dore, Gregory J.			Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study	LANCET			English	Article							LIVER-RELATED MORTALITY; POSITIVE BLOOD-DONORS; HEPATOCELLULAR-CARCINOMA; VIRUS-INFECTION; NATURAL-HISTORY; FOLLOW-UP; NON-A; COHORT; PREVALENCE; AUSTRALIA	Background Hepatitis B and hepatitis C virus infections are common causes of death related to liver disease. In this large study, we aimed to investigate all cause mortality of the viruses in a community-based setting. Methods In the study population, 39 109 people had hepatitis B, 75 834 had hepatitis C, and 2604 had hepatitis B and hepatitis C co-infection, notified to the New South Wales state health department, Australia, between 1990 and 2002. Their data were probabilistically linked to the National Death Index. Standardised mortality ratios for all causes of death were calculated and adjusted for age, sex, and calendar year. Results The number of deaths identified by the linkage were 1233 (3.2%) for hepatitis B, 4008 (5.3)% for hepatitis C, and 186 (7.1)% for hepatitis B and C co-infection. Raised risk of liver-related death (standardised mortality ratios 12.2, 95% CI 10.7-13.9; 16.8, 15.4-18.3, and 32.9, 23.1-46.7, for hepatitis B, hepatitis Q and hepatitis B and C co-infected patients, respectively) and drug-induced death (1.4, 1.0-2.0; 19.3, 18.1-20.5; and 24.7, 18.2-33.5, respectively) were detected. In people with hepatitis C, raised risk of dying from drug-related causes was significantly greater than from liver-related causes (p=0.012), with the greatest excess risk in women aged 15-24 years (56.9, 39.2-79.9). Interpretation All groups had increased risk of liver-related death compared with the standard population, with the greatest excess in people diagnosed with hepatitis B and hepatitis C co-infection. Our data highlight that young people with hepatitis C and with co-infection face a higher mortality risk from continued drug use than from their infection, whereas the main cause of hepatitis B death was liver related.	Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW 2010, Australia	University of New South Wales Sydney; Kirby Institute	Amin, J (corresponding author), Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW 2010, Australia.	jamin@nchecr.unsw.edu.au	Kaldor, John M/D-4545-2011; Dore, Gregory John/ABD-5665-2021	Dore, Gregory John/0000-0002-4741-2622; Amin, Janaki/0000-0003-2161-9366; Law, Matthew/0000-0002-3540-8837				*AUSTR BUR STAT, 2002, DRUG IND DEATHS GUID; Australian Bureau of Statistics, 2019, POP AG SEX TABL; Backmund M, 2003, EUR ADDICT RES, V9, P45, DOI 10.1159/000067733; BEASLEY RP, 1981, LANCET, V2, P1129; Breslow NE., 1987, STATISTICAL METHODS, P48; BRUIX J, 1989, LANCET, V2, P1004; Chen G, 2005, INT J EPIDEMIOL, V34, P132, DOI 10.1093/ije/dyh339; COLOMBO M, 1989, LANCET, V2, P1006; Copeland L, 2004, ARCH INTERN MED, V164, P1214, DOI 10.1001/archinte.164.11.1214; Crook PD, 2003, INT J EPIDEMIOL, V32, P118, DOI 10.1093/ije/dyg039; Day C, 2003, ADDICTION, V98, P93, DOI 10.1046/j.1360-0443.2003.00266.x; Di Marco V, 1999, HEPATOLOGY, V30, P257, DOI 10.1002/hep.510300109; Dore GJ, 2003, J CLIN VIROL, V26, P171, DOI 10.1016/S1386-6532(02)00116-6; Fattovich G, 2003, SEMIN LIVER DIS, V23, P47, DOI 10.1055/s-2003-37590; Gronbaek K, 1999, J HEPATOL, V31, P800, DOI 10.1016/S0168-8278(99)80280-3; Harris HE, 2002, BMJ-BRIT MED J, V324, P450, DOI 10.1136/bmj.324.7335.450; *IARC, 1994, HEP VIR; JARO MA, 1995, STAT MED, V14, P491, DOI 10.1002/sim.4780140510; Kaldor JM, 1996, MED J AUSTRALIA, V165, P322, DOI 10.5694/j.1326-5377.1996.tb124993.x; Kamitsukasa H, 2005, HEPATOLOGY, V41, P819, DOI 10.1002/hep.20648; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; Law MG, 2003, INT J EPIDEMIOL, V32, P717, DOI 10.1093/ije/dyg101; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; *NAT CTR HIV EP CL, HIV AIDS VIR HEP SEX; Niederau C, 1998, HEPATOLOGY, V28, P1687, DOI 10.1002/hep.510280632; *NSW HLTH, NOT DIS RESP PROT NS; O'Sullivan BG, 2004, AUST NZ J PUBL HEAL, V28, P212, DOI 10.1111/j.1467-842X.2004.tb00697.x; Osella AR, 2000, INT J EPIDEMIOL, V29, P922, DOI 10.1093/ije/29.5.922; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Rodger AJ, 2000, HEPATOLOGY, V32, P582, DOI 10.1053/jhep.2000.9714; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Seeff LB, 2001, HEPATOLOGY, V33, P455, DOI 10.1053/jhep.2001.21905; Seeff LB, 2000, ANN INTERN MED, V132, P105, DOI 10.7326/0003-4819-132-2-200001180-00003; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shi J, 2005, BRIT J CANCER, V92, P607, DOI 10.1038/sj.bjc.6602333; SIMONETTI RG, 1989, LANCET, V2, P1338; Tanaka H, 2004, INT J CANCER, V112, P1075, DOI 10.1002/ijc.20507; Weatherburn D, 2003, ADDICTION, V98, P83, DOI 10.1046/j.1360-0443.2003.00248.x; Xu B, 2003, J GASTROEN HEPATOL, V18, P1345, DOI 10.1046/j.1440-1746.2003.03187.x	39	199	203	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 9	2006	368	9539					938	945		10.1016/S0140-6736(06)69374-4	http://dx.doi.org/10.1016/S0140-6736(06)69374-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	083ZX	16962883				2022-12-28	WOS:000240502300031
J	Scheen, AJ				Scheen, A. J.			Does the metabolic syndrome help to select patients requiring high statin dose?	LANCET			English	Editorial Material							MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; CORONARY; RISK; DISEASE; ATORVASTATIN; PARTICIPANTS; TRIALS		CHU Sart Tilman B35, Dept Med, B-4000 Liege, Belgium	University of Liege	Scheen, AJ (corresponding author), CHU Sart Tilman B35, Dept Med, B-4000 Liege, Belgium.	andre.scheen@chu.ulg.ac.be						Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Deedwania P, 2006, LANCET, V368, P919, DOI 10.1016/S0140-6736(06)69292-1; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Kahn R, 2005, DIABETOLOGIA, V48, P1684, DOI 10.1007/s00125-005-1876-2; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Nigam A, 2006, AM HEART J, V151, P514, DOI 10.1016/j.ahj.2005.03.050; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Shepherd J, 2006, DIABETES CARE, V29, P1220, DOI 10.2337/dc05-2465; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; Stern MP, 2004, DIABETES CARE, V27, P2676, DOI 10.2337/diacare.27.11.2676; Wilson PWF, 2004, ENDOCRIN METAB CLIN, V33, P467, DOI 10.1016/j.ecl.2004.03.012; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	14	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2006	368	9539					893	894		10.1016/S0140-6736(06)69293-3	http://dx.doi.org/10.1016/S0140-6736(06)69293-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083ZX	16962860	Green Submitted			2022-12-28	WOS:000240502300004
J	King, DA; Peckham, C; Waage, JK; Brownlie, J; Woolhouse, MEJ				King, D. A.; Peckham, C.; Waage, J. K.; Brownlie, J.; Woolhouse, M. E. J.			Infectious diseases: Preparing for the future	SCIENCE			English	Editorial Material									Univ Edinburgh, Ctr Infect Dis, Edinburgh EH9 3JT, Midlothian, Scotland; Dept Trade & Ind, Off Sci & Innovat, London SW1H 0ET, England; Inst Child Hlth, London WC1N 1EH, England; Univ London Imperial Coll Sci & Technol, Dept Agr Sci, London SW7 2AZ, England; Univ London Royal Vet Coll, Hatfield AL9 7TA, Herts, England; Univ Edinburgh, Ctr Infect Dis, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh; University of London; University College London; Imperial College London; University of London; University of London Royal Veterinary College; University of Edinburgh	Woolhouse, MEJ (corresponding author), Univ Edinburgh, Ctr Infect Dis, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	mark.woolhouse@ed.ac.uk	peckham, catherine s/I-6300-2013					[Anonymous], 2005, MILLENNIUM DEV GOALS; BRAHMBHATT M, AVIAN HUMAN PANDEMIC; Enserink M, 2003, SCIENCE, V302, P2045, DOI 10.1126/science.302.5653.2045; Fouchier R, 2005, NATURE, V435, P419, DOI 10.1038/435419a; World Health Organisation (WHO), DAT; 2006, INFECT DIS PREPARING	6	118	127	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2006	313	5792					1392	1393		10.1126/science.1129134	http://dx.doi.org/10.1126/science.1129134			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	081WQ	16959992				2022-12-28	WOS:000240348700025
J	Wansink, B; Chandon, P				Wansink, Brian; Chandon, Pierre			RETRACTED: Meal size, not body size, explains errors in estimating the calorie content of meals (Retracted article. See vol. 170, pg. 138, 2019)	ANNALS OF INTERNAL MEDICINE			English	Article; Retracted Publication							PORTION SIZES; OBESITY; JUDGMENT; VALIDITY; WEIGHT	Background: Although most people underestimate the calories they consume during a meal or during the day, calorie underestimation is especially extreme among overweight persons. The reason for this systematic bias is unknown. Objective: To investigate whether the association between calorie underestimation and body mass reflects a tendency for all persons to underestimate calories as the size of a meal increases. Design: Overweight and normal-weight adults estimated the number of calories of a fast-food meal they had ordered and eaten (study 1) or of 15 fast-food meals that were chosen by the experimenter (study 2) in a randomized, controlled trial. Their estimations were compared with the actual number of calories of the meals. Setting: Study 1 was a field study conducted in fast-food restaurants in 3 medium-sized midwestern U.S. cities. Study 2 was conducted in a laboratory at a major U.S. research university. Participants: Study 1 involved 105 lunchtime diners (average body mass index [BMI], 24.2 kg/m(2) [range, 17.2 to 33.5 kg/m(2)]). Study 2 involved 40 undergraduate students (average BMI, 23.2 kg/m(2) [range, 16.1 to 32.3 kg/m(2)]). Measurements: Participants were asked to estimate the number of calories in a fast-food meal they had ordered and eaten (study 1) or in 15 sizes of the same fast-food meal (study 2). The actual number of calories in the meals in the field study was obtained by unobtrusively recording the food that was ordered (identified from the wrappings and containers). Weight and height were self-reported. Results: Although participants strongly underestimated the number of calories in larger meals (by -38.0% in study 1 and by -22.6% in study 2), they almost perfectly estimated the number of calories in smaller meals (by -2.9% in study 1 and by 3.0% in study 2). After the authors controlled for body weight-related differences in meal size, the calorie estimations of normal-weight and overweight participants were identical in both studies. Limitations: These studies examined fast-food meals. Weight and height were self-reported. There were too few observations to distinguish between obese (BMI >= 30 kg/m(2)) and overweight (BMI > 25 kg/m(2) but < 30 kg/m(2)) participants. Conclusions: Greater underestimation of calories by overweight persons is a consequence of their tendency to consume larger meals. Calorie underestimation is related to meal size, not body size.	Cornell Univ, Ithaca, NY 14853 USA; INSEAD, Fontainebleau, France	Cornell University; INSEAD Business School	Wansink, B (corresponding author), Cornell Univ, 110 Warren Hall, Ithaca, NY 14853 USA.		Wansink, Brian/G-4284-2010; Wansink, Brian/G-1219-2011					ARKES HR, 1991, PSYCHOL BULL, V110, P486, DOI 10.1037/0033-2909.110.3.486; CHANDON P, 2007, IN PRESS J MRKETING, V43; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Ledikwe JH, 2005, J NUTR, V135, P905, DOI 10.1093/jn/135.4.905; LICHTMAN SW, 1992, NEW ENGL J MED, V327, P1893, DOI 10.1056/NEJM199212313272701; Livingstone MBE, 2003, J NUTR, V133, p895S, DOI 10.1093/jn/133.3.895S; Muhlheim LS, 1998, INT J EAT DISORDER, V24, P259, DOI 10.1002/(SICI)1098-108X(199811)24:3&lt;259::AID-EAT3&gt;3.0.CO;2-L; Nielsen Samara Joy, 2003, JAMA (Journal of the American Medical Association), V289, P450, DOI 10.1001/jama.289.4.450; Rolls B, 2005, VOLUMETRICS EATING P; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Stevens S. S., 2017, PSYCHOPHYSICS INTRO; Subar AF, 2003, AM J EPIDEMIOL, V158, P1, DOI 10.1093/aje/kwg092; TEGHTSOONIAN M, 1965, AM J PSYCHOL, V78, P392, DOI 10.2307/1420573; Tooze JA, 2004, AM J CLIN NUTR, V79, P795; Trabulsi J, 2001, AM J PHYSIOL-ENDOC M, V281, pE891, DOI 10.1152/ajpendo.2001.281.5.E891; Wansink B, 2004, ANNU REV NUTR, V24, P455, DOI 10.1146/annurev.nutr.24.012003.132140; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323; Young LR, 2002, AM J PUBLIC HEALTH, V92, P246, DOI 10.2105/AJPH.92.2.246; YOUNG LR, 2005, PORTION TELLER SMART	19	91	91	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 5	2006	145	5					326	332		10.7326/0003-4819-145-5-200609050-00005	http://dx.doi.org/10.7326/0003-4819-145-5-200609050-00005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080NZ	16954358				2022-12-28	WOS:000240255900002
J	Emery, P; Ponchel, F				Emery, Paul; Ponchel, Frederique			Inhibiting toll-like receptors in inflammatory disease	LANCET			English	Editorial Material							RHEUMATOID-ARTHRITIS; SIGNALING PATHWAY; ACTIVATE		Univ Leeds, Leeds Inst Mol Med, Acad Sect Musculoskeletal Dis, Leeds LS7 4SA, W Yorkshire, England	University of Leeds	Emery, P (corresponding author), Univ Leeds, Leeds Inst Mol Med, Acad Sect Musculoskeletal Dis, Leeds LS7 4SA, W Yorkshire, England.	p.emery@leeds.ac.uk	emery, paul/B-3560-2013; Ponchel, frederique/AAL-1224-2021	Ponchel, frederique/0000-0002-3969-7701				Andreakos E, 2004, IMMUNOL REV, V202, P250, DOI 10.1111/j.0105-2896.2004.00202.x; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Emery P, 2006, BRIT MED J, V332, P152, DOI 10.1136/bmj.332.7534.152; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Johnson BJ, 2005, J BIOL CHEM, V280, P4037, DOI 10.1074/jbc.M411569200; Kyburz D, 2003, ARTHRITIS RHEUM-US, V48, P642, DOI 10.1002/art.10848; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Mackie Sarah L, 2005, Curr Rheumatol Rep, V7, P400, DOI 10.1007/s11926-005-0029-4; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Seibl R, 2003, AM J PATHOL, V162, P1221, DOI 10.1016/S0002-9440(10)63918-1; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; Vanags D, 2006, LANCET, V368, P855, DOI 10.1016/S0140-6736(06)69210-6	12	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 2	2006	368	9538					821	822		10.1016/S0140-6736(06)69301-X	http://dx.doi.org/10.1016/S0140-6736(06)69301-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	082FD	16950340				2022-12-28	WOS:000240371200006
J	Feldmann, H				Feldmann, Heinz			Focus on research: Marburg hemorrhagic fever - The forgotten cousin strikes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EBOLA-VIRUS		Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB, Canada; Univ Manitoba, Winnipeg, MB, Canada	Public Health Agency of Canada; University of Manitoba	Feldmann, H (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB, Canada.							Daddario-DiCaprio KM, 2006, LANCET, V367, P1399, DOI 10.1016/S0140-6736(06)68546-2; Geisbert TW, 2003, LANCET, V362, P1953, DOI 10.1016/S0140-6736(03)15012-X; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2004, SCIENCE, V303, P628; Towner JS, 2006, J VIROL, V80, P6497, DOI 10.1128/JVI.00069-06	5	17	19	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2006	355	9					866	869		10.1056/NEJMp068160	http://dx.doi.org/10.1056/NEJMp068160			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	078OM	16943398				2022-12-28	WOS:000240113100003
J	Davison, SN; Simpson, C				Davison, Sara N.; Simpson, Christy			Hope and advance care planning in patients with end stage renal disease: qualitative interview study	BRITISH MEDICAL JOURNAL			English	Article							DIALYSIS PATIENTS; CARDIOPULMONARY-RESUSCITATION; PATIENTS PREFERENCES; DIRECTIVES; DISCONTINUATION; ATTITUDES; ONCOLOGY	Objective To understand hope in the context of advance care planning from the perspective of patients with end stage renal disease. Design Qualitative in-depth interview study. Setting Outpatient department of a university affiliated nephrology programme. Participants 19 patients with end stage renal disease purposively selected from the renal insufficiency, haemodialysis, and peritoneal dialysis clinics. Results Patients' hopes were highly individualised and were shaped by personal values. They reflected a preoccupation with their daily lives. Participants identified hope as central to the process of advance care planning in that hope helped them to determine future goals of care and provided insight into the perceived benefits of advance care planning and their willingness to engage in end of life discussions. More information earlier in the course of the illness focusing on the impact on daily life, along with empowerment of the patient and enhancing professional and personal relationships, were key factors in sustaining patients' ability to hope. is helped them to imagine possibilities for a future that were consistent with their values and hopes. The reliance on health professionals to initiate end of life discussions and the daily focus of clinical care were seen as potential barriers to hope. Conclusions Facilitated advance care planning through the provision of timely appropriate information can positively enhance rather than diminish patients' hope. Current practices concerning disclosure of prognosis are ethically and psychologically inadequate in that they do not meet the needs of patients.	Univ Alberta, Div Nephrol & Immunol, Edmonton, AB, Canada; Dalhousie Univ, Dept Bioeth, Halifax, NS, Canada	University of Alberta; Dalhousie University	Davison, SN (corresponding author), Univ Alberta, Div Nephrol & Immunol, Edmonton, AB, Canada.	sara.davison@ualberta.ca		Simpson, Christy/0000-0001-7201-5867				[Anonymous], 1999, DEATH FORETOLD PROPH; Carson V, 1990, Perspect Psychiatr Care, V26, P28; Chambers EJ, 2004, SUPPORTIVE CARE RENA, P1; CHAMBERS FJ, 2004, SUPPORTIVE CARE RENA, P1; CHRISTAKIS NA, 1999, DEATH FARETOLD PROPH; Cohen LM, 1997, PSYCHOSOMATICS, V38, P27, DOI 10.1016/S0033-3182(97)71500-7; COHEN LM, 1993, PSYCHOSOMATICS, V34, P395, DOI 10.1016/S0033-3182(93)71842-3; DAVISON S, 2002, SEMIN DIALYSIS, V15, P1; DESOUSA R, 1987, RATIONALITY EMOTION, P195; ELLIOTT TR, 1991, J PERS SOC PSYCHOL, V61, P608, DOI 10.1037/0022-3514.61.4.608; Forbes MA, 1999, ADV NURS SCI, V22, P74, DOI 10.1097/00012272-199912000-00008; GOOD MJD, 1994, SOC SCI MED, V38, P855, DOI 10.1016/0277-9536(94)90157-0; Hines S C, 2001, J Palliat Med, V4, P481, DOI 10.1089/109662101753381629; Hines SC, 1999, ANN INTERN MED, V130, P825, DOI 10.7326/0003-4819-130-10-199905180-00016; Holley JL, 1999, AM J KIDNEY DIS, V33, P688, DOI 10.1016/S0272-6386(99)70220-9; HOLLEY JL, 1993, AM J KIDNEY DIS, V22, P413, DOI 10.1016/S0272-6386(12)70144-0; JOHNSTON SC, 1995, ARCH INTERN MED, V155, P1025, DOI 10.1001/archinte.155.10.1025; KODISH E, 1995, J CLIN ONCOL, V13, P1817, DOI 10.1200/JCO.1995.13.7.1817; MIYAJI NT, 1993, SOC SCI MED, V36, P264; MORRISON RS, 1994, ARCH INTERN MED, V154, P2311, DOI 10.1001/archinte.154.20.2311; MOSS AH, 1992, J AM SOC NEPHROL, V3, P1238; Moss AH, 2001, AM J KIDNEY DIS, V38, P847, DOI 10.1053/ajkd.2001.27705; Perry E, 1996, J AM SOC NEPHROL, V7, P2160; SARDELL AN, 1993, CANCER, V72, P3355, DOI 10.1002/1097-0142(19931201)72:11<3355::AID-CNCR2820721135>3.0.CO;2-D; Simpson C, 2004, BIOETHICS, V18, P428, DOI 10.1111/j.1467-8519.2004.00408.x; Thorne S, 1997, RES NURS HEALTH, V20, P169; Thorne S., 2004, INT J QUAL METH, V3, P1, DOI [DOI 10.1177/160940690400300101, 10.1177/160940690400300101]; *US REN DAT SYST N, 2004, US REN DAT SYST USRD; WONGWYLIE G, 1997, QUAL HEALTH RES, V7, P56	29	189	193	0	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 28	2006	333	7574					886	889		10.1136/bmj.38965.626250.55	http://dx.doi.org/10.1136/bmj.38965.626250.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	101WT	16990294	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000241772600015
J	Morton, DL; Thompson, JF; Cochran, AJ; Mozzillo, N; Elashoff, R; Essner, R; Nieweg, OE; Roses, DF; Hoekstra, HJ; Karakousis, CP; Reintgen, DS; Coventry, BJ; Glass, EC; Wang, HJ				Morton, Donald L.; Thompson, John F.; Cochran, Alistair J.; Mozzillo, Nicola; Elashoff, Robert; Essner, Richard; Nieweg, Omgo E.; Roses, Daniel F.; Hoekstra, Harald J.; Karakousis, Constantine P.; Reintgen, Douglas S.; Coventry, Brendon J.; Glass, Edwin C.; Wang, He-Jing		MSLT Grp	Sentinel-node biopsy or nodal observation in melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EARLY-STAGE MELANOMA; AMERICAN JOINT COMMITTEE; IN-TRANSIT METASTASIS; LYMPH-NODE; PROGNOSTIC-FACTORS; CUTANEOUS MELANOMA; MULTICENTER TRIAL; RANDOMIZED-TRIAL; REGIONAL NODES; LYMPHADENECTOMY	Background: We evaluated the contribution of sentinel-node biopsy to outcomes in patients with newly diagnosed melanoma. Methods: Patients with a primary cutaneous melanoma were randomly assigned to wide excision and postoperative observation of regional lymph nodes with lymphadenectomy if nodal relapse occurred, or to wide excision and sentinel-node biopsy with immediate lymphadenectomy if nodal micrometastases were detected on biopsy. Results: Among 1269 patients with an intermediate-thickness primary melanoma, the mean (+/-SE) estimated 5-year disease-free survival rate for the population was 78.3+/-1.6% in the biopsy group and 73.1+/-2.1% in the observation group (hazard ratio for death, 0.74; 95% confidence interval [CI], 0.59 to 0.93; P=0.009). Five-year melanoma-specific survival rates were similar in the two groups (87.1+/-1.3% and 86.6+/-1.6%, respectively). In the biopsy group, the presence of metastases in the sentinel node was the most important prognostic factor; the 5-year survival rate was 72.3+/-4.6% among patients with tumor-positive sentinel nodes and 90.2+/-1.3% among those with tumor-negative sentinel nodes (hazard ratio for death, 2.48; 95% CI, 1.54 to 3.98; P < 0.001). The incidence of sentinel-node micrometastases was 16.0% (122 of 764 patients), and the rate of nodal relapse in the observation group was 15.6% (78 of 500 patients). The corresponding mean number of tumor-involved nodes was 1.4 in the biopsy group and 3.3 in the observation group (P < 0.001), indicating disease progression during observation. Among patients with nodal metastases, the 5-year survival rate was higher among those who underwent immediate lymphadenectomy than among those in whom lymphadenectomy was delayed (72.3+/-4.6% vs. 52.4+/-5.9%; hazard ratio for death, 0.51; 95% CI, 0.32 to 0.81; P=0.004). Conclusions: The staging of intermediate-thickness (1.2 to 3.5 mm) primary melanomas according to the results of sentinel-node biopsy provides important prognostic information and identifies patients with nodal metastases whose survival can be prolonged by immediate lymphadenectomy. (ClinicalTrials.gov number, NCT00275496.)	St Johns Hlth Ctr, John Wayne Canc Inst, Dept Surg Oncol, Santa Monica, CA 90404 USA; St Johns Hlth Ctr, John Wayne Canc Inst, Dept Biostat, Santa Monica, CA 90404 USA; Royal Prince Alfred Hosp, Sydney Melanoma Unit, Camperdown, NSW 2050, Australia; Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; Natl Canc Inst, Dept Surg Oncol, Naples, Italy; Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA USA; Netherlands Canc Inst, Dept Surg, Amsterdam, Netherlands; NYU, Sch Med, Dept Surg, New York, NY USA; Univ Med Ctr Groningen, Dept Surg Oncol, Groningen, Netherlands; Univ Groningen, Groningen, Netherlands; Millard Fillmore Hosp, Dept Surg, Buffalo, NY USA; Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, Tampa, FL 33612 USA; Royal Adelaide Hosp, Dept Surg, Adelaide, SA 5000, Australia; Vet Affairs Greater Los Angeles Healthcare Syst, Dept Nucl Med, Los Angeles, CA USA	John Wayne Cancer Institute; John Wayne Cancer Institute; Melanoma Institute Australia; University of Sydney; University of California System; University of California Los Angeles; IRCCS Fondazione Pascale; University of California System; University of California Los Angeles; Netherlands Cancer Institute; New York University; University of Groningen; University of Groningen; State University of New York (SUNY) System; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Royal Adelaide Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Morton, DL (corresponding author), St Johns Hlth Ctr, John Wayne Canc Inst, Dept Surg Oncol, 2200 Santa Monica Blvd, Santa Monica, CA 90404 USA.	mortond@jwci.org	hoekstra, harald/AAR-3263-2021; Essner, Richard/AAA-9658-2019; Nieweg, Omgo E./AAN-6887-2020; Thompson, John/F-9075-2013	Thompson, John/0000-0002-2816-2496	NCI NIH HHS [CA 29605] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA029605] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andersen BL, 2005, CANCER-AM CANCER SOC, V104, P1540, DOI 10.1002/cncr.21309; Balch CM, 2000, ANN SURG ONCOL, V7, P87, DOI 10.1007/s10434-000-0087-9; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Balch CM, 2001, J CLIN ONCOL, V19, P3635, DOI 10.1200/JCO.2001.19.16.3635; Cascinelli N, 1998, LANCET, V351, P793, DOI 10.1016/S0140-6736(97)08260-3; Chao C, 2002, AM J SURG, V184, P520, DOI 10.1016/S0002-9610(02)01102-9; Cochran AJ, 2004, MODERN PATHOL, V17, P747, DOI 10.1038/modpathol.3800117; COCHRAN AJ, 1989, AM J SURG PATHOL, V13, P600, DOI 10.1097/00000478-198907000-00008; Cochran AJ, 2001, MODERN PATHOL, V14, P604, DOI 10.1038/modpathol.3880358; Gershenwald JE, 1999, J CLIN ONCOL, V17, P976, DOI 10.1200/JCO.1999.17.3.976; Kang JC, 2005, J CLIN ONCOL, V23, P4764, DOI 10.1200/JCO.2005.20.537; Kilbridge KL, 2001, J CLIN ONCOL, V19, P812, DOI 10.1200/JCO.2001.19.3.812; MORTON D, 1990, 42 ANN M SOC SURG ON; Morton DL, 2005, ANN SURG, V242, P302, DOI 10.1097/01.sla.0000181092.50141.fa; Morton DL, 2004, BRIT J DERMATOL, V151, P308, DOI 10.1111/j.1365-2133.2004.06133.x; Morton DL, 1999, ANN SURG, V230, P453, DOI 10.1097/00000658-199910000-00001; MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392; MORTON DL, 1991, ANN SURG, V214, P491, DOI 10.1097/00000658-199110000-00013; Morton DL, 2003, ANN SURG, V238, P538, DOI 10.1097/01.sla.0000086543.45557.cb; Pawlik TM, 2005, J CLIN ONCOL, V23, P4588, DOI 10.1200/JCO.2005.12.245; REINTGEN D, 1994, ANN SURG, V220, P759, DOI 10.1097/00000658-199412000-00009; THOMPSON JF, 1995, MELANOMA RES, V5, P255, DOI 10.1097/00008390-199508000-00008; van Poll D, 2005, ANN SURG ONCOL, V12, P597, DOI 10.1245/ASO.2005.08.012; VERONESI U, 1977, NEW ENGL J MED, V297, P627, DOI 10.1056/NEJM197709222971202; WONG JH, 1991, ANN SURG, V214, P637, DOI 10.1097/00000658-199111000-00015; Zogakis TG, 2005, ARCH SURG-CHICAGO, V140, P865, DOI 10.1001/archsurg.140.9.865	26	1339	1376	1	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2006	355	13					1307	1317		10.1056/NEJMoa060992	http://dx.doi.org/10.1056/NEJMoa060992			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088EF	17005948				2022-12-28	WOS:000240793600004
J	Veneman, AM				Veneman, Ann M.			Achieving Millennium Development Goal 4	LANCET			English	Editorial Material							CHILDREN		UNICEF, New York, NY 10017 USA	UNICEF	Veneman, AM (corresponding author), UNICEF, New York, NY 10017 USA.	psalama@unicef.org						*BEST PRACT PRINC, 2005, BACKGR PAP HIGH LEV; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; BOERMA T, 2006, B WORLD HEALTH ORGAN, V84, P145; BRYCE J, 2006, LANCET          0918, DOI [10.1016/S0140-6736(06)68477-8, DOI 10.1016/S0140-6736(06)68477-8, DOI 10.1016/S0140-6736(06)69339-2]; Bryce J, 2006, LANCET, V368, P817, DOI 10.1016/S0140-6736(06)69299-4; HOEKSTRA E, 2006, LANCET          0918; LAWN JE, 2005, LANCET, V364, P9; Salama P, 2004, LANCET, V364, P1801, DOI 10.1016/S0140-6736(04)17405-9; STOLTENBERG J, 2006, LANCET          0918; UNAIDS, 2006, REP GLOB AIDS EP; *UNICEF, 2006, ACC CHILD SURV DEV P; *UNICEF, 2006, UNICEF JOINT HLTH NU; WARDLAW T, 2006, LANCET          0918, DOI DOI 10.1016/S0140-6736(06)69334-3	13	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2006	368	9541					1044	1047		10.1016/S0140-6736(06)69333-1	http://dx.doi.org/10.1016/S0140-6736(06)69333-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089IC	16997648				2022-12-28	WOS:000240873000006
J	Watanabe, Y				Watanabe, Yoshinori			A one-sided view of kinetochore attachment in meiosis	CELL			English	Editorial Material							SEGREGATION; ORIENTATION	Meiosis includes a reductional division in which homologous chromosomes, rather than sister chromatids, are segregated to opposite poles of the spindle. In this issue of Cell, Petronczki et al. (2006) report that casein kinase 1 contributes to this process by promoting the attachment of both kinetochores of a homolog to only one pole of the meiotic spindle in budding yeast.	Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan	University of Tokyo	Watanabe, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp		Watanabe, Yoshinori/0000-0002-5488-4812				Chelysheva L, 2005, J CELL SCI, V118, P4621, DOI 10.1242/jcs.02583; Hauf S, 2004, CELL, V119, P317, DOI 10.1016/j.cell.2004.10.014; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Tanaka TU, 2002, CURR OPIN CELL BIOL, V14, P365, DOI 10.1016/S0955-0674(02)00328-9; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Winey M, 2005, MOL BIOL CELL, V16, P1178, DOI 10.1091/mbc.E04-09-0765; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013; Yu HG, 2000, J CELL BIOL, V151, P131, DOI 10.1083/jcb.151.1.131	9	7	8	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 22	2006	126	6					1030	1032		10.1016/j.cell.2006.09.005	http://dx.doi.org/10.1016/j.cell.2006.09.005			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990129	Bronze			2022-12-28	WOS:000240897600010
J	Reynolds, TM; Smellie, WSA; Twomey, PJ				Reynolds, Timothy M.; Smellie, W. Stuart A.; Twomey, Patrick J.			Cases in primary care laborator medicine - Glycated haemoglobin (HbA(1c)) monitoring	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Gen Hosp, Clin Lab, Bishop Auckland DL14 6AD, England; Queens Hosp, Dept Clin Chem, Burton Upon Trent DE13 0RB, England; Ipswich Hosp, Dept Chem Pathol, Ipswich IP4 5PD, Suffolk, England	Ipswich Hospital NHS Trust; Ipswich Hospital	Smellie, WSA (corresponding author), Gen Hosp, Clin Lab, Bishop Auckland DL14 6AD, England.	info@smellie.com	Reynolds, Tim/AAW-5715-2020; Twomey, Patrick J/AAN-7614-2021	Reynolds, Tim/0000-0002-9729-4775; Twomey, Patrick J/0000-0001-7284-4673				*AM COLL END, 2002, ENDOCRINE PRACTIC S1, V8; [Anonymous], 1999, Diabet Med, V16, P716; [Anonymous], 2005, DIABETES CARE, V28, pS4; [Anonymous], REV GMS CONTR 2006 7; BEACH KW, 1979, J THEOR BIOL, V81, P547, DOI 10.1016/0022-5193(79)90052-3; Department of Health, 2002, NAT SERV FRAM DIAB S; Diabet Control Complications Trial DCCT Res Grp, 1995, AM J CARDIOL, V75, P894; GOLDSTEIN DE, 1995, DIABETES CARE, V18, P896, DOI 10.2337/diacare.18.6.896; Kilpatrick ES, 2004, J CLIN PATHOL, V57, P344, DOI 10.1136/jcp.2003.010918; *NAT I HLTH CLIN E, MAN TYP 2 DIAB MAN B; National Institute for Health and Clinical Excellence, TYP 1 DIAB DIAGN MAN; *NHS CONF, 2003, QUAL OUTC FRAM ACC G; Rohlfing CL, 2002, DIABETES CARE, V25, P275, DOI 10.2337/diacare.25.2.275; Smellie WSA, 2006, J CLIN PATHOL, V59, P781, DOI 10.1136/jcp.200X.033944; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6	15	33	37	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2006	333	7568					586	588		10.1136/bmj.38947.627847.AE	http://dx.doi.org/10.1136/bmj.38947.627847.AE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089KB	16974013	Green Published			2022-12-28	WOS:000240878200017
J	Thomas, L; Hayashi, M; Jiang, X; Moriya, R; Rettner, C; Parkin, SSP				Thomas, Luc; Hayashi, Masamitsu; Jiang, Xin; Moriya, Rai; Rettner, Charles; Parkin, Stuart S. P.			Oscillatory dependence of current-driven magnetic domain wall motion on current pulse length	NATURE			English	Article							FERROMAGNETS; NANOWIRES; STRIPS	Magnetic domain walls, in which the magnetization direction varies continuously from one direction to another, have long been objects of considerable interest(1). New concepts for devices based on such domain walls are made possible by the direct manipulation of the walls using spin-polarized electrical current(2,3) through the phenomenon of spin momentum transfer(4,5). Most experiments to date have considered the current-driven motion of domain walls under quasi-static conditions(6-12), whereas for technological applications, the walls must be moved on much shorter timescales. Here we show that the motion of domain walls under nanosecond-long current pulses is surprisingly sensitive to the pulse length. In particular, we find that the probability of dislodging a domain wall, confined to a pinning site in a permalloy nanowire, oscillates with the length of the current pulse, with a period of just a few nanoseconds. Using an analytical model(13-17) and micromagnetic simulations, we show that this behaviour is connected to a current-induced oscillatory motion of the domain wall. The period is determined by the wall's mass(18) and the slope of the confining potential. When the current is turned off during phases of the domain wall motion when it has enough momentum, the domain wall is driven out of the confining potential in the opposite direction to the flow of spin angular momentum. This dynamic amplification effect could be exploited in magnetic nanodevices based on domain wall motion.	IBM Corp, Almaden Res Ctr, San Jose, CA 95120 USA; Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA	International Business Machines (IBM); Stanford University	Thomas, L (corresponding author), IBM Corp, Almaden Res Ctr, 650 Harry Rd, San Jose, CA 95120 USA.	lucthom@us.ibm.com; parkin@almaden.ibm.com	Hayashi, Masamitsu/H-2809-2011; Hayashi, Masamitsu/N-8033-2019; Parkin, Stuart/D-2521-2012; Moriya, Rai/P-1460-2016	Hayashi, Masamitsu/0000-0003-2134-2563; Hayashi, Masamitsu/0000-0003-2134-2563; Parkin, Stuart/0000-0003-4702-6139; Moriya, Rai/0000-0001-7471-7432				[Anonymous], 1997, LLG MICROMAGNETIC SI; Barnes SE, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.107204; BERGER L, 1984, J APPL PHYS, V55, P1954, DOI 10.1063/1.333530; BERGER L, 1986, PHYS REV B, V33, P1572, DOI 10.1103/PhysRevB.33.1572; Berger L, 1996, PHYS REV B, V54, P9353, DOI 10.1103/PhysRevB.54.9353; Grollier J, 2003, APPL PHYS LETT, V83, P509, DOI 10.1063/1.1594841; Klaui M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.026601; Klaui M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.106601; Li Z, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.024417; Malozemoff A.P., 1979, MAGNETIC DOMAIN WALL; McMichael RD, 1997, IEEE T MAGN, V33, P4167, DOI 10.1109/20.619698; Nakatani Y, 2005, J MAGN MAGN MATER, V290, P750, DOI 10.1016/j.jmmm.2004.11.355; Novosad V, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.024455; O'Handley R. C., 2000, MODERN MAGNETIC MAT; Park JP, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.020403; Ravelosona D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.117203; Saitoh E, 2004, NATURE, V432, P203, DOI 10.1038/nature03009; Shibata J, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.020403; SLONCZEWSKI JC, 1996, J MAGN MAGN MATER, V159, P1; Tatara G, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.086601; Thiaville A, 2005, EUROPHYS LETT, V69, P990, DOI 10.1209/epl/i2004-10452-6; Vernier N, 2004, EUROPHYS LETT, V65, P526, DOI 10.1209/epl/i2003-10112-5; Yamanouchi M, 2004, NATURE, V428, P539, DOI 10.1038/nature02441; Zhang S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.127204	25	364	372	1	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2006	443	7108					197	200		10.1038/nature05093	http://dx.doi.org/10.1038/nature05093			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16971945				2022-12-28	WOS:000240467000043
J	Mathew, R; Haque, K; Woothipoom, W				Mathew, R.; Haque, K.; Woothipoom, W.			Lesson of the week - Acute renal failure induced by contrast medium: steps towards prevention	BRITISH MEDICAL JOURNAL			English	Article							PERCUTANEOUS CORONARY INTERVENTION; INDUCED NEPHROPATHY; NEPHROTOXICITY; METAANALYSIS; PREDICTION; TRIAL		UCL, London WC1E 6BT, England; N Middlesex Univ Hosp, London N18 1QX, England	University of London; University College London	Mathew, R (corresponding author), UCL, Mortimer St, London WC1E 6BT, England.	rgmathew@hotmail.com						Aspelin P, 2003, NEW ENGL J MED, V348, P491, DOI 10.1056/NEJMoa021833; Barrett BJ, 2006, NEW ENGL J MED, V354, P379, DOI 10.1056/NEJMcp050801; BARRETT BJ, 1993, RADIOLOGY, V188, P171, DOI 10.1148/radiology.188.1.8511292; Cox CD, 2004, J CLIN PHARMACOL, V44, P327, DOI 10.1177/0091270004263466; Freeman RV, 2002, AM J CARDIOL, V90, P1068, DOI 10.1016/S0002-9149(02)02771-6; HOU SH, 1983, AM J MED, V74, P243, DOI 10.1016/0002-9343(83)90618-6; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levy EM, 1996, JAMA-J AM MED ASSOC, V275, P1489, DOI 10.1001/jama.275.19.1489; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Merten GJ, 2004, JAMA-J AM MED ASSOC, V291, P2328, DOI 10.1001/jama.291.19.2328; Morcos SK, 2004, CLIN RADIOL, V59, P381, DOI 10.1016/j.crad.2003.11.005; *ROYAL COLL RAD, 2005, BFCR057 RCR; Thomsen HS, 2003, BRIT J RADIOL, V76, P513, DOI 10.1259/bjr/26964464; Trivedi HS, 2003, NEPHRON CLIN PRACT, V93, pC29, DOI 10.1159/000066641; Weisbord Steven D, 2005, J Intensive Care Med, V20, P63, DOI 10.1177/0885066604273503; WHITTAKER C, CONTRAST INDUCED NEP; Zagler A, 2006, AM HEART J, V151, P140, DOI 10.1016/j.ahj.2005.01.055	17	15	18	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 9	2006	333	7567					539	540		10.1136/bmj.38943.401852.80	http://dx.doi.org/10.1136/bmj.38943.401852.80			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	084LD	16960210	Green Published			2022-12-28	WOS:000240533500020
J	Sylvestre, MP; Huszti, E; Hanley, JA				Sylvestre, Marie-Pierre; Huszti, Ella; Hanley, James A.			Do Oscar winners live longer than less successful peers? A reanalysis of the evidence	ANNALS OF INTERNAL MEDICINE			English	Article							BIAS	In an article published in Annals of Internal Medicine in 2001, Redelmeier and Singh reported that Academy Award-winning actors and actresses lived almost 4 years longer than their less successful peers. However, the statistical method used to derive this statistically significant difference gave winners an unfair advantage because it credited an Oscar winner's years of life before winning toward survival subsequent to winning. When the authors of the current article reanalyzed the data using methods that avoided this "immortal time" bias, the survival advantage was closer to 1 year and was not statistically significant. The type of bias in Redelmeier and Singh's study is not limited to longevity comparisons of persons who reach different ranks within their profession; it can, and often does, occur in nonexperimental studies of life- or time-extending benefits of medical interventions. The current authors suggest ways in which researchers and readers may avoid and recognize this bias.	McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 1A2, Canada; Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University	Hanley, JA (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, 1020 Pine Ave West, Montreal, PQ H3A 1A2, Canada.	james.hanley@mcgill.ca	Sylvestre, Marie-Pierre/F-2743-2014	Sylvestre, Marie-Pierre/0000-0001-5803-4615				COLTON TC, 1974, STAT MED, P297; Farr W, 1975, VITAL STAT MEMORIAL; GAIL MH, 1972, ANN INTERN MED, V76, P815, DOI 10.7326/0003-4819-76-5-815; Glesby MJ, 1996, ANN INTERN MED, V124, P999, DOI 10.7326/0003-4819-124-11-199606010-00008; Hanley JA, 2006, INT J EPIDEMIOL, V35, P802, DOI 10.1093/ije/dyl036; HILL AB, 1984, SHORT TXB MED STAT, P278; Redelmeier DA, 2001, ANN INTERN MED, V134, P955, DOI 10.7326/0003-4819-134-10-200105150-00009; ROTHMAN KJ, 1992, AM J PUBLIC HEALTH, V82, P761, DOI 10.2105/AJPH.82.5.761; Suissa S, 2003, AM J RESP CRIT CARE, V168, P49, DOI 10.1164/rccm.200210-1231OC; Walker AM, 1991, OBSERVATION INFERENC	10	109	110	1	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 5	2006	145	5					361	363		10.7326/0003-4819-145-5-200609050-00009	http://dx.doi.org/10.7326/0003-4819-145-5-200609050-00009			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080NZ	16954361				2022-12-28	WOS:000240255900006
J	Coker, R; Mounier-Jack, S				Coker, Richard; Mounier-Jack, Sandra			Pandemic influenza preparedness in the Asia-Pacific region	LANCET			English	Article								Concerns are mounting that the threat of another influenza pandemic will become a reality and that the epicentre of the outbreak could be the Asia-Pacific region. We assessed the documents that some Asia-Pacific countries have published as part of preparedness planning for an outbreak of influenza in people. Regional approaches were polarised. Thailand, China, and Vietnam had set out a strategic vision to strengthen future capacity in preparedness planning. By contrast, Hong Kong, Australia, and New Zealand took a strategic approach aimed mainly at harnessing available resources or preparing for the deployment of resources such as stockpiled antiviral agents and vaccines. The plans of Hong Kong, Australia, and New Zealand compared favourably with the best European plans. The plans of resource-poor countries addressed some issues that were largely neglected by most European plans. Other countries (including those that do not yet have plans) could benefit from analysis of the strengths and weaknesses of the plans drawn up by countries in the region and in Europe.	Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Coker, R (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England.	richard.coker@lshtm.ac.uk						Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Mounier-Jack S, 2006, LANCET, V367, P1405, DOI 10.1016/S0140-6736(06)68511-5	2	80	80	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 2	2006	368	9538					886	889		10.1016/S0140-6736(06)69209-X	http://dx.doi.org/10.1016/S0140-6736(06)69209-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	082FD	16950366	Green Published, Bronze			2022-12-28	WOS:000240371200036
J	Gould, IM				Gould, Ian M.			Community-acquired MRSA: can we control it?	LANCET			English	Editorial Material							RESISTANT STAPHYLOCOCCUS-AUREUS; INFECTIONS; EMERGENCE; COLONIZATION; PNEUMONIA; BARS; SKIN		Aberdeen Royal Infirm, Dept Med Microbiol, Aberdeen AB25 2ZN, Scotland	University of Aberdeen	Gould, IM (corresponding author), Aberdeen Royal Infirm, Dept Med Microbiol, Aberdeen AB25 2ZN, Scotland.	i.m.gould@abdn.ac.uk						Barrett SP, 1998, J HOSP INFECT, V39, P85, DOI 10.1016/S0195-6701(98)90322-X; Bootsma MCJ, 2006, P NATL ACAD SCI USA, V103, P5620, DOI 10.1073/pnas.0510077103; Chickering HT, 1919, J AMER MED ASSOC, V72, P617, DOI 10.1001/jama.1919.02610090001001; Coia JE, 2006, J HOSP INFECT, V63, P354, DOI 10.1016/j.jhin.2006.03.004; COIA JE, 2006, J HOSP INFECT S1, V63, P44; Cooper BS, 2004, P NATL ACAD SCI USA, V101, P10223, DOI 10.1073/pnas.0401324101; Dancer SJ, 2006, J HOSP INFECT, V62, P261, DOI 10.1016/j.jhin.2005.09.018; Diederen BMW, 2006, J INFECTION, V52, P157, DOI 10.1016/j.jinf.2005.09.001; Graham PL, 2006, ANN INTERN MED, V144, P318, DOI 10.7326/0003-4819-144-5-200603070-00006; Hunt C, 1999, JAMA-J AM MED ASSOC, V282, P1123; Jensen JUS, 2006, J HOSP INFECT, V63, P84, DOI 10.1016/j.jhin.2005.10.016; King MD, 2006, ANN INTERN MED, V144, P309, DOI 10.7326/0003-4819-144-5-200603070-00005; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Moellering RC, 2006, ANN INTERN MED, V144, P368, DOI 10.7326/0003-4819-144-5-200603070-00014; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; Que TL, 2003, EUR J CLIN MICROBIOL, V22, P268, DOI 10.1007/s10096-002-0880-4; ROUNDTREE P. M., 1958, MED JOUR AUSTRALIA II, V45, P789; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978	19	25	25	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 2	2006	368	9538					824	826		10.1016/S0140-6736(06)69303-3	http://dx.doi.org/10.1016/S0140-6736(06)69303-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	082FD	16950342				2022-12-28	WOS:000240371200008
J	Prem, AR				Prem, A. R.			ABC of urology - Common paediatric problems	BRITISH MEDICAL JOURNAL			English	Editorial Material									Armed Forces Hosp, Dept Urol, Al Khoud, Oman		Prem, AR (corresponding author), Armed Forces Hosp, Dept Urol, Al Khoud, Oman.							Austin JC, 2004, UROL CLIN N AM, V31, P543, DOI 10.1016/j.ucl.2004.04.018; ELDER JS, 2002, CAMPBELLS UROLOGY, P2334; Kolon TF, 2004, UROL CLIN N AM, V31, P469, DOI 10.1016/j.ucl.2004.04.009; Rickwood AMK, 1999, BJU INT, V83, P45, DOI 10.1046/j.1464-410x.1999.0830s1045.x	4	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 2	2006	333	7566					486	489		10.1136/bmj.333.7566.486	http://dx.doi.org/10.1136/bmj.333.7566.486			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085QP	16946339	Green Published			2022-12-28	WOS:000240618900024
J	Seeger, MA; Schiefner, A; Eicher, T; Verrey, F; Diederichs, K; Pos, KM				Seeger, Markus A.; Schiefner, Andre; Eicher, Thomas; Verrey, Francois; Diederichs, Kay; Pos, Klaas M.			Structural asymmetry of AcrB trimer suggests a peristaltic pump mechanism	SCIENCE			English	Article							MULTIDRUG EFFLUX SYSTEM; ATOMIC-RESOLUTION STRUCTURES; ORGANIC-SOLVENT TOLERANCE; MEDIATED DRUG-RESISTANCE; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; TRANSPORTER ACRB; REENTRANT LOOP; BACTERIORHODOPSIN	The AcrA/AcrB/TolC complex spans the inner and outer membranes of Escherichia coli and serves as its major drug-resistance pump. Driven by the proton motive force, it mediates the efflux of bile salts, detergents, organic solvents, and many structurally unrelated antibiotics. Here, we report a crystallographic structure of trimeric AcrB determined at 2.9 and 3.0 angstrom resolution in space groups that allow asymmetry of the monomers. This structure reveals three different monomer conformations representing consecutive states in a transport cycle. The structural data imply an alternating access mechanism and a novel peristaltic mode of drug transport by this type of transporter.	Univ Zurich, Inst Physiol, Zurich, Switzerland; Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; Univ Konstanz, Dept Biol, D-78457 Constance, Germany; Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Konstanz; Swiss Federal Institutes of Technology Domain; ETH Zurich	Pos, KM (corresponding author), Univ Zurich, Inst Physiol, Winterthurerstr 190, Zurich, Switzerland.	kmpos@access.unizh.ch		Verrey, Francois/0000-0003-3250-9824; Schiefner, Andre/0000-0001-5215-4122; Seeger, Markus/0000-0003-1761-8571				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Ambudkar SV, 2006, EUR J PHARM SCI, V27, P392, DOI 10.1016/j.ejps.2005.10.010; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Edmonds BW, 2004, FRONT BIOSCI-LANDMRK, V9, P1556, DOI 10.2741/1264; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; Guan L, 2001, J BACTERIOL, V183, P1734, DOI 10.1128/JB.183.5.1734-1739.2001; Gutman N, 2003, J BIOL CHEM, V278, P16082, DOI 10.1074/jbc.M213120200; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Lanyi JK, 2004, MOL MEMBR BIOL, V21, P143, DOI 10.1080/09687680410001666345; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Li XZ, 1998, J BACTERIOL, V180, P2987, DOI 10.1128/JB.180.11.2987-2991.1998; Luecke H, 2000, BBA-BIOENERGETICS, V1460, P133, DOI 10.1016/S0005-2728(00)00135-3; Markham PN, 2001, CURR OPIN MICROBIOL, V4, P509, DOI 10.1016/S1369-5274(00)00243-5; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Mirza O, 2006, EMBO J, V25, P1177, DOI 10.1038/sj.emboj.7601028; Murakami S, 2004, J BIOL CHEM, V279, P3743, DOI 10.1074/jbc.M308893200; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Nehme D, 2005, ANTIMICROB AGENTS CH, V49, P4375, DOI 10.1128/AAC.49.10.4375-4378.2005; Neutze R, 2002, BBA-BIOMEMBRANES, V1565, P144, DOI 10.1016/S0005-2736(02)00566-7; Poole K, 2004, CLIN MICROBIOL INFEC, V10, P12, DOI 10.1111/j.1469-0691.2004.00763.x; Pos KM, 2004, FEBS LETT, V564, P333, DOI 10.1016/S0014-5793(04)00272-8; Pos KM, 2002, ACTA CRYSTALLOGR D, V58, P1865, DOI 10.1107/S0907444902013963; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; Sobczak M, 2005, CURR OPIN MICROBIOL, V8, P161, DOI 10.1016/j.mib.2005.02.005; Tamura N, 2005, BIOCHEMISTRY-US, V44, P11115, DOI 10.1021/bi050452u; Touze T, 2004, MOL MICROBIOL, V53, P697, DOI 10.1111/j.1365-2958.2004.04158.x; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; White DG, 1997, J BACTERIOL, V179, P6122, DOI 10.1128/jb.179.19.6122-6126.1997; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	34	415	433	4	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2006	313	5791					1295	1298		10.1126/science.1131542	http://dx.doi.org/10.1126/science.1131542			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16946072	Green Submitted			2022-12-28	WOS:000240313500043
J	Abbatt, JPD; Benz, S; Cziczo, DJ; Kanji, Z; Lohmann, U; Mohler, O				Abbatt, J. P. D.; Benz, S.; Cziczo, D. J.; Kanji, Z.; Lohmann, U.; Moehler, O.			Solid ammonium sulfate aerosols as ice nuclei: A pathway for cirrus cloud formation	SCIENCE			English	Article							SULFURIC-ACID; RELATIVE-HUMIDITY; AQUEOUS PARTICLES; PHYSICAL STATE; CHAMBER AIDA; NUCLEATION; MODEL; TEMPERATURE; MECHANISMS; NITRATE	Laboratory measurements support a cirrus cloud formation pathway involving heterogeneous ice nucleation by solid ammonium sulfate aerosols. Ice formation occurs at low ice-saturation ratios consistent with the formation of continental cirrus and an interhemispheric asymmetry observed for cloud onset. In a climate model, this mechanism provides a widespread source of ice nuclei and leads to fewer but larger ice crystals as compared with a homogeneous freezing scenario. This reduces both the cloud albedo and the longwave heating by cirrus. With the global ammonia budget dominated by agricultural practices, this pathway might further couple anthropogenic activity to the climate system.	Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; Forschungszentrum Karlsruhe, Inst Meteorol & Climate Res, D-76021 Karlsruhe, Germany; ETH, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland	University of Toronto; Helmholtz Association; Karlsruhe Institute of Technology; Swiss Federal Institutes of Technology Domain; ETH Zurich	Abbatt, JPD (corresponding author), Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada.	jabbatt@chem.utoronto.ca	Kanji, Zamin/F-6465-2019; Möhler, Ottmar/J-9426-2012; Kanji, Zamin/K-7390-2012; Kanji, Zamin A./N-8412-2019; Lohmann, Ulrike/B-6153-2009	Kanji, Zamin/0000-0001-8610-3921; Möhler, Ottmar/0000-0002-7551-9814; Kanji, Zamin A./0000-0001-8610-3921; Lohmann, Ulrike/0000-0001-8885-3785; Abbatt, Jonathan/0000-0002-3372-334X				Adams PJ, 1999, J GEOPHYS RES-ATMOS, V104, P13791, DOI 10.1029/1999JD900083; Bertram AK, 1996, J PHYS CHEM-US, V100, P2376, DOI 10.1021/jp952551v; Bertram AK, 2000, J PHYS CHEM A, V104, P584, DOI 10.1021/jp9931197; Chelf JH, 2001, J GEOPHYS RES-ATMOS, V106, P1215, DOI 10.1029/2000JD900477; Chen YL, 2000, J ATMOS SCI, V57, P3752, DOI 10.1175/1520-0469(2000)057<3752:IFBSAS>2.0.CO;2; Colberg CA, 2003, ATMOS CHEM PHYS, V3, P909, DOI 10.5194/acp-3-909-2003; Cziczo DJ, 1999, J GEOPHYS RES-ATMOS, V104, P13781, DOI 10.1029/1999JD900112; Cziczo DJ, 2001, GEOPHYS RES LETT, V28, P963, DOI 10.1029/2000GL012568; DeMott P. J., 2002, CIRRUS, P102; DeMott PJ, 2003, P NATL ACAD SCI USA, V100, P14655, DOI 10.1073/pnas.2532677100; DENTENER FJ, 1994, J ATMOS CHEM, V19, P331, DOI 10.1007/BF00694492; Dibb JE, 2000, J GEOPHYS RES-ATMOS, V105, P3709, DOI 10.1029/1999JD900424; Dibb JE, 1996, J GEOPHYS RES-ATMOS, V101, P1779, DOI 10.1029/94JD03117; Haag W, 2003, ATMOS CHEM PHYS, V3, P1791, DOI 10.5194/acp-3-1791-2003; Heymsfield AJ, 1995, J ATMOS SCI, V52, P4302, DOI 10.1175/1520-0469(1995)052<4302:RHATIO>2.0.CO;2; Huebert BJ, 1998, J GEOPHYS RES-ATMOS, V103, P16493, DOI 10.1029/98JD00770; Hung HM, 2002, J PHYS CHEM A, V106, P293, DOI 10.1021/jp012064h; Kanji ZA, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006766; Karcher B, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006219; Koop T, 2000, NATURE, V406, P611, DOI 10.1038/35020537; Koop T, 1998, J PHYS CHEM A, V102, P8924, DOI 10.1021/jp9828078; Lohmann U, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004443; Mangold A, 2005, METEOROL Z, V14, P485, DOI 10.1127/0941-2948/2005/0053; Martin ST, 2004, ATMOS CHEM PHYS, V4, P183, DOI 10.5194/acp-4-183-2004; Mohler O, 2003, ATMOS CHEM PHYS, V3, P211; Prenni AJ, 2001, J GEOPHYS RES-ATMOS, V106, P3037, DOI 10.1029/2000JD900454; PRUPPACHER HR, 1984, MICROPHYSICS CLOUDS; Shilling JE, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006664; Strom J, 2003, ATMOS CHEM PHYS, V3, P1807, DOI 10.5194/acp-3-1807-2003; Tabazadeh A, 1998, GEOPHYS RES LETT, V25, P1379, DOI 10.1029/97GL03585; Talbot RW, 1998, GEOPHYS RES LETT, V25, P1367, DOI 10.1029/98GL00184; Wise ME, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004313; Zobrist B, 2006, ATMOS CHEM PHYS, V6, P3115, DOI 10.5194/acp-6-3115-2006; Zuberi B, 2001, J PHYS CHEM A, V105, P6458, DOI 10.1021/jp010094e	34	182	184	5	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2006	313	5794					1770	1773		10.1126/science.1129726	http://dx.doi.org/10.1126/science.1129726			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16946035				2022-12-28	WOS:000240655700044
J	Chatterjee, R				Chatterjee, Rhitu			2006 Visualization challenge winners	SCIENCE			English	Editorial Material																			0	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2006	313	5794					1730	1735		10.1126/science.313.5794.1730	http://dx.doi.org/10.1126/science.313.5794.1730			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990531				2022-12-28	WOS:000240655700015
J	Pike-Overzet, K; de Ridder, D; Weerkamp, F; Baert, MRM; Verstegen, MM; Brugman, MH; Howe, SJ; Reinders, MJT; Thrasher, AJ; Wagemaker, G; van Dongen, JJM; Staal, FJT				Pike-Overzet, Karin; de Ridder, Dick; Weerkamp, Floor; Baert, Miranda R. M.; Verstegen, Monique M.; Brugman, Martijn H.; Howe, Steven J.; Reinders, Marcel J. T.; Thrasher, Adrian J.; Wagemaker, Gerard; van Dongen, Jacques J. M.; Staal, Frank J. T.			Gene therapy - Is IL2RG oncogenic in T-cell development?	NATURE			English	Letter									Erasmus Univ, Med Ctr, Dept Immunol, NL-3015 GE Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Hematol, NL-3015 GE Rotterdam, Netherlands; Delft Univ Technol, Fac Elect Engn, Informat & Commun Theory Grp, NL-2628 CD Delft, Netherlands; UCL, Inst Child Hlth, Mol Immunol Unit, London WC1N 1EH, England	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Delft University of Technology; University of London; University College London	Pike-Overzet, K (corresponding author), Erasmus Univ, Med Ctr, Dept Immunol, NL-3015 GE Rotterdam, Netherlands.	f.staal@erasmusmc.nl	van Dongen, Jacques J.M./F-8537-2015; de Ridder, Dick/F-3169-2010; Howe, Steven J/C-4801-2008; Brugman, Martijn/F-3389-2011; Pike-Overzet, Karin/AAT-3716-2021	van Dongen, Jacques J.M./0000-0001-7686-0021; de Ridder, Dick/0000-0002-4944-4310; Howe, Steven J/0000-0003-2940-2874; Brugman, Martijn/0000-0003-2675-2705; Pike-Overzet, Karin/0000-0002-8827-246X; Thrasher, Adrian/0000-0002-6097-6115; Verstegen, Monique/0000-0001-9908-6673; van Dongen, Jacques J.M./0000-0002-3650-7087				Dik WA, 2005, J EXP MED, V201, P1715, DOI 10.1084/jem.20042524; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Marshall E, 2003, SCIENCE, V299, P320, DOI 10.1126/science.299.5605.320; Weerkamp F, 2006, TRENDS IMMUNOL, V27, P125, DOI 10.1016/j.it.2006.01.006; Woods NB, 2006, NATURE, V440, P1123, DOI 10.1038/4401123a	5	49	50	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2006	443	7109					E5	E5		10.1038/nature05218	http://dx.doi.org/10.1038/nature05218			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085RL	16988660				2022-12-28	WOS:000240622000033
J	Champion, PAD; Stanley, SA; Champion, MM; Brown, EJ; Cox, JS				Champion, Patricia A. DiGiuseppe; Stanley, Sarah A.; Champion, Matthew M.; Brown, Eric J.; Cox, Jeffery S.			C-terminal signal sequence promotes virulence factor secretion in Mycobacterium tuberculosis	SCIENCE			English	Article							PROTEIN SECRETION; BOVIS BCG; ESAT-6; COMPLEX; PATHOGENESIS; MEMBRANES; ANTIGENS; SYSTEM; CFP-10	Mycobacterium tuberculosis uses the ESX-1/Snm system [ early secreted antigen 6 kilodaltons (ESAT-6) system 1/secretion in mycobacteria] to deliver virulence factors into host macrophages during infection. Despite its essential role in virulence, the mechanism of ESX-1 secretion is unclear. We found that the unstructured C terminus of the CFP-10 substrate was recognized by Rv3871, a cytosolic component of the ESX-1 system that itself interacts with the membrane protein Rv3870. Point mutations in the signal that abolished binding of CFP-10 to Rv3871 prevented secretion of the CFP-10 ( culture filtrate protein, 10 kilodaltons)/ESAT-6 virulence factor complex. Attachment of the signal to yeast ubiquitin was sufficient for secretion from M. tuberculosis cells, demonstrating that this ESX-1 signal is portable.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Microbial Pathogenesis & Host Def, San Francisco, CA 94143 USA; Appl Biosyst Inc, Foster City, CA 94404 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Thermo Fisher Scientific; Applied Biosystems	Cox, JS (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, 600 16th St,Campus Box 2200, San Francisco, CA 94143 USA.	Jeffery.Cox@ucsf.edu	Champion, Patricia A/AAD-8244-2019	Champion, Matthew M./0000-0001-5927-5277; Champion, Patricia/0000-0002-6733-596X	NIAID NIH HHS [AI51667, AI63302] Funding Source: Medline; PHS HHS [A105155] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI063302] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Brodin P, 2004, TRENDS MICROBIOL, V12, P500, DOI 10.1016/j.tim.2004.09.007; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Converse SE, 2005, J BACTERIOL, V187, P1238, DOI 10.1128/JB.187.4.1238-1245.2005; Emr S D, 1982, Prog Clin Biol Res, V91, P3; Flanagan JJ, 2003, J BIOL CHEM, V278, P18628, DOI 10.1074/jbc.M300173200; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Martz E, 2002, TRENDS BIOCHEM SCI, V27, P107, DOI 10.1016/S0968-0004(01)02008-4; Mattow J, 2003, ELECTROPHORESIS, V24, P3405, DOI 10.1002/elps.200305601; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; Ramamurthi KS, 2002, ANNU REV CELL DEV BI, V18, P107, DOI 10.1146/annurev.cellbio.18.012502.105912; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Rosenkrands I, 2000, ELECTROPHORESIS, V21, P935, DOI 10.1002/(SICI)1522-2683(20000301)21:5<935::AID-ELPS935>3.3.CO;2-G; Skjot RLV, 2002, INFECT IMMUN, V70, P5446, DOI 10.1128/IAI.70.10.5446-5453.2002; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Zieske LR, 2006, J EXP BOT, V57, P1501, DOI 10.1093/jxb/erj168	25	156	180	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2006	313	5793					1632	1636		10.1126/science.1131167	http://dx.doi.org/10.1126/science.1131167			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973880				2022-12-28	WOS:000240498900044
J	Lundegaard, LF; Weck, G; McMahon, MI; Desgreniers, S; Loubeyre, P				Lundegaard, Lars F.; Weck, Gunnar; McMahon, Malcolm I.; Desgreniers, Serge; Loubeyre, Paul			Observation of an O-8 molecular lattice in the epsilon phase of solid oxygen	NATURE			English	Article							HIGH-PRESSURE; GPA; METALLIZATION; SPECTROSCOPY	Of the simple diatomic molecules, oxygen is the only one to carry a magnetic moment. This makes solid oxygen particularly interesting: it is considered a 'spin-controlled' crystal(1) that displays unusual magnetic order(2). At very high pressures, solid oxygen changes from an insulating to a metallic state(3); at very low temperatures, it even transforms to a superconducting state(4). Structural investigations of solid oxygen began in the 1920s and at present, six distinct crystallographic phases are established unambiguously(1). Of these, the 1 phase of solid oxygen is particularly intriguing: it exhibits a dark-red colour, very strong infrared absorption, and a magnetic collapse(1). It is also stable over a very large pressure domain and has been the subject of numerous X-ray diffraction(5-7), spectroscopic(8-11) and theoretical studies(12-14). But although epsilon-oxygen has been shown to have a monoclinic C2/m symmetry(5-7,15) and its infrared absorption behaviour attributed to the association of oxygen molecules into larger units(9,14), its exact structure remains unknown. Here we use single-crystal X-ray diffraction data collected between 13 and 18 GPa to determine the structure of epsilon-oxygen. We find that epsilon-oxygen is characterized by the association of four O-2 molecules into a rhombohedral molecular unit, held together by what are probably weak chemical bonds. This structure is consistent with existing spectroscopic data, and further validated by the observation of a newly predicted Raman stretching mode.	Univ Edinburgh, SUPA, Sch Phys, Edinburgh EH9 3JZ, Midlothian, Scotland; Univ Edinburgh, Ctr Sci Extreme Condit, Edinburgh EH9 3JZ, Midlothian, Scotland; CEA, Dept Phys Theor & Appl, F-91680 Bruyeres Le Chatel, France; Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada	University of Edinburgh; University of Edinburgh; CEA; University of Ottawa	McMahon, MI (corresponding author), Univ Edinburgh, SUPA, Sch Phys, Edinburgh EH9 3JZ, Midlothian, Scotland.	mim@ph.ed.ac.uk; paul.loubeyre@cea.fr	McMahon, Malcolm I/D-9765-2012	McMahon, Malcolm I/0000-0003-4343-344X; Desgreniers, Serge/0000-0001-7353-6867; Lundegaard, Lars Fahl/0000-0003-1271-3182	Engineering and Physical Sciences Research Council [GR/S28396/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		AGNEW SF, 1987, J CHEM PHYS, V86, P5239, DOI 10.1063/1.452547; AKAHAMA Y, 1995, PHYS REV LETT, V74, P4690, DOI 10.1103/PhysRevLett.74.4690; Akahama Y, 1996, PHYS REV B, V54, P15602, DOI 10.1103/PhysRevB.54.R15602; Akahama Y, 2000, PHYS REV B, V61, P8801, DOI 10.1103/PhysRevB.61.8801; ALTOMARE A, 1993, J APPL CRYSTALLOGR, V26, P343, DOI 10.1107/S0021889892010331; Aquilanti V, 1999, PHYS REV LETT, V82, P69, DOI 10.1103/PhysRevLett.82.69; *BRUK AN XRAY SYST, 1995, SMART SAINT ASTRO XP; DESGRENIERS S, 1990, J PHYS CHEM-US, V94, P1117, DOI 10.1021/j100366a020; DESGRENIERS S, 1996, HIGH PRESSURE SCI TE, P363; Freiman YA, 2004, PHYS REP, V401, P1, DOI 10.1016/j.physrep.2004.06.002; Gebauer R, 2000, PHYS REV B, V61, P6145, DOI 10.1103/PhysRevB.61.6145; Goncharenko IN, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.205701; Goncharenko IN, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.055502; Gorelli FA, 1999, PHYS REV LETT, V83, P4093, DOI 10.1103/PhysRevLett.83.4093; HANFLAND M, 1993, PHYS REV LETT, V70, P3760, DOI 10.1103/PhysRevLett.70.3760; JOHNSON SW, 1993, J APPL CRYSTALLOGR, V26, P320, DOI 10.1107/S0021889892008422; KIM KS, 1990, J CHEM PHYS, V92, P1887, DOI 10.1063/1.458070; LONG CA, 1973, J CHEM PHYS, V58, P4824, DOI 10.1063/1.1679066; McMahon MI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.255502; Neaton JB, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.205503; NICOL M, 1979, CHEM PHYS LETT, V68, P49, DOI 10.1016/0009-2614(79)80066-4; PAULING L, 1964, NATURE CHEM BOND; SCHIFERL D, 1981, ACTA CRYSTALLOGR B, V37, P1329, DOI 10.1107/S0567740881005852; SCHIFERL D, 1983, ACTA CRYSTALLOGR B, V39, P153, DOI 10.1107/S0108768183002219; Serra S, 1998, PHYS REV LETT, V80, P5160, DOI 10.1103/PhysRevLett.80.5160; Sheldrick G.M., 1997, SHELXL97 PROGRAMS CR; Shimizu K, 1998, NATURE, V393, P767, DOI 10.1038/31656; Sihachakr D, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.134105; *WAV INC, 1998, SPARTAN VERS 5 1; Weck G, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevB.88.035504	30	135	137	6	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2006	443	7108					201	204		10.1038/nature05174	http://dx.doi.org/10.1038/nature05174			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16971946				2022-12-28	WOS:000240467000044
J	Massberg, S; von Andrian, UH				Massberg, Steffen; von Andrian, Ulrich H.			Fingolimod and sphingosine-1-phosphate - Modifers of lymphocyte migration	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									CBR, Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School			von Andrian, Ulrich H/A-5775-2008; Massberg, Steffen/AAN-6054-2021					Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650	2	107	118	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 14	2006	355	11					1088	1091		10.1056/NEJMp068159	http://dx.doi.org/10.1056/NEJMp068159			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083NJ	16971715				2022-12-28	WOS:000240462800003
J	Covas, MI; Nyyssonen, K; Poulsen, HE; Kaikkonen, J; Zunft, HJF; Kiesewetter, H; Gaddi, A; de la Torre, R; Mursu, J; Baumler, H; Nascetti, S; Salonen, JT; Fito, M; Virtanen, J; Marrugat, J				Covas, Maria-Isabel; Nyyssonen, Kristiina; Poulsen, Henrik E.; Kaikkonen, Jari; Zunft, Hans-Joachim F.; Kiesewetter, Holger; Gaddi, Antonio; de la Torre, Rafael; Mursu, Jaakko; Baumler, Hans; Nascetti, Simona; Salonen, Jukka T.; Fito, Montserrat; Virtanen, Jyrki; Marrugat, Jaume		EUROLIVE Study Grp	The effect of polyphenols in olive oil on heart disease risk factors - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							LOW-DENSITY-LIPOPROTEIN; OXIDATIVE STRESS; PHENOLIC-COMPOUNDS; LDL OXIDATION; LOW-FAT; BETA-CAROTENE; CHOLESTEROL; ENZYMES; HEALTHY; SERUM	Background: Virgin olive oils are richer in phenolic content than refined olive oil. Small, randomized, crossover, controlled trials on the antioxidant effect of phenolic compounds from real-life daily doses of olive oil in humans have yielded conflicting results. Little information is available on the effect of the phenolic compounds of olive oil on plasma lipid levels. No international study with a large sample size has been done. Objective: To evaluate whether the phenolic content of olive oil further benefits plasma lipid levels and lipid oxidative damage compared with monounsaturated acid content. Design: Randomized, crossover, controlled trial. Setting: 6 research centers from 5 European countries. Participants: 200 healthy male volunteers. Measurements: Glucose levels, plasma lipid levels, oxidative damage to lipid levels, and endogenous and exogenous antioxidants at baseline and before and after each intervention. Intervention: In a crossover study, participants were randomly assigned to 3 sequences of daily administration of 25 mL of 3 olive oils. Olive oils had low (2.7 mg/kg of olive oil), medium (164 mg/kg), or high (366 mg/kg) phenolic content but were otherwise similar. Intervention periods were 3 weeks preceded by 2-week washout periods. Results: A linear increase in high-density lipoprotein (HDL) cholesterol levels was observed for low-, medium-, and high-polyphenol olive oil: mean change, 0.025 mmol/L (95% CI, 0.003 to 0.05 mmol/L), 0.032 mmol/L (CI, 0.005 to 0.05 mmol/L), and 0.045 mmol/L (CI, 0.02 to 0.06 mmol/L), respectively. Total cholesterol-HDL cholesterol ratio decreased linearly with the phenolic content of the olive oil. Triglyceride levels decreased by an average of 0.05 mmol/L for all olive oils. Oxidative stress markers decreased linearly with increasing phenolic content. Mean changes for oxidized low-density lipoprotein levels were 1.21 U/L (CI, -0.8 to 3.6 U/L), -1.48 U/L (-3.6 to 0.6 U/L), and -3.21 U/L (-5.1 to -0.8 U/L) for the low-, medium-, and high-polyphenol olive oil, respectively. Limitations: The olive oil may have interacted with other dietary components, participants' dietary intake was self-reported, and the intervention periods were short. Conclusions: Olive oil is more than a monounsaturated fat. Its phenolic content can also provide benefits for plasma lipid levels and oxidative damage.	Municipal Inst Med Res, IMIM, Lipids & Cardiovasc Epidemiol Unit, Barcelona 08003, Spain; Univ Kuopio, FIN-70211 Kuopio, Finland; Oy Jurilab, Kuopio, Finland; Univ Copenhagen Hosp, Rigshosp, Copenhagen, Denmark; German Inst Human Nutrit, Postdam Rehbruecke, Germany; Univ Med Berlin, Charite, Berlin, Germany; St Orsola Marcello Malpighi Hosp, Ctr Studio Arteriosclerosi & Malattie Dismetabol, Bologna, Italy	Institut Hospital del Mar d'Investigacions Mediques (IMIM); University of Eastern Finland; Rigshospitalet; University of Copenhagen; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; IRCCS Azienda Ospedaliero-Universitaria di Bologna	Covas, MI (corresponding author), Municipal Inst Med Res, IMIM, Lipids & Cardiovasc Epidemiol Unit, Carrer Dr Aiguader 80, Barcelona 08003, Spain.	mcovas@imim.es	de la Torre, Rafael/D-3561-2018; , Bäumler/N-1902-2019; Virtanen, Jyrki/G-5149-2013; Fito, Montserrat/C-1822-2012; Nascetti, Simona/GPF-8232-2022; Virtanen, Jyrki/AAC-8945-2020	de la Torre, Rafael/0000-0002-6765-1866; , Bäumler/0000-0002-2573-2289; Virtanen, Jyrki/0000-0002-0648-999X; Fito, Montserrat/0000-0002-1817-483X; Virtanen, Jyrki/0000-0002-0648-999X; Marrugat, Jaume/0000-0003-3320-554X; Poulsen, Henrik Enghusen/0000-0003-4242-9924				Badeau M, 2005, J STEROID BIOCHEM, V96, P271, DOI 10.1016/j.jsbmb.2005.04.034; Biswas SK, 2005, BIOCHEM BIOPH RES CO, V338, P1368, DOI 10.1016/j.bbrc.2005.10.098; BRINTON EA, 1990, J CLIN INVEST, V85, P144, DOI 10.1172/JCI114405; BUCOLO G, 1973, CLIN CHEM, V19, P476; Connor WE, 1997, NEW ENGL J MED, V337, P562; Connor WE, 1997, NEW ENGL J MED, V337, P566; Covas MI, 2006, FREE RADICAL BIO MED, V40, P608, DOI 10.1016/j.freeradbiomed.2005.09.027; Covas MI, 2000, INT J CLIN PHARM RES, V20, P49; Devaraj S, 2002, LIPIDS, V37, P931, DOI 10.1007/s11745-006-0982-3; FIELDING CJ, 1995, J CLIN INVEST, V95, P611, DOI 10.1172/JCI117705; FORTES C, 2005, BRIT MED J, V331, pE366, DOI DOI 10.1136/BMJ.331.7508.E366; FULLER CJ, 1994, AM J CLIN NUTR, V60, p1010S, DOI 10.1093/ajcn/60.6.1010S; Gardner CD, 2005, ANN INTERN MED, V142, P725, DOI 10.7326/0003-4819-142-9-200505030-00007; Gimeno E, 2002, FOOD CHEM, V78, P207, DOI 10.1016/S0308-8146(01)00399-5; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; HERTOG MGL, 1995, ARCH INTERN MED, V155, P381, DOI 10.1001/archinte.155.4.381; Mangas-Cruz MA, 2001, CLIN NUTR, V20, P211, DOI 10.1054/clnu.2000.0382; Marrugat J, 2004, EUR J NUTR, V43, P140, DOI 10.1007/s00394-004-0452-8; McGill CR, 2003, J NUTR BIOCHEM, V14, P656, DOI 10.1016/j.jnutbio.2003.08.003; Meilhac O, 2001, ARTERIOSCL THROM VAS, V21, P1681, DOI 10.1161/hq1001.097106; Meisinger C, 2005, CIRCULATION, V112, P651, DOI 10.1161/CIRCULATIONAHA.104.529297; Mursu J, 2004, FREE RADICAL BIO MED, V37, P1351, DOI 10.1016/j.freeradbiomed.2004.06.002; Navab M, 1996, ARTERIOSCL THROM VAS, V16, P831, DOI 10.1161/01.ATV.16.7.831; Nielsen SE, 1999, BRIT J NUTR, V81, P447, DOI 10.1017/S000711459900080X; Owen RW, 2000, FOOD CHEM TOXICOL, V38, P647, DOI 10.1016/S0278-6915(00)00061-2; PARTHASARATHY S, 1990, P NATL ACAD SCI USA, V87, P3894, DOI 10.1073/pnas.87.10.3894; Perez-Jimenez F, 2005, EUR J CLIN INVEST, V35, P421, DOI 10.1111/j.1365-2362.2005.01516.x; PETERSON JI, 1968, ANAL BIOCHEM, V23, P301, DOI 10.1016/0003-2697(68)90361-8; Psaltopoulou T, 2004, AM J CLIN NUTR, V80, P1012, DOI 10.1093/ajcn/80.4.1012; Senn S, 2002, CROSS OVER TRIALS CL; SIEDEL J, 1983, CLIN CHEM, V29, P1075; SUGIUCHI H, 1995, CLIN CHEM, V41, P717; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; Toshima S, 2000, ARTERIOSCL THROM VAS, V20, P2243, DOI 10.1161/01.ATV.20.10.2243; Visioli F, 2000, CIRCULATION, V102, P2169; WITZTUM JL, 1994, LANCET, V344, P793, DOI 10.1016/S0140-6736(94)92346-9; Yokozawa T, 2002, J AGR FOOD CHEM, V50, P3549, DOI 10.1021/jf020029h; Zern TL, 2005, J NUTR, V135, P2291, DOI 10.1093/jn/135.10.2291	40	544	560	0	59	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 5	2006	145	5					333	341		10.7326/0003-4819-145-5-200609050-00006	http://dx.doi.org/10.7326/0003-4819-145-5-200609050-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080NZ	16954359				2022-12-28	WOS:000240255900003
J	Prokhorenko, VI; Nagy, AM; Waschuk, SA; Brown, LS; Birge, RR; Miller, RJD				Prokhorenko, Valentyn I.; Nagy, Andrea M.; Waschuk, Stephen A.; Brown, Leonid S.; Birge, Robert R.; Miller, R. J. Dwayne			Coherent control of retinal isomerization in bacteriorhodopsin	SCIENCE			English	Article							FEMTOSECOND PRIMARY EVENT; QUANTUM YIELD; MOLECULAR-DYNAMICS; PHOTOISOMERIZATION; ABSORPTION; EXCITATION; SPECTROSCOPY; PHOTOCYCLE; CHROMOPHORE; MODEL	Optical control of the primary step of photoisomerization of the retinal molecule in bacteriorhodopsin from the all-trans to the 13-cis state was demonstrated under weak field conditions (where only 1 of 300 retinal molecules absorbs a photon during the excitation cycle) that are relevant to understanding biological processes. By modulating the phases and amplitudes of the spectral components in the photoexcitation pulse, we showed that the absolute quantity of 13-cis retinal formed upon excitation can be enhanced or suppressed by +/-20% of the yield observed using a short transform-limited pulse having the same actinic energy. The shaped pulses were shown to be phase-sensitive at intensities too low to access different higher electronic states, and so these pulses apparently steer the isomerization through constructive and destructive interference effects, a mechanism supported by observed signatures of vibrational coherence. These results show that the wave properties of matter can be observed and even manipulated in a system as large and complex as a protein.	Univ Toronto, Inst Opt Sci, Dept Chem, Toronto, ON M5S 3H6, Canada; Univ Toronto, Inst Opt Sci, Dept Phys, Toronto, ON M5S 3H6, Canada; Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada; Univ Connecticut, Dept Chem, Storrs, CT USA	University of Toronto; University of Toronto; University of Guelph; University of Connecticut	Miller, RJD (corresponding author), Univ Toronto, Inst Opt Sci, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada.	dmiller@lphys.chem.utoronto.ca	Brown, Leonid/X-7445-2019; Brown, Leonid/A-1050-2008	Brown, Leonid/0000-0002-5614-8317; Brown, Leonid/0000-0002-5614-8317	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034548] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM034548, R01 GM034548-17] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALASHOV SP, 1991, PHOTOCHEM PHOTOBIOL, V54, P955, DOI 10.1111/j.1751-1097.1991.tb02116.x; Blum K., 2012, P SOC BRAIN MAPP THE, Vthird edn.; DIOUMAEV AK, 1989, J PHOTOCH PHOTOBIO B, V3, P397, DOI 10.1016/1011-1344(89)80044-2; Edman K, 1999, NATURE, V401, P822, DOI 10.1038/44623; Flores SC, 2004, J PHYS CHEM B, V108, P6745, DOI 10.1021/jp0370526; FRAGNITO HL, 1989, CHEM PHYS LETT, V160, P101, DOI 10.1016/0009-2614(89)87564-5; Gai F, 1998, SCIENCE, V279, P1886, DOI 10.1126/science.279.5358.1886; Gelman D, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2136155; Gonzalez-Luque R, 2000, P NATL ACAD SCI USA, V97, P9379, DOI 10.1073/pnas.97.17.9379; Hasson KC, 1996, P NATL ACAD SCI USA, V93, P15124, DOI 10.1073/pnas.93.26.15124; Hauer J, 2006, CHEM PHYS LETT, V421, P523, DOI 10.1016/j.cplett.2006.01.115; Hayashi S, 2003, BIOPHYS J, V85, P1440, DOI 10.1016/S0006-3495(03)74576-7; Herbst J, 2002, SCIENCE, V297, P822, DOI 10.1126/science.1072144; Herek JL, 2002, NATURE, V417, P533, DOI 10.1038/417533a; Hoki K, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.168305; Hou BX, 2003, CHEM PHYS LETT, V381, P549, DOI 10.1016/j.cplett.2003.10.038; Kamalov VF, 1996, J PHYS CHEM-US, V100, P2762, DOI 10.1021/jp952971k; Kennis JTM, 2002, J PHYS CHEM B, V106, P6067, DOI 10.1021/jp014681b; Kobayashi T, 2001, NATURE, V414, P531, DOI 10.1038/35107042; Logunov SL, 1997, J PHYS CHEM B, V101, P6629, DOI 10.1021/jp970955c; Morita R, 2001, OPT COMMUN, V197, P73, DOI 10.1016/S0030-4018(01)01409-2; MYERS AB, 1983, J CHEM PHYS, V79, P603, DOI 10.1063/1.445807; Oesterhelt D, 1974, Methods Enzymol, V31, P667; Ohtsuki Y, 2003, CHEM PHYS LETT, V369, P525, DOI 10.1016/S0009-2614(02)02030-4; PAYE J, 1992, IEEE J QUANTUM ELECT, V28, P2262, DOI 10.1109/3.159533; POLLAND HJ, 1986, BIOPHYS J, V49, P651, DOI 10.1016/S0006-3495(86)83692-X; POLLARD WT, 1990, J CHEM PHYS, V92, P4012, DOI 10.1063/1.457815; Prokhorenko VI, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1886750; SCHNEIDER G, 1989, CHEM PHYS, V131, P17, DOI 10.1016/0301-0104(89)87078-8; Shapiro M, 2003, REP PROG PHYS, V66, P859, DOI 10.1088/0034-4885/66/6/201; SHI SH, 1990, J CHEM PHYS, V92, P364, DOI 10.1063/1.458438; TITTOR J, 1990, FEBS LETT, V263, P269, DOI 10.1016/0014-5793(90)81390-A; Vogt G, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.068305; WANG Q, 1994, SCIENCE, V266, P422, DOI 10.1126/science.7939680; XIE A, 1990, BIOPHYS J, V58, P1127, DOI 10.1016/S0006-3495(90)82455-3; Ye T, 1999, J PHYS CHEM B, V103, P5122, DOI 10.1021/jp9846227	36	308	322	2	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 1	2006	313	5791					1257	1261		10.1126/science.1130747	http://dx.doi.org/10.1126/science.1130747			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16946063				2022-12-28	WOS:000240313500032
J	Voorhees, PW				Voorhees, Peter W.			Materials science - Step dances on silicon	SCIENCE			English	Editorial Material							SI(001)		Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA	Northwestern University	Voorhees, PW (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.	p-voorhees@northwestern.edu	Voorhees, Peter/B-6700-2009					BARTELT NC, 1994, PHYS REV LETT, V73, P1656, DOI 10.1103/PhysRevLett.73.1656; BURTON WK, 1951, PHILOS T R SOC S-A, V243, P299, DOI 10.1098/rsta.1951.0006; FRANK FC, 1949, DISCUSS FARADAY SOC, P48, DOI 10.1039/df9490500048; HAMERS RJ, 1986, PHYS REV B, V34, P5343, DOI 10.1103/PhysRevB.34.5343; Hannon JB, 2006, SCIENCE, V313, P1266, DOI 10.1126/science.1129342; WEBB MB, 1991, SURF SCI, V242, P23, DOI 10.1016/0039-6028(91)90236-L	6	4	4	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 1	2006	313	5791					1247	+		10.1126/science.1131892	http://dx.doi.org/10.1126/science.1131892			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16946058				2022-12-28	WOS:000240313500027
J	Krishnamurthy, PC; Du, GQ; Fukuda, Y; Sun, DX; Sampath, J; Mercer, KE; Wang, JF; Sosa-Pineda, B; Murti, KG; Schuetz, JD				Krishnamurthy, Partha C.; Du, Guoqing; Fukuda, Yu; Sun, Daxi; Sampath, Janardhan; Mercer, Kelly E.; Wang, Junfeng; Sosa-Pineda, Beatriz; Murti, K. Gopal; Schuetz, John D.			Identification of a mammalian mitochondrial porphyrin transporter	NATURE			English	Article							RAT-LIVER MITOCHONDRIA; PROTOPORPHYRIN-IX; HEME; BINDING; MEMBRANES; ATP; BIOSYNTHESIS; OXIDASE; CELLS	The movement of anionic porphyrins ( for example, haem) across intracellular membranes is crucial to many biological processes, but their mitochondrial translocation and coordination with haem biosynthesis is not understood. Transport of porphyrins into isolated mitochondria is energy-dependent(1-3), as expected for the movement of anions into a negatively charged environment. ATP-binding cassette transporters actively facilitate the transmembrane movement of substances. We found that the mitochondrial ATP-binding cassette transporter ABCB6 is upregulated ( messenger RNA and protein in human and mouse cells) by elevation of cellular porphyrins and postulated that ABCB6 has a function in porphyrin transport. We also predicted that ABCB6 is functionally linked to haem biosynthesis, because its mRNA is found in both human bone marrow and CD71(+) early erythroid cells ( by database searching), and because our results show that ABCB6 is highly expressed in human fetal liver, and Abcb6 in mouse embryonic liver. Here we demonstrate that ABCB6 is uniquely located in the outer mitochondrial membrane and is required for mitochondrial porphyrin uptake. After ABCB6 is upregulated in response to increased intracellular porphyrin, mitochondrial porphyrin uptake activates de novo porphyrin biosynthesis. This process is blocked when the Abcb6 gene is silenced. Our results challenge previous assumptions about the intracellular movement of porphyrins and the factors controlling haem biosynthesis.	St Jude Childrens Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Sci Imaging Resource Ctr, Memphis, TN 38105 USA; Univ Tennessee, Hlth Sci Ctr, Memphis, TN 38103 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Schuetz, JD (corresponding author), St Jude Childrens Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA.	john.schuetz@stjude.org	Schuetz, John D/N-2692-2018	Fukuda, Yu/0000-0001-6182-540X				AFT RL, 1983, J BIOL CHEM, V258, P2069; AFT RL, 1984, J BIOL CHEM, V259, P301; FERREIRA GC, 1988, J BIOL CHEM, V263, P3835; Furuya KN, 1997, CANCER RES, V57, P3708; GARDNER LC, 1988, J BIOL CHEM, V263, P6676; Graf GA, 2004, J BIOL CHEM, V279, P24881, DOI 10.1074/jbc.M402634200; Hirsch-Ernst KI, 1998, BIOCHEM BIOPH RES CO, V249, P151, DOI 10.1006/bbrc.1998.9110; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Kepczynski M, 2002, PHOTOCHEM PHOTOBIOL, V76, P127, DOI 10.1562/0031-8655(2002)076<0127:DLBCOP>2.0.CO;2; KOLLER ME, 1979, FEBS LETT, V100, P47, DOI 10.1016/0014-5793(79)81128-X; KOLLER ME, 1980, BIOCHEM J, V188, P329, DOI 10.1042/bj1880329; Krieg RC, 2003, PHOTOCHEM PHOTOBIOL, V78, P393, DOI 10.1562/0031-8655(2003)078<0393:ILIACF>2.0.CO;2; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; KUROSS SA, 1988, BLOOD, V71, P876; KUZELOVA K, 1994, BIOCHEMISTRY-US, V33, P9447, DOI 10.1021/bi00198a010; Lavi A, 2002, BIOPHYS J, V82, P2101, DOI 10.1016/S0006-3495(02)75557-4; LIGHT WR, 1990, J BIOL CHEM, V265, P15632; LIGHT WR, 1990, J BIOL CHEM, V265, P15623; Locher KP, 2004, CURR OPIN STRUC BIOL, V14, P426, DOI 10.1016/j.sbi.2004.06.005; Mitsuhashi N, 2000, J BIOL CHEM, V275, P17536, DOI 10.1074/jbc.275.23.17536; PIOMELLI S, 1976, PEDIATRICS, V57, P136; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Rebeiz N, 1996, ARCH BIOCHEM BIOPHYS, V333, P475, DOI 10.1006/abbi.1996.0417; RICCHELLI F, 1995, EUR J BIOCHEM, V233, P165, DOI 10.1111/j.1432-1033.1995.165_1.x; Sassa S, 1982, Trans Assoc Am Physicians, V95, P42; Sassa S, 2000, J INTERN MED, V247, P169, DOI 10.1046/j.1365-2796.2000.00618.x; Susa S, 2002, BLOOD, V100, P4678, DOI 10.1182/blood-2002-08-2621; TSIFTSOGLOU AS, 1983, P NATL ACAD SCI-BIOL, V80, P7528, DOI 10.1073/pnas.80.24.7528; Visvader JE, 1997, P NATL ACAD SCI USA, V94, P13707, DOI 10.1073/pnas.94.25.13707	29	286	300	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2006	443	7111					586	589		10.1038/nature05125	http://dx.doi.org/10.1038/nature05125			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	17006453				2022-12-28	WOS:000240988200046
J	Schroeder, JI; Nambara, E				Schroeder, Julian I.; Nambara, Eiji			A quick release mechanism for abscisic acid	CELL			English	Editorial Material							ARABIDOPSIS; LEAVES	The hormone abscisic acid regulates development and survival of plants in response to environmental stresses. Lee et al. (2006) now demonstrate that in response to stress, abscisic acid can be made available via polymerization of a beta-glucosidase enzyme. This enzyme is reported to hydrolyze glucose-conjugated abscisic acid, thus increasing active abscisic acid concentrations.	Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, La Jolla, CA 92093 USA; RIKEN, Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan	University of California System; University of California San Diego; RIKEN	Schroeder, JI (corresponding author), Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, La Jolla, CA 92093 USA.	julian@biomail.ucsd.edu	Nambara, Eiji/E-5533-2012	Schroeder, Julian/0000-0002-3283-5972				Christmann A, 2005, PLANT PHYSIOL, V137, P209, DOI 10.1104/pp.104.053082; Dietz KJ, 2000, J EXP BOT, V51, P937, DOI 10.1093/jexbot/51.346.937; FINKELSTEIN RR, 2002, ARABIDOPSIS BOOK; Hartung W, 2002, J EXP BOT, V53, P27, DOI 10.1093/jexbot/53.366.27; Kim YW, 1998, BBA-PROTEIN STRUCT M, V1388, P457, DOI 10.1016/S0167-4838(98)00209-X; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Xie XD, 2006, CURR BIOL, V16, P882, DOI 10.1016/j.cub.2006.03.028; ZEEVAART JAD, 1983, PLANT PHYSIOL, V71, P477, DOI 10.1104/pp.71.3.477; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	10	34	38	3	24	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 22	2006	126	6					1023	1025		10.1016/j.cell.2006.09.001	http://dx.doi.org/10.1016/j.cell.2006.09.001			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990126	Bronze			2022-12-28	WOS:000240897600007
J	D'Orazio, JA; Nobuhisa, T; Cui, RT; Arya, M; Spry, M; Wakamatsu, K; Igras, V; Kunisada, T; Granter, SR; Nishimura, EK; Ito, S; Fisher, DE				D'Orazio, John A.; Nobuhisa, Tetsuji; Cui, Rutao; Arya, Michelle; Spry, Malinda; Wakamatsu, Kazumasa; Igras, Vivien; Kunisada, Takahiro; Granter, Scott R.; Nishimura, Emi K.; Ito, Shosuke; Fisher, David E.			Topical drug rescue strategy and skin protection based on the role of Mc1r in UV-induced tanning	NATURE			English	Article							STEM-CELL FACTOR; HUMAN MELANOCYTES; DNA-DAMAGE; TRANSCRIPTION FACTOR; ULTRAVIOLET-LIGHT; CYCLIC-AMP; EXPRESSION; GENE; KERATINOCYTES; MELANOGENESIS	Ultraviolet-light (UV)-induced tanning is defective in numerous 'fair-skinned' individuals, many of whom contain functional disruption of the melanocortin 1 receptor (MC1R)(1-3). Although this suggested a critical role for the MC1R ligand melanocyte stimulating hormone (MSH) in this response, a genetically controlled system has been lacking in which to determine the precise role of MSH - MC1R. Here we show that ultraviolet light potently induces expression of MSH in keratinocytes, but fails to stimulate pigmentation in the absence of functional MC1R in red/blonde-haired Mc1r(e/e) mice. However, pigmentation could be rescued by topical application of the cyclic AMP agonist forskolin, without the need for ultraviolet light, demonstrating that the pigmentation machinery is available despite the absence of functional MC1R. This chemically induced pigmentation was protective against ultraviolet-light-induced cutaneous DNA damage and tumorigenesis when tested in the cancer-prone, xerodermapigmentosum-complementation-group- C-deficient genetic background. These data emphasize the essential role of intercellular MSH signalling in the tanning response, and suggest a clinical strategy for topical small-molecule manipulation of pigmentation.	Dana Farber Canc Inst, Melanoma Program, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Hematol Oncol, Boston, MA 02115 USA; Childrens Hosp, Boston, MA 02115 USA; Univ Kentucky, Coll Med, Dept Pediat, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA; Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA; Fujita Hlth Univ, Sch Hlth Sci, Dept Chem, Aichi 4701192, Japan; Gifu Univ, Grad Sch Med, Dept Tissue & Organ Dev, Gifu 501, Japan; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Kanazawa Univ, Dept Stem Cell Med, Canc Res Inst, Kanazawa, Ishikawa 9200934, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; University of Kentucky; University of Kentucky; Fujita Health University; Gifu University; Harvard University; Brigham & Women's Hospital; Kanazawa University	Fisher, DE (corresponding author), Dana Farber Canc Inst, Melanoma Program, 44 Binney St, Boston, MA 02115 USA.	david_fisher@dfci.harvard.edu	Wakamatsu, Kazumasa/AAZ-5877-2020	Wakamatsu, Kazumasa/0000-0003-1748-9001; Cui, Rutao/0000-0002-4377-9988; Ito, Shosuke/0000-0001-9182-5144				Bayerl C, 1995, PHOTODERMATOL PHOTO, V11, P149, DOI 10.1111/j.1600-0781.1995.tb00157.x; Chakraborty AK, 1996, BBA-MOL CELL RES, V1313, P130, DOI 10.1016/0167-4889(96)00063-8; Cook AL, 2003, J INVEST DERMATOL, V121, P1150, DOI 10.1046/j.1523-1747.2003.12562.x; Corre S, 2004, J BIOL CHEM, V279, P51226, DOI 10.1074/jbc.M409768200; ELLER MS, 1994, NATURE, V372, P413, DOI 10.1038/372413a0; Eller MS, 1996, P NATL ACAD SCI USA, V93, P1087, DOI 10.1073/pnas.93.3.1087; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; Grichnik JM, 1998, J INVEST DERMATOL, V111, P233, DOI 10.1046/j.1523-1747.1998.00272.x; HIROBE T, 1992, DEVELOPMENT, V114, P435; Kadekaro AL, 2005, CANCER RES, V65, P4292, DOI 10.1158/0008-5472.CAN-04-4535; Kobayashi N, 1998, J INVEST DERMATOL, V110, P806, DOI 10.1046/j.1523-1747.1998.00178.x; Kunisada T, 1998, J EXP MED, V187, P1565, DOI 10.1084/jem.187.10.1565; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lassalle MW, 2003, PIGM CELL RES, V16, P81, DOI 10.1034/j.1600-0749.2003.00004.x; Lin CB, 2002, J INVEST DERMATOL, V119, P1330, DOI 10.1046/j.1523-1747.2002.19615.x; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; Naysmith L, 2004, J INVEST DERMATOL, V122, P423, DOI 10.1046/j.0022-202X.2004.22221.x; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Park SB, 1999, CLIN EXP DERMATOL, V24, P315; Price ER, 1998, J BIOL CHEM, V273, P33042, DOI 10.1074/jbc.273.49.33042; Rees JL, 2004, AM J HUM GENET, V75, P739, DOI 10.1086/425285; Rouzaud F, 2005, MUTAT RES-FUND MOL M, V571, P133, DOI 10.1016/j.mrfmmm.2004.09.014; Sakai C, 1997, EMBO J, V16, P3544, DOI 10.1093/emboj/16.12.3544; SANDS AT, 1995, NATURE, V377, P162, DOI 10.1038/377162a0; SEAMON KB, 1981, J CYCLIC NUCL PROT, V7, P201; Sturm RA, 2003, ANN NY ACAD SCI, V994, P348, DOI 10.1111/j.1749-6632.2003.tb03199.x; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Van Raamsdonk CD, 2004, NAT GENET, V36, P961, DOI 10.1038/ng1412; Wakamatsu K, 2002, PIGM CELL RES, V15, P174, DOI 10.1034/j.1600-0749.2002.02017.x; Wintzen M, 1996, J INVEST DERMATOL, V106, P673, DOI 10.1111/1523-1747.ep12345496	30	243	259	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2006	443	7109					340	344		10.1038/nature05098	http://dx.doi.org/10.1038/nature05098			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085RL	16988713				2022-12-28	WOS:000240622000047
J	Wynn, JG; Alemseged, Z; Bobe, R; Geraads, D; Reed, D; Roman, DC				Wynn, Jonathan G.; Alemseged, Zeresenay; Bobe, Rene; Geraads, Denis; Reed, Denne; Roman, Diana C.			Geological and palaeontological context of a Pliocene juvenile hominin at Dikika, Ethiopia	NATURE			English	Article							MIDDLE AWASH VALLEY; HADAR FORMATION; AFAR; PLIOPLEISTOCENE; ARAMIS; RIFT; GONA; AGE	Since 1999, the Dikika Research Project (DRP; initiated by Z.A.) has conducted surveys and excavations in badlands that expose Pliocene and Pleistocene sediments south of the Awash River in Ethiopia, between surrounding hominin localities at Hadar(1), Gona(2) and the Middle Awash region(3). Here we report our geological mapping and stratigraphic measurement of the DRP area, and the context of a remarkably well-preserved skeleton of the earliest known juvenile hominin at the Dikika DIK-1 locality(4). Our mapping of the DRP area permits a complete definition of the hominin-bearing Hadar Formation and provides a cohesive structural and tectonic framework defining its relationships to adjacent strata. Our findings reveal the basin-scale tectonic, depositional and palaeoenvironmental history of the area, as well as a clear taphonomic and palaeontological context for the juvenile hominin. Such data are crucial for understanding the environmental context of human evolution(5,6), and can be integrated into larger-scale tectonic and palaeoenvironmental studies(7,8). Our basin-scale approach to palaeoenvironments provides a means to elucidate the complex geological history occurring at the scale of temporally and geographically controlled fossil point localities(3,9-11), which occur within the rich tectonic and depositional history of the Awash Valley.	Univ St Andrews, Sch Geog & Geosci, St Andrews KY16 9AL, Fife, Scotland; Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; Univ Georgia, Dept Anthropol, Athens, GA 30602 USA; CNRS, UPR 2147, F-75014 Paris, France; Univ Texas, Dept Anthropol, Austin, TX 78712 USA; Univ S Florida, Dept Geol, Tampa, FL 33620 USA	University of St Andrews; Max Planck Society; University System of Georgia; University of Georgia; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); University of Texas System; University of Texas Austin; State University System of Florida; University of South Florida	Wynn, JG (corresponding author), Univ S Florida, Dept Geol, Tampa, FL 33620 USA.	jwynn@cas.usf.edu	Roman, Diana/AAY-4877-2020; Wynn, Jonathan/C-1646-2010; Geraads, Denis/AAY-6051-2020; GERAADS, Denis/AAC-7241-2021	Roman, Diana/0000-0003-1282-5803; GERAADS, Denis/0000-0003-2475-8011; Bobe, Rene/0000-0001-9059-2203				Alemseged Z, 2006, NATURE, V443, P296, DOI 10.1038/nature05047; Behrensmeyer AK, 2006, SCIENCE, V311, P476, DOI 10.1126/science.1116051; BERNOR RL, 1997, NEOGENE PALEONTOLOGY, P219; Beyene A, 2005, J AFR EARTH SCI, V41, P41, DOI 10.1016/j.jafrearsci.2005.03.003; Boisserie JR, 2004, J VERTEBR PALEONTOL, V24, P464, DOI 10.1671/2475; BROWN FH, 1982, NATURE, V299, P212, DOI 10.1038/299212a0; Cooke HBS, 1978, KIRTLANDIA, V29, P1; FEIBEL CS, 1997, GSA TODAY, V7, P1; Gentry A.W., 1985, CAHIERS PALEONTOLOGI, V1, P119; GENTRY AW, 1981, KIRTLANDIA, V33, P1; Haile-Selassie Y, 2004, GEOBIOS-LYON, V37, P536, DOI 10.1016/j.geobios.2003.03.012; HAILEAB B, 1992, J HUM EVOL, V22, P453, DOI 10.1016/0047-2484(92)90080-S; Harris John M., 2003, P531; Kalb J.E., 1982, Newsletters on Stratigraphy, V11, P95; Kimbel WH, 1996, J HUM EVOL, V31, P549, DOI 10.1006/jhev.1996.0079; LEAKEY MG, 1995, NATURE, V376, P565, DOI 10.1038/376565a0; Leakey MG, 2001, NATURE, V410, P433, DOI 10.1038/35068500; Levin NE, 2004, EARTH PLANET SC LETT, V219, P93, DOI 10.1016/S0012-821X(03)00707-6; Quade J, 2004, GEOL SOC AM BULL, V116, P1529, DOI 10.1130/B25358.1; SABATIER M., 1982, PALEOVERTEBRATA, V12, P1; TAIEB M, 1972, CR ACAD SCI D NAT, V275, P819; TAIEB M, 1976, NATURE, V260, P289, DOI 10.1038/260289a0; Todd NE, 2001, P 1 INT C LA TERR EL, P693; Vrba E. S., 1997, Palaeontologia Africana, V34, P127; WALTER RC, 1994, GEOLOGY, V22, P6, DOI 10.1130/0091-7613(1994)022<0006:AOLATF>2.3.CO;2; White TD, 2006, NATURE, V440, P883, DOI 10.1038/nature04629; WHITE TD, 1993, NATURE, V366, P261, DOI 10.1038/366261a0; WOLDEGABRIEL G, 1994, NATURE, V371, P330, DOI 10.1038/371330a0; WoldeGabriel G, 2001, NATURE, V412, P175, DOI 10.1038/35084058; Wolfenden E, 2004, EARTH PLANET SC LETT, V224, P213, DOI 10.1016/j.epsl.2004.04.022	30	62	64	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2006	443	7109					332	336		10.1038/nature05048	http://dx.doi.org/10.1038/nature05048			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085RL	16988711				2022-12-28	WOS:000240622000045
J	Halpern, SD; Hansen-Flaschen, J				Halpern, Scott D.; Hansen-Flaschen, John			Terminal withdrawal of life-sustaining supplemental oxygen	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ASSISTED SUICIDE; ASSOCIATION; SEDATION; THERAPY; SUPPORT; DISEASE; CARE		Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Div Pulm Allergy & Crit Care Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Bioeth, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Halpern, SD (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, 711 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	scott.halpern@uphs.upenn.edu		Hansen-Flaschen, John/0000-0003-1989-7244				Abernethy AP, 2005, PALLIATIVE MED, V19, P168, DOI 10.1177/026921630501900219; Abrahm JL, 2002, CHEST, V121, P220, DOI 10.1378/chest.121.1.220; Alpers A, 1997, JAMA-J AM MED ASSOC, V277, P1705, DOI 10.1001/jama.277.21.1705; Ashby M, 2005, PALLIATIVE MED, V19, P389, DOI 10.1191/0269216305pm1043oa; BAILEY PL, 1990, ANESTHESIOLOGY, V73, P826, DOI 10.1097/00000542-199011000-00005; Booth S, 2004, RESP MED, V98, P66, DOI 10.1016/j.rmed.2003.08.008; Bruera E, 2003, PALLIATIVE MED, V17, P659, DOI 10.1191/0269216303pm826oa; Capellier G, 1999, Minerva Anestesiol, V65, P388; Chan JD, 2004, CHEST, V126, P286, DOI 10.1378/chest.126.1.286; Cohen LM, 1996, GEN HOSP PSYCHIAT, V18, P431, DOI 10.1016/S0163-8343(96)00091-6; DAVIS WB, 1983, NEW ENGL J MED, V309, P878, DOI 10.1056/NEJM198310133091502; *ESRD NETW NEW ENG, 2002, 2001 ANN REP CTR MED, P60; Gallagher Romayne, 2004, J Pain Palliat Care Pharmacother, V18, P3; Hjalmarsen A, 1999, EUR NEUROL, V42, P27, DOI 10.1159/000008065; Kampelmacher MJ, 1997, EUR RESPIR J, V10, P828; Lo B, 2005, JAMA-J AM MED ASSOC, V294, P1810, DOI 10.1001/jama.294.14.1810; Luce JM, 2000, AM J RESP CRIT CARE, V162, P2029, DOI 10.1164/ajrccm.162.6.1-00; Miller FG, 2000, ANN INTERN MED, V132, P470, DOI 10.7326/0003-4819-132-6-200003210-00008; Pearlman RA, 2005, J GEN INTERN MED, V20, P234, DOI 10.1111/j.1525-1497.2005.40225.x; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1983, DEC FOR LIF SUST TRE, P3; Quill TE, 1997, NEW ENGL J MED, V337, P1768, DOI 10.1056/NEJM199712113372413; Rubenfeld GD, 2004, CRIT CARE CLIN, V20, P435, DOI 10.1016/j.ccc.2004.03.005; Waugh Jonathan B, 2004, Respir Care, V49, P902	23	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2006	296	11					1397	1400		10.1001/jama.296.11.1397	http://dx.doi.org/10.1001/jama.296.11.1397			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085HS	16985234				2022-12-28	WOS:000240595800029
J	Lambrew, JM; Shalala, DE				Lambrew, Jeanne M.; Shalala, Donna E.			Federal health policy response to Hurricane Katrina - What it was and what it could have been	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									George Washington Univ, Sch Publ Hlth & Hlth Serv, Ctr Amer Progress, Washington, DC 20006 USA; Univ Miami, Coral Gables, FL 33124 USA	George Washington University; University of Miami	Lambrew, JM (corresponding author), George Washington Univ, Sch Publ Hlth & Hlth Serv, Ctr Amer Progress, 2021 K St NW,Suite 800, Washington, DC 20006 USA.	jlambrew@gwu.edu						Berggren RE, 2006, NEW ENGL J MED, V354, P1549, DOI 10.1056/NEJMp068039; Brodie M, 2006, AM J PUBLIC HEALTH, V96, P1402, DOI 10.2105/AJPH.2005.084475; LEAVITT MO, 2005, COMMUNICATION   0927; LEAVITT MO, 2005, COMMUNICATION   0930; National Association of Community Health Centers Inc., 2006, LEG DIS HLTH CTR HUR; PATEL K, 2005, EXPANDING COVERAGE U; Redlener, 2006, EDGE CHILDREN FAMILI; *REP STUD COMM, 2005, OP OFFS; Rosenbaum S, 2006, JAMA-J AM MED ASSOC, V295, P437, DOI 10.1001/jama.295.4.437; The Kaiser Commission on Medicaid and the Uninsured, 2006, COMP 17 APPR KATR WA; *US CTR MED MED SE, 2005, DIAS REL EM MED WAIV; *US CTR MED MED SE, 2005, CMS TAK EM STEPS EAS; *US DEP HHS, 2006, HHS AW 550 MILL HURR; *US DEP HHS, 2006, HHS REL 1 ROUND HURR; *US GOV ACC OFF, 2006, GAO06576R US; Weeks Linton, 2006, WASH POST, pA03; Weisler RH, 2006, JAMA-J AM MED ASSOC, V296, P585, DOI 10.1001/jama.296.5.585; WEISMAN J, 2005, WASH POST       0124, pA3; Zuckerman S., 2006, INITIAL HLTH POLICY	19	17	17	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2006	296	11					1394	1397		10.1001/jama.296.11.1394	http://dx.doi.org/10.1001/jama.296.11.1394			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085HS	16985233				2022-12-28	WOS:000240595800028
J	Sulmasy, DP				Sulmasy, Daniel P.			Spiritual issues in the care of dying patients "... it's okay between me and God"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; TERMINALLY-ILL PATIENTS; INAPPROPRIATE TREATMENT; TREATMENT PREFERENCES; ASSISTED SUICIDE; END; PHYSICIANS; ATTITUDES; CANCER; RELIGION	Spiritual issues arise frequently in the care of dying patients, yet health care professionals may not recognize them, may not believe they have a duty to address these issues, and may not understand how best to respond to their patients' spiritual needs. The case of a patient with a strong religious belief in a miraculous cure of metastatic pancreatic cancer is used to explore how better understanding of this belief and more explicitly spiritual conversation with the patient by his treating team might have provided opportunities for an improved plan of care. This article distinguishes spirituality from religion; describes the salient spiritual needs of patients at the end of life as encompassing questions of meaning, value, and relationship; delineates the role physicians ought to play in ascertaining and responding to those needs; and discusses the particular issue of miracles, arguing that expectations of miraculous cure ought not preclude referral to hospice care.	St Vincents Hosp Manhattan, John J Conley Dept Eth, New York, NY 10011 USA; New York Med Coll, Valhalla, NY 10595 USA	Saint Vincents Hospital Manhattan; New York Medical College	Sulmasy, DP (corresponding author), St Vincents Hosp Manhattan, John J Conley Dept Eth, 153 W 11th St, New York, NY 10011 USA.	daniel_sulmasy@nymc.edu						Astrow AB, 2005, J CLIN ONCOL, V23, P2569, DOI 10.1200/JCO.2005.07.151; Astrow AB, 2001, AM J MED, V110, P283; BLACK BC, DENIAL CONTEXT ILLNE; Brett AS, 2003, ARCH INTERN MED, V163, P1645, DOI 10.1001/archinte.163.14.1645; Buckley Jenny, 2004, Nurs Stand, V19, P33; Burker EJ, 2005, J BEHAV MED, V28, P513, DOI 10.1007/s10865-005-9025-4; Buryska JF, 2001, J MED ETHICS, V27, P118, DOI 10.1136/jme.27.2.118; Byock I, 2003, ANN INTERN MED, V138, P335, DOI 10.7326/0003-4819-138-4-200302180-00013; Clarfield AM, 2006, J GERONTOL A-BIOL, V61, P621, DOI 10.1093/gerona/61.6.621; Clark D, 2001, J Palliat Med, V4, P353, DOI 10.1089/109662101753123977; Cohen CB, 2001, HASTINGS CENT REP, V31, P29, DOI 10.2307/3527702; Cohen SR, 1996, CANCER-AM CANCER SOC, V77, P576, DOI 10.1002/(SICI)1097-0142(19960201)77:3<576::AID-CNCR22>3.0.CO;2-0; Cohen SR, 1997, PALLIATIVE MED, V11, P3; Connors RB, 1996, HASTINGS CENT REP, V26, P23, DOI 10.2307/3527604; Coyle Nessa, 2003, J Support Oncol, V1, P206; Crawley L, 2000, JAMA-J AM MED ASSOC, V284, P2518, DOI 10.1001/jama.284.19.2518; Curlin FA, 2005, J GEN INTERN MED, V20, P629, DOI 10.1111/j.1525-1497.2005.0119.x; Daaleman TP, 2000, JAMA-J AM MED ASSOC, V284, P2514, DOI 10.1001/jama.284.19.2514; Du Val G, 2001, J MED ETHICS, V27, pI24, DOI 10.1136/jme.27.suppl_1.i24; Dugan D O, 1995, HEC Forum, V7, P228, DOI 10.1007/BF01463335; Dula A, 2005, CLIN GERIATR MED, V21, P239, DOI 10.1016/j.cger.2004.10.003; DuVal G, 2004, J GEN INTERN MED, V19, P251, DOI 10.1111/j.1525-1497.2004.21238.x; Ehman JW, 1999, ARCH INTERN MED, V159, P1803, DOI 10.1001/archinte.159.15.1803; El-Rayes Basil F, 2003, Clin Adv Hematol Oncol, V1, P430; Ellis MR, 1999, J FAM PRACTICE, V48, P105; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V284, P2460, DOI 10.1001/jama.284.19.2460; Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833; Fisch MJ, 2003, J CLIN ONCOL, V21, P2754, DOI 10.1200/JCO.2003.06.093; Goldstein D, 2004, INTERN MED J, V34, P475, DOI 10.1111/j.1444-0903.2004.00658.x; Graves Darci L, 2002, Acad Med, V77, P1167, DOI 10.1097/00001888-200211000-00035; Heeren O, 2001, INT J GERIATR PSYCH, V16, P203, DOI 10.1002/1099-1166(200102)16:2<203::AID-GPS306>3.0.CO;2-M; Hills Judith, 2005, J Palliat Med, V8, P782, DOI 10.1089/jpm.2005.8.782; Johnson KS, 2005, J AM GERIATR SOC, V53, P711, DOI 10.1111/j.1532-5415.2005.53224.x; *JOINT COMM ACCR H, 2004, SPIR ASS; Kaldjian LC, 1998, AIDS, V12, P103, DOI 10.1097/00002030-199801000-00012; King DE, 2004, TEACH LEARN MED, V16, P64, DOI 10.1207/s15328015tlm1601_13; KING DE, 1994, J FAM PRACTICE, V39, P349; Kristeller JL, 1999, PSYCHO-ONCOLOGY, V8, P451, DOI 10.1002/(SICI)1099-1611(199909/10)8:5<451::AID-PON422>3.3.CO;2-V; LAPUMA J, 1992, AM J MED, V92, P346, DOI 10.1016/0002-9343(92)90262-A; LeFavi Robert G, 2003, J Pastoral Care Counsel, V57, P281; Lo B, 2002, JAMA-J AM MED ASSOC, V287, P749, DOI 10.1001/jama.287.6.749; Lynn J, 2001, JAMA-J AM MED ASSOC, V285, P925, DOI 10.1001/jama.285.7.925; MacLean CD, 2003, J GEN INTERN MED, V18, P38, DOI 10.1046/j.1525-1497.2003.20403.x; Maugans TA, 1996, ARCH FAM MED, V5, P11, DOI 10.1001/archfami.5.1.11; MAUGANS TA, 1991, J FAM PRACTICE, V32, P210; Moadel A, 1999, PSYCHO-ONCOL, V8, P378, DOI 10.1002/(SICI)1099-1611(199909/10)8:5<378::AID-PON406>3.0.CO;2-A; Monroe MH, 2003, ARCH INTERN MED, V163, P2751, DOI 10.1001/archinte.163.22.2751; O'Connell KA, 2006, SOC SCI MED, V62, P1486, DOI 10.1016/j.socscimed.2005.08.001; OCONNELL LJ, 2006, TIME LISTENING CARIN; Orr RD, 1997, J MED ETHICS, V23, P142, DOI 10.1136/jme.23.3.142; Pargament KI, 2000, J CLIN PSYCHOL, V56, P519, DOI 10.1002/(SICI)1097-4679(200004)56:4<519::AID-JCLP6>3.0.CO;2-1; Perron V, 2001, PRIMARY CARE, V28, P427, DOI 10.1016/S0095-4543(05)70032-4; Post SG, 2000, ANN INTERN MED, V132, P578, DOI 10.7326/0003-4819-132-7-200004040-00010; Puchalski Christina M, 2002, J Palliat Med, V5, P289, DOI 10.1089/109662102753641287; Puchalski CM, 1998, ACAD MED, V73, P970, DOI 10.1097/00001888-199809000-00015; RINPOCHE S, 2002, TIBETAN BOOK LIVING, P199; Steinhauser KE, 2006, ARCH INTERN MED, V166, P101, DOI 10.1001/archinte.166.1.101; Suarez-Almazor ME, 2002, J CLIN ONCOL, V20, P2134, DOI 10.1200/JCO.2002.08.025; Sulmasy Daniel P, 2002, Ethical Perspect, V9, P103, DOI 10.2143/EP.9.2.503850; Sulmasy Daniel P, 2002, Gerontologist, V42 Spec No 3, P24; Sulmasy DP, 1999, ACAD MED, V74, P1002, DOI 10.1097/00001888-199909000-00012; Sulmasy DP, 1997, THEOR MED, V18, P63, DOI 10.1023/A:1005749217702; Sulmasy DP, 1997, JAMA-J AM MED ASSOC, V277, P1854; SULMASY DP, 2001, J GEN INTERN MED S1, V16, P223; SULMASY DP, IN PRESS BALM GILEAD; SULMASY DP, 1997, HEALERS CALLING SPIR, P66; Sulmasy DP, 2006, REBIRTH CLIN INTRO S; Torke Alexia M, 2005, J Palliat Med, V8, P593, DOI 10.1089/jpm.2005.8.593; Wagner JT, 1996, CRIT CARE CLIN, V12, P15, DOI 10.1016/S0749-0704(05)70212-8; Wilson KG, 2000, ARCH INTERN MED, V160, P2454, DOI 10.1001/archinte.160.16.2454; [No title captured]; 2006, CBS NEWS        0413	72	124	125	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2006	296	11					1385	1392		10.1001/jama.296.11.1385	http://dx.doi.org/10.1001/jama.296.11.1385			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	085HS	16985231				2022-12-28	WOS:000240595800026
J	Dewey, M; Teige, F; Schnapauff, D; Laule, M; Borges, AC; Wernecke, KD; Schink, T; Baumann, G; Rutsch, W; Rogalla, P; Taupitz, M; Hamm, B				Dewey, Marc; Teige, Florian; Schnapauff, Dirk; Laule, Michael; Borges, Adrian C.; Wernecke, Klaus-Dieter; Schink, Tania; Baumann, Gert; Rutsch, Wolfgang; Rogalla, Patrik; Taupitz, Matthias; Hamm, Bernd			Noninvasive detection of coronary artery stenoses with multislice computed tomography or magnetic resonance imaging	ANNALS OF INTERNAL MEDICINE			English	Article							MR-ANGIOGRAPHY; DIAGNOSTIC-ACCURACY; HEART-DISEASE; CT; RECONSTRUCTION; METAANALYSIS; CONTRAST; STROKE; TESTS	Background: Multislice computed tomography (CT) and magnetic resonance imaging (MRI) are the main candidates for noninvasive coronary angiography; however, multislice CT, unlike MRI, exposes patients to radiation and an iodinated intravenous contrast agent. Objective: To compare the diagnostic accuracy of multislice CT and MRI for noninvasive detection of clinically significant coronary stenoses (>= 50%). Design: Prospective intention-to-diagnose study. Setting: Single tertiary referral center, Berlin, Germany. Patients: 129 consecutive patients with suspected coronary artery disease. Interventions: Multislice CT and MRI were both performed within a median of 1 day before conventional coronary angiography, which served as the reference standard. Measurements: Diagnostic performance of multislice CT and MRI. Results: 129 patients completed the study. Altogether, 108 patients with 430 vessels could be examined with both multislice CT and MRI and were used for analysis. In the per-patient analysis, the sensitivity of multislice CT (92% [95% CI, 82% to 96%]) was significantly higher than that of MRI (74% [CI, 61% to 83%]; P = 0.013). The sensitivity for detecting clinically significant stenoses was 82% for multislice CT and 54% for MRI (P < 0.001). Specificity and negative predictive value of multislice CT and MRI in the per-vessel analysis were 90% versus 87% (P = 0.73) and 95% versus 90% (P = 0.032), respectively. The effective radiation dose used with multislice CT (mean, 12.3 mSv [SD, 1.4]) in a consecutive subgroup of 73 patients was not significantly different from that used with diagnostic cardiac catheterization (11.4 mSv [SD, 4.8]) (P = 0.169). Most patients (74%) indicated that they would prefer multislice CT for future diagnostic imaging (P < 0.001). Limitations: This was a single-center study with 129 patients. Conclusions: In patients referred for conventional coronary angiography, multislice CT compares favorably with MRI for noninvasive detection of coronary stenoses.	Humboldt Univ, Dept Radiol, Charite, Sch Med, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Dewey, M (corresponding author), Humboldt Univ, Dept Radiol, Charite, Sch Med, Schumannstr 20-21, D-10117 Berlin, Germany.	marc.dewey@charite.de	Schink, Tania/A-4585-2017; Laule, Michael E/A-6548-2013	Schink, Tania/0000-0002-0224-1866; Dewey, Marc/0000-0002-4402-2733; Laule, Michael/0000-0002-7579-295X; Taupitz, Matthias/0000-0002-2994-8263				Altman D, 2000, STAT CONFIDENCE, P108; ALTMAN D, 2000, STAT CONFIDENCE, P159; Austen W G, 1975, Circulation, V51, P5; BEGG CB, 1986, J CHRON DIS, V39, P575; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Brenner DJ, 2004, RADIOLOGY, V232, P735, DOI 10.1148/radiol.2323031095; Brophy JM, 2003, ANN INTERN MED, V138, P777, DOI 10.7326/0003-4819-138-10-200305200-00005; Brunner E., 2002, NONPARAMETRIC ANAL L, P187; CONNOR RJ, 1987, BIOMETRICS, V43, P207, DOI 10.2307/2531961; Cooper R, 2000, CIRCULATION, V102, P3137; Danias PG, 2004, J AM COLL CARDIOL, V44, P1867, DOI 10.1016/j.jacc.2004.07.051; Deshpande VS, 2002, J MAGN RESON IMAGING, V15, P473, DOI 10.1002/jmri.10087; Dewey M, 2006, J MAGN RESON IMAGING, V23, P674, DOI 10.1002/jmri.20568; Dewey M, 2004, ROFO-FORTSCHR RONTG, V176, P478, DOI 10.1055/s-2004-812991; Dewey M, 2004, INVEST RADIOL, V39, P223, DOI 10.1097/01.rli.0000115201.27096.6e; Efron B., 1994, MONOGRAPHS STAT APPL; Hoffmann MHK, 2005, RADIOLOGY, V234, P86, DOI 10.1148/radiol.2341031408; Hoffmann MHK, 2005, JAMA-J AM MED ASSOC, V293, P2471, DOI 10.1001/jama.293.20.2471; KALENDER WA, 2004, COMPUTED TOMOGRAPHY; Kim WY, 2001, NEW ENGL J MED, V345, P1863, DOI 10.1056/NEJMoa010866; Knottnerus JA, 2003, J CLIN EPIDEMIOL, V56, P1118, DOI 10.1016/S0895-4356(03)00206-3; Leber AW, 2005, J AM COLL CARDIOL, V46, P147, DOI 10.1016/j.jacc.2005.03.071; Leschka S, 2005, EUR HEART J, V26, P1482, DOI 10.1093/eurheartj/ehi261; McCarthy RM, 2003, RADIOLOGY, V227, P283, DOI 10.1148/radiol.2271011415; Mollet NR, 2004, J AM COLL CARDIOL, V43, P2265, DOI 10.1016/j.jacc.2004.03.032; Nieman K, 2002, CIRCULATION, V106, P2051, DOI 10.1161/01.CIR.0000037222.58317.3D; NOTO TJ, 1991, CATHETER CARDIO DIAG, V24, P75, DOI 10.1002/ccd.1810240202; *R DEV COR TEAM, 2005, R PROJ STAT COMP LAN; RAO JNK, 1992, BIOMETRICS, V48, P577, DOI 10.2307/2532311; Ropers D, 2003, CIRCULATION, V107, P664, DOI 10.1161/01.CIR.0000055738.31551.A9; Sakuma H, 2005, RADIOLOGY, V237, P316, DOI 10.1148/radiol.2371040830; Shea SM, 2002, J MAGN RESON IMAGING, V15, P597, DOI 10.1002/jmri.10106; SIMEL DL, 1987, MED DECIS MAKING, V7, P107, DOI 10.1177/0272989X8700700208; Sommer T, 2005, RADIOLOGY, V234, P718, DOI 10.1148/radiol.2343031784; Stamm G, 2002, ROFO-FORTSCHR RONTG, V174, P1570, DOI 10.1055/s-2002-35937; Taupitz M, 2001, MAGN RESON MED, V46, P932, DOI 10.1002/mrm.1279; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; van Buuren F, 2005, Z KARDIOL, V94, P212, DOI 10.1007/s00392-005-0227-0; Weber OM, 2003, MAGNET RESON MED, V50, P1223, DOI 10.1002/mrm.10653; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010; Zhou X, 2002, STAT METHODS DIAGNOS, P104	41	111	119	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2006	145	6					407	415		10.7326/0003-4819-145-6-200609190-00004	http://dx.doi.org/10.7326/0003-4819-145-6-200609190-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087OU	16983128				2022-12-28	WOS:000240752500002
J	Poon, EG; Cina, JL; Churchill, W; Patel, N; Featherstone, E; Rothschild, JM; Keohane, CA; Whittemore, AD; Bates, DW; Gandhi, TK				Poon, Eric G.; Cina, Jennifer L.; Churchill, William; Patel, Nirali; Featherstone, Erica; Rothschild, Jeffrey M.; Keohane, Carol A.; Whittemore, Anthony D.; Bates, David W.; Gandhi, Tejal K.			Medication dispensing errors and potential adverse drug events before and after implementing bar code technology in the pharmacy	ANNALS OF INTERNAL MEDICINE			English	Article							PHYSICIAN ORDER ENTRY; HOSPITALIZED-PATIENTS; SYSTEMS; SAFETY; PREVENTION; CARE	Background: Many dispensing errors made in hospital pharmacies can harm patients. Some hospitals are investing in bar code technology to reduce these errors, but data about its efficacy are limited. Objective: To evaluate whether implementation of bar code technology reduced dispensing errors and potential adverse drug events (ADEs). Design: Before-and-after study using direct observations. Setting: Hospital pharmacy at a 735-bed tertiary care academic medical center. Intervention: A bar code-assisted dispensing system was implemented in 3 configurations. In 2 configurations, all doses were scanned once during the dispensing process. In the third configuration, only 1 dose was scanned if several doses of the same medication were being dispensed. Measurements: Target dispensing errors, defined as dispensing errors that bar code technology was designed to address, and target potential ADEs, defined as target dispensing errors that can harm patients. Results: In the pre- and post-bar code implementation periods, the authors observed 115 164 and 253 984 dispensed medication doses, respectively. Overall, the rates of target potential ADEs and all potential ADEs decreased by 74% and 63%, respectively. Of the 3 configurations of bar code technology studied, the 2 configurations that required staff to scan all doses had a 93% to 96% relative reduction in the incidence of target dispensing errors (P < 0.001) and 86% to 97% relative reduction in the incidence of potential ADEs (P < 0.001). However, the configuration that did not require scanning of every dose had only a 60% relative reduction in the incidence of target dispensing errors (P < 0.001) and an increased (by 2.4-fold) incidence of target potential ADEs (P = 0.014). There were several potentially life-threatening ADEs involving intravenous dopamine and intravenous heparin in that configuration. Limitations: The authors used surrogate outcomes; did not mask assessors to the purpose of study; and excluded the controlled substance fill process (a process with low error rates at baseline) from the study, which may bias the combined decrease in error rates toward a larger magnitude. Conclusions: The overall rates of dispensing errors and potential ADEs substantially decreased after implementing bar code technology. However, the technology should be configured to scan every dose during the dispensing process.	Harvard Univ, Div Gen Med & Primary Care, Sch Med, Brigham & Womens Hosp, Boston, MA 02120 USA; Partners Informat Syst, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Poon, EG (corresponding author), Harvard Univ, Div Gen Med & Primary Care, Sch Med, Brigham & Womens Hosp, 1620 Tremont St,3rd Floor, Boston, MA 02120 USA.	epoon@partners.org	Bates, David/AAE-7283-2019	Poon, Eric/0000-0002-7251-5842	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS014053] Funding Source: NIH RePORTER; AHRQ HHS [HS14053-02] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Bates DW, 2000, BRIT MED J, V320, P788, DOI 10.1136/bmj.320.7237.788; Bates DW, 1999, ARCH INTERN MED, V159, P2553, DOI 10.1001/archinte.159.21.2553; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Berger RG, 2004, J AM MED INFORM ASSN, V11, P100, DOI 10.1197/jamia.M1411; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; BUSH GW, 2004, STATE UNION ADDRESS; Cina JL, 2006, JT COMM J QUAL PATIE, V32, P73, DOI 10.1016/S1553-7250(06)32010-7; Gandhi TK, 2000, J GEN INTERN MED, V15, P149, DOI 10.1046/j.1525-1497.2000.04199.x; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; *IS SIGM, YIELD SIGM CONV TABL; Kaushal R, 2003, ARCH INTERN MED, V163, P1409, DOI 10.1001/archinte.163.12.1409; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Kucukarslan SN, 2003, ARCH INTERN MED, V163, P2014, DOI 10.1001/archinte.163.17.2014; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; Leape LL, 1999, JAMA-J AM MED ASSOC, V282, P267, DOI 10.1001/jama.282.3.267; *MARKL FDN RW JOHN, 2004, CONN AM HEALTHC FIN; *MARKL FDN RW JOHN, 2004, ACH EL CONN HEALTHC; Murray M, 2001, AHRQ PUBLICATION, P111; *NAT COMM VIT HLTH, 2001, INF HLTH STRAT BUILD; Neuenschwander M, 2003, AM J HEALTH-SYST PH, V60, P1219; Oren E, 2003, AM J HEALTH-SYST PH, V60, P1447, DOI 10.1093/ajhp/60.14.1447; Patterson ES, 2004, J AM MED INFORM ASSN, V11, P50, DOI 10.1197/jamia.M1364; Patterson ES, 2002, J AM MED INFORM ASSN, V9, P540, DOI 10.1197/jamia.M1061; Pedersen CA, 2003, AM J HEALTH-SYST PH, V60, P52, DOI 10.1093/ajhp/60.1.52; Rothschild JM, 2005, CRIT CARE MED, V33, P533, DOI 10.1097/01.ccm.0000155912.73313.cd; Thompson T, 2004, DECADE HLTH INFORM T; 2004, FED REG, V69, P9119	28	175	179	1	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2006	145	6					426	434		10.7326/0003-4819-145-6-200609190-00006	http://dx.doi.org/10.7326/0003-4819-145-6-200609190-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087OU	16983130				2022-12-28	WOS:000240752500004
J	Hickie, I; Davenport, T; Wakefield, D; Vollmer-Conna, U; Cameron, B; Vernon, SD; Reeves, WC; Lloyd, A				Hickie, Ian; Davenport, Trace; Wakefield, Denis; Vollmer-Conna, Ute; Cameron, Barbara; Vernon, Suzanne D.; Reeves, William C.; Lloyd, Andrew		Dubbo Infection Outcomes Study	Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							ACUTE SICKNESS BEHAVIOR; PRIMARY-CARE; Q-FEVER; PROLONGED FATIGUE; GLANDULAR FEVER; MONONUCLEOSIS; DISEASE; DISORDERS; ILLNESS; SCALE	Objective To delineate the risk factors, symptom patterns, and longitudinal course of prolonged illnesses after a variety of acute infections. Design Prospective cohort stud), following patients from the time of acute infection with Epstein-Barr virus (glandular fever), Coxiella burnetti (Q fever), or Ross River virus (epidemic polyarthritis). Setting The region surrounding the township of Dubbo in rural Australia, encompassing a 200 km geographical radius and 104 400 residents. Participants 253 patients enrolled and followed at regular intervals over 12 months by self report, structured interview, and clinical assessment. Outcome measures Detailed medical, psychiatric, and laboratory evaluations at six months to apply diagnostic criteria for chronic fatigue syndrome. Premorbid and intercurrent illness characteristics recorded to define risk factors for chronic fatigue syndrome. Self reported illness phenotypes compared between infective groups. Results Prolonged. illness characterised by disabling fatigue, musculoskeletal pain, neurocognitive difficulties, and mood disturbance Was evident in 29 (12%) of 253 participants at six months, of whom 28 (11%) met die diagnostic criteria for chronic fatigue syndrome. This post-infective fatigue syndrome phenotype was stereotyped and occurred at a similar 1 incidence after each infection. The syndrome was predicted largely by the severity of the acute illness rather dian by demographic, psychological, or microbiological factors. Conclusions A relatively uniform post-infective fatigue syndrome persists in a significant minority of patients for six months or more after clinical infection With several different viral and non-viral micro-organisms. Post-infective fatigue syndrome is a valid illness model for investigating one pathophysiological pathway to chronic fatigue syndrome.	Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia; Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2050, Australia; Univ New S Wales, Sch Psychiat, Kensington, NSW 2033, Australia; Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Atlanta, GA 31033 USA	University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney; Centers for Disease Control & Prevention - USA	Lloyd, A (corresponding author), Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia.	alloyd@unsw.edu.au	Hickie, Ian B/K-8975-2015; Lloyd, Andrew/AAF-6071-2022; Lloyd, Andrew/AFJ-8960-2022; Lloyd, Andrew/E-7334-2017	Hickie, Ian B/0000-0001-8832-9895; Lloyd, Andrew/0000-0001-6277-8887; Lloyd, Andrew/0000-0001-6277-8887; 	PHS HHS [U50/CCU019851-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AB RICKINSON, 2001, FIELDS VIROLOGY, P2575; Afari N, 2003, AM J PSYCHIAT, V160, P221, DOI 10.1176/appi.ajp.160.2.221; Ayres JG, 1998, QJM-MON J ASSOC PHYS, V91, P105, DOI 10.1093/qjmed/91.2.105; Buchwald DS, 2000, AM J MED, V109, P531, DOI 10.1016/S0002-9343(00)00560-X; Cameron B, 2006, J INFECT DIS, V193, P664, DOI 10.1086/500248; Candy B, 2003, PSYCHOL MED, V33, P847, DOI 10.1017/S0033291703007554; CRAIG AR, 1984, BRIT J MED PSYCHOL, V57, P173, DOI 10.1111/j.2044-8341.1984.tb01597.x; Evans AC, 1934, J AMER MED ASSOC, V103, P0665, DOI 10.1001/jama.1934.02750350029008; Eysenck H.J., 1975, MANUAL EYSENCK PERSO; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; GOLD D, 1990, JAMA-J AM MED ASSOC, V264, P48, DOI 10.1001/jama.264.1.48; Hadzi-Pavlovic D, 2000, SOC PSYCH PSYCH EPID, V35, P471, DOI 10.1007/s001270050266; Harley D, 2002, MED J AUSTRALIA, V177, P352, DOI 10.5694/j.1326-5377.2002.tb04836.x; Harley D, 2001, CLIN MICROBIOL REV, V14, P909, DOI 10.1128/CMR.14.4.909-932.2001; HENEINE W, 1994, CLIN INFECT DIS, V18, pS121, DOI 10.1093/clinids/18.Supplement_1.S121; Hickie I, 1999, PSYCHOL MED, V29, P855, DOI 10.1017/S0033291799008582; Hickie IB, 2001, MED J AUSTRALIA, V175, pS10; HOTOPF M, 1996, J NEUROL NEUROSUR PS, V60, P495; ISAACS R, 1948, BLOOD, V3, P858, DOI 10.1182/blood.V3.8.858.858; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Mawle AC, 1995, CLIN INFECT DIS, V21, P1386, DOI 10.1093/clinids/21.6.1386; Robertson P, 2003, J MED VIROL, V70, P617, DOI 10.1002/jmv.10439; SHADICK NA, 1994, ANN INTERN MED, V121, P560, DOI 10.7326/0003-4819-121-8-199410150-00002; SHARLICK NA, 1994, ANN INTERN MED, V121, P560; Vollmer-Conna U, 2004, PSYCHOL MED, V34, P1289, DOI 10.1017/S0033291704001953; Vollmer-Conna U, 2001, PSYCHOL MED, V31, P761, DOI 10.1017/S0033291701003841; VonKorff M, 1996, J CLIN EPIDEMIOL, V49, P297, DOI 10.1016/0895-4356(95)00512-9; WESSELY S, 1995, LANCET, V345, P1333, DOI 10.1016/S0140-6736(95)92537-6; White PD, 2004, PSYCHOL MED, V34, P499, DOI 10.1017/S0033291703001302; White PD, 1998, BRIT J PSYCHIAT, V173, P475, DOI 10.1192/bjp.173.6.475; WHITE PD, 1995, PSYCHOL MED, V25, P907, DOI 10.1017/S0033291700037399; White PD, 2001, LANCET, V358, P1946, DOI 10.1016/S0140-6736(01)06961-6; Wilson A, 2001, AUST NZ J PSYCHIAT, V35, P520, DOI 10.1046/j.1440-1614.2001.00888.x; WITTCHEN HU, 1991, BRIT J PSYCHIAT, V159, P645, DOI 10.1192/bjp.159.5.645; Working Group of the Royal Australasian College of Physicians, 2002, Med J Aust, V176, pS17; WORSWICK D, 1985, J MED MICROBIOL, V19, P281, DOI 10.1099/00222615-19-3-281	36	419	422	0	31	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 16	2006	333	7568					575	578		10.1136/bmj.38933.585764.AE	http://dx.doi.org/10.1136/bmj.38933.585764.AE			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	089KB	16950834	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000240878200014
J	Griffith, CA; Penteado, P; Rannou, P; Brown, R; Boudon, V; Baines, KH; Clark, R; Drossart, P; Buratti, B; Nicholson, P; McKay, CP; Coustenis, A; Negrao, A; Jaumann, R				Griffith, C. A.; Penteado, P.; Rannou, P.; Brown, R.; Boudon, V.; Baines, K. H.; Clark, R.; Drossart, P.; Buratti, B.; Nicholson, P.; McKay, C. P.; Coustenis, A.; Negrao, A.; Jaumann, R.			Evidence for a polar ethane cloud on Titan	SCIENCE			English	Article							SURFACE; ATMOSPHERE; METHANE; TEMPERATURES; TRITON; WINDS; RAIN; N-2; ICE	Spectra from Cassini's Visual and Infrared Mapping Spectrometer reveal the presence of a vast tropospheric cloud on Titan at latitudes 51 degrees to 68 degrees north and all longitudes observed (10 degrees to 190 degrees west). The derived characteristics indicate that this cloud is composed of ethane and forms as a result of stratospheric subsidence and the particularly cool conditions near the moon's north pole. Preferential condensation of ethane, perhaps as ice, at Titan's poles during the winters may partially explain the lack of liquid ethane oceans on Titan's surface at middle and lower latitudes.	Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Versailles, Serv Aeron, F-91371 Verrieres Le Buisson, France; Univ Bourgogne, Phys Lab, CNRS, UMR 5027, F-21078 Dijon, France; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; US Geol Survey, Denver, CO 80225 USA; Observ Paris, Meudon, France; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; NASA, Ames Res Ctr, Mountain View, CA USA; Observ Astron Lisboa, P-1349018 Lisbon, Portugal; Deutsch Zentrum Luft & Raumfahrt, Inst Planetary Explorat, Oberpfaffenhofen, Germany	University of Arizona; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of the Interior; United States Geological Survey; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Cornell University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Universidade de Lisboa; Helmholtz Association; German Aerospace Centre (DLR)	Griffith, CA (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.		Jaumann, Ralf/N-1001-2018; Penteado, Paulo/F-9081-2012; RANNOU, Pascal/I-9059-2012; BOUDON, Vincent/A-4504-2010; Drossart, Pierre/H-8670-2013	Jaumann, Ralf/0000-0002-9759-6597; Penteado, Paulo/0000-0001-6759-2037; Negrao, Alberto/0000-0001-6042-1294; RANNOU, pascal/0000-0003-0836-723X				Barth EL, 2003, ICARUS, V162, P94, DOI 10.1016/S0019-1035(02)00067-2; Boudon V, 2006, J QUANT SPECTROSC RA, V98, P394, DOI 10.1016/j.jqsrt.2005.06.003; Brown ME, 2002, NATURE, V420, P795, DOI 10.1038/nature01302; Brown RH, 2003, ICARUS, V164, P461, DOI 10.1016/S0019-1035(03)00134-9; COUSTENIS A, 1995, ICARUS, V115, P126, DOI 10.1006/icar.1995.1084; Elachi C, 2005, SCIENCE, V308, P970, DOI 10.1126/science.1109919; Flasar FM, 2005, SCIENCE, V308, P975, DOI 10.1126/science.1111150; Fulchignoni M, 2005, NATURE, V438, P785, DOI 10.1038/nature04314; Griffith CA, 2000, SCIENCE, V290, P509, DOI 10.1126/science.290.5491.509; Griffith CA, 2005, SCIENCE, V310, P474, DOI 10.1126/science.1117702; Griffith CA, 2003, SCIENCE, V300, P628, DOI 10.1126/science.1081897; Lorenz RD, 2006, SCIENCE, V312, P724, DOI 10.1126/science.1123257; Lorenz RD, 2001, GEOPHYS RES LETT, V28, P4453, DOI 10.1029/2001GL013728; LUNINE J, 2005, 36 ANN LUN PLAN SCI; LUNINE JI, 1983, SCIENCE, V222, P1229, DOI 10.1126/science.222.4629.1229; Mayo LA, 2005, ICARUS, V176, P316, DOI 10.1016/j.icarus.2005.01.020; MCDONALD JE, 1964, J ATMOS SCI, V21, P76, DOI 10.1175/1520-0469(1964)021<0076:OACGTM>2.0.CO;2; MCKELLAR ARW, 1989, ICARUS, V80, P361, DOI 10.1016/0019-1035(89)90146-2; Niemann HB, 2005, NATURE, V438, P779, DOI 10.1038/nature04122; Osegovic JP, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002435; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; Quirico E, 1997, ICARUS, V127, P354, DOI 10.1006/icar.1996.5663; Rannou P, 2006, SCIENCE, V311, P201, DOI 10.1126/science.1118424; Roe HG, 2005, ASTROPHYS J, V618, pL49, DOI 10.1086/427499; Roe HG, 2002, ASTROPHYS J, V581, P1399, DOI 10.1086/344403; Rothman LS, 2003, J QUANT SPECTROSC RA, V82, P5, DOI 10.1016/S0022-4073(03)00146-8; STAMNES K, 1988, APPL OPTICS, V27, P2502, DOI 10.1364/AO.27.002502; THOMPSON WR, 1990, NASA C PUBL, V3077, P303; Tobie G, 2006, NATURE, V440, P61, DOI 10.1038/nature04497; Tokano T, 2005, ICARUS, V173, P222, DOI 10.1016/j.icarus.2004.08.019; Tomasko MG, 2005, NATURE, V438, P765, DOI 10.1038/nature04126; TOON OB, 1988, ICARUS, V75, P255, DOI 10.1016/0019-1035(88)90005-X; West RA, 2005, NATURE, V436, P670, DOI 10.1038/nature03824; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963	34	140	140	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2006	313	5793					1620	1622		10.1126/science.1128245	http://dx.doi.org/10.1126/science.1128245			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973876				2022-12-28	WOS:000240498900040
J	Menot, G; Bard, E; Rostek, F; Weijers, JWH; Hopmans, EC; Schouten, S; Damste, JSS				Menot, Guillemette; Bard, Edouard; Rostek, Frauke; Weijers, Johan W. H.; Hopmans, Ellen C.; Schouten, Stefan; Damste, Jaap S. Sinninghe			Early reactivation of European rivers during the last deglaciation	SCIENCE			English	Article							TERRESTRIAL ORGANIC-MATTER; NORTH-ATLANTIC OCEAN; SEA-LEVEL CHANGE; GLACIAL MAXIMUM; ICE-SHEET; HEINRICH EVENTS; OXYGEN-ISOTOPE; SEDIMENTS; SIGNALS; GISP2	During the Last Glacial Maximum, the sea-level lowstand combined with the large extent of the Fennoscandian and British ice sheets led to the funneling of European continental runoff, resulting in the largest river system that ever drained the European continent. Here, we show an abrupt and early reactivation of the European hydrological cycle at the onset of the last deglaciation, leading to intense discharge of the Channel River into the Bay of Biscay. This freshwater influx, probably combined with inputs from proglacial or ice-dammed lakes, dramatically affected the hydrology of the region, both on land and in the ocean.	Univ Aix Marseille 3, Coll France, CEREGE, CNRS,UMR 6635, F-13545 Aix En Provence, France; Netherlands Inst Sea Res, Dept Marine Biogeochem & Toxicol, NL-1790 AB Den Burg, Netherlands	UDICE-French Research Universities; Aix-Marseille Universite; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Menot, G (corresponding author), Univ Aix Marseille 3, Coll France, CEREGE, CNRS,UMR 6635, Europole Arbois,BP 80, F-13545 Aix En Provence, France.	gmenot@cerege.fr; bard@cerege.fr	Bard, Edouard/G-7717-2014; Damste, Jaap S Sinninghe/F-6128-2011; Ménot, Guillemette/A-5403-2017	Damste, Jaap S Sinninghe/0000-0002-8683-1854; Ménot, Guillemette/0000-0003-2423-8294				Adegbie AT, 2003, PALAEOGEOGR PALAEOCL, V197, P323, DOI 10.1016/S0031-0182(03)00474-7; Allen JRM, 1999, NATURE, V400, P740, DOI 10.1038/23432; Alley RB, 2002, QUATERNARY SCI REV, V21, P431, DOI 10.1016/S0277-3791(01)00072-5; Antoine P, 2003, J QUATERNARY SCI, V18, P227, DOI 10.1002/jqs.762; Auffret G, 2002, MAR GEOL, V188, P79, DOI 10.1016/S0025-3227(02)00276-1; Bard E, 2000, SCIENCE, V289, P1321, DOI 10.1126/science.289.5483.1321; Bourillet JF, 2003, J QUATERNARY SCI, V18, P261, DOI 10.1002/jqs.757; Bowen DQ, 2002, QUATERNARY SCI REV, V21, P89, DOI 10.1016/S0277-3791(01)00102-0; BROECKER WS, 1989, NATURE, V341, P318, DOI 10.1038/341318a0; Damste JSS, 2002, J LIPID RES, V43, P1641, DOI 10.1194/jlr.M200148-JLR200; Damste JSS, 2000, CHEM COMMUN, P1683, DOI 10.1039/b004517i; Denton G. H., 1981, LAST GREAT ICE SHEET; Ganopolski A, 2001, NATURE, V409, P153, DOI 10.1038/35051500; Goni MFS, 2000, QUATERNARY RES, V54, P394, DOI 10.1006/qres.2000.2176; Grousset FE, 2000, GEOLOGY, V28, P123; Herfort L, 2006, LIMNOL OCEANOGR, V51, P2196, DOI 10.4319/lo.2006.51.5.2196; Hopmans EC, 2004, EARTH PLANET SC LETT, V224, P107, DOI 10.1016/j.epsl.2004.05.012; Ivy-Ochs S, 2006, J QUATERNARY SCI, V21, P115, DOI 10.1002/jqs.955; Jennerjahn TC, 2004, SCIENCE, V306, P2236, DOI 10.1126/science.1102490; Johnsen SJ, 2001, J QUATERNARY SCI, V16, P299, DOI 10.1002/jqs.622; JONES GA, 1988, NATURE, V336, P56, DOI 10.1038/336056a0; Lambeck K, 2002, QUATERNARY SCI REV, V21, P343, DOI 10.1016/S0277-3791(01)00071-3; Lambeck K, 1997, PALAEOGEOGR PALAEOCL, V129, P1, DOI 10.1016/S0031-0182(96)00061-2; Manabe S, 1997, PALEOCEANOGRAPHY, V12, P321, DOI 10.1029/96PA03932; Mangerud J, 2004, QUATERNARY SCI REV, V23, P1313, DOI 10.1016/j.quascirev.2003.12.009; Marks L, 2002, QUATERNARY SCI REV, V21, P103, DOI 10.1016/S0277-3791(01)00086-5; McCabe AM, 1998, NATURE, V392, P373, DOI 10.1038/32866; Nebout NC, 2002, GEOLOGY, V30, P863, DOI 10.1130/0091-7613(2002)030<0863:EAAAHP>2.0.CO;2; Pailler D, 2002, PALAEOGEOGR PALAEOCL, V181, P431, DOI 10.1016/S0031-0182(01)00444-8; Renssen H, 2003, QUATERNARY SCI REV, V22, P209, DOI 10.1016/S0277-3791(02)00190-7; Rinterknecht VR, 2006, SCIENCE, V311, P1449, DOI 10.1126/science.1120702; Rosell-Mele A, 1998, PALEOCEANOGRAPHY, V13, P694, DOI 10.1029/98PA02355; Schefuss E, 2005, NATURE, V437, P1003, DOI 10.1038/nature03945; Scourse JD, 2000, EARTH PLANET SC LETT, V182, P187, DOI 10.1016/S0012-821X(00)00241-7; STOCKER TF, 1991, NATURE, V351, P729, DOI 10.1038/351729a0; Stuiver M, 2000, QUATERNARY RES, V53, P277, DOI 10.1006/qres.2000.2127; Svendsen JI, 2004, QUATERNARY SCI REV, V23, P1229, DOI 10.1016/j.quascirev.2003.12.008; Tzedakis PC, 2002, SCIENCE, V297, P2044, DOI 10.1126/science.1073083; Weijers JWH, 2006, ENVIRON MICROBIOL, V8, P648, DOI 10.1111/j.1462-2920.2005.00941.x; Zaragosi S, 2001, EARTH PLANET SC LETT, V188, P493, DOI 10.1016/S0012-821X(01)00332-6	40	101	107	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2006	313	5793					1623	1625		10.1126/science.1130511	http://dx.doi.org/10.1126/science.1130511			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973877	Green Submitted			2022-12-28	WOS:000240498900041
J	Taubner, T; Korobkin, D; Urzhumov, Y; Shvets, G; Hillenbrand, R				Taubner, Thomas; Korobkin, Dmitriy; Urzhumov, Yaroslav; Shvets, Gennady; Hillenbrand, Rainer			Near-field microscopy through a SiC superlens	SCIENCE			English	Article							METAMATERIALS; RESOLUTION		Max Planck Inst Biochem, Nanophoton Grp, D-82152 Martinsried, Germany; Univ Texas, Dept Phys, Austin, TX 78712 USA	Max Planck Society; University of Texas System; University of Texas Austin	Hillenbrand, R (corresponding author), Max Planck Inst Biochem, Nanophoton Grp, Klopferspitz 18, D-82152 Martinsried, Germany.	hillenbr@biochem.mpg.de	Hillenbrand, Rainer/N-3428-2016; Urzhumov, Yaroslav A/E-8360-2010; Taubner, Thomas/E-8779-2012	Hillenbrand, Rainer/0000-0002-1904-4551; Taubner, Thomas/0000-0002-0628-3043				Fang N, 2005, SCIENCE, V308, P534, DOI 10.1126/science.1108759; Hillenbrand R, 2002, NATURE, V418, P159, DOI 10.1038/nature00899; Korobkin D, 2006, J OPT SOC AM B, V23, P468, DOI 10.1364/JOSAB.23.000468; Lewis A, 2003, NAT BIOTECHNOL, V21, P1377, DOI 10.1038/nbt898; Melville DOS, 2005, OPT EXPRESS, V13, P2127, DOI 10.1364/OPEX.13.002127; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Smith DR, 2004, SCIENCE, V305, P788, DOI 10.1126/science.1096796; ZENHAUSERN F, 1995, SCIENCE, V269, P1083, DOI 10.1126/science.269.5227.1083	8	473	486	4	200	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2006	313	5793					1595	1595		10.1126/science.1131025	http://dx.doi.org/10.1126/science.1131025			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973871				2022-12-28	WOS:000240498900034
J	Cerny, S; Kunzendorf, U				Cerny, Simon; Kunzendorf, Ulrich			Radiographic appearance of lanthanum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Kiel, D-24105 Kiel, Germany	University of Kiel	Cerny, S (corresponding author), Univ Kiel, D-24105 Kiel, Germany.	public@nephro.uni-kiel.de	Kunzendorf, Ulrich/A-8257-2010						0	26	29	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 14	2006	355	11					1160	1160		10.1056/NEJMicm050535	http://dx.doi.org/10.1056/NEJMicm050535			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083NJ	16971722				2022-12-28	WOS:000240462800010
J	Prescher, JA; Bertozzi, CR				Prescher, Jennifer A.; Bertozzi, Carolyn R.			Chemical technologies for probing glycans	CELL			English	Review							MASS-SPECTROMETRY; OLIGOSACCHARIDES; GLYCOSYLATION; SYSTEMS	Glycans are central to many biological processes, but efforts to define their functions at the molecular level have been frustrated by a lack of suitable technologies. Here we highlight chemical tools that are beginning to address this need.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Bertozzi, CR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	crb@berkeley.edu						BROWN JR, 2003, CARBOHYDRATE BASED D, P883; Dell A, 2001, SCIENCE, V291, P2351, DOI 10.1126/science.1058890; Dube DH, 2003, CURR OPIN CHEM BIOL, V7, P616, DOI 10.1016/j.cbpa.2003.08.006; Hang HC, 2004, CHEM BIOL, V11, P337, DOI 10.1016/j.chembiol.2004.02.023; Hanson S, 2004, TRENDS BIOCHEM SCI, V29, P656, DOI 10.1016/j.tibs.2004.10.004; Hsu KL, 2006, NAT CHEM BIOL, V2, P153, DOI 10.1038/nchembio767; Keppler OT, 2001, GLYCOBIOLOGY, V11, p11R, DOI 10.1093/glycob/11.2.11R; Kiessling LL, 2000, CURR OPIN CHEM BIOL, V4, P696, DOI 10.1016/S1367-5931(00)00153-8; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Morelle W, 2005, CURR PHARM DESIGN, V11, P2615, DOI 10.2174/1381612054546897; Murrell MF, 2004, CHEMBIOCHEM, V5, P1334, DOI 10.1002/cbic.200400143; Murrey HE, 2006, P NATL ACAD SCI USA, V103, P21, DOI 10.1073/pnas.0503381102; Nandi A, 2006, ANAL CHEM, V78, P452, DOI 10.1021/ac051207j; Park YM, 2005, MASS SPECTROM REV, V24, P232, DOI 10.1002/mas.20010; Prescher JA, 2005, NAT CHEM BIOL, V1, P13, DOI 10.1038/nchembio0605-13; VARKI A, 1999, ESSENTIALS GLYCOBIOL, P1, DOI [10.1101/9781621824213, DOI 10.1101/9781621824213]	16	158	163	5	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2006	126	5					851	854		10.1016/j.cell.2006.08.017	http://dx.doi.org/10.1016/j.cell.2006.08.017			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959565	Bronze			2022-12-28	WOS:000240675000013
J	Siddiqi, I; Clarke, J				Siddiqi, Irfan; Clarke, John			Entangled solid-state circuits	SCIENCE			English	Editorial Material							QUANTUM-STATE		Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Siddiqi, I (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	irfan_siddiqi@berkeley.edu; jclarke@berkeley.edu	Siddiqi, Irfan/E-5548-2015					Chiorescu I, 2003, SCIENCE, V299, P1869, DOI 10.1126/science.1081045; Chuang IL, 1998, P ROY SOC A-MATH PHY, V454, P447, DOI 10.1098/rspa.1998.0170; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; LEONHARDT U, 1995, PHYS REV LETT, V74, P4101, DOI 10.1103/PhysRevLett.74.4101; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Steffen M, 2006, SCIENCE, V313, P1423, DOI 10.1126/science.1130886; STOKES G G, 1851, CAMBRIDGE PHILOS SOC, V9, P399; Vion D, 2002, SCIENCE, V296, P886, DOI 10.1126/science.1069372; von Neumann J, 1929, PHYS Z, V30, P467	10	4	4	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2006	313	5792					1400	1401		10.1126/science.1132544	http://dx.doi.org/10.1126/science.1132544			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16959997	Green Submitted			2022-12-28	WOS:000240348700031
J	Tu, HP; Nelson, O; Bezprozvanny, A; Wang, ZN; Lee, SF; Hao, YH; Serneels, L; De Strooper, B; Yu, G; Bezprozvanny, I				Tu, Huiping; Nelson, Omar; Bezprozvanny, Arseny; Wang, Zhengnan; Lee, Sheu-Fen; Hao, Yi-Heng; Serneels, Lutgarde; De Strooper, Bart; Yu, Gang; Bezprozvanny, Ilya			Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations	CELL			English	Article							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE ACTIVITY; 1,4,5-TRISPHOSPHATE RECEPTOR ISOFORMS; CAPACITATIVE CALCIUM-ENTRY; LONG-TERM POTENTIATION; ENDOPLASMIC-RETICULUM; STORES; CELLS; MICE; COMPARTMENTS	Alzheimer's disease (AD) is a progressive and irreversible neurodegenerative disorder. Mutations in presenilins 1 and 2 (PS1 and PS2) account for similar to 40% of familial AD (FAD) cases. FAD mutations and genetic deletions of presenilins have been associated with calcium (Ca2+) signaling abnormalities. We demonstrate that wild-type presenilins, but not PS1-M146V and PS2-N141I FAD mutants, can form low-conductance divalent-cation-permeable ion channels in planar lipid bilayers. In experiments with PS1/2 double knockout (DKO) mouse embryonic fibroblasts (MEFs), we find that presenilins account for similar to 80% of passive Ca2+ leak from the endoplasmic reticulum. Deficient Ca2+ signaling in DKO MEFs can be rescued by expression of wild-type PS1 or PS2 but not by expression of PS1-M146V or PS2-N141I mutants. The ER Ca2+ leak function of presenilins is independent of their gamma-secretase activity. Our data suggest a Ca2+ signaling function for presenilins and provide support for the "Ca2+ hypothesis of AD".	Univ Texas, SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; Katholieke Univ Leuven, B-3000 Louvain, Belgium; Flanders Interuniv Inst Biotechnol VIB4, Ctr Human Genet, B-3000 Louvain, Belgium; Univ Texas, SW Med Ctr Dallas, Ctr Basic Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; KU Leuven; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Bezprozvanny, I (corresponding author), Univ Texas, SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	ilya.bezprozvanny@utsouthwestern.edu	de+Strooper, Bart/Z-1638-2019; De Strooper, Bart/F-6507-2012	De Strooper, Bart/0000-0001-5455-5819; Serneels, Lutgarde/0000-0002-5463-4231	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023104, P30AG012300] Funding Source: NIH RePORTER; NIA NIH HHS [P30 AG12300, R01 AG023104, P30 AG012300] Funding Source: Medline; NINDS NIH HHS [R01 NS038082, R01 NS38082, R01 NS038082-05A2] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Begley JG, 1999, J NEUROCHEM, V72, P1030, DOI 10.1046/j.1471-4159.1999.0721030.x; Camello C, 2002, CELL CALCIUM, V32, P355, DOI 10.1016/S0143416002001926; Cedazo-Minguez A, 2002, J BIOL CHEM, V277, P36646, DOI 10.1074/jbc.M112117200; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Herms J, 2003, J BIOL CHEM, V278, P2484, DOI 10.1074/jbc.M206769200; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Hofer AM, 1999, METH MOL B, V114, P249; ITO E, 1994, P NATL ACAD SCI USA, V91, P534, DOI 10.1073/pnas.91.2.534; Kasri NN, 2006, CELL CALCIUM, V40, P41, DOI 10.1016/j.ceca.2006.03.005; KHACHATURIAN ZS, 1989, ANN NY ACAD SCI, V568, P1, DOI 10.1111/j.1749-6632.1989.tb12485.x; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Leissring MA, 1999, J NEUROCHEM, V72, P1061, DOI 10.1046/j.1471-4159.1999.0721061.x; Leissring MA, 1999, J BIOL CHEM, V274, P32535, DOI 10.1074/jbc.274.46.32535; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; Leissring MA, 2001, NEUROBIOL DIS, V8, P469, DOI 10.1006/nbdi.2001.0382; Lomax RB, 2002, J BIOL CHEM, V277, P26479, DOI 10.1074/jbc.M201845200; Mattson MP, 2000, TRENDS NEUROSCI, V23, P222, DOI 10.1016/S0166-2236(00)01548-4; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Pinton P, 2000, J CELL BIOL, V148, P857, DOI 10.1083/jcb.148.5.857; Ris L, 2003, J BIOL CHEM, V278, P44393, DOI 10.1074/jbc.M300971200; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schneider I, 2001, J BIOL CHEM, V276, P11539, DOI 10.1074/jbc.M010977200; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Smith IF, 2005, CELL CALCIUM, V38, P427, DOI 10.1016/j.ceca.2005.06.021; Stutzmann GE, 2004, J NEUROSCI, V24, P508, DOI 10.1523/JNEUROSCI.4386-03.2004; Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006; Takeda T, 2005, FASEB J, V19, P2069, DOI 10.1096/fj.05-3744fje; Tandon A, 2002, GENOME BIOL, V3; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Tu HP, 2005, BIOPHYS J, V88, P1056, DOI 10.1529/biophysj.104.049601; Tu HP, 2005, BIOPHYS J, V88, P1046, DOI 10.1529/biophysj.104.049593; Van Coppenolle F, 2004, J CELL SCI, V117, P4135, DOI 10.1242/jcs.01274; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; WOODBURY DJ, 1990, BIOPHYS J, V58, P833, DOI 10.1016/S0006-3495(90)82429-2; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	41	520	538	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2006	126	5					981	993		10.1016/j.cell.2006.06.059	http://dx.doi.org/10.1016/j.cell.2006.06.059			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959576	Green Accepted, Bronze			2022-12-28	WOS:000240675000024
J	Olaussen, KA; Dunant, A; Fouret, P; Brambilla, E; Andre, F; Haddad, V; Taranchon, E; Filipits, M; Pirker, R; Popper, HH; Stahel, R; Sabatier, L; Pignon, J; Tursz, T; Le Chevalier, T; Soria, JC				Olaussen, Ken A.; Dunant, Ariane; Fouret, Pierre; Brambilla, Elisabeth; Andre, Fabrice; Haddad, Vincent; Taranchon, Estelle; Filipits, Martin; Pirker, Robert; Popper, Helmut H.; Stahel, Rolf; Sabatier, Laure; Pignon, Jean-Pierre; Tursz, Thomas; Le Chevalier, Thierry; Soria, Jean-Charles		IALT Bio Investigators	DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NUCLEOTIDE EXCISION-REPAIR; MESSENGER-RNA LEVELS; GENE-EXPRESSION; TUMOR RESPONSE; SURVIVAL; POLYMORPHISM; ASSOCIATION; RECOMBINATION; RESISTANCE; CARCINOMA	Background: Adjuvant cisplatin-based chemotherapy improves survival among patients with completely resected non-small-cell lung cancer, but there is no validated clinical or biologic predictor of the benefit of chemotherapy. Methods: We used immunohistochemical analysis to determine the expression of the excision repair cross-complementation group 1 (ERCC1) protein in operative specimens of non-small-cell lung cancer. The patients had been enrolled in the International Adjuvant Lung Cancer Trial, thereby allowing a comparison of the effect of adjuvant cisplatin-based chemotherapy on survival, according to ERCC1 expression. Overall survival was analyzed with a Cox model adjusted for clinical and pathological factors. Results: Among 761 tumors, ERCC1 expression was positive in 335 (44%) and negative in 426 (56%). A benefit from cisplatin-based adjuvant chemotherapy was associated with the absence of ERCC1 (test for interaction, P=0.009). Adjuvant chemotherapy, as compared with observation, significantly prolonged survival among patients with ERCC1-negative tumors (adjusted hazard ratio for death, 0.65; 95% confidence interval [CI], 0.50 to 0.86; P=0.002) but not among patients with ERCC1-positive tumors (adjusted hazard ratio for death, 1.14; 95% CI, 0.84 to 1.55; P=0.40). Among patients who did not receive adjuvant chemotherapy, those with ERCC1-positive tumors survived longer than those with ERCC1-negative tumors (adjusted hazard ratio for death, 0.66; 95% CI, 0.49 to 0.90; P=0.009). Conclusions: Patients with completely resected non-small-cell lung cancer and ERCC1-negative tumors appear to benefit from adjuvant cisplatin-based chemotherapy, whereas patients with ERCC1-positive tumors do not.	Inst Gustave Roussy, Dept Med, F-94805 Villejuif, France; Commissariat Energie Atom, Lab Radiobiol & Oncol, Fontenay Aux Roses, France; Univ Paris 11, Paris, France; Inst Gustave Roussy, Biostat & Epidemiol Unit, F-94805 Villejuif, France; Inst Gustave Roussy, Dept Pathol & Translat Res, F-94805 Villejuif, France; Ctr Hosp Univ Albert Michallon, Dept Pathol, Grenoble, France; Univ Paris 06, Paris, France; Med Univ Vienna, Dept Internal Med, Vienna, Austria; Univ Med Sch Graz, Inst Pathol, Graz, Austria; Univ Spital Zurich, Klin & Poliklin Onkol, Zurich, Switzerland	UNICANCER; Gustave Roussy; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; CHU Grenoble Alpes; UDICE-French Research Universities; Sorbonne Universite; Medical University of Vienna; University of Zurich; University Zurich Hospital	Soria, JC (corresponding author), Inst Gustave Roussy, Dept Med, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	soria@igr.fr	Chabowski, Mariusz/H-9847-2019; Soria, Jean-Charles/F-3619-2014; ANDRE, François/E-5555-2015; ANDRE, Fabrice/AAL-2683-2020; Le Discorde, Magali/A-5127-2009	Chabowski, Mariusz/0000-0002-9232-4525; ANDRE, Fabrice/0000-0001-5795-8357; Le Discorde, Magali/0000-0001-5126-0900; Sabatier, Laure/0000-0003-0552-6549; PIGNON, Jean-Pierre/0000-0003-2047-1582; Olaussen, Ken/0000-0002-3115-8914; Filipits, Martin/0000-0003-2847-4534				Al-Haddad S, 1999, AM J PATHOL, V155, P2057, DOI 10.1016/S0002-9440(10)65524-1; Altaha R, 2004, INT J MOL MED, V14, P959; Brambilla E, 2005, LUNG CANCER-J IASLC, V49, pS44, DOI 10.1016/S0169-5002(05)80261-2; Chen PC, 2000, CANCER EPIDEM BIOMAR, V9, P843; DABHOLKAR M, 1992, J NATL CANCER I, V84, P1512, DOI 10.1093/jnci/84.19.1512; DABHOLKAR M, 1994, J CLIN INVEST, V94, P703, DOI 10.1172/JCI117388; De Silva IU, 2000, MOL CELL BIOL, V20, P7980, DOI 10.1128/MCB.20.21.7980-7990.2000; DOUILLARD JY, 2005, J CLIN ONCOL, V23, pA7013; Gurublihagavatula S, 2005, SEMIN RESP CRIT CARE, V26, P298, DOI 10.1055/s-2005-871988; Handra-Luca A, 2003, AM J PATHOL, V163, P957, DOI 10.1016/S0002-9440(10)63455-4; Jemal A, 2005, CA-CANCER J CLIN, V55, P259; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Joshi MBM, 2005, CLIN CANCER RES, V11, P2215; KIM DY, 2003, P AN M AM SOC CLIN, V22, P1079; Langer R, 2005, CLIN CANCER RES, V11, P7462, DOI 10.1158/1078-0432.CCR-05-0042; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Lord RVN, 2002, CLIN CANCER RES, V8, P2286; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Metzger R, 1998, J CLIN ONCOL, V16, P309, DOI 10.1200/JCO.1998.16.1.309; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Mu D, 1996, J BIOL CHEM, V271, P8285, DOI 10.1074/jbc.271.14.8285; Murray David, 2003, Am J Clin Oncol, V26, pe169, DOI 10.1097/01.coc.0000091359.11281.f4; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Nix P, 2004, CANC THER, P47; Park David J, 2003, Clin Adv Hematol Oncol, V1, P162; Reed E, 1998, CANCER TREAT REV, V24, P331, DOI 10.1016/S0305-7372(98)90056-1; Reed E, 2000, ONCOL REP, V7, P1123; Rosell R, 2002, LUNG CANCER, V38, P217, DOI 10.1016/S0169-5002(02)00224-6; SANCAR A, 1994, SCIENCE, V266, P1954, DOI 10.1126/science.7801120; Sargent RG, 2000, NUCLEIC ACIDS RES, V28, P3771, DOI 10.1093/nar/28.19.3771; Shirota Y, 2001, J CLIN ONCOL, V19, P4298, DOI 10.1200/JCO.2001.19.23.4298; Simon GR, 2005, CHEST, V127, P978, DOI 10.1378/chest.127.3.978; Strauss GM, 2004, J CLIN ONCOL, V22, p621S; Sturgis EM, 2002, ARCH OTOLARYNGOL, V128, P1084, DOI 10.1001/archotol.128.9.1084; Viguier J, 2005, CLIN CANCER RES, V11, P6212, DOI 10.1158/1078-0432.CCR-04-2216; Wachters FM, 2005, LUNG CANCER-J IASLC, V50, P211, DOI 10.1016/j.lungcan.2005.06.013; Warnecke-Eberz U, 2004, CLIN CANCER RES, V10, P3794, DOI 10.1158/1078-0432.CCR-03-0079; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623; Yu JJ, 1997, MUTAT RES-GENOMICS, V382, P13, DOI 10.1016/S1383-5726(97)00004-6; Zamble DB, 1996, BIOCHEMISTRY-US, V35, P10004, DOI 10.1021/bi960453+; Zhou W, 2004, CLIN CANCER RES, V10, P4939, DOI 10.1158/1078-0432.CCR-04-0247	41	1416	1528	4	106	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 7	2006	355	10					983	991		10.1056/NEJMoa060570	http://dx.doi.org/10.1056/NEJMoa060570			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080UF	16957145				2022-12-28	WOS:000240273300004
J	Ayas, NT; Barger, LK; Cade, BE; Hashimoto, DM; Rosner, B; Cronin, JW; Speizer, FE; Czeisler, CA				Ayas, Najib T.; Barger, Laura K.; Cade, Brian E.; Hashimoto, Dean M.; Rosner, Bernard; Cronin, John W.; Speizer, Frank E.; Czeisler, Charles A.			Extended work duration and the risk of self-reported percutaneous injuries in interns	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SLEEP-DEPRIVATION; PERFORMANCE; RESIDENTS; NIGHT; WAKEFULNESS; ALCOHOL; FATIGUE; CALL; EEG	Context In their first year of postgraduate training, interns commonly work shifts that are longer than 24 hours. Extended-duration work shifts are associated with increased risks of automobile crash, particularly during a commute from work. Interns may be at risk for other occupation-related injuries. Objective To assess the relationship between extended work duration and rates of percutaneous injuries in a diverse population of interns in the United States. Design, Setting, and Participants National prospective cohort study of 2737 of the estimated 18 447 interns in US postgraduate residency programs from July 2002 through May 2003. Each month, comprehensive Web-based surveys that asked about work schedules and the occurrence of percutaneous injuries in the previous month were sent to all participants. Case-crossover within-subjects analyses were performed. Main Outcome Measures Comparisons of rates of percutaneous injuries during day work (6:30 AM to 5:30 PM) after working overnight (extended work) vs day work that was not preceded by working overnight (nonextended work). We also compared injuries during the nighttime (11:30 PM to 7:30 AM) vs the daytime (7:30 AM to 3:30 PM). Results From a total of 17 003 monthly surveys, 498 percutaneous injuries were reported (0.029/intern-month). In 448 injuries, at least 1 contributing factor was reported. Lapse in concentration and fatigue were the 2 most commonly reported contributing factors (64% and 31% of injuries, respectively). Percutaneous injuries were more frequent during extended work compared with nonextended work (1.31/1000 opportunities vs 0.76/1000 opportunities, respectively; odds ratio [OR], 1.61; 95% confidence interval [CI], 1.46-1.78). Extended work injuries occurred after a mean of 29.1 consecutive work hours; nonextended work injuries occurred after a mean of 6.1 consecutive work hours. Injuries were more frequent during the nighttime than during the daytime (1.48/1000 opportunities vs 0.70/1000 opportunities, respectively; OR, 2.04; 95% CI, 1.98-2.11). Conclusion Extended work duration and night work were associated with an increased risk of percutaneous injuries in this study population of physicians during their first year of clinical training.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Sleep Med, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Harvard Work Hours Hlth & Safety Grp, Div Sleep Med, Boston, MA USA; Univ British Columbia, Sleep Disorders Program, Vancouver, BC V5Z 1M9, Canada; Vancouver Gen Hosp, Dept Med, Vancouver, BC, Canada; Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute	Czeisler, CA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Sleep Med, 221 Longwood Ave, Boston, MA 02115 USA.	caczeisler@hms.harvard.edu	Cade, Brian/J-6770-2019	Cade, Brian/0000-0003-1424-0673	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS012032, F32HS014130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH007567] Funding Source: NIH RePORTER; AHRQ HHS [R01 HS12032, F32 HS14130] Funding Source: Medline; NHLBI NIH HHS [T32 HL079010] Funding Source: Medline; NIOSH CDC HHS [1 R01 OH07567] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIOSH CDC HHS		Arnedt JT, 2005, JAMA-J AM MED ASSOC, V294, P1025, DOI 10.1001/jama.294.9.1025; Baldwin DC, 2004, SLEEP, V27, P217, DOI 10.1093/sleep/27.2.217; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; Cajochen C, 1999, AM J PHYSIOL-REG I, V277, pR640, DOI 10.1152/ajpregu.1999.277.3.R640; CARSKADON MA, 1992, SLEEP, V15, P396, DOI 10.1093/sleep/15.5.396; COOPERSTOCK M, 1987, OBSTET GYNECOL, V70, P852; Dawson D, 1997, NATURE, V388, P235, DOI 10.1038/40775; DIJK DJ, 1994, NEUROSCI LETT, V166, P63, DOI 10.1016/0304-3940(94)90841-9; Gerberding JL, 2003, NEW ENGL J MED, V348, P826, DOI 10.1056/NEJMcp020892; Grantcharov TP, 2001, BRIT MED J, V323, P1222, DOI 10.1136/bmj.323.7323.1222; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; *NAT RES MATCH PRO, POS OFF PERC FILL US; Parks DK, 2000, CHRONOBIOL INT, V17, P61, DOI 10.1081/CBI-100101032; Rosner B., 1999, FUNDAMENTALS BIOSTAT; TORSVALL L, 1987, ELECTROEN CLIN NEURO, V66, P502, DOI 10.1016/0013-4694(87)90096-4; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Wertz AT, 2006, JAMA-J AM MED ASSOC, V295, P163, DOI 10.1001/jama.295.2.163; PHYS HLTH STUDY, V1; PHYS HLTH STUDY, V2	21	269	274	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2006	296	9					1055	1062		10.1001/jama.296.9.1055	http://dx.doi.org/10.1001/jama.296.9.1055			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	081DW	16954484	Bronze			2022-12-28	WOS:000240298400006
J	Sharp, WD; Clague, DA				Sharp, Warren D.; Clague, David A.			50-Ma initiation of Hawaiian-Emperor bend records major change in Pacific plate motion	SCIENCE			English	Article							IZU-BONIN-MARIANA; SUBDUCTION; EVOLUTION; HOTSPOT; PLUME; AGE	The Hawaiian-Emperor bend has played a prominent yet controversial role in deciphering past Pacific plate motions and the tempo of plate motion change. New ages for volcanoes of the central and southern Emperor chain define large changes in volcanic migration rate with little associated change in the chain's trend, which suggests that the bend did not form by slowing of the Hawaiian hot spot. Initiation of the bend near Kimmei seamount about 50 million years ago (MA) was coincident with realignment of Pacific spreading centers and early magmatism in western Pacific arcs, consistent with formation of the bend by changed Pacific plate motion.	Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA	Berkeley Geochronolgy Center; Monterey Bay Aquarium Research Institute	Sharp, WD (corresponding author), Berkeley Geochronol Ctr, 2455 Ridge Rd, Berkeley, CA 94709 USA.	wsharp@bgc.org						Atwater T., 1989, GEOLOGY N AM, VN, P21; Bercovici D, 2003, EARTH PLANET SC LETT, V205, P107, DOI 10.1016/S0012-821X(02)01009-9; Bloomer S.H., 1995, AM GEOPHYSICAL UNION, V88, P1, DOI DOI 10.1029/GM088P0001; CANDE SC, 1992, J GEOPHYS RES-SOL EA, V97, P13917, DOI 10.1029/92JB01202; Clague DA, 1987, VOLCANISM HAWAII, V1350, P5; Cosca MA, 1998, ISL ARC, V7, P579, DOI 10.1046/j.1440-1738.1998.00211.x; DALRYMPLE GB, 1976, EARTH PLANET SC LETT, V31, P313, DOI 10.1016/0012-821X(76)90113-8; Davis AS, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000190; DePaolo DJ, 1996, J GEOPHYS RES-SOL EA, V101, P11643, DOI 10.1029/96JB00070; Doubrovine PV, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000745; Duncan RA, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000704; GORDON RG, 1978, NATURE, V274, P752, DOI 10.1038/274752a0; Gurnis M, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000681; Hall CE, 2003, EARTH PLANET SC LETT, V212, P15, DOI 10.1016/S0012-821X(03)00242-5; HILDE TWC, 1977, TECTONOPHYSICS, V38, P145, DOI 10.1016/0040-1951(77)90205-0; Koppers AAP, 2005, SCIENCE, V307, P904, DOI 10.1126/science.1107260; MCDOUGALL I, 1964, GEOL SOC AM BULL, V75, P107, DOI 10.1130/0016-7606(1964)75[107:PAFLOT]2.0.CO;2; MORGAN WJ, 1971, NATURE, V230, P42, DOI 10.1038/230042a0; NORTON IO, 1995, TECTONICS, V14, P1080, DOI 10.1029/95TC01256; PATRIAT P, 1984, NATURE, V311, P615, DOI 10.1038/311615a0; PEARCE JA, 1992, P OCEAN DRILLING PRO, V0125; Richards MA, 1996, EARTH PLANET SC LETT, V137, P19, DOI 10.1016/0012-821X(95)00209-U; Steinberger B, 2004, NATURE, V430, P167, DOI 10.1038/nature02660; STERN RJ, 1992, GEOL SOC AM BULL, V104, P1621, DOI 10.1130/0016-7606(1992)104<1621:SZIEFT>2.3.CO;2; Tarduno JA, 2003, SCIENCE, V301, P1064, DOI 10.1126/science.1086442; Tarduno JA, 1997, EARTH PLANET SC LETT, V153, P171, DOI 10.1016/S0012-821X(97)00169-6; WILSON JT, 1963, CAN J PHYS, V41, P863, DOI 10.1139/p63-094; Yin A, 2000, ANNU REV EARTH PL SC, V28, P211, DOI 10.1146/annurev.earth.28.1.211	28	228	261	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2006	313	5791					1281	1284		10.1126/science.1128489	http://dx.doi.org/10.1126/science.1128489			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16946069				2022-12-28	WOS:000240313500039
J	Arber, N; Eagle, CJ; Spicak, J; Racz, I; Dite, P; Hajer, J; Zavoral, M; Lechuga, MJ; Gerletti, P; Tang, J; Rosenstein, RB; Macdonald, K; Bhadra, P; Fowler, R; Wittes, J; Zauber, AG; Solomon, SD; Levin, B				Arber, Nadir; Eagle, Craig J.; Spicak, Julius; Racz, Istvan; Dite, Petr; Hajer, Jan; Zavoral, Miroslav; Lechuga, Maria J.; Gerletti, Paola; Tang, Jie; Rosenstein, Rebecca B.; Macdonald, Katie; Bhadra, Pritha; Fowler, Robert; Wittes, Janet; Zauber, Ann G.; Solomon, Scott D.; Levin, Bernard		PreSAP Trial Investigators	Celecoxib for the prevention of colorectal adenomatous polyps	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED-TRIAL; CHEMOPREVENTION; TUMORIGENESIS; EXPRESSION; ASPIRIN; CANCER	Background: Overexpression of cyclooxygenase 2 (COX-2) has been associated with colorectal adenomatous polyps and cancer, prompting researchers to propose its inhibition as a chemopreventive intervention. Methods: The Prevention of Colorectal Sporadic Adenomatous Polyps trial was a randomized, placebo-controlled, double-blind study of the COX-2 inhibitor celecoxib given daily in a single 400-mg dose. At 107 centers in 32 countries, we randomly assigned 1561 subjects who had had adenomas removed before enrollment to receive celecoxib (933 subjects) or placebo (628 subjects) daily, after stratification according to the use or nonuse of low-dose aspirin. The primary outcome was detection of adenomas at either year 1 or year 3 by colonoscopy and was compared among the groups with the use of the Mantel-Cox test. Results: Colonoscopies were performed at year 1 on 88.7 percent of the subjects who had undergone randomization and at year 3 on 79.2 percent. Of the 557 subjects in the placebo group and the 840 subjects in the celecoxib group who were included in the efficacy analysis, 264 and 270, respectively, were found to have at least one adenoma at year 1, at year 3, or both. The cumulative rate of adenomas detected through year 3 was 33.6 percent in the celecoxib group and 49.3 percent in the placebo group (relative risk, 0.64; 95 percent confidence interval, 0.56 to 0.75; P < 0.001). The cumulative rate of advanced adenomas detected through year 3 was 5.3 percent in the celecoxib group and 10.4 percent in the placebo group (relative risk, 0.49; 95 percent confidence interval, 0.33 to 0.73; P < 0.001). Adjudicated serious cardiovascular events occurred in 2.5 percent of subjects in the celecoxib group and 1.9 percent of those in the placebo group (relative risk, 1.30; 95 percent confidence interval, 0.65 to 2.62). Conclusions: The use of 400 mg of celecoxib once daily significantly reduced the occurrence of colorectal adenomas within three years after polypectomy.	Univ Texas, MD Anderson Canc Ctr, Div Canc Prevent & Populat Sci, Houston, TX 77030 USA; Tel Aviv Sourasky Med Ctr, Integrated Canc Prevent Ctr, Tel Aviv, Israel; Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; Pfizer, New York, NY USA; Inst Clin & Expt Med, Prague, Czech Republic; Fac Hosp Brno Bohunice, Brno, Czech Republic; Fac Hosp Kralovske Vinohrady, Prague, Czech Republic; Cent Mil Hosp, Prague, Czech Republic; Petz Aladar Cty Hosp, Gyor, Hungary; Stat Collaborat, Washington, DC USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Brigham & Womens Hosp, Boston, MA 02115 USA	University of Texas System; UTMD Anderson Cancer Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Pfizer; Institute for Clinical & Experimental Medicine (IKEM); University Hospital Brno; University Hospital Vinohrady; Military University Hospital Prague; Memorial Sloan Kettering Cancer Center; Harvard University; Brigham & Women's Hospital	Levin, B (corresponding author), Univ Texas, MD Anderson Canc Ctr, Div Canc Prevent & Populat Sci, 1155 Pressler St,Unit 1370, Houston, TX 77030 USA.		Solomon, Scott/I-5789-2013; Zavoral, Miroslav/AAO-9443-2020; Zavoral, Miroslav/D-9174-2017; Ferreira, Fabio/E-7942-2018	Zavoral, Miroslav/0000-0001-7883-7431; Zavoral, Miroslav/0000-0001-7883-7431; Ferreira, Fabio/0000-0002-5340-2578; Hajer, Jan/0000-0003-3780-3088; Arber, Nadir/0000-0001-5283-6991; Prof. Dr. Racz, Istvan/0000-0001-9740-6995				American Cancer Society, 2006, CANC FACTS FIG 2006; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Ferlay J, 2004, GLOBOCAN 2002 CANC I; Giardiello FM, 2002, NEW ENGL J MED, V346, P1054, DOI 10.1056/NEJMoa012015; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES PR, P342; KOCH GG, 1984, AM J MED, V77, P43; LEHMANN EL, 1975, NONPARAMETRICS STATI, P132; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; *PFIZ, 2005, CEL CEL; Pisani P, 2002, INT J CANCER, V97, P72, DOI 10.1002/ijc.1571; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Sandler RS, 2003, NEW ENGL J MED, V348, P1939; Shureiqi I, 2005, CANCER RES, V65, P11486, DOI 10.1158/0008-5472.CAN-05-2180; Sinicrope FA, 1999, GASTROENTEROLOGY, V117, P350, DOI 10.1053/gast.1999.0029900350; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Stokes ME, 2000, CATEGORICAL DATA ANA; TANAKA Y, 1987, J BIOL CHEM, V262, P1374	22	769	801	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2006	355	9					885	895		10.1056/NEJMoa061652	http://dx.doi.org/10.1056/NEJMoa061652			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	078OM	16943401	Bronze			2022-12-28	WOS:000240113100006
J	Morgan, RA; Dudley, ME; Wunderlich, JR; Hughes, MS; Yang, JC; Sherry, RM; Royal, RE; Topalian, SL; Kammula, US; Restifo, NP; Zheng, ZL; Nahvi, A; de Vries, CR; Rogers-Freezer, LJ; Mavroukakis, SA; Rosenberg, SA				Morgan, Richard A.; Dudley, Mark E.; Wunderlich, John R.; Hughes, Marybeth S.; Yang, James C.; Sherry, Richard M.; Royal, Richard E.; Topalian, Suzanne L.; Kammula, Udai S.; Restifo, Nicholas P.; Zheng, Zhili; Nahvi, Azam; de Vries, Christiaan R.; Rogers-Freezer, Linda J.; Mavroukakis, Sharon A.; Rosenberg, Steven A.			Cancer regression in patients after transfer of genetically engineered lymphocytes	SCIENCE			English	Article							T-CELLS; ANTIGEN; TUMOR; TCR; IMMUNOTHERAPY; AUTOIMMUNITY; RECOGNITION; MELANOMA; THERAPY; GENES	Through the adoptive transfer of lymphocytes after host immunodepletion, it is possible to mediate objective cancer regression in human patients with metastatic melanoma. However, the generation of tumor-specific T cells in this mode of immunotherapy is often limiting. Here we report the ability to specifically confer tumor recognition by autologous lymphocytes from peripheral blood by using a retrovirus that encodes a T cell receptor. Adoptive transfer of these transduced cells in 15 patients resulted in durable engraftment at levels exceeding 10% of peripheral blood lymphocytes for at least 2 months after the infusion. We observed high sustained levels of circulating, engineered cells at 1 year after infusion in two patients who both demonstrated objective regression of metastatic melanoma lesions. This study suggests the therapeutic potential of genetically engineered cells for the biologic therapy of cancer.	NCI, Surg Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Rosenberg, SA (corresponding author), NCI, Surg Branch, Ctr Canc Res, NIH, 10 Ctr Dr, Bethesda, MD 20892 USA.	SAR@mail.nih.gov	Wilson, Matthew H/K-3193-2013; Restifo, Nicholas Phillip/Z-1614-2019; Restifo, Nicholas Phillip/M-6549-2019; Restifo, Nicholas P/A-5713-2008	Restifo, Nicholas P./0000-0003-4229-4580	DIVISION OF CLINICAL SCIENCES - NCI [Z01SC006670] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01BC010649, Z01BC010763, Z01SC003811, Z01SC003800] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 CA999999, Z01 SC003811-32, Z01 BC010763-01] Funding Source: Medline	DIVISION OF CLINICAL SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Blattman JN, 2004, SCIENCE, V305, P200, DOI 10.1126/science.1100369; Cohen CJ, 2005, J IMMUNOL, V175, P5799, DOI 10.4049/jimmunol.175.9.5799; Cohen CJ, 2006, CANCER RES, V66, P8878, DOI 10.1158/0008-5472.CAN-06-1450; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Hughes MS, 2005, HUM GENE THER, V16, P457, DOI 10.1089/hum.2005.16.457; Kohn DB, 1998, NAT MED, V4, P775, DOI 10.1038/nm0798-775; Krogsgaard M, 2005, NAT IMMUNOL, V6, P239, DOI 10.1038/ni1173; Morgan RA, 2003, J IMMUNOL, V171, P3287, DOI 10.4049/jimmunol.171.6.3287; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; RIDDELL SR, 1990, J IMMUNOL METHODS, V128, P189, DOI 10.1016/0022-1759(90)90210-M; Rosenberg SA, 1999, IMMUNITY, V10, P281, DOI 10.1016/S1074-7613(00)80028-X; ROSENBERG SA, 1986, SCIENCE, V233, P1318, DOI 10.1126/science.3489291; Sadelain M, 2003, NAT REV CANCER, V3, P35, DOI 10.1038/nrc971; Schumacher TNM, 2002, NAT REV IMMUNOL, V2, P512, DOI 10.1038/nri841; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Yang L, 2005, P NATL ACAD SCI USA, V102, P4518, DOI 10.1073/pnas.0500600102; Zhao YB, 2005, J IMMUNOL, V174, P4415, DOI 10.4049/jimmunol.174.7.4415	19	1915	2192	6	253	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2006	314	5796					126	129		10.1126/science.1129003	http://dx.doi.org/10.1126/science.1129003			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	16946036	Green Accepted			2022-12-28	WOS:000241031200051
J	Furukawa, A; Tanaka, H				Furukawa, Akira; Tanaka, Hajime			Violation of the incompressibility of liquid by simple shear flow	NATURE			English	Article							POLYMER-SOLUTIONS; STRESS RHEOLOGY; HIGH-PRESSURE; LUBRICANTS; VISCOSITY; FLUCTUATIONS; STATE; TEMPERATURE; DEPENDENCE; FLUIDS	In standard fluid dynamics(1,2), the density change associated with flow is often assumed to be negligible, implying that the fluid is incompressible. For example, this has been established for simple shear flows, where no pressure change is associated with flow: there is no volume deformation due to viscous stress and inertial effects can be neglected. Accordingly, any flow-induced instabilities ( such as cavitation) are unexpected for simple shear flows. Here we demonstrate that the incompressibility condition can be violated even for simple shear flows, by taking into account the coupling between the flow and density fluctuations, which arises owing to the density dependence of the viscosity. We show that a liquid can become mechanically unstable above a critical shear rate that is given by the inverse of the derivative of viscosity with respect to pressure. Our model predicts that, for very viscous liquids, this shear-induced instability should occur at moderate shear rates that are experimentally accessible. Our results explain the unusual shear-induced instability observed in viscous lubricants(3-5), and may illuminate other poorly understood phenomena associated with mechanical instability of liquids at low Reynolds number; for example, shear-induced cavitation and bubble growth(6), and shear-banding of very viscous liquids such as metallic glasses(7) and the Earth's mantle(8).	Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan	University of Tokyo	Furukawa, A (corresponding author), Univ Tokyo, Inst Ind Sci, 4-6-1 Komaba, Tokyo 1538505, Japan.	furu@iis.u-tokyo.ac.jp	Tanaka, Hajime/ABF-1451-2021; Furukawa, Akira/C-8629-2009	Tanaka, Hajime/0000-0002-4444-1890; 				Alsop GI, 2004, FLOW PROCESSES FAULT; Archer LA, 1997, RHEOL ACTA, V36, P579; BAIR S, 1990, J TRIBOL-T ASME, V112, P246, DOI 10.1115/1.2920248; Bair S, 1996, RHEOL ACTA, V35, P13, DOI 10.1007/BF00366549; BAIR S, 1992, J TRIBOL-T ASME, V114, P1, DOI 10.1115/1.2920862; BAIR S, 1993, J TRIBOL-T ASME, V115, P507, DOI 10.1115/1.2921667; BOTTINGA Y, 1995, GEOCHIM COSMOCHIM AC, V59, P2725, DOI 10.1016/0016-7037(95)00168-Y; BRENNEN CE, 1995, CAVIATION BUBBLE DYN; BRUINSMA R, 1992, PHYS REV A, V45, P994, DOI 10.1103/PhysRevA.45.994; de Gennes PG, 2002, LANGMUIR, V18, P3413, DOI 10.1021/la0116342; ESTLER WT, 1975, PHYS REV A, V12, P2118, DOI 10.1103/PhysRevA.12.2118; Granick S, 2003, NAT MATER, V2, P221, DOI 10.1038/nmat854; HANES DM, 1985, J FLUID MECH, V150, P357, DOI 10.1017/S0022112085000167; HELFAND E, 1989, PHYS REV LETT, V62, P2468, DOI 10.1103/PhysRevLett.62.2468; Joseph DD, 1998, J FLUID MECH, V366, P367, DOI 10.1017/S0022112098001530; KESTIN J, 1980, PHYSICA A, V100, P335, DOI 10.1016/0378-4371(80)90124-7; Landau L. D., 1976, MECHANICS, V1; Larson R. G., 1999, STRUCTURE RHEOLOGY C, P443; Lohse D, 2003, PHYS TODAY, V56, P36, DOI 10.1063/1.1564347; MILNER ST, 1993, PHYS REV E, V48, P3674, DOI 10.1103/PhysRevE.48.3674; Neto C, 2005, REP PROG PHYS, V68, P2859, DOI 10.1088/0034-4885/68/12/R05; Onuki A, 1997, J PHYS-CONDENS MAT, V9, P6119, DOI 10.1088/0953-8984/9/29/001; Onuki A, 2002, PHASE TRANSITION DYN; Rogallo RS, 1981, NASATM81315; Roland CM, 2005, REP PROG PHYS, V68, P1405, DOI 10.1088/0034-4885/68/6/R03; SPAEPEN F, 1977, ACTA METALL MATER, V25, P407, DOI 10.1016/0001-6160(77)90232-2; STRUMPF HJ, 1974, J CHEM PHYS, V60, P3109, DOI 10.1063/1.1681497; Tanaka H, 2000, J PHYS-CONDENS MAT, V12, pR207, DOI 10.1088/0953-8984/12/15/201; Tritton D. J., 1988, PHYS FLUID DYNAMICS; YASUTOMI S, 1984, J TRIBOL-T ASME, V106, P291, DOI 10.1115/1.3260907	30	48	48	3	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2006	443	7110					434	438		10.1038/nature05119	http://dx.doi.org/10.1038/nature05119			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	17006510				2022-12-28	WOS:000240798800041
J	ter Steege, H; Pitman, NCA; Phillips, OL; Chave, J; Sabatier, D; Duque, A; Molino, JF; Prevost, MF; Spichiger, R; Castellanos, H; von Hildebrand, P; Vasquez, R				ter Steege, Hans; Pitman, Nigel C. A.; Phillips, Oliver L.; Chave, Jerome; Sabatier, Daniel; Duque, Alvaro; Molino, Jean-Francois; Prevost, Marie-Francois; Spichiger, Rodolphe; Castellanos, Hernan; von Hildebrand, Patricio; Vasquez, Rodolfo			Continental-scale patterns of canopy tree composition and function across Amazonia	NATURE			English	Article							FOREST; DIVERSITY; DISTURBANCE; DENSITY	The world's greatest terrestrial stores of biodiversity and carbon are found in the forests of northern South America, where large-scale biogeographic patterns and processes have recently begun to be described(1-4). Seven of the nine countries with territory in the Amazon basin and the Guiana shield have carried out large-scale forest inventories, but such massive data sets have been little exploited by tropical plant ecologists(5-8). Although forest inventories often lack the species-level identifications favoured by tropical plant ecologists, their consistency of measurement and vast spatial coverage make them ideally suited for numerical analyses at large scales, and a valuable resource to describe the still poorly understood spatial variation of biomass, diversity, community composition and forest functioning across the South American tropics(9). Here we show, by using the seven forest inventories complemented with trait and inventory data collected elsewhere, two dominant gradients in tree composition and function across the Amazon, one paralleling a major gradient in soil fertility and the other paralleling a gradient in dry season length. The data set also indicates that the dominance of Fabaceae in the Guiana shield is not necessarily the result of root adaptations to poor soils ( nodulation or ectomycorrhizal associations) but perhaps also the result of their remarkably high seed mass there as a potential adaptation to low rates of disturbance.	Inst Environm Biol, Sect Plant Ecol & Biodivers, NL-3584 CA Utrecht, Netherlands; Natl Herbarium Netherlands, Utrecht Univ Branch, NL-3584 CA Utrecht, Netherlands; Amazon Conservat Assoc, Washington, DC 20009 USA; Univ Leeds, Sch Geog, Earth & Biosphere Inst, Leeds LS2 9JT, W Yorkshire, England; Univ Toulouse 3, CNRS, UMR 5174, F-31062 Toulouse, France; IRD, UMR AMAP, F-34398 Montpellier 5, France; Univ Nacl Colombia, Dept Ciencias Forestales, Medellin 1027, Colombia; IRD, UMR AMAP, Cayenne 97323, French Guiana; Conservatoire & Jardin Bot Ville Geneve, CH-1292 Geneva, Switzerland; UNEG, Puerto Ordaz, Edo Bolivar, Venezuela; Fdn Puerto Rastrojo, Bogota 241438, Colombia; Jardin Bot Missouri, Proyecto Flora Peru, Jaen, Cajamarca, Peru	Utrecht University; University of Leeds; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universidad Nacional de Colombia; Institut de Recherche pour le Developpement (IRD)	ter Steege, H (corresponding author), Inst Environm Biol, Sect Plant Ecol & Biodivers, Sorbonnelaan 14-16, NL-3584 CA Utrecht, Netherlands.	h.tersteege@bio.uu.nl	Steege, Hans ter/B-5866-2011; Sabatier, Daniel/D-9117-2011; Phillips, Oliver/A-1523-2011; Pitman, Nigel C A/A-7681-2008; Molino, Jean-François/C-5011-2009	Steege, Hans ter/0000-0002-8738-2659; Phillips, Oliver/0000-0002-8993-6168; Pitman, Nigel C A/0000-0002-9211-2880; Molino, Jean-François/0000-0001-8853-7133; Sabatier, Daniel/0000-0003-0883-1530	Natural Environment Research Council [NE/B504630/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bongers F., 2004, Biodiversity of West African forests: an ecological atlas of woody plant species, P41, DOI 10.1079/9780851997346.0041; Bush MB, 2004, SCIENCE, V303, P827, DOI 10.1126/science.1090795; CASPER BB, 1992, OECOLOGIA, V90, P212, DOI 10.1007/BF00317178; CHAVE J, IN PRESS ECOL APPL; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Fearnside PM, 1997, FOREST ECOL MANAG, V90, P59, DOI 10.1016/S0378-1127(96)03840-6; Gregory-Wodzicki KM, 2000, GEOL SOC AM BULL, V112, P1091, DOI 10.1130/0016-7606(2000)112<1091:UHOTCA>2.0.CO;2; HAMMOND DS, 1995, ECOLOGY, V76, P2544, DOI 10.2307/2265827; Houghton J. T., 2001, CLIMATE CHANGE 2001; JANZEN D H, 1974, Biotropica, V6, P69, DOI 10.2307/2989823; Malhi Y, 2004, GLOBAL CHANGE BIOL, V10, P563, DOI 10.1111/j.1529-8817.2003.00778.x; Phillips OL, 2004, PHILOS T R SOC B, V359, P381, DOI 10.1098/rstb.2003.1438; *RADAMBRASIL, 1968, LEV REC NAT; RANKIN JM, 1978, THESIS U MICHIGAN; *SEED INF DAT, SID REL 6 0; Sombroek W, 2001, AMBIO, V30, P388, DOI 10.1639/0044-7447(2001)030[0388:SATPOA]2.0.CO;2; Sprent J.I., 2001, NODULATION LEGUMES; Stevens P.F., 2005, ANGIOSPERM PHYLOGENY; Ter Steege H, 2001, ECOLOGY, V82, P3197, DOI 10.1890/0012-9658(2001)082[3197:CCDADI]2.0.CO;2; Ter Steege H, 2003, BIODIVERS CONSERV, V12, P2255, DOI 10.1023/A:1024593414624; Ter Steege H, 2000, J TROP ECOL, V16, P801, DOI 10.1017/S0266467400001735; Ter Steege H, 1998, BIODIVERS CONSERV, V7, P1457, DOI 10.1023/A:1008893920157; Ter Steege H., 2003, TROPENBOS SERIES, V22; Terborgh J, 1998, J TROP ECOL, V14, P645, DOI 10.1017/S0266467498000455; TERSTEEGE H, 2000, TROPENBOS SERIES, V18, P35; VAN ROOSMALEN M. G. M., 1985, FRUITS GUIANAN FLORA; VONROMPAEY RSA, 1993, THESIS WAGENINGEN U	27	508	523	5	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2006	443	7110					444	447		10.1038/nature05134	http://dx.doi.org/10.1038/nature05134			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	17006512				2022-12-28	WOS:000240798800043
J	Gryseels, B; Polman, K; Clerinx, J; Kestens, L				Gryseels, Bruno; Polman, Katja; Clerinx, Jan; Kestens, Luc			Human schistosomiasis	LANCET			English	Review							SUB-SAHARAN AFRICA; PRIMARY-HEALTH-CARE; QUANTITATIVE POST-MORTEM; REPUBLIC-OF-CHINA; MANSONI INFECTION; PARASITIC DISEASES; IMMUNE-RESPONSES; DRUG-RESISTANCE; PUBLIC-HEALTH; GENITAL SCHISTOSOMIASIS	Schistosomiasis or bilharzia is a tropical disease caused by worms of the genus Schistosoma. The transmission cycle requires contamination of surface water by excreta, specific freshwater snails as intermediate hosts, and human water contact. The main disease-causing species are S haematobium, S mansoni, and S japonicum. According to WHO, 200 million people are infected worldwide, leading to the loss of 1.53 million disability-adjusted life years, although these figures need revision. Schistosomiasis is characterised by focal epidemiology and overdispersed population distribution, with higher infection rates in children than in adults. Complex immune mechanisms lead to the slow acquisition of immune resistance, though innate factors also play a part. Acute schistosomiasis, a feverish syndrome, is mostly seen in travellers after primary infection. Chronic schistosomal disease affects mainly individuals with long-standing infections in poor rural areas. Immunopathological reactions against schistosome eggs trapped in the tissues lead to inflammatory and obstructive disease in the urinary system (S haematobium) or intestinal disease, hepatosplenic inflammation, and liver fibrosis (S mansoni, S japonicum). The diagnostic standard is microscopic demonstration of eggs in the excreta. Praziquantel is the drug treatment of choice. Vaccines are not yet available. Great advances have been made in the control of the disease through population-based chemotherapy but these required political commitment and strong health systems.	Inst Trop Med, B-2000 Antwerp, Belgium	Institute of Tropical Medicine (ITM)	Gryseels, B (corresponding author), Inst Trop Med, Natl Str 155, B-2000 Antwerp, Belgium.	bgryseels@itg.be						Abath FGC, 2006, TRENDS PARASITOL, V22, P85, DOI 10.1016/j.pt.2005.12.004; ABDELWAHAB MF, 1993, AM J GASTROENTEROL, V88, P560; ALI MI, 1989, TROP MED PARASITOL, V40, P195; APPLETON CC, 1984, S AFR MED J, V65, P467; Barakat R, 2005, AM J TROP MED HYG, V73, P365, DOI 10.4269/ajtmh.2005.73.365; Barsoum R, 2004, KIDNEY INT, V66, P2472, DOI 10.1111/j.1523-1755.2004.66042.x; Bedwani R, 1998, BRIT J CANCER, V77, P1186, DOI 10.1038/bjc.1998.197; Bergquist NR, 1998, PARASITOL TODAY, V14, P99, DOI 10.1016/S0169-4758(97)01207-6; Bian Y, 2004, INT J HEALTH PLAN M, V19, pS79, DOI 10.1002/hpm.771; BLAS B L, 1986, Southeast Asian Journal of Tropical Medicine and Public Health, V17, P67; Booth M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-13; Booth M, 1996, TROP MED INT HEALTH, V1, P646; Botros S, 2005, INT J PARASITOL, V35, P787, DOI 10.1016/j.ijpara.2005.02.005; Bottieau E, 2006, J INFECTION, V52, P339, DOI 10.1016/j.jinf.2005.07.022; BRADLEY AK, 1984, ANN TROP MED PARASIT, V78, P265, DOI 10.1080/00034983.1984.11811815; Brindley PJ, 2005, TRENDS PARASITOL, V21, P533, DOI 10.1016/j.pt.2005.08.015; BRINKMANN UK, 1988, TROP MED PARASITOL, V39, P157; Brooker S, 2000, PARASITOL TODAY, V16, P303, DOI 10.1016/S0169-4758(00)01687-2; BROWN DS, 1994, FRRESHWATER SNAILS A; Butterworth A. E., 1993, Human schistosomiasis., P331; Capron A, 2005, TRENDS PARASITOL, V21, P143, DOI 10.1016/j.pt.2005.01.003; CHEEVER AW, 1978, JNCI-J NATL CANCER I, V61, P13, DOI 10.1093/jnci/61.1.13; CHEEVER AW, 1968, AM J TROP MED HYG, V17, P38, DOI 10.4269/ajtmh.1968.17.38; CHEEVER AW, 1978, AM J TROP MED HYG, V27, P55, DOI 10.4269/ajtmh.1978.27.55; Cheever AW, 2000, IMMUNOL TODAY, V21, P465, DOI 10.1016/S0167-5699(00)01626-1; Chen M. G., 1989, Tropical Diseases Bulletin, V86, pR1; CHEN MG, 1989, TROPICAL DIS B, V86, P1; Chen Ming Gang, 1993, P237; CHENEY PG, 1988, STUD PHILOL, V85, P1; Chitsulo L, 2000, ACTA TROP, V77, P41, DOI 10.1016/S0001-706X(00)00122-4; CIOLI D, 1993, PARASITOL TODAY, V9, P162, DOI 10.1016/0169-4758(93)90138-6; Cowie RH, 2001, INT J PEST MANAGE, V47, P23, DOI 10.1080/09670870150215577; Davis A., 1993, Human schistosomiasis., P367; Dayan AD, 2003, ACTA TROP, V86, P141, DOI 10.1016/S0001-706X(03)00031-7; DEELDER AM, 1994, TROP GEOGR MED, V46, P233; Dessein AJ, 1999, AM J HUM GENET, V65, P709, DOI 10.1086/302526; DEVLAS SJ, 1992, PARASITOLOGY, V104, P451, DOI 10.1017/S003118200006371X; DEVLAS SJ, 1992, PARASITOL TODAY, V8, P274, DOI 10.1016/0169-4758(92)90144-Q; Doumenge J P, 1984, World Health Stat Q, V37, P186; El-Katsha S., 2002, GENDER BEHAV HLTH SC; ELEM B, 1981, Medical Journal of Zambia, V15, P48; Elliott AM, 2003, T ROY SOC TROP MED H, V97, P103, DOI 10.1016/S0035-9203(03)90040-X; Engels D, 1995, T ROY SOC TROP MED H, V89, P599, DOI 10.1016/0035-9203(95)90403-4; Engels D, 1996, T ROY SOC TROP MED H, V90, P523, DOI 10.1016/S0035-9203(96)90304-1; ENGELS D, 1993, B WORLD HEALTH ORGAN, V71, P207; FALLON PG, 1994, AM J TROP MED HYG, V51, P83, DOI 10.4269/ajtmh.1994.51.83; FELDMEIER H, 1993, ACTA TROP, V52, P205, DOI 10.1016/0001-706X(93)90009-Z; Feldmeier H., 1993, Human schistosomiasis., P271; Feldmeier H, 1999, TROP MED INT HEALTH, V4, P791, DOI 10.1046/j.1365-3156.1999.00511.x; Feng GCY, 1997, STROKE, V28, P1648, DOI 10.1161/01.STR.28.8.1648; Fenwick A, 2006, T ROY SOC TROP MED H, V100, P200, DOI 10.1016/j.trstmh.2005.03.014; Fenwick A, 2003, TRENDS PARASITOL, V19, P509, DOI 10.1016/j.pt.2003.09.005; Fernando R, 2002, SEX TRANSM INFECT, V78, P76, DOI 10.1136/sti.78.1.76; Ferrari TCD, 2004, MEM I OSWALDO CRUZ, V99, P59, DOI 10.1590/S0074-02762004000900010; FINE J, 1975, Medical Journal of Zambia, V9, P98; Forsyth D M, 1970, Lancet, V2, P472; Geerts S, 2000, CLIN MICROBIOL REV, V13, P207, DOI 10.1128/CMR.13.2.207-222.2000; GRYSEELS B, 1991, PARASITOL TODAY, V7, P244, DOI 10.1016/0169-4758(91)90238-J; GRYSEELS B, 1991, T ROY SOC TROP MED H, V85, P626, DOI 10.1016/0035-9203(91)90371-5; Gryseels B, 1996, AM J TROP MED HYG, V55, P103, DOI 10.4269/ajtmh.1996.55.103; GRYSEELS B, 1989, TROP MED PARASITOL, V40, P134; Gryseels B, 2000, PARASITOL TODAY, V16, P46, DOI 10.1016/S0169-4758(99)01597-5; Gryseels B, 2001, TROP MED INT HEALTH, V6, P864, DOI 10.1046/j.1365-3156.2001.00811.x; GRYSEELS B, 1987, T ROY SOC TROP MED H, V81, P202, DOI 10.1016/0035-9203(87)90215-X; Gryseels B, 1996, PARASITOL TODAY, V12, P115, DOI 10.1016/0169-4758(96)80671-5; GRYSEELS B, 1992, TROP GEOGR MED, V44, P189; GRYSEELS B, 1988, ANN TROP MED PARASIT, V82, P581, DOI 10.1080/00034983.1988.11812294; Guyatt H, 1995, AM J TROP MED HYG, V53, P660, DOI 10.4269/ajtmh.1995.53.660; Hatz CFR, 2001, ADV PARASIT, V48, P225, DOI 10.1016/S0065-308X(01)48007-9; Hatz CFR, 2005, J TRAVEL MED, V12, P1, DOI 10.2310/7060.2005.00001; Hayashi S, 2000, ACTA TROP, V77, P133, DOI 10.1016/S0001-706X(00)00126-1; Hewitson JP, 2005, PARASITE IMMUNOL, V27, P271, DOI 10.1111/j.1365-3024.2005.00764.x; HOMEIDA M, 1988, AM J TROP MED HYG, V39, P196, DOI 10.4269/ajtmh.1988.39.196; HOMEIDA M, 1988, AM J TROP MED HYG, V38, P86, DOI 10.4269/ajtmh.1988.38.86; Horak P, 2005, PARASITE IMMUNOL, V27, P247, DOI 10.1111/j.1365-3024.2005.00776.x; Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102; *IARC WORK GROUP E, 1999, IARC MON EV CARC RIS, V61, P45; JARALLAH JS, 1993, TROP GEOGR MED, V45, P297; Jelinek, 1996, J Travel Med, V3, P160, DOI 10.1111/j.1708-8305.1996.tb00731.x; JONES ME, 1992, LANCET, V340, P1549, DOI 10.1016/0140-6736(92)92805-P; Jordan P, 2000, ACTA TROP, V77, P9, DOI 10.1016/S0001-706X(00)00121-2; Jordan P., 1993, HUMAN SCHISTOSOMIASI; Jordan Peter, 1993, P87; Kabatereine NB, 1999, PARASITOLOGY, V118, P101, DOI 10.1017/S0031182098003576; Kallestrup P, 2005, J INFECT DIS, V192, P1956, DOI 10.1086/497696; Kallestrup P, 2005, J INFECT DIS, V191, P1311, DOI 10.1086/428907; Karanja DMS, 1997, AM J TROP MED HYG, V56, P515, DOI 10.4269/ajtmh.1997.56.515; Kardorff R, 1996, AM J TROP MED HYG, V54, P586; Kheir MM, 1999, AM J TROP MED HYG, V60, P307, DOI 10.4269/ajtmh.1999.60.307; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; King CL, 1998, J IMMUNOL, V160, P3578; KLOETZEL K, 1992, MEM I OSWALDO CRUZ, V87, P221, DOI 10.1590/S0074-02761992000800034; KLOETZEL K, 1967, T ROY SOC TROP MED H, V61, P803, DOI 10.1016/0035-9203(67)90038-7; KORAITIM MM, 1995, J UROLOGY, V154, P1714, DOI 10.1016/S0022-5347(01)66763-6; Laamrani Hammou, 2002, Cahiers Agricultures, V11, P23; Lambertucci J. R., 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P399, DOI 10.1590/S0036-46651993000500003; Lambertucci JR, 2000, ACTA TROP, V77, P101, DOI 10.1016/S0001-706X(00)00124-8; LAMBERTUCCI RL, 1993, HUMAN SCHISTOSOMIASI, P195; LEHMAN JS, 1970, LANCET, V2, P822; Lengeler C, 2002, TRENDS PARASITOL, V18, P375, DOI 10.1016/S1471-4922(02)02318-8; Lengeler C, 2002, B WORLD HEALTH ORGAN, V80, P235; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Macdonald G., 1973, , Epidemiology and control of schistosomiasis (bilharziasis)., P337; Magnussen P, 2003, ACTA TROP, V86, P243, DOI 10.1016/S0001-706X(03)00045-7; Minai M, 2003, PARASITOL INT, V52, P321, DOI 10.1016/S1383-5769(03)00047-3; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; MOTT KE, 1990, B WORLD HEALTH ORGAN, V68, P691; Mountford AP, 2005, PARASITE IMMUNOL, V27, P243, DOI 10.1111/j.1365-3024.2005.00798.x; Mutapi F, 2003, PARASITE IMMUNOL, V25, P87, DOI 10.1046/j.1365-3024.2003.00610.x; Mwanakasale V, 2003, AM J TROP MED HYG, V69, P420, DOI 10.4269/ajtmh.2003.69.420; Mwinzi PNM, 2004, AM J TROP MED HYG, V71, P783, DOI 10.4269/ajtmh.2004.71.783; Naus CWA, 2003, ANN TROP MED PARASIT, V97, P711, DOI 10.1179/000349803225002363; Noya O, 2002, MEM I OSWALDO CRUZ, V97, P167, DOI 10.1590/S0074-02762002000900032; Olds G. R., 2000, Current Treatment Options in Infectious Diseases, V2, P88; ONGOM VL, 1972, T ROY SOC TROP MED H, V66, P852, DOI 10.1016/0035-9203(72)90119-8; Oomen JMV, 1990, ILRI PUBLICATION, V45; Ouma JH, 1998, PARASITOLOGY, V117, P123, DOI 10.1017/S0031182098002935; Palmer PES, 2005, INT REGISTRY TROPICA; Pearce EJ, 2005, PARASITE IMMUNOL, V27, P265, DOI 10.1111/j.1365-3024.2005.00765.x; Poggensee G, 2001, ACTA TROP, V79, P193, DOI 10.1016/S0001-706X(01)00086-9; POLMAN K, 2000, THESIS U LEIDEN LEID; Rabello A, 1997, MEM I OSWALDO CRUZ, V92, P669, DOI 10.1590/S0074-02761997000500021; Rabello ALT, 1997, CLIN INFECT DIS, V24, P304, DOI 10.1093/clinids/24.3.304; Raghavan N, 2006, TRENDS PARASITOL, V22, P148, DOI 10.1016/j.pt.2006.02.008; RATARD RC, 1992, T ROY SOC TROP MED H, V86, P274, DOI 10.1016/0035-9203(92)90306-W; Renganathan E, 1998, PARASITOL TODAY, V14, P390, DOI 10.1016/S0169-4758(98)01310-6; Richter J, 2003, LANCET, V362, P900, DOI 10.1016/S0140-6736(03)14334-6; Richter J, 2003, ACTA TROP, V86, P161, DOI 10.1016/S0001-706X(03)00032-9; Richter J, 1998, TROP MED INT HEALTH, V3, P728, DOI 10.1046/j.1365-3156.1998.00285.x; Rocha Manoel Otavio C., 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P311, DOI 10.1590/S0036-46651995000400005; ROCHA MOC, 1995, ANN TROP MED PARASIT, V89, P271, DOI 10.1080/00034983.1995.11812952; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Ross AGP, 2001, CLIN MICROBIOL REV, V14, P270, DOI 10.1128/CMR.14.2.270-295.2001; Secor WE, 2005, PARASITE IMMUNOL, V27, P309, DOI 10.1111/j.1365-3024.2005.00778.x; SMITH JH, 1975, AM J TROP MED HYG, V24, P806, DOI 10.4269/ajtmh.1975.24.806; Sow S, 2003, TROP MED INT HEALTH, V8, P744, DOI 10.1046/j.1365-3156.2003.01080.x; STELMA FF, 1995, AM J TROP MED HYG, V53, P167, DOI 10.4269/ajtmh.1995.53.167; Tan HZ, 2004, ACTA TROP, V90, P1, DOI 10.1016/j.actatropica.2003.09.008; Tsang VCW, 1997, IMMUNOL INVEST, V26, P175, DOI 10.3109/08820139709048925; UTROSKA JA, 1989, WHOSCHISTO89102; Utzinger J, 2003, ANTIMICROB AGENTS CH, V47, P1487, DOI 10.1128/AAC.47.5.1487-1495.2003; Utzinger J, 2000, TROP MED INT HEALTH, V5, P771, DOI 10.1046/j.1365-3156.2000.00646.x; van Dam GJ, 2004, J CLIN MICROBIOL, V42, P5458, DOI 10.1128/JCM.42.12.5458-5461.2004; van den Biggelaar AHJ, 2002, J INFECT DIS, V186, P1474, DOI 10.1086/344352; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; vanLieshout L, 1997, TROP MED INT HEALTH, V2, P551, DOI 10.1046/j.1365-3156.1997.d01-324.x; Vennervald BJ, 2000, ACTA TROP, V77, P81, DOI 10.1016/S0001-706X(00)00116-9; *WHO, 2002, WHOCDSCPEPVC20024; WHO Expert Committee, 2002, TECHN REP SER WHO; WILLIAMS EH, 1986, J TROP MED HYG, V89, P193; Woolhouse MEJ, 1999, NAT MED, V5, P1225, DOI 10.1038/15169; Xiao SH, 2002, ACTA TROP, V82, P175, DOI 10.1016/S0001-706X(02)00009-8; Zhang W, 2003, ACTA TROP, V85, P303, DOI 10.1016/S0001-706X(02)00263-2; 1993, MMWR MORB MORTAL WKL, V42, P565	155	1400	1474	6	303	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2006	368	9541					1106	1118		10.1016/S0140-6736(06)69440-3	http://dx.doi.org/10.1016/S0140-6736(06)69440-3			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089IC	16997665				2022-12-28	WOS:000240873000026
J	Poulin, PR; Nelson, KA				Poulin, Peter R.; Nelson, Keith A.			Irreversible organic crystalline chemistry monitored in real time	SCIENCE			English	Article							GEMINATE RECOMBINATION; FEMTOSECOND-PHOTODISSOCIATION; VIBRATIONAL-RELAXATION; DYNAMICS; TRIIODIDE; I-3(-); SPECTROSCOPY; BREAKING; LIQUID; BOND	Because multiple laser shots are typically required to monitor ultrafast photochemical reaction dynamics, sample depletion and product accumulation have greatly restricted the range of substrates and structural environments amenable to study. By implementing a two-dimensional spatial delay gradient across the profile of a femtosecond probe pulse, we can monitor in a single laser shot organic crystalline reaction dynamics despite the formation of permanent photoproducts that cannot be conveniently removed. We monitored the photolysis of the triiodide anion, I-3(-), and subsequent recombination or relaxation of its reaction products, in three very different pure organic molecular crystals. The experimental results and associated molecular dynamics simulations illustrate the intimate connection between lattice structure and reaction dynamics, highlighting the role of lattice constraints in directing phase-coherent geminate recombination of photofragments within a crystalline reaction cage.	MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Nelson, KA (corresponding author), MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	kanelson@mit.edu						BANIN U, 1993, J CHEM PHYS, V99, P9318, DOI 10.1063/1.465501; BENJAMIN I, 1993, J CHEM PHYS, V98, P8337, DOI 10.1063/1.464539; Bihary Z, 2004, J CHEM PHYS, V120, P7576, DOI 10.1063/1.1689958; BRENNER DW, 1990, PHYS REV B, V42, P9458, DOI 10.1103/PhysRevB.42.9458; Brenner DW, 2002, J PHYS-CONDENS MAT, V14, P783, DOI 10.1088/0953-8984/14/4/312; CHEN ECM, 1985, J PHYS CHEM-US, V89, P4099, DOI 10.1021/j100265a035; FERRARO JR, 1986, J PHYS CHEM SOLIDS, V47, P301, DOI 10.1016/0022-3697(86)90099-5; Gershgoren E, 2001, J PHYS CHEM A, V105, P5081, DOI 10.1021/jp0039518; Gershgoren E, 1998, J PHYS CHEM A, V102, P9, DOI 10.1021/jp972138i; Hess S, 1999, J CHEM PHYS, V111, P5461, DOI 10.1063/1.479807; JOHNSON AE, 1992, J PHYS CHEM-US, V96, P7841, DOI 10.1021/j100199a004; KLINER DAV, 1993, J CHEM PHYS, V98, P5375, DOI 10.1063/1.464910; Kuhne T, 1996, J CHEM PHYS, V105, P10788, DOI 10.1063/1.472887; MIGCHELSEN T, 1967, ACTA CRYSTALLOGR, V23, P796, DOI 10.1107/S0365110X6700372X; Poulin PR, 2005, SPRINGER SERIES CHEM, V79, P529; Ryzhkov LR, 1996, J PHYS CHEM-US, V100, P163, DOI 10.1021/jp9518015; Scheffer JR, 2001, SCIENCE, V291, P1712, DOI 10.1126/science.291.5509.1712; SCHMIDT G M J, 1971, Pure and Applied Chemistry, V27, P647; Sherwood J. N., 1978, PLASTICALLY CRYSTALL; Toda F., 2002, ORGANIC SOLID STATE; TOPP MR, 1971, CHEM PHYS LETT, V9, P1, DOI 10.1016/0009-2614(71)80165-3; Turro NJ, 2002, CHEM COMMUN, P2279, DOI 10.1039/b205552j; Wakeham GP, 2000, OPT LETT, V25, P505, DOI 10.1364/OL.25.000505; Wakeham GP, 2002, THERMOCHIM ACTA, V384, P7, DOI 10.1016/S0040-6031(01)00774-2; Wang ZH, 1999, CHEM PHYS LETT, V313, P155, DOI 10.1016/S0009-2614(99)00974-4; ZADOYAN R, 1994, J CHEM PHYS, V101, P6648, DOI 10.1063/1.468359; Zimmerman HE, 2002, ACCOUNTS CHEM RES, V35, P77, DOI 10.1021/ar000210g	28	74	75	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2006	313	5794					1756	1760		10.1126/science.1127826	http://dx.doi.org/10.1126/science.1127826			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16946037				2022-12-28	WOS:000240655700039
J	Ye, S; Li, Y; Chen, LP; Jiang, YX				Ye, Sheng; Li, Yang; Chen, Liping; Jiang, Youxing			Crystal structures of a ligand-free MthK gating ring: Insights into the ligand gating mechanism of K+ channels	CELL			English	Article							RCK DOMAIN; BINDING; HINGE; GATE; PORE; SEQUENCE; COMPLEX; SYSTEM; KTRAB; FLUX	MthK is a prokaryotic Ca2+-gated K+ channel that, like other ligand-gated channels, converts the chemical energy of ligand binding to the mechanical force of channel opening. The channel's eight ligand-binding domains, the RCK domains, form an octameric gating ring in which Ca2+ binding induces conformational changes that open the channel. Here we present the crystal structures of the MthK gating ring in closed and partially open states at 2.8 angstrom, both obtained from the same crystal grown in the absence of Ca2+. Furthermore, our biochemical and electrophysiological analyses demonstrate that MthK is regulated by both Ca2+ and pH. Ca2+ regulates the channel by changing the equilibrium of the gating ring between closed and open states, while pH regulates channel gating by affecting gating-ring stability. Our findings, along with the previously determined open MthK structure, allow us to elucidate the ligand gating mechanism of RCK-regulated K+ channels.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Jiang, YX (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA.	youxing.jiang@utsouthwestern.edu			NIGMS NIH HHS [GM071621] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071621] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albright RA, 2006, CELL, V126, P1147, DOI 10.1016/j.cell.2006.08.028; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKKER EP, 1987, J BACTERIOL, V169, P3743, DOI 10.1128/jb.169.8.3743-3749.1987; Bao L, 2002, J GEN PHYSIOL, V120, P173, DOI 10.1085/jgp.20028627; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bellamacina CR, 1996, FASEB J, V10, P1257, DOI 10.1096/fasebj.10.11.8836039; Bian S, 2001, P NATL ACAD SCI USA, V98, P4776, DOI 10.1073/pnas.081072398; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Ding SH, 2005, J GEN PHYSIOL, V126, P213, DOI 10.1085/jgp.200509287; Dong JB, 2005, J BIOL CHEM, V280, P41716, DOI 10.1074/jbc.M508144200; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Hellmer J, 2003, FEBS LETT, V547, P165, DOI 10.1016/S0014-5793(03)00706-3; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; Kuo MMC, 2005, FEMS MICROBIOL REV, V29, P961, DOI 10.1016/j.femsre.2005.03.003; Kuo MMC, 2003, EMBO J, V22, P4049, DOI 10.1093/emboj/cdg409; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Liu YS, 2001, NAT STRUCT BIOL, V8, P883, DOI 10.1038/nsb1001-883; Magidovich E, 2004, BIOCHEMISTRY-US, V43, P13242, DOI 10.1021/bi048377v; Magleby RL, 2003, J GEN PHYSIOL, V121, P81, DOI 10.1085/jgp.20028721; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MUNRO AW, 1991, MOL MICROBIOL, V5, P607, DOI 10.1111/j.1365-2958.1991.tb00731.x; Nakamura T, 1998, J BACTERIOL, V180, P3491, DOI 10.1128/JB.180.13.3491-3494.1998; Niu XW, 2004, NEURON, V42, P745, DOI 10.1016/j.neuron.2004.05.001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; PICO A, 2003, THESIS ROCKEFLLER U; Ptak CP, 2005, BIOCHEMISTRY-US, V44, P62, DOI 10.1021/bi048390f; Roosild TP, 2004, TRENDS BIOCHEM SCI, V29, P39, DOI 10.1016/j.tibs.2003.11.008; Roosild TP, 2002, CELL, V109, P781, DOI 10.1016/S0092-8674(02)00768-7; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; SCHLOSSER A, 1993, MOL MICROBIOL, V9, P533, DOI 10.1111/j.1365-2958.1993.tb01714.x; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	43	84	86	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 22	2006	126	6					1161	1173		10.1016/j.cell.2006.08.029	http://dx.doi.org/10.1016/j.cell.2006.08.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990139	Bronze			2022-12-28	WOS:000240897600021
J	Humes, DJ; Simpson, J				Humes, D. J.; Simpson, J.			Acute appendicitis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIAL; COMPUTED-TOMOGRAPHY; ULCERATIVE-COLITIS; SUSPECTED APPENDICITIS; ABDOMINAL-PAIN; CROHNS-DISEASE; APPENDECTOMY; DIAGNOSIS; ULTRASONOGRAPHY; PREGNANCY		Univ Nottingham Hosp, Queens Med Ctr, Sect Surg, Div Gastrointestinal Surg, Nottingham NG7 2UH, England	University of Nottingham	Simpson, J (corresponding author), Univ Nottingham Hosp, Queens Med Ctr, Sect Surg, Div Gastrointestinal Surg, Nottingham NG7 2UH, England.	j.simpson@nottingham.ac.uk		Humes, David/0000-0002-7071-4098				Abou-Nukta F, 2006, ARCH SURG-CHICAGO, V141, P504, DOI 10.1001/archsurg.141.5.504; ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; Ahmed I, 2005, ANN ROY COLL SURG, V87, P191, DOI 10.1308/1478708051649; ALVARADO A, 1986, ANN EMERG MED, V15, P557, DOI 10.1016/S0196-0644(86)80993-3; Andersen BR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001439.pub2; Andersson R, 1999, BRIT MED J, V318, P963, DOI 10.1136/bmj.318.7189.963; Andersson RE, 2003, GASTROENTEROLOGY, V124, P40, DOI 10.1053/gast.2003.50021; Andersson RE, 2001, NEW ENGL J MED, V344, P808, DOI 10.1056/NEJM200103153441104; Andersson REB, 2004, BRIT J SURG, V91, P28, DOI 10.1002/bjs.4464; Andersson REB, 2001, INT J EPIDEMIOL, V30, P1281, DOI 10.1093/ije/30.6.1281; Beasley SW, 2000, BRIT MED J, V321, P907, DOI 10.1136/bmj.321.7266.907; Benjamin IS, 2002, BMJ-BRIT MED J, V325, P505, DOI 10.1136/bmj.325.7363.505; Bickell NA, 2006, J AM COLL SURGEONS, V202, P401, DOI 10.1016/j.jamcollsurg.2005.11.016; Birnbaum BA, 2000, RADIOLOGY, V215, P337, DOI 10.1148/radiology.215.2.r00ma24337; Blomqvist PG, 2001, ANN SURG, V233, P455, DOI 10.1097/00000658-200104000-00001; BRAVEMAN P, 1994, NEW ENGL J MED, V331, P444, DOI 10.1056/NEJM199408183310706; BUSCHARD K, 1973, ACTA CHIR SCAND, V139, P293; Cobben LP, 2004, AM J ROENTGENOL, V183, P671, DOI 10.2214/ajr.183.3.1830671; Cosnes J, 2002, GUT, V51, P803, DOI 10.1136/gut.51.6.803; Di Sebastiano P, 1999, LANCET, V354, P461, DOI 10.1016/S0140-6736(98)10463-4; ERIKSSON S, 1995, BRIT J SURG, V82, P166, DOI 10.1002/bjs.1800820207; Fitz RH, 1886, T ASSOC AM PHYSICIAN, V1, P107; Flum DR, 2005, J AM COLL SURGEONS, V201, P933, DOI 10.1016/j.jamcollsurg.2005.04.039; Flum DR, 2002, ARCH SURG-CHICAGO, V137, P799, DOI 10.1001/archsurg.137.7.799; Green R, 2005, PEDIATRICS, V116, P978, DOI 10.1542/peds.2005-0273; GROSFELD JL, 1973, J PEDIATR SURG, V8, P285, DOI 10.1016/S0022-3468(73)80096-X; Guttman R, 2004, CAN FAM PHYSICIAN, V50, P355; Jones PF, 2001, BRIT J SURG, V88, P1570, DOI 10.1046/j.0007-1323.2001.01910.x; Kang JY, 2003, BRIT J SURG, V90, P1586, DOI 10.1002/bjs.4363; Katkhouda N, 2005, ANN SURG, V242, P439, DOI 10.1097/01.sla.0000179648.75373.2f; Keyzer C, 2004, RADIOLOGY, V232, P164, DOI 10.1148/radiol.2321031115; Larner A J, 1988, Br J Hosp Med, V39, P540; Mayer EA, 2002, GASTROENTEROLOGY, V122, P2032, DOI 10.1053/gast.2002.33584; McBurney C., 1889, NY STATE MED J, V50, P676; Murphy JB, 1904, AM J MED SCI, V128, P187; Nitta N, 2005, J MAGN RESON IMAGING, V21, P156, DOI 10.1002/jmri.20241; Paulson EK, 2003, NEW ENGL J MED, V348, P236, DOI 10.1056/NEJMcp013351; Radford-Smith GL, 2002, GUT, V51, P808, DOI 10.1136/gut.51.6.808; Rao PM, 1999, ANN SURG, V229, P344, DOI 10.1097/00000658-199903000-00007; Rao PM, 1998, NEW ENGL J MED, V338, P141, DOI 10.1056/NEJM199801153380301; Sachar DB, 2002, GUT, V51, P764, DOI 10.1136/gut.51.6.764; Sauerland S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001546.pub3; Styrud J, 2006, WORLD J SURG, V30, P1033, DOI 10.1007/s00268-005-0304-6; TEMPLE CL, 1995, ANN SURG, V221, P278, DOI 10.1097/00000658-199503000-00010; Terasawa T, 2004, ANN INTERN MED, V141, P537, DOI 10.7326/0003-4819-141-7-200410050-00011; Thomas SH, 2003, BRIT J SURG, V90, P5, DOI 10.1002/bjs.4009; Tzanakis NE, 2005, WORLD J SURG, V29, P1151, DOI 10.1007/s00268-005-7853-6; Wagner JM, 1996, JAMA-J AM MED ASSOC, V276, P1589, DOI 10.1001/jama.276.19.1589; Weston AR, 2005, INT J TECHNOL ASSESS, V21, P368, DOI 10.1017/S0266462305050488; HOSP EPISODE STAT PR	50	244	263	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2006	333	7567					530	534B		10.1136/bmj.38940.664363.AE	http://dx.doi.org/10.1136/bmj.38940.664363.AE			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	084LD	16960208	Green Published			2022-12-28	WOS:000240533500018
J	Comstock, LE; Kasper, DL				Comstock, Laurie E.; Kasper, Dennis L.			Bacterial glycans: Key mediators of diverse host immune responses	CELL			English	Review							MYCOBACTERIUM-TUBERCULOSIS; SIALIC-ACID; PATHWAY; LIPOPOLYSACCHARIDE; CAPACITY; PROTEIN; SYSTEM	Recent studies have shown that the synthesis of various polysaccharides by bacteria can induce immune responses that are beneficial to the bacterium, the host, or both. Here, we discuss the diverse interactions between bacterial glycans and the host immune system.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab,Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Kasper, DL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab,Dept Med, Boston, MA 02115 USA.	dennis_kasper@hms.harvard.edu						Bergman M, 2006, NAT REV MICROBIOL, V4, P151, DOI 10.1038/nrmicro1344; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Bouchet V, 2003, P NATL ACAD SCI USA, V100, P8898, DOI 10.1073/pnas.1432026100; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Cobb BA, 2004, CELL, V117, P677, DOI 10.1016/j.cell.2004.05.001; Coyne MJ, 2005, SCIENCE, V307, P1778, DOI 10.1126/science.1106469; FINNE J, 1983, LANCET, V2, P355; Horn C, 1999, J BIOL CHEM, V274, P32023, DOI 10.1074/jbc.274.45.32023; Kang YS, 2006, CELL, V125, P47, DOI 10.1016/j.cell.2006.01.046; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; MESCHER MF, 1974, J BACTERIOL, V120, P945, DOI 10.1128/JB.120.2.945-954.1974; Romain F, 1999, INFECT IMMUN, V67, P5567, DOI 10.1128/IAI.67.11.5567-5572.1999; SLEYTR UB, 1976, J BACTERIOL, V126, P377, DOI 10.1128/JB.126.1.377-383.1976; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004	16	138	146	1	25	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 8	2006	126	5					847	850		10.1016/j.cell.2006.08.021	http://dx.doi.org/10.1016/j.cell.2006.08.021			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959564	Bronze			2022-12-28	WOS:000240675000012
J	Lampson, MA; Kapoor, TM				Lampson, Michael A.; Kapoor, Tarun M.			Targeting protein stability with a small molecule	CELL			English	Editorial Material							DEGRADATION	Both genetic approaches and small-molecule inhibitors can be used to perturb protein function. Banaszynski et al. (2006) now describe a strategy to regulate the stability of a target protein, in which specificity is provided by a genetically encoded tag and temporal control is imparted by a small molecule.	Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10021 USA	Rockefeller University	Kapoor, TM (corresponding author), Rockefeller Univ, Lab Chem & Cell Biol, 1230 York Ave, New York, NY 10021 USA.	kapoor@rockefeller.edu						Banaszynski LA, 2006, CHEM BIOL, V13, P11, DOI 10.1016/j.chembiol.2005.10.010; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; INOUE S, 1967, J GEN PHYSIOL, V50, P259, DOI 10.1085/jgp.50.6.259; Jackson C L, 2000, Subcell Biochem, V34, P233; Janse DM, 2004, J BIOL CHEM, V279, P21415, DOI 10.1074/jbc.M402954200; Schneekloth JS, 2004, J AM CHEM SOC, V126, P3748, DOI 10.1021/ja039025z; Shogren-Knaak MA, 2001, ANNU REV CELL DEV BI, V17, P405, DOI 10.1146/annurev.cellbio.17.1.405; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X	8	13	13	1	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 8	2006	126	5					827	829		10.1016/j.cell.2006.08.023	http://dx.doi.org/10.1016/j.cell.2006.08.023			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959558	Bronze			2022-12-28	WOS:000240675000006
J	Naccache, L				Naccache, Lionel			Is she conscious?	SCIENCE			English	Editorial Material							BRAIN		Hop La Pitie Salpetriere, Dept Clin Neurophysiol, F-75013 Paris, France; INSERM, Cognit Neuroimaging Unit, F-91401 Orsay, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Naccache, L (corresponding author), Hop La Pitie Salpetriere, Dept Clin Neurophysiol, F-75013 Paris, France.	lionel.naccache@wanadoo.fr		naccache, lionel/0000-0002-2874-1009				Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Greenwald AG, 1996, SCIENCE, V273, P1699, DOI 10.1126/science.273.5282.1699; Laureys S, 2005, CURR OPIN NEUROL, V18, P726, DOI 10.1097/01.wco.0000189874.92362.12; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Naccache L, 2005, P NATL ACAD SCI USA, V102, P7713, DOI 10.1073/pnas.0500542102; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Rossetti Y, 1998, CONSCIOUS COGN, V7, P520, DOI 10.1006/ccog.1998.0370; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; Thompson-Schill SL, 1999, NEURON, V23, P513, DOI 10.1016/S0896-6273(00)80804-1; Turing A.M., 1950, MIND, P433, DOI DOI 10.1093/MIND/LIX.236.433; Weiskrantz L., 1997, CONSCIOUSNESS LOST F	11	47	47	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2006	313	5792					1395	1396		10.1126/science.1132881	http://dx.doi.org/10.1126/science.1132881			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16959993				2022-12-28	WOS:000240348700027
J	Prehna, G; Ivanov, MI; Bliska, JB; Stebbins, CE				Prehna, Gerd; Ivanov, Maya I.; Bliska, James B.; Stebbins, C. Erec			Yersinia virulence depends on mimicry of host Rho-family nucleotide dissociation inhibitors	CELL			English	Article							SER/THR PROTEIN-KINASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SALMONELLA-TYPHIMURIUM; EFFECTOR DOMAIN; EXCHANGE FACTOR; PSEUDOTUBERCULOSIS; COMPLEX; REFINEMENT; ACTIVATION	Yersinia spp. cause gastroenteritis and the plague, representing historically devastating pathogens that are currently an important biodefense and antibiotic resistance concern. A critical virulence determinant is the Yersinia protein kinase A, or YpkA, a multidomain protein that disrupts the eukaryotic actin cytoskeleton. Here we solve the crystal structure of a YpkA-Rac1 complex and find that YpkA possesses a Rac1 binding domain that mimics host guanidine nucleotide dissociation inhibitors (GDIs) of the Rho GTPases. YpkA inhibits nucleotide exchange in Rac1 and RhoA, and mutations that disrupt the YpkA-GTPase interface abolish this activity in vitro and impair in vivo YpkA-induced cytoskeletal disruption. In cell culture experiments, the kinase and the GDI domains of YpkA act synergistically to promote cytoskeletal disruption, and a Y. pseudotuberculosis mutant lacking YpkA GDI activity shows attenuated virulence in a mouse infection assay. We conclude that virulence in Yersinia depends strongly upon mimicry of host GDI proteins by YpkA.	Rockefeller Univ, Lab Struct Microbiol, New York, NY 10021 USA; SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Ctr Infect Dis, Stony Brook, NY 11794 USA	Rockefeller University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Stebbins, CE (corresponding author), Rockefeller Univ, Lab Struct Microbiol, 1230 York Ave, New York, NY 10021 USA.	stebbins@rockefeller.edu	Stebbins, Erec/N-2565-2018	Stebbins, Erec/0000-0001-6229-5308; Prehna, Gerd/0000-0001-5539-7533	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056510] Funding Source: NIH RePORTER; NIAID NIH HHS [1U19AI056510, R01AI433890] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aepfelbacher M, 1999, BIOL CHEM, V380, P795, DOI 10.1515/BC.1999.099; Aepfelbacher M, 2004, Rev Physiol Biochem Pharmacol, V152, P65; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barz C, 2000, FEBS LETT, V482, P139, DOI 10.1016/S0014-5793(00)02045-7; Black DS, 2000, MOL MICROBIOL, V37, P515, DOI 10.1046/j.1365-2958.2000.02021.x; Buchwald G, 2002, EMBO J, V21, P3286, DOI 10.1093/emboj/cdf329; Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cornelis GR, 2000, P NATL ACAD SCI USA, V97, P8778, DOI 10.1073/pnas.97.16.8778; Dukuzumuremyi JM, 2000, J BIOL CHEM, V275, P35281, DOI 10.1074/jbc.M003009200; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Friebel A, 2000, METHOD ENZYMOL, V325, P82; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004; GALYOV EE, 1993, NATURE, V361, P730, DOI 10.1038/361730a0; GALYOV EE, 1994, J BACTERIOL, V176, P4543, DOI 10.1128/JB.176.15.4543-4548.1994; Grizot S, 2001, BIOCHEMISTRY-US, V40, P10007, DOI 10.1021/bi010288k; Hakansson S, 1996, MOL MICROBIOL, V20, P593, DOI 10.1046/j.1365-2958.1996.5251051.x; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Henderson DA, 1999, SCIENCE, V283, P1279, DOI 10.1126/science.283.5406.1279; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; Logsdon LK, 2003, INFECT IMMUN, V71, P4595, DOI 10.1128/IAI.71.8.4595-4607.2003; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Maesaki R, 1999, J STRUCT BIOL, V126, P166, DOI 10.1006/jsbi.1999.4114; McCormick JB, 1998, CURR OPIN MICROBIOL, V1, P125, DOI 10.1016/S1369-5274(98)80152-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nejedlik L, 2004, YEAST, V21, P759, DOI 10.1002/yea.1135; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rudolph MG, 1999, J BIOL CHEM, V274, P30501, DOI 10.1074/jbc.274.43.30501; RYPNIEWSKI WR, 1993, BIOCHEMISTRY-US, V32, P9851, DOI 10.1021/bi00088a041; Scheffzek K, 2000, NAT STRUCT BIOL, V7, P122, DOI 10.1038/72392; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; SIMONET M, 1992, INFECT IMMUN, V60, P4414, DOI 10.1128/IAI.60.10.4414-4417.1992; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Trulzsch K, 2004, INFECT IMMUN, V72, P5227, DOI 10.1128/IAI.72.9.5227-5234.2004; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Wei YY, 1997, NAT STRUCT BIOL, V4, P699, DOI 10.1038/nsb0997-699; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	44	93	97	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2006	126	5					869	880		10.1016/j.cell.2006.06.056	http://dx.doi.org/10.1016/j.cell.2006.06.056			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959567	Bronze			2022-12-28	WOS:000240675000015
J	Steffen, M; Ansmann, M; Bialczak, RC; Katz, N; Lucero, E; McDermott, R; Neeley, M; Weig, EM; Cleland, AN; Martinis, JM				Steffen, Matthias; Ansmann, M.; Bialczak, Radoslaw C.; Katz, N.; Lucero, Erik; McDermott, R.; Neeley, Matthew; Weig, E. M.; Cleland, A. N.; Martinis, John M.			Measurement of the entanglement of two superconducting qubits via state tomography	SCIENCE			English	Article							QUANTUM; IMPLEMENTATION; ALGORITHM	Demonstration of quantum entanglement, a key resource in quantum computation arising from a nonclassical correlation of states, requires complete measurement of all states in varying bases. By using simultaneous measurement and state tomography, we demonstrated entanglement between two solid-state qubits. Single qubit operations and capacitive coupling between two superconducting phase qubits were used to generate a Bell-type state. Full two-qubit tomography yielded a density matrix showing an entangled state with fidelity up to 87%. Our results demonstrate a high degree of unitary control of the system, indicating that larger implementations are within reach.	Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Calif NanoSyst Inst, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Martinis, JM (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	martinis@physics.ucsb.edu	Cleland, Andrew/AAG-7581-2019; Weig, Eva M/E-9973-2010	Weig, Eva M/0000-0003-4294-8601; Katz, Nadav/0000-0002-9264-078X				Berkley AJ, 2003, SCIENCE, V300, P1548, DOI 10.1126/science.1084528; Chiorescu I, 2003, SCIENCE, V299, P1869, DOI 10.1126/science.1081045; DiVincenzo DP, 2000, FORTSCHR PHYS, V48, P771, DOI 10.1002/1521-3978(200009)48:9/11<771::AID-PROP771>3.0.CO;2-E; GELLER M, COMMUNICATION; Haffner H, 2005, NATURE, V438, P643, DOI 10.1038/nature04279; Leibfried D, 2005, NATURE, V438, P639, DOI 10.1038/nature04251; Martinis JM, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.210503; McDermott R, 2005, SCIENCE, V307, P1299, DOI 10.1126/science.1107572; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Schuch N, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.032301; Steffen M, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.224518; Steffen M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.050502; Vandersypen LMK, 2000, APPL PHYS LETT, V76, P646, DOI 10.1063/1.125846; Vandersypen LMK, 2001, NATURE, V414, P883, DOI 10.1038/414883a; Vion D, 2002, SCIENCE, V296, P886, DOI 10.1126/science.1069372; Wallraff A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060501; Wootters WK, 2001, QUANTUM INF COMPUT, V1, P27; Yamamoto T, 2003, NATURE, V425, P941, DOI 10.1038/nature02015	18	359	371	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2006	313	5792					1423	1425		10.1126/science.1130886	http://dx.doi.org/10.1126/science.1130886			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16960003	Green Submitted			2022-12-28	WOS:000240348700038
J	Turner, RE; Baustian, JJ; Swenson, EM; Spicer, JS				Turner, R. Eugene; Baustian, Joseph J.; Swenson, Erick M.; Spicer, Jennifer S.			Wetland sedimentation from Hurricanes Katrina and Rita	SCIENCE			English	Article							MISSISSIPPI RIVER; GULF	More than 131 x 10(6) metric tons (MT) of inorganic sediments accumulated in coastal wetlands when Hurricanes Katrina and Rita crossed the Louisiana coast in 2005, plus another 281 x 10(6) MT when accumulation was prorated for open water area. The annualized combined amount of inorganic sediments per hurricane equals ( i) 12% of the Mississippi River's suspended load, (ii) 5.5 times the inorganic load delivered by overbank flooding before flood protection levees were constructed, and (iii) 227 times the amount introduced by a river diversion built for wetland restoration. The accumulation from hurricanes is sufficient to account for all the inorganic sediments in healthy saltmarsh wetlands.	Louisiana State Univ, Coastal Ecol Inst, Baton Rouge, LA 70803 USA; Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Turner, RE (corresponding author), Louisiana State Univ, Coastal Ecol Inst, Baton Rouge, LA 70803 USA.	euturne@lsu.edu						Baumann R.H., 1980, THESIS LOUISIANA STA; BAUMANN RH, 1990, ENVIRON GEOL WATER S, V15, P189, DOI 10.1007/BF01706410; BELT CB, 1975, SCIENCE, V189, P681, DOI 10.1126/science.189.4204.681; Cahoon D.R., 1995, J COASTAL RES, P280; Chakrapani GJ, 2005, CURR SCI INDIA, V88, P569; KESEL RH, 1988, ENVIRON GEOL WATER S, V11, P271, DOI 10.1007/BF02574816; MORGAN JP, 1958, CONTRIBUTION LOUISIA, V583; MORTON TA, 2005, 20051215 USGS; NYMAN JA, 1993, MAR ECOL PROG SER, V96, P269, DOI 10.3354/meps096269; Parsons ML, 1998, J COASTAL RES, V14, P939; Reed DJ, 1997, ESTUARIES, V20, P301, DOI 10.2307/1352345; Rybczyk JM, 2002, ESTUARIES, V25, P985, DOI 10.1007/BF02691346; SNEDDEN GA, IN PRESS ESTUAR COAS; Stone GW, 2005, J COASTAL RES, P40; Turner RE, 2004, ECOL RES, V19, P29, DOI 10.1111/j.1440-1703.2003.00610.x; Turner RE, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P583; TURNER RE, 1991, ESTUARIES, V14, P139, DOI 10.2307/1351687; Wheelock K.W, 2003, THESIS LOUISIANA STA	18	220	229	2	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2006	314	5798					449	452		10.1126/science.1129116	http://dx.doi.org/10.1126/science.1129116			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	16990516				2022-12-28	WOS:000241382500037
J	Porter, SR; Scully, C				Porter, S. R.; Scully, C.			Oral malodour (halitosis)	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PERIODONTITIS; ASSOCIATION; MOUTHRINSE; BACTERIA; TONGUE; SALIVA; ZINC		UCL Eastman Dent Inst, Oral Med Unit, London WC1X 8LD, England	University of London; University College London	Porter, SR (corresponding author), UCL Eastman Dent Inst, Oral Med Unit, 256 Grays Inn Rd, London WC1X 8LD, England.	S.Porter@eastman.ucl.ac.uk	Porter, Stephen/B-3519-2009	Porter, Stephen/0000-0002-3328-2759				Aizawa F, 2005, Oral Dis, V11 Suppl 1, P80, DOI 10.1111/j.1601-0825.2005.01099.x; Awano S, 2002, INT DENT J, V52, P212, DOI 10.1002/j.1875-595X.2002.tb00927.x; Borden Loretta C, 2002, Compend Contin Educ Dent, V23, P531; Burton J P, 2005, Oral Dis, V11 Suppl 1, P29, DOI 10.1111/j.1601-0825.2005.01084.x; Burton JP, 2006, J APPL MICROBIOL, V100, P754, DOI 10.1111/j.1365-2672.2006.02837.x; Frascella J, 1998, J CLIN DENT, V9, P39; Frascella J, 2000, Compend Contin Educ Dent, V21, P241; GAFFAR A, 1990, AM J DENT, V3, P7; Greenman J, 2004, J DENT RES, V83, P81, DOI 10.1177/154405910408300116; Hoshi K, 2002, INT DENT J, V52, P207, DOI 10.1002/j.1875-595X.2002.tb00926.x; Hu D, 2005, Oral Dis, V11 Suppl 1, P51, DOI 10.1111/j.1601-0825.2005.01091.x; Hunter C M, 2005, Oral Dis, V11 Suppl 1, P48, DOI 10.1111/j.1601-0825.2005.01090.x; Kato H, 2005, Oral Dis, V11 Suppl 1, P67, DOI 10.1111/j.1601-0825.2005.01096.x; Kleinberg I, 2002, INT DENT J, V52, P236, DOI 10.1002/j.1875-595X.2002.tb00932.x; Kozlovsky A, 1996, J PERIODONTOL, V67, P577, DOI 10.1902/jop.1996.67.6.577; Krespi Y P, 2005, Oral Dis, V11 Suppl 1, P92; McKeown L, 2003, Int J Dent Hyg, V1, P213, DOI 10.1034/j.1601-5037.2003.00056.x; Mitchell S C, 2005, Oral Dis, V11 Suppl 1, P10, DOI 10.1111/j.1601-0825.2005.01081.x; Morita M, 2001, J CLIN PERIODONTOL, V28, P813, DOI 10.1034/j.1600-051x.2001.028009813.x; MUDD SH, 1995, AM J HUM GENET, V57, P882; Nachnani S, 2005, Oral Dis, V11 Suppl 1, P40, DOI 10.1111/j.1601-0825.2005.01088.x; Niles H P, 2005, Oral Dis, V11 Suppl 1, P54, DOI 10.1111/j.1601-0825.2005.01092.x; Outhouse TL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005519.pub2; Pratten J, 2003, ARCH ORAL BIOL, V48, P737, DOI 10.1016/S0003-9969(03)00154-7; Quirynen M, 1998, J PERIODONTOL, V69, P374, DOI 10.1902/jop.1998.69.3.374; Reingewirtz Y, 1999, QUINTESSENCE INT, V30, P319; Rolla G, 2002, INT DENT J, V52, P233; Rosenberg M, 1999, QUINTESSENCE INT, V30, P324; ROSENBERG M, 1992, J PERIODONTOL, V63, P776, DOI 10.1902/jop.1992.63.9.776; Rosenberg M, 1996, J AM DENT ASSOC, V127, P475, DOI 10.14219/jada.archive.1996.0239; Scully C, 2005, BRIT DENT J, V199, P498, DOI 10.1038/sj.bdj.4812806; SCULLY C, HALITOSIS; Sterer N, 2005, J MED MICROBIOL, V54, P1225, DOI 10.1099/jmm.0.46105-0; Sterer N, 2002, INT DENT J, V52, P229, DOI 10.1002/j.1875-595X.2002.tb00930.x; Tomas Carmona I, 2001, Med Oral, V6, P40; TONZETICH J, 1978, INT DENT J, V28, P309; Washio J, 2005, J MED MICROBIOL, V54, P889, DOI 10.1099/jmm.0.46118-0; Winkel EG, 2003, J CLIN PERIODONTOL, V30, P300, DOI 10.1034/j.1600-051X.2003.00342.x; YAEGAKI K, 1992, J PERIODONTOL, V63, P783, DOI 10.1902/jop.1992.63.9.783; Yaegaki K, 1992, Clin Prev Dent, V14, P5; Yaegaki K, 1999, QUINTESSENCE INT, V30, P328; YAEGAKI K, 1992, J PERIODONTAL RES, V27, P233, DOI 10.1111/j.1600-0765.1992.tb01673.x; Young A, 2002, J CLIN PERIODONTOL, V29, P1078, DOI 10.1034/j.1600-051X.2002.291205.x	43	132	142	1	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2006	333	7569					632	635		10.1136/bmj.38954.631968.AE	http://dx.doi.org/10.1136/bmj.38954.631968.AE			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089KD	16990322	Green Published			2022-12-28	WOS:000240878500017
J	Wardlaw, T; Salama, P; Johansson, EW; Mason, E				Wardlaw, Tessa; Salama, Peter; Johansson, Emily White; Mason, Elizabeth			Pneumonia: the leading killer of children	LANCET			English	Editorial Material							MORTALITY; DEATHS		UNICEF, New York, NY 10017 USA; WHO, CAH Dept, CH-1211 Geneva, Switzerland	UNICEF; World Health Organization	Wardlaw, T (corresponding author), UNICEF, New York, NY 10017 USA.	twardlaw@unicef.org	Johansson, Emily/AAQ-3794-2020					Bryce J, 2005, LANCET, V365, P2193, DOI 10.1016/S0140-6736(05)66777-3; Bryce J, 2005, HLTH POLICY PLAN S1, V20, pi5, DOI [10.1093/heapol/czi055, DOI 10.1093/HEAPOL/CZI055]; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; PANDEY MR, 1991, LANCET, V338, P993, DOI 10.1016/0140-6736(91)91847-N; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; SMITH KR, 2006, INT SOC ENV EP PAR F; [UNICEF WHO], 2006, PNEUM FORG KILL CHIL; *US AG INT DEV BAS, SCAL COMM BAS TREATM; *US AG INT DEV REP, 2004, CHWS SEN CAN APPR TR; VENEMAN AM, 2005, 58 WORLD HLTH ASS MA; *WHO, 2006, M REP WHO EXP CONS C; WHO/UNICEF, 2004, JOINT STAT MAN PNEUM; World Health Organization, 1991, TECHN BAS WHO REC MA; 2006, WKLY EPIDEMIOL REC, V81, P7; 2006, WKLY EPIDEMIOL REC, V81, P9	18	199	214	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2006	368	9541					1048	1050		10.1016/S0140-6736(06)69334-3	http://dx.doi.org/10.1016/S0140-6736(06)69334-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	089IC	16997649				2022-12-28	WOS:000240873000007
J	Miranda, KC; Huynh, T; Tay, Y; Ang, YS; Tam, WL; Thomson, AM; Lim, B; Rigoutsos, I				Miranda, Kevin C.; Huynh, Tien; Tay, Yvonne; Ang, Yen-Sin; Tam, Wai-Leong; Thomson, Andrew M.; Lim, Bing; Rigoutsos, Isidore			A pattern-based method for the identification of microRNA binding sites and their corresponding heteroduplexes	CELL			English	Article							INSULIN-SECRETION; CAENORHABDITIS-ELEGANS; TARGET PREDICTIONS; RNA INTERFERENCE; DISCOVERY; GENES; NETWORKS; FAMILIES	We present rna22, a method for identifying microRNA binding sites and their corresponding heteroduplexes. Rna22 does not rely upon cross-species conservation, is resilient to noise, and, unlike previous methods, it first finds putative microRNA binding sites in the sequence of interest, then identifies the targeting microRNA. Computationally, we show that rna22 identifies most of the currently known heteroduplexes. Experimentally, with luciferase assays, we demonstrate average repressions of 30% or more for 168 of 226 tested targets. The analysis suggests that some microRNAs may have as many as a few thousand targets, and that between 74% and 92% of the gene transcripts in four model genomes are likely under microRNA control through their untranslated and amino acid coding regions. We also extended the method's key idea to a low-error microRNA-precursor-discovery scheme; our studies suggest that the number of microRNA precursors in mammalian genomes likely ranges in the tens of thousands.	IBM Corp, Thomas J Watson Res Ctr, Bioinformat & Pattern Discovery Grp, Yorktown Hts, NY 10598 USA; Genome Inst Singapore, Singapore 138672, Singapore; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	International Business Machines (IBM); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Rigoutsos, I (corresponding author), IBM Corp, Thomas J Watson Res Ctr, Bioinformat & Pattern Discovery Grp, POB 218, Yorktown Hts, NY 10598 USA.	rigoutso@us.ibm.com	Rigoutsos, Isidore/C-5381-2012; Tam, Wai Leong/P-1497-2019	Tam, Wai Leong/0000-0003-2365-5264; Rigoutsos, Isidore/0000-0003-1529-8631	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054973] Funding Source: NIH RePORTER; NIAID NIH HHS [AI54973] Funding Source: Medline; NIDDK NIH HHS [DK04763] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altschul SF, 1996, METHOD ENZYMOL, V266, P460; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Brazma A, 1998, J COMPUT BIOL, V5, P279, DOI 10.1089/cmb.1998.5.279; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Darzentas N, 2005, PROTEINS, V61, P926, DOI 10.1002/prot.20608; DOOLITTLE RF, 1983, SCIENCE, V221, P275, DOI 10.1126/science.6304883; Enright AJ, 2004, GENOME BIOL, V5; Ettwiller LM, 2003, GENOME RES, V13, P883, DOI 10.1101/gr.866403; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Gusfield D., 1997, ALGORITHMS STRINGS T; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hobert O, 2004, TRENDS BIOCHEM SCI, V29, P462, DOI 10.1016/j.tibs.2004.07.001; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; KAWAI K, 1995, DIABETOLOGIA, V38, P274, DOI 10.1007/BF00400630; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; MacDonald PE, 2001, MOL ENDOCRINOL, V15, P1423, DOI 10.1210/me.15.8.1423; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Murphy E, 2003, P NATL ACAD SCI USA, V100, P13585, DOI 10.1073/pnas.1735466100; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Pesole G, 2000, Brief Bioinform, V1, P236, DOI 10.1093/bib/1.3.236; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rigoutsos I, 2006, P NATL ACAD SCI USA, V103, P6605, DOI 10.1073/pnas.0601688103; Rigoutsos I, 2003, NUCLEIC ACIDS RES, V31, P4625, DOI 10.1093/nar/gkg639; Rigoutsos I, 2002, NUCLEIC ACIDS RES, V30, P3901, DOI 10.1093/nar/gkf464; Rigoutsos I, 1998, BIOINFORMATICS, V14, P55, DOI 10.1093/bioinformatics/14.1.55; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shibuya T, 2002, NUCLEIC ACIDS RES, V30, P2710, DOI 10.1093/nar/gkf338; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	48	1481	1541	0	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 22	2006	126	6					1203	1217		10.1016/j.cell.2006.07.031	http://dx.doi.org/10.1016/j.cell.2006.07.031			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990141	Green Submitted, Bronze			2022-12-28	WOS:000240897600024
J	Pueyo, S; Jovani, R				Pueyo, Salvador; Jovani, Roger			Comment on "A keystone mutualism drives pattern in a power function"	SCIENCE			English	Editorial Material							LAWS		Univ Barcelona, Dept Ecol, E-08028 Barcelona, Catalonia, Spain; Inst Nacl de Pesquisas da Amazonia, Coordenacao Pesquisas Ecol, BR-69083000 Manaus, Amazonas, Brazil; CSIC, Dept Appl Biol, Estac Biol Donana, E-41080 Seville, Spain	University of Barcelona; Institute Nacional de Pesquisas da Amazonia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Pueyo, S (corresponding author), Univ Barcelona, Dept Ecol, Avinguda Diagonal 645, E-08028 Barcelona, Catalonia, Spain.	spueyo@ub.edu	Jovani, Roger/C-7080-2013	Jovani, Roger/0000-0002-8693-9742				BACH CE, 1991, OECOLOGIA, V87, P233, DOI 10.1007/BF00325261; Bonabeau E, 1999, P NATL ACAD SCI USA, V96, P4472, DOI 10.1073/pnas.96.8.4472; Engen S, 1996, MATH BIOSCI, V132, P169, DOI 10.1016/0025-5564(95)00054-2; Krause J, 2002, LIVING GROUPS; May R, 1999, PHILOS T R SOC B, V354, P1951, DOI 10.1098/rstb.1999.0534; Newman M. E. J., 1992, THEORY CRITICAL PHEN; Pueyo S, 2006, OIKOS, V112, P392, DOI 10.1111/j.0030-1299.2006.14188.x; Sjoberg M, 2000, ECOL LETT, V3, P90, DOI 10.1046/j.1461-0248.2000.00113.x; SOLE RV, 2006, SELF ORG COMPLEX ECO; Solow AR, 2005, ECOL LETT, V8, P361, DOI 10.1111/j.1461-0248.2005.00738.x; Vandermeer J, 2006, SCIENCE, V311, P1000, DOI 10.1126/science.1121432; Vetterling W.T., 1988, NUMERICAL RECIPES C	12	22	22	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2006	313	5794								10.1126/science.1129595	http://dx.doi.org/10.1126/science.1129595			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990535	Green Submitted			2022-12-28	WOS:000240655700026
J	Snyder, SH				Snyder, Solomon H.			Adam finds an exciting mate	SCIENCE			English	Editorial Material									Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu						Fukata Y, 2006, SCIENCE, V313, P1792, DOI 10.1126/science.1129947; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Sagane K, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-33; Steinlein OK, 2004, NAT REV NEUROSCI, V5, P400, DOI 10.1038/nrn1388	6	4	4	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2006	313	5794					1744	1745		10.1126/science.1133501	http://dx.doi.org/10.1126/science.1133501			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990538				2022-12-28	WOS:000240655700032
J	Gyorik, S; Menafoglio, A				Gyoerik, Sandor; Menafoglio, Andrea			Elevated jugular venous pressure	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Osped Reg Bellinzona & Valli, Bellinzona, Switzerland	Regional Hospital of Bellinzona & Valleys, San Giovanni	Gyorik, S (corresponding author), Osped Reg Bellinzona & Valli, Bellinzona, Switzerland.	sigylo@hotmail.com							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 14	2006	355	11					E10	E10		10.1056/NEJMicm050023	http://dx.doi.org/10.1056/NEJMicm050023			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083NJ	16971712				2022-12-28	WOS:000240462800011
J	Li, Y; Bor, YC; Misawa, Y; Xue, YM; Rekosh, D; Hammarskjold, ML				Li, Ying; Bor, Yeou-cherng; Misawa, Yukiko; Xue, Yuming; Rekosh, David; Hammarskjold, Marie-Louise			An intron with a constitutive transport element is retained in a Tap messenger RNA	NATURE			English	Article							RETENTION EVENTS; MAMMALIAN-CELLS; NUCLEAR EXPORT; EXPRESSION; PROTEIN; CTE; TRANSLATION; PREDICTION; ISOFORM	Alternative splicing is a key factor contributing to genetic diversity and evolution(1). Intron retention, one form of alternative splicing, is common in plants(2) but rare in higher eukaryotes(3-8), because messenger RNAs with retained introns are subject to cellular restriction at the level of cytoplasmic export and expression(9,10). Often, retention of internal introns restricts the export of these mRNAs and makes them the targets for degradation by the cellular nonsense-mediated decay machinery if they contain premature stop codons(11,12). In fact, many of the database entries for complementary DNAs with retained introns represent them as artefacts that would not affect the proteome(11). Retroviruses are important model systems in studies of regulation of RNAs with retained introns, because their genomic and mRNAs contain one or more unspliced introns(10). For example, Mason - Pfizer monkey virus overcomes cellular restrictions by using a cis-acting RNA element known as the constitutive transport element (CTE)(13). The CTE interacts directly with the Tap protein ( also known as nuclear RNA export factor 1, encoded by NXF1), which is thought to be a principal export receptor for cellular mRNA(14), leading to the hypothesis that cellular mRNAs with retained introns use cellular CTE equivalents to overcome restrictions to their expression(10). Here we show that the Tap gene contains a functional CTE in its alternatively spliced intron 10. Tap mRNA containing this intron is exported to the cytoplasm and is present in polyribosomes. A small Tap protein is encoded by this mRNA and can be detected in human and monkey cells. Our results indicate that Tap regulates expression of its own intron-containing RNA through a CTE-mediated mechanism. Thus, CTEs are likely to be important elements that facilitate efficient expression of mammalian mRNAs with retained introns.	Univ Virginia, Myles H thaler Ctr AIDS & Human Retrovirus Res, Charlottesville, VA 22908 USA; Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Hammarskjold, ML (corresponding author), Univ Virginia, Myles H thaler Ctr AIDS & Human Retrovirus Res, Charlottesville, VA 22908 USA.	mh7g@virginia.edu						Azios NG, 2001, ONCOGENE, V20, P5199, DOI 10.1038/sj.onc.1204555; Bor YC, 2006, GENE DEV, V20, P1597, DOI 10.1101/gad.1402306; Bouillet P, 2001, MAMM GENOME, V12, P163, DOI 10.1007/s003350010242; BRAY M, 1994, P NATL ACAD SCI USA, V91, P1256, DOI 10.1073/pnas.91.4.1256; CHANG DD, 1990, SCIENCE, V249, P614, DOI 10.1126/science.2143313; Coyle JH, 2003, MOL CELL BIOL, V23, P92, DOI 10.1128/MCB.23.1.92-103.2003; Ernst RK, 1997, RNA, V3, P210; Forrest ST, 2004, J BIOL CHEM, V279, P32897, DOI 10.1074/jbc.M404882200; Galante PAF, 2004, RNA, V10, P757, DOI 10.1261/rna.5123504; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Guzik BW, 2001, MOL CELL BIOL, V21, P2545, DOI 10.1128/MCB.21.7.2545-2554.2001; HAMMARSKJOLD ML, 1989, J VIROL, V63, P1959; Hammarskjold ML, 2001, CURR TOP MICROBIOL, V259, P77; Herold A, 2001, RNA, V7, P1768; Hiller M, 2005, NUCLEIC ACIDS RES, V33, P5611, DOI 10.1093/nar/gki870; Hillman RT, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r8; Jin L, 2003, GENE DEV, V17, P3075, DOI 10.1101/gad.1155703; Kang YB, 1999, VIROLOGY, V262, P200, DOI 10.1006/viro.1999.9906; Keene JD, 2005, CHROMOSOME RES, V13, P327, DOI 10.1007/s10577-005-0848-1; Kreahling J, 2004, TRENDS GENET, V20, P1, DOI 10.1016/j.tig.2003.11.001; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Ner-Gaon H, 2004, PLANT J, V39, P877, DOI 10.1111/j.1365-313X.2004.02172.x; Ohler U, 2005, PLOS COMPUT BIOL, V1, P113, DOI 10.1371/journal.pcbi.0010015; Pasquinelli AE, 1997, EMBO J, V16, P7500, DOI 10.1093/emboj/16.24.7500; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Sasaki M, 2005, GENOMICS, V85, P641, DOI 10.1016/j.ygeno.2005.01.003; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Wehrly K, 1997, METHODS, V12, P288, DOI 10.1006/meth.1997.0481; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	29	93	98	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2006	443	7108					234	237		10.1038/nature05107	http://dx.doi.org/10.1038/nature05107			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16971948				2022-12-28	WOS:000240467000052
J	Urato, AC; Caughey, AB				Urato, Adam C.; Caughey, Aaron B.			Universal prenatal herpes screening is a bad idea in pregnancy	LANCET			English	Editorial Material							TRANSMISSION; DELIVERY; WOMEN; RISK		Univ S Florida, Tampa, FL 33606 USA	State University System of Florida; University of South Florida	Urato, AC (corresponding author), Univ S Florida, Tampa, FL 33606 USA.	aurato@health.usf.edu						ACOG, 2000, INT J GYNECOL OBSTET, V68, P165; Baker DA, 2005, AM J OBSTET GYNECOL, V193, P1887, DOI 10.1016/j.ajog.2005.08.007; Brown ZA, 2005, OBSTET GYNECOL, V106, P845, DOI 10.1097/01.AOG.0000180779.35572.3a; Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203; Casper Corey, 2002, Herpes, V9, P10; Centers for Disease Control and Prevention, 2006, MMWR-MORBID MORTAL W, V55; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; Gaytant M A, 2000, Ned Tijdschr Geneeskd, V144, P1832; Gaytant MA, 2002, SEX TRANSM DIS, V29, P710, DOI 10.1097/00007435-200211000-00015; Glass N, 2005, AHRQ PUBLICATION; Gutierrez KM, 1999, J INFECT DIS, V180, P199, DOI 10.1086/314848; Lindsay MK, 2006, AM J OBSTET GYNECOL, V195, P4, DOI 10.1016/j.ajog.2006.02.014; LOWBEER NM, 2002, CLIN GUIDELINE; Sheffield JS, 2003, OBSTET GYNECOL, V102, P1396, DOI 10.1016/j.obstetgynecol.2003.08.015	14	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2006	368	9539					898	899		10.1016/S0140-6736(06)69348-3	http://dx.doi.org/10.1016/S0140-6736(06)69348-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	083ZX	16962863				2022-12-28	WOS:000240502300007
J	Felten, DL				Felten, David L.			IRBs: Going too far or not far enough?	SCIENCE			English	Letter									William Beaumont Hosp, Beaumont Res Inst, Royal Oak, MI 48073 USA	Beaumont Health	Felten, DL (corresponding author), William Beaumont Hosp, Beaumont Res Inst, Royal Oak, MI 48073 USA.		Dubnov-Raz, Gal/L-3297-2016; HIRANO, NAOTO/F-6009-2016; Gunsalus, C.K./R-2381-2019; Fine, Maoz/S-5582-2019	Dubnov-Raz, Gal/0000-0003-1469-8043; HIRANO, NAOTO/0000-0003-3491-0312; Gunsalus, C.K./0000-0003-4018-533X; Fine, Maoz/0000-0003-4911-4562					0	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2006	313	5792					1388	1388		10.1126/science.313.5792.1388	http://dx.doi.org/10.1126/science.313.5792.1388			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16959990				2022-12-28	WOS:000240348700015
J	Blundy, J; Cashman, K; Humphreys, M				Blundy, Jon; Cashman, Kathy; Humphreys, Madeleine			Magma heating by decompression-driven crystallization beneath andesite volcanoes	NATURE			English	Article							MOUNT ST-HELENS; EXPERIMENTAL CONSTRAINTS; PHASE-RELATIONS; SOLUTION MODEL; HILLS VOLCANO; ASCENT RATES; TI OXIDES; ERUPTION; DACITE; EQUILIBRIA	Explosive volcanic eruptions are driven by exsolution of H2O-rich vapour from silicic magma(1). Eruption dynamics involve a complex interplay between nucleation and growth of vapour bubbles and crystallization, generating highly nonlinear variation in the physical properties of magma as it ascends beneath a volcano(2). This makes explosive volcanism difficult to model and, ultimately, to predict. A key unknown is the temperature variation in magma rising through the sub-volcanic system, as it loses gas and crystallizes en route(3). Thermodynamic modelling of magma that degasses, but does not crystallize, indicates that both cooling and heating are possible(4). Hitherto it has not been possible to evaluate such alternatives because of the difficulty of tracking temperature variations in moving magma several kilometres below the surface. Here we extend recent work on glassy melt inclusions trapped in plagioclase crystals(5) to develop a method for tracking pressure-temperature-crystallinity paths in magma beneath two active andesite volcanoes. We use dissolved H2O in melt inclusions to constrain the pressure of H2O at the time an inclusion became sealed, incompatible trace element concentrations to calculate the corresponding magma crystallinity and plagioclase-melt geothermometry to determine the temperature. These data are allied to ilmenite-magnetite geothermometry to show that the temperature of ascending magma increases by up to 100 degrees C, owing to the release of latent heat of crystallization. This heating can account for several common textural features of andesitic magmas, which might otherwise be erroneously attributed to pre-eruptive magma mixing.	Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA	University of Bristol; University of Oregon	Blundy, J (corresponding author), Univ Bristol, Dept Earth Sci, Wills Mem Bldg, Bristol BS8 1RJ, Avon, England.	Jon.Blundy@bris.ac.uk	Humphreys, Madeleine CS/C-3999-2015; Facility, Edinburgh Ion Microprobe/AAD-8512-2020	Humphreys, Madeleine CS/0000-0001-9343-1237; Facility, Edinburgh Ion Microprobe/0000-0001-6248-6657				ANDERSEN DJ, 1988, AM MINERAL, V73, P714; Bachmann O, 2002, AM MINERAL, V87, P1062; BACON CR, 1988, AM MINERAL, V73, P57; Blundy J, 2001, CONTRIB MINERAL PETR, V140, P631, DOI 10.1007/s004100000219; Blundy J, 2005, GEOLOGY, V33, P793, DOI 10.1130/G21668.1; Cashman KV, 2004, GEOPHYS MONOGR SER, V150, P109, DOI 10.1029/150GM10; Costa F, 2004, J PETROL, V45, P855, DOI 10.1093/petrology/egg114; Couch S, 2003, J PETROL, V44, P1455, DOI 10.1093/petrology/44.8.1455; Couch S, 2001, NATURE, V411, P1037, DOI 10.1038/35082540; CRISWELL CW, 1987, J GEOPHYS RES-SOLID, V92, P10237, DOI 10.1029/JB092iB10p10237; Devine JD, 2003, J PETROL, V44, P1375, DOI 10.1093/petrology/44.8.1375; Dirksen O, 2006, J VOLCANOL GEOTH RES, V155, P201, DOI 10.1016/j.jvolgeores.2006.03.029; Ginibre C, 2002, CONTRIB MINERAL PETR, V142, P436, DOI 10.1007/s004100100298; Hammer JE, 2002, CONTRIB MINERAL PETR, V144, P144, DOI 10.1007/s00410-002-0393-2; Hess KU, 1996, AM MINERAL, V81, P1297; HILDRETH W, 1981, J GEOPHYS RES, V86, P153, DOI 10.1029/JB086iB11p10153; Holtz F, 2005, J PETROL, V46, P319, DOI 10.1093/petrology/egh077; Humphreys MCS, 2006, AM MINERAL, V91, P667, DOI 10.2138/am.2006.1936; Klimm K, 2003, PRECAMBRIAN RES, V124, P327, DOI 10.1016/S0301-9268(03)00092-5; Larsen JF, 2005, AM MINERAL, V90, P417, DOI 10.2138/am.2005.1456; Martel C, 2003, CONTRIB MINERAL PETR, V144, P397, DOI 10.1007/s00410-002-0404-3; Martel C, 1999, J GEOPHYS RES-SOL EA, V104, P29453, DOI 10.1029/1999JB900191; Mastin LG, 2001, CONTRIB MINERAL PETR, V141, P307, DOI 10.1007/s004100000210; Melnik O, 1999, NATURE, V402, P37, DOI 10.1038/46950; Melnik O, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003183; Newman S, 2002, COMPUT GEOSCI-UK, V28, P597, DOI 10.1016/S0098-3004(01)00081-4; Putirka KA, 2005, AM MINERAL, V90, P336, DOI 10.2138/am.2005.1449; RUTHERFORD MJ, 1993, J GEOPHYS RES-SOL EA, V98, P19667, DOI 10.1029/93JB01613; Scaillet B, 1999, J PETROL, V40, P381, DOI 10.1093/petrology/40.3.381; SCANDONE R, 1985, J VOLCANOL GEOTH RES, V23, P239, DOI 10.1016/0377-0273(85)90036-8; SPENCER KJ, 1981, AM MINERAL, V66, P1189; Venezky DY, 1999, J VOLCANOL GEOTH RES, V89, P213, DOI 10.1016/S0377-0273(98)00133-4	32	237	243	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 7	2006	443	7107					76	80		10.1038/nature05100	http://dx.doi.org/10.1038/nature05100			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16957729				2022-12-28	WOS:000240313900042
J	Bourhis, J; Overgaard, J; Audry, H; Ang, KK; Saunders, M; Bernier, J; Horiot, JC; Le Maitre, A; Pajak, TF; Paulsen, MG; O'Sullivan, B; Dobrowsky, W; Hliniak, A; Skladowski, K; Hay, JH; Pinto, LH; Fallai, C; Fu, KK; Sylvester, R; Pignon, JP				Bourhis, Jean; Overgaard, Jens; Audry, Helene; Ang, Kian K.; Saunders, Michele; Bernier, Jacques; Horiot, Jean-Claude; Le Maitre, Aurlie; Pajak, Thomas F.; Paulsen, Michael G.; O'Sullivan, Brian; Dobrowsky, Werner; Hliniak, Andrzej; Skladowski, Krzysztof; Hay, John H.; Pinto, Luiz H. J.; Fallai, Carlo; Fu, Karen K.; Sylvester, Richard; Pignon, Jean-Pierre		Carcinomas, MAR	Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis	LANCET			English	Article							SQUAMOUS-CELL CARCINOMA; CONVENTIONAL RADIOTHERAPY; RANDOMIZED-TRIAL; RADIATION-THERAPY; FRACTIONATION; CHEMOTHERAPY	Background Several trials have studied the role of unconventional fractionated radiotherapy in head and neck squamous cell carcinoma, but the effect of such treatment on survival is not clear. The aim of this meta-analysis was to assess whether this type of radiotherapy could improve survival. Methods Randomised trials comparing conventional radiotherapy with hyperfractionated or accelerated radiotherapy, or both, in patients with non-metastatic HNSCC were identified and updated individual patient data were obtained. Overall survival was the main endpoint. Trials were grouped in three pre-specified categories: hyperfractionated, accelerated, and accelerated with total dose reduction. Findings 15 trials with 6515 patients were included. The median follow-up was 6 years. Tumours sites were mostly oropharynx and larynx; 5221 (74%) patients had stage III-IV disease (International Union Against Cancer, 1987). There was a significant survival benefit with altered fractionated radiotherapy, corresponding to an absolute benefit of 3.4% at 5 years (hazard ratio 0.92, 95% CI 0.86-0.97; p=0.003). The benefit was significantly higher with hyperfractionated radiotherapy (8% at 5 years) than with accelerated radiotherapy (2% with accelerated fractionation without total dose reduction and 1.7% with total dose reduction at 5 years, p=0.02). There was a benefit on locoregional control in favour of altered fractionation versus conventional radiotherapy (6.4% at 5 years; p<0.0001), which was particularly efficient in reducing local failure, whereas the benefit on nodal control was less pronounced. The benefit was significantly higher in the youngest patients (hazard ratio 0.78 [0.65-0.94] for under 50 year olds, 0.95 [0.83-1.09] for 51-60 year olds, 0.92 [0.81-1.06] for 61-70 year olds, and 1.08 [0.89-1.30] for over 70 year olds; test for trends p=0.007). Interpretation Altered fractionated radiotherapy improves survival in patients with head and neck squamous cell carcinoma. Comparison of the different types of altered radiotherapy suggests that hyperfractionation has the greatest benefit.	Inst Gustave Roussy, Dept Biostat & Epidemiol, F-94805 Villejuif, France; Inst Gustave Roussy, Dept Radiat Oncol, Villejuif, France; Danish Canc Soc, Dept Expt Clin Oncol, DK-8000 Aarhus, Denmark; Univ Texas, MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; Mt Vernon Hosp, Northwood HA6 2RN, Middx, England; Univ Geneva, Fac Med, CH-1211 Geneva 4, Switzerland; Ctr F Leclerc, Dijon, France; RTOG Stat Headquarters, Philadelphia, PA USA; So Zone Radiat Oncol Mater Ctr, Brisbane, Qld, Australia; Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON M4X 1K9, Canada; Newcastle Gen Hosp, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Oncol Inst Ctr, Warsaw, Poland; Maria Curie Mem Inst, Gliwice, Poland; British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; Inst Nacl Canc, Rio De Janeiro, Brazil; Ist Nazl Tumori, Dipartimento Radiotherapia, I-20133 Milan, Italy; Univ Calif San Francisco, San Francisco, CA 94143 USA; EORTC Stat Headquarters, Brussels, Belgium	UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Danish Cancer Society; University of Texas System; UTMD Anderson Cancer Center; University of Geneva; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Newcastle General Hospital; Maria Sklodowska-Curie National Research Institute of Oncology; British Columbia Cancer Agency; National Cancer Institute (Inca); Fondazione IRCCS Istituto Nazionale Tumori Milan; University of California System; University of California San Francisco	Pignon, JP (corresponding author), Inst Gustave Roussy, Dept Biostat & Epidemiol, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	jppignon@igr.fr	Fallai, Carlo/J-3936-2017; Składowski, Krzysztof/GLV-3023-2022; Bernier, Jacques/AAE-7248-2020; Poulsen, Michael/F-4858-2010; Pinto, Luiz Henrique/D-9561-2013	Fallai, Carlo/0000-0001-8070-0282; Składowski, Krzysztof/0000-0002-0554-6171; Bernier, Jacques/0000-0002-0138-9906; Poulsen, Michael/0000-0002-3410-1382; Bourhis, Jean/0000-0001-5162-1171; PIGNON, Jean-Pierre/0000-0003-2047-1582	NCI NIH HHS [2U10CA11488-36] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U10CA011488] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABE O, 1995, NEW ENGL J MED, V333, P1444; ALBERTI W, 1995, BRIT MED J, V311, P899; [Anonymous], 1992, Lancet, V339, P1; BOURHIS J, 2004, P AN M AM SOC CLIN, V22, P488; Bourhis J, 2006, J CLIN ONCOL, V24, p280S; Bourhis J, 2006, J CLIN ONCOL, V24, P2873, DOI 10.1200/JCO.2006.08.057; Cummings B., 2000, Radiotherapy and Oncology, V56, pS8; DATTA N R, 1989, International Journal of Radiation Oncology, Biology, Physics, V17, P132; Dische S, 1997, RADIOTHER ONCOL, V44, P123, DOI 10.1016/S0167-8140(97)00094-7; Dobrowsky W, 2000, RADIOTHER ONCOL, V57, P119, DOI 10.1016/S0167-8140(00)00233-4; Ferlay J, 2004, GLOBOCAN 2002 CANC I; Fu KK, 2000, INT J RADIAT ONCOL, V48, P7, DOI 10.1016/S0360-3016(00)00663-5; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hliniak A, 2002, RADIOTHER ONCOL, V62, P1, DOI 10.1016/S0167-8140(01)00494-7; HORIOT JC, 1992, RADIOTHER ONCOL, V25, P231, DOI 10.1016/0167-8140(92)90242-M; Horiot JC, 1997, RADIOTHER ONCOL, V44, P111, DOI 10.1016/S0167-8140(97)00079-0; Jackson SM, 1997, RADIOTHER ONCOL, V43, P39, DOI 10.1016/S0167-8140(97)01944-0; Khalil AA, 2003, INT J RADIAT ONCOL, V55, P568, DOI 10.1016/S0360-3016(02)03790-2; MARCIAL VA, 1987, INT J RADIAT ONCOL, V13, P41, DOI 10.1016/0360-3016(87)90258-6; Olmi P, 2003, INT J RADIAT ONCOL, V55, P78, DOI 10.1016/S0360-3016(02)03792-6; Overgaard J, 2003, LANCET, V362, P933, DOI 10.1016/S0140-6736(03)14361-9; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; PIGNON JP, 2000, COCHRANE LIB; PINTO LHJ, 1991, INT J RADIAT ONCOL, V21, P557, DOI 10.1016/0360-3016(91)90670-Y; Poulsen MG, 2001, RADIOTHER ONCOL, V60, P113, DOI 10.1016/S0167-8140(01)00347-4; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Skladowski K, 2000, RADIOTHER ONCOL, V55, P101, DOI 10.1016/S0167-8140(00)00139-0; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	29	766	783	0	57	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2006	368	9538					843	854		10.1016/S0140-6736(06)69121-6	http://dx.doi.org/10.1016/S0140-6736(06)69121-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	082FD	16950362				2022-12-28	WOS:000240371200032
J	Damschen, EI; Haddad, NM; Orrock, JL; Tewksbury, JJ; Levey, DJ				Damschen, Ellen I.; Haddad, Nick M.; Orrock, John L.; Tewksbury, Joshua J.; Levey, Douglas J.			Corridors increase plant species richness at large scales	SCIENCE			English	Article							SEED PREDATION; FRAGMENTED LANDSCAPES; MICROECOSYSTEM; DISPERSAL; ABUNDANCE; ECOSYSTEM	Habitat fragmentation is one of the largest threats to biodiversity. Landscape corridors, which are hypothesized to reduce the negative consequences of fragmentation, have become common features of ecological management plans worldwide. Despite their popularity, there is little evidence documenting the effectiveness of corridors in preserving biodiversity at large scales. Using a large-scale replicated experiment, we showed that habitat patches connected by corridors retain more native plant species than do isolated patches, that this difference increases over time, and that corridors do not promote invasion by exotic species. Our results support the use of corridors in biodiversity conservation.	N Carolina State Univ, Dept Zool, Raleigh, NC 27695 USA; Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50010 USA; Univ Washington, Dept Biol, Seattle, WA 98195 USA; Univ Florida, Dept Zool, Gainesville, FL 32611 USA	University of North Carolina; North Carolina State University; Iowa State University; University of Washington; University of Washington Seattle; State University System of Florida; University of Florida	Damschen, EI (corresponding author), Natl Ctr Ecol Anal & Synth, 735 State St,Suite 300, Santa Barbara, CA 93101 USA.	damschen@nceas.ucsb.edu	Damschen, Ellen/E-4919-2011	Damschen, Ellen/0000-0001-7435-0669				Balmford A, 2005, ECOL LETT, V8, P1218, DOI 10.1111/j.1461-0248.2005.00814.x; Beier P, 1998, CONSERV BIOL, V12, P1241, DOI 10.1046/j.1523-1739.1998.98036.x; Brockway DG, 1998, FOREST ECOL MANAG, V106, P125, DOI 10.1016/S0378-1127(97)00308-3; Collinge SK, 2000, ECOLOGY, V81, P2211, DOI 10.1890/0012-9658(2000)081[2211:EOGFOI]2.0.CO;2; FROST CC, 1993, TALL TIMB FIR EC C T; Gilbert F, 1998, P ROY SOC B-BIOL SCI, V265, P577, DOI 10.1098/rspb.1998.0333; Gonzalez A, 1998, SCIENCE, V281, P2045, DOI 10.1126/science.281.5385.2045; Haddad NM, 2003, ECOLOGY, V84, P609, DOI 10.1890/0012-9658(2003)084[0609:CUBDT]2.0.CO;2; Hoyle M, 2004, OIKOS, V105, P359, DOI 10.1111/j.0030-1299.2004.12832.x; KILGO JC, 2005, ECOLOGY MANAGEMENT F, P99; Kirkman LK, 2001, AM J BOT, V88, P2119, DOI 10.2307/3558437; Levey DJ, 2005, SCIENCE, V309, P146, DOI 10.1126/science.1111479; Orrock JL, 2005, ECOL APPL, V15, P793, DOI 10.1890/04-1129; Orrock JL, 2003, ECOLOGY, V84, P2589, DOI 10.1890/02-0439; Orrock JL, 2006, J ECOL, V94, P838, DOI 10.1111/j.1365-2745.2006.01125.x; OUTCALT KW, 1998, LONGLEAF PINE FOREST; Proches S, 2005, SCIENCE, V310, P779, DOI 10.1126/science.310.5749.779; SIMBERLOFF D, 1992, CONSERV BIOL, V6, P493, DOI 10.1046/j.1523-1739.1992.06040493.x; Tewksbury JJ, 2002, P NATL ACAD SCI USA, V99, P12923, DOI 10.1073/pnas.202242699; Townsend PA, 2005, ECOLOGY, V86, P466, DOI 10.1890/03-0607; Van Lear DH, 2005, FOREST ECOL MANAG, V211, P150, DOI 10.1016/j.foreco.2005.02.014; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wilson EO, 1975, ECOLOGY EVOLUTION CO	23	237	257	18	258	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 1	2006	313	5791					1284	1286		10.1126/science.1130098	http://dx.doi.org/10.1126/science.1130098			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16946070				2022-12-28	WOS:000240313500040
J	Singh, SP; Burns, T				Singh, Swaran P.; Burns, Tom			Controversy - Race and mental health: there is more to race than racism	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PSYCHOTIC ILLNESS; SOCIAL ADVERSITY; NATIONAL COHORT; ETHNIC-GROUPS; SCHIZOPHRENIA; PATHWAYS; CARE; PSYCHIATRISTS; LONDON; AESOP		Univ Warwick, Warwick Med Sch, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England; Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England	University of Warwick; University of Oxford	Singh, SP (corresponding author), Univ Warwick, Warwick Med Sch, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England.	S.P.Singh@warwick.ac.uk		Singh, Swaran/0000-0003-3454-2089				[Anonymous], 2005, DEL RAC QUAL MENT HL; Bhugra D, 1999, INT REV PSYCHIATR, V11, P236, DOI 10.1080/09540269974429; Bhugra D, 1997, PSYCHOL MED, V27, P791, DOI 10.1017/S0033291797005369; Bhugra D, 2001, ADV PSYCHIAT TREAT, V7, P283, DOI DOI 10.1192/APT.7.4.283; Burnett R, 1999, PSYCHOL MED, V29, P475, DOI 10.1017/S0033291798008125; Cantor-Graae E, 2005, AM J PSYCHIAT, V162, P12, DOI 10.1176/appi.ajp.162.1.12; Cole E, 1995, BRIT J PSYCHIAT, V167, P770, DOI 10.1192/bjp.167.6.770; *COMM HEALTHC AUD, 2005, COUNT ME RES NAT CEN; FERNANDO S, 2001, MENTAL HLTH RACE CUL; Hjern A, 2004, PSYCHOL MED, V34, P1025, DOI 10.1017/S003329170300148X; JABLENSKY A, 1994, BRIT J PSYCHIAT, V165, P434, DOI 10.1192/bjp.165.4.434; JABLENSKY A, 2000, NEW OXFORD TXB PSYCH, P592; KING M, 1994, BMJ-BRIT MED J, V309, P1115, DOI 10.1136/bmj.309.6962.1115; Koffman J, 1997, BRIT J PSYCHIAT, V171, P238, DOI 10.1192/bjp.171.3.238; LEWIS G, 1990, BRIT J PSYCHIAT, V157, P410, DOI 10.1192/bjp.157.3.410; MACATTRAM M, 2005, CENSUS REVEALS UNPRE; Minnis H, 2001, BRIT MED J, V323, P905, DOI 10.1136/bmj.323.7318.905; Morgan C, 2005, BRIT J PSYCHIAT, V186, P290, DOI 10.1192/bjp.186.4.290; Morgan C, 2005, BRIT J PSYCHIAT, V186, P281, DOI 10.1192/bjp.186.4.281; Murthy RS, 2005, PSYCHOL MED, V35, P341, DOI 10.1017/S0033291704003551; *NAT I MENT HLTH, 2003, INS OUTS IMPR MENT H; *NORF SUFF CAMBR S, 2003, IND INQ DEATH D BENN; Odegaard O., 1932, ACTA PSYCHIAT NEUROL, V4, P1, DOI DOI 10.1097/00005053-193312000-00060; Sainsbury Centre for Mental Health, 2002, BREAK CIRCL FEAR REV; SARTORIUS N, 1986, PSYCHOL MED, V16, P909, DOI 10.1017/S0033291700011910; Sashidharan SP, 1999, BRIT MED J, V319, P254, DOI 10.1136/bmj.319.7204.254; SASHIDHARAN SP, 2001, PSYCHIAT B, V25, P244; SELLWOOD W, 1994, SOC PSYCH PSYCH EPID, V29, P172; Sharpley M, 2001, BRIT J PSYCHIAT, V178, pS60, DOI 10.1192/bjp.178.40.s60; Singh SP, 1997, BRIT J PSYCHIAT, V171, P305, DOI 10.1192/bjp.171.4.305; VanOs J, 1996, PSYCHOL MED, V26, P203, DOI 10.1017/S0033291700033845; Wicks S, 2005, AM J PSYCHIAT, V162, P1652, DOI 10.1176/appi.ajp.162.9.1652	32	56	57	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2006	333	7569					648	651		10.1136/bmj.38930.501516.BE	http://dx.doi.org/10.1136/bmj.38930.501516.BE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	089KD	16990327	Green Published, Green Submitted			2022-12-28	WOS:000240878500022
J	Ivanov, II; McKenzie, BS; Zhou, L; Tadokoro, CE; Lepelley, A; Lafaille, JJ; Cua, DJ; Littman, DR				Ivanov, Ivaylo I.; McKenzie, Brent S.; Zhou, Liang; Tadokoro, Carlos E.; Lepelley, Alice; Lafaille, Juan J.; Cua, Daniel J.; Littman, Dan R.			The orphan nuclear receptor ROR gamma t directs the differentiation program of proinflammatory IL-17(+) T helper cells	CELL			English	Article							ISOLATED LYMPHOID FOLLICLES; AUTOIMMUNE ENCEPHALOMYELITIS; TRANSCRIPTION FACTOR; TGF-BETA; LINEAGE COMMITMENT; INTERLEUKIN-17; INFLAMMATION; IL-23; IMMUNE; INDUCTION	IL-17-producing T lymphocytes have been recently shown to comprise a distinct lineage of proinflammatory T helper cells, termed Th17 cells, that are major contributors to autoimmune disease. We show here that the orphan nuclear receptor ROR gamma t is the key transcription factor that orchestrates the differentiation of this effector cell lineage. ROR gamma t induces transcription of the genes encoding IL-17 and the related cytokine IL-17F in naive CD4(+) T helper cells and is required for their expression in response to IL-6 and TGF-beta, the cytokines known to induce IL-17. Th17 cells are constitutively present throughout the intestinal lamina propria, express ROR gamma t, and are absent in mice deficient for ROR gamma t or IL-6. Mice with ROR gamma t-deficient T cells have attenuated autoimmune disease and lack tissue-infiltrating Th17 cells. Together, these studies suggest that ROR gamma t is a key regulator of immune homeostasis and highlight its potential as a therapeutic target in inflammatory diseases.	NYU, Sch Med, Skirball Inst Biomol Med, Mol Pathogenesis Program, New York, NY 10016 USA; NYU, Sch Med, Howard Hughes Med Inst, Skirball Inst Biomol Med, New York, NY 10016 USA; Schering Plough BioPharm, DNAX Discovery Res, Palo Alto, CA 94304 USA	New York University; Howard Hughes Medical Institute; New York University; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Cua, DJ (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Mol Pathogenesis Program, 550 1St Ave, New York, NY 10016 USA.	daniel.cua@spcorp.com; littman@saturn.med.nyu.edu	Tadokoro, Carlos E/D-5111-2011; Lepelley, Alice/P-1197-2018	Lepelley, Alice/0000-0001-8656-7291; Tadokoro, Carlos Eduardo/0000-0002-7874-5657				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Barczyk A, 2003, RESP MED, V97, P726, DOI 10.1053/rmed.2003.1507; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Christen U, 2004, IMMUNOL RES, V30, P309, DOI 10.1385/IR:30:3:309; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eberl G, 2003, IMMUNOL REV, V195, P81, DOI 10.1034/j.1600-065X.2003.00074.x; Eugster HP, 1998, EUR J IMMUNOL, V28, P2178, DOI 10.1002/(SICI)1521-4141(199807)28:07<2178::AID-IMMU2178>3.0.CO;2-D; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gately MK, 1998, ANNU REV IMMUNOL, V16, P495, DOI 10.1146/annurev.immunol.16.1.495; Glimcher LH, 2000, GENE DEV, V14, P1693; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107, DOI 10.4049/jimmunol.165.11.6107; Ilvanov II, 2006, CURR TOP MICROBIOL, V308, P59; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Jetten AM, 2001, PROG NUCLEIC ACID RE, V69, P205, DOI 10.1016/S0079-6603(01)69048-2; Jetten Anton M., 2004, Current Drug Targets - Inflammation and Allergy, V3, P395, DOI 10.2174/1568010042634497; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; Kinugasa T, 2000, GASTROENTEROLOGY, V118, P1001, DOI 10.1016/S0016-5085(00)70351-9; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lorenz RG, 2003, J IMMUNOL, V170, P5475, DOI 10.4049/jimmunol.170.11.5475; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Newberry RD, 2005, IMMUNOL REV, V206, P6, DOI 10.1111/j.0105-2896.2005.00282.x; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Pabst O, 2005, EUR J IMMUNOL, V35, P98, DOI 10.1002/eji.200425432; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Stamp LK, 2004, IMMUNOL CELL BIOL, V82, P1, DOI 10.1111/j.1440-1711.2004.01212.x; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Taylor RT, 2005, IMMUNOL RES, V33, P167, DOI 10.1385/IR:33:2:167; TREMBLEAU S, 1995, IMMUNOL TODAY, V16, P383, DOI 10.1016/0167-5699(95)80006-9; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Witowski J, 2004, CELL MOL LIFE SCI, V61, P567, DOI 10.1007/s00018-003-3228-z; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	58	3749	4147	10	204	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 22	2006	126	6					1121	1133		10.1016/j.cell.2006.07.035	http://dx.doi.org/10.1016/j.cell.2006.07.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990136	Bronze			2022-12-28	WOS:000240897600018
J	Klein, DJ; Ferre-D'Amare, AR				Klein, Daniel J.; Ferre-D'Amare, Adrian R.			Structural basis of glmS ribozyme activation by glucosamine-6-phosphate	SCIENCE			English	Article							DELTA VIRUS RIBOZYME; SELF-CLEAVAGE ACTIVITY; HAIRPIN RIBOZYME; CRYSTAL-STRUCTURE; GENE-EXPRESSION; LIGAND-BINDING; RNA; RIBOSWITCH; CATALYSIS; PSEUDOKNOT	The glmS ribozyme is the only natural catalytic RNA known to require a small-molecule activator for catalysis. This catalytic RNA functions as a riboswitch, with activator-dependent RNA cleavage regulating glmS messenger RNA expression. We report crystal structures of the glmS ribozyme in precleavage states that are unliganded or bound to the competitive inhibitor glucose-6-phosphate and in the postcleavage state. All structures superimpose closely, revealing a remarkably rigid RNA that contains a preformed active and coenzyme-binding site. Unlike other riboswitches, the glmS ribozyme binds its activator in an open, solvent-accessible pocket. Our structures suggest that the amine group of the glmS ribozyme-bound coenzyme performs general acid-base and electrostatic catalysis.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Ferre-D'Amare, AR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	aferre@fhcrc.org			NIGMS NIH HHS [GM63576] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063576] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Bevilacqua PC, 2003, BIOCHEMISTRY-US, V42, P2259, DOI 10.1021/bi027273m; Carothers JM, 2006, RNA, V12, P567, DOI 10.1261/rna.2251306; Das SR, 2005, NAT CHEM BIOL, V1, P45, DOI 10.1038/nchembio703; EDWARDS TE, IN PRESS STRUCTURE; Fedor MJ, 2005, NAT REV MOL CELL BIO, V6, P399, DOI 10.1038/nrm1647; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; Gilbert SD, 2006, J MOL BIOL, V359, P754, DOI 10.1016/j.jmb.2006.04.003; Hampel KJ, 2006, BIOCHEMISTRY-US, V45, P7861, DOI 10.1021/bi060337z; Jansen JA, 2006, NAT STRUCT MOL BIOL, V13, P517, DOI 10.1038/nsmb1094; Kolk MH, 1998, SCIENCE, V280, P434, DOI 10.1126/science.280.5362.434; Kuzmin YI, 2005, J MOL BIOL, V349, P989, DOI 10.1016/j.jmb.2005.04.005; Lebruska LL, 2002, CHEM BIOL, V9, P465, DOI 10.1016/S1074-5521(02)00130-8; McCarthy TJ, 2005, CHEM BIOL, V12, P1221, DOI 10.1016/j.chembiol.2005.09.006; Montange RK, 2006, NATURE, V441, P1172, DOI 10.1038/nature04819; Nakano S, 2000, SCIENCE, V287, P1493, DOI 10.1126/science.287.5457.1493; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Perrotta AT, 1999, SCIENCE, V286, P123, DOI 10.1126/science.286.5437.123; Pinard R, 2001, EMBO J, V20, P6434, DOI 10.1093/emboj/20.22.6434; PLEIJ CWA, 1985, NUCLEIC ACIDS RES, V13, P1717, DOI 10.1093/nar/13.5.1717; Roth A, 2006, RNA, V12, P607, DOI 10.1261/rna.2266506; Rupert PB, 2002, SCIENCE, V298, P1421, DOI 10.1126/science.1076093; Rupert PB, 2001, NATURE, V410, P780, DOI 10.1038/35071009; Salter J, 2006, BIOCHEMISTRY-US, V45, P686, DOI 10.1021/bi051887k; Schmeing TM, 2002, NAT STRUCT BIOL, V9, P225, DOI 10.1038/nsb758; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Soukup GA, 2006, NUCLEIC ACIDS RES, V34, P968, DOI 10.1093/nar/gkj497; Thore S, 2006, SCIENCE, V312, P1208, DOI 10.1126/science.1128451; Wadkins TS, 1999, RNA, V5, P720, DOI 10.1017/S1355838299990209; WHITE HB, 1976, J MOL EVOL, V7, P101, DOI 10.1007/BF01732468; Wilkinson SR, 2005, RNA, V11, P1788, DOI 10.1261/rna.2203605; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Xue YF, 2001, INT J SYST EVOL MICR, V51, P1335, DOI 10.1099/00207713-51-4-1335	36	286	309	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2006	313	5794					1752	1756		10.1126/science.1129666	http://dx.doi.org/10.1126/science.1129666			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990543				2022-12-28	WOS:000240655700038
J	Ma, Y; Creanga, A; Lum, L; Beachy, PA				Ma, Yong; Creanga, Adrian; Lum, Lawrence; Beachy, Philip A.			Prevalence of off-target effects in Drosophila RNA interference screens	NATURE			English	Article							FUNCTIONAL GENOMIC ANALYSIS; SIGNALING PATHWAY; CULTURED-CELLS; COMPONENTS; SECRETION; PROTEIN; SIRNAS	RNA interference (RNAi) in both plants and animals is mediated by small RNAs of approximately 21 - 23 nucleotides in length for regulation of target gene expression at multiple levels through partial sequence complementarities(1,2). Combined with widespread genome sequencing, experimental use of RNAi has the potential to interrogate systematically all genes in a given organism with respect to a particular function(3-9). However, owing to a tolerance for mismatches and gaps in base-pairing with targets(10-12), small RNAs could have up to hundreds of potential target sequences in a genome(13,14), and some small RNAs in mammalian systems have been shown to affect the levels of many messenger RNAs besides their intended targets(15,16). The use of long double-stranded RNAs (dsRNAs) in Drosophila, where Dicer-mediated processing produces small RNAs inside cells, has been thought to reduce the probability of such 'off-target effects' (OTEs)(5). Here we show, however, that OTEs mediated by short homology stretches within long dsRNAs are prevalent in Drosophila. We have performed a genome-wide RNAi screen for novel components of Wingless (Wg) signal transduction(17) in Drosophila S2R+ cells, and found few, if any, legitimate candidates. Rather, many of the top candidates exert their effects on Wg response through OTEs on known pathway components or through promiscuous OTEs produced by tandem trinucleotide repeats present in many dsRNAs and genes. Genes containing such repeats are overrepresented in candidate lists from published screens, suggesting that they represent a common class of false positives. Our results suggest simple measures to improve the reliability of genome-wide RNAi screens in Drosophila and other organisms.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Beachy, PA (corresponding author), Stanford Univ, Dept Dev Biol, B300 Beckman Bldg,279 Campus Dr W, W Stanford, CA 94305 USA.	pbeachy@stanford.edu						Armknecht S, 2005, METHOD ENZYMOL, V392, P55, DOI 10.1016/S0076-6879(04)92004-6; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Jackson AL, 2004, TRENDS GENET, V20, P521, DOI 10.1016/j.tig.2004.08.006; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin XY, 2005, NUCLEIC ACIDS RES, V33, P4527, DOI 10.1093/nar/gki762; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Moffat J, 2006, NAT REV MOL CELL BIO, V7, P177, DOI 10.1038/nrm1860; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zeng WL, 2000, NATURE, V403, P789, DOI 10.1038/35001615	26	226	237	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2006	443	7109					359	363		10.1038/nature05179	http://dx.doi.org/10.1038/nature05179			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085RL	16964239				2022-12-28	WOS:000240622000051
J	Agranoff, D; Fernandez-Reyes, D; Papadopoulos, MC; Rojas, SA; Herbster, M; Loosemore, A; Tarelli, E; Sheldon, J; Schwenk, A; Pollak, R; Rayner, CFJ; Krishna, S				Agranoff, Dan; Fernandez-Reyes, Delmiro; Papadopoulos, Marios C.; Rojas, Sergio A.; Herbster, Mark; Loosemore, Alison; Tarelli, Edward; Sheldon, Jo; Schwenk, Achim; Pollak, Richard; Rayner, Charlotte F. J.; Krishna, Sarjeev			Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum	LANCET			English	Article							MASS-SPECTROMETRY; AMYLOID-A; PROTEIN; CANCER; BIOMARKER	Background We investigated the potential of proteomic fingerprinting with mass spectrometric serum profiling, coupled with pattern recognition methods, to identify biomarkers that could improve diagnosis of tuberculosis. Methods We obtained serum proteomic profiles from patients with active tuberculosis and controls by surface-enhanced laser desorption ionisation time of flight mass spectrometry. A supervised machine-learning approach based on the support vector machine (SVM) was used to obtain a classifier that distinguished between the groups in two independent test sets. We used k-fold cross validation and random sampling of the SVM classifier to assess the classifier further. Relevant mass peaks were selected by correlational analysis and assessed with SVM We tested the diagnostic potential of candidate biomarkers, identified by peptide mass fingerprinting, by conventional immunoassays and SVM classifiers trained on these data. Findings Our SVM classifier discriminated the proteomic profile of patients with active tuberculosis from that of controls with overlapping clinical features. Diagnostic accuracy was 94% (sensitivity 93.5%, specificity 94.9%) for patients with tuberculosis and was unaffected by HIV status. A classifier trained on the 20 most informative peaks achieved diagnostic accuracy of 90%. From these peaks, two peptides (serum amyloid A protein and transthyretin) were identified and quantitated by immunoassay. Because these peptides reflect inflammatory states, we also quantitated neopterin and C reactive protein. Application of an SVM classifier using combinations of these values gave diagnostic accuracies of up to 84% for tuberculosis. Validation on a second, prospectively collected testing set gave similar accuracies using the whole proteomic signature and the 20 selected peaks. Using combinations of the four biomarkers, we achieved diagnostic accuracies of up to 78%. Interpretation The potential biomarkers for tuberculosis that we identified through proteomic fingerprinting and pattern recognition have a plausible biological connection with the disease and could be used to develop new diagnostic tests.	Univ London, St Georges, Ctr Infect, Div Cellular & Mol Med, London SW17 0RE, England; Univ London, St Georges, Biom Ctr, London SW17 0RE, England; Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; Natl Inst Med Res, Div Math Biol, London NW7 1AA, England; UCL, Dept Comp Sci, London WC1E 6BT, England; N Middlesex Univ Hosp NHS Trust, London, England; St Georges Healthcare Trust, London, England	St Georges University London; University of London; St Georges University London; University of London; MRC National Institute for Medical Research; MRC National Institute for Medical Research; University of London; University College London; St Georges University London	Krishna, S (corresponding author), Univ London, St Georges, Ctr Infect, Div Cellular & Mol Med, London SW17 0RE, England.	s.krishna@sgul.ac.uk		Pollok, Richard/0000-0001-6452-6763; Krishna, Sanjeev/0000-0003-0066-0634; Papadopoulos, Marios/0000-0001-9174-4176; Fernandez-Reyes, Delmiro/0000-0001-5070-9198	Medical Research Council [MC_U117585869] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [MC_U117585869] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adam BL, 2002, CANCER RES, V62, P3609; [Anonymous], GLOB TUB CONTR SURV; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Buhimschi IA, 2005, BJOG-INT J OBSTET GY, V112, P173, DOI 10.1111/j.1471-0528.2004.00340.x; Cho WCS, 2004, CLIN CANCER RES, V10, P43, DOI 10.1158/1078-0432.CCR-0413-3; Cristianini N, 2000, INTRO SUPPORT VECTOR; CROWLE AJ, 1989, INFECT IMMUN, V57, P840, DOI 10.1128/IAI.57.3.840-844.1989; Drobniewski FA, 2003, LANCET INFECT DIS, V3, P141, DOI 10.1016/S1473-3099(03)00544-9; Duda R. O., 2001, PATTERN CLASSIFICATI; Freund Y, 1999, MACHINE LEARNING, PROCEEDINGS, P124; FREUND Y, 1996, BAR 13 INT C MACH LE, P148; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hanekom WA, 1997, J PEDIATR-US, V131, P925, DOI 10.1016/S0022-3476(97)70046-5; Hosp M, 1997, LUNG, V175, P265, DOI 10.1007/PL00007573; Issaq HJ, 2002, BIOCHEM BIOPH RES CO, V292, P587, DOI 10.1006/bbrc.2002.6678; JOACHIMS T, 1999, MAKING LARGE SCALE S; Kiernan UA, 2003, FEBS LETT, V537, P166, DOI 10.1016/S0014-5793(03)00097-8; Koyanagi A, 2004, ANN TROP MED PARASIT, V98, P391, DOI 10.1179/000349804225003424; McClelland J. L., 1986, PARALLEL DISTRIBUTED, V2; Mwinga A, 2004, TROP MED INT HEALTH, V9, P827, DOI 10.1111/j.1365-3156.2004.01274.x; Papadopoulos MC, 2004, LANCET, V363, P1358, DOI 10.1016/S0140-6736(04)16046-7; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Perkins MD, 2003, CHEST, V123, P107, DOI 10.1378/chest.123.1.107; Perkins MD, 2002, B WORLD HEALTH ORGAN, V80, P512; PETERSON PA, 1971, J BIOL CHEM, V246, P34; Petricoin EF, 2004, CURR OPIN BIOTECH, V15, P24, DOI 10.1016/j.copbio.2004.01.005; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Quinlan J. R., 2014, C4 5 PROGRAMS MACHIN; Rathman G, 2003, INT J TUBERC LUNG D, V7, P942; *RES TRAIN TROP DI, WHO TDR TB SPEC BANK; Rosenblatt F., 1962, PRINCIPLES NEURODYNA, DOI 10.21236/AD0256582; Salazar A, 2001, EUR J CLIN INVEST, V31, P1070, DOI 10.1046/j.1365-2362.2001.00913.x; SCHWEIGHOFER A, MATLAB INTERFACE SVM; Thiede B, 2005, METHODS, V35, P237, DOI 10.1016/j.ymeth.2004.08.015; Tolson J, 2004, LAB INVEST, V84, P845, DOI 10.1038/labinvest.3700097; Vapnik V., 1998, STAT LEARNING THEORY; von Eggeling F, 2001, ELECTROPHORESIS, V22, P2898, DOI 10.1002/1522-2683(200108)22:14<2898::AID-ELPS2898>3.0.CO;2-A; WESTON J, SPIDER DEP EMPIRICAL; Witten I.H., 2000, DATA MINING PRACTICA; Yi R, 2004, PROTEOMICS, V4, P3477, DOI 10.1002/pmic.200400897; Zhang Z, 2004, CANCER RES, V64, P5882, DOI 10.1158/0008-5472.CAN-04-0746	41	221	245	1	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 16	2006	368	9540					1012	1021		10.1016/S0140-6736(06)69342-2	http://dx.doi.org/10.1016/S0140-6736(06)69342-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	086UO	16980117	Green Published, Bronze			2022-12-28	WOS:000240698700030
J	Compston, JE; Seeman, E				Compston, Juliet E.; Seeman, Ego			Compliance with osteoporosis therapy is the weakest link	LANCET			English	Editorial Material							POSTMENOPAUSAL OSTEOPOROSIS; FRACTURE RATES; ADHERENCE; PERSISTENCE; IMPACT; WOMEN		Univ Cambridge, Addenbrookes Hosp, Sch Clin, Dept Med, Cambridge CB2 2QQ, England; Austin & Repatriat Med Ctr, Dept Endocrinol, Heidelberg, Vic 3084, Australia	Addenbrooke's Hospital; University of Cambridge; Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Compston, JE (corresponding author), Univ Cambridge, Addenbrookes Hosp, Sch Clin, Dept Med, Cambridge CB2 2QQ, England.	jec1001@cam.ac.uk	Seeman, Ego/AAC-3656-2019	Seeman, Ego/0000-0002-9692-048X				CANNER PL, 1980, NEW ENGL J MED, V303, P1038; Caro JJ, 2004, OSTEOPOROSIS INT, V15, P1003, DOI 10.1007/s00198-004-1652-z; Clowes JA, 2004, J CLIN ENDOCR METAB, V89, P1117, DOI 10.1210/jc.2003-030501; Cooper A, 2006, INT J CLIN PRACT, V60, P896, DOI 10.1111/j.1742-1241.2006.01059.x; Cramer JA, 2005, CURR MED RES OPIN, V21, P1453, DOI 10.1185/030079905X61875; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; GUILERA M, 2005, OSTEOPOROSIS INT, V17, P1; HORWITZ RI, 1990, LANCET, V336, P542, DOI 10.1016/0140-6736(90)92095-Y; Huybrechts KF, 2006, BONE, V38, P922, DOI 10.1016/j.bone.2005.10.022; McCombs JS, 2004, MATURITAS, V48, P271, DOI 10.1016/j.maturitas.2004.02.005; Siris ES, 2006, MAYO CLIN PROC, V81, P1013, DOI 10.4065/81.8.1013; Solomon DH, 2005, ARCH INTERN MED, V165, P2414, DOI 10.1001/archinte.165.20.2414	12	59	62	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 16	2006	368	9540					973	974		10.1016/S0140-6736(06)69394-X	http://dx.doi.org/10.1016/S0140-6736(06)69394-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	086UO	16980096				2022-12-28	WOS:000240698700008
J	Lin, JT; Zhang, JS; Dong, XP; Fang, HH; Chen, JT; Su, N; Gao, Q; Zhang, ZS; Liu, YX; Wang, ZH; Yang, M; Sun, RH; Li, CG; Lin, S; Ji, M; Liu, Y; Wang, X; Wood, J; Feng, ZJ; Wang, Y; Yin, WD				Lin, Jiangtao; Zhang, Jiansan; Dong, Xiaoping; Fang, Hanhua; Chen, Jiangting; Su, Nan; Gao, Qiang; Zhang, Zhenshan; Liu, Yuxuan; Wang, Zhihong; Yang, Meng; Sun, Ruihua; Li, Changgui; Lin, Su; Ji, Mei; Liu, Yan; Wang, Xu; Wood, John; Feng, Zijian; Wang, Yu; Yin, Weidong			Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial	LANCET			English	Article							PANDEMIC VACCINES; VIRUS-VACCINE; ANTIGENICITY; REACTOGENICITY; CHILDREN	Background Avian influenza A virus H5N1 has caused widespread infections that have resulted in severe disease or death in poultry and wild birds as well as human beings. This virus has the potential to emerge as a pandemic threat and H5N1 vaccines are being developed in many countries. Our aim was to assess the safety and immunogenicity of an inactivated adjuvanted whole-virion H5N1 vaccine. Methods A stratified randomised, placebo-controlled, double-blind phase I clinical trial was done in 120 volunteers aged 18-60 years. Volunteers were assigned to receive two doses of placebo (n=24) or an inactivated whole-virion influenza A (H5N1) vaccine with 1.25 mu g (24), 2.5 mu g (24), 5 mu g (24), or 10 mu g (24) haernagglutinin per dose with aluminium hydroxide adjuvant on day 0 and 28. Serum samples were obtained on day 0, 14, 28, 42, and 56 for haemagglutination inhibition and virus neutralisation assays. This trial is registered with the ClinicalTrials.gov registry with the number NCT00356798. Findings All four formulations of vaccines were well tolerated. No serious adverse event was reported and most local and systemic reactions were mild and transient. All formulations induced antibody responses after the first dose; the highest immune response of 78% seropositivity was seen in the 10 mu g group after two vaccine doses. Two individuals dropped out: one in the 1.25 mu g group (withdrew consent) and one in the 10 mu g group (discontinued); one individual was also excluded from the final analysis. Interpretation A two-dose regimen of an adjuvanted 10 mu g inactivated whole-virion H5N1 vaccine met all European regulatory requirements for annual licensing of seasonal influenza vaccine. Lower doses of this vaccine could achieve immune responses equivalent to those elicited by adjuvanted or non-adjuvanted split-virion vaccines. The use of a whole virion vaccine could be more adaptable to the antigen-sparing strategy recommended by WHO for protection against an influenza pandemic.	Sinovac Biotech Co Ltd, Beijing, Peoples R China; Chinese Japanese Friendship Hosp, Beijing, Peoples R China; Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; Natl Inst Control Pharmaceut & Biol Prod, Beijing, Peoples R China; Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England	China-Japan Friendship Hospital; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute of Food & Drug Control - China; National Institute for Biological Standards & Control	Yin, WD (corresponding author), Sinovac Biotech Co Ltd, Beijing, Peoples R China.	yinwd@sinovac.com	Zhang, zs/GXN-3521-2022; su, nan/GRS-5213-2022; fang, han/GSN-6404-2022					ALMAZROU A, 1991, CAN MED ASSOC J, V145, P213; [Anonymous], COMM DIS SURV RESP; Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; *CDC, AV INFL CURR SIT; *CHIN STAT FOOD DR, 2005, SPEC PROC DRUG APPR; Cintra Otávio A. L., 2006, J. Pediatr. (Rio J.), V82, ps83, DOI [10.1590/S0021-75572006000400010, 10.2223/JPED.1494]; *DIV MICR INF DIS, AD TOX TABL; European Committee for Proprietary Medial Products, 1997, CPMPBWP21496 EUR COM; GROSS PA, 1977, J INFECT DIS, V136, P623, DOI 10.1093/infdis/136.5.623; Hehme N, 2004, VIRUS RES, V103, P163, DOI 10.1016/j.virusres.2004.02.029; Hehme N, 2002, MED MICROBIOL IMMUN, V191, P203, DOI 10.1007/s00430-002-0147-9; Kendal AP, 1982, CONCEPTS PROCEDURES; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; NICHOLSON KG, 1979, J BIOL STAND, V7, P123, DOI 10.1016/S0092-1157(79)80044-X; REED L. J., 1938, AMER JOUR HYG, V27, P493; Stephenson I, 2006, LANCET INFECT DIS, V6, P71, DOI 10.1016/S1473-3099(06)70364-4; Stephenson I, 2003, LANCET, V362, P1959, DOI 10.1016/S0140-6736(03)15014-3; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; *WHO, DEV EV INFL PAND VAC; *WHO, RESP AV INFL PAND TH; WHO, COM NUMB CONF HUM CA; Wood JM, 2004, NAT REV MICROBIOL, V2, P842, DOI 10.1038/nrmicro979; Wood JM, 2002, VACCINE, V20, pB40, DOI 10.1016/S0264-410X(02)00509-1; WRIGHT PF, 1977, J INFECT DIS, V136, pS731, DOI 10.1093/infdis/136.Supplement_3.S731	26	221	252	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 16	2006	368	9540					991	997		10.1016/S0140-6736(06)69294-5	http://dx.doi.org/10.1016/S0140-6736(06)69294-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	086UO	16980114				2022-12-28	WOS:000240698700027
J	Roy-Byrne, PP; Craske, MG; Stein, MB				Roy-Byrne, Peter P.; Craske, Michelle G.; Stein, Murray B.			Panic disorder	LANCET			English	Review							COGNITIVE-BEHAVIORAL THERAPY; GENERALIZED ANXIETY DISORDER; RANDOMIZED EFFECTIVENESS TRIAL; COMMON MENTAL-DISORDERS; DSM-IV DISORDERS; PRIMARY-CARE; SUICIDAL IDEATION; RECEPTOR-BINDING; DOUBLE-BLIND; BENZODIAZEPINE-RECEPTOR	Panic disorder is a common mental disorder that affects up to 5% of the population at some point in life. It is often disabling, especially when complicated by agoraphobia, and is associated with substantial functional morbidity and reduced quality of life. The disorder is also costly for individuals and society, as shown by increased use of health care, absenteeism, and reduced workplace productivity. Some physical illnesses leg, asthma) commonly occur with panic disorder, and certain lifestyle factors (eg, smoking) increase the risk for the disorder, but causal pathways are still unclear. Genetic and early experiential susceptibility factors also exist, but their exact nature and pathophysiological mechanisms remain unknown. Despite an imprecise, although increased, understanding of cause, strong evidence supports the use of several effective treatments (eg, pharmacological, cognitive-behavioural). The adaptation and dissemination of these treatments to the frontlines of medical-care delivery should be urgent goals for the public-health community.	Univ Washington, Harborview Med Ctr, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA; Vet Affairs San Diego Healthcare Syst, La Jolla, CA USA	Harborview Medical Center; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Roy-Byrne, PP (corresponding author), Univ Washington, Harborview Med Ctr, Sch Med, Dept Psychiat & Behav Sci, Box 359911, Seattle, WA 98104 USA.	roybyrne@u.washington.edu	Milev, Roumen/F-4521-2012; Stein, Dan/A-1752-2008; Roy-Byrne, Peter/AAV-2991-2020; Carlbring, Per/R-1220-2019; Carlbring, Per/D-3628-2009; roy-byrne, peter/AAC-9130-2019; Hood, Sean David/H-5058-2014; Faravelli, Carlo/B-7961-2014; Andersson, Gerhard/J-8529-2012; Bandelow, Borwin/E-7295-2011	Milev, Roumen/0000-0001-6884-171X; Stein, Dan/0000-0001-7218-7810; Carlbring, Per/0000-0002-2172-8813; Carlbring, Per/0000-0002-2172-8813; Hood, Sean David/0000-0003-2852-7923; Faravelli, Carlo/0000-0002-8131-8031; Andersson, Gerhard/0000-0003-4753-6745; Bandelow, Borwin/0000-0003-2511-3768	NIMH NIH HHS [MH64122, MH065324] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH065324, K24MH064122] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alsene K, 2003, NEUROPSYCHOPHARMACOL, V28, P1694, DOI 10.1038/sj.npp.1300232; *AM PSYCH ASS, 1987, DIAGN STAT MAN MENT, P235; Amer Psychiat Assoc, 1998, AM J PSYCHIAT, V155, P1; American Psychiatric Association, 1980, DIAGN STAT MAN MENT, P230; American Psychiatric Association, 1994, DSM IV DIAGN STAT MA; Arntz A, 1996, BEHAV RES THER, V34, P113, DOI 10.1016/0005-7967(95)00061-5; Aschenbrand SG, 2003, J AM ACAD CHILD PSY, V42, P1478, DOI 10.1097/00004583-200312000-00015; Bakker A, 2002, ACTA PSYCHIAT SCAND, V106, P163, DOI 10.1034/j.1600-0447.2002.02255.x; Barlow DH, 2000, JAMA-J AM MED ASSOC, V283, P2529, DOI 10.1001/jama.283.19.2529; Barlow DH., 2002, ANXIETY ITS DISORDER, VSecond; Bebbington PE, 2000, PSYCHOL MED, V30, P1369, DOI 10.1017/S0033291799002974; Biederman J, 2005, DEPRESS ANXIETY, V22, P114, DOI 10.1002/da.20122; Biederman J, 1997, J AM ACAD CHILD PSY, V36, P214, DOI 10.1097/00004583-199702000-00012; Bienvenu OJ, 2006, BRIT J PSYCHIAT, V188, P432, DOI 10.1192/bjp.bp.105.010827; BLOCK RI, 1987, PHARMACOL BIOCHEM BE, V28, P7, DOI 10.1016/0091-3057(87)90003-7; Bouton ME, 2001, PSYCHOL REV, V108, P4, DOI 10.1037//0033-295X.108.1.4; Bower P, 2005, BRIT J PSYCHIAT, V186, P11, DOI 10.1192/bjp.186.1.11; BOYER W, 1995, INT CLIN PSYCHOPHARM, V10, P45, DOI 10.1097/00004850-199503000-00006; Bradwejn J, 2005, BRIT J PSYCHIAT, V187, P352, DOI 10.1192/bjp.187.4.352; Brandt CA, 1998, J NEURAL TRANSM, V105, P1325, DOI 10.1007/s007020050134; Bremner JD, 2000, BIOL PSYCHIAT, V47, P96, DOI 10.1016/S0006-3223(99)00188-2; Breslau N, 1999, ARCH GEN PSYCHIAT, V56, P1141, DOI 10.1001/archpsyc.56.12.1141; Bromet EJ, 2005, SOC PSYCH PSYCH EPID, V40, P681, DOI 10.1007/s00127-005-0927-9; Bruce SE, 2005, AM J PSYCHIAT, V162, P1179, DOI 10.1176/appi.ajp.162.6.1179; Bruce SE, 2003, AM J PSYCHIAT, V160, P1432, DOI 10.1176/appi.ajp.160.8.1432; BUCHANAN CM, 1992, PSYCHOL BULL, V111, P62, DOI 10.1037/0033-2909.111.1.62; Carlbring P, 2005, BEHAV RES THER, V43, P1321, DOI 10.1016/j.brat.2004.10.002; CHARNEY DS, 1986, J CLIN PSYCHIAT, V47, P580; CHARNEY DS, 1992, ACTA PSYCHIAT SCAND, V86, P273, DOI 10.1111/j.1600-0447.1992.tb03266.x; CLARK DM, 1986, BEHAV RES THER, V24, P461, DOI 10.1016/0005-7967(86)90011-2; Craske MG, 2005, PSYCHIAT SERV, V56, P988, DOI 10.1176/appi.ps.56.8.988; Craske MG, 2002, J NERV MENT DIS, V190, P611, DOI 10.1097/00005053-200209000-00006; Craske MG, 2002, J ABNORM PSYCHOL, V111, P53, DOI 10.1037//0021-843X.111.1.53; Craske MG, 1997, CLIN PSYCHOL-SCI PR, V4, P153, DOI 10.1111/j.1468-2850.1997.tb00107.x; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; DEBEURS E, 1995, AUST NZ J PSYCHIAT, V29, P104, DOI 10.3109/00048679509075898; Deckert J, 1998, MOL PSYCHIATR, V3, P81, DOI 10.1038/sj.mp.4000345; Domschke K, 2004, INT J NEUROPSYCHOPH, V7, P183, DOI 10.1017/s146114570400416X; Eaton WW, 1998, BRIT J PSYCHIAT, V173, P501, DOI 10.1192/bjp.173.6.501; EHLERS A, 1995, J ABNORM PSYCHOL, V104, P164, DOI 10.1037/0021-843X.104.1.164; Fullerton J, 2003, AM J HUM GENET, V72, P879, DOI 10.1086/374178; Furukawa TA, 2006, BRIT J PSYCHIAT, V188, P305, DOI 10.1192/bjp.188.4.305; Gardenswartz CA, 2001, BEHAV THER, V32, P725, DOI 10.1016/S0005-7894(01)80017-4; Gelernter J, 2004, AM J MED GENET B, V128B, P94, DOI 10.1002/ajmg.b.30019; Gelernter J, 2001, AM J MED GENET, V105, P548, DOI 10.1002/ajmg.1496; Goddard AW, 2004, AM J PSYCHIAT, V161, P2186, DOI 10.1176/appi.ajp.161.12.2186; Goddard AW, 2001, ARCH GEN PSYCHIAT, V58, P681, DOI 10.1001/archpsyc.58.7.681; Goddard AW, 2001, ARCH GEN PSYCHIAT, V58, P556, DOI 10.1001/archpsyc.58.6.556; GOISMAN RM, 1995, COMPR PSYCHIAT, V36, P303, DOI 10.1016/S0010-440X(95)90076-4; Goodwin RD, 2005, EUR NEUROPSYCHOPHARM, V15, P435, DOI 10.1016/j.euroneuro.2005.04.006; Goodwin RD, 2003, J CLIN EPIDEMIOL, V56, P914, DOI 10.1016/S0895-4356(03)00126-4; Goodwin RD, 2002, DEPRESS ANXIETY, V15, P69, DOI 10.1002/da.10023; Goodwin RD, 2002, J AFFECT DISORDERS, V70, P27, DOI 10.1016/S0165-0327(01)00398-6; Goodwin RD, 2006, DEPRESS ANXIETY, V23, P124, DOI 10.1002/da.20151; Gorman JM, 2000, AM J PSYCHIAT, V157, P493, DOI 10.1176/appi.ajp.157.4.493; Gould RA, 1995, CLIN PSYCHOL REV, V15, P819, DOI 10.1016/0272-7358(95)00048-8; Hamilton SP, 2004, NEUROPSYCHOPHARMACOL, V29, P558, DOI 10.1038/sj.npp.1300311; Hamilton SP, 2003, P NATL ACAD SCI USA, V100, P2550, DOI 10.1073/pnas.0335669100; Hamilton SP, 2002, BIOL PSYCHIAT, V51, P591, DOI 10.1016/S0006-3223(01)01322-1; Hamilton SP, 2001, MOL PSYCHIATR, V6, P59, DOI 10.1038/sj.mp.4000788; Hayward C, 2000, J AM ACAD CHILD PSY, V39, P207, DOI 10.1097/00004583-200002000-00021; Hettema JM, 2001, AM J PSYCHIAT, V158, P1568, DOI 10.1176/appi.ajp.158.10.1568; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Inada Y, 2003, PSYCHIAT RES, V118, P25, DOI 10.1016/S0165-1781(03)00064-7; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Isensee B, 2003, ARCH GEN PSYCHIAT, V60, P692, DOI 10.1001/archpsyc.60.7.692; Kampman M, 2002, J CLIN PSYCHIAT, V63, P772, DOI 10.4088/JCP.v63n0904; Katon W, 2006, PSYCHOL MED, V36, P353, DOI 10.1017/S0033291705006896; KATON W, 1984, AM J MED, V77, P101, DOI 10.1016/0002-9343(84)90443-1; Katschnig H, 1998, J CLIN PSYCHOPHARM, V18, p6S, DOI 10.1097/00004714-199812001-00003; Kawakami N, 2005, PSYCHIAT CLIN NEUROS, V59, P441, DOI 10.1111/j.1440-1819.2005.01397.x; Kendler KS, 2005, AM J PSYCHIAT, V162, P1243, DOI 10.1176/appi.ajp.162.7.1243; Kent JM, 2005, AM J PSYCHIAT, V162, P1379, DOI 10.1176/appi.ajp.162.7.1379; Kent Justine M, 2003, Curr Psychiatry Rep, V5, P266, DOI 10.1007/s11920-003-0055-8; Kessler RC, 1998, ARCH GEN PSYCHIAT, V55, P801, DOI 10.1001/archpsyc.55.9.801; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KLEIN DF, 1964, PSYCHOPHARMACOLOGIA, V5, P397, DOI 10.1007/BF02193476; Krystal JH, 1996, J CLIN PSYCHIAT, V57, P23; Lang AJ, 2001, GERIATRICS-US, V56, P24; Lee YJ, 2005, NEUROSCI LETT, V377, P40, DOI 10.1016/j.neulet.2004.11.063; MacKinnon DF, 1998, AM J PSYCHIAT, V155, P829; MacKinnon DF, 2003, AM J PSYCHIAT, V160, P1696, DOI 10.1176/appi.ajp.160.9.1696; MacKinnon DF, 2002, AM J PSYCHIAT, V159, P30, DOI 10.1176/appi.ajp.159.1.30; Malizia AL, 1998, ARCH GEN PSYCHIAT, V55, P715, DOI 10.1001/archpsyc.55.8.715; MALLER RG, 1992, J ANXIETY DISORD, V6, P241, DOI 10.1016/0887-6185(92)90036-7; MARKS IM, 1993, BRIT J PSYCHIAT, V162, P776, DOI 10.1192/bjp.162.6.776; Massana G, 2002, NEUROIMAGE, V16, P836, DOI 10.1006/nimg.2002.1083; Massana G, 2003, NEUROIMAGE, V19, P80, DOI 10.1016/S1053-8119(03)00036-3; McNally RJ, 2002, BIOL PSYCHIAT, V52, P938, DOI 10.1016/S0006-3223(02)01475-0; Mitte K, 2005, J AFFECT DISORDERS, V88, P27, DOI 10.1016/j.jad.2005.05.003; Neumeister A, 2004, J NEUROSCI, V24, P589, DOI 10.1523/JNEUROSCI.4921-03.2004; *NICE NCG, 2004, ANX MAN ANX PAN DIS; NIXON PGF, 1993, J ROY COLL PHYS LOND, V27, P377; NOYES R, 1984, ARCH GEN PSYCHIAT, V41, P287; Otto MW, 2001, AM J PSYCHIAT, V158, P1989, DOI 10.1176/appi.ajp.158.12.1989; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Pignone MP, 2002, ANN INTERN MED, V136, P765, DOI 10.7326/0003-4819-136-10-200205210-00013; PITTS FN, 1967, NEW ENGL J MED, V277, P1329, DOI 10.1056/NEJM196712212772502; Pollack MH, 2003, CNS SPECTRUMS, V8, P17, DOI 10.1017/S109285290000691X; Proudfoot J, 2004, BRIT J PSYCHIAT, V185, P46, DOI 10.1192/bjp.185.1.46; REISS S, 1980, BEHAV THER, V11, P380, DOI 10.1016/S0005-7894(80)80054-2; RICKELS K, 1993, ARCH GEN PSYCHIAT, V50, P61; Rollman BL, 2003, GEN HOSP PSYCHIAT, V25, P74, DOI 10.1016/S0163-8343(03)00004-5; Rosenbaum JF, 2000, AM J PSYCHIAT, V157, P2002, DOI 10.1176/appi.ajp.157.12.2002; ROTH M, 1984, PSYCHIAT DEV, V2, P31; Roy-Byrne PP, 1999, J CLIN PSYCHIAT, V60, P492, DOI 10.4088/JCP.v60n0713; Roy-Byrne PP, 2005, ARCH GEN PSYCHIAT, V62, P290, DOI 10.1001/archpsyc.62.3.290; Roy-Byrne PP, 2001, ARCH GEN PSYCHIAT, V58, P869, DOI 10.1001/archpsyc.58.9.869; Roy-Byrne PP, 2000, GEN HOSP PSYCHIAT, V22, P405, DOI 10.1016/S0163-8343(00)00101-8; ROYBYRNE PP, 1990, ARCH GEN PSYCHIAT, V47, P534; ROYBYRNE PP, 1994, ANXIETY, V1, P151; ROYBYRNE PP, 1986, AM J PSYCHIAT, V143, P1424; ROYBYRNE PP, 2002, GUIDE TREATMENTS WOR, P337; Sakai Y, 2005, NEUROREPORT, V16, P927, DOI 10.1097/00001756-200506210-00010; Sand P, 2000, World J Biol Psychiatry, V1, P147, DOI 10.3109/15622970009150583; Sareen J, 2005, ARCH GEN PSYCHIAT, V62, P1249, DOI 10.1001/archpsyc.62.11.1249; Schmidt NB, 2000, BEHAV RES THER, V38, P1083, DOI 10.1016/S0005-7967(99)00138-2; Schmidt NB, 1997, J ABNORM PSYCHOL, V106, P355, DOI 10.1037/0021-843X.106.3.355; Schumacher J, 2005, MOL PSYCHIATR, V10, P428, DOI 10.1038/sj.mp.4001598; SHEEHAN DV, 1983, J CLIN PSYCHOPHARM, V3, P28; SHEEHAN DV, 1993, ACTA PSYCHIAT SCAND, V88, P1, DOI 10.1111/j.1600-0447.1993.tb03405.x; Sheikh JI, 2004, AM J GERIAT PSYCHIAT, V12, P102, DOI 10.1176/appi.ajgp.12.1.102; Sibille E, 2000, J NEUROSCI, V20, P2758; Simmons A, 2004, NEUROREPORT, V15, P2261, DOI 10.1097/00001756-200410050-00024; Simon NM, 2005, J CLIN PSYCHIAT, V66, P8; Stein MB, 2000, PSYCHIAT RES, V94, P191, DOI 10.1016/S0165-1781(00)00154-2; Stein MB, 2004, AM J PSYCHIAT, V161, P2230, DOI 10.1176/appi.ajp.161.12.2230; Stein MB, 1996, AM J PSYCHIAT, V153, P275; SWINSON RP, 1992, AM J PSYCHIAT, V149, P944; Thorgeirsson TE, 2003, AM J HUM GENET, V72, P1221, DOI 10.1086/375141; Tsao JCI, 2002, BEHAV THER, V33, P493, DOI 10.1016/S0005-7894(02)80013-2; Uchida RR, 2003, BRAZ J MED BIOL RES, V36, P925, DOI 10.1590/S0100-879X2003000700014; vanMegen HJGM, 1996, EUR NEUROPSYCHOPHARM, V6, P187, DOI 10.1016/0924-977X(96)00018-1; Vickers K, 2004, J ABNORM PSYCHOL, V113, P582, DOI 10.1037/0021-843X.113.4.582; Wang PS, 2000, J GEN INTERN MED, V15, P284, DOI 10.1046/j.1525-1497.2000.9908044.x; Watanabe A, 2005, PSYCHIAT CLIN NEUROS, V59, P119, DOI 10.1111/j.1440-1819.2005.01345.x; Watt MC, 2000, J PSYCHOSOM RES, V49, P107, DOI 10.1016/S0022-3999(00)00097-0; Watt MC, 1998, BEHAV RES THER, V36, P505, DOI 10.1016/S0005-7967(97)10029-8; Weems CF, 2002, J ABNORM PSYCHOL, V111, P471, DOI 10.1037//0021-843X.111.3.471; Weissman MM, 1997, ARCH GEN PSYCHIAT, V54, P305; WEISSMAN MM, 1989, NEW ENGL J MED, V321, P1209, DOI 10.1056/NEJM198911023211801; Weissman MM, 2004, ARCH GEN PSYCHIAT, V61, P273, DOI 10.1001/archpsyc.61.3.273; Westen D, 2001, J CONSULT CLIN PSYCH, V69, P875, DOI 10.1037//0022-006X.69.6.875; WHEELER EO, 1950, JAMA-J AM MED ASSOC, V142, P878, DOI 10.1001/jama.1950.02910300016005; Wiborg IM, 1996, ARCH GEN PSYCHIAT, V53, P689; Wittchen HU, 1998, ARCH GEN PSYCHIAT, V55, P1017, DOI 10.1001/archpsyc.55.11.1017; WOOLEY CF, 1982, AM J CARDIOL, V50, P1145, DOI 10.1016/0002-9149(82)90434-9; Young AS, 2001, ARCH GEN PSYCHIAT, V58, P55, DOI 10.1001/archpsyc.58.1.55; Zimmermann P, 2003, PSYCHOL MED, V33, P1211, DOI 10.1017/S0033291703008158	149	147	159	0	49	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 16	2006	368	9540					1023	1032		10.1016/S0140-6736(06)69418-X	http://dx.doi.org/10.1016/S0140-6736(06)69418-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	086UO	16980119				2022-12-28	WOS:000240698700032
J	Tuskan, GA; DiFazio, S; Jansson, S; Bohlmann, J; Grigoriev, I; Hellsten, U; Putnam, N; Ralph, S; Rombauts, S; Salamov, A; Schein, J; Sterck, L; Aerts, A; Bhalerao, RR; Bhalerao, RP; Blaudez, D; Boerjan, W; Brun, A; Brunner, A; Busov, V; Campbell, M; Carlson, J; Chalot, M; Chapman, J; Chen, GL; Cooper, D; Coutinho, PM; Couturier, J; Covert, S; Cronk, Q; Cunningham, R; Davis, J; Degroeve, S; Dejardin, A; Depamphilis, C; Detter, J; Dirks, B; Dubchak, I; Duplessis, S; Ehlting, J; Ellis, B; Gendler, K; Goodstein, D; Gribskov, M; Grimwood, J; Groover, A; Gunter, L; Hamberger, B; Heinze, B; Helariutta, Y; Henrissat, B; Holligan, D; Holt, R; Huang, W; Islam-Faridi, N; Jones, S; Jones-Rhoades, M; Jorgensen, R; Joshi, C; Kangasjarvi, J; Karlsson, J; Kelleher, C; Kirkpatrick, R; Kirst, M; Kohler, A; Kalluri, U; Larimer, F; Leebens-Mack, J; Leple, JC; Locascio, P; Lou, Y; Lucas, S; Martin, F; Montanini, B; Napoli, C; Nelson, DR; Nelson, C; Nieminen, K; Nilsson, O; Pereda, V; Peter, G; Philippe, R; Pilate, G; Poliakov, A; Razumovskaya, J; Richardson, P; Rinaldi, C; Ritland, K; Rouze, P; Ryaboy, D; Schmutz, J; Schrader, J; Segerman, B; Shin, H; Siddiqui, A; Sterky, F; Terry, A; Tsai, CJ; Uberbacher, E; Unneberg, P; Vahala, J; Wall, K; Wessler, S; Yang, G; Yin, T; Douglas, C; Marra, M; Sandberg, G; Van de Peer, Y; Rokhsar, D				Tuskan, G. A.; DiFazio, S.; Jansson, S.; Bohlmann, J.; Grigoriev, I.; Hellsten, U.; Putnam, N.; Ralph, S.; Rombauts, S.; Salamov, A.; Schein, J.; Sterck, L.; Aerts, A.; Bhalerao, R. R.; Bhalerao, R. P.; Blaudez, D.; Boerjan, W.; Brun, A.; Brunner, A.; Busov, V.; Campbell, M.; Carlson, J.; Chalot, M.; Chapman, J.; Chen, G. -L.; Cooper, D.; Coutinho, P. M.; Couturier, J.; Covert, S.; Cronk, Q.; Cunningham, R.; Davis, J.; Degroeve, S.; Dejardin, A.; dePamphilis, C.; Detter, J.; Dirks, B.; Dubchak, I.; Duplessis, S.; Ehlting, J.; Ellis, B.; Gendler, K.; Goodstein, D.; Gribskov, M.; Grimwood, J.; Groover, A.; Gunter, L.; Hamberger, B.; Heinze, B.; Helariutta, Y.; Henrissat, B.; Holligan, D.; Holt, R.; Huang, W.; Islam-Faridi, N.; Jones, S.; Jones-Rhoades, M.; Jorgensen, R.; Joshi, C.; Kangasjarvi, J.; Karlsson, J.; Kelleher, C.; Kirkpatrick, R.; Kirst, M.; Kohler, A.; Kalluri, U.; Larimer, F.; Leebens-Mack, J.; Leple, J. -C.; Locascio, P.; Lou, Y.; Lucas, S.; Martin, F.; Montanini, B.; Napoli, C.; Nelson, D. R.; Nelson, C.; Nieminen, K.; Nilsson, O.; Pereda, V.; Peter, G.; Philippe, R.; Pilate, G.; Poliakov, A.; Razumovskaya, J.; Richardson, P.; Rinaldi, C.; Ritland, K.; Rouze, P.; Ryaboy, D.; Schmutz, J.; Schrader, J.; Segerman, B.; Shin, H.; Siddiqui, A.; Sterky, F.; Terry, A.; Tsai, C. -J.; Uberbacher, E.; Unneberg, P.; Vahala, J.; Wall, K.; Wessler, S.; Yang, G.; Yin, T.; Douglas, C.; Marra, M.; Sandberg, G.; Van de Peer, Y.; Rokhsar, D.			The genome of black cottonwood, Populus trichocarpa (Torr. & Gray)	SCIENCE			English	Article							CINNAMYL ALCOHOL-DEHYDROGENASE; ARABIDOPSIS-THALIANA; HYBRID POPLAR; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATORS; PHENYLPROPANOID METABOLISM; GRAVITATIONAL INDUCTION; LIGNIN BIOSYNTHESIS; RESISTANCE GENES; QUAKING ASPEN	We report the draft genome of the black cottonwood tree, Populus trichocarpa. Integration of shotgun sequence assembly with genetic mapping enabled chromosome-scale reconstruction of the genome. More than 45,000 putative protein-coding genes were identified. Analysis of the assembled genome revealed a whole-genome duplication event; about 8000 pairs of duplicated genes from that event survived in the Populus genome. A second, older duplication event is indistinguishably coincident with the divergence of the Populus and Arabidopsis lineages. Nucleotide substitution, tandem gene duplication, and gross chromosomal rearrangement appear to proceed substantially more slowly in Populus than in Arabidopsis. Populus has more protein-coding genes than Arabidopsis, ranging on average from 1.4 to 1.6 putative Populus homologs for each Arabidopsis gene. However, the relative frequency of protein domains in the two genomes is similar. Overrepresented exceptions in Populus include genes associated with lignocellulosic wall biosynthesis, meristem development, disease resistance, and metabolite transport.	Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; Oak Ridge Natl Lab, Div Life Sci, Oak Ridge, TN 37831 USA; Univ Tennessee, Dept Plant Sci, Knoxville, TN 37996 USA; W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA; Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, SE-90187 Umea, Sweden; Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1Z4, Canada; US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, SE-90183 Umea, Sweden; Univ Henri Poincare, INRA Nancy, INRA, Tree Microbe Interact Unit, F-54280 Champenoux, France; Virginia Polytech Inst & State Univ, Dept Forestry, Blacksburg, VA 24061 USA; Michigan Technol Univ, Sch Forest Resources & Environm Sci, Biotechnol Res Ctr, Houghton, MI 49931 USA; Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3B2, Canada; Penn State Univ, Dept Biol, Inst Mol Evolutionary Genet, University Pk, PA 16802 USA; Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; CNRS, UMR 6098, F-13288 Marseille, France; Univ Aix Marseille 1, F-13288 Marseille, France; Univ Aix Marseille 2, F-13288 Marseille, France; Univ Georgia, Warnell Sch Forest Resources, Athens, GA 30602 USA; Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; Univ Florida, Sch Forest Resources & Conservat, Inst Genet, Gainesville, FL 32611 USA; Univ Florida, Plant Mol & Cellular Biol Program, Gainesville, FL 32611 USA; INRA, Unit Forest Improvement Genet & Physiol, F-45166 Olivet, France; Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA; Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Stanford Univ, Sch Med, Stanford Human Genome Ctr, Palo Alto, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Palo Alto, CA 94305 USA; US Forest Serv, Inst Forest Genet, USDA, Davis, CA 95616 USA; Fed Res Ctr Forests, A-1140 Vienna, Austria; Univ Helsinki, Inst Biotechnol, Plant Mol Biol Lab, FI-00014 Helsinki, Finland; Univ Helsinki, Dept Biol & Environm Sci, FI-00014 Helsinki, Finland; Univ Turku, Dept Biol, FI-20014 Turku, Finland; Texas A&M Univ, Dept Forest Sci, College Stn, TX 77843 USA; Texas A&M Univ, So Inst Forest Genet, USDA, Forest Serv, College Stn, TX 77843 USA; MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Univ Tennessee, Dept Mol Sci, Memphis, TN 38163 USA; Univ Tennessee, Ctr Excellence Genom & Bioinformat, Memphis, TN 38163 USA; US Forest Serv, So Inst Forest Genet, USDA, Saucier, MS 39574 USA; Univ Tubingen, D-72076 Tubingen, Germany; AlbaNova Univ Ctr, KTH, Dept Biotechnol, SE-10691 Stockholm, Sweden	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; West Virginia University; Umea University; University of British Columbia; University of British Columbia; University of British Columbia; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Flanders Institute for Biotechnology (VIB); Ghent University; Swedish University of Agricultural Sciences; Umea University; INRAE; Universite de Lorraine; Virginia Polytechnic Institute & State University; Michigan Technological University; University of Toronto; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; State University System of Florida; University of Florida; State University System of Florida; University of Florida; INRAE; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Arizona; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Stanford University; Stanford University; United States Department of Agriculture (USDA); United States Forest Service; University of Helsinki; University of Helsinki; University of Turku; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA); United States Forest Service; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; United States Department of Agriculture (USDA); United States Forest Service; Eberhard Karls University of Tubingen; Royal Institute of Technology	Tuskan, GA (corresponding author), Oak Ridge Natl Lab, Div Environm Sci, POB 2008, Oak Ridge, TN 37831 USA.	gtk@ornl.gov	Jones, Steven J/C-3621-2009; dePamphilis, Claude W/P-6652-2016; Helariutta, Yrjo/AAE-8149-2020; Putnam, Nicholas/B-9968-2008; Pilate, Gilles/D-1666-2011; LEPLE, Jean-Charles/H-4210-2012; Pereda-Loth, Veronica/A-1296-2011; Gribskov, Michael/AAH-5905-2021; Déjardin, Annabelle/AAU-1840-2021; Grimwood, Jane/ABD-5737-2021; Kelleher, Colin/L-1986-2019; LEPLE, Jean-Charles/AAT-7414-2021; Heinze, Berthold/A-8734-2011; Tuskan, Gerald/A-6225-2011; Pilate, Gilles/E-8784-2017; Rombauts, Stephane/P-2420-2019; , DUPLESSIS/G-4150-2011; Kohler, Annegret/AAD-1876-2019; Schmutz, Jeremy/N-3173-2013; Van de Peer, Yves/D-4388-2009; Blaudez, Damien/AAF-6517-2020; Nieminen, Kaisa/N-9051-2015; Coutinho, Pedro M/C-4473-2008; Van de Peer, Yves/AAE-7666-2019; Douglas, Carl J/B-1384-2013; Marra, Marco A/B-5987-2008; Tsai, CJ/C-2450-2009; CHALOT, Michel/A-1113-2012; Leebens-Mack, James/AAF-6770-2019; Terry, Astrid Y/A-2538-2011; Couturier, Jérémy/AAF-6588-2020; Schein, Jacquie E/G-3674-2015; Kangasjärvi, Jaakko/A-3024-2015; Gunter, Lee E/L-3480-2016; Boerjan, Wout/Y-4158-2019; Rombauts, Stephane M/D-7640-2014; Karlsson, Jan/E-7199-2015; Holt, Robert A/C-3303-2009; Jansson, Stefan/A-1119-2009; Henrissat, Bernard/J-2475-2012; LEPLE, Jean charles/L-9604-2014; KALLURI, UDAYA/A-6218-2011; Sterck, Lieven/A-9439-2016; Kangasjärvi, Jaakko/AAP-8639-2021; Hamberger, Bjoern/I-2122-2012	Jones, Steven J/0000-0003-3394-2208; Helariutta, Yrjo/0000-0002-7287-8459; Putnam, Nicholas/0000-0002-1315-782X; LEPLE, Jean-Charles/0000-0003-4125-0738; Heinze, Berthold/0000-0002-7571-9138; Tuskan, Gerald/0000-0003-0106-1289; Pilate, Gilles/0000-0003-4802-8849; Rombauts, Stephane/0000-0002-3985-4981; , DUPLESSIS/0000-0002-2072-2989; Schmutz, Jeremy/0000-0001-8062-9172; Van de Peer, Yves/0000-0003-4327-3730; Van de Peer, Yves/0000-0003-4327-3730; Marra, Marco A/0000-0001-7146-7175; Tsai, CJ/0000-0002-9282-7704; CHALOT, Michel/0000-0001-8614-0917; Leebens-Mack, James/0000-0003-4811-2231; Terry, Astrid Y/0000-0002-5234-1224; Couturier, Jérémy/0000-0003-3127-2669; Kangasjärvi, Jaakko/0000-0002-8959-1809; Gunter, Lee E/0000-0003-1211-7532; Boerjan, Wout/0000-0003-1495-510X; Rombauts, Stephane M/0000-0002-3985-4981; Karlsson, Jan/0000-0002-6002-929X; Holt, Robert A/0000-0002-7259-1247; Jansson, Stefan/0000-0002-7906-6891; Henrissat, Bernard/0000-0002-3434-8588; LEPLE, Jean charles/0000-0003-4125-0738; Sterck, Lieven/0000-0001-7116-4000; Kangasjärvi, Jaakko/0000-0002-8959-1809; /0000-0003-3281-8088; , Dawn/0000-0001-8996-3572; Brun-Jacob, Annick/0000-0002-0299-2766; Montanini, Barbara/0000-0002-5419-7975; Goodstein, David/0000-0001-6287-2697; Rokhsar, Daniel/0000-0002-8704-2224; Nelson, David/0000-0003-0583-5421; Kelleher, Colin/0000-0002-1551-8297; Campbell, Malcolm/0000-0002-1396-6651; Degroeve, Sven/0000-0001-8349-3370; Ehlting, Jurgen/0000-0003-2302-696X; Hamberger, Bjoern/0000-0003-1249-1807; Blaudez, Damien/0000-0003-3287-3482; Davis, John/0000-0002-8522-5406; Dejardin, Annabelle/0000-0002-7576-5476; KALLURI, UDAYA/0000-0002-5963-8370; Bhalerao, Rishikesh/0000-0003-4384-7036; Nieminen, Kaisa/0000-0001-7004-9422; Cronk, Quentin/0000-0002-4027-7368; Grigoriev, Igor/0000-0002-3136-8903; Nilsson, Ove/0000-0002-1033-1909; Jorgensen, Richard/0000-0002-0382-2371; Gribskov, Michael/0000-0002-1718-0242; DiFazio, Stephen/0000-0003-4077-1590; Unneberg, Per/0000-0001-5735-3315				Adams KL, 2005, TRENDS GENET, V21, P539, DOI 10.1016/j.tig.2005.07.009; Andersson-Gunneras S, 2003, PLANT J, V34, P339, DOI 10.1046/j.1365-313X.2003.01727.x; Arimura G, 2004, PLANT J, V37, P603, DOI 10.1111/j.1365-313X.2003.01987.x; Aubourg S, 2002, MOL GENET GENOMICS, V267, P730, DOI 10.1007/s00438-002-0709-y; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; BRADSHAW HD, 1993, THEOR APPL GENET, V86, P301, DOI 10.1007/BF00222092; Chapman BA, 2006, P NATL ACAD SCI USA, V103, P2730, DOI 10.1073/pnas.0507782103; Cline MG, 2002, ANN BOT-LONDON, V90, P417, DOI 10.1093/aob/mcf195; COLLINSON ME, 1992, P ROY SOC EDINB B, V98, P155, DOI 10.1017/S0269727000007521; Costa MA, 2003, PHYTOCHEMISTRY, V64, P1097, DOI 10.1016/S0031-9422(03)00517-X; Cukovic D, 2001, BIOL CHEM, V382, P645, DOI 10.1515/BC.2001.076; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; DESA MM, 1992, PLANT PHYSIOL, V98, P728, DOI 10.1104/pp.98.2.728; Deslandes L, 2002, P NATL ACAD SCI USA, V99, P2404, DOI 10.1073/pnas.032485099; Djerbi S, 2005, PLANTA, V221, P739, DOI 10.1007/s00425-005-1498-4; Dode L.A., 1905, B SOC HIST NAT AUTUN, V18, P161; Eckenwalder JE, 1996, BIOL POPULUS ITS IMP; Ehlting J, 2005, PLANT J, V42, P618, DOI 10.1111/j.1365-313X.2005.02403.x; Eriksson ME, 2000, NAT BIOTECHNOL, V18, P784, DOI 10.1038/77355; FAO ( Food and Agriculture Organization of the United Nations), 2003, STAT WORLDS FOR 2003; Gebre GM, 1998, TREE PHYSIOL, V18, P645; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; HANLEY SJ, IN PRESS TREE GENET; Hellgren JM, 2004, PLANT PHYSIOL, V135, P212, DOI 10.1104/pp.104.038927; Hokamp Karsten, 2003, Journal of Structural and Functional Genomics, V3, P95, DOI 10.1023/A:1022661917301; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Joshi CP, 2004, NEW PHYTOL, V164, P53, DOI 10.1111/j.1469-8137.2004.01155.x; Kakimoto T, 1996, SCIENCE, V274, P982, DOI 10.1126/science.274.5289.982; Kiba T, 2004, PLANT CELL PHYSIOL, V45, P1063, DOI 10.1093/pcp/pch128; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Koornneef M, 2003, CHROMOSOME RES, V11, P183, DOI 10.1023/A:1022827624082; Li LG, 2001, PLANT CELL, V13, P1567, DOI 10.1105/tpc.13.7.1567; Lindroth RL, 1996, BIOCHEM SYST ECOL, V24, P357, DOI 10.1016/0305-1978(96)00043-9; Lockton S, 2005, TRENDS GENET, V21, P60, DOI 10.1016/j.tig.2004.11.013; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; MACKAY JJ, 1995, MOL GEN GENET, V247, P537, DOI 10.1007/BF00290344; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Meilan Richard, 2006, V344, P143; Mellerowicz EJ, 2001, PLANT MOL BIOL, V47, P239, DOI 10.1023/A:1010699919325; Meyers BC, 2005, CURR OPIN PLANT BIOL, V8, P129, DOI 10.1016/j.pbi.2005.01.002; Mitton JB, 1996, BIOSCIENCE, V46, P25, DOI 10.2307/1312652; Moyle R, 2002, PLANT J, V31, P675, DOI 10.1046/j.1365-313X.2002.01386.x; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; OMALLEY DM, 1992, PLANT PHYSIOL, V98, P1364, DOI 10.1104/pp.98.4.1364; Perrin RM, 1999, SCIENCE, V284, P1976, DOI 10.1126/science.284.5422.1976; Peters DJ, 2002, PLANT J, V32, P701, DOI 10.1046/j.1365-313X.2002.01458.x; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; REGNIER R, 1956, REV SOC SAVANTES NOR, V1, P1; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Roudier F, 2005, PLANT CELL, V17, P1749, DOI 10.1105/tpc.105.031732; RUONALA R, IN PRESS PLANT J; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Samuga A, 2004, GENE, V334, P73, DOI 10.1016/j.gene.2004.02.057; Santamaria O, 2005, FOREST PATHOL, V35, P95, DOI 10.1111/j.1439-0329.2004.00389.x; SCHIEX T, 2001, LNCS, V2066, P118; Schrader J, 2004, PLANT CELL, V16, P2278, DOI 10.1105/tpc.104.024190; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Shockey JM, 2003, PLANT PHYSIOL, V132, P1065, DOI 10.1104/pp.103.020552; Somssich IE, 1996, P NATL ACAD SCI USA, V93, P14199, DOI 10.1073/pnas.93.24.14199; Sterck L, 2005, NEW PHYTOL, V167, P165, DOI 10.1111/j.1469-8137.2005.01378.x; Sterky F, 2004, P NATL ACAD SCI USA, V101, P13951, DOI 10.1073/pnas.0401641101; Stettler R. F., 1996, BIOL POPULUS ITS IMP, P1; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; Tuskan GA, 2004, PLANT BIOLOGY, V6, P2, DOI 10.1055/s-2003-44715; Tuskan GA, 2004, CAN J FOREST RES, V34, P85, DOI [10.1139/x03-283, 10.1139/X03-283]; Tuskan GA, 2001, FOREST CHRON, V77, P259, DOI 10.5558/tfc77259-2; Tuskan GA, 1998, BIOMASS BIOENERG, V14, P307, DOI 10.1016/S0961-9534(97)10065-4; Weijers D, 2005, EMBO J, V24, P1874, DOI 10.1038/sj.emboj.7600659; Whetten RW, 1998, ANNU REV PLANT PHYS, V49, P585, DOI 10.1146/annurev.arplant.49.1.585; Whitham S, 1996, P NATL ACAD SCI USA, V93, P8776, DOI 10.1073/pnas.93.16.8776; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Wullschleger S, 2005, CAN J FOREST RES, V35, P1779, DOI 10.1139/x05-101; Xu Y, 1997, J COMPUT BIOL, V4, P325, DOI 10.1089/cmb.1997.4.325; Yin TM, 2004, THEOR APPL GENET, V109, P451, DOI 10.1007/s00122-004-1653-5; Zahn LM, 2005, J HERED, V96, P225, DOI 10.1093/jhered/esi033	79	3072	3679	28	680	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2006	313	5793					1596	1604		10.1126/science.1128691	http://dx.doi.org/10.1126/science.1128691			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973872	Green Submitted			2022-12-28	WOS:000240498900035
J	Turney, CSM; Roberts, RG; Jacobs, Z				Turney, Chris S. M.; Roberts, Richard G.; Jacobs, Zenobia			Archaeology: Progress and pitfalls in radiocarbon dating	NATURE			English	Letter							BP; CALIBRATION; KYR		Univ Wollongong, Sch Earth & Environm Sci, GeoQuEST Res Ctr, Wollongong, NSW 2522, Australia	University of Wollongong	Turney, CSM (corresponding author), Univ Wollongong, Sch Earth & Environm Sci, GeoQuEST Res Ctr, Wollongong, NSW 2522, Australia.	turney@uow.edu.au	Roberts, Richard Graham/B-8245-2013; Palmer, Jonathan G/J-7834-2012; Turney, Chris S M/P-8701-2018; Jacobs, Zenobia/B-2721-2012	Roberts, Richard Graham/0000-0002-0128-4119; Palmer, Jonathan G/0000-0002-6665-4483; Turney, Chris S M/0000-0001-6733-0993; Jacobs, Zenobia/0000-0001-5424-5837				Beck JW, 2001, SCIENCE, V292, P2453, DOI 10.1126/science.1056649; COLMAN SM, 1987, QUATERNARY RES, V28, P314, DOI 10.1016/0033-5894(87)90070-6; Eggins SM, 2005, QUATERNARY SCI REV, V24, P2523, DOI 10.1016/j.quascirev.2005.07.006; Fairbanks RG, 2005, QUATERNARY SCI REV, V24, P1781, DOI 10.1016/j.quascirev.2005.04.007; Guilderson TP, 2005, SCIENCE, V307, P362, DOI 10.1126/science.1104164; Higham TFG, 2006, RADIOCARBON, V48, P179, DOI 10.1017/S0033822200066388; Hughen K, 2004, SCIENCE, V303, P202, DOI 10.1126/science.1090300; Kitagawa H, 2000, RADIOCARBON, V42, P369; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; Roberts RG, 1997, RADIAT MEAS, V27, P819, DOI 10.1016/S1350-4487(97)00221-7; Turney CSM, 2001, QUATERNARY RES, V55, P3, DOI 10.1006/qres.2000.2195; van der Plicht J, 2004, RADIOCARBON, V46, P1225, DOI 10.1017/S0033822200033117; Voelker AHL, 2000, RADIOCARBON, V42, P437, DOI 10.1017/S0033822200030368	13	23	24	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2006	443	7108					E3	E3		10.1038/nature05214	http://dx.doi.org/10.1038/nature05214			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	083OB	16971901	Bronze			2022-12-28	WOS:000240467000034
J	Broder, DH; Pogliano, K				Broder, Dan H.; Pogliano, Kit			Forespore engulfment mediated by a ratchet-like mechanism	CELL			English	Article							BACILLUS-SUBTILIS; GENE-EXPRESSION; TRANSCRIPTION FACTOR; MEMBRANE-FUSION; MOTHER-CELL; SPORULATION; PROTEIN; LOCALIZATION; RECEPTOR; TRANSLOCATION	A key step in bacterial endospore formation is engulfment, during which one bacterial cell engulfs another in a phagocytosis-like process that normally requires SpoIID, SpoIIM, and SpoIIP (DMP). We here describe a second mechanism involving the zipper-like interaction between the forespore protein SpoIIQ and its mother cell ligand SpoIIIAH, which are essential for engulfment when DMP activity is reduced or SpoIIB is absent. They are also required for the rapid engulfment observed during the enzymatic removal of peptidoglycan, a process that does not require DMP. These results suggest the existence of two separate engulfment machineries that compensate for one another in intact cells, thereby rendering engulfment robust. Photobleaching analysis demonstrates that SpoIIQ assembles a stationary structure, suggesting that SpoIIQ and SpoIIIAH function as a ratchet that renders forward membrane movement irreversible. We suggest that ratchet-mediated engulfment minimizes the utilization of chemical energy during this dramatic cellular reorganization, which occurs during starvation.	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Pogliano, K (corresponding author), Univ Calif San Diego, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	kpogliano@ucsd.edu		Pogliano, Kit/0000-0002-7868-3345	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057045] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 57045, R01 GM057045-11, R01 GM057045] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abanes-De Mello A, 2002, GENE DEV, V16, P3253, DOI 10.1101/gad.1039902; ANTAL T, 2005, IN PRESS PHYS E 1006, DOI DOI 10.1103/PHYS-REVE.72.046104; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; Blaylock B, 2004, GENE DEV, V18, P2916, DOI 10.1101/gad.1252704; CUTTING S, 1991, J MOL BIOL, V221, P1237; Doan T, 2005, MOL MICROBIOL, V55, P1767, DOI 10.1111/j.1365-2958.2005.04501.x; DRIKS A, 1991, P NATL ACAD SCI USA, V88, P9934, DOI 10.1073/pnas.88.22.9934; DUBNAU D, 1971, J MOL BIOL, V56, P209, DOI 10.1016/0022-2836(71)90460-8; Dworkin J, 2005, CELL, V121, P401, DOI 10.1016/j.cell.2005.02.032; Eichenberger P, 2003, J MOL BIOL, V327, P945, DOI 10.1016/S0022-2836(03)00205-5; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; GRIFFIN FM, 1975, J EXP MED, V142, P1263, DOI 10.1084/jem.142.5.1263; GRIFFIN FM, 1974, J EXP MED, V139, P323, DOI 10.1084/jem.139.2.323; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; ISBERG RR, 1995, TRENDS CELL BIOL, V5, P120, DOI 10.1016/S0962-8924(00)88962-X; Jiang X, 2005, MOL MICROBIOL, V58, P102, DOI 10.1111/j.1365-2958.2005.04811.x; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Krantz BA, 2006, J MOL BIOL, V355, P968, DOI 10.1016/j.jmb.2005.11.030; Kroos L, 2000, CURR OPIN MICROBIOL, V3, P553, DOI 10.1016/S1369-5274(00)00140-5; Liu NJL, 2006, MOL MICROBIOL, V59, P1097, DOI 10.1111/j.1365-2958.2005.05004.x; LondonoVallejo JA, 1997, MOL MICROBIOL, V24, P29, DOI 10.1046/j.1365-2958.1997.3181680.x; LOPEZDIAZ I, 1986, J GEN MICROBIOL, V132, P341; MAI J, 2001, IN PRESS PHYS E 0611, DOI DOI 10.1103/PHYSREVE.64.011102; MARGOLIS PS, 1993, J BACTERIOL, V175, P528, DOI 10.1128/JB.175.2.528-540.1993; MCABEE DD, 1985, J CELL PHYSIOL, V124, P240, DOI 10.1002/jcp.1041240211; Okamoto K, 2002, EMBO J, V21, P3659, DOI 10.1093/emboj/cdf358; Perez AR, 2006, J BACTERIOL, V188, P1159, DOI 10.1128/JB.188.3.1159-1164.2006; Perez AR, 2000, J BACTERIOL, V182, P1096, DOI 10.1128/JB.182.4.1096-1108.2000; Pogliano J, 1999, MOL MICROBIOL, V31, P1149, DOI 10.1046/j.1365-2958.1999.01255.x; Pogliano K, 1997, J BACTERIOL, V179, P3331, DOI 10.1128/jb.179.10.3331-3341.1997; Rubio A, 2005, J BACTERIOL, V187, P5000, DOI 10.1128/JB.187.14.5000-5002.2005; Rubio A, 2004, EMBO J, V23, P1636, DOI 10.1038/sj.emboj.7600171; Rudner DZ, 2001, DEV CELL, V1, P733, DOI 10.1016/S1534-5807(01)00094-6; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; SAWANO A, 2000, NUCLEIC ACIDS RES, V28, P78, DOI DOI 10.1093/NAR/28.16.E78; Scheffel A, 2006, NATURE, V440, P110, DOI 10.1038/nature04382; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Sharp MD, 1999, P NATL ACAD SCI USA, V96, P14553, DOI 10.1073/pnas.96.25.14553; SMITH K, 1993, J BACTERIOL, V175, P3618, DOI 10.1128/jb.175.11.3618-3627.1993; STERLINI JM, 1969, BIOCHEM J, V113, P29, DOI 10.1042/bj1130029; Sun YL, 2000, J BACTERIOL, V182, P2919, DOI 10.1128/JB.182.10.2919-2927.2000; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439	43	76	79	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2006	126	5					917	928		10.1016/j.cell.2006.06.053	http://dx.doi.org/10.1016/j.cell.2006.06.053			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959571	Green Accepted, Bronze			2022-12-28	WOS:000240675000019
J	Levine, RJ; Lam, C; Qian, C; Yu, KF; Maynard, SE; Sachs, BP; Sibai, BM; Epstein, FH; Romero, R; Thadhani, R; Karumanchi, SA				Levine, Richard J.; Lam, Chun; Qian, Cong; Yu, Kai F.; Maynard, Sharon E.; Sachs, Benjamin P.; Sibai, Baha M.; Epstein, Franklin H.; Romero, Roberto; Thadhani, Ravi; Karumanchi, S. Ananth		CPEP Study Grp	Soluble endoglin and other circulating antiangiogenic factors in preeclampsia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ANGIOGENIC FACTORS; PREGNANCY; RISK; RECEPTOR; WOMEN; HYPERTENSION; TRIAL; PATHOPHYSIOLOGY; NICOTINE	Background: Alterations in circulating soluble fms-like tyrosine kinase 1 (sFlt1), an antiangiogenic protein, and placental growth factor (PlGF), a proangiogenic protein, appear to be involved in the pathogenesis of preeclampsia. Since soluble endoglin, another antiangiogenic protein, acts together with sFlt1 to induce a severe preeclampsia-like syndrome in pregnant rats, we examined whether it is associated with preeclampsia in women. Methods: We performed a nested case-control study of healthy nulliparous women within the Calcium for Preeclampsia Prevention trial. The study included all 72 women who had preterm preeclampsia (<37 weeks), as well as 480 randomly selected women - 120 women with preeclampsia at term (at >= 37 weeks), 120 women with gestational hypertension, 120 normotensive women who delivered infants who were small for gestational age, and 120 normotensive controls who delivered infants who were not small for gestational age. Results: Circulating soluble endoglin levels increased markedly beginning 2 to 3 months before the onset of preeclampsia. After the onset of clinical disease, the mean serum level in women with preterm preeclampsia was 46.4 ng per milliliter, as compared with 9.8 ng per milliliter in controls (P<0.001). The mean serum level in women with preeclampsia at term was 31.0 ng per milliliter, as compared with 13.3 ng per milliliter in controls (P<0.001). Beginning at 17 weeks through 20 weeks of gestation, soluble endoglin levels were significantly higher in women in whom preterm preeclampsia later developed than in controls (10.2 ng per milliliter vs. 5.8 ng per milliliter, P<0.001), and at 25 through 28 weeks of gestation, the levels were significantly higher in women in whom term preeclampsia developed than in controls (8.5 ng per milliliter vs. 5.9 ng per milliliter, P<0.001). An increased level of soluble endoglin was usually accompanied by an increased ratio of sFlt1:PlGF. The risk of preeclampsia was greatest among women in the highest quartile of the control distributions for both biomarkers but not for either biomarker alone. Conclusions: Rising circulating levels of soluble endoglin and ratios of sFlt1:PlGF herald the onset of preeclampsia.	Beth Israel Deaconess Med Ctr, Dept Med, Div Renal, Ctr Vasc Biol, Boston, MA 02215 USA; NICHHD, Div Epidemiol Stat & Prevent Res, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; NICHHD, Perinatol Res Branch, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Mol & Vasc Med Div, Ctr Vasc Biol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Allied Technol Grp, Rockville, MD USA; George Washington Univ, Sch Med, Dept Med, Washington, DC USA; Univ Cincinnati, Coll Med, Dept Obstet & Gynecol, Cincinnati, OH 45267 USA; Wayne State Univ, Sch Med, Detroit, MI USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA	Harvard University; Beth Israel Deaconess Medical Center; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; George Washington University; University System of Ohio; University of Cincinnati; Wayne State University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Levine, RJ (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Renal, Ctr Vasc Biol, 330 Brookline Ave,RW 663B, Boston, MA 02215 USA.	sananth@bidmc.harvard.edu	Karumanchi, Subbian Ananth/AAI-1694-2021; Romero, Roberto/A-5268-2019	Romero, Roberto/0000-0002-4448-5121	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD002400, Z01HD000864, R01HD039223, Z01HD000373, N01HD053246, N01HD013121] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065997, R01DK067397] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NHLBI NIH HHS [R01 HL-079594] Funding Source: Medline; NICHD NIH HHS [N01-HD-5-3246, N01-HD-3124, N01-HD-3125, N01-HD-3154, N01-HD-3122, N01-HD-1-3121, N01-HD-3126, R01 HD-39223, N01-HD-3123] Funding Source: Medline; NIDDK NIH HHS [R01 DK-065997, R01 DK-67397] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bdolah Y, 2004, SEMIN NEPHROL, V24, P548, DOI 10.1016/S0270-9295(04)00125-1; Belgore FM, 2000, BRIT J BIOMED SCI, V57, P207; Buhimschi CS, 2005, AM J OBSTET GYNECOL, V192, P734, DOI 10.1016/j.ajog.2004.12.052; Chaiworapongsa T, 2004, AM J OBSTET GYNECOL, V190, P1541, DOI 10.1016/j.ajog.2004.03.043; Chaiworapongsa T, 2005, J MATERN-FETAL NEO M, V17, P3, DOI 10.1080/14767050400028816; Chappell LC, 2002, AM J OBSTET GYNECOL, V187, P127, DOI 10.1067/mob.2002.122969; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Conde-Agudelo A, 1999, AM J OBSTET GYNECOL, V181, P1026, DOI 10.1016/S0002-9378(99)70341-8; Cooke JP, 2004, ANN MED, V36, P33, DOI 10.1080/07853890310017576; England LJ, 2002, AM J OBSTET GYNECOL, V186, P1035, DOI 10.1067/mob.2002.122404; FISHER KA, 1981, MEDICINE, V60, P267, DOI 10.1097/00005792-198107000-00002; Fisher Susan J, 2004, Reprod Biol Endocrinol, V2, P53, DOI 10.1186/1477-7827-2-53; GOUGOS A, 1992, INT IMMUNOL, V4, P83, DOI 10.1093/intimm/4.1.83; Heeschen C, 2001, NAT MED, V7, P833, DOI 10.1038/89961; Hertig A, 2004, CLIN CHEM, V50, P1702, DOI 10.1373/clinchem.2004.036715; Hinchey J, 1996, NEW ENGL J MED, V334, P494, DOI 10.1056/NEJM199602223340803; Koga K, 2003, J CLIN ENDOCR METAB, V88, P2348, DOI 10.1210/jc.2002-021942; Levine RJ, 2005, JAMA-J AM MED ASSOC, V293, P77, DOI 10.1001/jama.293.1.77; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Levine RJ, 1996, CONTROL CLIN TRIALS, V17, P442, DOI 10.1016/S0197-2456(96)00106-7; Levine RJ, 1997, NEW ENGL J MED, V337, P69, DOI 10.1056/NEJM199707103370201; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Polliotti BM, 2003, OBSTET GYNECOL, V101, P1266, DOI 10.1016/S0029-7844(03)00338-7; Powers RW, 2005, AM J OBSTET GYNECOL, V193, P185, DOI 10.1016/j.ajog.2004.11.038; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0; Schmidt-Lucke C, 2005, INT J CARDIOL, V100, P207, DOI 10.1016/j.ijcard.2004.05.046; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Strevens H, 2003, BJOG-INT J OBSTET GY, V110, P831, DOI 10.1111/j.1471-0528.2003.02162.x; Taylor RN, 2003, AM J OBSTET GYNECOL, V188, P177, DOI 10.1067/mob.2003.111; Tidwell SC, 2001, AM J OBSTET GYNECOL, V184, P1267, DOI 10.1067/mob.2001.113129; Toporsian M, 2005, CIRC RES, V96, P684, DOI 10.1161/01.res.0000159936.38601.22; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; ZHANG J, 1995, OBSTET GYNECOL, V86, P200, DOI 10.1016/0029-7844(95)00142-E; 2006, N ENGL J MED, V354, P980	36	1329	1417	6	65	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 7	2006	355	10					992	1005		10.1056/NEJMoa055352	http://dx.doi.org/10.1056/NEJMoa055352			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080UF	16957146				2022-12-28	WOS:000240273300005
J	Solomon, T				Solomon, Tom			Control of Japan encephalitis - Within our grasp?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Liverpool, Viral Brain Infect Grp, Liverpool L69 3BX, Merseyside, England; Walton Ctr Neurol & Neurosurg, Liverpool, Merseyside, England	University of Liverpool; Walton Centre	Solomon, T (corresponding author), Univ Liverpool, Viral Brain Infect Grp, Liverpool L69 3BX, Merseyside, England.			Solomon, Tom/0000-0001-7266-6547	Medical Research Council [G116/194] Funding Source: Medline; MRC [G116/194] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ostlund MR, 2004, SCAND J INFECT DIS, V36, P512, DOI 10.1080/00365540410020640; Shlim DR, 2002, CLIN INFECT DIS, V35, P183, DOI 10.1086/341247; Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476; Tsai Theodore F., 2000, Vaccine, V18, P1, DOI 10.1016/S0264-410X(00)00037-2; 2005, BBC NEWS ONLINE 0824	5	204	232	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2006	355	9					869	871		10.1056/NEJMp058263	http://dx.doi.org/10.1056/NEJMp058263			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	078OM	16943399				2022-12-28	WOS:000240113100004
J	Galletto, R; Amitani, I; Baskin, RJ; Kowalczykowski, SC				Galletto, Roberto; Amitani, Ichiro; Baskin, Ronald J.; Kowalczykowski, Stephen C.			Direct observation of individual RecA filaments assembling on single DNA molecules	NATURE			English	Article							STRAND-EXCHANGE PROTEINS; ESCHERICHIA-COLI; DUPLEX DNA; ATP HYDROLYSIS; BINDING; RECOMBINATION; POLYMERIZATION; RECBCD; TRANSLOCATION; BIOCHEMISTRY	Escherichia coli RecA is essential for the repair of DNA double-strand breaks by homologous recombination(1). Repair requires the formation of a RecA nucleoprotein filament. Previous studies have indicated a mechanism of filament assembly whereby slow nucleation of RecA protein on DNA is followed by rapid growth(2-7). However, many aspects of this process remain unclear, including the rates of nucleation and growth and the involvement of ATP hydrolysis, largely because visualization at the single-filament level is lacking. Here we report the direct observation of filament assembly on individual double-stranded DNA molecules using fluorescently modified RecA. The nucleoprotein filaments saturate the DNA and extend it 1.6-fold. At early time points, discrete RecA clusters are seen, permitting analysis of single-filament growth from individual nuclei. Formation of nascent RecA filaments is independent of ATP hydrolysis but is dependent on the type of nucleotide cofactor and the RecA concentration, suggesting that nucleation involves binding of 4 - 5 ATP - RecA monomers to DNA. Individual RecA filaments grow at rates of 3 - 10 nm s(-1). Growth is bidirectional and, in contrast to nucleation, independent of nucleotide cofactor, suggesting addition of 2 - 7 monomers s(-1). These results are in accord with extensive genetic and biochemical studies, and indicate that assembly in vivo is controlled at the nucleation step. We anticipate that our approach and conclusions can be extended to the related eukaryotic counterpart, Rad51 (ref. 8), and to regulation by assembly mediators(9-11).	Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA; Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95616 USA; Univ Calif Davis, Ctr Genet & Dev, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu		Galletto, Roberto/0000-0001-6435-122X				Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; CAZENAVE C, 1983, EMBO J, V2, P2247, DOI 10.1002/j.1460-2075.1983.tb01730.x; CHOW SA, 1988, J BIOL CHEM, V263, P3335; EGELMAN EH, 1986, J MOL BIOL, V191, P677, DOI 10.1016/0022-2836(86)90453-5; Fulconis R, 2004, BIOPHYS J, V87, P2552, DOI 10.1529/biophysj.104.043059; Hegner M, 1999, P NATL ACAD SCI USA, V96, P10109, DOI 10.1073/pnas.96.18.10109; Kim JI, 2002, P NATL ACAD SCI USA, V99, P7917, DOI 10.1073/pnas.122218499; KOWALCZYKOWSKI S, 1977, J MOL BIOL, V115, P201, DOI 10.1016/0022-2836(77)90097-3; Kowalczykowski SC, 2005, NATURE, V433, P591, DOI 10.1038/433591a; KOWALCZYKOWSKI SC, 1991, BIOCHIMIE, V73, P289, DOI 10.1016/0300-9084(91)90216-N; KOWALCZYKOWSKI SC, 1994, ANNU REV BIOCHEM, V63, P991, DOI 10.1146/annurev.biochem.63.1.991; KOWALCZYKOWSKI SC, 1987, P NATL ACAD SCI USA, V84, P3127, DOI 10.1073/pnas.84.10.3127; KOWALCZYKOWSKI SC, 1991, ANNU REV BIOPHYS BIO, V20, P539, DOI 10.1146/annurev.bb.20.060191.002543; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; MENETSKI JP, 1990, P NATL ACAD SCI USA, V87, P21, DOI 10.1073/pnas.87.1.21; MENETSKI JP, 1988, BIOCHEMISTRY-US, V27, P1205, DOI 10.1021/bi00404a021; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; PUGH BF, 1987, J BIOL CHEM, V262, P1326; REGISTER JC, 1985, J BIOL CHEM, V260, P2308; Sattin BD, 2004, BIOPHYS J, V87, P3430, DOI 10.1529/biophysj.104.045567; SHANER SL, 1987, J BIOL CHEM, V262, P9211; SHANER SL, 1987, J BIOL CHEM, V262, P9220; Shivashankar GV, 1999, P NATL ACAD SCI USA, V96, P7916, DOI 10.1073/pnas.96.14.7916; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; van der Heijden T, 2005, NUCLEIC ACIDS RES, V33, P2099, DOI 10.1093/nar/gki512; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Zaitsev EN, 1998, NUCLEIC ACIDS RES, V26, P650, DOI 10.1093/nar/26.2.650; Zaitsev EN, 2000, GENE DEV, V14, P740	30	188	189	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2006	443	7113					875	878		10.1038/nature05197	http://dx.doi.org/10.1038/nature05197			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	16988658				2022-12-28	WOS:000241362700056
J	Frank, E; Carrera, JS; Stratton, T; Bickel, J; Nora, LM				Frank, Erica; Carrera, Jennifer S.; Stratton, Terry; Bickel, Janet; Nora, Lois Margaret			Experiences of belittlement and harassment and their correlates among medical students in the United States: longitudinal survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							US WOMEN PHYSICIANS; SEXUAL-HARASSMENT; GENDER DISCRIMINATION; ABUSE; PERCEPTIONS; MISTREATMENT; EDUCATION; PERSPECTIVES; SURGERY; SCHOOL	Objective To determine medical students' perceptions of having been harassed or belittled and their correlates, for the purposes of reducing such abuses. Design Longitudinal survey. Setting 16 nationally representative US medical schools. Participants 2884 students from class of 2003. Main outcome measures Experiences of harassment and belittlement at freshman orientation, at entry to wards, and in senior year by other students, by residents or fellows, by preclinical professors, by clinical professors or attendings, or by patients. Results 2316 students provided data (response rate 80.3%). Among seniors, 42% (581/1387) reported having experienced harassment and 84% (1166/1393) belittlement during medical school. These types of abuse were caused by other students (11% (158/1389) and 32% (443/1390) of students experienced such harassment or belittlement, respectively). Harassment and belittlement was also caused by residents (27% (374/1387) and 71% (993/1393)), preclinical professors (9% (131/1386) and 29% (398/1385)), clinical professors (21% (285/1386) and 63% (878/1390)), and patients (25% (352/1387) and 43% (592/1388)). Only 13% (181/1385) of students classified any of these experiences as severe. Medical students who reported having been harassed or belittled did not differ significantly from those not reporting such experiences by sex, ethnicity, political orientation, or religion. They did differ significantly by chosen specialty and were significantly more likely to be stressed, depressed, and suicidal, to drink alcohol or to binge drink, and to state that their faculty did not care about medical students. They were also significantly less likely to be glad they trained to become a doctor. Conclusion Most medical students in the United States report having been harassed or belittled during their training. Although few students characterised the harassment or belittlement as severe, poor mental health and low career satisfaction were significantly correlated with These experiences.	Univ British Columbia, Dept Hlth Care & Epidemiol, Vancouver, BC V6T 2K9, Canada; Univ Kentucky, Coll Med, Off Med Acad Affairs, Lexington, KY 40506 USA; Fac Career & Divers, Falls Church, VA USA; Northeastern Ohio Univ Coll Med & Pharm, Rootstown, OH 44272 USA; Emory Univ, Sch Med, Dept Family & Prevent Med, Atlanta, GA 30303 USA	University of British Columbia; University of Kentucky; Northeast Ohio Medical University (NEOMED); Emory University	Frank, E (corresponding author), Univ British Columbia, Dept Hlth Care & Epidemiol, Vancouver, BC V6T 2K9, Canada.	erica.frank@ubc.ca		Carrera, Jennifer/0000-0003-4730-6894; Frank, Erica/0000-0001-7159-5417				*AM ASS MED COLL, FACTS APPL MATR GRAD; *AM ASS MED COLL, AAMC DAT WAR STUD RE; *AM ASS MED COLL, MATR AG ANT MATR 199; BALDWIN DC, 1991, JAMA-J AM MED ASSOC, V265, P2074, DOI 10.1001/jama.265.16.2074; Baldwin DC, 2001, ACAD MED, V76, pS5, DOI 10.1097/00001888-200110001-00003; BALDWIN DWC, 1991, WESTERN J MED, V155, P140; Bergus G R, 1997, Fam Med, V29, P618; Corbie-Smith G, 1999, ACAD MED, V74, P695, DOI 10.1097/00001888-199906000-00018; Dillman D.A., 2007, MAIL INTERNET SURVEY, V2nd; Dresler CM, 1996, ARCH SURG-CHICAGO, V131, P1128; Elnicki DM, 2002, TEACH LEARN MED, V14, P92, DOI 10.1207/S15328015TLM1402_05; Frank E, 1998, ARCH INTERN MED, V158, P342, DOI 10.1001/archinte.158.4.342; Frank E, 1999, AM J PSYCHIAT, V156, P1887; Frank E, 1998, ARCH INTERN MED, V158, P352, DOI 10.1001/archinte.158.4.352; Frank E, 1999, ARCH INTERN MED, V159, P1417, DOI 10.1001/archinte.159.13.1417; Geisler J. P., 1999, Clinical and Experimental Obstetrics and Gynecology, V26, P53; Grant L, 1988, J Am Med Womens Assoc (1972), V43, P109; Kassebaum DG, 1998, ACAD MED, V73, P1149, DOI 10.1097/00001888-199811000-00011; KOMAROMY M, 1993, NEW ENGL J MED, V328, P322, DOI 10.1056/NEJM199302043280507; Larsson C, 2003, MED EDUC, V37, P39, DOI 10.1046/j.1365-2923.2003.01404.x; LEFKOPOULOU M, 1989, J AM STAT ASSOC, V84, P810, DOI 10.2307/2289671; Lempp H, 2004, BMJ-BRIT MED J, V329, P770, DOI 10.1136/bmj.329.7469.770; LILLEMOE KD, 1994, SURGERY, V116, P255; Lyon DS, 1997, OBSTET GYNECOL, V90, P634; Mangus R S, 1998, JAMA, V280, P851, DOI 10.1001/jama.280.9.851; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Marvel MK, 1998, J FAM PRACTICE, V47, P343; MOSCARELLO R, 1994, CAN MED ASSOC J, V150, P357; *NIH, SUPP US MED SCH FISC; Nora LM, 2002, ACAD MED, V77, P1226, DOI 10.1097/00001888-200212000-00018; Nora LM, 1996, ACAD MED, V71, pS22, DOI 10.1097/00001888-199610000-00033; Richardson DA, 1997, ACAD MED, V72, P728, DOI 10.1097/00001888-199708000-00022; Schuchert MK, 1998, ACAD MED, V73, P907, DOI 10.1097/00001888-199808000-00018; SHEEHAN KH, 1990, JAMA-J AM MED ASSOC, V263, P533, DOI 10.1001/jama.263.4.533; SILVER HK, 1990, JAMA-J AM MED ASSOC, V263, P527, DOI 10.1001/jama.263.4.527; Taylor A. D., 1999, CHOOSE MED SPECIALTY; Uhari M, 1994, JAMA, V271, P1049; White GE, 2000, MED EDUC, V34, P980, DOI 10.1046/j.1365-2923.2000.00684.x; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	39	136	149	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 30	2006	333	7570					682	684C		10.1136/bmj.38924.722037.7C	http://dx.doi.org/10.1136/bmj.38924.722037.7C			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092AA	16956894	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000241068200018
J	Peng, P; Chan, SWL; Shah, GA; Jacobsen, SE				Peng, Peng; Chan, Simon W-L.; Shah, Govind A.; Jacobsen, Steve E.			Plant genetics - Increased outcrossing in hothead mutants	NATURE			English	Letter							ARABIDOPSIS-THALIANA		Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Peng, P (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	jacobsen@ucla.edu						ABBOTT RJ, 1989, HEREDITY, V62, P411, DOI 10.1038/hdy.1989.56; HERMAN PL, 1989, PLANT CELL, V1, P1051, DOI 10.1105/tpc.1.11.1051; Krolikowski KA, 2003, PLANT J, V35, P501, DOI 10.1046/j.1365-313X.2003.01824.x; Li JM, 2002, SCIENCE, V295, P1299; Lolle SJ, 2005, NATURE, V434, P505, DOI 10.1038/nature03380	5	18	18	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2006	443	7110					E8	E8		10.1038/nature05251	http://dx.doi.org/10.1038/nature05251			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	17006468	Bronze			2022-12-28	WOS:000240798800034
J	Artandi, SE				Artandi, Steven E.			Focus on research: Telomeres, telomerase, and human disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Artandi, SE (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.								0	59	68	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 21	2006	355	12					1195	1197		10.1056/NEJMp068187	http://dx.doi.org/10.1056/NEJMp068187			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085IT	16990382				2022-12-28	WOS:000240598500003
J	Sackoff, JE; Hanna, DB; Pfeiffer, MR; Torian, LV				Sackoff, Judith E.; Hanna, David B.; Pfeiffer, Melissa R.; Torian, Lucia V.			Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED PATIENTS; INJECTING DRUG-USERS; MORTALITY-RATES; HEPATOCELLULAR-CARCINOMA; MULTIPLE IMPUTATION; DISEASE PROGRESSION; TRENDS; HIV/AIDS; ASSOCIATION	Background: Monitoring the full spectrum of causes of death among persons with AIDS is increasingly important as survival improves because of highly active antiretroviral therapy. Objective: To describe recent trends in deaths due to HIV-related and non-HIV-related causes among persons with AIDS, identify factors associated with these deaths, and identify leading causes of non-HIV-related deaths. Design: Population-based cohort analysis. Setting: New York City. Patients: All adults (age >= 13 years) living with AIDS between 1999 and 2004 who were reported to the New York City HIV/AIDS Reporting System and Vital Statistics Registry through 2004 (n 68669). Measurements: Underlying cause of death on the death certificate Results: Between 1999 and 2004, the percentage of deaths due to non-HIV-related causes increased by 32.8% (from 19.8% to 26.3%; P = 0.015). The age-adjusted mortality rate decreased by 49.6 deaths per 10 000 persons with AIDS (P < 0.001) annually for HIV-related causes but only by 7.5 deaths per 10 000 persons with AIDS (P = 0.004) annually for non-HIV-related causes. Of deaths due to non-HIV-related causes, 76% could be attributed to substance abuse, cardiovascular disease, or a non-AIDS-defining type of cancer. Compared with men who have sex with men, injection drug users had a statistically significantly increased risk for death due to HIV-related causes (hazard ratio, 1.59 [95% CI, 1.49 to 1.70]) and non-HIV-related causes (hazard ratio, 2.54 [CI, 2.24 to 2.87]). Limitations: Compared with autopsy and chart review, death certificates may lack specificity in the underlying cause of death or detailed clinical and treatment-related information. Conclusions: Non-HIV-related causes of death account for one fourth of all deaths of persons with AIDS. Cardiovascular disease, non-AIDS-defining cancer, and substance abuse account for most non-HIV-related deaths. Reducing deaths from these causes requires a shift in the health care model for persons with AIDS from a primary focus on managing HIV infection to providing care that addresses all aspects of physical and mental health.	New York City Dept Hlth & Mental Hyg, HIV Epidemiol Program, Bur HIV AIDS Prevent & Control, New York, NY USA	New York City Department of Health & Mental Hygiene	Sackoff, JE (corresponding author), New York City Dept Hlth & Mental Hyg, HIV Epidemiol Program, Bur HIV AIDS Prevent & Control, New York, NY USA.	jsackoff@health.nyc.gov			PHS HHS [U62/CCU223595] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aberg JA, 2004, CLIN INFECT DIS, V39, P609, DOI 10.1086/423390; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Arday D. R., 1993, Tobacco Control, V2, P156, DOI 10.1136/tc.2.2.156; Arias Elizabeth, 2003, Natl Vital Stat Rep, V52, P1; Bedimo R, 2004, CLIN INFECT DIS, V39, P1380, DOI 10.1086/424883; Bernicker EH, 1996, AM J MED SCI, V311, P215, DOI 10.1097/00000441-199605000-00004; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; Bonnet F, 2002, HIV Med, V3, P195, DOI 10.1046/j.1468-1293.2002.00117.x; Casau NC, 2005, CLIN INFECT DIS, V41, P855, DOI 10.1086/432797; *CDCP, 2005, TRENDS ANN AG ADJ RA; Centers for Disease Control and Prevention (CDC), 2002, MMWR-MORBID MORTAL W, V51, P642; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; Engels EA, 2002, JAIDS, V31, P536, DOI 10.1097/00126334-200212150-00012; Frieden TR, 2005, AM J PUBLIC HEALTH, V95, P1016, DOI 10.2105/AJPH.2004.058164; GREENBERG AE, 1993, JAMA-J AM MED ASSOC, V269, P2995, DOI 10.1001/jama.269.23.2995; Gritz ER, 2004, NICOTINE TOB RES, V6, P71, DOI 10.1080/14622200310001656885; JONES JL, 1999, CDC MORB MORTAL WKLY, V48, P1; Klinkenberg WD, 2004, AIDS CARE, V16, pS22, DOI 10.1080/09540120412331315303; Krentz HB, 2005, HIV MED, V6, P99, DOI 10.1111/j.1468-1293.2005.00271.x; Krieger N, 2002, AM J EPIDEMIOL, V156, P471, DOI 10.1093/aje/kwf068; Lee LM, 2003, PUBLIC HEALTH REP, V118, P400, DOI 10.1093/phr/118.5.400; Lethbridge-Cejku M, 2004, VITAL HLTH STAT, V10, P1; Lewden C, 2005, INT J EPIDEMIOL, V34, P121, DOI 10.1093/ije/dyh307; Louie JK, 2002, J INFECT DIS, V186, P1023, DOI 10.1086/343862; Miller N, 2005, LANCET, V365, P1849, DOI 10.1016/S0140-6736(05)66615-9; Mocroft A, 2002, AIDS, V16, P1663, DOI 10.1097/00002030-200208160-00012; Molenberghs G, 2002, STAT MED, V21, P1387, DOI 10.1002/sim.1118; National Center for Health Statistics, 1999, VIT STAT US MORT 199; Niaura R, 1999, ANN BEHAV MED, V21, pS116; *NY CIT DEP HLTH M, 2004, TAK CAR NY POL HEALT; *NY CIT DEP HLTH M, 2005, HIV EP PROGR 1 QUART; *NY CIT DEP HLTH M, 2004, SUMM VIT STAT 2003 C; *NY STAT DEP HLTH, 2005, SCREEN ONG ASS SUBST; *NY STAT DEP HLTH, 2005, SMOK CESS HIV INF PA; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Prins M, 2000, AIDS, V14, P1829, DOI 10.1097/00002030-200008180-00019; Prins M, 1997, AIDS, V11, P1747, DOI 10.1097/00002030-199714000-00012; Puoti M, 2004, AIDS, V18, P2285, DOI 10.1097/00002030-200411190-00009; Royston P, 2005, STATA J, V5, P279, DOI 10.1177/1536867X0500500212; Royston P, 2005, STATA J, V5, P188, DOI 10.1177/1536867X0500500204; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Schafer JL, 1998, MULTIVAR BEHAV RES, V33, P545, DOI 10.1207/s15327906mbr3304_5; SELIK R, 2004, 11 C RETR OPP INF SA; Selik RM, 2002, J ACQ IMMUN DEF SYND, V29, P378, DOI 10.1097/00126334-200204010-00009; Selik RM, 2003, JAIDS-J ACQ IMM DEF, V32, P62, DOI 10.1097/00126334-200301010-00009; Sepkowitz KA, 2001, NEW ENGL J MED, V344, P1764, DOI 10.1056/NEJM200106073442306; Smit C, 2006, AIDS, V20, P741, DOI 10.1097/01.aids.0000216375.99560.a2; Smith DK, 2003, J URBAN HEALTH, V80, P676, DOI 10.1093/jurban/jtg074; U.S. Census Bureau, 2000, US CENS; Vandentorren S, 2001, EUR J EPIDEMIOL, V17, P7, DOI 10.1023/A:1010972410865; WEBER R, 2005, 12 C RETR OPP INF BO; WHO, 2019, INT STAT CLASS DIS R, V10th; 2004, MMWR MORB MORTAL WKL, V53, P866	53	348	356	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2006	145	6					397	406		10.7326/0003-4819-145-6-200609190-00003	http://dx.doi.org/10.7326/0003-4819-145-6-200609190-00003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	087OU	16983127				2022-12-28	WOS:000240752500001
J	Zhong, CB; Liljenquist, K				Zhong, Chen-Bo; Liljenquist, Katie			Washing away your sins: Threatened morality and physical cleansing	SCIENCE			English	Article								Physical cleansing has been a focal element in religious ceremonies for thousands of years. The prevalence of this practice suggests a psychological association between bodily purity and moral purity. In three studies, we explored what we call the "Macbeth effect'' - that is, a threat to one's moral purity induces the need to cleanse oneself. This effect revealed itself through an increased mental accessibility of cleansing-related concepts, a greater desire for cleansing products, and a greater likelihood of taking antiseptic wipes. Furthermore, we showed that physical cleansing alleviates the upsetting consequences of unethical behavior and reduces threats to one's moral self-image. Daily hygiene routines such as washing hands, as simple and benign as they might seem, can deliver a powerful antidote to threatened morality, enabling people to truly wash away their sins.	Univ Toronto, Joseph L Rotman Sch Management, Dept Org Behav & HR Management, Toronto, ON M5S 3E6, Canada; Northwestern Univ, JL Kellogg Grad Sch Management, Dept Management & Org, Evanston, IL 60208 USA	University of Toronto; Northwestern University	Zhong, CB (corresponding author), Univ Toronto, Joseph L Rotman Sch Management, Dept Org Behav & HR Management, Toronto, ON M5S 3E6, Canada.	chenbo.zhong@rotman.utoronto.ca						*BIBLE, ACTS, V22; Fuller C. J., 1992, CAMPHOR FLAME POPULA; Haidt J., 1997, PSYCHOL DEV SOC, V9, P107, DOI [10.1177%2F097133369700900105, DOI 10.1177/097133369700900105]; Haidt J., 2004, HDB EXPT EXISTENTIAL, P322; Lakoff George, 1987, WOMEN FIRE, DOI DOI 10.7208/CHICAGO/9780226471013.001.0001; Moll J, 2005, COGN BEHAV NEUROL, V18, P68, DOI 10.1097/01.wnn.0000152236.46475.a7; ROZIN P, 1994, J PERS SOC PSYCHOL, V66, P870, DOI 10.1037//0022-3514.66.5.870; SHAKESPEARE W, 1998, MACBETH; Tetlock PE, 2000, J PERS SOC PSYCHOL, V78, P853, DOI 10.1037/0022-3514.78.5.853; Wicklund RA, 1981, BASIC APPL SOC PSYCH, V2, P89, DOI 10.1207/s15324834basp0202_2	10	651	687	11	250	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2006	313	5792					1451	1452		10.1126/science.1130726	http://dx.doi.org/10.1126/science.1130726			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16960010				2022-12-28	WOS:000240348700047
J	Bashyam, R; Zelenay, P				Bashyam, Rajesh; Zelenay, Piotr			A class of non-precious metal composite catalysts for fuel cells	NATURE			English	Article							FE-BASED CATALYSTS; OXYGEN REDUCTION; PLATINUM MONOLAYER; O-2 REDUCTION; CARBON-BLACK; ELECTROCATALYSTS; CATHODE; POLYPYRROLE; PROTON; ENERGY	Fuel cells, as devices for direct conversion of the chemical energy of a fuel into electricity by electrochemical reactions, are among the key enabling technologies for the transition to a hydrogen-based economy(1-3). Of several different types of fuel cells under development today, polymer electrolyte fuel cells (PEFCs) have been recognized as a potential future power source for zero-emission vehicles(4,5). However, to become commercially viable, PEFCs have to overcome the barrier of high catalyst cost caused by the exclusive use of platinum and platinum-based catalysts(6-8) in the fuel-cell electrodes. Here we demonstrate a new class of low-cost (non-precious metal)/(heteroatomic polymer) nanocomposite catalysts for the PEFC cathode, capable of combining high oxygen-reduction activity with good performance durability. Without any optimization, the cobalt-polypyrrole composite catalyst enables power densities of about 0.15 W cm(-2) in H-2-O-2 fuel cells and displays no signs of performance degradation for more than 100 hours. The results of this study show that heteroatomic polymers can be used not only to stabilize the non-precious metal in the acidic environment of the PEFC cathode but also to generate active sites for oxygen reduction reaction.	Los Alamos Natl Lab, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Zelenay, P (corresponding author), Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87545 USA.	zelenay@lanl.gov	T, Maiyalagan/C-5716-2011	T, Maiyalagan/0000-0003-3528-3824				Alonso-Vante N, 2002, ELECTROCHIM ACTA, V47, P3807, DOI 10.1016/S0013-4686(02)00351-1; ALONSOVANTE N, 1986, NATURE, V323, P431; APPLEBY AJ, 1993, J ELECTROANAL CHEM, V357, P117, DOI 10.1016/0022-0728(93)80378-U; ATANASOSKI R, VIIC9 US DOE; BECK F, 1977, J APPL ELECTROCHEM, V7, P239, DOI 10.1007/BF00618991; Berger DJ, 1999, SCIENCE, V286, P49; Brumfiel G, 2003, NATURE, V422, P104, DOI 10.1038/422104a; Dusastre V, 2001, NATURE, V414, P331; Faubert G, 1996, ELECTROCHIM ACTA, V41, P1689, DOI 10.1016/0013-4686(95)00423-8; Fernandez JL, 2005, J AM CHEM SOC, V127, P13100, DOI 10.1021/ja0534710; Hepel M, 1996, J ELECTROCHEM SOC, V143, P498, DOI 10.1149/1.1836471; Jacobson MZ, 2005, SCIENCE, V308, P1901, DOI 10.1126/science.1109157; JASINSKI R, 1964, NATURE, V201, P1212, DOI 10.1038/2011212a0; LALANDE G, 1995, ELECTROCHIM ACTA, V40, P2635, DOI 10.1016/0013-4686(95)00104-M; Lefevre M, 2003, ELECTROCHIM ACTA, V48, P2749, DOI 10.1016/S0013-4686(03)00393-1; Lu W, 2002, SCIENCE, V297, P983, DOI 10.1126/science.1072651; Medard C, 2006, ELECTROCHIM ACTA, V51, P3202, DOI 10.1016/j.electacta.2005.09.012; Schultz MG, 2003, SCIENCE, V302, P624, DOI 10.1126/science.1089527; Semelsberger TA, 2005, INT J HYDROGEN ENERG, V30, P425, DOI 10.1016/j.ijhydene.2004.11.007; SKOTHEIM TA, 1989, SYNTHETIC MET, V28, P229; Steele BCH, 2001, NATURE, V414, P345, DOI 10.1038/35104620; Thomas SC, 2002, ELECTROCHIM ACTA, V47, P3741, DOI 10.1016/S0013-4686(02)00344-4; Villers D, 2004, J ELECTROCHEM SOC, V151, pA1507, DOI 10.1149/1.1781611; Wang B, 2005, J POWER SOURCES, V152, P1, DOI 10.1016/j.jpowsour.2005.05.098; Xie J, 2005, J ELECTROCHEM SOC, V152, pA1011, DOI 10.1149/1.1873492; Yuasa M, 2005, CHEM MATER, V17, P4278, DOI 10.1021/cm050958z; ZELENAY P, 2005, VIIC7 US DOE; Zhang J, 2005, J PHYS CHEM B, V109, P22701, DOI 10.1021/jp055634c; Zhang J, 2004, J PHYS CHEM B, V108, P10955, DOI 10.1021/jp0379953; Zhang X, 2005, J POWER SOURCES, V145, P223, DOI 10.1016/j.jpowsour.2005.01.074	30	1830	1881	31	1503	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2006	443	7107					63	66		10.1038/nature05118	http://dx.doi.org/10.1038/nature05118			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16957726				2022-12-28	WOS:000240313900039
J	Hiroi, T; Abe, M; Kitazato, K; Abe, S; Clark, BE; Sasaki, S; Ishiguro, M; Barnouin-Jha, OS				Hiroi, Takahiro; Abe, Masanao; Kitazato, Kohei; Abe, Shinsuke; Clark, Beth E.; Sasaki, Sho; Ishiguro, Masateru; Barnouin-Jha, Olivier S.			Developing space weathering on the asteroid 25143 Itokawa	NATURE			English	Article							HAYABUSA; ITOKAWA	Puzzlingly, the parent bodies of ordinary chondrites (the most abundant type of meteorites) do not seem to be abundant among asteroids. One possible explanation is that surfaces of the parent bodies become optically altered, to become the S-type asteroids which are abundant in the main asteroid belt. The process is called 'space weathering' - it makes the visible and near-infrared reflectance spectrum of a body darker and redder(1). A recent survey of small, near-Earth asteroids suggests that the surfaces of small S asteroids may have developing stages of space weathering(2). Here we report that a dark region on a small (550-metre) asteroid-25143 Itokawa-is significantly more space-weathered than a nearby bright region. Spectra of both regions are consistent with those of LL5-6 chondrites after continuum removal(3). A simple calculation(4) suggests that the dark area has a shorter mean optical path length and about 0.04 per cent by volume more nanophase metallic iron particles than the bright area. This clearly shows that space-weathered materials accumulate on small asteroids, which are likely to be the parent bodies of LL chondrites. We conclude that, because LL meteorites are the least abundant of ordinary (H, L, and LL) chondrites, there must be many asteroids with ordinary-chondrite compositions in near-Earth orbits.	Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Kanagawa 2298510, Japan; Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan; Kobe Univ, Grad Sch Sci & Technol, Kobe, Hyogo 6578501, Japan; Ithaca Coll, Ctr Nat Sci 267, Ithaca, NY 14850 USA; Natl Astron Observ Japan, RISE Project Off, Mizusawa, Oshu 0230861, Japan; Seoul Natl Univ, Coll Nat Sci, Sch Earth Environm Sci, Seoul 151742, South Korea; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA	Brown University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); University of Tokyo; Kobe University; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Seoul National University (SNU); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Hiroi, T (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.	takahiro_hiroi@brown.edu	Barnouin, Olivier S/I-7475-2015; Sasaki, Sho/S-3845-2019	Barnouin, Olivier S/0000-0002-3578-7750; Sasaki, Sho/0000-0002-7646-5248; Abe, Shinsuke/0000-0002-6247-4979				Abe M, 2006, SCIENCE, V312, P1334, DOI 10.1126/science.1125718; Abe S, 2006, SCIENCE, V312, P1344, DOI 10.1126/science.1126272; ADAMS JB, 1971, SCIENCE, V171, P567, DOI 10.1126/science.171.3971.567; Al-Bassam K. S., 1978, Meteoritics, V13, P257, DOI 10.1111/j.1945-5100.1978.tb00815.x; Binzel RP, 2004, ICARUS, V170, P259, DOI 10.1016/j.icarus.2004.04.004; Binzel RP, 2001, METEORIT PLANET SCI, V36, P1167, DOI 10.1111/j.1945-5100.2001.tb01950.x; GASKELL RW, 2006, LUNAR PLANET SCI, V37; Hapke B, 2001, J GEOPHYS RES-PLANET, V106, P10039, DOI 10.1029/2000JE001338; HIROI T, 1994, J GEOPHYS RES-PLANET, V99, P10867, DOI 10.1029/94JE00841; ISHIGURO M, 2006, LUNAR PLANET SCI, V37; JOHNSON PB, 1974, PHYS REV B, V9, P5056, DOI 10.1103/PhysRevB.9.5056; KLEIN C, 1985, MANUAL MINERALOGY, P375; MCSWEEN HY, 1991, ICARUS, V90, P107, DOI 10.1016/0019-1035(91)90072-2; Saito J, 2006, SCIENCE, V312, P1341, DOI 10.1126/science.1125722	14	71	73	3	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2006	443	7107					56	58		10.1038/nature05073	http://dx.doi.org/10.1038/nature05073			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16957724	Green Submitted			2022-12-28	WOS:000240313900037
J	Sato, S; Iida, J; Suzuki, K; Kawano, M; Ozeki, T; Fujita, M				Sato, Sota; Iida, Junya; Suzuki, Kosuke; Kawano, Masaki; Ozeki, Tomoji; Fujita, Makoto			Fluorous nanodroplets structurally confined in an organopalladium sphere	SCIENCE			English	Article							ORGANIC-SYNTHESIS; SEPARATION; STRATEGY	The distinct properties of fluorous phases are practically useful for separation, purification, and reaction control in organic synthesis. Here, we report the formation of a liquid-like fluorous droplet, composed of 24 perfluoroalkyl chains confined in the interior of a 5-nanometer-sized, roughly spherical shell that spontaneously assembled in solution from 12 palladium ions and 24 bridging ligands. Crystallographic analysis confirmed the rigid shell framework and amorphous interior. Perfluoroalkanes can dissolve in this well-defined fluorous phase, whereas they can hardly dissolve in a surrounding polar organic solution, and their solubility (up to similar to eight perfluoroalkane molecules per spherical complex) can be finely controlled by tuning the length of perfluoroalkyl chains tethered to the shell.	Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan; Japan Sci & Technol Corp, CREST, Bunkyo Ku, Tokyo 1138656, Japan; Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528551, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Tokyo Institute of Technology	Fujita, M (corresponding author), Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	mfujita@appchem.t.u-tokyo.ac.jp	Fujita, Makoto/E-6350-2012; Suzuki, Kosuke/C-4918-2012; SATO, Sota/V-2817-2019	Suzuki, Kosuke/0000-0002-8123-1462; Sato, Sota/0000-0002-7395-2112				Battiste JL, 2004, J FLUORINE CHEM, V125, P1331, DOI 10.1016/j.jfluchem.2004.03.011; Fish RH, 1999, CHEM-EUR J, V5, P1677, DOI 10.1002/(SICI)1521-3765(19990604)5:6<1677::AID-CHEM1677>3.0.CO;2-X; GLADYSZ JA, 2004, HDB FLUOROUS CHEM, pCH4; Hoang KC, 2004, LANGMUIR, V20, P7347, DOI 10.1021/la049128a; HORVATH IT, 1994, SCIENCE, V266, P72, DOI 10.1126/science.266.5182.72; Horvath IT, 1998, ACCOUNTS CHEM RES, V31, P641, DOI 10.1021/ar970342i; KIRSCH P, 2004, MODERN FLUOROORGANIC, pCH3; Krafft MP, 2001, ADV DRUG DELIVER REV, V47, P209, DOI 10.1016/S0169-409X(01)00107-7; Riess JG, 2002, TETRAHEDRON, V58, P4113, DOI 10.1016/S0040-4020(02)00262-4; Studer A, 1997, SCIENCE, V275, P823, DOI 10.1126/science.275.5301.823; Studer A, 1997, J ORG CHEM, V62, P2917, DOI 10.1021/jo970095w; Tominaga M, 2004, ANGEW CHEM INT EDIT, V43, P5621, DOI 10.1002/anie.200461422; Tominaga M, 2005, J AM CHEM SOC, V127, P11950, DOI 10.1021/ja054069o; Yoshida J, 2002, CHEM REV, V102, P3693, DOI 10.1021/cr0103524; Zhang W, 2003, TETRAHEDRON, V59, P4475, DOI 10.1016/S0040-4020(03)00592-1	15	237	237	5	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 1	2006	313	5791					1273	1276		10.1126/science.1129830	http://dx.doi.org/10.1126/science.1129830			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16946067				2022-12-28	WOS:000240313500036
J	Wilson, TD				Wilson, Timothy D.			The power of social psychological interventions	SCIENCE			English	Editorial Material							THREAT		Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA	University of Virginia	Wilson, TD (corresponding author), Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA.	tdw@virginia.edu						Aronson J, 2002, J EXP SOC PSYCHOL, V38, P113, DOI 10.1006/jesp.2001.1491; Cohen GL, 2006, SCIENCE, V313, P1307, DOI 10.1126/science.1128317; Lewin K., 1951, FIELD THEORY SOCIAL; Ross L., 1991, PERSON SITUATION; Rothstein R., 2004, CLASS SCH; Sherman DK, 2006, ADV EXP SOC PSYCHOL, V38, P183, DOI 10.1016/S0065-2601(06)38004-5; Steele C.M., 1988, ADV EXP SOC PSYCHOL, P261, DOI DOI 10.1016/S0065-2601(08)60229-4; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; Steele CM, 2002, ADV EXP SOC PSYCHOL, V34, P379, DOI 10.1016/S0065-2601(02)80009-0; STORMS MD, 1976, NEW DIRECTIONS ATTRI, P143; VALINS S, 1972, ATTRIBUTION PERCEIV, P137; WALTON GM, IN PRESS J PERS SOC; Wilson TD, 2005, PSYCHOL INQ, V16, P185, DOI 10.1207/s15327965pli1604_09; WILSON TD, 1985, J PERS SOC PSYCHOL, V49, P287, DOI 10.1037/0022-3514.49.1.287; Wilson TD, 2002, IMPROVING ACAD ACHIE, P89, DOI [DOI 10.1016/B978-012064455-1/50008-7, 10.1016/B978-012064455-1/50008-7]	15	28	29	2	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2006	313	5791					1251	1252		10.1126/science.1133017	http://dx.doi.org/10.1126/science.1133017			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	081JI	16946061				2022-12-28	WOS:000240313500030
J	Bertagnolli, MM; Eagle, CJ; Zauber, AG; Redston, M; Solomon, SD; Kim, KM; Tang, J; Rosenstein, RB; Wittes, J; Corle, D; Hess, TM; Woloj, GM; Boisserie, F; Anderson, WF; Viner, JL; Bagheri, D; Burn, J; Chung, DC; Dewar, T; Foley, TR; Hoffman, N; Macrae, F; Pruitt, RE; Saltzman, JR; Salzberg, B; Sylwestrowicz, T; Gordon, GB; Hawk, ET				Bertagnolli, Monica M.; Eagle, Craig J.; Zauber, Ann G.; Redston, Mark; Solomon, Scott D.; Kim, KyungMann; Tang, Jie; Rosenstein, Rebecca B.; Wittes, Janet; Corle, Donald; Hess, Timothy M.; Woloj, G. Mabel; Boisserie, Frederic; Anderson, William F.; Viner, Jaye L.; Bagheri, Donya; Burn, John; Chung, Daniel C.; Dewar, Thomas; Foley, T. Raymond; Hoffman, Neville; Macrae, Finlay; Pruitt, Ronald E.; Saltzman, John R.; Salzberg, Bruce; Sylwestrowicz, Thomas; Gordon, Gary B.; Hawk, Ernest T.		APC Study Investigators	Celecoxib for the prevention of sporadic colorectal adenomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-FIBER DIET; RANDOMIZED-TRIAL; VITAMIN-D; LOW-FAT; RECURRENCE; ASPIRIN; SUPPLEMENTATION; RISK	Background: Studies showing that drugs that inhibit cyclooxygenase-2 (COX-2) reduce the number of colorectal adenomas in animals and patients with familial adenomatous polyposis suggest that COX-2 inhibitors may also prevent sporadic colorectal neoplasia. Methods: We randomly assigned patients who had adenomas removed before study entry to receive placebo (679 patients) or 200 mg (685 patients) or 400 mg (671 patients) of celecoxib twice daily. Randomization was stratified for the use of low-dose aspirin. Follow-up colonoscopies were performed at one and three years after randomization. The occurrence of newly detected colorectal adenomas was compared among the groups with the life-table extension of the Mantel-Haenszel test. Results: Follow-up colonoscopies were completed at year 1 in 89.5 percent of randomized patients, and at year 3 in 75.7 percent. The estimated cumulative incidence of the detection of one or more adenomas by year 3 was 60.7 percent for patients receiving placebo, as compared with 43.2 percent for those receiving 200 mg of celecoxib twice a day (risk ratio, 0.67; 95 percent confidence interval, 0.59 to 0.77; P < 0.001) and 37.5 percent for those receiving 400 mg of celecoxib twice a day (risk ratio, 0.55; 95 percent confidence interval, 0.48 to 0.64; P < 0.001). Serious adverse events occurred in 18.8 percent of patients in the placebo group, as compared with 20.4 percent of those in the low-dose celecoxib group (risk ratio, 1.1; 95 percent confidence interval, 0.9 to 1.3; P=0.5) and 23.0 percent of those in the high-dose group (risk ratio, 1.2; 95 percent confidence interval, 1.0 to 1.5; P=0.06). As compared with placebo, celecoxib was associated with an increased risk of cardiovascular events (risk ratio for the low dose, 2.6; 95 percent confidence interval, 1.1 to 6.1; and risk ratio for the high dose, 3.4; 95 percent confidence interval, 1.5 to 7.9). Conclusions: These findings indicate that celecoxib is an effective agent for the prevention of colorectal adenomas but, because of potential cardiovascular events, cannot be routinely recommended for this indication.	Brigham & Womens Hosp, Div Surg Oncol, Boston, MA 02115 USA; Pfizer, New York, NY USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Univ Wisconsin, Madison, WI USA; Stat Collaborat, Washington, DC USA; NCI, Bethesda, MD 20892 USA; CCS Associates, Mountain View, CA USA; Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Massachusetts Gen Hosp, Boston, MA 02114 USA; Harris Methodist Hosp Ft Worth, Ft Worth, TX USA; Reg Gastroenterol Associates Lancaster, Lancaster, PA USA; Sir Charles Gairdner Hosp, Perth, WA, Australia; Royal Melbourne Hosp, Melbourne, Vic, Australia; Nashville Med Res Inst, Nashville, TN USA; Atlanta Gastroenterol Associates, Atlanta, GA USA; Univ Saskatchewan, St Pauls Hosp, Saskatoon, SK, Canada; GD Searle & Co, Skokie, IL 60077 USA	Harvard University; Brigham & Women's Hospital; Pfizer; Memorial Sloan Kettering Cancer Center; University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Newcastle University - UK; Harvard University; Massachusetts General Hospital; University of Western Australia; Royal Melbourne Hospital; St. Paul's Hospital; University of Saskatchewan; Pfizer	Bertagnolli, MM (corresponding author), Brigham & Womens Hosp, Div Surg Oncol, 75 Francis St, Boston, MA 02115 USA.	mbertagnolli@partners.org	Solomon, Scott/I-5789-2013	Burn, John/0000-0002-9823-2322	DIVISION OF CANCER PREVENTION AND CONTROL [N01CN095015] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CN-95015] Funding Source: Medline	DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		American Cancer Society, 2006, CANC FACTS FIG 2006; Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Baron JA, 1999, NEW ENGL J MED, V340, P101, DOI 10.1056/NEJM199901143400204; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Benamouzig R, 2003, GASTROENTEROLOGY, V125, P328, DOI 10.1016/S0016-5085(03)00887-4; Grau MV, 2003, J NATL CANCER I, V95, P1765, DOI 10.1093/jnci/djg110; Hawk ET, 2005, J CLIN ONCOL, V23, P378, DOI 10.1200/JCO.2005.08.097; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES PR, P342; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; MCKEOWNEYSSEN GE, 1994, J CLIN EPIDEMIOL, V47, P525, DOI 10.1016/0895-4356(94)90299-2; MCKEOWNEYSSEN GE, 1995, J CLIN EPIDEMIOL, V48, pR1; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Sandler RS, 2003, NEW ENGL J MED, V348, P1939; Schatzkin A, 2000, NEW ENGL J MED, V342, P1149, DOI 10.1056/NEJM200004203421601; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; STOKES ME, 2000, CATEGORICAL DATA ANA, P596; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; VANELTEREN P, 1960, B INT STATIST INST, V37, P351; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P1102; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301	25	811	839	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2006	355	9					873	884		10.1056/NEJMoa061355	http://dx.doi.org/10.1056/NEJMoa061355			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	078OM	16943400	Bronze			2022-12-28	WOS:000240113100005
J	Brisman, JL; Song, JK; Newell, DW				Brisman, Jonathan L.; Song, Joon K.; Newell, David W.			Medical progress: Cerebral aneurysms	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							UNRUPTURED INTRACRANIAL ANEURYSMS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIGITAL-SUBTRACTION-ANGIOGRAPHY; MAGNETIC-RESONANCE ANGIOGRAPHY; LEFT-VENTRICULAR DYSFUNCTION; GUGLIELMI DETACHABLE COILS; HEALTH-CARE PROFESSIONALS; SUBARACHNOID HEMORRHAGE; ENDOVASCULAR TREATMENT; NATURAL-HISTORY		JFK Med Ctr, New Jersey Neurosci Inst, Dept Cerebrovasc & Endovasc Neurosurg, Edison, NJ 08818 USA; Roosevelt Med Ctr, Inst Neurol & Neurosurg, Dept Endovasc Surg, New York, NY USA; Swedish Med Ctr, Seattle Neurosci Inst, Dept Neurosurg, Seattle, WA USA	Swedish Medical Center	Brisman, JL (corresponding author), JFK Med Ctr, New Jersey Neurosci Inst, Dept Cerebrovasc & Endovasc Neurosurg, Edison, NJ 08818 USA.	jbrisman@solarishs.org						Ausman JI, 1999, SURG NEUROL, V51, P227; Bardach NS, 2002, STROKE, V33, P1851, DOI 10.1161/01.STR.0000019126.43079.7B; Barker FG, 2003, NEUROSURGERY, V52, P995, DOI 10.1227/01.NEU.0000057743.56678.5F; Barker FG, 1996, J NEUROSURG, V84, P405, DOI 10.3171/jns.1996.84.3.0405; Bederson JB, 2000, STROKE, V31, P2742, DOI 10.1161/01.STR.31.11.2742; Berman MF, 2003, STROKE, V34, P2200, DOI 10.1161/01.STR.0000086528.32334.06; Brilstra EH, 1999, STROKE, V30, P470, DOI 10.1161/01.STR.30.2.470; Brisman JL, 2005, NEUROSURGERY, V57, P1103, DOI 10.1227/01.NEU.0000185631.20246.1A; Brisman JL, 2005, AM J NEURORADIOL, V26, P1237; Bulsara KR, 2003, J NEUROSURG, V98, P524, DOI 10.3171/jns.2003.98.3.0524; Butler WE, 1996, NEUROSURGERY, V38, P506; Chappell ET, 2003, NEUROSURGERY, V52, P624, DOI 10.1227/01.NEU.0000047895.82857.EB; Cloft HJ, 2004, AM J NEURORADIOL, V25, P60; Cloft HJ, 2002, AM J NEURORADIOL, V23, P1706; Connors JJ, 2005, NEUROLOGY, V64, P190, DOI 10.1212/01.WNL.0000148958.34025.09; Dammert S, 2004, NEURORADIOLOGY, V46, P427, DOI 10.1007/s00234-003-1155-1; David CA, 1999, J NEUROSURG, V91, P396, DOI 10.3171/jns.1999.91.3.0396; Deibert E, 2003, J NEUROSURG, V98, P741, DOI 10.3171/jns.2003.98.4.0741; Derdeyn CP, 2003, AM J NEURORADIOL, V24, P1404; DION JE, 1987, STROKE, V18, P997, DOI 10.1161/01.STR.18.6.997; Edlow JA, 2000, NEW ENGL J MED, V342, P29, DOI 10.1056/NEJM200001063420106; Elliott JP, 1998, J NEUROSURG, V88, P277, DOI 10.3171/jns.1998.88.2.0277; Eskridge JM, 1998, NEUROSURGERY, V42, P510, DOI 10.1097/00006123-199803000-00016; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Friedman DP, 2003, AM J NEURORADIOL, V24, P1772; Friedman JA, 2003, AM J NEURORADIOL, V24, P526; GREENBERG MS, 2000, HDB NEUROSURGERY, P754; HARBAUGH RE, POSITION STATEMENT I; Harrison MJ, 1997, NEUROSURGERY, V40, P947, DOI 10.1097/00006123-199705000-00014; HEISERMAN JE, 1994, AM J NEURORADIOL, V15, P1401; Henkes H, 2004, NEUROSURGERY, V54, P268, DOI 10.1227/01.NEU.0000103221.16671.F0; Hoh BL, 2004, NEUROSURGERY, V54, P1329, DOI 10.1227/01.NEU.0000125325.22576.83; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Jain R, 2004, AM J NEURORADIOL, V25, P126; Johnston SC, 1999, NEUROLOGY, V52, P1799, DOI 10.1212/WNL.52.9.1799; Johnston SC, 2000, ANN NEUROL, V48, P11; Johnston SC, 2002, STROKE, V33, P2536, DOI 10.1161/01.STR.0000034708.66191.7D; Johnston SC, 2001, STROKE, V32, P597, DOI 10.1161/01.STR.32.3.597; Johnston SC, 2000, STROKE, V31, P111, DOI 10.1161/01.STR.31.1.111; Johnston SC, 1998, NEUROLOGY, V50, P1413, DOI 10.1212/WNL.50.5.1413; JUVELA S, 1993, J NEUROSURG, V79, P174, DOI 10.3171/jns.1993.79.2.0174; Juvela S, 2008, J NEUROSURG, V108, P1052, DOI 10.3171/JNS/2008/108/5/1052; Kangasniemi M, 2004, NEUROSURGERY, V54, P336, DOI 10.1227/01.NEU.0000103448.07132.E1; Khush K, 2005, J AM SOC ECHOCARDIOG, V18, P168, DOI 10.1016/j.echo.2004.08.045; KING JT, 1994, J NEUROSURG, V81, P837, DOI 10.3171/jns.1994.81.6.0837; Kobayashi S, 1999, SURG NEUROL, V51, P355; Kouskouras C, 2004, NEURORADIOLOGY, V46, P842, DOI 10.1007/s00234-004-1259-2; Lindsay KW, 2003, ACTA NEUROCHIR, V145, P97, DOI 10.1007/s00701-002-1066-7; Liu AY, 2003, AM J NEURORADIOL, V24, P1520; Lylyk P, 2005, J NEUROSURG, V102, P235, DOI 10.3171/jns.2005.102.2.0235; Maurice-Williams RS, 2004, J NEUROL NEUROSUR PS, V75, P807, DOI 10.1136/jnnp.2004.036962; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Moret J, 1997, J NEURORADIOLOGY, V24, P30; Morris P, 1997, PRACTICAL NEUROANGIO; Mount L A, 1974, Clin Neurosurg, V21, P166; Murayama Y, 2003, STROKE, V34, P2031, DOI 10.1161/01.STR.0000083394.33633.C2; Murayama Y, 2003, J NEUROSURG, V98, P959, DOI 10.3171/jns.2003.98.5.0959; Okahara M, 2002, STROKE, V33, P1803, DOI 10.1161/01.STR.0000019510.32145.A9; Polin RS, 2000, J NEUROSURG, V92, P284, DOI 10.3171/jns.2000.92.2.0284; Qureshi AI, 2001, J NEUROSURG, V94, P880, DOI 10.3171/jns.2001.94.6.0880; Raaymakers TWM, 1999, NEW ENGL J MED, V341, P1344; Raaymakers TWM, 1998, STROKE, V29, P1531, DOI 10.1161/01.STR.29.8.1531; Rabinstein AA, 2004, AM J NEURORADIOL, V25, P1778; Raymond J, 2003, STROKE, V34, P1398, DOI 10.1161/01.STR.0000073841.88563.E9; Rosenwasser RH, 1999, NEUROSURGERY, V44, P975, DOI 10.1097/00006123-199905000-00022; Schievink WI, 1997, NEW ENGL J MED, V336, P1267; Shanno GB, 2001, NEUROSURGERY, V48, P1066, DOI 10.1097/00006123-200105000-00019; Slob MJ, 2004, AM J NEURORADIOL, V25, P1373; Solomon RA, 1996, STROKE, V27, P13, DOI 10.1161/01.STR.27.1.13; SOLOMON RA, 1994, J NEUROSURG, V80, P440, DOI 10.3171/jns.1994.80.3.0440; Solomon RA., 2004, MANAGEMENT CEREBRAL MANAGEMENT CEREBRAL, P271; STAPF C, 2004, MANAGEMENT CEREBRAL, P183; Tanoue S, 2000, NEUROSURGERY, V47, P866, DOI 10.1097/00006123-200010000-00016; Thornton J, 2000, NEUROSURGERY, V46, P1294, DOI 10.1097/00006123-200006000-00003; Thornton J, 2002, NEUROSURGERY, V50, P239, DOI 10.1097/00006123-200202000-00003; Tipper G, 2005, CLIN RADIOL, V60, P565, DOI 10.1016/j.crad.2004.09.012; Tsutsumi K, 2000, J NEUROSURG, V93, P550, DOI 10.3171/jns.2000.93.4.0550; Tummala Ramachandra P, 2005, Neurosurg Focus, V18, pe9; Tummala RP, 2001, NEUROSURGERY, V49, P1059, DOI 10.1097/00006123-200111000-00007; Tung P, 2004, STROKE, V35, P548, DOI 10.1161/01.STR.0000114874.96688.54; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; White PM, 2000, RADIOLOGY, V217, P361, DOI 10.1148/radiology.217.2.r00nv06361; White PM, 2001, RADIOLOGY, V219, P739, DOI 10.1148/radiology.219.3.r01ma16739; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Wiebers D, 1999, NEW ENGL J MED, V340, P744; Wiebers D, 1998, NEW ENGL J MED, V339, P1725, DOI 10.1056/nejm199812103392401; WIEBERS DO, 1981, NEW ENGL J MED, V304, P696, DOI 10.1056/NEJM198103193041203; WIEBERS DO, 1987, J NEUROSURG, V66, P23, DOI 10.3171/jns.1987.66.1.0023; Wijdicks EFM, 2005, MAYO CLIN PROC, V80, P550, DOI 10.4065/80.4.550; WINN HR, 1983, J NEUROSURG, V59, P642, DOI 10.3171/jns.1983.59.4.0642; Winn HR., 2004, MANAGEMENT CEREBRAL, P303; Yanaka K, 2004, SURG NEUROL, V62, P538, DOI 10.1016/j.surneu.2003.12.011; Yoshino Y, 2004, J NEUROSURG, V101, P996, DOI 10.3171/jns.2004.101.6.0996; Zaroff JG, 1999, NEUROSURGERY, V44, P34, DOI 10.1097/00006123-199901000-00013; Zaroff JG, 2000, J AM SOC ECHOCARDIOG, V13, P774, DOI 10.1067/mje.2000.105763; 2005, MEDTECH INSIGHT, V7, P47	98	556	591	2	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2006	355	9					928	939		10.1056/NEJMra052760	http://dx.doi.org/10.1056/NEJMra052760			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	078OM	16943405				2022-12-28	WOS:000240113100010
J	Kumar, KK; Rajagopalan, B; Hoerling, M; Bates, G; Cane, M				Kumar, K. Krishna; Rajagopalan, Balaji; Hoerling, Martin; Bates, Gary; Cane, Mark			Unraveling the mystery of Indian monsoon failure during El Nino	SCIENCE			English	Article							SUMMER MONSOON; SOUTHERN OSCILLATION; RAINFALL; OCEAN	The 132-year historical rainfall record reveals that severe droughts in India have always been accompanied by El Nino events. Yet El Nino events have not always produced severe droughts. We show that El Nino events with the warmest sea surface temperature (SST) anomalies in the central equatorial Pacific are more effective in focusing drought-producing subsidence over India than events with the warmest SSTs in the eastern equatorial Pacific. The physical basis for such different impacts is established using atmospheric general circulation model experiments forced with idealized tropical Pacific warmings. These findings have important implications for Indian monsoon forecasting.	Natl Ocean & Atmospher Adm, Earth Syst Res Lab, Boulder, CO 80305 USA; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Indian Inst Trop Meteorol, Pune 411008, Maharashtra, India; Univ Colorado, Dept Civil Environm & Architectural Engn, Boulder, CO 80309 USA; Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Columbia University; Ministry of Earth Sciences (MoES) - India; Indian Institute of Tropical Meteorology (IITM); University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Hoerling, M (corresponding author), Natl Ocean & Atmospher Adm, Earth Syst Res Lab, Boulder, CO 80305 USA.	martin.hoerling@noaa.gov	Rajagopalan, Balaji/CAJ-3111-2022; BALAJI, RAJAGOPALAN/A-5383-2013	Rajagopalan, Balaji/0000-0002-6883-7240; BALAJI, RAJAGOPALAN/0000-0003-1433-7520; Cane, Mark/0000-0001-5408-2388				Annamalai H, 2005, Q J ROY METEOR SOC, V131, P805, DOI 10.1256/qj.04.08; Cane MA, 1997, SCIENCE, V275, P957, DOI 10.1126/science.275.5302.957; Gadgil S, 2005, CURR SCI INDIA, V88, P1389; Gadgil S, 2002, CURR SCI INDIA, V83, P394; Gadgil S, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019733; Goswami BN, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023216; Hastenrath S, 1991, CLIMATE DYNAMICS TRO, DOI DOI 10.1007/978-94-011-3156-8; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 SCI; Krishna KK, 1995, WEATHER, V50, P449, DOI DOI 10.1002/j.1477-8696.1995.tb06071.x; Kumar KK, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021979; Kumar KK, 2004, INT J CLIMATOL, V24, P1375, DOI 10.1002/joc.1081; Kumar KK, 1999, SCIENCE, V284, P2156, DOI 10.1126/science.284.5423.2156; Philander S. G, 2004, OUR AFFAIR EL NINO; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43854; SHUKLA J, 1983, MON WEATHER REV, V111, P1830, DOI 10.1175/1520-0493(1983)111<1830:TSOALR>2.0.CO;2; Shukla J, 1987, MONSOONS; TRENBERTH K, 1993, P 18 ANN CLIM DIAGN, V50	18	535	543	6	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2006	314	5796					115	119		10.1126/science.1131152	http://dx.doi.org/10.1126/science.1131152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	16959975				2022-12-28	WOS:000241031200048
J	Dalmiya, N; Palmer, A; Darnton-Hill, I				Dalmiya, Nita; Palmer, Amanda; Darnton-Hill, Ian			Sustaining vitamin A supplementation requires a new vision	LANCET			English	Editorial Material									UNICEF, Nutr Sect, New York, NY 10017 USA	UNICEF	Dalmiya, N (corresponding author), UNICEF, Nutr Sect, New York, NY 10017 USA.	ndalmiya@unicef.org		Palmer, Amanda/0000-0002-3212-955X				BENDECH MA, 2005, SIGHT LIFE NEWSLETTE, V3, P42; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; *UNICEF, 2006, UNICEF JOINT HLTH NU; *UNICEF, 2006, MON SIT CHILDR WOM V; *UNICEF CAN, 2006, GLOB CHILD SURV HLTH; UNICEF data, 2006, PROGR CHILDR REP CAR; United Nations Childrens Fund (UNICEF), 1999, STAT WORLDS CHILDR 2	7	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 23	2006	368	9541					1052	1054		10.1016/S0140-6736(06)69336-7	http://dx.doi.org/10.1016/S0140-6736(06)69336-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089IC	16997651				2022-12-28	WOS:000240873000009
J	Lee, KH; Piao, HL; Kim, HY; Choi, SM; Jiang, F; Hartung, W; Hwang, I; Kwak, JM; Lee, IJ; Hwang, I				Lee, Kwang Hee; Piao, Hai Lan; Kim, Ho-Youn; Choi, Sang Mi; Jiang, Fan; Hartung, Wolfram; Hwang, Ildoo; Kwak, June M.; Lee, In-Jung; Hwang, Inhwan			Activation of glucosidase via stress-induced polymerization rapidly increases active pools of abscisic acid	CELL			English	Article							ZEAXANTHIN EPOXIDASE; ARABIDOPSIS-THALIANA; LOW-TEMPERATURE; GENE; BIOSYNTHESIS; IDENTIFICATION; RESPONSES; DROUGHT; PROTEIN; SALT	Abscisic acid (ABA) is a phytohormone critical for plant growth, development, and adaptation to various stress conditions. Plants have to adjust ABA levels constantly to respond to changing physiological and environmental conditions. To date, the mechanisms for fine-tuning ABA levels remain elusive. Here we report that AtBG1, a beta-glucosidase, hydrolyzes glucose-conjugated, biologically inactive ABA to produce active ABA. Loss of AtBG1 causes defective stomatal movement, early germination, abiotic stress-sensitive phenotypes, and lower ABA levels, whereas plants with ectopic AtBG1 accumulate higher ABA levels and display enhanced tolerance to abiotic stress. Dehydration rapidly induces polymerization of AtBG1, resulting in a 4-fold increase in enzymatic activity. Furthermore, diurnal increases in ABA levels are attributable to polymerization-mediated AtBG1 activation. We propose that the activation of inactive ABA pools by polymerized AtBG1 is a mechanism by which plants rapidly adjust ABA levels and respond to changing environmental cues.	Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea; Pohang Univ Sci & Technol, Ctr Plant Intracellular Trafficking, Pohang 790784, South Korea; Kyungpook Natl Univ, Coll Agr & Life Sci, Div Plant Biosci, Taegu 702701, South Korea; Univ Wurzburg, Julius von Sachs Inst Biowissensch, D-97082 Wurzburg, Germany; Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Kyungpook National University; University of Wurzburg; University System of Maryland; University of Maryland College Park	Hwang, I (corresponding author), Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea.	jhhwang@postech.ac.kr	Lee, In-Jung/GLS-0432-2022; Kwak, June M/G-8332-2011	Lee, In-Jung/0000-0001-7154-4820; Kwak, June M/0000-0001-6948-5155				Ali-Rachedi S, 2004, PLANTA, V219, P479, DOI 10.1007/s00425-004-1251-4; ALLAN AC, 1994, PLANT CELL, V6, P1319; ANDERSON BE, 1994, PLANT PHYSIOL, V104, P1177, DOI 10.1104/pp.104.4.1177; Audran C, 1998, PLANT PHYSIOL, V118, P1021, DOI 10.1104/pp.118.3.1021; BAIER M, 1988, J EXPT BOT, V41, P351; BANOWETZ GM, 1994, HYBRIDOMA, V13, P537, DOI 10.1089/hyb.1994.13.537; Chiwocha SDS, 2005, PLANT J, V42, P35, DOI 10.1111/j.1365-313X.2005.02359.x; Cutler AJ, 1999, TRENDS PLANT SCI, V4, P472, DOI 10.1016/S1360-1385(99)01497-1; Cutler Paul, 2004, Methods Mol Biol, V244, P167; Dietz KJ, 2000, J EXP BOT, V51, P937, DOI 10.1093/jexbot/51.346.937; GAMBLE PE, 1986, EUR J BIOCHEM, V160, P117, DOI 10.1111/j.1432-1033.1986.tb09947.x; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; Hartung W, 2002, J EXP BOT, V53, P27, DOI 10.1093/jexbot/53.366.27; Himmelbach A, 2003, CURR OPIN PLANT BIOL, V6, P470, DOI 10.1016/S1369-5266(03)00090-6; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Iuchi S, 2000, PLANT PHYSIOL, V123, P553, DOI 10.1104/pp.123.2.553; Jin JB, 2001, PLANT CELL, V13, P1511, DOI 10.1105/tpc.13.7.1511; Kim YW, 1998, BBA-PROTEIN STRUCT M, V1388, P457, DOI 10.1016/S0167-4838(98)00209-X; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; KUZNETSOV G, 1993, J BIOL CHEM, V268, P2001; LeonKloosterziel KM, 1996, PLANT PHYSIOL, V110, P233, DOI 10.1104/pp.110.1.233; Levchenko V, 2005, P NATL ACAD SCI USA, V102, P4203, DOI 10.1073/pnas.0500146102; Marana SR, 2001, BBA-PROTEIN STRUCT M, V1545, P41, DOI 10.1016/S0167-4838(00)00260-0; Marin E, 1996, EMBO J, V15, P2331, DOI 10.1002/j.1460-2075.1996.tb00589.x; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Park M, 2004, PLANT PHYSIOL, V134, P625, DOI 10.1104/pp.103.030635; Pih KT, 1997, MOL CELLS, V7, P567; Qin XQ, 1999, P NATL ACAD SCI USA, V96, P15354, DOI 10.1073/pnas.96.26.15354; ROCK CD, 1991, P NATL ACAD SCI USA, V88, P7496, DOI 10.1073/pnas.88.17.7496; Sauter A, 2002, PLANT CELL ENVIRON, V25, P223, DOI 10.1046/j.1365-3040.2002.00747.x; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; Seo M, 2000, PLANT J, V23, P481, DOI 10.1046/j.1365-313x.2000.00812.x; Seo M, 2002, TRENDS PLANT SCI, V7, P41, DOI 10.1016/S1360-1385(01)02187-2; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Takeuchi M, 2000, PLANT J, V23, P517, DOI 10.1046/j.1365-313x.2000.00823.x; Tan BC, 1997, P NATL ACAD SCI USA, V94, P12235, DOI 10.1073/pnas.94.22.12235; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Wilkinson S, 2002, PLANT CELL ENVIRON, V25, P195, DOI 10.1046/j.0016-8025.2001.00824.x; Xu ZJ, 2002, PLANT PHYSIOL, V129, P1285, DOI 10.1104/pp.001784; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; ZEEVAART JAD, 1999, BIOCH MOL BIOL PLANT, P189; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	44	461	501	6	118	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 22	2006	126	6					1109	1120		10.1016/j.cell.2006.07.034	http://dx.doi.org/10.1016/j.cell.2006.07.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990135	Bronze			2022-12-28	WOS:000240897600017
J	Leake, MC; Chandler, JH; Wadhams, GH; Bai, F; Berry, RM; Armitage, JP				Leake, Mark C.; Chandler, Jennifer H.; Wadhams, George H.; Bai, Fan; Berry, Richard M.; Armitage, Judith P.			Stoichiometry and turnover in single, functioning membrane protein complexes	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; ESCHERICHIA-COLI; FLAGELLAR MOTOR; BACTERIAL FLAGELLA; GENERATING UNITS; PLASMA-MEMBRANE; ROTARY MOTOR; LIVING CELLS; MOLECULES; DYNAMICS	Many essential cellular processes are carried out by complex biological machines located in the cell membrane. The bacterial flagellar motor is a large membrane-spanning protein complex that functions as an ion-driven rotary motor to propel cells through liquid media(1-3). Within the motor, MotB is a component of the stator that couples ion flow to torque generation and anchors the stator to the cell wall(4,5). Here we have investigated the protein stoichiometry, dynamics and turnover of MotB with single-molecule precision in functioning bacterial flagellar motors in Escherichia coli. We monitored motor function by rotation of a tethered cell body(6), and simultaneously measured the number and dynamics of MotB molecules labelled with green fluorescent protein (GFP - MotB) in the motor by total internal reflection fluorescence microscopy. Counting fluorophores by the stepwise photobleaching of single GFP molecules showed that each motor contains similar to 22 copies of GFP - MotB, consistent with similar to 11 stators each containing two MotB molecules. We also observed a membrane pool of similar to 200 GFP - MotB molecules diffusing at similar to 0.008 mu m(2) s(-1). Fluorescence recovery after photobleaching and fluorescence loss in photobleaching showed turnover of GFP MotB between the membrane pool and motor with a rate constant of the order of 0.04 s(-1): the dwell time of a given stator in the motor is only similar to 0.5 min. This is the first direct measurement of the number and rapid turnover of protein subunits within a functioning molecular machine.	Univ Oxford, Dept Biochem, Microbiol Unit, Oxford OX1 3QU, England; Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England	University of Oxford; University of Oxford	Armitage, JP (corresponding author), Univ Oxford, Dept Biochem, Microbiol Unit, S Parks Rd, Oxford OX1 3QU, England.	judith.armitage@bioch.ox.ac.uk	Leake, Mark/C-1245-2011	Leake, Mark/0000-0002-1715-1249; Bai, Fan/0000-0001-6119-8936	Engineering and Physical Sciences Research Council [GR/R45659/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Berry RM, 1999, ADV MICROB PHYSIOL, V41, P291, DOI 10.1016/S0065-2911(08)60169-1; BERRY RM, 1995, BIOPHYS J, V69, P280, DOI 10.1016/S0006-3495(95)79900-3; BLAIR DF, 1988, SCIENCE, V242, P1678, DOI 10.1126/science.2849208; BLOCK SM, 1984, NATURE, V309, P470, DOI 10.1038/309470a0; Chu S, 2003, PHILOS T R SOC A, V361, P689, DOI 10.1098/rsta.2002.1157; Deich J, 2004, P NATL ACAD SCI USA, V101, P15921, DOI 10.1073/pnas.0404200101; DEMOT R, 1994, MOL MICROBIOL, V12, P333; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Goodwin JS, 2005, METHODS, V37, P154, DOI 10.1016/j.ymeth.2005.05.013; KHAN S, 1988, J MOL BIOL, V202, P575, DOI 10.1016/0022-2836(88)90287-2; Kojima S, 2004, BIOCHEMISTRY-US, V43, P26, DOI 10.1021/bi035405l; Leake MC, 2004, BIOPHYS J, V87, P1112, DOI 10.1529/biophysj.103.033571; Macnab R., 1996, ESCHERICHIA COLI SAL, V2nd ed, P119; Mashanov GI, 2004, J BIOL CHEM, V279, P15274, DOI 10.1074/jbc.M312140200; Mashanov GI, 2003, METHODS, V29, P142, DOI 10.1016/S1046-2023(02)00305-5; Mullineaux CW, 2006, J BACTERIOL, V188, P3442, DOI 10.1128/JB.188.10.3442-3448.2006; Mullineaux CW, 2002, TRENDS PLANT SCI, V7, P237, DOI 10.1016/S1360-1385(02)02283-5; Ray N, 2005, J BIOL CHEM, V280, P17961, DOI 10.1074/jbc.M413521200; Reid SW, 2006, P NATL ACAD SCI USA, V103, P8066, DOI 10.1073/pnas.0509932103; SILVERMAN M, 1974, NATURE, V249, P73, DOI 10.1038/249073a0; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; Sowa Y, 2005, NATURE, V437, P916, DOI 10.1038/nature04003; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; Van Way SM, 2000, J MOL BIOL, V297, P7, DOI 10.1006/jmbi.2000.3548	27	426	432	0	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2006	443	7109					355	358		10.1038/nature05135	http://dx.doi.org/10.1038/nature05135			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085RL	16971952				2022-12-28	WOS:000240622000050
J	Lazare, A				Lazare, Aaron			Apology in medical practice - An emerging clinical skill	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Massachusetts, Sch Med, Off Chancellor, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Lazare, A (corresponding author), Univ Massachusetts, Sch Med, Off Chancellor, 55 Lake Ave N, Worcester, MA 01655 USA.	aaron.azare@umassmed.edu						Barkan E., 2000, GUILT NATIONS RESTIT; DEWAAL F, 1999, PEACE MAKING PRIMATE, P43; ETZIIONI A, 1997, REPENTANCE COMP PERS; Frazer J., 1922, GOLDEN BOUGH STUDY M; Gertner Reni, 2005, ST LOUIS DAILY  1222; Homer Robert., 1974, ILIAD; *JOINT COMM ACCR H, 2001, RI122 JOINT COMM ACC; Kohn KT, 1999, ERR IS HUMAN BUILDIN; Kowalczyk L., 2005, BOSTON GLOBE    0724, pA1; Lazare, 2004, APOLOGY; LAZARE A, 1987, ARCH INTERN MED, V147, P1653, DOI 10.1001/archinte.147.9.1653; LAZARE A, 1995, MED INTERVIEW CLIN C; LEAPE LL, 2004, FOCUS PATIENT SAFETY, V8, P1; Mazor KM, 2004, ANN INTERN MED, V140, P409, DOI 10.7326/0003-4819-140-6-200403160-00006; SHAPIRO J, 2000, US NEWS ONLINE  0717; Taft L, 2000, YALE LAW J, V109, P1135, DOI 10.2307/797485; Taft L., 2005, ANN HLTH LAW, V14, P55; TAVUCHIS N, 1991, MEA CLUPA SOCIOLOGY; Woods M. S., 2004, HEALING WORDS POWER; Zimmerman Rachel, 2004, WALL STREET J, pA1	20	86	86	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2006	296	11					1401	1404		10.1001/jama.296.11.1401	http://dx.doi.org/10.1001/jama.296.11.1401			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085HS	16985235				2022-12-28	WOS:000240595800030
J	Hsu, SD; Chou, SJ; Hsieh, HF; Yu, JC				Hsu, Sheng-Der; Chou, Shao-Jiun; Hsieh, Huan-Fa; Yu, Jyh-Cherng			A case of breast carcinoma, chemotherapy, and acute appendicitis	LANCET			English	Editorial Material							THERAPY		Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan; Cardinal Tien Hosp, Dept Surg, Taipei, Taiwan; Yee Zen Gen Hosp, Dept Surg, Tayuan, Taiwan	National Defense Medical Center; Tri-Service General Hospital	Hsieh, HF (corresponding author), Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan.	doc20106@ndmctsgh.edu.tw		Hsu, Sheng-Der/0000-0001-9698-8954				Coleman RE, 2003, CANCER-AM CANCER SOC, V97, P880, DOI 10.1002/cncr.11124; DAVID SW, 1992, CANCER, V69, P17; JOHN MS, 1987, ANN SURG, V206, P711; SHERMAN NJ, 1973, ARCH SURG-CHICAGO, V107, P39; YATES J, 1982, BLOOD, V60, P454	5	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 16	2006	368	9540					1038	1038		10.1016/S0140-6736(06)69419-1	http://dx.doi.org/10.1016/S0140-6736(06)69419-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	086UO	16980121				2022-12-28	WOS:000240698700034
J	Navarro, V; Muntaner, C; Borrell, C; Benach, J; Quiroga, A; Rodriguez-Sanz, M; Verges, N; Pasarin, MI				Navarro, Vicente; Muntaner, Carles; Borrell, Carme; Benach, Joan; Quiroga, Agueda; Rodriguez-Sanz, Maica; Verges, Nuria; Pasarin, M. Isabel			Politics and health outcomes	LANCET			English	Article							12 OECD COUNTRIES; WELFARE-STATE; INEQUALITIES; SERVICES	The aim of this study was to examine the complex interactions between political traditions, policies, and public health outcomes, and to find out whether different political traditions have been associated with systematic patterns in population health over time. We analysed a number of political, economic, social, and health variables over a 50-year period, in a set of wealthy countries belonging to the Organisation for Economic Co-operation and Development (OECD). Our findings support the hypothesis that the political ideologies of governing parties affect some indicators of population health. Our analysis makes an empirical link between politics and policy, by showing that political parties with egalitarian ideologies tend to implement redistributive policies. An important finding of our research is that policies aimed at reducing social inequalities, such as welfare state and labour market policies, do seem to have a salutary effect on the selected health indicators, infant mortality and life expectancy at birth.	Johns Hopkins Univ, Baltimore, MD 21218 USA; Ctr Addict & Mental Hlth, Toronto, ON, Canada; Univ Toronto, Toronto, ON, Canada; Pompeu Fabra Univ, Barcelona, Spain; Agencia Salut Publ Barcelona, Barcelona, Spain; Univ Maryland, College Pk, MD 20742 USA	Johns Hopkins University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; Pompeu Fabra University; Public Health Agency of Barcelona; University System of Maryland; University of Maryland College Park	Navarro, V (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.	vnavarro@jhsph.edu	Muntaner, C/A-5043-2010; Benach, Joan/H-2519-2013; Bosch, Núria Vergés/D-4417-2014; Navarro, Vicente/E-8174-2014; Vergés Bosch, Núria/AAZ-7633-2021	Benach, Joan/0000-0003-2285-742X; Bosch, Núria Vergés/0000-0001-8010-7809; Navarro, Vicente/0000-0002-3310-3984; Vergés Bosch, Núria/0000-0001-8010-7809; Borrell, Carme/0000-0002-1170-2505				Bambra C, 2005, J SOC POLICY, V34, P195, DOI 10.1017/S0047279404008542; Caramani D., 2000, SOC EUROPE ELECTIONS; Conceicao P, 2000, YOUNG PERSONS GUIDE; Esping-Andersen G., 1990, 3 WORLDS WELFARE CAP; HELMERT U, 2004, POLITICAL SOCIAL CON, P147; Huber E., 2001, CONT SOCIOLOGY; Huber Evelyne, 1997, COMP WELFARE STATES; *INT LAB ORG, BUR STAT ILOLABORSTA; Korpi W, 2001, RATION SOC, V13, P235, DOI 10.1177/104346301013002005; Korpi W, 2000, SOC POLIT, V7, P127, DOI 10.1093/sp/7.2.127; *LUX INC STUD, LUX INC STUD DAT; Muller WC., 2000, COALITION GOVT W EUR; Navarro V, 2001, INT J HEALTH SERV, V31, P1, DOI 10.2190/1GY8-V5QN-A1TA-A9KJ; NAVARRO V, 1989, INT J HEALTH SERV, V19, P383, DOI 10.2190/A767-1TBY-MCBH-9170; Navarro V., 2002, POLITICAL EC SOCIAL; Navarro V., 2004, POLITICAL EC DETERMI; Navarro V.., 2004, POLITICAL SOCIAL CON; *ORG EC COOP DEV, 2000, OECD HLTH DAT 2000; Raphael D, 2004, HEALTH POLICY, V68, P63, DOI 10.1016/j.healthpol.2003.08.003; SAEZ MA, 2000, SISTEMAS POLITICOS U; van Doorslaer E, 1999, J HEALTH ECON, V18, P291, DOI 10.1016/S0167-6296(98)00043-5; Wagstaff A, 1999, J PUBLIC ECON, V72, P73, DOI 10.1016/S0047-2727(98)00085-1	22	330	334	1	76	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 16	2006	368	9540					1033	1037		10.1016/S0140-6736(06)69341-0	http://dx.doi.org/10.1016/S0140-6736(06)69341-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	086UO	16980120				2022-12-28	WOS:000240698700033
J	Brasaemle, DL				Brasaemle, Dawn L.			A metabolic push to proliferate	SCIENCE			English	Editorial Material							LIPID BODIES; CHOLESTEROL; CAVEOLIN		Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Brasaemle, DL (corresponding author), Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA.	brasaemle@aesop.rutgers.edu						Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Ehehalt R, 2006, MOL CELL BIOCHEM, V284, P135, DOI 10.1007/s11010-005-9034-1; Farrell GC, 2004, HEPATOLOGY, V40, P1252, DOI 10.1002/hep.20522; Fernandez MA, 2006, SCIENCE, V313, P1628, DOI 10.1126/science.1130773; Martin S, 2005, SEMIN CELL DEV BIOL, V16, P163, DOI 10.1016/j.semcdb.2005.01.007; Mashek DG, 2006, CURR OPIN LIPIDOL, V17, P274, DOI 10.1097/01.mol.0000226119.20307.2b; Meshulam T, 2006, BIOCHEMISTRY-US, V45, P2882, DOI 10.1021/bi051999b; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; Shteyer E, 2004, HEPATOLOGY, V40, P1322, DOI 10.1002/hep.20462	9	26	26	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2006	313	5793					1581	1582		10.1126/science.1133253	http://dx.doi.org/10.1126/science.1133253			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083YS	16973864				2022-12-28	WOS:000240498900027
J	Efeyan, A; Garcia-Cao, I; Herranz, D; Velasco-Miguel, S; Serrano, M				Efeyan, Alejo; Garcia-Cao, Isabel; Herranz, Daniel; Velasco-Miguel, Susana; Serrano, Manuel			Policing of oncogene activity by p53	NATURE			English	Article							TUMOR-SUPPRESSOR; P19(ARF); LOCUS; PRODUCT		Spanish Natl Canc Ctr, Madrid 28029, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Efeyan, A (corresponding author), Spanish Natl Canc Ctr, Madrid 28029, Spain.	mserrano@cnio.es	Herranz, Daniel/L-6986-2017; Herranz, Daniel/D-8121-2011; Efeyan, Alejo/J-8197-2016; Serrano, Manuel/H-2634-2015	Herranz, Daniel/0000-0003-1768-5969; Efeyan, Alejo/0000-0002-3806-6799; Serrano, Manuel/0000-0001-7177-9312				Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Kamijo T, 1999, CANCER RES, V59, P2464; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	10	100	102	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2006	443	7108					159	159		10.1038/443159a	http://dx.doi.org/10.1038/443159a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16971940				2022-12-28	WOS:000240467000033
J	Gurnett, DA				Gurnett, Donald A.			James A. Van Allen (1914-2006) - Obituary	NATURE			English	Biographical-Item									Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA	University of Iowa	Gurnett, DA (corresponding author), Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA.	donald-gurnett@uiowa.edu						VANALLEN JA, PUBLICATION LIST	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2006	443	7108					158	158		10.1038/443158a	http://dx.doi.org/10.1038/443158a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16971938	Bronze			2022-12-28	WOS:000240467000032
J	Laarman, GJ; Suttorp, MJ; Dirksen, MT; van Heerebeek, L; Kiemeneij, F; Slagboom, T; van der Wieken, LR; Tijssen, JGP; Rensing, BJ; Patterson, M				Laarman, Gerrit J.; Suttorp, Maarten J.; Dirksen, Maurits T.; van Heerebeek, Loek; Kiemeneij, Ferdinand; Slagboom, Ton; van der Wieken, L. Ron; Tijssen, Jan G. P.; Rensing, Benno J.; Patterson, Mark			Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; INTRAVENOUS THROMBOLYTIC THERAPY; PRIMARY ANGIOPLASTY; IMPLANTATION; BENEFIT; TERM	BACKGROUND: Drug-eluting coronary-artery stents have been shown to decrease restenosis and therefore the likelihood that additional procedures will be required after percutaneous coronary intervention (PCI). We evaluated the use of a drug-eluting stent in patients undergoing PCI for acute myocardial infarction with ST-segment elevation. METHODS: We randomly assigned 619 patients presenting with an acute myocardial infarction with ST-segment elevation to receive either a paclitaxel-eluting stent or an uncoated stent. The primary end point was a composite of death from cardiac causes, recurrent myocardial infarction, or target-lesion revascularization at 1 year. RESULTS: Baseline clinical and angiographic characteristics in both groups were well matched. There was a trend toward a lower rate of serious adverse events in the paclitaxel-stent group than in the uncoated-stent group (8.8% vs. 12.8%; adjusted relative risk, 0.63; 95% confidence interval, 0.37 to 1.07; P=0.09). A nonsignificant trend was also detected in favor of the paclitaxel-stent group, as compared with the uncoated-stent group, in the rate of death from cardiac causes or recurrent myocardial infarction (5.5% vs. 7.2%, P=0.40) and in the rate of target-lesion revascularization (5.3% vs. 7.8%, P=0.23). The incidence of stent thrombosis during 1 year of follow-up was the same in both groups (1.0%). CONCLUSIONS: Although the use of paclitaxel-eluting stents in acute myocardial infarction with ST-segment elevation reduced the incidence of serious adverse cardiac events at 1 year by 4.0 percentage points, as compared with uncoated stents, the difference was not statistically significant.	Onze Lieve Vrouw Hosp, Dept Intervent Cardiol, NL-1090 HM Amsterdam, Netherlands; St Antonius Hosp, Dept Intervent Cardiol, Nieuwegein, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands	Onze Lieve Vrouwe Gasthuis Hospital; St. Antonius Hospital Utrecht; University of Amsterdam; Academic Medical Center Amsterdam	Laarman, GJ (corresponding author), Onze Lieve Vrouw Hosp, Dept Intervent Cardiol, Oosterpk 9, NL-1090 HM Amsterdam, Netherlands.	g.j.laarman@olvg.nl						Betriu A, 1997, NEW ENGL J MED, V336, P1621; Betriu A, 1997, NEW ENGL J MED, V337, P287; Boersma E, 2006, EUR HEART J, V27, P779, DOI 10.1093/eurheartj/ehi810; Cheneau E, 2005, CATHETER CARDIO INTE, V65, P469, DOI 10.1002/ccd.20395; Colombo A, 2003, CIRCULATION, V108, P788, DOI 10.1161/01.CIR.0000086926.62288.A6; Grines CL, 1999, NEW ENGL J MED, V341, P1949, DOI 10.1056/NEJM199912233412601; Hofma SH, 2005, HEART, V91, P1176, DOI 10.1136/hrt.2005.064519; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Lemos PA, 2004, J AM COLL CARDIOL, V43, P704, DOI 10.1016/j.jacc.2003.12.022; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; PASSAMANI E, 1985, NEW ENGL J MED, V312, P932; PFISTERER ME, 2006, 55 ANN SCI SESS AM C; Saia F, 2003, CIRCULATION, V108, P1927, DOI 10.1161/01.CIR.0000096053.87580.CD; Spaulding C, 2006, NEW ENGL J MED, V355, P1093, DOI 10.1056/NEJMoa062006; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Valgimigli M, 2005, JAMA-J AM MED ASSOC, V293, P2109, DOI 10.1001/jama.293.17.2109; Weaver WD, 1997, JAMA-J AM MED ASSOC, V278, P2093, DOI 10.1001/jama.278.23.2093; Weaver WD, 1998, JAMA-J AM MED ASSOC, V279, P1876; Zhu MM, 2001, AM J CARDIOL, V88, P297, DOI 10.1016/S0002-9149(01)01645-9; Zijlstra F, 1999, NEW ENGL J MED, V341, P1413, DOI 10.1056/NEJM199911043411901	21	341	367	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 14	2006	355	11					1105	1113		10.1056/NEJMoa062598	http://dx.doi.org/10.1056/NEJMoa062598			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083NJ	16971717				2022-12-28	WOS:000240462800005
J	Benjamin, DK; Smith, PB; Murphy, MD; Roberts, R; Mathis, L; Avant, D; Califf, RM; Li, JS				Benjamin, Daniel K., Jr.; Smith, Philip Brian; Murphy, M. Dianne; Roberts, Rosemary; Mathis, Lisa; Avant, Debbie; Califf, Robert M.; Li, Jennifer S.			Peer-reviewed publication of clinical trials completed for pediatric exclusivity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; PLASMODIUM-FALCIPARUM MALARIA; JUVENILE RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; OPEN-LABEL; CHILDREN; ADOLESCENTS; EFFICACY; PHARMACOKINETICS; ATOVAQUONE	Context Much of pediatric drug use is off-label because appropriate pediatric studies have not been conducted and the drugs have not been labeled by the US Food and Drug Administration (FDA) for use in children. In 1997, Congress authorized the FDA to grant extensions of marketing rights known as "pediatric exclusivity" if FDA-requested pediatric trials were conducted. As a result, there have been over 100 product labeling changes. The publication status of studies completed for pediatric exclusivity has not been evaluated. Objective To quantify the dissemination of results of studies conducted for pediatric exclusivity into the peer-review literature. Design Cohort study of all trials conducted for pediatric exclusivity between 1998 and 2004 as determined by MEDLINE and EMBASE searches through 2005, the subsequent labeling changes, and the publication of those studies in peer-reviewed journals. We categorized any labeling changes resulting from the studies as positive or negative for the drug under study. We then evaluated aspects of the studies and product label changes that were associated with subsequent publication in peer-reviewed medical journals. Main Outcome Measures Publication of the trial data in peer-reviewed journals. Results Between 1998 and 2004, 253 studies were submitted to the FDA for pediatric exclusivity: 125 (50%) evaluated efficacy, 51 (20%) were multi-dose pharmacokinetic, 34 (13%) were single-dose pharmacokinetic, and 43 (17%) were safety studies. Labeling changes were positive for 127/253 (50%) of studies; only 113/253 (45%) were published. Efficacy studies and those with a positive labeling change were more likely to be published. Conclusions The pediatric exclusivity program has been successful in encouraging drug studies in children. However, the dissemination of these results in the peer-reviewed literature is limited. Mechanisms to more widely disperse this information through publication warrant further evaluation.	Duke Univ, Duke Clin Res Inst, Durham, NC 27705 USA; Duke Univ, Dept Pediat, Durham, NC 27705 USA; Duke Univ, Dept Med, Durham, NC 27705 USA; US FDA, Ctr Drug Evaluat & Res, Off Counter Terrorism & Pediat Drug Dev, Rockville, MD 20857 USA; US FDA, Ctr Drug Evaluat & Res, Off Commissioner, Rockville, MD 20857 USA; US FDA, Ctr Drug Evaluat & Res, Off Pediat Therapeut, Rockville, MD 20857 USA	Duke University; Duke University; Duke University; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Benjamin, DK (corresponding author), Duke Univ, Duke Clin Res Inst, POB 17969, Durham, NC 27705 USA.	danny.benjamin@duke.edu	Smith, Phillip B/I-5565-2014		NICHD NIH HHS [U10 HD045962-04, 1U10-HD45962-03, U10 HD045962] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD045962] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		*AAMC EX COMM, 2005, PRINC PROT INT COND; Anabwani G, 1999, PEDIATR INFECT DIS J, V18, P456, DOI 10.1097/00006454-199905000-00011; Bhandari M, 2004, CAN MED ASSOC J, V170, P477; Camus D, 2004, CLIN INFECT DIS, V38, P1716, DOI 10.1086/421086; Dickersin K, 2003, JAMA-J AM MED ASSOC, V290, P516, DOI 10.1001/jama.290.4.516; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Emslie G J, 1998, Depress Anxiety, V7, P32, DOI 10.1002/(SICI)1520-6394(1998)7:1<32::AID-DA4>3.0.CO;2-7; Emslie GJ, 2002, J AM ACAD CHILD PSY, V41, P1205, DOI 10.1097/00004583-200210000-00010; Faucher JF, 2002, CLIN INFECT DIS, V35, P1147, DOI 10.1086/342908; Findling RL, 2000, J AM ACAD CHILD PSY, V39, P1008, DOI 10.1097/00004583-200008000-00016; Foster KW, 2005, J AM ACAD DERMATOL, V53, P798, DOI 10.1016/j.jaad.2005.07.028; Geller DA, 2001, J AM ACAD CHILD PSY, V40, P773, DOI 10.1097/00004583-200107000-00011; Haidich AB, 2001, AM J EPIDEMIOL, V154, P873, DOI 10.1093/aje/154.9.873; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Lell B, 1998, LANCET, V351, P709, DOI 10.1016/S0140-6736(97)09222-2; *MCKESS PHARM SYST, DRUGT; Michelson D, 2002, AM J PSYCHIAT, V159, P1896, DOI 10.1176/appi.ajp.159.11.1896; Michelson D, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e83; *NIH, WORLD MED ASS DECL H; NIH, BELM REP ETH PRINC G; Olson CM, 2002, JAMA-J AM MED ASSOC, V287, P2825, DOI 10.1001/jama.287.21.2825; Papanikolaou PN, 2004, AM J MED, V117, P582, DOI 10.1016/j.amjmed.2004.04.026; Roberts R, 2003, JAMA-J AM MED ASSOC, V290, P905, DOI 10.1001/jama.290.7.905; Rongkavilit C, 2001, ANTIMICROB AGENTS CH, V45, P3585, DOI 10.1128/AAC.45.12.3585-3590.2001; Sabchareon A, 1998, T ROY SOC TROP MED H, V92, P201, DOI 10.1016/S0035-9203(98)90749-0; Silverman E, 2005, NEW ENGL J MED, V352, P1655, DOI 10.1056/NEJMoa041810; Silverman E, 2005, ARTHRITIS RHEUM-US, V52, P554, DOI 10.1002/art.20861; Sorof JM, 2002, PEDIATR NEPHROL, V17, P345, DOI 10.1007/s00467-002-0851-0; Spencer T, 2002, J CLIN PSYCHIAT, V63, P1140, DOI 10.4088/JCP.v63n1209; Steinherz PG, 2002, LEUKEMIA LYMPHOMA, V43, P1945, DOI 10.1080/1042819021000015880; Wilens TE, 2002, J CLIN PSYCHOPHARM, V22, P568, DOI 10.1097/00004714-200212000-00006; Wilson JT, 1975, BASIC THERAPEUTIC AS, P411; Winner P, 2000, PEDIATRICS, V106, P989, DOI 10.1542/peds.106.5.989; WOLF AR, 2004, PEDIAT ANESTESIA, V14, P505; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234; 2001, PUBLIC CITIZENS PATE	37	111	112	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2006	296	10					1266	1273		10.1001/jama.296.10.1266	http://dx.doi.org/10.1001/jama.296.10.1266			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083EA	16968851	Green Accepted			2022-12-28	WOS:000240437500029
J	Okin, PM; Wachtell, K; Devereux, RB; Harris, KE; Jern, S; Kjeldsen, SE; Julius, S; Lindholm, LH; Nieminen, MS; Edelman, JM; Hille, DA; Dahlof, B				Okin, Peter M.; Wachtell, Kristian; Devereux, Richard B.; Harris, Katherine E.; Jern, Sverker; Kjeldsen, Sverre E.; Julius, Stevo; Lindholm, Lars H.; Nieminen, Markku S.; Edelman, Jonathan M.; Hille, Darcy A.; Dahloef, Bjoern			Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							END-POINT REDUCTION; LOSARTAN INTERVENTION; RISK-FACTORS; RHYTHM CONTROL; HEART-FAILURE; LIFE; STROKE; ATENOLOL; PREDICTORS; PREVENTION	Context Atrial fibrillation (AF) is associated with increased risk of mortality and cardiovascular events, particularly stroke, making prevention of new-onset AF a clinical priority. Although the presence and severity of electrocardiographic left ventricular hypertrophy (LVH) appear to predict development of AF, whether regression of electrocardiographic LVH is associated with a decreased incidence of AF is unclear. Objective To test the hypothesis that in-treatment regression or continued absence of electrocardiographic LVH during antihypertensive therapy is associated with a decreased incidence of AF, independent of blood pressure and treatment modality. Design, Setting, and Participants Double-blind, randomized, parallel-group study conducted in 1995-2001 among 8831 men and women with hypertension, aged 55-80 years (median, 67 years), with electrocardiographic LVH by Cornell voltage-duration product or Sokolow-Lyon voltage, with no history of AF, without AF on the baseline electrocardiogram, and enrolled in the Losartan Intervention for Endpoint Reduction in Hypertension Study. Interventions Losartan-or atenolol-based treatment regimens, with follow-up assessments at 6 months and then yearly until death or study end. Main Outcome Measure New-onset AF in relation to electrocardiographic LVH determined at baseline and subsequently. Electrocardiographic LVH was measured using sex-adjusted Cornell product criteria ({R-aVL + S-V3 [+6 mm in women]} X QRS duration). Results After a mean (SD) follow-up of 4.7 (1.1) years, new-onset AF occurred in 290 patients with in-treatment regression or continued absence of Cornell product LVH for a rate of 14.9 per 1000 patient-years and in 411 patients with in-treatment persistence or development of LVH by Cornell product criteria for a rate of 19.0 per 1000 patient-years. In time-dependent Cox analyses adjusted for treatment effects, baseline differences in risk factors for AF, baseline and in-treatment blood pressure, and baseline severity of electrocardiographic LVH, lower in-treatment Cornell product LVH treated as a time-varying covariate was associated with a 12.4% lower rate of new-onset AF (adjusted hazard ratio [HR], 0.88; 95% CI, 0.80-0.97; P = .007) for every 1050 mm X msec (per 1-SD) lower Cornell product, with persistence of the benefit of losartan vs atenolol therapy on developing AF (HR, 0.83; 95% CI, 0.71-0.97; P = .01). Conclusions Lower Cornell product electrocardiographic LVH during antihypertensive therapy is associated with a lower likelihood of new-onset AF, independent of blood pressure lowering and treatment modality in essential hypertension. These findings suggest that antihypertensive therapy targeted at regression or prevention of electrocardiographic LVH may reduce the incidence of new-onset AF.	Cornell Univ, Weill Med Coll, Greenberg Div Cardiol, New York, NY 10021 USA; Glostrup Univ Hosp, Dept Med, Glostrup, Denmark; Merck Res Labs, West Point, PA USA; Sahlgrens Univ Hosp, Gothenburg, Sweden; Univ Oslo, Ulleval Hosp, Oslo, Norway; Univ Michigan, Med Ctr, Ann Arbor, MI USA; Umea Univ, Umea, Sweden; Univ Helsinki, Cent Hosp, Dept Med, Div Cardiol, Helsinki, Finland; Merck & Co Inc, Whitehouse Stn, NJ USA	Cornell University; University of Copenhagen; Merck & Company; Sahlgrenska University Hospital; University of Oslo; University of Michigan System; University of Michigan; Umea University; University of Helsinki; Helsinki University Central Hospital; Merck & Company	Okin, PM (corresponding author), Cornell Univ, Weill Med Coll, Greenberg Div Cardiol, 525 E 68th St, New York, NY 10021 USA.	pokin@med.cornell.edu						Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; COX DR, 1972, J R STAT SOC B, V34, P187; Dahlof B, 1997, AM J HYPERTENS, V10, P705; Dahlof B, 2004, J HUM HYPERTENS, V18, P367, DOI 10.1038/sj.jhh.1001710; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Dahlof B, 1998, HYPERTENSION, V32, P989, DOI 10.1161/01.HYP.32.6.989; DAVIS CE, 1976, AM J EPIDEMIOL, V104, P493, DOI 10.1093/oxfordjournals.aje.a112321; Gerdts E, 2002, HYPERTENSION, V39, P739, DOI 10.1161/hy0302.105683; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Healey JS, 2005, J AM COLL CARDIOL, V45, P1832, DOI 10.1016/j.jacc.2004.11.070; Herweg B, 2005, J CARDIOVASC ELECTR, V16, P2, DOI 10.1046/j.1540-8167.2005.04283.x; Huang JL, 2003, BASIC RES CARDIOL, V98, P16, DOI 10.1007/s00395-003-0385-z; Hylck EM, 2000, ARCH INTERN MED, V160, P1612, DOI 10.1001/archinte.160.11.1612; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Maggioni AP, 2005, AM HEART J, V149, P548, DOI 10.1016/j.ahj.2004.09.033; Marini C, 2005, STROKE, V36, P1115, DOI 10.1161/01.STR.0000166053.83476.4a; MOLLOY TJ, 1992, J AM COLL CARDIOL, V20, P1180, DOI 10.1016/0735-1097(92)90376-X; Okin PM, 2003, CIRCULATION, V108, P684, DOI 10.1161/01.CIR.0000083724.28630.C3; Okin PM, 2004, JAMA-J AM MED ASSOC, V292, P2343, DOI 10.1001/jama.292.19.2343; OKIN PM, 1995, J AM COLL CARDIOL, V25, P417, DOI 10.1016/0735-1097(94)00371-V; Psaty BM, 1997, CIRCULATION, V96, P2455; Snapinn SM, 2005, AM STAT, V59, P301, DOI 10.1198/000313005X70371; SOKOLOW M, 1949, AM HEART J, V37, P161, DOI 10.1016/0002-8703(49)90562-1; Tsao HM, 2001, J CARDIOVASC ELECTR, V12, P809, DOI 10.1046/j.1540-8167.2001.00809.x; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724; Verdecchia P, 2003, HYPERTENSION, V41, P218, DOI 10.1161/01.HYP.0000052830.02773.E4; Vermes E, 2003, CIRCULATION, V107, P2926, DOI 10.1161/01.CIR.0000072793.81076.D4; Wachtell K, 2005, J AM COLL CARDIOL, V45, P712, DOI 10.1016/j.jacc.2004.10.068; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	34	211	222	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2006	296	10					1242	1248		10.1001/jama.296.10.1242	http://dx.doi.org/10.1001/jama.296.10.1242			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083EA	16968848	Bronze			2022-12-28	WOS:000240437500026
J	Hanawalt, PC				Hanawalt, Philip C.			Research collaborations: Trial, trust, and truth	CELL			English	Editorial Material								Successful advances in biomedical research increasingly require multigroup collaborations and publication of results in multiauthored papers. It is essential to consider at the outset how to maximize the value of such collaborations while avoiding potential pitfalls.	Stanford Univ, Dept Biol Sci, Stanford, CA 94306 USA	Stanford University	Hanawalt, PC (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94306 USA.	hanawalt@stanford.edu						Powell Kendall, 2006, Nature, V441, P122, DOI 10.1038/nj7089-122a; Shamoo A.E., 2003, RESPONSIBLE CONDUCT; STENECK NH, 2003, ORI INTRO RESPONSIBL	3	9	9	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 8	2006	126	5					823	825		10.1016/j.cell.2006.08.018	http://dx.doi.org/10.1016/j.cell.2006.08.018			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959557	Bronze			2022-12-28	WOS:000240675000005
J	Hof, B; Westerweel, J; Schneider, TM; Eckhardt, B				Hof, Bjoern; Westerweel, Jerry; Schneider, Tobias M.; Eckhardt, Bruno			Finite lifetime of turbulence in shear flows	NATURE			English	Article							PLANE COUETTE-FLOW; PIPE-FLOW; TRANSITION; REPELLERS	Generally, the motion of fluids is smooth and laminar at low speeds but becomes highly disordered and turbulent as the velocity increases. The transition from laminar to turbulent flow can involve a sequence of instabilities in which the system realizes progressively more complicated states(1), or it can occur suddenly(2,3). Once the transition has taken place, it is generally assumed that, under steady conditions, the turbulent state will persist indefinitely. The flow of a fluid down a straight pipe provides a ubiquitous example of a shear flow undergoing a sudden transition from laminar to turbulent motion(4-6). Extensive calculations(7,8) and experimental studies(9) have shown that, at relatively low flow rates, turbulence in pipes is transient, and is characterized by an exponential distribution of lifetimes. They(8,9) also suggest that for Reynolds numbers exceeding a critical value the lifetime diverges (that is, becomes infinitely large), marking a change from transient to persistent turbulence. Here we present experimental data and numerical calculations covering more than two decades of lifetimes, showing that the lifetime does not in fact diverge but rather increases exponentially with the Reynolds number. This implies that turbulence in pipes is only a transient event (contrary to the commonly accepted view), and that the turbulent and laminar states remain dynamically connected, suggesting avenues for turbulence control(10).	Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; Delft Univ Technol, Lab Aero & Hydrodynam, NL-2628 CA Delft, Netherlands; Univ Marburg, Fachbereich Phys, D-35032 Marburg, Germany	University of Manchester; Delft University of Technology; Philipps University Marburg	Hof, B (corresponding author), Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England.	bjorn@reynolds.ph.man.ac.uk; j.westerweel@tudelft.nl	Westerweel, Jerry/G-9087-2011; Eckhardt, Bruno/D-5948-2012; Schneider, Tobias/C-5797-2015	Eckhardt, Bruno/0000-0003-4050-3254; Schneider, Tobias/0000-0002-8617-8998; Westerweel, Jerry/0000-0002-2799-5242				Bottin S, 1998, EUR PHYS J B, V6, P143, DOI 10.1007/s100510050536; BROSA U, 1989, J STAT PHYS, V55, P1303, DOI 10.1007/BF01041090; Drazin P.G., 1982, HYDRODYNAMIC STABILI; Eckhardt B, 1999, PHYS REV E, V60, P509, DOI 10.1103/PhysRevE.60.509; ECKHARDT B, UNPUB ANN REV FLUID; Faisst H, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.224502; Faisst H, 2004, J FLUID MECH, V504, P343, DOI 10.1017/S0022112004008134; Grossmann S, 2000, REV MOD PHYS, V72, P603, DOI 10.1103/RevModPhys.72.603; Hof B, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.214502; Hof B, 2004, SCIENCE, V305, P1594, DOI 10.1126/science.1100393; HOF B, 2005, P IUTAM S LAM TURB T, P221; KADANOFF LP, 1984, P NATL ACAD SCI USA, V81, P1276, DOI 10.1073/pnas.81.4.1276; KANTZ H, 1985, PHYSICA D, V17, P75, DOI 10.1016/0167-2789(85)90135-6; Kerswell RR, 2005, NONLINEARITY, V18, pR17, DOI 10.1088/0951-7715/18/6/R01; Moehlis J, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/056; Niemela JJ, 2000, NATURE, V404, P837, DOI 10.1038/35009036; Peixinho J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.094501; Reynolds O., 1883, P R SOC LOND, V35, P84, DOI [10.1098/rspl.1883.0018, DOI 10.1098/RSPL.1883.0018]; Rotta J., 1956, ING ARCH, V24, P258, DOI [10.1007/BF00536526, DOI 10.1007/BF00536526]; Schmiegel A, 1997, PHYS REV LETT, V79, P5250, DOI 10.1103/PhysRevLett.79.5250; SHINBROT T, 1993, NATURE, V363, P411, DOI 10.1038/363411a0; Wedin H, 2004, J FLUID MECH, V508, P333, DOI 10.1017/S0022112004009346; WYGNANSKI I, 1975, J FLUID MECH, V69, P283, DOI 10.1017/S0022112075001449; WYGNANSKI IJ, 1973, J FLUID MECH, V59, P281, DOI 10.1017/S0022112073001576; [No title captured]	25	223	225	6	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 7	2006	443	7107					59	62		10.1038/nature05089	http://dx.doi.org/10.1038/nature05089			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16957725				2022-12-28	WOS:000240313900038
J	Zhao, Y; Rodrigo, J; Hoveyda, AH; Snapper, ML				Zhao, Yu; Rodrigo, Jason; Hoveyda, Amir H.; Snapper, Marc L.			Enantioselective silyl protection of alcohols catalysed by an amino-acid-based small molecule	NATURE			English	Article							KINETIC RESOLUTION; ASYMMETRIC CATALYSIS; SECONDARY ALCOHOLS; CHIRAL CATALYSTS; DISCOVERY; ALDEHYDES; SILANES	Reliable, selective and environmentally friendly chemical transformations are crucial to the development of new therapeutics and the design of novel materials. Chiral catalysts that can be easily prepared and used to obtain organic molecules of high enantiomeric purity are critical to modern chemical synthesis(1). The development of protecting groups that shield reactive functionalities has also proved indispensable in the preparation of complex biologically active molecules(2). Here we present a chiral catalyst that promotes the enantioselective protection of a secondary alcohol as one of the most commonly used protected forms of an alcohol: a silyl ether. The catalyst is a small, simple molecule that can be prepared in three steps from commercial materials without the need for rigorously controlled conditions. Enantioselective silylations are performed with commercial silyl chlorides and produce yields of up to 96 per cent at an enantiomeric ratio of up to 98:2. Chiral catalysts for selective formation of commonly used protecting groups such as silyl ethers should significantly enhance the ability of chemical synthesis to deliver, in a more practical and efficient manner, important organic molecules.	Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA	Boston College	Hoveyda, AH (corresponding author), Boston Coll, Merkert Chem Ctr, Dept Chem, 2609 Beacon St, Chestnut Hill, MA 02467 USA.	amir.hoveyda@bc.edu; marc.snapper@bc.edu						BASSINDALE AR, 1985, TETRAHEDRON LETT, V26, P3403, DOI 10.1016/S0040-4039(00)98309-6; Blackmond DG, 2000, ACCOUNTS CHEM RES, V33, P402, DOI 10.1021/ar990083s; Cole BM, 1996, ANGEW CHEM INT EDIT, V35, P1668, DOI 10.1002/anie.199616681; Corey E. J., 1989, LOGIC CHEM SYNTHESIS; COREY EJ, 1972, J AM CHEM SOC, V94, P6190, DOI 10.1021/ja00772a043; Denmark SE, 2005, J AM CHEM SOC, V127, P3774, DOI 10.1021/ja047339w; Evans JW, 2004, J AM CHEM SOC, V126, P8134, DOI 10.1021/ja047845l; Gutmann V., 1978, DONOR ACCEPTOR APPRO; Isobe T, 2001, CHEM COMMUN, P243, DOI 10.1039/b009173l; Jacobsen E. N., 1999, COMPREHENSIVE ASYMME; Jarvo E. R., 2004, COMPREHENSIVE ASYMME, P189; Jarvo ER, 1999, J AM CHEM SOC, V121, P11638, DOI 10.1021/ja9931776; KELLY TR, 1989, J AM CHEM SOC, V111, P3744, DOI 10.1021/ja00192a039; Kocienski P. J, 2005, PROTECTING GROUPS; Miller SJ, 1998, J AM CHEM SOC, V120, P1629, DOI 10.1021/ja973892k; Myers AG, 1996, TETRAHEDRON LETT, V37, P3083, DOI 10.1016/0040-4039(96)00501-1; Porter JR, 2001, J AM CHEM SOC, V123, P984, DOI 10.1021/ja003747y; Rendler S, 2005, ANGEW CHEM INT EDIT, V44, P7620, DOI 10.1002/ANIE.200502631; Sculimbrene BR, 2001, J AM CHEM SOC, V123, P10125, DOI 10.1021/ja016779+; Taylor MS, 2006, ANGEW CHEM INT EDIT, V45, P1520, DOI 10.1002/anie.200503132; Thayer AM, 2005, CHEM ENG NEWS, V83, P40, DOI 10.1021/cen-v083n036.p040; Traverse JF, 2005, ORG LETT, V7, P3151, DOI 10.1021/ol050814q; Vasbinder MM, 2001, ANGEW CHEM INT EDIT, V40, P2824, DOI 10.1002/1521-3773(20010803)40:15<2824::AID-ANIE2824>3.0.CO;2-J; Vedejs E, 2005, ANGEW CHEM INT EDIT, V44, P3974, DOI 10.1002/anie.200460842; [No title captured]	25	163	163	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2006	443	7107					67	70		10.1038/nature05102	http://dx.doi.org/10.1038/nature05102			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	081JM	16957727				2022-12-28	WOS:000240313900040
J	Hornberger, J; Robertus, K				Hornberger, John; Robertus, Katherine			Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults	ANNALS OF INTERNAL MEDICINE			English	Article							NATURAL-HISTORY; VARICELLA; EPIDEMIOLOGY; IMMUNIZATION; INFECTIONS	Background: The Shingles Prevention Study showed that a varicella-zoster virus (VZV) vaccine administered to adults 60 years of age or older reduced the incidence of herpes zoster from 11.12 to 5.42 cases per 1000 person-years. Median follow-up was 3.1 years, and relative risk reduction was 51.3% (95% CI, 44.2% to 57.6%). Objective: To assess the extent to which clinical and cost variables influence the cost-effectiveness of VZV vaccination for preventing herpes zoster in immunocompetent older adults. Design: Decision theoretical model. Data Sources: English-language data published to March 2006 identified from MEDLINE on herpes zoster rates, vaccine effectiveness, quality of life, medical resource use, and unit costs. Target Population: Immunocompetent adults 60 years of age or older with a history of VZV infection. Time Horizon: Lifetime. Perspective: U.S. societal. Interventions: Varicella-zoster virus vaccination versus no vaccination. Outcome Measures: Incremental quality-adjusted survival and cost per quality-adjusted life-year (QALY) gained. Results of Base-Case Analysis: By reducing incidence and severity of herpes zoster, vaccination can increase quality-adjusted survival by 0.6 day compared with no vaccination. One scenario in which vaccination costs less than $100000 per QALY gained is when 1) the unit cost of vaccination is less than $200, 2) the age at vaccination is less than 70 years, and 3) the duration of vaccine efficacy is more than 30 years. Results of Sensitivity Analysis: Vaccination would be more cost-effective in "younger" older adults (age 60 to 64 years) than in "older" older adults (age >= 80 years). Longer life expectancy and a higher level of vaccine efficacy offset a lower risk for herpes zoster in the younger group. Other factors influencing cost-effectiveness include quality-of-life adjustments for acute zoster, unit cost of the vaccine, risk for herpes zoster, and duration of vaccine efficacy. Limitations: The effectiveness of VZV vaccination remains uncertain beyond the median 3.1-year duration of follow-up in the Shingles Prevention Study. Conclusions: Varicella-zoster virus vaccination to prevent herpes zoster in older adults would increase QALYs compared with no vaccination. Resolution of uncertainties about the average quality-of-life effects of acute zoster and the duration of vaccine efficacy is needed to better determine the cost-effectiveness of zoster vaccination in older adults.	Acumen LLC, Burlingame, CA 94010 USA; SPHERE Inst, Burlingame, CA USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Hornberger, J (corresponding author), Acumen LLC, 500 Airport Blvd,Suite 365, Burlingame, CA 94010 USA.	jhornberger@acumen-llc.com	Hornberger, John/M-4932-2019					Brisson M, 2000, VACCINE, V18, P2775, DOI 10.1016/S0264-410X(00)00100-6; *BUR LAB STAT US D, 2006, Q CENS WAG EMPL; *BUR LAB STAT US D, 2003, NONF CAS INV DAYS AW; *CDCP, 2006, VAR VACC CLIN QUEST; *CDCP NAT IMM PROG, 2006, PED VFC VACC PRIC LI; Coleman MS, 2005, VACCINE, V23, P915, DOI 10.1016/j.vaccine.2004.07.028; Coplan PM, 2004, J PAIN, V5, P344, DOI 10.1016/j.jpain.2004.06.001; *CTR MED MED SERV, 2006, MED FEE SERV PARTS A; *CTR MED MED SERV, 2005, PRIC 2006 1 PSF 10 2; *CTR MED MED SERV, 2006, ICD 9 PROV DIAGN COD; *CTR MED MED SERV, 2004, NAT HLTH CAR EXP PRO; DONAHUE JG, 1995, ARCH INTERN MED, V155, P1605, DOI 10.1001/archinte.155.15.1605; Edmunds WJ, 2001, VACCINE, V19, P3076, DOI 10.1016/S0264-410X(01)00044-5; Galil K, 1997, ARCH INTERN MED, V157, P1209, DOI 10.1001/archinte.157.11.1209; GARBER AM, 2004, HLTH AFF MILLWOOD S; Gilden DH, 2005, NEW ENGL J MED, V352, P2344, DOI 10.1056/NEJMe058090; *HGSADMINISTRATORS, 2005, 2005 MED FEE SCHED; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; Kost RG, 1996, NEW ENGL J MED, V335, P32, DOI 10.1056/NEJM199607043350107; Lin F, 2000, J INFECT DIS, V181, P1897, DOI 10.1086/315492; LIPSCOMB J, 1989, MED CARE, V27, pS233, DOI 10.1097/00005650-198903001-00019; MCCORMICK A, 1995, MORBIDITY STAT GEN P; MOLIN L, 1969, ACTA DERM-VENEREOL, V49, P569; Mukamel DB, 2001, AM J PREV MED, V21, P29, DOI 10.1016/S0749-3797(01)00312-9; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Oxman MN, 1995, NEUROLOGY, V45, pS41, DOI 10.1212/WNL.45.12_Suppl_8.S41; RAGOZZINO MW, 1982, MEDICINE, V61, P310, DOI 10.1097/00005792-198209000-00003; Rohan P, 2005, FDA CLIN BRIEFING DO; SCHMADER K, 1995, J INFECT DIS, V171, P701, DOI 10.1093/infdis/171.3.701; Schmader K, 2001, CLIN INFECT DIS, V32, P1481, DOI 10.1086/320169; Sisk JE, 1997, JAMA-J AM MED ASSOC, V278, P1333, DOI 10.1001/jama.278.16.1333; Smith KJ, 2000, AM J MED, V108, P723, DOI 10.1016/S0002-9343(00)00445-9; Smith KJ, 2000, PHARMACOECONOMICS, V18, P95, DOI 10.2165/00019053-200018020-00001; STRAUS SE, 1988, ANN INTERN MED, V108, P221, DOI 10.7326/0003-4819-108-2-221; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; Weaver M, 2001, ARCH INTERN MED, V161, P111, DOI 10.1001/archinte.161.1.111; 2006, MOSBYS DRUG CONSULT	37	92	96	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 5	2006	145	5					317	325		10.7326/0003-4819-145-5-200609050-00004	http://dx.doi.org/10.7326/0003-4819-145-5-200609050-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080NZ	16954357				2022-12-28	WOS:000240255900001
J	Smith, VP				Smith, Vaughan P.			Where next for China? Rose tinted spectacles do not help	BRITISH MEDICAL JOURNAL			English	Letter												VSmith1951@aol.com						Potts M, 2006, BRIT MED J, V333, P361, DOI 10.1136/bmj.38938.412593.80; 2006, BMJ, V333, P368	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 2	2006	333	7566					500	500		10.1136/bmj.333.7566.500-a	http://dx.doi.org/10.1136/bmj.333.7566.500-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085QP	16946348	Green Published			2022-12-28	WOS:000240618900031
J	Chergui, M				Chergui, Majed			Chemistry - Controlling biological functions	SCIENCE			English	Editorial Material							QUANTUM CONTROL; PROTEIN		Ecole Polytech Fed Lausanne, Lab Spect Ultrarapide, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Chergui, M (corresponding author), Ecole Polytech Fed Lausanne, Lab Spect Ultrarapide, CH-1015 Lausanne, Switzerland.	majed.chergui@epfl.ch						Bardeen CJ, 1998, J AM CHEM SOC, V120, P13023, DOI 10.1021/ja9824627; Gawelda W, 2006, J AM CHEM SOC, V128, P5001, DOI 10.1021/ja054932k; Herek JL, 2002, NATURE, V417, P533, DOI 10.1038/417533a; Hummer G, 2004, P NATL ACAD SCI USA, V101, P15330, DOI 10.1073/pnas.0405295101; Prokhorenko VI, 2006, SCIENCE, V313, P1257, DOI 10.1126/science.1130747; Rabitz H, 2000, SCIENCE, V288, P824, DOI 10.1126/science.288.5467.824	6	6	7	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 1	2006	313	5791					1246	1247		10.1126/science.1132749	http://dx.doi.org/10.1126/science.1132749			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16946057				2022-12-28	WOS:000240313500026
J	Finlayson, C; Pacheco, FG; Rodriguez-Vidal, J; Fa, DA; Lopez, JMG; Perez, AS; Finlayson, G; Allue, E; Preysler, JB; Caceres, I; Carrion, JS; Fernandez-Jalvo, Y; Gleed-Owen, CP; Espejo, FJJ; Lopez, P; Saez, JAL; Cantal, JAR; Marco, AS; Guzman, FG; Brown, K; Fuentes, N; Valarino, CA; Villalpando, A; Stringer, CB; Ruiz, FM; Sakamoto, T				Finlayson, Clive; Giles Pacheco, Francisco; Rodriguez-Vidal, Joaquin; Fa, Darren A.; Gutierrez Lopez, Jose Maria; Santiago Perez, Antonio; Finlayson, Geraldine; Allue, Ethel; Preysler, Javier Baena; Caceres, Isabel; Carrion, Jose S.; Fernandez Jalvo, Yolanda; Gleed-Owen, Christopher P.; Jimenez Espejo, Francisco J.; Lopez, Pilar; Lopez Saez, Jose Antonio; Riquelme Cantal, Jose Antonio; Sanchez Marco, Antonio; Giles Guzman, Francisco; Brown, Kimberly; Fuentes, Noemi; Valarino, Claire A.; Villalpando, Antonio; Stringer, Christopher B.; Martinez Ruiz, Francisca; Sakamoto, Tatsuhiko			Late survival of Neanderthals at the southernmost extreme of Europe	NATURE			English	Article								The late survival of archaic hominin populations and their long contemporaneity with modern humans is now clear for southeast Asia(1). In Europe the extinction of the Neanderthals, firmly associated with Mousterian technology, has received much attention, and evidence of their survival after 35 kyr BP has recently been put in doubt(2). Here we present data, based on a high-resolution record of human occupation from Gorham's Cave, Gibraltar, that establish the survival of a population of Neanderthals to 28 kyr BP. These Neanderthals survived in the southernmost point of Europe, within a particular physiographic context, and are the last currently recorded anywhere. Our results show that the Neanderthals survived in isolated refuges well after the arrival of modern humans in Europe.	Gibraltar Museum, Gibraltar, Gibraltar; Univ Toronto, Dept Social Sci, Toronto, ON M1C 1A4, Canada; Museo Arqueol El Puerto Maria, El Puerto Santa Maria 11500, Spain; Univ Huelva, Fac Ciencias Expt, Dept Geodinam & Paleontol, Huelva 21071, Spain; Museo Municipal, Villamartin 11650, Spain; Univ Rovira & Virgili, Inst Catala Paleoecol Humana & Evolucio Social, Area Prehist, Tarragona 43003, Spain; Univ Autonoma Madrid, Dept Prehist & Arqueol, E-28049 Madrid, Spain; Univ Murcia, Dept Plant Biol, E-30100 Murcia, Spain; CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain; Herpetol Conservat Trust, Bournemouth BH1 4AP, Dorset, England; CSIC, UGR, Inst Andaluz Ciencias Tierra, Granada 18002, Spain; Univ London, Royal Holloway & Bedford New Coll, Dept Geog, Egham TW20 0EX, Surrey, England; CSIC, Hist Inst, Lab Arqueobot, E-28014 Madrid, Spain; Univ Granada, Dept Prehist & Arqueol, E-18071 Granada, Spain; Univ Cadiz, Fac Filosofia & Letras, Area Prehist, Cadiz 11003, Spain; Univ Cambridge, Dept Biol Anthropol, Cambridge CB2 3DZ, England; Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Yokosuka, Kanagawa 2370061, Japan	University of Toronto; Universidad de Huelva; ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Autonomous University of Madrid; University of Murcia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT); University of Granada; University of London; Royal Holloway University London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Historia (IH); University of Granada; Universidad de Cadiz; University of Cambridge; Natural History Museum London; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Finlayson, C (corresponding author), Gibraltar Museum, 18-20 Bomb House Lane, Gibraltar, Gibraltar.	jcfinlay@gibraltar.gi	Cáceres, Isabel/G-2636-2015; Jimenez-Espejo, Francisco J/F-4486-2016; baena, javier/L-2383-2013; Fa, Darren A./F-1863-2015; Marco, Antonio Sánchez/F-9837-2010; Martinez-Ruiz, Francisca/C-5908-2014; Carrion, Jose S/A-8983-2015; Jimenez-Espejo, Francisco J./AAR-2318-2020; Gutierrez-Lopez, Jose Maria/AAM-8329-2020; Fa, Darren/Z-4376-2019	Cáceres, Isabel/0000-0001-8487-2591; Jimenez-Espejo, Francisco J/0000-0002-0335-8580; baena, javier/0000-0002-6373-8286; Fa, Darren A./0000-0002-5900-9814; Marco, Antonio Sánchez/0000-0003-0654-1935; Martinez-Ruiz, Francisca/0000-0002-8301-4453; Carrion, Jose S/0000-0002-6949-4382; Gutierrez-Lopez, Jose Maria/0000-0001-5257-0556; Fa, Darren/0000-0002-5900-9814; Giles Guzman, Francisco Jose/0000-0002-8092-7302; Fernandez-Jalvo, Yolanda/0000-0002-1089-7136; Rodriguez-Vidal, Joaquin/0000-0002-9475-3307				Barton Nick, 2000, P211; Bea F, 1996, CHEM GEOL, V133, P145, DOI 10.1016/S0009-2541(96)00073-3; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Busk G., 1865, 34 M BRIT ASS ADV SC, P91; Chiu TC, 2005, QUATERNARY SCI REV, V24, P1797, DOI 10.1016/j.quascirev.2005.04.002; d'Errico F, 2003, QUATERNARY SCI REV, V22, P769, DOI 10.1016/S0277-3791(03)00009-X; Fairbanks RG, 2005, QUATERNARY SCI REV, V24, P1781, DOI 10.1016/j.quascirev.2005.04.007; Finlayson C, 2005, TRENDS ECOL EVOL, V20, P457, DOI 10.1016/j.tree.2005.05.019; FINLAYSON C, 2000, NEANDERTHALS MODERN; GARROD DAE, 1928, J ROYAL ANTHR I, V58, P91; Gaudzinski S, 2004, INT J OSTEOARCHAEOL, V14, P201, DOI 10.1002/oa.756; Grayson DK, 2003, J ARCHAEOL SCI, V30, P1633, DOI 10.1016/S0305-4403(03)00064-5; Higham T, 2006, P NATL ACAD SCI USA, V103, P553, DOI 10.1073/pnas.0510005103; Higham TFG, 2006, RADIOCARBON, V48, P179, DOI 10.1017/S0033822200066388; KISCH HJ, 1991, J METAMORPH GEOL, V9, P665, DOI 10.1111/j.1525-1314.1991.tb00556.x; MARTIN JD, 2004, QUALITATIVE QUANTITA; Mellars P, 1999, CURR ANTHROPOL, V40, P341, DOI 10.1086/200024; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; Mellars P., 1996, NEANDERTHAL LEGACY, DOI [10.1515/9781400843602, DOI 10.1515/9781400843602]; Pettitt P.B., 2000, NEANDERTHALS EDGE, P155; Reimer PJ, 2006, QUATERNARY SCI REV, V25, P855, DOI 10.1016/j.quascirev.2005.09.009; Romano FP, 2006, X-RAY SPECTROM, V35, P1, DOI 10.1002/xrs.880; RUIZ CB, 2003, JUNTA ANDALUCIA ARQU; SAKAMOTO T, 2006, INTEGRATED ODP, V2, P37; Skinner AR, 2005, APPL RADIAT ISOTOPES, V62, P219, DOI 10.1016/j.apradiso.2004.08.008; Waechter J.D.A., 1964, B INST ARCHAEOL, V4, P189; Zilhao Joao, 2000, P111	27	311	320	1	221	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2006	443	7113					850	853		10.1038/nature05195	http://dx.doi.org/10.1038/nature05195			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	096FJ	16971951				2022-12-28	WOS:000241362700050
J	Ahel, I; Rass, U; El-Khamisy, SF; Katyal, S; Clements, PM; McKinnon, PJ; Caldecott, KW; West, SC				Ahel, Ivan; Rass, Ulrich; El-Khamisy, Sherif F.; Katyal, Sachin; Clements, Paula M.; McKinnon, Peter J.; Caldecott, Keith W.; West, Stephen C.			The neurodegenerative disease protein aprataxin resolves abortive DNA ligation intermediates	NATURE			English	Article							STRAND BREAK REPAIR; HISTIDINE TRIAD SUPERFAMILY; AMP-LYSINE HYDROLASE; ATAXIA; HINT; FHIT; MUTATIONS; MECHANISM; BINDING; DAMAGE	Ataxia oculomotor apraxia-1 (AOA1) is a neurological disorder caused by mutations in the gene (APTX) encoding aprataxin(1,2). Aprataxin is a member of the histidine triad (HIT) family of nucleotide hydrolases and transferases(3), and inactivating mutations are largely confined to this HIT domain. Aprataxin associates with the DNA repair proteins XRCC1 and XRCC4, which are partners of DNA ligase III and ligase IV, respectively(4-7), suggestive of a role in DNA repair. Consistent with this, APTX-defective cell lines are sensitive to agents that cause single-strand breaks and exhibit an increased incidence of induced chromosomal aberrations(4,5,8). It is not, however, known whether aprataxin has a direct or indirect role in DNA repair, or what the physiological substrate of aprataxin might be. Here we show, using purified aprataxin protein and extracts derived from either APTX-defective chicken DT40 cells or Aptx(-/-) mouse primary neural cells, that aprataxin resolves abortive DNA ligation intermediates. Specifically, aprataxin catalyses the nucleophilic release of adenylate groups covalently linked to 5'-phosphate termini at single-strand nicks and gaps, resulting in the production of 5'-phosphate termini that can be efficiently rejoined. These data indicate that neurological disorders associated with APTX mutations may be caused by the gradual accumulation of unrepaired DNA strand breaks resulting from abortive DNA ligation events.	Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; Fac Pharm, Dept Biochem, Cairo, Egypt; St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA	Cancer Research UK; University of Sussex; St Jude Children's Research Hospital	West, SC (corresponding author), Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	stephen.west@cancer.org.uk	Caldecott, Keith/S-4245-2019	Ahel, Ivan/0000-0002-9446-3756; Rass, Ulrich/0000-0001-9275-9062; West, Stephen/0000-0001-8848-9418; Katyal, Sachin/0000-0002-7790-4054; , Sherif/0000-0003-2721-7763; Caldecott, Keith/0000-0003-4255-9016	MRC [G0001259] Funding Source: UKRI; Medical Research Council [G0001259] Funding Source: Medline; Medical Research Council [G0300662B] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Abner CW, 2004, DNA REPAIR, V3, P1141, DOI 10.1016/j.dnarep.2004.03.009; Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; Barnes DE, 2002, CURR BIOL, V12, pR262, DOI 10.1016/S0960-9822(02)00788-1; Barnes LD, 1996, BIOCHEMISTRY-US, V35, P11529, DOI 10.1021/bi961415t; Bieganowski P, 2002, J BIOL CHEM, V277, P10852, DOI 10.1074/jbc.M111480200; Brenner C, 2002, BIOCHEMISTRY-US, V41, P9003, DOI 10.1021/bi025942q; Brenner C, 1997, NAT STRUCT BIOL, V4, P231, DOI 10.1038/nsb0397-231; Caldecott KW, 2003, CELL, V112, P7, DOI 10.1016/S0092-8674(02)01247-3; Clements PM, 2004, DNA REPAIR, V3, P1493, DOI 10.1016/j.dnarep.2004.06.017; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; Draganescu A, 2000, J BIOL CHEM, V275, P4555, DOI 10.1074/jbc.275.7.4555; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gueven N, 2004, HUM MOL GENET, V13, P1081, DOI 10.1093/hmg/ddh122; Henle ES, 1997, J BIOL CHEM, V272, P19095, DOI 10.1074/jbc.272.31.19095; Kijas AW, 2006, J BIOL CHEM, V281, P13939, DOI 10.1074/jbc.M507946200; Krakowiak A, 2004, J BIOL CHEM, V279, P18711, DOI 10.1074/jbc.M314271200; Lima CD, 1997, SCIENCE, V278, P286, DOI 10.1126/science.278.5336.286; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Luo H, 2004, MOL CELL BIOL, V24, P8356, DOI 10.1128/MCB.24.19.8356-8365.2004; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Mosesso P, 2005, CELL MOL LIFE SCI, V62, P485, DOI 10.1007/s00018-004-4441-0; PLATEAU P, 1989, J BACTERIOL, V171, P6437, DOI 10.1128/jb.171.12.6437-6445.1989; Pogozelski WK, 1998, CHEM REV, V98, P1089, DOI 10.1021/cr960437i; Sano Y, 2004, ANN NEUROL, V55, P241, DOI 10.1002/ana.10808; Seidle HF, 2005, J BIOL CHEM, V280, P20927, DOI 10.1074/jbc.M502889200; Tomkinson AE, 2006, CHEM REV, V106, P687, DOI 10.1021/cr040498d; Ward JF, 1998, CONT CANC RES, P65; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7	30	284	299	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2006	443	7112					713	716		10.1038/nature05164	http://dx.doi.org/10.1038/nature05164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HX	16964241				2022-12-28	WOS:000241160500051
J	Gregersen, JW; Kranc, KR; Ke, XY; Svendsen, P; Madsen, LS; Thomsen, AR; Cardon, LR; Bell, JI; Fugger, L				Gregersen, Jon W.; Kranc, Kamil R.; Ke, Xiayi; Svendsen, Pia; Madsen, Lars S.; Thomsen, Allan Randrup; Cardon, Lon R.; Bell, John I.; Fugger, Lars			Functional epistasis on a common MHC haplotype associated with multiple sclerosis	NATURE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MYELIN BASIC-PROTEIN; OLIGONUCLEOTIDE HYBRIDIZATION; AFRICAN-AMERICANS; HUMAN GENOME; HLA-DR; ALLELES; HLA-DR2; MAP; SUSCEPTIBILITY	Genes in the major histocompatibility complex (MHC) encode proteins important in activating antigen-specific immune responses. Alleles at adjacent MHC loci are often in strong linkage disequilibrium; however, little is known about the mechanisms responsible for this linkage disequilibrium. Here we report that the human MHC HLA-DR2 haplotype, which predisposes to multiple sclerosis(1-3), shows more extensive linkage disequilibrium than other common caucasian HLA haplotypes in the DR region and thus seems likely to have been maintained through positive selection. Characterization of two multiple-sclerosis-associated HLA-DR alleles at separate loci by a functional assay in humanized mice indicates that the linkage disequilibrium between the two alleles may be due to a functional epistatic interaction, whereby one allele modifies the T-cell response activated by the second allele through activation-induced cell death. This functional epistasis is associated with a milder form of multiple-sclerosis-like disease. Such epistatic interaction might prove to be an important general mechanism for modifying exuberant immune responses that are deleterious to the host and could also help to explain the strong linkage disequilibrium in this and perhaps other HLA haplotypes.	Aarhus Univ Hosp, Dept Clin Immunol, DK-8200 Aarhus N, Denmark; Univ Oxford, MRC Human Immunol Unit, Weatherall Inst Mol Med, John Radcliffe Hosp, Oxford OX3 9DS, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Copenhagen Hosp, Dept Clin Immunol, Rigshosp, DK-2100 Copenhagen O, Denmark; Univ Copenhagen, Inst Med Microbiol & Immunol, DK-2200 Copenhagen N, Denmark; Univ Oxford, Off Regius Prof Med, Oxford OX3 7BN, England	Aarhus University; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Oxford	Fugger, L (corresponding author), Aarhus Univ Hosp, Dept Clin Immunol, Skejby Sygehus, DK-8200 Aarhus N, Denmark.	lars.fugger@imm.ox.ac.uk	Kranc, Kamil/B-3449-2009; Ke, Xiayi/C-7674-2009	Thomsen, Allan Randrup/0000-0002-2392-9803	MRC [MC_U137881016] Funding Source: UKRI; Medical Research Council [MC_U137881016] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bateson W., 1909, MENDELS PRINCIPLES H, P79; FERNANDEZVINA MA, 1991, IMMUNOGENETICS, V34, P299, DOI 10.1007/BF00211994; FOGDELL A, 1995, TISSUE ANTIGENS, V46, P333, DOI 10.1111/j.1399-0039.1995.tb02503.x; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; GAO XJ, 1991, IMMUNOGENETICS, V34, P401, DOI 10.1007/BF01787491; GAO XJ, 1991, TISSUE ANTIGENS, V38, P24, DOI 10.1111/j.1399-0039.1991.tb02031.x; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835; Lee A, 1999, EUR J IMMUNOGENET, V26, P275, DOI 10.1046/j.1365-2370.1999.00144.x; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; Madsen LS, 1999, NAT GENET, V23, P343, DOI 10.1038/15525; MEHRA NK, 1991, HUM IMMUNOL, V32, P246, DOI 10.1016/0198-8859(91)90087-P; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; MORAES ME, 1991, HUM IMMUNOL, V31, P139, DOI 10.1016/0198-8859(91)90017-4; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; OTA K, 1990, NATURE, V346, P183, DOI 10.1038/346183a0; Phillips PC, 1998, GENETICS, V149, P1167; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Song EY, 2000, HUM IMMUNOL, V61, P937, DOI 10.1016/S0198-8859(00)00155-5; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Suvannavejh GC, 2000, J CLIN INVEST, V105, P223, DOI 10.1172/JCI8561; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Walsh EC, 2003, AM J HUM GENET, V73, P580, DOI 10.1086/378101; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; ZINKERNAGEL RM, 1985, NATURE, V316, P814, DOI 10.1038/316814a0	27	150	153	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2006	443	7111					574	577		10.1038/nature05133	http://dx.doi.org/10.1038/nature05133			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	17006452				2022-12-28	WOS:000240988200043
J	Saliba, KJ; Martin, RE; Broer, A; Henry, RI; McCarthy, CS; Downie, MJ; Allen, RJW; Mullin, KA; McFadden, GI; Broer, S; Kirk, K				Saliba, Kevin J.; Martin, Rowena E.; Broeer, Angelika; Henry, Roselani I.; McCarthy, C. Siobhan; Downie, Megan J.; Allen, Richard J. W.; Mullin, Kylie A.; McFadden, Geoffrey I.; Broeer, Stefan; Kirk, Kiaran			Sodium-dependent uptake of inorganic phosphate by the intracellular malaria parasite	NATURE			English	Article							PLASMODIUM-FALCIPARUM; MEMBRANE-TRANSPORT; ACID; CHLOROQUINE; EXPRESSION; RETROVIRUS; PROTEINS; CLONING; CELLS	As the malaria parasite, Plasmodium falciparum, grows within its host erythrocyte it induces an increase in the permeability of the erythrocyte membrane to a range of low-molecular-mass solutes, including Na+ and K+ ( ref. 1). This results in a progressive increase in the concentration of Na+ in the erythrocyte cytosol(2,3). The parasite cytosol has a relatively low Na+ concentration(2,4) and there is therefore a large inward Na+ gradient across the parasite plasma membrane. Here we show that the parasite exploits the Na+ electrochemical gradient to energize the uptake of inorganic phosphate (P-i), an essential nutrient. P-i was taken up into the intracellular parasite by a Na+-dependent transporter, with a stoichiometry of 2Na(+): 1P(i) and with an apparent preference for the monovalent over the divalent form of P-i. A P-i transporter (PfPiT) belonging to the PiT family was cloned from the parasite and localized to the parasite surface. Expression of PfPiT in Xenopus oocytes resulted in Na+-dependent P-i uptake with characteristics similar to those observed for P-i uptake in the parasite. This study provides new insight into the significance of the malaria-parasite-induced alteration of the ionic composition of its host cell.	Australian Natl Univ, Sch Biochem & Mol Biol, Canberra, ACT 0200, Australia; Australian Natl Univ, Sch Med, Canberra, ACT 0200, Australia; Univ Melbourne, Sch Bot, Parkville, Vic 3010, Australia	Australian National University; Australian National University; University of Melbourne	Kirk, K (corresponding author), Australian Natl Univ, Sch Biochem & Mol Biol, Canberra, ACT 0200, Australia.	kiaran.kirk@anu.edu.au	Martin, Rowena E/C-9992-2009; Broer, Stefan/A-1286-2008; McFadden, Geoffrey McFadden I/F-7667-2014; Saliba, Kevin J/C-9166-2009; Allen, Richard/B-4752-2008; Kirk, Kiaran/C-8299-2009	Martin, Rowena E/0000-0001-7408-5295; Broer, Stefan/0000-0002-8040-1634; McFadden, Geoffrey McFadden I/0000-0002-5351-1627; Saliba, Kevin J/0000-0003-3345-8440; Kirk, Kiaran/0000-0002-5613-2622; Henry, Roselani/0000-0001-7448-7358				Allen RJW, 2004, J BIOL CHEM, V279, P11264, DOI 10.1074/jbc.M311110200; Bai L, 2000, AM J PHYSIOL-CELL PH, V279, pC1135, DOI 10.1152/ajpcell.2000.279.4.C1135; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Broer A, 2004, J BIOL CHEM, V279, P24467, DOI 10.1074/jbc.M400904200; Broer S, 1997, J BIOL CHEM, V272, P30096, DOI 10.1074/jbc.272.48.30096; Broer Stefan, 2003, Methods Mol Biol, V227, P245, DOI 10.1385/1-59259-387-9:245; Dubyak GR, 2004, ADV PHYSIOL EDUC, V28, P143, DOI 10.1152/advan.00046.2004; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; Kirk K, 2001, PHYSIOL REV, V81, P495, DOI 10.1152/physrev.2001.81.2.495; Kumler WD, 1943, J AM CHEM SOC, V65, P2355, DOI 10.1021/ja01252a028; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; LEE P, 1988, AM J TROP MED HYG, V39, P157, DOI 10.4269/ajtmh.1988.39.157; Martin RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r26; Mullin KA, 2006, P NATL ACAD SCI USA, V103, P9572, DOI 10.1073/pnas.0602293103; Opekarova M, 2003, BBA-BIOMEMBRANES, V1610, P11, DOI 10.1016/S0005-2736(02)00708-3; Rager N, 2001, J BIOL CHEM, V276, P41095, DOI 10.1074/jbc.M107037200; Salaun C, 2001, J VIROL, V75, P5584, DOI 10.1128/JVI.75.12.5584-5592.2001; Saliba KJ, 1998, J BIOL CHEM, V273, P10190, DOI 10.1074/jbc.273.17.10190; Staines HM, 2001, AM J PHYSIOL-CELL PH, V280, pC1576, DOI 10.1152/ajpcell.2001.280.6.C1576; TURNER RJ, 1985, ANN NY ACAD SCI, V456, P10, DOI 10.1111/j.1749-6632.1985.tb14839.x; Wunsch S, 1998, J CELL BIOL, V140, P335, DOI 10.1083/jcb.140.2.335	22	76	77	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 5	2006	443	7111					582	585		10.1038/nature05149	http://dx.doi.org/10.1038/nature05149			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	17006451				2022-12-28	WOS:000240988200045
J	Gerstein, HC; Yusuf, S; Holman, RR; Bosch, J; Anand, S; Avezum, A; Budaj, A; Chiasson, J; Conget, I; Dagenais, G; Davis, M; Diaz, R; Dinccag, N; Enjalbert, M; Escalante, A; Fodor, G; Hanefeld, M; Hedner, T; Jolly, K; Keltai, M; Laakso, M; Lanas, F; Lonn, E; McQueen, M; Mohan, V; Phillips, A; Piegas, L; Pirags, V; Probstfield, J; Shaw, J; Schmid, I; Teo, K; Zimmet, P; Zinman, B; Gerstein, HC; Yusuf, S; Bosch, J; Pogue, J; Sheridan, P; Dinccag, N; Hanefeld, M; Hoogwerf, B; Laakso, M; Mohan, V; Shaw, J; Zinman, B; Holman, RR; Diaz, R; Guerrero, RA; Albisu, J; Alvarez, MS; Arregui, V; Avaca, H; Baglivo, H; Balbuena, M; Bello, F; Bono, J; Botto, M; Brandani, L; Brandes, M; Bruera, D; Venere, RC; Caccavo, A; Cacurri, A; Caime, G; Capozzi, M; Carrique, A; Carrique, P; Cartasegna, L; Casabe, J; Casaccia, G; Castellanos, C; Castro, L; Cendali, G; Cerchi, P; Cerdan, M; Cinalli, M; Cipullo, M; Cismondi, M; Citta, N; Citta, L; Crespo, C; Crunger, P; Cuneo, C; De Loredo, L; De Loredo, S; del Cerro, S; Denaro, R; Esperatti, E; Esposito, L; Farras, H; Fernandez, A; Fernandez, M; Fernandez, S; Ferrari, G; Focaccia, M; Frontini, L; Gabito, A; Gambarte, A; Garrido, M; Garrido, I; Guglielmotti, V; Hershson, A; Hoffman, V; Juarisit, G; Klyver, M; Lagrutta, M; Liberman, A; Llanos, J; Marquez, LL; Lopez, R; Lowenstein, D; Lowenstein, J; Lucero, C; Luciardi, H; Clos, EL; Luna, M; Luquez, C; MacKinnon, I; Maffia, M; Mahfoud, C; Majul, C; Maldonado, N; Manuale, O; Marcucci, G; Martin, S; Martinez, G; Martos, M; Marzetti, E; Memoli, R; Molina, M; Montana, O; Morales, S; Morell, Y; Navarrete, S; Nieto, F; Ocampo, L; Orce, R; Orlandini, A; Oteiza, E; Pepa, C; Piasentin, J; Piskorz, D; Plastino, M; Pomposiello, J; Quiroga, G; Ramos, F; Ramos, H; Reissig, F; Risolo, A; Riverso, Z; Rodrigues, H; Rodriquez, C; Saavedra, S; Sago, L; Sanchez, R; Schwindt, C; Schygiel, P; Sebastian, F; Sposetti, G; Streitenberger, P; Suarez, G; Suzrez, F; Vico, M; Vignau, S; Visco, V; Castro, AV; Zaidman, C; Shaw, J; Zimmet, P; Allen, C; Arsov, T; Bartlett, N; Batrouney, B; Borger, R; Brooks, B; Buchanan, P; Buckland, A; Calvert, D; Carr, J; Chan, Y; Ching, H; Chronopoulos, A; Coates, P; Cohen, N; Colagiuri, S; Colman, P; Correcha, M; d'Emden, M; Ding, G; Edwards, W; Estensen, K; Fitzpatrick, B; Freeborn, J; Friebel, H; Fulcher, G; Garland, C; Gauld, A; Gein, J; Glatthaar, C; Graham, J; Gronan, A; Gunser, A; Hackney, P; Hall, C; Hay, L; Heazlewood, V; Heyward, D; Higgins, B; Hines, M; Hodge, A; Honisett, S; Jovanovska, A; Karrasch, J; Kean, M; Lawton, M; Lee, C; Legg, H; Long, F; Lucas, E; Lynch, L; Marangou, A; Margrie, F; Martin, L; McKenzie, J; McKinnon, A; McNamara, M; Mencel, J; Moses, R; Murphy, C; Naidu, V; Nairn, J; Nankervis, A; Nattrass, N; Ngweso, A; Nugent, T; O'Brien, R; Palmer, N; Parry, H; Pasculli, K; Patrikios, P; Perampalam, S; Phillips, J; Phillips, S; Por, E; Pringle, S; Prior, E; Proietto, J; Rando, L; Ridley, D; Roberts, A; Robertson, P; Robinson, K; Rodgers, C; Ross, G; Rowe, J; Siddall, R; Silva, D; Simpson, R; Slobodniuk, R; Smith, G; Socha, L; Soden, V; Speedy, M; Spence, E; Steed, K; Stephens, C; Stewart, R; Stuckey, B; Sumithran, P; Sunderland, J; Tapp, E; Tejani, N; Tong, C; Topliss, D; Tran, H; Vanlint, S; Wagner, J; Walsh, J; Warner, J; Webb, A; Welborn, T; Wentworth, J; White, C; Wigg, S; Willenberg, V; Wilson, D; Wood, M; Wu, S; Yue, D; Yuen, R; Baillie, SME; Campbell, G; Cressall, J; Heir, J; Jones, D; Myrie, J; Watlington, M; West, A; Avezum, A; Piegas, L; Bertolami, M; Borges, J; de Araujo, DB; Cartena, L; Salvarani, NDC; Faludi, A; Telo, DF; Grespan, S; Gross, J; Halpern, A; Hirota, A; Maeda, S; Monte, O; Nakamura, Y; Salles, JN; Oliveira, O; Pinto, C; Rabelo, L; Rabelo, A; Silveiro, S; Turatti, L; Zatz, H; Zoubel, V; Dagenais, G; Abbott, C; Abu-Bakare, A; Allison, R; Anand, S; Anderlic, T; Auger, D; Barnie, A; Beauchef, J; Beers, S; Beliveau, L; Berard, L; Bolduc, H; Bondy, G; Bradley, J; Bragaglia, P; Brault, S; Brittain, M; Brossoit, R; Brown, S; Capes, S; Carmichael, P; Caron, D; Caruana, L; Cha, J; Champion, P; Chan, S; Chan, Y; Chausse, I; Cheung, R; Chiasson, J; Chilvers, M; Chisholm, S; Clearwaters, M; Colborne, C; Conway, J; Czolpinski, T; Dallaire, S; David, M; Davis, A; DeAngelis, D; Delpech, I; Denton, R; Dufour, A; Dunn, P; Duong, H; Eddy, D; Erickson-Nesmith, S; Fay, D; Frohlich, GFJ; Fyfe, M; Galandzy, S; Gauthier, S; Gillett, J; Girard, G; Gosselin, G; Gourgues, M; Gray, S; Grunbaum, D; Gupta, M; Halle, J; Hanley, A; Hardin, P; Harris, S; Harvey, N; Hoag, G; Hogard, M; Houlden, R; Hughes, D; Hunt, D; Janzen, L; Jenkins, O; Krider, J; Kwan, S; Lai, C; Lam, A; Lambing, L; Lau, D; Lavallee, C; Lavallee, P; LeDrew, G; Lee, H; Legare, C; Leong, W; Lesperance, D; Lochnan, H; Ludwig, S; MacNair, D; Mann, S; Marin, M; MacFadyen, J; MacLean, S; Marucci, J; Masson, C; Maurice, P; Mawani, S; McCarthy, A; McCarthy, G; McInnis, D; McLean, S; McLean, A; Monier, D; Montreuil, S; Neal, L; Newman, S; O'Keefe, D; Oprici, T; Otis, J; Ouellet, G; Parmar, M; Paul, M; Petrella, R; Petrella, S; Phillips, R; Poisson, D; Prieur, S; Rabasa-Lhoret, R; Rajakumar, G; Rajakumar, A; Raymond, J; Richard, D; Rideout, G; Robert, C; Robitaille, Y; Ross, D; Ross, S; Rowe, R; Salmon, C; Saunier, D; Savard, C; Savard, D; Sayeed, R; Sayeed, Z; Sestier, F; Shaban, J; Shu, D; Sigal, R; Silverberg, J; Smith, E; Smith, R; Soucy, J; Starra, R; Stearn, B; Steel, D; Steinson, D; Sternberg, B; Stewart, D; Stone, F; Sussex, B; Tippe, D; Toupin-Halle, A; Trapsa, D; Tremblay, S; Troung, N; van Buuren, J; VanSickle, L; Verdonk, R; Whitsitt, P; Wilson, R; Winkler, L; Wong, W; Woo, V; Wozniak, P; Yale, J; Zaniol, D; Zaychkowsky, L; Zimakas, G; Zinman, B; Zmijowskyj, T; Lanas, F; Altamirano, MA; Murua, FB; Landaeta, O; Larenas, G; Kiefer, VR; Roddriguez, L; Carrasco, OT; Laakso, M; Harkonen, P; Hiltunen, L; Jantunen, A; Keinanen-Kiukaanniemi, S; Laakso, MM; Lahdensuo, E; Rutanen, J; Saastamoinen, E; Salaspuro, V; Sivenius, K; Valle, T; Hanefeld, M; Budziarek, P; Engeli, S; Fache, K; Fischer, C; Flehmig, K; Gordalla, A; Gottschalk, I; Habel, M; Hampel, R; Henkel, E; Holtzl, S; Jordan, J; Kletetschka, M; Kresse, C; Lehmann, D; Mehling, H; Otte, C; Pein, M; Pfeffer, B; Ploog, B; Schaper, F; Scholz, G; Stoffels, G; Strauss, A; Wilhelm, K; Keltai, M; Balazs, B; Balogh, E; Birkus, Z; Boros, T; Gyarmati, G; Hati, K; Hati, K; Hermanyi, Z; Benko, MH; Kempler, P; Kohari, A; Kornel, S; Laszlo, Z; Laszlo, ZZ; Nagy, F; Nemeth, C; Poor, F; Pusztai, P; Sandor, K; Somogyi, A; Takacs, J; Toth, A; Varga, E; Voros, P; Mohan, V; Aravind, S; Aravind, SR; Ayyar, V; Dharmalingam, M; Ganapathi, B; Gayatri, R; Gopal, U; Idiculla, J; Kalaivani, U; Karkuzhali, K; Kavitha, L; Krishnan, S; Kumar, P; Kumar, K; Monika, M; Muniswamy, M; Devi, MP; Pais, P; Poongothai, S; Prakash, S; Ramu, M; Rao, PV; Rao, C; Shailaja, K; Sreenivas, T; Sudha, S; Udayakumar, K; Yajnik, C; Pirags, V; Erina, A; Gailiss, E; Gara, S; Gozite, A; Hansone, S; Kreislere, I; Liepa, L; Ozolina, M; Putane, L; Raibarts, J; Rasa, I; Rozkova, N; Rudzite, E; Staka, A; Veze, I; Escalante, A; Arellano, S; Banuelos, K; Calvo, C; Carbajal, M; Cardona, E; Castaneda, R; Chavira, J; Dominguez, C; Escalante, M; Flores, E; Gomez, F; Gonzalez, J; Gonzalez-Barcena, D; Granados, C; Illescas, J; Jimenez, M; Mancillas, L; Mejia, L; Mendoza, C; Mendoza, L; Munoz, M; Munoz, A; Padilla, V; Pascoe, S; Plascencia, O; Ramos, C; Reza, A; Rubio, I; Ruiz, E; Vidrio, M; Alhakim, M; Bemelmans, V; de Backer, W; Rooda, SE; Guldemond, F; Hulshof, M; Jonker, J; Koppeschaar, H; Meinema, K; Pondman-Mulder, M; Ponteyn-Rose, S; van Asten, K; de Walle, VV; van Kempen, W; Bryne, B; Enderle, B; Furuseth, K; Halse, J; Henriksen, T; Faehn, AH; Knudsrod, O; Lerssl, S; Loennicken, C; Murud, K; Steinbo, E; Vaaler, S; Budaj, A; Baranowska, A; Baranska, M; Blaszak, J; Bronisz, M; Ceremuzynski, L; Cywinska, H; Czempik, E; Gmytrasiewicz, M; Grochola, A; Grzegorz, O; Ignaczak, P; Janik, K; Jankiewicz, B; Kania, G; Kawka-Urbanek, T; Kolaczek, M; Kopcik, D; Kordys, M; Krainska, A; Majer, J; Makuch, M; Miekus, P; Mormul, J; Mrowczynska, A; Nowak, D; Nowakowski, P; Ogorek, M; Oleskowaska, L; Paliszewska, L; Przywoska-Para, B; Pszonak, S; Rozwodowska, M; Rucinski, M; Rzyman, M; Sikora-Frac, M; Stecka-Wierzbicka, J; Swiatkowski, M; Swierczynski, R; Szczepanska, A; Szpajer, M; Ukleja-Adamowicz, M; Urbaniak, A; Winek, D; Wojewoda, P; Zaborksa, B; Zadrosny, J; Zak, J; Zalska, B; Fodor, G; Bilicky, M; Caprnda, M; Dukat, A; Dukat, A; Gajdosova, M; Lietava, J; Penz, P; Thurzo, M; Vachulova, A; Conget, I; Hurtado, EA; Armayor, M; Bernardino, J; Sien, CC; Carrarro, R; Pareno, LD; Diez, L; Esteban, G; Lopez, LF; Gabriel, R; Herola, AG; Girones, C; Iamas, LG; Hermosa, G; Fernandez, PL; Macia, M; Morillejo, DM; Puig, J; Roldan, C; Urioste, LR; Carranza, ES; Segura, J; Serrano, I; Tudelilla, F; Hedner, T; Anders, M; Andren, L; Berndtson, I; Dahlen, G; Eriksson, A; Escar, M; Jungersten, L; Lindh, G; Nielsen, H; Polhem, LNB; Sandberg, M; Skrtic, S; Svensson, S; Wallerstedt, S; Dinccag, N; Kaya, S; Oglagu, Z; Tutuncu, Y; Davies, M; Barron, J; Beaverstock, J; Borthwick, L; Bradford, B; Bryan, L; Capps, N; Coates, F; Dickson, S; Donaldson, D; Forbes, F; Fox, C; Hall, K; Hollway, M; Howe, J; Jamieson, J; MacLeod, K; MacLeod, M; Maiden, J; Matthews, D; McIntosh, M; McQuaid, S; Millward, A; Nayani, G; Neil, A; Page, M; Piper, J; Ramell, M; Reynolds, T; Ross, S; Shore, A; Tonks, L; White, S; Wylie, J; Anderson, S; Anteola, E; Araghi, A; Bahtyiar, G; Baker, S; Bakris, G; Basta, E; Bastien, A; Bell, D; Bergenstal, R; Lopez, LB; Bigger, J; Brautigam, D; Bultermeier, N; Burgos-Calderon, R; Cacia, D; Casale, M; Charles, C; Chiarot, J; Cipolle, M; Coley, L; Cushman, B; de Lemos, J; Deshmukh, M; DeVivo, L; Donovan, D; Elliott, W; Farag, A; Flack, J; Fuste, P; Garay, S; De La Rosa, DG; De La Rosa, RG; Getaneh, A; Ginsberg, H; Goland, R; Goldberg, R; Griffin, S; Griffith, L; Grimm, R; Guber, H; Serrano, BG; Haddad, G; Hagen, M; Hall, K; Hamrahian, A; Herr, D; Hoogwerf, B; Izhar, M; Joseph, L; Kashyap, S; Kelly, M; Kempainen, S; Khera, A; Kringas, M; Levin, J; Linz, P; List, S; Lopez-Jimenez, C; Los, E; Manaiermam, M; Margolis, K; Matzinger, M; McFarlane, S; McGill, J; McGuire, D; Caban, GM; Mehta, A; Merkle, L; Meyer, B; Monk, A; Montalvo-Burke, L; Nelson, C; Neri, G; Nicasio, J; Octaviani, C; Ovalle, F; Padilla, S; Pepper, P; Portalatin, O; Probstfield, J; Ramirez, J; Kashyap, SR; Riddle, M; Cruz, AR; Saavedra, G; Scharf, D; Seibold, L; Shah, S; Shay, D; Siraj, E; Slavik, B; Smith, M; Solomon, S; Spencer, J; Stephens, E; Thomas, L; Vasquez, E; Ocasio, WV; Vetrano, M; Walsh, S; Zimmerman, R; Bosch, J; Barr, N; Choppick, C; Desai, D; George, J; Gerstein, HC; Khatib, P; Killman, K; MacRae, L; MacRae, S; Pasha, F; Pogue, J; Rangachari, U; Reiding, V; Robinson, D; Santarelli, L; Shannon, J; Sheridan, P; Yusuf, S; Pascual, A; Rovito, C; Fricke, B; McBride, E; Richmond, S; Smith, P; Frenette, L; Magi, A; Montecinos, A; Keenan, J; Starrett, J; Ramo, J; Tarvainen, M; Guth, A; Weise, B; Keltai, K; Kumar, V; Balode, I; Zilgalve, G; Garcia, I; Liceaga, P; Moreno, A; Bratten, G; Ronning, I; Nowak, W; West, W; Margo, B; Martinez, O; Dahl, G; Bookelmann, Y; Schoonhoven, M; Cetin, Z; Clare, S; Sackett, DL; Altman, D; Bennett, P; Clark, CM; Hamman, R; Ryden, L				Gerstein, H. C.; Yusuf, S.; Holman, R. R.; Bosch, J.; Anand, S.; Avezum, A.; Budaj, A.; Chiasson, J.; Conget, I.; Dagenais, G.; Davis, M.; Diaz, R.; Dinccag, N.; Enjalbert, M.; Escalante, A.; Fodor, G.; Hanefeld, M.; Hedner, T.; Jolly, K.; Keltai, M.; Laakso, M.; Lanas, F.; Lonn, E.; McQueen, M.; Mohan, V.; Phillips, A.; Piegas, L.; Pirags, V.; Probstfield, J.; Shaw, J.; Schmid, I.; Teo, K.; Zimmet, P.; Zinman, B.; Gerstein, H. C.; Yusuf, S.; Bosch, J.; Pogue, J.; Sheridan, P.; Dinccag, N.; Hanefeld, M.; Hoogwerf, B.; Laakso, M.; Mohan, V.; Shaw, J.; Zinman, B.; Holman, R. R.; Diaz, R.; Ahuad Guerrero, R.; Albisu, J.; Alvarez, M. S.; Arregui, V.; Avaca, H.; Baglivo, H.; Balbuena, M.; Bello, F.; Bono, J.; Botto, M.; Brandani, L.; Brandes, M.; Bruera, D.; Cabral Venere, R.; Caccavo, A.; Cacurri, A.; Caime, G.; Capozzi, M.; Carrique, A.; Carrique, P.; Cartasegna, L.; Casabe, J.; Casaccia, G.; Castellanos, C.; Castro, L.; Cendali, G.; Cerchi, P.; Cerdan, M.; Cinalli, M.; Cipullo, M.; Cismondi, M.; Citta, N.; Citta, L.; Crespo, C.; Crunger, P.; Cuneo, C.; De Loredo, L.; De Loredo, S.; del Cerro, S.; Denaro, R.; Esperatti, E.; Esposito, L.; Farras, H.; Fernandez, A.; Fernandez, M.; Fernandez, S.; Ferrari, G.; Focaccia, M.; Frontini, L.; Gabito, A.; Gambarte, A.; Garrido, M.; Garrido, I.; Guglielmotti, V.; Hershson, A.; Hoffman, V.; Juarisit, G.; Klyver, M.; Lagrutta, M.; Liberman, A.; Llanos, J.; Lobo Marquez, L.; Lopez, R.; Lowenstein, D.; Lowenstein, J.; Lucero, C.; Luciardi, H.; Luduena Clos, E.; Luna, M.; Luquez, C.; MacKinnon, I.; Maffia, M.; Mahfoud, C.; Majul, C.; Maldonado, N.; Manuale, O.; Marcucci, G.; Martin, S.; Martinez, G.; Martos, M.; Marzetti, E.; Memoli, R.; Molina, M.; Montana, O.; Morales, S.; Morell, Y.; Navarrete, S.; Nieto, F.; Ocampo, L.; Orce, R.; Orlandini, A.; Oteiza, E.; Pepa, C.; Piasentin, J.; Piskorz, D.; Plastino, M.; Pomposiello, J.; Quiroga, G.; Ramos, F.; Ramos, H.; Reissig, F.; Risolo, A.; Riverso, Z.; Rodrigues, H.; Rodriquez, C.; Saavedra, S.; Sago, L.; Sanchez, R.; Schwindt, C.; Schygiel, P.; Sebastian, F.; Sposetti, G.; Streitenberger, P.; Suarez, G.; Suzrez, F.; Vico, M.; Vignau, S.; Visco, V.; Vizcaya Castro, A.; Zaidman, C.; Shaw, J.; Zimmet, P.; Allen, C.; Arsov, T.; Bartlett, N.; Batrouney, B.; Borger, R.; Brooks, B.; Buchanan, P.; Buckland, A.; Calvert, D.; Carr, J.; Chan, Y.; Ching, H.; Chronopoulos, A.; Coates, P.; Cohen, N.; Colagiuri, S.; Colman, P.; Correcha, M.; d'Emden, M.; Ding, G.; Edwards, W.; Estensen, K.; Fitzpatrick, B.; Freeborn, J.; Friebel, H.; Fulcher, G.; Garland, C.; Gauld, A.; Gein, J.; Glatthaar, C.; Graham, J.; Gronan, A.; Gunser, A.; Hackney, P.; Hall, C.; Hay, L.; Heazlewood, V.; Heyward, D.; Higgins, B.; Hines, M.; Hodge, A.; Honisett, S.; Jovanovska, A.; Karrasch, J.; Kean, M.; Lawton, M.; Lee, C.; Legg, H.; Long, F.; Lucas, E.; Lynch, L.; Marangou, A.; Margrie, F.; Martin, L.; McKenzie, J.; McKinnon, A.; McNamara, M.; Mencel, J.; Moses, R.; Murphy, C.; Naidu, V.; Nairn, J.; Nankervis, A.; Nattrass, N.; Ngweso, A.; Nugent, T.; O'Brien, R.; Palmer, N.; Parry, H.; Pasculli, K.; Patrikios, P.; Perampalam, S.; Phillips, J.; Phillips, S.; Por, E.; Pringle, S.; Prior, E.; Proietto, J.; Rando, L.; Ridley, D.; Roberts, A.; Robertson, P.; Robinson, K.; Rodgers, C.; Ross, G.; Rowe, J.; Siddall, R.; Silva, D.; Simpson, R.; Slobodniuk, R.; Smith, G.; Socha, L.; Soden, V.; Speedy, M.; Spence, E.; Steed, K.; Stephens, C.; Stewart, R.; Stuckey, B.; Sumithran, P.; Sunderland, J.; Tapp, E.; Tejani, N.; Tong, C.; Topliss, D.; Tran, H.; Vanlint, S.; Wagner, J.; Walsh, J.; Warner, J.; Webb, A.; Welborn, T.; Wentworth, J.; White, C.; Wigg, S.; Willenberg, V.; Wilson, D.; Wood, M.; Wu, S.; Yue, D.; Yuen, R.; Baillie, S. Marshall E.; Campbell, G.; Cressall, J.; Heir, J.; Jones, D.; Myrie, J.; Watlington, M.; West, A.; Avezum, A.; Piegas, L.; Bertolami, M.; Borges, J.; Branco de Araujo, D.; Cartena, L.; Campos Salvarani, N. de; Faludi, A.; Fernades Telo, D.; Grespan, S.; Gross, J.; Halpern, A.; Hirota, A.; Maeda, S.; Monte, O.; Nakamura, Y.; Nunes Salles, J.; Oliveira, O.; Pinto, C.; Rabelo, L.; Rabelo, A., Jr.; Silveiro, S.; Turatti, L.; Zatz, H.; Zoubel, V.; Dagenais, G.; Abbott, C.; Abu-Bakare, A.; Allison, R.; Anand, S.; Anderlic, T.; Auger, D.; Barnie, A.; Beauchef, J.; Beers, S.; Beliveau, L.; Berard, L.; Bolduc, H.; Bondy, G.; Bradley, J.; Bragaglia, P.; Brault, S.; Brittain, M.; Brossoit, R.; Brown, S.; Capes, S.; Carmichael, P.; Caron, D.; Caruana, L.; Cha, J.; Champion, P.; Chan, S.; Chan, Y.; Chausse, I.; Cheung, R.; Chiasson, J.; Chilvers, M.; Chisholm, S.; Clearwaters, M.; Colborne, C.; Conway, J.; Czolpinski, T.; Dallaire, S.; David, M.; Davis, A.; DeAngelis, D.; Delpech, I.; Denton, R.; Dufour, A.; Dunn, P.; Duong, H.; Eddy, D.; Erickson-Nesmith, S.; Fay, D.; Frohlich, G. Fox J.; Fyfe, M.; Galandzy, S.; Gauthier, S.; Gillett, J.; Girard, G.; Gosselin, G.; Gourgues, M.; Gray, S.; Grunbaum, D.; Gupta, M.; Halle, J.; Hanley, A.; Hardin, P.; Harris, S.; Harvey, N.; Hoag, G.; Hogard, M.; Houlden, R.; Hughes, D.; Hunt, D.; Janzen, L.; Jenkins, O.; Krider, J.; Kwan, S.; Lai, C.; Lam, A.; Lambing, L.; Lau, D.; Lavallee, C.; Lavallee, P.; LeDrew, G.; Lee, H.; Legare, C.; Leong, W.; Lesperance, D.; Lochnan, H.; Ludwig, S.; MacNair, D.; Mann, S.; Marin, M.; MacFadyen, J.; MacLean, S.; Marucci, J.; Masson, C.; Maurice, P.; Mawani, S.; McCarthy, A.; McCarthy, G.; McInnis, D.; McLean, S.; McLean, A.; Monier, D.; Montreuil, S.; Neal, L.; Newman, S.; O'Keefe, D.; Oprici, T.; Otis, J.; Ouellet, G.; Parmar, M.; Paul, M.; Petrella, R.; Petrella, S.; Phillips, R.; Poisson, D.; Prieur, S.; Rabasa-Lhoret, R.; Rajakumar, G.; Rajakumar, A.; Raymond, J.; Richard, D.; Rideout, G.; Robert, C.; Robitaille, Y.; Ross, D.; Ross, S.; Rowe, R.; Salmon, C.; Saunier, D.; Savard, C.; Savard, D.; Sayeed, R.; Sayeed, Z.; Sestier, F.; Shaban, J.; Shu, D.; Sigal, R.; Silverberg, J.; Smith, E.; Smith, R.; Soucy, J.; Starra, R.; Stearn, B.; Steel, D.; Steinson, D.; Sternberg, B.; Stewart, D.; Stone, F.; Sussex, B.; Tippe, D.; Toupin-Halle, A.; Trapsa, D.; Tremblay, S.; Troung, N.; van Buuren, J.; VanSickle, L.; Verdonk, R.; Whitsitt, P.; Wilson, R.; Winkler, L.; Wong, W.; Woo, V.; Wozniak, P.; Yale, J.; Zaniol, D.; Zaychkowsky, L.; Zimakas, G.; Zinman, B.; Zmijowskyj, T.; Lanas, F.; Atkinson Altamirano, M.; Bello Murua, F.; Landaeta, O.; Larenas, G.; Raddatz Kiefer, V.; Roddriguez, L.; Torres Carrasco, O.; Laakso, M.; Harkonen, P.; Hiltunen, L.; Jantunen, A.; Keinanen-Kiukaanniemi, S.; Laakso, M. M.; Lahdensuo, E.; Rutanen, J.; Saastamoinen, E.; Salaspuro, V.; Sivenius, K.; Valle, T.; Hanefeld, M.; Budziarek, P.; Engeli, S.; Fache, K.; Fischer, C.; Flehmig, K.; Gordalla, A.; Gottschalk, I.; Habel, M.; Hampel, R.; Henkel, E.; Hoeltzl, S.; Jordan, J.; Kletetschka, M.; Kresse, C.; Lehmann, D.; Mehling, H.; Otte, C.; Pein, M.; Pfeffer, B.; Ploog, B.; Schaper, F.; Scholz, G.; Stoffels, G.; Strauss, A.; Wilhelm, K.; Keltai, M.; Balazs, B.; Balogh, E.; Birkus, Z.; Boros, T.; Gyarmati, G.; Hati, K.; Hati, K.; Hermanyi, Z.; Herold Benko, M.; Kempler, P.; Kohari, A.; Kornel, S.; Laszlo, Z.; Laszlo, Z. Z.; Nagy, F.; Nemeth, C.; Poor, F.; Pusztai, P.; Sandor, K.; Somogyi, A.; Takacs, J.; Toth, A.; Varga, E.; Voros, P.; Mohan, V.; Aravind, S.; Aravind, S. R.; Ayyar, V.; Dharmalingam, M.; Ganapathi, B.; Gayatri, R.; Gopal, U.; Idiculla, J.; Kalaivani, U.; Karkuzhali, K.; Kavitha, L.; Krishnan, S.; Kumar, P.; Kumar, K.; Monika, M.; Muniswamy, M.; Padmalatha Devi, M.; Pais, P.; Poongothai, S.; Prakash, S.; Ramu, M.; Rao, P. V.; Rao, C.; Shailaja, K.; Sreenivas, T.; Sudha, S.; Udayakumar, K.; Yajnik, C.; Pirags, V.; Erina, A.; Gailiss, E.; Gara, S.; Gozite, A.; Hansone, S.; Kreislere, I.; Liepa, L.; Ozolina, M.; Putane, L.; Raibarts, J.; Rasa, I.; Rozkova, N.; Rudzite, E.; Staka, A.; Veze, I.; Escalante, A.; Arellano, S.; Banuelos, K.; Calvo, C.; Carbajal, M.; Cardona, E.; Castaneda, R.; Chavira, J.; Dominguez, C.; Escalante, M.; Flores, E.; Gomez, F.; Gonzalez, J.; Gonzalez-Barcena, D.; Granados, C.; Illescas, J.; Jimenez, M.; Mancillas, L.; Mejia, L.; Mendoza, C.; Mendoza, L.; Munoz, M.; Munoz, A.; Padilla, V.; Pascoe, S.; Plascencia, O.; Ramos, C.; Reza, A.; Rubio, I.; Ruiz, E.; Vidrio, M.; Alhakim, M.; Bemelmans, V.; de Backer, W.; Eelkman Rooda, S.; Guldemond, F.; Hulshof, M.; Jonker, J.; Koppeschaar, H.; Meinema, K.; Pondman-Mulder, M.; Ponteyn-Rose, S.; van Asten, K.; de Walle, V. van; van Kempen, W.; Bryne, B.; Enderle, B.; Furuseth, K.; Halse, J.; Henriksen, T.; Hertzenberg Faehn, A.; Knudsrod, O.; Lerssl, S.; Loennicken, C.; Murud, K.; Steinbo, E.; Vaaler, S.; Budaj, A.; Baranowska, A.; Baranska, M.; Blaszak, J.; Bronisz, M.; Ceremuzynski, L.; Cywinska, H.; Czempik, E.; Gmytrasiewicz, M.; Grochola, A.; Grzegorz, O.; Ignaczak, P.; Janik, K.; Jankiewicz, B.; Kania, G.; Kawka-Urbanek, T.; Kolaczek, M.; Kopcik, D.; Kordys, M.; Krainska, A.; Majer, J.; Makuch, M.; Miekus, P.; Mormul, J.; Mrowczynska, A.; Nowak, D.; Nowakowski, P.; Ogorek, M.; Oleskowaska, L.; Paliszewska, L.; Przywoska-Para, B.; Pszonak, S.; Rozwodowska, M.; Rucinski, M.; Rzyman, M.; Sikora-Frac, M.; Stecka-Wierzbicka, J.; Swiatkowski, M.; Swierczynski, R.; Szczepanska, A.; Szpajer, M.; Ukleja-Adamowicz, M.; Urbaniak, A.; Winek, D.; Wojewoda, P.; Zaborksa, B.; Zadrosny, J.; Zak, J.; Zalska, B.; Fodor, G.; Bilicky, M.; Caprnda, M.; Dukat, A.; Dukat, A.; Gajdosova, M.; Lietava, J.; Penz, P.; Thurzo, M.; Vachulova, A.; Conget, I.; Aguilera Hurtado, E.; Armayor, M.; Bernardino, J.; Campo Sien, C.; Carrarro, R.; de Teresa Pareno, L.; Diez, L.; Esteban, G.; Fernandez Lopez, L.; Gabriel, R.; Garcia Herola, A.; Girones, C.; Guerrero Iamas, L.; Hermosa, G.; Lopez Fernandez, P.; Macia, M.; Mendez Morillejo, D.; Puig, J.; Roldan, C.; Ruilope Urioste, L.; Sanchez Carranza, E.; Segura, J.; Serrano, I.; Tudelilla, F.; Hedner, T.; Anders, M.; Andren, L.; Berndtson, I.; Dahlen, G.; Eriksson, A.; Escar, M.; Jungersten, L.; Lindh, G.; Nielsen, H.; Polhem, L. Ny B.; Sandberg, M.; Skrtic, S.; Svensson, S.; Wallerstedt, S.; Dinccag, N.; Kaya, S.; Oglagu, Z.; Tutuncu, Y.; Davies, M.; Barron, J.; Beaverstock, J.; Borthwick, L.; Bradford, B.; Bryan, L.; Capps, N.; Coates, F.; Dickson, S.; Donaldson, D.; Forbes, F.; Fox, C.; Hall, K.; Hollway, M.; Howe, J.; Jamieson, J.; MacLeod, K.; MacLeod, M.; Maiden, J.; Matthews, D.; McIntosh, M.; McQuaid, S.; Millward, A.; Nayani, G.; Neil, A.; Page, M.; Piper, J.; Ramell, M.; Reynolds, T.; Ross, S.; Shore, A.; Tonks, L.; White, S.; Wylie, J.; Anderson, S.; Anteola, E.; Araghi, A.; Bahtyiar, G.; Baker, S.; Bakris, G.; Basta, E.; Bastien, A.; Bell, D.; Bergenstal, R.; Berrios Lopez, L.; Bigger, J.; Brautigam, D.; Bultermeier, N.; Burgos-Calderon, R.; Cacia, D.; Casale, M.; Charles, C.; Chiarot, J.; Cipolle, M.; Coley, L.; Cushman, B.; de Lemos, J.; Deshmukh, M.; DeVivo, L.; Donovan, D.; Elliott, W.; Farag, A.; Flack, J.; Fuste, P.; Garay, S.; Garcia De La Rosa, D.; Garcia De La Rosa, R.; Getaneh, A.; Ginsberg, H.; Goland, R.; Goldberg, R.; Griffin, S.; Griffith, L.; Grimm, R.; Guber, H.; Guzman Serrano, B.; Haddad, G.; Hagen, M.; Hall, K.; Hamrahian, A.; Herr, D.; Hoogwerf, B.; Izhar, M.; Joseph, L.; Kashyap, S.; Kelly, M.; Kempainen, S.; Khera, A.; Kringas, M.; Levin, J.; Linz, P.; List, S.; Lopez-Jimenez, C.; Los, E.; Manaiermam, M.; Margolis, K.; Matzinger, M.; McFarlane, S.; McGill, J.; McGuire, D.; Medina Caban, G.; Mehta, A.; Merkle, L.; Meyer, B.; Monk, A.; Montalvo-Burke, L.; Nelson, C.; Neri, G.; Nicasio, J.; Octaviani, C.; Ovalle, F.; Padilla, S.; Pepper, P.; Portalatin, O.; Probstfield, J.; Ramirez, J.; Rao Kashyap, S.; Riddle, M.; Rivera Cruz, A.; Saavedra, G.; Scharf, D.; Seibold, L.; Shah, S.; Shay, D.; Siraj, E.; Slavik, B.; Smith, M.; Solomon, S.; Spencer, J.; Stephens, E.; Thomas, L.; Vasquez, E.; Vega Ocasio, W.; Vetrano, M.; Walsh, S.; Zimmerman, R.; Bosch, J.; Barr, N.; Choppick, C.; Desai, D.; George, J.; Gerstein, H. C.; Khatib, P.; Killman, K.; MacRae, L.; MacRae, S.; Pasha, F.; Pogue, J.; Rangachari, U.; Reiding, V.; Robinson, D.; Santarelli, L.; Shannon, J.; Sheridan, P.; Yusuf, S.; Pascual, A.; Rovito, C.; Fricke, B.; McBride, E.; Richmond, S.; Smith, P.; Frenette, L.; Magi, A.; Montecinos, A.; Keenan, J.; Starrett, J.; Ramo, J.; Tarvainen, M.; Gueth, A.; Weise, B.; Keltai, K.; Kumar, V.; Balode, I.; Zilgalve, G.; Garcia, I.; Liceaga, P.; Moreno, A.; Bratten, G.; Ronning, I.; Nowak, W.; West, W.; Margo, B.; Martinez, O.; Dahl, G.; Bookelmann, Y.; Schoonhoven, M.; Cetin, Z.; Clare, S.; Sackett, D. L.; Altman, D.; Bennett, P.; Clark, C. M.; Hamman, R.; Ryden, L.		DREAM Trial Investigators	Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial	LANCET			English	Article							LIFE-STYLE INTERVENTION; PHARMACOLOGICAL-TREATMENT; INSULIN-RESISTANCE; HEART-FAILURE; PREVENTION; MELLITUS; THIAZOLIDINEDIONES; PRESERVATION; METFORMIN; OUTCOMES	Background Rosiglitazone is a thiazolidinedione that reduces insulin resistance and might preserve insulin secretion. The aim of this study was to assess prospectively the drugs ability to prevent type 2 diabetes in individuals at high risk of developing the condition. Methods 5269 adults aged 30 years or more with impaired fasting glucose or impaired glucose tolerance, or both, and no previous cardiovascular disease were recruited from 191 sites in 21 countries and randomly assigned to receive rosiglitazone (8 mg daily; n=2365) or placebo (2634) and followed for a median of 3 years. The primary outcome was a composite of incident diabetes or death. Analyses were done by intention to treat. This trial is registered at ClinicalTrials.gov, number NCT00095654. Findings At the end of study, 59 individuals had dropped out from the rosiglitazone group and 46 from the placebo group. 306 (11.6%) individuals given rosiglitazone and 686 (26.0%) given placebo developed the composite primary outcome (hazard ratio 0.40, 95% CI 0.35-0.46; p<0.0001); 1330 (50.5%) individuals in the rosiglitazone group and 798 (30.3%) in the placebo group became normoglycaemic (1.71,1-57-1.87; p<0.0001). Cardiovascular event rates were much the same in both groups, although 14 (0.5%) participants in the rosiglitazone group and two (0.1%) in the placebo group developed heart failure (p=0.01). Interpretation Rosiglitazone at 8 mg daily for 3 years substantially reduces incident type 2 diabetes and increases the likelihood of regression to normoglycaemia in adults with impaired fasting glucose or impaired glucose tolerance, or both.	Populat Hlth Res Inst, DREAM Project Off, Hamilton, ON L8L 2X2, Canada	Population Health Research Institute	Gerstein, HC (corresponding author), Populat Hlth Res Inst, DREAM Project Off, 237 Barton St E,2nd Floor, Hamilton, ON L8L 2X2, Canada.	dream@cardio.on.ca	Jantunen, Ari/D-2658-2009; de Lemos, James/ABD-6669-2021; Gerstein, Hertzel/ABB-8781-2020; Zinman, Bernard/E-7266-2013; Takács, Ján/ABE-7743-2020; Mancillas, Leonardo/AAO-3212-2020; von Ungern-Sternberg, Britta/CAG-9904-2022; Keltai, Katalin/V-4350-2019; Sigal, Ronald/AAU-6081-2020; Ovalle, Fernando/Q-6647-2019; Avezum, Alvaro AA/K-6137-2016; Silveiro, Sandra Pinho/V-7922-2019; Pirags, Valdis/AAQ-5492-2020; Sigal, Ron/AAK-7627-2020; Lanas, Fernando/AAE-8842-2022; Siraj, Elias/S-8152-2019; TUTUNCU, YILDIZ/D-3955-2015; Denton, Richard/ABC-9914-2020; Gerstein, Hertzel C/B-1235-2013; Turatti, Luiz Alberto Andreotti/AAM-5631-2021; Piskorz, Daniel/AAJ-8751-2020; Avezum, Alvaro/AAP-7687-2020; Jolly, Kate/AAA-1341-2019; Bosch, Jacqueline/AAP-6910-2021; Fusté, Pere/P-7244-2015; Shaw, Jonathan/E-7388-2010; Zimmet, Paul/O-8486-2019; Petrella, Robert J/G-6557-2018; Honisett, Suzy/AAV-8333-2020; Monte, Osmar/G-9063-2012; Fernandez, Michael/D-2889-2009; Topliss, Duncan/AAK-7082-2020; Bernardino, Jose Ignacio/H-7898-2017; Gray, Stuart/L-2489-2017	Jantunen, Ari/0000-0002-0761-6882; Gerstein, Hertzel/0000-0001-8072-2836; Mancillas, Leonardo/0000-0002-5556-7018; von Ungern-Sternberg, Britta/0000-0002-8043-8541; Keltai, Katalin/0000-0002-8294-9062; Ovalle, Fernando/0000-0002-6711-071X; Avezum, Alvaro AA/0000-0002-3073-6890; Silveiro, Sandra Pinho/0000-0003-4891-4074; Pirags, Valdis/0000-0002-3650-7394; TUTUNCU, YILDIZ/0000-0002-3905-6429; Gerstein, Hertzel C/0000-0001-8072-2836; Piskorz, Daniel/0000-0002-8615-5446; Jolly, Kate/0000-0002-6224-2115; Bosch, Jacqueline/0000-0001-6292-4207; Fusté, Pere/0000-0002-8129-9897; Shaw, Jonathan/0000-0002-6187-2203; Zimmet, Paul/0000-0003-0627-0776; Fernandez, Michael/0000-0003-2273-733X; Davies, Melanie/0000-0002-9987-9371; Kashyap, Sangeeta/0000-0002-7489-6650; Yusuf, Salim/0000-0003-4776-5601; Chippada, Apparao/0000-0002-9683-2738; Colman, Peter/0000-0001-8718-6175; Bernardino, Jose Ignacio/0000-0003-3501-8529; , Chippada Appa Rao/0000-0002-4817-8946; Andreotti Turatti, Luiz Alberto/0000-0002-0089-5794; Gray, Stuart/0000-0001-8969-9636; Bryan, Laura/0000-0002-9422-2338				Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Buse JB, 2005, ENDOCRIN METAB CLIN, V34, P221, DOI 10.1016/j.ecl.2004.11.003; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Diabetes Prevention Progam, 2005, DIABETES, V54, P1150; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; *DREAM TRIAL INV, IN PRESS N ENGL J ME; Finegood DT, 2001, DIABETES, V50, P1021, DOI 10.2337/diabetes.50.5.1021; Genuth S, 2003, DIABETES CARE, V26, P3160; Gerstein HC, 2004, DIABETOLOGIA, V47, P1519, DOI 10.1007/s00125-004-1485-5; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kosaka K, 2005, DIABETES RES CLIN PR, V67, P152, DOI 10.1016/j.diabres.2004.06.010; Lachin JM, 1999, CONTROL CLIN TRIALS, V20, P408, DOI 10.1016/S0197-2456(99)00022-7; Leiter LA, 2005, DIABETIC MED, V22, P963, DOI 10.1111/j.1464-5491.2005.01605.x; Lupi R, 2004, AM J PHYSIOL-ENDOC M, V286, pE560, DOI 10.1152/ajpendo.00561.2002; Masoudi FA, 2005, CIRCULATION, V111, P583, DOI 10.1161/01.CIR.0000154542.13412.B1; Nakamura T, 2001, DIABETES RES CLIN PR, V54, P181, DOI 10.1016/S0168-8227(01)00319-9; Nesto RW, 2003, CIRCULATION, V108, P2941, DOI 10.1161/01.CIR.0000103683.99399.7E; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Sarafidis PA, 2006, AM J HYPERTENS, V19, P646, DOI 10.1016/j.amjhyper.2005.12.017; Secree R, 2003, DIABETES ATLAS, P17; Semenkovich CF, 2005, NAT MED, V11, P822, DOI 10.1038/nm0805-822; Snijder MB, 2004, INT J OBESITY, V28, P402, DOI 10.1038/sj.ijo.0802567; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; Xiang AH, 2004, J CLIN ENDOCR METAB, V89, P2846, DOI 10.1210/jc.2003-032044; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Yki-Jarvinen H, 2005, ANN MED, V37, P347, DOI 10.1080/07853890510037383; Yusuf S, 2000, NEW ENGL J MED, V342, P145	28	1275	1314	2	158	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2006	368	9541					1096	1105		10.1016/S0140-6736(06)69420-8	http://dx.doi.org/10.1016/S0140-6736(06)69420-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089IC	16997664				2022-12-28	WOS:000240873000025
J	Clayton, RN				Clayton, Robert N.			Meteorites and their parent asteroids	SCIENCE			English	Editorial Material							OXYGEN-ISOTOPE; ORIGIN		Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA	University of Chicago	Clayton, RN (corresponding author), Univ Chicago, Enrico Fermi Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA.	r-clayton@uchicago.edu						Burnett DS, 2003, SPACE SCI REV, V105, P509, DOI 10.1023/A:1024425810605; Clayton RN, 2002, NATURE, V415, P860, DOI 10.1038/415860b; Clayton RN, 2003, SPACE SCI REV, V106, P19, DOI 10.1023/A:1024669116828; Clayton RN, 1996, GEOCHIM COSMOCHIM AC, V60, P1999, DOI 10.1016/0016-7037(96)00074-9; Greenwood RC, 2006, SCIENCE, V313, P1763, DOI 10.1126/science.1128865; Greenwood RC, 2005, NATURE, V435, P916, DOI 10.1038/nature03612; Krot AN, 2005, TREATISE GEOCHEM, V1, P83; Lyons JR, 2005, NATURE, V435, P317, DOI 10.1038/nature03557; PAHLEVAN K, 2005, LUN PLAN SCI C, V36; Wiechert U, 2001, SCIENCE, V294, P345, DOI 10.1126/science.1063037; Wiechert UH, 2004, EARTH PLANET SC LETT, V221, P373, DOI 10.1016/S0012-821X(04)00090-1; Yurimoto H, 2004, SCIENCE, V305, P1763, DOI 10.1126/science.1100989	13	7	7	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2006	313	5794					1743	1744		10.1126/science.1133137	http://dx.doi.org/10.1126/science.1133137			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990537				2022-12-28	WOS:000240655700031
J	Tang, J; Maximov, A; Shin, OH; Dai, H; Rizo, J; Sudhof, TC				Tang, Jiong; Maximov, Anton; Shin, Ok-Ho; Dai, Han; Rizo, Josep; Sudhof, Thomas C.			A complexin/synaptotagmin 1 switch controls fast synaptic vesicle exocytosis	CELL			English	Article							SNARE COMPLEX; TRANSMITTER RELEASE; SYNAPTOTAGMIN-I; NEUROTRANSMITTER RELEASE; 3-DIMENSIONAL STRUCTURE; PHOSPHOLIPID-BINDING; FUSION; COMPONENTS; TERMINALS; PROTEINS	Ca2+ binding to synaptotagmin 1 triggers fast exocytosis of synaptic vesicles that have been primed for release by SNARE-complex assembly. Besides synaptotagmin 1, fast Ca2+-triggered exocytosis requires complexins. Synaptotagmin 1 and complexins both bind to assembled SNARE complexes, but it is unclear how their functions are coupled. Here we propose that complexin binding activates SNARE complexes into a metastable state and that Ca2+ binding to synaptotagmin 1 triggers fast exocytosis by displacing complexin from metastable SNARE complexes. Specifically, we demonstrate that, biochemically, synaptotagmin 1 competes with complexin for SNARE-complex binding, thereby dislodging complexin from SNARE complexes in a Ca2+-dependent manner. Physiologically, increasing the local concentration of complexin selectively impairs fast Ca2+-triggered exocytosis but retains other forms of SNARE-dependent fusion. The hypothesis that Ca2+-induced displacement of complexins from SNARE complexes triggers fast exocytosis accounts for the loss-of-function and gain-of-function phenotypes of complexins and provides a molecular explanation for the high speed and synchronicity of fast Ca2+-triggered neurotransmitter release.	Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA.	thomas.sudhof@utsouthwestern.edu	Karakhanov, Edward/P-1660-2015					Archer DA, 2002, J BIOL CHEM, V277, P18249, DOI 10.1074/jbc.C200166200; Banerjee A, 1996, J BIOL CHEM, V271, P20227, DOI 10.1074/jbc.271.34.20227; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bowen ME, 2005, BIOPHYS J, V89, P690, DOI 10.1529/biophysj.104.054064; Bracher A, 2002, J BIOL CHEM, V277, P26517, DOI 10.1074/jbc.M203460200; BRIAN AA, 1984, P NATL ACAD SCI-BIOL, V81, P6159, DOI 10.1073/pnas.81.19.6159; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Chen XC, 2006, BIOPHYS J, V90, P2062, DOI 10.1529/biophysj.105.071415; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Deak F, 2004, NAT CELL BIOL, V6, P1102, DOI 10.1038/ncb1185; Dykes IM, 2004, GENE EXPR PATTERNS, V4, P93, DOI 10.1016/S1567-133X(03)00143-1; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Hill JJ, 2006, BIOCHEM BIOPH RES CO, V342, P791, DOI 10.1016/j.bbrc.2006.02.029; Hu KA, 2002, J BIOL CHEM, V277, P41652, DOI 10.1074/jbc.M205044200; ISHIZUKA T, 1995, BIOCHEM BIOPH RES CO, V213, P1107, DOI 10.1006/bbrc.1995.2241; Itakura M, 1999, BIOCHEM BIOPH RES CO, V265, P691, DOI 10.1006/bbrc.1999.1756; Katz B., 1969, RELEASE NEURAL TRANS; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Ono S, 1998, EUR J NEUROSCI, V10, P2143, DOI 10.1046/j.1460-9568.1998.00225.x; Pabst S, 2002, J BIOL CHEM, V277, P7838, DOI 10.1074/jbc.M109507200; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Rickman C, 2004, J BIOL CHEM, V279, P12574, DOI 10.1074/jbc.M310710200; Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Sorensen JB, 2005, TRENDS NEUROSCI, V28, P453, DOI 10.1016/j.tins.2005.06.007; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tokumaru H, 2001, CELL, V104, P421, DOI 10.1016/S0092-8674(01)00229-X; Trommershauser J, 2003, BIOPHYS J, V84, P1563, DOI 10.1016/S0006-3495(03)74967-4; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925	44	331	343	1	35	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 22	2006	126	6					1175	1187		10.1016/j.cell.2006.08.030	http://dx.doi.org/10.1016/j.cell.2006.08.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990140	Bronze			2022-12-28	WOS:000240897600022
J	Schachinger, V; Erbs, S; Elsasser, A; Haberbosch, W; Hambrecht, R; Holschermann, H; Yu, JT; Corti, R; Mathey, DG; Hamm, CW; Suselbeck, T; Assmus, B; Tonn, T; Dimmeler, S; Zeiher, AM				Schaechinger, Volker; Erbs, Sandra; Elsaesser, Albrecht; Haberbosch, Werner; Hambrecht, Rainer; Hoelschermann, Hans; Yu, Jiangtao; Corti, Roberto; Mathey, Detlef G.; Hamm, Christian W.; Sueselbeck, Tim; Assmus, Birgit; Tonn, Torsten; Dimmeler, Stefanie; Zeiher, Andreas M.		REPAIR-AMI Investigators	Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REGENERATION ENHANCEMENT; TOPCARE-AMI; TRANSPLANTATION; HEART	BACKGROUND: Pilot trials suggest that the intracoronary administration of autologous progenitor cells may improve left ventricular function after acute myocardial infarction. METHODS: In a multicenter trial, we randomly assigned 204 patients with acute myocardial infarction to receive an intracoronary infusion of progenitor cells derived from bone marrow (BMC) or placebo medium into the infarct artery 3 to 7 days after successful reperfusion therapy. RESULTS: At 4 months, the absolute improvement in the global left ventricular ejection fraction (LVEF) was significantly greater in the BMC group than in the placebo group (mean [+/-SD] increase, 5.5+/-7.3% vs. 3.0+/-6.5%; P=0.01). Patients with a baseline LVEF at or below the median value of 48.9% derived the most benefit (absolute improvement in LVEF, 5.0%; 95% confidence interval, 2.0 to 8.1). At 1 year, intracoronary infusion of BMC was associated with a reduction in the prespecified combined clinical end point of death, recurrence of myocardial infarction, and any revascularization procedure (P=0.01). CONCLUSIONS: Intracoronary administration of BMC is associated with improved recovery of left ventricular contractile function in patients with acute myocardial infarction. Large-scale studies are warranted to examine the potential effects of progenitor-cell administration on morbidity and mortality.	Goethe Univ Frankfurt, Dept Internal Med 3, D-60590 Frankfurt, Germany; Herzzentrum Leipzig, Dept Cardiol, Leipzig, Germany; Max Planck Inst Physiol & Clin Res, Kerckhoff Klin, Dept Cardiol, D-6350 Bad Nauheim, Germany; Zent Klinikum Suhl, Dept Internal Med, Suhl, Germany; Univ Giessen Klinikum, Dept Cardiol, D-6300 Giessen, Germany; Zent Klinikum, Dept Cardiol, Bad Berka, Germany; Univ Hamburg, Ctr Cardiovasc, Hamburg, Germany; Univ Klinikum, Dept Cardiol, Mannheim, Germany; Red Cross Blood Donor Serv Baden Wurttemberg Hess, Inst Transfus Med & Immunohematol, Frankfurt, Germany; Univ Spital Zurich, Dept Cardiol, Zurich, Switzerland	Goethe University Frankfurt; Heart Center Leipzig GMBH; Kerckhoff Clinic; Max Planck Society; University Hospital of Giessen & Marburg; University of Hamburg; Ruprecht Karls University Heidelberg; University of Zurich; University Zurich Hospital	Zeiher, AM (corresponding author), Goethe Univ Frankfurt, Dept Internal Med 3, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	zeiher@em.uni-frankfurt.de	Assmus, Birgit/L-3274-2017; Hamm, Christian W./I-3155-2017; Assmus, Birgit/ABF-6853-2021; Assmus, Birgit/AAX-3004-2021	Assmus, Birgit/0000-0003-2658-6444; Hamm, Christian W./0000-0001-6763-4161; Assmus, Birgit/0000-0003-2658-6444; Dimmeler, Stefanie/0000-0002-1045-2436				Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Britten MB, 2003, CIRCULATION, V108, P2212, DOI 10.1161/01.CIR.0000095788.78169.AF; Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283; Fernandez-Aviles F, 2004, CIRC RES, V95, P742, DOI 10.1161/01.RES.0000144798.54040.ed; Halkin A, 2005, J AM COLL CARDIOL, V45, P1397, DOI 10.1016/j.jacc.2005.01.041; Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0; Kawamoto A, 2001, CIRCULATION, V103, P634; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Lange RA, 2002, NEW ENGL J MED, V346, P954, DOI 10.1056/NEJM200203283461302; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Montalescot G, 2001, NEW ENGL J MED, V344, P1895, DOI 10.1056/NEJM200106213442503; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; Schachinger Volker, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS23, DOI 10.1038/ncpcardio0441; Schomig A, 2000, NEW ENGL J MED, V343, P385, DOI 10.1056/NEJM200008103430602; Stone GW, 2002, NEW ENGL J MED, V346, P957, DOI 10.1056/NEJMoa013404; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Sutherland D R, 1996, J Hematother, V5, P213, DOI 10.1089/scd.1.1996.5.213; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9	21	1481	1588	0	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 21	2006	355	12					1210	1221		10.1056/NEJMoa060186	http://dx.doi.org/10.1056/NEJMoa060186			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085IT	16990384				2022-12-28	WOS:000240598500005
J	Stephenson, I				Stephenson, Iain			H5N1 vaccines: how prepared are we for a pandemic?	LANCET			English	Editorial Material							MF59-ADJUVANTED INFLUENZA; VIRUS; ANTIGENICITY; SAFETY		Leicester Royal Infirm, Infect Dis Unit, Leicester LE1 5WW, Leics, England	University of Leicester	Stephenson, I (corresponding author), Leicester Royal Infirm, Infect Dis Unit, Leicester LE1 5WW, Leics, England.	iain.stephenson@uhl-tr.nhs.uk						Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; BROWN D, 2006, WASHINGTON POST 0505; Fedson DS, 2005, J PUBLIC HEALTH POL, V26, P4, DOI 10.1057/palgrave.jphp.3200008; Fuminger IGS, 1998, TXB INFLUENZA, P324; LIN J, 2006, LANCET          0907, DOI DOI 10.1016/S0140-6736(06)69294-5; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; NICHOLSON KG, 1979, J BIOL STAND, V7, P123, DOI 10.1016/S0092-1157(79)80044-X; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Stephenson I, 2005, J INFECT DIS, V191, P1210, DOI 10.1086/428948; Stephenson I, 2004, LANCET INFECT DIS, V4, P499, DOI 10.1016/S1473-3099(04)01105-3; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; WRIGHT PF, 1977, J INFECT DIS, V136, pS731, DOI 10.1093/infdis/136.Supplement_3.S731; 2006, AVIAN INFLUENZA 0829	14	24	28	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 16	2006	368	9540					965	966		10.1016/S0140-6736(06)69340-9	http://dx.doi.org/10.1016/S0140-6736(06)69340-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	086UO	16980092				2022-12-28	WOS:000240698700004
J	Murray, SA; Sheikh, A				Murray, Scott A.; Sheikh, Aziz			Serial interviews for patients with progressive diseases	LANCET			English	Editorial Material							TERMINALLY-ILL PATIENTS; QUALITATIVE RESEARCH; CANCER; CARE		Univ Edinburgh, Gen Practice Sect, Div Community Hlth Sci, Primary Palliat Care Res Grp, Edinburgh EH8 9DX, Midlothian, Scotland	University of Edinburgh	Murray, SA (corresponding author), Univ Edinburgh, Gen Practice Sect, Div Community Hlth Sci, Primary Palliat Care Res Grp, Edinburgh EH8 9DX, Midlothian, Scotland.	Scott.Murray@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056				Boulton M, 1999, BMJ-BRIT MED J, V319, P232, DOI 10.1136/bmj.319.7204.232; Coyle N, 2004, J PAIN SYMPTOM MANAG, V27, P300, DOI 10.1016/j.jpainsymman.2003.08.008; Emanuel EJ, 2004, ARCH INTERN MED, V164, P1999, DOI 10.1001/archinte.164.18.1999; Holland J, 2004, FEASIBILITY STUDY PO; Malterud K, 2001, LANCET, V358, P397, DOI 10.1016/S0140-6736(01)05548-9; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Murray SA, 2002, BRIT MED J, V325, P929, DOI 10.1136/bmj.325.7370.929; World Health Organization, 2004, PALL CAR SOL FACTS; Yedidia MJ, 2001, J PAIN SYMPTOM MANAG, V22, P807, DOI 10.1016/S0885-3924(01)00325-6	10	27	27	1	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 9	2006	368	9539					901	902		10.1016/S0140-6736(06)69350-1	http://dx.doi.org/10.1016/S0140-6736(06)69350-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	083ZX	16962865				2022-12-28	WOS:000240502300009
J	Walter, KM; Zimov, SA; Chanton, JP; Verbyla, D; Chapin, FS				Walter, K. M.; Zimov, S. A.; Chanton, J. P.; Verbyla, D.; Chapin, F. S., III			Methane bubbling from Siberian thaw lakes as a positive feedback to climate warming	NATURE			English	Article							ATMOSPHERIC METHANE; CARBON-DIOXIDE; CH4; EMISSIONS; ALASKA; TUNDRA; FLUX; CO2	Large uncertainties in the budget of atmospheric methane, an important greenhouse gas, limit the accuracy of climate change projections(1,2). Thaw lakes in North Siberia are known to emit methane(3), but the magnitude of these emissions remains uncertain because most methane is released through ebullition (bubbling), which is spatially and temporally variable. Here we report a new method of measuring ebullition and use it to quantify methane emissions from two thaw lakes in North Siberia. We show that ebullition accounts for 95 per cent of methane emissions from these lakes, and that methane flux from thaw lakes in our study region may be five times higher than previously estimated(3). Extrapolation of these fluxes indicates that thaw lakes in North Siberia emit 3.8 teragrams of methane per year, which increases present estimates of methane emissions from northern wetlands (<6-40 teragrams per year; refs 1, 2, 4-6) by between 10 and 63 per cent. We find that thawing permafrost along lake margins accounts for most of the methane released from the lakes, and estimate that an expansion of thaw lakes between 1974 and 2000, which was concurrent with regional warming, increased methane emissions in our study region by 58 per cent. Furthermore, the Pleistocene age (35,260-42,900 years) of methane emitted from hotspots along thawing lake margins indicates that this positive feedback to climate warming has led to the release of old carbon stocks previously stored in permafrost.	Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA; NE Sci Stn, Cherskii 678830, Russia; Florida State Univ, Dept Oceanog, Tallahassee, FL 32306 USA; Univ Alaska, Dept Forest Sci, Fairbanks, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks; State University System of Florida; Florida State University; University of Alaska System; University of Alaska Fairbanks	Walter, KM (corresponding author), Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA.	ftkmw1@uaf.edu	Zimov, Sergey/K-3009-2018; Chapin, F Stuart/AAZ-3931-2020	Chapin, F Stuart/0000-0002-2558-9910; Zimov, Sergey/0000-0002-0053-6599				ASELMANN I, 1989, J ATMOS CHEM, V8, P307, DOI 10.1007/BF00052709; BARTLETT KB, 1992, J GEOPHYS RES-ATMOS, V97, P16645, DOI 10.1029/91JD00610; Bastviken D, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002238; Casper P, 2000, BIOGEOCHEMISTRY, V49, P1, DOI 10.1023/A:1006269900174; Conrad R, 2002, CHEMOSPHERE, V47, P797, DOI 10.1016/S0045-6535(02)00120-0; Corradi C, 2005, GLOBAL CHANGE BIOL, V11, P1910, DOI 10.1111/j.1365-2486.2005.01023.x; Czudek T., 1970, QUATERNARY RES, V1, P103, DOI [10.1016/0033-5894(70)90013-X, DOI 10.1016/0033-5894(70)90013-X]; Dlugokencky EJ, 1998, NATURE, V393, P447, DOI 10.1038/30934; Fletcher SEM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002223; FUNG I, 1991, J GEOPHYS RES-ATMOS, V96, P13033, DOI 10.1029/91JD01247; IPCC, 2001, CLIMATE CHANGE 2001; KELLER M, 1994, J GEOPHYS RES-ATMOS, V99, P8307, DOI 10.1029/92JD02170; KLING GW, 1992, HYDROBIOLOGIA, V240, P23, DOI 10.1007/BF00013449; MOSTAKHOV SE, 1973, MEZHD C MERZL PODZ V; Nakagawa F, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2000GB001384; NAKAYAMA T, 1995, THESIS HOKKAIDO U, P1; Phelps AR, 1998, J GEOPHYS RES-ATMOS, V103, P29029, DOI 10.1029/98JD00044; Reeburgh WS, 1998, J GEOPHYS RES-ATMOS, V103, P29005, DOI 10.1029/98JD00993; Romanovskii NN, 2000, PERMAFROST PERIGLAC, V11, P137, DOI 10.1002/1099-1530(200004/06)11:2<137::AID-PPP345>3.3.CO;2-C; Romanovsky N.N., 1993, OSNOVY KRIOGENEZA LI; ROULET NT, 1994, J GEOPHYS RES-ATMOS, V99, P1439, DOI 10.1029/93JD00261; Roulet NT, 1997, J GEOPHYS RES-ATMOS, V102, P29313, DOI 10.1029/97JD01237; Sazonova TS, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003680; Smith LC, 2005, SCIENCE, V308, P1429, DOI 10.1126/science.1108142; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; WILLMOTT CJ, 1930, ARCTIC TERRESTRIAL A; Worthy DEJ, 2000, J GEOPHYS RES-ATMOS, V105, P4031, DOI 10.1029/1999JD901100; Zhuang Q, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002239; Zimov SA, 1997, SCIENCE, V277, P800, DOI 10.1126/science.277.5327.800; Zimov SA, 2006, SCIENCE, V312, P1612, DOI 10.1126/science.1128908; [No title captured]	31	680	717	17	443	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 7	2006	443	7107					71	75		10.1038/nature05040	http://dx.doi.org/10.1038/nature05040			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16957728				2022-12-28	WOS:000240313900041
J	Emanuel, EJ				Emanuel, Ezekiel J.			Changing premed requirements and the medical curriculum	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EDUCATION; CARE; QUALITY		NIH, Dept Clin Bioeth, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Emanuel, EJ (corresponding author), NIH, Dept Clin Bioeth, Ctr Clin, Bldg 10,Room 1C118, Bethesda, MD 20892 USA.	eemanuel@nih.gov						*AD HOC COMM DEANS, 2004, ED DOCT PROV HIGH QU; *ASS AM MED COLL, 1999, MED SCH OBJ PROJ 3; Bloche MG, 2006, NEW ENGL J MED, V354, P993, DOI 10.1056/NEJMp068019; BLOOM SW, 1988, J HEALTH SOC BEHAV, V29, P294, DOI 10.2307/2136864; CHRISTAKIS NA, 1995, JAMA-J AM MED ASSOC, V274, P706, DOI 10.1001/jama.274.9.706; EMANUEL EJ, 2001, ENDS HUMAN LIFE MED; ENARSON C, 1992, JAMA-J AM MED ASSOC, V268, P1141, DOI 10.1001/jama.268.9.1141; Flexner A., 1910, MEDICAL ED US CANADA; Institute of Medicine, 1999, TO ERR IS HUM; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSS QUAL CHASM NEW; LEAPE LL, 2005, JAMA-J AM MED ASSOC, V205, P2384; *LIAIS COMM MED ED, ACCR STAND; LUDMERER KM, 1985, LEARNING HEAL DEV AM, pCH9; MAKOUL G, 2003, JAMA-J AM MED ASSOC, V289, P293; Malin JL, 2006, J CLIN ONCOL, V24, P626, DOI 10.1200/JCO.2005.03.3365; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; *NRC COMM UND BIOL, 2003, BIO 2010 TRANSF UND; *PROJ PAN GEN PROF, 1984, J MED EDUC, V59, P1; Whitcomb ME, 2006, ACAD MED, V81, P413, DOI 10.1097/01.ACM.0000222262.85760.13; Williams SC, 2005, NEW ENGL J MED, V353, P255, DOI 10.1056/NEJMsa043778; Wood EB, 2002, ACAD MED, V77, P285, DOI 10.1097/00001888-200204000-00005	21	52	53	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2006	296	9					1128	1131		10.1001/jama.296.9.1128	http://dx.doi.org/10.1001/jama.296.9.1128			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	081DW	16954492				2022-12-28	WOS:000240298400014
J	Colver, A; Hourihane, B				Colver, Allan; Hourihane, Butjonathan			For and against - Are the dangers of childhood food allergy exaggerated?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PEANUT ALLERGY; ANAPHYLACTIC REACTIONS; MANAGEMENT PLAN; FATAL REACTIONS; NUT ALLERGY; CHILDREN; EPINEPHRINE; PEDIATRICIANS; ADOLESCENTS; CHALLENGES		Newcastle Univ, Royal Victoria Infirm, Sir James Spence Inst, Sch Clin Med Sci Child Hlth, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Natl Univ Ireland Univ Coll Cork, Cork, Ireland	Newcastle University - UK; University College Cork	Colver, A (corresponding author), Newcastle Univ, Royal Victoria Infirm, Sir James Spence Inst, Sch Clin Med Sci Child Hlth, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	allan.colver@ncl.ac.uk; j.hourihane@ucc.ie						Alves B, 2001, ARCH DIS CHILD, V85, P349; Avery NJ, 2003, PEDIAT ALLERG IMM-UK, V14, P378, DOI 10.1034/j.1399-3038.2003.00072.x; Baral VR, 2005, POSTGRAD MED J, V81, P693, DOI 10.1136/pgmj.2004.030288; Bindslev-Jensen C, 2004, ALLERGY, V59, P690, DOI 10.1111/j.1398-9995.2004.00466.x; Bock SA, 2001, J ALLERGY CLIN IMMUN, V107, P191, DOI 10.1067/mai.2001.112031; *CHILD ACC PREV TR, 2006, CHILD ACC FACTS FACT; Christie L, 2002, J AM DIET ASSOC, V102, P1648, DOI 10.1016/S0002-8223(02)90351-2; Clark AT, 2003, ARCH DIS CHILD, V88, P79, DOI 10.1136/adc.88.1.79; Colver AF, 2005, ACTA PAEDIATR, V94, P689, DOI 10.1080/08035250510031566; Estelle F, 2006, J ALLERGY CLIN IMMUN, V117, P367, DOI 10.1016/j.jaci.2005.12.002; Ewan PW, 2001, LANCET, V357, P111, DOI 10.1016/S0140-6736(00)03543-1; Fleischer DM, 2005, J ALLERGY CLIN IMMUN, V116, P1087, DOI 10.1016/j.jaci.2005.09.002; Fleischer DM, 2003, J ALLERGY CLIN IMMUN, V112, P183, DOI 10.1067/mai.2003.1517; Foucard T, 1999, ALLERGY, V54, P261, DOI 10.1034/j.1398-9995.1999.00924.x; Foucard Tony, 2005, Lakartidningen, V102, P3465; Gold MS, 2000, J ALLERGY CLIN IMMUN, V106, P171, DOI 10.1067/mai.2000.106041; *HC HLTH COMM, 2004, REP PROV ALL SERV; Hill DJ, 2004, PEDIAT ALLERG IMM-UK, V15, P435, DOI 10.1111/j.1399-3038.2004.00188.x; Hourihane JO, 1997, CLIN EXP ALLERGY, V27, P634, DOI [10.1111/j.1365-2222.1997.tb01190.x, 10.1046/j.1365-2222.1997.d01-559.x]; Hourihane JO, 2002, ARCH DIS CHILD, V87, P450; Hu W, 2005, Med Humanit, V31, P12; Kapoor S, 2004, ALLERGY, V59, P185, DOI 10.1046/j.1398-9995.2003.00365.x; Kemp AS, 2003, J PAEDIATR CHILD H, V39, P372, DOI 10.1046/j.1440-1754.2003.00157.x; Kristjansson I, 1999, SCAND J PRIM HEALTH, V17, P30, DOI 10.1080/028134399750002863; Macdougall CF, 2002, ARCH DIS CHILD, V86, P236, DOI 10.1136/adc.86.4.236; Moneret-Vautrin DA, 2001, ALLERGY, V56, P1071, DOI 10.1034/j.1398-9995.2001.00047.x; *NAT ASTHM CAMP, ASTHMA J S, V6; Neugut AI, 2001, ARCH INTERN MED, V161, P15, DOI 10.1001/archinte.161.1.15; Osterballe M, 2005, PEDIAT ALLERG IMM-UK, V16, P567, DOI 10.1111/j.1399-3038.2005.00251.x; PERRY T, 2001, J ALLERGY CLIN IMMUN, V114, P1164; Pumphrey R, 2004, CURR OPIN ALLERGY CL, V4, P285, DOI 10.1097/01.all.0000136762.89313.0b; Pumphrey RSH, 2000, LANCET, V355, P1099, DOI 10.1016/S0140-6736(05)72220-0; Pumphrey RSH, 2000, CLIN EXP ALLERGY, V30, P1144, DOI 10.1046/j.1365-2222.2000.00864.x; Rangaraj S, 2004, PEDIAT ALLERG IMM-UK, V15, P449, DOI 10.1111/j.1399-3038.2004.00174.x; *RCP, 2003, ALL UNM NEED; Roberts G, 2003, J ALLERGY CLIN IMMUN, V112, P168, DOI 10.1067/mai.2003.1569; Roberts Graham, 2003, Paediatr Respir Rev, V4, P205, DOI 10.1016/S1526-0542(03)00058-7; Roberts S, 2005, ARCH DIS CHILD, V90, P564, DOI 10.1136/adc.2003.036814; Sampson HA, 1997, J ALLERGY CLIN IMMUN, V100, P444, DOI 10.1016/S0091-6749(97)70133-7; Sampson HA, 2004, J ALLERGY CLIN IMMUN, V113, P805, DOI 10.1016/j.jaci.2004.03.014; Sicherer SH, 2000, PEDIATRICS, V105, P359, DOI 10.1542/peds.105.2.359; Sicherer SH, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e6; SLATER J, 2002, ARCH DIS CHILD; *STAT OFF, 2005, GOV RESP HOUS COMM H; Tariq SM, 1996, BRIT MED J, V313, P514, DOI 10.1136/bmj.313.7056.514; Torr Tina, 2002, Paediatr Nurs, V14, P30; Vickers DW, 1997, CLIN EXP ALLERGY, V27, P898; Wren C, 2000, HEART, V83, P410, DOI 10.1136/heart.83.4.410	48	15	16	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2006	333	7566					494	498A		10.1136/bmj.333.7566.494	http://dx.doi.org/10.1136/bmj.333.7566.494			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	085QP	16946341	Green Published			2022-12-28	WOS:000240618900026
J	Horton, R				Horton, Richard			Phase I clinical trials: a call for papers	LANCET			English	Editorial Material							ONCOLOGY TRIALS		Lancet, London NW1 7BY, England		Horton, R (corresponding author), Lancet, London NW1 7BY, England.							Apolone G, 2005, BRIT J CANCER, V93, P504, DOI 10.1038/sj.bjc.6602750; Emery P, 2006, LANCET, V368, P821, DOI 10.1016/S0140-6736(06)69301-X; Glannon W, 2006, J MED ETHICS, V32, P252, DOI 10.1136/jme.2005.015685; Joffe S, 2006, J CLIN ONCOL, V24, P2987, DOI 10.1200/JCO.2005.04.9296; Kaiser J, 2006, SCIENCE, V311, P1852, DOI 10.1126/science.311.5769.1852; Khandekar J, 2006, ARCH INTERN MED, V166, P1440, DOI 10.1001/archinte.166.14.1440; Markman M, 2006, ARCH INTERN MED, V166, P1446, DOI 10.1001/archinte.166.14.1446; Self CH, 2006, LANCET, V367, P1038, DOI 10.1016/S0140-6736(06)68396-7; Vanags D, 2006, LANCET, V368, P855, DOI 10.1016/S0140-6736(06)69210-6; 2006, LANCET, V367, P960; 2006, LANCET, V367, P1214; 2006, SCRIP           0728, P3; 2006, SCRIP           0728, P2	13	5	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 2	2006	368	9538					827	828		10.1016/S0140-6736(06)69305-7	http://dx.doi.org/10.1016/S0140-6736(06)69305-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	082FD	16950344				2022-12-28	WOS:000240371200010
J	Zhang, CS; Griffith, BR; Fu, Q; Albermann, C; Fu, X; Lee, IK; Li, LJ; Thorson, JS				Zhang, Changsheng; Griffith, Byron R.; Fu, Qiang; Albermann, Christoph; Fu, Xun; Lee, In-Kyoung; Li, Lingjun; Thorson, Jon S.			Exploiting the reversibility of natural product glycosyltransferase-catalyzed reactions	SCIENCE			English	Article							GLYCOSYLATION; CALICHEAMICIN; GLYCORANDOMIZATION; OLIGOSACCHARIDES; BIOSYNTHESIS; PURIFICATION; TOOLS	Glycosyltransferases (GTs), an essential class of ubiquitous enzymes, are generally perceived as unidirectional catalysts. In contrast, we report that four glycosyltransferases from two distinct natural product biosynthetic pathways-calicheamicin and vancomycin-readily catalyze reversible reactions, allowing sugars and aglycons to be exchanged with ease. As proof of the broader applicability of these new reactions, more than 70 differentially glycosylated calicheamicin and vancomycin variants are reported. This study suggests the reversibility of GT-catalyzed reactions may be general and useful for generating exotic nucleotide sugars, establishing in vitro GT activity in complex systems, and enhancing natural product diversity.	Univ Wisconsin, Natl Cooperat Drug Discovery Grp Program, Sch Pharm, Pharmaceut Sci Div,Lab Biosynthet Chem, Madison, WI 53705 USA; Univ Wisconsin, Dept Chem, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Thorson, JS (corresponding author), Univ Wisconsin, Natl Cooperat Drug Discovery Grp Program, Sch Pharm, Pharmaceut Sci Div,Lab Biosynthet Chem, 777 Highland Ave, Madison, WI 53705 USA.	jsthorson@pharmacy.wisc.edu	Zhang, Changsheng/B-5965-2012; Thorson, Jon S/L-3696-2013	Zhang, Changsheng/0000-0003-2349-3138; Thorson, Jon S/0000-0002-7148-0721	NATIONAL CANCER INSTITUTE [R01CA084374, U19CA113297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070637] Funding Source: NIH RePORTER; NCI NIH HHS [CA84374, U19 CA113297] Funding Source: Medline; NIAID NIH HHS [AI52218] Funding Source: Medline; NIGMS NIH HHS [GM70637] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; Bililign T, 2002, CHEMBIOCHEM, V3, P1143, DOI 10.1002/1439-7633(20021104)3:11<1143::AID-CBIC1143>3.0.CO;2-W; Blanchard S, 2006, CURR OPIN CHEM BIOL, V10, P263, DOI 10.1016/j.cbpa.2006.04.001; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; CARDINI C. E., 1955, JOUR BIOL CHEM, V214, P149; Deangelis PL, 2003, J BIOL CHEM, V278, P35199, DOI 10.1074/jbc.M306431200; Fu X, 2003, NAT BIOTECHNOL, V21, P1467, DOI 10.1038/nbt909; GLASER L, 1957, J BIOL CHEM, V228, P729; Griffith BR, 2005, CURR OPIN BIOTECH, V16, P622, DOI 10.1016/j.copbio.2005.10.002; HITCHCOCK SA, 1995, J AM CHEM SOC, V117, P5750, DOI 10.1021/ja00126a014; KIM SH, 1994, J AM CHEM SOC, V116, P1766, DOI 10.1021/ja00084a018; Koeller KM, 2000, CHEM REV, V100, P4465, DOI 10.1021/cr990297n; Losey HC, 2001, BIOCHEMISTRY-US, V40, P4745, DOI 10.1021/bi010050w; MARUMO K, 1992, EUR J BIOCHEM, V204, P539, DOI 10.1111/j.1432-1033.1992.tb16665.x; Miller KD, 1999, J BIOL CHEM, V274, P34011, DOI 10.1074/jbc.274.48.34011; Minami A, 2005, TETRAHEDRON LETT, V46, P6187, DOI 10.1016/j.tetlet.2005.07.083; NEUFELD EF, 1963, ADV CARBOHYD CHEM, V18, P309; NICOLAOU KC, 1993, J AM CHEM SOC, V115, P7625, DOI 10.1021/ja00070a006; Oberthur M, 2004, ORG LETT, V6, P2873, DOI 10.1021/ol049187f; Quiros LM, 2000, J BIOL CHEM, V275, P11713, DOI 10.1074/jbc.275.16.11713; Rupprath C, 2005, CURR MED CHEM, V12, P1637, DOI 10.2174/0929867054367167; Sears P, 2001, SCIENCE, V291, P2344, DOI 10.1126/science.1058899; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; WALKER S, 1992, P NATL ACAD SCI USA, V89, P4608, DOI 10.1073/pnas.89.10.4608; Walsh CT, 2003, BIOCHEM SOC T, V31, P487, DOI 10.1042/BST0310487	25	236	245	10	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2006	313	5791					1291	1294		10.1126/science.1130028	http://dx.doi.org/10.1126/science.1130028			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	081JI	16946071				2022-12-28	WOS:000240313500042
J	Llano, M; Saenz, DT; Meehan, A; Wongthida, P; Peretz, M; Walker, WH; Teo, WL; Poeschla, EM				Llano, Manuel; Saenz, Dyana T.; Meehan, Anne; Wongthida, Phonphimon; Peretz, Mary; Walker, William H.; Teo, Wulin; Poeschla, Eric M.			An essential role for LEDGF/p75 in HIV integration	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-CELLS; IDENTIFICATION; REVEALS; BINDING; DOMAIN; REPLICATION; INFECTION; PROTEINS	Chromosomal integration enables human immunodeficiency virus (HIV) to establish a permanent reservoir that can be therapeutically suppressed but not eradicated. Participation of cellular proteins in this obligate replication step is poorly understood. We used intensified RNA interference and dominant-negative protein approaches to show that the cellular transcriptional coactivator lens epithelium - derived growth factor (LEDGF)/p75 (p75) is an essential HIV integration cofactor. The mechanism requires both linkages of a molecular tether that p75 forms between integrase and chromatin. Fractionally minute levels of endogenous p75 are sufficient to enable integration, showing that cellular factors that engage HIV after entry may elude identification in less intensive knockdowns. Perturbing the p75-integrase interaction may have therapeutic potential.	Mayo Clin, Coll Med, Program Mol Med, Rochester, MN 55905 USA	Mayo Clinic	Poeschla, EM (corresponding author), Mayo Clin, Coll Med, Program Mol Med, Rochester, MN 55905 USA.	emp@mayo.edu		Teo, Wulin/0000-0001-7815-7014				Busschots K, 2005, J BIOL CHEM, V280, P17841, DOI 10.1074/jbc.M411681200; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Ge H, 1998, EMBO J, V17, P6723, DOI 10.1093/emboj/17.22.6723; Llano M, 2004, J BIOL CHEM, V279, P55570, DOI 10.1074/jbc.M408508200; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Vandegraaff N, 2006, VIROLOGY, V346, P415, DOI 10.1016/j.virol.2005.11.022; Vandekerckhove L, 2006, J VIROL, V80, P1886, DOI 10.1128/JVI.80.4.1886-1896.2006; Vanegas M, 2005, J CELL SCI, V118, P1733, DOI 10.1242/jcs.02299; Zielske SP, 2006, J VIROL, V80, P7275, DOI 10.1128/JVI.02470-05	15	399	425	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2006	314	5798					461	464		10.1126/science.1132319	http://dx.doi.org/10.1126/science.1132319			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	16959972				2022-12-28	WOS:000241382500041
J	Hallas, J; Dall, M; Andries, A; Andersen, BS; Aalykke, C; Hansen, JM; Andersen, M; Lassen, AT				Hallas, Jesper; Dall, Michael; Andries, Alin; Andersen, Birthe Sogaard; Aalykke, Claus; Moller Hansen, Jane; Andersen, Morten; Touborg Lassen, Annmarie			Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ORAL ANTIPLATELET THERAPY; ASPIRIN; CLOPIDOGREL; PREVENTION; PRETREATMENT; WARFARIN; STROKE; NUMBER	Objectives To assess the risk of serious upper gastrointestinal bleeding associated with the newer antithrombotic agents used alone or in combination with other antithrombotic drugs; to describe the trends in use of antithrombotic drugs in the background population. Design Population based case-control study. Setting Funen County, Denmark (population 470000). Subjects 1443 cases of serious upper gastrointestinal bleeding identified during 2000-4; 57 720 age and sex matched controls. Main outcome measure Exposure to low dose aspirin, clopidogrel, dipyridamole, vitamin K antagonists, and combined antithrombotic treatment. Results Adjusted odds ratios associating drug use with upper gastrointestinal bleeding were 1.8 (95% confidence interval 1.5 to 2.1) for low dose aspirin, 1.1 (0.6 to 2.1) for clopidogrel, 1.9 (1.3 to 2.8) for dipyridamole, and 1.8 (1.3 to 2.4) for vitamin K antagonists. Corresponding figures for combined use were 7.4 (3.5 to 15) for clopidogrel and aspirin, 5.3 (2.9 to 9.5) for vitamin K antagonists and aspirin, and 2.3 (1.7 to 3.3) for dipyridamole and aspirin. Other combinations were used too infrequently to allow estimation. The number of treatment years needed to produce one excess case varied from 124 for the clopidogrel-aspirin combination to 8800 for clopidogrel alone. During the study period, exposure to combined antithrombotic regimens increased by 425% in the background population. Conclusion Antithrombotic treatment is becoming increasingly aggressive. Combined antithrombotic treatment confers particular risk and is associated with high incidence of gastrointestinal bleeding.	Univ So Denmark, IST, Dept Clin Pharmacol, DK-5000 Odense, Denmark; Univ So Denmark, Res Unit Gen Practice, Odense, Denmark; Odense Univ Hosp, Dept Med Gastroenterol, DK-5000 Odense, Denmark; Odense Univ Hosp, Dept Cardiol, Odense, Denmark; Odense Univ Hosp, Dept Infect Med, Odense, Denmark	University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Hallas, J (corresponding author), Univ So Denmark, IST, Dept Clin Pharmacol, DK-5000 Odense, Denmark.	jhallas@health.sdu.dk	Andersen, Morten/H-3555-2011; Lassen, Annmarie/AAA-5816-2019	Andersen, Morten/0000-0001-7029-2860; Hallas, Jesper/0000-0002-8097-8708				Altman DG, 1998, BRIT MED J, V317, P1309, DOI 10.1136/bmj.317.7168.1309; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bjerre LM, 2000, BRIT MED J, V320, P503, DOI 10.1136/bmj.320.7233.503; Buresly K, 2005, ARCH INTERN MED, V165, P784, DOI 10.1001/archinte.165.7.784; Chan FKL, 2005, NEW ENGL J MED, V352, P238, DOI 10.1056/NEJMoa042087; COLLET JP, 2000, PHARMACOEPIDEM DR S, P765; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Diener HC, 1996, J NEUROL SCI, V143, P1, DOI 10.1016/S0022-510X(96)00308-5; Fork FT, 2000, SCAND J GASTROENTERO, V35, P464; Gaist D, 1997, DAN MED BULL, V44, P445; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; LANAS A, 2006, GUT             0510; Massel D, 2001, J AM COLL CARDIOL, V37, P569, DOI 10.1016/S0735-1097(00)01135-9; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Mehta SR, 2001, LANCET, V358, P527; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB; ROCKALL TA, 1995, BRIT MED J, V311, P222, DOI 10.1136/bmj.311.6999.222; Rothman KJ, 2002, EPIDEMIOLOGY INTRO, P78; Sabatine MS, 2005, JAMA-J AM MED ASSOC, V294, P1224, DOI 10.1001/jama.294.10.1224; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Tran H, 2004, JAMA-J AM MED ASSOC, V292, P1867, DOI 10.1001/jama.292.15.1867; WHO Collaborating Centre for Drug Statistics Methodology, 2006, ATC IND DDDS GUID AT; Yusuf S, 2001, NEW ENGL J MED, V345, P494	24	293	319	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 7	2006	333	7571					726	728A		10.1136/bmj.38947.697558.AE	http://dx.doi.org/10.1136/bmj.38947.697558.AE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	094OK	16984924	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000241248600018
J	Jacinto, E; Facchinetti, V; Liu, D; Soto, N; Wei, SN; Jung, SY; Huang, QJ; Qin, J; Su, B				Jacinto, Estela; Facchinetti, Valeria; Liu, Dou; Soto, Nelyn; Wei, Shiniu; Jung, Sung Yun; Huang, Qiaojia; Qin, Jun; Su, Bing			SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity	CELL			English	Article							PROTEIN-KINASE-B; FOXO TRANSCRIPTION FACTORS; CELL-GROWTH; TUBEROUS SCLEROSIS; BINDING PARTNER; SIGNAL RELAY; TOR; ACTIVATION; TSC2; SURVIVAL	Mammalian target of rapamycin (mTOR) controls cell growth and proliferation via the raptor-mTOR (TORC1) and rictor-mTOR (TORC2) protein complexes. Recent biochemical studies suggested that TORC2 is the elusive PDK2 for Akt/PKB Ser473 phosphorylation in the hydrophobic motif. Phosphorylation at Ser473, along with Thr308 of its activation loop, is deemed necessary for Akt function, although the regulatory mechanisms and physiological importance of each phosphorylation site remain to be fully understood. Here, we report that SIN1/MIP1 is an essential TORC2/PDK2 subunit. Genetic ablation of sin 1 abolished Akt-Ser473 phosphorylation and disrupted rictor-mTOR interaction but maintained Thr308 phosphorylation. Surprisingly, defective Ser473 phosphorylation affected only a subset of Akt targets in vivo, including FoxO1/3a, while other Akt targets, TSC2 and GSK3, and the TORC1 effectors, S6K and 4E-BP1, were unaffected. Our findings reveal that the SIN1-rictor-mTOR function in Akt-Ser473 phosphorylation is required for TORC2 function in cell survival but is dispensable for TORC1 function.	Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Baylor College of Medicine; Baylor College of Medicine	Jacinto, E (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	jqin@bcm.tmc.edu; bsu@mdanderson.org		Jung, Sung Yun/0000-0003-1521-7977; Jacinto, Estela/0000-0001-7118-1759	NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070225] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434] Funding Source: NIH RePORTER; NCI NIH HHS [CA16672] Funding Source: Medline; NHLBI NIH HHS [HL070225] Funding Source: Medline; NIAID NIH HHS [AI063348] Funding Source: Medline; NIDDK NIH HHS [DK62434] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bayascas JR, 2005, MOL CELL, V18, P143, DOI 10.1016/j.molcel.2005.03.020; Biondi RM, 2004, TRENDS BIOCHEM SCI, V29, P136, DOI 10.1016/j.tibs.2004.01.005; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Brognard J, 2001, CANCER RES, V61, P3986; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cheng J, 2005, MOL CELL BIOL, V25, P5955, DOI 10.1128/MCB.25.14.5955-5964.2005; Cheng JK, 2005, J BIOL CHEM, V280, P13477, DOI 10.1074/jbc.M414258200; COLICELLI J, 1991, P NATL ACAD SCI USA, V88, P2913, DOI 10.1073/pnas.88.7.2913; Collins BJ, 2003, EMBO J, V22, P4202, DOI 10.1093/emboj/cdg407; Dong JX, 2004, GENE DEV, V18, P2479, DOI 10.1101/gad.1240504; Dong LQ, 2005, AM J PHYSIOL-ENDOC M, V289, pE187, DOI 10.1152/ajpendo.00011.2005; Dufner A, 1999, MOL CELL BIOL, V19, P4525; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Inoki K, 2006, TRENDS CELL BIOL, V16, P206, DOI 10.1016/j.tcb.2006.02.002; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Jung SY, 2005, MOL ENDOCRINOL, V19, P2451, DOI 10.1210/me.2004-0476; Kawakami Y, 2004, J BIOL CHEM, V279, P47720, DOI 10.1074/jbc.M408797200; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lawlor MA, 2001, J CELL SCI, V114, P2903; Lee S, 2005, MOL BIOL CELL, V16, P4572, DOI 10.1091/mbc.E05-04-0342; Lee S, 1999, MOL BIOL CELL, V10, P2829, DOI 10.1091/mbc.10.9.2829; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Peterson RT, 1999, CURR BIOL, V9, pR521, DOI 10.1016/S0960-9822(99)80326-1; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Radimerski T, 2002, NAT CELL BIOL, V4, P251, DOI 10.1038/ncb763; Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Schroder W, 2005, CELL SIGNAL, V17, P761, DOI 10.1016/j.cellsig.2004.10.015; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Troussard AA, 2003, J BIOL CHEM, V278, P22374, DOI 10.1074/jbc.M303083200; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; Wilkinson MG, 1999, EMBO J, V18, P4210, DOI 10.1093/emboj/18.15.4210; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Zhang DY, 2006, EMBO J, V25, P97, DOI 10.1038/sj.emboj.7600913	69	1100	1142	4	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 6	2006	127	1					125	137		10.1016/j.cell.2006.08.033	http://dx.doi.org/10.1016/j.cell.2006.08.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	16962653	Bronze			2022-12-28	WOS:000241445800019
J	Tsong, AE; Tuch, BB; Li, H; Johnson, AD				Tsong, Annie E.; Tuch, Brian B.; Li, Hao; Johnson, Alexander D.			Evolution of alternative transcriptional circuits with identical logic	NATURE			English	Article							MATING-TYPE GENES; MADS-BOX PROTEIN; CANDIDA-ALBICANS; NEUROSPORA-CRASSA; HOX PROTEIN; DNA-BINDING; YEAST; MCM1; GENOME; DIFFERENTIATION	Evolution of gene regulation is an important contributor to the variety of life. Here, we analyse the evolution of a combinatorial transcriptional circuit composed of sequence-specific DNA-binding proteins that are conserved among all eukaryotes. This circuit regulates mating in the ascomycete yeast lineage. We first identify a group of mating genes that was transcriptionally regulated by an activator in a fungal ancestor, but is now transcriptionally regulated by a repressor in modern bakers' yeast. Despite this change in regulatory mechanism, the logical output of the overall circuit remains the same. By examining the regulation of mating in modern yeasts that are related to different extents, we deduce specific, sequential changes in both cis- and trans-regulatory elements that constitute the transition from positive to negative regulation. These changes indicate specific mechanisms by which fitness barriers were traversed during the transition.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Johnson, AD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	ajohnson@cgl.ucsf.edu						Acton TB, 1997, MOL CELL BIOL, V17, P1881, DOI 10.1128/MCB.17.4.1881; Acton TB, 2000, MOL CELL BIOL, V20, P1, DOI 10.1128/MCB.20.1.1-11.2000; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Belloch C, 2000, INT J SYST EVOL MICR, V50, P405, DOI 10.1099/00207713-50-1-405; BENDER A, 1986, CELL, V47, P929, DOI 10.1016/0092-8674(86)90808-1; Bennett RJ, 2003, MOL CELL BIOL, V23, P8189, DOI 10.1128/MCB.23.22.8189-8201.2003; Broach J.R., 1992, MOL CELLULAR BIOL SA, P583; Butler G, 2004, P NATL ACAD SCI USA, V101, P1632, DOI 10.1073/pnas.0304170101; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Calderone RA., 2002, CANDIDA CANDIDIASIS; Care RS, 1999, MOL MICROBIOL, V34, P792, DOI 10.1046/j.1365-2958.1999.01641.x; Carroll S.B., 2001, DNA DIVERSITY; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Darwin C., 1877, ORIGIN SPECIES; Davidson E. H., 2001, DEV EVOLUTION; DEBUCHY R, 1993, MOL GEN GENET, V241, P667, DOI 10.1007/BF00279909; Doebley J, 1998, PLANT CELL, V10, P1075, DOI 10.1105/tpc.10.7.1075; Galant R, 2002, NATURE, V415, P910, DOI 10.1038/nature717; Gerhart J, 1997, CELLS EMBRYOS EVOLUT; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Hull CM, 2000, SCIENCE, V289, P307, DOI 10.1126/science.289.5477.307; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; JACOBSON MP, 2006, PROTEIN LOCAL OPTIMI; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; KELLY M, 1988, EMBO J, V7, P1537, DOI 10.1002/j.1460-2075.1988.tb02973.x; Kjaerulff S, 1997, EMBO J, V16, P4021, DOI 10.1093/emboj/16.13.4021; Kurischko C, 1999, MOL GEN GENET, V262, P180, DOI 10.1007/s004380051073; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Ludwig MZ, 1998, DEVELOPMENT, V125, P949; Mead J, 1996, MOL CELL BIOL, V16, P2135; PHILLEY ML, 1994, GENETICS, V137, P715; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SMITH DL, 1992, CELL, V68, P133, DOI 10.1016/0092-8674(92)90212-U; STABEN C, 1990, P NATL ACAD SCI USA, V87, P4917, DOI 10.1073/pnas.87.13.4917; Tan S, 1998, NATURE, V391, P660, DOI 10.1038/35563; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Tsong AE, 2003, CELL, V115, P389, DOI 10.1016/S0092-8674(03)00885-7; TURGEON BG, 1993, MOL GEN GENET, V238, P270; van Beest M, 2000, J BIOL CHEM, V275, P27266; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wong S, 2002, P NATL ACAD SCI USA, V99, P9272, DOI 10.1073/pnas.142101099	47	212	221	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2006	443	7110					415	420		10.1038/nature05099	http://dx.doi.org/10.1038/nature05099			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	17006507				2022-12-28	WOS:000240798800037
J	Yarchoan, R				Yarchoan, Robert			Key role for a viral lytic gene in Kaposi's sarcoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NCI, HIV & AIDS Malignancy Branch, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yarchoan, R (corresponding author), NCI, HIV & AIDS Malignancy Branch, Ctr Canc Res, Bethesda, MD 20892 USA.							Bais C, 1998, NATURE, V392, P210, DOI 10.1038/32472; Grisotto MG, 2006, J CLIN INVEST, V116, P1264, DOI 10.1172/JCI26666; Montaner S, 2006, CANCER RES, V66, P168, DOI 10.1158/0008-5472.CAN-05-1026; Schwarz M, 2001, J IMMUNOL, V167, P505, DOI 10.4049/jimmunol.167.1.505; Sodhi A, 2004, FASEB J, V18, P422, DOI 10.1096/fj.03-1035hyp	5	13	13	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2006	355	13					1383	1385		10.1056/NEJMcibr063911	http://dx.doi.org/10.1056/NEJMcibr063911			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088EF	17005960				2022-12-28	WOS:000240793600018
J	Lesnewski, R				Lesnewski, Ruth			Mistakes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												rlesnewski@institute2000.org							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2006	296	11					1327	1328		10.1001/jama.296.11.1327	http://dx.doi.org/10.1001/jama.296.11.1327			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	085HS	16985218				2022-12-28	WOS:000240595800001
J	Lau, J; Ioannidis, JPA; Terrin, N; Schmid, CH; Olkin, I				Lau, Joseph; Ioannidis, John P. A.; Terrin, Norma; Schmid, Christopher H.; Olkin, Ingram			Evidence based medicine - The case of the misleading funnel plot	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DETECT PUBLICATION BIAS; STATISTICAL TESTS; METAANALYSIS; TRIALS; STATEMENT; EFFICACY; THERAPY		Tufts Univ, New England Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; Stanford Univ, Dept Stat, Palo Alto, CA 94304 USA	Tufts Medical Center; Tufts University; University of Ioannina; Stanford University	Ioannidis, JPA (corresponding author), Tufts Univ, New England Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA.	jlaul@tufts-nemc.org	Ioannidis, John P. A./G-9836-2011; Bannuru, Raveendhara/G-2601-2011; Schmid, Christopher H./J-2398-2014	Bannuru, Raveendhara/0000-0002-8069-5783; Schmid, Christopher H./0000-0002-0855-5313	AHRQ HHS [R01 HS10254] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS010254] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Alderson P, 2004, COCHRANE LIB; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FRYBACK DG, 1991, MED DECIS MAKING, V11, P88, DOI 10.1177/0272989X9101100203; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hrobjartsson A, 2004, J INTERN MED, V256, P91, DOI 10.1111/j.1365-2796.2004.01355.x; IOANNIDIS JPA, 1995, ANN INTERN MED, V122, P856, DOI 10.7326/0003-4819-122-11-199506010-00009; Ioannidis JPA, 2001, P NATL ACAD SCI USA, V98, P831, DOI 10.1073/pnas.021529998; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Light RJ, 1984, SUMMING SCI REVIEWIN; Macaskill P, 2001, STAT MED, V20, P641, DOI 10.1002/sim.698; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Schmid CH, 1998, STAT MED, V17, P1923, DOI 10.1002/(SICI)1097-0258(19980915)17:17<1923::AID-SIM874>3.0.CO;2-6; Schmid CH, 2004, J CLIN EPIDEMIOL, V57, P683, DOI 10.1016/j.jclinepi.2003.12.001; Schwarzer G, 2002, STAT MED, V21, P2465, DOI 10.1002/sim.1224; Sterne J, 2001, SYSTEMATIC REV HLTH; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tang JL, 2000, J CLIN EPIDEMIOL, V53, P477, DOI 10.1016/S0895-4356(99)00204-8; Tasche MJA, 2000, THORAX, V55, P913, DOI 10.1136/thorax.55.11.913; Terrin N, 2005, J CLIN EPIDEMIOL, V58, P894, DOI 10.1016/j.jclinepi.2005.01.006; Terrin N, 2003, STAT MED, V22, P2113, DOI 10.1002/sim.1461	26	1018	1033	0	51	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2006	333	7568					597	600		10.1136/bmj.333.7568.597	http://dx.doi.org/10.1136/bmj.333.7568.597			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089KB	16974018	Green Published			2022-12-28	WOS:000240878200021
J	Bouwens, RJ; Illingworth, GD				Bouwens, Rychard J.; Illingworth, Garth D.			Rapid evolution of the most luminous galaxies during the first 900 million years	NATURE			English	Article							NEAR-INFRARED CAMERA; HUBBLE DEEP FIELD; DATA REDUCTION; DROP GALAXIES; Z-APPROXIMATE-TO-6; Z-SIMILAR-TO-6; REIONIZATION; UNIVERSE; MODEL	The first 900 million years (Myr) to redshift z approximate to 6 ( the first seven per cent of the age of the Universe) remains largely unexplored for the formation of galaxies. Large samples of galaxies have been found at z approximate to 6 (refs 1 - 4) but detections at earlier times are uncertain and unreliable. It is not at all clear how galaxies built up from the first stars when the Universe was about 300 Myr old ( z approximate to 12 - 15) to z approximate to 6, just 600 Myr later. Here we report the results of a search for galaxies at z approximate to 7 - 8, about 700 Myr after the Big Bang, using the deepest near-infrared and optical images ever taken. Under conservative selection criteria we find only one candidate galaxy at z approximate to 7 - 8, where ten would be expected if there were no evolution in the galaxy population between z approximate to 7 - 8 and z approximate to 6. Using less conservative criteria, there are four candidates, where 17 would be expected with no evolution. This demonstrates that very luminous galaxies are quite rare 700 Myr after the Big Bang. The simplest explanation is that the Universe is just too young to have built up many luminous galaxies at z approximate to 7 - 8 by the hierarchical merging of small galaxies.	Univ Calif Santa Cruz, Univ Calif Observ, Lick Observ, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Dept Astron, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Bouwens, RJ (corresponding author), Univ Calif Santa Cruz, Univ Calif Observ, Lick Observ, Santa Cruz, CA 95064 USA.	bouwens@ucolick.org		Illingworth, Garth/0000-0002-8096-2837				Becker RH, 2001, ASTRON J, V122, P2850, DOI 10.1086/324231; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; BLAKESLEE JP, 2003, ASP C SER, V295; Bouwens R, 2003, ASTROPHYS J, V593, P640, DOI 10.1086/376588; Bouwens R, 1998, ASTROPHYS J, V506, P557, DOI 10.1086/306258; BOUWENS RJ, 2004, APJ, V616, P79; BOUWENS RJ, 2005, IN PRESS ASTROPHYS J; Bunker AJ, 2004, MON NOT R ASTRON SOC, V355, P374, DOI 10.1111/j.1365-2966.2004.08326.x; Dickinson M, 2004, ASTROPHYS J, V600, pL99, DOI 10.1086/381119; Dow-Hygelund CC, 2005, ASTROPHYS J, V630, pL137, DOI 10.1086/491700; Fan XH, 2002, ASTRON J, V123, P1247, DOI 10.1086/339030; Giavalisco M, 2004, ASTROPHYS J, V600, pL103, DOI 10.1086/381244; LABBE I, 2006, IN PRESS ASTROPHYS J; Madau P, 1998, ASTROPHYS J, V498, P106, DOI 10.1086/305523; MADAU P, 1995, ASTROPHYS J, V441, P18, DOI 10.1086/175332; Mo HJ, 1996, MON NOT R ASTRON SOC, V282, P347, DOI 10.1093/mnras/282.2.347; RICHARD J, 2006, IN PRESS ASTRON ASTR; Schiminovich D, 2005, ASTROPHYS J, V619, pL47, DOI 10.1086/427077; Skinner CJ, 1998, P SOC PHOTO-OPT INS, V3354, P2, DOI 10.1117/12.317208; Somerville RS, 2004, ASTROPHYS J, V600, pL171, DOI 10.1086/378628; SPERGEL DN, 2006, UNPUB ASTROPHYS J; Stanway ER, 2005, MON NOT R ASTRON SOC, V359, P1184, DOI 10.1111/j.1365-2966.2005.08977.x; STARK D, 2006, UNPUB ASTROPHYS J; Steidel CC, 1999, ASTROPHYS J, V519, P1, DOI 10.1086/307363; Steidel CC, 1996, ASTROPHYS J, V462, pL17, DOI 10.1088/1538-4357/462/1/L17; Thompson RI, 2005, ASTRON J, V130, P1, DOI 10.1086/430528; Thompson RI, 1999, ASTRON J, V117, P17, DOI 10.1086/300705; Yan HJ, 2005, ASTROPHYS J, V634, P109, DOI 10.1086/491695; Yan HJ, 2004, ASTROPHYS J, V612, pL93, DOI 10.1086/424690; YAN HJ, 2006, IN PRESS ASTROPHYS J	32	87	87	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2006	443	7108					189	192		10.1038/nature05156	http://dx.doi.org/10.1038/nature05156			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16971943				2022-12-28	WOS:000240467000041
J	Yahr, TL				Yahr, Timothy L.			A critical new pathway for toxin secretion?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PSEUDOMONAS-AERUGINOSA		Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	University of Iowa	Yahr, TL (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.			Yahr, Timothy/0000-0001-9054-8704				Nordfelth R, 2005, INFECT IMMUN, V73, P3104, DOI 10.1128/IAI.73.5.3104-3114.2005; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103	4	17	22	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 14	2006	355	11					1171	1172		10.1056/NEJMcibr063931	http://dx.doi.org/10.1056/NEJMcibr063931			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083NJ	16971725				2022-12-28	WOS:000240462800014
J	Gray, N; Henningfeld, J				Gray, Nigel; Henningfeld, Jack			Dissent over harm reduction for tobacco	LANCET			English	Editorial Material							DISEASE		Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; Pinney Associates Inc, Bethesda, MD 20814 USA	Johns Hopkins University	Henningfeld, J (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	jhenning@pinneyassociates.com						BORLAND R, 1991, AUST J PUBLIC HEALTH, V15, P130; Fichtenberg CM, 2000, NEW ENGL J MED, V343, P1772, DOI 10.1056/NEJM200012143432406; FIORE MC, 2000, CLIN PRACTICE; Gray NJ, 2004, NICOTINE TOB RES, V6, P759, DOI 10.1080/1462220042000274248; Henningfield JE, 2002, AM J PREV MED, V23, P226, DOI 10.1016/S0749-3797(02)00502-0; Hughes JR, 2005, TOB CONTROL, V14, P49, DOI 10.1136/tc.2004.008367; *STUD GROUP TOB PR, 2004, GUID PRINC DEV TOB P; Weinstein N., 2001, PUBLIC UNDERSTANDING	8	13	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2006	368	9539					899	901		10.1016/S0140-6736(06)69349-5	http://dx.doi.org/10.1016/S0140-6736(06)69349-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	083ZX	16962864				2022-12-28	WOS:000240502300008
J	Smith, CH				Smith, Charles H.			Reflections on Wallace	NATURE			English	Biographical-Item									Western Kentucky Univ, Lib Publ Serv, Bowling Green, KY 42101 USA	Western Kentucky University	Smith, CH (corresponding author), Western Kentucky Univ, Lib Publ Serv, Bowling Green, KY 42101 USA.							FICHMAN M, 2003, ELUSIVE VICTORIAN EV	1	8	8	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2006	443	7107					33	34		10.1038/443033a	http://dx.doi.org/10.1038/443033a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JM	16957716	Bronze			2022-12-28	WOS:000240313900024
J	Shinnar, R; Citro, F				Shinnar, Reuel; Citro, Francesco			Energy - A road map to US decarbonization	SCIENCE			English	Editorial Material									CUNY City Coll, Clean Fuels Inst, New York, NY 11031 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Shinnar, R (corresponding author), CUNY City Coll, Clean Fuels Inst, New York, NY 11031 USA.	shinnar@ccny.cuny.edu						ANDERSON RB, 1984, FISCHERTROPSCH SYNTH; BUSH GW, 2003, COMMUNICATION   0120; Chang C. D., 1983, HYDROCARBONS METHANO; Davis S. C., 2006, TRANSPORTATION ENERG; EPRI (Electric Power Research Institute), 2004, POW DEL SYST FUT PRE; HOLT N, 2004, GASIFICATION PROCESS; *NAT REN EN LAB SA, 2003, ASS PAR TROUGH POW T; *NRC, 2006, TRENDS OIL SUPPL DEM; *NRC NAT AC ENG, 2004, HYDR EC OPP COSTS BA; *NUCL EN AG INT EN, 1998, PROJ COSTS GEN EL UP; SHINNAR R, 2005, IN PRESS IEEE T 1030; SHINNAR R, 2006, AAAS ANN M ST LOUIS	12	49	51	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 1	2006	313	5791					1243	1244		10.1126/science.1130338	http://dx.doi.org/10.1126/science.1130338			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16946055				2022-12-28	WOS:000240313500024
J	Bausch, DG; Nichol, ST; Muyembe-Tamfum, JJ; Borchert, M; Rollin, PE; Sleurs, H; Campbell, P; Tshioko, FK; Roth, C; Colebunders, R; Pirard, P; Mardel, S; Olinda, LA; Zeller, H; Tshomba, A; Kulidri, A; Libande, ML; Mulangu, S; Formenty, P; Grein, T; Leirs, H; Braack, L; Ksiazek, T; Zaki, S; Bowen, MD; Smit, SB; Leman, PA; Burt, FJ; Kemp, A; Swanepoel, R				Bausch, Daniel G.; Nichol, Stuart T.; Muyembe-Tamfum, Jean Jacques; Borchert, Matthias; Rollin, Pierre E.; Sleurs, Hilde; Campbell, Patricia; Tshioko, Florimund K.; Roth, Catherine; Colebunders, Robert; Pirard, Patricia; Mardel, Simon; Olinda, Loku A.; Zeller, Herve; Tshomba, Antoine; Kulidri, Amayo; Libande, Modeste L.; Mulangu, Sabue; Formenty, Pierre; Grein, Thomas; Leirs, Herwig; Braack, Leo; Ksiazek, Tom; Zaki, Sherif; Bowen, Michael D.; Smit, Sheilagh B.; Leman, Patricia A.; Burt, Felicity J.; Kemp, Alan; Swanepoel, Robert		Int Sci Tech Comm Marbug	Marburg hemorrhagic fever associated with multiple genetic lineages of virus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EBOLA-VIRUS; OUTBREAK; CONGO; DISEASE; KIKWIT; REEMERGENCE; DECLINE; GABON	Background: An outbreak of Marburg hemorrhagic fever was first observed in a gold-mining village in northeastern Democratic Republic of the Congo in October 1998. Methods: We investigated the outbreak of Marburg hemorrhagic fever most intensively in May and October 1999. Sporadic cases and short chains of human-to-human transmission continued to occur until September 2000. Suspected cases were identified on the basis of a case definition; cases were confirmed by the detection of virus antigen and nucleic acid in blood, cell culture, antibody responses, and immunohistochemical analysis. Results: A total of 154 cases (48 laboratory-confirmed and 106 suspected) were identified (case fatality rate, 83 percent); 52 percent of cases were in young male miners. Only 27 percent of these men reported having had contact with other affected persons, whereas 67 percent of patients who were not miners reported such contact (P < 0.001). Most of the affected miners (94 percent) worked in an underground mine. Cessation of the outbreak coincided with flooding of the mine. Epidemiologic evidence of multiple introductions of infection into the population was substantiated by the detection of at least nine genetically distinct lineages of virus in circulation during the outbreak. Conclusions: Marburg hemorrhagic fever can have a very high case fatality rate. Since multiple genetic variants of virus were identified, ongoing introduction of virus into the population helped perpetuate this outbreak. The findings imply that reservoir hosts of Marburg virus inhabit caves, mines, or similar habitats.	Ctr Dis Control & Prevent, Atlanta, GA USA; Tulane Sch Publ Hlth & Trop Med, New Orleans, LA USA; Minist Hlth, Kinshasa, DEM REP CONGO; Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; Inst Trop Med, B-2000 Antwerp, Belgium; Med Sans Frontieres, Brussels, Belgium; Med Sans Frontieres, Amsterdam, Netherlands; World Hlth Org, Kinshasa, DEM REP CONGO; World Hlth Org, Geneva, Switzerland; Minist Hlth, Kisangani, DEM REP CONGO; Inst Pasteur, Paris, France; Kilo Moto Hosp, Off Mines Or, Watsa, DEM REP CONGO; Minist Hlth, Watsa, DEM REP CONGO; Danish Pest Infestat Lab, Lyngby, Denmark; S African Natl Pk Board, Pretoria, South Africa; Natl Inst Communicable Dis, Johannesburg, South Africa	Centers for Disease Control & Prevention - USA; Tulane University; Institute Nacional de Recherche Biomedical; Institute of Tropical Medicine (ITM); Doctors Without Borders; Doctors Without Borders; World Health Organization; World Health Organization; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Aarhus University; National Institute for Communicable Diseases (NICD)	Swanepoel, R (corresponding author), Natl Inst Communicable Dis, Private Bag X4, ZA-2131 Johannesburg, South Africa.	bobs@nicd.ac.za	Leirs, Herwig/B-8197-2008; Braack, Leo/AAW-3025-2020; Burt, Felicity/AAB-6993-2020	Leirs, Herwig/0000-0002-7612-5024; Braack, Leo/0000-0002-5286-5052; Burt, Felicity/0000-0002-7238-7799; /0000-0002-2051-467X; Antoine, Tshomba/0000-0003-2440-8468; Rollin, Pierre/0000-0002-4608-2641				[Anonymous], 1999, Wkly Epidemiol Rec, V74, P157; Bausch DG, 2004, EMERGING INFECTIONS 6, P35; Bausch DG, 2003, EMERG INFECT DIS, V9, P1531, DOI 10.3201/eid0912.030355; Bertherat E, 1999, Med Trop (Mars), V59, P201; Biot M, 2000, TROP MED INT HEALTH, V5, P384, DOI 10.1046/j.1365-3156.2000.00564.x; Borchert M, 2006, EMERG INFECT DIS, V12, P433, DOI 10.3201/eid1203.050622; Borchert M, 2002, TROP MED INT HEALTH, V7, P902, DOI 10.1046/j.1365-3156.2002.00945.x; Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Bwaka MA, 1999, J INFECT DIS, V179, pS1, DOI 10.1086/514308; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P73; Colebunders R, 2004, J INFECTION, V48, P347, DOI 10.1016/S0163-4453(03)00122-1; Egbring R, 1971, MARBURG VIRUS DIS, P42; Feldmann H, 1996, ARCH VIROL, P77; Formenty P, 1999, J INFECT DIS, V179, pS120, DOI 10.1086/514296; GEAR JSS, 1975, BRIT MED J, V4, P489, DOI 10.1136/bmj.4.5995.489; Geisbert TW, 1998, ULTRASTRUCT PATHOL, V22, P3, DOI 10.3109/01913129809032253; Georges AJ, 1999, J INFECT DIS, V179, pS65, DOI 10.1086/514290; Johnson ED, 1996, ARCH VIROL, P101; Khan AS, 1999, J INFECT DIS, V179, pS76, DOI 10.1086/514306; Ksiazek TG, 1999, J INFECT DIS, V179, pS177, DOI 10.1086/514321; Ksiazek TG, 1999, J INFECT DIS, V179, pS192, DOI 10.1086/514313; Leroy EM, 2004, SCIENCE, V303, P628; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Leroy EM, 2002, LANCET, V359, P712, DOI 10.1016/S0140-6736(02)07796-6; Leroy EM, 2002, J GEN VIROL, V83, P67, DOI 10.1099/0022-1317-83-1-67; Martini G A, 1968, Ger Med Mon, V13, P457; Monath TP, 1999, J INFECT DIS, V179, pS127, DOI 10.1086/514281; Nikiforov V V, 1994, Zh Mikrobiol Epidemiol Immunobiol, P104; PATTYN S, 1977, LANCET, V1, P573; Peterson AT, 2004, EMERG INFECT DIS, V10, P40, DOI 10.3201/eid1001.030125; Rodriguez LL, 1999, J INFECT DIS, V179, pS170, DOI 10.1086/514291; Sanchez A, 1999, J INFECT DIS, V179, pS164, DOI 10.1086/514282; Siegert R, 1968, Ger Med Mon, V13, P1; SMITH DH, 1982, LANCET, V1, P816; STILLE W, 1971, P10; TODOROVITCH K, 1971, P19; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; 2005, MMWR MORB MORTAL WKL, V54, P308; 1999, WKLY EPIDEMIOL REC, V74, P145; 1978, W WHO, V56, P247	41	159	165	1	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2006	355	9					909	919		10.1056/NEJMoa051465	http://dx.doi.org/10.1056/NEJMoa051465			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	078OM	16943403	Green Accepted			2022-12-28	WOS:000240113100008
J	Deuschl, G; Schade-Brittinger, C; Krack, P; Volkmann, J; Schafer, H; Botzel, K; Daniels, C; Deutschlander, A; Dillmann, U; Eisner, W; Gruber, D; Hamel, W; Herzog, J; Hilker, R; Klebe, S; Kloss, M; Koy, J; Krause, M; Kupsch, A; Lorenz, D; Lorenzl, S; Mehdorn, HM; Moringlane, JR; Oertel, W; Pinsker, MO; Reichmann, H; Reuss, A; Schneider, G; Schnitzler, A; Steude, U; Sturm, V; Timmermann, L; Tronnier, V; Trottenberg, T; Wojtecki, L; Wolf, E; Poewe, W; Voges, J				Deuschl, Guenther; Schade-Brittinger, Carmen; Krack, Paul; Volkmann, Jens; Schaefer, Helmut; Boetzel, Kai; Daniels, Christine; Deutschlaender, Angela; Dillmann, Ulrich; Eisner, Wilhelm; Gruber, Doreen; Hamel, Wolfgang; Herzog, Jan; Hilker, Ruediger; Klebe, Stephan; Kloss, Manja; Koy, Jan; Krause, Martin; Kupsch, Andreas; Lorenz, Delia; Lorenzl, Stefan; Mehdorn, H. Maximilian; Moringlane, Jean Richard; Oertel, Wolfgang; Pinsker, Marcus O.; Reichmann, Heinz; Reuss, Alexander; Schneider, Gerd-Helge; Schnitzler, Alfons; Steude, Ulrich; Sturm, Volker; Timmermann, Lars; Tronnier, Volker; Trottenberg, Thomas; Wojtecki, Lars; Wolf, Elisabeth; Poewe, Werner; Voges, Juergen		German Parkinson Study Grp	A randomized trial of deep-brain stimulation for Parkinson's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; 5-YEAR FOLLOW-UP; SUBTHALAMIC NUCLEUS; BILATERAL STIMULATION; CONSECUTIVE SERIES; LEVODOPA; RELIABILITY; ENTACAPONE; EFFICACY; SCALE	Background: Neurostimulation of the subthalamic nucleus reduces levodopa-related motor complications in advanced Parkinson's disease. We compared this treatment plus medication with medical management. Methods: In this randomized-pairs trial, we enrolled 156 patients with advanced Parkinson's disease and severe motor symptoms. The primary end points were the changes from baseline to six months in the quality of life, as assessed by the Parkinson's Disease Questionnaire (PDQ-39), and the severity of symptoms without medication, according to the Unified Parkinson's Disease Rating Scale, part III (UPDRS-III). Results: Pairwise comparisons showed that neurostimulation, as compared with medication alone, caused greater improvements from baseline to six months in the PDQ-39 (50 of 78 pairs, P=0.02) and the UPDRS-III (55 of 78, P < 0.001), with mean improvements of 9.5 and 19.6 points, respectively. Neurostimulation resulted in improvements of 24 to 38 percent in the PDQ-39 subscales for mobility, activities of daily living, emotional well-being, stigma, and bodily discomfort. Serious adverse events were more common with neurostimulation than with medication alone (13 percent vs. 4 percent, P < 0.04) and included a fatal intracerebral hemorrhage. The overall frequency of adverse events was higher in the medication group (64 percent vs. 50 percent, P=0.08). Conclusions: In this six-month study of patients under 75 years of age with severe motor complications of Parkinson's disease, neurostimulation of the subthalamic nucleus was more effective than medical management alone.	Univ Kiel, Univ Klinikum Schleswig Holstein, Dept Neurol, D-24105 Kiel, Germany; Univ Marburg, Marburg, Germany; Univ Munich, Munich, Germany; Univ Homburg, D-6650 Homburg, Germany; Humboldt Univ, Charite Hosp, Berlin, Germany; Univ Cologne, Cologne, Germany; Univ Heidelberg, Heidelberg, Germany; Dresden Univ, Dresden, Germany; Univ Dusseldorf, D-4000 Dusseldorf, Germany; Innsbruck Med Univ, Innsbruck, Austria	University of Kiel; Schleswig Holstein University Hospital; Philipps University Marburg; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cologne; Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Heinrich Heine University Dusseldorf; Medical University of Innsbruck	Deuschl, G (corresponding author), Univ Kiel, Univ Klinikum Schleswig Holstein, Dept Neurol, Campus Kiel,Schittenhelmstr 10, D-24105 Kiel, Germany.	g.deuschl@neurologie.uni-kiel.de	Schnitzler, Alfons/Q-5520-2019; Deuschl, Gunther/A-7986-2010; Klebe, Stephan/AAD-2082-2022; Mehdorn, Maximilian/D-2495-2010; Schnitzler, Alfons/AAT-1054-2021; Schnitzler, Alfons/K-4625-2014; Wojtecki, Lars/AAT-6604-2021; Volkmann, Jens/AAK-7570-2020	Schnitzler, Alfons/0000-0002-6414-7939; Deuschl, Gunther/0000-0002-4176-9196; Schnitzler, Alfons/0000-0002-6414-7939; Wojtecki, Lars/0000-0002-6205-4405; Timmermann, Lars/0000-0002-5301-3580; Volkmann, Jens/0000-0002-9570-593X; Schneider, Gerd-Helge/0000-0002-1301-2938; Krack, Paul/0000-0002-3508-7295				Ardouin C, 1999, ANN NEUROL, V46, P217, DOI 10.1002/1531-8249(199908)46:2<217::AID-ANA11>3.0.CO;2-Z; Berger K, 1999, AKTUEL NEUROL, V26, P180, DOI 10.1055/s-2007-1017628; Berney A, 2002, NEUROLOGY, V59, P1427, DOI 10.1212/01.WNL.0000032756.14298.18; Biglan KM, 2006, MOVEMENT DISORD, V21, P616, DOI 10.1002/mds.20764; BULLINGER M, 1998, SF 36 FRAGEBOGEN GES; Fahn S., 1987, RECENT DEV PARKINSON, VVol. 2, P153; Findley L, 2002, MOVEMENT DISORD, V17, P60; FLEMENBAUM A, 1973, PSYCHOL REP, V32, P783, DOI 10.2466/pr0.1973.33.3.783; FLEMING TR, 1984, CONTROL CLIN TRIALS, V5, P348, DOI 10.1016/S0197-2456(84)80014-8; Goetz CG, 2005, MOVEMENT DISORD, V20, P523, DOI 10.1002/mds.20464; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Houeto JL, 2002, J NEUROL NEUROSUR PS, V72, P701, DOI 10.1136/jnnp.72.6.701; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Karusu T.B., 1976, GERIATRIC PSYCHIAT, P77; Kim SYH, 2005, ARCH NEUROL-CHICAGO, V62, P1357, DOI 10.1001/archneur.62.9.1357; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Lezcano E, 2004, EUR J NEUROL, V11, P451, DOI 10.1111/j.1468-1331.2004.00804.x; Limousin P, 1998, NEW ENGL J MED, V339, P1105, DOI 10.1056/NEJM199810153391603; MARCONI R, 1994, MOVEMENT DISORD, V9, P2, DOI 10.1002/mds.870090103; Martinez-Martin P, 2000, MOVEMENT DISORD, V15, P65, DOI 10.1002/1531-8257(200001)15:1<65::AID-MDS1011>3.0.CO;2-Y; Martinez-Martin P, 2002, MOVEMENT DISORD, V17, P372, DOI 10.1002/mds.10044; Martinez-Martin P, 1998, J NEUROL, V245, pS2, DOI 10.1007/PL00007733; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Obeso JA, 2001, NEW ENGL J MED, V345, P956, DOI 10.1056/nejmoa000827; Oertel W, 2003, LEITLINIEN DTSCH GES, P38; PETO V, 1995, QUAL LIFE RES, V4, P241, DOI 10.1007/BF02260863; Peto V, 2001, AGE AGEING, V30, P299, DOI 10.1093/ageing/30.4.299; Poewe WH, 2002, ACTA NEUROL SCAND, V105, P245, DOI 10.1034/j.1600-0404.2002.1o174.x; Rascol O, 2000, NEW ENGL J MED, V342, P1484, DOI 10.1056/NEJM200005183422004; Reichmann H, 2005, ACTA NEUROL SCAND, V111, P21, DOI 10.1111/j.1600-0404.2004.00363.x; Rodriguez-Oroz MC, 2005, BRAIN, V128, P2240, DOI 10.1093/brain/awh571; Saint-Cyr JA, 2000, BRAIN, V123, P2091, DOI 10.1093/brain/123.10.2091; Schrag A, 2000, MOVEMENT DISORD, V15, P1112, DOI 10.1002/1531-8257(200011)15:6<1112::AID-MDS1008>3.0.CO;2-A; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P308, DOI 10.1136/jnnp.69.3.308; Schupbach WMM, 2005, J NEUROL NEUROSUR PS, V76, P1640, DOI 10.1136/jnnp.2005.063206; Weaver F, 2005, J NEUROSURG, V103, P956, DOI 10.3171/jns.2005.103.6.0956	36	1862	1901	11	267	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2006	355	9					896	908		10.1056/NEJMoa060281	http://dx.doi.org/10.1056/NEJMoa060281			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	078OM	16943402	Green Published			2022-12-28	WOS:000240113100007
J	Jensen, LJ; Jensen, TS; de Lichtenberg, U; Brunak, S; Bork, P				Jensen, Lars Juhl; Jensen, Thomas Skot; de Lichtenberg, Ulrik; Brunak, Soren; Bork, Peer			Co-evolution of transcriptional and posttranslational cell-cycle regulation	NATURE			English	Article							FISSION YEAST; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; DNA-REPLICATION; IDENTIFICATION; PHOSPHORYLATION; COMPLEX; MICROARRAY; PROTEINS	DNA microarray studies have shown that hundreds of genes are transcribed periodically during the mitotic cell cycle of humans(1), budding yeast(2,3), fission yeast(4-6) and the plant Arabidopsis thaliana(7). Here we show that despite the fact the protein complexes involved in this process are largely the same among all eukaryotes, their regulation has evolved considerably. Our comparative analysis of several large-scale data sets reveals that although the regulated subunits of each protein complex are expressed just before its time of action, the identity of the periodically expressed proteins differs significantly between organisms. Moreover, we show that these changes in transcriptional regulation have co-evolved with post-translational control independently in several lineages; loss or gain of cell-cycle-regulated transcription of specific genes is often mirrored by changes in phosphorylation of the proteins that they encode. Our results indicate that many different solutions have evolved for assembling the same molecular machines at the right time during the cell cycle, involving both transcriptional and post-translational layers that jointly control the dynamics of biological systems.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	European Molecular Biology Laboratory (EMBL); Technical University of Denmark; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Bork, P (corresponding author), European Mol Biol Lab, D-69117 Heidelberg, Germany.	bork@embl.de	Jensen, Lars Juhl/C-6492-2008; Bork, Peer/F-1813-2013; de Lichtenberg, Ulrik/AAY-7279-2020; Brunak, Soren/O-6621-2016	Jensen, Lars Juhl/0000-0001-7885-715X; Bork, Peer/0000-0002-2627-833X; Brunak, Soren/0000-0003-0316-5866; de Lichtenberg, Ulrik/0000-0002-0985-9343				Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; de Lichtenberg U, 2005, BIOINFORMATICS, V21, P1164, DOI 10.1093/bioinformatics/bti093; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Dyczkowski Jerzy, 2005, Genome Inform, V16, P125; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; FORSBURG SL, 1991, ANNU REV CELL BIOL, V7, P227, DOI 10.1146/annurev.cb.07.110191.001303; Kearsey SE, 2003, MOL CELL, V12, P1067, DOI 10.1016/S1097-2765(03)00441-6; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; Marguerat S, 2006, YEAST, V23, P261, DOI 10.1002/yea.1351; Menges M, 2003, PLANT MOL BIOL, V53, P423, DOI 10.1023/B:PLAN.0000019059.56489.ca; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Oliva A, 2005, PLOS BIOL, V3, P1239, DOI 10.1371/journal.pbio.0030225; OTA K, 2004, P 4 INT WORKSH BIOIN, P26; Peng X, 2005, MOL BIOL CELL, V16, P1026, DOI 10.1091/mbc.E04-04-0299; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Sherlock G, 2004, NAT GENET, V36, P795, DOI 10.1038/ng0804-795; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Yanow SK, 2001, EMBO J, V20, P4648, DOI 10.1093/emboj/20.17.4648; Zhu YH, 2005, CELL CYCLE, V4, P1254, DOI 10.4161/cc.4.9.1975	26	154	157	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2006	443	7111					594	597		10.1038/nature05186	http://dx.doi.org/10.1038/nature05186			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	17006448				2022-12-28	WOS:000240988200048
J	Zhang, JJ; Ding, EL; Song, YQ				Zhang, Jingjing; Ding, Eric L.; Song, Yiqing			Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events - Meta-analysis of randomized trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	46th Annual Conference on Cardiovascular Disease Epidemiology and Prevention	MAR 02-05, 2006	Phoenix, AZ	Amer Heart Assoc, Natl Heart, Lung & Blood Inst			LOW-BACK-PAIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; QUALITY-OF-LIFE; UPPER GASTROINTESTINAL TOXICITY; COMPARATOR-CONTROLLED-TRIAL; DOUBLE-BLIND; RHEUMATOID-ARTHRITIS; CARDIOVASCULAR EVENTS; COX-2 INHIBITORS; GASTRODUODENAL ULCERS	Context Adverse effects of selective cyclooxygenase 2 (COX-2) inhibitors on renal events and arrhythmia have been controversial, with suggestions of a class effect. Objective To quantitatively evaluate adverse risks of renal events ( renal dysfunction, hypertension, and peripheral edema) and arrhythmia events and to explore drug class effects and temporal trends of apparent effects of the COX-2 inhibitors: rofecoxib, celecoxib, valdecoxib, parecoxib, etoricoxib, and lumiracoxib. Data Sources A systematic search of EMBASE and MEDLINE ( through June 2006), bibliographies, US Food and Drug Administration reports, and pharmaceutical industry clinical trial databases. Study Selection From relevant reports, 114 randomized double-blind clinical trials were included. Data Extraction Information on publication year, participant characteristics, trial duration, drug, control, dose, and events were extracted using a standardized protocol. Data Synthesis Results were pooled via random-effects models and meta-regressions. Of 116 094 participants from 114 trial reports including 127 trial populations ( 40 rofecoxib, 37 celecoxib, 29 valdecoxib + parecoxib, 15 etoricoxib, and 6 lumiracoxib), there were a total of 6394 composite renal events ( 2670 peripheral edema, 3489 hypertension, 235 renal dysfunction) and 286 arrhythmia events. Results indicated significant heterogeneity of renal effects across agents ( P for interaction=. 02), indicating no class effect. Compared with controls, rofecoxib was associated with increased risk of arrhythmia ( relative risk [RR], 2.90; 95% confidence interval [CI], 1.07-7.88) and composite renal events ( RR, 1.53; 95% CI, 1.33-1.76); adverse renal effects increased with greater dose and duration ( both P <=. 05). For all individual renal end points, rofecoxib was associated with increased risk of peripheral edema ( RR, 1.43; 95% CI, 1.23-1.66), hypertension ( RR, 1.55; 95% CI, 1.29-1.85), and renal dysfunction ( RR, 2.31; 95% CI, 1.05-5.07). In contrast, celecoxib was associated with lower risk of both renal dysfunction ( RR, 0.61; 95% CI, 0.40-0.94) and hypertension ( RR, 0.83; 95% CI, 0.71-0.97) compared with controls. Other agents were not significantly associated with risk. Time-cumulative analyses indicated that for rofecoxib the adverse risks for peripheral edema and hypertension were evident by the end of year 2000 and for risk of arrhythmia by 2004. Conclusions In this comprehensive analysis of 114 randomized trials with 116 094 participants, rofecoxib was associated with increased renal and arrhythmia risks. A COX-2 inhibitor class effect was not evident. Future safety monitoring is warranted and may benefit from an active and continuous cumulative surveillance system.	Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Ding, EL (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave,Kresge 9th Floor, Boston, MA 02115 USA.	eding@jhu.edu	Ding, Eric L./K-1118-2019	Ding, Eric L./0000-0002-5881-8097	NATIONAL CANCER INSTITUTE [T32CA009001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062290, R01DK066401] Funding Source: NIH RePORTER; NCI NIH HHS [T32-CA009001] Funding Source: Medline; NIDDK NIH HHS [R01-DK062290, R01-DK066401] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Acevedo E, 2001, SCAND J RHEUMATOL, V30, P19; Ahmad SR, 2002, DRUG SAFETY, V25, P537, DOI 10.2165/00002018-200225070-00007; Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819; Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Aw TJ, 2005, ARCH INTERN MED, V165, P490, DOI 10.1001/archinte.165.5.IOI50013; Bensen W, 2002, RHEUMATOLOGY, V41, P1008, DOI 10.1093/rheumatology/41.9.1008; Berlin JA, 1999, JAMA-J AM MED ASSOC, V281, P830, DOI 10.1001/jama.281.9.830; Bogaty P, 2004, CIRCULATION, V110, P934, DOI 10.1161/01.CIR.0000139338.12464.5F; Bombardier C, 2006, NEW ENGL J MED, V354, P1196; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Brewer T, 1999, JAMA-J AM MED ASSOC, V281, P824, DOI 10.1001/jama.281.9.824; Caldwell B, 2006, J ROY SOC MED, V99, P132, DOI 10.1258/jrsm.99.3.132; CAMU F, 1908, AM J THER, V9, P43; Cannon GW, 2000, ARTHRITIS RHEUM-US, V43, P978, DOI 10.1002/1529-0131(200005)43:5<978::AID-ANR4>3.0.CO;2-0; Catella-Lawson F, 1999, J PHARMACOL EXP THER, V289, P735; Chan FKL, 2002, NEW ENGL J MED, V347, P2104, DOI 10.1056/NEJMoa021907; Chang IJ, 2005, HYPERTENSION, V45, P178, DOI 10.1161/01.HYP.0000153049.77150.d7; Cheng HF, 2005, CURR PHARM DESIGN, V11, P1795, DOI 10.2174/1381612053764922; Chrubasik S, 2003, RHEUMATOLOGY, V42, P141, DOI 10.1093/rheumatology/keg053; Chrubasik S, 2001, RHEUMATOLOGY, V40, P1388, DOI 10.1093/rheumatology/40.12.1388; Claire B, 2000, NEW ENGL J MED, V343, P1520, DOI [DOI 10.1056/NEJME058314, 10.1056/NEJM200011233432103]; Coats TL, 2004, CLIN THER, V26, P1249, DOI 10.1016/S0149-2918(04)80081-X; Collantes Eduardo, 2002, BMC Fam Pract, V3, P10, DOI 10.1186/1471-2296-3-10; Curfman GD, 2006, NEW ENGL J MED, V354, P1193, DOI 10.1056/NEJMe068054; Curfman GD, 2005, NEW ENGL J MED, V353, P2813, DOI 10.1056/NEJMe058314; Curtis SP, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-58; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Desjardins PJ, 2004, J AM PODIAT MED ASSN, V94, P305, DOI 10.7547/0940305; Dieppe PA, 2004, BRIT MED J, V329, P867, DOI 10.1136/bmj.329.7471.867; Dougados M, 2001, ARTHRITIS RHEUM-US, V44, P180, DOI 10.1002/1529-0131(200101)44:1<180::AID-ANR24>3.0.CO;2-K; Egger M, 1997, BMJ-BRIT MED J, V315, P1371, DOI 10.1136/bmj.315.7119.1371; Egger M, 2001, SYSTEMATIC REV HLTH; Emery P, 1999, LANCET, V354, P2106, DOI 10.1016/S0140-6736(99)02332-6; Fenwick SW, 2003, GASTROENTEROLOGY, V125, P716, DOI 10.1016/S0016-5085(03)01061-8; Fleischmann R, 2006, CLIN RHEUMATOL, V25, P42, DOI 10.1007/s10067-005-1126-5; Fontanarosa PB, 2004, JAMA-J AM MED ASSOC, V292, P2647, DOI 10.1001/jama.292.21.2647; Geba GP, 2002, JAMA-J AM MED ASSOC, V287, P64, DOI 10.1001/jama.287.1.64; Geusens P, 2004, INT J CLIN PRACT, V58, P1033, DOI 10.1111/j.1368-5031.2004.00398.x; Geusens PP, 2002, SCAND J RHEUMATOL, V31, P230, DOI 10.1080/030097402320318431; Gibofsky A, 2003, ARTHRITIS RHEUM-US, V48, P3102, DOI 10.1002/art.11330; Gottesdiener K, 2002, RHEUMATOLOGY, V41, P1052, DOI 10.1093/rheumatology/41.9.1052; Guan YF, 1997, AM J PHYSIOL-RENAL, V273, pF18, DOI 10.1152/ajprenal.1997.273.1.F18; HARRIS RC, 1994, J CLIN INVEST, V94, P2504, DOI 10.1172/JCI117620; Harris RC, 2001, AM J PHYSIOL-RENAL, V281, pF1, DOI 10.1152/ajprenal.2001.281.1.F1; Hawkey CJ, 2003, GUT, V52, P820, DOI 10.1136/gut.52.6.820; Hermann M, 2005, HYPERTENSION, V45, P193, DOI 10.1161/01.HYP.0000153053.82032.bf; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hocherl K, 2002, BRIT J PHARMACOL, V136, P1117, DOI 10.1038/sj.bjp.0704821; Hubbard RC, 2003, BRIT J ANAESTH, V90, P166, DOI 10.1093/bja/aeg038; Hunt RH, 2003, ALIMENT PHARM THER, V17, P201, DOI 10.1046/j.1365-2036.2003.01407.x; Jajic Z, 2005, CLIN EXP RHEUMATOL, V23, P809; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; Kargman S, 1996, GASTROENTEROLOGY, V111, P445, DOI 10.1053/gast.1996.v111.pm8690211; Katz N, 2003, SPINE, V28, P851, DOI 10.1097/00007632-200305010-00002; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Kivitz AJ, 2004, ALIMENT PHARM THER, V19, P1189, DOI 10.1111/j.1365-2036.2004.01956.x; Kivitz AJ, 2004, J AM GERIATR SOC, V52, P666, DOI 10.1111/j.1532-5415.2004.52201.x; Kivitz AJ, 2001, J INT MED RES, V29, P467, DOI 10.1177/147323000102900602; Komhoff M, 1997, AM J PHYSIOL-RENAL, V272, pF460, DOI 10.1152/ajprenal.1997.272.4.F460; Krymchantowski AV, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-10; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; Laine L, 2004, GASTROENTEROLOGY, V127, P395, DOI 10.1053/j.gastro.2004.05.001; Lanza FL, 1999, ALIMENT PHARM THERAP, V13, P761, DOI 10.1046/j.1365-2036.1999.00529.x; Lehmann R, 2005, CURR MED RES OPIN, V21, P517, DOI 10.1185/030079905X38196; Leung AT, 2002, CURR MED RES OPIN, V18, P49, DOI 10.1185/030079902125000282; Lisse J, 2001, J GERONTOL A-BIOL, V56, pM167, DOI 10.1093/gerona/56.3.M167; Lisse JR, 2003, ANN INTERN MED, V139, P539, DOI 10.7326/0003-4819-139-7-200310070-00005; Matsumoto AK, 2002, J RHEUMATOL, V29, P1623; McKenna F, 2001, SCAND J RHEUMATOL, V30, P11; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; Myllykangas-Luosujarvi R, 2002, SCAND J RHEUMATOL, V31, P337, DOI 10.1080/030097402320817059; Nantel F, 1999, FEBS LETT, V457, P475, DOI 10.1016/S0014-5793(99)01088-1; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Niccoli L, 2002, CLIN EXP RHEUMATOL, V20, P201; Nussmeier NA, 2005, NEW ENGL J MED, V352, P1081, DOI 10.1056/NEJMoa050330; OBANION MK, 1992, P NATL ACAD SCI USA, V89, P4888, DOI 10.1073/pnas.89.11.4888; Ofman JJ, 2002, J RHEUMATOL, V29, P804; Ott E, 2003, J THORAC CARDIOV SUR, V125, P1481, DOI 10.1016/S0022-5223(03)00125-9; Pallay RM, 2004, SCAND J RHEUMATOL, V33, P257, DOI 10.1080/03009740410005728; Palmer BF, 1995, J INVEST MED, V43, P516; Palmer R, 2003, AM J HYPERTENS, V16, P135, DOI 10.1016/S0895-7061(02)03203-X; Pamuk ON, 2006, CLIN RHEUMATOL, V25, P123, DOI 10.1007/s10067-005-1167-9; Psaty BM, 2005, NEW ENGL J MED, V352, P1133, DOI 10.1056/NEJMe058042; Rasmussen G Lynn, 2002, Am J Orthop (Belle Mead NJ), V31, P336; Rasmussen GL, 2005, ANESTH ANALG, V101, P1104, DOI 10.1213/01.ane.0000169294.41210.9e; Ray WA, 2006, NEW ENGL J MED, V354, P194, DOI 10.1056/NEJMsb053432; Reid MS, 2005, ADDICTION, V100, P32, DOI 10.1111/j.1360-0443.2005.00989.x; Reines SA, 2004, NEUROLOGY, V62, P66, DOI 10.1212/WNL.62.1.66; Reynolds LW, 2003, J PAIN SYMPTOM MANAG, V25, P133, DOI 10.1016/S0885-3924(02)00637-1; Richter CM, 2004, J HYPERTENS, V22, P191, DOI 10.1097/00004872-200401000-00029; Rossat J, 1999, CLIN PHARMACOL THER, V66, P76, DOI 10.1016/S0009-9236(99)70056-1; Rothman K., 1998, MODERN EPIDEMIOLOGY; ROTHMAN KJ, 2003, EPISHEET SPREADSHEET; Rubin BR, 2004, ARTHRITIS RHEUM-US, V50, P598, DOI 10.1002/art.20007; Saag K, 2000, ARCH FAM MED, V9, P1124, DOI 10.1001/archfami.9.10.1124; Sandhu GK, 2004, ANN PHARMACOTHER, V38, P700, DOI 10.1345/aph.1D296; SCHLONDORFF D, 1993, KIDNEY INT, V44, P643, DOI 10.1038/ki.1993.293; Schnitzer TJ, 1999, CLIN THER, V21, P1688, DOI 10.1016/S0149-2918(99)80048-4; Schnitzer TJ, 2005, J RHEUMATOL, V32, P1093; Schnitzer TJ, 2005, ARTHRIT RHEUM-ARTHR, V53, P827, DOI 10.1002/art.21586; Schnitzer TJ, 2004, ARTHRIT RHEUM-ARTHR, V51, P549, DOI 10.1002/art.20525; Schwartz JI, 2002, CLIN PHARMACOL THER, V72, P50, DOI 10.1067/mcp.2002.126182; Schwartz JI, 2001, J CLIN PHARMACOL, V41, P1120, DOI 10.1177/00912700122012616; Sikes DH, 2002, EUR J GASTROEN HEPAT, V14, P1101, DOI 10.1097/00042737-200210000-00011; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Simon LS, 1999, JAMA-J AM MED ASSOC, V282, P1921, DOI 10.1001/jama.282.20.1921; Singh G, 2006, AM J MED, V119, P255, DOI 10.1016/j.amjmed.2005.09.054; Singh G, 1999, J RHEUMATOL, V26, P18; Smith MR, 2006, J CLIN ONCOL, V24, P2723, DOI 10.1200/JCO.2005.03.7804; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Stichtenoth DO, 2005, KIDNEY INT, V68, P2197, DOI 10.1111/j.1523-1755.2005.00676.x; Stichtenoth DO, 2000, CURR PHARM DESIGN, V6, P1737, DOI 10.2174/1381612003398717; Stoltz RR, 2002, AM J GASTROENTEROL, V97, P65; Swan SK, 2000, ANN INTERN MED, V133, P1, DOI 10.7326/0003-4819-133-1-200007040-00002; Ta LE, 2004, PAIN, V111, P13, DOI 10.1016/j.pain.2004.04.029; Tannenbaum H, 2004, ANN RHEUM DIS, V63, P1419, DOI 10.1136/ard.2003.015974; TARGUM SL, 2001, CONSULTATION NDA 21; Thal LJ, 2005, NEUROPSYCHOPHARMACOL, V30, P1204, DOI 10.1038/sj.npp.1300690; Truitt KE, 2001, AGING-CLIN EXP RES, V13, P112, DOI 10.1007/BF03351533; Tsoukas C, 2006, BLOOD, V107, P1785, DOI 10.1182/blood-2004-09-3501; van der Heijde D, 2005, ARTHRITIS RHEUM-US, V52, P1205, DOI 10.1002/art.20985; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Whelton A, 2000, ARCH INTERN MED, V160, P1465, DOI 10.1001/archinte.160.10.1465; Whelton A, 2002, J HYPERTENS, V20, pS31; Whelton A, 2002, AM J CARDIOL, V90, P959, DOI 10.1016/S0002-9149(02)02661-9; White WB, 2002, HYPERTENSION, V39, P929, DOI 10.1161/01.HYP.0000014323.99765.16; White WB, 2002, AM J CARDIOL, V89, P425, DOI 10.1016/S0002-9149(01)02265-2; Wiesenhutter CW, 2005, MAYO CLIN PROC, V80, P470, DOI 10.4065/80.4.470; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692; Zacher J, 2003, CURR MED RES OPIN, V19, P725, DOI 10.1185/030079903125002469; Zerbini C, 2005, CURR MED RES OPIN, V21, P2037, DOI 10.1185/030079905X75069; Zhao SZ, 1999, PHARMACOTHERAPY, V19, P1269, DOI 10.1592/phco.19.16.1269.30879	134	229	240	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2006	296	13					1619	1632		10.1001/jama.296.13.jrv60015	http://dx.doi.org/10.1001/jama.296.13.jrv60015			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	090JS	16968832				2022-12-28	WOS:000240948200022
J	Scadden, DT; Muse, VV; Hasserjian, RP; Basgoz, N; Harris, NL; Walker, BD				Scadden, David T.; Muse, Victorine V.; Hasserjian, Robert P.; Basgoz, Nesli; Harris, Nancy Lee; Walker, Bruce D.			A man with dyspnea, fever, and lymphadenopathy - HHV-8-associated multicentric Castleman's disease and Kaposi's sarcoma associated with HIV infection.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							IMMUNODEFICIENCY-VIRUS-INFECTION; RECONSTITUTION INFLAMMATORY SYNDROME; ACTIVE ANTIRETROVIRAL THERAPY; ANTI-CD20 MONOCLONAL-ANTIBODY; BONE-MARROW; HUMAN-HERPESVIRUS-8 INFECTION; PROLONGED REMISSION; HERPES-VIRUS; IN-VIVO; AIDS		Massachusetts Gen Hosp, Dept Hematol Oncol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Scadden, DT (corresponding author), Massachusetts Gen Hosp, Dept Hematol Oncol, Boston, MA 02114 USA.							Aaron L, 2002, CLIN INFECT DIS, V35, P880, DOI 10.1086/342696; Adams GB, 1999, AIDS RES HUM RETROV, V15, P551, DOI 10.1089/088922299311079; Baillou C, 2003, AIDS, V17, P563, DOI 10.1097/00002030-200303070-00012; BECK JT, 1994, NEW ENGL J MED, V330, P602, DOI 10.1056/NEJM199403033300904; Bower M, 2005, J CLIN ONCOL, V23, P5224, DOI 10.1200/JCO.2005.14.597; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cannon M, 2000, SEMIN ONCOL, V27, P409; CANQUE B, 1995, VIROLOGY, V208, P779, DOI 10.1006/viro.1995.1211; Casper C, 2004, BLOOD, V103, P1632, DOI 10.1182/blood-2003-05-1721; Cattani P, 2003, CLIN MICROBIOL INFEC, V9, P274, DOI 10.1046/j.1469-0691.2003.00490.x; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Colomo L, 2004, AM J SURG PATHOL, V28, P736, DOI 10.1097/01.pas.0000126781.87158.e3; Connick E, 2004, CLIN INFECT DIS, V39, P1852, DOI 10.1086/426078; Corbellino M, 2001, BLOOD, V98, P3473, DOI 10.1182/blood.V98.12.3473; DELACRETAZ F, 1987, VIRCHOWS ARCH A, V411, P543, DOI 10.1007/BF00713285; DOLIN R, 1982, NEW ENGL J MED, V306, P657; Du MQ, 2001, BLOOD, V97, P2130, DOI 10.1182/blood.V97.7.2130; Du MQ, 2002, BLOOD, V100, P3415, DOI 10.1182/blood-2002-02-0487; Dupin N, 2000, BLOOD, V95, P1406, DOI 10.1182/blood.V95.4.1406.004k26_1406_1412; FENG CS, 1991, PATHOLOGY, V23, P5, DOI 10.3109/00313029109061430; Gandhi RT, 2003, CLIN INFECT DIS, V37, P1693, DOI 10.1086/379773; Gill PS, 1999, J CLIN ONCOL, V17, P1876, DOI 10.1200/JCO.1999.17.6.1876; Gill V, 1996, BRIT J HAEMATOL, V93, P30, DOI 10.1046/j.1365-2141.1996.4801017.x; HAMILTONDUTOIT SJ, 1989, LANCET, V1, P554; Kahn JO, 1998, NEW ENGL J MED, V339, P33, DOI 10.1056/NEJM199807023390107; KARCHER DS, 1991, AM J CLIN PATHOL, V95, P63, DOI 10.1093/ajcp/95.1.63; Kaufmann GR, 2000, AIDS, V14, P2643, DOI 10.1097/00002030-200012010-00003; Kofteridis DP, 2004, AIDS, V18, P585, DOI 10.1097/00002030-200402200-00037; LACHANT NA, 1985, AM J CLIN PATHOL, V83, P27, DOI 10.1093/ajcp/83.1.27; Luppi M, 2000, NEW ENGL J MED, V343, P1378, DOI 10.1056/NEJM200011093431905; Markowitz M, 2005, LANCET, V365, P1031, DOI 10.1016/S0140-6736(05)74227-6; Marrache F, 2003, AIDS, V17, P1409, DOI 10.1097/00002030-200306130-00023; Mbulaiteye SM, 2003, J INFECT DIS, V187, P1780, DOI 10.1086/374973; MCCLAIN KL, 1995, NEW ENGL J MED, V332, P12, DOI 10.1056/NEJM199501053320103; Moses AV, 1996, BLOOD, V87, P919, DOI 10.1182/blood.V87.3.919.bloodjournal873919; Nador RG, 1996, BLOOD, V88, P645, DOI 10.1182/blood.V88.2.645.bloodjournal882645; Oksenhendler E, 1998, NEW ENGL J MED, V338, P1585, DOI 10.1056/NEJM199805283382204; Oksenhendler E, 1996, AIDS, V10, P61, DOI 10.1097/00002030-199601000-00009; Oksenhendler E, 2002, BLOOD, V99, P2331, DOI 10.1182/blood.V99.7.2331; PAVLIDIS NA, 1992, ANN ONCOL, V3, P85, DOI 10.1093/oxfordjournals.annonc.a058082; Pellett PE, 2003, TRANSFUSION, V43, P1260, DOI 10.1046/j.1537-2995.2003.00490.x; SCADDEN DT, 1990, BLOOD, V76, P317; Senanayake S, 2003, J MED VIROL, V71, P399, DOI 10.1002/jmv.10500; Shelburne SA, 2005, AIDS, V19, P399, DOI 10.1097/01.aids.0000161769.06158.8a; SHIRAMIZU B, 1994, CANCER RES, V54, P2069; Sloand EM, 2000, BLOOD, V96, P2735; Waterston A, 2004, ACTA ONCOL, V43, P698, DOI 10.1080/02841860410002752; ZON LI, 1987, BRIT J HAEMATOL, V66, P251, DOI 10.1111/j.1365-2141.1987.tb01307.x; 1954, N ENGL J MED, V250, P1001	49	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2006	355	13					1358	1368		10.1056/NEJMcpc069021	http://dx.doi.org/10.1056/NEJMcpc069021			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088EF	17005954				2022-12-28	WOS:000240793600012
J	Shapiro, AMJ; Ricordi, C; Hering, BJ; Auchincloss, H; Lindblad, R; Robertson, P; Secchi, A; Brendel, MD; Berney, T; Brennan, DC; Cagliero, E; Alejandro, R; Ryan, EA; DiMercurio, B; Morel, P; Polonsky, KS; Reems, JA; Bretzel, RG; Bertuzzi, F; Froud, T; Kandaswamy, R; Sutherland, DER; Eisenbarth, G; Segal, M; Preiksaitis, J; Korbutt, GS; Barton, FB; Viviano, L; Seyfert-Margolis, V; Bluestone, J; Lakey, JRT				Shapiro, A. M. James; Ricordi, Camillo; Hering, Bernhard J.; Auchincloss, Hugh; Lindblad, Robert; Robertson, Paul; Secchi, Antonio; Brendel, Mathias D.; Berney, Thierry; Brennan, Daniel C.; Cagliero, Enrico; Alejandro, Rodolfo; Ryan, Edmond A.; DiMercurio, Barbara; Morel, Philippe; Polonsky, Kenneth S.; Reems, Jo-Anna; Bretzel, Reinhard G.; Bertuzzi, Federico; Froud, Tatiana; Kandaswamy, Raja; Sutherland, David E. R.; Eisenbarth, George; Segal, Miriam; Preiksaitis, Jutta; Korbutt, Gregory S.; Barton, Franca B.; Viviano, Lisa; Seyfert-Margolis, Vicki; Bluestone, Jeffrey; Lakey, Jonathan R. T.			International trial of the edmonton protocol for islet transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DIABETES-MELLITUS; INSULIN-SECRETION; CULTURED ISLETS; TISSUE FACTOR; IMMUNOSUPPRESSION; RECIPIENTS; OUTCOMES; NETWORK; DONOR; MASS	Background: Islet transplantation offers the potential to improve glycemic control in a subgroup of patients with type 1 diabetes mellitus who are disabled by refractory hypoglycemia. We conducted an international, multicenter trial to explore the feasibility and reproducibility of islet transplantation with the use of a single common protocol (the Edmonton protocol). Methods: We enrolled 36 subjects with type 1 diabetes mellitus, who underwent islet transplantation at nine international sites. Islets were prepared from pancreases of deceased donors and were transplanted within 2 hours after purification, without culture. The primary end point was defined as insulin independence with adequate glycemic control 1 year after the final transplantation. Results: Of the 36 subjects, 16 (44%) met the primary end point, 10 (28%) had partial function, and 10 (28%) had complete graft loss 1 year after the final transplantation. A total of 21 subjects (58%) attained insulin independence with good glycemic control at any point throughout the trial. Of these subjects, 16 (76%) required insulin again at 2 years; 5 of the 16 subjects who reached the primary end point (31%) remained insulin-independent at 2 years. Conclusions: Islet transplantation with the use of the Edmonton protocol can successfully restore long-term endogenous insulin production and glycemic stability in subjects with type 1 diabetes mellitus and unstable control, but insulin independence is usually not sustainable. Persistent islet function even without insulin independence provides both protection from severe hypoglycemia and improved levels of glycated hemoglobin. (ClinicalTrials.gov number, NCT00014911.)	Univ Alberta, Clin Islet Transplant Program, Edmonton, AB T6G 2C8, Canada; Univ Miami, Miami, FL 33152 USA; Univ Minnesota, Minneapolis, MN USA; Harvard Univ, Sch Med, Boston, MA USA; Emmes Corp, Rockville, MD USA; Univ Washington, Seattle, WA 98195 USA; Ist Sci San Raffaele, I-20132 Milan, Italy; Univ Giessen, Giessen, Germany; Univ Geneva, CH-1211 Geneva 4, Switzerland; Washington Univ, St Louis, MO 63130 USA; NIAID, Rockville, MD USA; Univ Colorado, Barbara Davis Ctr, Boulder, CO 80309 USA; Immune Tolerance Network, San Francisco, CA USA; Immune Tolerance Network, Bethesda, MD USA	University of Alberta; University of Miami; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Harvard Medical School; Emmes Corporation; University of Washington; University of Washington Seattle; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Justus Liebig University Giessen; University of Geneva; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Colorado System; University of Colorado Boulder; Immune Tolerance Network; Immune Tolerance Network	Shapiro, AMJ (corresponding author), Univ Alberta, Clin Islet Transplant Program, 2000 Coll Plaza,8215 112th St, Edmonton, AB T6G 2C8, Canada.	shapiro@islet.ca	Berney, Thierry/ABE-9450-2021; RICORDI, CAMILLO/AAA-4740-2019	Berney, Thierry/0000-0002-4230-9378; Barton, Franca/0000-0002-6628-5745; Ricordi, Camillo/0000-0001-8092-7153				Adams AB, 2005, J IMMUNOL, V174, P542, DOI 10.4049/jimmunol.174.1.542; Adams AB, 2002, DIABETES, V51, P265, DOI 10.2337/diabetes.51.2.265; ALEJANDRO R, 1986, J CLIN INVEST, V78, P1339, DOI 10.1172/JCI112720; Benhamou PY, 2001, DIABETOLOGIA, V44, P859; Bertuzzi F, 2004, J CLIN ENDOCR METAB, V89, P5724, DOI 10.1210/jc.2004-0659; Braghi S, 2000, DIABETES, V49, P218, DOI 10.2337/diabetes.49.2.218; Contreras JL, 2004, DIABETES, V53, P2804, DOI 10.2337/diabetes.53.11.2804; Desai NM, 2003, TRANSPLANTATION, V76, P1623, DOI 10.1097/01.TP.0000081043.23751.81; Frank Adam M, 2005, Adv Surg, V39, P137, DOI 10.1016/j.yasu.2005.04.010; Froud T, 2005, AM J TRANSPLANT, V5, P2037, DOI 10.1111/j.1600-6143.2005.00957.x; Froud T, 2004, CELL TRANSPLANT, V13, P475; Froud T, 2004, CELL TRANSPLANT, V13, P55, DOI 10.3727/000000004772664897; Goss JA, 2004, TRANSPLANTATION, V77, P462, DOI 10.1097/01.TP.0000100397.86756.A3; Goss JA, 2003, TRANSPLANTATION, V76, P199, DOI 10.1097/01.TP.0000073976.26604.96; Hering BJ, 2005, JAMA-J AM MED ASSOC, V293, P830, DOI 10.1001/jama.293.7.830; Hering BJ, 2004, AM J TRANSPLANT, V4, P390, DOI 10.1046/j.1600-6143.2003.00351.x; HERING BJ, 2005, JAMA-J AM MED ASSOC, V293, P1594; HERING BJ, 1999, GRAFT, V2, P12; Hyder A, 2005, TOXICOL IN VITRO, V19, P541, DOI 10.1016/j.tiv.2005.01.005; Jaeger C, 1997, DIABETES, V46, P1907, DOI 10.2337/diabetes.46.11.1907; Johansson H, 2005, DIABETES, V54, P1755, DOI 10.2337/diabetes.54.6.1755; King A, 2005, DIABETOLOGIA, V48, P2074, DOI 10.1007/s00125-005-1922-0; LAKEY JR, 2004, CURRENT HUMAN ISLET; Lakey JRT, 1999, CELL TRANSPLANT, V8, P285, DOI 10.1177/096368979900800309; Lopez-Talavera JC, 2004, ENDOCRINOLOGY, V145, P467, DOI 10.1210/en.2003-1070; Matsumoto S, 2005, LANCET, V365, P1642, DOI 10.1016/S0140-6736(05)66383-0; Nanji SA, 2004, BIODRUGS, V18, P315, DOI 10.2165/00063030-200418050-00004; Owen RJT, 2003, RADIOLOGY, V229, P165, DOI 10.1148/radiol.2291021632; RICORDI C, 1989, DIABETES, V38, P140, DOI 10.2337/diab.38.1.S140; Ricordi C, 2004, NAT REV IMMUNOL, V4, P258, DOI 10.1038/nri1332; Robertson RP, 2004, NEW ENGL J MED, V350, P694, DOI 10.1056/NEJMra032425; Rotrosen D, 2002, J ALLERGY CLIN IMMUN, V110, P17, DOI 10.1067/mai.2002.124258; Ryan EA, 2002, DIABETES, V51, P2148, DOI 10.2337/diabetes.51.7.2148; Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Shapiro AMJ, 2005, THER DRUG MONIT, V27, P35, DOI 10.1097/00007691-200502000-00008; Shapiro AMJ, 2005, TRANSPLANTATION, V79, P1304, DOI 10.1097/01.TP.0000157300.53976.2A; Shapiro AMJ, 2003, IMMUNOL REV, V196, P219, DOI 10.1046/j.1600-065X.2003.00085.x; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; SUTTON R, 1989, DIABETES, V38, P182, DOI 10.2337/diab.38.1.S182; Vantyghem MC, 2003, DIABETES METAB, V29, P595, DOI 10.1016/S1262-3636(07)70074-5; Villiger P, 2005, AM J TRANSPLANT, V5, P2992, DOI 10.1111/j.1600-6143.2005.01108.x	42	1430	1535	1	94	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2006	355	13					1318	1330		10.1056/NEJMoa061267	http://dx.doi.org/10.1056/NEJMoa061267			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088EF	17005949	Bronze, Green Published			2022-12-28	WOS:000240793600005
J	Amadio, JP; Walsh, CA				Amadio, Jordan P.; Walsh, Christopher A.			Brain evolution and uniqueness in the human genome	CELL			English	Editorial Material							GENE; SIZE	Despite an ever-expanding database of sequenced mammalian genomes to be mined for clues, the emergence of the unique human brain remains an evolutionary enigma. In their new study, Pollard et al. (2006) trawl the human genome and those of other mammals in search of short conserved DNA elements that show extremely rapid evolution only in humans. As they report in a recent issue of Nature, their scan yielded a gene for a novel noncoding RNA that adopts a human-specific structure and may regulate neurodevelopment.	Childrens Hosp, Howard Hughes Med Inst, Beth Israel Deaconess Med Ctr, Div Genet, Boston, MA 02115 USA; MIT, Broad Inst, Boston, MA 02115 USA; Harvard Univ, Boston, MA 02115 USA; Harvard Mit Div Hlth Sci & Technol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University	Walsh, CA (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Beth Israel Deaconess Med Ctr, Div Genet, Boston, MA 02115 USA.	cwalsh@bidmc.harvard.edu						Evans PD, 2004, HUM MOL GENET, V13, P1139, DOI 10.1093/hmg/ddh126; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Goodrich JA, 2006, NAT REV MOL CELL BIO, V7, P612, DOI 10.1038/nrm1946; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Olson EC, 2002, CURR OPIN GENET DEV, V12, P320, DOI 10.1016/S0959-437X(02)00305-2; POLLARD KS, 2006, IN PRESS NATURE; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Zhang JZ, 2003, GENETICS, V165, P2063	11	16	17	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 22	2006	126	6					1033	1035		10.1016/j.cell.2006.09.007	http://dx.doi.org/10.1016/j.cell.2006.09.007			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089RF	16990130	Bronze			2022-12-28	WOS:000240897600011
J	Nesbit, J				Nesbit, Jeff			2006 Visualization challenge	SCIENCE			English	Editorial Material																			0	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2006	313	5794					1729	1729		10.1126/science.313.5794.1729	http://dx.doi.org/10.1126/science.313.5794.1729			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086ED	16990530				2022-12-28	WOS:000240655700014
J	Lagerqvist, B; Husted, S; Kontny, F; Stahle, E; Swahn, E; Wallentin, L				Lagerqvist, Bo; Husted, Steen; Kontny, Fredrik; Stahle, Elisabeth; Swahn, Eva; Wallentin, Lars		FRISC-II Investigators	5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study	LANCET			English	Article							ARTERY-DISEASE; MYOCARDIAL-INFARCTION; UNSTABLE ANGINA; INTERVENTIONAL STRATEGY; SEGMENT ELEVATION; TASK-FORCE; MANAGEMENT; GUIDELINES; WOMEN; MEN	Background The FRISC-II invasive trial compared an early invasive with a non-invasive strategy in terms of death and myocardial infarction in non-ST-elevation acute coronary syndrome. We present 5-year follow-up results, overall and in subgroups based on recommended risk stratification criteria. Methods In the FRISC-II trial, 2457 patients with non-ST-elevation acute coronary syndrome were randomised to early invasive strategy (coronary angiography and, if appropriate, revascularisation, within 7 days from admission) or non-invasive primarily medical strategy. Risk stratification was done on the basis of risk indicators at randomisation: age older than 65 years, male sex, diabetes mellitus, previous myocardial infarction, ST-segment depression, raised troponin concentration (>0.03 mu g/L), and raised C-reactive protein or interleukin 6. Information on events after 24 months was taken from national registries. Analyses were done on an intention-to-treat basis. Findings At 5 years the groups differed in terms of the primary composite endpoint of death, myocardial infarction, or both (invasive 217, 19.9 %; noninvasive 270, 24.5 %; risk ratio 0.81; 95% CI 0.69-0.95; p=0.009). 5-year mortality was 117 (9.7%) in the invasive group compared with 124 (10.1%) in the noninvasive group (0.95; 0.75-1.21; p=0.693). Rates of myocardial infarction were 141 (12.9%) in the invasive and 195 (17.7%) in the non-invasive group (0.73; 0.60-0.89; p=0.002). The benefit of the invasive strategy was confined to male patients, non-smokers, and patients with two or more risk indicators. Interpretation The 5-year outcome of this trial indicates sustained benefit of an early invasive strategy in patients non-ST-elevation acute coronary syndrome at moderate to high risk.	Univ Uppsala Hosp, Dept Cardiol, S-75185 Uppsala, Sweden; Univ Uppsala Hosp, Uppsala Clin Res Ctr, S-75185 Uppsala, Sweden; Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark; Volvat Med Ctr, Dept Cardiol, Oslo, Norway; Univ Uppsala Hosp, Dept Thorac Surg, Uppsala, Sweden; Linkoping Univ Hosp, Dept Cardiol, S-58185 Linkoping, Sweden	Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Aarhus University; Uppsala University; Uppsala University Hospital; Linkoping University	Wallentin, L (corresponding author), Univ Uppsala Hosp, Dept Cardiol, S-75185 Uppsala, Sweden.	lars.wallentin@ucr.uu.se						Bertrand ME, 2002, EUR HEART J, V23, P1809, DOI 10.1053/euhj.2002.3385; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Clayton TC, 2004, EUR HEART J, V25, P1641, DOI 10.1016/j.ehj.2004.07.032; de Winter RJ, 2005, NEW ENGL J MED, V353, P1095, DOI 10.1056/NEJMoa044259; Diderholm E, 2002, AM HEART J, V143, P760, DOI 10.1067/mhj.2002.121733; Fox KAA, 2005, LANCET, V366, P914, DOI 10.1016/S0140-6736(05)67222-4; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001; Hammar N, 2001, INT J EPIDEMIOL, V30, pS30, DOI 10.1093/ije/30.suppl_1.S30; Lagerqvist B, 2005, HEART, V91, P1047, DOI 10.1136/hrt.2003.031369; Lagerqvist B, 2002, J AM COLL CARDIOL, V40, P1902, DOI 10.1016/S0735-1097(02)02572-X; Lagerqvist B, 2001, J AM COLL CARDIOL, V38, P41, DOI 10.1016/S0735-1097(01)01308-0; SCOTT SM, 1994, CIRCULATION, V90, P120; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; Wallentin L, 1999, LANCET, V354, P708; Wallentin L, 2000, LANCET, V356, P9, DOI 10.1016/S0140-6736(00)02427-2	17	198	215	1	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 16	2006	368	9540					998	1004		10.1016/S0140-6736(06)69416-6	http://dx.doi.org/10.1016/S0140-6736(06)69416-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	086UO	16980115				2022-12-28	WOS:000240698700028
J	Nkomo, VT; Gardin, JM; Skelton, TN; Gottdiener, JS; Scott, CG; Enriquez-Sarano, M				Nkomo, Vuyisile T.; Gardin, Julius M.; Skelton, Thomas N.; Gottdiener, John S.; Scott, Christopher G.; Enriquez-Sarano, Maurice			Burden of valvular heart diseases: a population-based study	LANCET			English	Article							AORTIC REGURGITATION; DOPPLER-ECHOCARDIOGRAPHY; MITRAL REGURGITATION; PREVALENCE; VALVE; RECOMMENDATIONS; COMMITTEE; WOMEN	Background Valvular heart diseases are not usually regarded as a major public-health problem. Our aim was to assess their prevalence and effect on overall survival in the general population. Methods We pooled population-based studies to obtain data for 11911 randomly selected adults from the general population who had been assessed prospectively with echocardiography. We also analysed data from a community study of 16 501 adults who had been assessed by clinically indicated echocardiography. Findings In the general population group, moderate or severe valve disease was identified in 615 adults. There was no difference in the frequency of such diseases between men and women (p=0.90). Prevalence increased with age, from 0.7% (95% CI 0.5-1.0) in 18-44 year olds to 13.3% (11.7-15.0) in the 75 years and older group (p<0.0001). The national prevalence of valve disease, corrected for age and sex distribution from the US 2000 population, is 2.5% (2.2-2.7). In the community group, valve disease was diagnosed in 1505 (1.8% adjusted) adults and frequency increased considerably with age, from 0.3% (0.2-0.3) of the 18-44 year olds to 11.7% (11.0-12.5) of those aged 75 years and older, but was diagnosed less often in women than in men (odds ratio 0.90, 0.81-1.01; p=0.07). The adjusted mortality risk ratio associated with valve disease was 1.36 (1.15-1.62; p=0.0005) in the population and 1.75 (1.61-1.90; p<0.0001) in the community. Interpretation Moderate or severe valvular diseases: are notably common in this population and increase with age. In the community women are less often diagnosed than are men, which could indicate an important imbalance in view of the associated lower survival. Valve diseases thus represent an important public-health problem.	Mayo Clin, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA; St Johns Hosp, Detroit, MI USA; Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; Univ Maryland, Baltimore, MD 21201 USA	Mayo Clinic; University of Mississippi; University of Mississippi Medical Center; University System of Maryland; University of Maryland Baltimore	Enriquez-Sarano, M (corresponding author), Mayo Clin, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA.	sarano.maurice@mayo.edu		Scott, Christopher/0000-0003-1340-0647	NHLBI NIH HHS [HL 64928] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064928] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKASAKA T, 1987, CIRCULATION, V76, P262, DOI 10.1161/01.CIR.76.2.262; Aronow WS, 1997, AM J CARDIOL, V79, P379, DOI 10.1016/S0002-9149(96)00769-2; Bonow R O, 1998, J Heart Valve Dis, V7, P672; Carabello BA, 2002, J CARD FAIL, V8, pS258, DOI 10.1054/jcaf.2002.129250; Chen LW, 1998, CURR OPIN CARDIOL, V13, P397, DOI 10.1097/00001573-199811000-00003; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; FURBERG CD, 1994, AM J CARDIOL, V74, P236, DOI 10.1016/0002-9149(94)90363-8; Gardin J M, 1992, J Am Soc Echocardiogr, V5, P63; HATLE L, 1984, HERZ, V9, P213; HELMCKE F, 1987, CIRCULATION, V75, P175, DOI 10.1161/01.CIR.75.1.175; HUGHES GH, 1987, CONTROL CLIN TRIALS, V8, pS68; Iung B, 2005, EUR HEART J, V26, P2714, DOI 10.1093/eurheartj/ehi471; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Jones EC, 2001, AM J CARDIOL, V87, P298, DOI 10.1016/S0002-9149(00)01362-X; Jost CHA, 2000, AM J MED, V108, P614, DOI 10.1016/S0002-9343(00)00361-2; Klein A L, 1990, J Am Soc Echocardiogr, V3, P54; Klodas E, 1996, CIRCULATION, V94, P2472, DOI 10.1161/01.CIR.94.10.2472; Lebowitz NE, 2000, J AM COLL CARDIOL, V36, P461, DOI 10.1016/S0735-1097(00)00744-0; LINDROOS M, 1993, J AM COLL CARDIOL, V21, P1220, DOI 10.1016/0735-1097(93)90249-Z; Lucas G, 2000, Rev Prat, V50, P1642; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; MOHTY D, 2001, CIRCULATION S1, V104, P1, DOI 10.1161/hc37t1.094903; NISHIMURA RA, 1985, MAYO CLIN PROC, V60, P321, DOI 10.1016/S0025-6196(12)60540-0; OLSON LJ, 1987, MAYO CLIN PROC, V62, P22, DOI 10.1016/S0025-6196(12)61522-5; PERRY GJ, 1987, J AM COLL CARDIOL, V9, P952, DOI 10.1016/S0735-1097(87)80254-1; POMERANCE A, 1967, BRIT HEART J, V29, P222; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Singh JP, 1999, AM J CARDIOL, V83, P897, DOI 10.1016/S0002-9149(98)01064-9; *SOC THOR SURG, STS NAT DAT SPRING 2; Soler-Soler J, 2000, HEART, V83, P721, DOI 10.1136/heart.83.6.721; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; U. S. Bureau of the Census, 2001, US CENS 2000; who, 2004, WHO TECH REP SER, V923, P1; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	35	2791	2974	5	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 16	2006	368	9540					1005	1011		10.1016/S0140-6736(06)69208-8	http://dx.doi.org/10.1016/S0140-6736(06)69208-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	086UO	16980116				2022-12-28	WOS:000240698700029
J	Schuwirth, LWT; van der Vleuten, CPM				Schuwirth, Lambert W. T.; van der Vleuten, Cees P. M.			Medical education - Challenges for educationalists	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EXPERT PERFORMANCE; ACQUISITION; PROGRAMS		Univ Maastricht, NL-6200 MD Maastricht, Netherlands	Maastricht University	Schuwirth, LWT (corresponding author), Univ Maastricht, POB 616,Dokter Tanslaan 10, NL-6200 MD Maastricht, Netherlands.	l.schuwirth@educ.unimaas.nl						Bogg J, 2001, MED EDUC, V35, P590, DOI 10.1046/j.1365-2923.2001.00951.x; Brett JF, 2001, J APPL PSYCHOL, V86, P930, DOI 10.1037//0021-9010.86.5.930; Colliver JA, 2003, TEACH LEARN MED, V15, P154, DOI 10.1207/S15328015TLM1503_01; Davis MH, 2006, LANCET, V367, P377, DOI 10.1016/S0140-6736(06)68116-6; Elstein AS, 1978, MED PROBLEM SOLVING; ERICSSON KA, 1994, AM PSYCHOL, V49, P725, DOI 10.1037/0003-066X.49.8.725; Ericsson KA, 2004, ACAD MED, V79, pS70, DOI 10.1097/00001888-200410001-00022; Gaba DM, 2002, NEW ENGL J MED, V347, P1249, DOI 10.1056/NEJMsa020846; Issenberg SB, 2005, MED TEACH, V27, P10, DOI 10.1080/01421590500046924; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; McLachlan J, 2006, MED EDUC, V40, P2, DOI 10.1111/j.1365-2929.2005.02359.x; NORCINI JJ, 1995, ANN INTERN MED, V123, P795, DOI 10.7326/0003-4819-123-10-199511150-00008; Norman G, 2003, MED EDUC, V37, P582, DOI 10.1046/j.1365-2923.2003.01586.x; Prince Katinka, 2004, Educ Health (Abingdon), V17, P323; Reed DA, 2005, JAMA-J AM MED ASSOC, V294, P1052, DOI 10.1001/jama.294.9.1052; Southgate L, 2001, MED EDUC, V35, P2; Torgerson CJ, 2002, MED EDUC, V36, P1002, DOI 10.1046/j.1365-2923.2002.01335.x; van der Vleuten CPM, 2005, MED EDUC, V39, P309, DOI 10.1111/j.1365-2929.2005.02094.x	18	60	64	2	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2006	333	7567					544	546		10.1136/bmj.38952.701875.94	http://dx.doi.org/10.1136/bmj.38952.701875.94			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	084LD	16960212	Green Published			2022-12-28	WOS:000240533500022
J	Banaszynski, LA; Chen, LC; Maynard-Smith, LA; Ooi, AGL; Wandless, TJ				Banaszynski, Laura A.; Chen, Lin-chun; Maynard-Smith, Lystranne A.; Ooi, A. G. Lisa; Wandless, Thomas J.			A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules	CELL			English	Article							KINASE INHIBITORS; RNA INTERFERENCE; MAMMALIAN-CELLS; GENE-EXPRESSION; HALF-LIFE; IN-VIVO; SPECIFICITY; UBIQUITIN; DIFFERENTIATION; LOCALIZATION	Rapid and reversible methods for perturbing the function of specific proteins are desirable tools for probing complex biological systems. We have developed a general technique to regulate the stability of specific proteins in mammalian cells using cell-permeable, synthetic molecules. We engineered mutants of the human FKBP12 protein that are rapidly and constitutively degraded when expressed in mammalian cells, and this instability is conferred to other proteins fused to these destabilizing domains. Addition of a synthetic ligand that binds to the destabilizing domains shields them from degradation, allowing fused proteins to perform their cellular functions. Genetic fusion of the destabilizing domain to a gene of interest ensures specificity, and the attendant small-molecule control confers speed, reversibility, and dose-dependence to this method. This general strategy for regulating protein stability should enable conditional perturbation of specific proteins with unprecedented control in a variety of experimental settings.	Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Stanford Univ, Dept Mol Pharmacol, Stanford, CA 94305 USA	Stanford University; Stanford University	Wandless, TJ (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	wandless@stanford.edu	Banaszynski, Laura/B-9612-2009		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068589, R01GM073046] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM073046, R01 GM073046, R01 GM073046-02, R01 GM068589, GM068589, R01 GM068589-01, R01 GM073046-01A1, R01 GM068589-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Banaszynski LA, 2006, CHEM BIOL, V13, P11, DOI 10.1016/j.chembiol.2005.10.010; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bishop AC, 1998, CURR BIOL, V8, P257, DOI 10.1016/S0960-9822(98)70198-8; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Heo WD, 2003, CELL, V113, P315; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; HOLT DA, 1993, J AM CHEM SOC, V115, P9925, DOI 10.1021/ja00075a008; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Iuliucci JD, 2001, J CLIN PHARMACOL, V41, P870, DOI 10.1177/00912700122010771; Janse DM, 2004, J BIOL CHEM, V279, P21415, DOI 10.1074/jbc.M402954200; Kanemaki M, 2003, NATURE, V423, P720, DOI 10.1038/nature01692; Kohler JJ, 2003, CHEM BIOL, V10, P1303, DOI 10.1016/j.chembiol.2003.11.018; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Liberles SD, 1997, P NATL ACAD SCI USA, V94, P7825, DOI 10.1073/pnas.94.15.7825; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Medema RH, 2004, BIOCHEM J, V380, P593, DOI 10.1042/BJ20040260; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Pan XQ, 2005, J BIOL CHEM, V280, P22385, DOI 10.1074/jbc.M500081200; PARK EC, 1992, P NATL ACAD SCI USA, V89, P1249, DOI 10.1073/pnas.89.4.1249; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Pollock R, 2002, CURR OPIN BIOTECH, V13, P459, DOI 10.1016/S0958-1669(02)00373-7; Raab RM, 2004, BIOTECHNOL BIOENG, V88, P121, DOI 10.1002/bit.20216; Ryding ADS, 2001, J ENDOCRINOL, V171, P1, DOI 10.1677/joe.0.1710001; Schneekloth JS, 2004, J AM CHEM SOC, V126, P3748, DOI 10.1021/ja039025z; Schreiber SL, 2003, CHEM ENG NEWS, V81, P51, DOI 10.1021/cen-v081n009.p051; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X; Tan DS, 2005, NAT CHEM BIOL, V1, P74, DOI 10.1038/nchembio0705-74; Wang H, 2003, P NATL ACAD SCI USA, V100, P4287, DOI 10.1073/pnas.0636870100; Yang W, 2000, J MED CHEM, V43, P1135, DOI 10.1021/jm9904396; Zaccolo M, 1996, J MOL BIOL, V255, P589, DOI 10.1006/jmbi.1996.0049	42	586	641	10	113	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 8	2006	126	5					995	1004		10.1016/j.cell.2006.07.025	http://dx.doi.org/10.1016/j.cell.2006.07.025			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	086LO	16959577	Green Accepted, Bronze			2022-12-28	WOS:000240675000025
J	Landrigan, CP; Barger, LK; Cade, BE; Ayas, NT; Czeisler, CA				Landrigan, Christopher P.; Barger, Laura K.; Cade, Brian E.; Ayas, Najib T.; Czeisler, Charles A.			Interns' compliance with accreditation council for graduate medical education work-hour limits	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERFORMANCE; RESIDENTS; ALCOHOL; FATIGUE; IMPACT; SLEEP; RISK	Context Sleep deprivation is associated with increased risk of serious medical errors and motor vehicle crashes among interns. The Accreditation Council for Graduate Medical Education (ACGME) introduced duty-hour standards in 2003 to reduce work hours. Objective To estimate compliance with the ACGME duty-hour standards among interns. Design, Setting, and Participants National prospective cohort study with monthly Web-based survey assessment of intern work and sleep hours using a validated instrument, conducted preimplementation (July 2002 through May 2003) and postimplementation (July 2003 through May 2004) of ACGME standards. Participants were 4015 of the approximately 37 253 interns in US residency programs in all specialties during this time; they completed 29 477 reports of their work and sleep hours. Main Outcome Measure Overall and monthly rates of compliance with the ACGME standards. Results Postimplementation, 1068 (83.6%; 95% confidence interval [CI], 81.4%-85.5%) of 1278 of interns reported work hours in violation of the standards during 1 or more months. Working shifts greater than 30 consecutive hours was reported by 67.4% (95% CI, 64.8%-70.0%). Averaged over 4 weeks, 43.0% (95% CI, 40.3%-45.7%) reported working more than 80 hours weekly, and 43.7% (95% CI, 41.0%-46.5%) reported not having 1 day in 7 off work duties. Violations were reported during 3765 (44.0%; 95% CI, 43.0%-45.1%) of the 8553 intern-months assessed postimplementation (including vacation and ambulatory rotations), and during 2660 (61.5%; 95% CI, 60.0%-62.9%) of 4327 intern-months during which interns worked exclusively in inpatient settings. Postimplementation, 29.0% (95% CI, 28.7%-29.7%) of reported work weeks were more than 80 hours per week, 12.1% (95% CI, 11.8%-12.6%) were 90 or more hours per week, and 3.9% (95% CI, 3.7%-4.2%) were 100 or more hours per week. Comparing preimplementation to postimplementation responses, reported mean work duration decreased 5.8% from 70.7 (95% CI, 70.5-70.9) hours to 66.6 (95% CI, 66.3-66.9) hours per week (P<.001), and reported mean sleep duration increased 6.1% (22 minutes) from 5.91 (95% CI, 5.88-5.94) hours to 6.27 (95% CI, 6.23-6.31) hours per night (P<.001). However, reported mean sleep during extended shifts decreased 4.5%, from 2.69 (95% CI, 2.66-2.73) hours to 2.57 (95% CI, 2.52-2.62) hours (P<.001). Conclusion In the first year following implementation of the ACGME duty-hour standards, interns commonly reported noncompliance with these requirements.	Brigham & Womens Hosp, Dept Med, Div Sleep Med, Harvard Work Hours Hlth & Safety Grp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Div Sleep Med, Boston, MA USA; Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Med,Div Gen Pediat, Boston, MA USA; Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University of British Columbia	Landrigan, CP (corresponding author), Brigham & Womens Hosp, Dept Med, Div Sleep Med, Harvard Work Hours Hlth & Safety Grp, 221 Longwood Ave, Boston, MA 02115 USA.	clandrigan@rics.bwh.harvard.edu	Cade, Brian/J-6770-2019	Cade, Brian/0000-0003-1424-0673; Landrigan, Christopher/0000-0001-8386-4100	AHRQ HHS [R01 HS12032, K08 HS13333] Funding Source: Medline; NHLBI NIH HHS [T32 HL079010] Funding Source: Medline; NIOSH CDC HHS [1 R01 OH07567] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS013333, R01HS012032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH007567] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIOSH CDC HHS; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))		*ACCR COUNC GRAD M, ACGME PROC ADDR COMP; *ACCR COUNC GRAD M, INF REL ACGMES EFF A; *ACCR COUNC GRAD M, RES SURV; *ACCR COUNC GRAD M, FREQ ASK QUEST PROP; *ACCR COUNC GRAD M, COMM PROGR REQ DUT H; Accreditation Council for Graduate Medical Education, ACGMES APPR LIM RES; Accreditation Council for Graduate Medical Education, 2004, ACGMES APPR LIM RES; Accreditation Council on Graduate Medical Education, STAT JUST IMP FIN AP; *AM AC MED COLL, MED IND MED ED IME P; *AM MED ASS, RES RES WORK HOURS S; *AM MED STUD ASS, COMP STAT PUERT RIC; Arnedt JT, 2005, JAMA-J AM MED ASSOC, V294, P1025, DOI 10.1001/jama.294.9.1025; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; *BRIT MED ASS, TIM GUID EWTD JUN DO; CONYERS J, 1228 HR; CULL WL, 2005, RESIDENT FATIGUE ACG; Dawson D, 1997, NATURE, V388, P235, DOI 10.1038/40775; Fischer JE, 2005, AM J SURG, V190, P1, DOI 10.1016/j.amjsurg.2005.03.023; Gaba DM, 2002, NEW ENGL J MED, V347, P1249, DOI 10.1056/NEJMsa020846; Henshaw John L., 2002, COMMUNICATION; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; *NAT RES MATCH PRO, ADV DAT TABL 2003 RE; *NAT RES MATCH PRO, POS OFF PERC FILL US; *NURS HLTH STUUD, NURS HLTH STUD HIST; Petersen L A, 1998, Jt Comm J Qual Improv, V24, P77; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Philibert I, 2005, SLEEP, V28, P1392, DOI 10.1093/sleep/28.11.1392; *PUBL CIT HLTH RES, 2002, HRG PUBL, V1570; Reiter ER, 2005, LARYNGOSCOPE, V115, P773, DOI 10.1097/01.MLG.0000157696.03159.24; Steinbrook R, 2002, NEW ENGL J MED, V347, P1296, DOI 10.1056/NEJMhpr022383; Watson JC, 2005, NEUROLOGY, V64, pE11, DOI 10.1212/01.WNL.0000152728.17155.41	32	114	115	1	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2006	296	9					1063	1070		10.1001/jama.296.9.1063	http://dx.doi.org/10.1001/jama.296.9.1063			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	081DW	16954485	Bronze			2022-12-28	WOS:000240298400007
J	Lorber, B				Lorber, Bennett			Update in infectious diseases	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RESISTANT STAPHYLOCOCCUS-AUREUS; CLOSTRIDIUM-DIFFICILE; MORTALITY; STRAIN; VIRUS; RISK		Temple Univ, Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Lorber, B (corresponding author), Temple Univ Hosp & Med Sch, Infect Dis Sect, Broad & Ontario Str, Philadelphia, PA 19140 USA.	bennett.lorber@temple.edu						Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Gafter-Gvili A, 2005, ANN INTERN MED, V142, P979, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00008; Geng E, 2005, JAMA-J AM MED ASSOC, V293, P2740, DOI 10.1001/jama.293.22.2740; Golden MR, 2005, NEW ENGL J MED, V352, P676, DOI 10.1056/NEJMoa041681; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; Knight CL, 2006, ANN INTERN MED, V145, P52, DOI 10.7326/0003-4819-145-1-200607040-00010; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Maskell NA, 2005, NEW ENGL J MED, V352, P865, DOI 10.1056/NEJMoa042473; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Pepin J, 2005, CLIN INFECT DIS, V40, P1591, DOI 10.1086/430315; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X	16	13	14	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 5	2006	145	5					354	360		10.7326/0003-4819-145-5-200609050-00008	http://dx.doi.org/10.7326/0003-4819-145-5-200609050-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080NZ	16954360				2022-12-28	WOS:000240255900005
J	Kolbe, AR; Hutson, RA				Kolbe, Athena R.; Hutson, Royce A.			Human rights abuse and other criminal violations in Port-au-Prince, Haiti: a random survey of households	LANCET			English	Article								Background Reliable evidence of the frequency and severity of human rights abuses in Haiti after the departure of the elected president in 2004 was scarce. We assessed data from a random survey of households in the greater Port-au-Prince area. Methods Using random Global Positioning System (GPS) coordinate sampling, 1260 households (5720 individuals) were sampled. They were interviewed with a structured questionnaire by trained interviewers about their experiences after the departure of President Jean-Bertrand Aristide. The response rate was 90.7%. Information on demographic characteristics, crime, and human rights violations was obtained. Findings Our findings suggested that 8000 individuals were murdered in the greater Port-au-Prince area during the 22-month period assessed. Almost half of the identified perpetrators were government forces or outside political actors. Sexual assault of women and girls was common, with findings suggesting that 3 5 000 women were victimised in the area; more than half of all female victims were younger than 18 years. Criminals were the most identified perpetrators, but officers from the Haitian National Police accounted for 13.8% and armed anti-Lavalas groups accounted for 10.6% of identified perpetrators of sexual assault. Kidnappings and extrajudicial detentions, physical assaults, death threats, physical threats, and threats of sexual violence were also common. Interpretation Our results indicate that crime and systematic abuse of human rights were common in Port-au-Prince. Although criminals were the most identified perpetrators of violations, political actors and UN soldiers were also frequently identified. These findings suggest the need for a systematic response from the newly elected Haitian government, the UN, and social service organisations to address the legal, medical, psychological, and economic consequences of widespread human rights abuses and crime.	Wayne State Univ, Sch Social Work, Detroit, MI USA	Wayne State University	Hutson, RA (corresponding author), Wayne State Univ, Sch Social Work, Thompson Home,4756 Cass Ave, Detroit, MI USA.	roycehutson@wayne.edu	Kolbe, Athena/AAZ-6768-2021	Kolbe, Athena R./0000-0002-4170-8262; Hutson, Royce/0000-0001-6887-0027				*AMN INT, PERP AB THREAT HUM R; *AMN INT, 2004, BREAK CYCL VIOL LAST; [Anonymous], HUM RIGHTS WATCH WOR; [Anonymous], RESTAVEK CHILD DOMES; BENDER B, 2004, BOSTON GLOBE BO 1023, P8; *BRIT BROADC CORP, BRAZ REP UN TROOPS A; BUNCOMBE A, 2005, INDEPENDENT LON 0729, P33; BUNCOMBE A, 2005, INDEPENDENT LON 0730, P30; Copelon Rhonda, 1995, WOMENS RIGHTS HUMAN, P197; DeSanty J. A., 2001, Northern Journal of Applied Forestry, V18, P42; Dueck J., 2001, HURIDOCS EVENTS STAN; DUFF L, 2004, CENSORED 2005 TOP 25, P272; DUFF L, 2005, CENSORED 2006 TOP 22, P368; Dupuy A, 2005, J LAT AM CARIBB ANTH, V10, P186, DOI 10.1525/jlat.2005.10.1.186; Griffin Thomas M., 2004, HAITI HUMAN RIGHTS I; *HUM RIGHTS WATCH, HAIT REC SOLD PAR MA; *I HAIT STAT INF, 2003, REC GEN POP HAB AOUT; LINDSAY R, 2004, TORONTO STAR TO 1107, P2; LUNDE D, 1992, TORTURE ITS CONSEQUE, P310; Perry B, 2000, SOC SCI MED, V50, P1177, DOI 10.1016/S0277-9536(99)00364-0; Putnam FW, 2003, J AM ACAD CHILD PSY, V42, P269, DOI 10.1097/00004583-200303000-00006; Roberts L, 2004, LANCET, V364, P1857, DOI 10.1016/S0140-6736(04)17441-2; SOMERFELT T, 2002, CHILD DOMESTIC LABOR; *US STAT DEP, COUNTR REP HUM RIGHT	24	63	64	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 2	2006	368	9538					864	873		10.1016/S0140-6736(06)69211-8	http://dx.doi.org/10.1016/S0140-6736(06)69211-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	082FD	16950364				2022-12-28	WOS:000240371200034
J	Thompson, RH				Thompson, R. Houston			Radical nephrectomy: too radical for small renal masses?	LANCET			English	Editorial Material							NEPHRON-SPARING SURGERY; CELL CARCINOMA; EXPERIENCE; TUMORS		Mayo Clin, Dept Urol, Rochester, MN 55905 USA	Mayo Clinic	Thompson, RH (corresponding author), Mayo Clin, Dept Urol, Rochester, MN 55905 USA.	Thompson.robert@mayo.edu						Becker F, 2006, EUR UROL, V49, P308, DOI 10.1016/j.eururo.2005.10.020; Gill IS, 2003, J UROLOGY, V170, P64, DOI 10.1097/01.ju.0000072272.02322.ff; Huang WC, 2006, LANCET ONCOL, V7, P735, DOI 10.1016/S1470-2045(06)70803-8; Lau WKO, 2000, MAYO CLIN PROC, V75, P1236; Leibovich BC, 2004, J UROLOGY, V171, P1066, DOI 10.1097/01.ju.0000113274.40885.db; Miller DC, 2006, J UROLOGY, V175, P853, DOI 10.1016/S0022-5347(05)00422-2; NOVICK AC, 1989, J UROLOGY, V141, P835, DOI 10.1016/S0022-5347(17)41026-3; Nuttall M, 2005, BJU INT, V96, P58, DOI 10.1111/j.1464-410X.2005.05567.x; Patard JJ, 2004, J UROLOGY, V171, P2181, DOI 10.1097/01.ju.0000124846.37299.5e; ROBSON CJ, 1969, J UROLOGY, V101, P297, DOI 10.1016/S0022-5347(17)62331-0; Russo P, 2000, SEMIN ONCOL, V27, P160; Thompson RH, 2005, J UROLOGY, V174, P855, DOI 10.1097/01.ju.0000169453.29706.42; ZINCKE H, 1985, MAYO CLIN PROC, V60, P651, DOI 10.1016/S0025-6196(12)60739-3	13	12	12	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 2	2006	368	9538					823	824		10.1016/S0140-6736(06)69302-1	http://dx.doi.org/10.1016/S0140-6736(06)69302-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	082FD	16950341				2022-12-28	WOS:000240371200007
J	Eisenstein, M				Eisenstein, Michael			Quality control	NATURE			English	Article																			0	30	31	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 31	2006	442	7106					1067	1070		10.1038/4421067a	http://dx.doi.org/10.1038/4421067a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	078YF	16943838	Bronze			2022-12-28	WOS:000240142000056
J	Gewin, V				Gewin, Virginia			Nanotech's big issue	NATURE			English	News Item								Lack of regulation and risk assessment could hamper the nanotechnology sector. As nanotechnological products start to reach the market place, concerns are being raised about the potential risk to health if the nanoparticles are inhaled or ingested. Companies have had to act on their own initiative because there are no regulations anywhere in the world to govern nanotech-related products. The greatest concern focuses on nano-sized particles used in consumer products, such as cosmetics or mineral supplements.										Brumfiel G, 2006, NATURE, V440, P262, DOI 10.1038/440262a	1	16	16	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2006	443	7108					137	137		10.1038/443137a	http://dx.doi.org/10.1038/443137a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16607694	Bronze			2022-12-28	WOS:000240467000013
